Citrus Sinensis ID: 011234

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490
Protein Sequence
MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccEEEEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHccccccccccHHHHHHHHcccccccccccccccEEEEEEEccccccccccccccEEEEEEccccccccHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHccHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEcccccccccccccHcccccccccccccccHHHHHHHHEEEEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHccccccccEEcHHHHHHHHccccHccccccccccEEEEEEEcccccccccccccEEEEEEEcccccccccHHHHHHHHHHHHHHcccHEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEcccccccccccccccEEEEEEEcccccccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHccccccccccHHHHHHHHHHHHHHHcccHcHcccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
mglspesvkvknwevnnsdnnnnsksrkvkkkkdggaeqeeeeEIGCWVRFRFiescmpsrskvdssmsgtstnydgkssnekrrdrpvvpvsstttsnaesasstpkfSEELKVASQLRKFMFNDLKlatrnfrpesllgeggfgcvfkgwveengtapvkpgtgLTVAVKTLNHDGLQGHKEWLAEVNFlgnllhpnLVKLVGYcieddqrllvyefmprgslenhlfrkgslplpwsIRMKIALGAAKGLAFLheeaekpviyrdfktsnilldadynaklsdfglakdapedgkthvstrvmgtygyaapeyvmtghltsksdVYSFGVVLLEMLTgrrsmdknrpngehnlvewarphlgdkrrfyrlldprleghfsikgsQKATQLAAQClsrdpkarprMSEVVETLKplqnlkdmassSYYFQTmqadntwsirnskngirtqggfmtrngqplrtlshpngphaspyrhpqqspkpngkq
Flexible Loop (DISEMBL)
mglspesvkvknwevnnsdnnnnsksrkvkkkkdggaeqeeeeeigcwvrFRFIESCMpsrskvdssmsgtstnydgkssnekrrdrpvvpvsstttsnaesasstpkfsEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFglakdapedgkthvstrVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTgrrsmdknrpngehnlvewarphlgdkRRFYRLLDPRLEGHfsikgsqkaTQLAAQCLsrdpkarprMSEVVEtlkplqnlkDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGphaspyrhpqqspkpngkq
Low Complexity Region (SEG)
MGLSPESVKvknwevnnsdnnnnsksrkvkkkkDGGAeqeeeeeIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVsstttsnaesasstPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Disordered region (IsUnstruct)
********************************************IGCWVRFRFIESC************************************************************QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD*****KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG*************NLVEWARPHLGDKRRFYRLLDPRLEGHFSI********************************************YYFQTMQADNTWSI************************************************
Disordered Region (DISOPRED)
*********************************************GCWVRFRFIE****************************************************************RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL************************************************************************
Disordered Region (DISEMBL)
MGLSPESVKVKNWEVNNSDNNNN********************EIGCWVRFRFIESCM*****************************************************ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK************************EVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGP******************
Disordered Region (DISPRO)
**LSPESVKVKNWEVNNSDNNNNSK*R**********EQEEEEEIGCWVRFRFIESCMPS*******************************************************ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL*********************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	490	2.2.26 [Sep-21-2011]
Q9LFP7	493	Probable receptor-like pr	yes	no	0.973	0.967	0.766	0.0
Q9SRH7	490	Receptor-like serine/thre	no	no	0.912	0.912	0.784	0.0
Q06548	410	Protein kinase APK1A, chl	no	no	0.716	0.856	0.591	1e-125
Q8GXZ3	410	Serine/threonine-protein	no	no	0.648	0.775	0.664	1e-124
P46573	412	Protein kinase APK1B, chl	no	no	0.648	0.771	0.644	1e-123
P43293	389	Probable serine/threonine	no	no	0.663	0.835	0.621	1e-123
O49840	426	Protein kinase 2B, chloro	no	no	0.744	0.856	0.592	1e-121
O48814	395	Serine/threonine-protein	no	no	0.714	0.886	0.566	1e-119
O49839	426	Protein kinase 2A, chloro	no	no	0.630	0.725	0.629	1e-116
Q8H186	389	Probable receptor-like pr	no	no	0.628	0.791	0.602	1e-113

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 384/501 (76%), Positives = 415/501 (82%), Gaps = 24/501 (4%)

Query: 1   MGLSPESVKVK-NW--EVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESC 57
           MGL  ++VK K NW  E      N N K +     K    E+EE E  GCWV+FRF+  C
Sbjct: 1   MGL--DAVKAKGNWKSEKPKETENKNHKKKNGDDNKSRNEEEEEGEASGCWVKFRFMIGC 58

Query: 58  MPSRSKVDSSMSG------TSTNYDGKSSNEKRRDRPVVPVSSTTT-SNAESASSTPKFS 110
           +PS+S +D+S S       T T  + KS+NEK  D+PV  VSSTTT SNAES+SSTP  S
Sbjct: 59  IPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVIS 118

Query: 111 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
           EEL ++S LRKF FNDLKL+TRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVA
Sbjct: 119 EELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVA 178

Query: 171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 230
           VKTLN DGLQGHKEWLAE+NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF
Sbjct: 179 VKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 238

Query: 231 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
           R+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 239 RR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLA 297

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           KDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP
Sbjct: 298 KDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 357

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
           NGEHNLVEWARPHL DKRRFYRLLDPRLEGHFSIKG+QK TQLAAQCLSRDPK RP+MS+
Sbjct: 358 NGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSD 417

Query: 411 VVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQ---PLRTLS 467
           VVE LKPL +LKDMASSSYYFQTMQA+        KNG     GF +RNGQ     RTLS
Sbjct: 418 VVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSRNGQHQPVFRTLS 471

Query: 468 HPNGPHASPYRHPQQSPKPNG 488
            P+G  +SPYRH   SPKP G
Sbjct: 472 SPHG--SSPYRHQIPSPKPKG 490

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  712 bits (1839), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/455 (78%), Positives = 394/455 (86%), Gaps = 8/455 (1%)

Query: 37  AEQEEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTT 96
           +E  EEE  GCWV+FR+I  C  S S V++S++ +++    +S+  +  D+PV PVSSTT
Sbjct: 38  SEHYEEEANGCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTT 97

Query: 97  T-SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEE 155
           T SNAES+ STP  SEEL + S L+KF F DLKLATRNFRPESLLGEGGFGCVFKGWVEE
Sbjct: 98  TTSNAESSLSTPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEE 157

Query: 156 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL 215
           NGTAPVKPGTGLTVAVKTLN DGLQGHKEWLAE+N+LGNLLHPNLVKLVGYCIEDDQRLL
Sbjct: 158 NGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLL 217

Query: 216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 275
           VYEFMPRGSLENHLFR+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNIL
Sbjct: 218 VYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNIL 276

Query: 276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
           LD +YNAKLSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL
Sbjct: 277 LDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 336

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
           LEMLTGRRSMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFS+KG+QK TQLAA
Sbjct: 337 LEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAA 396

Query: 396 QCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGF 455
           QCLSRD K RP+MSEVVE LKPL +LKDMAS+SYYFQTMQA+       + +G  +  GF
Sbjct: 397 QCLSRDSKIRPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERL----KAGSGSGSGRGF 452

Query: 456 MTRNGQPL-RTLSHPNG-PHASPYRHPQQSPKPNG 488
            +RNGQP+ RTLS P+G   +SPYRH   SPKP G
Sbjct: 453 GSRNGQPVFRTLSSPHGQAGSSPYRHQIPSPKPKG 487

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  448 bits (1153), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 217/367 (59%), Positives = 278/367 (75%), Gaps = 16/367 (4%)

Query: 57  CMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVA 116
           C+ ++ K +SS  G ST YD K              S  + +++ S   +P+   E+  +
Sbjct: 4   CLSAQVKAESS--GASTKYDAKDIG-----------SLGSKASSVSVRPSPRTEGEILQS 50

Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
             L+ F F +LK ATRNFRP+S+LGEGGFGCVFKGW++E      +PGTGL +AVK LN 
Sbjct: 51  PNLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQ 110

Query: 177 DGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL- 235
           DG QGH+EWLAEVN+LG   H +LVKL+GYC+ED+ RLLVYEFMPRGSLENHLFR+G   
Sbjct: 111 DGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYF 170

Query: 236 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W +R+K+ALGAAKGLAFLH  +E  VIYRDFKTSNILLD++YNAKLSDFGLAKD P
Sbjct: 171 QPLSWKLRLKVALGAAKGLAFLHS-SETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGP 229

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              K+HVSTRVMGT+GYAAPEY+ TGHLT+KSDVYSFGVVLLE+L+GRR++DKNRP+GE 
Sbjct: 230 IGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGER 289

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
           NLVEWA+P+L +KR+ +R++D RL+  +S++ + K   L+ +CL+ + K RP MSEVV  
Sbjct: 290 NLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSH 349

Query: 415 LKPLQNL 421
           L+ +Q+L
Sbjct: 350 LEHIQSL 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  445 bits (1144), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 216/325 (66%), Positives = 260/325 (80%), Gaps = 7/325 (2%)

Query: 102 SASSTPKFSEELKVA---SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 158
           S  STP+F ++ +     +Q+  F   +L+  T++FRP+ +LGEGGFG V+KG++++N  
Sbjct: 34  SDPSTPRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLR 93

Query: 159 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 218
             +K    L VAVK LN +GLQGH+EWL EVNFLG L HPNLVKL+GYC EDD RLLVYE
Sbjct: 94  VGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE 150

Query: 219 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           FM RGSLENHLFRK + PL WS RM IALGAAKGLAFLH  AE+PVIYRDFKTSNILLD+
Sbjct: 151 FMLRGSLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDS 209

Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           DY AKLSDFGLAK  P+  +THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEM
Sbjct: 210 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEM 269

Query: 339 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
           LTGR+S+DK RP+ E NLV+WARP L DKR+  +++DPRLE  +S++ +QKA  LA  CL
Sbjct: 270 LTGRKSVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCL 329

Query: 399 SRDPKARPRMSEVVETLKPLQNLKD 423
           S++PKARP MS+VVETL+PLQ   D
Sbjct: 330 SQNPKARPLMSDVVETLEPLQCTGD 354

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  443 bits (1140), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 207/321 (64%), Positives = 257/321 (80%), Gaps = 3/321 (0%)

Query: 105 STPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 164
           + P+   E+  +  L+ F F +LK ATRNFRP+S+LGEGGFG VFKGW++E      KPG
Sbjct: 40  TNPRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPG 99

Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           TG+ +AVK LN DG QGH+EWLAEVN+LG   HPNLVKL+GYC+ED+ RLLVYEFMPRGS
Sbjct: 100 TGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGS 159

Query: 225 LENHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           LENHLFR+GS   PL W++R+K+ALGAAKGLAFLH  AE  VIYRDFKTSNILLD++YNA
Sbjct: 160 LENHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNA 218

Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           KLSDFGLAKD P   K+HVSTR+MGTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GR
Sbjct: 219 KLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGR 278

Query: 343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 402
           R++DKNRP GE  LVEWARP L +KR+ +R++D RL+  +S++ + K   LA +CL+ + 
Sbjct: 279 RAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEI 338

Query: 403 KARPRMSEVVETLKPLQNLKD 423
           K RP M+EVV  L+ +Q L +
Sbjct: 339 KLRPNMNEVVSHLEHIQTLNE 359

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  442 bits (1138), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 204/328 (62%), Positives = 263/328 (80%), Gaps = 3/328 (0%)

Query: 98  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 157
           S+  S S  P+   E+   + L+ F  ++LK ATRNFRP+S++GEGGFGCVFKGW++E+ 
Sbjct: 32  SSTASFSYMPRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESS 91

Query: 158 TAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY 217
            AP KPGTG+ +AVK LN +G QGH+EWLAE+N+LG L HPNLVKL+GYC+E++ RLLVY
Sbjct: 92  LAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVY 151

Query: 218 EFMPRGSLENHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 275
           EFM RGSLENHLFR+G+   PL W+ R+++ALGAA+GLAFLH  A+  VIYRDFK SNIL
Sbjct: 152 EFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNIL 210

Query: 276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
           LD++YNAKLSDFGLA+D P    +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVL
Sbjct: 211 LDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVL 270

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
           LE+L+GRR++DKN+P GEHNLV+WARP+L +KRR  R++DPRL+G +S+  + K   LA 
Sbjct: 271 LELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLAL 330

Query: 396 QCLSRDPKARPRMSEVVETLKPLQNLKD 423
            C+S D K+RP M+E+V+T++ L   K+
Sbjct: 331 DCISIDAKSRPTMNEIVKTMEELHIQKE 358

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  435 bits (1118), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 218/368 (59%), Positives = 272/368 (73%), Gaps = 3/368 (0%)

Query: 57  CMPSRSKVDSSMSGTSTNYDGKSSNEKRR-DRPVVPVSSTTTSNAESAS-STPKFSEELK 114
           C+ S +KVDSS      N    SS    +  R  VP S +  S +   S  TP+   E+ 
Sbjct: 4   CLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEGEIL 63

Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
            +  L+ F FN+LK ATRNFRP+SLLGEGGFG VFKGW++       KPG+G+ VAVK L
Sbjct: 64  SSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKL 123

Query: 175 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS 234
             +G QGHKEWL EVN+LG L HPNLVKLVGYC+E + RLLVYEFMP+GSLENHLFR+G+
Sbjct: 124 KTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGA 183

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W+IRMK+A+GAAKGL FLH +A+  VIYRDFK +NILLDA++N+KLSDFGLAK  P
Sbjct: 184 QPLTWAIRMKVAIGAAKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGP 242

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
              KTHVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK++   E 
Sbjct: 243 TGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQ 302

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
           +LV+WA P+LGDKR+ +R++D RL G +  KG+  A  LA QCL+ D K RP+MSEV+  
Sbjct: 303 SLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAK 362

Query: 415 LKPLQNLK 422
           L  L++ K
Sbjct: 363 LDQLESTK 370

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  427 bits (1099), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 208/367 (56%), Positives = 267/367 (72%), Gaps = 17/367 (4%)

Query: 56  SCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKV 115
           SC  SR K D   +G S++  G S + ++    V     T     E  SSTP        
Sbjct: 3   SCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVAAAQKT---EGEILSSTP-------- 51

Query: 116 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 175
              ++ F FN+LKLATRNFRP+S++GEGGFGCVFKGW++E+   P KPGTGL +AVK LN
Sbjct: 52  ---VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLN 108

Query: 176 HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL 235
            +G QGH+EWL E+N+LG L HPNLVKL+GYC+ED+ RLLVYEFM +GSLENHLFR+G+ 
Sbjct: 109 QEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAY 168

Query: 236 --PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
             PLPW +R+ +AL AAKGLAFLH +  K VIYRD K SNILLDADYNAKLSDFGLA+D 
Sbjct: 169 FKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGLARDG 227

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P    ++VSTRVMGTYGYAAPEY+ +GHL ++SDVYSFGV+LLE+L+G+R++D NRP  E
Sbjct: 228 PMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKE 287

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            NLV+WARP+L  KR+   ++D RL+  +  + + +   +A QCLS +PK+RP M +VV 
Sbjct: 288 ENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVR 347

Query: 414 TLKPLQN 420
            L+ LQ+
Sbjct: 348 ALQQLQD 354

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  419 bits (1078), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 195/310 (62%), Positives = 247/310 (79%), Gaps = 1/310 (0%)

Query: 112 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 171
           E+  +  L+ F FN+LK AT+NFR ++LLGEGGFGCVFKGW+++      +PG+G+ VAV
Sbjct: 64  EILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAV 123

Query: 172 KTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
           K L  +G QGHKEWL EVN+LG L HPNLV LVGYC E + RLLVYEFMP+GSLENHLFR
Sbjct: 124 KQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFR 183

Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
           +G+ PL W+IRMK+A+GAAKGL FLH EA+  VIYRDFK +NILLDAD+NAKLSDFGLAK
Sbjct: 184 RGAQPLTWAIRMKVAVGAAKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFGLAK 242

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
             P    THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD +   
Sbjct: 243 AGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG 302

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
            E++LV+WA P+LGDKR+ +R++D +L G +  KG+  A  LA QCL+ D K RP+MSEV
Sbjct: 303 NEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEV 362

Query: 412 VETLKPLQNL 421
           + TL+ L+++
Sbjct: 363 LVTLEQLESV 372

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  408 bits (1049), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 188/312 (60%), Positives = 242/312 (77%), Gaps = 4/312 (1%)

Query: 112 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 171
           E+  ++ ++ F FN+LKLATRNFR +S++GEGGFGCVF+GW++E    P K  +GL +AV
Sbjct: 39  EILSSTTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAV 98

Query: 172 KTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
           K LN DG QGH+EWL E+N+LG L HPNLVKL+GYC+ED+QRLLVYEFM +GSLENHLF 
Sbjct: 99  KRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFA 158

Query: 232 KGSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
            G+    PL W +R+K+AL AAKGLAFLH +  K VIYRD K SNILLD+D+NAKLSDFG
Sbjct: 159 NGNKDFKPLSWILRIKVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDSDFNAKLSDFG 217

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
           LA+D P   +++VSTRVMGT+GYAAPEYV TGHL ++SDVYSFGVVLLE+L GR+++D N
Sbjct: 218 LARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHN 277

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
           RP  E NLV+WARP+L  +R+   ++D RL   +  +G+ +   +A QCLS +PK+RP M
Sbjct: 278 RPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTM 337

Query: 409 SEVVETLKPLQN 420
            +VV  L  LQ+
Sbjct: 338 DQVVRALVQLQD 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	490
255552850	479	Protein kinase APK1B, chloroplast precur	0.971	0.993	0.825	0.0
224077698	480	predicted protein [Populus trichocarpa]	0.969	0.989	0.819	0.0
359473277	481	PREDICTED: probable receptor-like protei	0.969	0.987	0.797	0.0
255558222	495	Protein kinase APK1B, chloroplast precur	0.981	0.971	0.785	0.0
147857978	495	hypothetical protein VITISV_008843 [Viti	0.969	0.959	0.773	0.0
359488899	475	PREDICTED: probable receptor-like protei	0.961	0.991	0.791	0.0
356567562	487	PREDICTED: probable receptor-like protei	0.902	0.907	0.841	0.0
356526888	487	PREDICTED: probable receptor-like protei	0.902	0.907	0.837	0.0
449461917	490	PREDICTED: probable receptor-like protei	0.975	0.975	0.768	0.0
351722951	485	serine/threonine protein kinase-like pro	0.910	0.919	0.824	0.0

>gi|255552850|ref|XP_002517468.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223543479|gb|EEF45010.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  816 bits (2107), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/492 (82%), Positives = 433/492 (88%), Gaps = 16/492 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL P+S+KVKN E  +    N               + EEE+EIGCW + R I  CMPS
Sbjct: 1   MGLGPDSLKVKNLEDKSKKKKN--------------KKDEEEKEIGCWPKLRLIGGCMPS 46

Query: 61  RSKVDSSMSGTSTNY-DGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 118
           RSKVD+S+SGT+  Y + KS+ EK +D+PVVPV SSTTTSN ESASSTPKFSEELK+ASQ
Sbjct: 47  RSKVDNSLSGTTAQYVESKSTEEKSKDQPVVPVISSTTTSNGESASSTPKFSEELKLASQ 106

Query: 119 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 178
           LR F FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRIFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDG 166

Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
           LQGHKEWLAEV+FLGNLLHPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP
Sbjct: 167 LQGHKEWLAEVSFLGNLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 226

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           WSIRMKIALGAAKGLAFLHEEAE+ VIYRDFKTSNILLDADYNAKLSDFGLAKD PE GK
Sbjct: 227 WSIRMKIALGAAKGLAFLHEEAERSVIYRDFKTSNILLDADYNAKLSDFGLAKDGPESGK 286

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 287 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 346

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           WARPH GD+RRFYRLLDPRLEGHFSIKG+QKA QLA+QCLSRDPKARPRMSEVVETLKPL
Sbjct: 347 WARPHFGDRRRFYRLLDPRLEGHFSIKGAQKAIQLASQCLSRDPKARPRMSEVVETLKPL 406

Query: 419 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYR 478
            NLKDMASSSYYFQTMQAD   S  ++KNGIRTQ GF+TRNGQPLR+LS  +   ASPY 
Sbjct: 407 PNLKDMASSSYYFQTMQADRNKSNMHTKNGIRTQAGFVTRNGQPLRSLSSLSDTRASPYN 466

Query: 479 HPQQSPKPNGKQ 490
            P QSPKPNGK+
Sbjct: 467 QPYQSPKPNGKK 478

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224077698|ref|XP_002305368.1| predicted protein [Populus trichocarpa] gi|222848332|gb|EEE85879.1| predicted protein [Populus trichocarpa]

 Score =  802 bits (2072), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/492 (81%), Positives = 431/492 (87%), Gaps = 17/492 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGLSP+SVKVKN            +  K KK K     +++EE+IGCW +FR   SCMPS
Sbjct: 1   MGLSPDSVKVKN----------FKEKSKSKKNKKNQGNEKDEEDIGCWFKFRSTGSCMPS 50

Query: 61  RSKVDSSMSGTSTNY-DGKSSNEKRRDRPVVPV--SSTTTSNAESASSTPKFSEELKVAS 117
           RSKVDSS+SG ST+Y   KS NEK +D+P+VP   S+TTTSNAESASS P FSEELK+AS
Sbjct: 51  RSKVDSSLSGISTHYVPSKSKNEKNKDQPIVPAMSSTTTTSNAESASSLPTFSEELKLAS 110

Query: 118 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 177
           QLRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHD
Sbjct: 111 QLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHD 170

Query: 178 GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL 237
           GLQGHKEWLAEV+FLGNLLH NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR+ SLPL
Sbjct: 171 GLQGHKEWLAEVSFLGNLLHKNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPL 229

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
           PWSIRMKIALGAA+GLAFLHEEA++PVIYRDFKTSNILLDADYNAKLSDFGLAKDAP+ G
Sbjct: 230 PWSIRMKIALGAAQGLAFLHEEADRPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDGG 289

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV
Sbjct: 290 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 349

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
           EWARPH GDKRRFYRLLDPRLEGHFSIKG+QK  QLAAQCLSRDPKARP+MSEVVE LKP
Sbjct: 350 EWARPHFGDKRRFYRLLDPRLEGHFSIKGAQKGIQLAAQCLSRDPKARPQMSEVVEALKP 409

Query: 418 LQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPY 477
           L NLKDMASSSYYFQ+MQAD   S  N+KNG RTQ GF+TRNGQPLR+LS      ASPY
Sbjct: 410 LPNLKDMASSSYYFQSMQADRNKSNMNAKNGTRTQAGFVTRNGQPLRSLSD---VRASPY 466

Query: 478 RHPQQSPKPNGK 489
             PQQSPKP G+
Sbjct: 467 NQPQQSPKPKGR 478

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473277|ref|XP_003631281.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera] gi|296086431|emb|CBI32020.3| unnamed protein product [Vitis vinifera]

 Score =  800 bits (2067), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/494 (79%), Positives = 432/494 (87%), Gaps = 19/494 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL    VKV++WEV  S         K +KKKDGG    EEE   CWV+ RF+ SC+ S
Sbjct: 1   MGLGGNDVKVESWEVGKS---------KGRKKKDGG----EEETGCCWVKLRFMASCISS 47

Query: 61  RSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQL 119
           RSKVDSS+SGTST+Y+ +S+N+  RD+PV PV SSTTTSNAES SST K  EELKVAS+L
Sbjct: 48  RSKVDSSISGTSTHYENRSTNDTSRDQPVAPVVSSTTTSNAESNSSTSKLEEELKVASRL 107

Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 179
           RKF FNDLK+ATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLTVAVKTLNHDGL
Sbjct: 108 RKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNHDGL 167

Query: 180 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
           QGHKEWLAEVNFLG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFR+ +LPLPW
Sbjct: 168 QGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-ALPLPW 226

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
           +IRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKLSDFGLAKD PE  KT
Sbjct: 227 AIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLSDFGLAKDGPEGDKT 286

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
           HVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW
Sbjct: 287 HVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 346

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
           ARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPK RP MSEVVE LKPL 
Sbjct: 347 ARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVRPLMSEVVEALKPLP 406

Query: 420 NLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNG-QPLRTLSHPNGPHASPY- 477
           NLKDMASSSYYFQTMQA+   S  N++NG+RTQ G ++RNG Q  R+LS PNG HASPY 
Sbjct: 407 NLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQRSLSIPNGSHASPYH 466

Query: 478 --RHPQQSPKPNGK 489
             ++P QSPKPNGK
Sbjct: 467 QNQYPYQSPKPNGK 480

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558222|ref|XP_002520138.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540630|gb|EEF42193.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  790 bits (2041), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 396/504 (78%), Positives = 428/504 (84%), Gaps = 23/504 (4%)

Query: 1   MGLSPES---VKVKNWEVNNSDNNNNSKSRKVKKKKD-----GGA---EQEEEEEIGCWV 49
           MGL  E     K  +WEV      N       KKK+D     GGA   +  EE E GCW 
Sbjct: 1   MGLGSEDGNRAKASSWEVCKPKGRN-------KKKQDVSNSSGGASPGDVVEEAETGCWF 53

Query: 50  RFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVP-VSSTTTSNAESASSTPK 108
           +FRFI SC+ SRSKVDSS+SGTST+ + KS+N+  RD+P  P +SSTTTSNAES SST K
Sbjct: 54  KFRFIGSCISSRSKVDSSVSGTSTHCESKSTNDTSRDQPTAPTISSTTTSNAESNSSTSK 113

Query: 109 FSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT 168
             EELK+AS+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGTGLT
Sbjct: 114 LEEELKIASRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLT 173

Query: 169 VAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH 228
           VAVKTLNHDGLQGHKEWLAEVN+LG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSLENH
Sbjct: 174 VAVKTLNHDGLQGHKEWLAEVNYLGDLVHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENH 233

Query: 229 LFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
           LFR+ SLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDADYNAKLSDFG
Sbjct: 234 LFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFG 292

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
           LAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEM+TGRRSMDKN
Sbjct: 293 LAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMITGRRSMDKN 352

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
           RP GEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPKARP M
Sbjct: 353 RPIGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKARPLM 412

Query: 409 SEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSH 468
           SEVVE LKPL NLKDMASSSYYFQ+MQAD   S  N+K+  RTQGG + RNGQ  R+LS 
Sbjct: 413 SEVVEVLKPLPNLKDMASSSYYFQSMQADKIASSPNAKSSNRTQGGLL-RNGQQQRSLSI 471

Query: 469 PNGPHASPYRH--PQQSPKPNGKQ 490
           PNG HASPY H  P QSPKPNGKQ
Sbjct: 472 PNGSHASPYHHQYPFQSPKPNGKQ 495

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147857978|emb|CAN82516.1| hypothetical protein VITISV_008843 [Vitis vinifera]

 Score =  781 bits (2016), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/508 (77%), Positives = 428/508 (84%), Gaps = 33/508 (6%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL    VKV++WEV  S         K +KKKDGG    EEE   CWV+ RF+ SC+ S
Sbjct: 1   MGLGGNDVKVESWEVGKS---------KGRKKKDGG----EEETGCCWVKLRFMASCISS 47

Query: 61  RSKVDSSMSGTSTNYDGKSSNEKR--------------RDRPVVPV-SSTTTSNAESASS 105
           RSKVDSS+SGTST+YD     +                RD+PV PV SSTTTSNAES SS
Sbjct: 48  RSKVDSSISGTSTHYDLGVXFDVEPRSLNVFWCDFGLCRDQPVAPVVSSTTTSNAESNSS 107

Query: 106 TPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 165
           T K  EELKVAS+LRKF FNDLK+ATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGT
Sbjct: 108 TSKLEEELKVASRLRKFSFNDLKMATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 167

Query: 166 GLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 225
           GLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKL+GYCIEDDQRLLVYEFMPRGSL
Sbjct: 168 GLTVAVKTLNHDGLQGHKEWLAEVNFLGDLIHPNLVKLIGYCIEDDQRLLVYEFMPRGSL 227

Query: 226 ENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
           ENHLFR+ +LPLPW+IRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAKLS
Sbjct: 228 ENHLFRR-ALPLPWAIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAKLS 286

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           DFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRRSM
Sbjct: 287 DFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRRSM 346

Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           DKNRPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA QLAA CLSRDPK R
Sbjct: 347 DKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAQLAAHCLSRDPKVR 406

Query: 406 PRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNG-QPLR 464
           P MSEVVE LKPL NLKDMASSSYYFQTMQA+   S  N++NG+RTQ G ++RNG Q  R
Sbjct: 407 PLMSEVVEALKPLPNLKDMASSSYYFQTMQAERIGSSPNARNGVRTQQGILSRNGHQQQR 466

Query: 465 TLSHPNGPHASPY---RHPQQSPKPNGK 489
           +LS PNG HASPY   ++P QSPKPNGK
Sbjct: 467 SLSIPNGSHASPYHQNQYPYQSPKPNGK 494

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488899|ref|XP_003633841.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Vitis vinifera]

 Score =  775 bits (2001), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 388/490 (79%), Positives = 424/490 (86%), Gaps = 19/490 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL P++++V NWEV NS         K +KKKD     +EEE  GCW++FRF+ SCM +
Sbjct: 1   MGLGPDAIQVGNWEVGNS---------KGRKKKD-----DEEEATGCWIKFRFMGSCMSA 46

Query: 61  RSKVDSSMSGTSTNY-DGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFSEELKVASQ 118
           RSKV+SS+S +ST Y + KS+N+  RD+PV PV SS+TTSN ES  STP   EELKVASQ
Sbjct: 47  RSKVESSVSSSSTQYAESKSTNDTSRDQPVAPVVSSSTTSNGESTPSTPNTGEELKVASQ 106

Query: 119 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 178
           LRKF FN+LK ATRNFRPESLLGEGGFGCVFKGW+   GT PVKPGTGLTVAVKTLNHDG
Sbjct: 107 LRKFTFNELKSATRNFRPESLLGEGGFGCVFKGWINGTGTTPVKPGTGLTVAVKTLNHDG 166

Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
           LQGHKEWLAEVNFLG+LLHPNLVKL+GYCIEDDQRLLVYEFMPRGSLENHLFR+ +LPLP
Sbjct: 167 LQGHKEWLAEVNFLGDLLHPNLVKLIGYCIEDDQRLLVYEFMPRGSLENHLFRR-ALPLP 225

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           WSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLD DYNAKLSDFGLAKD PE  K
Sbjct: 226 WSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDVDYNAKLSDFGLAKDGPEGDK 285

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE
Sbjct: 286 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 345

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           WARPHLG++RRFYRLLDPRLEG FSIKG+QKA QLAA CLSRDPKARP MSEVVE LKPL
Sbjct: 346 WARPHLGERRRFYRLLDPRLEGRFSIKGAQKAAQLAAHCLSRDPKARPLMSEVVEALKPL 405

Query: 419 QNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYR 478
            NLKDMASSS +FQTMQA+ T S  NS++GIR Q GF++RNGQP R+LS PNGPHASPY 
Sbjct: 406 PNLKDMASSSSFFQTMQAERTGSTPNSRSGIRAQAGFLSRNGQPNRSLSMPNGPHASPYN 465

Query: 479 H--PQQSPKP 486
           H  P +SPKP
Sbjct: 466 HNNPHRSPKP 475

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567562|ref|XP_003551987.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  773 bits (1995), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/448 (84%), Positives = 405/448 (90%), Gaps = 6/448 (1%)

Query: 46  GCWVRFRFIESCMPSRSKVDSSMSGTSTNY-DGKSSNEKRRDRPVVPV-SSTTTSNAESA 103
           GCW R RFI SC+ SRSKVDSS+SGTSTNY + KS+ +  RD+P VPV SSTTTSNAES 
Sbjct: 41  GCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTVPVVSSTTTSNAESN 100

Query: 104 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 163
           SST K  EE KV+S+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 101 SSTSKLEEEFKVSSRLRKFTFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160

Query: 164 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 223
           GTGLTVAVKTLNHDGLQGHKEWLAEVN+LG+L+HP+LVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRG 220

Query: 224 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           SLENHLFR+ SLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YNAK
Sbjct: 221 SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNAK 279

Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           LSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRR
Sbjct: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339

Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
           SMDKNRPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFSIKG+QKA  LAA CLSRDPK
Sbjct: 340 SMDKNRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPK 399

Query: 404 ARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL 463
           ARP MSEVVE LKPL NLKDMASSSYYFQTMQAD   +  N++NG RTQG  +TRNGQ  
Sbjct: 400 ARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSASPNTRNG-RTQGALLTRNGQQQ 458

Query: 464 RTLSHPNGPHASPYRH--PQQSPKPNGK 489
           R+LS P+G HASPY H  PQ SPKPNGK
Sbjct: 459 RSLSIPHGTHASPYHHQFPQPSPKPNGK 486

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356526888|ref|XP_003532048.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  767 bits (1981), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/448 (83%), Positives = 404/448 (90%), Gaps = 6/448 (1%)

Query: 46  GCWVRFRFIESCMPSRSKVDSSMSGTSTNY-DGKSSNEKRRDRPVV-PVSSTTTSNAESA 103
           GCW R RFI SC+ SRSKVDSS+SGTSTNY + KS+ +  RD+P +  VSSTTTSNAES 
Sbjct: 41  GCWFRLRFIGSCISSRSKVDSSVSGTSTNYAESKSTIDTSRDQPTLRVVSSTTTSNAESN 100

Query: 104 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 163
           SST K  EELKVAS+LRKF FNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKP
Sbjct: 101 SSTSKLEEELKVASRLRKFAFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKP 160

Query: 164 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 223
           GTGLTVAVKTLNHDGLQGHKEWLAEVN+LG+L+HP+LVKL+GYCIEDDQRLLVYEFMPRG
Sbjct: 161 GTGLTVAVKTLNHDGLQGHKEWLAEVNYLGDLVHPHLVKLIGYCIEDDQRLLVYEFMPRG 220

Query: 224 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           SLENHLFR+ SLPLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDA+YN+K
Sbjct: 221 SLENHLFRR-SLPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDAEYNSK 279

Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           LSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTS+SDVYSFGVVLLEMLTGRR
Sbjct: 280 LSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYSFGVVLLEMLTGRR 339

Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
           SMDKNRPNGEHNLVEWARPHLG++RRFY+L+DPRLEGHFSIKG+QKA  LAA CLSRDPK
Sbjct: 340 SMDKNRPNGEHNLVEWARPHLGERRRFYKLIDPRLEGHFSIKGAQKAAHLAAHCLSRDPK 399

Query: 404 ARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL 463
           ARP MSEVVE LKPL NLKDMASSSYYFQTMQAD      N++NG RTQG  +TRNGQ  
Sbjct: 400 ARPLMSEVVEALKPLPNLKDMASSSYYFQTMQADRFSVSPNTRNG-RTQGALLTRNGQQQ 458

Query: 464 RTLSHPNGPHASPYRH--PQQSPKPNGK 489
           R+LS P+G HASPY H  PQ SPKPNGK
Sbjct: 459 RSLSIPHGTHASPYHHQFPQPSPKPNGK 486

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461917|ref|XP_004148688.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus] gi|449505857|ref|XP_004162587.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Cucumis sativus]

 Score =  765 bits (1975), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/497 (76%), Positives = 416/497 (83%), Gaps = 19/497 (3%)

Query: 1   MGLSPESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPS 60
           MGL+P   KV+ W    S         +   +K    E E EEE GCWV+ +FI SC+PS
Sbjct: 1   MGLAPNDSKVETWIEGKS---------RTASEKKKKKENELEEETGCWVKLKFIGSCIPS 51

Query: 61  RSKVDSSMSG---------TSTNYDGKSSNEKRRDRPVVPV-SSTTTSNAESASSTPKFS 110
           RSKVDSS+SG         TST+ D KS  +++RD     + SS TT NAES+SSTPK S
Sbjct: 52  RSKVDSSLSGSKVDSFISGTSTHCDSKSKLDEKRDILATALGSSATTDNAESSSSTPKLS 111

Query: 111 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
            ELKVAS+LRKF FN+LKLATRNFRPESLLGEGGFGCVFKGW+EENGTAP KPGTGLTVA
Sbjct: 112 AELKVASRLRKFTFNELKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPAKPGTGLTVA 171

Query: 171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 230
           VKTLNHDGLQGHKEW+AEVNFLG+L H NLV+L+G CIEDDQRLLVYEFMPRGSLENHLF
Sbjct: 172 VKTLNHDGLQGHKEWMAEVNFLGDLNHSNLVRLIGCCIEDDQRLLVYEFMPRGSLENHLF 231

Query: 231 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
           RKG LPLPWSIR+KIALGAAKGLAFLHEEAE+PVIYRDFKTSNILLDADYNAKLSDFGLA
Sbjct: 232 RKGPLPLPWSIRLKIALGAAKGLAFLHEEAERPVIYRDFKTSNILLDADYNAKLSDFGLA 291

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           KD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP
Sbjct: 292 KDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 351

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
           NGEHNLVEWARP LGDKR+FYRL+DPRLE HFSIKG+QKA +LAA CLSRDPKARP MSE
Sbjct: 352 NGEHNLVEWARPLLGDKRKFYRLIDPRLECHFSIKGAQKAAELAAHCLSRDPKARPPMSE 411

Query: 411 VVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPN 470
           VVE LKPL NLKDMASSSYYFQTMQAD   S  N+K+ +RTQ  F+ RNGQ +R+LS PN
Sbjct: 412 VVEILKPLPNLKDMASSSYYFQTMQADRARSTPNAKSVVRTQSMFVARNGQHIRSLSSPN 471

Query: 471 GPHASPYRHPQQSPKPN 487
           GPHASPY HP QSPKP+
Sbjct: 472 GPHASPYNHPNQSPKPD 488

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351722951|ref|NP_001235470.1| serine/threonine protein kinase-like protein [Glycine max] gi|223452506|gb|ACM89580.1| serine/threonine protein kinase-like protein [Glycine max]

 Score =  763 bits (1969), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 375/455 (82%), Positives = 407/455 (89%), Gaps = 9/455 (1%)

Query: 42  EEEIGCWVRFRFIESCMPSRSKVDSSMSG--TSTNY-DGKSSNEKRRDRPVVP-VSSTTT 97
           E E GCWVR RFI SC+ SRSKVD+S+SG  TST+Y + KS+N+  RD+P  P VSSTTT
Sbjct: 32  EAEAGCWVRLRFIGSCISSRSKVDTSVSGSGTSTHYAESKSTNDTSRDQPTAPAVSSTTT 91

Query: 98  SNAES-ASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 156
           SNAES +SST K  EELK+AS+LRKF FN+LKLATRNFRPES LGEGGFGCVFKGW+EEN
Sbjct: 92  SNAESNSSSTSKLEEELKIASRLRKFSFNELKLATRNFRPESFLGEGGFGCVFKGWIEEN 151

Query: 157 GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV 216
           GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG+L+HPNLVKLVGYCIE+DQRLLV
Sbjct: 152 GTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGDLVHPNLVKLVGYCIEEDQRLLV 211

Query: 217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 276
           YEFMPRGSLENHLFR+ S+PLPWSIRMKIALGAAKGLAFLHEEAE+PVIYRDFKTSNILL
Sbjct: 212 YEFMPRGSLENHLFRR-SIPLPWSIRMKIALGAAKGLAFLHEEAERPVIYRDFKTSNILL 270

Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 336
           DA+YNAKLSDFGLAKD PE  KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL
Sbjct: 271 DAEYNAKLSDFGLAKDGPEGDKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 330

Query: 337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQ 396
           EMLTGRRSMDK+RPNGEHNLVEWARPHLG++RRFYRL+DPRLEGHFS+KG+QKA  LAA 
Sbjct: 331 EMLTGRRSMDKHRPNGEHNLVEWARPHLGERRRFYRLIDPRLEGHFSVKGAQKAALLAAH 390

Query: 397 CLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFM 456
           CLSRDPKARP MSEVVE LKPL NLKDMASSSYYFQ MQAD   +  N++NG R QG  +
Sbjct: 391 CLSRDPKARPLMSEVVEALKPLPNLKDMASSSYYFQAMQADRIGASPNTRNG-RMQGALL 449

Query: 457 TRNGQPLRTLSHPNGPHASPYRH--PQQSPKPNGK 489
           TRNGQ  R+LS PNG +ASPY H  PQ SPKPNGK
Sbjct: 450 TRNGQQQRSLSIPNGTYASPYHHQFPQPSPKPNGK 484

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	490
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.885	0.880	0.783	3.9e-186
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.893	0.893	0.769	1.3e-180
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.885	0.958	0.760	8.1e-179
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.644	0.747	0.648	2.2e-112
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.746	0.859	0.579	4.6e-112
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.673	0.848	0.613	5.9e-112
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.630	0.753	0.670	9.7e-112
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.744	0.856	0.555	4.3e-109
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.714	0.886	0.555	2.7e-107
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.753	0.953	0.526	3.6e-105

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1805 (640.5 bits), Expect = 3.9e-186, P = 3.9e-186
 Identities = 355/453 (78%), Positives = 382/453 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSG------TSTNYDGKSSNEKRRDRPVVPVXXXXXXX 99
             GCWV+FRF+  C+PS+S +D+S S       T T  + KS+NEK  D+PV  V       
Sbjct:    47 GCWVKFRFMIGCIPSKSDLDASSSSIYGSNCTVTTMESKSANEKSNDQPVGQVSSTTTTS 106

Query:   100 XX-XXXXXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 158
                     P  SEEL ++S LRKF FNDLKL+TRNFRPESLLGEGGFGCVFKGW+EENGT
Sbjct:   107 NAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGT 166

Query:   159 APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 218
             APVKPGTGLTVAVKTLN DGLQGHKEWLAE+NFLGNLLHPNLVKLVGYCIEDDQRLLVYE
Sbjct:   167 APVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYE 226

Query:   219 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
             FMPRGSLENHLFR+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLDA
Sbjct:   227 FMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDA 285

Query:   279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
             DYNAKLSDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM
Sbjct:   286 DYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 345

Query:   339 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
             LTGRRSMDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFSIKG+QK TQLAAQCL
Sbjct:   346 LTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCL 405

Query:   399 SRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTR 458
             SRDPK RP+MS+VVE LKPL +LKDMASSSYYFQTMQA+        KNG     GF +R
Sbjct:   406 SRDPKIRPKMSDVVEALKPLPHLKDMASSSYYFQTMQAERL------KNGSGRSQGFGSR 459

Query:   459 NGQ--PL-RTLSHPNGPHASPYRHPQQSPKPNG 488
             NGQ  P+ RTLS P+G  +SPYRH   SPKP G
Sbjct:   460 NGQHQPVFRTLSSPHG--SSPYRHQIPSPKPKG 490

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1753 (622.1 bits), Expect = 1.3e-180, P = 1.3e-180
 Identities = 343/446 (76%), Positives = 377/446 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVXXXXXXXXXXXX- 104
             GCWV+FR+I  C  S S V++S++ +++    +S+  +  D+PV PV             
Sbjct:    47 GCWVKFRYIVCCASSTSDVETSLTLSTSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSL 106

Query:   105 XXPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 164
               P  SEEL + S L+KF F DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG
Sbjct:   107 STPIISEELNIYSHLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG 166

Query:   165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
             TGLTVAVKTLN DGLQGHKEWLAE+N+LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS
Sbjct:   167 TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 226

Query:   225 LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             LENHLFR+ SLPLPWSIRMKIALGAAKGL+FLHEEA KPVIYRDFKTSNILLD +YNAKL
Sbjct:   227 LENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKL 285

Query:   285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             SDFGLAKDAP++GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS
Sbjct:   286 SDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 345

Query:   345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             MDKNRPNGEHNLVEWARPHL DKRRFYRLLDPRLEGHFS+KG+QK TQLAAQCLSRD K 
Sbjct:   346 MDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKI 405

Query:   405 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPL- 463
             RP+MSEVVE LKPL +LKDMAS+SYYFQTMQA+   +   S +G R   GF +RNGQP+ 
Sbjct:   406 RPKMSEVVEVLKPLPHLKDMASASYYFQTMQAERLKAGSGSGSG-R---GFGSRNGQPVF 461

Query:   464 RTLSHPNGPH-ASPYRHPQQSPKPNG 488
             RTLS P+G   +SPYRH   SPKP G
Sbjct:   462 RTLSSPHGQAGSSPYRHQIPSPKPKG 487

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1736 (616.2 bits), Expect = 8.1e-179, P = 8.1e-179
 Identities = 339/446 (76%), Positives = 378/446 (84%)

Query:    46 GCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVXXXXXXXXXXXXX 105
             G W RF+FI SC+ SRSKVDSSM+ T+   + K   EK    P  P              
Sbjct:    18 GFWFRFKFIFSCISSRSKVDSSMNATAVIAEPKKVIEKLEGHPA-PTKDTGCAESGSST- 75

Query:   106 XPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 165
              P  S ELK +S+LR FMFNDLKLATRNFRPESLLGEGGFGCVFKGW+EENGTAPVKPGT
Sbjct:    76 -PLMSGELKYSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGT 134

Query:   166 GLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 225
             GLTVAVKTLN DGLQGHKEWLAE+NFLGNL+HP+LVKLVGYC+E+DQRLLVYEFMPRGSL
Sbjct:   135 GLTVAVKTLNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSL 194

Query:   226 ENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
             ENHLFR+ +LPLPWS+RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD +YNAKLS
Sbjct:   195 ENHLFRR-TLPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLS 253

Query:   286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
             DFGLAKDAP++ K+HVSTRVMGTYGYAAPEYVMTGHLT+KSDVYSFGVVLLE+LTGRRS+
Sbjct:   254 DFGLAKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSV 313

Query:   346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
             DK+RPNGE NLVEW RPHL DK+RFYRLLDPRLEGH+SIKG+QKATQ+AAQCL+RD KAR
Sbjct:   314 DKSRPNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKAR 373

Query:   406 PRMSEVVETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG-FMTRNGQPLR 464
             P+MSEVVE LKPL NLKD ASSS  FQTMQ         +KNG+RTQGG F++RNG P+R
Sbjct:   374 PKMSEVVEALKPLPNLKDFASSSSSFQTMQPV-------AKNGVRTQGGGFVSRNGPPMR 426

Query:   465 TLSHPNGPHASPYRHPQQSPKPNGKQ 490
             +LS  N P ASPYR+ +QSPKP GK+
Sbjct:   427 SLSSLNLPQASPYRYARQSPKPKGKE 452

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1109 (395.4 bits), Expect = 2.2e-112, P = 2.2e-112
 Identities = 207/319 (64%), Positives = 256/319 (80%)

Query:   107 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 166
             P+   E+  +  L+ F F +LK ATRNFRP+S+LGEGGFG VFKGW++E      KPGTG
Sbjct:    53 PRTEGEILQSPNLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTG 112

Query:   167 LTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 226
             + +AVK LN DG QGH+EWLAEVN+LG   HPNLVKL+GYC+ED+ RLLVYEFMPRGSLE
Sbjct:   113 VVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLE 172

Query:   227 NHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             NHLFR+GS   PL W++R+K+ALGAAKGLAFLH  AE  VIYRDFKTSNILLD++YNAKL
Sbjct:   173 NHLFRRGSYFQPLSWTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKL 231

Query:   285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             SDFGLAKD P   K+HVSTR+MGTYGYAAPEY+ TGHLT+KSDVYS+GVVLLE+L+GRR+
Sbjct:   232 SDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRA 291

Query:   345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             +DKNRP GE  LVEWARP L +KR+ +R++D RL+  +S++ + K   LA +CL+ + K 
Sbjct:   292 VDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKL 351

Query:   405 RPRMSEVVETLKPLQNLKD 423
             RP M+EVV  L+ +Q L +
Sbjct:   352 RPNMNEVVSHLEHIQTLNE 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 1106 (394.4 bits), Expect = 4.6e-112, P = 4.6e-112
 Identities = 214/369 (57%), Positives = 267/369 (72%)

Query:    56 SCMPSRSKVDSSMSGTSTNYDGKSSN-EKRRDRPVVPVXXXXXXXXXXXXX-XPKFSEEL 113
             +C+ S +KVDSS      N    SS    +  R  VP                P+   E+
Sbjct:     3 NCLDSSAKVDSSSHSPHANSASLSSRVSSKTSRSTVPSSLSINSYSSVESLPTPRTEGEI 62

Query:   114 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 173
               +  L+ F FN+LK ATRNFRP+SLLGEGGFG VFKGW++       KPG+G+ VAVK 
Sbjct:    63 LSSPNLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKK 122

Query:   174 LNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L  +G QGHKEWL EVN+LG L HPNLVKLVGYC+E + RLLVYEFMP+GSLENHLFR+G
Sbjct:   123 LKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRG 182

Query:   234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
             + PL W+IRMK+A+GAAKGL FLH+ A+  VIYRDFK +NILLDA++N+KLSDFGLAK  
Sbjct:   183 AQPLTWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAG 241

Query:   294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
             P   KTHVST+VMGT+GYAAPEYV TG LT+KSDVYSFGVVLLE+L+GRR++DK++   E
Sbjct:   242 PTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGME 301

Query:   354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              +LV+WA P+LGDKR+ +R++D RL G +  KG+  A  LA QCL+ D K RP+MSEV+ 
Sbjct:   302 QSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLA 361

Query:   414 TLKPLQNLK 422
              L  L++ K
Sbjct:   362 KLDQLESTK 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
 Identities = 205/334 (61%), Positives = 264/334 (79%)

Query:   107 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 166
             P+   E+   + L+ F  ++LK ATRNFRP+S++GEGGFGCVFKGW++E+  AP KPGTG
Sbjct:    41 PRTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTG 100

Query:   167 LTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 226
             + +AVK LN +G QGH+EWLAE+N+LG L HPNLVKL+GYC+E++ RLLVYEFM RGSLE
Sbjct:   101 IVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLE 160

Query:   227 NHLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             NHLFR+G+   PL W+ R+++ALGAA+GLAFLH  A+  VIYRDFK SNILLD++YNAKL
Sbjct:   161 NHLFRRGTFYQPLSWNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKL 219

Query:   285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
             SDFGLA+D P    +HVSTRVMGT GYAAPEY+ TGHL+ KSDVYSFGVVLLE+L+GRR+
Sbjct:   220 SDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRA 279

Query:   345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             +DKN+P GEHNLV+WARP+L +KRR  R++DPRL+G +S+  + K   LA  C+S D K+
Sbjct:   280 IDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKS 339

Query:   405 RPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 438
             RP M+E+V+T++ L   K+ AS       +  DN
Sbjct:   340 RPTMNEIVKTMEELHIQKE-ASKEQQNPQISIDN 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
 Identities = 212/316 (67%), Positives = 256/316 (81%)

Query:   107 PKFSEELKVA---SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 163
             P+F ++ +     +Q+  F   +L+  T++FRP+ +LGEGGFG V+KG++++N    +K 
Sbjct:    39 PRFRDDSRTPISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLK- 97

Query:   164 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 223
                L VAVK LN +GLQGH+EWL EVNFLG L HPNLVKL+GYC EDD RLLVYEFM RG
Sbjct:    98 --SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRG 155

Query:   224 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
             SLENHLFRK + PL WS RM IALGAAKGLAFLH  AE+PVIYRDFKTSNILLD+DY AK
Sbjct:   156 SLENHLFRKTTAPLSWSRRMMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAK 214

Query:   284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
             LSDFGLAK  P+  +THVSTRVMGTYGYAAPEYVMTGHLT++SDVYSFGVVLLEMLTGR+
Sbjct:   215 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRK 274

Query:   344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
             S+DK RP+ E NLV+WARP L DKR+  +++DPRLE  +S++ +QKA  LA  CLS++PK
Sbjct:   275 SVDKTRPSKEQNLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 334

Query:   404 ARPRMSEVVETLKPLQ 419
             ARP MS+VVETL+PLQ
Sbjct:   335 ARPLMSDVVETLEPLQ 350

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 1078 (384.5 bits), Expect = 4.3e-109, P = 4.3e-109
 Identities = 206/371 (55%), Positives = 264/371 (71%)

Query:    56 SCMPSRSKVDSSMSGTSTNYDGKSSN-EKRRDRPVVPVXXXXXXXXXXXXXXP----KFS 110
             +C+ S +KVD+S      N     S    +  R   P               P    +  
Sbjct:     3 NCLDSSAKVDNSNHSPHANSASSGSKVSSKTSRSTGPSGLSTTSYSTDSSFGPLPTLRTE 62

Query:   111 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
              E+  +  L+ F FN+LK AT+NFR ++LLGEGGFGCVFKGW+++      +PG+G+ VA
Sbjct:    63 GEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVA 122

Query:   171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF 230
             VK L  +G QGHKEWL EVN+LG L HPNLV LVGYC E + RLLVYEFMP+GSLENHLF
Sbjct:   123 VKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF 182

Query:   231 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
             R+G+ PL W+IRMK+A+GAAKGL FLHE A+  VIYRDFK +NILLDAD+NAKLSDFGLA
Sbjct:   183 RRGAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLA 241

Query:   291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
             K  P    THVST+V+GT+GYAAPEYV TG LT+KSDVYSFGVVLLE+++GRR+MD +  
Sbjct:   242 KAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNG 301

Query:   351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               E++LV+WA P+LGDKR+ +R++D +L G +  KG+  A  LA QCL+ D K RP+MSE
Sbjct:   302 GNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSE 361

Query:   411 VVETLKPLQNL 421
             V+ TL+ L+++
Sbjct:   362 VLVTLEQLESV 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1061 (378.5 bits), Expect = 2.7e-107, P = 2.7e-107
 Identities = 204/367 (55%), Positives = 266/367 (72%)

Query:    56 SCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVXXXXXXXXXXXXXXPKFSEELKV 115
             SC  SR K D   +G S++  G S + ++    V                  K   E+  
Sbjct:     3 SCFSSRVKADIFHNGKSSDLYGLSLSSRKSSSTVA--------------AAQKTEGEILS 48

Query:   116 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 175
             ++ ++ F FN+LKLATRNFRP+S++GEGGFGCVFKGW++E+   P KPGTGL +AVK LN
Sbjct:    49 STPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLN 108

Query:   176 HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL 235
              +G QGH+EWL E+N+LG L HPNLVKL+GYC+ED+ RLLVYEFM +GSLENHLFR+G+ 
Sbjct:   109 QEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAY 168

Query:   236 --PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
               PLPW +R+ +AL AAKGLAFLH +  K VIYRD K SNILLDADYNAKLSDFGLA+D 
Sbjct:   169 FKPLPWFLRVNVALDAAKGLAFLHSDPVK-VIYRDIKASNILLDADYNAKLSDFGLARDG 227

Query:   294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
             P    ++VSTRVMGTYGYAAPEY+ +GHL ++SDVYSFGV+LLE+L+G+R++D NRP  E
Sbjct:   228 PMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKE 287

Query:   354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              NLV+WARP+L  KR+   ++D RL+  +  + + +   +A QCLS +PK+RP M +VV 
Sbjct:   288 ENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVR 347

Query:   414 TLKPLQN 420
              L+ LQ+
Sbjct:   348 ALQQLQD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 1041 (371.5 bits), Expect = 3.6e-105, P = 3.6e-105
 Identities = 198/376 (52%), Positives = 266/376 (70%)

Query:    56 SCMPSRSKVDSSMS--GTSTNYDGKSSNEKRRDRPVVPVXXXXXXXXXX-XXXXPKFSEE 112
             +C+ S ++V +  S  G S+    K +   R     +P                P+   E
Sbjct:     3 NCLDSSARVGNRESTFGGSSRISRKPNQSSRLSSLTIPSYSNNSFTTSSWSNLTPRSEGE 62

Query:   113 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 172
             L  +  L+ F FN+LK ATRNF+P S++GEGGFGCV+KGW+ E   +P KPG+G+ VAVK
Sbjct:    63 LLPSPTLKAFTFNELKTATRNFKPNSMIGEGGFGCVYKGWIGERSLSPSKPGSGMVVAVK 122

Query:   173 TLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK 232
              L  +G QGHKEWL EV++LG L H NLVKL+GYC+E ++RLLVYE+MP+GSLENHLFR+
Sbjct:   123 KLKSEGFQGHKEWLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLFRR 182

Query:   233 GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
             G+ P+PW  RMK+A  AA+GL+FLHE     VIYRDFK SNILLD D+NAKLSDFGLAK 
Sbjct:   183 GAEPIPWKTRMKVAFSAARGLSFLHEAK---VIYRDFKASNILLDVDFNAKLSDFGLAKA 239

Query:   293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
              P   +THV+T+V+GT GYAAPEY+ TG LTSKSDVYSFGVVLLE+L+GR ++DK++   
Sbjct:   240 GPTGDRTHVTTQVIGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGV 299

Query:   353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             E NLV+WA P+L D+R+ +R++D +L G +  KG+  A  +A +CL+ +PK RP M++V+
Sbjct:   300 ERNLVDWAIPYLVDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVL 359

Query:   413 ETLKPLQ-NLKDMASS 427
              TL+ L+ + K M S+
Sbjct:   360 STLQQLETSSKKMGST 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LFP7	Y5158_ARATH	2, ., 7, ., 1, 1, ., 1	0.7664	0.9734	0.9675	yes	no
Q9SRH7	Y3130_ARATH	2, ., 7, ., 1, 1, ., 1	0.7846	0.9122	0.9122	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00028989001 SubName- Full=Chromosome chr1 scaffold_46, whole genome shotgun sequence; (481 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	490
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-57
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-57
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-57
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-55
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-53
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-36
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-32
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-30
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-29
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-28
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-28
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-25
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-24
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-24
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-24
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-22
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-21
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	8e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-19
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-19
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-19
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-18
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	9e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-17
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	6e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-16
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-16
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-16
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-15
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-15
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-15
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-14
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-13
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	6e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	9e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-11
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-06
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	9e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.001

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  190 bits (484), Expect = 3e-57
 Identities = 96/280 (34%), Positives = 138/280 (49%), Gaps = 26/280 (9%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 195
              LGEG FG V+KG ++         G  + VAVKTL  D   Q  +E+L E   +  L
Sbjct: 4   GKKLGEGAFGEVYKGTLK-----GKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HPN+VKL+G C E++  ++V E+MP G L ++L +     L  S  +  AL  A+G+ +
Sbjct: 59  DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           L     K  I+RD    N L+  +   K+SDFGL++D  +D    V         + APE
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPE 174

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +  G  TSKSDV+SFGV+L E+ T         P    +  E    +L   ++ YRL  
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYL---KKGYRLPK 225

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           P            +  +L  QC + DP+ RP  SE+VE L
Sbjct: 226 PP-------NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  189 bits (483), Expect = 4e-57
 Identities = 95/280 (33%), Positives = 134/280 (47%), Gaps = 27/280 (9%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 195
              LGEG FG V+KG ++            + VAVKTL  D   Q  +E+L E   +  L
Sbjct: 4   GKKLGEGAFGEVYKGKLK-----GKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL 58

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HPN+VKL+G C E++   +V E+M  G L ++L RK    L  S  +  AL  A+G+ +
Sbjct: 59  DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEY 117

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           L     K  I+RD    N L+  +   K+SDFGL++D  +D   +          + APE
Sbjct: 118 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD-DYYRKRGGKLPIRWMAPE 173

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +  G  TSKSDV+SFGV+L E+ T         P    +  E    +L   +  YRL  
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYL---KNGYRLPQ 224

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           P            +   L  QC + DP+ RP  SE+VE L
Sbjct: 225 PP-------NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  189 bits (483), Expect = 4e-57
 Identities = 94/285 (32%), Positives = 134/285 (47%), Gaps = 34/285 (11%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 191
           +     LG G FG V+K             GTG  VAVK L       +  +    E+  
Sbjct: 1   YELLRKLGSGSFGTVYKA---------KHKGTGKIVAVKILKKRSEKSKKDQTARREIRI 51

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L  L HPN+V+L+    + D   LV E+   G L ++L R G L      + KIAL   +
Sbjct: 52  LRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS-EDEAK-KIALQILR 109

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL +LH      +I+RD K  NILLD +   K++DFGLAK   +   + ++T V GT  Y
Sbjct: 110 GLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFV-GTPWY 164

Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
            APE ++ G     K DV+S GV+L E+LTG+                     L   +  
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLI 211

Query: 371 YRLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            R+L P LE        GS++A  L  +CL++DP  RP   E+++
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (469), Expect = 1e-55
 Identities = 80/279 (28%), Positives = 119/279 (42%), Gaps = 67/279 (24%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           LGEGGFG V+    ++ G           VA+K +  +      E  L E+  L  L HP
Sbjct: 1   LGEGGFGTVYLARDKKTGK---------KVAIKIIKKEDSSSLLEELLREIEILKKLNHP 51

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VKL G   +++   LV E+   GSL++ L       L     ++I L   +GL +LH 
Sbjct: 52  NIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH- 109

Query: 259 EAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                +I+RD K  NILLD+D    KL+DFGL+K    D        ++GT  Y APE +
Sbjct: 110 --SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVL 165

Query: 318 M-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
           +  G+ + KSD++S GV+L E+                                      
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                       +   L  + L +DP+ RP   E++E L
Sbjct: 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  182 bits (464), Expect = 3e-54
 Identities = 96/283 (33%), Positives = 135/283 (47%), Gaps = 38/283 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG V+KG ++         GT   VAVKTL      +  +E+L E + +  L HP
Sbjct: 7   LGEGAFGEVYKGTLK-----GDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V+L+G C + +   +V E+MP G L + L RK    L     +++AL  AKG+ +L  
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE- 119

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST------RVMGTYGYA 312
              K  ++RD    N L+  +   K+SDFGL++D  ED             + M      
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +  G  TSKSDV+SFGV+L E+ T         P    +  E     L D    YR
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDG---YR 222

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           L  P            +  +L  QC + DP+ RP  SE+VE L
Sbjct: 223 LPRPE-------NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  180 bits (459), Expect = 2e-53
 Identities = 96/295 (32%), Positives = 132/295 (44%), Gaps = 53/295 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHP 198
           LGEG FG V+KG          K G    VAVKTL  D   +  K++L E   +  L HP
Sbjct: 3   LGEGAFGEVYKG------KLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHP 56

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-------FRKGSLPLPWSIRMKIALGAAK 251
           N+V+L+G C E++   LV E+M  G L ++L              L     +  A+  AK
Sbjct: 57  NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTRV 305
           G+ +L     K  ++RD    N L+  D   K+SDFGL++D  +D          +  R 
Sbjct: 117 GMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---HNL-VEWAR 361
           M      APE +  G  TSKSDV+SFGV+L E+ T           G      L  E   
Sbjct: 174 M------APESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVL 217

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            +L   R+ YRL  P            +  +L   C   DP+ RP  SE+VE L+
Sbjct: 218 EYL---RKGYRLPKPEY-------CPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  179 bits (457), Expect = 3e-53
 Identities = 84/282 (29%), Positives = 124/282 (43%), Gaps = 34/282 (12%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 192
           +     LGEG FG V+               TG  VA+K +    ++  +E  L E+  L
Sbjct: 1   YEILEKLGEGSFGKVYLA---------RDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L HPN+V+L     ++D+  LV E+   G L + L ++G L      R          
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSA 109

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L +LH    K +++RD K  NILLD D + KL+DFGLA+      K    T V GT  Y 
Sbjct: 110 LEYLHS---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT--TFV-GTPEYM 163

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFY 371
           APE ++        D++S GV+L E+LTG+       P  G+  L+E  +     K  F 
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKIGKPKPPFP 217

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                          S +A  L  + L +DP+ R    E ++
Sbjct: 218 P---------PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (365), Expect = 6e-40
 Identities = 76/282 (26%), Positives = 124/282 (43%), Gaps = 49/282 (17%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F     +G+GGFG V+K   +          TG  VA+K +  +  +  ++ + E+  L 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILK 52

Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              HPN+VK  G  ++ D+  +V EF   GSL++ L +  +  L  S    +     KGL
Sbjct: 53  KCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGL 111

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      +I+RD K +NILL +D   KL DFGL+     D K   +   +GT  + A
Sbjct: 112 EYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTM--VGTPYWMA 165

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSMDKNRPNGEHNLVEWARPHL 364
           PE +       K+D++S G+  +E+  G+         +++ K   NG            
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG------------ 213

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                   L +P        K S +      +CL ++P+ RP
Sbjct: 214 -----PPGLRNPE-------KWSDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 2e-39
 Identities = 84/272 (30%), Positives = 129/272 (47%), Gaps = 33/272 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLL 196
           LLG G FG V+    +          TG  +AVK+  L+ D  +  +    E+  L +L 
Sbjct: 7   LLGRGSFGSVYLALDK---------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 197 HPNLVKLVGYCIEDDQR-LLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           HPN+V+  G   ++++  L ++ E++  GSL + L + G LP P  IR K      +GLA
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLA 115

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      +++RD K +NIL+D+D   KL+DFG AK   +      +  V GT  + AP
Sbjct: 116 YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E +        +D++S G  ++EM TG+       P  E      A   +G         
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAALYKIG-----SSGE 221

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            P +  H     S++A     +CL RDPK RP
Sbjct: 222 PPEIPEHL----SEEAKDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 8e-36
 Identities = 72/208 (34%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLL 196
           L+G G FG V+KG   E         TG  VA+K   L     +  K  + E++ L NL 
Sbjct: 7   LIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK 57

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKGLA 254
           HPN+VK +G  IE    L ++ E+   GSL   + + G  P       +   L   +GLA
Sbjct: 58  HPNIVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL---QGLA 113

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LHE+    VI+RD K +NIL   D   KL+DFG+A    +  K      V+GT  + AP
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAP 168

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     ++ SD++S G  ++E+LTG 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  132 bits (333), Expect = 4e-35
 Identities = 72/206 (34%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 198
           LGEG FG V     +  G       TG  VAVK+LNH G + H  ++  E+  L  L H 
Sbjct: 12  LGEGHFGKVELCRYDPLGD-----NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66

Query: 199 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           N+VK  G C +   R   L+ E++P GSL ++L ++    +     +  +    KG+ +L
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYL 125

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST--RVMGTYGYAAP 314
                +  I+RD    NIL++++   K+SDFGLAK  PED   +          + Y AP
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-AP 181

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E + T   +S SDV+SFGV L E+ T
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (320), Expect = 1e-32
 Identities = 98/378 (25%), Positives = 148/378 (39%), Gaps = 45/378 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 189
           ++R    LGEG FG V+     +             VA+K L        KE    L E+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRK------------LVALKVLAKKLESKSKEVERFLREI 48

Query: 190 NFLGNLLHP-NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIAL 247
             L +L HP N+VKL  +  ++    LV E++  GSLE+ L       PL  S  + I  
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGLAKDAPEDGKT----HVS 302
                L +LH    K +I+RD K  NILLD D    KL DFGLAK  P+ G T     + 
Sbjct: 109 QILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165

Query: 303 TRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEHNLVE 358
           +  +GT GY APE ++     + +S SD++S G+ L E+LTG      +   +     ++
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE----- 413
                          L   L        S+ A+ L  + L++DPK R   S  +      
Sbjct: 226 IIL------ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Query: 414 ----TLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHP 469
                   L +L     S+    ++       I +  +   +       +         P
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDD-SNFSKELAP 338

Query: 470 NGPHASPYRHPQQSPKPN 487
           NG  +SP+          
Sbjct: 339 NGVSSSPHNSSSLLLSTA 356

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 1e-32
 Identities = 70/209 (33%), Positives = 110/209 (52%), Gaps = 27/209 (12%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 197
           + +G+G FG V  G              G  VAVK L  D       +LAE + +  L H
Sbjct: 12  ATIGKGEFGDVMLGDYR-----------GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRH 59

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           PNLV+L+G  ++ +   +V E+M +GSL ++L  +G   +  + ++  AL   +G+ +L 
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE 119

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVMGTYGYAAP 314
              EK  ++RD    N+L+  D  AK+SDFGLAK+A    + GK  V         + AP
Sbjct: 120 ---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAP 168

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT-GR 342
           E +     ++KSDV+SFG++L E+ + GR
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 8e-32
 Identities = 89/274 (32%), Positives = 126/274 (45%), Gaps = 47/274 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 196
           LG+G FG V    V +  T       G   A+K L    +   KE    L E N L  + 
Sbjct: 1   LGKGSFGKVLL--VRKKDT-------GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN 51

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM--KIALGAAKGL 253
           HP +VKL  Y  + +++L LV E+ P G L +HL ++G      +     +I L     L
Sbjct: 52  HPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----L 106

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      +IYRD K  NILLDAD + KL+DFGLAK+   +G +  +T   GT  Y A
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLA 161

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR--FY 371
           PE ++        D +S GV+L EMLTG+                   P   + R+  + 
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAEDRKEIYE 203

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           ++L   L   F    S +A  L +  L +DP  R
Sbjct: 204 KILKDPLR--FPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 6e-31
 Identities = 81/281 (28%), Positives = 130/281 (46%), Gaps = 35/281 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
            +G+G FG V+KG ++              VAVKT         K  +L E   L    H
Sbjct: 2   KIGKGNFGDVYKGVLK----------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH 51

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           PN+VKL+G C++     +V E +P GSL   L RK    L     ++++L AA G+ +L 
Sbjct: 52  PNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLE 110

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPE 315
               K  I+RD    N L+  +   K+SDFG++++  E+G  +  +  +      + APE
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAPE 165

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +  G  TS+SDV+S+G++L E  +   +      N +       R  +      YR+  
Sbjct: 166 ALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ------TRERI---ESGYRMPA 216

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           P+L          +  +L  QC + DP+ RP  SE+   L+
Sbjct: 217 PQLCPE-------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 6e-30
 Identities = 71/296 (23%), Positives = 117/296 (39%), Gaps = 61/296 (20%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 190
            +     +G+G FG V+   V            G    +K   L++   +  ++ L EV 
Sbjct: 1   KYEIIKQIGKGSFGKVYL--VRRKSD-------GKLYVLKEIDLSNMSEKEREDALNEVK 51

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHL--FRKGSLPLP----WSIRM 243
            L  L HPN++K      E+  +L  V E+   G L   +   +K   P P        +
Sbjct: 52  ILKKLNHPNIIKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           ++ L     L +LH    + +++RD K  NI L ++   KL DFG++K           T
Sbjct: 111 QLCLA----LKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKT 162

Query: 304 RVMGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
            V GT  Y +PE      Y        KSD++S G VL E+ T +   +           
Sbjct: 163 VV-GTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENLLE----- 210

Query: 358 EWARPHLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 L  K  +  Y    P +   +    S +   L +  L +DP+ RP ++++
Sbjct: 211 ------LALKILKGQY----PPIPSQY----SSELRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 81/282 (28%), Positives = 118/282 (41%), Gaps = 33/282 (11%)

Query: 139 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLL 196
            LG+G FG V +G W    G         + VAVK L  D L     ++L E   + +L 
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKV-------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD 54

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           H NL++L G  +     ++V E  P GSL + L +        S     A+  A G+ +L
Sbjct: 55  HENLIRLYG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---RVMGTYGYAA 313
                K  I+RD    NILL +D   K+ DFGL +  P++   +V     +V   + + A
Sbjct: 114 ES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCA 168

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE + T   +  SDV+ FGV L EM T          +G   L         D +   RL
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQIL------KKID-KEGERL 220

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
             P           Q    +  QC + +P  RP  + + E L
Sbjct: 221 ERPE-------ACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 1e-29
 Identities = 87/302 (28%), Positives = 128/302 (42%), Gaps = 62/302 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LG+G FG V++G         VK      VA+KT+N +     + E+L E + +      
Sbjct: 14  LGQGSFGMVYEG----LAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------FRKGSLPLPWSIRMKIALGAA 250
           ++V+L+G        L+V E M +G L+++L           G  P      +++A   A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE------DGKTHVSTR 304
            G+A+L   A K  ++RD    N ++  D   K+ DFG+ +D  E       GK  +  R
Sbjct: 130 DGMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            M      APE +  G  T+KSDV+SFGVVL EM T               L E  +P+ 
Sbjct: 187 WM------APESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAE--QPYQ 223

Query: 365 GDKRRFYRLLDPRLEGHFSIKGS---------QKATQLAAQCLSRDPKARPRMSEVVETL 415
           G        L       F I G           K  +L   C   +PK RP   E+V +L
Sbjct: 224 G--------LSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Query: 416 KP 417
           K 
Sbjct: 276 KD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  115 bits (290), Expect = 2e-29
 Identities = 87/285 (30%), Positives = 132/285 (46%), Gaps = 47/285 (16%)

Query: 139 LLGEGGFGCVFKGWVEENGT-APVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 197
           LLG G FG V++G   ++G    VK      V++      G +  K+   E+  L  L H
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVK-----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGLA 254
           PN+V+ +G   E+D   +  E +P GSL   L + GS P P  IR+   +I L    GL 
Sbjct: 62  PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP-VIRLYTRQILL----GLE 116

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-----GTY 309
           +LH   ++  ++RD K +NIL+D +   KL+DFG+AK         V          G+ 
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSP 165

Query: 310 GYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            + APE +   G     +D++S G  +LEM TG+       P  +   V  A   +G  +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVA-AVFKIGRSK 218

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P +  H     S +A     +CL RDP  RP  +E++E
Sbjct: 219 EL-----PPIPDHL----SDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 5e-29
 Identities = 69/208 (33%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 134 FRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           F  E  LG G FG V++G W              + VA+K L  D L   +++  EV  L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWK-----------NRVRVAIKILKSDDLLKQQDFQKEVQAL 56

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L H +L+ L   C   +   ++ E M +GSL   L       LP +  + +A   A+G
Sbjct: 57  KRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +A+L    E+  I+RD    NIL+  D   K++DFGLA+   ED       ++   Y + 
Sbjct: 117 MAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWT 171

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           APE    G  ++KSDV+SFG++L EM T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  113 bits (284), Expect = 1e-28
 Identities = 84/278 (30%), Positives = 131/278 (47%), Gaps = 36/278 (12%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V+ G W+E+             VA+KT+  +G    ++++ E   +  L HP
Sbjct: 12  IGSGQFGLVWLGYWLEKR-----------KVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            LV+L G C E     LV+EFM  G L ++L  ++G       + M   L   +G+A+L 
Sbjct: 60  KLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGM--CLDVCEGMAYLE 117

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                 VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +++PE  
Sbjct: 118 SSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVF 173

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                +SKSDV+SFGV++ E+ +  ++  +NR N E  +VE            +RL  PR
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE-------TINAGFRLYKPR 224

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           L        SQ   +L   C    P+ RP  S ++  L
Sbjct: 225 L-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 91/273 (33%), Positives = 127/273 (46%), Gaps = 43/273 (15%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V+ G W   NGT  V        AVKTL   G    + +L E   +  L H 
Sbjct: 14  LGAGQFGEVWMGTW---NGTTKV--------AVKTLK-PGTMSPEAFLQEAQIMKKLRHD 61

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS---LPLPWSIRMKIALGAAKGLAF 255
            LV+L   C E++   +V E+M +GSL + L + G    L LP  + M  A   A+G+A+
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDM--AAQIAEGMAY 118

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAP 314
           L     +  I+RD    NIL+  +   K++DFGLA+   +D  T     +      + AP
Sbjct: 119 LE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAP 173

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRL 373
           E    G  T KSDV+SFG++L E++T  R      P  G  N     R  L    R YR+
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTN-----REVLEQVERGYRM 223

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
             PR          ++   L  QC  +DP+ RP
Sbjct: 224 --PRPPNC-----PEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 4e-28
 Identities = 72/227 (31%), Positives = 117/227 (51%), Gaps = 24/227 (10%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 197
           LG G FG V+KG W+ E     VK    + VA+K L  +   + +KE L E   + ++ H
Sbjct: 15  LGSGAFGTVYKGVWIPEG--EKVK----IPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSL----ENHLFRKGSLP-LPWSIRMKIALGAAKG 252
           P++V+L+G C+   Q  L+ + MP G L     NH    GS   L W +++      AKG
Sbjct: 69  PHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKG 121

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +++L E   K +++RD    N+L+    + K++DFGLAK    D K + +        + 
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE 358
           A E ++    T KSDV+S+GV + E++T G +  +        +L+E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  112 bits (281), Expect = 5e-28
 Identities = 83/279 (29%), Positives = 124/279 (44%), Gaps = 36/279 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG G  G V K           +P TG  +AVKT+  +      K+ L E++ L     P
Sbjct: 9   LGAGNSGVVSK--------VLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            +V   G    +    +  E+M  GSL+  + ++    +P  I  KIA+   KGL +LHE
Sbjct: 60  YIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAPEYV 317
           + +  +I+RD K SNIL+++    KL DFG++        KT V     GT  Y APE +
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERI 171

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD-- 375
                + KSD++S G+ L+E+ TGR                   P  G       +++  
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQYIVNEP 220

Query: 376 -PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            PRL      K S         CL +DP+ RP   E++E
Sbjct: 221 PPRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  112 bits (281), Expect = 7e-28
 Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGL-QGHKEWLAEVNFLGNLLH 197
           LGEG FG VF G         ++P      VAVKTL         K++  E   L N  H
Sbjct: 13  LGEGAFGKVFLGECYH-----LEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG------------SLPLPWSIRMKI 245
            N+VK  G C E D  ++V+E+M  G L   L   G               L  S  ++I
Sbjct: 68  ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A G+ +L   A +  ++RD  T N L+  D   K+ DFG+++D        V    
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           M    +  PE +M    T++SDV+SFGVVL E+ T
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (280), Expect = 9e-28
 Identities = 91/294 (30%), Positives = 133/294 (45%), Gaps = 19/294 (6%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 190
           R  +   +LGEG FG V     +     P   GTG  VAVKTL  +  Q +   W  E+N
Sbjct: 4   RYLKKIRVLGEGHFGKVSLYCYD-----PANDGTGEMVAVKTLKRECGQQNTSGWKKEIN 58

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
            L  L H N+VK  G C E   +   L+ E++P GSL ++L  K  L L  +  +  A  
Sbjct: 59  ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNL--AQLLLFAQQ 115

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +G+A+LH    +  I+RD    N+LLD D   K+ DFGLAK  PE G  +   R  G 
Sbjct: 116 ICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGD 171

Query: 309 YG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + A E +     +  SDV+SFGV L E+LT      ++ P     ++   +  +  
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQM-T 229

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
             R   LL+  +         Q+   L   C   + K RP    ++  LK + +
Sbjct: 230 VVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  110 bits (277), Expect = 2e-27
 Identities = 95/296 (32%), Positives = 136/296 (45%), Gaps = 49/296 (16%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTG-LTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL 196
            LG G FG V++G      T  + PG+G + VAVKTL      Q  KE+L E + + N  
Sbjct: 2   FLGSGAFGEVYEG----TATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN 57

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPW---SIRMKIALGAAK 251
           HPN+VKL+G C+ ++ + ++ E M  G L ++L   R      P       + I L  AK
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDA------PEDGKTH 300
           G  +L +      I+RD    N L+     DAD   K+ DFGLA+D        ++G+  
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 359
           +  R M      APE ++ G  T++SDV+SFGV++ E+LT G       +P    N  E 
Sbjct: 175 LPVRWM------APESLLDGKFTTQSDVWSFGVLMWEILTLG------QQPYPALNNQEV 222

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
               L       RL  P            K  QL   C ++DP  RP    + E L
Sbjct: 223 ----LQHVTAGGRLQKPE-------NCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  109 bits (275), Expect = 2e-27
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 47/287 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           +G+G FG VFK          V+       A+K ++   +     +E + E   L  L  
Sbjct: 8   IGKGSFGVVFKV---------VRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGL 253
             +++     ++  +  +V E+   G L   L  +   PLP    W   ++I LG    L
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----L 114

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           A LH    K +++RD K+ N+ LDA  N K+ D G+AK       T+ +  ++GT  Y +
Sbjct: 115 AHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLS 169

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE         KSDV++ GVVL E  TG+   D    N +  L+           +  R 
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRG 216

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
           + P +   +    SQ+  QL  QCL++D + RP      +T + L+N
Sbjct: 217 VFPPVSQMY----SQQLAQLIDQCLTKDYRQRP------DTFQLLRN 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 4e-27
 Identities = 83/281 (29%), Positives = 127/281 (45%), Gaps = 34/281 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V KG          K G  + VAVKTL       G KE+L E + +  L HP
Sbjct: 3   LGHGNFGSVVKGVYLM------KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHP 56

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            +V+L+G C  +   +LV E  P G L  +L ++  +P+     +  A   A G+A+L  
Sbjct: 57  CIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYLES 113

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 316
              K  ++RD    N+LL   + AK+SDFG+++ A   G  +      G +   + APE 
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPEC 169

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           +  G  +SKSDV+S+GV L E  + G +   + +      ++E             RL  
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG----------ERLPR 219

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           P        +  Q+   +   C    P+ RP  SE+  T +
Sbjct: 220 PE-------ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 5e-27
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW--LAEVNFLGN 194
           E ++G G FG V +G ++  G   +       VA+KTL   G    +    L E + +G 
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEI------DVAIKTL-KAGSSDKQRLDFLTEASIMGQ 61

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
             HPN+++L G   +    +++ E+M  GSL+  L R+          + +  G A G+ 
Sbjct: 62  FDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMK 120

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGYA 312
           +L   +E   ++RD    NIL++++   K+SDFGL++  +  E   T    ++     + 
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWT 175

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-RRFY 371
           APE +     TS SDV+SFG+V+ E+++           GE    + +   +       Y
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS----------YGERPYWDMSNQDVIKAVEDGY 225

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           RL  P               QL   C  +D   RP  S++V TL
Sbjct: 226 RLPPPM-------DCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 1e-26
 Identities = 80/278 (28%), Positives = 120/278 (43%), Gaps = 36/278 (12%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V  G W  +           + VA+K +  +G     +++ E   +  L HP
Sbjct: 12  LGSGQFGVVHLGKWRGK-----------IDVAIKMI-REGAMSEDDFIEEAKVMMKLSHP 59

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           NLV+L G C +     +V E+M  G L N+L  RKG L   W + M       + + +L 
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLE 117

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                  I+RD    N L+  D   K+SDFGLA+   +D  T  S        +A PE  
Sbjct: 118 ---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVF 173

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                +SKSDV+SFGV++ E+ +  +   +   N E  +VE      G     YRL  P+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--SVSAG-----YRLYRPK 224

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           L          +   +   C    P+ RP   +++  L
Sbjct: 225 L-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  113 bits (283), Expect = 2e-26
 Identities = 90/301 (29%), Positives = 141/301 (46%), Gaps = 36/301 (11%)

Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDG 178
           +    ND+  + +    E+++  G  G  +KG   +NG   V         VK +N  + 
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFV---------VKEINDVNS 728

Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
           +       +E+  +G L HPN+VKL+G C  +    L++E++   +L   L       L 
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLS 778

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           W  R KIA+G AK L FLH      V+  +     I++D      L    L      D K
Sbjct: 779 WERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTK 837

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLV 357
             +S+       Y APE   T  +T KSD+Y FG++L+E+LTG+   D     G H ++V
Sbjct: 838 CFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE--FGVHGSIV 889

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQ--KATQLAAQCLSRDPKARPRMSEVVETL 415
           EWAR    D       +DP + G  S+  ++  +   LA  C + DP ARP  ++V++TL
Sbjct: 890 EWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Query: 416 K 416
           +
Sbjct: 949 E 949

Length = 968

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (269), Expect = 3e-26
 Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 45/278 (16%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL 196
            +LG+G  G V+K              TG   A+K ++ DG  +  K+ L E+  L +  
Sbjct: 7   KVLGQGSSGVVYKV---------RHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
            P +VK  G   ++ +  +V E+M  GSL + L + G +P P  +   IA    KGL +L
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEP--VLAYIARQILKGLDYL 115

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H   ++ +I+RD K SN+L+++    K++DFG++K   E+     +T V GT  Y +PE 
Sbjct: 116 H--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFV-GTVTYMSPER 171

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD- 375
           +     +  +D++S G+ LLE   G+                           F+ L+  
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-----------------FFELMQA 214

Query: 376 ------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 406
                 P L    F    S +     + CL +DPK RP
Sbjct: 215 ICDGPPPSLPAEEF----SPEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  104 bits (262), Expect = 2e-25
 Identities = 85/283 (30%), Positives = 132/283 (46%), Gaps = 36/283 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLH 197
           +LG+G +G V+ G   +     VK      V + T N    +   E L  EV+ L +L H
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVK-----QVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            N+V+ +G C++D+   +  EF+P GS+ + L R G LP P  +  K       G+A+LH
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEP--VFCKYTKQILDGVAYLH 119

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG----KTHVSTRVMGTYGYAA 313
                 V++RD K +N++L  +   KL DFG A+     G     +++   + GT  + A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +       KSD++S G  + EM TG+    SMD+            A  ++G     
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----------AMFYIGA---- 222

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +R L PRL   F    S  A      CL+RD   RP   +++ 
Sbjct: 223 HRGLMPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 72/208 (34%), Positives = 104/208 (50%), Gaps = 24/208 (11%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G W   N T PV        AVKTL    +   K++LAE   +  L HP
Sbjct: 14  LGAGQFGEVWEGLW---NNTTPV--------AVKTLKPGTMDP-KDFLAEAQIMKKLRHP 61

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFL 256
            L++L   C  ++   +V E M  GSL  +L      +L LP  I M  A   A G+A+L
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM--AAQVASGMAYL 119

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPE 315
             +     I+RD    N+L+  +   K++DFGLA+   ED        +      + APE
Sbjct: 120 EAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPE 174

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT-GR 342
             +    + KSDV+SFG++L E++T GR
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  104 bits (261), Expect = 2e-25
 Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 42/285 (14%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G +G V++G W + +          LTVAVKTL  D ++   E+L E   +  + HP
Sbjct: 14  LGGGQYGEVYEGVWKKYS----------LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           NLV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L  
Sbjct: 63  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE- 121

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYV 317
             +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE +
Sbjct: 122 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESL 177

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDP 376
                + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+ 
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEK 220

Query: 377 --RLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R+E     +G   K  +L   C   +P  RP  +E+ +  + +
Sbjct: 221 GYRMERP---EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  104 bits (262), Expect = 2e-25
 Identities = 86/296 (29%), Positives = 125/296 (42%), Gaps = 63/296 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQG-HKEWLAEVNFLGNLLH 197
           +G G FG V+           V   TG  +AVK +   D      KE   E+  L  L H
Sbjct: 8   IGGGTFGKVYTA---------VNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH 58

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           PNLVK  G  +  ++  +  E+   G+LE  L   G + L   +     L   +GLA+LH
Sbjct: 59  PNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLH 116

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV---MGTYGYAAP 314
                 +++RD K +NI LD +   KL DFG A    ++  T +   V    GT  Y AP
Sbjct: 117 S---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL-KNNTTTMGEEVQSLAGTPAYMAP 172

Query: 315 EYV----MTGHLTSKSDVYSFGVVLLEMLTGRR---SMDKNRPNGEHNLVEWA------- 360
           E +      GH  + +D++S G V+LEM TG+R    +D           E+        
Sbjct: 173 EVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDN----------EFQIMFHVGA 221

Query: 361 --RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
             +P + D       L    EG   +           +CL  DPK RP  SE+++ 
Sbjct: 222 GHKPPIPDS------LQLSPEGKDFLD----------RCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (261), Expect = 4e-25
 Identities = 64/238 (26%), Positives = 98/238 (41%), Gaps = 48/238 (20%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---------K 183
           +F+   ++GEG F  V             +  T    A+K L+   L            K
Sbjct: 2   DFKFGKIIGEGSFSTVVLAK---------EKETNKEYAIKILDKRQLIKEKKVKYVKIEK 52

Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           E L  +N      HP ++KL  Y  +D++ L  V E+ P G L  ++ + GSL      R
Sbjct: 53  EVLTRLN-----GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TR 105

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A      L +LH    K +I+RD K  NILLD D + K++DFG AK    +     +
Sbjct: 106 FYAAE-ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN 161

Query: 303 TRVM------------------GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
                                 GT  Y +PE +        SD+++ G ++ +MLTG+
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 83/292 (28%), Positives = 121/292 (41%), Gaps = 44/292 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G         V+    L VAVKTL      Q   ++L E   +    H 
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVE----LQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL---PWSIRMK----IALGAAK 251
           N+V+L+G   E   R ++ E M  G L++  F + + P    P S+ MK     A   AK
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           G  +L E      I+RD    N LL        AK++DFG+A+D           R M  
Sbjct: 128 GCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWAR--PHL 364
             +  PE  + G  TSK+DV+SFGV+L E+ +        R N E    +    R  P  
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPK 244

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           G     YR++                      C    P+ RP  + ++E ++
Sbjct: 245 GCPGPVYRIM--------------------TDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  101 bits (254), Expect = 3e-24
 Identities = 66/219 (30%), Positives = 104/219 (47%), Gaps = 32/219 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLH 197
           LGEG FG V+KG  E  G       T  +VA+KTL  N +  +  +E+  E   + +L H
Sbjct: 13  LGEGAFGKVYKG--ELTGPNERLSAT--SVAIKTLKENAEP-KVQQEFRQEAELMSDLQH 67

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--------------GSLPLPWSIRM 243
           PN+V L+G C ++    +++E++  G L   L R                   L  S  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            IA+  A G+ +L   +    ++RD    N L+      K+SDFGL++    D  +    
Sbjct: 128 HIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYY 180

Query: 304 RVMGT----YGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           RV         +  PE ++ G  T++SD++SFGVVL E+
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 43/295 (14%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 196
           +LGEG FG V +G + ++  + +K      VAVKT+  D       +E+L+E   + +  
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK------VAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59

Query: 197 HPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLF--RKGSLP--LPWSIRMKIA 246
           HPN++KL+G C E          +++  FM  G L + L   R G LP  LP    +K  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A G+ +L   + +  I+RD    N +L  D    ++DFGL+K     G  +   R+ 
Sbjct: 120 VDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQGRIA 175

Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + A E +     TSKSDV++FGV + E+ T  R          H + ++      
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--RGQTPYPGVENHEIYDYL----- 228

Query: 366 DKRRFYRLLDPR--LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R   RL  P   L+  + +            C   DPK RP  +++ E L+ +
Sbjct: 229 --RHGNRLKQPEDCLDELYDL---------MYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  101 bits (253), Expect = 4e-24
 Identities = 73/218 (33%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E    +P K    + VAVK L    L   K++  E   L NL H +
Sbjct: 13  LGEGAFGKVF--LAECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-----------------KGSLPLPWSIR 242
           +VK  G C + D  ++V+E+M  G L N   R                 KG L L  S  
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL--SQM 125

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           + IA   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D        V 
Sbjct: 126 LHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              M    +  PE +M    T++SDV+SFGV+L E+ T
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  101 bits (252), Expect = 7e-24
 Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 42/300 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 191
           LGEG FG V    V      P       V+ G  L VAVK L  D  +  + ++L EV  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------------FRKGSL 235
           L  L  PN+++L+G C+++D   ++ E+M  G L   L                     L
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132

Query: 236 PLP-WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
           P   +S  + +AL  A G+ +L   +    ++RD  T N L+  +   K++DFG++++  
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE- 353
                 +  R +    + A E ++ G  T+ SDV++FGV L E+L     + K +P GE 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL----MLCKEQPYGEL 245

Query: 354 --HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
               ++E A     D+ R   L  P           Q   +L  QC SRD + RP  S++
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  100 bits (251), Expect = 8e-24
 Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 40/235 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 191
           N      +G+G FG VF+      G  P +P T   VAVK L  +       ++  E   
Sbjct: 6   NIEYVRDIGQGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAAL 61

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK------------------- 232
           +    HPN+VKL+G C       L++E+M  G L   L  +                   
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 233 -GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
              LPL  + ++ IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 292 DA------PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +              +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  100 bits (251), Expect = 1e-23
 Identities = 83/296 (28%), Positives = 126/296 (42%), Gaps = 42/296 (14%)

Query: 140 LGEGGFGCV-------FKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 191
           LGEG FG V        + + E+           + VAVK L  D      +++L EV  
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------GSLPLPWSI 241
           L  L  PN+ +L+G C  D    ++ E+M  G L N   +K           S  L +S 
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSFST 131

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            + +A   A G+ +L        ++RD  T N L+  +Y  K++DFG++++        V
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE---HNLV 357
             R      + A E V+ G  T+KSDV++FGV L E+LT  R      +P        ++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQVI 243

Query: 358 EWA-RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-QLAAQCLSRDPKARPRMSEV 411
           E A      D R+ Y L  P            K   +L  +C  RD + RP   E+
Sbjct: 244 ENAGHFFRDDGRQIY-LPRP--------PNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score =  100 bits (249), Expect = 1e-23
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 23/219 (10%)

Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWL 186
           L     R   LLG G FG V KG W+ E  +  +       VA+KT+ +  G Q  +E  
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIP------VAIKTIQDRSGRQTFQEIT 57

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-RKGSLP----LPWSI 241
             +  +G+L H  +V+L+G C       LV +  P GSL +H+   + SL     L W +
Sbjct: 58  DHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCV 116

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L E     +++R+    NILL +D   +++DFG+A     D K + 
Sbjct: 117 QI------AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +       + A E ++ G  T +SDV+S+GV + EM++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 99.5 bits (249), Expect = 2e-23
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 25/215 (11%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 189
           +     LGEG +G V+K   ++ G           VA+K +      +G+      L E+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGE---------IVALKKIRLDNEEEGIP--STALREI 49

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALG 248
           + L  L HPN+VKL+     + +  LV+E+     L+ +L  R G L     I+  I   
Sbjct: 50  SLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IK-SIMYQ 106

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLA+ H      +++RD K  NIL++ D   KL+DFGLA+      +T+ +  V+ T
Sbjct: 107 LLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-T 161

Query: 309 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             Y APE ++     S + D++S G +  EM+TG+
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 80/280 (28%), Positives = 119/280 (42%), Gaps = 39/280 (13%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 195
           S LGEG  G V K           +   TG+  A+KT+  D      K+ L E+    + 
Sbjct: 7   SRLGEGAGGSVTK----------CRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC 56

Query: 196 LHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAAK 251
             P +VK  G  +++    +    E+   GSL++     +K    +   +  KIA    K
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVMGTYG 310
           GL++LH    + +I+RD K SNILL      KL DFG++ +       T       GT  
Sbjct: 117 GLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSF 168

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM--DKNRPNGEHNLVEWARPHLGDKR 368
           Y APE +     +  SDV+S G+ LLE+   R     +   P G   L+ +         
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------- 219

Query: 369 RFYRLLDPRL--EGHFSIKGSQKATQLAAQCLSRDPKARP 406
               + +P L  E    IK S++      QCL +DP  RP
Sbjct: 220 -IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN----HDGLQGHKEWLAEVNFLGNL 195
           +GEG  G VFK    E         TG TVA+K +       G+    + L E+  L   
Sbjct: 8   IGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIP--NQALREIKALQAC 56

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HP +VKL+         +LV E+MP   L   L R    PLP +          KG+A+
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +H      +++RD K +N+L+ AD   K++DFGLA+   E+     S +V  T  Y APE
Sbjct: 115 MHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170

Query: 316 YVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            ++ G        D+++ G +  E+L G 
Sbjct: 171 -LLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 97.8 bits (243), Expect = 4e-23
 Identities = 87/279 (31%), Positives = 134/279 (48%), Gaps = 34/279 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLH 197
           LLG+G FG VFKG +++             VAVKT   D  Q  K ++L+E   L    H
Sbjct: 2   LLGKGNFGEVFKGTLKDK----------TPVAVKTCKEDLPQELKIKFLSEARILKQYDH 51

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           PN+VKL+G C +     +V E +P G   + L RK    L     +K AL AA G+A+L 
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE 110

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAAPEY 316
               K  I+RD    N L+  +   K+SDFG+++   ED   + S+ +      + APE 
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAPEA 165

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
           +  G  +S+SDV+S+G++L E      S+      G  N  + AR  +    + YR+  P
Sbjct: 166 LNYGRYSSESDVWSYGILLWETF----SLGVCPYPGMTN--QQAREQV---EKGYRMSCP 216

Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           +       K      ++  +C    P+ RP+ SE+ + L
Sbjct: 217 Q-------KCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 98.4 bits (246), Expect = 5e-23
 Identities = 71/221 (32%), Positives = 102/221 (46%), Gaps = 38/221 (17%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 188
            +F     LG G FG V    V   G+           A+K L+   +   K+    L E
Sbjct: 1   DDFEFIKTLGTGSFGRVML--VRHKGSGKY-------YALKILSKAKIVKLKQVEHVLNE 51

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---K 244
              L ++ HP LV L G   +DD  L LV E++P G L +HL + G  P P + R    +
Sbjct: 52  KRILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQ 109

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           + L     L +LH      ++YRD K  N+LLD+D   K++DFG AK         V  R
Sbjct: 110 VVLA----LEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGR 154

Query: 305 VM---GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
                GT  Y APE ++  G+     D ++ G+++ EML G
Sbjct: 155 TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.6 bits (243), Expect = 6e-23
 Identities = 72/217 (33%), Positives = 109/217 (50%), Gaps = 26/217 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLA--- 187
           N+R   LLG+G FG V+               TG  +AVK +  D       KE  A   
Sbjct: 3   NWRRGKLLGQGAFGRVY---------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           E+  L NL H  +V+  G C+ DD+ L ++ E+MP GS+++ L   G   L  ++  K  
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYT 110

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTR 304
               +G+ +LH      +++RD K +NIL D+  N KL DFG +K         T + + 
Sbjct: 111 RQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS- 166

Query: 305 VMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLT 340
           V GT  + +PE V++G     K+DV+S G  ++EMLT
Sbjct: 167 VTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.3 bits (245), Expect = 6e-23
 Identities = 74/214 (34%), Positives = 109/214 (50%), Gaps = 16/214 (7%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  E+  
Sbjct: 4   RHLKFIQQLGKGNFGSV-----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEI 58

Query: 192 LGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
           L +L H N+VK  G C    +R   LV E++P GSL ++L +K    L     +  A   
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQI 117

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG-- 307
            KG+ +L     K  ++RD  T NIL++++   K+ DFGL K  P+D K +   R  G  
Sbjct: 118 CKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGES 173

Query: 308 -TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + Y APE +     +  SDV+SFGVVL E+ T
Sbjct: 174 PIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 77/289 (26%), Positives = 112/289 (38%), Gaps = 38/289 (13%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNL 195
            ++GEG +G V K   +          TG  VA+K    + D     K  L EV  L  L
Sbjct: 7   GVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQL 57

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            H N+V L        +  LV+E++ R  LE      G LP P ++R        + +A+
Sbjct: 58  RHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLP-PDAVR-SYIWQLLQAIAY 115

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
            H      +I+RD K  NIL+      KL DFG A+       + ++  V  T  Y APE
Sbjct: 116 CHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE 171

Query: 316 YVMTGHLTSKS-DVYSFGVVLLEMLTGR----------------RSMDKNRPNGEHNLVE 358
            ++      K  DV++ G ++ E+L G                 + +    P   H  + 
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP--SHQELF 229

Query: 359 WARPHLGDKRRFYRLLDPR-LEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            + P       F     P  LE  +  K S  A      CL  DPK R 
Sbjct: 230 SSNPRFA-GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 81/296 (27%), Positives = 131/296 (44%), Gaps = 52/296 (17%)

Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
           L  +  +    +G+G FG V  G              G  VAVK + +D     + +LAE
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDATA--QAFLAE 49

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 304
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                 + APE +     ++KSDV+SFG++L E+ +  R             V + R  L
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPL 205

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVETLK 416
            D       + PR+E  + +            +  QC   D   RP   ++ E L+
Sbjct: 206 KD-------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.4 bits (242), Expect = 1e-22
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 18/212 (8%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E     P +    + VAVKTL        K++  E   L NL H +
Sbjct: 13  LGEGAFGKVF--LAECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------FRKGSLP--LPWSIRMKIALG 248
           +VK  G C+E D  ++V+E+M  G L   L           +G+ P  L  S  + IA  
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+ +L   A +  ++RD  T N L+  +   K+ DFG+++D        V    M  
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             +  PE +M    T++SDV+S GVVL E+ T
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 65/207 (31%), Positives = 87/207 (42%), Gaps = 20/207 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL 196
           LG+GGFG V          A     TG   A K L+   L   +G +  L E   L  + 
Sbjct: 1   LGKGGFGEVC---------ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS 51

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
              +V L  Y  E    L LV   M  G L+ H++  G    P +  +  A     GL  
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH+     ++YRD K  N+LLD   N ++SD GLA +     K        GT GY APE
Sbjct: 111 LHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPE 164

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +         D ++ G  L EM+ GR
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 97.0 bits (241), Expect = 2e-22
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 50/311 (16%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGLQGH-KEWLAEVN 190
           N      LGEG FG V K          +K   G T VAVK L  +      ++ L+E N
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFN 55

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------------- 229
            L  + HP+++KL G C +D   LL+ E+   GSL + L                     
Sbjct: 56  LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 230 -FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
                   L     +  A   ++G+ +L   AE  +++RD    N+L+      K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK 347
           L++D  E+      ++      + A E +     T++SDV+SFGV+L E++T G      
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
             P    NL++            YR+  P          S++   L   C  ++P  RP 
Sbjct: 233 IAPERLFNLLKTG----------YRMERPE-------NCSEEMYNLMLTCWKQEPDKRPT 275

Query: 408 MSEVVETLKPL 418
            +++ + L+ +
Sbjct: 276 FADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 96.0 bits (239), Expect = 2e-22
 Identities = 75/303 (24%), Positives = 129/303 (42%), Gaps = 49/303 (16%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLA 187
             NF+ E  +G+G F  V+K     +G           VA+K +    +   K   + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDG---------RVVALKKVQIFEMMDAKARQDCLK 51

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLP----WSI 241
           E++ L  L HPN++K +   IE+++  +V E    G L   +  F+K    +P    W  
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +++       L  +H    K +++RD K +N+ + A    KL D GL +      KT  
Sbjct: 112 FVQL----CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTA 162

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           +  ++GT  Y +PE +       KSD++S G +L EM                       
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQS 204

Query: 362 PHLGDKRRFYRLLDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
           P  GDK   Y L     +  +    +   S++   L ++C++ DP+ RP +S V++  K 
Sbjct: 205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264

Query: 418 LQN 420
           +  
Sbjct: 265 MHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 74/288 (25%), Positives = 114/288 (39%), Gaps = 39/288 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKEWLAEV 189
           +F    ++G+G FG V    V++  T           A+K +N          +  L E 
Sbjct: 1   HFELLRVIGKGAFGKVCI--VQKRDT-------KKMFAMKYMNKQKCVEKGSVRNVLNER 51

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
             L  L HP LV L  Y  +D++ + LV + +  G L  HL +K        ++  I   
Sbjct: 52  RILQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVKFWIC-E 108

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               L +LH    K +I+RD K  NILLD   +  ++DF +A     D  T   T   GT
Sbjct: 109 IVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGT 162

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            GY APE +     +   D +S GV   E L G+R    +       + +  R       
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS----RTIRDQIRAKQETAD 218

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                        +    S +A     + L RDP+   R+ + ++ LK
Sbjct: 219 V-----------LYPATWSTEAIDAINKLLERDPQK--RLGDNLKDLK 253

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 78/288 (27%), Positives = 134/288 (46%), Gaps = 34/288 (11%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 195
           E ++G G FG V +G ++  G   +       VA+KTL      +  +++L+E + +G  
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 62

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN++ L G   +    +++ EFM  G+L++ L    G   +   + M    G A G+ 
Sbjct: 63  DHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM--LRGIAAGMK 120

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 311
           +L   +E   ++RD    NIL++++   K+SDFGL++   +D      T  +G      +
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
            APE +     TS SDV+S+G+V+ E+++ G R           N +E          + 
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----------QD 227

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           YRL  P       +       QL   C  +D  ARP+  ++V TL  +
Sbjct: 228 YRLPPP-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 82/278 (29%), Positives = 126/278 (45%), Gaps = 40/278 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG FG V +G             TG  VAVK +  D     + +L E   +  L H N
Sbjct: 14  IGEGEFGAVLQGEY-----------TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKN 60

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G  I  +   +V E M +G+L N L  +G   +     ++ +L  A+G+ +L   
Sbjct: 61  LVRLLG-VILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K +++RD    NIL+  D  AK+SDFGLA+          ++++     + APE +  
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGVDNSKL--PVKWTAPEALKH 171

Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
              +SKSDV+S+GV+L E+ + GR    K         VE          + YR+  P  
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE----------KGYRMEPP-- 219

Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           EG            L   C   +PK RP   ++ E L+
Sbjct: 220 EG-----CPADVYVLMTSCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 66/208 (31%), Positives = 109/208 (52%), Gaps = 18/208 (8%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLH 197
           ++G+G FGCV+ G + ++    +        AVK+LN    L+  +++L E   + +  H
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIH------CAVKSLNRITDLEEVEQFLKEGIIMKDFSH 55

Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGME 112

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 51/277 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVNFLGNLLH 197
           +GEG  G V+K              TG  VA+K +    L+   + L   E+  + +  H
Sbjct: 27  IGEGASGEVYKA---------TDRATGKEVAIKKMR---LRKQNKELIINEILIMKDCKH 74

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           PN+V      +  D+  +V E+M  GSL + +  +  + +       +     +GL +LH
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRMNEPQIAYVCREVLQGLEYLH 133

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPE 315
               + VI+RD K+ NILL  D + KL+DFG A           S R  V+GT  + APE
Sbjct: 134 S---QNVIHRDIKSDNILLSKDGSVKLADFGFAA----QLTKEKSKRNSVVGTPYWMAPE 186

Query: 316 YVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--RRFYR 372
            V+       K D++S G++ +EM  G        P           P+L +   R  + 
Sbjct: 187 -VIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRALFL 227

Query: 373 LLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           +     P L+     K S +      +CL +DP+ RP
Sbjct: 228 ITTKGIPPLKN--PEKWSPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 95.2 bits (237), Expect = 5e-22
 Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 44/290 (15%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--------NHDGLQGH--KEWLAE 188
           L+G+G +G V+      N T      TG  +AVK +         HD  Q    K   +E
Sbjct: 8   LIGKGTYGRVYLAL---NVT------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSE 58

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--PLPWSIRMKIA 246
           +  L +L H N+V+ +G+   ++   +  E++P GS+ + L   G     L      ++ 
Sbjct: 59  IETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL 118

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               +GLA+LH    K +++RD K  N+L+DAD   K+SDFG++K + +D   +     M
Sbjct: 119 ----EGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS-DDIYDNDQNMSM 170

Query: 307 -GTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
            G+  + APE + +     ++K D++S G V+LEM  GR      RP  +   +  A   
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA-AMFK 223

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           LG+KR       P +    S+  S  A      C + +P  RP   E+++
Sbjct: 224 LGNKRS-----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 72/255 (28%), Positives = 111/255 (43%), Gaps = 28/255 (10%)

Query: 168 TVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 226
            VA+K ++ +  Q    E   EV  +    HPN+VK     +  D+  LV  ++  GSL 
Sbjct: 28  KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLL 87

Query: 227 N---HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           +     + +G L     I   +     KGL +LH   +   I+RD K  NILL  D + K
Sbjct: 88  DIMKSSYPRGGLDEA--IIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVK 142

Query: 284 LSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEML 339
           ++DFG++    + G      R   +GT  + APE VM        K+D++SFG+  +E+ 
Sbjct: 143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELA 201

Query: 340 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKA-TQLAAQCL 398
           TG     K  P     L     P             P LE     K   K+  ++ + CL
Sbjct: 202 TGAAPYSKYPPMKVLMLTLQNDP-------------PSLETGADYKKYSKSFRKMISLCL 248

Query: 399 SRDPKARPRMSEVVE 413
            +DP  RP   E+++
Sbjct: 249 QKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 81/298 (27%), Positives = 124/298 (41%), Gaps = 63/298 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           +GEG +G V+K   +          TG  VA+K +    L+   E      L E+  L  
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVAIKKIK---LRFESEGIPKTALREIKLLKE 54

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLEN--HLFRKGSLPLPWSIRMKIALGAAK 251
           L HPN++KL+         L LV+EFM      +   L +     LP S+         +
Sbjct: 55  LNHPNIIKLLD-VFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH-VSTRVMGT 308
           GLAF H      +++RD K  N+L++ +   KL+DFGLA+   +P    TH V TR    
Sbjct: 110 GLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW--- 163

Query: 309 YGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPH-- 363
             Y APE ++     ++  D++S G +  E+L+ R       P   G+  + +  +    
Sbjct: 164 --YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-------PLFPGKSEIDQLFKIFRT 214

Query: 364 LGD-----------KRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARP 406
           LG              R Y+   P+  G          S +A  L +Q L  DP  R 
Sbjct: 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI 272

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 57/291 (19%)

Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
             LKL  +       LG G FG V+ G+   +            VA+K+L   G    + 
Sbjct: 6   ETLKLVKK-------LGAGQFGEVWMGYYNGH----------TKVAIKSLK-QGSMSPEA 47

Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
           +LAE N +  L HP LV+L    +  +   ++ E+M  GSL + L     + L  +  + 
Sbjct: 48  FLAEANLMKQLQHPRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLID 106

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DAPEDG 297
           +A   A+G+AF+     K  I+RD + +NIL+      K++DFGLA+        A E  
Sbjct: 107 MAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HN 355
           K  +         + APE +  G  T KSDV+SFG++L E++T  R       N E   N
Sbjct: 164 KFPIK--------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L            R YR+  PR +        ++  +L   C    P+ RP
Sbjct: 216 L-----------ERGYRM--PRPDN-----CPEELYELMRLCWKEKPEERP 248

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 35/219 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNHDGLQGH-KEWL-AEVNFLGNLL 196
           +G+G FG V K          V+    G  +  K +++  +    K+ L +EVN L  L 
Sbjct: 8   IGKGSFGTVRK----------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 197 HPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHL--FRKGSLPLP----WSIRMKIALG 248
           HPN+V+     I+   + L  V E+   G L   +   +K    +     W I  ++ L 
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 249 AAKGLAFLH--EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED---GKTHVST 303
               L   H   +    V++RD K +NI LDA+ N KL DFGLAK    D    KT+V  
Sbjct: 118 ----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-- 171

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
              GT  Y +PE +       KSD++S G ++ E+    
Sbjct: 172 ---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 60/287 (20%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F     LGEG +G V+K   +E G           VA+K +  +     +E + E++ L 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQ---------VVAIKVVPVEE--DLQEIIKEISILK 53

Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
               P +VK  G   ++    +V E+   GS+ + + +  +  L       I     KGL
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYG 310
            +LH       I+RD K  NILL+ +  AKL+DFG++    D      T     V+GT  
Sbjct: 113 EYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-----VIGTPF 164

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSMD--KNRPNGEHNLVEW 359
           + APE +      +K+D++S G+  +EM  G+         R++    N+P         
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-------- 216

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
             P L D  ++                S +      +CL +DP+ RP
Sbjct: 217 --PTLSDPEKW----------------SPEFNDFVKKCLVKDPEERP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 33/286 (11%)

Query: 140 LGEGGFG----CVFKGWVEENG-TAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLG 193
           LGEG FG    C  +G  E  G  AP   G  + VAVK L  D  +    ++L E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL---------ENHLFRKGSLP-LPWSIRM 243
            L +PN+++L+G C+ DD   ++ E+M  G L         E+      ++P +  +  +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +A+  A G+ +L   A    ++RD  T N L+   Y  K++DFG++++        +  
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG---EHNLVEWA 360
           R +    + A E ++ G  T+ SDV++FGV L EM T    + K +P     +  ++E  
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENT 245

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                ++ R   L    L             +L  +C SRD K RP
Sbjct: 246 GEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRP 284

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 92.4 bits (229), Expect = 6e-21
 Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 20/214 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E +   P +      VAVK L        +++  E   L  L H +
Sbjct: 13  LGEGAFGKVF--LAECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTVLQHQH 68

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSL---------ENHLFRKGSL----PLPWSIRMKIA 246
           +V+  G C E    L+V+E+M  G L         +  +   G       L     + IA
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               +  PE ++    T++SD++SFGVVL E+ T
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 91.8 bits (228), Expect = 8e-21
 Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 50/290 (17%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----------LAE 188
            LG G FGCV+K   + NG           +A+K +N       K+           ++E
Sbjct: 7   HLGSGAFGCVYKVRKKNNG--------QNLLALKEINVHNPAFGKDKRERDKSIGDIVSE 58

Query: 189 VNFLG-NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF----RKGSLPLP--WSI 241
           V  +   L HPN+V+     +E+D+  +V + +    L  H      +K        W+I
Sbjct: 59  VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +++ L     L +LH+E  K +++RD   +NI+L  D    ++DFGLAK    + K   
Sbjct: 119 FVQMVLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL-- 170

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
            T V+GT  Y+ PE V       K+DV++FG +L +M T         P    N++  A 
Sbjct: 171 -TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA- 222

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +    + +P  EG +    S+  T +   CL+ D +ARP + +V
Sbjct: 223 -----TKIVEAVYEPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 91.8 bits (228), Expect = 1e-20
 Identities = 67/203 (33%), Positives = 94/203 (46%), Gaps = 9/203 (4%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    + VAVK L        +E L +E+  + +L  H
Sbjct: 43  LGAGAFGKV----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            N+V L+G C      L++ E+   G L N L RK    L     +  +   AKG+AFL 
Sbjct: 99  ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL- 157

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
             A K  I+RD    N+LL      K+ DFGLA+D   D    V         + APE +
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                T +SDV+S+G++L E+ +
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 23/209 (11%)

Query: 139 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL 196
           +LG G FG V+KG WV E  T  +       VA+K LN   G + + E++ E   + ++ 
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIP------VAIKILNETTGPKANVEFMDEALIMASMD 67

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSL----ENHLFRKGS-LPLPWSIRMKIALGAAK 251
           HP+LV+L+G C+    +L V + MP G L      H    GS L L W +++      AK
Sbjct: 68  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AK 120

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+ +L E   + +++RD    N+L+ +  + K++DFGLA+    D K + +        +
Sbjct: 121 GMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            A E +     T +SDV+S+GV + E++T
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 15/203 (7%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
            +GEG FG V++G               + VAVKT  +      +E +L E   +    H
Sbjct: 13  CIGEGQFGDVYQG------VYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH 66

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 256
           P++VKL+G    ++   +V E  P G L ++L   K SL L  +  +  +   +  LA+L
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYL 123

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                K  ++RD    N+L+ +    KL DFGL++   ED   + +++      + APE 
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPES 179

Query: 317 VMTGHLTSKSDVYSFGVVLLEML 339
           +     TS SDV+ FGV + E+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 90.0 bits (223), Expect = 3e-20
 Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 32/286 (11%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           + ++G G FG VF+G ++  G   V       VA+KTL     +  + ++L+E + +G  
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEV------AVAIKTLKPGYTEKQRQDFLSEASIMGQF 63

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            H N+++L G   +    +++ E+M  G+L+ +L         + + + +  G A G+ +
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKY 122

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYA 312
           L   ++   ++RD    NIL++++   K+SDFGL++   D PE   T    ++     + 
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWT 177

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +     TS SDV+SFG+V+ E+++        RP  + +  E  +  + D    +R
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKA-INDG---FR 228

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           L  P       +       QL  QC  +D   RPR  ++V  L  L
Sbjct: 229 LPAP-------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 49/289 (16%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 189
           +F+    LG+G +G V+K  V+               A+K ++  G    KE    + E+
Sbjct: 1   DFKVLKKLGKGSYGSVYK--VKRLSD-------NQFYALKEVDL-GSMSQKEREDAVNEI 50

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--PLPWSIRMKIAL 247
             L ++ HPN++      ++ ++  +V E+ P G L   + ++      +P     +I +
Sbjct: 51  RILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              +GL  LHE+    +++RD K++NILL A+   K+ D G++K      K +++   +G
Sbjct: 111 QLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIG 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEHNLVEWARP 362
           T  Y APE       + KSD++S G +L EM T       RSM   R             
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------------- 210

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +  R   P +   +    SQ         L   PK RP   ++
Sbjct: 211 -----YKVQRGKYPPIPPIY----SQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)

Query: 133 NFRPESL-----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 186
           + R E L     LG G  G V K  V+   T       G  +A K ++        K+ L
Sbjct: 1   DLRNEDLETISDLGAGNGGSVSK--VKHIPT-------GTVMAKKVVHIGAKSSVRKQIL 51

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E+  +     P +V   G  + ++   +  EFM  GSL+  +++KG  P+P  I  KIA
Sbjct: 52  RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG-PIPVEILGKIA 109

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   +GL +L+      +++RD K SNIL+++    KL DFG++ +        ++   +
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFV 163

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +  G  T KSDV+S G+ ++E+  G+
Sbjct: 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 7e-20
 Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 42/281 (14%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V  G W  +             VA+K +  +G     E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQY-----------DVAIKMIK-EGSMSEDEFIEEAKVMMKLSHE 59

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C +     +V E+M  G L N+L   G    P  + +++     +G+A+L  
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLE- 117

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPE 315
              K  I+RD    N L+D     K+SDFGL++   +D   + S+  +G+     ++ PE
Sbjct: 118 --SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSS--VGSKFPVRWSPPE 171

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
            ++    +SKSDV++FGV++ E+ + G+   ++   N E   VE     +    R YR  
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSE--TVE----KVSQGLRLYR-- 222

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            P L        S+K   +   C     + RP   +++ ++
Sbjct: 223 -PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 8e-20
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 42/288 (14%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFL 192
           ++   L+G G +G V++G             TG  VA+K +N D       +   EV  L
Sbjct: 3   YQRLELIGRGAYGAVYRG---------KHVPTGRVVALKIINLDTPDDDVSDIQREVALL 53

Query: 193 GNLLH---PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW-SIRMKIAL 247
             L     PN+ K  G       RL ++ E+   GS+   L + G +   + S+ ++  L
Sbjct: 54  SQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVL 111

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            A   L ++H+     VI+RD K +NIL+    N KL DFG+A  A  +  +   +  +G
Sbjct: 112 VA---LKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVG 163

Query: 308 TYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           T  + APE +  G    +K+D++S G+ + EM TG              L+  ++P    
Sbjct: 164 TPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP---- 219

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
                    PRLE +     S+   +  A CL  +PK R    E++++
Sbjct: 220 ---------PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 88.4 bits (219), Expect = 8e-20
 Identities = 75/276 (27%), Positives = 124/276 (44%), Gaps = 32/276 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K    + VA+K +N +G    ++++ E   +  L HP 
Sbjct: 12  LGSGQFGVVHLG----------KWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPK 60

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     +V EFM  G L N+L R+    L   + + +     +G+ +L   
Sbjct: 61  LVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
           +    I+RD    N L+ +    K+SDFG+ +   +D  T  S+       ++ PE    
Sbjct: 120 S---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNF 175

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSDV+SFGV++ E+ T  +   + + N E  +VE          R +RL  P+L 
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEMI-------SRGFRLYRPKL- 225

Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                  S    ++   C    P+ RP  +E++  +
Sbjct: 226 ------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 73/207 (35%), Positives = 106/207 (51%), Gaps = 17/207 (8%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLHP 198
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 12  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66

Query: 199 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAF 255
           N+VK  G C ED      L+ EF+P GSL+ +L R K  + L    ++K A+   KG+ +
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDY 124

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAA 313
           L     +  ++RD    N+L+++++  K+ DFGL K A E  K + + +  +     + A
Sbjct: 125 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYA 180

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE ++       SDV+SFGV L E+LT
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 28/293 (9%)

Query: 140 LGEGGFG----CVFKG---WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 191
           LGEG FG    C  +G   +++++ +  V     + VAVK L  D  +  + ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---------KGSLPLPWSIR 242
           +  L  PN+++L+  CI  D   ++ E+M  G L   L R            + + +S  
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           + +A   A G+ +L   +    ++RD  T N L+  +Y  K++DFG++++        + 
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
            R +    + + E ++ G  T+ SDV++FGV L E+LT  +    ++ + E  ++E    
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
              D+ R   L  P L             +L   C  R+ K RP   E+  TL
Sbjct: 249 FFRDQGRQVYLPKPAL-------CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 74/294 (25%), Positives = 119/294 (40%), Gaps = 66/294 (22%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 192
           F     +G+G FG V+K          +   T   VA+K ++ +  +   E +  E+ FL
Sbjct: 3   FTLLECIGKGSFGEVYKA---------IDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFL 53

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW-SIRMKIALGAAK 251
                P + K  G  ++  +  ++ E+   GS    L + G L   + +  ++  L    
Sbjct: 54  SQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLDETYIAFILREVL---L 109

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGT 308
           GL +LHEE     I+RD K +NILL  + + KL+DFG++           T V     GT
Sbjct: 110 GLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GT 161

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG---RRSMD---------KNRPNGEHNL 356
             + APE +       K+D++S G+  +E+  G      +          KN P      
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP------ 215

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                              P LEG+   K S+      + CL++DPK RP   E
Sbjct: 216 -------------------PSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 38/217 (17%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---------GLQGHKEWLAEV 189
           +LG+G FG V          A +K GT    AVK L  D              K  LA  
Sbjct: 2   VLGKGSFGKVL--------LAELK-GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA 52

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI--RMKIA 246
                  HP L +L   C +   RL  V E++  G L  H+ R G    P +     +I 
Sbjct: 53  G-----KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           LG    L FLHE   + +IYRD K  N+LLD++ + K++DFG+ K+    G T  ++   
Sbjct: 107 LG----LQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157

Query: 307 GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           GT  Y APE +++      + D ++ GV+L EML G+
Sbjct: 158 GTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 68/224 (30%), Positives = 102/224 (45%), Gaps = 38/224 (16%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNH-----DGLQGHKEW 185
            +     LGEG +  V+K   +E G           VA+K   L       DG+  +   
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGR---------IVAIKKIKLGERKEAKDGI--NFTA 49

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL-PWSIR-- 242
           L E+  L  L HPN++ L+          LV+EFM    LE  + +  S+ L P  I+  
Sbjct: 50  LREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLTPADIKSY 107

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH 300
           M + L   +GL +LH      +++RD K +N+L+ +D   KL+DFGLA+   +P    TH
Sbjct: 108 MLMTL---RGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161

Query: 301 -VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
            V TR      Y APE +    H     D++S G +  E+L   
Sbjct: 162 QVVTRW-----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 78/305 (25%), Positives = 122/305 (40%), Gaps = 75/305 (24%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +GEG +G V+K     N        TG  VA+K +    ++  KE      + E+  L  
Sbjct: 7   IGEGTYGQVYKA---RNKK------TGELVALKKIR---MENEKEGFPITAIREIKLLQK 54

Query: 195 LLHPNLVKLVGYCIEDDQR--LLVYEFMP---RGSLENHLFRKGSLPLPWSIRMKIALGA 249
           L HPN+V+L        +    +V+E+M     G L++               +K     
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPE-------------VKFTESQ 101

Query: 250 AK--------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            K        GL +LH      +++RD K SNIL++ D   KL+DFGLA+   +      
Sbjct: 102 IKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158

Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR---------RSMDK---- 347
           + RV+ T  Y  PE ++       + D++S G +L E+  G+           ++K    
Sbjct: 159 TNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFEL 217

Query: 348 -NRPNGEHNLVEWARPHLGDKRRFYRLLDP------RLEGHFSIKGSQKATQLAAQCLSR 400
              P  E     W  P +  K  ++  L P      RL   F       A  L  + L+ 
Sbjct: 218 CGSPTDE----NW--PGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL 270

Query: 401 DPKAR 405
           DPK R
Sbjct: 271 DPKKR 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 76/291 (26%), Positives = 119/291 (40%), Gaps = 31/291 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 191
           N +  + LG G FG VF    +         G    V VK L          E+  E++ 
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEE----GGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-----RKGSLPLPWSIRMKIA 246
              L H N+V+L+G C E +   ++ E+   G L+  L       +   P P S + K+A
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 247 LGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           L    A G+  L   +    ++RD    N L+ +    K+S   L+KD        +   
Sbjct: 122 LCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           ++    + APE V     ++KSDV+SFGV++ E+ T                 E     L
Sbjct: 179 LI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT---------------QGELPFYGL 222

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            D+    RL   +LE         +  +L  +C + +PK RP  SE+V  L
Sbjct: 223 SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 4e-19
 Identities = 66/219 (30%), Positives = 101/219 (46%), Gaps = 45/219 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           LG+G FG V+    +E G           VA+K +     +    W     L EV  L  
Sbjct: 7   LGDGTFGSVYLARNKETGE---------LVAIKKMK----KKFYSWEECMNLREVKSLRK 53

Query: 195 L-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF-----RKGSLPLPWSIRMKIALG 248
           L  HPN+VKL     E+D+   V+E+M     E +L+     RKG  P   S+   I   
Sbjct: 54  LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGK-PFSESVIRSIIYQ 107

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD----APEDGKTHVSTR 304
             +GLA +H+       +RD K  N+L+      K++DFGLA++     P     +VSTR
Sbjct: 108 ILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTR 162

Query: 305 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
                 Y APE ++ +   +S  D+++ G ++ E+ T R
Sbjct: 163 -----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 43/283 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G FG V+K              TGL  A K +  +  +  ++++ E++ L    HPN
Sbjct: 13  LGDGAFGKVYKA---------QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V L      +++  ++ EF   G+L++ +  +    L       +     + L FLH  
Sbjct: 64  IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS- 121

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
               VI+RD K  NILL  D + KL+DFG+ AK+     K       +GT  + APE V 
Sbjct: 122 --HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVA 176

Query: 319 TGHLTS-----KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
                      K+D++S G+ L+E+           P+ E N +          R   ++
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME------PPHHELNPM----------RVLLKI 220

Query: 374 LD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           L    P L+     K S         CL +DP  RP  +E+++
Sbjct: 221 LKSEPPTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 29/211 (13%)

Query: 143 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPN 199
           G +G VF            K  TG   A+K +    +       + L E + L     P 
Sbjct: 4   GAYGRVFLA---------KKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPY 54

Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           +VKL  Y  +  + L LV E++P G L + L   GSL      R+ IA      L +LH 
Sbjct: 55  VVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLHS 111

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-------DAPEDGKTHVSTRVMGTYGY 311
                +I+RD K  NIL+D++ + KL+DFGL+K           D +     R++GT  Y
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE-DKRIVGTPDY 167

Query: 312 AAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG 341
            APE V+ G   SK+ D +S G +L E L G
Sbjct: 168 IAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.8 bits (212), Expect = 7e-19
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 14  LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 62

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH 257
           LV+L     +++   ++ E+M +GSL + L     G + LP  I     +  A+G+A++ 
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 121 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
             G  T KSDV+SFG++L E++T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.9 bits (212), Expect = 8e-19
 Identities = 85/283 (30%), Positives = 128/283 (45%), Gaps = 40/283 (14%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 186
           ++   + R +  LG+G FG V+ G W   NGT          VA+KTL   G    + +L
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTW---NGTT--------KVAIKTLK-PGTMMPEAFL 49

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS---LPLPWSIRM 243
            E   +  L H  LV L    + ++   +V EFM +GSL + L ++G    L LP  + M
Sbjct: 50  QEAQIMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDM 107

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A G+A++        I+RD + +NIL+  +   K++DFGLA+   ED +     
Sbjct: 108 --AAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQ 161

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE  + G  T KSDV+SFG++L E++T  R       N         R  
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---------REV 212

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R YR+  P+          +   +L   C  +DP  RP
Sbjct: 213 LEQVERGYRMPCPQ-------GCPESLHELMKLCWKKDPDERP 248

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 85.7 bits (212), Expect = 9e-19
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-----TLNHDGLQGHKEWLA----E 188
           +L+G G FG V+ G         +   +G  +AVK     +++       +  L     E
Sbjct: 6   ALIGSGSFGSVYLG---------MNASSGELMAVKQVELPSVSASSKDRKRSMLDALARE 56

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           +  L  L H N+V+ +G  ++ D   +  E++P GS+   L   G+      +R  +   
Sbjct: 57  IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL-VRNFVR-Q 114

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR---- 304
             KGL +LH    + +I+RD K +NIL+D     K+SDFG++K   E       T     
Sbjct: 115 ILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARP 170

Query: 305 -VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            + G+  + APE V     T K+D++S G +++EMLTG+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 1e-18
 Identities = 75/246 (30%), Positives = 101/246 (41%), Gaps = 58/246 (23%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 189
           +F    ++G G FG V+               TG   A+K L    +    +     AE 
Sbjct: 2   DFEVIKVIGRGAFGEVWLVR---------DKDTGQVYAMKVLRKSDMIKRNQIAHVRAER 52

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----M 243
           + L +   P +VKL  Y  +D++ L LV E+MP G L N L RK   P     R     +
Sbjct: 53  DILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAEL 110

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT---- 299
            +AL +   L F+H         RD K  NIL+DAD + KL+DFGL K   +        
Sbjct: 111 VLALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161

Query: 300 ------------------HVSTRVM-----GTYGYAAPEYVMTGH-LTSKSDVYSFGVVL 335
                             H   RV      GT  Y APE V+ G     + D +S GV+L
Sbjct: 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVIL 220

Query: 336 LEMLTG 341
            EML G
Sbjct: 221 YEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 70/215 (32%), Positives = 93/215 (43%), Gaps = 38/215 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGH----KEWLAEVN 190
           LG GGFG V    V+             T A+K +        G Q H    KE L E N
Sbjct: 1   LGVGGFGRVEL--VKVKSK-------NRTFALKCVKKRHIVETGQQEHIFSEKEILEECN 51

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVY---EFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
                 HP +VKL  Y    D++  +Y   E+   G L   L  +G     ++ R  IA 
Sbjct: 52  ------HPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIA- 100

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                  +LH    + +IYRD K  N+LLD++   KL DFG AK      KT       G
Sbjct: 101 CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCG 154

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y APE ++        D +S G++L E+LTGR
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 34/238 (14%)

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           L E+  L  L HPN++    + ++D+  L+  E+   G+L + + R+        + +  
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                  ++++H+     +++RD KT NI L      KL DFG++K    +  +   T V
Sbjct: 107 LFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-YSMAET-V 161

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV------EW 359
           +GT  Y +PE         KSD+++ G VL E+LT +R+ D   P    NLV       +
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNY 218

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
                           P +  +     S +   L    L +DP+ RP   EV++    
Sbjct: 219 T---------------PVVSVY-----SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 85/276 (30%), Positives = 117/276 (42%), Gaps = 34/276 (12%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 190
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGESMALNEKQ 52

Query: 191 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            L  + +   V  + Y  E  D   LV   M  G L+ H++  G         +  A   
Sbjct: 53  ILEKV-NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             GL  LH+E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV GT 
Sbjct: 112 CCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-GTV 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           GY APE V     T   D ++ G +L EM+ G+    + +   +   VE           
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------- 214

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
             RL+   ++  +S K S  A  L    L +DPK R
Sbjct: 215 --RLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 32/286 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 14  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 130 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 231

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D            ++ T L   C   +PK RP   E+V  LK
Sbjct: 232 KFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 77/289 (26%), Positives = 132/289 (45%), Gaps = 38/289 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 14  LGQGSFGMVYEGIAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L++ E M RG L+++L              P      +++A   A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 130 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGMSNE- 228

Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 229 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 54/189 (28%), Positives = 94/189 (49%), Gaps = 16/189 (8%)

Query: 164 GTGLTVAVKTL----NHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY 217
            TG  +AVK +    N    Q    +    E+  +  L HP++++++G   ED    L  
Sbjct: 23  KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82

Query: 218 EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 277
           E+M  GS+ + L + G      ++ +       +GL++LHE     +I+RD K +N+L+D
Sbjct: 83  EWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLID 137

Query: 278 AD-YNAKLSDFGLAKDAPED--GKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGV 333
           +     +++DFG A        G      +++GT  + APE V+ G    +S DV+S G 
Sbjct: 138 STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGC 196

Query: 334 VLLEMLTGR 342
           V++EM T +
Sbjct: 197 VIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 84/271 (30%), Positives = 123/271 (45%), Gaps = 40/271 (14%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V+ G W   NG           VAVKTL   G    + +L E   +  L H 
Sbjct: 14  LGNGQFGEVWMGTW---NGNT--------KVAVKTLK-PGTMSPESFLEEAQIMKKLRHD 61

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAF 255
            LV+L    + ++   +V E+M +GSL + L + G   +L LP  + M  A   A G+A+
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDM--AAQVAAGMAY 117

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +        I+RD +++NIL+      K++DFGLA+   ED +            + APE
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPE 173

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
             + G  T KSDV+SFG++L E++T  R       N         R  L    R YR+  
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPC 224

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           P+              +L  QC  +DP+ RP
Sbjct: 225 PQ-------DCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 89/288 (30%), Positives = 134/288 (46%), Gaps = 67/288 (23%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNF 191
            +LG+GG+G VF+  V +   A     TG   A+K L    +        H +  AE N 
Sbjct: 2   KVLGKGGYGKVFQ--VRKVTGA----DTGKIFAMKVLKKATIVRNQKDTAHTK--AERNI 53

Query: 192 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK------ 244
           L  + HP +V L+ Y  +   +L L+ E++  G L  HL R+G       I M+      
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREG-------IFMEDTACFY 105

Query: 245 ---IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTH 300
              I+L     L  LH++    +IYRD K  NILLDA  + KL+DFGL K++  +G  TH
Sbjct: 106 LSEISLA----LEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
                 GT  Y APE +M +GH     D +S G ++ +MLTG                  
Sbjct: 159 T---FCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTG------------------ 196

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKAR 405
           A P   + R+  + +D  L+G  ++    + +A  L  + L R+P +R
Sbjct: 197 APPFTAENRK--KTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.9 bits (207), Expect = 4e-18
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)

Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 7   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 54

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 55  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 109

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 110 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 165

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 216

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 217 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 248

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 68/246 (27%), Positives = 106/246 (43%), Gaps = 44/246 (17%)

Query: 195 LLH----PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
           +LH    P +V   G    D +  +  E M  GSL+  L + G +P    I  KI++   
Sbjct: 52  VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN--ILGKISIAVL 109

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS--TRVMGT 308
           +GL +L E+ +  +++RD K SNIL+++    KL DFG++      G+   S     +GT
Sbjct: 110 RGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS------GQLIDSMANSFVGT 161

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-------------DKNRPNGEHN 355
             Y +PE +   H T +SD++S G+ L+EM  GR  +                       
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKE 221

Query: 356 LVEWARPHLGDKRR---FYRLLD-------PRLE-GHFSIKGSQKATQLAAQCLSRDPKA 404
                  H  D  R    + LLD       P+L  G F    S +      +CL ++PK 
Sbjct: 222 SHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAF----SDEFQDFVDKCLKKNPKE 277

Query: 405 RPRMSE 410
           R  + E
Sbjct: 278 RADLKE 283

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 77/300 (25%), Positives = 123/300 (41%), Gaps = 49/300 (16%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 189
           NFR E  +G G F  V++     +G           VA+K +    L   +   + + E+
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGV---------PVALKKVQIFDLMDAKARADCIKEI 53

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL 247
           + L  L HPN++K     IED++  +V E    G L   +  F+K    +P     K  +
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++G
Sbjct: 114 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE +       KSD++S G +L EM                       P  GDK
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 210

Query: 368 RRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
              Y L          P    H+    S++  QL   C++ DP+ RP ++ V +  K + 
Sbjct: 211 MNLYSLCKKIEQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 7e-18
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 16/212 (7%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNF 191
             + E ++G G FG V  G ++  G   +       VA+KTL     +  + ++L+E + 
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREI------PVAIKTLKAGYTEKQRRDFLSEASI 58

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           +G   HPN++ L G   +    ++V E+M  GSL+  L RK          + +  G A 
Sbjct: 59  MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIAS 117

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGT 308
           G+ +L   ++   ++RD    NIL++++   K+SDFGL++   D PE   T    ++   
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--P 172

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             + APE +     TS SDV+S+G+V+ E+++
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 84.1 bits (208), Expect = 7e-18
 Identities = 57/166 (34%), Positives = 83/166 (50%), Gaps = 19/166 (11%)

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 251
           HP LV L   C + + RL  V EF+  G L  H+ R+  LP      +S  + +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
              FLHE   + +IYRD K  N+LLDA+ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHN 355
            APE +         D ++ GV++ EM+ GR   D      N + N
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 85/314 (27%), Positives = 131/314 (41%), Gaps = 57/314 (18%)

Query: 113 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 172
           L +  Q      NDL+           +G G  G V+K   ++ G           +AVK
Sbjct: 3   LTIDGQKYPADLNDLEN-------LGEIGSGTCGQVYKMRFKKTGH---------VMAVK 46

Query: 173 TLNHDG-LQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 229
            +   G  + +K  L +++ +    H  P +VK  GY I D    +  E M   +  + L
Sbjct: 47  QMRRTGNKEENKRILMDLDVV-LKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKL 103

Query: 230 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
            ++   P+P  I  K+ +   K L +L E+    VI+RD K SNILLDA  N KL DFG+
Sbjct: 104 LKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGI 161

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK----SDVYSFGVVLLEMLTGRRSM 345
           +     D K    TR  G   Y APE +       K    +DV+S G+ L+E+ TG+   
Sbjct: 162 SGRLV-DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF-- 216

Query: 346 DKNRPNGEHNLVEWARPHLGDKRRF---YRLLD---PRLEGHFSIKGSQKATQLAAQCLS 399
                           P+   K  F    ++L    P L  +     S         CL+
Sbjct: 217 ----------------PYKNCKTEFEVLTKILQEEPPSLPPNEGF--SPDFCSFVDLCLT 258

Query: 400 RDPKARPRMSEVVE 413
           +D + RP+  E+++
Sbjct: 259 KDHRKRPKYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.1 bits (213), Expect = 1e-17
 Identities = 59/194 (30%), Positives = 92/194 (47%), Gaps = 19/194 (9%)

Query: 165 TGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLV--GYCIEDDQRLLVYEF 219
           TG  VA+K L  D  +   +   +  E      L HPN+V L+  G          V+E+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEY 60

Query: 220 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--- 276
           +P  +L   L   G+LP   + R+   L     LA  H +    +++RD K  NI++   
Sbjct: 61  VPGRTLREVLAADGALPAGETGRL--MLQVLDALACAHNQG---IVHRDLKPQNIMVSQT 115

Query: 277 DADYNAKLSDFGLAKDAPEDGKTHV-----STRVMGTYGYAAPEYVMTGHLTSKSDVYSF 331
               +AK+ DFG+    P      V     +T V+GT  Y APE +    +T  SD+Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 332 GVVLLEMLTGRRSM 345
           G++ LE LTG+R +
Sbjct: 176 GLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 58/303 (19%)

Query: 127 LKLATRNFRPESLL------GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 180
           L+L      P S L      GEG  G V                TG  VAVK ++    Q
Sbjct: 8   LQLVVDPGDPRSYLDNFVKIGEGSTGIV---------CIATDKSTGRQVAVKKMDLRKQQ 58

Query: 181 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
             +    EV  + +  HPN+V++    +  D+  +V EF+  G+L +         +   
Sbjct: 59  RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD---------IVTH 109

Query: 241 IRMK------IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LA 290
            RM       + L   K L+FLH +    VI+RD K+ +ILL +D   KLSDFG    ++
Sbjct: 110 TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVS 166

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           K+ P          ++GT  + APE +      ++ D++S G++++EM+ G        P
Sbjct: 167 KEVPR------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                        L   +R    L P+L+     K S +      + L RDP  R   +E
Sbjct: 221 -------------LQAMKRIRDNLPPKLKNL--HKVSPRLRSFLDRMLVRDPAQRATAAE 265

Query: 411 VVE 413
           ++ 
Sbjct: 266 LLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 42/287 (14%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGN 194
           E +LG G FG + +G ++     P K    L VA+ TL   G    +   +LAE   LG 
Sbjct: 10  ERILGTGRFGELCRGCLK----LPSK--RELPVAIHTL-RAGCSDKQRRGFLAEALTLGQ 62

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
             H N+V+L G     +  ++V E+M  G+L++ L RK    L     M +  G A G+ 
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGLASGMK 121

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG--YA 312
           +L   +E   +++      +L+++D   K+S F       ED    + T + G     +A
Sbjct: 122 YL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWA 175

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF- 370
           APE +   H +S SDV+SFG+V+ E+++ G R               W        +   
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY-------------WDMSGQDVIKAVE 222

Query: 371 --YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
             +RL  PR              QL   C  ++   RPR S++   L
Sbjct: 223 DGFRLPAPR-------NCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 69/207 (33%), Positives = 93/207 (44%), Gaps = 20/207 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLL 196
           LG+GGFG V    V+          TG   A K L+   L+   G K  L E   L  + 
Sbjct: 1   LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN 51

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            P +V L  Y  E    L LV   M  G L+ H++  G   L     +  +     G+  
Sbjct: 52  SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      ++YRD K  N+LLD   N +LSD GLA +   DGKT   T+  GT GY APE
Sbjct: 111 LHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKT--ITQRAGTNGYMAPE 164

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +     +   D ++ G  + EM+ GR
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 81.4 bits (201), Expect = 2e-17
 Identities = 63/248 (25%), Positives = 109/248 (43%), Gaps = 28/248 (11%)

Query: 169 VAVKTLNHDGLQGHKEWLA--EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE 226
           V +K +  + +   +   A  E   L  L HPN+++     +ED   ++V E+ P G+L 
Sbjct: 28  VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLA 87

Query: 227 NHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLS 285
            ++ ++ +  L       I     + L  LH    K +++RD KT NILLD      K+ 
Sbjct: 88  EYIQKRCNSLLD---EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIG 144

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           DFG++K      K +    V+GT  Y +PE         KSD+++ G VL E+ + +R+ 
Sbjct: 145 DFGISKILSSKSKAYT---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Query: 346 D-KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
           +  N P     ++      + D+                   S    QL    L+ DP  
Sbjct: 202 EAANLPALVLKIMSGTFAPISDRY------------------SPDLRQLILSMLNLDPSK 243

Query: 405 RPRMSEVV 412
           RP++S+++
Sbjct: 244 RPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 26/205 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 196
           +G G FG V+      N        T   VAVK +++ G Q +++W   + EV FL  L 
Sbjct: 29  IGHGSFGAVY---FATNSH------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN ++  G  +++    LV E+   GS  + L      PL       I  GA +GLA+L
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAITHGALQGLAYL 137

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      +I+RD K  NILL      KL+DFG A       K+  +   +GT  + APE 
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEV 188

Query: 317 VMT---GHLTSKSDVYSFGVVLLEM 338
           ++    G    K DV+S G+  +E+
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 23/218 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-L 196
            LGEG FG V K   E  G     P    TVAVK L  D   +   + ++E+  +  +  
Sbjct: 19  PLGEGAFGQVVKA--EAVGL--DNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 74

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR------KGSLPLPWSIRMKI----- 245
           H N++ L+G C ++    +V E+   G+L + L          S   P      +     
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 246 ---ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A   A+G+ FL   A K  I+RD    N+L+  D+  K++DFGLA+D         +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)

Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+      P      + VA+K L      + +KE L
Sbjct: 4   LKETEFKKIKVLGSGAFGTVYKGLWI------PEGEKVKIPVAIKELREATSPKANKEIL 57

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL----ENHLFRKGS-LPLPWSI 241
            E   + ++ +P++ +L+G C+    +L + + MP G L      H    GS   L W +
Sbjct: 58  DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L E   + +++RD    N+L+    + K++DFGLAK    D K + 
Sbjct: 117 QI------AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH 167

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 81.2 bits (200), Expect = 6e-17
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 22/219 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 189
           +F    +LG+G FG V          A  K GT    A+K L  D +    +    + E 
Sbjct: 1   DFNFLMVLGKGSFGKVM--------LAERK-GTDELYAIKILKKDVVIQDDDVECTMVEK 51

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
             L     P  +  +  C +   RL  V E++  G L  H+ + G    P ++    A  
Sbjct: 52  RVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--AAE 109

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-G 307
            + GL FLH    + +IYRD K  N++LD++ + K++DFG+ K+   DG   V+TR   G
Sbjct: 110 ISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCG 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
           T  Y APE +         D +++GV+L EML G+   D
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 26/231 (11%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKE 184
           +L L+   F  E  LGE  FG ++KG +   G    +      VA+KTL + +  Q   E
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQ-----LVAIKTLKDINNPQQWGE 53

Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK------------ 232
           +  E + +  L HPN+V L+G   ++    +++E++ +G L   L  +            
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 233 -GSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
            G++   L     + IA+  A G+ +L   +    +++D    NIL+    + K+SD GL
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +++        V  + +    +  PE +M G  +S SD++SFGVVL E+ +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 80.4 bits (198), Expect = 8e-17
 Identities = 75/295 (25%), Positives = 131/295 (44%), Gaps = 41/295 (13%)

Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 186
           L     +   +LG G FG V+KG W       P      + VA+K L  +   + +KE L
Sbjct: 4   LKETELKKVKVLGSGAFGTVYKGIW------IPDGENVKIPVAIKVLRENTSPKANKEIL 57

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF----RKGSLPL-PWSI 241
            E   +  +  P + +L+G C+    +L V + MP G L +++     R GS  L  W +
Sbjct: 58  DEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCV 116

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+++L E     +++RD    N+L+ +  + K++DFGLA+    D   + 
Sbjct: 117 QI------AKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 167

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 360
           +        + A E ++    T +SDV+S+GV + E++T G +  D        +L+E  
Sbjct: 168 ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG 227

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                      RL  P +        +     +  +C   D + RPR  E+V+  
Sbjct: 228 E----------RLPQPPI-------CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 24/214 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLH 197
           LGEG FG V +G + ++ +        L VAVKT+          +++L+E   +    H
Sbjct: 7   LGEGEFGSVMEGQLNQDDSI-------LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDH 59

Query: 198 PNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLF--RKGSLP--LPWSIRMKIAL 247
           PN+++L+G C++  +       +++  FM  G L + L   R G  P  LP  + +K   
Sbjct: 60  PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+ +L   + K  I+RD    N +L+ + N  ++DFGL+K    +G  +   R+  
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAK 175

Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + A E +     T+KSDV+SFGV + E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.3 bits (199), Expect = 1e-16
 Identities = 61/236 (25%), Positives = 98/236 (41%), Gaps = 60/236 (25%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 191
           +     +G G +G V            V   TG  VA+K +++  D L   K  L E+  
Sbjct: 2   YELLKPIGSGAYGVVCSA---------VDKRTGRKVAIKKISNVFDDLIDAKRILREIKL 52

Query: 192 LGNLLHPNLVKL--VGYCIEDDQRL------LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           L +L H N++ L  +   +            +V E M     E  L +         I+ 
Sbjct: 53  LRHLRHENIIGLLDI---LRPPSPEDFNDVYIVTELM-----ETDLHK--------VIKS 96

Query: 244 KIALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L             +GL +LH      VI+RD K SNIL++++ + K+ DFGLA+  
Sbjct: 97  PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Query: 294 PEDGKT------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             D         +V TR      Y APE +++    +K+ D++S G +  E+LT +
Sbjct: 154 DPDEDEKGFLTEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 79/303 (26%), Positives = 134/303 (44%), Gaps = 40/303 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 198
           +G+G FG VFKG   +N T  V       VA+K ++ +  +   E +  E+  L     P
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 119

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 317
           E +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNTFVGTPFWMAPEVI 173

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                 SK+D++S G+  +E+  G     +  P     L+    P             P 
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PT 220

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 437
           LEG++    S+   +    CL+++P  RP   E+++    ++  K    +SY  + +   
Sbjct: 221 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK---KTSYLTELIDRY 273

Query: 438 NTW 440
             W
Sbjct: 274 KRW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 83/301 (27%), Positives = 123/301 (40%), Gaps = 68/301 (22%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 197
           ++GEG +G V+K    +         TG  VA+K ++       +E   E N L     H
Sbjct: 13  VIGEGTYGKVYKA-RHKK--------TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNH 62

Query: 198 PNLVKLVG------YCIEDDQRLLVYEFMPRGS---LENHLFRKG-SLPLPWSIRMKIAL 247
           PN+    G          DDQ  LV E    GS   L   L +KG  L   W     IA 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAY 117

Query: 248 ---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVST 303
                 +GLA+LHE     VI+RD K  NILL  +   KL DFG++       G+ +   
Sbjct: 118 ILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174

Query: 304 RVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
              GT  + APE +           ++SDV+S G+  +E+  G                 
Sbjct: 175 ---GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG----------------- 214

Query: 359 WARPHLGDK---RRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             +P L D    R  +++     P L+       S+K     ++CL ++ + RP M E++
Sbjct: 215 --KPPLCDMHPMRALFKIPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELL 270

Query: 413 E 413
           E
Sbjct: 271 E 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 30/215 (13%)

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 251
           +P LV L   C +   RL LV E++  G L  H+ R+  LP      ++  + IAL    
Sbjct: 55  NPFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN--- 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
              FLHE   + +IYRD K  N+LLDAD + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR-RF 370
            APE +         D ++ GV++ EM+ GR   D    N + N  ++    + +K  R 
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI 222

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            R L            S KA+ +    L++DPK R
Sbjct: 223 PRFL------------SVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 47/167 (28%), Positives = 72/167 (43%), Gaps = 16/167 (9%)

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           P + KL       D   LV E++  G   + +   G LP  W  +  IA     G+  LH
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLH 114

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +I+RD K  N+L+D   + KL+DFGL+++         + + +GT  Y APE +
Sbjct: 115 QRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETI 165

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-----NGEHNLVEW 359
           +       SD +S G V+ E L G        P     N     + W
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 66/217 (30%), Positives = 103/217 (47%), Gaps = 21/217 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           F    LP   L +   +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A +  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 138 SCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  + APE +     T +SDV+SFGV+L E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 72/298 (24%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 133 NFRPESLLGEGGFGCVFKGWVE-ENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           NF+ E  +G G F  V++     +     +K        V+       +  ++ + E++ 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALK-------KVQIFEMMDAKARQDCVKEIDL 55

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGA 249
           L  L HPN++K +   IED++  +V E    G L   +  F+K    +P     K  +  
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              +  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++GT 
Sbjct: 116 CSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y +PE +       KSD++S G +L EM                       P  GDK  
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDKMN 212

Query: 370 FYRLLD-------PRLEG-HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
            + L         P L   H+    S+K  +L + C+  DP  RP +  V +  K + 
Sbjct: 213 LFSLCQKIEQCDYPPLPTEHY----SEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 72/208 (34%), Positives = 95/208 (45%), Gaps = 24/208 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGNL 195
           +G+G FG V     +           G   AVK L    +   KE    +AE N  L N+
Sbjct: 3   IGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI-ALGAAKGL 253
            HP LV L  Y  +   +L  V +++  G L  HL R+ S P P   R +  A   A  L
Sbjct: 54  KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAEIASAL 109

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      +IYRD K  NILLD+  +  L+DFGL K+  E  KT  ++   GT  Y A
Sbjct: 110 GYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLA 164

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D +  G VL EML G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 189
           N+R   LLG+G FG V+  +        V  G  L       + +  +  KE  A   E+
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-------DVDTGRELAAKQVQFDPESPETSKEVSALECEI 55

Query: 190 NFLGNLLHPNLVKLVGYCIED--DQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
             L NL H  +V+  G C+ D  ++ L ++ E+MP GS+++ L   G+L    S+  K  
Sbjct: 56  QLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT--ESVTRKYT 112

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-V 305
               +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    R V
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            GT  + +PE +       K+DV+S G  ++EMLT +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 69/214 (32%), Positives = 99/214 (46%), Gaps = 22/214 (10%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGN 194
            +LG+G FG V     E  GT  +        A+K L  D +    +    + E   L  
Sbjct: 6   MVLGKGSFGKVMLA--ERKGTDEL-------YAIKILKKDVIIQDDDVECTMVEKRVLAL 56

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              P  +  +  C +   RL  V E++  G L  H+ + G    P ++    A   A GL
Sbjct: 57  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--AAEIAIGL 114

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYA 312
            FLH    K +IYRD K  N++LDA+ + K++DFG+ K+    GKT   TR   GT  Y 
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYI 168

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
           APE +         D ++FGV+L EML G+   D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 18/213 (8%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-LAEVNF 191
           NF+    LGEG +  V+KG    N T      TG  VA+K ++ D  +G     + E++ 
Sbjct: 1   NFKQLEKLGEGTYATVYKG---RNRT------TGEIVALKEIHLDAEEGTPSTAIREISL 51

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAA 250
           +  L H N+V+L      +++ +LV+E+M    L+ ++   G    L  +          
Sbjct: 52  MKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLL 110

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           KG+AF HE     V++RD K  N+L++     KL+DFGLA+       T  +  V  T  
Sbjct: 111 KGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLW 165

Query: 311 YAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           Y AP+ ++     S S D++S G ++ EM+TGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 22/218 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 187
           N+R   LLG+G FG V+  +  +         TG  +AVK +  + +  +  KE  A   
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALEC 53

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L NLLH  +V+  G   +  +R L    E MP GS+++ L   G+L    ++  K 
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT--ENVTRKY 111

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR- 304
                +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    + 
Sbjct: 112 TRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS 168

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           V GT  + +PE +       K+D++S G  ++EMLT +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 36/210 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 196
           +G G FG V+                   VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 23  IGHGSFGAVYFARDVRTNE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGS----LENHLFRKGSLPLPWSIRMKIALGAAKG 252
           HPN ++  G  + +    LV E+   GS    LE H  +K   PL       I  GA +G
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH--KK---PLQEVEIAAICHGALQG 127

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTYGY 311
           LA+LH       I+RD K  NILL      KL+DFG A   +P       +   +GT  +
Sbjct: 128 LAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSP-------ANSFVGTPYW 177

Query: 312 AAPEYVMT---GHLTSKSDVYSFGVVLLEM 338
            APE ++    G    K DV+S G+  +E+
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 65/222 (29%), Positives = 108/222 (48%), Gaps = 30/222 (13%)

Query: 134 FRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNF 191
                LL EG FG +F G  ++E      KPG    V VKT+ +H         L E   
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDE------KPGKEEEVFVKTVKDHASEIQVTLLLQESCL 61

Query: 192 LGNLLHPNLVKLVGYCIED-DQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMK---- 244
           L  L H N++ ++  CIED +   ++Y +M  G+L+  L   R G    P ++  +    
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PED-----GK 298
           +A+  A G+++LH+   + VI++D    N ++D +   K++D  L++D  P D       
Sbjct: 122 MAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +   + M      A E ++    +S SDV+SFGV+L E++T
Sbjct: 179 ENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 73/250 (29%), Positives = 98/250 (39%), Gaps = 45/250 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN-------FL 192
           +G+GG+G VF            K  TG  VA+K +    L      L EV         L
Sbjct: 9   VGQGGYGQVF---------LAKKKDTGEIVALKRMKKSLLF----KLNEVRHVLTERDIL 55

Query: 193 GNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIAL 247
                  LVKL+ Y  +DD+ L L  E++P G     L   G L       +   M  A+
Sbjct: 56  TTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            A   L ++H         RD K  N L+DA  + KL+DFGL+K       +     V+G
Sbjct: 115 DALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVG 160

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWA----RP 362
           +  Y APE +         D +S G +L E L G      + PN    NL  W     RP
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRP 220

Query: 363 HLGDKRRFYR 372
              D R    
Sbjct: 221 VYDDPRFNLS 230

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 50/284 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LG G  G V+K +            T   +AVK +  D  ++  K+ ++E+  L     P
Sbjct: 9   LGHGNGGTVYKAYH---------LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSP 59

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            ++   G    +++  +  EFM  GSL+  ++RK    +P  +  +IA+   KGL +L  
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLWS 113

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAPEYV 317
                +++RD K SN+L++     KL DFG++        KT+V     GT  Y APE +
Sbjct: 114 ---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERI 165

Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--------HNLVEWARPHLGDKRR 369
                   SDV+S G+  +E+  GR    + + N            +V+   P L     
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV--- 222

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     G F    S+K      QC+ + PK RP    +++
Sbjct: 223 ----------GQF----SEKFVHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL 195
           E ++GEG FG V +  ++       K G  +  A+K L     +  H+++  E+  L  L
Sbjct: 7   EDVIGEGNFGQVIRAMIK-------KDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 196 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------PLPWS 240
             HPN++ L+G C       +  E+ P G+L + L +   L               L   
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             ++ A   A G+ +L   +EK  I+RD    N+L+  +  +K++DFGL++     G+  
Sbjct: 120 QLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEV 171

Query: 301 VSTRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + MG     + A E +     T+KSDV+SFGV+L E+++
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 79/280 (28%), Positives = 119/280 (42%), Gaps = 36/280 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 3   IGRGNFGEVFSGRLRADNTP---------VAVKSCRETLPPDLKAKFLQEARILKQYSHP 53

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V+L+G C +     +V E +  G     L  +G   L     +++   AA G+ +L  
Sbjct: 54  NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLES 112

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAPEY 316
              K  I+RD    N L+      K+SDFG++++  EDG  + ST  M      + APE 
Sbjct: 113 ---KHCIHRDLAARNCLVTEKNVLKISDFGMSREE-EDG-VYASTGGMKQIPVKWTAPEA 167

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLD 375
           +  G  +S+SDV+SFG++L E  +       N  N +    +E          +  RL  
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE----------QGVRLPC 217

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           P L             +L  +C   DP  RP  S V + L
Sbjct: 218 PEL-------CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 76/213 (35%), Positives = 106/213 (49%), Gaps = 31/213 (14%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVN 190
           +LG+G FG VF   V +       P  G   A+K L    L+          ++ LAEVN
Sbjct: 3   VLGQGSFGKVF--LVRK----ITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN 56

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
                 HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A   
Sbjct: 57  ------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-EL 107

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    GT 
Sbjct: 108 ALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162

Query: 310 GYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTG 341
            Y APE V   GH T  +D +SFGV++ EMLTG
Sbjct: 163 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 67/220 (30%), Positives = 95/220 (43%), Gaps = 37/220 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G     G +  +      V VK L           +L EV     L HP
Sbjct: 3   IGNGWFGKVLLGEAH-RGMSKAR------VVVKELRASATPDEQLLFLQEVQPYRELNHP 55

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSIRMKIALGAAKGL 253
           N+++ +G CIE    LLV EF P G L+N+L R        +     +  ++A   A GL
Sbjct: 56  NVLQCLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQK-DVLQRMACEVASGL 113

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PED-----GKTHVSTRVMG 307
            +LH+      I+ D    N  L AD + K+ D+GLA +  PED         V  R   
Sbjct: 114 LWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR--- 167

Query: 308 TYGYAAPEYV-------MTGHLTSKSDVYSFGVVLLEMLT 340
              + APE V       +    T KS+++S GV + E+ T
Sbjct: 168 ---WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.1 bits (192), Expect = 7e-16
 Identities = 80/295 (27%), Positives = 122/295 (41%), Gaps = 43/295 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 26  LGEGCFGQVVMA--EAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    + +                 +
Sbjct: 84  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 200

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 201 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 250

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQL---AAQCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 251 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 87/273 (31%), Positives = 117/273 (42%), Gaps = 42/273 (15%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 195
           LLG+G FG V    V+E  T       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA--AKG 252
            HP L  L  Y  +   RL  V E+   G L  HL R+      +S       GA     
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV----FSEDRARFYGAEIVSA 107

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +    GT  Y 
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYL 163

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +         D +  GVV+ EM+ GR             L+      L ++ RF R
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEEIRFPR 217

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L P            +A  L +  L +DPK R
Sbjct: 218 TLSP------------EAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 89/274 (32%), Positives = 114/274 (41%), Gaps = 45/274 (16%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 195
           LLG+G FG V    V E  T       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT 52

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA--AKG 252
            HP L  L  Y  +   RL  V E+   G L  HL R+         R +   GA     
Sbjct: 53  RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARF-YGAEIVSA 107

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L +LH      V+YRD K  N++LD D + K++DFGL K+   DG T       GT  Y 
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGDKRRFY 371
           APE +         D +  GVV+ EM+ GR        N +H  L E     L ++ RF 
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHEKLFELI---LMEEIRFP 215

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           R L            S +A  L A  L +DPK R
Sbjct: 216 RTL------------SPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 20  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHE 258
           +VKL+G    D +  ++ EF P G+++  +      L  P  I++ I     + L +LH 
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-QIQV-ICRQMLEALQYLHS 128

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +I+RD K  N+LL  D + KL+DFG++  A            +GT  + APE VM
Sbjct: 129 ---MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 319 TGHLTS-----KSDVYSFGVVLLEM 338
              +       K+D++S G+ L+EM
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 71/215 (33%), Positives = 99/215 (46%), Gaps = 39/215 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGNLLH 197
           +GEG +G VFK    E         TG  VA+K    + D     K  L E+  L  L H
Sbjct: 9   IGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH 59

Query: 198 PNLVKLVGYCIE---DDQRL-LVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAK 251
           PNLV L    IE     ++L LV+E+    ++ N L +  +G   +P  +  KI     +
Sbjct: 60  PNLVNL----IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRG---VPEHLIKKIIWQTLQ 111

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKT-HVSTRVMGT 308
            + F H+      I+RD K  NIL+      KL DFG A+    P D  T +V+TR    
Sbjct: 112 AVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---- 164

Query: 309 YGYAAPEYVMTGHLT--SKSDVYSFGVVLLEMLTG 341
             Y APE ++ G        DV++ G V  E+LTG
Sbjct: 165 -WYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 72/238 (30%), Positives = 104/238 (43%), Gaps = 44/238 (18%)

Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-TLNHDGLQG-HKEWLA 187
             R++     LGEG FG V+K           +  TG  VA+K  L H+   G     L 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKA---------RQIKTGRVVALKKILMHNEKDGFPITALR 56

Query: 188 EVNFLGNLLHPNLVKLVGYCIE-----DDQRLLVYEFMP------RGSLENHLFRKGSLP 236
           E+  L  L HPN+V L+   +E       +R  VY   P       G LEN   +   L 
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LT 113

Query: 237 LPWSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--- 291
               I+  M   L   +G+ +LHE     +++RD K +NIL+D     K++DFGLA+   
Sbjct: 114 ES-QIKCYMLQLL---EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 292 DAPEDGK------THVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             P + K      T   T ++ T  Y  PE ++     T+  D++  G V  EM T R
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 31/222 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K   +          TG  VA+K +  D    G+      + E
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTA--IRE 49

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIA 246
           ++ L  L HPN+VKL+     +++  LV+EF+ +  L+  +       +PLP        
Sbjct: 50  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQ 108

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTR 304
           L   +GLAF H      V++RD K  N+L++ +   KL+DFGLA+    P    TH    
Sbjct: 109 L--LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---E 160

Query: 305 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           V+ T  Y APE ++   + ++  D++S G +  EM+T RR++
Sbjct: 161 VV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 84/282 (29%), Positives = 116/282 (41%), Gaps = 46/282 (16%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 190
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVR---------ATGKMYACKRLEKKRIKKRKGESMALNEKQ 52

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            L  +    +V L       D   LV   M  G L+ H++  G+   P     +    AA
Sbjct: 53  ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFEEERALFYAA 109

Query: 251 K---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           +   GL  LH E     +YRD K  NILLD   + ++SD GLA   PE     +  RV G
Sbjct: 110 EILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-G 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE +     T   D +  G ++ EM+ G+                   P  G K
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ------------------SPFRGRK 205

Query: 368 RRFYR-LLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKAR 405
            +  R  +D R+   E  +S K S++A  +    L++DPK R
Sbjct: 206 EKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 66/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 194
           +LG+G FG V    ++E+G            AVK L  D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVMLARLKESGR---------LYAVKVLKKDVILQDDDVECTMTEKRILSLA 52

Query: 195 LLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
             HP L +L   C +   RL  V EF+  G L  H+ +        +      + +A  L
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--L 109

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +GKT  ++   GT  Y A
Sbjct: 110 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIA 164

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D ++ GV+L EML G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 78/313 (24%), Positives = 136/313 (43%), Gaps = 50/313 (15%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL 195
           + ++GEG FG V K  ++       K G  +  A+K +     +  H+++  E+  L  L
Sbjct: 12  QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64

Query: 196 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------PLPWS 240
             HPN++ L+G C       L  E+ P G+L + L +   L               L   
Sbjct: 65  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++     G+  
Sbjct: 125 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEV 176

Query: 301 VSTRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
              + MG     + A E +     T+ SDV+S+GV+L E++    S+      G      
Sbjct: 177 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SLGGTPYCGMTCAEL 232

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL-KP 417
           + +   G     YRL  P       +    +   L  QC    P  RP  ++++ +L + 
Sbjct: 233 YEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280

Query: 418 LQNLKDMASSSYY 430
           L+  K   +++ Y
Sbjct: 281 LEERKTYVNTTLY 293

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHP 198
           LG G FGCV KG  +            + VA+K L ++  +    E + E   +  L +P
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQ-------IDVAIKVLKNENEKSVRDEMMREAEIMHQLDNP 55

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            +V+++G C E +  +LV E    G L   L  K    +  S  +++    + G+ +L  
Sbjct: 56  YIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEG 113

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 316
              K  ++RD    N+LL   + AK+SDFGL+K    D  ++   R  G +   + APE 
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPEC 169

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT 340
           +     +S+SDV+S+G+ + E  +
Sbjct: 170 INFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 60/186 (32%), Positives = 88/186 (47%), Gaps = 23/186 (12%)

Query: 164 GTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFM 220
           GTG   A+K L    +   K+      E + L  L HP +V ++    ++++   + EF+
Sbjct: 41  GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV 100

Query: 221 PRGSLENHLFRKGSLPLPWSIRMKIA--LGAAKGLAF--LHEEAEKPVIYRDFKTSNILL 276
             G L  HL + G  P        +A    A   LAF  LH    K +IYRD K  N+LL
Sbjct: 101 VGGELFTHLRKAGRFP------NDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLL 151

Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVL 335
           D   + K++DFG AK  P+   T     + GT  Y APE + + GH     D ++ GV+L
Sbjct: 152 DNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLL 205

Query: 336 LEMLTG 341
            E + G
Sbjct: 206 YEFIAG 211

Length = 329

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 30/216 (13%)

Query: 197 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 251
           HP LV L   C + + RL  V E++  G L  H+ R+  LP      +S  + +AL    
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN--- 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
              +LHE     +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y
Sbjct: 111 ---YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRR 369
            APE +         D ++ GV++ EM+ GR   D   +  N + N  ++          
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL--------- 213

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           F  +L+ ++    S+  S KA  +    L++DPK R
Sbjct: 214 FQVILEKQIRIPRSL--SVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 26/231 (11%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HK 183
           ++ L+T  F  E  LGE  FG V+KG +   GTAP +      VA+KTL  D  +G   +
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHL--FGTAPGEQTQ--AVAIKTLK-DKAEGPLRE 53

Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK------GSLPL 237
           E+  E      L HPN+V L+G   ++    +++ +     L   L  +      GS   
Sbjct: 54  EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 238 PWSIR--------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
             +++        + I    A G+ FL   +   V+++D  T N+L+    N K+SD GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            ++        +    +    + +PE +M G  +  SD++S+GVVL E+ +
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 69/289 (23%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G +G V+K      G           VA+K +  +     +    E++ L    HPN
Sbjct: 11  IGSGTYGDVYKARDIATGE---------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V   G  +  D+  +V E+   GSL++ +++    PL       +     KGLA+LHE 
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE- 119

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR--VMGTYGYAAPEYV 317
                I+RD K +NILL  D + KL+DFG++    +   T ++ R   +GT  + APE  
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT-IAKRKSFIGTPYWMAPEVA 173

Query: 318 ---MTGHLTSKSDVYSFGVVLLEM-----------------LTGRRSMDKNRPNGEHNLV 357
                G    K D+++ G+  +E+                 L  + +             
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPP---------- 223

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
               P L DK ++                S        +CL++DPK RP
Sbjct: 224 ----PKLKDKEKW----------------SPVFHDFIKKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 24/206 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G FG V+K   +E         TG+  A K ++    +  ++++ E++ L +  HPN
Sbjct: 13  LGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +VKL+     ++   ++ EF   G+++  +      PL       +     + L +LHE 
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               +I+RD K  NIL   D + KL+DFG++  A            +GT  + APE VM 
Sbjct: 123 K---IIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 320 GHLTS-------KSDVYSFGVVLLEM 338
              TS       K+DV+S G+ L+EM
Sbjct: 178 E--TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 20/209 (9%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 196
           E  LG G FG V+     ++            VAVKT+   G    + +LAE N +  L 
Sbjct: 11  EKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVMKTLQ 59

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLA 254
           H  LVKL    +  +   ++ EFM +GSL + L        PLP  I     +  A+G+A
Sbjct: 60  HDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 116

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           F+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + AP
Sbjct: 117 FIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAP 172

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           E +  G  T KSDV+SFG++L+E++T  R
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 65/208 (31%), Positives = 96/208 (46%), Gaps = 30/208 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG G FG V KG  +   +         TVAVK L +D        E L E N +  L +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEK-------TVAVKILKNDNNDPALKDELLREANVMQQLDN 55

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLEN------HLFRKGSLPLPWSIRMKIALGAAK 251
           P +V+++G C E +  +LV E    G L        H+  K    L   + M        
Sbjct: 56  PYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM-------- 106

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY-- 309
           G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +  
Sbjct: 107 GMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPV 162

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLE 337
            + APE +     +SKSDV+SFGV++ E
Sbjct: 163 KWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 30/212 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           +GEG +G V+K   +          TG  VA+K +    L+   E      + E++ L  
Sbjct: 7   IGEGTYGVVYKARDKL---------TGEIVALKKIR---LETEDEGVPSTAIREISLLKE 54

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
           L HPN+V+L+   +  + +L LV+EF+    L+ ++       L   +         +G+
Sbjct: 55  LNHPNIVRLLD-VVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGI 112

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGTYGY 311
           A+ H      V++RD K  N+L+D +   KL+DFGLA+    P    TH    V+ T  Y
Sbjct: 113 AYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWY 165

Query: 312 AAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            APE ++     S   D++S G +  EM+  R
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 55/217 (25%), Positives = 100/217 (46%), Gaps = 21/217 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LH 197
           LGEG FG V +   E  G    +P   +TVAVK L  +   +   + ++E+  +  +  H
Sbjct: 20  LGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRM 243
            N++ L+G C ++    ++ E+  +G+L   L               +     L +   +
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L     +  I+RD    N+L+  D   K++DFGLA+   +      ++
Sbjct: 138 SCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  + APE +     T +SDV+SFG+++ E+ T
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 64/216 (29%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 186
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +       + +
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLIMARKLIHLEIKPAIRNQII 51

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 109

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 110 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 163

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-L 196
           ++GEG FG V K  ++       K G  +  A+K +     +  H+++  E+  L  L  
Sbjct: 2   VIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 54

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL-PWSIR------------- 242
           HPN++ L+G C       L  E+ P G+L + L +   L   P                 
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++     G+    
Sbjct: 115 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 166

Query: 303 TRVMGTYG--YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            + MG     + A E +     T+ SDV+S+GV+L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 71/219 (32%), Positives = 107/219 (48%), Gaps = 39/219 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 194
           LG+G +G V+K          +   T   VA+K +  D  +   +  A     E+ FL  
Sbjct: 15  LGKGAYGIVWKA---------IDRRTKEVVALKKI-FDAFRNATD--AQRTFREIMFLQE 62

Query: 195 LL-HPNLVKLVG-YCIEDDQRL-LVYEFMPRGSLENHL---FRKGSLPLPWSIRMK-IAL 247
           L  HPN+VKL+     E+D+ + LV+E+M     E  L    R   L     +  + I  
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILE---DVHKRYIMY 114

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTR 304
              K L ++H      VI+RD K SNILL++D   KL+DFGLA+   +  E+ +  V T 
Sbjct: 115 QLLKALKYIHS-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 305 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            + T  Y APE ++     +K  D++S G +L EML G+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 75.1 bits (184), Expect = 7e-15
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 21/217 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 23  LGEGCFGQVVMA--EALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM-------------- 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    + +S  +              
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  + APE +     T +SDV+SFGV++ E+ T
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 84/282 (29%), Positives = 119/282 (42%), Gaps = 46/282 (16%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVN 190
           FR   +LG+GGFG V    V           TG   A K L    ++   G    L E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKR 52

Query: 191 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            L  +    +V L  Y  E  D   LV   M  G L+ H++  G+   P     +    A
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGN---PGFDEQRAIFYA 108

Query: 250 AK---GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           A+   GL  L  E    ++YRD K  NILLD   + ++SD GLA   PE G+T V  RV 
Sbjct: 109 AELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE-GET-VRGRV- 162

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT GY APE +     T   D +  G ++ EM+ G+    K +       V+        
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREE----- 212

Query: 367 KRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKAR 405
                  +D R+   +  +S K S+ A  +    L+++PK R
Sbjct: 213 -------VDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 33/218 (15%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVN 190
           + +     +G+G  G V+        TA +   TG  VA+K +N    Q  KE +  E+ 
Sbjct: 19  KKYTRFEKIGQGASGTVY--------TA-IDVATGQEVAIKQMNLQQ-QPKKELIINEIL 68

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            +    HPN+V  +   +  D+  +V E++  GSL +         +     M     AA
Sbjct: 69  VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD---------VVTETCMDEGQIAA 119

Query: 251 ------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVST 303
                 + L FLH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    +
Sbjct: 120 VCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RS 173

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            ++GT  + APE V       K D++S G++ +EM+ G
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 74/275 (26%), Positives = 125/275 (45%), Gaps = 35/275 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 198
           +G+G FG V+KG   +N T  V       VA+K ++ +  +   E +  E+  L     P
Sbjct: 12  IGKGSFGEVYKGI--DNRTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            + +  G  ++  +  ++ E++  GS  + L + G  PL  +    I     KGL +LH 
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLHS 119

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
           E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT  + APE + 
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIK 174

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
                 K+D++S G+  +E+  G        P     L+    P             P L
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTL 221

Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           EG +    S+   +    CL++DP+ RP   E+++
Sbjct: 222 EGQY----SKPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 72/236 (30%), Positives = 108/236 (45%), Gaps = 34/236 (14%)

Query: 117 SQLRKFMFNDLKLATRNFR--PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLT 168
           S  R     D ++A   F+  PE L      +G G FG V+  +  +  T  V       
Sbjct: 2   STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY--FARDVRTNEV------- 52

Query: 169 VAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 225
           VA+K +++ G Q +++W   + EV FL  + HPN ++  G  + +    LV E+   GS 
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSA 111

Query: 226 ENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
            + L      PL       I  GA +GLA+LH      +I+RD K  NILL      KL+
Sbjct: 112 SD-LLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLA 167

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEM 338
           DFG A  A        +   +GT  + APE ++    G    K DV+S G+  +E+
Sbjct: 168 DFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 88/276 (31%), Positives = 116/276 (42%), Gaps = 49/276 (17%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 195
           LLG+G FG V    V E  T       G   A+K L  + +    E    + E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 52

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA--AKG 252
            HP L  L  Y  +   RL  V E+   G L  HL R+         R +   GA     
Sbjct: 53  RHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF-YGAEIVSA 107

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  +    GT  Y 
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRR 369
           APE +         D +  GVV+ EM+ GR    + D  R      L E     L ++ R
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELI---LMEEIR 213

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           F R L P            +A  L A  L +DPK R
Sbjct: 214 FPRTLSP------------EAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 24/217 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLA--- 187
           N+R   LLG G FG V+  +  +         TG  +AVK +  + D  +  KE  A   
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALEC 53

Query: 188 EVNFLGNLLHPNLVKLVGYCIED--DQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMK 244
           E+  L NL H  +V+  G C+ D  +++L ++ E+MP GS+++ L   G+L    ++  +
Sbjct: 54  EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT--ENVTRR 110

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                 +G+++LH      +++RD K +NIL D+  N KL DFG +K       +    +
Sbjct: 111 YTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 305 -VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            V GT  + +PE +       K+DV+S    ++EMLT
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 196
           +LG+G FG V +  ++         G+   VAVK L  D       +E+L E   +    
Sbjct: 6   MLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59

Query: 197 HPNLVKLVGYCIED--DQRL----LVYEFMPRGSLENHLF--RKGSLP--LPWSIRMKIA 246
           HPN++KL+G  +      RL    ++  FM  G L   L   R G  P  LP    ++  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A G+ +L   + K  I+RD    N +L+ +    ++DFGL+K               
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + A E +     T+ SDV++FGV + E++T
Sbjct: 177 LPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 46/313 (14%)

Query: 136 PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-E 188
           PE L      +G+G FG VFKG   +N T  V       VA+K ++ +  +   E +  E
Sbjct: 2   PEELFTKLERIGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQE 52

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIAL 247
           +  L     P + K  G  ++  +  ++ E++  GS  + L R G       +  +K  L
Sbjct: 53  ITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL 111

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              KGL +LH E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V G
Sbjct: 112 ---KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-G 163

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  + APE +      SK+D++S G+  +E+  G        P     L+    P     
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP----- 218

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASS 427
                   P L G F    S+   +    CL++DP  RP   E+   LK    +K+   +
Sbjct: 219 --------PTLTGEF----SKPFKEFIDACLNKDPSFRPTAKEL---LKHKFIVKNAKKT 263

Query: 428 SYYFQTMQADNTW 440
           SY  + +     W
Sbjct: 264 SYLTELIDRFKRW 276

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 195
           +LG+G FG V             + GT    A+K L  D +    +    + E   L   
Sbjct: 7   VLGKGSFGKV---------MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS 57

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
             P  +  +  C +   RL  V E++  G L   + + G    P ++    A   A GL 
Sbjct: 58  GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLF 115

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAA 313
           FLH    K +IYRD K  N++LD++ + K++DFG+ K+   DG   V+T+   GT  Y A
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIA 169

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
           PE +         D ++FGV+L EML G+   +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 44/297 (14%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 196
           L+GEG +G V K   +E         TG  VA+K    + D     K  + E+  L  L 
Sbjct: 8   LVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR 58

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           H NLV L+       +  LV+EF+    L++   +  G   L  S   K      +G+ F
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEF 115

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKT-HVSTRVMGTYGYA 312
            H      +I+RD K  NIL+      KL DFG A+   AP +  T +V+TR      Y 
Sbjct: 116 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYR 167

Query: 313 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR------RSMDK---------NRPNGEHNL 356
           APE ++      ++ D+++ G ++ EMLTG         +D+         N       +
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            +      G +    + ++P LE  F  K S     LA QCL  DP  RP  S+++ 
Sbjct: 228 FQKNPLFAGMRLPEVKEIEP-LEKRFP-KLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 85/276 (30%), Positives = 119/276 (43%), Gaps = 34/276 (12%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLA--EVN 190
           FR   +LG+GGFG V    V           TG   A K L    ++  K E +A  E  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVR---------ATGKMYACKKLEKKRIKKRKGEAMALNEKQ 52

Query: 191 FLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            L  +    +V L  Y  E  D   LV   M  G L+ H++  G+        +  A   
Sbjct: 53  ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEI 111

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             GL  LH E    ++YRD K  NILLD   + ++SD GLA + PE G+T +  RV GT 
Sbjct: 112 TCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-GET-IRGRV-GTV 165

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
           GY APE V     T   D +  G ++ EM+ G+    + +   +   VE         RR
Sbjct: 166 GYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---------RR 216

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                    +  +S K S+ A  +  Q L++DP  R
Sbjct: 217 V-----KEDQEEYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 72/214 (33%), Positives = 98/214 (45%), Gaps = 32/214 (14%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 194
           +LG+G FG VF         A +K GT    A+K L  D +    +    + E   L   
Sbjct: 2   MLGKGSFGKVF--------LAELK-GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 52

Query: 195 LLHPNLVKLVGYCI--EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK- 251
             HP L  L  YC     +    V E++  G L  H+       LP     +    AA+ 
Sbjct: 53  WEHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP-----RATFYAAEI 105

Query: 252 --GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP-EDGKTHVSTRVMGT 308
             GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT       GT
Sbjct: 106 ICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGT 159

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++     +  D +SFGV+L EML G+
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 81/291 (27%), Positives = 119/291 (40%), Gaps = 45/291 (15%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGN 194
              +G G FG V K   + +GT          +AVK      D  +  K  L +++ +  
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGT---------IMAVKRIRSTVDEKE-QKRLLMDLDVVMR 58

Query: 195 LLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKGSLPLPWSIRMKIALGAA 250
               P +VK  G    +    +  E M   SL+    +++      +P  I  KIA+   
Sbjct: 59  SSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS---TRVMG 307
           K L +L EE +  +I+RD K SNILLD + N KL DFG++      G+   S   TR  G
Sbjct: 118 KALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS------GQLVDSIAKTRDAG 169

Query: 308 TYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEMLTGRRSMDK-NRPNGEHNLVEWARPH 363
              Y APE +          +SDV+S G+ L E+ TG+    K N         +  +  
Sbjct: 170 CRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVV 224

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
            GD       L    E  FS             CL +D   RP+  E++E 
Sbjct: 225 KGDPPI----LSNSEEREFSP----SFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 22/208 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGN 194
           ++G+G FG V     + +G            AVK L    +   KE    +AE N  L N
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKC---------YAVKVLQKKIVLNRKEQKHIMAERNVLLKN 52

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
           + HP LV L  Y  +  ++L  V +F+  G L  HL R+ S P P + R   A   A  L
Sbjct: 53  VKHPFLVGL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASAL 109

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      ++YRD K  NILLD+  +  L+DFGL K+      T  +T   GT  Y A
Sbjct: 110 GYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLA 164

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +      +  D +  G VL EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.8 bits (178), Expect = 5e-14
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWL 186
           +L   +F   S LG G  G V K           KP +GL +A K ++ +       + +
Sbjct: 1   ELKDDDFERISELGAGNGGVVTK--------VQHKP-SGLIMARKLIHLEIKPAIRNQII 51

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E+  L     P +V   G    D +  +  E M  GSL+  L  K +  +P  I  K++
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVS 109

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   +GLA+L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 163

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 67/216 (31%), Positives = 97/216 (44%), Gaps = 34/216 (15%)

Query: 136 PESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---L 186
           PE L      +G G FG V+      N            VA+K +++ G Q +++W   +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDII 63

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV FL  L HPN ++  G  + +    LV E+   GS  + L      PL       + 
Sbjct: 64  KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVT 121

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRV 305
            GA +GLA+LH      +I+RD K  NILL      KL DFG A   AP       +   
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXF 171

Query: 306 MGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEM 338
           +GT  + APE ++    G    K DV+S G+  +E+
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 78/274 (28%), Positives = 116/274 (42%), Gaps = 39/274 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL 196
           LG+GGFG V          A     TG   A K LN   L   +G++  + E   L  + 
Sbjct: 1   LGKGGFGEVS---------ACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV- 50

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLF----RKGSLPLPWSIRMKIALGAAK 251
           H   +  + Y  +    L LV   M  G L  H++         P P +      +    
Sbjct: 51  HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQI--IS 108

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL  LH+   + +IYRD K  N+LLD D N ++SD GLA +  +DG++  +    GT G+
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSK-TKGYAGTPGF 163

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +         D ++ GV L EM+  R      R  GE   VE       +K    
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF---RARGEK--VE-------NKELKQ 211

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           R+L+  +   +  K S  +       L++DP+ R
Sbjct: 212 RILNDSVT--YPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 66/219 (30%), Positives = 88/219 (40%), Gaps = 33/219 (15%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH---------DGLQGHKE 184
           FR  ++LG G FG V     E   T       G   A+K L           + L   K 
Sbjct: 1   FRCLAVLGRGHFGKVL--LAEYKKT-------GELYAIKALKKGDIIARDEVESLMCEKR 51

Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
                N      HP LV L   C + +  +  V E+   G L  H+        P   R 
Sbjct: 52  IFETANSER---HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEP---RA 103

Query: 244 KI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A     GL +LHE     ++YRD K  N+LLD +   K++DFGL K+    G    S
Sbjct: 104 VFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TS 159

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T   GT  + APE +     T   D +  GV++ EML G
Sbjct: 160 T-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 22/160 (13%)

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E   L  + HP +++L  +  E DQR L  + E++P G L ++L   G     +S    +
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR----FSNSTGL 104

Query: 246 ALGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              +     L +LH    K ++YRD K  NILLD + + KL+DFG AK      K    T
Sbjct: 105 FYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRT 155

Query: 304 RVM-GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
             + GT  Y APE +   GH  +  D ++ G+++ EML G
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 55/205 (26%)

Query: 228 HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 287
            ++ KG L +P  I  KIA+   K L +LH +    VI+RD K SN+L++ +   KL DF
Sbjct: 92  KVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDF 148

Query: 288 G--------LAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVL 335
           G        +AK           T   G   Y APE +           KSDV+S G+ +
Sbjct: 149 GISGYLVDSVAK-----------TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITM 197

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD------PRL-EGHFSIKGSQ 388
           +E+ TGR   D            W  P       F +L        P+L    FS     
Sbjct: 198 IELATGRFPYDS-----------WKTP-------FQQLKQVVEEPSPQLPAEKFSP---- 235

Query: 389 KATQLAAQCLSRDPKARPRMSEVVE 413
           +      +CL ++ K RP   E+++
Sbjct: 236 EFQDFVNKCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 69/211 (32%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLG-N 194
           +LG+G FG V    ++         G G   AVK L  D +    +    + E   L   
Sbjct: 2   VLGKGSFGKVLLAELK---------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA 52

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK--- 251
             +P L  L       +    V EF+  G L  H+  KG   L      +    AA+   
Sbjct: 53  WENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-----YRATFYAAEIVC 107

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL FLH    K +IYRD K  N++LD D + K++DFG+ K+    G    ST   GT  Y
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRAST-FCGTPDY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE +     T   D +SFGV+L EML G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 53/151 (35%), Positives = 74/151 (49%), Gaps = 17/151 (11%)

Query: 197 HPNLVKLVGYCI--EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK--- 251
           HP L  L  +C     +    V E++  G L  H+   G          +    AA+   
Sbjct: 55  HPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA-----RARFYAAEIIC 107

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL FLH+   K +IYRD K  N+LLD D + K++DFG+ K+   +G+   ST   GT  Y
Sbjct: 108 GLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN-MNGEGKAST-FCGTPDY 162

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE +         D +SFGV+L EML G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 52/150 (34%), Positives = 78/150 (52%), Gaps = 16/150 (10%)

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           P LV L  Y  + D +L L+ +++  G L  HL+++        +R+ IA      L  L
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHL 121

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYAAP 314
           H+     +IYRD K  NILLD++ +  L+DFGL+K+  A E+ + +      GT  Y AP
Sbjct: 122 HQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175

Query: 315 EYVMT---GHLTSKSDVYSFGVVLLEMLTG 341
           E +     GH     D +S GV+  E+LTG
Sbjct: 176 EVIRGGSGGH-DKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 66/256 (25%), Positives = 102/256 (39%), Gaps = 65/256 (25%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGN 194
           L+G+GG G V+  +          P     VA+K +  D L       K +L E     +
Sbjct: 9   LIGKGGMGEVYLAY---------DPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAAD 58

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMP----------------RGSLENHLFRKGSLPLP 238
           L+HP +V +  Y I  D    VY  MP                + SL   L  K S+   
Sbjct: 59  LIHPGIVPV--YSICSDGDP-VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 291
            SI  KI       + ++H    K V++RD K  NILL       + D+G A        
Sbjct: 116 LSIFHKIC----ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEE 168

Query: 292 -----DAPEDGKTH----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-- 340
                D  E    +    +  +++GT  Y APE ++    +  +D+Y+ GV+L +MLT  
Sbjct: 169 DLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228

Query: 341 -------GRRSMDKNR 349
                  GR+   ++ 
Sbjct: 229 FPYRRKKGRKISYRDV 244

Length = 932

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 65/230 (28%), Positives = 100/230 (43%), Gaps = 35/230 (15%)

Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
             L++   +F    ++G G FG V    V    +  V        A+K L+   +    +
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEV--QLVRHKSSKQV-------YAMKLLSKFEMIKRSD 86

Query: 185 ----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
               W  E + + +     +V+L  Y  +DD+ L +V E+MP G L N L     +P  W
Sbjct: 87  SAFFW-EERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKW 143

Query: 240 SI----RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
           +      + +AL A   + F+H         RD K  N+LLD   + KL+DFG       
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDA 194

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
           +G     T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 195 NGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 69/209 (33%), Positives = 97/209 (46%), Gaps = 24/209 (11%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVN-FLGN 194
           ++G+G FG V     + +G+           AVK L    +   KE    +AE N  L N
Sbjct: 2   VIGKGSFGKVLLAKRKSDGS---------FYAVKVLQKKTILKKKEQNHIMAERNVLLKN 52

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI-ALGAAKG 252
           L HP LV L  Y  +  ++L  V +++  G L  HL R+     P   R +  A   A  
Sbjct: 53  LKHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP---RARFYAAEVASA 108

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + +LH      +IYRD K  NILLD+  +  L+DFGL K+  E  +T  ++   GT  Y 
Sbjct: 109 IGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYL 163

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           APE +         D +  G VL EML G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 84/271 (30%), Positives = 117/271 (43%), Gaps = 41/271 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 196
           +G+G FG V +  V +  T  +        A+KT+    +    E    LAE   L  + 
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRI-------YALKTIRKAHIVSRSEVTHTLAERTVLAQVN 51

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            P +V L  +  +  ++L LV  F+  G L +HL R+G   L      +     A+ L  
Sbjct: 52  CPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL-----SRARFYTAELLCA 105

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTYGYAAP 314
           L    +  VIYRD K  NILLD   +  L DFGL K +  +D KT+      GT  Y AP
Sbjct: 106 LENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT---FCGTPEYLAP 162

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E ++    T   D ++ GV+L EMLTG        P  + N+ E  R  L +  RF    
Sbjct: 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGL------PPFYDENVNEMYRKILQEPLRFPDGF 216

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D            + A  L    LSRDP  R
Sbjct: 217 D------------RDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 64/231 (27%), Positives = 101/231 (43%), Gaps = 53/231 (22%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAE 188
            F   + +GEG +G V++              +G  VA+K +      DG+      L E
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISS--LRE 56

Query: 189 VNFLGNLLHPNLVKL---------------VGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
           +  L NL HPN+V+L               + YC +D   LL  + MP            
Sbjct: 57  ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPT----------- 103

Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
             P   S    + L   +GL +LHE     +I+RD K SN+LL      K++DFGLA+  
Sbjct: 104 --PFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-T 157

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGR 342
                  ++ +V+ T  Y APE +   T + T+  D+++ G +L E+L  +
Sbjct: 158 YGLPAKPMTPKVV-TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           L FLH      VIYRD K  NILLDA+ + KL+DFG+ K+   +G T  +T   GT  Y 
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           APE +         D ++ GV++ EM+ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 35/215 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 194
           +GEG +G V+KG             TG  VA+K +    L+  +E +      E++ L  
Sbjct: 8   IGEGTYGVVYKG---------RNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKE 55

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSI---RMKIAL-GAA 250
           L HPN+V L    +++ +  L++EF+    L+ +L    SLP    +    +K  L    
Sbjct: 56  LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYL---DSLPKGQYMDAELVKSYLYQIL 111

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVSTRVMGT 308
           +G+ F H    + V++RD K  N+L+D     KL+DFGLA+    P      V T  + T
Sbjct: 112 QGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP----VRVYTHEVVT 164

Query: 309 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             Y APE ++     S   D++S G +  EM T +
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 64/259 (24%), Positives = 113/259 (43%), Gaps = 43/259 (16%)

Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           TG  VAVK ++    Q  +    EV  + +  H N+V +    +  D+  +V EF+  G+
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 225 LENHLFRKGSLPLPWSIRMK------IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           L +         +    RM       + L   + L++LH +    VI+RD K+ +ILL +
Sbjct: 106 LTD---------IVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTS 153

Query: 279 DYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV 334
           D   KLSDFG    ++K+ P+         ++GT  + APE +      ++ D++S G++
Sbjct: 154 DGRIKLSDFGFCAQVSKEVPK------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207

Query: 335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLA 394
           ++EM+ G                 +  P L   RR    L PR++    +    +     
Sbjct: 208 VIEMIDGEPPY-------------FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG--FL 252

Query: 395 AQCLSRDPKARPRMSEVVE 413
              L R+P  R    E+++
Sbjct: 253 DLMLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 72/292 (24%), Positives = 125/292 (42%), Gaps = 44/292 (15%)

Query: 66  SSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNA-------ESASSTPKFSEELKVASQ 118
             +   ST      S  +RR    +P+     S A        S+SS+   S     ++ 
Sbjct: 8   PGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAP 67

Query: 119 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NH 176
                 ++L+   R       +G G  G V+K          +   TG   A+K +  NH
Sbjct: 68  SAAKSLSELERVNR-------IGSGAGGTVYK---------VIHRPTGRLYALKVIYGNH 111

Query: 177 DGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRKGSL 235
           +     ++   E+  L ++ HPN+VK       + +  ++ EFM  GSLE  H+  +  L
Sbjct: 112 ED-TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFL 170

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
                    +A     G+A+LH    + +++RD K SN+L+++  N K++DFG+++   +
Sbjct: 171 A-------DVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSK-----SDVYSFGVVLLEMLTGR 342
                 S+  +GT  Y +PE + T            D++S GV +LE   GR
Sbjct: 221 TMDPCNSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 25/179 (13%)

Query: 188 EVNFLGNLLHPNLVKLV-GYCIEDDQRLLVYEFMP--RGSLENHLFRKGSLPLPWSIRMK 244
           E++ L  + H  ++ L+  Y      +  V   MP  +  L  ++ R G LPL  +I   
Sbjct: 136 EIDILKTISHRAIINLIHAY----RWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI--T 189

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           I     + LA+LH    + +I+RD KT NI LD   NA L DFG A       K      
Sbjct: 190 IQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA------CKLDAHPD 240

Query: 305 VMGTYGYA------APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNL 356
               YG++      +PE +      +K+D++S G+VL EM     ++  K   +    L
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299

Length = 392

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 25/225 (11%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE---VNFL 192
           ++G GGFG V+            K  TG   A+K L+   +   QG    L E   ++ +
Sbjct: 1   IIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 51

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
                P +V +       D+   + + M  G L  HL + G          ++   A + 
Sbjct: 52  STGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-----EKEMRFYATEI 106

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K H S   +GT+GY 
Sbjct: 107 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS---VGTHGYM 162

Query: 313 APEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 44/280 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V          A VK  +G  VAVK ++    Q  +    EV  + +  H N
Sbjct: 28  IGEGSTGIVC--------IATVK-SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   K L
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLKAL 129

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++     S  ++GT  + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMA 184

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +       + D++S G++++EM+ G        P     ++   R +L  K +    
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKLKNLHK 241

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           + P L+G               + L RDP  R   +E+++
Sbjct: 242 VSPSLKGFLD------------RLLVRDPAQRATAAELLK 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 65/242 (26%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 190
            ++P   +G G +G V            +   +G  VA+K + H  D     K  L E+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSA---------IDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK 56

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR---------LLVYEFM---------PRGSLENHLFRK 232
            L +  H N++      I D  R          +V + M             L     R 
Sbjct: 57  ILRHFKHDNII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRY 111

Query: 233 GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK- 291
               L             +GL ++H      VI+RD K SN+L++ D   ++ DFG+A+ 
Sbjct: 112 FLYQL------------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156

Query: 292 --DAPEDGKT----HVSTRVMGTYGYAAPE--YVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
              +P + K     +V+TR      Y APE    +  + T+  D++S G +  EML GRR
Sbjct: 157 LSSSPTEHKYFMTEYVATR-----WYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRR 209

Query: 344 SM 345
            +
Sbjct: 210 QL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 85/302 (28%), Positives = 137/302 (45%), Gaps = 48/302 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLLH 197
           LG+G +G V+K           +P TG+T+A+K +  + L   K  + + E++ L   + 
Sbjct: 9   LGKGNYGSVYK--------VLHRP-TGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVS 58

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP--LPWSIRMKIALGAAKGLAF 255
           P +V   G    +    +  E+M  GSL+  L+  G     +P  +  +I     KGL F
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKF 117

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-GKTHVSTRVMGTYGYAAP 314
           L EE    +I+RD K +N+L++ +   KL DFG++ +      KT++     G   Y AP
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAP 170

Query: 315 EYVMTGHL------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL-GDK 367
           E + +G        T +SDV+S G+ +LEM  GR       P    N+       + GD 
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP---PETYANIFAQLSAIVDGDP 227

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLK-DM 424
                   P L   +    S  A    A+CL++ P  RP  ++++E   L   +N   DM
Sbjct: 228 --------PTLPSGY----SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDM 275

Query: 425 AS 426
           A 
Sbjct: 276 AE 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.7 bits (162), Expect = 3e-12
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G VF           +   TG  VA+K +N       +  + E+  +  L +PN
Sbjct: 27  IGQGASGTVFTA---------IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V  +   +  D+  +V E++  GSL + +          +   +  L A   L FLH  
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA---LEFLHAN 134

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
               VI+RD K+ N+LL  D + KL+DFG  A+  PE  K    + ++GT  + APE V 
Sbjct: 135 Q---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVT 188

Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
                 K D++S G++ +EM+ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 22/207 (10%)

Query: 162 KPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 221
           KPG    V +K     G +G    L E   L N+ HP+++++    +      +V   +P
Sbjct: 87  KPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LP 137

Query: 222 RGSLENHLF-RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
             S + + +  K S PLP    + I     +GL +LH +    +I+RD KT NI ++   
Sbjct: 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVD 194

Query: 281 NAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLE 337
              + D G A+    AP          + GT    APE +      SK+D++S G+VL E
Sbjct: 195 QVCIGDLGAAQFPVVAPAF------LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFE 248

Query: 338 MLTGRRSMDKNRPNGEHNLVEWARPHL 364
           ML    ++ ++ P+     V+    HL
Sbjct: 249 MLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Length = 357

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 35/94 (37%), Positives = 55/94 (58%), Gaps = 5/94 (5%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRVMGTY 309
           +GL ++H      V++RD K SN+LL+ + + K+ DFGLA+   PE   T   T  + T 
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            Y APE ++     +K+ D++S G +L EML+ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 4e-12
 Identities = 68/260 (26%), Positives = 115/260 (44%), Gaps = 32/260 (12%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA+K +N       +  + E+  +    +PN
Sbjct: 27  IGQGASGTVYTA---------IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALDF 130

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 184

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPHLGDKRR---- 369
           E V       K D++S G++ +EM+ G    +++N     + +     P L +  R    
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244

Query: 370 FYRLLDPRLEGHFSIKGSQK 389
           F   L+  LE     +GS K
Sbjct: 245 FRDFLNRCLEMDVDRRGSAK 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 22/210 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG+G +G V+         A     T + +A+K +     +  +    E+     L H 
Sbjct: 15  VLGKGTYGIVY---------AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA--KGLAFL 256
           N+V+ +G   E+    +  E +P GSL   L R    PL  + +  I       +GL +L
Sbjct: 66  NIVQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           H+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y AP
Sbjct: 125 HDNQ---IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLA--GINPCTETFTGTLQYMAP 178

Query: 315 EYVMTGH--LTSKSDVYSFGVVLLEMLTGR 342
           E +  G     + +D++S G  ++EM TG+
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 5e-12
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 27/207 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 185

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           E V       K D++S G++ +EM+ G
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 18/205 (8%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LGEG +  VFKG  +          T   VA+K +  +  +G     + EV+ L NL H 
Sbjct: 13  LGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V L      +    LV+E++    L+ +L   G+L    ++++       +GL++ H+
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK 121

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              + +++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++
Sbjct: 122 ---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLL 176

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTGR 342
            +   ++  D++  G +L EM TGR
Sbjct: 177 GSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 65.2 bits (159), Expect = 7e-12
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 45/282 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           +GEG FG       +E+G   V         +K +N   +     +E   EV  L N+ H
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYV---------IKEINISKMSPKEREESRKEVAVLSNMKH 58

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP------WSIRMKIALGAAK 251
           PN+V+      E+    +V ++   G L   +  +  +  P      W +++ +AL    
Sbjct: 59  PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL---- 114

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
               +H+   + +++RD K+ NI L  D   KL DFG+A+    +    ++   +GT  Y
Sbjct: 115 --KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYY 167

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            +PE        +KSD+++ G VL EM T + + +        NLV      L   R  Y
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA---GNMKNLV------LKIIRGSY 218

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               P +  H+    S     L +Q   R+P+ RP ++ ++E
Sbjct: 219 ----PPVSSHY----SYDLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.5 bits (157), Expect = 8e-12
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 19/159 (11%)

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGL 253
           PN+V L  Y + +D   LV +    G L +H+ +  ++P      W+  M +AL A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH E    ++ RD   +NILLD   + +L+ F    +  +         +     Y A
Sbjct: 101 --LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCA 150

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
           PE       T   D +S G +L E+LTG +++ +  P+G
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSG 188

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.9 bits (160), Expect = 9e-12
 Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNL 195
           LLG+G FG V    V E  +       G   A+K L  + +    E    L E   L N 
Sbjct: 2   LLGKGTFGKVI--LVREKAS-------GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
            HP L  L  Y  +   RL  V E++  G L  HL R+       +      + +A  L 
Sbjct: 53  RHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LD 109

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      ++YRD K  N++LD D + K++DFGL K+   D  T  +    GT  Y AP
Sbjct: 110 YLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAP 164

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +         D +  GVV+ EM+ GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 16/181 (8%)

Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           +G  VAVK ++    Q  +    EV  + +  H N+V++    +  ++  ++ EF+  G+
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 225 LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           L + +       L       +     + L +LH +    VI+RD K+ +ILL  D   KL
Sbjct: 105 LTDIV---SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKL 158

Query: 285 SDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           SDFG    ++KD P+         ++GT  + APE +      ++ D++S G++++EM+ 
Sbjct: 159 SDFGFCAQISKDVPK------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVD 212

Query: 341 G 341
           G
Sbjct: 213 G 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 76/302 (25%), Positives = 124/302 (41%), Gaps = 42/302 (13%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 191
           ++ + ++G+G +G V          + +   TG  VA+K +N   + +      L E+  
Sbjct: 2   YKIQEVIGKGSYGVV---------CSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKL 52

Query: 192 LGNLLHPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           L  L HP++V++    +   +R      +V+E M     + H   K +  L         
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFL 109

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRV 305
               + L ++H      V +RD K  NIL +AD   K+ DFGLA+ A  D  T +  T  
Sbjct: 110 YQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 306 MGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------NLV 357
           + T  Y APE   +     T   D++S G +  E+LTG+        N  H      +L+
Sbjct: 167 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--NVVHQLDLITDLL 224

Query: 358 EWARPHLGDK------RRFYRLLDPRLEGHFSIK---GSQKATQLAAQCLSRDPKARPRM 408
               P    +      RR+   +  +    FS K       A +L  + L+ DPK RP  
Sbjct: 225 GTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA 284

Query: 409 SE 410
            E
Sbjct: 285 EE 286

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 11/94 (11%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SNI ++ D   K+ DFGLA+   ++   +V+TR      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180

Query: 311 YAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGR 342
           Y APE +M    H     D++S G ++ E+LTG+
Sbjct: 181 YRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 40/218 (18%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT----LNHDGLQGHKEWLAEVNFLG 193
           + +GEG +G V+K              TG  VA+K     L+ +G+      L E+  L 
Sbjct: 5   AEIGEGAYGTVYKA---------RDLNTGRFVALKKVRVPLSEEGIP--LSTLREIALLK 53

Query: 194 NLL---HPNLVKLVGYC--IEDDQRL---LVYEFMPR---GSLENHLFRKGSLPLPWSIR 242
            L    HPN+V+L+  C     D+ L   LV+E + +     L      K  LP P +I+
Sbjct: 54  QLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLP-PETIK 110

Query: 243 --MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             M+  L   +G+ FLH      +++RD K  NIL+ +D   K++DFGLA+    +    
Sbjct: 111 DLMRQLL---RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL- 163

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
             T V+ T  Y APE ++     +  D++S G +  E+
Sbjct: 164 --TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 20/184 (10%)

Query: 169 VAVKTLNHDGLQGHKEWLA----EVNFLGNLLHPNLVKLVGYCIEDDQRL----LVYEFM 220
           V ++T      +GHK  +     E+  L  +   N++K+ G+ I+    L    L+ E+ 
Sbjct: 46  VIIRTFKKFH-KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 221 PRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
            RG L   L ++  L      ++ +A+   KGL  L++   KP  Y++  + + L+  +Y
Sbjct: 105 TRGYLREVLDKEKDLSF--KTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENY 160

Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEM 338
             K+   GL K        +V+  V     Y + + +       T K D+YS GVVL E+
Sbjct: 161 KLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEI 215

Query: 339 LTGR 342
            TG+
Sbjct: 216 FTGK 219

Length = 283

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 80/311 (25%), Positives = 111/311 (35%), Gaps = 72/311 (23%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAE 188
           ++F+   LLG+G  G VF   V   GT  +        A+K L+   +    +    L E
Sbjct: 1   KHFKKIKLLGKGDVGRVF--LVRLKGTGKL-------FALKVLDKKEMIKRNKVKRVLTE 51

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK---GSLPLPWSIRMKI 245
              L  L HP L  L      +    LV ++ P G L   L ++     L      R   
Sbjct: 52  QEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEE-VARFYA 109

Query: 246 A-LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV--- 301
           A +  A  L +LH      ++YRD K  NILL    +  LSDF L+K +  +        
Sbjct: 110 AEVLLA--LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL 164

Query: 302 ---------------------STRVM---GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLL 336
                                S R     GT  Y APE +   GH  S  D ++ G++L 
Sbjct: 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLY 223

Query: 337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR--FYRLLDPRLEGHFSIKGSQKATQLA 394
           EML G                    P  G  R   F  +L   +    S   S  A  L 
Sbjct: 224 EMLYGT------------------TPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLI 265

Query: 395 AQCLSRDPKAR 405
            + L +DP  R
Sbjct: 266 RKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 60/224 (26%), Positives = 98/224 (43%), Gaps = 31/224 (13%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----- 186
           + +   + +GEG +G VFK    +NG        G  VA+K +    +Q  +E +     
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVR---VQTGEEGMPLSTI 49

Query: 187 ---AEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
              A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 108

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 109 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 165

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
               T V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 166 L---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 72/290 (24%), Positives = 105/290 (36%), Gaps = 66/290 (22%)

Query: 165 TGLTVAVKTLNHDGLQGHKEWL---AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 221
           T   VAVK +N D     ++      E+     L HPN++  V   I D +  +V   M 
Sbjct: 24  TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82

Query: 222 RGS----LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD 277
            GS    L+ H F +G   LP      I       L ++H    K  I+R  K S+ILL 
Sbjct: 83  YGSCEDLLKTH-FPEG---LPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLS 135

Query: 278 ADYNAKLSDFGLAKDAPEDGKTHV--------STRVMGTYGYAAPEYV---MTGHLTSKS 326
            D    LS    +    + GK           S + +    + +PE +   + G+   KS
Sbjct: 136 GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL---PWLSPEVLQQNLQGY-NEKS 191

Query: 327 DVYSFGVVLLEMLTG--------RRSMDKNRPNGEHNLVEWAR---PHLGDKRRFYRLLD 375
           D+YS G+   E+  G           M          L+E  R   P L DK  +    D
Sbjct: 192 DIYSVGITACELANGHVPFKDMPATQM----------LLEKVRGTVPCLLDKSTYPLYED 241

Query: 376 PRLEGHFSIKGSQKAT---------------QLAAQCLSRDPKARPRMSE 410
              +   S +                     Q    CL RDP++RP  S+
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 32/219 (14%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 189
           + P + +G G +G V+K            P +G  VA+K++    N DGL      + EV
Sbjct: 2   YEPVAEIGVGAYGTVYKA---------RDPHSGHFVALKSVRVQTNEDGLP--LSTVREV 50

Query: 190 NFLGNLL---HPNLVKLVGYC--IEDDQRL---LVYEFMPRGSLENHLFRKGSLPLPWSI 241
             L  L    HPN+V+L+  C     D+     LV+E + +  L  +L +     LP   
Sbjct: 51  ALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAET 109

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
              +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+         +
Sbjct: 110 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQM 162

Query: 302 S-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
           + T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 23/212 (10%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G V  +G  P +      V VK L     +Q   ++L E     +L H 
Sbjct: 3   IGNGWFGKVILGEVN-SGYTPAQ------VVVKELRVSASVQEQMKFLEEAQPYRSLQHS 55

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSL--PLPWSIRMKIALGAAKGLA 254
           NL++ +G C E    LLV EF P G L+ +L   RK  L  P P +++ ++A   A GL 
Sbjct: 56  NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEIALGLL 114

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
            LH+      I+ D    N LL AD   K+ D+GL+ +  ++       ++     + AP
Sbjct: 115 HLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171

Query: 315 EYV--MTGHL-----TSKSDVYSFGVVLLEML 339
           E V  + G+L     T +S+V+S GV + E+ 
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 49/145 (33%), Positives = 70/145 (48%), Gaps = 20/145 (13%)

Query: 206 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW----SIRMKIALGAAKGLAFLHEEA 260
           Y  +DD+ L +V E+MP G L N L     +P  W    +  + +AL A   + F+H   
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH--- 165

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT- 319
                 RD K  N+LLD   + KL+DFG      ++G     T V GT  Y +PE + + 
Sbjct: 166 ------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQ 218

Query: 320 ---GHLTSKSDVYSFGVVLLEMLTG 341
              G+   + D +S GV L EML G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 45/147 (30%), Positives = 73/147 (49%), Gaps = 10/147 (6%)

Query: 211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK 270
           D+   + + M  G L  HL + G          ++   AA+ +  L     + V+YRD K
Sbjct: 70  DKLSFILDLMNGGDLHYHLSQHGVFS-----EAEMRFYAAEIILGLEHMHNRFVVYRDLK 124

Query: 271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVY 329
            +NILLD   + ++SD GLA D  +  K H S   +GT+GY APE +  G    S +D +
Sbjct: 125 PANILLDEHGHVRISDLGLACDFSKK-KPHAS---VGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 330 SFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           S G +L ++L G     +++   +H +
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 68/210 (32%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 196
           +G+G FG V++           K  T    A+K L+   +   KE    + E N L   L
Sbjct: 1   IGKGTFGQVYQ---------VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL 51

Query: 197 HPNLVKLVG--YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
                 +VG  +  + D  L LV ++M  G L  HL ++G        R K  + A   L
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS---EDRAKFYI-AELVL 107

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           A  H   +  ++YRD K  NILLDA  +  L DFGL+K    D KT  +    GT  Y A
Sbjct: 108 ALEHLH-KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLA 164

Query: 314 PEYVM--TGHLTSKSDVYSFGVVLLEMLTG 341
           PE ++   G+ T   D +S GV++ EM  G
Sbjct: 165 PEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 52/154 (33%), Positives = 74/154 (48%), Gaps = 23/154 (14%)

Query: 198 PNLVKLVGYC-IEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW----SIRMKIALGAAK 251
           P +V+L  +C  +DD+ L +V E+MP G L N L     +P  W    +  + +AL A  
Sbjct: 103 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 159

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            +  +H         RD K  N+LLD   + KL+DFG      E G     T V GT  Y
Sbjct: 160 SMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDY 209

Query: 312 AAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
            +PE + +    G+   + D +S GV L EML G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 23/226 (10%)

Query: 188 EVNFLGNLLHPNLVKLV-GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           E   L  L HPN+V     +  ED    +V  F   G L + L  +    LP +  ++  
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +  A  L +LHE   K +++RD KT N+ L      K+ D G+A+    + +  +++ ++
Sbjct: 109 VQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLI 163

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y +PE         KSDV++ G  + EM T + + +    N   +LV         
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---SLV--------- 211

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
               YR+++ +L        S +  +L A  LS+ P+ RP +  ++
Sbjct: 212 ----YRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 53/220 (24%), Positives = 89/220 (40%), Gaps = 37/220 (16%)

Query: 141 GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLH 197
           G G +G V+K               G   A+K    D  Q     +    E+  L  L H
Sbjct: 9   GRGTYGRVYKAK-------RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 198 PNLVKLVGYCIEDDQRL--LVYEFMPRGSLE--NHLFRKGSLPLPWSIRMKIALGAAKGL 253
            N+V LV   +E   +   L++++      +      +   + +P S+   +      G+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DAP------EDGKTHV 301
            +LH      V++RD K +NIL+  +       K+ D GLA+  +AP       D     
Sbjct: 122 HYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP---- 174

Query: 302 STRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 340
              V+ T  Y APE ++   H T   D+++ G +  E+LT
Sbjct: 175 ---VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.1 bits (156), Expect = 6e-11
 Identities = 51/159 (32%), Positives = 75/159 (47%), Gaps = 17/159 (10%)

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +H    K +I+RD K++NILL ++   KL DFG +K         V     GT  Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
                  + K+D++S GV+L E+LT +R  D     GE N+ E     L  +   Y  L 
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GE-NMEEVMHKTLAGR---YDPLP 266

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
           P +        S +  ++    LS DPK RP  S+++  
Sbjct: 267 PSI--------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 60/177 (33%), Positives = 81/177 (45%), Gaps = 13/177 (7%)

Query: 170 AVKTLNHDGLQGHKE---WLAEVN-FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL 225
           AVK L    +   KE    ++E N  L N+ HP LV L       D+   V +++  G L
Sbjct: 24  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 83

Query: 226 ENHLFRKGSLPLPWSIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
             HL R+     P   R +  A   A  L +LH      ++YRD K  NILLD+  +  L
Sbjct: 84  FYHLQRERCFLEP---RARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVL 137

Query: 285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +DFGL K+  E   T  ++   GT  Y APE +         D +  G VL EML G
Sbjct: 138 TDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 18/169 (10%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A+G+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D             
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T++SDV+SFGV+L E+ +   S     P  + N     R   G + R
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGAS---PYPGVQINEEFCQRLKDGTRMR 297

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                 P +              +   C   DPK RP  S +VE L  L
Sbjct: 298 APENATPEIYR------------IMLACWQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 57/207 (27%), Positives = 104/207 (50%), Gaps = 22/207 (10%)

Query: 140 LGEGGFGCVFKGW--VEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLL 196
           LGEG +  VFKG   + EN            VA+K +  +  +G     + EV+ L +L 
Sbjct: 14  LGEGTYATVFKGRSKLTEN-----------LVALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           H N+V L      D    LV+E++ +  L+ ++   G++    ++++ +     +GLA+ 
Sbjct: 63  HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYC 120

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H    + V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ 
Sbjct: 121 HR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDV 175

Query: 317 VM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           ++ +   +++ D++  G +  EM +GR
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 39/217 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVNFLGNLLH 197
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 8   IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 58

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMP----------RGSLENHLFRKGSLPLPWSIRMKIAL 247
            N+V+L      D +  LV+E+             G ++  + +     L          
Sbjct: 59  KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL---------- 108

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              KGLAF H      V++RD K  N+L++ +   KL+DFGLA+      + + S  V+ 
Sbjct: 109 --LKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV- 161

Query: 308 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRR 343
           T  Y  P+ +    L S S D++S G +  E+    R
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 61.7 bits (149), Expect = 1e-10
 Identities = 80/292 (27%), Positives = 119/292 (40%), Gaps = 43/292 (14%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F    L+G G +G V+KG         VK  TG   A+K ++  G +  +E   E+N L 
Sbjct: 8   FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 57

Query: 194 NLLH-PNLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
              H  N+    G  I+      DDQ  LV EF   GS+ + +       L       I 
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 117

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               +GL+ LH+     VI+RD K  N+LL  +   KL DFG++  A  D         +
Sbjct: 118 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 172

Query: 307 GTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           GT  + APE +            KSD++S G+  +EM  G   +    P     L+    
Sbjct: 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--- 229

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R   PRL+   S K S+K       CL ++   RP   ++++
Sbjct: 230 ----------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 37/114 (32%), Positives = 57/114 (50%), Gaps = 3/114 (2%)

Query: 231 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
            + S PL     ++ +   A+G+ FL   A K  I+RD    N+LL     AK+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS 344
           +D   D    V         + APE +     T +SDV+S+G++L E+ +  +S
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 66/226 (29%), Positives = 99/226 (43%), Gaps = 44/226 (19%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFL 192
             +GEG +G V+K              TG  VA+K +    L   KE      + E+  L
Sbjct: 13  GQIGEGTYGQVYKA---------RDKDTGELVALKKVR---LDNEKEGFPITAIREIKIL 60

Query: 193 GNLLHPNLVKLVGYCIEDDQRL----------LVYEFMPR---GSLENHL--FRKGSLPL 237
             L H N+V L     +    L          LV+E+M     G LE+ L  F +  +  
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK- 119

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
             S  MK  L   +GL + H+   K  ++RD K SNILL+     KL+DFGLA+    + 
Sbjct: 120 --SF-MKQLL---EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
               + +V+ T  Y  PE ++       + DV+S G +L E+ T +
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 32/243 (13%)

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           +E++ L    H  +VK       DD+ LL+ E+   G L   + ++    LP+    ++ 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L   + +  L E   + +++RD K++NI L      KL DFG +K   +     V++   
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y APE       + K+D++S GV+L E+LT                    RP  G 
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLT------------------LHRPFKGP 274

Query: 367 KRR------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL 418
            +R       Y   DP     F    S     L    LS++P  RP   +++ T  LK +
Sbjct: 275 SQREIMQQVLYGKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329

Query: 419 QNL 421
            NL
Sbjct: 330 ANL 332

Length = 478

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 47/219 (21%)

Query: 142 EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGNLL 196
           EG +G V++   ++         TG  VA+K L  +     KE      L E+N L  L 
Sbjct: 15  EGTYGVVYRARDKK---------TGEIVALKKLKMEK---EKEGFPITSLREINILLKLQ 62

Query: 197 HPNLVKL----VGYCIEDDQRLLVYEFMP---RGSLENHLFRKGSLPLPWSIR-----MK 244
           HPN+V +    VG  +  D+  +V E++    +  +E           P+        M 
Sbjct: 63  HPNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSLMETM-------KQPFLQSEVKCLML 113

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             L    G+A LH+     +++RD KTSN+LL+     K+ DFGLA++     K +  T+
Sbjct: 114 QLL---SGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQ 165

Query: 305 VMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           ++ T  Y APE ++     ++  D++S G +  E+LT +
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 5/93 (5%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL +LH      +++RD K  N+L++++   K+ DFGLA+    D   H++  V+  Y 
Sbjct: 114 RGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169

Query: 311 YAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           Y APE +M + H TS  D++S G +  E+L  R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 61/227 (26%), Positives = 91/227 (40%), Gaps = 23/227 (10%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F     LG G FG V          A  K      VA+K      +   K+   
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVI--------LATYKNEDFPPVAIKRFEKSKIIKQKQVDH 77

Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
             +E   L  + HP  V L G   ++    LV EF+  G     L R    P        
Sbjct: 78  VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP------ND 131

Query: 245 IALGAAKGLAFLHEEAEK-PVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           +    A  +  + E  +   ++YRD K  N+LLD D   K++DFG AK    D +T+   
Sbjct: 132 VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-- 187

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
            + GT  Y APE ++       +D ++ G+ + E+L G      N P
Sbjct: 188 -LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 14/149 (9%)

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA-AKGLAF 255
           P LV L  Y  + D +L L+ +++  G L  HL ++          ++I  G     L  
Sbjct: 65  PFLVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLALEH 120

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH+     +IYRD K  NILLD++ +  L+DFGL+K+  ED +   +    GT  Y AP+
Sbjct: 121 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-EVERAYSFCGTIEYMAPD 176

Query: 316 YVM---TGHLTSKSDVYSFGVVLLEMLTG 341
            V     GH     D +S GV++ E+LTG
Sbjct: 177 IVRGGDGGH-DKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 18/168 (10%)

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP------LPWSI 241
           EV  L  + HPN+V       E+ +  +V E+   G L   + R+  +       L W +
Sbjct: 49  EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTH 300
             +I+LG    L  +H+   + +++RD K+ NI L  +   AKL DFG+A+    +    
Sbjct: 109 --QISLG----LKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSME 157

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
           ++   +GT  Y +PE        +K+D++S G VL E+ T +   + N
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 24/218 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           NF    +LG G +G VF   V +         TG   A+K L    L    + +      
Sbjct: 1   NFELLKVLGTGAYGKVF--LVRKVT----GHDTGKLYAMKVLQKAALVQKAKTVEHTRTE 54

Query: 193 GNLLH-----PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            N+L      P LV L  Y  + + +L L+ +++  G +  HL+++ +        ++  
Sbjct: 55  RNVLEHVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS---EDEVRFY 110

Query: 247 LGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
            G     L  LH+     ++YRD K  NILLD++ +  L+DFGL+K+   + K    +  
Sbjct: 111 SGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-F 166

Query: 306 MGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTG 341
            GT  Y APE +    GH     D +S G+++ E+LTG
Sbjct: 167 CGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 50/169 (29%), Positives = 69/169 (40%), Gaps = 18/169 (10%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           AKG+ FL   A +  I+RD    NILL  +   K+ DFGLA+D  +D             
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T +SDV+SFGV+L E+ +               L     P +     
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------------LGASPYPGVKIDEE 290

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           F R L            + +  Q    C   +P  RP  SE+VE L  L
Sbjct: 291 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 48/281 (17%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGNL 195
           LG+G F  ++KG    ++    V PG  ++V +K L       H++ LA     + +  L
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLA 254
            H +LVKL G C+  D+ ++V E++  G L+  L R K ++ L W  ++ +A   A  L 
Sbjct: 59  SHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 255 FLHEEAEKPVIYRDFKTSNILL-DADYN------AKLSDFGLAKDAPEDGKTHVSTRVMG 307
           +L    +K +++ +    NIL+     N       KLSD G+              RV  
Sbjct: 116 YLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREERVER 167

Query: 308 TYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
              + APE +  G   LT  +D +SFG  LLE+ +          NGE  L   +     
Sbjct: 168 I-PWIAPECIRNGQASLTIAADKWSFGTTLLEICS----------NGEEPLSTLSS---S 213

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           +K RFY     + +    +    +   L  QC + DP  RP
Sbjct: 214 EKERFY-----QDQHRLPMPDCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 46/223 (20%)

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAF 255
           H ++V L G C+ D + ++V EF+  G L+  + RK   L  PW  + K+A   A  L++
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120

Query: 256 LHEEAEKPVIYRDFKTSNILL-----DADYNA--KLSDFGLAKDAPEDGKTHVSTR--VM 306
           L    +K +++ +  T NILL     D +     KLSD G+           V +R   +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQECV 169

Query: 307 GTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
               + APE V  + +L+  +D +SFG  L E+            NGE  L +     L 
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY----------NGEIPLKD---KTLA 216

Query: 366 DKRRFYRLLDPRLEGHFSI--KGSQKATQLAAQCLSRDPKARP 406
           +K RFY       EG   +     ++   L   C++ DP  RP
Sbjct: 217 EKERFY-------EGQCMLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LGEG +  V+KG    NG           VA+K ++    +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGISRINGQ---------LVALKVISMKTEEGVPFTAIREASLLKGLKHA 63

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V L       +    V+E+M     +  +   G L  P+++R+       +GLA++H 
Sbjct: 64  NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH-PYNVRL-FMFQLLRGLAYIHG 121

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
           +    +++RD K  N+L+      KL+DFGLA+      +T+ S  V  T  Y  P+ ++
Sbjct: 122 QH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTGR 342
                +S  D++  G + +EML G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 8e-10
 Identities = 52/182 (28%), Positives = 82/182 (45%), Gaps = 16/182 (8%)

Query: 165 TGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMP 221
           TG  VA+K +          K    E+  L +L H N++ L    I   + +  V E + 
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92

Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
            G+  + L      PL             +GL ++H      V++RD K SNIL++ + +
Sbjct: 93  -GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCD 146

Query: 282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLT 340
            K+ DFGLA+        +VSTR      Y APE ++T      + D++S G +  EML 
Sbjct: 147 LKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE 201

Query: 341 GR 342
           G+
Sbjct: 202 GK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 29/212 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           +GEG +G V+K              T  T+A+K +    L+   E      + E++ L  
Sbjct: 10  IGEGTYGVVYKARDRV---------TNETIALKKIR---LEQEDEGVPSTAIREISLLKE 57

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           + H N+V+L      + +  LV+E++    L+ H+           +         +G+A
Sbjct: 58  MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTRVMGTYGY 311
           + H      V++RD K  N+L+D   NA KL+DFGLA+    P    TH       T  Y
Sbjct: 117 YCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWY 169

Query: 312 AAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++ + H ++  D++S G +  EM+  +
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 24/170 (14%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           AKG++FL   A K  I+RD    NILL      K+ DFGLA+D   D    V        
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T +SDV+S+G++L E+ +               L     P +    +
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---------------LGSSPYPGMPVDSK 325

Query: 370 FYRLLDPRLEGH--FSIKGS-QKATQLAAQCLSRDPKARPRMSEVVETLK 416
           FY+++    EG+   S + +  +   +   C   DP  RP   ++V+ ++
Sbjct: 326 FYKMIK---EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 55/197 (27%), Positives = 83/197 (42%), Gaps = 38/197 (19%)

Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
               PL     +  +   A+G+ FL   A +  I+RD    NILL  +   K+ DFGLA+
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Query: 292 DAPED------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           D  +D      G   +  + M      APE +     T++SDV+SFGV+L E+ +     
Sbjct: 222 DIYKDPDYVRKGDARLPLKWM------APESIFDKVYTTQSDVWSFGVLLWEIFS----- 270

Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRD 401
                     L     P +     F R    RL+    ++  + AT     +   C   +
Sbjct: 271 ----------LGASPYPGVQIDEEFCR----RLKEGTRMRAPEYATPEIYSIMLDCWHNN 316

Query: 402 PKARPRMSEVVETLKPL 418
           P+ RP  SE+VE L  L
Sbjct: 317 PEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 33/93 (35%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+    +   +V TR      
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H T   D++S G ++ EMLTG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            GL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A  +   +V TR      
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ EMLTG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 55/205 (26%), Positives = 101/205 (49%), Gaps = 18/205 (8%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LGEG +  V+KG  +          T   VA+K +  +  +G     + EV+ L +L H 
Sbjct: 14  LGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V L      +    LV+E++ +  L+ +L   G+     ++++ +     +GL + H 
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR 122

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              + V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++
Sbjct: 123 ---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILL 177

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTGR 342
            +   +++ D++  G +  EM TGR
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHK-EWLAEVNFLGNLL 196
           LGEG +  V+KG  +  G           VA+K   L H+  +G     + E + L +L 
Sbjct: 13  LGEGSYATVYKGRSKLTGQL---------VALKEIRLEHE--EGAPFTAIREASLLKDLK 61

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           H N+V L           LV+E++    L+ ++   G      ++R+       +GLA+ 
Sbjct: 62  HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYC 119

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H+   + V++RD K  N+L+      KL+DFGLA+      KT+ +  V  T  Y  P+ 
Sbjct: 120 HQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174

Query: 317 VM--TGHLTSKSDVYSFGVVLLEMLTGR 342
           ++  T + TS  D++  G +  EM TGR
Sbjct: 175 LLGSTEYSTS-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 43/222 (19%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           ++    +GEG F  V K    + G            A+K +       H + L +VN L 
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGK---------YYAIKCMKK-----HFKSLEQVNNLR 46

Query: 194 NLL-------HPNLVKLVGYCIEDDQ--RL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            +        HPN+++L+   + D +  RL LV+E M     E  L +    PLP     
Sbjct: 47  EIQALRRLSPHPNILRLIE-VLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVK 103

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK----T 299
                  K L  +H      + +RD K  NIL+  D   KL+DFG  +      K     
Sbjct: 104 SYMYQLLKSLDHMHR---NGIFHRDIKPENILIK-DDILKLADFGSCRGI--YSKPPYTE 157

Query: 300 HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLT 340
           ++STR      Y APE ++T G+   K D+++ G V  E+L+
Sbjct: 158 YISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 68/256 (26%), Positives = 103/256 (40%), Gaps = 69/256 (26%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNF 191
           +F    ++G G FG V             K  TG   A+K L   + L+  KE +A V  
Sbjct: 2   DFESIKVIGRGAFGEV---------RLVQKKDTGHIYAMKKLRKSEMLE--KEQVAHVRA 50

Query: 192 LGNLL----HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI- 245
             ++L    +P +VKL  Y  +D+  L L+ E++P G +   L +K +     + R  I 
Sbjct: 51  ERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET-RFYIA 108

Query: 246 ----ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL------------ 289
               A+ +   L ++H         RD K  N+LLDA  + KLSDFGL            
Sbjct: 109 ETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159

Query: 290 ----AKDAPEDGKTHVST---------------RVM-----GTYGYAAPEYVMTGHLTSK 325
               +   P +    +S                R +     GT  Y APE  +      +
Sbjct: 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE 219

Query: 326 SDVYSFGVVLLEMLTG 341
            D +S GV++ EML G
Sbjct: 220 CDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 29/208 (13%)

Query: 217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 276
           Y+      ++N L   GS  L     +      A+G+ FL   A K  ++RD    N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270

Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLL 336
                 K+ DFGLA+D   D              + APE +     T+ SDV+S+G++L 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ---- 392
           E+ +               L     P +     FY     +++  + +     ATQ    
Sbjct: 331 EIFS---------------LGGTPYPGMIVDSTFYN----KIKSGYRMAKPDHATQEVYD 371

Query: 393 LAAQCLSRDPKARPR---MSEVVETLKP 417
           +  +C + +P+ RP    +S++VE+L P
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 61/259 (23%), Positives = 106/259 (40%), Gaps = 37/259 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 197
           +G G FG V            +   TG+  V VK L  +   +   E+L + +    L H
Sbjct: 3   IGNGWFGKVLLS--------EIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH 54

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGAAK 251
           PN+++ +G C+E    LLV+E+   G L+++L       R   L L      ++A   A 
Sbjct: 55  PNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAA 110

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  +H+      ++ D    N  L +D   K+ D+G+     ++              +
Sbjct: 111 GVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167

Query: 312 AAPEYV-------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            APE V       +T   T  S+V++ GV L E+        +N      +L +    + 
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF-------ENAAQPYSHLSDREVLNH 220

Query: 365 GDKRRFYRLLDPRLEGHFS 383
             K +  +L  P+LE  +S
Sbjct: 221 VIKDQQVKLFKPQLELPYS 239

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.8 bits (140), Expect = 3e-09
 Identities = 59/224 (26%), Positives = 94/224 (41%), Gaps = 33/224 (14%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
              + P   +G G +G V          +     T   VA+K + +  D     K  L E
Sbjct: 4   DTKYVPIKPIGRGAYGIV---------CSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE 54

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  L +L H N++ +    +    R       +VYE M     + H   + S  L     
Sbjct: 55  IKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK---T 299
                   +GL ++H      V++RD K SN+LL+A+ + K+ DFGLA+   E G     
Sbjct: 111 QYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTE 167

Query: 300 HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
           +V TR      Y APE ++     T+  DV+S G +  E+L  +
Sbjct: 168 YVVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 38/235 (16%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           DL     + RP   LG G  G VF         + V       VAVK +     Q  K  
Sbjct: 2   DLGSRYMDLRP---LGCGSNGLVF---------SAVDSDCDKRVAVKKIVLTDPQSVKHA 49

Query: 186 LAEVNFLGNLLHPNLVKL--------------VGYCIEDDQRLLVYEFMPRGSLENHLFR 231
           L E+  +  L H N+VK+              VG   E +   +V E+M    L N +  
Sbjct: 50  LREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLAN-VLE 107

Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLA 290
           +G L      R+       +GL ++H      V++RD K +N+ ++  D   K+ DFGLA
Sbjct: 108 QGPLSEEH-ARL-FMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLA 162

Query: 291 K--DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
           +  D     K ++S  ++  + Y +P  +++  + T   D+++ G +  EMLTG+
Sbjct: 163 RIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 84/297 (28%), Positives = 127/297 (42%), Gaps = 63/297 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLL-H 197
           +G+G +G V+K   +++G+           AVK L  D +    E + AE N L +L  H
Sbjct: 30  IGKGTYGKVYKVTNKKDGS---------LAAVKIL--DPISDVDEEIEAEYNILQSLPNH 78

Query: 198 PNLVKLVGYCIEDD-----QRLLVYEFMPRGS---LENHLFRKGSLPLPWSIRMKIALGA 249
           PN+VK  G   + D     Q  LV E    GS   L   L   G   L  ++   I  GA
Sbjct: 79  PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGA 137

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV---- 305
             GL  LH      +I+RD K +NILL  +   KL DFG++           STR+    
Sbjct: 138 LLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQL-------TSTRLRRNT 187

Query: 306 -MGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            +GT  + APE +           ++ DV+S G+  +E+  G   +    P     L + 
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLFKI 245

Query: 360 AR---PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            R   P L    ++ R  +     HF            +QCL +D +ARP ++ ++E
Sbjct: 246 PRNPPPTLLHPEKWCRSFN-----HF-----------ISQCLIKDFEARPSVTHLLE 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 77/292 (26%), Positives = 118/292 (40%), Gaps = 43/292 (14%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F    ++G G +G V+KG         VK  TG   A+K ++    +  +E   E+N L 
Sbjct: 18  FELVEVVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTEDE-EEEIKLEINMLK 67

Query: 194 NLLH-PNLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
              H  N+    G  I+      DDQ  LV EF   GS+ + +       L       I 
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               +GLA LH      VI+RD K  N+LL  +   KL DFG++  A  D         +
Sbjct: 128 REILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 182

Query: 307 GTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           GT  + APE +            +SD++S G+  +EM  G   +    P     L+    
Sbjct: 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 242

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           P             P+L+   S K S+K       CL ++  +RP   ++++
Sbjct: 243 P-------------PKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 49/290 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGNLL- 196
           +G+G +G VFK   ++NG+           AVK L+  HD     +E  AE N L  L  
Sbjct: 26  IGKGTYGKVFKVLNKKNGS---------KAAVKILDPIHDI---DEEIEAEYNILKALSD 73

Query: 197 HPNLVKLVG-YCIED----DQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGA 249
           HPN+VK  G Y  +D    DQ  LV E    GS+ + +  F K    +   I   I   A
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
             GL  LH       I+RD K +NILL  +   KL DFG++  A            +GT 
Sbjct: 134 LMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTP 188

Query: 310 GYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            + APE +     +     ++ DV+S G+  +E+  G   +    P              
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------------- 234

Query: 365 GDKRRFYRL-LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              R  +++  +P    H     S +      +CL++D + RP +S++++
Sbjct: 235 --MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 7/158 (4%)

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E + L  + HP++++L G    +    L+   +PR   + + +      +     + I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              + + +LHE     +I+RD K  NI ++   +  L DFG A   P D   +      G
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           T    APE +         D++S G+VL EM T   S+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 34/212 (16%)

Query: 140 LGEGGFGCVF----KGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGN 194
           LG+G FG V+    K  V E     +K      + V  LN ++ +Q ++E       L  
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLK-----EIPVGELNPNETVQANQE----AQLLSK 58

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLP------WSIRMKIA 246
           L HP +VK     +E D   ++ E+     L+  L   +     L       W I++ + 
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL- 117

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
                G+ ++H+   + +++RD K  NI L  +   K+ DFG+++     G   ++T   
Sbjct: 118 -----GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFT 166

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           GT  Y +PE +      SKSD++S G +L EM
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 77/302 (25%), Positives = 118/302 (39%), Gaps = 57/302 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           +G+G FG VFK        A  K  T   VA+K +    ++  KE      L E+  L  
Sbjct: 20  IGQGTFGEVFK--------ARHKK-TKQIVALKKVL---MENEKEGFPITALREIKILQL 67

Query: 195 LLHPNLVKLVGYCIEDDQR--------LLVYEFMPR--GSLENHLFRKGSLPLPWSIRMK 244
           L H N+V L+  C               LV+EF       L ++   K +L     + MK
Sbjct: 68  LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV-MK 126

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS 302
           + L    GL ++H      +++RD K +NIL+  D   KL+DFGLA+     ++ K +  
Sbjct: 127 MLL---NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180

Query: 303 TRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE--- 358
           T  + T  Y  PE ++         D++  G ++ EM T    M  N    +  L+    
Sbjct: 181 TNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240

Query: 359 -------W---ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
                  W    +  L  K        R +  RL+ +        A  L  + L  DP  
Sbjct: 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK---DPHALDLIDKLLVLDPAK 297

Query: 405 RP 406
           R 
Sbjct: 298 RI 299

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 17/167 (10%)

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSL-----PLPWSI 241
           E   L  + HPN+V        D    +V E+   G L   +  ++G L      L W +
Sbjct: 48  EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           +M +      G+  +HE   K V++RD K+ NI L  +   KL DFG A+     G  + 
Sbjct: 108 QMCL------GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AYA 157

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
            T V GT  Y  PE        +KSD++S G +L E+ T +     N
Sbjct: 158 CTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 30/93 (32%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A ++   +V+TR      
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180

Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 35/102 (34%), Positives = 59/102 (57%), Gaps = 9/102 (8%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGT 308
           GL ++H      V++RD K  N+L++AD   K+ DFGLA+   + P +    + T  + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172

Query: 309 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNR 349
             Y APE +++    +K+ DV+S G +L E+L GR+ + K +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 63/297 (21%), Positives = 131/297 (44%), Gaps = 48/297 (16%)

Query: 59  PSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQ 118
           P    ++           G S   +  D+ +     +  +NA          EE  + + 
Sbjct: 5   PIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDED-----EEKMIDND 59

Query: 119 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 178
           + +          ++++  +++G G FG V++          +   T   VA+K +  D 
Sbjct: 60  INRS-------PNKSYKLGNIIGNGSFGVVYEA---------ICIDTSEKVAIKKVLQDP 103

Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGY----CIEDDQRLL----VYEFMPRGSLENHL- 229
              ++E L     + NL H N++ L  Y    C + +++ +    V EF+P+ ++  ++ 
Sbjct: 104 QYKNRELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMK 158

Query: 230 -FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDF 287
            + + +  LP  +    +    + LA++H    K + +RD K  N+L+D + +  KL DF
Sbjct: 159 HYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF 215

Query: 288 GLAKD--APEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           G AK+  A +   +++ +R      Y APE ++   + T+  D++S G ++ EM+ G
Sbjct: 216 GSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 36/219 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQGHKEWLAEVNFLGNL 195
           +GEG +G V+K              TG  VA+K     ++ +G+      L E++ L  L
Sbjct: 9   IGEGTYGKVYKA---------RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQML 57

Query: 196 LH-PNLVKL--VGYCIEDDQRL---LVYEFMPRGSLENHL---FRKGSLPLPWSIRMKIA 246
                +V+L  V +  E + +    LV+E++    L+  +    R    PLP        
Sbjct: 58  SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVST 303
               KG+A  H+     V++RD K  N+L+D      K++D GL +    P    TH   
Sbjct: 117 YQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH--- 170

Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
             + T  Y APE ++   H ++  D++S G +  EM   
Sbjct: 171 -EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 48/174 (27%), Positives = 69/174 (39%), Gaps = 47/174 (27%)

Query: 206 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGLAFLHEEA 260
           Y  +D + L L+ EF+P G +   L +K +L       +     +A+ A   L F+H   
Sbjct: 68  YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH--- 124

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL----------------AKDAPED-------- 296
                 RD K  N+LLDA  + KLSDFGL                  + P D        
Sbjct: 125 ------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 297 ---------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                     +  ++   +GT  Y APE  M        D +S GV++ EML G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 58/218 (26%), Positives = 88/218 (40%), Gaps = 53/218 (24%)

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           AE + L    +  +VKL  Y  +D   L  V +++P G + + L R G      + R  I
Sbjct: 50  AERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYI 107

Query: 246 ALGAAKGLAFLHEEAEK-PVIYRDFKTSNILLDADYNAKLSDFGLA-------------- 290
           A      L    E   K   I+RD K  NIL+D D + KL+DFGL               
Sbjct: 108 A-----ELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQK 162

Query: 291 -----KDA--PEDGKTHVSTRVM--------------------GTYGYAAPEYVM-TGHL 322
                +D+  P +  + +    +                    GT  Y APE ++ TG+ 
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY- 221

Query: 323 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNLVEW 359
           T   D +S GV+L EML G+     + P   +  ++ W
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G +G V+K              TG   A+K +  +  +       E+  + +  H N
Sbjct: 17  IGSGTYGDVYKA---------RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V   G  +  D+  +  EF   GSL++     G  PL  S    ++    +GL +LH +
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK 125

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +   ++RD K +NILL  + + KL+DFG++  A            +GT  + APE    
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAV 180

Query: 320 ---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV---EWARPHLGDKRRFYRL 373
              G      D+++ G+  +E+   +  M    P     L+    +  P L DK      
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDK------ 234

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     +K S          L+++PK RP   ++++
Sbjct: 235 ----------MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 51/187 (27%), Positives = 85/187 (45%), Gaps = 32/187 (17%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEML------TGRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303

Query: 407 RMSEVVE 413
            + E ++
Sbjct: 304 SVDEALQ 310

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A G+ FL   A K  ++RD    N+L+      K+ DFGLA+D   D             
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            + APE +     T+ SDV+SFG++L E+ T
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 50/204 (24%), Positives = 97/204 (47%), Gaps = 18/204 (8%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LGEG +  V+KG  + NG           VA+K +     +G     + E + L  L H 
Sbjct: 13  LGEGSYATVYKGKSKVNGK---------LVALKVIRLQEEEGTPFTAIREASLLKGLKHA 63

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V L       +   LV+E++     +      G L  P ++++ +     +GL+++H+
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH-PENVKLFL-FQLLRGLSYIHQ 121

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              + +++RD K  N+L+      KL+DFGLA+   +   +H  +  + T  Y  P+ ++
Sbjct: 122 ---RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 319 -TGHLTSKSDVYSFGVVLLEMLTG 341
            +   ++  D++  G + +EM+ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 17/211 (8%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEW-LAEVNF 191
           F    ++GEG +G V K   +E         T   VA+K   + +  +  KE  L E+  
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKM 53

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L  L   N+V+L        +  LV+E++ +  LE  L    +   P  +R  I     K
Sbjct: 54  LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYI-YQLIK 111

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            + + H+     +++RD K  N+L+  +   KL DFG A++  E G     T  + T  Y
Sbjct: 112 AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWY 167

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            +PE ++        D++S G +L E+  G+
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 73/283 (25%), Positives = 109/283 (38%), Gaps = 46/283 (16%)

Query: 82  EKRRDRPVVPVSSTTTSNA---ESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPES 138
               D P    S    S+A   +   + P  +  + +A    K   +D  LA  +FR   
Sbjct: 103 ASAGDGP----SGAEDSDASHLDFDEAPPDAAGPVPLAQA--KLKHDDEFLA--HFRVID 154

Query: 139 LLGEGGFG----CVFKGWVEE-------NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
            L  G FG    C  +   EE       N T   KP     +A +           E   
Sbjct: 155 DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLE--N 212

Query: 188 EVNFLGNLLHPNLVKL--------VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
           E+  LG L H N++K+          Y I       +Y FM   + +     K   PL  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD----WKDR-PLLK 267

Query: 240 SIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
             R  MK  L A   + ++H+   K +I+RD K  NI L+ D    L DFG A    E  
Sbjct: 268 QTRAIMKQLLCA---VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF-EKE 320

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +       +GT    +PE +        +D++S G++LL+ML+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 183

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+ G 
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 53/177 (29%), Positives = 74/177 (41%), Gaps = 29/177 (16%)

Query: 206 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP------WSIRMKIALGAAKGLAFLHE 258
           Y  +D+  L LV ++   G L   L  K    LP      +   M IA+ +   L ++H 
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH- 125

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                   RD K  NIL+D + + +L+DFG      EDG    S  V GT  Y +PE + 
Sbjct: 126 --------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQ 176

Query: 319 T-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
                 G    + D +S GV + EML G        P    +LVE     +  K RF
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+ G 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 20/151 (13%)

Query: 206 YCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKP 263
           +C  + +R L  V E++  G     L   G+LP+  + RM  A      L +LH      
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEYLHNYG--- 121

Query: 264 VIYRDFKTSNILLDADYNAKLSDFGLAK-------------DAPEDGKTHVSTRVMGTYG 310
           +++RD K  N+L+ +  + KL+DFGL+K                +D +  +  +V GT  
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           Y APE ++        D ++ G++L E L G
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 26/222 (11%)

Query: 140 LGEGGFGCVFKGWVEENGT----APVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGN 194
           LGEG +G V K +    G       VK         K     G+ G H   L E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGL 253
           + H N++ LV   +E D   LV + M    L+  + RK  L      ++K I L    GL
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTES---QVKCILLQILNGL 132

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--------DAPEDGKTHVSTRV 305
             LH+      ++RD   +NI +++    K++DFGLA+        D     +T      
Sbjct: 133 NVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 306 MG----TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           M     T  Y APE +M         D++S G +  E+LTG+
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 42/149 (28%), Positives = 65/149 (43%), Gaps = 22/149 (14%)

Query: 206 YCIEDDQRL-LVYEFMPRGSLENHLFR-----KGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           Y  +D   L LV E+ P G L + L R        +   +   + +A+ +   + ++H  
Sbjct: 68  YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH-- 125

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
                  RD K  N+L+D   + KL+DFG A     +     S   +GT  Y APE + T
Sbjct: 126 -------RDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTT 177

Query: 320 GHLTSKS------DVYSFGVVLLEMLTGR 342
            +   K       D +S GV+  EM+ GR
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 48/174 (27%), Positives = 69/174 (39%), Gaps = 47/174 (27%)

Query: 206 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGLAFLHEEA 260
           Y  +D   L L+ EF+P G +   L +K +L       +     +A+ +   L F+H   
Sbjct: 68  YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH--- 124

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDA-------------PED-------- 296
                 RD K  N+LLD+  + KLSDFGL    K A             P D        
Sbjct: 125 ------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 297 ---------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                     +  ++   +GT  Y APE  M        D +S GV++ EML G
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A  +    + T  + T  Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYY 188

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ E++ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 46/232 (19%)

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAF 255
           H +L  + G C+   + ++V EF+  G L+  L + KG +P+ W  ++ +A   A  L++
Sbjct: 75  HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSY 132

Query: 256 LHEEAEKPVIYRDFKTSNILLD----ADYNA---KLSDFGLAKDAPEDGKTHVSTRVMGT 308
           L    +K +++ +    NILL     A+  +   KLSD G++  A    +     R+   
Sbjct: 133 LE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS--REERVERI--- 184

Query: 309 YGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
             + APE V  G  L++ +D +SFG  LLE+            +GE  L E       +K
Sbjct: 185 -PWIAPECVPGGNSLSTAADKWSFGTTLLEICF----------DGEVPLKERTPS---EK 230

Query: 368 RRFY----RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            RFY    RL +P           ++   L +QCL+ +P  RP    ++  L
Sbjct: 231 ERFYEKKHRLPEP---------SCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 63/297 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKT--EVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAF-LH 257
           LV   G C+  D+ ++V E++  GSL+ +L +  +L  + W       L  AK LA+ LH
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALH 114

Query: 258 EEAEKPVIYRDFKTSNILLDADYNA--------KLSDFG-----LAKDAPEDGKTHVSTR 304
              +K + + +    N+LL  + +         KLSD G     L K+   +       R
Sbjct: 115 FLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------R 167

Query: 305 VMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
           +     +  PE +    +L+  +D +SFG  L E+ +G      ++P    + ++  +  
Sbjct: 168 I----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----GDKP---LSALDSQK-- 213

Query: 364 LGDKRRFY--RLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
              K +FY  R   P          + K T+LA    QC+  +P  RP    ++  L
Sbjct: 214 ---KLQFYEDRHQLP----------APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 65/256 (25%), Positives = 96/256 (37%), Gaps = 72/256 (28%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL---AEVNFLGNLL 196
           LG G FG V             K  T    A+KTL    +    +     AE + L    
Sbjct: 9   LGIGAFGEV---------CLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD 59

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAK 251
           +  +VKL  Y  +D   L  V +++P G + + L R    P      +   + +A+ +  
Sbjct: 60  NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA-------------------KD 292
            + F+H         RD K  NIL+D D + KL+DFGL                    +D
Sbjct: 119 KMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169

Query: 293 A--PEDGKTHVST------------------------RVMGTYGYAAPEYVMTGHLTSKS 326
           +  P D    VS                          ++GT  Y APE ++    T   
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229

Query: 327 DVYSFGVVLLEMLTGR 342
           D +S GV+L EML G+
Sbjct: 230 DWWSVGVILFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 6/91 (6%)

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +H   +   ++RD K  N+LLD + + +L+DFG      +DG    S  V GT  Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173

Query: 316 YVMT-----GHLTSKSDVYSFGVVLLEMLTG 341
            +       G    + D +S GV + EML G
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 29/167 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +F    ++G+G FG V    V+       K  TG   A+KTL    +   K+ LA V   
Sbjct: 2   DFHTVKVIGKGAFGEV--RLVQ-------KKDTGKIYAMKTLLKSEMF-KKDQLAHVKAE 51

Query: 193 GNLL----HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP----WSIRM 243
            ++L     P +V L  Y  +D Q L L+ EF+P G L   L +  +        +    
Sbjct: 52  RDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC 110

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
            +A+ A   L F+H         RD K  NIL+D   + KLSDFGL+
Sbjct: 111 VLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 9e-06
 Identities = 29/82 (35%), Positives = 42/82 (51%), Gaps = 6/82 (7%)

Query: 265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----T 319
           ++RD K  N+LLD + + +L+DFG       DG T  S   +GT  Y +PE +       
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 320 GHLTSKSDVYSFGVVLLEMLTG 341
           G    + D +S GV + EML G
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 26/223 (11%)

Query: 119 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 178
           LR+   +D +L  R       +G G +G V+K              TG   AVK +  + 
Sbjct: 3   LRRNPQHDYELIQR-------VGSGTYGDVYKA---------RNLHTGELAAVKIIKLEP 46

Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
                    E+  +    H N+V   G  +  ++  +  E+   GSL++     G  PL 
Sbjct: 47  GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLS 104

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GLA+LH + +   ++RD K +NILL  + + KL+DFG+A  A     
Sbjct: 105 ELQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITAT 159

Query: 299 THVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEM 338
                  +GT  + APE       G      D+++ G+  +E+
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 45/187 (24%), Positives = 68/187 (36%), Gaps = 59/187 (31%)

Query: 206 YCIED-DQRLLVYEFMPRGSLENHLFRKGSLPLP----WSIRMKIALGAAKGLAFLHEEA 260
           Y  +D D    V +++P G + + L R G  P      +   +  A+ +   + F+H   
Sbjct: 68  YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--- 124

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGL--------------AKDAPEDGKTHVSTR-- 304
                 RD K  NIL+D D + KL+DFGL              + D         S    
Sbjct: 125 ------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 305 -----------------------------VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL 335
                                        ++GT  Y APE ++    T   D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 336 LEMLTGR 342
            EML G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 19/168 (11%)

Query: 188 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS------LPLPW 239
           E+  L  L HPN++ L  V     D +  L++++          F + S      + LP 
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 293
           S+   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 108 SMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 340
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 34/97 (35%), Positives = 44/97 (45%), Gaps = 10/97 (10%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 195
           LG G FG V    VE       K    +TVAVK L        +E L      +++LGN 
Sbjct: 43  LGAGAFGKV----VEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 97

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK 232
            H N+V L+G C      L++ E+   G L N L RK
Sbjct: 98  -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 3/83 (3%)

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           ++H E    +I+RD KT N+L++   +  L DFG A  A     T     + GT    AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331

Query: 315 EYVMTGHLTSKSDVYSFGVVLLE 337
           E +     T   D++S G+V+ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 19/168 (11%)

Query: 188 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS------LPLPW 239
           E+  L  L HPN++ L  V     D +  L++++          F + S      + LP 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 293
            +   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 108 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT 340
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 69/335 (20%), Positives = 127/335 (37%), Gaps = 64/335 (19%)

Query: 59  PSRSKVDSSMSGTSTNYD---GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKV 115
            SRS   +  SG+  + +      S   +           TT+   +    P   ++ KV
Sbjct: 44  TSRSTNSARRSGSKRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPP-PKKKKV 102

Query: 116 ASQLRK----------FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGT 165
              L             +  D+ ++T+ F+  SLLGEG FG V + W  +          
Sbjct: 103 TYALPNQSREEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKE------- 155

Query: 166 GLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLVGYCIEDDQRLLVYEF 219
               AVK +  +  +  ++   E+ F+  +   +      L+K+  Y   +   + +   
Sbjct: 156 --YCAVKIV-RNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI--V 210

Query: 220 MPR--GSLENHLFRKGSLPLPWSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL 275
           MP+    L + + + G    P+S R   +I       L + H E    +++ D K  NIL
Sbjct: 211 MPKYGPCLLDWIMKHG----PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENIL 264

Query: 276 LDADYNA----------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
           ++                     ++ D G   D     + H  T ++ T  Y +PE V+ 
Sbjct: 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCD-----ERHSRTAIVSTRHYRSPEVVLG 319

Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                 +D++S G ++ E+ TG+   D +  N EH
Sbjct: 320 LGWMYSTDMWSMGCIIYELYTGKLLYDTH-DNLEH 353

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	490
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
smart00090	237	RIO RIO-like kinase.	99.8
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.39
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.27
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.26
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.05
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.89
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.8
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.7
PRK09902	216	hypothetical protein; Provisional	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.66
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.61
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.51
PF01636	239	APH: Phosphotransferase enzyme family This family	98.38
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.36
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.35
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.13
PLN02876	822	acyl-CoA dehydrogenase	98.12
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.01
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.91
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.9
PRK10593	297	hypothetical protein; Provisional	97.86
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.69
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.62
PRK05231	319	homoserine kinase; Provisional	97.49
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.39
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.37
PLN02236	344	choline kinase	97.23
KOG2270	520	consensus Serine/threonine protein kinase involved	97.06
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.94
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.78
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.72
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.6
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.57
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.56
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.5
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.43
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.4
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.35
PRK12396	409	5-methylribose kinase; Reviewed	96.18
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.14
PLN02756	418	S-methyl-5-thioribose kinase	96.01
PRK06148	1013	hypothetical protein; Provisional	95.74
COG2334	331	Putative homoserine kinase type II (protein kinase	95.74
PTZ00384	383	choline kinase; Provisional	95.36
PRK11768	325	serine/threonine protein kinase; Provisional	95.33
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.1
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.05

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=428.17  Aligned_cols=291  Identities=57%  Similarity=0.982  Sum_probs=254.6

Q ss_pred             hhhhhchhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC
Q 011234          118 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH  197 (490)
Q Consensus       118 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H  197 (490)
                      ..+.|.+.++..+|++|....+||+|+||.||+|...+          |..||||.+.....+..++|.+|+.+|.+++|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----------~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H  130 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----------GTVVAVKRLSSNSGQGEREFLNEVEILSRLRH  130 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----------CCEEEEEEecCCCCcchhHHHHHHHHHhcCCC
Confidence            46779999999999999999999999999999999864          46899998876643315669999999999999


Q ss_pred             CceeceeeEEEecC-ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       198 pnIv~l~~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ||||+|+|||.+.+ +.+||||||++|+|.++|.......++|..+++||.++|+||+|||.....+|||||||++||||
T Consensus       131 ~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  131 PNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             cCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            99999999999998 49999999999999999987654378999999999999999999999887789999999999999


Q ss_pred             cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                      |+++++||+|||+|+..... .....+...||.+|+|||++..+..+.++|||||||+|+||++|+.+.+...+.....+
T Consensus       211 D~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l  289 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL  289 (361)
T ss_pred             CCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence            99999999999999766542 12221211799999999999999999999999999999999999999987776777779


Q ss_pred             HHhhhcccCCchhhhhccCcccc-CCCCh-HhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLE-GHFSI-KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ++|+.+.+.+. .+.+++|+.+. +.++. .....+..+..+|++.+|.+||+|.+|++.|+.+..
T Consensus       290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            99988777666 78899999987 66664 577889999999999999999999999999966543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-53  Score=403.85  Aligned_cols=252  Identities=29%  Similarity=0.443  Sum_probs=212.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +.+.++.||+|..|+||+++|+.         |+..+|+|++... .....+++.+|+++++.++|||||.+||.|..++
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~---------t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKP---------TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcC---------CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            45667899999999999999986         7889999999544 3455688999999999999999999999999999


Q ss_pred             c-eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          212 Q-RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       212 ~-~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      . +.|+||||++|+|++++...+  .+++.....|+.+|++||.|||+ .+   ||||||||+||||+..|.|||||||.
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence            4 999999999999999997764  68999999999999999999996 55   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCC--CCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~~~~  367 (490)
                      +..+...    ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||....+  .+...+..+....    
T Consensus       226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----  297 (364)
T KOG0581|consen  226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----  297 (364)
T ss_pred             cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----
Confidence            9877543    44568999999999999999999999999999999999999999976411  2222222221110    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                            ..|.+...   .+++++++||..||++||.+||++.|+++|-
T Consensus       298 ------ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  298 ------PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             ------CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                  11222111   3589999999999999999999999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-52  Score=422.90  Aligned_cols=250  Identities=28%  Similarity=0.473  Sum_probs=216.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+|...++||+|||+.||++++..         +|..||+|++.+...   ...+.+.+||+|.++|+|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~---------tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLD---------TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcC---------CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            469999999999999999999865         788999999976432   33456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+++|||+|+|..++|..++.+++  .+++.+++.++.||+.||.|||+.+   |||||||..|+||+++.+|||+|||
T Consensus        89 Ds~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999987544  8999999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ||..+..++...  ..+||||.|.|||++.....+..+||||+|||||.||+|++||+...-.+..+.+.....      
T Consensus       164 LAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y------  235 (592)
T KOG0575|consen  164 LATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY------  235 (592)
T ss_pred             eeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc------
Confidence            999887554333  458999999999999999999999999999999999999999986543333332222111      


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                  .+|...+.++++||.++|+.||.+|||+++||.+=
T Consensus       236 ------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  236 ------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             ------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence                        12234488999999999999999999999999863

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-52  Score=401.36  Aligned_cols=255  Identities=28%  Similarity=0.392  Sum_probs=209.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-------HHHHHHHHHHHhcCCCCceece
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      .+.|.+.+.||+|+||.|-+|..+.         ||..||||++++.....       ...+.+|++||++|+|||||++
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~---------tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKK---------TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcc---------cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            4568899999999999999998775         89999999998763322       1235689999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC---C
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---Y  280 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~  280 (490)
                      +++|...+..||||||+.||+|.+.+..++  .+.+..-..++.|++.||.|||++|   |+||||||+|||+..+   .
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcce
Confidence            999999999999999999999999998876  5666777889999999999999999   9999999999999665   7


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCC-cchh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-EHNL  356 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGvil~elltG~~pf~~~~~~~-~~~~  356 (490)
                      .+||+|||+|+...+   ......+|||+.|.|||++.+..   +..++|+||+||+||-+|+|.+||....... ....
T Consensus       317 llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ  393 (475)
T KOG0615|consen  317 LLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ  393 (475)
T ss_pred             EEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH
Confidence            799999999998753   34556789999999999998654   3458899999999999999999997643322 1122


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      +...+..      +.        .......++++.+||.+||..||++|||+.|+|++-.
T Consensus       394 I~~G~y~------f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  394 ILKGRYA------FG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             HhcCccc------cc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            2111111      11        0122345899999999999999999999999998743

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-51  Score=396.65  Aligned_cols=252  Identities=29%  Similarity=0.464  Sum_probs=208.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..+|.+.+.||.|+||+||+|+++.         ++..||||.+.+..  ....+.+..|+.+|+.++|||||.+++++.
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~---------~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~   79 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKK---------SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE   79 (429)
T ss_pred             cccceehhhccCcceEEEEEeEecc---------CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe
Confidence            3578999999999999999999987         56799999998773  444566789999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC------CCe
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------YNA  282 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~  282 (490)
                      .++.+|||||||.||+|.++|.+++  .+++..+..++.||+.||++||+++   ||||||||.||||+..      -.+
T Consensus        80 ~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~L  154 (429)
T KOG0595|consen   80 DDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVL  154 (429)
T ss_pred             cCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceE
Confidence            9999999999999999999999887  6899999999999999999999988   9999999999999764      458


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||+|+.+...   ......||++.|||||+++...|+.|+|+||+|+|||+|++|+.||+...+.+....++....
T Consensus       155 KIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~  231 (429)
T KOG0595|consen  155 KIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE  231 (429)
T ss_pred             EecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc
Confidence            99999999988754   334568999999999999999999999999999999999999999987665443332222211


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..               ..++...+..+.+|+...|.+++.+|.++.+.+.+
T Consensus       232 ~~---------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  232 IV---------------PVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             cc---------------CchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence            11               11222224455677777777777777776665544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-51  Score=389.56  Aligned_cols=251  Identities=31%  Similarity=0.443  Sum_probs=210.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh---HHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|+++++||+|+||+||+++.++         +++.+|+|++++.....   .+...+|..||..++||+||.++..|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~d---------t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF   94 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKD---------TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF   94 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcc---------cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec
Confidence            3579999999999999999999875         88899999998775433   34568899999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ++.+.+|||+||+.||+|..+|.+.+  .+++..+..++..|+.||.|||+.+   ||||||||+|||||.+|+++|+||
T Consensus        95 Qt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDF  169 (357)
T KOG0598|consen   95 QTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDF  169 (357)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecc
Confidence            99999999999999999999998877  6889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.....+.  ....+|||+.|||||++.+..|+.++|+|||||++|||++|.+||...+.......+      ....
T Consensus       170 gL~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I------~~~k  241 (357)
T KOG0598|consen  170 GLCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI------LKGK  241 (357)
T ss_pred             ccchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH------hcCc
Confidence            99996544322  234589999999999999999999999999999999999999999765432221111      1111


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP----RMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP----s~~evl~~  414 (490)
                                 ...++.-.+.++++|+.++|.+||++|.    ++.+|-+|
T Consensus       242 -----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  242 -----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             -----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                       0111222378999999999999999995    45554433

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-49  Score=397.60  Aligned_cols=258  Identities=35%  Similarity=0.585  Sum_probs=212.8

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcE-EEEEEecCCChhh--HHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT-VAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~-vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++.+.+.||.|+||+||+|.+.           |.. ||||++.......  .++|.+|+.+|.+|+|||||+++|++.+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~-----------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWR-----------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeC-----------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            3445566999999999999995           445 9999998654322  5689999999999999999999999998


Q ss_pred             cC-ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEccc
Q 011234          210 DD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       210 ~~-~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF  287 (490)
                      .. .++|||||+++|+|.+++.......+++..++.++.+|+.||.|||+++.  ||||||||+||||+.++ ++||+||
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DF  188 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADF  188 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCC
Confidence            87 79999999999999999987434479999999999999999999999774  99999999999999998 9999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhh--cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |+++......  ...+...||+.|||||++.  ...|+.++|||||||+||||+||..||...........         
T Consensus       189 Glsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~---------  257 (362)
T KOG0192|consen  189 GLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA---------  257 (362)
T ss_pred             ccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---------
Confidence            9998765422  2233468999999999999  66999999999999999999999999976544211111         


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                             +........++..++..+..||.+||..||..||++.+++..|+.+...
T Consensus       258 -------v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  258 -------VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             -------HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                   1111112223334688999999999999999999999999999877553

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-51  Score=375.90  Aligned_cols=253  Identities=26%  Similarity=0.395  Sum_probs=207.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceee-EEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVG-YCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~  208 (490)
                      .+|++++.||+|+||.||++.+..         +|..||.|.+..+.  .....++..|+.+|++|+|||||++++ .|.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~---------~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~   89 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLL---------DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI   89 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeecc---------CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence            368899999999999999999876         67799999987553  344567899999999999999999999 455


Q ss_pred             ecCc-eEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCceEEcCCCCeEE
Q 011234          209 EDDQ-RLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEK-PVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       209 ~~~~-~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~-~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +++. ++||||||.+|+|...|..  .....+++..+++++.|++.||..+|+.-++ -|+||||||.||+|+.+|.+||
T Consensus        90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL  169 (375)
T KOG0591|consen   90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL  169 (375)
T ss_pred             ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence            5555 8999999999999998864  3345799999999999999999999994322 2999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++.+...  .......+|||.||+||++.+..|+.+|||||+||++|||+.-++||.+....   .+.+.     
T Consensus       170 GDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~~K-----  239 (375)
T KOG0591|consen  170 GDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLCKK-----  239 (375)
T ss_pred             ccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHHHH-----
Confidence            999999988653  44456789999999999999999999999999999999999999999765211   11111     


Q ss_pred             CCchhhhhccCccccCCC---C-hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          365 GDKRRFYRLLDPRLEGHF---S-IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~---~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                  .-.+++   | ...+.++..||..|+..||+.||+...++..+
T Consensus       240 ------------I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  240 ------------IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ------------HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                        111111   1 33488999999999999999999855444433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-49  Score=393.30  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=216.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh---HHHHHHHHHHHhcC-CCCceecee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNL-LHPNLVKLV  204 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~l~  204 (490)
                      ....+|..++.||+|+|++||+|+.+.         ++..+|||++.+.....   .+.+..|-.+|.+| .||.|++|+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~---------t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy  140 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKA---------TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLY  140 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecC---------CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEE
Confidence            445689999999999999999999876         78899999998764322   23466799999999 799999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ..|+++..+|+|+||+++|+|.++|.+.+  .|++...+.++.+|+.||+|||++|   ||||||||+|||||+||++||
T Consensus       141 ~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikI  215 (604)
T KOG0592|consen  141 FTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKI  215 (604)
T ss_pred             EEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEE
Confidence            99999999999999999999999999887  6888899999999999999999999   999999999999999999999


Q ss_pred             ccccccccCCCCCCc---------cee--eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          285 SDFGLAKDAPEDGKT---------HVS--TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~---------~~~--~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      .|||.|+.+......         ...  ..++||..|++||+|..+..+..+|||+||||||+|+.|.+||.+..+.-.
T Consensus       216 TDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli  295 (604)
T KOG0592|consen  216 TDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI  295 (604)
T ss_pred             eeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence            999999877543221         111  458999999999999999999999999999999999999999976543322


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..                +++.  +...|+...++.+.+||.++|..||.+|+|..+|.+|.
T Consensus       296 Fq----------------kI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 FQ----------------KIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HH----------------HHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            11                1111  22244455578999999999999999999999998874

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.5e-50  Score=373.66  Aligned_cols=266  Identities=26%  Similarity=0.365  Sum_probs=214.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +.|+.+.++|+|+||+||+|++++         ||+.||||.+....  ....+-.++|+++|++|+|+|+|.++++|..
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~---------TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr   72 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKD---------TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR   72 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCC---------cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh
Confidence            358888999999999999999987         89999999886442  3334557899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ...++||+|||+.. +.+-|.+... .++...+..++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+
T Consensus        73 krklhLVFE~~dhT-vL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   73 KRKLHLVFEYCDHT-VLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             cceeEEEeeecchH-HHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchh
Confidence            99999999999764 4445555533 6889999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc-----
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-----  363 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~-----  363 (490)
                      |+.+...  ....+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|.+....+...++....-.     
T Consensus       148 AR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  148 ARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH  225 (396)
T ss_pred             hHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence            9987642  233466789999999999988 68999999999999999999999999887766655544332111     


Q ss_pred             ---cCCchhhhhccCcc------ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 ---LGDKRRFYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ---~~~~~~~~~~~~~~------l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         +.....|..+.-|.      ++..|+ ..+.-+.+|++.||..||.+|++.++++.+
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence               11112221111111      122222 235678999999999999999999999976

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-48  Score=375.66  Aligned_cols=259  Identities=31%  Similarity=0.471  Sum_probs=209.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-  211 (490)
                      +|...+.||+|+||.||++.+.+         +|..+|||.+........+.+.+|+.+|++|+|||||+++|...... 
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~---------~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~   88 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKK---------TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN   88 (313)
T ss_pred             hhhhhccccCccceEEEEEEecC---------CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence            57778999999999999999876         57799999987664334667899999999999999999999755444 


Q ss_pred             -ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEccccc
Q 011234          212 -QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGL  289 (490)
Q Consensus       212 -~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG~  289 (490)
                       .++++|||+++|+|.+++.+.+. .+++..+..++.||++||.|||+++   ||||||||+||||+. ++.+||+|||+
T Consensus        89 ~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~  164 (313)
T KOG0198|consen   89 DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGL  164 (313)
T ss_pred             eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcc
Confidence             68999999999999999998877 7999999999999999999999988   999999999999999 79999999999


Q ss_pred             cccCCCC-CCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPED-GKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~-~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +...... ..........||+.|||||++..+ ....++|||||||++.||+||.+||...  ...   ..+.       
T Consensus       165 a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~---~~~~-------  232 (313)
T KOG0198|consen  165 AKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEE---AEAL-------  232 (313)
T ss_pred             ccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cch---HHHH-------
Confidence            9876531 111223357899999999999863 3345999999999999999999999753  111   1110       


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                         +.+........++...+.++.+|+.+||.+||++|||+.++|++..-.+
T Consensus       233 ---~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  233 ---LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             ---HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence               0111011111344455899999999999999999999999999875433

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-48  Score=356.74  Aligned_cols=238  Identities=29%  Similarity=0.401  Sum_probs=206.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHH---HHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~---~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++++.||.|+||.|.+++.+.         +|..+|+|++++...-..+   ...+|.++|+.+.||+++++++.|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~---------~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKH---------SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEcc---------CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            4579999999999999999999987         6789999999887554433   457799999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+.+||||||++||.|..++.+.+  .+++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||+||
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEec
Confidence            99999999999999999999998766  6889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+.....     ....|||+.|+|||++....|+.++|+|||||++|||+.|.+||...++....+.+      +...
T Consensus       189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~~~~  257 (355)
T KOG0616|consen  189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------LEGK  257 (355)
T ss_pred             cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------HhCc
Confidence            999987543     34589999999999999999999999999999999999999999876653222211      1111


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCC
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  405 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  405 (490)
                      -            .||...+.++++|+.++|+.|-.+|
T Consensus       258 v------------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 V------------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             c------------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            1            2334447899999999999999998

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-48  Score=384.34  Aligned_cols=258  Identities=31%  Similarity=0.454  Sum_probs=214.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+.+.+++.||+|.||.||.|.+...          ..||+|.++... .....|++|+++|++|+|+|||+++++|..+
T Consensus       205 r~~l~l~~~LG~G~FG~V~~g~~~~~----------~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~  273 (468)
T KOG0197|consen  205 REELKLIRELGSGQFGEVWLGKWNGS----------TKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ  273 (468)
T ss_pred             HHHHHHHHHhcCCccceEEEEEEcCC----------CcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence            34456678899999999999999753          269999987653 3446789999999999999999999999998


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +.+|||||||+.|+|.++|.......+.....+.++.|||+|++||++++   +|||||.+.||||+++..+||+|||+|
T Consensus       274 ~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLA  350 (468)
T KOG0197|consen  274 EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLA  350 (468)
T ss_pred             CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccc
Confidence            89999999999999999998855667899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...++ .........-.+.|.|||.+..+.++.+||||||||+||||+| |+.||......+....++           
T Consensus       351 r~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-----------  418 (468)
T KOG0197|consen  351 RLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-----------  418 (468)
T ss_pred             cccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-----------
Confidence            954433 3333333334678999999999999999999999999999998 777776654332222222           


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                            ....-.-|..|+..+.+||..||..+|++|||++.+...|+.+..
T Consensus       419 ------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  419 ------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             ------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence                  111223345679999999999999999999999999999987644

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=382.81  Aligned_cols=266  Identities=27%  Similarity=0.382  Sum_probs=216.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHH--HHHHHHHHhcCC-CCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGNLL-HPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~l~~~~  207 (490)
                      -++|.+++.||.|.||.||+|+.+.         +|..||||.++..-.. .++  -++|+..|++|+ |||||++.+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~---------~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi   78 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKE---------TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVI   78 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecC---------CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHh
Confidence            3578999999999999999999876         6778999999765433 233  378999999999 99999999999


Q ss_pred             EecC-ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          208 IEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       208 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      .+.+ .+|+||||| ..+|+.++..+ ...|++..++.|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|
T Consensus        79 ~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaD  153 (538)
T KOG0661|consen   79 RDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIAD  153 (538)
T ss_pred             hccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecc
Confidence            9988 999999999 56999998877 568999999999999999999999999   99999999999999888999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhh-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--hcc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--~~~  363 (490)
                      ||+||......   ..+..+.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.+..+.++...+-..  .+.
T Consensus       154 FGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~  230 (538)
T KOG0661|consen  154 FGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD  230 (538)
T ss_pred             cccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence            99999876532   235578899999999986 578999999999999999999999999988776655433221  111


Q ss_pred             ---cCCchhhhhccCcc--------ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          364 ---LGDKRRFYRLLDPR--------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ---~~~~~~~~~~~~~~--------l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         +.....+...++-.        +..-++ .++.++.+||.+||..||.+|||+.|++++-
T Consensus       231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             cccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence               11111111111111        111122 3689999999999999999999999999875

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.3e-47  Score=379.65  Aligned_cols=258  Identities=26%  Similarity=0.355  Sum_probs=212.3

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH---HHHHHHHHHHhcCCCCceecee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      ++..++|+++.+||+|+||.||+|+-+.         ||..+|+|++++......   +.+..|-.+|....+|+||+||
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~---------Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy  207 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKD---------TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY  207 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEcc---------CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence            3456799999999999999999998876         899999999998755433   4467899999999999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ..|.+.+++||||||++||++..+|.+.+  .|++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||
T Consensus       208 YsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKL  282 (550)
T KOG0605|consen  208 YSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKL  282 (550)
T ss_pred             EEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEee
Confidence            99999999999999999999999999887  7899999999999999999999999   999999999999999999999


Q ss_pred             ccccccccCCCC----------------------CCc------c-----------------eeeccccCCCCCCchhhhc
Q 011234          285 SDFGLAKDAPED----------------------GKT------H-----------------VSTRVMGTYGYAAPEYVMT  319 (490)
Q Consensus       285 ~DFG~a~~~~~~----------------------~~~------~-----------------~~~~~~Gt~~y~aPE~l~~  319 (490)
                      +||||+.-+...                      ...      .                 .....+|||.|||||++.+
T Consensus       283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~  362 (550)
T KOG0605|consen  283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG  362 (550)
T ss_pred             ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence            999998532110                      000      0                 0112589999999999999


Q ss_pred             CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhh
Q 011234          320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS  399 (490)
Q Consensus       320 ~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~  399 (490)
                      ..|+..+|+|||||||||||.|.+||....+......+..-+..+.-              .-...++.++.+||.+||.
T Consensus       363 kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------------P~~~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  363 KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------------PEEVDLSDEAKDLITRLLC  428 (550)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------------CCcCcccHHHHHHHHHHhc
Confidence            99999999999999999999999999887766443322211111110              0011236899999999999


Q ss_pred             cCCCCCC---CHHHHHHH
Q 011234          400 RDPKARP---RMSEVVET  414 (490)
Q Consensus       400 ~dP~~RP---s~~evl~~  414 (490)
                       ||++|.   .+.||-+|
T Consensus       429 -d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  429 -DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             -CHHHhcCcccHHHHhcC
Confidence             999996   47777765

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-47  Score=378.48  Aligned_cols=269  Identities=26%  Similarity=0.339  Sum_probs=214.6

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..+.|+.++.||+|.||.||+|++..         +|..||+|.+..+..  ....-..+||.||++|+||||++|.+..
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~---------tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv  185 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLE---------TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV  185 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecc---------cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence            34568899999999999999999876         788999999987652  3345568999999999999999999998


Q ss_pred             Eec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          208 IED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .+.  +.+|||+|||++ +|.-++... ...|++.++..++.||+.||.|||..+   |+|||||.+|||||.+|.+||+
T Consensus       186 t~~~~~siYlVFeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  186 TSKLSGSIYLVFEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             EecCCceEEEEEecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEec
Confidence            876  689999999975 888877543 457999999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--c
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~  362 (490)
                      |||||+.+....... .+..+-|.+|+|||+|.+. .|+.++|+||.||||.||+.|++.|.+....+..+.+-.+.  +
T Consensus       261 DFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP  339 (560)
T KOG0600|consen  261 DFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP  339 (560)
T ss_pred             cccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence            999999876554333 3556779999999999874 79999999999999999999999999887766555442211  0


Q ss_pred             ccCCch--h--hhhccCcc------ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKR--R--FYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~--~--~~~~~~~~------l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....+.  .  .+..+.+.      +.+. -...+..+.+|+..||..||.+|.|+.++|+.
T Consensus       340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  340 TEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            000000  0  01111111      1111 11226788999999999999999999999975

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=368.21  Aligned_cols=265  Identities=27%  Similarity=0.373  Sum_probs=216.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-HHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ...+|++...||.|.-++||+|+...         +++.||||+++.+.... ...+.+|+..|+.++||||++++..|.
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p---------~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIP---------TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecc---------cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            34579999999999999999999876         67899999998776554 477889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .+..+|+||.||.+|++.+++...-...+++..+..|++++++||.|||++|   .||||||+.||||+.+|.|||+|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence            9999999999999999999998766667999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCCcce-e-eccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          289 LAKDAPEDGKTHV-S-TRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       289 ~a~~~~~~~~~~~-~-~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      .+..+...+.... . ..++||++|||||+++.  ..|+.|+|||||||+..||.+|..||....+.....+.-...+..
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~  251 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPT  251 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCC
Confidence            8876654432221 1 45799999999999654  579999999999999999999999998776553322221111110


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .        .-..+..+-....+..++++|..||++||.+|||+++++++
T Consensus       252 ~--------~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  252 L--------LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             c--------ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            0        00011111112236689999999999999999999999976

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-47  Score=381.12  Aligned_cols=253  Identities=29%  Similarity=0.393  Sum_probs=209.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC----Ch-hhHHHHHHHHHHHhcCC-CCceec
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GL-QGHKEWLAEVNFLGNLL-HPNLVK  202 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-HpnIv~  202 (490)
                      ...+.|.+.+.||+|+||.|++|++..         +|..||+|++...    .. ...+.+.+|+.+++.+. ||||++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---------t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~   84 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRL---------TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIR   84 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeecc---------CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeE
Confidence            345689999999999999999999876         6789999987764    11 22345668999999999 999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CC
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YN  281 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~  281 (490)
                      +++++.....+++|||||.||+|++++...+  .+.+..+..++.||+.|++|||+.+   |+||||||+|||++.+ ++
T Consensus        85 l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   85 LLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             EEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCC
Confidence            9999999999999999999999999998854  6888999999999999999999998   9999999999999999 99


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCC-CC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +||+|||++.....  ........|||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.....   .+.. 
T Consensus       160 ~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~~-  233 (370)
T KOG0583|consen  160 LKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLYR-  233 (370)
T ss_pred             EEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHHH-
Confidence            99999999998741  122335689999999999999876 75 7899999999999999999999863211   1111 


Q ss_pred             hhcccCCchhhhhccCccccCCCChHh-HHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                        ......            -.++... +.++..|+.+||..||.+|+++.+|+++=
T Consensus       234 --ki~~~~------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~  276 (370)
T KOG0583|consen  234 --KIRKGE------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP  276 (370)
T ss_pred             --HHhcCC------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence              111010            1223333 78899999999999999999999999553

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-46  Score=361.55  Aligned_cols=261  Identities=28%  Similarity=0.352  Sum_probs=215.7

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHH---HHHHHHHHHhcCCCCceec
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~---~~~~E~~~l~~l~HpnIv~  202 (490)
                      +..+..++|++++.||.|.-|+||++.+..         ++..+|+|++.+......+   +...|-+||+.++||.++.
T Consensus        71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~---------t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPT  141 (459)
T KOG0610|consen   71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRG---------TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPT  141 (459)
T ss_pred             CCccCHHHHHHHHHcCCCCceeEEEEEecC---------CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccch
Confidence            345566789999999999999999999875         5679999999987655443   4566999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ||..|..+...|||||||+||+|..+++++....+++..++.++..|+-||+|||-.|   ||+|||||+||||.++|+|
T Consensus       142 LYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHI  218 (459)
T KOG0610|consen  142 LYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHI  218 (459)
T ss_pred             hhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcE
Confidence            9999999999999999999999999999998889999999999999999999999999   9999999999999999999


Q ss_pred             EEccccccccCCC---------------------------------CCCc---------------------ceeeccccC
Q 011234          283 KLSDFGLAKDAPE---------------------------------DGKT---------------------HVSTRVMGT  308 (490)
Q Consensus       283 kL~DFG~a~~~~~---------------------------------~~~~---------------------~~~~~~~Gt  308 (490)
                      .|+||.|+.....                                 ....                     .....++||
T Consensus       219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT  298 (459)
T KOG0610|consen  219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT  298 (459)
T ss_pred             EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence            9999998753311                                 0000                     011236899


Q ss_pred             CCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHH
Q 011234          309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQ  388 (490)
Q Consensus       309 ~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  388 (490)
                      -.|+|||++.+...+.++|+|+|||++||||+|..||.+......                +..++-..+.-.-....+.
T Consensus       299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs~  362 (459)
T KOG0610|consen  299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVSS  362 (459)
T ss_pred             cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcchh
Confidence            999999999999999999999999999999999999987644322                1122211111111124478


Q ss_pred             HHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 011234          389 KATQLAAQCLSRDPKARPR----MSEVVET  414 (490)
Q Consensus       389 ~l~~Li~~cL~~dP~~RPs----~~evl~~  414 (490)
                      .+++||+++|.+||.+|.-    +.||-+|
T Consensus       363 ~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  363 AAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            9999999999999999988    7777665

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.9e-47  Score=378.86  Aligned_cols=248  Identities=29%  Similarity=0.417  Sum_probs=215.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|.+.+.||+|+||+||+|+.+.         +...||+|.+.+...  .+.+.+.+|++|++.|+|||||.++++|+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~---------t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt   72 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKY---------TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET   72 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccc---------ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc
Confidence            468889999999999999998765         788999999987654  345678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ..++|+|.|||.| +|..+|...+  .++++.+..|+.+++.||.|||+.+   |+|||+||.|||++.+|.+|+||||+
T Consensus        73 ~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   73 SAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             cceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhh
Confidence            9999999999965 9999997765  7999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.+..  .+.+.+++.||+.|||||++.+..|+..+|+||||||+|||++|++||....      ..+.....+.+.  
T Consensus       147 Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~--  216 (808)
T KOG0597|consen  147 ARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP--  216 (808)
T ss_pred             hhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC--
Confidence            998765  4566788999999999999999999999999999999999999999995432      111111111111  


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                -.++...+..+..|+..+|.+||..|.+..+++.|
T Consensus       217 ----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  217 ----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                      12344668899999999999999999999999987

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.1e-46  Score=344.79  Aligned_cols=267  Identities=26%  Similarity=0.381  Sum_probs=213.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--HHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .+|..++.||+|.||+||+|++..         +|+.||||.++.....+  ....++|++.|+.++|+||+.++++|..
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~---------t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~   72 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTE---------TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH   72 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecC---------CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC
Confidence            368888999999999999999876         88899999998664332  3457899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+.+.||+|||+ .+|+..|..+ ...+....+..++.++++||+|||++.   |+||||||.|+||+.+|.+||+|||+
T Consensus        73 ~~~l~lVfEfm~-tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   73 KSNLSLVFEFMP-TDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             CCceEEEEEecc-ccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccc
Confidence            999999999995 5999888665 457899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--------
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------  360 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--------  360 (490)
                      |+.+.......  +..+-|.+|+|||.+.| ..|+..+|+||.|||+.||+-|.+-|.+....+....+-.+        
T Consensus       148 Ar~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  148 ARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             hhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence            99887544332  23367999999999986 57999999999999999999999998877655444333111        


Q ss_pred             hcccCCchhh--hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGDKRRF--YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ++.+..-.++  +..+......++-..++.++.+|+.+||..||.+|+++.|++++
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            1221111111  11112222222333457778999999999999999999999865

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=380.54  Aligned_cols=251  Identities=26%  Similarity=0.391  Sum_probs=215.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ..|.....||+|+.|.||.|....         ++..||||.+........+-+++|+.+|+.++|+|||.+++.|...+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~---------~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d  343 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKIS---------TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD  343 (550)
T ss_pred             hhhcchhhhccccccceeeeeecc---------CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc
Confidence            468888999999999999998765         67789999998877666667899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+|+|||||+||+|.+.+...   .+++.++..|++++++||+|||..+   |||||||.+|||++.+|.+||+|||++.
T Consensus       344 eLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  344 ELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             eeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeee
Confidence            999999999999999988654   5899999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .+.....  .....+||++|||||++....|+.++||||||++++||+.|.+||-...+.....++..            
T Consensus       418 qi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------------  483 (550)
T KOG0578|consen  418 QISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------------  483 (550)
T ss_pred             ccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------------
Confidence            8765432  34568999999999999999999999999999999999999999965443322222210            


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         +....-..+...+..+++|+.+||+.|+++|+++.|+|+|
T Consensus       484 ---ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  484 ---NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               0111112334458999999999999999999999999987

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-47  Score=382.34  Aligned_cols=249  Identities=29%  Similarity=0.406  Sum_probs=211.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hh--hHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +-|++++.||.|+-|.|.+|++..         ||+.+|||++.+.. ..  ....+.+||-||+.+.||||+++|+++.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~---------TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe   82 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAE---------TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE   82 (786)
T ss_pred             cceeccccccCCCCceehhhhccc---------ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence            348899999999999999999976         89999999997662 21  1234678999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +..++|||+||+++|.|++++.+++  ++++..+.++++||+.|+.|||..+   |+||||||+|+|||..+++||+|||
T Consensus        83 ~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   83 NKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             cCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccc
Confidence            9999999999999999999999987  6888999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +|..-..+.   ....-||++.|.|||++.+..|. .++||||.|||||.||+|+.||++.+..   .+....+..    
T Consensus       158 MAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~~G----  227 (786)
T KOG0588|consen  158 MASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQRG----  227 (786)
T ss_pred             eeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHHcC----
Confidence            998765442   23456999999999999998885 6899999999999999999999854322   121111110    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                 .-+.|...+.++++||.+||..||++|.|++||++|.
T Consensus       228 -----------~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  228 -----------VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -----------cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                       0122344589999999999999999999999999984

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=371.17  Aligned_cols=249  Identities=28%  Similarity=0.437  Sum_probs=214.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .|+..++||+|+||.||+|.+..         +++.||+|++..+... ..+++.+|+.+|.+++++||.++|+.|..+.
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~---------t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~   84 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNK---------TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT   84 (467)
T ss_pred             ccccchhccccccceeeeeeecc---------ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc
Confidence            57778999999999999999876         7889999999877543 3567888999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+|++||||.||++.+.|....  .+.+..+..++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||++.
T Consensus        85 ~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~  159 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAG  159 (467)
T ss_pred             cHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceee
Confidence            9999999999999999986554  4477777889999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .........  ..++||+.|||||++.+..|+.++||||||++.|||++|.+|+....+.....++             .
T Consensus       160 ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------p  224 (467)
T KOG0201|consen  160 QLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------P  224 (467)
T ss_pred             eeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------c
Confidence            776543322  5689999999999999889999999999999999999999999877663322221             1


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....|.+.+.+    +..+++||..||.+||+.||++.++|.+
T Consensus       225 k~~PP~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  225 KSAPPRLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCCCCcccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            22344455544    7889999999999999999999999976

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=356.49  Aligned_cols=283  Identities=27%  Similarity=0.354  Sum_probs=224.4

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEec--CCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ...+|...+.||+|+||.|..+.+..         +|..||||.+.  .+.....+..++|+++|+.++|+||+.+++++
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~---------t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~   90 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKR---------TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIF   90 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcC---------CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeec
Confidence            34567778999999999999998876         78899999987  44555667889999999999999999999998


Q ss_pred             Ee-----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          208 IE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       208 ~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..     -+.+|+|+|+| +.+|...|....  .+....+..++.||+.||+|+|+.+   |+||||||+|+|++.+..+
T Consensus        91 ~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~l  164 (359)
T KOG0660|consen   91 RPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDL  164 (359)
T ss_pred             ccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCE
Confidence            76     24689999999 679998886553  5899999999999999999999999   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||||||+|+...........+..+-|.+|.|||++.. ..|+.+.||||+||||.||++|++.|.+........++....
T Consensus       165 KI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l  244 (359)
T KOG0660|consen  165 KICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL  244 (359)
T ss_pred             EeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence            9999999998764433344466788999999998864 689999999999999999999999999887666555443222


Q ss_pred             cccCC----------chhhhhccCccc----cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhccccCcccc
Q 011234          362 PHLGD----------KRRFYRLLDPRL----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLKDMA  425 (490)
Q Consensus       362 ~~~~~----------~~~~~~~~~~~l----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~l~~~~~~~  425 (490)
                      .....          ...+...+....    ...|+ ..++.+.+|+.+||..||.+|+|++|+|+|  |..+....+.+
T Consensus       245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            11110          001111111111    11122 447889999999999999999999999987  56776666655


Q ss_pred             ccc
Q 011234          426 SSS  428 (490)
Q Consensus       426 ~~~  428 (490)
                      ...
T Consensus       324 ~~~  326 (359)
T KOG0660|consen  324 VCQ  326 (359)
T ss_pred             CCC
Confidence            333

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-46  Score=379.23  Aligned_cols=246  Identities=28%  Similarity=0.427  Sum_probs=208.8

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCC-CCceece
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKL  203 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l  203 (490)
                      .+..++|.++++||+|+||+|+++..+.         +++.+|||+++++..   .+.+..+.|.+|+.... ||.++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~---------~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKG---------TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcC---------CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            4556789999999999999999999876         778999999998754   33456778999988776 9999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      +..|...+++|+||||+.||++..++ ..  ..+++..+..++..|+.||+|||+++   |||||||.+|||||.+|.+|
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~-~~--~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHI-HT--DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEE-ec--ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEE
Confidence            99999999999999999999954433 22  26899999999999999999999999   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+++.....+  ....++|||+.|||||++.+..|+.++|+|||||+|||||.|+.||.+.++.+..+.+.     
T Consensus       509 iADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~-----  581 (694)
T KOG0694|consen  509 IADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV-----  581 (694)
T ss_pred             ecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-----
Confidence            99999999765332  23466999999999999999999999999999999999999999998765443322221     


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  408 (490)
                       .+            ...||...+.++..|++++|.+||++|.-+
T Consensus       582 -~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  582 -ND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -cC------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             11            123566679999999999999999999755

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-45  Score=369.31  Aligned_cols=268  Identities=30%  Similarity=0.432  Sum_probs=208.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      +..++|++.+.||+|+||.||+|.+....    ...++..||||++.... ......+.+|+.+|..+ +||||++++++
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGID----KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccC----CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            34567999999999999999999864211    11256789999987543 23345688999999999 89999999998


Q ss_pred             EEec-CceEEEEEecCCCCHHHHHhhcC----------------------------------------------------
Q 011234          207 CIED-DQRLLVYEFMPRGSLENHLFRKG----------------------------------------------------  233 (490)
Q Consensus       207 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~----------------------------------------------------  233 (490)
                      +... +.+++||||+++|+|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            8765 46889999999999999986532                                                    


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeecc
Q 011234          234 --------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV  305 (490)
Q Consensus       234 --------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~  305 (490)
                              ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..............
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence                    124778888999999999999999988   999999999999999999999999999865433222222234


Q ss_pred             ccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCCh
Q 011234          306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI  384 (490)
Q Consensus       306 ~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  384 (490)
                      .++..|+|||++.+..++.++|||||||+||||++ |..||........  .....    ....      .    ...+.
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~----~~~~------~----~~~~~  300 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRL----KDGT------R----MRAPE  300 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHH----hcCC------C----CCCCC
Confidence            56788999999999999999999999999999997 9999975432211  11100    0000      0    01122


Q ss_pred             HhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          385 KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       385 ~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ..+..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus       301 ~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            33678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-46  Score=337.41  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=216.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      ...++|++++.||+|-||.||+|+.+.         ++..||+|++.+...   +...++.+|++|-+.|+||||+++|+
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekk---------s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~   89 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKK---------SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG   89 (281)
T ss_pred             cchhhccccccccCCccccEeEeeecc---------CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence            344679999999999999999999876         677999999977643   23467899999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      +|.++...||++||..+|+|+..|.......+++.....++.|++.||.|+|..+   ||||||||+|+|++..+.+||+
T Consensus        90 ~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   90 YFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             heeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeecc
Confidence            9999999999999999999999998766667899999999999999999999877   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||.+...+..    .....|||..|.+||.+.+..++..+|+|++|++.||++.|.+||......+....+..      
T Consensus       167 dfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k------  236 (281)
T KOG0580|consen  167 DFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK------  236 (281)
T ss_pred             CCCceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH------
Confidence            99998765422    23457999999999999999999999999999999999999999976542211111110      


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                                  ..-.+|...+..+.+||.+||..+|.+|....|++++-.
T Consensus       237 ------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  237 ------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             ------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence                        111233445889999999999999999999999998743

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-46  Score=358.98  Aligned_cols=248  Identities=23%  Similarity=0.387  Sum_probs=212.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHH---HHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~---~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+|++.+.||+|.||.|-+|+...         .|+.||||.++++...+..   .+.+||+||+.|+||||+.+|++|.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~---------sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHK---------SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhcc---------CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            479999999999999999998754         7889999999988665544   4578999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+.+.|||||..+|.|++++...+  .+++..++.+++||..|+.|||.++   ++|||||.+|||||.++++||+|||
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccc
Confidence            9999999999999999999998876  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++..+...   .....+||++.|.+||++++..|. ..+|.|||||+||.|+.|..||++.+..   .++.....    .
T Consensus       199 LSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~lvrQIs~----G  268 (668)
T KOG0611|consen  199 LSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RLVRQISR----G  268 (668)
T ss_pred             hhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HHHHHhhc----c
Confidence            99877554   334568999999999999998885 6899999999999999999999875322   22221110    0


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       .   ..        .+.-+.++.-||++||..||++|.|+.+|..+-
T Consensus       269 -a---Yr--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  269 -A---YR--------EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -c---cc--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence             0   00        112256788999999999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-45  Score=346.67  Aligned_cols=267  Identities=24%  Similarity=0.322  Sum_probs=212.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--HHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|+.+..|++|+||.||+|+++.         |++.||+|.++.+....  --.-++||.+|.+++|||||.+-.+...
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~---------t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG  146 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKK---------TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVG  146 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCC---------cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEec
Confidence            468888999999999999999876         78899999998764211  1235899999999999999999998765


Q ss_pred             c--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          210 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       210 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .  +.+|||||||++ +|..++...+ .++...++..++.|++.||+|||.+.   |+|||||++|+|++..|.+||+||
T Consensus       147 ~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDF  221 (419)
T KOG0663|consen  147 SNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADF  221 (419)
T ss_pred             cccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEeccc
Confidence            4  579999999965 9999887764 58999999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh------
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA------  360 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~------  360 (490)
                      |+|+.+...-  ...+..+-|.+|+|||++.+ ..|+.++|+||+|||+.||+++.+.|.+....+..+.+-..      
T Consensus       222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte  299 (419)
T KOG0663|consen  222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE  299 (419)
T ss_pred             chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence            9999886542  23456778999999999987 47999999999999999999999999988766655543211      


Q ss_pred             --hcccCCc-----hhhhhccCccccCCCChH-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 --RPHLGDK-----RRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 --~~~~~~~-----~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        ++.+...     ..+....-..+...|... .+....+|+..+|..||.+|.|+.+.|++
T Consensus       300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence              1111110     011111111122223322 46888999999999999999999999865

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-44  Score=354.43  Aligned_cols=252  Identities=29%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      |++.+.||+|+||.||+|.+..         +|..||+|.+......   ....+.+|+.++..++|+||+++++++.++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~   72 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEec---------CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence            7788999999999999999876         6779999998754322   234577899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~  149 (285)
T cd05631          73 DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLA  149 (285)
T ss_pred             CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999999999998887655456899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........   .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..   ..      
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~------  217 (285)
T cd05631         150 VQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR---RV------  217 (285)
T ss_pred             EEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH---Hh------
Confidence            87543221   2345799999999999999999999999999999999999999976543221111110   00      


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                         ..  ....++...+.++.+||.+||+.||.+||+     +++++++
T Consensus       218 ---~~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         218 ---KE--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---hc--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence               00  011223334778999999999999999997     7888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-45  Score=367.51  Aligned_cols=266  Identities=26%  Similarity=0.422  Sum_probs=215.6

Q ss_pred             hhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceec
Q 011234          125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       125 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .++.+..+++.+...||+|.||+||+|.|..            .||||+++.+..  ...+.|..|+..|++-+|.||+-
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlL  452 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILL  452 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhhee
Confidence            5566667778889999999999999999976            599999987754  34578999999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ++|||..... .||..+|+|-+|+.+|.-.. ..|.....+.|+.||++|+.|||.++   |||||||..||+|.++++|
T Consensus       453 FMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  453 FMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence            9999988777 99999999999999997654 36888899999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||+|||++..-.............|...|||||++..   ..|+..+||||||||+|||++|..||...........+  
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV--  605 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV--  605 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe--
Confidence            9999999975433222222234568889999999974   47899999999999999999999999843322221111  


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                           +...-..+..      ....++++++++|+..||..++++||.+.+|+..|+.+..
T Consensus       606 -----GrG~l~pd~s------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  606 -----GRGYLMPDLS------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             -----cccccCccch------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                 1110000111      1223568899999999999999999999999998887655

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-45  Score=356.58  Aligned_cols=264  Identities=25%  Similarity=0.344  Sum_probs=207.8

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--------------hHHHHHHHHHHH
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------GHKEWLAEVNFL  192 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--------------~~~~~~~E~~~l  192 (490)
                      .....++|++++.||+|.||.|-+|++..         ++..||||++.+....              ..+.+.+||.||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~---------~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail  162 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEV---------DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL  162 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecC---------CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence            34556789999999999999999999876         6779999999754221              134678999999


Q ss_pred             hcCCCCceeceeeEEEec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011234          193 GNLLHPNLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       193 ~~l~HpnIv~l~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      ++|+|||||+|+++..+.  +.+|||+|||..|.+...-...  ..+.+.++++++++++.||+|||.++   |||||||
T Consensus       163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIK  237 (576)
T KOG0585|consen  163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIK  237 (576)
T ss_pred             HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccc
Confidence            999999999999998764  6899999999988876432222  13889999999999999999999999   9999999


Q ss_pred             CCceEEcCCCCeEEccccccccCCCC---CCcceeeccccCCCCCCchhhhcCC----CCccccchhhHHHHHHHHhCCC
Q 011234          271 TSNILLDADYNAKLSDFGLAKDAPED---GKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       271 p~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~sDvwSlGvil~elltG~~  343 (490)
                      |+|+||+++|++||+|||.+..+...   +........+||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.
T Consensus       238 PsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~  317 (576)
T KOG0585|consen  238 PSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQL  317 (576)
T ss_pred             hhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccC
Confidence            99999999999999999999866322   1112223478999999999998732    3568999999999999999999


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ||-+........                .+.+..+.-....+...++++||.+||.+||+.|.+..+|..|..-.+.
T Consensus       318 PF~~~~~~~l~~----------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  318 PFFDDFELELFD----------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             CcccchHHHHHH----------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            996543221111                1222222211122347889999999999999999999999988764444

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-43  Score=352.33  Aligned_cols=274  Identities=28%  Similarity=0.436  Sum_probs=209.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .++|++.+.||+|+||.||+|.+......       ....+++..||+|++.... .....++.+|+.+|..++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            35799999999999999999987543210       1223456689999987653 233467899999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-----------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      +++++.+.+..++||||+++|+|.+++....                 ...+++..+..++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999886432                 123677888999999999999999988   99


Q ss_pred             ecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh--CCC
Q 011234          266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRR  343 (490)
Q Consensus       266 HrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt--G~~  343 (490)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986644333223334556889999999998899999999999999999987  456


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                      ||.......   ........+....       .......+..++..+.+||.+||..||.+|||+.+|.+.|++
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRDQG-------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhhcc-------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            665432211   1111111100000       000011122346789999999999999999999999988863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=356.98  Aligned_cols=247  Identities=25%  Similarity=0.342  Sum_probs=204.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|++.....   .....+.+|+.+|+.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRI---------SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            368999999999999999998875         677999999865432   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecC
Confidence            9999999999999999999997654  6888999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++......     ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+      .... 
T Consensus       147 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~-  214 (291)
T cd05612         147 FAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAGK-  214 (291)
T ss_pred             cchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-
Confidence            99866432     12357999999999999989999999999999999999999999754322111111      0000 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~L  415 (490)
                                 ..++...+..+.+||.+||..||.+||+     +.+++++-
T Consensus       215 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         215 -----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             -----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence                       0122233678999999999999999995     88888663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-44  Score=362.68  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=204.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+|++.+.||+|+||.||+|++..         +|..||||++.....   .....+.+|+.+|..++||||+++++++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   88 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKG---------TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ   88 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            579999999999999999999875         677999999875422   23456789999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         89 DENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             cCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999997654  5788899999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.......     ...+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..+.   ....  
T Consensus       164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~---i~~~--  230 (329)
T PTZ00263        164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEK---ILAG--  230 (329)
T ss_pred             CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHH---HhcC--
Confidence            998664321     23579999999999999999999999999999999999999996543211   1110   0000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~L  415 (490)
                              .+  .++...+..+.+||.+||+.||.+|++     +.+++.+-
T Consensus       231 --------~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp  272 (329)
T PTZ00263        231 --------RL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP  272 (329)
T ss_pred             --------Cc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence                    00  112223678899999999999999986     68888763

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=375.24  Aligned_cols=270  Identities=24%  Similarity=0.297  Sum_probs=218.2

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      .+...+++|.+.|.+|||+.||+|++..         .|..||+|++-..+....+.+.+||.+|+.|. |+|||.+++.
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~---------~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yids  103 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVK---------GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDS  103 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecC---------CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence            3455678999999999999999999875         34789999987777778888999999999998 9999999993


Q ss_pred             -EEec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          207 -CIED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       207 -~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                       ....      -+++|+||||.||.|-+++..+....|.+.++++|+.++++|+.+||... .+|||||||-+||||+.+
T Consensus       104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~  182 (738)
T KOG1989|consen  104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSAD  182 (738)
T ss_pred             ccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCC
Confidence             2221      25689999999999999998776667999999999999999999999987 779999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcce-----e--eccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHV-----S--TRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~-----~--~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~  349 (490)
                      |..||||||.|...........     .  -...-|+.|+|||.+.   +..++.|+|||+|||+||-|++...||+...
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            9999999999874322111100     0  0123589999999874   6789999999999999999999999997653


Q ss_pred             CCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCcccccc
Q 011234          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASS  427 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~~~~~~  427 (490)
                      ...                    +++..+.-......+..+.+||+.||+.||++||++-+|+..+..+.+.......
T Consensus       263 ~la--------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~  320 (738)
T KOG1989|consen  263 KLA--------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPD  320 (738)
T ss_pred             cee--------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccc
Confidence            322                    2222221111235589999999999999999999999999999888776654333

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.5e-44  Score=360.37  Aligned_cols=243  Identities=32%  Similarity=0.412  Sum_probs=200.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      +.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+|..++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKA---------TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            469999999999998865         677999999875422   23345778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      +||||+++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        72 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            9999999999999987654  6889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ....       
T Consensus       147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~---~~~~-------  211 (323)
T cd05571         147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LMEE-------  211 (323)
T ss_pred             cCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH---HcCC-------
Confidence            2211  1234679999999999999999999999999999999999999996532211   11110   0000       


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                           ..++...+.++.+||.+||..||++||     ++.+++++
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                 112233478899999999999999999     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-44  Score=359.27  Aligned_cols=255  Identities=26%  Similarity=0.354  Sum_probs=207.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....   .....+..|+.++..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKD---------TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            368999999999999999999875         677999999875422   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCc
Confidence            9999999999999999999997654  6888999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.....     .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+......+.   
T Consensus       147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---  218 (333)
T cd05600         147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ---  218 (333)
T ss_pred             CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccccc---
Confidence            9986543     22346799999999999999999999999999999999999999976543222111110000000   


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                            .+.. .......+.++.+||.+||..+|.+||++.+++++-
T Consensus       219 ------~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         219 ------RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             ------CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence                  0000 000113377899999999999999999999999873

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-43  Score=348.40  Aligned_cols=246  Identities=21%  Similarity=0.320  Sum_probs=200.5

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh---HHHHHHHHHHHhcCCCCceeceeeEEEe----c
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIE----D  210 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~  210 (490)
                      ..||+|++|.||+|.+           +|..||||.+.......   .+.+.+|+.+|.+++||||+++++++.+    .
T Consensus        26 ~~i~~g~~~~v~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-----------NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEE-----------CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            6799999999999987           46689999997653322   3567799999999999999999999877    3


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ...++||||+++|+|.+++....  .+++.....++.+++.||.|||+. +   ++||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccch
Confidence            46889999999999999997654  688899999999999999999984 6   88999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++......     ....|+..|+|||++.+  ..++.++|||||||++|||++|..||........   ....   ... 
T Consensus       170 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~~~i---~~~-  237 (283)
T PHA02988        170 EKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---YDLI---INK-  237 (283)
T ss_pred             Hhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---HHHH---Hhc-
Confidence            98654321     23468899999999976  6899999999999999999999999975432211   1110   000 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               .....++..++..+.+||.+||+.||++|||+.+|++.|+.++.
T Consensus       238 ---------~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 ---------NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ---------CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                     00111223457889999999999999999999999999987753

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-43  Score=348.95  Aligned_cols=268  Identities=23%  Similarity=0.294  Sum_probs=204.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||+|++.....  ...+.+.+|+.+++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKE---------TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR   71 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECC---------CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence            369999999999999999999875         677899999875422  234567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++||||++++.|..+. .. ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~-~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          72 RGKLYLVFEYVEKNMLELLE-EM-PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             CCEEEEEEecCCCCHHHHHH-hc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccC
Confidence            99999999999887665443 32 236889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC----
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  365 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  365 (490)
                      +......... ......|++.|+|||++.+..++.++|||||||++|||++|++||...........+......+.    
T Consensus       147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07848         147 ARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM  225 (287)
T ss_pred             cccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence            9876432211 12345789999999999988999999999999999999999999976443221111111000000    


Q ss_pred             ----CchhhhhccCccc------cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 ----DKRRFYRLLDPRL------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ----~~~~~~~~~~~~l------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ....+.....+..      ...+....+..+.+||.+||+.||++|||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                0000000000000      001111246789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-44  Score=378.58  Aligned_cols=268  Identities=28%  Similarity=0.440  Sum_probs=224.1

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +...+....+.||+|+||+||+|+.....    .......||||.++..... ...+|.+|+++|..|+|||||+|+|+|
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~----p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLL----PGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCC----CCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            33456677789999999999999875422    1124568999999987655 678999999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC--------CCC----CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG--------SLP----LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      .+++..|+|+|||..|||.++|....        +.+    ++..+.+.||.|||.|+.||-++.   +|||||-.+|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhce
Confidence            99999999999999999999997532        223    888999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~  354 (490)
                      |.++..|||+|||+++.....++........-.++||+||.++.++|+.+||||||||+|||+++ |..||.+....+..
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI  715 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI  715 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence            99999999999999998876666655444455789999999999999999999999999999996 88888765544333


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ..+...                .+ -..|..|+.++.+||..||+.+|.+||+++||-..|..+..
T Consensus       716 e~i~~g----------------~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  716 ECIRAG----------------QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHcC----------------Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            333211                11 23456779999999999999999999999999999986543

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.6e-43  Score=361.76  Aligned_cols=264  Identities=27%  Similarity=0.406  Sum_probs=207.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+...    ....++..||||+++... ....+.+.+|+.+|..+ +||||+++++++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~----~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL----FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc----ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            34689999999999999999975321    112356789999987543 23445688999999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKG-------------------------------------------------------  233 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------------------  233 (490)
                      ..+..++|||||++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            9999999999999999999986432                                                       


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          234 ------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       234 ------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                                        ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              124778889999999999999999988   99999999999999999999999999986644


Q ss_pred             CCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ...........++..|+|||++.+..++.++|||||||++|||++ |..||.......  .........           
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-----------  333 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-----------  333 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-----------
Confidence            322222222345678999999999999999999999999999998 888886532211  111111100           


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                         .....+...+.++.+||.+||+.||++||++.+|++.|+.
T Consensus       334 ---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         334 ---YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               0001111236789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-43  Score=354.35  Aligned_cols=266  Identities=25%  Similarity=0.384  Sum_probs=207.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||++++..         +|..||+|.+.... ......+.+|+++|+.++||||+++++++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            4689999999999999999998875         67789999987653 2334578899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          75 DGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             CCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            999999999999999999987654  5889999999999999999999853  299999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc--
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--  367 (490)
                      +.......    .....||..|+|||++.+..++.++|||||||++|||++|+.||............  ..+.....  
T Consensus       151 ~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~--~~~~~~~~~~  224 (331)
T cd06649         151 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF--GRPVVDGEEG  224 (331)
T ss_pred             cccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--cccccccccC
Confidence            87654321    23457999999999999989999999999999999999999999653321110000  00000000  


Q ss_pred             --------------------------hhhhhccC----ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 --------------------------RRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 --------------------------~~~~~~~~----~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                                ......++    ...........+.++.+||.+||..||++|||+.+|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                      00000000    0000000112367899999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-43  Score=362.48  Aligned_cols=265  Identities=27%  Similarity=0.408  Sum_probs=208.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++...+.    ..++..||+|++..... .....+.+|+.+|+.+ +|+|||++++++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK----EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc----ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            4579999999999999999998754221    12456899999975432 3345688999999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcC-------------------------------------------------------
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKG-------------------------------------------------------  233 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~-------------------------------------------------------  233 (490)
                      ..+..++|||||++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            9999999999999999999985431                                                       


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcc
Q 011234          234 -------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH  300 (490)
Q Consensus       234 -------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~  300 (490)
                                   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                         124778889999999999999999988   9999999999999999999999999998654432222


Q ss_pred             eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCcccc
Q 011234          301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE  379 (490)
Q Consensus       301 ~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  379 (490)
                      ......++..|||||++.+..++.++|||||||++|||++ |..||........  .....              .....
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~--------------~~~~~  333 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMV--------------KRGYQ  333 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHH--------------HcccC
Confidence            2222345678999999998999999999999999999997 9999965432111  11110              00001


Q ss_pred             CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       380 ~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ...+...+.++.+||.+||+.||.+||++.+|++.|+.+
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         334 MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111122367899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-44  Score=357.75  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=214.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|..+++||+|+||.+++++++.+         +..+++|.+......  ..+....|+.+++++.|||||.+++.|.+
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~---------~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~   74 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSD---------DKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE   74 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccC---------CceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence            4688999999999999999998874         447999998766433  33457889999999999999999999999


Q ss_pred             cCc-eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          210 DDQ-RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~-~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ++. .+|||+||+||+|.+.|.+..+..++++.+..++.||+.||.|||++.   |+|||||+.||+++.++.|||+|||
T Consensus        75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfG  151 (426)
T KOG0589|consen   75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFG  151 (426)
T ss_pred             CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchh
Confidence            988 999999999999999998887778999999999999999999999877   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.+....  ......+||+.||.||++.+..|+.++|||||||++|||++-+++|...+...   ++.....      
T Consensus       152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki~~------  220 (426)
T KOG0589|consen  152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKINR------  220 (426)
T ss_pred             hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHHhh------
Confidence            999886653  23455789999999999999999999999999999999999999997653322   1111100      


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         ..     ....+...+.++..||..||..+|..||++.++|.+
T Consensus       221 ---~~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 ---GL-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ---cc-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence               01     112233448999999999999999999999999986

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.7e-43  Score=347.06  Aligned_cols=267  Identities=24%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|.+.+.||.|+||.||+|.+..         ++..||+|+++.... .....+.+|+.+++.++||||+++++++..+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   75 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE   75 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECC---------CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            469999999999999999998865         677999999875432 2234677899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||++ ++|.+++...+. .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          76 RCLTLVFEYLD-SDLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             CeEEEEEeCCC-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcce
Confidence            99999999996 599988866543 5788999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--------h
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--------R  361 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--------~  361 (490)
                      +.......  ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+...        .
T Consensus       151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07871         151 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW  228 (288)
T ss_pred             eeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence            76533221  1233568999999998875 56899999999999999999999999765433222211110        0


Q ss_pred             cccCCchhhhhccCccccC----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +.......+.....+....    ......+.++.+||.+||..||.+|||++|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1111111111111111100    0011236788999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-43  Score=356.87  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=196.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+..         +|..||||++..... .....+.+|+++|+.++|+||+++++++...
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  144 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRP---------TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN  144 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECC---------CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence            357778899999999999998865         577999999865432 3345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +.+++||||+++|+|.+..      ...+..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       145 ~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        145 GEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             CeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccc
Confidence            9999999999999986532      3456778889999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      +.......  ......||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+.....  ..
T Consensus       216 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~  291 (353)
T PLN00034        216 RILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MS  291 (353)
T ss_pred             eecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--cc
Confidence            86543211  1233579999999998743     234568999999999999999999997432221111111000  00


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                  .....+...+.++.+||.+||..||++||++.||+++
T Consensus       292 ------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 ------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0011122346789999999999999999999999975

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=356.29  Aligned_cols=253  Identities=26%  Similarity=0.329  Sum_probs=215.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh---HHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      ...|.+.+.||.|.||.||+|+.+.         +|..+|+|++.+.....   ...+.+|+.+|++|. |||||.++++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~---------tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~  104 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKS---------TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA  104 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecC---------CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3468999999999999999999876         68899999998775543   357889999999999 9999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC----CCCe
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DYNA  282 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~  282 (490)
                      |.+...+++|||+|.||.|.+.|...   .+++..+..++.||+.++.|||+.+   |+||||||+|+|+..    ++.+
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~i  178 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRI  178 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcE
Confidence            99999999999999999999999877   3899999999999999999999988   999999999999953    3579


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+.... 
T Consensus       179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~-  254 (382)
T KOG0032|consen  179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGD-  254 (382)
T ss_pred             EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCC-
Confidence            9999999998765   233456899999999999999999999999999999999999999998765443332221111 


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                   ..+...+....+..+.++|.+||..||.+|+|+.++|+|-
T Consensus       255 -------------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp  294 (382)
T KOG0032|consen  255 -------------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP  294 (382)
T ss_pred             -------------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence                         1122233344589999999999999999999999999984

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=359.00  Aligned_cols=244  Identities=30%  Similarity=0.465  Sum_probs=204.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +...-++-||.|+.|.||+|++.           ++.||||.++.-       -..+|+-|++|+||||+.|.|+|....
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~-----------netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP  185 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH-----------NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP  185 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc-----------CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence            33445678999999999999985           458999987421       235799999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      -+|||||||..|-|+..|....  .+.......+..+||.|+.|||.+.   |||||||.-||||..+..|||+|||.++
T Consensus       186 cyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  186 CYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             eeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence            9999999999999999997654  6788889999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ...+.   ...-.++||..|||||++.+...+.|+|||||||||||||||..||..-....    +     .++-.    
T Consensus       261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I-----IwGVG----  324 (904)
T KOG4721|consen  261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I-----IWGVG----  324 (904)
T ss_pred             hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e-----EEecc----
Confidence            76443   12234899999999999999999999999999999999999999996432211    1     11111    


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                         ...+.-..|..|+.-++-||++||.-.|..||++.+|+.||+-
T Consensus       325 ---sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  325 ---SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ---CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence               1122334456778999999999999999999999999999963

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.3e-43  Score=344.06  Aligned_cols=263  Identities=28%  Similarity=0.484  Sum_probs=211.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+.....    ..+...||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE----RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC----CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            468899999999999999998765321    12446899999875432 3345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      +..+++|||+++++|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence            999999999999999999975421              35788899999999999999999988   9999999999999


Q ss_pred             cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcch
Q 011234          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~  355 (490)
                      +.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+   
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---  234 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---  234 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            9999999999999986544332233334567889999999998899999999999999999998 999987543321   


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ......              .......+..++.++.+|+.+||+.||.+||++.+|+++|+.+
T Consensus       235 ~~~~i~--------------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 VIEMIR--------------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HHHHHH--------------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            111111              0001112334578999999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-43  Score=354.75  Aligned_cols=244  Identities=29%  Similarity=0.387  Sum_probs=200.3

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      +.||+|+||.||+|.+..         +|..||+|++.....   .....+.+|+.+|+.++||||+++++++...+..+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKA---------SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            469999999999998865         677999999975422   23456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      +||||+++|+|.+++....  .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++...
T Consensus        72 lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          72 FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            9999999999998887654  6889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....   .....       
T Consensus       147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~---~~~~~-------  211 (328)
T cd05593         147 TDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---ILMED-------  211 (328)
T ss_pred             Ccc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHH---hccCC-------
Confidence            221  11234679999999999999999999999999999999999999996543211   1110   00000       


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                           ..++...+.++.+||.+||..||.+|+     ++.+++++.
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  252 (328)
T cd05593         212 -----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS  252 (328)
T ss_pred             -----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence                 012233477899999999999999997     899999873

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-43  Score=351.59  Aligned_cols=241  Identities=32%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||+|+||.||+|.+..         ++..||+|++....   ......+.+|+.+|..++||||+++++++...+..++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRD---------TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            7999999999999865         67789999987532   23345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            99999999999997654  6889999999999999999999988   999999999999999999999999999864322


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .  ......+||+.|+|||++.+..++.++|||||||++|||++|..||......      +.........         
T Consensus       147 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~---------  209 (312)
T cd05585         147 D--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEP---------  209 (312)
T ss_pred             C--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC---------
Confidence            1  1223467999999999999999999999999999999999999999653211      1111111110         


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSEVVET  414 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~evl~~  414 (490)
                         ..++...+..+.+||.+||..||.+||+   +.+++.+
T Consensus       210 ---~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 ---LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence               1122334778999999999999999975   6777765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-43  Score=353.81  Aligned_cols=244  Identities=31%  Similarity=0.404  Sum_probs=199.7

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      +.||+|+||.||++....         +|..||+|++.....   .....+.+|+.++..++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            469999999999998865         677999999875422   23345678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      |||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          72 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            9999999999998887654  6889999999999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+      ....       
T Consensus       147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~-------  211 (323)
T cd05595         147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEE-------  211 (323)
T ss_pred             CCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC-------
Confidence            2211  123467999999999999999999999999999999999999999654322111100      0000       


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                           ..++...+.++.+||.+||..||.+|+     ++.+++++-
T Consensus       212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             -----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence                 012233478899999999999999998     899998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=333.21  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=208.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+.|.+.+.||+|.|+.||++.+..         +|+.+|+|+++....  .+.+++.+|++|.+.|+|||||++.+.+.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~---------tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~   80 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   80 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhcc---------chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc
Confidence            4568888999999999999997765         889999999875432  35677889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCeEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~  285 (490)
                      +++..|||+|+|.|++|..-|..+  .-+++..+-.++.||++||.|+|.++   |||||+||+|+|+..   .--+||+
T Consensus        81 ~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   81 EESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             ccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeec
Confidence            999999999999999998666554  35778888899999999999999999   999999999999954   3459999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+|......   ......+|||.|||||++....|+..+|||+.|||||-||.|.+||.+.........+......  
T Consensus       156 ~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd--  230 (355)
T KOG0033|consen  156 DFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD--  230 (355)
T ss_pred             ccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC--
Confidence            99999987622   3334578999999999999999999999999999999999999999764322111111110000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                                  +...+....++++++||++||..||.+|.|+.|.|++-.
T Consensus       231 ------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  231 ------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             ------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence                        111122344889999999999999999999999998753

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-43  Score=356.75  Aligned_cols=249  Identities=26%  Similarity=0.323  Sum_probs=204.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|.+.+.||+|+||.||+|.+...        .+..||+|++....   ......+.+|+.++..++||||+++++++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNE--------DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECC--------CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            34799999999999999999987542        23589999986532   22345678899999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DF  175 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDF  175 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecC
Confidence            99999999999999999999997654  6889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++......     ....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+      .   
T Consensus       176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i------~---  241 (340)
T PTZ00426        176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI------L---  241 (340)
T ss_pred             CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH------h---
Confidence            999865432     12357999999999999989999999999999999999999999754321111100      0   


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                             ...  ..++...+..+.+||.+||+.||.+|+     ++.+++++-
T Consensus       242 -------~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp  285 (340)
T PTZ00426        242 -------EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP  285 (340)
T ss_pred             -------cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence                   000  012223367789999999999999995     899998773

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=5.4e-43  Score=340.75  Aligned_cols=260  Identities=25%  Similarity=0.408  Sum_probs=208.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|++.+.||+|+||.||+|++....      ..+..||+|.++.... .....+.+|+.++..++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   77 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPS------KRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR   77 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCC------CceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec
Confidence            346899999999999999999876432      2567899999886532 334568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.++|+|||.
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          78 GNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             CCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcc
Confidence            999999999999999999987653 36889999999999999999999988   99999999999999999999999998


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   ..+...    .. 
T Consensus       154 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~-  224 (266)
T cd05064         154 LQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE----DG-  224 (266)
T ss_pred             cccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH----CC-
Confidence            7654322111 1112345678999999999999999999999999999775 999996543221   111110    00 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                               .....+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       225 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 ---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     00011233467899999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-43  Score=359.38  Aligned_cols=255  Identities=25%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++....   ......+.+|+.+|..++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKD---------TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            379999999999999999999875         67799999997542   123345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..|||||||++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecc
Confidence            9999999999999999999997654  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcc------------------------------------eeeccccCCCCCCchhhhcCCCCccccchhhH
Q 011234          289 LAKDAPEDGKTH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFG  332 (490)
Q Consensus       289 ~a~~~~~~~~~~------------------------------------~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlG  332 (490)
                      ++..+.......                                    .....+||+.|+|||++.+..++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            987543211000                                    01124699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC---HH
Q 011234          333 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MS  409 (490)
Q Consensus       333 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~  409 (490)
                      |++|||++|..||...........+      ......        +........+..+.+||.+||. +|.+|++   +.
T Consensus       227 ~il~el~~G~~Pf~~~~~~~~~~~i------~~~~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~  291 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQETYRKI------INWKET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN  291 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHHHHHHHH------HcCCCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence            9999999999999754322111000      000000        0000011236789999999996 9999997   99


Q ss_pred             HHHHHh
Q 011234          410 EVVETL  415 (490)
Q Consensus       410 evl~~L  415 (490)
                      +++++-
T Consensus       292 ~ll~h~  297 (364)
T cd05599         292 EIKSHP  297 (364)
T ss_pred             HHhcCC
Confidence            998763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.1e-43  Score=358.97  Aligned_cols=255  Identities=25%  Similarity=0.310  Sum_probs=201.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .|++++.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+|..++|+||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVD---------THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            58899999999999999998865         677999999975432   234567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+.+|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcC
Confidence            999999999999999999987654  5888999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCC---------------------------------------------cceeeccccCCCCCCchhhhcCCCCc
Q 011234          290 AKDAPEDGK---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTS  324 (490)
Q Consensus       290 a~~~~~~~~---------------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~~~  324 (490)
                      +........                                             .......+||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            764311000                                             00112357999999999999889999


Q ss_pred             cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhh--hcCC
Q 011234          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL--SRDP  402 (490)
Q Consensus       325 ~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL--~~dP  402 (490)
                      ++|||||||++|||++|..||...........+  .  ....          .+........+.++.+||.+||  ..++
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i--~--~~~~----------~~~~~~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKV--I--NWEN----------TLHIPPQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHH--H--cccc----------ccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence            999999999999999999999764332111100  0  0000          0000011123678999999954  5566


Q ss_pred             CCCCCHHHHHHHh
Q 011234          403 KARPRMSEVVETL  415 (490)
Q Consensus       403 ~~RPs~~evl~~L  415 (490)
                      ..|+++.+|+++-
T Consensus       294 ~~R~~~~~~l~hp  306 (381)
T cd05626         294 LGRNGADDIKAHP  306 (381)
T ss_pred             cCCCCHHHHhcCc
Confidence            6699999999873

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-43  Score=357.45  Aligned_cols=254  Identities=26%  Similarity=0.342  Sum_probs=200.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKD---------TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            478999999999999999998865         677999999975422   22345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+.+|||||||++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeecc
Confidence            9999999999999999999997654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc---------------------------------ceeeccccCCCCCCchhhhcCCCCccccchhhHHHH
Q 011234          289 LAKDAPEDGKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  335 (490)
Q Consensus       289 ~a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil  335 (490)
                      +++........                                 ......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            98754321100                                 011235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCC---CCCCHHHHH
Q 011234          336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK---ARPRMSEVV  412 (490)
Q Consensus       336 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~---~RPs~~evl  412 (490)
                      |||++|..||...........+..    .....    .+.+    .  ...+.++.+||.+|+. +|.   .||+++||+
T Consensus       227 ~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~----~~p~----~--~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~  291 (363)
T cd05628         227 YEMLIGYPPFCSETPQETYKKVMN----WKETL----IFPP----E--VPISEKAKDLILRFCC-EWEHRIGAPGVEEIK  291 (363)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHc----CcCcc----cCCC----c--CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence            999999999975433221111100    00000    0000    0  1236788999998664 444   468999999


Q ss_pred             HH
Q 011234          413 ET  414 (490)
Q Consensus       413 ~~  414 (490)
                      ++
T Consensus       292 ~h  293 (363)
T cd05628         292 TN  293 (363)
T ss_pred             CC
Confidence            87

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.5e-43  Score=367.61  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=206.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      .|.+.+.||+|+||.||+|....+        .+..||+|.+..........+.+|+.+|..++|||||++++++..++.
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~--------~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~  139 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD--------PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK  139 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC--------CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE
Confidence            488999999999999999987652        256789998766555555567789999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      .||||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla  216 (478)
T PTZ00267        140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFS  216 (478)
T ss_pred             EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCc
Confidence            99999999999999887542  2346889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....   ....    
T Consensus       217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~~~~---~~~~----  286 (478)
T PTZ00267        217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---IMQQ---VLYG----  286 (478)
T ss_pred             eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHhC----
Confidence            87654333233345679999999999999999999999999999999999999996532211   1110   0000    


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        ..+     .++...+..+.+||.+||..||++||++.+++.+
T Consensus       287 --~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        287 --KYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --CCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              000     1122346789999999999999999999999864

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.5e-43  Score=350.86  Aligned_cols=266  Identities=26%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|.+.... ......+.+|+++|+.++|+||++++++|.+
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKP---------SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS   74 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence            4689999999999999999998865         67789999887653 2334568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ++..++||||+++++|.+++...+  .+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg  149 (333)
T cd06650          75 DGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFG  149 (333)
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCC
Confidence            999999999999999999997654  578899999999999999999974 5   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---ccc-
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR---PHL-  364 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~---~~~-  364 (490)
                      ++......    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||................   ... 
T Consensus       150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (333)
T cd06650         150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES  225 (333)
T ss_pred             cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence            98765332    1233578999999999998899999999999999999999999997543221111000000   000 


Q ss_pred             -----------------CCc---hhhhhccCcccc---CCCC-hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 -----------------GDK---RRFYRLLDPRLE---GHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 -----------------~~~---~~~~~~~~~~l~---~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                       ...   .......+....   ...+ ...+.++.+||.+||+.||++|||+.|++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             ccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                             000   000000000000   0000 1135778999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.2e-43  Score=360.07  Aligned_cols=265  Identities=24%  Similarity=0.334  Sum_probs=211.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-C-----Cceeceee
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H-----PNLVKLVG  205 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~  205 (490)
                      -+|.++++||+|+||.|.+|++..         |++.||||+++... .-..+...|+.||..|+ |     -|||++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~---------T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d  255 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHK---------TGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLD  255 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecC---------CCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence            378999999999999999999876         88999999998653 33456678999999997 4     48999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC--CCeE
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAK  283 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~k  283 (490)
                      +|...++.|||+|.+ ..+|+++|..+....++...++.|+.||+.||.+||+.+   |||+||||+||||..-  ..||
T Consensus       256 ~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vK  331 (586)
T KOG0667|consen  256 YFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIK  331 (586)
T ss_pred             ccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCcee
Confidence            999999999999999 679999999888788999999999999999999999988   9999999999999643  3799


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc-
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-  362 (490)
                      |+|||.+......-.     ..+-+..|+|||++.+..|+.+.||||||||++||++|.+.|.+..+.+....+....- 
T Consensus       332 VIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~  406 (586)
T KOG0667|consen  332 VIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL  406 (586)
T ss_pred             EEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence            999999987644322     34567889999999999999999999999999999999999988877665443321100 


Q ss_pred             -------ccCCchhhhhc------------------------------cCcc-------ccCCCChHhHHHHHHHHHHhh
Q 011234          363 -------HLGDKRRFYRL------------------------------LDPR-------LEGHFSIKGSQKATQLAAQCL  398 (490)
Q Consensus       363 -------~~~~~~~~~~~------------------------------~~~~-------l~~~~~~~~~~~l~~Li~~cL  398 (490)
                             .......++.-                              .+..       +...+.......+.+++++||
T Consensus       407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L  486 (586)
T KOG0667|consen  407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL  486 (586)
T ss_pred             CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence                   00000000000                              0000       000111233677899999999


Q ss_pred             hcCCCCCCCHHHHHHHh
Q 011234          399 SRDPKARPRMSEVVETL  415 (490)
Q Consensus       399 ~~dP~~RPs~~evl~~L  415 (490)
                      ..||.+|+|..++++|-
T Consensus       487 ~~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  487 EWDPAERITPAQALNHP  503 (586)
T ss_pred             ccCchhcCCHHHHhcCc
Confidence            99999999999999884

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-43  Score=351.52  Aligned_cols=266  Identities=26%  Similarity=0.399  Sum_probs=200.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|.+..         +|..||||.+...  .......+.+|+.+|+.++||||+++++++...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   71 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTH---------TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP   71 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECC---------CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence            48889999999999999998865         6779999998643  223345688999999999999999999988654


Q ss_pred             C-----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          211 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      +     ..|+||||| +++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~  145 (338)
T cd07859          72 SRREFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKIC  145 (338)
T ss_pred             CCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEc
Confidence            3     479999999 579999887654  5889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCc-ceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |||+++........ ......+||+.|+|||++.+  ..++.++|||||||++|||++|++||...........+.....
T Consensus       146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            99999865332211 12234679999999999876  6789999999999999999999999975432211111100000


Q ss_pred             --------cc--CCchhhhhccCcc----ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 --------HL--GDKRRFYRLLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~--~~~~~~~~~~~~~----l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              .+  .....+...+...    +...+ ...+..+.+||.+||+.||++|||+.|++++
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                    00  0000000000000    00001 1235678999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.8e-43  Score=343.56  Aligned_cols=267  Identities=25%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcC---CCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNL---LHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~HpnIv~l~~~  206 (490)
                      ++|++.+.||+|+||.||+|.+...        +|..||+|.+.....  .....+.+|+.++..+   .||||++++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~   72 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   72 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCC--------CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEE
Confidence            3699999999999999999987542        456899998865422  1223456677776655   69999999998


Q ss_pred             EEe-----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          207 CIE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       207 ~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +..     ....++||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~  148 (290)
T cd07862          73 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQ  148 (290)
T ss_pred             EecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCC
Confidence            853     356899999995 69999987665556899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|.+||......+....+....
T Consensus       149 ~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~  225 (290)
T cd07862         149 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI  225 (290)
T ss_pred             EEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            999999999865432   12234578999999999998899999999999999999999999997654322211111000


Q ss_pred             cccCCchhhh-------hccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRRFY-------RLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~-------~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       .......+.       ..+....   ........+..+.+|+.+||+.||++|||+.+++++
T Consensus       226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         226 -GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             -CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence             000000000       0000000   000111236778999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-43  Score=348.18  Aligned_cols=249  Identities=25%  Similarity=0.363  Sum_probs=214.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--HHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .-|.+++.||+|.|++|-+|++.-         ||..||||++.+.....  ...+.+|++.|+.++|||||++|++...
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVF---------TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT   88 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVF---------TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT   88 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhc---------ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence            458899999999999999999876         89999999998876544  3468899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-CCCCeEEcccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFG  288 (490)
                      ...+|||+|+-++|+|+++|.++.. .+.++.+.+++.||+.|+.|+|+..   +|||||||+||++- .-|-|||.|||
T Consensus        89 QTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   89 QTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             cceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeecc
Confidence            9999999999999999999998754 6899999999999999999999988   99999999999874 56889999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCc-cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~-~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++..+..+...   +..||+..|.|||++.+..|+. ++||||||||||-|++|++||...+..+..             
T Consensus       165 FSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------------  228 (864)
T KOG4717|consen  165 FSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------------  228 (864)
T ss_pred             ccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------------
Confidence            99887665433   4579999999999999998875 789999999999999999999765433221             


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         -.++|-.  ...|...+.++++||..||..||.+|.+.+||..+
T Consensus       229 ---TmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  229 ---TMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---hhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               1223322  23455669999999999999999999999999875

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=359.63  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=211.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +.|.|+..||.|+||.||+|..+.         ++...|.|+|........++++-||.||..+.||+||+|++.|+.++
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nke---------t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en  102 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKE---------TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN  102 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhccc---------chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence            358889999999999999998875         66678899998777777888999999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+||+.|||.||-.+..+...++ .+.+.++..+++|++.||.|||++.   |||||||..|||++-+|.++|+|||.+.
T Consensus       103 kLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSA  178 (1187)
T KOG0579|consen  103 KLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSA  178 (1187)
T ss_pred             ceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccc
Confidence            99999999999999988877654 7999999999999999999999988   9999999999999999999999999876


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ....  .......+.||++|||||+++.     ..|+.++|||||||+|.||..+.+|.....+.-.  ++..+...   
T Consensus       179 Kn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaKSe---  251 (1187)
T KOG0579|consen  179 KNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSE---  251 (1187)
T ss_pred             cchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhhcC---
Confidence            4422  2223356899999999999863     5899999999999999999999999765433221  11111111   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                              .|.+  .-|...+..+.+++.+||.+||..||++.++++|-
T Consensus       252 --------PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp  290 (1187)
T KOG0579|consen  252 --------PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP  290 (1187)
T ss_pred             --------CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence                    0111  12334588899999999999999999999999874

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-42  Score=337.65  Aligned_cols=257  Identities=26%  Similarity=0.411  Sum_probs=209.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ..+|.+.+.||+|+||.||+|.+..         ++..||+|.+..+. ....++.+|+++++.+.|+||+++++++..+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   74 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEec---------CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence            3468888999999999999999875         56689999987553 3456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~  151 (263)
T cd05052          75 PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS  151 (263)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccc
Confidence            99999999999999999997665556899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   .....         
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~---------  218 (263)
T cd05052         152 RLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL---------  218 (263)
T ss_pred             cccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---------
Confidence            876443211 1112234668999999998999999999999999999998 899986542211   11111         


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                           ........+...+..+.+||.+||..||++||++.++++.|+.+
T Consensus       219 -----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         219 -----EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 01111122333478899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3e-43  Score=352.91  Aligned_cols=244  Identities=30%  Similarity=0.402  Sum_probs=198.9

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      +.||+|+||.||+|.+..         +|..||+|++.....   .....+..|++++..++||||+++++++...+..|
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            469999999999998865         677999999975422   23345678999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |||||+++|+|..++....  .+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            9999999999998887654  68899999999999999999997 57   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+      ....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~~~~------  212 (325)
T cd05594         147 IKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE------  212 (325)
T ss_pred             CCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------hcCC------
Confidence            32211  123457999999999999999999999999999999999999999654321111111      0000      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                            ..++...+.++.+||.+||+.||++|+     ++.+++++-
T Consensus       213 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         213 ------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence                  012223367899999999999999996     899999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.2e-43  Score=349.86  Aligned_cols=247  Identities=30%  Similarity=0.443  Sum_probs=199.7

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+++.....      .++..||||++.....    .....+..|+.+|+.++||||+++++++..++..
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~   75 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGA------DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKL   75 (323)
T ss_pred             ceeeecCCeEEEEEEEcccC------CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeE
Confidence            67999999999999875321      2678999999875422    2234567899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++++|.+++...+  .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          76 YLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             EEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999999999987654  5788888899999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ...             +
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~---~~~-------------~  212 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT---IDK-------------I  212 (323)
T ss_pred             ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH---HHH-------------H
Confidence            32221  12345799999999999988899999999999999999999999975432111   110             0


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                      ....  ..++...+..+.+||.+||+.||++||     ++.+++++-
T Consensus       213 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~  257 (323)
T cd05584         213 LKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP  257 (323)
T ss_pred             HcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence            0000  112233467899999999999999999     889988763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-42  Score=349.87  Aligned_cols=257  Identities=28%  Similarity=0.382  Sum_probs=203.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcCC-CCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  207 (490)
                      +|++.+.||+|+||.||+++.....      .+|..||+|++.....    ...+.+..|+.+|..+. |+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGH------DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF   74 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccC------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE
Confidence            4889999999999999999875321      2678999999865321    22345778999999995 99999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ..++..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          75 QTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             ecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999999999987654  5889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++........ .....+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.  ....  
T Consensus       150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~--  224 (332)
T cd05614         150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRIL--  224 (332)
T ss_pred             cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHh--
Confidence            999865432221 12346799999999999765 47889999999999999999999996543222111110  0000  


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                            ..++    .++...+..+.+||.+||+.||++||     ++.+++++-
T Consensus       225 ------~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  268 (332)
T cd05614         225 ------KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP  268 (332)
T ss_pred             ------cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence                  0111    12223477899999999999999999     788888764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-42  Score=344.84  Aligned_cols=266  Identities=22%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|....         +|..||||++..... .....+.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKV---------NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT   74 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECC---------CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec
Confidence            3679999999999999999998865         577899999875432 223456789999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      +...++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~  149 (303)
T cd07869          75 KETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGL  149 (303)
T ss_pred             CCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCc
Confidence            999999999994 68888876543 35888899999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC--
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--  366 (490)
                      +.......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  ...+.....+..  
T Consensus       150 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  225 (303)
T cd07869         150 ARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPN  225 (303)
T ss_pred             ceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCC
Confidence            87543221  11233568999999999875 468889999999999999999999997543211  111100000000  


Q ss_pred             c------hhhhhc--------cCccccCCCC-hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 K------RRFYRL--------LDPRLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~------~~~~~~--------~~~~l~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .      ......        ....+...++ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0      000000        0000000000 0124678899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-43  Score=356.27  Aligned_cols=255  Identities=29%  Similarity=0.367  Sum_probs=206.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|.+.+.||+|+||.||+|.+..         +|..||||++.....   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKD---------TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            368999999999999999999875         677999999875422   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCC
Confidence            9999999999999999999997763  6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCC---------------------------CcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhC
Q 011234          289 LAKDAPEDG---------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  341 (490)
Q Consensus       289 ~a~~~~~~~---------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG  341 (490)
                      ++.......                           .........||+.|+|||++.+..++.++|||||||+||||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            998664432                           00112345799999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-HHHHHHHh
Q 011234          342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETL  415 (490)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evl~~L  415 (490)
                      +.||...........+      ....        ..+........+.++.+||.+||. ||.+||+ +.+++++.
T Consensus       227 ~~Pf~~~~~~~~~~~i------~~~~--------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         227 FPPFYSDTLQETYNKI------INWK--------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CCCCCCCCHHHHHHHH------hccC--------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            9999765422111100      0000        000000001137889999999997 9999999 99999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.5e-43  Score=335.85  Aligned_cols=266  Identities=26%  Similarity=0.373  Sum_probs=206.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCc-eeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPN-LVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~  209 (490)
                      .|..++.||+|+||+||+|+...         +|..||+|.++.+...  .-...++|+.+|+.|+|+| ||.+++++..
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~---------~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~   82 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKR---------TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHT   82 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEec---------CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeee
Confidence            46667889999999999999986         7789999999765432  2245689999999999999 9999999998


Q ss_pred             cC------ceEEEEEecCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          210 DD------QRLLVYEFMPRGSLENHLFRKGS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~~------~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .+      .+++|+||+ .-+|..++.....  ..++...+..++.||+.||+|||+++   |+||||||.||||+++|.
T Consensus        83 ~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~  158 (323)
T KOG0594|consen   83 SNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGV  158 (323)
T ss_pred             cccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCc
Confidence            87      789999999 5699999977653  35777889999999999999999999   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+|+........  .+..++|..|+|||++.+. .|+...||||+|||++||+++++.|.+....+....+-..
T Consensus       159 lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~  236 (323)
T KOG0594|consen  159 LKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL  236 (323)
T ss_pred             EeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH
Confidence            999999999966533222  3456789999999999986 8999999999999999999999999887653332222110


Q ss_pred             --------hcccC---Cch-hhhhccCcc-ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 --------RPHLG---DKR-RFYRLLDPR-LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 --------~~~~~---~~~-~~~~~~~~~-l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              ++...   +.. .++....+. +.... .....+..+|+.+||+.+|.+|.|+..+++|
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccccCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                    11110   000 111111010 00000 1113588999999999999999999999987

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-43  Score=358.24  Aligned_cols=255  Identities=23%  Similarity=0.318  Sum_probs=200.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|.+.+.||+|+||.||+|....         +|..||||++.....   .....+.+|++++..++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKD---------TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            368999999999999999998875         677999999865422   23356788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..||||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999987654  6888999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc---------------------------------------------ceeeccccCCCCCCchhhhcCCCC
Q 011234          289 LAKDAPEDGKT---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLT  323 (490)
Q Consensus       289 ~a~~~~~~~~~---------------------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~  323 (490)
                      +++........                                             ......+||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            98643211000                                             000124799999999999999999


Q ss_pred             ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCC
Q 011234          324 SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK  403 (490)
Q Consensus       324 ~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~  403 (490)
                      .++|||||||++|||++|..||...........+      ......+ .     +..  ....+.++.+||.+||. +|.
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~-~-----~p~--~~~~s~~~~dli~~lL~-~~~  291 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKI------INWRETL-Y-----FPD--DIHLSVEAEDLIRRLIT-NAE  291 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHH------HccCCcc-C-----CCC--CCCCCHHHHHHHHHHhc-CHh
Confidence            9999999999999999999999654322111100      0000000 0     000  01236789999999997 777


Q ss_pred             CC---CCHHHHHHHh
Q 011234          404 AR---PRMSEVVETL  415 (490)
Q Consensus       404 ~R---Ps~~evl~~L  415 (490)
                      +|   +++.+++++-
T Consensus       292 ~r~~r~~~~~~l~hp  306 (377)
T cd05629         292 NRLGRGGAHEIKSHP  306 (377)
T ss_pred             hcCCCCCHHHHhcCC
Confidence            65   5999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.2e-43  Score=358.45  Aligned_cols=253  Identities=27%  Similarity=0.325  Sum_probs=200.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +|++++.||+|+||.||+|++..         ++..||+|++.....   .....+.+|+.+|+.++|+||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVD---------TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            58899999999999999998865         677999999875422   233567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..|+|||||++|+|.+++.+.+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCC
Confidence            999999999999999999987654  5788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCC---------------------------------------------CcceeeccccCCCCCCchhhhcCCCCc
Q 011234          290 AKDAPEDG---------------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTS  324 (490)
Q Consensus       290 a~~~~~~~---------------------------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~~~  324 (490)
                      +..+....                                             ........+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            75331000                                             000112357999999999999999999


Q ss_pred             cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC
Q 011234          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  404 (490)
Q Consensus       325 ~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~  404 (490)
                      ++|||||||+||||++|++||....+......+.    ...          ..+........+.++.+||.+|+ .+|.+
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~~~----------~~~~~p~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI----NWQ----------TSLHIPPQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH----ccC----------CCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence            9999999999999999999997643321111000    000          00000011123678899999976 59999


Q ss_pred             CCC---HHHHHHH
Q 011234          405 RPR---MSEVVET  414 (490)
Q Consensus       405 RPs---~~evl~~  414 (490)
                      |++   +.+++++
T Consensus       293 R~~~~~~~ei~~h  305 (382)
T cd05625         293 RLGKNGADEIKAH  305 (382)
T ss_pred             cCCCCCHHHHhcC
Confidence            987   8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.3e-43  Score=349.17  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=197.5

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHH---hcCCCCceeceeeEE
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFL---GNLLHPNLVKLVGYC  207 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~  207 (490)
                      |++.+.||+|+||.||+|.+..         +|..||||+++...   ....+.+.+|++++   ..++||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKK---------TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            6788999999999999998865         67799999997542   12234556666554   567899999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+..|+||||+++++|..++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcc
Confidence            9999999999999999999887542   5899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++.......  ......+|++.|+|||++.+..++.++|||||||++|||++|..||...........+      ....
T Consensus       146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~~~  217 (324)
T cd05589         146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VNDE  217 (324)
T ss_pred             cCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC
Confidence            9987543221  1123467999999999999999999999999999999999999999754322111100      0000


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                                  ..++...+..+.+||.+||+.||.+||     ++.+++++.
T Consensus       218 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         218 ------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence                        012223477889999999999999999     577777653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2e-42  Score=338.54  Aligned_cols=264  Identities=25%  Similarity=0.427  Sum_probs=207.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +..++|++.+.||+|+||.||+|.+...    ....++..||||.+.... .....++.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~----~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~   78 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccC----CCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3456899999999999999999987532    112356789999986543 23445688999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGS--------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      ......++||||+++++|.+++.....        ..+++..+..++.|++.||.|||+.+   ++||||||+|||++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence            999999999999999999999865321        23577888999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ..+
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~  232 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLR  232 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999876543322222222356788999999998899999999999999999999 688886543211   111


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ....   ..  +         ...+...+..+.+|+.+||+.||++|||+.|+++.|+
T Consensus       233 ~~~~---~~--~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVME---GG--L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHc---CC--c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1100   00  0         0112233678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-43  Score=339.88  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=200.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-  211 (490)
                      .|...+++|.|+||.||+|....         ++..||||.+-.+..    .-.+|+.+|+.+.|||||++..+|.... 
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e---------~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~   91 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRE---------TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTE   91 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcC---------CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCC
Confidence            47778999999999999999986         567899998765532    2346999999999999999998887532 


Q ss_pred             ----ceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CCeEE
Q 011234          212 ----QRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKL  284 (490)
Q Consensus       212 ----~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL  284 (490)
                          ...||||||+. +|.+.+...  ....++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||
T Consensus        92 ~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   92 SDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             CchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEe
Confidence                34589999974 899888642  2346777888899999999999999988   9999999999999876 89999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||||.|+.+..+...   .....|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+....+....+-..  .
T Consensus       168 cDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~--l  242 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV--L  242 (364)
T ss_pred             ccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH--h
Confidence            999999987654322   23457899999999987 58999999999999999999999999886554443332211  1


Q ss_pred             cCCchhhhhccCc--------ccc-----CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDP--------RLE-----GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~--------~l~-----~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      --........+++        .+.     .-+....++++.+|+.++|..+|.+|.++.|++.+
T Consensus       243 G~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  243 GTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            0011111111111        111     11334458899999999999999999999999965

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-42  Score=347.71  Aligned_cols=243  Identities=29%  Similarity=0.434  Sum_probs=194.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhc-CCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|.+..         ++..||||+++....   ...+.+..|..++.. ++||||+++++++...+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKG---------TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999998865         677899999875421   223445667777765 4799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999999999999887654  6888999999999999999999988   999999999999999999999999999764


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ...       
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~~~i---~~~-------  211 (316)
T cd05592         147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LFDSI---LND-------  211 (316)
T ss_pred             CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HHHHH---HcC-------
Confidence            3322  22234679999999999999899999999999999999999999997543211   11100   000       


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~-evl~~  414 (490)
                           ...++...+.++.+||.+||..||.+||++. +++++
T Consensus       212 -----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 -----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                 0112233467889999999999999999875 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-42  Score=348.71  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=200.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCC-CceeceeeEEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLH-PNLVKLVGYCI  208 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~  208 (490)
                      +|++.+.||+|+||.||+|.+..         ++..||||++....   ....+.+..|++++..+.| ++|+.+++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            58899999999999999998865         67789999987542   2234567789999999976 56888999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecC
Confidence            9999999999999999999987654  5788999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++........  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .....   ...  
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i---~~~--  216 (324)
T cd05587         147 MCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSI---MEH--  216 (324)
T ss_pred             cceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH---HcC--
Confidence            9875322211  1234679999999999999999999999999999999999999997543211   11110   000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~-----~evl~~  414 (490)
                                ...++...+.++.+|+.+||..||.+|++.     .+++++
T Consensus       217 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 ----------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                      011223347789999999999999999976     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.8e-43  Score=359.27  Aligned_cols=254  Identities=26%  Similarity=0.293  Sum_probs=202.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+|++.+.||+|+||.||+|++..         ++..||||++.....   .....+.+|+.+|..+.|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVD---------TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ   71 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            369999999999999999998865         677999999865422   22345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++.+|+|||||++|+|.+++...+  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999999999997654  5788889999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCC-----------------------------------------CcceeeccccCCCCCCchhhhcCCCCcccc
Q 011234          289 LAKDAPEDG-----------------------------------------KTHVSTRVMGTYGYAAPEYVMTGHLTSKSD  327 (490)
Q Consensus       289 ~a~~~~~~~-----------------------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sD  327 (490)
                      +|..+....                                         ........+||+.|||||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            975331000                                         000112357999999999999999999999


Q ss_pred             chhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-
Q 011234          328 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-  406 (490)
Q Consensus       328 vwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-  406 (490)
                      ||||||++|||++|+.||...........+..    ..          ..+........+..+.+||.+|+ .+|.+|+ 
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~----~~----------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~  291 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPAETQLKVIN----WE----------TTLHIPSQAKLSREASDLILRLC-CGAEDRLG  291 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHHHHHHHHhc----cC----------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence            99999999999999999976543221111100    00          00000011123678899999977 5999999 


Q ss_pred             --CHHHHHHH
Q 011234          407 --RMSEVVET  414 (490)
Q Consensus       407 --s~~evl~~  414 (490)
                        ++.+++++
T Consensus       292 ~~t~~ell~h  301 (376)
T cd05598         292 KNGADEIKAH  301 (376)
T ss_pred             CCCHHHHhCC
Confidence              89999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.6e-42  Score=362.91  Aligned_cols=270  Identities=22%  Similarity=0.338  Sum_probs=198.5

Q ss_pred             hhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC------CC
Q 011234          125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL------HP  198 (490)
Q Consensus       125 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------Hp  198 (490)
                      +++....++|++.+.||+|+||.||+|++..         ++..||||+++... ....++..|+.++..+.      |.
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~  191 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRK---------RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRF  191 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcC---------CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCc
Confidence            3445567889999999999999999998865         67789999996432 22234455666666654      45


Q ss_pred             ceeceeeEEEec-CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEE
Q 011234          199 NLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       199 nIv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl  276 (490)
                      +|+.+++++..+ ..+|||||++ +++|.+++.+.+  .+++..+..|+.||+.||.|||+ .+   ||||||||+||||
T Consensus       192 ~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl  265 (467)
T PTZ00284        192 PLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILM  265 (467)
T ss_pred             ceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            689999988765 5788999998 789999887664  68899999999999999999997 47   9999999999999


Q ss_pred             cCCC----------------CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh
Q 011234          277 DADY----------------NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       277 ~~~~----------------~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt  340 (490)
                      +.++                .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||+||||++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt  340 (467)
T PTZ00284        266 ETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT  340 (467)
T ss_pred             ecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence            8765                499999998864322     1234689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcchhHHhhhcccC----------Cchhhhhcc---Ccccc---------C--CCChHhHHHHHHHHHH
Q 011234          341 GRRSMDKNRPNGEHNLVEWARPHLG----------DKRRFYRLL---DPRLE---------G--HFSIKGSQKATQLAAQ  396 (490)
Q Consensus       341 G~~pf~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~l~---------~--~~~~~~~~~l~~Li~~  396 (490)
                      |+.||...........+......+.          ....++...   .+...         .  .........+.+||.+
T Consensus       341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~  420 (467)
T PTZ00284        341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG  420 (467)
T ss_pred             CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence            9999976544322222211100000          000000000   00000         0  0001124568899999


Q ss_pred             hhhcCCCCCCCHHHHHHHh
Q 011234          397 CLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       397 cL~~dP~~RPs~~evl~~L  415 (490)
                      ||+.||.+|||+.|+|+|-
T Consensus       421 mL~~dP~~R~ta~e~L~Hp  439 (467)
T PTZ00284        421 LLHYDRQKRLNARQMTTHP  439 (467)
T ss_pred             hCCcChhhCCCHHHHhcCc
Confidence            9999999999999999864

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.2e-42  Score=345.12  Aligned_cols=263  Identities=24%  Similarity=0.398  Sum_probs=207.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|++.+.||+|+||.||+|.+...+..     .+..||+|.+.... ....+++..|+.+++.++||||+++++++..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCc-----cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            34799999999999999999987653221     23459999987543 3345678899999999999999999999876


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      . ..++|+||+++|+|.+++..... .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence            4 57899999999999999876533 5788899999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ......    .. 
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~----~~-  227 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KG-  227 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh----CC-
Confidence            987654332222222345678999999999999999999999999999997 999986532211   111110    00 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               .....+..++.++.+|+.+||..||.+||++.+++..|..+..
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         228 ---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                     0001112336778999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-42  Score=338.04  Aligned_cols=262  Identities=30%  Similarity=0.452  Sum_probs=209.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+....    ...++..||||.+...... ..+.+.+|+++|..+.|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLE----PENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeecccc----CcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            346888999999999999999875421    0124678999998765443 45678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKG------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ....++||||+++++|.+++...+            ...+++..+..++.||+.||.|||+.+   ++||||||+|||++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~  156 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVG  156 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEc
Confidence            999999999999999999997543            234788899999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.......   .
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~  233 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---V  233 (280)
T ss_pred             CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence            999999999999976533322222233456788999999999999999999999999999998 999986543221   1


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .+.....              .....+...+..+.+|+.+||..||++||++.||++.|+
T Consensus       234 ~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         234 IECITQG--------------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1111100              000112234678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4e-42  Score=337.48  Aligned_cols=261  Identities=26%  Similarity=0.452  Sum_probs=207.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+...+.     .++..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGM-----DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCC-----CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            468889999999999999998743221     256789999987543 33346788899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG---------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +..|+||||+++++|.+++....               ...+++..+..++.||+.||.|||+.+   |+||||||+|||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEE
Confidence            99999999999999999985332               124788889999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---  233 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---  233 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence            99999999999999987644332222333456778999999988889999999999999999998 98898653321   


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                      ...+......              ....+..++..+.+++.+||+.||.+||++.+|+++|..
T Consensus       234 ~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         234 EVIEMVRKRQ--------------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHHcCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111111000              001122336789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-42  Score=347.87  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      +|.+.+.||+|+||.||+|++..         ++..||+|++.....   .....+..|..++..+ +|++|+++++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            58889999999999999998865         677999999876432   2234566788888777 5899999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..++||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCC
Confidence            9999999999999999999987654  5888999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +....   ...  
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i---~~~--  216 (323)
T cd05616         147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---MEH--  216 (323)
T ss_pred             CceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHH---HhC--
Confidence            9875432221  1234679999999999999999999999999999999999999997543211   11110   000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~-----~evl~~  414 (490)
                                ...++...+.++.+|+.+||+.||.+|++.     .+++++
T Consensus       217 ----------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         217 ----------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ----------CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                      011233347889999999999999999984     565544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-42  Score=333.64  Aligned_cols=260  Identities=27%  Similarity=0.457  Sum_probs=209.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+...+.      +...||||.+..... .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGK------KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS   77 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCC------CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC
Confidence            578999999999999999999865321      345899999875533 3345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        78 ~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          78 RPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             CceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence            999999999999999999876543 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ................++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .........      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~------  224 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVEDG------  224 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHHcC------
Confidence            87752222222222345678999999998899999999999999999998 99998543221   111111000      


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                              .....+..++..+.+|+.+||+.+|++||++.+|+++|+.+
T Consensus       225 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 --------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    00011223467899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=334.39  Aligned_cols=250  Identities=27%  Similarity=0.394  Sum_probs=212.2

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      |.+++.||+|+||.||+|.++.         +|..||||.+..+  .+.++++.|+.||.++..|+||++||.|.....+
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~E---------sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDL  103 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRE---------SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDL  103 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhc---------cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCce
Confidence            6677899999999999998887         7889999988655  4567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+|||||.-|++.+.+..+ +.++.+..+..+++..++||+|||...   -||||||..||||+.+|.+||+|||.|..+
T Consensus       104 WIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  104 WIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             EeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh
Confidence            9999999999999988655 458999999999999999999999988   899999999999999999999999999876


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .+.  ......+.||+.|||||++..-.|+.++||||||++..||..|++||....+......+.             . 
T Consensus       180 TDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-------------T-  243 (502)
T KOG0574|consen  180 TDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-------------T-  243 (502)
T ss_pred             hhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-------------C-
Confidence            442  122345789999999999999999999999999999999999999997655432211110             0 


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       .|...-.-|...+.++.++|++||.++|++|-|+.++++|-
T Consensus       244 -~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  244 -KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             -CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence             11111123445689999999999999999999999999873

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-42  Score=348.33  Aligned_cols=243  Identities=29%  Similarity=0.429  Sum_probs=196.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|++..         ++..||||++....   ......+..|+.++..+ +||||+++++++...+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKE---------SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            469999999999998875         67799999987542   12334567888888876 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999999999999887654  6889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ..+..   ....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i---~~~~------  212 (320)
T cd05590         147 IFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAI---LNDE------  212 (320)
T ss_pred             CcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---hcCC------
Confidence            32211  2234679999999999999999999999999999999999999997543221   11111   1000      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~------~evl~~  414 (490)
                            ..++...+.++.+||.+||+.||.+||++      .+++.+
T Consensus       213 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 ------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                  01122236789999999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=339.48  Aligned_cols=253  Identities=31%  Similarity=0.410  Sum_probs=205.0

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .|++.++||+|+||.||++.+..         ++..||+|++......   ....+.+|+.+++.++||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcC---------CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            37888999999999999998765         5779999998754322   23456789999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCC
Confidence            999999999999999999887655456899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........   .....|+..|+|||++.+..++.++|||||||++|||++|..||...........+..  ....    
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~--~~~~----  219 (285)
T cd05605         149 AVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER--RVKE----  219 (285)
T ss_pred             ceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--Hhhh----
Confidence            986543221   1235789999999999988999999999999999999999999975432211111100  0000    


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                              ....++...+..+.+||.+||..||.+||     ++.+++++
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 --------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             --------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                    01112223477889999999999999999     88888766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-42  Score=347.57  Aligned_cols=243  Identities=28%  Similarity=0.412  Sum_probs=197.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  213 (490)
                      ++||+|+||.||+|.+..         ++..||||++.....   .....+..|++++..+ +||||+++++++...+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKG---------TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            469999999999998865         677999999875422   2334567789988866 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999999999999887654  6888999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..+..   ....      
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i---~~~~------  212 (321)
T cd05591         147 ILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESI---LHDD------  212 (321)
T ss_pred             ccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHH---HcCC------
Confidence            32221  1234679999999999998899999999999999999999999997543221   11110   0000      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-------RMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-------s~~evl~~  414 (490)
                            ..++...+.++.+||.+||+.||++|+       ++.+++++
T Consensus       213 ------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 ------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                  011222367899999999999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.3e-42  Score=347.12  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=198.1

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  213 (490)
                      ++||+|+||.||+|.+..         ++..||||+++....   .....+..|+.++..+ +||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKK---------TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            469999999999999875         677999999975422   2334577899999888 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            99999999999998887654  6899999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC--cchhHHhhhcccCCchhhh
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG--EHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~  371 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .....++....        
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  216 (329)
T cd05588         147 IRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------  216 (329)
T ss_pred             ccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------
Confidence            22111  1234679999999999999999999999999999999999999996432211  00011111000        


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR------MSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs------~~evl~~  414 (490)
                       +....  ..++...+..+.+||.+||+.||.+|++      +.+++++
T Consensus       217 -~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         217 -ILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -HHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             00000  0122234678999999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.4e-42  Score=353.94  Aligned_cols=268  Identities=23%  Similarity=0.375  Sum_probs=209.8

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      ...++|.+.++||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.+|..+. ||||++++++
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLS----RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccC----CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            33567999999999999999999874321    112456799999975533 33456889999999996 9999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcC-----------------------------------------------------
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKG-----------------------------------------------------  233 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~-----------------------------------------------------  233 (490)
                      +.+.+..|||||||++|+|.++|....                                                     
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            999999999999999999999886431                                                     


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011234          234 -----------------------------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       234 -----------------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                                                               ...+++..+..++.||+.||.|||+.+   |+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence                                                     124678888999999999999999988   999999999


Q ss_pred             ceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCC
Q 011234          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       273 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~  351 (490)
                      |||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            99999999999999999986543322222233457788999999998899999999999999999997 98998653221


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ..  .......              ......+...+..+.+||.+||+.||++||++.+|.+.|+.+.
T Consensus       347 ~~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 ST--FYNKIKS--------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HH--HHHHHhc--------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            11  0000000              0000112234678999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-42  Score=353.90  Aligned_cols=264  Identities=21%  Similarity=0.247  Sum_probs=200.6

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ...+|.+.+.||+|+||.||+|.+..         ++..||+|....      ..+.+|+++|+.|+|||||++++++..
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~---------~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~  154 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNK---------TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY  154 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECC---------CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence            34579999999999999999998875         678999997532      346789999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....++|||++ .++|..++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       155 ~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~  228 (391)
T PHA03212        155 NKFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGA  228 (391)
T ss_pred             CCeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCc
Confidence            99999999999 578988886654  5789999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc----hhHHhhhcccC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH----NLVEWARPHLG  365 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~----~~~~~~~~~~~  365 (490)
                      ++....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.........    ..........+
T Consensus       229 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g  307 (391)
T PHA03212        229 ACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG  307 (391)
T ss_pred             ccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc
Confidence            975432211 1223467999999999999999999999999999999999999887543221100    00000000000


Q ss_pred             C---------c---hhhh-hcc-----CccccCCC--ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 D---------K---RRFY-RLL-----DPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~---------~---~~~~-~~~-----~~~l~~~~--~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .         .   ...+ ...     .+.....+  ....+.++.+||.+||+.||.+|||+.|++++-
T Consensus       308 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             CChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence            0         0   0000 000     00000000  012366899999999999999999999999653

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=348.63  Aligned_cols=265  Identities=28%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||.|+||.||+|.....+    ...++..||+|++.... ....+.+..|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIE----KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccc----cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            457999999999999999999764321    11256789999987543 23345678899999999 7999999999886


Q ss_pred             ec-CceEEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 011234          209 ED-DQRLLVYEFMPRGSLENHLFRKGS-----------------------------------------------------  234 (490)
Q Consensus       209 ~~-~~~~lv~E~~~~g~L~~~l~~~~~-----------------------------------------------------  234 (490)
                      .. ..++++|||+++++|.+++.....                                                     
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            54 568899999999999999864321                                                     


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccC
Q 011234          235 ------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT  308 (490)
Q Consensus       235 ------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt  308 (490)
                            ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++..+.............++
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~  238 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP  238 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence                  25789999999999999999999988   999999999999999999999999999876443222222334567


Q ss_pred             CCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhH
Q 011234          309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGS  387 (490)
Q Consensus       309 ~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  387 (490)
                      ..|+|||++.+..++.++|||||||++|||++ |..||........  +....    ....          ....+...+
T Consensus       239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~----~~~~----------~~~~~~~~~  302 (337)
T cd05054         239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRL----KEGT----------RMRAPEYAT  302 (337)
T ss_pred             ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHH----hccC----------CCCCCccCC
Confidence            88999999999999999999999999999998 9999965332211  11110    0000          001112236


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          388 QKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       388 ~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .++.+|+.+||+.+|++||++.||+++|+.+
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            7899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-42  Score=346.39  Aligned_cols=243  Identities=29%  Similarity=0.427  Sum_probs=195.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhc-CCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|.+..         +|..||+|+++....   .....+..|..++.. ++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKG---------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            469999999999999875         677999999975421   223456678888875 4899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+.+|+|..++....  .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            99999999999999987654  5788999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||......   ...+....           
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~-----------  210 (316)
T cd05620         147 VFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRV-----------  210 (316)
T ss_pred             ccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-----------
Confidence            2211  1223467999999999999999999999999999999999999999654321   11111100           


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~-evl~~  414 (490)
                      ..+    .++...+.++.+||.+||+.||++||++. +++++
T Consensus       211 ~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         211 DTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            001    11222367899999999999999999984 66644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-43  Score=325.35  Aligned_cols=254  Identities=27%  Similarity=0.389  Sum_probs=208.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----h----hHHHHHHHHHHHhcCC-CCcee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----Q----GHKEWLAEVNFLGNLL-HPNLV  201 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~----~~~~~~~E~~~l~~l~-HpnIv  201 (490)
                      ...|...+.||.|..++|.++.++.         +|..+|+|++.....    .    -.++-.+|+.||+++. ||+|+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~---------t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II   86 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKE---------TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII   86 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcc---------cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence            3468888999999999999998876         778899998864321    1    1234467999999986 99999


Q ss_pred             ceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          202 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       202 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .+.++|..+...++|+|.|+.|.|.|+|...-  .+++.....|++|+.+|+.|||..+   ||||||||+|||++++.+
T Consensus        87 ~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~  161 (411)
T KOG0599|consen   87 DLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMN  161 (411)
T ss_pred             EeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccc
Confidence            99999999999999999999999999997664  7899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhc------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      +||+|||+|+.+..+...   ...|||++|+|||.+..      ..|+..+|+|++|||||.||.|.+||......    
T Consensus       162 i~isDFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm----  234 (411)
T KOG0599|consen  162 IKISDFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM----  234 (411)
T ss_pred             eEEeccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH----
Confidence            999999999988765433   45899999999999853      46888999999999999999999999654221    


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                        -..+..+.....|        ...-..+.+..+++||.+||+.||.+|.|++|+|.|-
T Consensus       235 --lMLR~ImeGkyqF--------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  235 --LMLRMIMEGKYQF--------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             --HHHHHHHhccccc--------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence              1222222222111        1111233478899999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=356.25  Aligned_cols=270  Identities=29%  Similarity=0.456  Sum_probs=217.0

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCceec
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .+.+..++..+.++||+|+||.||+|.+...+..     ....||||..+..   .....+++++|+++|++++|||||+
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-----~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-----KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCc-----eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            4455566777889999999999999999763221     1122899998853   3456678999999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      +||++..+..++||||+|.||+|.++|.+.+. .++..+...++.+++.||+|||+++   +|||||-.+|+|++.++.+
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeE
Confidence            99999999999999999999999999988764 6899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceee-ccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVST-RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~-~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      ||+|||+++.....   .... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.  
T Consensus       302 KISDFGLs~~~~~~---~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~--  376 (474)
T KOG0194|consen  302 KISDFGLSRAGSQY---VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV--  376 (474)
T ss_pred             EeCccccccCCcce---eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH--
Confidence            99999998865411   1111 1123578999999999999999999999999999998 788987654332222110  


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCcc
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~~  423 (490)
                          ...          ..-..+...+.++..++.+||..||++||+|.++.+.|+.+.....
T Consensus       377 ----~~~----------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  377 ----KNG----------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ----hcC----------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                000          0111222448889999999999999999999999999988766544

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-42  Score=335.12  Aligned_cols=256  Identities=30%  Similarity=0.475  Sum_probs=212.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ..+|++.+.||.|+||.||+|.+..          +..||+|++..........+..|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~----------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   74 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN----------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG   74 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC----------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence            4568899999999999999998864          457999999877665667788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~  151 (261)
T cd05148          75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLA  151 (261)
T ss_pred             CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccch
Confidence            99999999999999999998765567899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .........  .....++..|+|||++....++.++|||||||++|+|++ |..||.......   .......       
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-------  219 (261)
T cd05148         152 RLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA-------  219 (261)
T ss_pred             hhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh-------
Confidence            866432211  123346778999999988899999999999999999998 899996543211   1111110       


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                             ......+..++..+.++|.+||..||.+|||+.++++.|+.+
T Consensus       220 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 -------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   001112234478899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-42  Score=332.52  Aligned_cols=259  Identities=28%  Similarity=0.462  Sum_probs=204.9

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      |.+.+.||+|+||.||+|.+..+.      +++..||+|.+....  ......+.+|+.+++.++|+||+++++++....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   74 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDD------GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS   74 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCC------CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence            577899999999999999886532      245789999987543  233457889999999999999999999887655


Q ss_pred             c------eEEEEEecCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          212 Q------RLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       212 ~------~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .      .++||||+++|+|..++...    ....+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.
T Consensus        75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~  151 (273)
T cd05035          75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMT  151 (273)
T ss_pred             ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCe
Confidence            4      79999999999999888543    2235889999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......   ...+..
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05035         152 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYL  228 (273)
T ss_pred             EEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            99999999986644322222222345678999999988899999999999999999999 88888653321   111111


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..   .           .....+..++..+.+++.+||+.||++||++.++++.|+.+
T Consensus       229 ~~---~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 RH---G-----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             Hc---C-----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10   0           00112233477899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.5e-42  Score=364.27  Aligned_cols=256  Identities=26%  Similarity=0.331  Sum_probs=206.2

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|.+.+.||+|+||+||+|.+..         +|..||||++.....  .....+.+|+.+|..++|+||+++++.+
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~  100 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVS---------DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDF  100 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecce
Confidence            34689999999999999999998865         677999999876532  3345678899999999999999998877


Q ss_pred             EecC--------ceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          208 IEDD--------QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       208 ~~~~--------~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ...+        .+++||||+++|+|.+++....  ...+++..+..++.|++.||.|||+.+   |+||||||+||||+
T Consensus       101 ~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~  177 (496)
T PTZ00283        101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLC  177 (496)
T ss_pred             ecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEe
Confidence            5432        3679999999999999986532  336889999999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (490)
                      .++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||+||||++|+.||......      
T Consensus       178 ~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------  251 (496)
T PTZ00283        178 SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------  251 (496)
T ss_pred             CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------
Confidence            99999999999998664332222334568999999999999999999999999999999999999999653221      


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +.........      .     ..++...+.++.+|+.+||..||.+||++.+++++
T Consensus       252 ~~~~~~~~~~------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 EVMHKTLAGR------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHHhcCC------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111000      0     11223347889999999999999999999999876

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.6e-42  Score=338.14  Aligned_cols=266  Identities=29%  Similarity=0.459  Sum_probs=212.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||++.....    ....++..+|+|.+..........+.+|+.++.+++||||+++++++...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~----~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNL----CPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccC----CCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            35789999999999999999976431    11225667999998776555567789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG-----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +..++||||+++++|.+++...+           ...+++..++.++.||+.||+|||+.+   ++||||||+|||++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence            99999999999999999986542           124899999999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~  233 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE  233 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            9999999999986643322222233456788999999998899999999999999999998 899986543221   111


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .....   .  .     .    ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       234 ~i~~~---~--~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         234 CITQG---R--V-----L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHcC---C--c-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11000   0  0     0    0111236789999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-42  Score=354.11  Aligned_cols=258  Identities=24%  Similarity=0.300  Sum_probs=205.4

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceecee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      ....++|++.+.||+|+||.||+|++..         ++..||+|++.....   .....+..|+.+++.++||||++++
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~  109 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKS---------SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH  109 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            3456689999999999999999998875         677999999865321   2234567899999999999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +++.+++..|+||||+++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL  183 (370)
T cd05596         110 YAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL  183 (370)
T ss_pred             EEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999988653   4788888999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|||++......... .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||...........+   
T Consensus       184 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i---  259 (370)
T cd05596         184 ADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI---  259 (370)
T ss_pred             EeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHH---
Confidence            999999865433221 12345799999999998653    4789999999999999999999999764322111100   


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L  415 (490)
                         .....        .+........+.++.+||.+||..+|.+  |+++.+++++-
T Consensus       260 ---~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         260 ---MDHKN--------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             ---HcCCC--------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence               00000        0000001123788999999999999988  99999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8e-43  Score=350.46  Aligned_cols=254  Identities=25%  Similarity=0.292  Sum_probs=204.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|.+.+.||+|+||.||+|.+..         +|..||+|+++....   ...+.+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKA---------TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            368999999999999999998875         677999999975432   23455778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCC
Confidence            9999999999999999999997652 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhh------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ++......... ......||+.|+|||++.      ...++.++|||||||++|||++|..||..........      .
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~  220 (330)
T cd05601         148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------N  220 (330)
T ss_pred             CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------H
Confidence            99876543222 223457999999999986      4567899999999999999999999996543211110      0


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .... ......       ......+..+.+||.+||. ||.+||++.+++.+
T Consensus       221 i~~~-~~~~~~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         221 IMNF-QRFLKF-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHcC-CCccCC-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0000 000000       0011237789999999997 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-42  Score=332.03  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=207.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+..          +..||+|.++... ...+++.+|+.++++++|+||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~----------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN----------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL   72 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC----------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec
Confidence            34579999999999999999998642          4579999987654 235678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~  149 (261)
T cd05068          73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGL  149 (261)
T ss_pred             CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcce
Confidence            999999999999999999997655456899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ......    .. 
T Consensus       150 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~-  220 (261)
T cd05068         150 ARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVD----QG-  220 (261)
T ss_pred             EEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----cC-
Confidence            9876532111 1111223457999999998899999999999999999999 999986543211   111000    00 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                               .....+...+..+.+|+.+||+.||.+||++.+|++.|+.+
T Consensus       221 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         221 ---------YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---------CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                     00011223367899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.3e-42  Score=337.66  Aligned_cols=265  Identities=29%  Similarity=0.447  Sum_probs=213.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||+|.+.....    ..++..|++|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP----TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC----CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            468889999999999999998643211    1245679999988776666678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..++||||+++++|.+++....              ...+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence            9999999999999999996542              124789999999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      .++.++|+|||++................|+..|+|||++.+..++.++|||||||++|||++ |..||.......   .
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  234 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V  234 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999986544332222334567889999999999999999999999999999998 999986543221   1


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .+......              ....+...+..+.+|+.+||+.||++||++.+|++.|+.+..
T Consensus       235 ~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         235 IECITQGR--------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHhCCC--------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            11110000              000112236789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=363.90  Aligned_cols=264  Identities=27%  Similarity=0.468  Sum_probs=225.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +......|.++||.|.||.||+|+++..++      ....||||.++.... ....+|+.|+.||.+++||||++|.|+.
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgk------re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGK------REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCC------cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            334467888999999999999999987654      456899999987654 3456899999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ......+||.|||++|+|+.+|..+.+ .|.+.+..-+++.|+.|++||-+++   +|||||...|||++.+..+|++||
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDF  775 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDF  775 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccc
Confidence            999999999999999999999988765 5999999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeecccc--CCCCCCchhhhcCCCCccccchhhHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhccc
Q 011234          288 GLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |+++.+.++.... .+...|  ...|.|||.+...+++.++|||||||+|||.+ .|.+||+.....+..+.++..    
T Consensus       776 GLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g----  850 (996)
T KOG0196|consen  776 GLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG----  850 (996)
T ss_pred             cceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhc----
Confidence            9999876654322 222333  56899999999999999999999999999966 599999877666555544321    


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                   +.-..|.+|+..+.+||..||++|-.+||.+.+|+.+|+++-.
T Consensus       851 -------------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  851 -------------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             -------------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                         1223355779999999999999999999999999999998744

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-42  Score=336.18  Aligned_cols=255  Identities=35%  Similarity=0.571  Sum_probs=199.2

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      +.+.||.|.||.||+|.+...     ....+..|+||.++... ....+.+.+|++++++++||||++++|++...+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~-----~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQK-----DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEEST-----TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcc-----cCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccc
Confidence            457899999999999999831     12257789999996543 334678999999999999999999999999888899


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      +||||+++|+|.++|.......+++..+..++.||+.||.|||+.+   |+|+||+++|||++.++.+||+|||++....
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999999998874557999999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ............+...|+|||.+....++.++||||||+++|||++ |+.||.....   ....+....    .      
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~----~------  221 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQ----G------  221 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHT----T------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc----c------
Confidence            3323322333456788999999999999999999999999999999 6788754421   111111110    0      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                          .....+..++..+.+||.+||..||++||++.+|++.|
T Consensus       222 ----~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 ----QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                00112223477899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=350.21  Aligned_cols=268  Identities=23%  Similarity=0.271  Sum_probs=204.7

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ...+|.+.+.||+|+||.||+|.....       .++..||+|.+...     ....+|+++|+.++||||+++++++..
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-------~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~  157 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGD-------EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW  157 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCC-------ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee
Confidence            345799999999999999999976432       25678999988643     234679999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....++|||++ +++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus       158 ~~~~~lv~e~~-~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~  231 (392)
T PHA03207        158 KSTVCMVMPKY-KCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA  231 (392)
T ss_pred             CCEEEEEehhc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcc
Confidence            99999999999 478988885443  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC----
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  365 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  365 (490)
                      +................||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.    
T Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~  311 (392)
T PHA03207        232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL  311 (392)
T ss_pred             ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence            9866543333233346799999999999999999999999999999999999999976543321111110000000    


Q ss_pred             ---C--chhh---hhccCccccCCCC-------hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 ---D--KRRF---YRLLDPRLEGHFS-------IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ---~--~~~~---~~~~~~~l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         .  ...+   +..+.......+.       ...+.++.+||.+||..||++|||+.|++.+-
T Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               0  0000   0000000000000       11256788999999999999999999999874

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.9e-42  Score=344.71  Aligned_cols=250  Identities=25%  Similarity=0.391  Sum_probs=197.1

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|.+..         ++..||+|++....   ......+..|+.++..+ +||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKK---------TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            469999999999999875         67799999997542   22334567889888776 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99999999999998886654  6889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc--chhHHhhhcccCCchhhh
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  371 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||........  .....+....        
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------  216 (329)
T cd05618         147 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------  216 (329)
T ss_pred             cCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------
Confidence            32211  12346799999999999999999999999999999999999999963221111  0111111000        


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR------MSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs------~~evl~~  414 (490)
                       +...  ...++...+..+.+||.+||+.||.+||+      +.+++++
T Consensus       217 -i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         217 -ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -HhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence             0000  01223344778999999999999999998      4677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.7e-42  Score=332.07  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=207.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..          +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~----------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   73 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN----------STKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKE   73 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC----------CceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4579999999999999999998643          44799998875432 356788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccc
Confidence            99999999999999999997655557888999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ........      
T Consensus       151 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~------  220 (261)
T cd05072         151 RVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRG------  220 (261)
T ss_pred             eecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcC------
Confidence            87643221 11223346778999999998889999999999999999998 999996543221   11111100      


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                          ...    ......+.++.+|+.+||..+|++||+++++++.|+.+
T Consensus       221 ----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 ----YRM----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----CCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                000    01112367889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-42  Score=344.00  Aligned_cols=243  Identities=28%  Similarity=0.428  Sum_probs=194.7

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhc-CCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGN-LLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|.+..         ++..||||+++....   .....+..|..++.. ++||||+++++++.+.+..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKG---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            469999999999999875         677899999875421   223446678888875 4899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999999999999987653  5788999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ......           .
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~-----------~  210 (316)
T cd05619         147 MLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR-----------M  210 (316)
T ss_pred             CCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH-----------h
Confidence            32211  1234679999999999999899999999999999999999999997543211   111110           0


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~-evl~~  414 (490)
                      ..+    .++...+.++.+||.+||+.||++||++. +++++
T Consensus       211 ~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         211 DNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             CCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence            001    11222367889999999999999999997 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.4e-42  Score=351.23  Aligned_cols=260  Identities=24%  Similarity=0.300  Sum_probs=204.3

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceec
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .+....++|++.+.||+|+||.||+|.+..         ++..||+|++....   ......+.+|+.+++.++||||++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~  107 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKS---------SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ  107 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEee
Confidence            334556789999999999999999999875         67799999986432   122345778999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      +++++.+++..|+|||||++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       108 ~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~  181 (370)
T cd05621         108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHL  181 (370)
T ss_pred             EEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCE
Confidence            999999999999999999999999988643   4788899999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      ||+|||++........ ......+||+.|+|||++.+.    .++.++|||||||+||||++|..||...........  
T Consensus       182 kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~--  258 (370)
T cd05621         182 KLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK--  258 (370)
T ss_pred             EEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH--
Confidence            9999999987643222 112346799999999999754    378899999999999999999999975432111100  


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L  415 (490)
                          ......        .+........+..+.+|+.+||..++.+  |+++.+++++-
T Consensus       259 ----i~~~~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         259 ----IMDHKN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             ----HHhCCc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence                000000        0000011123778999999999865544  89999999873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.1e-42  Score=337.71  Aligned_cols=267  Identities=27%  Similarity=0.406  Sum_probs=211.1

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~  205 (490)
                      .+..++|++.+.||+|+||.||+|.+.....    ......||+|.+.... ......+.+|+.++..+ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDN----PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCC----CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4555679999999999999999998864221    1245689999987543 23345688999999999 7999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRK--------------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      ++..++..++||||+++|+|..++...              ....+++..++.++.||+.||.|||+.+   |+||||||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp  160 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAA  160 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccce
Confidence            999999999999999999999998642              2346889999999999999999999988   99999999


Q ss_pred             CceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 011234          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~  350 (490)
                      +|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999999999999999999987654322222222345678999999988899999999999999999997 8888865322


Q ss_pred             CCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .......                 ........+..++..+.+|+.+||..||++|||+.++++.|+.+
T Consensus       241 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 EELFKLL-----------------KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHH-----------------HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1111100                 00011112233467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-41  Score=328.41  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=198.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+..         ++..||+|.+.... ......+.+|+++++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRA---------DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV   71 (252)
T ss_pred             CccCcccCccEEEEEEec---------CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEE
Confidence            469999999999999865         56789999876543 23345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++...+ ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        72 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          72 MELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             EeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999999986543 35889999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccC
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ..........++..|+|||.+.++.++.++|||||||++|||++ |..||.............                 
T Consensus       148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-----------------  210 (252)
T cd05084         148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-----------------  210 (252)
T ss_pred             cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-----------------
Confidence            11111111123457999999998899999999999999999997 888885432211101000                 


Q ss_pred             ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .......+...+..+.+|+.+||+.||++|||+.+|++.|+
T Consensus       211 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         211 QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            00111122334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-42  Score=359.25  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=196.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ..+|++.+.||+|+||.||+|.+..         ++..||||.+....    ....+|+.+|+.++|||||++++++...
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~  131 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICID---------TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTE  131 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECC---------CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeec
Confidence            4579999999999999999998865         67799999886442    2235699999999999999999987542


Q ss_pred             --------CceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          211 --------DQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       211 --------~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                              ..+++||||++ ++|.+++..  .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.++
T Consensus       132 ~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~  207 (440)
T PTZ00036        132 CFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNT  207 (440)
T ss_pred             ccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCC
Confidence                    24678999996 577776643  22346899999999999999999999988   99999999999998665


Q ss_pred             -CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          281 -NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       281 -~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                       .+||+|||+|+.......   .....||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+.........+.
T Consensus       208 ~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  284 (440)
T PTZ00036        208 HTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII  284 (440)
T ss_pred             CceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence             699999999986643221   1235789999999998764 68999999999999999999999997654322111110


Q ss_pred             hhhcccCCch------------hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          359 WARPHLGDKR------------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ~~~~~~~~~~------------~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..... ....            .+.......+...++...+.++.+||.+||..||.+|||+.|++++
T Consensus       285 ~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        285 QVLGT-PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhCC-CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            00000 0000            0000000111112233346789999999999999999999999976

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4e-42  Score=343.71  Aligned_cols=243  Identities=29%  Similarity=0.433  Sum_probs=197.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|.+..         ++..||||++.....   .....+..|+.++..+ +||||+++++++...+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKG---------TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999998865         677899999975422   2334567889999887 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            99999999999999887654  6899999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......   .....   .....      
T Consensus       147 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~---i~~~~------  212 (318)
T cd05570         147 ILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQS---ILEDE------  212 (318)
T ss_pred             CcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHH---HHcCC------
Confidence            22211  123357999999999999999999999999999999999999999654311   11110   00000      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~-----~evl~~  414 (490)
                            ..++...+..+.+||.+||..||.+||++     .+++++
T Consensus       213 ------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 ------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                  01222346789999999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7e-42  Score=342.69  Aligned_cols=238  Identities=31%  Similarity=0.411  Sum_probs=191.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHH-HHhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||+||+|.+..         +|..||||++.....   .....+..|.. +++.++||||+++++++...+..
T Consensus         1 ~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKA---------DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            469999999999999875         677999999875422   22344555555 56789999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+.+|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999999999999887654  6888999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ..   .......      
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~---~~i~~~~------  212 (323)
T cd05575         147 IEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MY---DNILNKP------  212 (323)
T ss_pred             ccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HH---HHHHcCC------
Confidence            3221  12234679999999999999999999999999999999999999996542211   11   1011000      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~  409 (490)
                          .  ..+...+..+.+||.+||+.||.+||++.
T Consensus       213 ----~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 ----L--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ----C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                0  11122377899999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.3e-42  Score=342.80  Aligned_cols=250  Identities=27%  Similarity=0.390  Sum_probs=198.3

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~  213 (490)
                      ++||+|+||.||+|.+..         ++..||+|++.....   ...+.+..|+.++..+ +||||+.+++++...+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKK---------NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            469999999999998875         567899999976532   2334577899999888 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|..++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            99999999999998887654  6899999999999999999999988   999999999999999999999999998753


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|..||............++.....         
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------  215 (327)
T cd05617         147 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI---------  215 (327)
T ss_pred             cCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH---------
Confidence            22211  1234679999999999999999999999999999999999999996543222211111111100         


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~------~evl~~  414 (490)
                      ...  ...++...+..+.+||.+||..||.+|+++      .+++++
T Consensus       216 ~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         216 LEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            000  001222336788999999999999999984      566655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-42  Score=346.38  Aligned_cols=242  Identities=30%  Similarity=0.384  Sum_probs=196.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  215 (490)
                      +.||+|+||.||+++....      ..+|..||+|++.....  .....+..|+++|.+++||||+++++++.+++..|+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   75 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG------PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL   75 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence            6799999999999987532      22688999999975432  223456789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      ||||+++|+|.+++.+..  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          76 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             EEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999999999986654  6899999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccC
Q 011234          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ...  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ....   ....        
T Consensus       151 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~i---~~~~--------  214 (318)
T cd05582         151 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET---MTMI---LKAK--------  214 (318)
T ss_pred             CCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH---HHHH---HcCC--------
Confidence            211  12346799999999999988899999999999999999999999975432111   1110   0000        


Q ss_pred             ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011234          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  410 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e  410 (490)
                          ..++...+..+.+||.+||+.||++||++.+
T Consensus       215 ----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ----LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                0122233678999999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-41  Score=333.71  Aligned_cols=262  Identities=28%  Similarity=0.424  Sum_probs=205.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+..++..     ....|++|.+..... ....++..|+.++..+.||||+++++++. .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS-----IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc-----eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence            4688999999999999999998653221     123588888764422 23456778899999999999999999875 4


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ...++++||+++|+|.+++..... .+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccc
Confidence            567899999999999999976533 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...............|+..|+|||++.+..++.++|||||||++|||++ |..||...........+.       ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~  229 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGER  229 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCc
Confidence            86644332222334567789999999998899999999999999999998 999996543321111111       0000


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                         .       ..+..++..+.+++.+||..||++|||+.|+++.|..+.+
T Consensus       230 ---~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 ---L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ---C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence               0       0111235678899999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-41  Score=333.93  Aligned_cols=247  Identities=28%  Similarity=0.390  Sum_probs=197.6

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||+|+||+||+|.+..         +|..||+|.+......   ..+.+..|+.+++.++|+||+++++++...+..++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRA---------TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEcc---------CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            7999999999998875         6779999998754322   234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          217 YEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      |||+++|+|.+++...  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            9999999999887542  2336899999999999999999999988   9999999999999999999999999997654


Q ss_pred             CCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........  .......          
T Consensus       149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~----------  214 (280)
T cd05608         149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL----------  214 (280)
T ss_pred             CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc----------
Confidence            3322  1234578999999999999999999999999999999999999997543221111  0000000          


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                      ...  ..++...+..+.+|+.+||+.||++||     ++++++++
T Consensus       215 ~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         215 NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            000  012233478899999999999999999     67777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.2e-41  Score=328.91  Aligned_cols=252  Identities=27%  Similarity=0.458  Sum_probs=202.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+..          +..+|+|.+.... .....+..|+.+|+.++||||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA----------QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK   72 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc----------CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC
Confidence            358889999999999999998753          3479999886543 23457888999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          73 PLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             CEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCcc
Confidence            99999999999999999875433 5889999999999999999999988   9999999999999999999999999988


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......   .........   .   
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~---~---  218 (256)
T cd05114         149 YVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRG---F---  218 (256)
T ss_pred             ccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCC---C---
Confidence            65432211 1122345678999999988889999999999999999999 89998654322   111111110   0   


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       ...       .+...+..+.+|+.+||+.||.+||++.++++.|.
T Consensus       219 -~~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         219 -RLY-------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             -CCC-------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             000       11112567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-41  Score=332.31  Aligned_cols=261  Identities=26%  Similarity=0.423  Sum_probs=208.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||++.....    ....++..+|+|.+..........+.+|+++++.++|+||+++++++...+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC----CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            4688899999999999999976431    122356789999988766566678999999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGS-------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      ..++||||+++++|.+++.....             ..+++..++.++.||+.||+|||+.+   |+||||||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence            99999999999999999876432             24788999999999999999999988   999999999999999


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~  357 (490)
                      ++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |.+||............
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  237 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI  237 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence            99999999999976543222222223345788999999999999999999999999999998 89998543222111111


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .       ..          .....+..++..+.+||.+||+.||.+||++.+|++.|+
T Consensus       238 ~-------~~----------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 T-------QG----------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H-------cC----------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0       00          000111233678899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-41  Score=330.60  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=204.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+..         ++..||+|++..........+.+|+.++..++||||+++++++..++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~   79 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLH---------TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE   79 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECC---------CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC
Confidence            479999999999999999998865         57789999987654444556788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.
T Consensus        80 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~  154 (267)
T cd06646          80 KLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAA  154 (267)
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccce
Confidence            9999999999999999886554  6889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      .......  ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||....+.......  ....     
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~-----  225 (267)
T cd06646         155 KITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSN-----  225 (267)
T ss_pred             eeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCC-----
Confidence            6543211  112356889999999884   345788999999999999999999998543322111000  0000     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                          ...+...  .....+..+.+||.+||..||++||++++|+++|
T Consensus       226 ----~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 ----FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                0001110  0112367899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=332.39  Aligned_cols=263  Identities=27%  Similarity=0.425  Sum_probs=209.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|.+.....    ..++..||+|.+.... ......+.+|+.+|..++|+||+++++++.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVK----GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCC----CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            34579999999999999999998864221    1245789999987553 234456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKG--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      .....++||||+++|+|.+++....        ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCC
Confidence            9999999999999999999986532        123678889999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  359 (490)
                      .+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~  233 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKF  233 (277)
T ss_pred             CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHH
Confidence            999999999986544322222233457889999999988899999999999999999998 999986543221   1111


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..    ..          .....+...+..+.+||.+||+.+|++|||+.++++.|+
T Consensus       234 ~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VI----DG----------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             Hh----cC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11    00          001122233778999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.3e-42  Score=350.24  Aligned_cols=254  Identities=27%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|....         ++..||+|++....   ......+..|+.++..++|+||+++++++.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKD---------TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            368899999999999999998875         67799999987532   123345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+.+||||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999999999987654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc---------------------------------ceeeccccCCCCCCchhhhcCCCCccccchhhHHHH
Q 011234          289 LAKDAPEDGKT---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  335 (490)
Q Consensus       289 ~a~~~~~~~~~---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil  335 (490)
                      ++.........                                 ......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            98754321100                                 001235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 011234          336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR---MSEVV  412 (490)
Q Consensus       336 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs---~~evl  412 (490)
                      |||++|..||....+......+.      .....+  .+.+    .  ...+.++.+||.+|+ .||.+|++   +.+++
T Consensus       227 yel~tG~~Pf~~~~~~~~~~~i~------~~~~~~--~~p~----~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  291 (360)
T cd05627         227 YEMLIGYPPFCSETPQETYRKVM------NWKETL--VFPP----E--VPISEKAKDLILRFC-TDSENRIGSNGVEEIK  291 (360)
T ss_pred             eecccCCCCCCCCCHHHHHHHHH------cCCCce--ecCC----C--CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHh
Confidence            99999999997654322111110      000000  0000    0  113678999999987 49999985   67777


Q ss_pred             HH
Q 011234          413 ET  414 (490)
Q Consensus       413 ~~  414 (490)
                      ++
T Consensus       292 ~h  293 (360)
T cd05627         292 SH  293 (360)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.1e-41  Score=338.61  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|.+.+.||+|+||.||+|.+...+.  ....++..||+|.+.... .....++..|+.++..+ +|+||+++++++
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDK--EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCC--cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34579999999999999999998753211  011234579999997653 23445688899999999 799999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      ...+..|+||||+++|+|.+++.....              ..+++..++.++.||+.||+|||+.+   ++||||||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  170 (307)
T cd05098          94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN  170 (307)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence            999999999999999999999976421              24788999999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~  250 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  250 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999876543221111122234578999999998899999999999999999998 888886432211


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                         ......              .......+...+.++.+||.+||..+|.+||++.+|++.|+.+..
T Consensus       251 ---~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         251 ---LFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             ---HHHHHH--------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence               111100              000011223346789999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-41  Score=336.54  Aligned_cols=266  Identities=26%  Similarity=0.385  Sum_probs=210.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|.+.+.||+|+||.||+|.+....    ...++..||+|.++... ....+.+.+|+.+++++ +|+||+++++++
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLS----KSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCC----CCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            3457999999999999999999864211    12256689999987553 23345688999999999 799999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+..++||||+.+|+|.+++.......+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.++|+||
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCC
Confidence            99999999999999999999997654445899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++................++..|+|||.+.+..++.++|||||||++|||++ |..||........  ......     
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~-----  258 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK-----  258 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH-----
Confidence            99986654322222223456788999999999999999999999999999998 9999865432211  111110     


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                               .......+...+..+.+|+.+||..+|++||++.+|++.|+.+
T Consensus       259 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 ---------EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     0000011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.5e-41  Score=333.13  Aligned_cols=263  Identities=28%  Similarity=0.415  Sum_probs=207.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|.......    ......+|+|.+..... .....+.+|+.+++.+.||||+++++.+...+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   76 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKG----RAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG   76 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCC----CCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            47888999999999999998754211    11345799998875542 33467889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011234          212 QRLLVYEFMPRGSLENHLFRKG----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      ..++||||+.+++|.+++....                      ...+++..++.++.|++.||.|||+.+   |+||||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di  153 (290)
T cd05045          77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL  153 (290)
T ss_pred             CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence            9999999999999999886421                      124788999999999999999999988   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  348 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~  348 (490)
                      ||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus       154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543322222223456778999999988899999999999999999998 99998654


Q ss_pred             CCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      .+..   +.+...              .......+...+.++.+|+.+||+.||++||++.++++.|+.+.
T Consensus       234 ~~~~---~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         234 APER---LFNLLK--------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             CHHH---HHHHHh--------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence            3221   111111              00111112234678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-41  Score=327.79  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=208.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||.+....   ......+.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL---------DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC---------CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            479999999999999999999875         56789999876432   233456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+..++||||+++++|.+++...  ....+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECc
Confidence            999999999999999999888532  2335788999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........  ......|+..|+|||.+.+..++.++|+||||+++|||++|+.||....... .........    
T Consensus       150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~----  222 (267)
T cd08228         150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKIEQ----  222 (267)
T ss_pred             cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHHhc----
Confidence            999886643221  1123568899999999998889999999999999999999999985432211 111111100    


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                            .   ..........+..+.+||.+||..+|++||++.+|++.|+.++
T Consensus       223 ------~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 ------C---DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ------C---CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                  0   0000111233678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=371.55  Aligned_cols=266  Identities=30%  Similarity=0.447  Sum_probs=217.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ....++.+.||+|.||.||.|.........    ....||||.+... ..+...+|++|..+|+.++|||||+++|++.+
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~----~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSV----SPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCc----cceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            345677889999999999999987643210    1446999998765 45667789999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKG-----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ....+|++|||.+|+|..+|...+     ...+.....+.++.+||+|+.||++++   +|||||..+|+||++...+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKI  843 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKI  843 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEE
Confidence            999999999999999999997651     236888999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+|+.+.............-...|||||.+..+.++.++|||||||+|||+++ |..||...+..+....+      
T Consensus       844 aDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~------  917 (1025)
T KOG1095|consen  844 ADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV------  917 (1025)
T ss_pred             cccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH------
Confidence            99999996655444433332233568999999999999999999999999999998 78888765443332211      


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      +...           .-..|..|+..+.+||.+||+.+|++||++..|++.+..+.+
T Consensus       918 ~~gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  918 LEGG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             HhCC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence            1111           113345678999999999999999999999999997766543

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-41  Score=332.99  Aligned_cols=273  Identities=27%  Similarity=0.412  Sum_probs=211.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCcc-------ccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAP-------VKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~-------~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      ..+|++.+.||+|+||.||+|.+...+...       .....+..||+|.+..... .....+.+|++++..++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999886533211       1223456799999876542 34567889999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      +++++..++..++||||+++++|.+++....         ...+++..++.++.|++.||.|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999987643         125889999999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh--CCCCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPN  351 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt--G~~pf~~~~~~  351 (490)
                      ||++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986544332233334567889999999998899999999999999999998  66777543211


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                         .............       ........+...+.++.+||.+||+.||.+|||+.+|++.|+
T Consensus       241 ---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 ---QVIENAGHFFRDD-------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHHHHhccccc-------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               1111111110000       000111112233678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-42  Score=344.08  Aligned_cols=270  Identities=27%  Similarity=0.442  Sum_probs=224.0

Q ss_pred             hhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceec
Q 011234          124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       124 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      ..++.+......+.++||+|.||.||+|.+....     ++....||||+.+.+ .....+.|+.|..+|++++|||||+
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-----kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIik  455 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-----KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIK  455 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccc-----cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhh
Confidence            3344555666777889999999999999987632     345668999999875 4455677999999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ++|+|.+ ...|||||+++.|.|..+|..+.. .++......++.||+.||.|||+..   +|||||...|||+.....|
T Consensus       456 LIGv~~e-~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  456 LIGVCVE-QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             eeeeeec-cceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCccee
Confidence            9999875 578999999999999999987754 6889999999999999999999987   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHH-hCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.+.++...... ...-.+.|||||.++-..++.++|||.|||+|||++ .|..||.+-...+..-.++.. 
T Consensus       531 KLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG-  608 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG-  608 (974)
T ss_pred             eecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-
Confidence            99999999998776554433 334467899999999999999999999999999976 599999765544433222211 


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                                      -....|.+|++.+..|+.+||+.||.+||.+.++...|..+...
T Consensus       609 ----------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe  652 (974)
T KOG4257|consen  609 ----------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE  652 (974)
T ss_pred             ----------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence                            11234667899999999999999999999999999999876553

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-41  Score=334.15  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +|++.+.||+|+||.||+|.+.....    ...+..||+|++...... ....+..|+.++..++||||+++++++...+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP----GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            57788999999999999998754211    114568999999765432 2456788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ..++++||+.+++|.+++....              ...+++..+..++.|++.||.|||+.+   |+||||||+|||++
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~  158 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF  158 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence            9999999999999999985321              124788889999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||......   ..
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~  235 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV  235 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH
Confidence            999999999999886643322222233456789999999998899999999999999999998 88888653221   11


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                      .+....             . ....++..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       236 ~~~i~~-------------~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRN-------------R-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHc-------------C-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111110             0 0011223447789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-41  Score=332.02  Aligned_cols=249  Identities=28%  Similarity=0.411  Sum_probs=198.6

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||+|+||.||++....         +|..||+|.+......   ....+..|+++++.++||||+++++++..+...++|
T Consensus         1 lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKN---------TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEcc---------CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            7999999999998875         6779999998653221   233456799999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.......+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            99999999999887666557899999999999999999999988   999999999999999999999999998866432


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .   ......|+..|+|||++.+..++.++|||||||++|||++|..||........  ..+.........         
T Consensus       149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~---------  214 (277)
T cd05607         149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE---------  214 (277)
T ss_pred             c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc---------
Confidence            1   12335789999999999988899999999999999999999999965332111  111111111100         


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       ... .....+.++.+||.+||+.||++||++.|+++.+.
T Consensus       215 -~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         215 -VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             -ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence             000 00123678999999999999999999987764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-41  Score=337.03  Aligned_cols=271  Identities=24%  Similarity=0.387  Sum_probs=211.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      +...+|.+.+.||+|+||.||+|++.....  .....+..||+|.+.... ......+.+|+.++..+ .||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCC--CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            445678999999999999999998643111  011245689999987542 33456788999999999 79999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      +...+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            9999999999999999999999976421              24778889999999999999999988   999999999


Q ss_pred             ceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCC
Q 011234          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       273 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~  351 (490)
                      |||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            99999999999999999987654332222223446778999999988899999999999999999998 77888543221


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      .   ......   ..           .....+..++..+.+|+.+||..+|.+||++.+|++.|..+...
T Consensus       247 ~---~~~~~~---~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 E---LFKLLK---EG-----------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             H---HHHHHH---cC-----------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1   111110   00           00011223478899999999999999999999999999877554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.2e-41  Score=330.20  Aligned_cols=274  Identities=31%  Similarity=0.435  Sum_probs=207.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-  210 (490)
                      .|++.+.||+|+||+||++.....     ...++..||+|.+..... .....+.+|+++|+.++||||+++++++... 
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPA-----NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG   79 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccc-----cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358899999999999999875431     123677899999876532 3456788999999999999999999987654 


Q ss_pred             -CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       ...++||||+++++|.+++...   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          80 GKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             CceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccc
Confidence             3578999999999999998654   5899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++......... ......++..|+|||.+.+..++.++|||||||++|||++|..||........ ......... ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~  231 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVV  231 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchh
Confidence            98765432211 11223456779999999888999999999999999999999999854322110 111100000 0000


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      .+....+.......+...+..+.+|+.+||..||++|||+.+|++.|+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111111111223345788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-41  Score=331.28  Aligned_cols=262  Identities=28%  Similarity=0.424  Sum_probs=206.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+.....    ..++..||+|.+..... .....+..|+.+++.++|+||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDG----DAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCC----CCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4579999999999999999998864210    11466899998875432 334568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC---C
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---N  281 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~  281 (490)
                      .+..++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++   .
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~  157 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRV  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcc
Confidence            9999999999999999999876532     25889999999999999999999988   99999999999998654   5


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........   ....
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~~  234 (277)
T cd05036         158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEFV  234 (277)
T ss_pred             eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH
Confidence            99999999987633222111122334568999999999999999999999999999997 9999975432211   1110


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .   .           .....++...+..+.+|+.+||+.||++||++.+|+++|.
T Consensus       235 ~---~-----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 T---G-----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             H---c-----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0   0           0011122334678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1e-41  Score=341.55  Aligned_cols=242  Identities=27%  Similarity=0.400  Sum_probs=196.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCC-CCceeceeeEEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  208 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~  208 (490)
                      +|.+.+.||+|+||.||+|.+..         +|..||+|++.....   ...+.+..|+.++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKG---------TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            47788999999999999998865         677999999875421   23345678899998886 577888999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccc
Confidence            9999999999999999999987654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   ......   ...  
T Consensus       147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~~--  216 (323)
T cd05615         147 MCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSI---MEH--  216 (323)
T ss_pred             cccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---HhC--
Confidence            9875433221  123457999999999999889999999999999999999999999754321   111110   000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  408 (490)
                                ...++...+.++.+|+.+||+.||.+|++.
T Consensus       217 ----------~~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 ----------NVSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ----------CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                      011223346788999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-41  Score=339.57  Aligned_cols=238  Identities=29%  Similarity=0.372  Sum_probs=190.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHH-HHhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      ++||+|+||.||+|++..         +|..||+|++.....   .....+..|.. +++.++||||+++++++.+.+..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKS---------DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            469999999999999875         577899999875422   22334555554 67889999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++++|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99999999999998886654  5788888999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||......   ...+.   ...        
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~---i~~--------  210 (321)
T cd05603         147 VEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDN---ILH--------  210 (321)
T ss_pred             CCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHH---Hhc--------
Confidence            2221  1223467999999999999889999999999999999999999999654211   11110   110        


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~  409 (490)
                        ..  ..++...+..+.++|.+||+.||.+||++.
T Consensus       211 --~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 --KP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              00  012223367899999999999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.3e-41  Score=332.93  Aligned_cols=252  Identities=32%  Similarity=0.445  Sum_probs=204.3

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      |++.+.||+|+||.||+|.+..         ++..||+|.+.....   .....+..|+.+++.++|+||+.+++.+.+.
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK   72 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcC---------CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence            7788999999999999998876         677999999865422   2234567899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+.+++|.+++...+...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          73 DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccce
Confidence            99999999999999999987665557899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........   .....|+..|+|||++.+..++.++|||||||++|+|++|..||...............   ...    
T Consensus       150 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~~----  219 (285)
T cd05630         150 VHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VKE----  219 (285)
T ss_pred             eecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hhh----
Confidence            76543221   12347899999999999999999999999999999999999999754322111111000   000    


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                             ....++...+.++.+|+.+||+.||++|||     +.|++++
T Consensus       220 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                   001122233678899999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-42  Score=347.42  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=204.9

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEE
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  218 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  218 (490)
                      +||+|.||+||-|++..         +...+|||.+........+-+..||.+.++|.|.|||+++|.+.+++..-|.||
T Consensus       582 VLGKGTYG~VYA~RD~~---------tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME  652 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMD---------TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME  652 (1226)
T ss_pred             EeecCceeEEEeecccc---------ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee
Confidence            69999999999999876         667899999987766666778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-CCCCeEEccccccccCCC
Q 011234          219 FMPRGSLENHLFRKGSLPL--PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       219 ~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFG~a~~~~~  295 (490)
                      -++||+|.++|..+-+ ++  .+..+-.+.+||++||.|||++.   |||||||-+||||+ -.|.+||+|||.++.+..
T Consensus       653 qVPGGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  653 QVPGGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             cCCCCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            9999999999976543 45  78888899999999999999988   99999999999995 478999999999987643


Q ss_pred             CCCcceeeccccCCCCCCchhhhcC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          296 DGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                        .......+.||..|||||++..+  .|+.++|||||||++.||.||++||-.......    ..++.      .++. 
T Consensus       729 --inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA----AMFkV------GmyK-  795 (1226)
T KOG4279|consen  729 --INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA----AMFKV------GMYK-  795 (1226)
T ss_pred             --CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH----hhhhh------ccee-
Confidence              34455678899999999999865  689999999999999999999999954321100    00000      0111 


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          .....|...+.+++.+|.+|+..||.+||++.++|+-
T Consensus       796 ----vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  796 ----VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             ----cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                1223455668999999999999999999999999863

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-41  Score=330.19  Aligned_cols=274  Identities=27%  Similarity=0.386  Sum_probs=207.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec-
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-  210 (490)
                      .+|++.+.||+|+||.||+|....     ....++..||+|.+........+.+.+|+++|..++||||+++++++... 
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP-----LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC-----CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            478999999999999999998643     12236789999999877666667889999999999999999999987543 


Q ss_pred             -CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence             46889999999999999987543 25889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcce-eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC---
Q 011234          290 AKDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---  365 (490)
Q Consensus       290 a~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---  365 (490)
                      +........... .....++..|+|||++.+..++.++|||||||++|||++|..++......    ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~  230 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQM  230 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccccccc
Confidence            987654322111 11123345699999999889999999999999999999988765332110    0000000000   


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ....+...+........+...+.++.+||.+||..+|++|||+.+|++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00001111111111112233467899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.2e-41  Score=330.40  Aligned_cols=263  Identities=24%  Similarity=0.392  Sum_probs=205.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|++.+.||+|+||+||+|.+..++..     ....||+|++..... ....++.+|+.++..+.|+||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGEN-----VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCc-----cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            45789999999999999999987653321     123589999875433 335678899999999999999999999875


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       ...+++|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~  155 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCc
Confidence             45789999999999999987643 26889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~-----  227 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEKG-----  227 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC-----
Confidence            987643322211122335678999999998899999999999999999998 889986432211   11111100     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               .....+..++.++.++|.+||..||++||++.++++.|..+..
T Consensus       228 ---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 ---------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ---------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     0001112346788999999999999999999999999876643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-41  Score=333.26  Aligned_cols=266  Identities=24%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcC---CCCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~  207 (490)
                      +|++.+.||+|+||.||+|.+..         +|..||+|.+......  ....+.+|+.++..+   +||||+++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~   71 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVC   71 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECC---------CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence            48889999999999999999875         6779999998754221  123455677766655   799999999988


Q ss_pred             Eec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          208 IED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       208 ~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ...     ...++||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        72 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~  147 (288)
T cd07863          72 ATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQV  147 (288)
T ss_pred             ccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence            653     45789999996 58988887655556899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~  361 (490)
                      ||+|||++.......   ......||..|+|||++.+..++.++|||||||++|+|++|.+||......+....+ ....
T Consensus       148 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (288)
T cd07863         148 KLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  224 (288)
T ss_pred             EECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC
Confidence            999999998654321   123356899999999999889999999999999999999999999654332211111 0000


Q ss_pred             c----ccCCchhh-hhccCc---cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 P----HLGDKRRF-YRLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~----~~~~~~~~-~~~~~~---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .    .+...... ...+.+   ..........+..+.+||.+||+.||++|||+.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0    00000000 000000   00001112336778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.7e-41  Score=324.11  Aligned_cols=251  Identities=28%  Similarity=0.417  Sum_probs=206.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|.+.+.||+|+||.||+|.+..         +|..|++|.+...  .......+.+|+.+++.++||||+++++++.+.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKA---------DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK   71 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcC---------CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence            47888999999999999998875         5678999998654  233456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          72 GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999999999997764457899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......|++.|+|||++.+..++.++|||||||++|+|++|..||......   ........   .    
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~---~----  216 (256)
T cd08529         149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIR---G----  216 (256)
T ss_pred             eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc---C----
Confidence            86644321  123457899999999999999999999999999999999999999654311   11111000   0    


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        ..     ...+...+..+.++|.+||+.+|++||++.+++++
T Consensus       217 --~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         217 --VF-----PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --CC-----CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence              00     01111336789999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.6e-41  Score=346.72  Aligned_cols=266  Identities=25%  Similarity=0.357  Sum_probs=203.0

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|.+..         +|..||||.+...  .....+.+.+|+.+|+.++|+||+++++++...
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   71 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPR---------DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPP   71 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECC---------CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence            48889999999999999998765         6779999998653  233456788999999999999999999999877


Q ss_pred             C-----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          211 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      +     ..|+||||+. ++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          72 HIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             CccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEec
Confidence            6     7899999995 68888876543  6889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+++....... .......|+..|+|||++.+. .++.++|||||||++|||++|+.||...........+...... 
T Consensus       146 Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~-  223 (372)
T cd07853         146 DFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT-  223 (372)
T ss_pred             cccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC-
Confidence            9999986543221 122335689999999998764 5789999999999999999999999765543222211110000 


Q ss_pred             CCchhh-----------hhc-cC-cccc--CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          365 GDKRRF-----------YRL-LD-PRLE--GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       365 ~~~~~~-----------~~~-~~-~~l~--~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .....+           ... .. +...  ..+....+.++.+||.+||+.||.+|||+.+++++-
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            000000           000 00 0000  011122367899999999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1e-41  Score=347.83  Aligned_cols=263  Identities=24%  Similarity=0.298  Sum_probs=205.6

Q ss_pred             hhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCce
Q 011234          124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNL  200 (490)
Q Consensus       124 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI  200 (490)
                      +.++....++|++.+.||+|+||.||+|.+..         ++..||+|++.....   .....+.+|+.+++.++||||
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~---------~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i  105 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV  105 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECC---------CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC
Confidence            33455667899999999999999999998876         677999999864321   223456789999999999999


Q ss_pred             eceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          201 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       201 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +++++++.+++..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       106 v~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~  179 (371)
T cd05622         106 VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSG  179 (371)
T ss_pred             CeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCC
Confidence            99999999999999999999999999988654   4788888999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                      .+||+|||++........ ......+||+.|+|||++.+.    .++.++|||||||++|||++|..||...........
T Consensus       180 ~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  258 (371)
T cd05622         180 HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK  258 (371)
T ss_pred             CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999987643221 112346799999999998753    378999999999999999999999975432111110


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHhh
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETLK  416 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L~  416 (490)
                            .......        +.-......+..+.+||.+||..++.+  |+++.+++++..
T Consensus       259 ------i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         259 ------IMNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             ------HHcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence                  0000000        000001134788999999999844433  789999998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-41  Score=325.94  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=205.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-----hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ++|.+.+.||+|+||.||+|....         ++..||+|.+.....     .....+.+|+.++++++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   72 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVD---------TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC   72 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcC---------CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            468999999999999999998765         677899998864421     123467889999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+++..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|
T Consensus        73 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          73 LRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             EccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence            999999999999999999999987654  5788899999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcce-eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++.......... .....|+..|+|||++.+..++.++|||||||++|||++|+.||........   ...      
T Consensus       148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~------  218 (263)
T cd06625         148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---IFK------  218 (263)
T ss_pred             cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---HHH------
Confidence            999876543211111 1235688899999999998899999999999999999999999864321110   000      


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                             .........++...+..+.+||.+||..+|.+|||+.+++++.
T Consensus       219 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         219 -------IATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -------HhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                   0000111122334477899999999999999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.4e-42  Score=342.05  Aligned_cols=242  Identities=28%  Similarity=0.363  Sum_probs=191.9

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHH-HHhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|++..         ++..||+|++.....   .....+..|.. +++.+.||||+++++++...+..
T Consensus         1 ~~lg~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKA---------EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            469999999999998875         567899999875422   22234444544 56789999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|.+++....  .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          72 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999999999999987654  5778888899999999999999988   999999999999999999999999999754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....   ...       
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~~-------  211 (325)
T cd05602         147 IEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI---LNK-------  211 (325)
T ss_pred             ccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHH---HhC-------
Confidence            32211  2234679999999999999999999999999999999999999996543211   11110   000       


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  413 (490)
                         .  ..++...+..+.+||.+||+.||.+|+++.+.+.
T Consensus       212 ---~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         212 ---P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             ---C--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence               0  0112233778999999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-42  Score=314.63  Aligned_cols=255  Identities=30%  Similarity=0.449  Sum_probs=204.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCC-CCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~  208 (490)
                      .++.+++..||.|+.|.|+++++..         +|...|||.+... +....+.++..+.++...+ +|+||+.+|||.
T Consensus        91 indl~~l~dlGsGtcG~V~k~~~rs---------~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   91 INDLENLGDLGSGTCGQVWKMRFRS---------TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             hHHhhhHHhhcCCCccceEEEEEcc---------cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            3456677889999999999999986         7889999999765 4455677888888876665 899999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .+...++.||.| ...++.++.+- ..++++..+-++...++.||.||-++.  +|||||+||+|||||+.|++||||||
T Consensus       162 ~n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  162 TNTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             eCchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccc
Confidence            999999999998 45666666544 447999999999999999999998854  49999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ++..+.+.   ...++..|.+.|||||.+.   ...|+.++|||||||+|+||.||+.||.......+  .....   +.
T Consensus       238 IsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkv---ln  309 (391)
T KOG0983|consen  238 ISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKV---LN  309 (391)
T ss_pred             ccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHH---Hh
Confidence            99877543   2335678999999999986   45789999999999999999999999976532211  11111   10


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                             ...|.+.++.  ..++.+.+|+..||.+|+.+||.+.+++++-
T Consensus       310 -------~ePP~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  310 -------EEPPLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             -------cCCCCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence                   1112222221  1388999999999999999999999999874

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-41  Score=339.60  Aligned_cols=240  Identities=30%  Similarity=0.385  Sum_probs=191.6

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHH-HHhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVN-FLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||+|+||.||+|.+..         +|..||+|++....   ......+..|.. +++.++||||+++++++...+..
T Consensus         1 ~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKL---------DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            469999999999998865         67799999986542   123344556655 46789999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99999999999998887654  6889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...   .....       
T Consensus       147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~~~~~-------  211 (325)
T cd05604         147 IAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYD---NILHK-------  211 (325)
T ss_pred             CCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHH---HHHcC-------
Confidence            3221  12234679999999999999999999999999999999999999996543211   111   01000       


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev  411 (490)
                         .+  .+....+..+.++|.+||..||.+||++.+.
T Consensus       212 ---~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~  244 (325)
T cd05604         212 ---PL--VLRPGASLTAWSILEELLEKDRQRRLGAKED  244 (325)
T ss_pred             ---Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence               00  1112236788999999999999999987633

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.5e-41  Score=327.62  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=199.7

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec-
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-  210 (490)
                      |.+.+.||+|+||.||+|.+...+       ....||+|.++...  ....+.+..|+.++..++|+||+++++++... 
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~-------~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   73 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDD-------SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTV   73 (272)
T ss_pred             CccccccCcccCceEEEeEEccCC-------CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCC
Confidence            456789999999999999886532       12369999887542  33456788899999999999999999987532 


Q ss_pred             -----CceEEEEEecCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          211 -----DQRLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       211 -----~~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                           ...++||||+.+|+|.+++...    ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        74 ~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  150 (272)
T cd05075          74 ESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMN  150 (272)
T ss_pred             cccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCC
Confidence                 2468999999999999887432    1234789999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......   ...+..
T Consensus       151 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~  227 (272)
T cd05075         151 VCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDYL  227 (272)
T ss_pred             EEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            99999999987644322111222346778999999998899999999999999999999 78888653221   111111


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..    ...          ...+...+..+.+||.+||+.||++|||+.+|++.|+.+
T Consensus       228 ~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQ----GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             Hc----CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10    000          011123367789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=338.38  Aligned_cols=257  Identities=23%  Similarity=0.283  Sum_probs=200.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||++++..         ++..||+|++....   ....+.+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKN---------TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            479999999999999999998875         57789999987532   123345778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..|+||||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999999997643 36889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ++......... .....+||+.|+|||++..     ..++.++|||||||++|+|++|+.||..........      ..
T Consensus       148 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i  220 (331)
T cd05597         148 SCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KI  220 (331)
T ss_pred             ceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HH
Confidence            98765433221 1223469999999999873     457889999999999999999999996543211110      01


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L  415 (490)
                      ...... ..+ .+     .....+..+.+||.+||..++.+  |+++.+++++-
T Consensus       221 ~~~~~~-~~~-~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         221 MNHKEH-FQF-PP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             HcCCCc-ccC-CC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            000000 000 00     01123778999999988654443  78999999883

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-41  Score=348.26  Aligned_cols=267  Identities=24%  Similarity=0.382  Sum_probs=208.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      +..++|.+.+.||+|+||.||+|++....    ...++..||||+++..... ..+.+.+|+.+|..+. |||||+++++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~----~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLS----HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCC----CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            34456888999999999999999975321    1124668999999765332 2346889999999998 9999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCC----------------------------------------------------
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGS----------------------------------------------------  234 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------------------------------------  234 (490)
                      +...+..++|||||++|+|.+++.....                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999999865321                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011234          235 --------------------------------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       235 --------------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                                                                  ..+++..+..++.||+.||.|||+.+   |+|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCC
Confidence                                                        13567778899999999999999987   9999999


Q ss_pred             CCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 011234          271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  349 (490)
Q Consensus       271 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~  349 (490)
                      |+|||++.++.+||+|||+++...............|+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999986543222111223457889999999998889999999999999999998 888986532


Q ss_pred             CCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ....  ......              .......+...+.++.+|+.+||..+|.+||++.+|++.|+.+
T Consensus       347 ~~~~--~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQ--FYNAIK--------------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHH--HHHHHH--------------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2111  000000              0000112223468899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.7e-41  Score=331.67  Aligned_cols=266  Identities=26%  Similarity=0.418  Sum_probs=207.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +..++|++.+.||+|+||.||+|.+....    ....+..||+|.+.... ......+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDII----KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccC----CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            34568999999999999999999875321    11235689999987553 23334678899999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      .+.+..++||||+++|+|.+++....        ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~  155 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHD  155 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCC
Confidence            99999999999999999999997532        123466778899999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+   ...
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~  232 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK  232 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence            9999999999986543222222222345778999999998899999999999999999998 788886432211   111


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..   .          +.. ....+...+..+.+|+.+||+.||++|||+.++++.|+..
T Consensus       233 ~~---~----------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 FV---M----------DGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HH---H----------cCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            10   0          000 0011223367899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.5e-41  Score=325.73  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..          +..||+|.+..... ....+.+|+.+++.++|+||+++++++. .
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG----------NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-E   72 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC----------CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence            3578999999999999999997653          45699999876543 3456889999999999999999999875 4


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          73 EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceee
Confidence            56899999999999999997655556899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||......   .........      
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~------  219 (260)
T cd05070         150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVERG------  219 (260)
T ss_pred             eeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcC------
Confidence            865432211 1122345678999999988899999999999999999999 88898653221   111111100      


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                              .....+...+..+.+|+.+||..||++|||+.++++.|+.
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 --------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                    0011122336789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.8e-41  Score=324.46  Aligned_cols=251  Identities=23%  Similarity=0.320  Sum_probs=205.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +|++.+.||.|+||.||++.+..         ++..||+|.++... ....+.+..|+.+++.++|+||+++++++.+++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   71 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVN---------SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG   71 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcC---------CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence            58889999999999999998865         57789999986542 334466788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcce
Confidence            9999999999999999887655556889999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|+..|+|||++.+..++.++|+||||+++|+|++|..||........   ....   ....    
T Consensus       149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~---~~~~----  216 (255)
T cd08219         149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKV---CQGS----  216 (255)
T ss_pred             eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHH---hcCC----
Confidence            6643221  12345789999999999888899999999999999999999999965322111   1000   0000    


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ....+...+..+.+||.+||+.||++||++.+|+..
T Consensus       217 -------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 -------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                   001122236778999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=347.07  Aligned_cols=246  Identities=30%  Similarity=0.432  Sum_probs=203.2

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh---HHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      |.-++.||.|+||.||-|++..         +...||||.+.-.+.+.   ..+++.|+++|.+|.|||+|.+.|+|..+
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~---------n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre   98 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE   98 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccC---------ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc
Confidence            5556789999999999999876         56799999998766554   35678999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ...||||||| -|+-.|++.-.. .++.+..+..|..+.+.||+|||+.+   .||||||..||||++.|.|||+|||.|
T Consensus        99 ~TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen   99 HTAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             chHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccch
Confidence            9999999999 678888876553 37888899999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ......      ..++|||+|||||++.   .+.|+-++|||||||+..||...++|+...+.....  .-.+.      
T Consensus       174 si~~PA------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL--YHIAQ------  239 (948)
T KOG0577|consen  174 SIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQ------  239 (948)
T ss_pred             hhcCch------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH--HHHHh------
Confidence            766432      4589999999999986   578999999999999999999999997433211110  00110      


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                           .-.|.+.   ....+..+..|+..||++-|.+|||.++++.+-
T Consensus       240 -----NesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  240 -----NESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             -----cCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence                 1111111   235589999999999999999999999988763

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-41  Score=331.66  Aligned_cols=273  Identities=26%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCC-----ccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceee
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGT-----APVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~-----~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      ++|++.+.||+|+||.||+|++...+.     .....+....||+|.+.... ......+.+|+++|..++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            579999999999999999998754211     00112234569999987653 233456889999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKG----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ++...+..++||||+++++|.+++....          ...+++..++.++.|++.||.|||+.+   ++||||||+|||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence            9999999999999999999999986532          113678889999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCCc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNGE  353 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt--G~~pf~~~~~~~~  353 (490)
                      ++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999986543322222233455778999999998899999999999999999998  556765432211 


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                        .+.........       .........+...+..+.+||.+||+.||++||++.+|++.|++
T Consensus       241 --~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 --VIENTGEFFRN-------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHhhhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              11110000000       00000001112236789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.4e-41  Score=332.71  Aligned_cols=261  Identities=25%  Similarity=0.407  Sum_probs=205.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|+...++       ....+++|.++.. .....+.+.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   74 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDG-------LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN   74 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCC-------CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence            47899999999999999999886532       2235788888743 233456788999999999 69999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      .+..++||||+++++|.+++.....              ..+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil  151 (297)
T cd05089          75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVL  151 (297)
T ss_pred             CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEE
Confidence            9999999999999999999965321              24788899999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--  226 (297)
T cd05089         152 VGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--  226 (297)
T ss_pred             ECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            9999999999999986432110   0111223557999999988899999999999999999997 999996543221  


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~  422 (490)
                       .....              ........+..++..+.+||.+||..||.+||++.++++.|+.+.+..
T Consensus       227 -~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         227 -LYEKL--------------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -HHHHH--------------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             11110              000111122234678999999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=325.15  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=202.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+..          +..+|+|.+..... ....+.+|+.+++.++|+||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~----------~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG----------KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR   72 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC----------CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            358889999999999999998752          34699999865432 3356888999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~  148 (256)
T cd05059          73 PIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLAR  148 (256)
T ss_pred             ceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccce
Confidence            99999999999999999876543 6889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........   .......       
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~~~-------  217 (256)
T cd05059         149 YVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---VESVSAG-------  217 (256)
T ss_pred             eccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---HHHHHcC-------
Confidence            65432111 1111234567999999998999999999999999999998 8899865432211   1111000       


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                             .....+...+..+.+|+.+||..+|++|||+.++++.|.
T Consensus       218 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         218 -------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence                   001112234778999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.2e-41  Score=325.29  Aligned_cols=256  Identities=27%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|...          .+..||+|.+..... ....+.+|+.+++.++|+||+++++++. 
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~----------~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   71 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN----------GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-   71 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC----------CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-
Confidence            3457999999999999999999864          356799999876543 3457889999999999999999999864 


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+.+++|.+++.......+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~  148 (260)
T cd05067          72 QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGL  148 (260)
T ss_pred             cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcc
Confidence            567899999999999999987765567899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......   .........     
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-----  219 (260)
T cd05067         149 ARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERG-----  219 (260)
T ss_pred             eeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcC-----
Confidence            976643221 11223346778999999998899999999999999999998 99999654321   111111000     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                               .....+...+.++.+||.+||..+|++||+++++++.|+.+
T Consensus       220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         220 ---------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence                     00011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-41  Score=336.71  Aligned_cols=268  Identities=24%  Similarity=0.352  Sum_probs=203.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|.+.+.||+|+||.||+|++..         ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   76 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKL---------TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD   76 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecC---------CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence            469999999999999999998765         567899999875432 2234577899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||++ ++|.+++...+. .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          77 KSLTLVFEYLD-KDLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             CeEEEEEeCCC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccc
Confidence            99999999996 588888766533 5788999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------  361 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------  361 (490)
                      ........  ......||..|+|||++.+ ..++.++|||||||++|+|++|++||......+....+....        
T Consensus       152 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07872         152 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW  229 (309)
T ss_pred             eecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            76533221  1223468999999998865 468899999999999999999999997654433222211110        


Q ss_pred             cccCCchhhhhccCccccC----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 PHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      +.+.....+.....+....    ......+.++.+||.+||..||.+|||+.|++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            0000000000000000000    01112367889999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-41  Score=325.71  Aligned_cols=252  Identities=26%  Similarity=0.415  Sum_probs=202.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+..          +..||||.+..... ...++.+|+.++..++||||+++++++...+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~----------~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   72 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG----------QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR   72 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC----------CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            468889999999999999997753          33599999875543 3467889999999999999999999999888


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+.+   ++|+||||+|||++.++.+||+|||+++
T Consensus        73 ~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          73 PIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             CcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccce
Confidence            99999999999999999876543 6899999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ......   ....  
T Consensus       149 ~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~~~~--  219 (256)
T cd05113         149 YVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVS---QGLR--  219 (256)
T ss_pred             ecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHh---cCCC--
Confidence            6543221 11122345678999999988889999999999999999998 999986433211   111110   0000  


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                               ...+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus       220 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 ---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                     0011123678999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-41  Score=323.23  Aligned_cols=251  Identities=29%  Similarity=0.499  Sum_probs=207.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||.|+||.||+|..           .|..||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-----------~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-----------RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG   72 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-----------cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC
Confidence            45789999999999999999976           356899999976644 457789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccc
Confidence            99999999999999999997765556899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......     ...++..|+|||++.+..++.++||||||+++|+|++ |..||.......   +......       
T Consensus       150 ~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~-------  214 (256)
T cd05039         150 KEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEK-------  214 (256)
T ss_pred             cccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhc-------
Confidence            87633211     2234678999999988899999999999999999997 999986442211   1111100       


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                             ......+...+..+.+||.+||..+|++||++.++++.|+.+
T Consensus       215 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 -------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                   000111223368899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=9.1e-41  Score=323.18  Aligned_cols=250  Identities=28%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      .||+|+||.||+|.+...       +++..||+|+++...  ....+++..|+.+++.+.||||+++++++. .+..++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~-------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv   73 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK-------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLV   73 (257)
T ss_pred             cCCCcCCcceEEeEEecC-------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEE
Confidence            589999999999987532       256789999986543  233567889999999999999999999875 4567899


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          74 MELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99999999999987654  6889999999999999999999988   999999999999999999999999999876443


Q ss_pred             CCcce-eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          297 GKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ..... .....++..|+|||.+....++.++|||||||++|||++ |..||.......   .......            
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~i~~------------  213 (257)
T cd05116         149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQMIES------------  213 (257)
T ss_pred             CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC------------
Confidence            22111 122334678999999988889999999999999999998 999997543221   1111110            


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                        ......+..++.++.+||.+||+.||++||++.+|.+.|...
T Consensus       214 --~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         214 --GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              001112233478899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-41  Score=353.20  Aligned_cols=264  Identities=24%  Similarity=0.290  Sum_probs=200.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ...|.+.+.||+|+||.||+|.+..         ++..||||....      ..+.+|+++|++|+|+|||++++++...
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---------~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~  232 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPD---------YPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG  232 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECC---------CCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            4579999999999999999998875         577899996432      2456899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..+||||++ .++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       233 ~~~~lv~e~~-~~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        233 GLTCLVLPKY-RSDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             CEEEEEEEcc-CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCc
Confidence            9999999999 5799988865433 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCC-C----cc---hhHHhhhc
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-G----EH---NLVEWARP  362 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~-~----~~---~~~~~~~~  362 (490)
                      +..............+||..|+|||++.+..++.++|||||||+||||++|..++...... .    ..   ..+.....
T Consensus       308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~  387 (461)
T PHA03211        308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV  387 (461)
T ss_pred             eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence            8664332222233467999999999999999999999999999999999988765322111 0    01   11111111


Q ss_pred             ccCCch-----hhhhc--------cCccccC-CCC--hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKR-----RFYRL--------LDPRLEG-HFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~-----~~~~~--------~~~~l~~-~~~--~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ......     .+...        ..+.... .+.  ...+..+.+||.+||+.||.+|||+.|||++
T Consensus       388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000000     00000        0000000 000  0224578999999999999999999999986

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.2e-41  Score=330.32  Aligned_cols=252  Identities=31%  Similarity=0.435  Sum_probs=203.1

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      |+..+.||+|+||.||+|.+..         ++..||+|.+......   ....+.+|+.+|+.++|+||+.+++++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~   72 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRA---------TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK   72 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECC---------CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence            6778899999999999998875         6779999998654322   234567899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++...+...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          73 DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcc
Confidence            99999999999999999887655557999999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........   .....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.  ....      
T Consensus       150 ~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~------  218 (285)
T cd05632         150 VKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVL------  218 (285)
T ss_pred             eecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhh------
Confidence            76543211   123578999999999998899999999999999999999999997543221111110  0000      


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                          ..  ...++...+..+.+|+.+||+.||++||+     +.+++.+
T Consensus       219 ----~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         219 ----ET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ----cc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                00  01122233678899999999999999999     6677655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-41  Score=327.46  Aligned_cols=254  Identities=24%  Similarity=0.383  Sum_probs=204.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||+|.+..         ++..||+|.++.........+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~   79 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVN---------TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD   79 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcC---------CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence            468888999999999999998865         67789999987665455556788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++...+  .+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          80 KLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeee
Confidence            9999999999999999987654  6889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ......  .......|+..|+|||++.   ...++.++|||||||++|+|++|..||....+.........  ..     
T Consensus       155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~-----  225 (267)
T cd06645         155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SN-----  225 (267)
T ss_pred             EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cC-----
Confidence            654321  1123457899999999874   45688999999999999999999999865432211111000  00     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ...+....  ....+..+.+||.+||..||++||++.+|+++
T Consensus       226 ----~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 ----FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ----CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                00011100  01225678999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.2e-41  Score=333.93  Aligned_cols=269  Identities=23%  Similarity=0.379  Sum_probs=208.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|.+.+.||+|+||.||+|.+.....  ........||+|.++... ......+..|+.++..+ .||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~--~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDK--SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCC--ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34578899999999999999998643111  111245679999987543 23445688899999999 599999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      ...+..++||||+++|+|.+++....              ...+++..+..++.||+.||.|||+.+   |+||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence            99999999999999999999996542              134788899999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986643222111112234567999999998899999999999999999999 888886543211


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .   ......    .          .....+..++.++.+||.+||..||++||++.++++.|..+..
T Consensus       245 ~---~~~~~~----~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 L---FKLLRE----G----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             H---HHHHHc----C----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1   111100    0          0001223346788999999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.4e-41  Score=332.57  Aligned_cols=267  Identities=27%  Similarity=0.395  Sum_probs=205.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||++.+..         ++..+|+|.+..... ....++.+|++++.+++||||+++++++.++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRP---------SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD   71 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcC---------CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            368999999999999999998765         677899999875532 3345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      +..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+ .+   ++||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  146 (308)
T cd06615          72 GEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGV  146 (308)
T ss_pred             CEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCC
Confidence            99999999999999999997654  68899999999999999999997 46   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc--
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK--  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~--  367 (490)
                      +.......    .....|+..|+|||++.+..++.++|||||||++|+|++|..||......................  
T Consensus       147 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  222 (308)
T cd06615         147 SGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKES  222 (308)
T ss_pred             cccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCC
Confidence            87653321    234578999999999988889999999999999999999999996543221111110000000000  


Q ss_pred             --------------hhhhhccCcccc---CCCC-hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          368 --------------RRFYRLLDPRLE---GHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       368 --------------~~~~~~~~~~l~---~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                                    ....+..+....   ...+ ...+.++.+||.+||..||++||++.+|+++.-
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         223 HRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             cccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                          000000000000   0000 113667999999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-41  Score=339.74  Aligned_cols=263  Identities=22%  Similarity=0.306  Sum_probs=196.7

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ....+|++.+.||+|+||.||+|.+..         ++..||+|+....      ....|+.+|+.++|+||+++++++.
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~  127 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPG---------QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV  127 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECC---------CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE
Confidence            344579999999999999999998865         5678999985433      2346899999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..++||||+ .++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        128 SGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             eCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCc
Confidence            999999999999 568988886543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch--------hHHhh
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--------LVEWA  360 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~--------~~~~~  360 (490)
                      +++.....   .......||+.|+|||++.+..++.++|||||||++|||+++..++....+.....        +....
T Consensus       203 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~  279 (357)
T PHA03209        203 AAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII  279 (357)
T ss_pred             cccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH
Confidence            99754322   11234579999999999999999999999999999999998665543322221100        01000


Q ss_pred             hcc------cC---CchhhhhccC--ccccC---CC----ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPH------LG---DKRRFYRLLD--PRLEG---HF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~------~~---~~~~~~~~~~--~~l~~---~~----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...      +.   ........++  .....   .+    ....+.++.+||.+||+.||.+|||+.||+++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        280 STLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000      00   0000000000  00000   00    01225567789999999999999999999976

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7e-41  Score=326.04  Aligned_cols=260  Identities=27%  Similarity=0.467  Sum_probs=206.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+...+.      .+..||||.+... ......++..|+.+++.+.||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   77 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCC------CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC
Confidence            358889999999999999999876432      2457999998765 233456789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          78 RPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             CceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccc
Confidence            999999999999999999876533 6889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeec-cc--cCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          291 KDAPEDGKTHVSTR-VM--GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       291 ~~~~~~~~~~~~~~-~~--Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      .............. ..  ++..|+|||++.+..++.++|||||||++|||++ |..||......   ....+.....  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~--  228 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY--  228 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC--
Confidence            76543221111111 11  2457999999998999999999999999999886 99999654322   1111111000  


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                  ....+..++..+.+++.+||..+|++||++.+|+..|+.+
T Consensus       229 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                        0011123367789999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.3e-40  Score=329.10  Aligned_cols=273  Identities=26%  Similarity=0.419  Sum_probs=206.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceece
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      ++|++.+.||+|+||.||++.+......       ....+++..||+|.+.... ......+.+|+.+|+.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            4699999999999999999875431110       0122345679999997553 3345678899999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS---------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      ++++...+..++||||+++++|.+++.....         ..+++..+..++.||+.||+|||+.+   |+||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999999876431         23677889999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh--CCCCCCCCCCCC
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT--GRRSMDKNRPNG  352 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt--G~~pf~~~~~~~  352 (490)
                      |++.++.++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322222223345678999999988899999999999999999998  677875433221


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                      .   +..........       ........+..++..+.+||.+||+.||.+||++.+|++.|++
T Consensus       242 ~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 V---IENTGEFFRDQ-------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             H---HHHHHHHHhhc-------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            1   11000000000       0000001112346789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=8.3e-41  Score=327.67  Aligned_cols=253  Identities=26%  Similarity=0.390  Sum_probs=201.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.++||+|+||.||+|.+..         ++..||+|.+.... ......+.+|+.++.+++||||+++++++...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   71 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLL---------TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE   71 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence            368889999999999999998765         67789999986552 33445788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|..+.      .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          72 NRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             CEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            9999999999999986542      4678888999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~~~~~~~  369 (490)
                      ......    .....+|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..........    
T Consensus       143 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----  214 (279)
T cd06619         143 TQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD----  214 (279)
T ss_pred             eecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc----
Confidence            765432    1233578999999999998899999999999999999999999996532211110 0010000000    


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                         ...+.+   .....+.++.+||.+||+.||++||++.+++++..
T Consensus       215 ---~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         215 ---EDPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             ---cCCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence               000000   01123578899999999999999999999998743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=9e-41  Score=336.18  Aligned_cols=272  Identities=25%  Similarity=0.376  Sum_probs=210.8

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~  205 (490)
                      .+...+|++.+.||+|+||.||+|++...+.  .....+..||+|.+.... .....++.+|+.++.++ .||||+++++
T Consensus         8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDK--DKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccCHhHeeecceeccccCCcEEEEEEeccCC--ccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            3444579999999999999999998753211  011234579999887543 23456788999999999 7999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      ++...+..++||||+++|+|.+++....              ...+++..+..++.||+.||.|||+.+   |+||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence            9999999999999999999999987542              124778889999999999999999988   99999999


Q ss_pred             CceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 011234          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~  350 (490)
                      +|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986643222211222334568999999999999999999999999999998 8888865322


Q ss_pred             CCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      ...   ...   ...           ......+...+..+.+||.+||+.+|.+||++.++++.|+.+...
T Consensus       243 ~~~---~~~---~~~-----------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         243 EEL---FKL---LKE-----------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHH---HHH---HHc-----------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            111   110   000           001111223467899999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-40  Score=324.59  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=207.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|+..+.||+|+||.||+|.+..++.      ....||+|.+.... ......+..|++++..++|+||+++++++..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGR------KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK   77 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc
Confidence            3468888999999999999999865321      23479999987653 3345678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          78 FKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            999999999999999999987653 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCccee-eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTHVS-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~-~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +............ .....+..|+|||++.+..++.++|||||||++|||++ |..||.......   ........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~----  226 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDG----  226 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcC----
Confidence            9866433221111 11223457999999998899999999999999999997 999996543211   11111000    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                .....+...+..+.+|+.+||..+|++||++.+|++.|+++
T Consensus       227 ----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 ----------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      00011123367889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.6e-41  Score=341.10  Aligned_cols=265  Identities=25%  Similarity=0.335  Sum_probs=198.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...  .......+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   90 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTV---------LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFT   90 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcC---------CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeec
Confidence            4689999999999999999998765         6779999998654  2233456789999999999999999999986


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ...      ..|+||||+. ++|...+..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          91 PQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             cCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCE
Confidence            543      4799999996 467666532    4788889999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hh--
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW--  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~--  359 (490)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ +.  
T Consensus       163 kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  239 (359)
T cd07876         163 KILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG  239 (359)
T ss_pred             EEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999999764322   1123457899999999999999999999999999999999999999754321110000 00  


Q ss_pred             -------------hhcccCCc-----hhhhhccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          360 -------------ARPHLGDK-----RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       360 -------------~~~~~~~~-----~~~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                   ........     ..+...+....   ........+..+.+||.+||..||++|||+.|++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             CCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                         00000000     00000000000   0001112256789999999999999999999999763

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.1e-41  Score=327.92  Aligned_cols=266  Identities=26%  Similarity=0.402  Sum_probs=211.1

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +..++|.+.+.||+|+||.||+|.+...+     ..++..||+|.+.... ......+.+|+.+++.++|+||+++++++
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~-----~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~   77 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEK-----PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC   77 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCC-----CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34567999999999999999999987532     1246789999887543 33456688999999999999999999987


Q ss_pred             Ee-cCceEEEEEecCCCCHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          208 IE-DDQRLLVYEFMPRGSLENHLFRKGS------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       208 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      .. ....++++||+++++|.+++.....      ..+++..++.++.||+.||+|||+.+   ++||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~  154 (280)
T cd05043          78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEEL  154 (280)
T ss_pred             ecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCC
Confidence            76 4678999999999999999865422      35889999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  359 (490)
                      .+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |+.||....+..   ...+
T Consensus       155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~  231 (280)
T cd05043         155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY  231 (280)
T ss_pred             cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH
Confidence            999999999986644332222233456778999999998899999999999999999998 999996543221   1111


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      .....              ....+..++..+.+++.+||..||++|||+.++++.|+.+.
T Consensus       232 ~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         232 LKDGY--------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHcCC--------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11100              00111223678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.1e-41  Score=332.80  Aligned_cols=260  Identities=25%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..++       ....+|+|.+.... ......+.+|+.++.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~-------~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~   78 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE   78 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCC-------ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC
Confidence            357899999999999999999986532       12356888776432 23445788899999999 8999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      .++..++||||+++++|.+++...+              ...+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Ni  155 (303)
T cd05088          79 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNI  155 (303)
T ss_pred             CCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheE
Confidence            9999999999999999999997543              125788999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~  353 (490)
                      |++.++.+||+|||++......   .......++..|+|||++.+..++.++|||||||++|||++ |..||....... 
T Consensus       156 li~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-  231 (303)
T cd05088         156 LVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-  231 (303)
T ss_pred             EecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence            9999999999999998643211   01111234667999999988889999999999999999998 999986433211 


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                        ......              .......+...+..+.+||.+||+.+|++||++.+++..|+.+..
T Consensus       232 --~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         232 --LYEKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             --HHHHHh--------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence              111100              000011122236788999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.3e-40  Score=321.38  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=209.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.++...   ....+.+.+|++++++++|+||+++++++.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLL---------DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcC---------CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            579999999999999999998875         67789999886432   233567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      ..+..++||||+++++|.+++...  ....+++..++.++.+++.||.|||+.+   |+||||+|+||+++.++.++|+|
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEec
Confidence            999999999999999999988642  2345889999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++.........  .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+.....   
T Consensus       150 ~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~---  223 (267)
T cd08224         150 LGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKC---  223 (267)
T ss_pred             cceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcC---
Confidence            9998765432211  22356899999999999888999999999999999999999998543211 00111100000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                            ...+.    .....+..+.++|.+||..+|++||++.+|++.|+.++
T Consensus       224 ------~~~~~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 ------DYPPL----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ------CCCCC----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                  00000    01133678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=336.62  Aligned_cols=265  Identities=28%  Similarity=0.434  Sum_probs=216.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-HHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .....+.+.||+|.||.|.+|....          +..||||.++.+.... .++|.+|+++|.+|+|||||+++|+|..
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg----------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~  606 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG----------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ  606 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC----------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence            3456788999999999999998753          5689999998775443 4789999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++.+++|+|||++|+|..+|.++.-..+.-.....|+.||+.||+||.+.+   +|||||.+.|+|++.++++||+|||+
T Consensus       607 DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgm  683 (807)
T KOG1094|consen  607 DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGM  683 (807)
T ss_pred             CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccc
Confidence            999999999999999999998874323344555779999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHH--hCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML--TGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ell--tG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++.+.......+..+.+-.+.|||+|.+.-++++.++|||+||++|||++  +...||.......   .++.....+.+.
T Consensus       684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~  760 (807)
T KOG1094|consen  684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQ  760 (807)
T ss_pred             ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCC
Confidence            99887777777766777789999999999999999999999999999975  5677886543221   222222222211


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .       ......-|.-|+..+.+||.+||..|-.+||+++++..+|.+.
T Consensus       761 ~-------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  761 G-------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             C-------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1       1111223445688999999999999999999999999888653

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.5e-41  Score=324.41  Aligned_cols=260  Identities=27%  Similarity=0.383  Sum_probs=208.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||.|+||.||+|.+..         +|..||||.+....   .....++.+|+.+++.+.|+||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecC---------CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            468889999999999999998865         56789999876532   233457889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      .++..+++|||+++++|.+++...  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECc
Confidence            999999999999999999988642  2235889999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .........     
T Consensus       150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-----  221 (267)
T cd08229         150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE-----  221 (267)
T ss_pred             chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh-----
Confidence            999876643321  122356899999999998888999999999999999999999998643221 011111000     


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                           ....+..   .....+..+.+|+.+||..||++|||+.+|++.++++.
T Consensus       222 -----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 -----QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -----cCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                 0000000   11123678999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-40  Score=321.92  Aligned_cols=249  Identities=29%  Similarity=0.447  Sum_probs=201.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE-ec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-ED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  210 (490)
                      .+|.+.+.||+|+||.||+|..           .|..||+|.+....  ..+.+.+|+.+++.++|+||+++++++. ..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-----------~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   72 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-----------cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC
Confidence            4789999999999999999976           35579999987543  3457889999999999999999999765 45


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.......+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~  149 (256)
T cd05082          73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLT  149 (256)
T ss_pred             CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccc
Confidence            67899999999999999997765556889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      .......     ....++..|+|||++.+..++.++|||||||++|+|++ |+.||......   ........       
T Consensus       150 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~-------  214 (256)
T cd05082         150 KEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK-------  214 (256)
T ss_pred             eeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc-------
Confidence            7553321     12345668999999988899999999999999999997 99998643211   11111100       


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                             ......+..++..+.+|+.+||..||++|||+.++++.|+.+
T Consensus       215 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 -------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                   001111223467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-40  Score=324.02  Aligned_cols=255  Identities=28%  Similarity=0.414  Sum_probs=203.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ..+|++.+.||+|+||.||+|.+..         + ..||+|.+..... ..+.+.+|+.+++.++|+||+++++++. +
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~---------~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~   72 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG---------T-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   72 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC---------C-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence            3569999999999999999998753         2 3599999875432 3457889999999999999999999874 4


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++
T Consensus        73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCce
Confidence            66899999999999999997654446789999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||...........+.      ..   
T Consensus       150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~------~~---  219 (262)
T cd05071         150 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------RG---  219 (262)
T ss_pred             eeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh------cC---
Confidence            866433221 1122346778999999988899999999999999999999 888886543221111000      00   


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                              .....+...+..+.+||.+||+.||++||++.++++.|+.+
T Consensus       220 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 --------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                    00011223467889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-40  Score=324.54  Aligned_cols=260  Identities=26%  Similarity=0.455  Sum_probs=207.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+...+.      .+..+|+|.++.... ...+.+..|+.++..++||||+++++++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK------REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS   77 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC------CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            468899999999999999998764321      345799999875432 3345788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          78 KPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             CccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            999999999999999999976543 5889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcce-eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          291 KDAPEDGKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       291 ~~~~~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ........... .....++..|+|||++.+..++.++|||||||++||+++ |..||........   .......    .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~----~  226 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEG----Y  226 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCC----C
Confidence            87654322111 112233568999999998899999999999999999886 9999865432211   1111100    0


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .          ...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       227 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         227 R----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             c----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            0          011122367889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-42  Score=341.18  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=208.3

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecC--CChhhHHHHHHHHHHHhcCC-CCceecee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLL-HPNLVKLV  204 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~  204 (490)
                      .+..+.|++++.||+||.+.||++....          ...+|+|.+..  .+.+...-|..|+.+|.+|. |.+||+||
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~----------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~  426 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSD----------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLY  426 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCC----------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEe
Confidence            3455679999999999999999997653          33567765543  24455677899999999996 99999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +|-..++.+||||||= ..+|..+|..+......| .++.+..||+.|+.++|++|   |||.||||.|+|+ -.|.+||
T Consensus       427 DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKL  500 (677)
T KOG0596|consen  427 DYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKL  500 (677)
T ss_pred             eeeccCceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEe
Confidence            9999999999999985 569999998876654445 67889999999999999999   9999999999999 4579999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCC-----------CCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-----------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-----------~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      +|||+|..+..+.........+||+.||+||.+....           .+.++||||||||||+|+.|++||....    
T Consensus       501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~----  576 (677)
T KOG0596|consen  501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII----  576 (677)
T ss_pred             eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH----
Confidence            9999999998887777778899999999999986432           4678999999999999999999995321    


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHh-HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG-SQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       +.          ...+..+.+|.-+-+|+..- ..++.++++.||++||.+||+..|||++
T Consensus       577 -n~----------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 -NQ----------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HH----------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             11          12234455554444444322 3349999999999999999999999987

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5e-41  Score=327.28  Aligned_cols=254  Identities=29%  Similarity=0.408  Sum_probs=202.0

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      +.+.|++.+.||+|+||.||+|.+..         ++..||+|++.... .....+..|+.++..+ +|+||+++++++.
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   73 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcC---------CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            34578889999999999999998865         67799999986543 3345678899999998 6999999999987


Q ss_pred             ec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..      ...|+||||+.+++|.+++.......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCE
Confidence            53      45789999999999999987755557899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (490)
                      +|+|||++........  ......|+..|+|||++.     ...++.++|||||||++|||++|..||............
T Consensus       151 ~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~  228 (272)
T cd06637         151 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  228 (272)
T ss_pred             EEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            9999999976533211  123467899999999986     346888999999999999999999999643321111000


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         .          .....   .......+..+.+||.+||..||.+|||+.+++++
T Consensus       229 ---~----------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 ---P----------RNPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ---h----------cCCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence               0          00000   00111236789999999999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=322.72  Aligned_cols=257  Identities=29%  Similarity=0.436  Sum_probs=208.1

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +..++|.+.+.||+|+||.||+|.+..          +..||||.+..... ..+++.+|+.+++.++|+||+++++++.
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~----------~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG----------TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCS   71 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC----------CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence            345689999999999999999998653          35799999876543 3467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .....++||||+++++|.+++.......+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g  148 (261)
T cd05034          72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFG  148 (261)
T ss_pred             cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccc
Confidence            8899999999999999999997765557899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||......   .........    
T Consensus       149 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~----  220 (261)
T cd05034         149 LARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG----  220 (261)
T ss_pred             cceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC----
Confidence            9987643211 11112234678999999998899999999999999999998 99998654321   111111000    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                                .....+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus       221 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 ----------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                      0001112236789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-40  Score=329.43  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=206.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||.|+||.||+|....         ++..||+|.+..........+.+|+.+++.+.|+||+++++++....
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECC---------CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            579999999999999999998765         57789999988765555677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~  164 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (296)
T ss_pred             EEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccch
Confidence            999999999999999988543   4788899999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....  .....    .     
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~----~-----  231 (296)
T cd06654         165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIAT----N-----  231 (296)
T ss_pred             hcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhc----C-----
Confidence            6543211  122356899999999999888999999999999999999999999654332111  11000    0     


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          .......+...+..+.+||.+||..||++||++.+|+++
T Consensus       232 ----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         232 ----GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ----CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                000001122336778999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-42  Score=309.95  Aligned_cols=267  Identities=28%  Similarity=0.373  Sum_probs=211.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +..++|++.+.||+|||+-||+++...         ++..+|+|.+.....++.+..++|++..++++||||++++++..
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s---------~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l   88 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLS---------TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL   88 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccC---------cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence            455789999999999999999998655         67789999998777777888999999999999999999998766


Q ss_pred             ecC-----ceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          209 EDD-----QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       209 ~~~-----~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .+.     ..||+++|...|+|.+.+....  +..+++.+.+.|+.+|++||++||+.. .+++||||||.|||+.+.+.
T Consensus        89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCc
Confidence            543     4899999999999999986532  335899999999999999999999977 57999999999999999999


Q ss_pred             eEEccccccccCCCCCCcc-------eeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCC
Q 011234          282 AKLSDFGLAKDAPEDGKTH-------VSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN  351 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~-------~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~  351 (490)
                      ++|.|||.++...-.-...       .......|..|+|||.+.   +...+.++|||||||+||+|+.|..||+.....
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~  247 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ  247 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence            9999999998654211110       001134689999999886   456788999999999999999999999753322


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      +.- +.             ..+.++.+.-.-....+..+.+||+.||+.||.+||++.+++..++.+.
T Consensus       248 GgS-la-------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  248 GGS-LA-------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             CCe-EE-------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            111 00             0011111100001113888999999999999999999999999988763

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.3e-40  Score=321.54  Aligned_cols=253  Identities=29%  Similarity=0.442  Sum_probs=203.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+....      ++...||||.+..... ...+.+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v   73 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG------GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMV   73 (257)
T ss_pred             CcCCccCcccEEeeeEecCC------CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEE
Confidence            46899999999999986521      1345799999987766 556788999999999999999999999988 889999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            99999999999997754346899999999999999999999988   999999999999999999999999999876542


Q ss_pred             CCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          297 GKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ... .......++..|+|||++.+..++.++|||||||++|+|++ |..||........   ......   ...      
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~---~~~------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK---EGE------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---cCC------
Confidence            221 11223457889999999998899999999999999999998 9999864422211   111100   000      


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                          ....+...+..+.+|+.+||..+|++||++.++++.|.
T Consensus       219 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                00011223678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=339.18  Aligned_cols=242  Identities=29%  Similarity=0.362  Sum_probs=190.3

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcC---CCCceeceeeEEEecCce
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL---LHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~  213 (490)
                      ||+|+||.||+|++..         +|..||||++......   ....+..|..++..+   .||||+.+++++.+.+..
T Consensus         1 lG~G~~g~Vy~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKD---------TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            7999999999998875         6779999998654222   223345677777655   699999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |+||||+++|+|..++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99999999999999887654  6889999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhh
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      .....  .....+||..|+|||++.+. .++.++|||||||++|+|++|..||...........+      .....    
T Consensus       147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~----  214 (330)
T cd05586         147 LTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGKV----  214 (330)
T ss_pred             CCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCCC----
Confidence            32221  12346799999999998754 5899999999999999999999999654321111100      00000    


Q ss_pred             ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 011234          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP----RMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP----s~~evl~~  414 (490)
                          .+.   ....+..+.+||.+||..||.+||    ++.+++++
T Consensus       215 ----~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 ----RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ----CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                000   011267889999999999999998    57777765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-40  Score=319.96  Aligned_cols=253  Identities=34%  Similarity=0.526  Sum_probs=206.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-HHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+....      .++..||+|.+....... ...+.+|+.++..++|+||+++++++......++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   74 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLV   74 (262)
T ss_pred             CccccCCceEEEEEEEecCC------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEE
Confidence            46999999999999987521      146789999998664433 56788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          217 YEFMPRGSLENHLFRKG-------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      |||+++++|.+++....       ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.
T Consensus        75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~  151 (262)
T cd00192          75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGL  151 (262)
T ss_pred             EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccc
Confidence            99999999999987651       246899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +................++..|+|||.+....++.++|||||||++|+|++ |..||......   ...+....      
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~------  222 (262)
T cd00192         152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK------  222 (262)
T ss_pred             ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc------
Confidence            987755432222334567889999999988899999999999999999999 69998765221   11111100      


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                              ......+...+.++.+++.+||..||++|||+.+++++|+
T Consensus       223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                    0011122334788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-40  Score=322.86  Aligned_cols=256  Identities=28%  Similarity=0.381  Sum_probs=195.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+....       ++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   73 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGY-------TPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV   73 (269)
T ss_pred             CcccccCCceEEEEEEcCCC-------CceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence            36899999999999875421       456799998876532 3345688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          217 YEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      |||+++|+|.+++....   ....++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccc
Confidence            99999999999986532   224567778889999999999999988   999999999999999999999999999755


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcC-------CCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      .............|+..|+|||++.+.       .++.++|||||||++|||++ |..||.........   ....  ..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~--~~  225 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTV--RE  225 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHh--hc
Confidence            433222222345678899999988642       35789999999999999996 99999654322111   1100  00


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..   ....++.+    ....+..+.+|+.+|| .+|++|||+.+|+..|+
T Consensus       226 ~~---~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQ---LKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cc---CCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00   01111111    1123567889999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.1e-41  Score=336.70  Aligned_cols=256  Identities=23%  Similarity=0.298  Sum_probs=199.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||++.+..         ++..||+|++.....   .....+..|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            368999999999999999998865         567899999864321   22334778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..|+||||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecc
Confidence            99999999999999999999976432 6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ++........ ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||..........      ..
T Consensus       148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i  220 (332)
T cd05623         148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KI  220 (332)
T ss_pred             hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HH
Confidence            9876543222 1223357999999999986     3468899999999999999999999996543211111      01


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~  414 (490)
                      ......+ . + +    ......+.++.+||.+||..++.+  |+++.+++++
T Consensus       221 ~~~~~~~-~-~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         221 MNHKERF-Q-F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             hCCCccc-c-C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1000000 0 0 0    001234788999999999765544  6899999987

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.7e-40  Score=320.19  Aligned_cols=250  Identities=25%  Similarity=0.410  Sum_probs=198.0

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  218 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  218 (490)
                      ||+|+||.||+|.+...+       .+..||+|++..... ...+.+.+|+.+++.++|+||+++++++. ....++|||
T Consensus         3 ig~G~~g~v~~~~~~~~~-------~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e   74 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRK-------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVME   74 (257)
T ss_pred             cCCCCcccEEEEEEecCC-------CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEE
Confidence            899999999999875321       456799999876532 33456889999999999999999999875 457899999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCC
Q 011234          219 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK  298 (490)
Q Consensus       219 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~  298 (490)
                      |+++++|.+++.... ..+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||++........
T Consensus        75 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          75 MASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             eCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            999999999986543 36899999999999999999999988   99999999999999999999999999986543322


Q ss_pred             cce-eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          299 THV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       299 ~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      ... .....++..|+|||++.+..++.++|||||||++|||++ |..||...........+.                 .
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-----------------~  213 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-----------------Q  213 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-----------------C
Confidence            111 111233578999999988889999999999999999996 999996543221111110                 0


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ......+..++.++.+||.+||..||++||++.+|++.|+.+
T Consensus       214 ~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            001122334478899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.9e-41  Score=337.17  Aligned_cols=257  Identities=22%  Similarity=0.277  Sum_probs=200.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|.+.+.||+|+||.||++++..         ++..||+|++....   ......+..|+.++..++|+||+++++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKH---------TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            479999999999999999998865         67789999986532   122344678999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..|+||||+++|+|.+++..... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecc
Confidence            99999999999999999999976432 6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ++......... .....+||+.|+|||++.+     +.++.++|||||||+||||++|+.||........   ...   .
T Consensus       148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~---i  220 (331)
T cd05624         148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGK---I  220 (331)
T ss_pred             ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---HHH---H
Confidence            99866433221 1233579999999999875     5688899999999999999999999965432111   100   0


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L  415 (490)
                      ......+ . +...     ....+.++.+||.+||..++.+  |+++++++++-
T Consensus       221 ~~~~~~~-~-~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         221 MNHEERF-Q-FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             HcCCCcc-c-CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence            0000000 0 0000     0123678999999999876654  46888888763

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7e-41  Score=338.30  Aligned_cols=267  Identities=29%  Similarity=0.398  Sum_probs=204.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+...+    ...++..||||+++.... .....+.+|+.+|.++ +|+||+++++++.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC----ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            457999999999999999999864311    112577899999976432 3345688999999999 6899999999886


Q ss_pred             ec-CceEEEEEecCCCCHHHHHhhcCC-----------------------------------------------------
Q 011234          209 ED-DQRLLVYEFMPRGSLENHLFRKGS-----------------------------------------------------  234 (490)
Q Consensus       209 ~~-~~~~lv~E~~~~g~L~~~l~~~~~-----------------------------------------------------  234 (490)
                      .. ...++|||||++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            54 467899999999999999864321                                                     


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCccee
Q 011234          235 ------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       235 ------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  302 (490)
                                  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  238 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  238 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhc
Confidence                        13677888899999999999999988   999999999999999999999999999865432221112


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH  381 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  381 (490)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||........  ......    ...          ...
T Consensus       239 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~----~~~----------~~~  302 (343)
T cd05103         239 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLK----EGT----------RMR  302 (343)
T ss_pred             CCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHh----ccC----------CCC
Confidence            22345678999999998899999999999999999997 8889865322111  111000    000          000


Q ss_pred             CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          382 FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       382 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .+...+.++.+++.+||+.||++||++.+|+++|+.+.+
T Consensus       303 ~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            111125678999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.8e-40  Score=331.15  Aligned_cols=265  Identities=22%  Similarity=0.354  Sum_probs=191.0

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe--cCceE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRL  214 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~  214 (490)
                      .+.||+|+||.||+|.+...       .++..||+|.+.....  ...+.+|+.+|+.++||||+++++++..  +...|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~-------~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   76 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG-------KDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   76 (317)
T ss_pred             ccccccCCCeEEEEEEEccC-------CCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEE
Confidence            46899999999999987542       1467899999875532  2457789999999999999999998864  35678


Q ss_pred             EEEEecCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE----cCCCCeE
Q 011234          215 LVYEFMPRGSLENHLFRK-------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAK  283 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~k  283 (490)
                      +||||+ +++|.+++...       ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+|
T Consensus        77 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~k  152 (317)
T cd07868          77 LLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  152 (317)
T ss_pred             EEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEE
Confidence            999999 46888877532       1235889999999999999999999988   9999999999999    4567899


Q ss_pred             EccccccccCCCCCCc-ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc------h
Q 011234          284 LSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH------N  355 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~------~  355 (490)
                      |+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||.........      .
T Consensus       153 l~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  232 (317)
T cd07868         153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  232 (317)
T ss_pred             EeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHH
Confidence            9999999866432211 11234678999999999876 46899999999999999999999999654322110      0


Q ss_pred             hHHhhhcccC--------------CchhhhhccCcc------cc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011234          356 LVEWARPHLG--------------DKRRFYRLLDPR------LE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       356 ~~~~~~~~~~--------------~~~~~~~~~~~~------l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  412 (490)
                      ........++              ........+...      +.   .......+..+.+||.+||+.||.+|||++|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l  312 (317)
T cd07868         233 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  312 (317)
T ss_pred             HHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHh
Confidence            0000000000              000000000000      00   000011245688999999999999999999999


Q ss_pred             HH
Q 011234          413 ET  414 (490)
Q Consensus       413 ~~  414 (490)
                      ++
T Consensus       313 ~h  314 (317)
T cd07868         313 QD  314 (317)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.8e-41  Score=323.58  Aligned_cols=254  Identities=32%  Similarity=0.526  Sum_probs=203.2

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHH--HHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      |++.+.||+|+||.||++....         ++..||+|++.........  ...+|+.++++++||||+++++++.+..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKK---------NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN   71 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETT---------TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS
T ss_pred             CEEeEEEEeCCCEEEEEEEECC---------CCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc
Confidence            6788999999999999999876         6778999999877654332  3456999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+.+++|.+++....  .+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.++|+|||.+.
T Consensus        72 ~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   72 YLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence            9999999999999999998443  6899999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhh-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ....  .........|+..|+|||++. +..++.++||||||+++|+|++|..||..............   ........
T Consensus       147 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~  221 (260)
T PF00069_consen  147 KLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK---ILKRPLPS  221 (260)
T ss_dssp             ESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH---HHHTHHHH
T ss_pred             cccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh---cccccccc
Confidence            6421  122234567899999999998 78899999999999999999999999976511111111111   00000000


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        ..      .........+.+||.+||+.||++||++.+++++
T Consensus       222 --~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  222 --SS------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --HT------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cc------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00      0000114789999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-40  Score=325.24  Aligned_cols=249  Identities=24%  Similarity=0.413  Sum_probs=193.3

Q ss_pred             eeccCCceEEEEEEEccCCCc---------------cccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceece
Q 011234          139 LLGEGGFGCVFKGWVEENGTA---------------PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~---------------~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      .||+|+||.||+|.+...+..               .........||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999987532210               01123345799999876554455678889999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC---
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---  280 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---  280 (490)
                      ++++...+..++||||+++|+|..++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence            999999999999999999999998886543 36889999999999999999999987   99999999999997644   


Q ss_pred             ----CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHH-hCCCCCCCCCCCCcc
Q 011234          281 ----NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEH  354 (490)
Q Consensus       281 ----~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~  354 (490)
                          .+||+|||++......      ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.........
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence                3899999987644221      12357888999998875 56899999999999999985 789998654332211


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ....       ..        ..    .+......+.+||.+||+.+|++||++.+|++.|.
T Consensus       232 ~~~~-------~~--------~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         232 RFYE-------KK--------HR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHH-------hc--------cC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            1100       00        00    11112457899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5e-41  Score=340.90  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=199.8

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||.+....  ......+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   85 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF   85 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecC---------CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeee
Confidence            45689999999999999999998765         67789999987542  23345678899999999999999999988


Q ss_pred             EecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          208 IEDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       208 ~~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ....      ..++||||++ ++|.+.+..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~  157 (355)
T cd07874          86 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT  157 (355)
T ss_pred             eccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCC
Confidence            6543      4699999996 567766642    4788889999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~  360 (490)
                      +||+|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||............ ...
T Consensus       158 ~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (355)
T cd07874         158 LKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL  234 (355)
T ss_pred             EEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999999865332   1223457899999999999989999999999999999999999999764322111100 000


Q ss_pred             ---------------hcccCCchh-----hhhccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 ---------------RPHLGDKRR-----FYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ---------------~~~~~~~~~-----~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                     .........     +...+...+   ....+...+..+.+||.+||..||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                           000000000     000000000   001112235678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=319.01  Aligned_cols=253  Identities=30%  Similarity=0.469  Sum_probs=201.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+....      +++..||+|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v   73 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLV   73 (257)
T ss_pred             CccCccCceeEEEeEeeccC------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEE
Confidence            46999999999999875432      1446899999886654 24567889999999999999999999875 4568999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||..+   ++||||||+|||++.++.+||+|||+++.....
T Consensus        74 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          74 MELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             EEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999999997664  6889999999999999999999988   999999999999999999999999999866443


Q ss_pred             CCcce-eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhcc
Q 011234          297 GKTHV-STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL  374 (490)
Q Consensus       297 ~~~~~-~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  374 (490)
                      ..... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......   ....+.....          
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~----------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGE----------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCC----------
Confidence            22111 111223568999999998899999999999999999998 99999654321   1222111100          


Q ss_pred             CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       375 ~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                          ....+..++..+.+||.+||..||++||++.+|++.|..+.
T Consensus       216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                00112234678999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.4e-41  Score=340.05  Aligned_cols=264  Identities=22%  Similarity=0.294  Sum_probs=199.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~   93 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   93 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECC---------CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence            4679999999999999999998765         57789999987542  233456788999999999999999999876


Q ss_pred             ec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..      ...|+||||++ ++|.+.+..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875          94 PQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             ccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcE
Confidence            43      35799999995 577777642    4778889999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh-hh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW-AR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~-~~  361 (490)
                      ||+|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ..
T Consensus       166 kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  242 (364)
T cd07875         166 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG  242 (364)
T ss_pred             EEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999999865332   122345789999999999999999999999999999999999999976543221111100 00


Q ss_pred             ---------------cccCCchh-----hhhccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 ---------------PHLGDKRR-----FYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ---------------~~~~~~~~-----~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                     ........     +...+....   ........+..+.+||.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                           00000000     000000000   001111225678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-40  Score=325.68  Aligned_cols=253  Identities=26%  Similarity=0.418  Sum_probs=203.8

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      |++.+.||.|+||.||+|.+..         ++..+|+|.+........+.+.+|+.+++.++|+||+++++++...+..
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   77 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKE---------TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL   77 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECC---------CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEE
Confidence            6778899999999999998865         5778999999776656667788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++++|..++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          78 WILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999999998876532 36899999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ....  .......|+..|+|||++.     +..++.++|||||||++|||++|.+||........  .......      
T Consensus       154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~------  223 (282)
T cd06643         154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS------  223 (282)
T ss_pred             cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHHhhc------
Confidence            3321  1123356899999999984     34578899999999999999999999865332111  1111000      


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                           ..+.+  ..+...+.++.+||.+||+.||.+||++.+++++-.
T Consensus       224 -----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         224 -----EPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             -----CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence                 00000  112223678999999999999999999999987653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-40  Score=321.05  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=202.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---------hHHHHHHHHHHHhcCCCCceece
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------GHKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      +|.+.+.||.|+||.||+|.+..         ++..||+|.+......         ..+.+.+|+.+++.++||||+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~   71 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNAS---------SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQY   71 (267)
T ss_pred             CccccceeecCCCeEEEEEEecC---------CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeE
Confidence            47888999999999999998765         5668999988654221         12457789999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ++++...+..++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          72 LGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             EEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEE
Confidence            999999999999999999999999997654  6788899999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCc----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          284 LSDFGLAKDAPEDGKT----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      |+|||+++........    .......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......   .+..
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~  223 (267)
T cd06628         147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIFK  223 (267)
T ss_pred             ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHHH
Confidence            9999999876432111    11123468899999999998889999999999999999999999996532111   0000


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .          ....    ....+...+..+.++|.+||+.||.+||++.+|+++
T Consensus       224 ~----------~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         224 I----------GENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             H----------hccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            0          0001    111223346789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-40  Score=321.03  Aligned_cols=249  Identities=22%  Similarity=0.365  Sum_probs=193.2

Q ss_pred             ceeccCCceEEEEEEEccCCCc---cccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTA---PVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~---~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      +.||+|+||.||+|.+......   .........||+|.+..........+..|+.++..++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            3689999999999986432110   0111245579999987655555567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC-------eEEccc
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-------AKLSDF  287 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~kL~DF  287 (490)
                      +||||+++|+|..++.... ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.       ++++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999998876543 36899999999999999999999988   999999999999987664       899999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhh-cCCCCccccchhhHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |++......      ....|+..|+|||++. +..++.++|||||||++|||+ .|..||............       .
T Consensus       157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-------~  223 (262)
T cd05077         157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-------E  223 (262)
T ss_pred             CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-------h
Confidence            998755321      2245788999999886 567899999999999999998 578777543221110000       0


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .          ..  ........++.+||.+||+.||.+||++.+|++.|
T Consensus       224 ~----------~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 G----------QC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             c----------Cc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0          00  00111256789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.7e-40  Score=319.46  Aligned_cols=253  Identities=28%  Similarity=0.408  Sum_probs=202.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||+|+||.||+|.+..          +..||+|.+.... ...+.+.+|+.+++.+.|+||+++++++. .+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~----------~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   73 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG----------TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EE   73 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC----------CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CC
Confidence            468899999999999999998753          2369999886543 23456888999999999999999998875 46


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccce
Confidence            6899999999999999997655456889999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ...+.....      
T Consensus       151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~------  220 (260)
T cd05069         151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGY------  220 (260)
T ss_pred             EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC------
Confidence            65432211 1122346778999999988899999999999999999999 899986543211   111111000      


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                              ....+...+..+.+|+.+||..||++||++.+|++.|+.
T Consensus       221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 --------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                    001122336789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-40  Score=325.67  Aligned_cols=263  Identities=26%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+...    ....++..||+|.+.... .....++.+|+.+++.++||||+++++++.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGL----LPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             hHhceecccccccccccEEEEEEccc----CCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            45799999999999999999987431    111256789999987653 2334678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKG--------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      ++..++||||+++|+|.+++....                    ...+++..++.++.||+.||.|||+.+   ++||||
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl  156 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL  156 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence            999999999999999999986432                    124678889999999999999999988   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  348 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~  348 (490)
                      ||+|||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999876533221111222345678999999998899999999999999999997 87888543


Q ss_pred             CCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                      ....   ......    .         ... ...+...+.++.+||.+||+.||++|||+.||++.|+.
T Consensus       237 ~~~~---~~~~~~----~---------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         237 AHEE---VIYYVR----D---------GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CHHH---HHHHHh----c---------CCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            2211   111110    0         000 01112236789999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-40  Score=326.07  Aligned_cols=253  Identities=27%  Similarity=0.417  Sum_probs=204.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +.|++.+.||.|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.+.|+||+++++++..++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECC---------CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            569999999999999999998875         57789999998776666778889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|..++.... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999988876543 36899999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ......  .......|+..|+|||++.     ...++.++|||||||++|||++|..||........  .......    
T Consensus       159 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~----  230 (292)
T cd06644         159 KNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKS----  230 (292)
T ss_pred             eccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHhcC----
Confidence            543221  1123356889999999885     34578899999999999999999999865432111  1111000    


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ..+..  ..+...+.++.+||.+||..||++||++.+++++
T Consensus       231 -------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         231 -------EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -------CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                   00000  1112336788999999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.9e-40  Score=323.61  Aligned_cols=274  Identities=29%  Similarity=0.435  Sum_probs=205.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +.|++.+.||+|+||.||+|.+...+     ..++..||+|.+.... ......+.+|+.+++.+.||||+++++++...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-----~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   78 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCC-----CCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            34788999999999999999865321     1267899999987553 33346788999999999999999999998875


Q ss_pred             --CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 --~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                        ...++||||+++++|.+++.... ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        79 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          79 GGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             CCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCc
Confidence              56889999999999999986553 25899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC-
Q 011234          289 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD-  366 (490)
Q Consensus       289 ~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-  366 (490)
                      +++........ .......|+..|+|||++.+..++.++|||||||++|||++++.|+......    ......+.... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~----~~~~~~~~~~~~  230 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL----FLKMIGPTHGQM  230 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch----hhhhcccccccc
Confidence            99876433221 1222355777899999998888999999999999999999987764321100    00000000000 


Q ss_pred             -chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 -KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 -~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                       .......+........+...+..+.+|+.+||+.||++||++.++++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         231 TVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             0000000000000011223478899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-40  Score=324.26  Aligned_cols=267  Identities=23%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|.+..         +|..||+|.+.....  ...+.+.+|+.+++.++||||+++++++.++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKK---------TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE   71 (285)
T ss_pred             CceEeeEecccCceEEEEEEECC---------CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence            58889999999999999998865         577899999865422  2235678899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      +..++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  147 (285)
T cd07861          72 SRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGL  147 (285)
T ss_pred             CeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccc
Confidence            99999999996 689888865332 46899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh-HHhh-h-----
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWA-R-----  361 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~-~~~~-~-----  361 (490)
                      +.......  .......+++.|+|||++.+. .++.++|||||||++|+|++|++||........... .... .     
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (285)
T cd07861         148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV  225 (285)
T ss_pred             eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            87653321  112234678999999988654 578899999999999999999999975432111000 0000 0     


Q ss_pred             -cccCCchhhhhccCcc---ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 -PHLGDKRRFYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 -~~~~~~~~~~~~~~~~---l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       +.......+....+..   .........+.++.+||.+||..||.+|||+.+|+++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         226 WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             0000000000000000   0000111246788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=322.86  Aligned_cols=262  Identities=25%  Similarity=0.401  Sum_probs=208.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||+|+||.||+|.+..++..     ....||+|.+..... ....++.+|+.++..+.||||+++++++.. 
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEK-----VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCC-----cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            5688999999999999999998653321     234699998876543 344678899999999999999999999887 


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ...++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccc
Confidence            788999999999999999876543 5899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...............++..|+|||.+....++.++|||||||++|||++ |..||........   .....    ..  
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~----~~--  227 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLLE----KG--  227 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHh----CC--
Confidence            87653322221122234678999999988899999999999999999998 9999975432211   11110    00  


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              .....+..++..+.+++.+||..||.+||++.++++.|+.+.+
T Consensus       228 --------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         228 --------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    0001122235778999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.6e-41  Score=365.42  Aligned_cols=260  Identities=23%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceece
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      +.....++|.+++.||.|+||.||+|.+..         ++..||+|++.....  .....+..|+.+|..|.|||||++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---------tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl   77 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKR---------TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY   77 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECC---------CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeE
Confidence            344556789999999999999999999875         677899999875432  334568899999999999999999


Q ss_pred             eeEEEec--CceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCC----CCeeecCCCCCceE
Q 011234          204 VGYCIED--DQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAE----KPVIYRDFKTSNIL  275 (490)
Q Consensus       204 ~~~~~~~--~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~----~~iiHrDlkp~NIL  275 (490)
                      +++|...  ..+||||||+++|+|.++|....  ...+++..++.|+.||+.||.|||+.+.    .+||||||||+|||
T Consensus        78 ~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL  157 (1021)
T PTZ00266         78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF  157 (1021)
T ss_pred             EEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence            9988654  56899999999999999986531  2368999999999999999999998541    34999999999999


Q ss_pred             EcC-----------------CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHH
Q 011234          276 LDA-----------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLL  336 (490)
Q Consensus       276 l~~-----------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~  336 (490)
                      |+.                 .+.+||+|||++.......   .....+||+.|+|||++.+  ..++.++||||||||||
T Consensus       158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY  234 (1021)
T PTZ00266        158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY  234 (1021)
T ss_pred             eecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence            964                 2358999999998664322   2234579999999999864  45889999999999999


Q ss_pred             HHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          337 EMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       337 elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ||++|..||.......  .++....    ..        +.+.   ....+.++.+||.+||..+|.+||++.++|.+
T Consensus       235 ELLTGk~PF~~~~~~~--qli~~lk----~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        235 ELCSGKTPFHKANNFS--QLISELK----RG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHCCCCCCcCCcHH--HHHHHHh----cC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            9999999996432211  1111000    00        0000   01126789999999999999999999999954

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-42  Score=321.60  Aligned_cols=252  Identities=29%  Similarity=0.398  Sum_probs=210.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHH---HHHHHHHHhcCCCCceeceee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~---~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      +.-++|..+++||+|.||.|.+|+-+.         +|+.+|+|+++++......+   -+.|-++|...+||.+..+.-
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKa---------t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY  235 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKA---------TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY  235 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecc---------cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence            344678999999999999999998765         88899999999876544444   467999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .|...+.+|+||||..||.|+-+|.+..  .+++...+.+-..|+.||.|||+.+   ||+||||.+|+|+|.+|++||.
T Consensus       236 sFQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKit  310 (516)
T KOG0690|consen  236 SFQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKIT  310 (516)
T ss_pred             hhccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEee
Confidence            9999999999999999999999997765  6888888999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.....+.  ....+|||+.|+|||++....|+.++|+|.+||+||||++|+.||..........++-.      
T Consensus       311 DFGLCKE~I~~g~--t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------  382 (516)
T KOG0690|consen  311 DFGLCKEEIKYGD--TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------  382 (516)
T ss_pred             ecccchhcccccc--eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------
Confidence            9999986544332  34568999999999999999999999999999999999999999965433222222110      


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                      .            .-.||...+++++.|+..+|.+||.+|.-     +.||.++
T Consensus       383 e------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  383 E------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             h------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            0            11345555899999999999999999953     5566554

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=325.18  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=205.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+........+.+..|+.+++.++|+||+++++++..++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKE---------TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN   75 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcC---------CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC
Confidence            468899999999999999998865         56789999998766666678889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~  151 (280)
T cd06611          76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSA  151 (280)
T ss_pred             eEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccch
Confidence            9999999999999999887643 36899999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      .......  ......|++.|+|||++.     ...++.++|||||||++|+|++|..||........  ......   . 
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~-  223 (280)
T cd06611         152 KNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKILK---S-  223 (280)
T ss_pred             hhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHHhc---C-
Confidence            6533221  123356899999999985     34567899999999999999999999965432111  111100   0 


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ..+.+  ..+...+.++.+||.+||..||.+||++.+++++
T Consensus       224 -------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 -------EPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -------CCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                   00000  1112336789999999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.2e-40  Score=317.84  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=207.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||.|+||.||.+....         ++..|++|.+....  .....++.+|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   71 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTE---------DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD   71 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcC---------CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence            58899999999999999998765         56789999876543  34456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          72 NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcce
Confidence            99999999999999999997764456899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........      .....   
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~------~~~~~---  217 (256)
T cd08221         149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK------IVQGN---  217 (256)
T ss_pred             EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHcCC---
Confidence            86644321  22345789999999999888899999999999999999999999965332111100      00000   


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         ..     ..+...+.++.++|.+||..+|.+||++.++++++
T Consensus       218 ---~~-----~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 ---YT-----PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---CC-----CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               00     01122367899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.4e-40  Score=330.96  Aligned_cols=266  Identities=21%  Similarity=0.266  Sum_probs=198.1

Q ss_pred             cCceeccC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          136 PESLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       136 ~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++++||+|  +||+||++....         +|..||+|.+.....  .....+.+|+.+++.++||||+++++++..++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~   72 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKP---------TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN   72 (327)
T ss_pred             hhhhccccccceEEEEEEeecc---------cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC
Confidence            46789999  789999998876         678999999976532  23345677999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++++|||.+.
T Consensus        73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhh
Confidence            9999999999999999997654446899999999999999999999988   9999999999999999999999998754


Q ss_pred             cCCCCCCc-----ceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          292 DAPEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       292 ~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ........     .......++..|+|||++.+  ..++.++|||||||++|||++|..||........  .........
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~  227 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV  227 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence            43221110     01112356788999999976  4689999999999999999999999964322110  000000000


Q ss_pred             C---Cch-----h-------------hhh---------ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 G---DKR-----R-------------FYR---------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~---~~~-----~-------------~~~---------~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .   +..     .             +..         .........+....+..+.+||.+||+.||++|||+.+|+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0   000     0             000         000000001122336789999999999999999999999976


Q ss_pred             h
Q 011234          415 L  415 (490)
Q Consensus       415 L  415 (490)
                      -
T Consensus       308 p  308 (327)
T cd08227         308 S  308 (327)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.8e-40  Score=318.14  Aligned_cols=251  Identities=25%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      +|++.+.||+|+||.||++.+..         ++..||+|.+....  ....+.+.+|+.+++.++|+||+++++.+.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRT---------DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE   71 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcC---------CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC
Confidence            48899999999999999998865         56689999986543  2334567889999999999999999998764 


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      +...++||||+++++|.+++.......+++..+..++.+++.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccc
Confidence            446789999999999999997654456899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......  .......|++.|+|||++.+..++.++|||||||++|+|++|+.||......   .   .........  
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~---~~~~~~~~~--  218 (257)
T cd08223         149 ARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---S---LVYRIIEGK--  218 (257)
T ss_pred             eEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H---HHHHHHhcC--
Confidence            97664321  1223457899999999999999999999999999999999999998643211   1   100000000  


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          +     ...+...+..+.+|+.+||+.||++||++.+++++
T Consensus       219 ----~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 ----L-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----C-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0     01122346789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3e-40  Score=326.89  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=206.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|.+.+.||.|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++|+||+++++++...+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECC---------CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            579999999999999999998765         57789999997665555567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             EEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccce
Confidence            999999999999999988643   5788899999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|++.|+|||.+.+..++.++|||||||++|+|++|..||....+.......  ..    ..    
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--~~----~~----  231 (297)
T cd06656         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT----NG----  231 (297)
T ss_pred             EccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--cc----CC----
Confidence            6543321  123356899999999999888999999999999999999999999654332111100  00    00    


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         .+  ....+...+..+.+|+.+||..||++||++.+|+++
T Consensus       232 ---~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         232 ---TP--ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ---CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00  001122336778999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-40  Score=323.13  Aligned_cols=274  Identities=30%  Similarity=0.400  Sum_probs=209.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      ++|++.+.||+|+||.||+|.+...+     .+++..||||.+...... ....+.+|+.+++.+.|+||+++++++.. 
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~   78 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLG-----DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP   78 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCC-----CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC
Confidence            46888899999999999999876432     126789999999866443 45678999999999999999999999887 


Q ss_pred             -cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          210 -DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 -~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                       ....++||||+++++|.+++..... .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||
T Consensus        79 ~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          79 GGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccc
Confidence             5578999999999999999976543 5889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc--cC
Q 011234          289 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH--LG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~--~~  365 (490)
                      ++.......... ......++..|+|||.+.+..++.++|||||||++|||++|..|+.........    +....  ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~  230 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQM  230 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccc
Confidence            998765332211 111234566799999998889999999999999999999999988543221100    00000  00


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ....+...+........+..++.++.+|+.+||..+|++||++.+|++.|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         231 IVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00000111111111112233467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-40  Score=319.03  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=207.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..+|+|++........+.+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   73 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIA---------TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD   73 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecC---------CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence            478999999999999999998865         56689999998765556678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++.
T Consensus        74 ~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  149 (262)
T cd06613          74 KLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSA  149 (262)
T ss_pred             EEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccch
Confidence            9999999999999999886652 36889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      .......  ......|+..|+|||.+.+.   .++.++|||||||++|+|++|..||...........  .....+    
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~~~~----  221 (262)
T cd06613         150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISKSNF----  221 (262)
T ss_pred             hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccC----
Confidence            6543211  12335688999999998776   889999999999999999999999975432211110  000000    


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           ..+.+  ......+.++.+||.+||..||.+|||+.+|+.+
T Consensus       222 -----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         222 -----PPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             -----CCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 00000  1122346789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.2e-40  Score=317.46  Aligned_cols=251  Identities=27%  Similarity=0.407  Sum_probs=206.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+.....  ..++.+|+++++.++|+||+++++++.+..
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~   71 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE---------TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT   71 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC---------CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence            578999999999999999998875         466899999875532  568899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..|+++||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          72 DLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             cEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999999986543 36899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............   ..         
T Consensus       148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~---------  213 (256)
T cd06612         148 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PN---------  213 (256)
T ss_pred             hcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---cc---------
Confidence            7644321  123356889999999999889999999999999999999999999754332111000   00         


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ...+.  ...+...+..+.++|.+||+.||++|||+.+|+++
T Consensus       214 -~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         214 -KPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             -CCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence             00000  01122336789999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.1e-40  Score=318.45  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=205.1

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+..          +..||+|.+.... .....+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~----------~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNK----------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK   72 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecC----------CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC
Confidence            34679999999999999999997643          3469999887543 234578899999999999999999999887


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       ...+++|||+++++|.+++.......+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~  148 (260)
T cd05073          73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL  148 (260)
T ss_pred             -CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcc
Confidence             77899999999999999997765556888999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........ .......++..|+|||++....++.++|+|||||++|+|++ |..||.......   .........    
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~~----  220 (260)
T cd05073         149 ARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERGY----  220 (260)
T ss_pred             eeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhCCC----
Confidence            976543221 11222345678999999998889999999999999999998 899986532211   111110000    


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                ....+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       221 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         221 ----------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             ----------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence                      0011122367899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.3e-40  Score=321.43  Aligned_cols=261  Identities=26%  Similarity=0.404  Sum_probs=207.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|.+.+.||+|+||.||+|.+....      +....||||...... ....+.+.+|+.+++.+.||||+++++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPE------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCC------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            346889999999999999999876421      134579999887654 3445678899999999999999999998875


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       +..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCce
Confidence             567899999999999999976533 5899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++....... .......++..|+|||.+....++.++|||||||++|||++ |..||...........+..     ..  
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~-----~~--  225 (270)
T cd05056         154 SRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN-----GE--  225 (270)
T ss_pred             eeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----CC--
Confidence            986644321 11222334568999999988889999999999999999986 9999965432211111100     00  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .      .    ..+..++..+.+||.+||..+|++|||+.++++.|..+.+
T Consensus       226 ~------~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         226 R------L----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             c------C----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0      0    1122346789999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-40  Score=323.98  Aligned_cols=262  Identities=27%  Similarity=0.426  Sum_probs=208.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++.... ....+.+.+|+++++.++||||+++++++..
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIP---------TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN   74 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcC---------CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence            3578899999999999999998865         56789999886543 2345678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .+.+++||||+++++|.+++...+  .+++..+..++.+++.||.|||+ .+   ++||||||+||+++.++.++|+|||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~g  149 (284)
T cd06620          75 ENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFG  149 (284)
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCC
Confidence            999999999999999999887654  68899999999999999999997 45   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc-----chhHHhhhcc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-----HNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~-----~~~~~~~~~~  363 (490)
                      ++.......    .....|+..|+|||++.+..++.++|||||||++|+|++|..||........     ....++....
T Consensus       150 l~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd06620         150 VSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI  225 (284)
T ss_pred             cccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence            987543221    1235789999999999888999999999999999999999999975433211     0111111111


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ...       ..+.+.   ....+.++.+|+.+||..||++||++.|++++..-++.
T Consensus       226 ~~~-------~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         226 VQE-------PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             hhc-------cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            100       000110   11236789999999999999999999999988655544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.9e-40  Score=327.35  Aligned_cols=268  Identities=22%  Similarity=0.334  Sum_probs=202.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|.+.+.||.|+||.||+|.+..         ++..||+|.+..... .....+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~   76 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   76 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcC---------CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC
Confidence            579999999999999999998765         677899999865432 2234577899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||++ ++|.+++..... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        77 ~~~~lv~e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          77 KSLTLVFEYLD-KDLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             CeEEEEEeccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcch
Confidence            99999999996 689888866533 6889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--------
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--------  361 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--------  361 (490)
                      .........  .....+++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+....        
T Consensus       152 ~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  229 (301)
T cd07873         152 RAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW  229 (301)
T ss_pred             hccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence            765332211  123457899999998875 457889999999999999999999997654321111110000        


Q ss_pred             cccCCchhhhhccCccccC----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 PHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      +.+.....+.....+....    ......+..+.+||.+||+.||.+|||+.|++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~  287 (301)
T cd07873         230 PGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP  287 (301)
T ss_pred             hhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0000000000000000000    01123367889999999999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.5e-40  Score=318.76  Aligned_cols=255  Identities=27%  Similarity=0.469  Sum_probs=195.7

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEE-ecCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-EDDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~l  215 (490)
                      +.||+|+||.||+|.+....      ..+..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~l   74 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSD------GQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLV   74 (262)
T ss_pred             CcccccCCceEEEEEEecCC------CceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEE
Confidence            46899999999999875422      13567999988543 3344567889999999999999999999776 4556899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      ||||+.+|+|.+++..... .+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        75 v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          75 VLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             EEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999999876532 4677778889999999999999988   99999999999999999999999999976543


Q ss_pred             CCCcc--eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhcccCCchhhhh
Q 011234          296 DGKTH--VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       296 ~~~~~--~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      .....  ......++..|+|||++.+..++.++|||||||++|||++| .+||......   ......   ....     
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~---~~~~-----  219 (262)
T cd05058         151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYL---LQGR-----  219 (262)
T ss_pred             CcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---hcCC-----
Confidence            22111  11233467789999999888999999999999999999995 5566432211   111111   0000     


Q ss_pred             ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                        ..    ..+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       220 --~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 --RL----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             --CC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence              00    011122567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=321.42  Aligned_cols=250  Identities=28%  Similarity=0.425  Sum_probs=205.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+.... ......+.+|+.+++.++|+||+++++++.++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   71 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKR---------TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG   71 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECC---------CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence            368889999999999999998865         67789999987653 33345678899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ...++|+||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          72 SKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             CeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999999999998654   6889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +......  .......|+..|+|||++.+..++.++|||||||++|+|++|..||....+......+   .         
T Consensus       146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~---------  211 (274)
T cd06609         146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI---P---------  211 (274)
T ss_pred             eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh---h---------
Confidence            8765432  1123457889999999999888999999999999999999999999654322111000   0         


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ....+.+...   ..+..+.+++.+||..||++||++++++++
T Consensus       212 -~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         212 -KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             0011111111   136778999999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.5e-40  Score=320.83  Aligned_cols=256  Identities=30%  Similarity=0.476  Sum_probs=200.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+.....   ....+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~---~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG---PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeeccccc---CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            369999999999998865221   01134689999886543 23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-----CeEEcc
Q 011234          217 YEFMPRGSLENHLFRKG-----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-----NAKLSD  286 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~kL~D  286 (490)
                      |||+++++|.+++....     ...+++..++.++.||+.||.|||+.+   ++|+||||+|||++.++     .++|+|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999997532     224788999999999999999999988   99999999999999877     899999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||++................++..|+|||++.+..++.++|||||||++|||++ |..||......   .......    
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~----  227 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVT----  227 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHh----
Confidence            999976543322222223346788999999999999999999999999999998 99998643221   1111110    


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..          .....+...+..+.+||.+||..+|.+||++.+|++.|.
T Consensus       228 ~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AG----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cC----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            00          000112234778999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-40  Score=336.04  Aligned_cols=264  Identities=23%  Similarity=0.350  Sum_probs=198.2

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|.+.+.||.|+||.||+|.+..         ++..||||.+....  ....+.+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTR---------LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECC---------CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhh
Confidence            34689999999999999999998765         67789999987542  22345677899999999999999999987


Q ss_pred             Eec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          208 IED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       208 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ...      ...|++||++ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~  156 (343)
T cd07878          84 TPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCE  156 (343)
T ss_pred             cccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCC
Confidence            643      3568999998 78998877532   5899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW  359 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~  359 (490)
                      +||+|||+++.....     .....||..|+|||++.+ ..++.++|||||||++|+|++|..||...........+ ..
T Consensus       157 ~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  231 (343)
T cd07878         157 LRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV  231 (343)
T ss_pred             EEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence            999999999865432     133578999999999876 57899999999999999999999999754322111100 00


Q ss_pred             hhc-------ccCC--chhhhhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 ARP-------HLGD--KRRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~-------~~~~--~~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...       .+..  ...+...+.......   .....+..+.+||.+||..||.+|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000       0000  000000000000000   001124568899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.5e-40  Score=326.34  Aligned_cols=251  Identities=25%  Similarity=0.404  Sum_probs=206.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||.|+||.||+|.+..         +|..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVA---------TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcC---------CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            469999999999999999998765         67789999987665555667889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|..++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccch
Confidence            999999999999999988643   5889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.............  ..   .     
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~~---~-----  231 (296)
T cd06655         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TN---G-----  231 (296)
T ss_pred             hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hc---C-----
Confidence            6543321  1223568999999999998889999999999999999999999996643321111110  00   0     


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         .+.+  ..+...+..+.+||.+||..||.+||++.+|+.+
T Consensus       232 ---~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         232 ---TPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---Cccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence               0000  1122336789999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.3e-40  Score=327.49  Aligned_cols=263  Identities=25%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|++.+.||+|+||.||+|.+...+..     ....||+|.+..... ....++.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGET-----VKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCc-----ceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            35688999999999999999988653321     123689998876533 233468899999999999999999999875


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      . ..++++||+++|+|.+++..... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence            4 56799999999999999876532 5788999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ...+...    ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~  228 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEK----GE  228 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC----CC
Confidence            987643322222223445778999999998899999999999999999997 889986532211   1111110    00


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .          ...+..++..+.+++.+||..+|++||++.++++.|..+..
T Consensus       229 ~----------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         229 R----------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             C----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0          00112235688999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-40  Score=319.37  Aligned_cols=251  Identities=26%  Similarity=0.446  Sum_probs=196.3

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEEEecCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l  215 (490)
                      ++||+|+||.||+|.+..++       ....+|+|.+.... ......+..|+.++.++ +||||+++++++...+..++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   73 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   73 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCC-------CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence            36999999999999986532       12357889887532 33446788999999999 79999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          216 VYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ||||+++|+|.+++....              ...+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus        74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~  150 (270)
T cd05047          74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  150 (270)
T ss_pred             EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCe
Confidence            999999999999986542              124788999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..||.......   .....
T Consensus       151 ~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~  224 (270)
T cd05047         151 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL  224 (270)
T ss_pred             EEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH
Confidence            999999998633211   01111233567999999988899999999999999999997 999986432211   11110


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                    ........+...+.++.+|+.+||..||.+|||+.+++..|..+
T Consensus       225 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 --------------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             --------------hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                          00000111223367889999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.1e-40  Score=316.93  Aligned_cols=258  Identities=28%  Similarity=0.401  Sum_probs=207.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||.|+||.||+|....         ++..+|+|++..... .....+.+|+.+|+.++|+||+++++.+...
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP---------NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG   71 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC---------CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC
Confidence            468999999999999999998765         567899999875432 3456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      +..++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+
T Consensus        72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccch
Confidence            999999999999999999976432 36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcc--eeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          290 AKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +..........  ......|+..|+|||++... .++.++|+|||||++|+|++|..||........  .......   .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~---~  223 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQN---D  223 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhcC---C
Confidence            87665432221  22345789999999998876 789999999999999999999999965433211  1111110   0


Q ss_pred             chhhhhccCccccCCC-ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              .+.+.... ....+..+.+|+.+||..||++||++.+|+++
T Consensus       224 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 --------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                    00010000 11336788999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.7e-40  Score=323.17  Aligned_cols=258  Identities=28%  Similarity=0.376  Sum_probs=203.4

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceecee
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLV  204 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~  204 (490)
                      ++....+.|++.+.||.|+||.||+|.+..         ++..||+|++.... ....++..|+.++..+ +|+||++++
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~   79 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYY   79 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcC---------CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEe
Confidence            334455789999999999999999999865         56789999986553 2335678899999998 699999999


Q ss_pred             eEEEe------cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC
Q 011234          205 GYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       205 ~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      +++..      .+..+++|||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||+|+||+++.
T Consensus        80 ~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~  156 (282)
T cd06636          80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE  156 (282)
T ss_pred             eehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence            99863      457899999999999999997765556888889999999999999999988   999999999999999


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      ++.++|+|||++........  ......|+..|+|||.+.     ...++.++|||||||++|||++|..||....+...
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~  234 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA  234 (282)
T ss_pred             CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence            99999999999876532211  123356899999999886     34688899999999999999999999965432211


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....                .............+..+.+||.+||..||.+||++.||+++
T Consensus       235 ~~~~----------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 LFLI----------------PRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hhhH----------------hhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            1100                00000000111236789999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.1e-40  Score=318.36  Aligned_cols=256  Identities=23%  Similarity=0.356  Sum_probs=203.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+++.+.....||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   75 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLS---------TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS   75 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec
Confidence            445566666789999999999998765         56789999988776666678899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPL--PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~  285 (490)
                      .++..++||||+++++|.+++..... .+  ++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          76 ENGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             cCCEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEe
Confidence            99999999999999999999876422 34  78888899999999999999988   999999999999976 6799999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |||++........  ......|+..|+|||++.+.  .++.++|||||||++|+|++|..||........   ..+....
T Consensus       152 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~  226 (268)
T cd06624         152 DFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGM  226 (268)
T ss_pred             cchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhh
Confidence            9999876543221  12234689999999998654  378899999999999999999999864321111   0010000


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .            .....++...+.++.+|+.+||+.+|.+|||+.+++++
T Consensus       227 ~------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         227 F------------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             h------------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0            00111223346789999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=330.41  Aligned_cols=255  Identities=32%  Similarity=0.455  Sum_probs=215.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+.|+.-++||+|+||.||-++...         ||..+|.|.+.+...   ......+.|-.||..++.+.||.+--.|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvra---------TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRA---------TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEec---------chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence            4578999999999999999998876         889999998865533   2334568899999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+.+||||..|.||+|.-+|...+...+++..+..++.+|+.||++||+..   ||+|||||+|||||+.|+++|+|+
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeecc
Confidence            99999999999999999999999988778999999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|..+......   ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-++  +..+.+ 
T Consensus       332 GLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--rr~~~~-  405 (591)
T KOG0986|consen  332 GLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--RRTLED-  405 (591)
T ss_pred             ceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--HHHhcc-
Confidence            999988764322   33489999999999999999999999999999999999999997654443322221  111111 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                                 ...|+...++++++|.+.+|.+||.+|.-     +.+|.+|
T Consensus       406 -----------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  406 -----------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             -----------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence                       22445556899999999999999999965     4566655

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-39  Score=314.00  Aligned_cols=247  Identities=31%  Similarity=0.453  Sum_probs=197.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ++||.|+||.||+|...          .+..||+|.+...... ....+.+|+.++..++||||+++++++...+..++|
T Consensus         1 ~~ig~g~~g~vy~~~~~----------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   70 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK----------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIV   70 (250)
T ss_pred             CccCCCCCceEEEEEec----------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEE
Confidence            36999999999999754          3557999998765432 234688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.... ..+.+..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        71 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          71 MELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             EECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999999999886553 35789999999999999999999988   999999999999999999999999998754332


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccC
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      .. .......++..|+|||++.+..++.++||||||+++|+|++ |..||........   ......             
T Consensus       147 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~~-------------  209 (250)
T cd05085         147 IY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVEK-------------  209 (250)
T ss_pred             cc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc-------------
Confidence            11 11112244678999999998899999999999999999998 9999865422211   111100             


Q ss_pred             ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       ......+...+..+.+|+.+||..+|++||++.++++.|.
T Consensus       210 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         210 -GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence             0011122234678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-40  Score=327.92  Aligned_cols=255  Identities=29%  Similarity=0.373  Sum_probs=205.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|....         ++..||+|.+......   ..+.+..|+++|..++|+||+++++.+.
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKG---------TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ   71 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcC---------CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence            368899999999999999998865         5778999999765433   3456888999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +....++||||+.+++|.+++.......+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecc
Confidence            9999999999999999999987655557899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc---------------------------ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhC
Q 011234          289 LAKDAPEDGKT---------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG  341 (490)
Q Consensus       289 ~a~~~~~~~~~---------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG  341 (490)
                      ++.........                           .......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98754322110                           011234689999999999988899999999999999999999


Q ss_pred             CCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 011234          342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR----MSEVVET  414 (490)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs----~~evl~~  414 (490)
                      ..||........  +..              ..............+..+.+||.+||..||++||+    +.+++.+
T Consensus       229 ~~pf~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         229 TTPFKGSNRDET--FSN--------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCCCCCchHHH--HHH--------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            999965432211  110              01000000001113788999999999999999999    7777654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=313.83  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=199.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ++||.|+||.||+|.+..          +..||+|.+...... ....+..|+++++.+.|+||+++++++.+....++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~----------~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   70 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG----------NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIV   70 (251)
T ss_pred             CccccCCCceEEEEEEeC----------CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEE
Confidence            469999999999998753          558999998765443 456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+.+++|.+++..... .+++..+..++.+++.||.|||+.+   ++||||||+|||++.++.+||+|||++......
T Consensus        71 ~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          71 MELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            999999999999866533 6788999999999999999999988   999999999999999999999999999865432


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccC
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ..........++..|+|||.+.+..++.++|||||||++|+|++ |..||...........+   ..             
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~---~~-------------  210 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI---ES-------------  210 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH---hc-------------
Confidence            21111112234567999999988899999999999999999999 88888654322111111   00             


Q ss_pred             ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       ......+...+..+.+||.+||..+|++||++.||++.|+
T Consensus       211 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         211 -GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             0001112233678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.1e-40  Score=317.67  Aligned_cols=252  Identities=30%  Similarity=0.488  Sum_probs=201.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +|++.+.||.|+||.||+|...          +|..+|+|.+.....      .....+.+|+.+|+.++|+||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~----------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN----------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT   70 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc----------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeE
Confidence            4888999999999999999753          466899998864321      223457889999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+..++||||+++++|.+++.+..  .+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          71 CLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEecc
Confidence            999999999999999999999997654  5788999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCC----CcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          287 FGLAKDAPEDG----KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       287 FG~a~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||++.......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||.............    
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~----  221 (265)
T cd06631         146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG----  221 (265)
T ss_pred             chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh----
Confidence            99987643211    1111233568999999999998889999999999999999999999996532211110000    


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         ...    ...+    ..+...+..+.++|.+||..+|++||++.+++++
T Consensus       222 ---~~~----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         222 ---AHR----GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             ---hcc----CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               000    0001    1122336788999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-40  Score=321.42  Aligned_cols=248  Identities=23%  Similarity=0.395  Sum_probs=194.1

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  217 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  217 (490)
                      +.||.|+||.||+|.....+..  ..-....||+|.+........+.+..|+.+++.+.||||+++++++..++..++||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDY--GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCCcccchhheeeeecccccc--cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            4699999999999988643210  00124468899887655555567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--------eEEccccc
Q 011234          218 EFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--------AKLSDFGL  289 (490)
Q Consensus       218 E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~kL~DFG~  289 (490)
                      ||+++|+|.+++...+. .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.        ++|+|||+
T Consensus        79 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          79 EYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             ecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999876543 6889999999999999999999988   999999999999987765        69999998


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCC-CCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~-~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +......      ....|+..|+|||++.+ ..++.++|||||||++|||++|. .||........   ....    .. 
T Consensus       155 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~~~----~~-  220 (258)
T cd05078         155 SITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQFY----ED-  220 (258)
T ss_pred             ccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HHHH----Hc-
Confidence            8654321      23468889999999976 45899999999999999999995 55543221111   0000    00 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                                 ...++.....++.+||.+||+.||++|||+++|++.|+
T Consensus       221 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                       00122223577899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.6e-40  Score=358.00  Aligned_cols=260  Identities=22%  Similarity=0.332  Sum_probs=203.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++....   ....+.+.+|+++++.++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~---------tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPV---------CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECC---------CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            479999999999999999998865         67799999987542   223457889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKG---------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +.+..++||||++||+|.+++....         ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.+
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~d  149 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLF  149 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCC
Confidence            9999999999999999999886421         123556778899999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCC----------------cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCC
Q 011234          280 YNAKLSDFGLAKDAPEDGK----------------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~----------------~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~  343 (490)
                      +.+||+|||+++.......                .......+||+.|||||++.+..++.++|||||||++|||++|..
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            9999999999986521100                011123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcc
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPL  418 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-s~~evl~~L~~l  418 (490)
                      ||..........    . ........    +.+      ....+..+.+++.+||..||++|+ ++.++++.|+.+
T Consensus       230 PF~~~~~~ki~~----~-~~i~~P~~----~~p------~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        230 PYRRKKGRKISY----R-DVILSPIE----VAP------YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             CCCCcchhhhhh----h-hhccChhh----ccc------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            996532211100    0 00000000    000      012367789999999999999995 567777777654

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.8e-40  Score=318.34  Aligned_cols=259  Identities=25%  Similarity=0.437  Sum_probs=201.9

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      |.+.+.||+|+||.||+|.+..+.      +++..||||++....  ....+++.+|+++++.++||||+++++++....
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   74 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSED------GSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR   74 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccC------CCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            667889999999999999876532      367899999987542  234567889999999999999999999886542


Q ss_pred             ------ceEEEEEecCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          212 ------QRLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       212 ------~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                            ..++++||+.+|+|.+++...    ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~  151 (273)
T cd05074          75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMT  151 (273)
T ss_pred             CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCC
Confidence                  247889999999999887532    1235788899999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............++..|++||.+.+..++.++|||||||++|+|++ |.+||......   ....+.
T Consensus       152 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~  228 (273)
T cd05074         152 VCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYL  228 (273)
T ss_pred             EEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHH
Confidence            99999999986643322222223345678999999998899999999999999999999 88888643221   111111


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..    ...        +  ..+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       229 ~~----~~~--------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IK----GNR--------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             Hc----CCc--------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            00    000        0  01122367899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-39  Score=314.45  Aligned_cols=256  Identities=34%  Similarity=0.513  Sum_probs=205.0

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      |.+.+.||.|+||.||+|.+...+.     .++..||+|++...... ..+.+..|+.++..++|+||+++++++.+.+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG-----EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC-----CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe
Confidence            4577899999999999999876321     13578999999766433 45678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .+++|||+++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCcee
Confidence            999999999999999997654333899999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ......... ....++..|+|||.+.+..++.++|||||||++|+|++ |.+||......   ........   ..    
T Consensus       153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~---~~----  221 (258)
T smart00219      153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKK---GY----  221 (258)
T ss_pred             ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc---CC----
Confidence            654422211 12336789999999988889999999999999999998 78888653211   11111100   00    


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                             ....+...+.++.+++.+||..||++|||+.++++.|
T Consensus       222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   0011122477899999999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.9e-40  Score=318.25  Aligned_cols=255  Identities=29%  Similarity=0.408  Sum_probs=191.5

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEE
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  217 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  217 (490)
                      .||+|+||.||+|.....       .....+|+|.+..... .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus         2 ~lg~G~fg~v~~~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~   74 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG-------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL   74 (269)
T ss_pred             cCCccCCceEEEEEEecC-------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence            589999999999976432       1345789998765432 33456789999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          218 EFMPRGSLENHLFRKGS---LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       218 E~~~~g~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      ||+++|+|.+++.....   ...++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus        75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccc
Confidence            99999999999976432   23467788899999999999999988   9999999999999999999999999987543


Q ss_pred             CCCCcceeeccccCCCCCCchhhhc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          295 EDGKTHVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       295 ~~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ............++..|+|||++..       ..++.++|||||||++|||++ |..||........  +......   .
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~---~  226 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVRE---Q  226 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhc---c
Confidence            3222111223456778999998753       356789999999999999999 7788864432111  1100000   0


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .   .....+.    .+...+..+.+++..|| .||++||++++|++.|.
T Consensus       227 ~---~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 D---IKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             C---ccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            0   0111111    12233677888999998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-41  Score=340.01  Aligned_cols=255  Identities=29%  Similarity=0.441  Sum_probs=210.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      ..+.++||+|.||+|++|.|...+      ++-..||||+++.+... ...+|++|+.+|.+|+|+|+|+|||+..+ ..
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~ps------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPS------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCC------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            445688999999999999998643      24457999999887654 66789999999999999999999999887 77


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..||||+++.|+|.+.|.+.....|.......++.||+.||.||..++   +|||||...|+||...-.||||||||++.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRa  261 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRA  261 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceec
Confidence            899999999999999998844556888999999999999999999988   99999999999999988999999999998


Q ss_pred             CCCCCCccee-eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          293 APEDGKTHVS-TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       293 ~~~~~~~~~~-~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +........+ ....-.+.|+|||.+....++.++|||+|||++|||++ |..||.+.........+             
T Consensus       262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i-------------  328 (1039)
T KOG0199|consen  262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI-------------  328 (1039)
T ss_pred             cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-------------
Confidence            8655443332 22333668999999999999999999999999999997 67788665433222222             


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                          |..-.-.-+..|++++.+++..||..+|.+|||+..|.+.+
T Consensus       329 ----D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 ----DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ----cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                22222233556799999999999999999999999997543

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-39  Score=324.86  Aligned_cols=263  Identities=23%  Similarity=0.356  Sum_probs=190.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe--cCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l  215 (490)
                      ..||+|+||.||+|.....       .++..||+|.+.....  ...+.+|+.+|+.++||||+++++++..  +...++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~-------~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~l   77 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDG-------KDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWL   77 (317)
T ss_pred             eEeccCCCeeEEEEEecCC-------CccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEE
Confidence            5799999999999987542       1467899999875532  2457789999999999999999998854  457899


Q ss_pred             EEEecCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE----cCCCCeEE
Q 011234          216 VYEFMPRGSLENHLFRK-------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKL  284 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~kL  284 (490)
                      ||||+. ++|.+++...       ....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||
T Consensus        78 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl  153 (317)
T cd07867          78 LFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI  153 (317)
T ss_pred             EEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEE
Confidence            999995 5887776432       1235888999999999999999999988   9999999999999    56678999


Q ss_pred             ccccccccCCCCCCc-ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc-------ch
Q 011234          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-------HN  355 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~-------~~  355 (490)
                      +|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||........       ..
T Consensus       154 ~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~  233 (317)
T cd07867         154 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQ  233 (317)
T ss_pred             eeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHH
Confidence            999999876433211 11234578999999999876 4589999999999999999999999965432111       00


Q ss_pred             hHHhhhcccC-----Cchh---------hhhcc------Cccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011234          356 LVEWARPHLG-----DKRR---------FYRLL------DPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       356 ~~~~~~~~~~-----~~~~---------~~~~~------~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  412 (490)
                      +..... .++     ....         .....      ...+   ........+..+.+||.+||..||.+|||+.|++
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l  312 (317)
T cd07867         234 LDRIFS-VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQAL  312 (317)
T ss_pred             HHHHHH-hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHh
Confidence            000000 000     0000         00000      0000   0001112246688999999999999999999999


Q ss_pred             HH
Q 011234          413 ET  414 (490)
Q Consensus       413 ~~  414 (490)
                      ++
T Consensus       313 ~h  314 (317)
T cd07867         313 QD  314 (317)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-41  Score=336.45  Aligned_cols=263  Identities=27%  Similarity=0.426  Sum_probs=220.2

Q ss_pred             hhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceecee
Q 011234          125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       125 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      +.++....+.....+||.|.||.||.|.|+..         ...||||.++.+. ...++|+.|..+|+.++|||+|+|+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky---------slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKY---------SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeecc---------ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHh
Confidence            44555556677778999999999999999874         4479999998765 4567899999999999999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      |+|..+...|||.|||..|+|.++|.+..+..++....++++.||..|+.||...+   +|||||...|+|+.++..|||
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEe
Confidence            99999999999999999999999999887777888888999999999999999877   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+++.+..+..+. .....-.+.|.|||-+....++.++|||+|||+|||+.| |-.||.+.....           
T Consensus       407 ADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-----------  474 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----------  474 (1157)
T ss_pred             eccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-----------
Confidence            9999999886653322 111223678999999999999999999999999999986 667776543222           


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                            .|.++...+.-+-+..|++.+.+||+.||+.+|.+||++.|+-+.++.+
T Consensus       475 ------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  475 ------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence                  2233333333344567799999999999999999999999999888754

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-39  Score=315.89  Aligned_cols=252  Identities=27%  Similarity=0.405  Sum_probs=198.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+|.+.+.||+|+||.||+|.+..         ++..||+|.+....     ......+.+|+.+++.++||||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   72 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVD---------TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGC   72 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcC---------CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEE
Confidence            368999999999999999998765         67799999886432     1223457889999999999999999998


Q ss_pred             EEec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          207 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       207 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +.+.  ...+++|||+++++|.+++....  .+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||
T Consensus        73 ~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l  147 (266)
T cd06651          73 LRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKL  147 (266)
T ss_pred             EEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEE
Confidence            8763  56789999999999999987654  5788889999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCC-cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||++........ ........|+..|+|||++.+..++.++|||||||++|||++|+.||........   +..    
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~---~~~----  220 (266)
T cd06651         148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA---IFK----  220 (266)
T ss_pred             ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH---HHH----
Confidence            99999876532111 1111235688999999999988899999999999999999999999964321110   000    


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                               .........++...+..+.+|+ +||..+|++||+++||+++
T Consensus       221 ---------~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         221 ---------IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---------HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                     0000001122333467788888 6888999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.8e-40  Score=322.34  Aligned_cols=262  Identities=28%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             hhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceec
Q 011234          124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVK  202 (490)
Q Consensus       124 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~  202 (490)
                      ++.+....++|++.+.||+|+||.||+|.+..         ++..+|+|++.... ....++..|+.++..+ +|+||++
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~   79 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKK---------NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVK   79 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECC---------CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeee
Confidence            34445667899999999999999999998865         56789999886532 2235677899999999 6999999


Q ss_pred             eeeEEE-----ecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          203 LVGYCI-----EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       203 l~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +++++.     .++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.+   |+||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil  156 (286)
T cd06638          80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNIL  156 (286)
T ss_pred             eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEE
Confidence            999874     345689999999999999887532  2336888999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~  350 (490)
                      ++.++.+||+|||++........  ......|+..|+|||++..     ..++.++|||||||++|||++|..||.....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         157 LTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             ECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999999999886543211  1223468999999998853     4578899999999999999999999965432


Q ss_pred             CCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...  .....     ..      ..+.+  ..+...+..+.+||.+||+.||++|||+.||++++
T Consensus       235 ~~~--~~~~~-----~~------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         235 MRA--LFKIP-----RN------PPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hHH--Hhhcc-----cc------CCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            111  00000     00      00000  01112256799999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1e-39  Score=315.10  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||.|+||.||++....         +|..||+|.+....  ....+++.+|+.+++.++||||+++++++...
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKE---------DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN   71 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcC---------CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence            58889999999999999998865         56789999986532  23445788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+   ++|+||+|+|||++.++.++|+|||++
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          72 GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999999999999987655556889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......|+..|+|||++.+..++.++|+|||||++|+|++|..||.......   ..   .......   
T Consensus       149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~~~~~~~---  217 (256)
T cd08218         149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---LV---LKIIRGS---  217 (256)
T ss_pred             eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---HH---HHHhcCC---
Confidence            76543221  1123468899999999998889999999999999999999999986432111   11   0000000   


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              ....+...+.++.++|.+||+.+|.+||++.+|+++
T Consensus       218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         218 --------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                    001122336789999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-39  Score=318.23  Aligned_cols=261  Identities=26%  Similarity=0.400  Sum_probs=206.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++.+.||.|+||.||+|+.+....    ......||+|.+...... ....+.+|++++++++|+||+++++++.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   80 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE----EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA   80 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc----CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence            468899999999999999999865321    234568999988755433 346788999999999999999999999998


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGS-------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      +..++||||+++|+|.+++.....       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~  157 (275)
T cd05046          81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK  157 (275)
T ss_pred             CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence            999999999999999999976541       25899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .......
T Consensus       158 l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~~~~  233 (275)
T cd05046         158 VSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNRLQA  233 (275)
T ss_pred             EcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHHHHc
Confidence            999999875432211 11223456778999999988889999999999999999998 788885432211   1111000


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                                   .......+...+..+.+++.+||..||.+||++.+++..|.
T Consensus       234 -------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 -------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                         00000111233678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-39  Score=315.41  Aligned_cols=255  Identities=24%  Similarity=0.423  Sum_probs=204.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC------hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG------LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +|+..+.||+|+||.||+|....         ++..||+|++....      ....+.+.+|+.+++.++|+||++++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   71 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVK---------TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGA   71 (268)
T ss_pred             CccccceecCcCceEEEEEEEcC---------CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhce
Confidence            47888999999999999998754         67789999987532      1234578899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLS  285 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~  285 (490)
                      +.+.+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++ .+||+
T Consensus        72 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          72 TCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             eccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEc
Confidence            999999999999999999999987654  6888999999999999999999988   99999999999998776 59999


Q ss_pred             cccccccCCCCCC--cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          286 DFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       286 DFG~a~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |||++........  ........|+..|+|||++.+..++.++|||||||++|+|++|..||.............     
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----  221 (268)
T cd06630         147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-----  221 (268)
T ss_pred             ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH-----
Confidence            9999876643211  111223568999999999988889999999999999999999999996433221111110     


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              ..........++...+.++.+++.+||..||++||++.+++++
T Consensus       222 --------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         222 --------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                    0000011122333447889999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.1e-40  Score=320.95  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=202.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .|++.+.||+|+||.||+|.+..         ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNR---------TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT   75 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcC---------CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC
Confidence            36667889999999999998765         56789999987543 233456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06642          76 KLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             ceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccc
Confidence            999999999999999988542   5888999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|+..|+|||++.+..++.++|||||||++|||++|..||....+.....   .    ...     
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~----~~~-----  215 (277)
T cd06642         150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---L----IPK-----  215 (277)
T ss_pred             cccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---h----hhc-----
Confidence            6543221  1123468899999999998899999999999999999999999986433221100   0    000     


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       ...+    ......+..+.+||.+||..+|++||++.+++++-
T Consensus       216 -~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         216 -NSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             -CCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence             0011    11223367899999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.3e-39  Score=317.00  Aligned_cols=250  Identities=26%  Similarity=0.379  Sum_probs=205.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .|+..+.||.|+||.||+|.+..         ++..||+|++.... ......+.+|+.+++.+.|+||+++++++.+++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNR---------TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT   75 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEcc---------CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            47788999999999999998865         56789999987543 334567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~  149 (277)
T cd06640          76 KLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccce
Confidence            999999999999999988643   5788899999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......++..|+|||++.+..++.++|+|||||++|||++|..||....+......+              
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--------------  213 (277)
T cd06640         150 QLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI--------------  213 (277)
T ss_pred             eccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh--------------
Confidence            6643221  123356888999999998888999999999999999999999999654322111110              


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                         ............+..+.+||.+||..+|++||++.+++.+-.
T Consensus       214 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         214 ---PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             ---hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence               000011223345788999999999999999999999998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.3e-39  Score=319.53  Aligned_cols=267  Identities=28%  Similarity=0.377  Sum_probs=202.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|++....  ....+.+.+|+.+++.+.|+||+++++++..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRE---------TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR   71 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECC---------CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence            368899999999999999998865         57789999886442  1233567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....++||||++++.|..++....  .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||+
T Consensus        72 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          72 KRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             CCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccc
Confidence            999999999999888877665433  5899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-hcccC--
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLG--  365 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~~~~~--  365 (490)
                      +........  ......++..|+|||++.+ ..++.++|||||||++|+|++|..||......+....+... .....  
T Consensus       147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07847         147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH  224 (286)
T ss_pred             ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence            987654321  1123467889999999876 56889999999999999999999999765432221111100 00000  


Q ss_pred             ----Cchhhh-hccCccccCCCC-----hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 ----DKRRFY-RLLDPRLEGHFS-----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ----~~~~~~-~~~~~~l~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ....++ ....+......+     ...+..+.+||.+||+.||++||++.|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                000000 000000000000     1226778999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.6e-40  Score=322.64  Aligned_cols=246  Identities=30%  Similarity=0.436  Sum_probs=203.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||++.+..         ++..||+|++.....   .....+.+|+++|++++||||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG---------SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            368999999999999999999875         567899999865432   23456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.+||+|||
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCC
Confidence            9999999999999999999987664  6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++......     .....|++.|+|||.+.+..++.++||||||+++|+|++|..||......   .....   ..... 
T Consensus       147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~~~~-  214 (290)
T cd05580         147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEK---ILEGK-  214 (290)
T ss_pred             CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HhcCC-
Confidence            99876443     23357899999999998888999999999999999999999999654311   11110   00000 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                                 ..++...+..+.++|.+||..||.+|+     ++++++++
T Consensus       215 -----------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 -----------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             -----------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                       012222367889999999999999998     77787755

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.7e-40  Score=320.90  Aligned_cols=254  Identities=26%  Similarity=0.434  Sum_probs=202.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.+... .......+.+|+.++.+++|+||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRP---------TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE   71 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcC---------CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence            368899999999999999998865         5778999988754 223346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +..++||||+++++|..++.... ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecC
Confidence            99999999999999998886531 2268999999999999999999997 36   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ++.......    .....|+..|+|||++.+.      .++.++|||||||++|+|++|..||..............   
T Consensus       149 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---  221 (286)
T cd06622         149 VSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA---  221 (286)
T ss_pred             CcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH---
Confidence            987653221    1234688899999998543      357899999999999999999999965332211111100   


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                +... ....++...+.++.+||.+||..+|++||++.+++++-
T Consensus       222 ----------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         222 ----------IVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             ----------Hhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence                      0000 00112233478899999999999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.3e-39  Score=314.63  Aligned_cols=252  Identities=27%  Similarity=0.400  Sum_probs=199.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+|++.+.||+|+||.||+|.+..         +|..||||.+....     ....+.+.+|+.++..++||||++++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   72 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDAD---------TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGC   72 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcC---------CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeE
Confidence            468999999999999999998865         67799999886431     1234567889999999999999999998


Q ss_pred             EEec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          207 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       207 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +.+.  ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.++|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l  147 (265)
T cd06652          73 LRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKL  147 (265)
T ss_pred             eccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEE
Confidence            8764  46789999999999999987654  5788888999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||++......... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ...     
T Consensus       148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-----  220 (265)
T cd06652         148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK-----  220 (265)
T ss_pred             CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH-----
Confidence            999998765321111 112235689999999999888899999999999999999999999964321110  000     


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                               ..........+...+..+.++|.+||. +|++||++++|+++
T Consensus       221 ---------~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         221 ---------IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---------HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                     000001112233446788999999994 99999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-39  Score=314.11  Aligned_cols=252  Identities=29%  Similarity=0.505  Sum_probs=201.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||.|+||.||+|.+..          +..+|+|.+..... ...++.+|+++++.+.||||+++++++....
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~----------~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE----------KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS   72 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC----------CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence            468888999999999999998752          44799998875433 3456889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+.+++|.+++..... .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        73 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          73 PICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCccee
Confidence            99999999999999999876533 5789999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......   ...+.....       
T Consensus       149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-------  217 (256)
T cd05112         149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETINAG-------  217 (256)
T ss_pred             ecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHhCC-------
Confidence            6543211 11122345678999999998899999999999999999998 99998643221   111111000       


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .....+       ...+..+.+|+.+||+.+|++||++.++++.|.
T Consensus       218 ~~~~~~-------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 FRLYKP-------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCCC-------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            001111       112678999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.6e-39  Score=313.35  Aligned_cols=250  Identities=26%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|....         ++..||+|.+....  ......+.+|+.+|+.++||||+++++.+..+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKA---------DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED   71 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence            48889999999999999998865         56789999987543  23356788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CCeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~DFG~  289 (490)
                      +..++||||+++++|.+++.......+++..+..++.+++.||.|||+.+   |+|+||+|+||+++.+ +.+||+|||+
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          72 KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999999999997765556899999999999999999999988   9999999999999855 4589999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........   .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ......   ..   
T Consensus       149 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~---~~---  216 (256)
T cd08220         149 SKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIM---SG---  216 (256)
T ss_pred             ceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHH---hc---
Confidence            987644321   123568999999999998889999999999999999999999996543221   111100   00   


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              .....+...+..+.+++.+||..||++|||+.+++++
T Consensus       217 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         217 --------TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             --------CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                    0001122236789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-41  Score=311.18  Aligned_cols=255  Identities=24%  Similarity=0.289  Sum_probs=203.4

Q ss_pred             hhcCCCcC-ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      .+++|.+- .+||-|-.|.|..|.++.         ||+.+|+|++...     ....+|+++.-.. .|||||.++++|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~---------T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVy  124 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKR---------TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVY  124 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEecc---------chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhh
Confidence            45667765 579999999999998876         8889999998543     3456788876555 499999999998


Q ss_pred             Eec----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CC
Q 011234          208 IED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DY  280 (490)
Q Consensus       208 ~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~  280 (490)
                      ...    ..+.+|||+|+||.|+..+..++...+.+.++..|+.||+.|+.|||+.+   |.||||||+|+|...   |.
T Consensus       125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             hhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCc
Confidence            753    35678999999999999999999999999999999999999999999988   999999999999954   45


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||+|+.....   ......|-|+.|+|||++....|+..+|+||+||+||-||+|.+||....-...       
T Consensus       202 ~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------  271 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------  271 (400)
T ss_pred             ceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------
Confidence            6999999999876432   222446889999999999989999999999999999999999999965432111       


Q ss_pred             hcccCCch--hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          361 RPHLGDKR--RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       361 ~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .+.+..+.  ..|.+.++     -....++.++++|+.+|..+|.+|.|+.+++++-.
T Consensus       272 spgMk~rI~~gqy~FP~p-----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  272 SPGMKRRIRTGQYEFPEP-----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             ChhHHhHhhccCccCCCh-----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence            00000000  00111111     12345899999999999999999999999998743

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.2e-40  Score=321.77  Aligned_cols=264  Identities=23%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|.+..         +|..||+|.+.....  .....+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~---------~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD   71 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECC---------CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence            48888999999999999999875         677899999865422  1224577899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++|+||+. ++|.+++.... ..+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          72 KKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             CceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchh
Confidence            99999999996 68888876543 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc-------
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-------  362 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-------  362 (490)
                      +.......  ......++..|+|||++.+. .++.++|||||||++|+|++|..||........  .......       
T Consensus       147 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~  222 (284)
T cd07839         147 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTE  222 (284)
T ss_pred             hccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence            86543211  11234678999999998764 478999999999999999999988643221110  0000000       


Q ss_pred             ----ccCCchh--hhhccCcccc-CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 ----HLGDKRR--FYRLLDPRLE-GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ----~~~~~~~--~~~~~~~~l~-~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          .......  .+........ .......+.++.+||.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence                0000000  0000000000 01112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=315.09  Aligned_cols=247  Identities=30%  Similarity=0.473  Sum_probs=199.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|..           ++..||+|.+....  ....+.+|+.++..++||||+++++++..+ 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-----------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   71 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-----------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-   71 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-----------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-
Confidence            4689999999999999999864           45679999986543  335788999999999999999999998654 


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.
T Consensus        72 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          72 GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccce
Confidence            5799999999999999997765556889999999999999999999988   9999999999999999999999999987


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ......     .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||.............       ..   
T Consensus       149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~---  213 (254)
T cd05083         149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KG---  213 (254)
T ss_pred             eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CC---
Confidence            643211     12234567999999988899999999999999999997 999986543321111110       00   


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                             .....+...+..+.+|+.+||+.+|++||++.+|++.|+.
T Consensus       214 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         214 -------YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   0001112336788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-39  Score=317.70  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=201.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----------hhHHHHHHHHHHHhcCCCCceec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      +|.+.+.||.|+||.||+|....         +|..||+|.+.....          ...+.+..|+.++..++|+||++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   72 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVT---------TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQ   72 (272)
T ss_pred             ceeecceecccCceEEEEEeecC---------CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcce
Confidence            57888999999999999998765         577899998753211          11245678999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      +++++...+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          73 YLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             EEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeE
Confidence            9999999999999999999999999987664  6888999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|+|||++................|+..|+|||++....  ++.++|+||||+++|+|++|..||........  ..+..
T Consensus       148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~  225 (272)
T cd06629         148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG  225 (272)
T ss_pred             EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh
Confidence            999999997654322111223456899999999987654  88999999999999999999999853321100  00000


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ..      .....+........+..+.+||.+||..||++||++.+|+++
T Consensus       226 ----~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         226 ----NK------RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----cc------ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                00      000011111112336789999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7e-40  Score=321.71  Aligned_cols=267  Identities=27%  Similarity=0.365  Sum_probs=203.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|.+..         ++..||+|.++...  ....+.+.+|+++++.++|+||+++++++...
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   72 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKA---------TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK   72 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCC---------CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence            68899999999999999998865         56789999886542  22346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||++++.|..++...  ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.+||+|||++
T Consensus        73 ~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~  147 (288)
T cd07833          73 GRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA  147 (288)
T ss_pred             CEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecc
Confidence            9999999999876666555433  25889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC----
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG----  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~----  365 (490)
                      ......... ......|+..|+|||++.+. .++.++||||||+++|+|++|.+||......+...........+.    
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (288)
T cd07833         148 RALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQ  226 (288)
T ss_pred             cccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHh
Confidence            876544321 22345788999999999888 889999999999999999999999975432211111100000000    


Q ss_pred             ----Cchh-----hhhccCc-cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 ----DKRR-----FYRLLDP-RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ----~~~~-----~~~~~~~-~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ....     +....++ .....++...+.++.+||.+||..+|++||++++++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         227 ELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             hhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence                0000     0000000 00011222337889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-39  Score=313.89  Aligned_cols=248  Identities=25%  Similarity=0.466  Sum_probs=193.7

Q ss_pred             ceeccCCceEEEEEEEccCCCcc-ccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAP-VKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~-~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.||+|+||.||+|.+...+... ........|++|.+...... ...+.+|+.+|+.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999987633110 01112346888887655433 5678899999999999999999999888 788999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-------CeEEccccc
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-------NAKLSDFGL  289 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~kL~DFG~  289 (490)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999876543 6889999999999999999999988   99999999999999887       799999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcC--CCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +.....      .....++..|+|||++.+.  .++.++|||||||++|+|++ |..||.............       .
T Consensus       155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------~  221 (259)
T cd05037         155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------D  221 (259)
T ss_pred             cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------c
Confidence            986543      1224567889999999876  78999999999999999999 577775543211111000       0


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..            ..+......+.+||.+||..+|.+||++.+|++.|+
T Consensus       222 ~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 QH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00            001111368899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.9e-40  Score=324.60  Aligned_cols=249  Identities=27%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      |.....||.|+||.||++....         ++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~   94 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKH---------TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL   94 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECC---------CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence            4445679999999999998765         5778999998766555566788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++...
T Consensus        95 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          95 WVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             EEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            9999999999999987532   5788999999999999999999988   999999999999999999999999998755


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  ......|+..|+|||++.+..++.++|||||||++|||++|..||...........   ..          ..
T Consensus       169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~----------~~  233 (292)
T cd06658         169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IR----------DN  233 (292)
T ss_pred             ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH----------hc
Confidence            33221  12335689999999999888999999999999999999999999965332111110   00          01


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +.+.+..  ....+..+.+++.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111111  11236678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-39  Score=323.18  Aligned_cols=256  Identities=23%  Similarity=0.340  Sum_probs=200.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||++.+..         ++..||+|.+.....   .....+.+|+++++.++||||+++++.+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKE---------TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECC---------CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            368899999999999999998875         677899999876532   23456778999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .++..++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCC
Confidence            9999999999999999999997654  6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCC-------------cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          289 LAKDAPEDGK-------------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       289 ~a~~~~~~~~-------------~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      +++.......             ........|+..|+|||.+.+..++.++|||||||++|||++|..||.......   
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~---  223 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---  223 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            9864211100             001122467889999999988889999999999999999999999996543221   


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .....   ....     ...+..    ....+..+.+||.+||+.||++||++.++++.|+
T Consensus       224 ~~~~~---~~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         224 LFGQV---ISDD-----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHH---Hhcc-----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            11100   0000     000000    0123678899999999999999999655554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-39  Score=312.86  Aligned_cols=249  Identities=30%  Similarity=0.469  Sum_probs=202.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +|+..+.||+|+||.||+|....         ++..||+|.+....     ....+.+.+|+.+++.++|+||+++++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLD---------DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE   71 (258)
T ss_pred             CccccceeeecCCceEEEEEEcC---------CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE
Confidence            47788999999999999998865         56689999886543     22346788999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ......++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          72 REEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccC
Confidence            99999999999999999999987654  5788999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++.......   ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||........  ......  .. 
T Consensus       147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~--~~-  218 (258)
T cd06632         147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIGR--SK-  218 (258)
T ss_pred             ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHHh--cc-
Confidence            9988654332   123456899999999987766 89999999999999999999999965431111  000000  00 


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                 ....++...+..+.+|+.+||..+|.+||++.+++.+
T Consensus       219 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 -----------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -----------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                       0011222336788999999999999999999999865

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.3e-40  Score=321.92  Aligned_cols=267  Identities=28%  Similarity=0.382  Sum_probs=201.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||+|.+......  ..+.+.+|+++++.++||||+++++++..
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKE---------TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR   71 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECC---------CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence            368899999999999999998865         5678999987654322  34567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++||||++++.|..+.....  .+++..+..++.||+.||.|||+.+   |+|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          72 KKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             CCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeee
Confidence            999999999999988887765433  5889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-HhhhcccCCc
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~~~~~~~~  367 (490)
                      +.......  .......|+..|+|||++.+ ..++.++|||||||++|||++|.+||...........+ .+........
T Consensus       147 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         147 ARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence            88654332  11233568899999999875 45788999999999999999999999654321111000 0000000000


Q ss_pred             hhhh-------hccCccccC-----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFY-------RLLDPRLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~-------~~~~~~l~~-----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....       ....+....     ......+..+.+|+.+||..||++||++.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000       000000000     0011236789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-39  Score=313.33  Aligned_cols=255  Identities=23%  Similarity=0.366  Sum_probs=191.6

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEE
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVY  217 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~  217 (490)
                      .||+|+||.||+|......       ....+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~   74 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDT-------GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF   74 (268)
T ss_pred             cCCCCcCceEEEEEEEcCC-------CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence            5999999999999765422       23457788776543 334567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          218 EFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       218 E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      ||+++|+|.+++....  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCc
Confidence            9999999999987542  224667778899999999999999988   99999999999999999999999999864322


Q ss_pred             CCCcceeeccccCCCCCCchhhhc-------CCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          296 DGKTHVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ...........|+..|+|||++..       ..++.++|||||||++|||++ |..||......   ......   +.. 
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~---~~~-  224 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHV---IKD-  224 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---Hhh-
Confidence            222222234578899999998753       245789999999999999997 46677543221   111110   000 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       ......++.+..    ..+..+.+|+..|| .+|++||++.+|++.|.
T Consensus       225 -~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         225 -QQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -cccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence             011122222222    23677889999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-40  Score=332.14  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=211.4

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--HHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ....|.+.+.||+|.|+.|.+|++..         +|..||||.+++.....  ...+.+|+++|..|+|||||+++.+.
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~---------t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~  124 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHIL---------TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI  124 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecC---------CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            34579999999999999999999986         78899999998875432  34578999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .....+|+||||+.+|.++++|.+.++  +.+..+..++.|+..|++|||++.   |||||||++||||+.+.++||+||
T Consensus       125 ~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDf  199 (596)
T KOG0586|consen  125 ETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADF  199 (596)
T ss_pred             eecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeecc
Confidence            999999999999999999999998874  455788889999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++..+...   ......||++.|.|||++.+..| +..+|+||+|++||-|+.|..||++........-+      +..
T Consensus       200 gfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------l~g  270 (596)
T KOG0586|consen  200 GFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------LRG  270 (596)
T ss_pred             ccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------eee
Confidence            999987533   33456899999999999998776 46899999999999999999999876433221111      111


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..+            .+.-.+.++.+||+++|..+|.+|++++++.++-
T Consensus       271 k~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  271 KYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             eec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            111            1122377899999999999999999999988753

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.1e-39  Score=322.87  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=201.7

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      |.....||+|+||.||+|....         ++..||+|.+........+.+.+|+.++..+.||||+++++++..++..
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   93 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL   93 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcC---------CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence            4445679999999999998765         5678999998765545556788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++++|..++...   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        94 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          94 WVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             EEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            9999999999999877542   5789999999999999999999988   999999999999999999999999998765


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  ......|+..|+|||++.+..++.++|||||||++|||++|..||........   ........         
T Consensus       168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~---------  233 (297)
T cd06659         168 SKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSP---------  233 (297)
T ss_pred             ccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhccC---------
Confidence            43221  12335789999999999988999999999999999999999999964332111   11110000         


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       .+..  ......+..+.++|.+||+.+|.+||++.+++++-
T Consensus       234 -~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         234 -PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             -CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence             0000  01112357789999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-39  Score=318.67  Aligned_cols=267  Identities=27%  Similarity=0.362  Sum_probs=203.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||.|+||.||+|.+..         +|..||+|++.....  .....+.+|+.+++.++||||+++++++...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRE---------TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG   71 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECC---------CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence            48889999999999999998865         567899999876542  2346788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||++
T Consensus        72 ~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          72 SGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             CeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            9999999999 999999987654 46899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-------h
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-------R  361 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-------~  361 (490)
                      ........ .......|+..|+|||++.+. .++.++|||||||++|||++|.++|...........+ ...       .
T Consensus       147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (286)
T cd07832         147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETW  225 (286)
T ss_pred             ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHH
Confidence            87654322 112235689999999988654 4689999999999999999998888654321111000 000       0


Q ss_pred             cccCCchhhhhccCcc----ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRRFYRLLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~----l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +.............+.    .........+..+.+||.+||..||.+||++++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000000000    0000111235889999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-39  Score=314.59  Aligned_cols=255  Identities=31%  Similarity=0.434  Sum_probs=205.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.+.... .....++.+|+++++.+.||||+++++++...
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   71 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRP---------TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN   71 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcC---------CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC
Confidence            367888999999999999998865         57789999987653 24456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      +..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          72 GDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             CEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence            99999999999999999987653 478899999999999999999999 77   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........    ....|+..|+|||++.+..++.++|||||||++|+|++|..||........ ...+........   
T Consensus       148 ~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~---  219 (265)
T cd06605         148 SGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE---  219 (265)
T ss_pred             chhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC---
Confidence            876532211    125788999999999999999999999999999999999999965422111 111111111000   


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ..+.+.   ....+..+.+||.+||..||++|||+.+++.+
T Consensus       220 ----~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 ----PPPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ----CCCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                000110   01146789999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.8e-39  Score=310.76  Aligned_cols=252  Identities=28%  Similarity=0.422  Sum_probs=208.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +|++.+.||.|+||.||+|.+..         ++..||+|.+..... .....+.+|+.++..++|+||+++++++...+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   72 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKP---------TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG   72 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcC---------CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC
Confidence            68899999999999999998875         577899999876644 34567899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+ .+   ++||||+|+||+++.++.++|+|||++
T Consensus        73 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~  147 (264)
T cd06623          73 EISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGIS  147 (264)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccc
Confidence            9999999999999999997653  68999999999999999999999 88   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      .........  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.................        
T Consensus       148 ~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--------  217 (264)
T cd06623         148 KVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD--------  217 (264)
T ss_pred             eecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc--------
Confidence            876443222  1235688999999999988999999999999999999999999976543111122211110        


Q ss_pred             hhccCccccCCCChH-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                            ......+.. .+..+.++|.+||..+|++||++.+++++
T Consensus       218 ------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         218 ------GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ------CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  000111122 46789999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.4e-39  Score=311.32  Aligned_cols=251  Identities=25%  Similarity=0.358  Sum_probs=203.0

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      +|++.+.||.|+||.||+|.+..         +|..||+|.+....  ....+.+..|+.+++.++|+||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKS---------DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR   71 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecC---------CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence            48889999999999999998875         56789999987543  2334568889999999999999999998764 


Q ss_pred             -cCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCCeeecCCCCCceEEcCCCC
Q 011234          210 -DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH-----EEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 -~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH-----~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                       ....+++|||+++++|.+++...  ....+++..++.++.||+.||.|||     +.+   |+|+||+|+||+++.++.
T Consensus        72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~  148 (265)
T cd08217          72 SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNN  148 (265)
T ss_pred             CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCC
Confidence             34678999999999999998653  1336899999999999999999999     656   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||++........  ......|+..|+|||++.+..++.++||||||+++|+|++|..||......   ...+...
T Consensus       149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~  223 (265)
T cd08217         149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK  223 (265)
T ss_pred             EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh
Confidence            99999999987654322  123356899999999999888999999999999999999999999754311   1111111


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .              .....++...+..+.+|+.+||..+|++||++.+|+++
T Consensus       224 ~--------------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 E--------------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             c--------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            0              00112223346889999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=314.26  Aligned_cols=255  Identities=30%  Similarity=0.415  Sum_probs=201.6

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      ..++|++.+.||.|+||.||+|.+..         ++..||+|++..... ....+.+|+.+++++ .|+||+++++++.
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   73 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKK---------TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFI   73 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECC---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence            35689999999999999999998865         567899999876543 345688999999999 6999999999997


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      ...      ..++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++
T Consensus        74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~  150 (275)
T cd06608          74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNA  150 (275)
T ss_pred             ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCC
Confidence            654      4899999999999999886533  346889999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      .++|+|||++.......  .......|+..|+|||++..     ..++.++|||||||+||+|++|..||........  
T Consensus       151 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  226 (275)
T cd06608         151 EVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--  226 (275)
T ss_pred             eEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--
Confidence            99999999987654321  11233568999999998854     3467899999999999999999999964322111  


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ......           ...+.+  ..+...+..+.+||.+||..||++|||+.+|+++
T Consensus       227 ~~~~~~-----------~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LFKIPR-----------NPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHhhc-----------cCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111000           000000  1112246789999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.1e-39  Score=319.24  Aligned_cols=266  Identities=26%  Similarity=0.349  Sum_probs=201.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-----hHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-----GHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +|.+.+.||+|+||.||+|.+..         +|..||||.+......     ....+..|+.+++.++|+||+++++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   71 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKE---------TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF   71 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECC---------CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee
Confidence            47888999999999999998865         5779999998765432     234567899999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..++||||+ +++|.+++.... ..+++..+..++.||++||.|||+.+   |+|+||||+|||++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          72 GHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             ecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccc
Confidence            9999999999999 899999987654 36899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-hccc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-RPHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-~~~~  364 (490)
                      |++.........  .....++..|+|||.+.+ ..++.++|||||||++|||++|.++|...........+ ... .+..
T Consensus       147 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~  224 (298)
T cd07841         147 GLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTE  224 (298)
T ss_pred             eeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCch
Confidence            999876543211  122356888999998865 46789999999999999999998888654332111110 000 0000


Q ss_pred             CCchhhh---hcc-----CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 GDKRRFY---RLL-----DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~---~~~-----~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .....+.   ...     .+..........+..+.+||.+||..||++|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000   000     0000001112236789999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=317.24  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=198.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||.|+||.||+|....         ++..||||.+...... ....+.+|+.+++.++|+||+++++++.++
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   75 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKL---------TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK   75 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcC---------CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC
Confidence            579999999999999999998765         5678999998654322 224567899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+. ++|.+++..... .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~  150 (291)
T cd07844          76 KTLTLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLA  150 (291)
T ss_pred             CeEEEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccc
Confidence            99999999997 599998876543 6889999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC--c
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD--K  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~  367 (490)
                      +........  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||........  ........+..  .
T Consensus       151 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~  226 (291)
T cd07844         151 RAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTE  226 (291)
T ss_pred             cccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCCh
Confidence            754322111  122356889999999875 4588999999999999999999999965431110  00000000000  0


Q ss_pred             hhh-------------hhccC-ccccCCC-ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRF-------------YRLLD-PRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~-------------~~~~~-~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..+             ..... ..+.... ......++.+++.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         227 ETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            000             00000 0000000 01113778899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=353.91  Aligned_cols=260  Identities=26%  Similarity=0.326  Sum_probs=217.0

Q ss_pred             hhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCce
Q 011234          124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNL  200 (490)
Q Consensus       124 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnI  200 (490)
                      ..+++...++|.++++||+|+||.|.+++++.         ++..+|.|++++...   ....-|..|-.+|..-+.+-|
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~---------t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKS---------TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeec---------cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHH
Confidence            45566778899999999999999999999976         788999999987432   233457789999999999999


Q ss_pred             eceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          201 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       201 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +.++-.|.++.++|+|||||+||+|..++.+..  .+++..+++++..|+.||.-||+.|   +|||||||+|||||..|
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccC
Confidence            999999999999999999999999999998876  6999999999999999999999999   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhh----c-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM----T-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~----~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      ++||+|||.+-.+..++... ....+|||.|.+||++.    + +.|+..+|+||+||++|||++|..||...      .
T Consensus       213 HikLADFGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------s  285 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------S  285 (1317)
T ss_pred             cEeeccchhHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------H
Confidence            99999999998887665443 34578999999999996    2 67999999999999999999999999643      2


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCC--hHhHHHHHHHHHHhhhcCCCCCCC---HHHHHHHh
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPR---MSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~RPs---~~evl~~L  415 (490)
                      +++.....+....          .-.||  ...+.++.+||.+++. +|+.|..   ++++..|.
T Consensus       286 lveTY~KIm~hk~----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  286 LVETYGKIMNHKE----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HHHHHHHHhchhh----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            3332222222111          11222  3358999999999884 8889988   99998875

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.8e-39  Score=315.16  Aligned_cols=252  Identities=29%  Similarity=0.399  Sum_probs=196.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHH-HhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF-LGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.+..... .....+..|+.+ ++.++||||+++++++..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~   71 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVP---------TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR   71 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcC---------CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence            368999999999999999998875         678999999876532 233456667665 566789999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      ++..++||||++ |+|.+++...  ....+++..+..++.||+.||.|||+. +   ++||||||+|||++.++.+||+|
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~d  147 (283)
T cd06617          72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCD  147 (283)
T ss_pred             CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEee
Confidence            999999999995 6888877542  234689999999999999999999986 6   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||++.......   ..+...|+..|+|||++.+    ..++.++|+|||||++|+|++|..||........ .+..... 
T Consensus       148 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~-  222 (283)
T cd06617         148 FGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLKQVVE-  222 (283)
T ss_pred             ccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHHHHHh-
Confidence            99998654321   1233568899999998864    4568899999999999999999999964221100 0000000 


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                ...+.+   .....+.++.+||.+||..+|++||++.+++++
T Consensus       223 ----------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         223 ----------EPSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ----------cCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      000000   011236789999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-38  Score=313.69  Aligned_cols=259  Identities=30%  Similarity=0.399  Sum_probs=204.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|...+.||.|+||.||+|.+..         ++..||+|.+..... .....+.+|+++++.++||||++++++|.+.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   71 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKN---------TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE   71 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECC---------CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc
Confidence            368888999999999999999865         567899999875432 3456788999999999999999999998654


Q ss_pred             --CceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          211 --DQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       211 --~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                        +.+++||||+++++|.+++..  .....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d  148 (287)
T cd06621          72 SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCD  148 (287)
T ss_pred             CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEee
Confidence              468999999999999988753  22345788999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCC--CCcchhHHhhhccc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP--NGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~--~~~~~~~~~~~~~~  364 (490)
                      ||++........    ....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ........+.... 
T Consensus       149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-  223 (287)
T cd06621         149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM-  223 (287)
T ss_pred             cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC-
Confidence            999876533211    234678899999999989999999999999999999999999975532  1111222221110 


Q ss_pred             CCchhhhhccCccccCCCC--hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          365 GDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       .        .+.+.....  ...+..+.+||.+||..||.+|||+.|++++-.
T Consensus       224 -~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~  268 (287)
T cd06621         224 -P--------NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW  268 (287)
T ss_pred             -C--------chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence             0        000111111  123678999999999999999999999998643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.5e-39  Score=317.23  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=204.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||.|+||.||+|....         ++..||+|.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~   89 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVA---------TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD   89 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcC---------CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence            579999999999999999998754         56689999987554445567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..|+|+||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          90 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             cEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCccee
Confidence            999999999999999998654   4788899999999999999999988   9999999999999999999999999887


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  ......|++.|+|||.+....++.++|||||||++|+|++|..||.............  .   ...    
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~--~---~~~----  232 (293)
T cd06647         164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--T---NGT----  232 (293)
T ss_pred             ccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh--c---CCC----
Confidence            6543221  1233568899999999988889999999999999999999999997543322111100  0   000    


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          +.  ...+...+..+.+||.+||..+|++||++.+++.+
T Consensus       233 ----~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 ----PE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ----CC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00  00111235678999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.2e-39  Score=316.09  Aligned_cols=259  Identities=29%  Similarity=0.386  Sum_probs=201.6

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceecee
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLV  204 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~  204 (490)
                      ++....++|.+.+.||+|+||.||+|....         ++..+|+|++..... ....+.+|+.++..+ +||||++++
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---------~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~   85 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKK---------DGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFY   85 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            344457789999999999999999998865         677899999865422 235677899999998 799999999


Q ss_pred             eEEEec-----CceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          205 GYCIED-----DQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       205 ~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      +++...     +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~  162 (291)
T cd06639          86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLT  162 (291)
T ss_pred             EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEc
Confidence            998754     3589999999999999988532  2336889999999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~  352 (490)
                      .++.+||+|||++.........  .....|+..|+|||++...     .++.++|||||||++|||++|+.||.......
T Consensus       163 ~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~  240 (291)
T cd06639         163 TEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK  240 (291)
T ss_pred             CCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence            9999999999998865432211  1234688999999988643     36889999999999999999999996543211


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .  +..+....           .+.+  ..+......+.+||.+||+.||++||++.+++++
T Consensus       241 ~--~~~~~~~~-----------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 T--LFKIPRNP-----------PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             H--HHHHhcCC-----------CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1  11110000           0000  0112235679999999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-39  Score=313.65  Aligned_cols=249  Identities=28%  Similarity=0.429  Sum_probs=200.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCC---CCceeceeeEEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL---HPNLVKLVGYCI  208 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~  208 (490)
                      .|++.+.||.|+||.||+|.+..         ++..||+|.+.... .....++.+|+.+++.+.   ||||+++++++.
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~   72 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVP---------TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL   72 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcC---------CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee
Confidence            47788999999999999999865         57799999987542 233456788999999986   999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .+...++||||+++++|.+++...   .+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          73 KGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             eCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCC
Confidence            999999999999999999988543   6889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........  ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||............       .. 
T Consensus       147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~-  216 (277)
T cd06917         147 VAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PK-  216 (277)
T ss_pred             ceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------cc-
Confidence            9987654321  1233568999999998875 45788999999999999999999999654322111100       00 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           ...+.+...   ..+.++.+++.+||..||++||++.+++.+
T Consensus       217 -----~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         217 -----SKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -----CCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                 000111110   136789999999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.3e-39  Score=316.63  Aligned_cols=266  Identities=26%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||.|+||.||+|.+..         +|..||||.+.....  .....+.+|++++++++||||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   71 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE   71 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECC---------CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence            48889999999999999998865         677899998875432  2235678899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+. ++|.+++.......+++..+..++.||+.||+|||+.+   ++||||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          72 NKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             CcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccch
Confidence            99999999995 68998887655557899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhccc----
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHL----  364 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~----  364 (490)
                      .........  .....++..|+|||++.+.. ++.++|||||||++|+|++|+.||......... ..........    
T Consensus       148 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         148 RAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             hhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhh
Confidence            765432111  12345788999999887644 688999999999999999999999654321110 0001000000    


Q ss_pred             ---CCc----hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 ---GDK----RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ---~~~----~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         ...    ..+.......+. ......+.++.+||.+||+.||.+||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence               000    000000000000 0011235678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-39  Score=343.06  Aligned_cols=280  Identities=19%  Similarity=0.240  Sum_probs=192.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCcccc-C-----CCCcE----EEEEEecCCChhhHHHHHHHHHHHhcCCCCc
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-P-----GTGLT----VAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN  199 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~-~-----~~g~~----vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn  199 (490)
                      ...+|++++.||+|+||.||+|.++........ .     ..+..    ++.|.+.. .......+.+|+.+|..++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            456899999999999999999987542110000 0     00011    11111111 1123456788999999999999


Q ss_pred             eeceeeEEEecCceEEEEEecCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       200 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ||++++++...+..|+|+|++ +++|.+++....   ........+..++.||+.||.|||+.+   ||||||||+||||
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            999999999999999999998 568887775432   112335567789999999999999988   9999999999999


Q ss_pred             cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCC-CCCCCCCcch
Q 011234          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf-~~~~~~~~~~  355 (490)
                      +.++.+||+|||+++.+..... ......+||..|+|||++.+..++.++|||||||+||||++|..++ ..........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            9999999999999987644322 2223467999999999999999999999999999999999988644 3322221112


Q ss_pred             hHHhhhcc------cCC-chhhhhccCccccC----CC-----ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          356 LVEWARPH------LGD-KRRFYRLLDPRLEG----HF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~------~~~-~~~~~~~~~~~l~~----~~-----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      +.+.....      +.+ ...++..++.....    .+     ....+.++.++|.+||..||.+|||+.|++++-
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp  455 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP  455 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence            21111100      000 00111111000000    00     011245678899999999999999999999763

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-39  Score=312.99  Aligned_cols=249  Identities=26%  Similarity=0.350  Sum_probs=205.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +|++.+.||.|+||.||+|.+..         ++..||+|++.....   ...+.+.+|++++++++||||+++++++..
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRD---------TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEcc---------CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            48889999999999999998865         677899999875432   345678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....++||||+.+++|.+++...  ..+++..+..++.||++||.|||+.+   ++|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeeccc
Confidence            99999999999999999998765  36889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +.......   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||...............    ..   
T Consensus       147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~~---  216 (258)
T cd05578         147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ----ET---  216 (258)
T ss_pred             ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHh----cc---
Confidence            88765432   123356889999999998888999999999999999999999999765432111111110    00   


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM--SEVVE  413 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~--~evl~  413 (490)
                              ....++...+..+.++|.+||..||.+||++  .|+++
T Consensus       217 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 --------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                    1112223346889999999999999999999  77654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=9e-39  Score=311.02  Aligned_cols=254  Identities=26%  Similarity=0.426  Sum_probs=201.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----------hhhHHHHHHHHHHHhc-CCCCcee
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------LQGHKEWLAEVNFLGN-LLHPNLV  201 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~HpnIv  201 (490)
                      +|++.+.||+|+||.||+|.+..+        ++..+|+|.+....          .....++..|+.++.. ++||||+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~--------~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~   72 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN--------GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIV   72 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC--------CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCee
Confidence            478889999999999999998652        45689999875321          1233457789988865 7899999


Q ss_pred             ceeeEEEecCceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcC
Q 011234          202 KLVGYCIEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       202 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~  278 (490)
                      ++++++..++..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+ .+   |+|+||+|+|||++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~  149 (269)
T cd08528          73 RYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGE  149 (269)
T ss_pred             eEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECC
Confidence            999999999999999999999999988743  223468899999999999999999996 45   999999999999999


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      ++.+||+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......   ...
T Consensus       150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~  223 (269)
T cd08528         150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LAT  223 (269)
T ss_pred             CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHH
Confidence            9999999999998654432   2234578999999999998889999999999999999999999986432111   111


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..   ...      ...+..    ....+..+.+||.+||+.||++||++.|+.++|+
T Consensus       224 ~~---~~~------~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         224 KI---VEA------VYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HH---hhc------cCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            00   000      000101    1123678999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.3e-39  Score=316.88  Aligned_cols=267  Identities=26%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||.|+||.||+|.+..         ++..||+|.++.....  ....+.+|+.++..+.||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   75 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKK---------TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG   75 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECC---------CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence            468899999999999999998865         5678999998754322  22356789999999999999999999888


Q ss_pred             c--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          210 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       210 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .  +..|+||||+. ++|.+++..... .+++..++.++.||+.||.|||+.+   |+|+||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          76 SNLDKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             cCCCcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeec
Confidence            7  88999999996 599998876543 6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hhh----
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WAR----  361 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~----  361 (490)
                      |++.........  .....++..|+|||.+.+. .++.++|||||||++|+|++|.+||...........+. ...    
T Consensus       151 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         151 GLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence            999876543211  1234578899999988754 46889999999999999999999997543221111100 000    


Q ss_pred             ---c---ccC--CchhhhhccCccccCCCChH-hHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 ---P---HLG--DKRRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ---~---~~~--~~~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         +   .+.  ....+.......+...++.. .+..+.+||.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence               0   000  00000000011111222222 36788999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.2e-39  Score=310.05  Aligned_cols=251  Identities=22%  Similarity=0.381  Sum_probs=203.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|.+.+.||.|+||.||+|....         +|..||+|.+.....  ...+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~   71 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS---------DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN   71 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC---------CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence            47889999999999999999876         567899999865422  2345678899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGL  289 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFG~  289 (490)
                      +..++|+||+++++|.+++.......+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++ .+||+|||.
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          72 GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999999999997765556899999999999999999999988   99999999999998886 469999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........  ......|++.|+|||++.+..++.++|+|||||++|+|++|..||......      +.........  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~--  218 (257)
T cd08225         149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQGY--  218 (257)
T ss_pred             chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhccc--
Confidence            987643321  122346899999999998888999999999999999999999998643221      1111110000  


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          +     .......+..+.++|.+||..+|++|||+.+|+.+
T Consensus       219 ----~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ----F-----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----C-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                0     01112236789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.4e-39  Score=315.99  Aligned_cols=268  Identities=23%  Similarity=0.314  Sum_probs=198.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +.+|.+.+.||+|+||.||+|....         +|..||+|.+...... ....+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   74 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRI---------NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT   74 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcC---------CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence            4679999999999999999998865         5678999998654322 23456789999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccc
Confidence            999999999995 78877775543 35778888899999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++........  .....++..|+|||++.+ ..++.++|||||||++|+|++|..||.............+.........
T Consensus       150 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  227 (291)
T cd07870         150 ARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED  227 (291)
T ss_pred             ccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence            8764332211  123457899999998875 3578899999999999999999999975432111000000000000000


Q ss_pred             ---------hh-hhccCccccCCC-----ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 ---------RF-YRLLDPRLEGHF-----SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ---------~~-~~~~~~~l~~~~-----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                               .+ ...........+     ....+..+.+|+.+||..||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                     00 000000000000     00125678899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-38  Score=311.44  Aligned_cols=247  Identities=27%  Similarity=0.414  Sum_probs=201.5

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      |++.+.||.|+||.||+|.+..         ++..||||++..... .....+.+|+.++..++||||+++++++..++.
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   76 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   76 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECC---------CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe
Confidence            7788999999999999998765         567899999865432 334568889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06641          77 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ  150 (277)
T ss_pred             EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeeccccee
Confidence            99999999999999988543   5789999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........   ....   ...      
T Consensus       151 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~---~~~------  216 (277)
T cd06641         151 LTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV---LFLI---PKN------  216 (277)
T ss_pred             cccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH---HHHH---hcC------
Confidence            543211  12235688999999999888899999999999999999999999864322111   1100   000      


Q ss_pred             ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ..+    .++...+.++.++|.+||..+|.+||++.+++++
T Consensus       217 -~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 -NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             -CCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             001    1122336788999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.3e-40  Score=307.14  Aligned_cols=276  Identities=23%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..|++...||+|.||.||+|.-.+...     .....+|||.++....  .......+|+.+++.|+||||+.+..+|..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~-----kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~   98 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTND-----KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS   98 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCc-----ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence            368999999999999999996554221     0134799999876522  223567899999999999999999999887


Q ss_pred             -cCceEEEEEecCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC----CC
Q 011234          210 -DDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YN  281 (490)
Q Consensus       210 -~~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~  281 (490)
                       +..++|++||.++ +|...|..+.   ...++...+..|+.||+.|+.|||++-   |+||||||.|||+..+    |.
T Consensus        99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen   99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCe
Confidence             7789999999965 8888885432   246899999999999999999999999   9999999999999877    89


Q ss_pred             eEEccccccccCCCCCCcc-eeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-----
Q 011234          282 AKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-----  354 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~-----  354 (490)
                      |||+|||+++.+.+.-... ....++-|.+|+|||.+.+ ..|+.+.|||++|||+.||++-.+.|.+....-..     
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq  254 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ  254 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence            9999999999876543332 2244677999999999987 47999999999999999999999999654322111     


Q ss_pred             --hhHHhh----hcccCCchhhhh---------ccCccccCCC--------ChHhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011234          355 --NLVEWA----RPHLGDKRRFYR---------LLDPRLEGHF--------SIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       355 --~~~~~~----~~~~~~~~~~~~---------~~~~~l~~~~--------~~~~~~~l~~Li~~cL~~dP~~RPs~~ev  411 (490)
                        .+....    .+...+...+..         .+....-...        ....++...+|+.+||..||.+|.|++++
T Consensus       255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA  334 (438)
T KOG0666|consen  255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA  334 (438)
T ss_pred             HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence              111110    011111111100         0000000000        00014458999999999999999999999


Q ss_pred             HHHhh
Q 011234          412 VETLK  416 (490)
Q Consensus       412 l~~L~  416 (490)
                      +++.-
T Consensus       335 leh~y  339 (438)
T KOG0666|consen  335 LEHPY  339 (438)
T ss_pred             hcccc
Confidence            99864

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.2e-39  Score=317.50  Aligned_cols=254  Identities=29%  Similarity=0.396  Sum_probs=197.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~  210 (490)
                      +|...+.||+|+||.||++.+..         +|..||+|.+..... .....+.+|+.++.++. |+||+++++++..+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~   75 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKP---------SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE   75 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECC---------CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC
Confidence            56677899999999999998865         677999999875432 34456889999999996 99999999999999


Q ss_pred             CceEEEEEecCCCCHHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          211 DQRLLVYEFMPRGSLENHL---FRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l---~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +..+++|||+. ++|.++.   .......+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          76 GDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             CcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEee
Confidence            99999999985 4655443   223334689999999999999999999974 6   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||++........   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||....     ...+.....
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~  223 (288)
T cd06616         152 FGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQV  223 (288)
T ss_pred             cchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhh
Confidence            999976543211   1234689999999998766   68999999999999999999999996542     111111110


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...       ..+.+....+...+.++.+||.+||+.||++|||+.+|+.+
T Consensus       224 ~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         224 VKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCC-------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000       01111112222347789999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-38  Score=308.16  Aligned_cols=254  Identities=31%  Similarity=0.457  Sum_probs=203.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|.+.+.||+|+||.||+|....         ++..||+|.+......  ..+.+..|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   71 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLD---------TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR   71 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECC---------CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence            58889999999999999998765         5678999998765442  556788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++|+||+++++|.+++....  .+++..+..++.+++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++
T Consensus        72 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          72 EKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccc
Confidence            99999999999999999987653  4788889999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcce--eeccccCCCCCCchhhhcCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          291 KDAPEDGKTHV--STRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       291 ~~~~~~~~~~~--~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ...........  .....|+..|+|||++.+..   ++.++||||||+++|+|++|+.||........  . .+.. ...
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~-~~~~-~~~  222 (264)
T cd06626         147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I-MFHV-GAG  222 (264)
T ss_pred             cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H-HHHH-hcC
Confidence            87654322211  12356789999999998766   88999999999999999999999964321111  0 0000 000


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .        .+.+.  .....+..+.+||.+||+.||.+||++.+++.+
T Consensus       223 ~--------~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         223 H--------KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             C--------CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0        00010  011226778999999999999999999999854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-38  Score=313.46  Aligned_cols=250  Identities=28%  Similarity=0.415  Sum_probs=202.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      .|...+.||+|+||.||++.+..         ++..||+|.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~   90 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKS---------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE   90 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence            35556799999999999998765         567899999876555555678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .++|+||+++++|.+++...   .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++..
T Consensus        91 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~  164 (285)
T cd06648          91 LWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQ  164 (285)
T ss_pred             EEEEEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchh
Confidence            99999999999999988762   5888999999999999999999988   99999999999999999999999998876


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......  ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+...   .......         
T Consensus       165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~---~~~~~~~---------  230 (285)
T cd06648         165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA---MKRIRDN---------  230 (285)
T ss_pred             hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHhc---------
Confidence            543221  12235689999999999888899999999999999999999999965332111   1111100         


Q ss_pred             ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ..+...  .+...+..+.+||.+||..+|++||++.+++++
T Consensus       231 -~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         231 -LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence             000110  111236789999999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.1e-38  Score=323.60  Aligned_cols=265  Identities=23%  Similarity=0.301  Sum_probs=200.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||.+...  .......+.+|+.+++.++|+||+++++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   84 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTV---------TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVF   84 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECC---------CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeee
Confidence            34679999999999999999998875         6779999998643  233445678899999999999999999988


Q ss_pred             Eec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          208 IED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       208 ~~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ...      ...|+||||+. ++|.+.+..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~  156 (353)
T cd07850          85 TPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT  156 (353)
T ss_pred             ccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCC
Confidence            644      35799999995 588887753    2788889999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hh-
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW-  359 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~-  359 (490)
                      +||+|||+++.......   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .. 
T Consensus       157 ~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  233 (353)
T cd07850         157 LKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL  233 (353)
T ss_pred             EEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999986543211   23356889999999999999999999999999999999999999654321111000 00 


Q ss_pred             ----------hh----cccC-----CchhhhhccCcc----ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 ----------AR----PHLG-----DKRRFYRLLDPR----LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ----------~~----~~~~-----~~~~~~~~~~~~----l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                ..    ....     ....+...+...    .....+...+..+.+||.+||+.||++|||+.|+|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      00    0000     000000111000    0001112336678999999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-38  Score=303.62  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=206.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      +|.+.+.||.|+||.||++.+..         ++..|++|++..........+.+|+.+++.+.|+||+++++++..+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   71 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR---------TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE   71 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC---------CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            47888999999999999998865         567899999987655556788999999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .++++||+++++|.+++.... ..+++..+..++.|++.||.|||..+   ++||||+|+||+++.++.++|+|||.+..
T Consensus        72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccc
Confidence            999999999999999987653 36899999999999999999999988   99999999999999999999999999987


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      ......   .....|+..|+|||++.+..++.++||||||+++|+|++|..||............   ..  ..   .  
T Consensus       148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~--~~---~--  214 (253)
T cd05122         148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---AT--NG---P--  214 (253)
T ss_pred             cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hh--cC---C--
Confidence            654321   23457899999999998888999999999999999999999999654321111100   00  00   0  


Q ss_pred             ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         +.+  ..+...+..+.++|.+||..||++|||+.+++++
T Consensus       215 ---~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         215 ---PGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ---CCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               000  0111125789999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-38  Score=311.30  Aligned_cols=246  Identities=31%  Similarity=0.435  Sum_probs=196.9

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||+|+||.||+|.+..         +|..||+|.+.....   .....+..|+.+|+.++||||+++++++...+..|+|
T Consensus         1 lg~g~~g~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKA---------TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcC---------CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            6999999999998765         677899999865322   2234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.......+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            99999999999997765556899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.  .....           
T Consensus       149 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~-----------  212 (277)
T cd05577         149 K---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE-----------  212 (277)
T ss_pred             C---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc-----------
Confidence            1   1123467889999999988889999999999999999999999996543321111111  00000           


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                       ....++...+..+.++|.+||+.||.+||     ++.+++++
T Consensus       213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence             01112223377899999999999999999     66667653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-40  Score=331.97  Aligned_cols=248  Identities=24%  Similarity=0.401  Sum_probs=198.0

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC----ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .+...+||+|+|-+||+|.+..         +|..||=-.++..    .....+.|..|+.+|+.|+|||||++|.++.+
T Consensus        42 ~k~~evLGrGafKtVYka~De~---------~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEE---------EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             eehhhhcccccceeeeeccccc---------cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            4556789999999999998865         6777874333221    22345778999999999999999999999988


Q ss_pred             cCc--eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEcc
Q 011234          210 DDQ--RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSD  286 (490)
Q Consensus       210 ~~~--~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~D  286 (490)
                      ...  ..+|+|++..|+|..|+.+.+  .+....+..|++||++||.|||++. .+|||||||.+||+|+. -|.|||+|
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGD  189 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGD  189 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecc
Confidence            765  778999999999999998877  5677899999999999999999987 78999999999999975 58999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +|||.......    ...++|||.|||||+.. ..|+..+||||||++|+||+|+..||.....     ..+..+.....
T Consensus       190 LGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SG  259 (632)
T KOG0584|consen  190 LGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSG  259 (632)
T ss_pred             hhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcC
Confidence            99999775432    23478999999999776 8999999999999999999999999965322     22222222111


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..          ...+..-..+++++||.+||.. .++|+|+.|+|.+
T Consensus       260 iK----------P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  260 IK----------PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CC----------HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            11          1111112257899999999999 9999999999975

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-38  Score=303.67  Aligned_cols=253  Identities=29%  Similarity=0.448  Sum_probs=207.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|.+.+.||+|+||.||+|.+..         ++..|++|++.....  ...+.+.+|+.++++++|+||+++++++...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKD---------TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE   71 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence            47888999999999999998865         567899999876643  3456788999999999999999999999988


Q ss_pred             --CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 --~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                        ...++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          72 EKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             CCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccc
Confidence              88999999999999999987765  7899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      .+................++..|+|||.+.+..++.++||||||+++|+|++|..||.....     ......       
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~-------  214 (260)
T cd06606         147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAALY-------  214 (260)
T ss_pred             cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHHHH-------
Confidence            99877554321112345688999999999888899999999999999999999999975431     000000       


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         ..........++...+..+.++|.+||..||++||++.+++.+
T Consensus       215 ---~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         215 ---KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ---hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence               0110011112223337889999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-38  Score=310.87  Aligned_cols=244  Identities=28%  Similarity=0.406  Sum_probs=190.6

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHH---HHhcCCCCceeceeeEEEecCc
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVN---FLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~---~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      +||+|+||.||++.+..         +|..||+|.+.....   .....+.+|..   ++...+||||+.+++++..++.
T Consensus         1 ~lg~G~~g~Vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEECC---------CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            48999999999998865         677999998865422   11223344443   3444579999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .++||||+++++|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            999999999999999887654  6899999999999999999999988   99999999999999999999999999875


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .....    .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...............   .       
T Consensus       147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~-------  212 (279)
T cd05633         147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-------  212 (279)
T ss_pred             ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---h-------
Confidence            53321    123468999999998864 56899999999999999999999999754332211111100   0       


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                           .....++...+.++.++|.+||..||++||     ++.+++++.
T Consensus       213 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         213 -----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             -----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence                 001112233478899999999999999999     599998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-38  Score=314.99  Aligned_cols=268  Identities=22%  Similarity=0.323  Sum_probs=200.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|.+.....  .....+.+|+++++.++|+||+++++++.+
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   72 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRV---------TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS   72 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecC---------CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence            468999999999999999998865         577899998865432  223567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEcccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG  288 (490)
                      .+..++||||++ ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        73 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         73 EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccc
Confidence            999999999995 68888886665555788888899999999999999988   999999999999985 5579999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-hccc-
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-RPHL-  364 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-~~~~-  364 (490)
                      ++.......  .......|++.|+|||++.+ ..++.++|||||||++|+|++|.+||......+..... ... .+.. 
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  226 (294)
T PLN00009        149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE  226 (294)
T ss_pred             cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            997654321  11123467889999998876 45789999999999999999999999754332111100 000 0000 


Q ss_pred             -----CCchhhhhcc---CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 -----GDKRRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 -----~~~~~~~~~~---~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           .....+....   ............+.++.+++.+||+.||++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000000000   0000001112236778999999999999999999999975

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-38  Score=307.22  Aligned_cols=244  Identities=27%  Similarity=0.379  Sum_probs=198.8

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||.|+||.||+|.+..         ++..||+|++.....   ...+.+.+|+.+++.++||||+++++++.++...++|
T Consensus         1 lg~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKS---------KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            7999999999999865         577899999875432   2345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.+..  .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            99999999999997654  5888999999999999999999988   999999999999999999999999999876543


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .   ......|+..|++||.+.+..++.++|+||||+++|+|++|..||....... .....             .....
T Consensus       147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~-------------~~~~~  209 (262)
T cd05572         147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYN-------------DILKG  209 (262)
T ss_pred             c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHH-------------HHhcc
Confidence            2   1223568999999999988889999999999999999999999997543211 11110             01110


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                      .....++...+..+.++|.+||..||++||+     +.|++++
T Consensus       210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            1111233333678999999999999999999     7888764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-38  Score=315.24  Aligned_cols=249  Identities=29%  Similarity=0.419  Sum_probs=199.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..|.+.+.||+|+||.||+|.+..         +|..||+|.+.....   ...+.+.+|+.+++.++||||+++++++.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcC---------CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            458899999999999999998865         567899999864422   33456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          86 REHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             eCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecC
Confidence            9999999999996 67877775443 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ++......      ....|+..|+|||++.   ...++.++||||||+++|||++|..||.............     ..
T Consensus       161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~-----~~  229 (307)
T cd06607         161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QN  229 (307)
T ss_pred             cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-----cC
Confidence            98765332      2346888999999874   4568889999999999999999999986432111100000     00


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .        .+.   ......+..+.+||.+||..||++||++.+|+.+..
T Consensus       230 ~--------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         230 D--------SPT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             C--------CCC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            0        000   011224678999999999999999999999998643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=305.09  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=204.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ++||+|+|+.|--|....         +|..+|||++.+........+.+|++++.+++ |+||++++++|.++...|||
T Consensus        84 e~LGeGAyasVqtcv~i~---------t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV  154 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQ---------TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV  154 (463)
T ss_pred             HHhcCccceeeeeeeeec---------cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence            679999999999998765         78899999998886667788999999999996 99999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC---CeEEccccccccC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDA  293 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFG~a~~~  293 (490)
                      ||-|.||.|..+|.++.  -+.+.++..++.+|+.||.|||..|   |.||||||+|||.....   -+|||||.+..-.
T Consensus       155 fEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  155 FEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             EecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence            99999999999998876  6889999999999999999999988   99999999999996554   4899999987643


Q ss_pred             CCCCC-----cceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          294 PEDGK-----THVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       294 ~~~~~-----~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      .....     +......+|+..|||||++.     ...|+.++|.||||||||.||+|.+||.+.-..+-    .|.+-.
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC----GWdrGe  305 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC----GWDRGE  305 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC----CccCCC
Confidence            32111     11123468999999999874     35789999999999999999999999975432111    111111


Q ss_pred             cC---CchhhhhccCccccCCCC----hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          364 LG---DKRRFYRLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ~~---~~~~~~~~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..   ...-|..+.+..+  +||    ...+.++.+||..+|..|+.+|.++.+++++-
T Consensus       306 ~Cr~CQ~~LFesIQEGkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             ccHHHHHHHHHHHhccCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            11   0111112221111  222    23488999999999999999999999999853

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-38  Score=310.23  Aligned_cols=260  Identities=25%  Similarity=0.348  Sum_probs=196.4

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCceeceeeEEEec-
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED-  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~-  210 (490)
                      |++.+.||+|+||.||+|....         ++..||+|.++.... .......+|+.++.++. |+||+++++++.+. 
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   71 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRK---------TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK   71 (282)
T ss_pred             CceEeeccccccceEEEEEEcC---------CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC
Confidence            6778999999999999998865         567899999875421 22234567999999886 99999999999987 


Q ss_pred             -CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       +..++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||+|+||+++. +.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~  145 (282)
T cd07831          72 TGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGS  145 (282)
T ss_pred             CCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccc
Confidence             88999999996 68888886543 36899999999999999999999988   999999999999999 9999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........   .....++..|+|||++.. ..++.++|||||||++|||++|..||......+.   +.......+...
T Consensus       146 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~  219 (282)
T cd07831         146 CRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPD  219 (282)
T ss_pred             ccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCC
Confidence            986643221   123468899999997754 5678899999999999999999999976543221   111111110000


Q ss_pred             h-hhhccC---------ccccC----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 R-FYRLLD---------PRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~-~~~~~~---------~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      . ....+.         +....    ......+..+.+||.+||..||++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         220 AEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             HHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0 000000         00000    0011337889999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-38  Score=319.78  Aligned_cols=270  Identities=26%  Similarity=0.380  Sum_probs=202.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||.+...  .......+.+|+.+++.++|+||+++++++.
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~   74 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSE---------TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMP   74 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecC---------CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHhee
Confidence            3579999999999999999998765         6779999998653  2233456778999999999999999999876


Q ss_pred             ec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          209 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       209 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ..     ...++||||+. ++|.+++...+  .+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~k  148 (337)
T cd07858          75 PPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLK  148 (337)
T ss_pred             cccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEE
Confidence            54     34799999995 78998886554  6899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hhh
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WAR  361 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~  361 (490)
                      |+|||++.......  .......|+..|+|||.+.. ..++.++|||||||++|+|++|++||...........+. ...
T Consensus       149 L~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  226 (337)
T cd07858         149 ICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG  226 (337)
T ss_pred             ECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            99999998664332  11233568899999998865 468999999999999999999999996543211111000 000


Q ss_pred             c-------ccC--Cchhhhhc----cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcc
Q 011234          362 P-------HLG--DKRRFYRL----LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPL  418 (490)
Q Consensus       362 ~-------~~~--~~~~~~~~----~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~l  418 (490)
                      .       ...  ........    .+..+. ......+.++.+||.+||+.||++|||+.+++++  +..+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            0       000  00000000    000000 0112347789999999999999999999999988  5544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.5e-38  Score=310.28  Aligned_cols=267  Identities=24%  Similarity=0.361  Sum_probs=201.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +|++.+.||.|+||.||+|.+..         +|..||||++...... ....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   71 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRT---------TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN   71 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECC---------CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC
Confidence            58889999999999999999865         6779999998765332 2356778999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ..++||||++ ++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+||++++++.++|+|||++
T Consensus        72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchh
Confidence            9999999997 58888886543 235899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-hccc---
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-RPHL---  364 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-~~~~---  364 (490)
                      ........  ......++..|++||++.+ ..++.++|||||||++|+|++|..||...........+ ... .+..   
T Consensus       148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence            76533211  1123457889999998865 45788999999999999999999999754332111110 000 0000   


Q ss_pred             ---CCchhhhhccCc---cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 ---GDKRRFYRLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ---~~~~~~~~~~~~---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         .....+......   .....+....+..+.++|.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence               000000000000   00001112236788999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3e-38  Score=304.00  Aligned_cols=251  Identities=25%  Similarity=0.395  Sum_probs=207.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|.+.+.||.|+||.||++.+..         ++..||+|++.....  .....+.+|+++++.++|+|++++++.+...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   71 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKS---------DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK   71 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcC---------CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence            58889999999999999999865         567899999876543  4556788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +..++||||+++++|.+++....  ...+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~  148 (258)
T cd08215          72 GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFG  148 (258)
T ss_pred             CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCcc
Confidence            99999999999999999987643  347899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.......  .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......   .....   ...  
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~---~~~--  218 (258)
T cd08215         149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE---LALKI---LKG--  218 (258)
T ss_pred             ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH---HHHHH---hcC--
Confidence            998765432  12234578999999999988889999999999999999999999996543211   11100   000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          .     ...++...+..+.+++.+||..+|++||++.+++++
T Consensus       219 ----~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 ----Q-----YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ----C-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0     011122336789999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-38  Score=313.03  Aligned_cols=266  Identities=23%  Similarity=0.323  Sum_probs=200.3

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      |++.+.||.|++|.||+|.+..         +|..||+|++.....  .....+.+|+.+++.++||||+++++++.+.+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~   71 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL---------TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN   71 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC---------CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC
Confidence            6778999999999999999865         577899999875432  22356788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+ +++|.+++.......+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          72 KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             eEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            999999999 469999987665456899999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhhcc------
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARPH------  363 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~~~------  363 (490)
                      ........  .....++..|+|||++.+. .++.++|||||||++|+|++|.+||.......... ........      
T Consensus       148 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         148 AFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             ccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence            65332111  1223568899999988654 57889999999999999999999996543211100 00000000      


Q ss_pred             -cCCchhhhhccC---ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 -LGDKRRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 -~~~~~~~~~~~~---~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ......+...+.   ...........+..+.+||.+||+.||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             000000000000   000001112235788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-38  Score=313.28  Aligned_cols=266  Identities=18%  Similarity=0.228  Sum_probs=191.2

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH-----------HHHHHHHHHHhcCCC
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGNLLH  197 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~H  197 (490)
                      +..++|++.++||+|+||.||+|.+..+..      .+..+|+|+.........           .....++..+..+.|
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~------~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h   82 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHC------INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH   82 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcc------cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC
Confidence            344689999999999999999999865321      144677776543321110           112334455677889


Q ss_pred             CceeceeeEEEecC----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          198 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       198 pnIv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      +||+++++++....    ..+++||++ ..++.+.+....  ..++..+..++.|++.||.|||+.+   |+||||||+|
T Consensus        83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~N  156 (294)
T PHA02882         83 LGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPEN  156 (294)
T ss_pred             CCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence            99999999766543    346788887 457776665432  4578888999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~  348 (490)
                      ||++.++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999866432211     1112346999999999999999999999999999999999999999765


Q ss_pred             CCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ......  +......+     ...+.....   ....++..+.+++..||..+|++||++.+|++.|+
T Consensus       237 ~~~~~~--~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        237 GHNGNL--IHAAKCDF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             ccchHH--HHHhHHHH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            322211  10000000     000111110   01123678999999999999999999999998764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3e-38  Score=310.41  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=207.0

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+.|++.+.||.|+||.||+|.+..         ++..||+|++..... ....+.+|+.+++.++|+||+++++++..
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   86 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRA---------TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV   86 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEcc---------CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence            45678899999999999999998865         566899999976544 45678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          87 GDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             CCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccch
Confidence            999999999999999999998764 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........  ......|+..|+|||++.+..++.++|||||||++|+|++|..||.........  .......      
T Consensus       163 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~~~~------  232 (286)
T cd06614         163 AAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLITTKG------  232 (286)
T ss_pred             hhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcC------
Confidence            875543211  112346788999999998888999999999999999999999998643222111  0000000      


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                          . +..  ......+..+.+||.+||+.+|.+||++.+++++.
T Consensus       233 ----~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         233 ----I-PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             ----C-CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence                0 000  01112367899999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=315.89  Aligned_cols=271  Identities=24%  Similarity=0.320  Sum_probs=199.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +|.+.+.||+|+||.||+|.....       +++..||+|.+....   ......+.+|+.++..++||||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG-------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLE   73 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC-------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeC
Confidence            478889999999999999998652       146789999988632   2234567889999999999999999999998


Q ss_pred             c--CceEEEEEecCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC----CC
Q 011234          210 D--DQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----DY  280 (490)
Q Consensus       210 ~--~~~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~  280 (490)
                      .  ...++||||++ ++|.+++....   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.    ++
T Consensus        74 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~  149 (316)
T cd07842          74 HADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERG  149 (316)
T ss_pred             CCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccc
Confidence            8  78999999996 57777664322   236889999999999999999999988   999999999999999    89


Q ss_pred             CeEEccccccccCCCCCC-cceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch---
Q 011234          281 NAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN---  355 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~---  355 (490)
                      .+||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|++||..........   
T Consensus       150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~  229 (316)
T cd07842         150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF  229 (316)
T ss_pred             eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchh
Confidence            999999999987643322 111234568899999998876 458899999999999999999999997554332000   


Q ss_pred             ---hHHhhhcccCC-----------chhhhhccCccccCCCC---------h--HhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011234          356 ---LVEWARPHLGD-----------KRRFYRLLDPRLEGHFS---------I--KGSQKATQLAAQCLSRDPKARPRMSE  410 (490)
Q Consensus       356 ---~~~~~~~~~~~-----------~~~~~~~~~~~l~~~~~---------~--~~~~~l~~Li~~cL~~dP~~RPs~~e  410 (490)
                         ........+..           ...+....+......++         .  ..+..+.+++.+||+.||++|||+.|
T Consensus       230 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~e  309 (316)
T cd07842         230 QRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEE  309 (316)
T ss_pred             HHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence               00000000000           00000000000000000         0  23567899999999999999999999


Q ss_pred             HHHH
Q 011234          411 VVET  414 (490)
Q Consensus       411 vl~~  414 (490)
                      ++++
T Consensus       310 il~~  313 (316)
T cd07842         310 ALEH  313 (316)
T ss_pred             HhcC
Confidence            9865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-38  Score=314.74  Aligned_cols=269  Identities=25%  Similarity=0.348  Sum_probs=197.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|....         ++..||||.+.....  .....+.+|+.+++.++||||+++++++..
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   82 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKK---------TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   82 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECC---------CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence            469999999999999999998765         677999998864422  123345789999999999999999999876


Q ss_pred             cC--------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          210 DD--------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~~--------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ..        ..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~  157 (310)
T cd07865          83 KATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGI  157 (310)
T ss_pred             ccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCc
Confidence            54        3499999995 58888876543 36899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCc--ceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          282 AKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +||+|||++.........  .......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+.
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~  237 (310)
T cd07865         158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS  237 (310)
T ss_pred             EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            999999999865432211  112234678899999988664 47889999999999999999999997654322222221


Q ss_pred             hhhcccC-----Cc--hhhhhccC-c-----cccCCC-ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          359 WARPHLG-----DK--RRFYRLLD-P-----RLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ~~~~~~~-----~~--~~~~~~~~-~-----~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .......     ..  ...+..+. +     .....+ +...+..+.+||.+||..||.+|||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            1110000     00  00000000 0     000000 00124567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-39  Score=322.37  Aligned_cols=265  Identities=25%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   74 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKP---------TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRP   74 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcC---------CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence            4689999999999999999998865         67799999986432 2334567889999999999999999998765


Q ss_pred             cC-----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          210 DD-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ..     ..++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          75 PSFESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             ccccccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEE
Confidence            43     4799999995 5888777433   6899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCC-cceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          285 SDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      +|||++........ ........|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........   ...
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~  224 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILG  224 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHH
Confidence            99999876543211 111233578999999998754 5688999999999999999999999965432111100   000


Q ss_pred             ccCC--chhh-----------hhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGD--KRRF-----------YRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~--~~~~-----------~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+..  ...+           ...........   .....+.++.+||.+||+.||++|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         225 VLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000  0000           00000000000   001225778999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=357.58  Aligned_cols=255  Identities=29%  Similarity=0.394  Sum_probs=206.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +-+|.-...||.|.||.||-|.+.+         +|+..|+|.++...  ....+.+.+|+.+|..|+|||||++||+-.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~---------tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLD---------TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCC---------ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee
Confidence            4478888999999999999998776         78899999886543  233456788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..+|.||||.+|+|.+++...+  .+++.....+..|++.||.|||+.|   ||||||||+||||+.+|.+|++|||
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccc
Confidence            9999999999999999999886543  4666667778899999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCCc--ceeeccccCCCCCCchhhhcC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          289 LAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       289 ~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      .|..+.....+  ......+||+.|||||++.+.   ....+.||||||||+.||+||++||...+....    -.....
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~ 1455 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVA 1455 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHh
Confidence            99877554211  111347899999999999764   456799999999999999999999965432211    111111


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .+..            ..+|...+.+..++|.+||..||..|.++.|++++=
T Consensus      1456 ~gh~------------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1456 AGHK------------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             ccCC------------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            1111            123344589999999999999999999999998763

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.6e-38  Score=316.10  Aligned_cols=269  Identities=28%  Similarity=0.338  Sum_probs=200.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||.|+||.||+|.+..         +|..||+|.+......  ....+.+|+.++..++|+||+++++++.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTT---------SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVV   76 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence            3579999999999999999998865         6779999998654321  1234568999999999999999999987


Q ss_pred             ec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          209 ED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      ..  +..++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~d  151 (309)
T cd07845          77 GKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIAD  151 (309)
T ss_pred             cCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence            65  46899999995 58888886543 36899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc-cc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-HL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~  364 (490)
                      ||++.........  .....++..|+|||++.+ ..++.++|||||||++|||++|.+||...........+..... ..
T Consensus       152 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  229 (309)
T cd07845         152 FGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN  229 (309)
T ss_pred             cceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9999876433211  122346788999999875 5688999999999999999999999976543322111111000 00


Q ss_pred             CCc----h-----hhhhccCccccC--CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          365 GDK----R-----RFYRLLDPRLEG--HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       365 ~~~----~-----~~~~~~~~~l~~--~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...    .     ..+.........  ......+..+.+||.+||+.||++|||+.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            000    0     000000000000  00011267789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.9e-38  Score=317.18  Aligned_cols=264  Identities=23%  Similarity=0.287  Sum_probs=196.0

Q ss_pred             ceeccC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      ..||+|  +||+||+|.+..         +|..||+|++....  ....+.+.+|+.+++.++||||++++++|..++..
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~   74 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTP---------TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL   74 (328)
T ss_pred             HHhCCcccCceeEEEEEEcC---------CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCce
Confidence            456666  999999998865         67899999987543  22345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+.+++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++++||+.+...
T Consensus        75 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             EEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            99999999999999988765556899999999999999999999988   999999999999999999999999865433


Q ss_pred             CCCCCcc-----eeeccccCCCCCCchhhhcC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc-c--
Q 011234          294 PEDGKTH-----VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-H--  363 (490)
Q Consensus       294 ~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~--  363 (490)
                      .......     ......++..|+|||++.+.  .++.++|||||||++|+|++|..||........  ....... .  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~  229 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYS  229 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCC
Confidence            2211110     00112356679999999763  478999999999999999999999965432111  0000000 0  


Q ss_pred             ------cCCch--------hh--------------hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          364 ------LGDKR--------RF--------------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ------~~~~~--------~~--------------~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                            .....        .+              .......+........+..+.+||.+||..||++|||+.+++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         230 PLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             CccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                  00000        00              000001111122234578899999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=304.92  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=200.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+|++.+.||+|+||.||+|.+..         +|..||+|.+...     .......+.+|+.+++.++|+||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   72 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDAD---------TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC   72 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcC---------CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            468999999999999999998765         6779999987532     12334567889999999999999999999


Q ss_pred             EEec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          207 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       207 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +.+.  ..+++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|
T Consensus        73 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l  147 (264)
T cd06653          73 LRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKL  147 (264)
T ss_pred             EEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEE
Confidence            8764  45789999999999999987654  5788889999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCC-cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+++....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||........  ...     
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-----  220 (264)
T cd06653         148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFK-----  220 (264)
T ss_pred             CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHH-----
Confidence            99999986532111 1111235689999999999888899999999999999999999999964321111  000     


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                               .........++...+..+.++|.+||. +|..||++.+++.+.
T Consensus       221 ---------~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         221 ---------IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ---------HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                     000111112333447889999999999 579999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.2e-38  Score=313.24  Aligned_cols=252  Identities=29%  Similarity=0.413  Sum_probs=200.7

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      |...+.||+|+||.||+|.+..         ++..||+|.+.....   .....+..|+.+++.++|+||+++++++.++
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   97 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVR---------TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE   97 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcC---------CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            7788999999999999998865         567899999875422   2345688899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++.++.++|+|||++
T Consensus        98 ~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635          98 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             CeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCc
Confidence            99999999996 58887776543 36899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ......      ....|+..|+|||++.   .+.++.++|||||||++|||++|..||..........  .+..      
T Consensus       173 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~~------  238 (317)
T cd06635         173 SIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQ------  238 (317)
T ss_pred             cccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHh------
Confidence            754321      2346889999999974   4568899999999999999999999986432111100  0000      


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                              ...........+..+.+||.+||+.+|.+||++.++++++..+...
T Consensus       239 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         239 --------NESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             --------ccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                    0000011112367799999999999999999999999987655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.9e-38  Score=313.03  Aligned_cols=268  Identities=23%  Similarity=0.307  Sum_probs=197.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCC-CCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLL-HPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||.+.....  .....+.+|+.+++.+. |+||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~---------~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~   71 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKN---------TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEH   71 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECC---------CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEe
Confidence            368899999999999999999865         677899998765422  22356788999999995 699999999988


Q ss_pred             ecCc-----eEEEEEecCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-C
Q 011234          209 EDDQ-----RLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-D  279 (490)
Q Consensus       209 ~~~~-----~~lv~E~~~~g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~  279 (490)
                      ..+.     .|+||||+++ +|.+++....   ...+++..++.++.||+.||.|||+.+   |+||||||+||+++. +
T Consensus        72 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~  147 (295)
T cd07837          72 VEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQK  147 (295)
T ss_pred             ecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCC
Confidence            7665     8999999975 8988876532   235899999999999999999999988   999999999999998 8


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-  357 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-  357 (490)
                      +.+||+|||++.........  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+ 
T Consensus       148 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~  225 (295)
T cd07837         148 GLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF  225 (295)
T ss_pred             CeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            89999999998765332111  122357889999998865 45789999999999999999999999754322111000 


Q ss_pred             Hhhh-c------ccCCchhhhh--ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          358 EWAR-P------HLGDKRRFYR--LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~-~------~~~~~~~~~~--~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .... +      ..........  ...+..........+..+.+||.+||..||.+||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000 0      0000000000  000000000111236789999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.5e-38  Score=305.99  Aligned_cols=243  Identities=28%  Similarity=0.423  Sum_probs=190.7

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHH---HHHHhcCCCCceeceeeEEEecCc
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAE---VNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E---~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      +||+|+||.||+|.+..         +|..||+|++......   ....+..|   +.+++...||||+.+++++...+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEec---------CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            48999999999998765         6779999998754322   11223334   344555689999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .++||||+.+++|..++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            999999999999999886554  6899999999999999999999988   99999999999999999999999999876


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .....    .....|+..|+|||++.++ .++.++|||||||++|+|++|..||...............   .       
T Consensus       147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~-------  212 (278)
T cd05606         147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-------  212 (278)
T ss_pred             cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh---h-------
Confidence            53321    1234789999999998754 6899999999999999999999999754322211111000   0       


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                       ..    ...++...+..+.+++.+||..||.+||     ++.+++++
T Consensus       213 -~~----~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         213 -TM----AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -cc----CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             00    1112223378899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.2e-38  Score=310.89  Aligned_cols=246  Identities=27%  Similarity=0.402  Sum_probs=199.0

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ...||+|+||.||++....         +|..||||.+..........+.+|+.+++.++|+||+++++++...+..++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   95 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV   95 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcC---------CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEE
Confidence            4679999999999998865         6779999998765545556788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++...   .+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~  169 (292)
T cd06657          96 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  169 (292)
T ss_pred             EecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence            9999999999877433   5788999999999999999999988   999999999999999999999999998765432


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      ..  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||........   ........          ..
T Consensus       170 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~~~----------~~  234 (292)
T cd06657         170 VP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL----------PP  234 (292)
T ss_pred             cc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhhC----------Cc
Confidence            21  12335689999999999888899999999999999999999999864322111   11111000          01


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+..  ....+..+.+++.+||..||.+||++.+++++
T Consensus       235 ~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         235 KLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            1100  01225678999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=309.46  Aligned_cols=274  Identities=23%  Similarity=0.318  Sum_probs=211.0

Q ss_pred             hchhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-C-C-
Q 011234          122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H-P-  198 (490)
Q Consensus       122 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-p-  198 (490)
                      +.+......+.+|.+.+.+|+|.||.|-++++..         ++..||||+++.-. ...+..+-|+++|.++. + | 
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---------~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~  148 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---------TKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPN  148 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecC---------CCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCC
Confidence            3444445668899999999999999999999876         57799999986432 23345567999999994 2 2 


Q ss_pred             ---ceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          199 ---NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       199 ---nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                         -+|.+.+||...++.|||+|.+ |-+++++|..++-.+++..++..++.|++++++|||+.+   ++|.||||+|||
T Consensus       149 g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENIL  224 (415)
T KOG0671|consen  149 GKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENIL  224 (415)
T ss_pred             CceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEE
Confidence               3788899999999999999998 779999999888889999999999999999999999998   999999999999


Q ss_pred             EcC--------------------CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHH
Q 011234          276 LDA--------------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  335 (490)
Q Consensus       276 l~~--------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil  335 (490)
                      +.+                    +..|+|+|||.|+......     ..++.|..|.|||++.+-.++..+||||+||||
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL  299 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL  299 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence            832                    2358999999998764433     346779999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCCcchhHHhhhcccCCc------------------------h---hhhhccCccccC-CCChHhH
Q 011234          336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK------------------------R---RFYRLLDPRLEG-HFSIKGS  387 (490)
Q Consensus       336 ~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------~---~~~~~~~~~l~~-~~~~~~~  387 (490)
                      +||++|...|......+...+.+.....++..                        .   ...+...+.-.. .-.....
T Consensus       300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~  379 (415)
T KOG0671|consen  300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH  379 (415)
T ss_pred             EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence            99999999998776444333332211110000                        0   000000000000 0112235


Q ss_pred             HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          388 QKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       388 ~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .++.+||++||..||.+|+|+.|+|.+
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhcC
Confidence            679999999999999999999999976

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-38  Score=302.72  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=204.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||++.+..         ++..+|+|.+....  ......+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLS---------DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG   71 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECC---------CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence            48889999999999999998765         56789999987543  23345678899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ...++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g  148 (256)
T cd08530          72 NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLG  148 (256)
T ss_pred             CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeecc
Confidence            99999999999999999886521  236889999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++......    ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||.......   ......       
T Consensus       149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~-------  214 (256)
T cd08530         149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQ-------  214 (256)
T ss_pred             chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh-------
Confidence            99876543    1223468899999999998899999999999999999999999996543211   111000       


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             .......+...+.++.+++.+||..+|++||++.+++++
T Consensus       215 -------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         215 -------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                   000011222347889999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-38  Score=300.21  Aligned_cols=249  Identities=32%  Similarity=0.522  Sum_probs=205.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||+|+||.||+|.+..         ++..||+|.+.....  .....+.+|++++.++.|+||+++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLE---------TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS   71 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcC---------CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence            47889999999999999998765         567899999977654  3456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++
T Consensus        72 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          72 DSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             CEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccc
Confidence            99999999999999999987653  6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      .........  .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........  ....   ...     
T Consensus       147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~~---~~~-----  214 (254)
T cd06627         147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFRI---VQD-----  214 (254)
T ss_pred             eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHH---hcc-----
Confidence            876543221  2335689999999999888889999999999999999999999864321100  0000   000     


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ....++...+..+.+++.+||..+|++||++.+++.+
T Consensus       215 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 -------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             -------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                   0011222336789999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-37  Score=303.65  Aligned_cols=245  Identities=22%  Similarity=0.264  Sum_probs=192.3

Q ss_pred             hcCCCcCcee--ccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          131 TRNFRPESLL--GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~l--G~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      .++|.+.+.+  |.|+||.||++....         ++..+|+|.+........     |+.+...+ +|+||+++++++
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKP---------TQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcC---------CCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence            4567777776  999999999998765         677899999865432211     22222222 699999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEcc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSD  286 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~D  286 (490)
                      ...+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++ .++|+|
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence            99999999999999999999987654  7899999999999999999999988   99999999999999988 999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++......      ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... .....+.... ..
T Consensus       154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~  225 (267)
T PHA03390        154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK  225 (267)
T ss_pred             CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc
Confidence            9998765432      12468899999999998899999999999999999999999997432221 1111111110 00


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evl~~  414 (490)
                                  ........+..+.+||.+||+.||.+||+ +++++++
T Consensus       226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                        00111234788999999999999999996 6999864

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-38  Score=305.63  Aligned_cols=244  Identities=27%  Similarity=0.393  Sum_probs=196.4

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||.|+||.||+|.+..         +|..||+|.+.....   .....+.+|++++..+.|+||+++++.+......|+|
T Consensus         1 lg~g~~~~vy~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKS---------TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECC---------CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            6899999999998865         577999999876543   3445688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++.+.+  .+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            99999999999997755  6899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CC------cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          297 GK------THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       297 ~~------~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ..      ........++..|+|||.+....++.++||||||+++|+|++|..||........   .....   ....  
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~~~~---~~~~--  218 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI---FQNIL---NGKI--  218 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh---cCCc--
Confidence            11      1122335688899999999888899999999999999999999999965432211   11100   0000  


Q ss_pred             hhccCccccCCCChH--hHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          371 YRLLDPRLEGHFSIK--GSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~--~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                .++..  .+..+.+|+.+||+.+|.+|||+..+.+.|
T Consensus       219 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         219 ----------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ----------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                      01111  267889999999999999999994444433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.4e-38  Score=318.58  Aligned_cols=269  Identities=24%  Similarity=0.346  Sum_probs=201.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||.|+||.||+|....         +|..||+|++....  ......+.+|+.+|+.++||||+++++++..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   75 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTR---------SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRP   75 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcC---------CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccc
Confidence            679999999999999999998875         67799999987542  2334567889999999999999999998763


Q ss_pred             ----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          210 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       210 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                          ....++||||+. ++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          76 PGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             cCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEec
Confidence                346899999994 68988886543  5899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCc--ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          286 DFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |||++.........  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            99999765432211  11234578999999999865 4688999999999999999999999965433221111100000


Q ss_pred             c---------cCC-chhhhhccCccccC---CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 H---------LGD-KRRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~---------~~~-~~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .         ... .......+......   ......+.++.++|.+||+.||.+||++.+++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            0         000 00000000000000   00112367899999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.9e-38  Score=318.30  Aligned_cols=268  Identities=29%  Similarity=0.362  Sum_probs=199.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      ..++|++.+.||.|+||.||+|.+..         +|..||+|.+...  .......+.+|+.++.++ +||||++++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~   75 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRR---------TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNV   75 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcC---------CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeee
Confidence            34579999999999999999998765         5678999988543  223345677899999999 99999999999


Q ss_pred             EEec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          207 CIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       207 ~~~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +...  ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl  148 (337)
T cd07852          76 IKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKL  148 (337)
T ss_pred             eccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEE
Confidence            8654  36799999996 6998888654   6788888999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCc---ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          285 SDFGLAKDAPEDGKT---HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~---~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|||++.........   .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~  228 (337)
T cd07852         149 ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV  228 (337)
T ss_pred             eeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            999999866443221   12234578999999998764 56788999999999999999999999654322211111000


Q ss_pred             hcccC----------CchhhhhccC----ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLG----------DKRRFYRLLD----PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~----------~~~~~~~~~~----~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .....          ....+.....    ..+.. .....+.++.+||.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000          0000000000    00000 111247789999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-39  Score=315.70  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEecCceE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL  214 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~  214 (490)
                      .++||.|.||+||-|.++.         +|+.||||++.+-...  ...++..|+.||.+++||.||.+...|+..+.++
T Consensus       569 devLGSGQFG~VYgg~hRk---------tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF  639 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRK---------TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF  639 (888)
T ss_pred             HhhccCCcceeeecceecc---------cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence            4789999999999999876         8899999999875432  3356788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC---CCeEEccccccc
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAK  291 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~DFG~a~  291 (490)
                      +|||-+ +|++.+.|.......+++.....++.||+.||.|||..+   |+|+||||+|||+...   -.+||||||+|+
T Consensus       640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccccee
Confidence            999999 667777776555557999999999999999999999988   9999999999999654   369999999999


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .+.+.   .....++||+.|+|||++....|+..-|+||+|||+|--|+|..||.....  ..+.++.+...        
T Consensus       716 iIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFM--------  782 (888)
T KOG4236|consen  716 IIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFM--------  782 (888)
T ss_pred             ecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccc--------
Confidence            98654   344568999999999999999999999999999999999999999964321  11222211110        


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                            +......+.+..+.+||..+|+..=.+|.|....+.+.
T Consensus       783 ------yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  783 ------YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             ------cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence                  11122234588999999999999999999999888764

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.1e-38  Score=307.49  Aligned_cols=251  Identities=28%  Similarity=0.397  Sum_probs=205.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCC-CCceeceeeEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLL-HPNLVKLVGYC  207 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  207 (490)
                      ++|.+.+.||.|+||.||+|....         +|..||+|++.....   .....+..|+.++..+. |+||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKE---------TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcC---------CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            368999999999999999998865         677999999875322   23456788999999999 99999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+..++||||+.+++|.+++...+  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCC
Confidence            99999999999999999999997664  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCc------------------ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011234          288 GLAKDAPEDGKT------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       288 G~a~~~~~~~~~------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~  349 (490)
                      |++.........                  .......|+..|+|||++....++.++||||||+++|+|++|..||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            998865433211                  11223567899999999988889999999999999999999999997543


Q ss_pred             CCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 011234          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM----SEVVET  414 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~----~evl~~  414 (490)
                      ....   ....             .  .....++...+..+.+||.+||+.||.+||++    .+++++
T Consensus       227 ~~~~---~~~~-------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         227 EYLT---FQKI-------------L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHH---HHHH-------------H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1111   0000             0  01112223336789999999999999999999    888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-38  Score=307.13  Aligned_cols=266  Identities=25%  Similarity=0.348  Sum_probs=200.8

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec-
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-  210 (490)
                      |++.+.||.|+||.||+|.+..         +|..||+|.+....  ......+.+|+.+++.+.|+||+++++++... 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK---------TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG   71 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC---------CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence            6778999999999999998875         56789999997653  22345678899999999999999999999988 


Q ss_pred             -CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       +..++||||++ ++|.+++.... ..+++..++.++.||+.||.|||+.+   ++|+||+|+|||+++++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          72 KGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             CCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccc
Confidence             88999999996 58988886553 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-h-cccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R-PHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~-~~~~~  366 (490)
                      +........ .......++..|+|||.+.+ ..++.++||||||+++|||++|..||...........+... . +....
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (287)
T cd07840         147 ARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN  225 (287)
T ss_pred             eeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence            987654321 11223457889999998764 46789999999999999999999999765432211111100 0 00000


Q ss_pred             chh-----hhhcc------CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRR-----FYRLL------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~-----~~~~~------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...     .....      ...+...+...++..+.++|.+||..||.+||++.+++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            000     00000      0000011111126789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.1e-37  Score=308.69  Aligned_cols=269  Identities=26%  Similarity=0.350  Sum_probs=200.7

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ...++|++.+.||+|+||.||+|.+..         +|..||+|.++....  .....+.+|+.+++.++||||++++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~   74 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD---------TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI   74 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC---------CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeehe
Confidence            456789999999999999999999875         567899999875432  223456789999999999999999999


Q ss_pred             EEecC----------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          207 CIEDD----------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       207 ~~~~~----------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      +.+..          ..++||||+++ +|...+... ...+++..+..++.||+.||+|||+.+   |+||||||+||++
T Consensus        75 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili  149 (302)
T cd07864          75 VTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILL  149 (302)
T ss_pred             ecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            87655          78999999965 777777654 336899999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      +.++.+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..........
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~  228 (302)
T cd07864         150 NNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE  228 (302)
T ss_pred             CCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999999876443221 1122356788999998865 457889999999999999999999997543221111


Q ss_pred             hHHhhh--------cccCCchhhhhccCc------cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          356 LVEWAR--------PHLGDKRRFYRLLDP------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~--------~~~~~~~~~~~~~~~------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+....        +.+.... .+...+.      .....+ ...+..+.+||.+||..||.+||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLP-YFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHHHHhCCCChhhcccccccc-cccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111100        0000000 0000000      000001 1236789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=301.98  Aligned_cols=242  Identities=26%  Similarity=0.336  Sum_probs=188.8

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh---HHHHHHHHHH-HhcCCCCceeceeeEEEecCce
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~---~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      +.||.|+||.||+|.+..         +|..||+|++.......   ...+..|..+ ...+.|+||+++++++..++..
T Consensus         2 ~~l~~g~~~~v~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRS---------TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecC---------CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            569999999999998865         56789999987653222   2234455544 4456899999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   ++||||+|+|||++.++.++|+|||++...
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999999999999987654  6888999999999999999999988   999999999999999999999999998754


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ..      .....|+..|+|||.+.+..++.++||||||+++|+|++|..||.............  .    ..      
T Consensus       148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~----~~------  209 (260)
T cd05611         148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL--S----RR------  209 (260)
T ss_pred             cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--h----cc------
Confidence            33      123568899999999988889999999999999999999999996543211110000  0    00      


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  413 (490)
                        ..........++..+.++|.+||+.||++||++.++.+
T Consensus       210 --~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         210 --INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             --cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence              00001111133688999999999999999997654433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=303.56  Aligned_cols=263  Identities=24%  Similarity=0.320  Sum_probs=197.9

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcC---CCCceeceeeEEE
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVGYCI  208 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~~~~  208 (490)
                      |++.+.||.|+||.||+|.+..         ++..||+|.+......  ....+.+|+.++..+   .|+||+++++++.
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~   71 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN---------TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH   71 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC---------CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence            6778999999999999999865         5678999998744221  223456777776655   6999999999999


Q ss_pred             ecCc-----eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          209 EDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       209 ~~~~-----~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ..+.     .+++|||+. ++|.+++.......+++..++.++.||+.||.|||+.+   ++|+||+|+|||++.++.+|
T Consensus        72 ~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          72 GPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             eccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEE
Confidence            8776     899999996 58998887655446899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||++........   .....++..|+|||++.+..++.++|||||||++|+|++|.+||..........  ......
T Consensus       148 l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~  222 (287)
T cd07838         148 IADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVI  222 (287)
T ss_pred             EeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHc
Confidence            999999977643321   123457889999999999899999999999999999999999997544321111  110000


Q ss_pred             cC-Cchhh-------hhccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LG-DKRRF-------YRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~-~~~~~-------~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .. ....+       ...+....   ........+..+.+||.+||+.||.+||++.+++.+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            00 00000       00000000   011112336788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=325.63  Aligned_cols=268  Identities=29%  Similarity=0.433  Sum_probs=200.8

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC-
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-  211 (490)
                      |...+.||+|+||.||+|+++.         +|+.||||.++... ....+.+.+|+++|++|+|+|||+++++-.+.. 
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnke---------tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~   85 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKE---------TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL   85 (732)
T ss_pred             eeehhhhcCCccceeeeecccc---------cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence            5556889999999999999886         89999999998753 334567889999999999999999999755433 


Q ss_pred             -----ceEEEEEecCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc--CCC--C
Q 011234          212 -----QRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADY--N  281 (490)
Q Consensus       212 -----~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~--~  281 (490)
                           ...+|||||.+|+|+..|.+- ....+++.+.+.++.++..||.|||+++   ||||||||.||++-  ++|  .
T Consensus        86 ~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   86 GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceE
Confidence                 468999999999999999653 3457999999999999999999999988   99999999999983  334  4


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhh-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .||+|||+|+...++.   ..+.++||..|.+||++. .+.|+..+|.|||||++|+..||..||...........+.|.
T Consensus       163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~  239 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH  239 (732)
T ss_pred             EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh
Confidence            7999999999886653   456789999999999998 489999999999999999999999999643322110101111


Q ss_pred             h-------------cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC--CHHHHHHHhhcc
Q 011234          361 R-------------PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP--RMSEVVETLKPL  418 (490)
Q Consensus       361 ~-------------~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP--s~~evl~~L~~l  418 (490)
                      .             ....+...+...++.  .-+........+..++..+|..+|.+|-  .+.+....+..+
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            0             000000011111111  1122233345566778888999999998  555555544433

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2e-37  Score=353.55  Aligned_cols=262  Identities=31%  Similarity=0.531  Sum_probs=206.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ..|...++||+|+||.||+|.+..         +|..||||.+......    ...|++++++++|||||++++++.+.+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~  756 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIK---------NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK  756 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECC---------CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence            457778899999999999998865         5678999998654321    134688999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..|+||||+++|+|.+++.     .++|..+..++.||+.||+|||....++|+||||||+|||++.++..++. ||...
T Consensus       757 ~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        757 GAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            9999999999999999984     37899999999999999999996544559999999999999998888875 66554


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .....      ....||+.|||||++.+..++.++|||||||++|||++|+.||+.... ......+|.+...... ...
T Consensus       831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~-~~~  902 (968)
T PLN00113        831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDC-HLD  902 (968)
T ss_pred             ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCcc-chh
Confidence            33211      223688999999999999999999999999999999999999954322 2234445544332221 122


Q ss_pred             hccCccccCC--CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          372 RLLDPRLEGH--FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       372 ~~~~~~l~~~--~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ..+++.+...  .+.....++.+++.+||+.||++||+|.||++.|+.+..
T Consensus       903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3444444332  334556678899999999999999999999999987644

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-38  Score=306.10  Aligned_cols=265  Identities=26%  Similarity=0.349  Sum_probs=202.5

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      |.+.+.||.|++|.||+|....         +|..+|+|.+......  ....+.+|+.+|+.++|+||+++++++...+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   71 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKL---------TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG   71 (283)
T ss_pred             CccceeeecCCCceEEEEEcCC---------CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC
Confidence            5678899999999999998765         5778999998765332  3456788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||.+.
T Consensus        72 ~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          72 DLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             CEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            9999999996 58888886653 47899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hh-------hc
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WA-------RP  362 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~-------~~  362 (490)
                      .......  ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+. ..       ..
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         147 SFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             ecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence            7654321  12234678899999998876 78999999999999999999999996554322111110 00       00


Q ss_pred             ccCC--chhhhhccCc--cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGD--KRRFYRLLDP--RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~--~~~~~~~~~~--~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+..  ..........  ..........+.++.+||.+||..||.+||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0000  0000000000  00001112347889999999999999999999999865

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-37  Score=305.08  Aligned_cols=256  Identities=28%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      +|++.+.||.|+||.||+|......      .+|..||+|++.....    ...+.+.+|+.+|..+ +|+||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~------~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGH------DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   74 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCC------CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe
Confidence            4788999999999999999875321      2678999999875422    2235677899999999 599999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ..+...++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   ++||||+|+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          75 QTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             ecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeC
Confidence            99999999999999999999997654  5788899999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |++......... ......|+..|+|||.+...  .++.++||||||+++|+|++|..||........  ..+.......
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~  226 (290)
T cd05613         150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILK  226 (290)
T ss_pred             ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhc
Confidence            999865432211 12235689999999998753  467899999999999999999999964322111  1111111100


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                      .            ...++...+..+.+|+.+||..||++||     ++.+++.+
T Consensus       227 ~------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         227 S------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             c------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            0            0112233467889999999999999997     67777655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-37  Score=309.00  Aligned_cols=265  Identities=25%  Similarity=0.297  Sum_probs=194.5

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      .+.+.+|.|+++.||++  ..         ++..||||++...  .......+..|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~i~~~~~~~~~v~~~~~--~~---------~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~   73 (314)
T cd08216           5 LIGKCFEDLMIVHLAKH--KP---------TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE   73 (314)
T ss_pred             hhhHhhcCCceEEEEEe--cC---------CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe
Confidence            34445555555555544  33         5779999998765  23445678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .+++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||.+..
T Consensus        74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~  150 (314)
T cd08216          74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVS  150 (314)
T ss_pred             EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCcccee
Confidence            999999999999999998654456889999999999999999999988   99999999999999999999999998875


Q ss_pred             CCCCCCc-----ceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          293 APEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       293 ~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      .......     .......++..|+|||++..  ..++.++|||||||++|||++|..||.......  ...+.......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~  228 (314)
T cd08216         151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVP  228 (314)
T ss_pred             eccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCc
Confidence            5322111     11123457889999999875  358899999999999999999999997543211  11111000000


Q ss_pred             ---Cchhhhh-----------ccCc----cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 ---DKRRFYR-----------LLDP----RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ---~~~~~~~-----------~~~~----~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         .......           ..++    ..........+.++.+|+.+||..||++|||+.+++++-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         229 CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence               0000000           0000    001112233467899999999999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.9e-38  Score=314.41  Aligned_cols=267  Identities=26%  Similarity=0.322  Sum_probs=197.9

Q ss_pred             CCC-cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--------------HHHHHHHHHHHhcCCC
Q 011234          133 NFR-PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--------------HKEWLAEVNFLGNLLH  197 (490)
Q Consensus       133 ~y~-~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H  197 (490)
                      +|. +.+.||.|+||.||+|.+..         ++..||||.+.......              ...+.+|+.+++.++|
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   79 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTL---------TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH   79 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECC---------CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC
Confidence            454 55789999999999998765         57789999986543221              1247789999999999


Q ss_pred             CceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       198 pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      +||+++++++..++..++||||+. |+|.+++....  .+++.....++.||+.||.|||+.+   |+||||+|+|||++
T Consensus        80 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~  153 (335)
T PTZ00024         80 ENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFIN  153 (335)
T ss_pred             cceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEEC
Confidence            999999999999999999999996 69999886544  5888999999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCC------------cceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCC
Q 011234          278 ADYNAKLSDFGLAKDAPEDGK------------THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~------------~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~p  344 (490)
                      .++.++|+|||++........            ........++..|+|||++.+. .++.++|||||||++|+|++|.+|
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        154 SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             CCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999976541110            0111223568899999998764 478899999999999999999999


Q ss_pred             CCCCCCCCcchhH-Hhhh-cc---cCCch------hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011234          345 MDKNRPNGEHNLV-EWAR-PH---LGDKR------RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       345 f~~~~~~~~~~~~-~~~~-~~---~~~~~------~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  413 (490)
                      |...........+ .... +.   +....      .+.......+. ......+.++.+||.+||+.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            9755432211111 0000 00   00000      00000000000 001123678899999999999999999999997


Q ss_pred             Hh
Q 011234          414 TL  415 (490)
Q Consensus       414 ~L  415 (490)
                      +-
T Consensus       313 ~~  314 (335)
T PTZ00024        313 HE  314 (335)
T ss_pred             Cc
Confidence            54

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=308.85  Aligned_cols=245  Identities=28%  Similarity=0.410  Sum_probs=203.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH---HHHHHHHHHHhcCC-CCceecee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL-HPNLVKLV  204 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~---~~~~~E~~~l~~l~-HpnIv~l~  204 (490)
                      +...+|..+.+||+|+||.|.+|..+.         +.+.+|||+++++.....   +--+.|-++|.... -|.+++++
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkg---------tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlH  416 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKG---------TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLH  416 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccC---------cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHH
Confidence            334579999999999999999997653         777899999988743222   22356788887764 68999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      .+|..-+.+|+||||+.||+|.-+|+..+  .+.+..+..+|..|+-||-|||+.+   ||+||||.+||||+.+|++||
T Consensus       417 ScFQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi  491 (683)
T KOG0696|consen  417 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKI  491 (683)
T ss_pred             HHhhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEe
Confidence            99999999999999999999999998877  5677788899999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++...-++.+  ...+|||+.|+|||++....|+..+|+|||||+|||||.|++||++....+..          
T Consensus       492 ~DFGmcKEni~~~~T--TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF----------  559 (683)
T KOG0696|consen  492 ADFGMCKENIFDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----------  559 (683)
T ss_pred             eecccccccccCCcc--eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------
Confidence            999999865444333  34589999999999999999999999999999999999999999875433211          


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs  407 (490)
                            ..+.+.  .-.||...+.++.+++...|.+.|.+|.-
T Consensus       560 ------~aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  560 ------QAIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------HHHHHc--cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence                  112221  12456666999999999999999999954

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.7e-37  Score=307.17  Aligned_cols=245  Identities=29%  Similarity=0.447  Sum_probs=195.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      |...+.||+|+||.||+|.+..         +|..||+|.+.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~---------~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSH---------TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            6667889999999999998765         677899999865432   2335678899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ...|+||||+. |+|.+++.... ..+++..++.++.||+.||.|||+.+   |+|+||+|+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCC
Confidence            99999999995 68887776543 36899999999999999999999988   999999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      .....      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||.............     ... 
T Consensus       169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~-----~~~-  236 (313)
T cd06633         169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-----QND-  236 (313)
T ss_pred             cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----hcC-
Confidence            64322      12356899999999984   4568889999999999999999999986543211111000     000 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             .+.   ......+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       237 -------~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         237 -------SPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000   0111225678999999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.8e-38  Score=310.24  Aligned_cols=269  Identities=28%  Similarity=0.348  Sum_probs=197.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||.|+||.||+|.+..         ++..||||.+......  ....+.+|+++++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIK---------TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAV   77 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence            4689999999999999999998865         5678999988644322  2245678999999999999999999876


Q ss_pred             ecC--------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          209 EDD--------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       209 ~~~--------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +..        ..++||||+. ++|...+... ...+++..+..++.||++||.|||+.+   |+||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~  152 (311)
T cd07866          78 ERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQG  152 (311)
T ss_pred             cccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCC
Confidence            543        4699999995 5777777554 336899999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCc---------ceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 011234          281 NAKLSDFGLAKDAPEDGKT---------HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~---------~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~  350 (490)
                      .++|+|||++.........         ...+...|++.|+|||++.+. .++.++|||||||++|||++|.+||.....
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~  232 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD  232 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999765432211         111234678899999988654 588999999999999999999999975443


Q ss_pred             CCcchhHHhhhcc-----cCCchhhhh--------ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          351 NGEHNLVEWARPH-----LGDKRRFYR--------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       351 ~~~~~~~~~~~~~-----~~~~~~~~~--------~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ......+......     +........        ...+.+...+ ......+.+||.+||..||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         233 IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            2211111100000     000000000        0000010000 1124678899999999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3e-37  Score=307.06  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=198.8

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .|...+.||.|+||.||+|.+..         ++..||+|.+...   ......++.+|+++++.++|+||+++++++..
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   86 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcC---------CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence            47778899999999999999865         5678999988643   22334567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....++||||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.++|+|||+
T Consensus        87 ~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          87 EHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             CCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCccc
Confidence            999999999996 68887775543 35889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +......      ....|+..|+|||++.   ...++.++|||||||++|+|++|..||..........  .+...    
T Consensus       162 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~----  229 (308)
T cd06634         162 ASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIAQN----  229 (308)
T ss_pred             ceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHhhc----
Confidence            8765332      2346889999999975   3567889999999999999999999985432111100  00000    


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                             ..+.   ......+..+.+||.+||..+|++||++.+++++.....
T Consensus       230 -------~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         230 -------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             -------CCCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                   0000   001123677899999999999999999999998865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=302.75  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=199.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~  211 (490)
                      |.+.+.||.|+||.||+|....         ++..||||.+..... .......+|+..+..+. |+||+++++++..++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~---------~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   71 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE---------TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND   71 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC---------CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC
Confidence            6778999999999999999865         567899999865432 22234567999999999 999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+ +|+|.+++.......+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccce
Confidence            999999999 889999887765456899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hhhcc----cC
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPH----LG  365 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~~~----~~  365 (490)
                      .......   .....|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||......+...... .....    +.
T Consensus       148 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         148 EIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             eccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence            6543221   123568899999998754 467899999999999999999999996554322111000 00000    00


Q ss_pred             CchhhhhccC--------ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~--------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....+....+        ..+...+ ...+..+.+||.+||..||++||++.|++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000        0000001 1125779999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-37  Score=311.74  Aligned_cols=267  Identities=26%  Similarity=0.360  Sum_probs=203.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|++.+.||.|+||.||+|....         +|..||||.+....  ....+.+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   71 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKR---------TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPP   71 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCC---------CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence            58899999999999999998765         57789999987543  33456788999999999999999999998877


Q ss_pred             C-----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          211 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .     ..|+||||+. ++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+
T Consensus        72 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~  145 (330)
T cd07834          72 SPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKIC  145 (330)
T ss_pred             CcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEc
Confidence            5     7899999996 58988886554  7899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCc-ceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc-
Q 011234          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP-  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-  362 (490)
                      |||++......... .......|+..|+|||++.+. .++.++|||||||++|+|++|.+||...........+..... 
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (330)
T cd07834         146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT  225 (330)
T ss_pred             ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCC
Confidence            99999876543210 112335688999999999887 889999999999999999999999976543211111100000 


Q ss_pred             ---------ccCCchhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 ---------HLGDKRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ---------~~~~~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                               .......+.........   .......+..+.+||.+||+.||++||++.+++.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                     00000000000000000   00111236788999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.8e-37  Score=303.89  Aligned_cols=258  Identities=28%  Similarity=0.363  Sum_probs=200.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      +|++.+.||+|+||.||++......      .++..||||++.....    ...+.+..|+.++.++ +||||+++++++
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~   74 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGH------DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF   74 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccc------cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee
Confidence            4788899999999999999865422      2567899999875422    2234577899999999 599999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ......++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          75 QTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             ecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEEC
Confidence            99999999999999999999987643  5888899999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |+++........ ......|+..|+|||.+.+..  .+.++||||||+++|+|++|..||........  ..+.......
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~  226 (288)
T cd05583         150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILK  226 (288)
T ss_pred             cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHc
Confidence            998865433211 122356899999999987654  78899999999999999999999964322111  1111110000


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .        .    ...+...+..+.++|.+||+.||++|||+.++.+.|+
T Consensus       227 ~--------~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         227 S--------K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             c--------C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            0        0    1112223677899999999999999999887776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.6e-38  Score=315.61  Aligned_cols=267  Identities=23%  Similarity=0.308  Sum_probs=197.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec-
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-  210 (490)
                      .+|.+.+.||.|+||.||+|....         +|..||+|.+........+.+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~---------~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~   75 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSD---------CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSG   75 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECC---------CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence            579999999999999999998865         6779999998766555567788999999999999999999876654 


Q ss_pred             -------------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          211 -------------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       211 -------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                                   ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~  148 (342)
T cd07854          76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFIN  148 (342)
T ss_pred             cccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEc
Confidence                         35789999996 6898877532   5889999999999999999999988   99999999999997


Q ss_pred             C-CCCeEEccccccccCCCCCCc-ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          278 A-DYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       278 ~-~~~~kL~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      . ++.+||+|||++......... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.........
T Consensus       149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~  228 (342)
T cd07854         149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM  228 (342)
T ss_pred             CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            4 567899999999765322111 11122467889999998764 56888999999999999999999999755432221


Q ss_pred             hhHHhhhcccCC--chhhhhccCc-----cccC-----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          355 NLVEWARPHLGD--KRRFYRLLDP-----RLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       355 ~~~~~~~~~~~~--~~~~~~~~~~-----~l~~-----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .......+....  ...+......     ....     .+....+.++.+||.+||..||.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         229 QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            111100000000  0000000000     0000     0011236788999999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-37  Score=306.21  Aligned_cols=257  Identities=30%  Similarity=0.451  Sum_probs=198.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      ...++|++.+.||.|+||.||+|.+..         ++..||||.+..... ....++..|+.++..+. |+||++++++
T Consensus        12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618          12 ADLNDLENLGEIGSGTCGQVYKMRFKK---------TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             CCcchheeeeEeeccCCeEEEEEEECC---------CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence            344678999999999999999999865         577899999875432 33456677887776665 9999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      +.+....++||||+ +++|.+++..... .+++..+..++.||+.||.|||+ .+   |+||||+|+||+++.++.+||+
T Consensus        83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~  157 (296)
T cd06618          83 FITDSDVFICMELM-STCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLC  157 (296)
T ss_pred             eecCCeEEEEeecc-CcCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEEC
Confidence            99999999999998 4578777765433 78999999999999999999997 46   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCC----CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      |||++........   .....|+..|+|||.+.+..    ++.++||||||+++|+|++|+.||......  ......  
T Consensus       158 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~--  230 (296)
T cd06618         158 DFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTK--  230 (296)
T ss_pred             ccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHH--
Confidence            9999876543221   12345788999999987553    788999999999999999999999643211  011110  


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                       .+....       +..  ......+.++.+||.+||..||.+||++.+++++.-
T Consensus       231 -~~~~~~-------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         231 -ILQEEP-------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -HhcCCC-------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence             000000       000  001123678999999999999999999999997743

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-37  Score=311.80  Aligned_cols=272  Identities=24%  Similarity=0.353  Sum_probs=202.7

Q ss_pred             chhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCce
Q 011234          123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNL  200 (490)
Q Consensus       123 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnI  200 (490)
                      ...++....++|.+.+.||+|+||.||+|....         +|..||+|++....  ....+.+.+|+.++..++|+||
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i   78 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV   78 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcC---------CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc
Confidence            334555677899999999999999999998765         67799999987542  2234567889999999999999


Q ss_pred             eceeeEEEec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          201 VKLVGYCIED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       201 v~l~~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      +++++++...      ...+++++++ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||
T Consensus        79 v~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NI  151 (345)
T cd07877          79 IGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL  151 (345)
T ss_pred             cceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHE
Confidence            9999988643      3467888887 78998877543   5889999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      +++.++.+||+|||++......     .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus       152 ll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~  226 (345)
T cd07877         152 AVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ  226 (345)
T ss_pred             EEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999998765322     123468899999998876 5688899999999999999999999965432211


Q ss_pred             chhHHhh--------hcccCCc--hhhhhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          354 HNLVEWA--------RPHLGDK--RRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       354 ~~~~~~~--------~~~~~~~--~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...+...        ...+...  ..+...+.......   .....+.++.+||.+||+.||.+||++.+++++-
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         227 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            1110000        0000000  00000000000000   0112366789999999999999999999999773

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.4e-37  Score=309.86  Aligned_cols=269  Identities=25%  Similarity=0.318  Sum_probs=194.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      +|++.+.||+|+||.||+|.+....       .+..||+|.+...  .....+.+.+|+.++.++ +||||+++++++..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   73 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS-------EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIV   73 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC-------cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeee
Confidence            4788899999999999999986521       1668999998643  222345678899999999 59999999987543


Q ss_pred             c----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          210 D----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       210 ~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .    ...++++||+. ++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        74 ~~~~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          74 FPGNFNELYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             ccccCCcEEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeC
Confidence            2    45788999984 78998886543  6889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCc--ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          286 DFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |||+++........  .......|+..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.....
T Consensus       148 Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  227 (332)
T cd07857         148 DFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG  227 (332)
T ss_pred             cCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC
Confidence            99999865432211  11233578999999998765 4689999999999999999999999975432111100000000


Q ss_pred             --------ccCCc--hhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 --------HLGDK--RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 --------~~~~~--~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              .+...  ..+...+.....   .......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                    00000  000000000000   00111235789999999999999999999999855

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-40  Score=298.92  Aligned_cols=255  Identities=28%  Similarity=0.383  Sum_probs=198.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHh-cCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLG-NLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~  210 (490)
                      +.+-+..||.|+||+|++-.++.         +|...|||.++.... .+.++++.|..... .-+.||||++||++..+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~---------sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKP---------SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCc---------cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            34455789999999999998876         788999999987654 45567888888654 44699999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHh---hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          211 DQRLLVYEFMPRGSLENHLF---RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      +..||.||+| ..+|+.+..   ......+++..+-.|....+.||.||-...+  |||||+||+||||+..|.+|||||
T Consensus       136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDF  212 (361)
T KOG1006|consen  136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDF  212 (361)
T ss_pred             CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecc
Confidence            9999999999 457765443   2223368899999999999999999987553  999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-ccc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~  364 (490)
                      |++..+.+.   ...+.-+|...|||||.+..  ..|+.+|||||||++|||+.||..|+.++..     ..+... ...
T Consensus       213 GIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~  284 (361)
T KOG1006|consen  213 GICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI  284 (361)
T ss_pred             cchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc
Confidence            999876432   23345689999999999963  4589999999999999999999999976543     111111 111


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ++...   +..+    .-....+..+..+|.-||.+|-+.||.+.+++.+
T Consensus       285 gdpp~---l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  285 GDPPI---LLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCCCe---ecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            22111   1111    1112347889999999999999999999998764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5e-38  Score=336.80  Aligned_cols=256  Identities=29%  Similarity=0.414  Sum_probs=192.7

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .....+|+.+++||+||||.||+++++-         +|..+|||.|.... ......+.+|+.+|++|+|||||++|..
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKl---------DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysA  545 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKL---------DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSA  545 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecc---------cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehh
Confidence            3455689999999999999999999987         57799999987663 2334567899999999999999998865


Q ss_pred             EEec----------------------------------------------------------------------------
Q 011234          207 CIED----------------------------------------------------------------------------  210 (490)
Q Consensus       207 ~~~~----------------------------------------------------------------------------  210 (490)
                      +.+.                                                                            
T Consensus       546 WVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~de  625 (1351)
T KOG1035|consen  546 WVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDE  625 (1351)
T ss_pred             hhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccc
Confidence            4310                                                                            


Q ss_pred             -------------------------------------------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHH
Q 011234          211 -------------------------------------------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL  247 (490)
Q Consensus       211 -------------------------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~  247 (490)
                                                                 ..+||-||||+...|.+++.++.. .-.....+++++
T Consensus       626 dg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~-~~~~d~~wrLFr  704 (1351)
T KOG1035|consen  626 DGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF-NSQRDEAWRLFR  704 (1351)
T ss_pred             cccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-chhhHHHHHHHH
Confidence                                                       013788999988777777765432 214567899999


Q ss_pred             HHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC----------------CCCcceeeccccCCCC
Q 011234          248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE----------------DGKTHVSTRVMGTYGY  311 (490)
Q Consensus       248 qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~----------------~~~~~~~~~~~Gt~~y  311 (490)
                      +|++||.|+|++|   ||||||||.||+|++++.|||+|||+|+....                .......+..+||..|
T Consensus       705 eIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalY  781 (1351)
T KOG1035|consen  705 EILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALY  781 (1351)
T ss_pred             HHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeee
Confidence            9999999999999   99999999999999999999999999987210                0111134567999999


Q ss_pred             CCchhhhcC---CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCcccc--CCCChHh
Q 011234          312 AAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE--GHFSIKG  386 (490)
Q Consensus       312 ~aPE~l~~~---~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~  386 (490)
                      +|||++.+.   .|+.|+|+|||||||+||+.   ||...-  +....+...+             +..+.  ..|....
T Consensus       782 vAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~LR-------------~g~iP~~~~f~~~~  843 (1351)
T KOG1035|consen  782 VAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNLR-------------KGSIPEPADFFDPE  843 (1351)
T ss_pred             ecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhcc-------------cCCCCCCccccccc
Confidence            999999764   59999999999999999995   464321  1111111111             11111  1122233


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          387 SQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       387 ~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...-..+|++||+.||.+|||+.|+|+.
T Consensus       844 ~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  844 HPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             chHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            4566789999999999999999999864

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-37  Score=312.62  Aligned_cols=268  Identities=25%  Similarity=0.360  Sum_probs=198.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..+|.+.+.||+|+||.||+|.+..         +|..||||.+.....  .....+.+|+.+++.+.||||+++++++.
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKR---------TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCC---------CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            3689999999999999999998765         677999999865321  22356788999999999999999999987


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ...      .+++||||+. .+|..++    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~  156 (342)
T cd07879          85 SAVSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCEL  156 (342)
T ss_pred             ccccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence            543      4689999995 4776654    225889999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.....     .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       157 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~  231 (342)
T cd07879         157 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  231 (342)
T ss_pred             EEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998765322     123467889999999876 468899999999999999999999997643221111110000


Q ss_pred             c--------ccCC--chhhhhccCccccCCC---ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcccc
Q 011234          362 P--------HLGD--KRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQN  420 (490)
Q Consensus       362 ~--------~~~~--~~~~~~~~~~~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~l~~  420 (490)
                      .        ....  ...+...+.......+   ....+..+.+||.+||+.||.+||++.+++.+  ++.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0        0000  0000000000000000   01235678999999999999999999999976  555543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.2e-37  Score=297.09  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=195.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +|.+.+.||+|+||.||++.+..         ++..+++|+++..     ......++..|+.+++.++||||+++++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK---------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF   71 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC---------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH
Confidence            58889999999999999998765         2334555554421     112334567799999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .+....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          72 LERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             hcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeec
Confidence            9999999999999999999988642  2346899999999999999999999988   999999999999975 579999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........  ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||......   .....   ...
T Consensus       148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~---~~~  219 (260)
T cd08222         148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLR---IVE  219 (260)
T ss_pred             ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH---HHc
Confidence            9999876543221  123356889999999998888999999999999999999999998643211   11110   000


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .       ..+    ..+...+.++.++|.+||..||++||++.+++++
T Consensus       220 ~-------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 G-------PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             C-------CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            0       011    1223446789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.9e-37  Score=307.72  Aligned_cols=264  Identities=25%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      ...+++|++.+.||.|+||.||+|....         +|..||||.+....  ....+.+..|+.++..++||||+++++
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   76 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQL---------TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD   76 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECC---------CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEee
Confidence            3467789999999999999999998765         67789999876432  223456788999999999999999999


Q ss_pred             EEEe-cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          206 YCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       206 ~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ++.. ....++||||+ +++|..++...   .+++..+..++.||+.||.|||+.+   |+||||+|+|||++.++.++|
T Consensus        77 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          77 IFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             eEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEe
Confidence            9876 45789999999 67898877533   5788888899999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hh---
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EW---  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~---  359 (490)
                      +|||++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|..||...........+ +.   
T Consensus       150 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~  224 (328)
T cd07856         150 CDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT  224 (328)
T ss_pred             CccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999998754322     123467889999998765 57899999999999999999999999654321111100 00   


Q ss_pred             -----hhcccC-CchhhhhccCccccCCCC-----hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 -----ARPHLG-DKRRFYRLLDPRLEGHFS-----IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 -----~~~~~~-~~~~~~~~~~~~l~~~~~-----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           ...... ....+...+.  .....+     ...+..+.++|.+||+.+|++||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         225 PPDDVINTICSENTLRFVQSLP--KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                 000000 0000100000  000011     1236789999999999999999999999877

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-36  Score=307.27  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=198.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|....         +|..||||.+....  ......+.+|+.+|+.++||||+++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            45689999999999999999998765         67789999986432  22345678999999999999999999998


Q ss_pred             EecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          208 IEDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       208 ~~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ..+.      ..++||||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~  156 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCE  156 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCC
Confidence            7654      358999999 78998887532   6889999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      ++|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||........  .....
T Consensus       157 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~  229 (343)
T cd07880         157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIM  229 (343)
T ss_pred             EEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence            999999999865332     123467899999999876 4688999999999999999999999975432111  00000


Q ss_pred             hcccCC------------chhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGD------------KRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~------------~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ......            ...+...+.....   .......+..+.++|.+||+.||.+|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000            0000000000000   00112336678999999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.1e-37  Score=334.66  Aligned_cols=146  Identities=27%  Similarity=0.365  Sum_probs=131.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|.+.+.||.|+||.||+|++..         ++..||||++.....   .....+..|+.++..++|+||+++++++.
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~   74 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKN---------NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ   74 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence            579999999999999999999875         577999999875432   22356788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..||||||+.+++|.+++...+  .+++..++.|+.||+.||.|||..+   ||||||||+||||+.++.+||+|||
T Consensus        75 ~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          75 SANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             ECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCC
Confidence            9999999999999999999987654  5788889999999999999999988   9999999999999999999999999


Q ss_pred             ccc
Q 011234          289 LAK  291 (490)
Q Consensus       289 ~a~  291 (490)
                      +++
T Consensus       150 ls~  152 (669)
T cd05610         150 LSK  152 (669)
T ss_pred             CCc
Confidence            986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-37  Score=300.03  Aligned_cols=264  Identities=27%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      |++.+.||+|+||.||+|....         ++..||+|.+....  ....+.+..|+.+++.++|+||+++++++.+.+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   71 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKK---------TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER   71 (282)
T ss_pred             CeeehcccccCcceEEEeeecC---------CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence            5677889999999999998875         57799999987653  223456788999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.
T Consensus        72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCccc
Confidence            9999999996 69999997653 36899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH-Hhh-------hc
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-EWA-------RP  362 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~-~~~-------~~  362 (490)
                      .......  ......++..|+|||.+.+. .++.++|||||||++|||++|.+||...........+ ...       ..
T Consensus       147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence            6644322  11234567889999998766 8899999999999999999999999654322111100 000       00


Q ss_pred             ccCCc----hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDK----RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~----~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .....    ..+...........+ ...+..+.++|.+||..||++||++.+++.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             hhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000    000000000000011 1126789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=315.75  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=212.3

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      +...+++++..||-|+||.|=++..+..         ...+|+|++++...   ...+.+..|-+||..++.|.||++|-
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~---------~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr  487 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQ---------KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR  487 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEeccc---------chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence            3445778888999999999999987653         22589999876532   23345788999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .|.++.++|++||-|-||.|...|..++  .|.......++..+++|++|||+.+   ||+|||||+|+||+.+|-+||.
T Consensus       488 Tfrd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLV  562 (732)
T KOG0614|consen  488 TFRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLV  562 (732)
T ss_pred             HhccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEe
Confidence            9999999999999999999999998877  5778888899999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+|+.+.....+   ..+|||+.|+|||++.+...+.++|.||||+++||||+|.+||.+.++....+++-....   
T Consensus       563 DFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---  636 (732)
T KOG0614|consen  563 DFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---  636 (732)
T ss_pred             ehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---
Confidence            99999988765443   458999999999999999999999999999999999999999988776655444422111   


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                                   .-++|......+.+||++++..+|.+|.-     +.+|-.|
T Consensus       637 -------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  637 -------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             -------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                         11344555888999999999999999975     4555544

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-37  Score=310.14  Aligned_cols=264  Identities=24%  Similarity=0.342  Sum_probs=199.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||++....  ......+.+|+.+++.+.|+||+++++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTK---------TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVF   83 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECC---------CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHh
Confidence            45689999999999999999999875         57789999986532  22345677899999999999999999988


Q ss_pred             EecCc------eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          208 IEDDQ------RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       208 ~~~~~------~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ...+.      .++|+||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~  156 (343)
T cd07851          84 TPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCE  156 (343)
T ss_pred             hccccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCC
Confidence            76654      89999999 67999988642   5899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      ++|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+...
T Consensus       157 ~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~  231 (343)
T cd07851         157 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL  231 (343)
T ss_pred             EEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Confidence            999999999865432     223467889999999865 46788999999999999999999999754332111110000


Q ss_pred             hcccC----------CchhhhhccCccccCCC---ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLG----------DKRRFYRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~----------~~~~~~~~~~~~l~~~~---~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .....          ....+...+.......+   ....+..+.+||.+||..||++|||+.+|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000          00000000000000000   01236789999999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-37  Score=299.77  Aligned_cols=272  Identities=29%  Similarity=0.453  Sum_probs=201.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~  210 (490)
                      ...+.++||+|.||+||+|.+.           ++.||||++..   +....|..|-+|.+.  +.|+||++++++-...
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-----------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-----------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-----------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            4566788999999999999985           46899999864   344567788777765  5799999999986554


Q ss_pred             C----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCCeeecCCCCCceEEcCCC
Q 011234          211 D----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------EKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       211 ~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------~~~iiHrDlkp~NILl~~~~  280 (490)
                      .    .++||+||.+.|+|.++|..+   .++|....+++..|++||+|||+..      +++|+|||||..||||.+|+
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl  353 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL  353 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC
Confidence            4    889999999999999999866   6899999999999999999999853      35699999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCC-----ccccchhhHHHHHHHHhCCCCCCC-CCCCCc
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLT-----SKSDVYSFGVVLLEMLTGRRSMDK-NRPNGE  353 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~-----~~sDvwSlGvil~elltG~~pf~~-~~~~~~  353 (490)
                      +..|+|||+|..+............+||.+|||||++.+. .+.     .+.||||+|.|||||++...-+.. ..+...
T Consensus       354 TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yq  433 (534)
T KOG3653|consen  354 TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQ  433 (534)
T ss_pred             cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCccc
Confidence            9999999999988655444334457999999999999764 222     368999999999999997765532 111111


Q ss_pred             chhHHh--hhcccCCchh--hhhccCccccCCCC-hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          354 HNLVEW--ARPHLGDKRR--FYRLLDPRLEGHFS-IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       354 ~~~~~~--~~~~~~~~~~--~~~~~~~~l~~~~~-~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      .-+...  ..|.+.+...  ......|.+...+- -.....+.+.+..||..||+.|.|+.=+-+.+.++...
T Consensus       434 lpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  434 LPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence            111100  0111111100  01111122211111 12367789999999999999999999888888776554

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-37  Score=319.80  Aligned_cols=256  Identities=28%  Similarity=0.387  Sum_probs=211.2

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  207 (490)
                      .-++-|++.+.||.|.+|.||++....         +|..+|+|++..+.. ..+++..|.++|+.+. |||++.+||+|
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~---------~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~   85 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVK---------TGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAF   85 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeee---------cCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            345679999999999999999999877         566788888876542 3356778999998874 99999999998


Q ss_pred             Ee-----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          208 IE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       208 ~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..     ++++|||||||.+|+.-|++....+..+.|..+..|++.++.||.+||.+.   +||||||-.|||++.++.|
T Consensus        86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcE
Confidence            74     468999999999999999998776778999999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (490)
                      ||+|||++..+...  .......+||+.|||||++..     ..|+..+|+||||++..||--|.+|+-...+.-..   
T Consensus       163 KLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL---  237 (953)
T KOG0587|consen  163 KLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL---  237 (953)
T ss_pred             EEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh---
Confidence            99999999876432  222344789999999999964     35778999999999999999999998654432111   


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                  |...-+|.....-+.+.++++.++|..||.+|..+||++.++|+|
T Consensus       238 ------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  238 ------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                        111122333333456679999999999999999999999999987

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=291.93  Aligned_cols=241  Identities=33%  Similarity=0.443  Sum_probs=196.6

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv  216 (490)
                      ||.|+||.||++.+..         ++..||+|++......   ....+..|+.+++.+.|+||+++++.+..++..++|
T Consensus         1 lg~G~~~~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKD---------TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECC---------CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            6999999999998865         5678999998765332   345678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            99999999999997654  5889999999999999999999988   999999999999999999999999999876443


Q ss_pred             CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       297 ~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .  .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ........             . 
T Consensus       147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~-------------~-  207 (250)
T cd05123         147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL-------------K-  207 (250)
T ss_pred             C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh-------------c-
Confidence            2  112345688999999999888889999999999999999999999965432   11111100             0 


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCCH---HHHHHH
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRM---SEVVET  414 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~---~evl~~  414 (490)
                       ....++...+..+.++|.+||..||++||++   .+++++
T Consensus       208 -~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         208 -DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence             0011222336788999999999999999999   666543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=268.20  Aligned_cols=266  Identities=24%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +|...+.||+|.||+||+|+..+         +++.||+|.++.+..  ......++|+-+|+.|.|.|||+++++...+
T Consensus         3 ~ydkmekigegtygtvfkarn~~---------t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd   73 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD   73 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCC---------ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence            46667899999999999999876         788999999875532  2234678999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ..+-+|+||| ..+|..+.....+ .++.+.+..++.|+++||.|+|+++   +.||||||.|+||+.+|.+||+|||++
T Consensus        74 kkltlvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   74 KKLTLVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             ceeEEeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchh
Confidence            9999999999 5688888766543 6888999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhccc--CC
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL--GD  366 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~--~~  366 (490)
                      +.+.-..  ......+-|..|.+|.++.+. -|+...|+||.|||+.|+.. |++.|.+..-.+....+-+..-..  ..
T Consensus       149 rafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  149 RAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ  226 (292)
T ss_pred             hhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence            9875421  122334568999999999875 58899999999999999985 777787765554433332221110  11


Q ss_pred             chhhhhccCccccCCCC---------hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFS---------IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~---------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...+..+.|-..-..|+         ++....-++|+.++|.-+|..|.++++.+++
T Consensus       227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            11111111111111111         1224456899999999999999999998865

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=316.79  Aligned_cols=244  Identities=27%  Similarity=0.302  Sum_probs=199.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      +..|.+...+|.|+|+.|-.+.+..         ++...++|++.....    +..+|+.++... +||||+++.+++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~---------t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~  387 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSP---------TDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYED  387 (612)
T ss_pred             chhhccccccCCCCccceeeeeccc---------cccchhheecccccc----ccccccchhhhhcCCCcceeecceecC
Confidence            5578888899999999999998876         677899999976622    234567666555 69999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE-cCCCCeEEcccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~kL~DFG  288 (490)
                      ..+.|+|||++.|+.|.+.+.....  + ...+..|+.+|+.|+.|||++|   ||||||||+|||+ +..++++|+|||
T Consensus       388 ~~~~~~v~e~l~g~ell~ri~~~~~--~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG  461 (612)
T KOG0603|consen  388 GKEIYLVMELLDGGELLRRIRSKPE--F-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFG  461 (612)
T ss_pred             CceeeeeehhccccHHHHHHHhcch--h-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEec
Confidence            9999999999999999888876642  2 2677789999999999999988   9999999999999 689999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      .++.....     ....+-|..|.|||++....|+.++||||||++||+||+|+.||......  ..+.           
T Consensus       462 ~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~-----------  523 (612)
T KOG0603|consen  462 FWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH-----------  523 (612)
T ss_pred             hhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH-----------
Confidence            99877554     12245688999999999999999999999999999999999999754332  1111           


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                            .....+.++...+..+++|+.+||+.||.+|+++.+++.+-..
T Consensus       524 ------~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  524 ------TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ------HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                  1111222334558999999999999999999999999977543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-37  Score=309.89  Aligned_cols=244  Identities=26%  Similarity=0.338  Sum_probs=196.8

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHH---HHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~---~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      -|..++.||-|+||.|.+++-.+         |...+|.|.+++.+.-...   .+..|-.||..-+.+-||+||..|.+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvD---------T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVD---------TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecc---------hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            47888999999999999997655         5668999999876543322   35679999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+.+|+||||++||++..+|.+.+  -|++..++.++..+..|+++.|..|   +|||||||+|||||.+|++||.||||
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccc
Confidence            999999999999999999999887  6889999999999999999999999   99999999999999999999999999


Q ss_pred             cccCC---------CCCCc-------------------------------ceeeccccCCCCCCchhhhcCCCCccccch
Q 011234          290 AKDAP---------EDGKT-------------------------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVY  329 (490)
Q Consensus       290 a~~~~---------~~~~~-------------------------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvw  329 (490)
                      ++-+.         +++..                               ......+||+.|+|||++....|+..+|+|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            86331         10000                               001125899999999999999999999999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCCCcchh-HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC
Q 011234          330 SFGVVLLEMLTGRRSMDKNRPNGEHNL-VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  406 (490)
Q Consensus       330 SlGvil~elltG~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  406 (490)
                      |.|||||||+.|++||....+.+.... +.|.           ..++-...    .+.+.++.+||.+++ .+++.|.
T Consensus       856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~-----------~~l~~~~~----~~ls~e~~~li~kLc-~sad~RL  917 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTPGETQYKVINWR-----------NFLHIPYQ----GNLSKEALDLIQKLC-CSADSRL  917 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCCCcceeeeeehh-----------hccccccc----cccCHHHHHHHHHHh-cChhhhh
Confidence            999999999999999988777654332 2221           11222222    233778888888765 4677774

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-37  Score=287.76  Aligned_cols=253  Identities=26%  Similarity=0.398  Sum_probs=202.2

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceece
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKL  203 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l  203 (490)
                      .+..++|.++++||+|+|+.|.+++++.         |.+.+|+|+++++-.   .+......|-.+..+- +||.+|-+
T Consensus       246 ~l~l~df~ll~vigrgsyakvl~~~~~~---------t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvgl  316 (593)
T KOG0695|consen  246 GLGLQDFDLLRVIGRGSYAKVLLVRLKK---------TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGL  316 (593)
T ss_pred             ccccccceeeeeecCcchhhhhheehcc---------cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEeh
Confidence            4556799999999999999999999876         778999999986532   2233445677777665 59999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      +.+|..+..+++|.||++||+|.-++++..  .++++.++.+...|+-||.|||+.|   ||+||||.+|+|||..|++|
T Consensus       317 hscfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghik  391 (593)
T KOG0695|consen  317 HSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIK  391 (593)
T ss_pred             hhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCcee
Confidence            999999999999999999999988887665  6999999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCC-CcchhHHhhhc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~~~~  362 (490)
                      |.|+|+++..-..+.  ....+|||+.|.|||++.+..|+..+|+|+|||+|+||+.|+.||+.-.-. .+.+..++.-.
T Consensus       392 ltdygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq  469 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ  469 (593)
T ss_pred             ecccchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH
Confidence            999999986544333  235689999999999999999999999999999999999999999743211 11111111111


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs  407 (490)
                               -++...+  ..|...+-.+..+++..|.+||.+|.-
T Consensus       470 ---------vilekqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  470 ---------VILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ---------HHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                     1111111  122223667788999999999999854

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.6e-36  Score=287.10  Aligned_cols=220  Identities=25%  Similarity=0.262  Sum_probs=178.5

Q ss_pred             CCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEEecCC
Q 011234          143 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR  222 (490)
Q Consensus       143 G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  222 (490)
                      |.||.||++++..         +|..||+|.+....     .+..|...+....||||+++++++.+.+..++||||+++
T Consensus         4 g~~~~v~~~~~~~---------~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   69 (237)
T cd05576           4 GVIDKVLLVMDTR---------TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEG   69 (237)
T ss_pred             cccceEEEEEEcc---------CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCC
Confidence            8999999999876         67799999987543     233455555566799999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCccee
Q 011234          223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       223 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  302 (490)
                      |+|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||.+......     .
T Consensus        70 ~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~  139 (237)
T cd05576          70 GKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----C  139 (237)
T ss_pred             CCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----c
Confidence            99999987654  5889999999999999999999988   999999999999999999999999987655332     1


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                      ....++..|+|||.+.+..++.++||||+||++|||++|..|+........            ..          .....
T Consensus       140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~~----------~~~~~  197 (237)
T cd05576         140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------TH----------TTLNI  197 (237)
T ss_pred             ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------cc----------cccCC
Confidence            224567789999999888899999999999999999999988753211000            00          00011


Q ss_pred             ChHhHHHHHHHHHHhhhcCCCCCCCH
Q 011234          383 SIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       383 ~~~~~~~l~~Li~~cL~~dP~~RPs~  408 (490)
                      +...+..+.+||.+||+.||++||++
T Consensus       198 ~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         198 PEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cccCCHHHHHHHHHHccCCHHHhcCC
Confidence            22236789999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=297.15  Aligned_cols=259  Identities=28%  Similarity=0.390  Sum_probs=202.1

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-------hhHHHHHHHHHHHhcCCCCcee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLLHPNLV  201 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~HpnIv  201 (490)
                      ...++|-++.+||+|||+.||+|.+..         ..+.||||+-.....       ...+...+|.+|.+.|+||.||
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~---------EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIV  530 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLT---------EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIV  530 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccc---------hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceee
Confidence            334578899999999999999998865         456899998643311       1134467899999999999999


Q ss_pred             ceeeEEEe-cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc---
Q 011234          202 KLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---  277 (490)
Q Consensus       202 ~l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---  277 (490)
                      ++|++|.- .+..|-|+|||+|.+|+-+|..+.  .+++..++.|+.||+.||.||.+.. .+|||=||||.||||-   
T Consensus       531 KlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  531 KLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCc
Confidence            99999865 467889999999999999987765  6889999999999999999999876 6799999999999994   


Q ss_pred             CCCCeEEccccccccCCCCCCcc-----eeeccccCCCCCCchhhhcC----CCCccccchhhHHHHHHHHhCCCCCCCC
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~----~~~~~sDvwSlGvil~elltG~~pf~~~  348 (490)
                      .-|.+||.|||+++.+..+....     ......||++|++||.+.-+    .++.++||||+|||+|..+.|+.||..+
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence            34779999999999886654332     23457899999999988643    5788999999999999999999999764


Q ss_pred             CCCCcchhHHhhhcccCCchhhhhccCccccCCCC--hHhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011234          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS--IKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  413 (490)
                      .....  ..+..           .++... +-.||  +..+.++.++|++||+..-++|....++..
T Consensus       688 qsQQd--ILqeN-----------TIlkAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  688 QSQQD--ILQEN-----------TILKAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhHHH--HHhhh-----------chhcce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            32211  11110           011100 00111  234788999999999999999998887753

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-38  Score=285.97  Aligned_cols=272  Identities=25%  Similarity=0.369  Sum_probs=207.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..|.-..+||+|.||.||+|+..+         +|+.||+|++-.+..  .--...++|+++|..|.|+|++.++++|..
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n---------~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~t   87 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKN---------TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcC---------ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence            346667889999999999999876         677899987644321  112356899999999999999999988764


Q ss_pred             c--------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          210 D--------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~--------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .        ...|+||.+|+. +|.-+|... ...++..++.+++.+++.||.|+|+..   |+|||+|++|+||+.+|.
T Consensus        88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgi  162 (376)
T KOG0669|consen   88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGI  162 (376)
T ss_pred             ccCCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCce
Confidence            2        347999999965 888887654 347889999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCC--cceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          282 AKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +||+|||+++.+.....  ....+..+-|..|.+||.+.+ ..|+.+.|||..||||.||++|.+.|.++.......++.
T Consensus       163 lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is  242 (376)
T KOG0669|consen  163 LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS  242 (376)
T ss_pred             EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence            99999999986643221  112234456999999999986 579999999999999999999999998887766655554


Q ss_pred             hh--------hcccCCchhhhhcc--CccccCCCC--------hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          359 WA--------RPHLGDKRRFYRLL--DPRLEGHFS--------IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       359 ~~--------~~~~~~~~~~~~~~--~~~l~~~~~--------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..        ++... ...++..+  .|...+.+.        ..-.+++.+|+.++|..||.+|+++.+++++.-..
T Consensus       243 ~LcGs~tkevWP~~d-~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVD-NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             HHhccCCcccCCCcc-cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            32        12111 11222222  111111111        11156889999999999999999999999986544

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=314.03  Aligned_cols=257  Identities=27%  Similarity=0.404  Sum_probs=213.4

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      .+.+++||.|+||+||+|.+...+..     -..+||||++... ..+...++++|+.+|.+|+||||++|++++.... 
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~-----vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-  771 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGEN-----VKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-  771 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCce-----ecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence            45568899999999999999764332     3568999998755 3455678999999999999999999999998765 


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      +.||++||++|+|.++++.++. .+-....+.|..||++||.|||.+.   ++||||-.+|||+.+-..+||.|||+++.
T Consensus       772 ~qlvtq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~l  847 (1177)
T KOG1025|consen  772 LQLVTQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKL  847 (1177)
T ss_pred             HHHHHHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhc
Confidence            8899999999999999987654 6778888999999999999999887   99999999999999999999999999998


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      ...+..........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+..++.+..           
T Consensus       848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g-----------  916 (1177)
T KOG1025|consen  848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG-----------  916 (1177)
T ss_pred             cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc-----------
Confidence            876655443333334678999999999999999999999999999886 88888776544443333321           


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                            ..-.-|+.++.++..++.+||..|+..||+++++...+.+
T Consensus       917 ------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  917 ------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             ------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence                  1123355678999999999999999999999999987753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=318.96  Aligned_cols=269  Identities=30%  Similarity=0.465  Sum_probs=211.9

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCC-CCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLL-HPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~  205 (490)
                      ....++..+.+.||+|.||.|++|.........  ......||||.++.... ...+.+..|+++|..+. |+||+.++|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~--~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKAL--LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeeccccc--ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            334445566779999999999999876432210  11256899999876533 45567899999999995 999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcC------------C--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKG------------S--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      ++...+..++|+||+..|+|.++|...+            .  ..+.....+.++.||+.|++||++..   +|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999998765            0  13788899999999999999999977   99999999


Q ss_pred             CceEEcCCCCeEEccccccccCCCCCCcceeecccc--CCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011234          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  348 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~  348 (490)
                      .|||+..+..+||+|||+|+........... ...|  ...|||||.+....|+.++|||||||+|||+++ |..||.+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            9999999999999999999976554433322 1222  345999999999999999999999999999998 77787552


Q ss_pred             CCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..  ...+.++              +.....-..|..|+.++.++|+.||+.+|++||++.++.+.|+..
T Consensus       526 ~~--~~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 PP--TEELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             Cc--HHHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11  1111221              112222234556689999999999999999999999999999873

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=288.23  Aligned_cols=267  Identities=28%  Similarity=0.421  Sum_probs=200.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~  208 (490)
                      .++..+.+.||+|.||.||+|.|.           |+.||||++...+   ...|.+|.+|...  |+|+||+.+++.-.
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-----------Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~  275 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-----------GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADN  275 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-----------CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence            457888999999999999999994           7789999997543   3567788887765  58999999998755


Q ss_pred             ecC----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCceEEcCC
Q 011234          209 EDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-----AEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       209 ~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-----~~~~iiHrDlkp~NILl~~~  279 (490)
                      .+.    ++|||.+|.+.|+|+|+|.+.   .++....+++++.++.||++||-.     |+..|.|||||..|||+.++
T Consensus       276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  276 KDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             cCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            443    689999999999999999874   688999999999999999999963     55679999999999999999


Q ss_pred             CCeEEccccccccCCCCCCc--ceeeccccCCCCCCchhhhcCC----C--CccccchhhHHHHHHHHhC----------
Q 011234          280 YNAKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGH----L--TSKSDVYSFGVVLLEMLTG----------  341 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~----~--~~~sDvwSlGvil~elltG----------  341 (490)
                      +.+.|+|+|||.....+...  ......+||..|||||++...-    +  -..+||||||.|+||+...          
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999999876554221  1223468999999999986431    1  2368999999999999763          


Q ss_pred             CCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCC-CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       342 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ++||....+.+.. . +..+.....     +.+.|.+... .+......+.+||+.||..||.-|.|+-.|-..|.++.+
T Consensus       433 ~~Pyyd~Vp~DPs-~-eeMrkVVCv-----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPS-F-EEMRKVVCV-----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCC-H-HHHhcceee-----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            3455443332211 0 000111110     1111111111 123346778899999999999999999999999988865


Q ss_pred             C
Q 011234          421 L  421 (490)
Q Consensus       421 ~  421 (490)
                      .
T Consensus       506 ~  506 (513)
T KOG2052|consen  506 S  506 (513)
T ss_pred             C
Confidence            3

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=6.3e-35  Score=311.13  Aligned_cols=268  Identities=21%  Similarity=0.245  Sum_probs=172.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeE---
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY---  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~---  206 (490)
                      ..++|.+.+.||+|+||.||+|++..+..     ..+..||||.+......  +.+..|  .+....+.+++.++..   
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-----~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-----KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-----ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            56789999999999999999999876311     12678999988644321  111111  1222222233222221   


Q ss_pred             ---EEecCceEEEEEecCCCCHHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011234          207 ---CIEDDQRLLVYEFMPRGSLENHLFRKGSL------------------PLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       207 ---~~~~~~~~lv~E~~~~g~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                         ...+...+|||||+.+++|.+++......                  ......+..++.||+.||.|||+.+   |+
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---Ii  277 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IV  277 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EE
Confidence               23456789999999999999988654210                  0112345679999999999999988   99


Q ss_pred             ecCCCCCceEEcC-CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC----------------------CC
Q 011234          266 YRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG----------------------HL  322 (490)
Q Consensus       266 HrDlkp~NILl~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----------------------~~  322 (490)
                      ||||||+||||+. ++.+||+|||+|+...... .......+|++.|||||.+...                      .+
T Consensus       278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             eCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            9999999999985 5799999999998654322 2223456899999999976422                      24


Q ss_pred             CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccc----cCCCC--hHhHHHHHHHHHH
Q 011234          323 TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL----EGHFS--IKGSQKATQLAAQ  396 (490)
Q Consensus       323 ~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l----~~~~~--~~~~~~l~~Li~~  396 (490)
                      +.++|||||||+||||+++..+++...    ..+.......-.+...+.....+..    ...+.  ........+||.+
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            456799999999999999776543210    0000000000000000001111110    00000  0013456689999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 011234          397 CLSRDPKARPRMSEVVET  414 (490)
Q Consensus       397 cL~~dP~~RPs~~evl~~  414 (490)
                      ||+.||++|||+.++++|
T Consensus       433 mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        433 MMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HccCCcccCCCHHHHhCC
Confidence            999999999999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=260.90  Aligned_cols=206  Identities=28%  Similarity=0.381  Sum_probs=170.9

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcC-CCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL-LHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~~  205 (490)
                      ++..++...+..||+|+||.|-+.++..         +|...|+|.+... ..+..+.++.|+.+..+. .+|.+|.+||
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~---------sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyG  112 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQ---------SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYG  112 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeecc---------CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence            3444555666789999999999998876         7889999998755 345567788999987655 6999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      .+..+...|+.||.| ..+|..+...  ..+..+++..+-+|+..+++||.|||++-  .|||||+||+||||+.+|.+|
T Consensus       113 a~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVK  189 (282)
T KOG0984|consen  113 ALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVK  189 (282)
T ss_pred             hhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEE
Confidence            999999999999999 4677765532  22447899999999999999999999965  399999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhc----CCCCccccchhhHHHHHHHHhCCCCCCCC
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----~~~~~~sDvwSlGvil~elltG~~pf~~~  348 (490)
                      +||||++..+.+.-   ..+-..|...|||||.+..    ..|+.++||||||+++.||.+++.||+.+
T Consensus       190 iCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  190 ICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             Ecccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            99999998765431   1222568999999999863    47999999999999999999999999754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=9.1e-34  Score=269.44  Aligned_cols=240  Identities=31%  Similarity=0.444  Sum_probs=194.4

Q ss_pred             CceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-HHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEEecCC
Q 011234          144 GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR  222 (490)
Q Consensus       144 ~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~  222 (490)
                      +||.||+|.+..         +|..||+|++....... .+.+.+|++.++.++|+||+++++++......+++|||+.+
T Consensus         1 ~~g~v~~~~~~~---------~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   71 (244)
T smart00220        1 SFGKVYLARDKK---------TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDG   71 (244)
T ss_pred             CceEEEEEEECC---------CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCC
Confidence            589999998865         56789999998765444 67889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCccee
Q 011234          223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       223 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  302 (490)
                      ++|.+++....  .+++..+..++.+++.+|.|||+.+   |+|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        72 ~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~  143 (244)
T smart00220       72 GDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL  143 (244)
T ss_pred             CCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence            99999987654  3888999999999999999999988   9999999999999999999999999998765432   22


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                      ....|+..|++||.+.+..++.++||||||+++|+|++|..||.....  .....+.........            ...
T Consensus       144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~------------~~~  209 (244)
T smart00220      144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF------------PPP  209 (244)
T ss_pred             ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC------------ccc
Confidence            345688999999999888899999999999999999999999865311  111111111000000            000


Q ss_pred             ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          383 SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       383 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....+.++.+++.+||..+|++||++.+++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            00036789999999999999999999999863

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.8e-34  Score=295.28  Aligned_cols=273  Identities=19%  Similarity=0.267  Sum_probs=187.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCc-------cccCCCCcEEEEEEecCCChhhHHH--------------HHH
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTA-------PVKPGTGLTVAVKTLNHDGLQGHKE--------------WLA  187 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-------~~~~~~g~~vAvK~~~~~~~~~~~~--------------~~~  187 (490)
                      ...++|.+.++||+|+||.||+|.+...+..       ......+..||||.+........++              ...
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            3467899999999999999999986432211       0122356789999987553322222              334


Q ss_pred             HHHHHhcCCCCce-----eceeeEEEe--------cCceEEEEEecCCCCHHHHHhhcCC--------------------
Q 011234          188 EVNFLGNLLHPNL-----VKLVGYCIE--------DDQRLLVYEFMPRGSLENHLFRKGS--------------------  234 (490)
Q Consensus       188 E~~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~--------------------  234 (490)
                      |+.++.++.|.++     ++++++|..        .+..||||||+++++|.+++.....                    
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777766554     677777653        3568999999999999998864211                    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCC
Q 011234          235 --LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA  312 (490)
Q Consensus       235 --~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~  312 (490)
                        ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+|+.|+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~  377 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS  377 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence              12456778899999999999999988   999999999999999999999999999765432111 111234588999


Q ss_pred             CchhhhcCC--------------------CC--ccccchhhHHHHHHHHhCCC-CCCCCCCCCc------chhHHhhhcc
Q 011234          313 APEYVMTGH--------------------LT--SKSDVYSFGVVLLEMLTGRR-SMDKNRPNGE------HNLVEWARPH  363 (490)
Q Consensus       313 aPE~l~~~~--------------------~~--~~sDvwSlGvil~elltG~~-pf~~~~~~~~------~~~~~~~~~~  363 (490)
                      |||.+....                    |+  .+.||||+||++|+|++|.. ||........      .....|..  
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--  455 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--  455 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--
Confidence            999875422                    11  24799999999999999875 6643211110      00111110  


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCC---CCCCCHHHHHHHhh
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP---KARPRMSEVVETLK  416 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP---~~RPs~~evl~~L~  416 (490)
                               .......-......+..+.+|+.+||..+|   .+|+|+.|+|+|-.
T Consensus       456 ---------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~  502 (507)
T PLN03224        456 ---------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF  502 (507)
T ss_pred             ---------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence                     000000011112347889999999999876   68999999998753

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=276.69  Aligned_cols=268  Identities=22%  Similarity=0.344  Sum_probs=205.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +.+..+.||-|+||+||.+.+-         ++|+.||+|.+..-  ....-+.+.+|+.+|..++|.|++..+++....
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDP---------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPp  124 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDP---------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPA  124 (449)
T ss_pred             cCCCCCcccccceeEEEeccCC---------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCC
Confidence            5677899999999999998654         47889999987543  344557889999999999999999999987654


Q ss_pred             C-----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          211 D-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       211 ~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .     ++|+|.|+| ..+|...|..-  +.++...+.-++.||++||+|||+.+   |+||||||.|+|++.+..+|||
T Consensus       125 h~dfFqEiYV~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKIC  198 (449)
T KOG0664|consen  125 NPSFFQELYVLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKIC  198 (449)
T ss_pred             CchHHHHHHHHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEec
Confidence            3     568899998 56888877543  37888889999999999999999999   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--c
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P  362 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~  362 (490)
                      |||+|+....+...+ .+..+-|-+|.|||++++ ..|+.+.||||+|||+.||+..+..|....+.....++....  +
T Consensus       199 DFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTP  277 (449)
T KOG0664|consen  199 DFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTP  277 (449)
T ss_pred             ccccccccchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCC
Confidence            999999776544433 344566889999999997 479999999999999999999999998887776665543221  1


Q ss_pred             ccCC------chh---hhhc-cCccccCCC----ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          363 HLGD------KRR---FYRL-LDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       363 ~~~~------~~~---~~~~-~~~~l~~~~----~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .+..      ...   +... ..|.+..-|    +.....+...++.++|..||++|.+..+.+.++.
T Consensus       278 s~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  278 SQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             cHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1000      000   0000 000000001    1122456788999999999999999999998864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=272.88  Aligned_cols=271  Identities=25%  Similarity=0.352  Sum_probs=218.1

Q ss_pred             hhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceec
Q 011234          124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       124 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      ..++.+...+++...++-+|.||.||.|.+.+.++.    .+.+.|-+|.++....+ ....++.|.-.|..+.|||+..
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~----n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~  351 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY----NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLS  351 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCc----chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccc
Confidence            345667777899999999999999999988764332    23456778887655332 3456789999999999999999


Q ss_pred             eeeEEEec-CceEEEEEecCCCCHHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          203 LVGYCIED-DQRLLVYEFMPRGSLENHLFR------KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       203 l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +.+++.++ ...++++.++.-|+|..+|..      ...+.+...+...++.|++.|+.|||..+   |||.||...|++
T Consensus       352 V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv  428 (563)
T KOG1024|consen  352 VLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV  428 (563)
T ss_pred             eeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence            99998765 567889999988999999972      22234666777889999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~  354 (490)
                      ||+...+||+|=.+++.+-..+.............||+||.+....|+.++|||||||+||||+| |+.|+...++.+..
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            99999999999999998876666655555556778999999999999999999999999999987 88888655444322


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..+.       +.          ..-.-|.+|++++..+|.-||+.+|++||++++++..|.++
T Consensus       509 ~ylk-------dG----------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  509 HYLK-------DG----------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             HHHh-------cc----------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            2211       11          11123457899999999999999999999999999998765

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=7.4e-35  Score=287.85  Aligned_cols=275  Identities=24%  Similarity=0.277  Sum_probs=212.0

Q ss_pred             hchhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-----
Q 011234          122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----  196 (490)
Q Consensus       122 ~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----  196 (490)
                      |.+.-+++...+|.+....|+|-|++|.+|.+..         .|..||||+|..... ..+.=+.|++||.+|+     
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---------r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~E  491 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---------RGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPE  491 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccC---------CCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCch
Confidence            3444556677889999999999999999998875         566999999987643 3455678999999996     


Q ss_pred             -CCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          197 -HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       197 -HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                       --|+++|+-.|...+++|||+|-+ ..+|.++|.+.+. ..|....+..++.|+.-||..|-.++   |+|.||||+||
T Consensus       492 dk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNi  567 (752)
T KOG0670|consen  492 DKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNI  567 (752)
T ss_pred             hhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccce
Confidence             358999999999999999999988 6799999987653 45788899999999999999999998   99999999999


Q ss_pred             EEcCC-CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          275 LLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      |+++. ..+||||||.|....+...+.    ..-+..|.|||++.+..|+...|+||+||+||||+||+..|.+...+..
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M  643 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM  643 (752)
T ss_pred             EeccCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence            99875 468999999998776543322    3346679999999999999999999999999999999999988766544


Q ss_pred             chhHHhh---------------hcccCCchhhh----------------hccCc------cccC--CCC---hHhHHHHH
Q 011234          354 HNLVEWA---------------RPHLGDKRRFY----------------RLLDP------RLEG--HFS---IKGSQKAT  391 (490)
Q Consensus       354 ~~~~~~~---------------~~~~~~~~~~~----------------~~~~~------~l~~--~~~---~~~~~~l~  391 (490)
                      ..+.--.               ..++.....|+                ..+.|      .+.+  .++   ...-..+.
T Consensus       644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r  723 (752)
T KOG0670|consen  644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR  723 (752)
T ss_pred             HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence            3322111               01111111110                00001      0000  112   22356789


Q ss_pred             HHHHHhhhcCCCCCCCHHHHHHH
Q 011234          392 QLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       392 ~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +|+.+||..||++|.|..++|.|
T Consensus       724 dLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  724 DLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             HHHHHHhccChhhcCCHHHHhcC
Confidence            99999999999999999999876

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-32  Score=270.16  Aligned_cols=132  Identities=24%  Similarity=0.358  Sum_probs=114.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-----C---Cceece
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----H---PNLVKL  203 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l  203 (490)
                      .+|.+.++||-|.|++||+|++..         ..+.||+|+.+... ...+..+.||++|++++     |   .+||+|
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq---------~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L  147 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQ---------NKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQL  147 (590)
T ss_pred             ceEEEEEeccccccceeEEEeecc---------CCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence            689999999999999999999976         45689999987543 23355688999999884     3   369999


Q ss_pred             eeEEEec----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          204 VGYCIED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       204 ~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ++.|...    .++|||+|++ |.+|..+|.......++...+.+|++||+.||.|||...  +|||-||||+|||+
T Consensus       148 lD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  148 LDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             eccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            9999764    4899999999 889999998887778999999999999999999999965  49999999999998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.7e-33  Score=252.87  Aligned_cols=260  Identities=22%  Similarity=0.312  Sum_probs=196.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~  209 (490)
                      .++|++.+.+|+|-|+.||.|....         +.+.++||+++.-   ..+.+.+|+.||..|. ||||++++++..+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~---------~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~D  104 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINIT---------NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKD  104 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccC---------CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence            4689999999999999999998765         4567999999754   3356889999999998 9999999999877


Q ss_pred             c--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CCeEEcc
Q 011234          210 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSD  286 (490)
Q Consensus       210 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~D  286 (490)
                      .  ....||+||+.+.+...+..     .+..-.+..++.+++.||.|||++|   |+|||+||.|++||.. -.++|+|
T Consensus       105 p~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  105 PESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             ccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeee
Confidence            5  35679999998877765542     4566678889999999999999999   9999999999999864 4699999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      +|+|..........+   .+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-....+.. .++..+. .++
T Consensus       177 WGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIak-VLG  251 (338)
T KOG0668|consen  177 WGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAK-VLG  251 (338)
T ss_pred             cchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHH-HhC
Confidence            999998766544332   356778999998865 5788999999999999999999999965443322 1222111 000


Q ss_pred             Cc------hhhhhccCccccC----------------CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 DK------RRFYRLLDPRLEG----------------HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~------~~~~~~~~~~l~~----------------~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..      ....-.+++.+.+                .-..-.++++.+|+.++|..|..+|+|+.|++.|-
T Consensus       252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            00      0000011111111                00011268899999999999999999999998763

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=262.28  Aligned_cols=263  Identities=23%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .+|.-+..+|.|.- .|.-|.+.-         .+..||+|.+...  .....+...+|+.++..+.|+||++++.+|.-
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v---------~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP   86 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQV---------LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP   86 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhh---------ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence            36777888999987 566665543         6778999987544  23445677899999999999999999999875


Q ss_pred             c------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          210 D------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      .      ...|+||||| ..+|...+.-    .++-..+..|+.|++.|++|||+.+   |+||||||+||++..++.+|
T Consensus        87 ~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lK  158 (369)
T KOG0665|consen   87 QKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLK  158 (369)
T ss_pred             cccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhhee
Confidence            4      3579999999 5799888862    4666788899999999999999999   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh----
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW----  359 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~----  359 (490)
                      |+|||+|+....+   ...+..+.|..|.|||++.+..|...+||||+||++.||++|...|.+....+....+..    
T Consensus       159 i~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  159 ILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGT  235 (369)
T ss_pred             eccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcC
Confidence            9999999865432   345667899999999999998899999999999999999999999975543332221110    


Q ss_pred             ------------hhcccCCc-----hhhhhccCcc-cc--CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          360 ------------ARPHLGDK-----RRFYRLLDPR-LE--GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       360 ------------~~~~~~~~-----~~~~~~~~~~-l~--~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                  ++......     ..+.+.+... +.  .+.+......+.+|+.+||..||++|.++.++|+|-
T Consensus       236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                        00000000     1111111111 00  011122366789999999999999999999999873

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=292.30  Aligned_cols=247  Identities=29%  Similarity=0.401  Sum_probs=187.0

Q ss_pred             CCcCceeccCCceE-EEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecC
Q 011234          134 FRPESLLGEGGFGC-VFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDD  211 (490)
Q Consensus       134 y~~~~~lG~G~fg~-Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~  211 (490)
                      |...+++|.|+-|+ ||+|.+.           |+.||||.+-.+.   ..-..+|+..|+.-+ |||||++|+.-.+..
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-----------~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q  576 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-----------GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ  576 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-----------CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc
Confidence            44457899998875 7999884           6789999875432   223468999999885 999999999988999


Q ss_pred             ceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---C--CCeEE
Q 011234          212 QRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---D--YNAKL  284 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~kL  284 (490)
                      ..||..|.| ..+|.+++...  ..........+.++.|++.||++||+.+   ||||||||.||||+.   +  ..++|
T Consensus       577 F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~i  652 (903)
T KOG1027|consen  577 FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKI  652 (903)
T ss_pred             eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEe
Confidence            999999999 57999999763  1111111334678899999999999988   999999999999965   3  46899


Q ss_pred             ccccccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhc
Q 011234          285 SDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      +|||+++.+..+.... ......||.+|+|||++....-+.++||||||||+|+.++| .+||...-..+. +       
T Consensus       653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-N-------  724 (903)
T KOG1027|consen  653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-N-------  724 (903)
T ss_pred             cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-h-------
Confidence            9999999886543221 13456799999999999998889999999999999998886 889965422211 0       


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .+.....+.. +.+        ....++.+||.+||+.||..||++.+||.|-
T Consensus       725 Il~~~~~L~~-L~~--------~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  725 ILTGNYTLVH-LEP--------LPDCEAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             hhcCccceee-ecc--------CchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence            1111111100 000        0022899999999999999999999999873

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=287.17  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=207.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|.++..+|.|.||.||+++++.         +++..|+|+++........-+..|+-+++.++|||||.++|.|...
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~---------s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~   84 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKR---------SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR   84 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccc---------cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh
Confidence            3579999999999999999999876         7889999999887666666677899999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +.+|++||||.+|+|.+..+-.+  ++++.++....+..++||+|||+.+   -+|||||-.|||+++.|.+||+|||.+
T Consensus        85 dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   85 DKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             cCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCch
Confidence            99999999999999999775544  7899999999999999999999998   899999999999999999999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      -.+...  ......+.||++|||||+..   .+.|...+|||++|++..|+-.-++|.....+.....+...        
T Consensus       160 aqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--------  229 (829)
T KOG0576|consen  160 AQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--------  229 (829)
T ss_pred             hhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--------
Confidence            765432  22234588999999999874   57899999999999999999888887644333222111110        


Q ss_pred             hhhhhccC-ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLD-PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~-~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ..++ +.+++  ....+..+.+|++.||.++|++||+++.+|.+
T Consensus       230 ----S~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  230 ----SGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ----cCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence                0111 11111  22347889999999999999999999877653

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1.9e-30  Score=240.37  Aligned_cols=212  Identities=37%  Similarity=0.601  Sum_probs=183.9

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE  218 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E  218 (490)
                      ||+|++|.||++....         ++..+++|++...... ....+.+|+..++.+.|++|+++++++......+++||
T Consensus         1 l~~g~~~~v~~~~~~~---------~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e   71 (215)
T cd00180           1 LGEGGFGTVYLARDKK---------TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVME   71 (215)
T ss_pred             CCcCCceEEEEEEecC---------CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEe
Confidence            6899999999998864         4678999999866443 34578899999999999999999999999899999999


Q ss_pred             ecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEccccccccCCCCC
Q 011234          219 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       219 ~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG~a~~~~~~~  297 (490)
                      |+.+++|.+++.... ..+++..+..++.+++.+|.|||+.+   ++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            999899999987652 36889999999999999999999988   999999999999998 8999999999998664432


Q ss_pred             CcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          298 KTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .  ......+...|++||.+... .++.+.|+|+||+++++|                                      
T Consensus       148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------  187 (215)
T cd00180         148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------  187 (215)
T ss_pred             c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence            1  12234578899999999877 888999999999999999                                      


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                 ..+.+++.+||..||++||++.+++++|
T Consensus       188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                       2467899999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-32  Score=272.13  Aligned_cols=197  Identities=24%  Similarity=0.340  Sum_probs=169.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH--------HHHHHHHHHHhcCC---CCce
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--------KEWLAEVNFLGNLL---HPNL  200 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~--------~~~~~E~~~l~~l~---HpnI  200 (490)
                      .+|..+..||+|+||.|++|.++.+         ...|+||.+.+...-..        -.+-.||.||..|+   |+||
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n---------~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKEN---------NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             ccceeeeeccccccceEEEeeeccc---------ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            3699999999999999999999874         44899999876643211        11345999999998   9999


Q ss_pred             eceeeEEEecCceEEEEEec-CCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          201 VKLVGYCIEDDQRLLVYEFM-PRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       201 v~l~~~~~~~~~~~lv~E~~-~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      ++++++|++++++||+||-- ++-+|+++|..+.  .+.+..+..|++||+.|+++||+.+   |||||||-+|+.++.+
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSN  706 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecC
Confidence            99999999999999999974 3568999998776  5788889999999999999999999   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCC
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~  346 (490)
                      |.+||+|||.|.....+.    ...++||..|.|||++.+..| +..-|||+||++||.++....||.
T Consensus       707 g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999987664432    245789999999999998776 567899999999999999888874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=245.08  Aligned_cols=253  Identities=22%  Similarity=0.330  Sum_probs=190.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeE-EEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY-CIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~-~~~  209 (490)
                      +.|.|.+.||+|.||.+-+|+++.         +...+++|.+.... ...++|.+|...--.|. |.||+.-|++ |..
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~---------s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQ---------SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccC---------CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            469999999999999999999976         66789999887653 45678999988766664 8999998875 667


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc--CCCCeEEccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDF  287 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kL~DF  287 (490)
                      .+.+++++||++.|+|...+...   .+-+.....++.|++.||.|+|+.+   +||||||.+||||-  +..++|||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeec
Confidence            78889999999999999888654   4677888899999999999999988   99999999999992  3347999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcC-----CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+.+..+...     ...--+..|.+||++...     .....+|||.|||++|..|+|.+||......+. ...+|..-
T Consensus       168 G~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w  241 (378)
T KOG1345|consen  168 GLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQW  241 (378)
T ss_pred             ccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHH
Confidence            9987653221     122346679999987532     345689999999999999999999985433322 23333221


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .........+.+.+         .+..+..+.++-|..++++|-...++....
T Consensus       242 ~~rk~~~~P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  242 LKRKNPALPKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             hcccCccCchhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            11111111112211         167888999999999999996555555443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.8e-29  Score=237.78  Aligned_cols=200  Identities=35%  Similarity=0.468  Sum_probs=173.5

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      |.+.+.||.|+||.||+|.+..         ++..+|+|.+...... ..+.+.+|+..+..++|+||+++++++.....
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~---------~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~   71 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG---------TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEP   71 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC---------CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence            5677899999999999998865         4678999999876544 56778899999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .++++||+++++|.+++..... .+++..+..++.+++.+|.|||..+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        72 ~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       72 LYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             eEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            9999999999999999876542 2788999999999999999999987   99999999999999999999999999987


Q ss_pred             CCCCCCcceeeccccCCCCCCchhh-hcCCCCccccchhhHHHHHHHHhCCCCCCC
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l-~~~~~~~~sDvwSlGvil~elltG~~pf~~  347 (490)
                      ....... ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus       148 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            6543211 12335678899999998 666788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=3.3e-30  Score=250.79  Aligned_cols=272  Identities=25%  Similarity=0.326  Sum_probs=200.3

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceee
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVG  205 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~  205 (490)
                      +....+.|.++++||+|.|++||++.+...      ......||+|.+......  ..+..|+++|..+. +.||+++.+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~------~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ------DTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh------ccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchh
Confidence            344456799999999999999999988763      225679999998766433  45889999999996 999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEE
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKL  284 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL  284 (490)
                      ++..++..++||||+++....+++.     .++...+..+++.++.||.++|.+|   ||||||||+|+|.+. .+.-.|
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceE
Confidence            9999999999999999999888875     3557788899999999999999999   999999999999975 467899


Q ss_pred             ccccccccCCCC------------------CC------------------------cceeeccccCCCCCCchhhhc-CC
Q 011234          285 SDFGLAKDAPED------------------GK------------------------THVSTRVMGTYGYAAPEYVMT-GH  321 (490)
Q Consensus       285 ~DFG~a~~~~~~------------------~~------------------------~~~~~~~~Gt~~y~aPE~l~~-~~  321 (490)
                      +|||+|......                  +.                        ........||++|.|||++.. ..
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            999998721100                  00                        000112479999999999975 56


Q ss_pred             CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh---------------c--ccC--------CchhhhhccC-
Q 011234          322 LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR---------------P--HLG--------DKRRFYRLLD-  375 (490)
Q Consensus       322 ~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~---------------~--~~~--------~~~~~~~~~~-  375 (490)
                      .+.++||||.|||+.-+++++.||-..... ...+.+.+.               .  .+.        +...-++-++ 
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~  333 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI  333 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence            788999999999999999999999543221 111111100               0  000        0000011111 


Q ss_pred             -cccc--------CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          376 -PRLE--------GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       376 -~~l~--------~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       ....        .......+..+.+|+.+||..||.+|.|++++|.|-
T Consensus       334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence             0000        001111255789999999999999999999999774

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3.4e-29  Score=279.33  Aligned_cols=198  Identities=20%  Similarity=0.272  Sum_probs=141.1

Q ss_pred             cCCC-CceeceeeEE-------EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011234          194 NLLH-PNLVKLVGYC-------IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       194 ~l~H-pnIv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      .+.| .||+.++++|       ......+++|||+ +++|.++|... ...+++..++.++.||+.||.|||+++   |+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            4455 5788888877       2334567889988 67999999654 336899999999999999999999988   99


Q ss_pred             ecCCCCCceEEcC-------------------CCCeEEccccccccCCCCCC--------------cceeeccccCCCCC
Q 011234          266 YRDFKTSNILLDA-------------------DYNAKLSDFGLAKDAPEDGK--------------THVSTRVMGTYGYA  312 (490)
Q Consensus       266 HrDlkp~NILl~~-------------------~~~~kL~DFG~a~~~~~~~~--------------~~~~~~~~Gt~~y~  312 (490)
                      ||||||+||||+.                   ++.+||+|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566666666653211000              00011246899999


Q ss_pred             CchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHH
Q 011234          313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ  392 (490)
Q Consensus       313 aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  392 (490)
                      |||++.+..|+.++|||||||+||||++|.+|+.....    .......          ..+.+..     ......+.+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhh-----hhcCHHHHH
Confidence            99999999999999999999999999999887642110    0000000          0111111     011345678


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHh
Q 011234          393 LAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       393 Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ++.+||+.||.+||++.||+++-
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhch
Confidence            89999999999999999998763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=7.8e-27  Score=212.48  Aligned_cols=167  Identities=26%  Similarity=0.275  Sum_probs=125.7

Q ss_pred             CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCccee
Q 011234          223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       223 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  302 (490)
                      |+|.+++..++ ..+++..++.++.||+.||.|||+.+         ||+|||++.++.+|+  ||++......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence            68999997653 36999999999999999999999855         999999999999999  9998765432      


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                       ...||+.|||||++.+..++.++|||||||++|||++|+.||.......  .............       .+.. ...
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~-------~~~~-~~~  131 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPAD-------DPRD-RSN  131 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccC-------Cccc-ccc
Confidence             1258999999999999999999999999999999999999996432211  1111110000000       0000 001


Q ss_pred             ChHhHH--HHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          383 SIKGSQ--KATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       383 ~~~~~~--~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      +.....  .+.++|.+||..||.+||++.++++++..+
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            111233  689999999999999999999999998654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7.2e-26  Score=226.57  Aligned_cols=263  Identities=22%  Similarity=0.235  Sum_probs=199.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC----CceeceeeEE-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH----PNLVKLVGYC-  207 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-  207 (490)
                      +|.+.+.||+|+||.||+|......        ...+|+|+...........+..|+.+|..+..    .++..+++.. 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~--------~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~   90 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK--------NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR   90 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC--------CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence            7999999999999999999886521        34789998766533322256678888888863    6888999888 


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-----CCe
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-----YNA  282 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~  282 (490)
                      ..+...|+||+.+ |.+|.++........++...+..|+.|++.+|.+||+.|   ++||||||+|+++...     ..+
T Consensus        91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~  166 (322)
T KOG1164|consen   91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTL  166 (322)
T ss_pred             CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceE
Confidence            4777889999998 899999886665567999999999999999999999998   9999999999999754     469


Q ss_pred             EEccccccc--cCCCCCCc---ce---eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          283 KLSDFGLAK--DAPEDGKT---HV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       283 kL~DFG~a~--~~~~~~~~---~~---~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      .|.|||+++  ........   ..   ...+.||..|+++....+...+.+.|+||++.++.||+.|..||.........
T Consensus       167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~  246 (322)
T KOG1164|consen  167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK  246 (322)
T ss_pred             EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence            999999998  43222211   11   12356999999999999999999999999999999999999999654433221


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .........             .....+....+..+.++...+-..+...+|....+...|..+..
T Consensus       247 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  247 SKFEKDPRK-------------LLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             HHHHHHhhh-------------hccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence            111110000             00000111225667777777777999999999999999876544

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=7e-26  Score=214.03  Aligned_cols=280  Identities=19%  Similarity=0.261  Sum_probs=209.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~  210 (490)
                      -+|++.++||+|+||+.|.|...-         +++.||||.-...  ....++..|.+..+.|. .++|...|-+..+.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~---------nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG   96 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLY---------NNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG   96 (449)
T ss_pred             ccceeccccccCcceeeecccccc---------cCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence            379999999999999999998876         5779999986433  23356677888888776 68999988877777


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-----CCeEEc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-----YNAKLS  285 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~kL~  285 (490)
                      -+..||||++ |-+|+|+..-.++ .|+...++.+|.|++.-++|+|++.   +|+|||||+|+||...     ..+.|+
T Consensus        97 ~~NiLVidLL-GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~Ihii  171 (449)
T KOG1165|consen   97 KYNILVIDLL-GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHII  171 (449)
T ss_pred             chhhhhhhhh-CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEE
Confidence            7889999998 8999998876654 7999999999999999999999988   9999999999999643     358999


Q ss_pred             cccccccCCCCCCc-c----eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          286 DFGLAKDAPEDGKT-H----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      |||+|+...+.... +    ......||..||+--...+...+.+.|+-|||.+++++|-|..||.+..........+. 
T Consensus       172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK-  250 (449)
T KOG1165|consen  172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK-  250 (449)
T ss_pred             eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH-
Confidence            99999977543221 1    22357899999999999999999999999999999999999999986543332222221 


Q ss_pred             hcccCCchh---hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC-ccccccchhhhcccC
Q 011234          361 RPHLGDKRR---FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMASSSYYFQTMQA  436 (490)
Q Consensus       361 ~~~~~~~~~---~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~-~~~~~~~~~~~~~~~  436 (490)
                         +++..+   +..+     .    ...+.++..-+.-.-..+-.+-|..+-+...+..+-.. ....+-.|.|.-...
T Consensus       251 ---IGe~Kr~T~i~~L-----c----~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln~  318 (449)
T KOG1165|consen  251 ---IGETKRSTPIEVL-----C----EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLNN  318 (449)
T ss_pred             ---hccccccCCHHHH-----H----hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccCC
Confidence               111111   1111     1    12267777778877788888999988777766554332 233444455544443


Q ss_pred             CCcc
Q 011234          437 DNTW  440 (490)
Q Consensus       437 ~~~~  440 (490)
                      ...|
T Consensus       319 g~gw  322 (449)
T KOG1165|consen  319 GKGW  322 (449)
T ss_pred             CCCC
Confidence            3444

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.3e-26  Score=228.61  Aligned_cols=168  Identities=18%  Similarity=0.139  Sum_probs=129.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----ChhhHHHHHHHHHHHhcCCCCceece
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----GLQGHKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      ...++|.+.+.||+|+||+||+|++...        ++..||||++...     .......+.+|+++|..|.|+||+..
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--------~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGD--------PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCC--------CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            4456799999999999999999987642        4567899987533     11234568899999999999999853


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCceEEcCCCCe
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF-KTSNILLDADYNA  282 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~  282 (490)
                      +..   .+..|||||||+|++|.. +..     ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+
T Consensus        87 l~~---~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         87 LLA---TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             EEE---cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCE
Confidence            322   256799999999999963 211     11   1457889999999999988   999999 9999999999999


Q ss_pred             EEccccccccCCCCCCcce------eeccccCCCCCCchhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHV------STRVMGTYGYAAPEYVMT  319 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~------~~~~~Gt~~y~aPE~l~~  319 (490)
                      ||+|||+|+.+........      .+..+|++.|+|||++..
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999997654432111      135678999999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1e-26  Score=247.72  Aligned_cols=253  Identities=21%  Similarity=0.287  Sum_probs=189.3

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEec----CC-Chh-hHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN----HD-GLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~----~~-~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ....++|.|++|.|+.+.......         .++.|...    .. ... ....+..|+.+-..|.|+|++..+..+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~---------~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~  391 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK---------SFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ  391 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc---------cchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh
Confidence            456889999999888776654321         23333222    11 111 1122566888888999999998888777


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +....+-+||||++ +|+.++...+  .+....+..++.|++.||+|||+.|   |.|||||++|+|+..+|.+||+|||
T Consensus       392 ~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  392 EIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             hcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecC
Confidence            76666666999999 9999997753  4677788899999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCCc--ceeeccccCCCCCCchhhhcCCCCc-cccchhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhh--hc
Q 011234          289 LAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWA--RP  362 (490)
Q Consensus       289 ~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~-~sDvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~--~~  362 (490)
                      .+..+......  .....++|+..|+|||++.+..|.. ..||||.|++++.|++|+.||......+... .....  ..
T Consensus       466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~  545 (601)
T KOG0590|consen  466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN  545 (601)
T ss_pred             cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence            99876544443  5566789999999999999998886 6899999999999999999997654443321 00000  00


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .......+            ....+...+.+|.+||+.||.+|.|+++|++.
T Consensus       546 ~~~~~~~~------------~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  546 IFEGPNRL------------LSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cccChHHH------------HHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            00001111            11226778999999999999999999999863

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.6e-26  Score=204.85  Aligned_cols=266  Identities=19%  Similarity=0.210  Sum_probs=205.1

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC-CceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~  207 (490)
                      +....|++++.||.|+||.+|+|....         .|..||||+-+...  ...++..|..+...|+| ..|..+..+.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~---------~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISIT---------SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeecc---------CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc
Confidence            345689999999999999999998876         68899999976553  23567889999999975 6777788888


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCeEE
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKL  284 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL  284 (490)
                      .+..+..+||+++ |.+|.+++.-..+ .++..+++-++-|++.-++|+|..+   +|||||||+|+|..-   ...+.|
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEE
Confidence            8888999999998 8999998865433 6888899999999999999999988   999999999999853   346899


Q ss_pred             ccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          285 SDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +|||+|+.+.+....     .......||..|.+--...+...+...|+-|+|.+|.++.-|..||.+..........+.
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            999999876543211     122457899999998888888889999999999999999999999987665544433332


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .....-.  ...+    .+..    ..+.++.-.+.-|-..--++-|...-+.+.+..|..
T Consensus       236 I~EkK~s--~~ie----~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  236 ISEKKMS--TPIE----VLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             HHHhhcC--CCHH----HHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            2110000  0000    0111    126778888999999999999998888777665433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.7e-24  Score=211.73  Aligned_cols=260  Identities=33%  Similarity=0.461  Sum_probs=197.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCC-ceeceeeEEEe
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHP-NLVKLVGYCIE  209 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~  209 (490)
                      |.+...||.|+||.||++.+.            ..+|+|.+......   ....+.+|+.++..+.|+ +|+++++++..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            677889999999999999886            26899998765432   356789999999999988 79999999977


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF  287 (490)
                      ....+++++|+.+++|.+++..... ..+.......++.|++.++.|+|..+   ++||||||+|||++..+ .++++||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEecc
Confidence            7778999999999999966654422 25888899999999999999999988   99999999999999988 6999999


Q ss_pred             cccccCCCCCCcc----eeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCC-CcchhHHh
Q 011234          288 GLAKDAPEDGKTH----VSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEW  359 (490)
Q Consensus       288 G~a~~~~~~~~~~----~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~-~~~~~~~~  359 (490)
                      |++..........    ......||..|+|||.+.+   ..+....|+||+|++++++++|..||...... ........
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            9998654433221    2355789999999999987   57888999999999999999999997654321 01111111


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .......      .................+.+++.+|+..+|..|.+..+....
T Consensus       227 ~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111000      000000000001223678899999999999999998887765

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=9.2e-25  Score=201.22  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=193.0

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEecCc
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ  212 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~  212 (490)
                      .+..+|.+...|..|+|++..+           .+++|+++.....  ..++|..|.-.|+-+.||||+.+++.|.....
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn-----------divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN-----------DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             hhhhhhccCCCcccccccccCc-----------chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            3445688999999999999653           5777887655332  33578889999999999999999999999999


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee-ecCCCCCceEEcCCCCeEEc--cccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVI-YRDFKTSNILLDADYNAKLS--DFGL  289 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii-HrDlkp~NILl~~~~~~kL~--DFG~  289 (490)
                      +.+|..||+.|+|++.|....+.-.+..++.+++++|+.|++|||+...  +| ---|....++||++.+.+|.  |--+
T Consensus       262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheeccccee
Confidence            9999999999999999988777777888999999999999999999763  44 34688999999999988874  2111


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCC---ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~---~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +..         .....-.+.||+||.++...-+   .++|+|||++++|||.|...||....+.+..-.+         
T Consensus       340 sfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---------  401 (448)
T KOG0195|consen  340 SFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---------  401 (448)
T ss_pred             eee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---------
Confidence            110         0112347889999999865443   4799999999999999999999876554322111         


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                             --..+..+.|+..+..+..|+.-|+..||.+||.+..|+-.|+.+
T Consensus       402 -------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  402 -------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             -------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                   111233345566688999999999999999999999999888865

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=8.2e-24  Score=197.97  Aligned_cols=173  Identities=10%  Similarity=0.086  Sum_probs=134.6

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHH---------HHHHHHHHHhcCCCCc
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---------EWLAEVNFLGNLLHPN  199 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~---------~~~~E~~~l~~l~Hpn  199 (490)
                      ....+|++.++||.|+||.||++..           ++..+|||++.........         .+.+|++.+.+|.|++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-----------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G   96 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-----------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG   96 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-----------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence            4567899999999999999998644           2336999999754322222         2578999999999999


Q ss_pred             eeceeeEEEec--------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          200 LVKLVGYCIED--------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       200 Iv~l~~~~~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      |..+.+++...        +..+|||||++|.+|.++.      .++.    ....+++.+|..||+.+   ++||||||
T Consensus        97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp  163 (232)
T PRK10359         97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQHG---MVSGDPHK  163 (232)
T ss_pred             CCcceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHcC---CccCCCCh
Confidence            99999886644        3578999999999998763      2222    24568999999999988   99999999


Q ss_pred             CceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh
Q 011234          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt  340 (490)
                      +||+++.+| ++|+|||...........              -.++....|+.++|+|+||+++..+..
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999988 999999988755322111              114556677889999999999887653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=9.1e-23  Score=188.14  Aligned_cols=139  Identities=17%  Similarity=0.176  Sum_probs=107.5

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--h------------------------HHHHHHHHH
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--G------------------------HKEWLAEVN  190 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~------------------------~~~~~~E~~  190 (490)
                      ...||+|+||.||+|.+.          +|..||||+++.....  .                        ......|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~----------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   71 (190)
T cd05147           2 NGCISTGKEANVYHATTA----------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR   71 (190)
T ss_pred             CCccccccceEEEEEECC----------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH
Confidence            468999999999999874          4679999999754211  0                        011235999


Q ss_pred             HHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCC
Q 011234          191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL-HEEAEKPVIYRDF  269 (490)
Q Consensus       191 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiHrDl  269 (490)
                      +|..+.+++|.....+..  ...+|||||+++++|...+....  .+++..+..++.|++.+|.|| |+.+   |+||||
T Consensus        72 ~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~--~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDl  144 (190)
T cd05147          72 NLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA--PLSESKARELYLQVIQIMRILYQDCR---LVHADL  144 (190)
T ss_pred             HHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence            999998877754443322  23389999998877765543332  688899999999999999999 6878   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccC
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ||+|||++ ++.++|+|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 578999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=4.9e-24  Score=217.63  Aligned_cols=229  Identities=30%  Similarity=0.379  Sum_probs=182.1

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--HHHHHHHHHHHhcCC-CCceeceeeEEEecCceEE
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l  215 (490)
                      ++|.|+||.|++++-...      ...|..+|.|++++.....  ......|..++..++ ||.+|++.-.+..+...++
T Consensus         1 vlg~g~~gkvfLvrk~~g------~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l   74 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGG------ADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL   74 (612)
T ss_pred             CCCcCCCcchHHHHHhcc------ccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence            379999999998754322      1256778999887653221  113345888888887 9999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      +++|..+|+|...+....  .+.+.....+...++-+++++|..+   |+|||+|++||+++.+|++++.|||+++....
T Consensus        75 ~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   75 ILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             hhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            999999999998886654  4666777778888999999999999   99999999999999999999999999987654


Q ss_pred             CCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccC
Q 011234          296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD  375 (490)
Q Consensus       296 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  375 (490)
                      ...      .|||..|||||++.  ....++|.||||++++||++|..||..    +.      ...          ++.
T Consensus       150 ~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~------~~~----------Il~  201 (612)
T KOG0603|consen  150 EKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DT------MKR----------ILK  201 (612)
T ss_pred             hhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HH------HHH----------Hhh
Confidence            322      28999999999997  677899999999999999999999965    11      111          111


Q ss_pred             ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH
Q 011234          376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM  408 (490)
Q Consensus       376 ~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~  408 (490)
                        ..-.+|...+..+.+++..++..+|..|.-.
T Consensus       202 --~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 --AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             --hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence              1113445558889999999999999999654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.87  E-value=9.8e-22  Score=181.58  Aligned_cols=142  Identities=17%  Similarity=0.153  Sum_probs=110.7

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---------------------h-----HHHHHHHH
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------------------G-----HKEWLAEV  189 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---------------------~-----~~~~~~E~  189 (490)
                      +.+.||+|+||.||+|.+.          +|..||||+++.....                     .     ...+..|.
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~----------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   70 (190)
T cd05145           1 INGCISTGKEANVYHARTG----------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEF   70 (190)
T ss_pred             CCceeecCCCcEEEEEEcC----------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHH
Confidence            3578999999999999864          4679999998765211                     0     11235789


Q ss_pred             HHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecC
Q 011234          190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRD  268 (490)
Q Consensus       190 ~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrD  268 (490)
                      ..+.++.|++|.....+...  ..+|||||++++++...+....  .++......++.|++.+|.+||+ .+   |+|||
T Consensus        71 ~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrD  143 (190)
T cd05145          71 RNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGD  143 (190)
T ss_pred             HHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence            99999999988655544433  3489999998875544322322  56778889999999999999999 88   99999


Q ss_pred             CCCCceEEcCCCCeEEccccccccCCC
Q 011234          269 FKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       269 lkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      |||+|||++ ++.++|+|||++.....
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecCC
Confidence            999999998 88999999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=5.4e-23  Score=219.61  Aligned_cols=249  Identities=25%  Similarity=0.325  Sum_probs=181.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +|...+.||.+.|=+|.+|++.+          |. |+||++-+..    +...++.+.|++ ...++|||.+.+.-+..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e----------G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~   91 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE----------GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV   91 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC----------ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH
Confidence            57788999999999999998764          44 8899875543    233455566666 66778999999998877


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .+...|||-+|.. -+|+|.|..+.  -+...+.+-|+.|++.||.-+|..+   |+|||||.+||||+.-+-+.|+||.
T Consensus        92 t~kAAylvRqyvk-hnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFA  165 (1431)
T KOG1240|consen   92 TDKAAYLVRQYVK-HNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFA  165 (1431)
T ss_pred             hhHHHHHHHHHHh-hhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhccc
Confidence            7888899999995 59999997664  3566677889999999999999998   9999999999999999999999997


Q ss_pred             cccc--CCCCCCcc---eeeccccCCCCCCchhhhcC-----------CCCccccchhhHHHHHHHHh-CCCCCCCCCCC
Q 011234          289 LAKD--APEDGKTH---VSTRVMGTYGYAAPEYVMTG-----------HLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       289 ~a~~--~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~-----------~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~  351 (490)
                      .-+.  +++++...   ....-.--.+|.|||.+...           ..+.+-||||+||+++||++ |+++|.-.   
T Consensus       166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---  242 (1431)
T KOG1240|consen  166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---  242 (1431)
T ss_pred             ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence            6542  23332221   11111223479999988542           15678899999999999987 58887421   


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                         .+..+......+..   ..+.. ++       ...++.||..|++.||++|.++++.|+.-.
T Consensus       243 ---QL~aYr~~~~~~~e---~~Le~-Ie-------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  243 ---QLLAYRSGNADDPE---QLLEK-IE-------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             ---HHHhHhccCccCHH---HHHHh-Cc-------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence               12222111100111   01110 11       346789999999999999999999998743

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=6.5e-22  Score=190.59  Aligned_cols=233  Identities=21%  Similarity=0.284  Sum_probs=149.9

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCC----------Cc
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLH----------PN  199 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H----------pn  199 (490)
                      .+...+.||.|+|+.||.+++..         ||+.+|+|+......   ...+++.+|.-....+.+          -.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~---------t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r   83 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVE---------TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLR   83 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred             EEEEccccccCCceEEEEEEEcc---------CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence            35567899999999999999876         889999998764432   234556666655544322          22


Q ss_pred             eeceeeEEEec---------C--------ceEEEEEecCCCCHHHHHh---hcCCC--CCCHHHHHHHHHHHHHHHHHhh
Q 011234          200 LVKLVGYCIED---------D--------QRLLVYEFMPRGSLENHLF---RKGSL--PLPWSIRMKIALGAAKGLAFLH  257 (490)
Q Consensus       200 Iv~l~~~~~~~---------~--------~~~lv~E~~~~g~L~~~l~---~~~~~--~l~~~~~~~i~~qi~~aL~yLH  257 (490)
                      ++..++.....         .        ..+++|+-+ .++|.+++.   .....  .+....++.+..|+++.+++||
T Consensus        84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh  162 (288)
T PF14531_consen   84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH  162 (288)
T ss_dssp             B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence            33333332211         1        236788877 578887753   22221  2334555677789999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC--------CCCccccch
Q 011234          258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--------HLTSKSDVY  329 (490)
Q Consensus       258 ~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--------~~~~~sDvw  329 (490)
                      ..|   |+|+||+|+|+|++.+|.++|+||+........    ... ...+..|.+||.....        .++.+.|.|
T Consensus       163 ~~G---lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW  234 (288)
T PF14531_consen  163 SYG---LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAW  234 (288)
T ss_dssp             HTT---EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHH
T ss_pred             hcc---eEecccceeeEEEcCCCCEEEcChHHHeecCce----eec-cCCCcccCChhhhhhhcccCcccceeeeccCHH
Confidence            999   999999999999999999999999987765321    111 2346789999977542        478899999


Q ss_pred             hhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCC
Q 011234          330 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR  405 (490)
Q Consensus       330 SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R  405 (490)
                      +||+++|.|.+|..||....+......            .| .        ... +.+..++.||..+|+.||.+|
T Consensus       235 ~LG~~ly~lWC~~lPf~~~~~~~~~~~------------~f-~--------~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  235 QLGITLYSLWCGRLPFGLSSPEADPEW------------DF-S--------RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHSS-STCCCGGGSTSGG------------GG-T--------TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHHccCCCCCCCccccccc------------cc-h--------hcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999999999999975433221110            11 1        111 348899999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=2.7e-21  Score=177.35  Aligned_cols=189  Identities=17%  Similarity=0.090  Sum_probs=140.1

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh----HHHHHHHHHHHhcCC-CCceeceeeEEEe
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG----HKEWLAEVNFLGNLL-HPNLVKLVGYCIE  209 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~----~~~~~~E~~~l~~l~-HpnIv~l~~~~~~  209 (490)
                      .+...|++|+||+||++..           .+..++.+.+.......    ...+.+|+++|.+|. |++|++++++   
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-----------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---   70 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-----------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---   70 (218)
T ss_pred             ccceeecCCCcceEEEeec-----------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---
Confidence            3567899999999996643           34577777766543311    124678999999996 5889999886   


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCceEEcCCCCeEEcccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF-KTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~kL~DFG  288 (490)
                       +..+++|||+.|.+|...+..        . ...++.|++.+|.+||+.|   |+|||| ||+|||++.++.++|+|||
T Consensus        71 -~~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG  137 (218)
T PRK12274         71 -DGRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQ  137 (218)
T ss_pred             -cCEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECC
Confidence             456999999999898754321        1 1347789999999999998   999999 7999999999999999999


Q ss_pred             ccccCCCCCCc----ce-------eeccccCCCCCCchhhhcC-CCC-ccccchhhHHHHHHHHhCCCCCCCCCC
Q 011234          289 LAKDAPEDGKT----HV-------STRVMGTYGYAAPEYVMTG-HLT-SKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       289 ~a~~~~~~~~~----~~-------~~~~~Gt~~y~aPE~l~~~-~~~-~~sDvwSlGvil~elltG~~pf~~~~~  350 (490)
                      +|.........    ..       .....+++.|++|+.-.-. ..+ ...++++.|+-+|.++|++.++....+
T Consensus       138 ~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        138 LAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             CceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            99865443310    00       0112368888888855322 233 467999999999999999988765543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3e-21  Score=186.60  Aligned_cols=261  Identities=21%  Similarity=0.270  Sum_probs=172.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccc--------------------------cCCCCcEEEEEEecCCChh-h--
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPV--------------------------KPGTGLTVAVKTLNHDGLQ-G--  181 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~--------------------------~~~~g~~vAvK~~~~~~~~-~--  181 (490)
                      .++|+|...||+|.-..||.|....++....                          ......+.|||.+-.-..+ .  
T Consensus       156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~  235 (598)
T KOG4158|consen  156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA  235 (598)
T ss_pred             hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence            3579999999999999999998876432100                          0111235677765321111 1  


Q ss_pred             --HHHHHHHHH--------------HHhc--------CCCCceeceeeEEEec---------------------------
Q 011234          182 --HKEWLAEVN--------------FLGN--------LLHPNLVKLVGYCIED---------------------------  210 (490)
Q Consensus       182 --~~~~~~E~~--------------~l~~--------l~HpnIv~l~~~~~~~---------------------------  210 (490)
                        .+.+.+|+-              ..+.        -.|||||++.++|.++                           
T Consensus       236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~  315 (598)
T KOG4158|consen  236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP  315 (598)
T ss_pred             HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence              111222211              1111        2499999999988752                           


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE--cCCC--CeEEcc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADY--NAKLSD  286 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~--~~kL~D  286 (490)
                      ..+|+||..++ .+|..++..+   ..+.....-++.|+++|+.|||.++   |.|||||.+||||  ++|+  .+.|+|
T Consensus       316 ~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  316 KTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             ceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcc
Confidence            13589998874 5999998655   3455566778899999999999999   9999999999998  4444  478999


Q ss_pred             ccccccCCCCCCc----ceeeccccCCCCCCchhhhcCC------CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          287 FGLAKDAPEDGKT----HVSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       287 FG~a~~~~~~~~~----~~~~~~~Gt~~y~aPE~l~~~~------~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                      ||++-.....+..    .......|.-.-||||+.....      --.++|.|+.|-+.||++....||........ +.
T Consensus       389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~  467 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DT  467 (598)
T ss_pred             cceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-ch
Confidence            9988643321111    1112356888999999876421      12489999999999999999999976322110 00


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                 +.+.+.--|    ..+..++..+++|+..+|+.||++|++..-..+.
T Consensus       468 -----------r~Yqe~qLP----alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  468 -----------RTYQESQLP----ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             -----------hhhhhhhCC----CCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence                       111111112    2234457889999999999999999986544443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=3.3e-21  Score=209.74  Aligned_cols=198  Identities=20%  Similarity=0.231  Sum_probs=158.6

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCceecee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLV  204 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~  204 (490)
                      .+....|.|.+.||+|+||.||+|...          .|..||+|+-+......   |.-=.+++.+|+   -+-|..+.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~----------~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~  760 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHS----------NGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHIS  760 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecC----------CCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHH
Confidence            344567999999999999999999875          36789999977664432   111122333333   35566666


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC------
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA------  278 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~------  278 (490)
                      ..+...+..+||+||.+.|+|.+++..  ...++|..++.++.|++..++.||..+   |||+||||+|+||..      
T Consensus       761 ~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  761 SAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             HHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCC
Confidence            666777888999999999999999973  447899999999999999999999999   999999999999942      


Q ss_pred             -CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCC
Q 011234          279 -DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       279 -~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~  343 (490)
                       .-.++|+|||.+..+..-.........++|-.+-.+|.+.|..++..+|.|.|+-+++-||.|+.
T Consensus       836 ~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence             33599999999876543222334456788999999999999999999999999999999999974

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=8.2e-22  Score=210.55  Aligned_cols=209  Identities=28%  Similarity=0.416  Sum_probs=150.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|..+++|..|+||.||.++++.         +...+|+| ++++.+.     ++-  ||.....|.+|          
T Consensus        83 ~df~~IklisngAygavylvrh~~---------trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv----------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKE---------TRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV----------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccc---------cccchhhc-ccccchh-----hhc--cccccCCccee----------
Confidence            468899999999999999999876         66789994 4433321     110  34444455544          


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                                 |+-..++..-+  .++...        +.+++|||+.+   |+|||+||+|.||+.-|++|+.|||+++
T Consensus       136 -----------gDc~tllk~~g--~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk  191 (1205)
T KOG0606|consen  136 -----------GDCATLLKNIG--PLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  191 (1205)
T ss_pred             -----------chhhhhcccCC--CCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhh
Confidence                       56666665544  343332        67899999988   9999999999999999999999999987


Q ss_pred             cCCCCCCc-------------ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          292 DAPEDGKT-------------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       292 ~~~~~~~~-------------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      .......+             .....+|||+.|.|||++....|+..+|+|++|+|+||++.|..||.+..+.+....+ 
T Consensus       192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v-  270 (1205)
T KOG0606|consen  192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV-  270 (1205)
T ss_pred             hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh-
Confidence            54221111             1123469999999999999999999999999999999999999999887654332211 


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP  406 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP  406 (490)
                           +.+...+.+-         ......+++++|.++|+.+|..|-
T Consensus       271 -----isd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  271 -----ISDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             -----hhhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence                 1111111111         112268899999999999999993

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.1e-20  Score=176.24  Aligned_cols=136  Identities=19%  Similarity=0.213  Sum_probs=105.9

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-----CCCceeceeeEEEe
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-----LHPNLVKLVGYCIE  209 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~  209 (490)
                      .-..+||+|+||.||.  +..         ++.. +||++........+.+.+|+.++..|     .||||++++|++.+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~---------~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et   72 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE---------DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET   72 (210)
T ss_pred             CCcceecCCCceEEEE--CCC---------CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence            3457899999999995  433         3334 69988765444567789999999999     57999999999988


Q ss_pred             cC---ceE-EEEEe--cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCceEEcC----
Q 011234          210 DD---QRL-LVYEF--MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL-AFLHEEAEKPVIYRDFKTSNILLDA----  278 (490)
Q Consensus       210 ~~---~~~-lv~E~--~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~~~~iiHrDlkp~NILl~~----  278 (490)
                      +.   ..+ +||||  +.+++|.+++.+.   .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    
T Consensus        73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~  144 (210)
T PRK10345         73 DCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISES  144 (210)
T ss_pred             CCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCC
Confidence            73   433 78999  5579999999653   35555  35577888777 8999998   999999999999974    


Q ss_pred             CCCeEEcccccc
Q 011234          279 DYNAKLSDFGLA  290 (490)
Q Consensus       279 ~~~~kL~DFG~a  290 (490)
                      ++.++|+||+.+
T Consensus       145 ~~~~~LiDg~G~  156 (210)
T PRK10345        145 EVIPVVCDNIGE  156 (210)
T ss_pred             CCcEEEEECCCC
Confidence            347999995544

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.5e-20  Score=192.09  Aligned_cols=218  Identities=26%  Similarity=0.440  Sum_probs=164.6

Q ss_pred             HhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-eecCCC
Q 011234          192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV-IYRDFK  270 (490)
Q Consensus       192 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i-iHrDlk  270 (490)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.-...++++|+.||.|||...   | .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeec
Confidence            46789999999999999999999999999999999999764 557888888999999999999999866   4 999999


Q ss_pred             CCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-------CCCccccchhhHHHHHHHHhCCC
Q 011234          271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-------HLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       271 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~~~~sDvwSlGvil~elltG~~  343 (490)
                      ..|+++|....+||.|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998766431111111112234579999998753       14667999999999999999999


Q ss_pred             CCCCCCCCCcc-hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          344 SMDKNRPNGEH-NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       344 pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      ||+........ ..+.....  ...    ..+.|.+....  ....++..++.+||..+|.+||++.+|-..++.+...
T Consensus       157 ~~~~~~~~~~~~eii~~~~~--~~~----~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK--GGS----NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             ccccccccCChHHHHHHHHh--cCC----CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            99764433322 22222211  000    11111111110  2245789999999999999999999999998876554

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.4e-19  Score=170.96  Aligned_cols=145  Identities=17%  Similarity=0.154  Sum_probs=110.2

Q ss_pred             cCCCcCceeccCCceEEEEEE-EccCCCccccCCCCcEEEEEEecCCChh------------------------hHHHHH
Q 011234          132 RNFRPESLLGEGGFGCVFKGW-VEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------------GHKEWL  186 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~-~~~~~~~~~~~~~g~~vAvK~~~~~~~~------------------------~~~~~~  186 (490)
                      ..|.+.+.||+|+||.||+|. +..         +|..||||++......                        ....+.
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~---------~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDG---------SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAE   98 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCC---------CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHH
Confidence            358899999999999999998 333         6789999998754210                        012346


Q ss_pred             HHHHHHhcCCCCc--eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011234          187 AEVNFLGNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       187 ~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      .|+.++.++.+..  +.+++++    ...+|||||+++++|...+....  .+.......++.||+.+|.+||..+.  |
T Consensus        99 ~E~~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~--i  170 (237)
T smart00090       99 KEFRNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGE--L  170 (237)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCC--E
Confidence            7999999997533  3333332    24589999999888876543332  45556677899999999999998653  9


Q ss_pred             eecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          265 IYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      +||||||+|||++ ++.++|+|||.+....
T Consensus       171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999999 8899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=1.9e-20  Score=188.08  Aligned_cols=174  Identities=26%  Similarity=0.415  Sum_probs=129.4

Q ss_pred             ceEEEEEecCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ++||.|++|...+|.++|.++ .....++.....++.|++.|+.|   ++   .+|||+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999743 33456788889999999999999   55   999999999999999989999999999


Q ss_pred             ccCCCCC----CcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          291 KDAPEDG----KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       291 ~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      .......    .....+..+||..||+||.+.+..|+.++||||||+||+||+. =...|+..      ...    ..+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~----~d~r  473 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATL----TDIR  473 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------Hhh----hhhh
Confidence            8765543    1122355789999999999999999999999999999999997 22222110      000    0000


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev  411 (490)
                      +     ..+++....+     .+.-..|+.++|...|.+||++.++
T Consensus       474 ~-----g~ip~~~~~d-----~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  474 D-----GIIPPEFLQD-----YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             c-----CCCChHHhhc-----CcHHHHHHHHhcCCCcccCchHHHH
Confidence            0     1111112122     2344689999999999999954443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.3e-19  Score=165.38  Aligned_cols=134  Identities=19%  Similarity=0.283  Sum_probs=112.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--------hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +.||+|++|.||+|.+           .|..|++|........        ....+.+|+.++..+.|++|.....++..
T Consensus         2 ~~l~~G~~~~vy~~~~-----------~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   70 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-----------LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD   70 (211)
T ss_pred             cccccCceEEEEEEee-----------CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe
Confidence            5799999999999987           2446889976533211        12356789999999999999888888878


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||++|++|.+++....     . ....++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         71 PENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             CCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCc
Confidence            888999999999999999885432     1 67889999999999999988   99999999999999 78999999998


Q ss_pred             ccc
Q 011234          290 AKD  292 (490)
Q Consensus       290 a~~  292 (490)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=5.9e-19  Score=164.04  Aligned_cols=131  Identities=21%  Similarity=0.323  Sum_probs=107.0

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +||+|+||.||+|.+           .|..|++|.......        .....+.+|++++..+.|+++.....++...
T Consensus         1 ~ig~G~~~~vy~~~~-----------~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~   69 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-----------LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP   69 (199)
T ss_pred             CCCCCceEEEEEeec-----------CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC
Confidence            489999999999985           355789998653321        1124567899999999988876666666677


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||++|++|.+++.....         .++.+++.+|.+||+.+   ++|||++|.|||++ ++.++|+|||++
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCC
Confidence            788999999999999988754321         78899999999999988   99999999999999 889999999998


Q ss_pred             ccC
Q 011234          291 KDA  293 (490)
Q Consensus       291 ~~~  293 (490)
                      ...
T Consensus       137 ~~~  139 (199)
T TIGR03724       137 KYS  139 (199)
T ss_pred             cCC
Confidence            764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.3e-18  Score=160.16  Aligned_cols=139  Identities=16%  Similarity=0.080  Sum_probs=108.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh----------------------hHHHHHHHH
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEV  189 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~  189 (490)
                      ..|.+.+.||+|+||.||+|...          +|..||||++......                      ....+..|+
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~----------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   84 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDP----------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF   84 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcC----------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence            34888999999999999999764          5778999987643200                      011256788


Q ss_pred             HHHhcCCCCc--eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 011234          190 NFLGNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  267 (490)
Q Consensus       190 ~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  267 (490)
                      .++..+.|++  +...++    ....++||||+++++|......        .....++.+++.++.++|+.+   |+||
T Consensus        85 ~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~  149 (198)
T cd05144          85 AALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHG  149 (198)
T ss_pred             HHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcC
Confidence            9999988774  444443    2456899999999998765421        234578889999999999988   9999


Q ss_pred             CCCCCceEEcCCCCeEEccccccccCCC
Q 011234          268 DFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       268 Dlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      ||||+||+++.++.++|+|||++.....
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=3.3e-18  Score=182.67  Aligned_cols=138  Identities=22%  Similarity=0.275  Sum_probs=111.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----C---hhhHHHHHHHHHHHhcCCCCceec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----G---LQGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-----~---~~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      ...|...+.||+|+||.||+|.+...           .+++|.....     .   ......+.+|++++..+.|++|+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-----------~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR-----------DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc-----------cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            34567789999999999999987432           2334332111     1   112345788999999999999998


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      .+.++......++||||+++++|.+++.          ....++.+++.+|.|||+.+   |+||||||+|||+ .++.+
T Consensus       401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~  466 (535)
T PRK09605        401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRL  466 (535)
T ss_pred             eEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcE
Confidence            8888877778899999999999999874          24678999999999999988   9999999999999 67899


Q ss_pred             EEccccccccC
Q 011234          283 KLSDFGLAKDA  293 (490)
Q Consensus       283 kL~DFG~a~~~  293 (490)
                      +|+|||+++..
T Consensus       467 ~liDFGla~~~  477 (535)
T PRK09605        467 YLIDFGLGKYS  477 (535)
T ss_pred             EEEeCcccccC
Confidence            99999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1.7e-19  Score=192.58  Aligned_cols=257  Identities=25%  Similarity=0.303  Sum_probs=194.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCC-CCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~  209 (490)
                      .|.+.+.||+|+|+.|-......+        ....+|+|.+....  .........|..+-..+. |.|++.+++....
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~--------~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~   92 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRD--------PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS   92 (601)
T ss_pred             cccccccccccccchhhhhhhcCC--------CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC
Confidence            366777899999999988876543        33467788776553  122233445777777777 9999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeecCCCCCceEEcCCC-CeEEccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH-EEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF  287 (490)
                      .+..+++++|..++++.+.+........+....-.++.|+..+|.|+| ..+   +.||||||+|.+++..+ .++++||
T Consensus        93 ~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   93 PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence            999999999999999998884222224555666789999999999999 777   99999999999999999 9999999


Q ss_pred             cccccCCC-CCCcceeecccc-CCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          288 GLAKDAPE-DGKTHVSTRVMG-TYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~-~~~~~~~~~~~G-t~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |+|..+.. .+........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+.......... ..|..   
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~---  245 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKS---  245 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecc---
Confidence            99998876 555555566788 9999999998874 55678999999999999999999987554333211 11110   


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  413 (490)
                       ....        ..............+++.+++..+|..|.+.+++..
T Consensus       246 -~~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  246 -NKGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -cccc--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence             0000        001112223677889999999999999999888753

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.5e-16  Score=139.79  Aligned_cols=136  Identities=21%  Similarity=0.122  Sum_probs=112.7

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC--CceeceeeEEEecCce
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQR  213 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~  213 (490)
                      +.+.||.|.++.||++....           ..+++|.......  ...+..|+.++..+.|  .++.++++++...+..
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-----------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~   68 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-----------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWS   68 (155)
T ss_pred             cceecccccccceEEEEecC-----------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCcc
Confidence            45789999999999998742           4699999866543  4567889999999976  5889999888877889


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      +++|||+.++.+..+         +......++.+++.+|.+||.....+++|+||+|+|||++..+.++|+|||.+...
T Consensus        69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            999999988777644         44556778899999999999864445999999999999999899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.1e-16  Score=147.12  Aligned_cols=137  Identities=20%  Similarity=0.168  Sum_probs=96.1

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh--HHH----------------------HHHHHHHH
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKE----------------------WLAEVNFL  192 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~--~~~----------------------~~~E~~~l  192 (490)
                      .+.||+|+||.||+|.+.          +|..||||++.......  ...                      ...|...+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~----------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l   71 (187)
T cd05119           2 GGPIGTGKEADVYLALDG----------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNL   71 (187)
T ss_pred             CcccccccceeEEEEECC----------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHH
Confidence            578999999999999764          36689999987542211  111                      12456666


Q ss_pred             hcCCCCc--eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCC
Q 011234          193 GNLLHPN--LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDF  269 (490)
Q Consensus       193 ~~l~Hpn--Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDl  269 (490)
                      ..+.+..  +.+++++    ...++||||++++.+........  ... .....++.+++.++.++|. .+   |+||||
T Consensus        72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl  141 (187)
T cd05119          72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RLL-EDPEELYDQILELMRKLYREAG---LVHGDL  141 (187)
T ss_pred             HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh--hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCC
Confidence            6654432  3444432    34689999999854432111110  011 4567899999999999999 77   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccCC
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      ||+||+++ ++.++|+|||.+....
T Consensus       142 ~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         142 SEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             ChhhEEEE-CCcEEEEECccccccc
Confidence            99999999 8999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.68  E-value=4.4e-16  Score=148.81  Aligned_cols=135  Identities=21%  Similarity=0.244  Sum_probs=102.6

Q ss_pred             ceec-cCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-------------hhHHHHHHHHHHHhcCCCCce--e
Q 011234          138 SLLG-EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGNLLHPNL--V  201 (490)
Q Consensus       138 ~~lG-~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnI--v  201 (490)
                      ..|| .|+.|+||.+...           +..++||.+.....             .....+.+|+.++..|.|++|  +
T Consensus        37 ~~lg~~~g~gtv~~v~~~-----------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP  105 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-----------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVP  105 (239)
T ss_pred             ceeecCCCCccEEEEEeC-----------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCc
Confidence            4687 8888899888663           45788887754221             122456789999999998775  6


Q ss_pred             ceeeEEEecCc----eEEEEEecCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          202 KLVGYCIEDDQ----RLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       202 ~l~~~~~~~~~----~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ..+++......    .++||||++| .+|.+++...   .++..    .+.+|+.+|.+||+.|   |+||||||+|||+
T Consensus       106 ~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv  175 (239)
T PRK01723        106 RPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILL  175 (239)
T ss_pred             eeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEE
Confidence            67766443322    2599999997 6898887542   34443    3568899999999998   9999999999999


Q ss_pred             cCCCCeEEccccccccC
Q 011234          277 DADYNAKLSDFGLAKDA  293 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~  293 (490)
                      +.++.++|+|||.+...
T Consensus       176 ~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        176 DPDGKFWLIDFDRGELR  192 (239)
T ss_pred             cCCCCEEEEECCCcccC
Confidence            99889999999988753

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.2e-15  Score=156.36  Aligned_cols=253  Identities=26%  Similarity=0.310  Sum_probs=186.8

Q ss_pred             cCCCcCceecc--CCceEEEEEEEccCCCccccCCCCcEEEEEEecC--CChhhHHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          132 RNFRPESLLGE--GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~--G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      ..|.+...+|.  |.+|.||.+....       ..++..+|+|.-+.  ........-++|+.-.+.++ |+|.++.+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~-------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTN-------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCc-------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            35777889999  9999999998722       12567899987332  22233334456777777776 9999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCceEEcCC-CC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK----GLAFLHEEAEKPVIYRDFKTSNILLDAD-YN  281 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~  281 (490)
                      +...+..++-+|+| +.+|..+...... .++...++.+..+...    ||.++|...   ++|-|+||+||++..+ ..
T Consensus       187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s  261 (524)
T KOG0601|consen  187 WEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTS  261 (524)
T ss_pred             cccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccce
Confidence            99999999999999 5788877654432 4777788888888888    999999988   9999999999999998 88


Q ss_pred             eEEccccccccCCCCCCcce---eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          282 AKLSDFGLAKDAPEDGKTHV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~---~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      .+++|||+...+........   ..+..|...|++||.+ .+.++...|+|+||.++.+..+|..++......      .
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~  334 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------S  334 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------C
Confidence            99999999988766542222   2234678899999955 578899999999999999999987765332000      0


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      |.     ..+..+      +..+|....+..+..++..|++.+|-.|++...++.+
T Consensus       335 W~-----~~r~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  335 WS-----QLRQGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             cc-----cccccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            11     000001      1122222335566669999999999999998887754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=4.1e-14  Score=146.72  Aligned_cols=141  Identities=21%  Similarity=0.196  Sum_probs=97.6

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH----------------------------------
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH----------------------------------  182 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~----------------------------------  182 (490)
                      .+.||.|++|.||+|++.          +|..||||+.+.......                                  
T Consensus       122 ~~plasaSigQVh~A~l~----------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~  191 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV----------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE  191 (437)
T ss_pred             CcceeeeehhheEEEEec----------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH
Confidence            368999999999999875          477999999865421110                                  


Q ss_pred             ------HHHHHHHHHHhcC----C-CCceeceeeEE-EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHH
Q 011234          183 ------KEWLAEVNFLGNL----L-HPNLVKLVGYC-IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA  250 (490)
Q Consensus       183 ------~~~~~E~~~l~~l----~-HpnIv~l~~~~-~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~  250 (490)
                            -++.+|+..+.++    . +++|. +-.++ ......+|||||++|++|.++...... ...   ...++..++
T Consensus       192 ~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~  266 (437)
T TIGR01982       192 KTLRRELDLRREAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLA  266 (437)
T ss_pred             HHHHHHHCHHHHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHH
Confidence                  0134455555444    2 34432 22222 224567999999999999887643211 122   234555555


Q ss_pred             H-HHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          251 K-GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       251 ~-aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      . .+..+|..|   ++|+|+||.||+++.++.++|+|||++..+..
T Consensus       267 ~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       267 RSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            5 467889888   99999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.4e-14  Score=137.74  Aligned_cols=206  Identities=23%  Similarity=0.311  Sum_probs=141.5

Q ss_pred             HHHHhcCCCCceeceeeEEEecC-----ceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011234          189 VNFLGNLLHPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAE  261 (490)
Q Consensus       189 ~~~l~~l~HpnIv~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~  261 (490)
                      +.-|-++.|.|||+++.|+.+..     ...++.|||..|+|..+|.+..  ...+......+++-||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            33455667999999999887643     4689999999999999997632  335677777899999999999999987 


Q ss_pred             CCeeecCCCCCceEEcCCCCeEEcccccc--ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHH
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML  339 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a--~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ell  339 (490)
                      .+|+|+++..+-|++..+|-+|+.----.  ................|-++|.|||.=.....+.++|||+||++..||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            67999999999999999998887521100  0000000011112234678999999877777888999999999999998


Q ss_pred             hCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          340 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       340 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .|..--.......+.. .......++       +-            ...-+.++.+||...|..||+|.+++.|.
T Consensus       277 ilEiq~tnseS~~~~e-e~ia~~i~~-------le------------n~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVE-ENIANVIIG-------LE------------NGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HheeccCCCcceeehh-hhhhhheee-------cc------------CccccCcCcccccCCCCCCcchhhhhcCc
Confidence            8764321111100000 000000000       00            11124678999999999999999998775

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=9.3e-14  Score=145.89  Aligned_cols=145  Identities=17%  Similarity=0.154  Sum_probs=94.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-----------------------------
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------------------  181 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-----------------------------  181 (490)
                      ..+|.. +.||+|++|.||+|++..         +|+.||||+++..-...                             
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~---------~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~  188 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKD---------NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPRE  188 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECC---------CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHH
Confidence            446776 789999999999999875         57899999997542110                             


Q ss_pred             -----HH------HHHHHHHHHhcCC----CCceeceeeEEEe-cCceEEEEEecCCCCHHHHH--hhcCCC--CCCHHH
Q 011234          182 -----HK------EWLAEVNFLGNLL----HPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHL--FRKGSL--PLPWSI  241 (490)
Q Consensus       182 -----~~------~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~~--~l~~~~  241 (490)
                           .+      ++.+|+..+.++.    +.+.+.+-.++.+ ....+|||||++|+.|.++.  ...+..  .+....
T Consensus       189 ~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~  268 (537)
T PRK04750        189 VVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG  268 (537)
T ss_pred             HHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH
Confidence                 01      1233444444332    3333333333332 35668999999999998742  222210  122222


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC----CeEEccccccccCCC
Q 011234          242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAKDAPE  295 (490)
Q Consensus       242 ~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~kL~DFG~a~~~~~  295 (490)
                      +..++.|       ++..|   ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       269 v~~~~~Q-------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        269 VEVFFTQ-------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHHHHH-------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2333333       33456   99999999999999888    999999999987754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=3.5e-13  Score=121.59  Aligned_cols=131  Identities=20%  Similarity=0.064  Sum_probs=95.2

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCcee-ceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~l  215 (490)
                      .+.|+.|.++.||++...           +..|++|+...... ....+..|+.++..+.+.+++ +++.+  .....++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-----------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~l   68 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-----------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVL   68 (170)
T ss_pred             eeecCCcccCceEEEEEC-----------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeE
Confidence            356899999999998763           45799998765432 123456789999888755544 34443  3334589


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ||||++|.++....      ..    ...++.+++.+|+.||..+  ...++|+|++|.||+++ ++.++|+|||.+..
T Consensus        69 v~e~i~G~~l~~~~------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          69 ITEFIEGSELLTED------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             EEEecCCCcccccc------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            99999998876430      01    1245678999999999876  22359999999999998 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=5.1e-12  Score=131.20  Aligned_cols=164  Identities=18%  Similarity=0.207  Sum_probs=124.4

Q ss_pred             CCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHH
Q 011234          165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK  244 (490)
Q Consensus       165 ~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~  244 (490)
                      ++.+|.|...+...........+-++.|+.|+||||+++++.+..++..|||+|-+  ..|..++...+     ......
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~  108 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCL  108 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHH
Confidence            56688888877654433344667889999999999999999999999999999987  47777776554     445566


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCc
Q 011234          245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS  324 (490)
Q Consensus       245 i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~  324 (490)
                      -+.||+.||.|||+.+  +++|++|.-+.|+|+..|..||++|.++........  ......--..|..|+.+....  -
T Consensus       109 Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence            7889999999998654  399999999999999999999999998865433221  001111122456666543222  4


Q ss_pred             cccchhhHHHHHHHHhC
Q 011234          325 KSDVYSFGVVLLEMLTG  341 (490)
Q Consensus       325 ~sDvwSlGvil~elltG  341 (490)
                      ..|.|-|||+++|++.|
T Consensus       183 s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             chhhhhHHHHHHHHhCc
Confidence            57999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=2.6e-13  Score=139.38  Aligned_cols=253  Identities=22%  Similarity=0.172  Sum_probs=179.6

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHH--HHHHHHHHhcCC-CCceecee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE--WLAEVNFLGNLL-HPNLVKLV  204 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~--~~~E~~~l~~l~-HpnIv~l~  204 (490)
                      .....+|..+..||.|.|+.|+.+.....        ++..+++|.+...-.....+  -+.|+.+...+. |.+++.++
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~--------~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPE--------GDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCC--------CCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            34456799999999999999999874421        45678999876553333222  245777777664 89999988


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CCeE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAK  283 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~k  283 (490)
                      ..+......|+-.|||.++++...+.-  ...+.+...+.+..|++.++.++|+..   ++|+|+||+||++..+ +..+
T Consensus       333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~  407 (524)
T KOG0601|consen  333 SSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSK  407 (524)
T ss_pred             CCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhh
Confidence            888877888899999999988766622  235677778899999999999999888   9999999999999876 7889


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCC--CchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYA--APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~--aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +.|||++..+....     ....+.-+++  +++......+..+.|++|||..+++.++|...-+...        .|..
T Consensus       408 ~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~  474 (524)
T KOG0601|consen  408 LGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT  474 (524)
T ss_pred             ccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee
Confidence            99999987532211     1122333444  4554456678889999999999999999875432111        1110


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ..-+        .-+    ..+.. ...+..+.+.++..++..||.+.++..+.....
T Consensus       475 i~~~--------~~p----~~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  475 IRSG--------DTP----NLPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             eecc--------ccc----CCCch-HHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            0000        000    01111 367788899999999999999999887665443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.39  E-value=8.8e-14  Score=149.74  Aligned_cols=248  Identities=23%  Similarity=0.264  Sum_probs=174.2

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .|.+.+-+-+|.|+.++.+.-.         ++|...++|+......   ...+....+-.++-...||.++...-.+..
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa---------~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~  875 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPA---------GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC  875 (1205)
T ss_pred             cceecccccCCCCcccccCCcc---------ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC
Confidence            4666677888999999876443         2555566665543321   112223334444444556777776655556


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....+|+++|+.+++|...|...+  ..+.+........+..+++|||...   +.|||++|.|+|+..++..++.|||.
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence            678899999999999999887665  4555556667777889999999977   89999999999999999999999984


Q ss_pred             cccCCCC-----------------------------CCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh
Q 011234          290 AKDAPED-----------------------------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       290 a~~~~~~-----------------------------~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt  340 (490)
                      ......-                             +.........||+.|.+||.+.+......+|+|++|++++|.++
T Consensus       951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen  951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred             ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence            3321100                             00011223679999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH
Q 011234          341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS  409 (490)
Q Consensus       341 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~  409 (490)
                      |.+||....+.....-+      ....     +  +.  ..-+...+.++.+++.+.|..+|.+|..+.
T Consensus      1031 g~pp~na~tpq~~f~ni------~~~~-----~--~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1031 GIPPFNAETPQQIFENI------LNRD-----I--PW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCCcchhhhhhcc------ccCC-----C--CC--CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999766554322111      0000     0  00  011233478899999999999999997766

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.35  E-value=1.1e-11  Score=113.92  Aligned_cols=145  Identities=14%  Similarity=0.091  Sum_probs=98.7

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----------------------hhHHHH----HHHHH
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------------------QGHKEW----LAEVN  190 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----------------------~~~~~~----~~E~~  190 (490)
                      ...||.|--+.||.|.......   ....+..+|||+.+....                      ...+.+    .+|++
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~---~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r   78 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNET---EQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMH   78 (197)
T ss_pred             CCccccCcceEEEEEecCcccc---cccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHH
Confidence            4679999999999997542100   011356899998752110                      001122    37999


Q ss_pred             HHhcCCC--CceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeec
Q 011234          191 FLGNLLH--PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL-HEEAEKPVIYR  267 (490)
Q Consensus       191 ~l~~l~H--pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~~~~iiHr  267 (490)
                      .|.++..  -++..++++    ..-+|||||+.+..+.....+.  ..++......+..+++.+|..| |..+   |||+
T Consensus        79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9998863  455555554    4568999999665442222121  1344555667889999999999 8888   9999


Q ss_pred             CCCCCceEEcCCCCeEEccccccccCC
Q 011234          268 DFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       268 Dlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      ||++.|||++ ++.+.|+|||.+....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            9999999996 4689999999886553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.27  E-value=5.4e-11  Score=105.37  Aligned_cols=143  Identities=22%  Similarity=0.216  Sum_probs=108.0

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEe-----cCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-----NHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~-----~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+.+|-+|+-+.|+++.+           .|+...||.-     ++..+   -..+...+|+++|.++.--.|.-..-++
T Consensus        11 ~l~likQGAEArv~~~~~-----------~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~   79 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-----------SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF   79 (229)
T ss_pred             cceeeeccceeeEeeecc-----------CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE
Confidence            567899999999999987           4667777742     22211   1235567899999998755665555567


Q ss_pred             EecCceEEEEEecCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC---CeE
Q 011234          208 IEDDQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAK  283 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~k  283 (490)
                      .+...-.|+|||++| -++.+++...............++..|-+.|.-||..+   |||+||..+||+|..++   .+.
T Consensus        80 ~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   80 IDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             EecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceE
Confidence            777778999999976 37888887654433333444788899999999999999   99999999999996655   358


Q ss_pred             Ecccccccc
Q 011234          284 LSDFGLAKD  292 (490)
Q Consensus       284 L~DFG~a~~  292 (490)
                      |+|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=7.5e-11  Score=104.98  Aligned_cols=132  Identities=22%  Similarity=0.305  Sum_probs=99.2

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEec-CC----Chh---hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HD----GLQ---GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~-~~----~~~---~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..|++|+-+.+|.+.+.           |..+++|.-. +.    .+.   ....-.+|+++|..+.--.|...+=+..+
T Consensus         2 ~~i~~GAEa~i~~~~~~-----------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-----------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD   70 (204)
T ss_pred             chhhCCcceeEEeeecc-----------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc
Confidence            46889999999998663           3356677532 21    111   12345679999999876566555556677


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+...|+|||++|..|.+.+...         ...++..+-.-+.-||..+   |||+||.++||++..+ .+.++|||+
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~-~i~~IDfGL  137 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGL  137 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCC-cEEEEECCc
Confidence            88889999999998888888654         1356677777788899999   9999999999999765 499999999


Q ss_pred             cccC
Q 011234          290 AKDA  293 (490)
Q Consensus       290 a~~~  293 (490)
                      +...
T Consensus       138 g~~s  141 (204)
T COG3642         138 GEFS  141 (204)
T ss_pred             cccc
Confidence            8743

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.23  E-value=2.7e-10  Score=115.03  Aligned_cols=216  Identities=17%  Similarity=0.239  Sum_probs=152.6

Q ss_pred             ceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe----cCceEEEEEec
Q 011234          145 FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE----DDQRLLVYEFM  220 (490)
Q Consensus       145 fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~E~~  220 (490)
                      -.+.|+++...         +|..|++|.++.+..+.......-++.++++.|+|||++.++|..    +..++|||+|+
T Consensus       289 ~~Ttyk~~s~~---------DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy  359 (655)
T KOG3741|consen  289 SITTYKATSNV---------DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY  359 (655)
T ss_pred             cceeEeeeecc---------CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence            35789998876         566899999965544443334556889999999999999998873    45789999999


Q ss_pred             CC-CCHHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          221 PR-GSLENHLFRKG-------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       221 ~~-g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      ++ ++|.++.....             ....++..+|.++.|+..||.++|+.|   +.-+-|.+.+||++.+.+++|..
T Consensus       360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~  436 (655)
T KOG3741|consen  360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISG  436 (655)
T ss_pred             CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEec
Confidence            86 68887764321             224678899999999999999999999   88899999999999999999988


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      .|.......+...                .+.+   -.+-|.=.||.+++.|.||..--........ ...+        
T Consensus       437 C~i~Dvl~~d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~~~--------  488 (655)
T KOG3741|consen  437 CGIMDVLQEDPTE----------------PLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQS-SHLT--------  488 (655)
T ss_pred             ccceeeecCCCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccccccccchHH-HHHH--------
Confidence            8877665443211                1111   1356888999999999999643111000000 0000        


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                    ......+.+++++|.-+...++++ -++.+++.++
T Consensus       489 --------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  489 --------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             --------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence                          011123677788888888888876 5666666554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=7.2e-11  Score=111.08  Aligned_cols=143  Identities=20%  Similarity=0.216  Sum_probs=106.6

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCC--CceeceeeEEEec---C
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLH--PNLVKLVGYCIED---D  211 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~---~  211 (490)
                      +.|+.|.++.||++...          .|..+++|....... .....+..|+.++..+.+  .++.+++.+....   +
T Consensus         4 ~~l~~G~~n~~~~v~~~----------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~   73 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG----------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLG   73 (223)
T ss_pred             eecCCCccceEEEEEec----------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccC
Confidence            56899999999999763          245799998765432 134567889999999875  3456677766553   3


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------------------------
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-------------------------------  260 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-------------------------------  260 (490)
                      ..++||||++|.+|.+.+..   ..++......++.+++++|.+||+..                               
T Consensus        74 ~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (223)
T cd05154          74 TPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR  150 (223)
T ss_pred             CceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence            66899999999888765532   14666777778888888888888531                               


Q ss_pred             ----------------------CCCeeecCCCCCceEEcC--CCCeEEccccccccC
Q 011234          261 ----------------------EKPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDA  293 (490)
Q Consensus       261 ----------------------~~~iiHrDlkp~NILl~~--~~~~kL~DFG~a~~~  293 (490)
                                            ...++|+|+++.|||++.  ++.+.|+||+.+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                                  244799999999999988  567899999987643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.05  E-value=3.8e-09  Score=102.34  Aligned_cols=141  Identities=16%  Similarity=0.063  Sum_probs=97.3

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHH----------HHHHHHHHHhcCCCCce--ecee
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHK----------EWLAEVNFLGNLLHPNL--VKLV  204 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~----------~~~~E~~~l~~l~HpnI--v~l~  204 (490)
                      +.+-.-....|+++.+           .|..|.||........ ..+          .+.+|...+..|..-+|  ..++
T Consensus        28 e~v~~~~~rrvvr~~~-----------~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pV   96 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-----------AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGV   96 (268)
T ss_pred             cEEecCCCceEEEEEE-----------CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCee
Confidence            3444444445666654           3557899976443311 111          36788888887753332  3344


Q ss_pred             eEEEe-----cCceEEEEEecCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC
Q 011234          205 GYCIE-----DDQRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       205 ~~~~~-----~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      ++...     ....+||||++++. +|.+++........+......++.+++..+.-||..|   |+|+||++.|||++.
T Consensus        97 a~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~  173 (268)
T PRK15123         97 AFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHL  173 (268)
T ss_pred             EEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEec
Confidence            44432     23468999999875 7988875432234556677789999999999999999   999999999999975


Q ss_pred             -------CCCeEEcccccccc
Q 011234          279 -------DYNAKLSDFGLAKD  292 (490)
Q Consensus       279 -------~~~~kL~DFG~a~~  292 (490)
                             ++.+.|+||+.+..
T Consensus       174 ~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        174 PFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             cccCCCCCceEEEEECCcccc
Confidence                   46899999998753

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=2.7e-08  Score=98.47  Aligned_cols=263  Identities=17%  Similarity=0.193  Sum_probs=159.2

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeE----E-
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGY----C-  207 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~----~-  207 (490)
                      ....+.||+|+-+.+|-.--..            ..+.|+..........+.   +..|... .||-+-.-+.|    . 
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~------------d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~   77 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVR------------DQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLH   77 (637)
T ss_pred             cCCCccccCCccceeeecchhh------------chhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhh
Confidence            3456789999999999643211            234577766544332222   2333333 46544331211    1 


Q ss_pred             -EecCc-eEEEEEecCCCC-HHHHHh---hcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          208 -IEDDQ-RLLVYEFMPRGS-LENHLF---RKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       208 -~~~~~-~~lv~E~~~~g~-L~~~l~---~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                       -+.+. .-++|..+.+.. +..++.   ++.+ -...|...++.++.++.+.+.||..|   .+-+|+.++|+|+.+++
T Consensus        78 G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~  154 (637)
T COG4248          78 GGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDS  154 (637)
T ss_pred             CCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCc
Confidence             12222 567888887642 222221   1222 23678999999999999999999999   88899999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCCc-
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGE-  353 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~-  353 (490)
                      .+.|.|=..-....+   .......+|...|.+||...     +..-+...|.|.||+++++||.| ++||.+...... 
T Consensus       155 ~V~LVdsDsfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a  231 (637)
T COG4248         155 KVVLVDSDSFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA  231 (637)
T ss_pred             eEEEEcccceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC
Confidence            999997543222211   12223467899999999764     23456789999999999999887 899975322111 


Q ss_pred             ch----hHHhhhcccCCchhhhhccCccccCCCChH-hHHHHHHHHHHhhhc--CCCCCCCHHHHHHHhhcccc
Q 011234          354 HN----LVEWARPHLGDKRRFYRLLDPRLEGHFSIK-GSQKATQLAAQCLSR--DPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~----~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~l~~Li~~cL~~--dP~~RPs~~evl~~L~~l~~  420 (490)
                      -.    .+..............  ..+ .....+.. .+..+..|..+|+..  ++.-|||++..+..|..+..
T Consensus       232 p~p~E~~Ia~g~f~ya~~~~~g--~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         232 PNPLETDIAHGRFAYASDQRRG--LKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             CCcchhhhhcceeeechhccCC--CCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence            00    0000000000000000  000 01122211 267788999999965  46789999999988876644

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.89  E-value=1.2e-08  Score=93.30  Aligned_cols=98  Identities=21%  Similarity=0.249  Sum_probs=63.0

Q ss_pred             HHHHHHHHhcCCCC--ceeceeeEEEecCceEEEEEecC--CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-hhhc
Q 011234          185 WLAEVNFLGNLLHP--NLVKLVGYCIEDDQRLLVYEFMP--RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF-LHEE  259 (490)
Q Consensus       185 ~~~E~~~l~~l~Hp--nIv~l~~~~~~~~~~~lv~E~~~--~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~  259 (490)
                      ..+|.+.|..+..-  ++.+++++.    ..+|||||++  |..+..+. ...   +.......++.+++..+.. +|..
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~~~~~  126 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKMLHKA  126 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHHHHhc
Confidence            46799999999765  455555442    4479999998  54554333 221   1122345566777775555 5787


Q ss_pred             CCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       260 ~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      |   |+|+||.+.|||++++ .+.|+|||.+....
T Consensus       127 g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  127 G---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             T---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             C---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            7   9999999999999877 99999999887553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.80  E-value=2.7e-09  Score=111.58  Aligned_cols=151  Identities=24%  Similarity=0.317  Sum_probs=104.7

Q ss_pred             HHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCccee-------eccccCCCCCCchhhhc
Q 011234          247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-------TRVMGTYGYAAPEYVMT  319 (490)
Q Consensus       247 ~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~-------~~~~Gt~~y~aPE~l~~  319 (490)
                      .+++.||.|+|....  +||++|.|++|.++.++..||+.|+.+............       .-..-...|.|||++..
T Consensus       106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999998653  999999999999999999999999987654432111110       01123568999999999


Q ss_pred             CCCCccccchhhHHHHHHHH-hCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhh
Q 011234          320 GHLTSKSDVYSFGVVLLEML-TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL  398 (490)
Q Consensus       320 ~~~~~~sDvwSlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL  398 (490)
                      ...+.++|+|||||++|.+. .|+..+............              ...+..-...++.+.+.++++=+.++|
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHh
Confidence            88899999999999999999 555444332211111100              011111111233455889999999999


Q ss_pred             hcCCCCCCCHHHHHH
Q 011234          399 SRDPKARPRMSEVVE  413 (490)
Q Consensus       399 ~~dP~~RPs~~evl~  413 (490)
                      ..++.-||++.+++.
T Consensus       250 ~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLS  264 (700)
T ss_pred             cCCcccCcchhhhhc
Confidence            999999998777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=8.8e-08  Score=90.51  Aligned_cols=135  Identities=17%  Similarity=0.106  Sum_probs=93.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh----------------------hHHHHHHHHHH
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ----------------------GHKEWLAEVNF  191 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~E~~~  191 (490)
                      +.+...||.|--+.||.|...          .|..+|||.-+.....                      ......+|.++
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~----------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~  162 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP----------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA  162 (304)
T ss_pred             HhhccccccCccceEEEEECC----------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence            456789999999999999875          4778999975422110                      11234679999


Q ss_pred             HhcCCCC--ceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011234          192 LGNLLHP--NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       192 l~~l~Hp--nIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      |..|.-.  .|.+.+++    +.-.+||||++|-.|...-.       .....-.++..|++-+.-+-..|   |||+|+
T Consensus       163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDl  228 (304)
T COG0478         163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDL  228 (304)
T ss_pred             HHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence            9998644  66666654    45689999998877664321       11222233333444444343556   999999


Q ss_pred             CCCceEEcCCCCeEEcccccccc
Q 011234          270 KTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .+-|||++++|.+.++||--+..
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             chheEEEecCCCEEEEeCccccc
Confidence            99999999999999999965543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.70  E-value=1.8e-07  Score=87.40  Aligned_cols=106  Identities=25%  Similarity=0.199  Sum_probs=80.8

Q ss_pred             HHHHHHHHHHhcCCC--CceeceeeEEEec----CceEEEEEecCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 011234          183 KEWLAEVNFLGNLLH--PNLVKLVGYCIED----DQRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAF  255 (490)
Q Consensus       183 ~~~~~E~~~l~~l~H--pnIv~l~~~~~~~----~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~y  255 (490)
                      ....+|...+..|..  -.+...+++....    ...+||+|++++. +|.+++.....  .+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            346778887777753  2244455554442    2458999999874 79988876432  5556677899999999999


Q ss_pred             hhhcCCCCeeecCCCCCceEEcCCC---CeEEccccccccC
Q 011234          256 LHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDA  293 (490)
Q Consensus       256 LH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFG~a~~~  293 (490)
                      ||..|   |+|+|+++.|||++.++   .+.|+||+.++..
T Consensus       134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   99999999999998887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.67  E-value=3e-07  Score=84.88  Aligned_cols=138  Identities=18%  Similarity=0.158  Sum_probs=100.1

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---C---hhhHHHHHHHHHHHhcCCCCc--eeceeeEEE-e-
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---G---LQGHKEWLAEVNFLGNLLHPN--LVKLVGYCI-E-  209 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~---~---~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~-~-  209 (490)
                      -|+||.+-|+...+.           |..+=+|.-...   .   ......|.+|+..|..|..-+  +.++. ++. . 
T Consensus        26 ~~rgG~SgV~r~~~~-----------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k   93 (216)
T PRK09902         26 YRRNGMSGVQCVERN-----------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVK   93 (216)
T ss_pred             cCCCCcceEEEEEeC-----------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeec
Confidence            467999999987663           335667764311   0   224567899999999886322  44444 222 1 


Q ss_pred             -c--CceEEEEEecCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--eE
Q 011234          210 -D--DQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--AK  283 (490)
Q Consensus       210 -~--~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~k  283 (490)
                       .  -..+||+|-+.+ -+|.+++......+.+......+..+|+..|.-||+.+   +.|+|+-+.|||++.++.  ++
T Consensus        94 ~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~  170 (216)
T PRK09902         94 IEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAG  170 (216)
T ss_pred             cCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEE
Confidence             1  235799998754 58888886654335677777889999999999999999   999999999999986677  99


Q ss_pred             Ecccccccc
Q 011234          284 LSDFGLAKD  292 (490)
Q Consensus       284 L~DFG~a~~  292 (490)
                      ++||.-++.
T Consensus       171 lIDlEk~r~  179 (216)
T PRK09902        171 FLDLEKSRR  179 (216)
T ss_pred             EEEhhccch
Confidence            999987654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.66  E-value=1.3e-07  Score=99.09  Aligned_cols=143  Identities=17%  Similarity=0.173  Sum_probs=92.9

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH------------------------------H----
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH------------------------------K----  183 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~------------------------------~----  183 (490)
                      ..|+.++-|.||+|++.          +|+.||||+.+..-....                              .    
T Consensus       131 ~PiAsASIaQVH~A~L~----------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~  200 (517)
T COG0661         131 EPIASASIAQVHRAVLK----------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK  200 (517)
T ss_pred             CchhhhhHhhheeEEec----------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence            67999999999999997          588999999874321100                              0    


Q ss_pred             ------HHHHHHHHHhcCC-----CCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 011234          184 ------EWLAEVNFLGNLL-----HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG  252 (490)
Q Consensus       184 ------~~~~E~~~l~~l~-----HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~a  252 (490)
                            ++.+|..-+.++.     .++|.-..=|+.-.....|+|||++|-.+.+...-.. ..++...+.....++.  
T Consensus       201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--  277 (517)
T COG0661         201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--  277 (517)
T ss_pred             HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--
Confidence                  1334555444442     3444333223334567799999999988888743222 2344333322222221  


Q ss_pred             HHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCC
Q 011234          253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED  296 (490)
Q Consensus       253 L~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~  296 (490)
                      +..+-..|   ++|.|.+|.||+++.+|.+.+.|||+...+...
T Consensus       278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            22222345   999999999999999999999999999877543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.61  E-value=6.8e-07  Score=84.71  Aligned_cols=139  Identities=16%  Similarity=0.131  Sum_probs=83.1

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc--eeceeeEEEecCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~l  215 (490)
                      ..||.|..+.||+.             .|..+++|......  ......+|.+++..+..-.  +.+.+++....+...+
T Consensus         7 ~~i~~G~t~~~y~~-------------~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~gl   71 (226)
T TIGR02172         7 TQTGEGGNGESYTH-------------KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGL   71 (226)
T ss_pred             eeecCCCCcceeEe-------------cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeee
Confidence            57899999999984             12247788876533  2345678999998886433  4566777777777889


Q ss_pred             EEEecCCCC-HHHHH--------------hh----cCC---CCCCHHHHH-HHHH----------HHHH-HHHHhhhc-C
Q 011234          216 VYEFMPRGS-LENHL--------------FR----KGS---LPLPWSIRM-KIAL----------GAAK-GLAFLHEE-A  260 (490)
Q Consensus       216 v~E~~~~g~-L~~~l--------------~~----~~~---~~l~~~~~~-~i~~----------qi~~-aL~yLH~~-~  260 (490)
                      |||+++|.+ +...+              ..    -..   ......... .+..          .+.. ...+|... .
T Consensus        72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            999998863 21111              00    000   011111100 0000          0011 12222211 1


Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ...++|+|+.|.||++++++ +.|+||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            23478999999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.54  E-value=8.1e-07  Score=82.34  Aligned_cols=138  Identities=11%  Similarity=0.087  Sum_probs=90.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHH---------HHHHHHHHhcCCC--
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---------WLAEVNFLGNLLH--  197 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~H--  197 (490)
                      ....+|.+.+++-......|.+-..           .|..+++|..+.......+.         ..+++..+..+..  
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-----------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-----------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-----------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            4556788888888877777766544           35678999887554322222         2334444444432  


Q ss_pred             -CceeceeeEEE-----ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          198 -PNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       198 -pnIv~l~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                       -.++.++.+..     .....+|||||++|..|.++..      +++    .++..|.++|.-||..|   ++|+|..|
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hp  163 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHP  163 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCc
Confidence             22223222222     2234578999999988876542      222    24455677899999999   99999999


Q ss_pred             CceEEcCCCCeEEccccccc
Q 011234          272 SNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~  291 (490)
                      .|++++.+ .++++||+..+
T Consensus       164 gNFlv~~~-~i~iID~~~k~  182 (229)
T PF06176_consen  164 GNFLVSNN-GIRIIDTQGKR  182 (229)
T ss_pred             CcEEEECC-cEEEEECcccc
Confidence            99999865 59999998655

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.51  E-value=1.2e-08  Score=105.68  Aligned_cols=186  Identities=18%  Similarity=0.120  Sum_probs=132.6

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc-eeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-LVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~  211 (490)
                      .+....-+++|+++.++|.+...         +. ....+.+...     ....-++++|.+++||| .+..++-+..++
T Consensus       243 ws~~fh~fvK~altknpKkRpta---------ek-lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTA---------EK-LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCCh---------hh-heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            34444567899999999976532         12 2224544332     33445899999999999 777777777888


Q ss_pred             ceEEEEEecCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          212 QRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      ..+++|+++.++ +-..... .....+..-+...+.+.-+++|+|||+..   =+|||    |||..+ +..++.||+..
T Consensus       308 ~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~  378 (829)
T KOG0576|consen  308 YLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVP  378 (829)
T ss_pred             ccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCC
Confidence            999999999776 2211110 00112333334456666778899999854   48998    887755 68999999998


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCC
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                      ..+....   ......+++.|+|||+.....+....|+|++|+-..+|--|-+|-
T Consensus       379 ~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  379 PQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            8765432   234567999999999999999999999999999888887777765

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.38  E-value=4.3e-06  Score=78.91  Aligned_cols=142  Identities=18%  Similarity=0.143  Sum_probs=81.7

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCC--ceeceeeEEEe---cC
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP--NLVKLVGYCIE---DD  211 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~~  211 (490)
                      ++.|+.|..+.||++....           ..+++|.....  .....+..|+.++..|...  -+.+++.+...   ..
T Consensus         2 i~~l~~G~~n~~~~v~~~~-----------~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~   68 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-----------GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNG   68 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-----------SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETS
T ss_pred             CccCCCCCeeeEEEEEECC-----------cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccc
Confidence            3578999999999987642           37899987654  3446677888888887532  24555654322   23


Q ss_pred             ceEEEEEecCCCCHHH----------------HHh---hc--CCCCCCHHH---------HHHH------------HHHH
Q 011234          212 QRLLVYEFMPRGSLEN----------------HLF---RK--GSLPLPWSI---------RMKI------------ALGA  249 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~----------------~l~---~~--~~~~l~~~~---------~~~i------------~~qi  249 (490)
                      ..+++|++++|..+..                .+.   ..  ....+....         ....            ...+
T Consensus        69 ~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (239)
T PF01636_consen   69 FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEEL  148 (239)
T ss_dssp             EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHH
T ss_pred             cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHH
Confidence            4689999999987777                111   11  101111110         0000            1112


Q ss_pred             HH-HHHHhhhc----CCCCeeecCCCCCceEEc-CCCCeEEccccccc
Q 011234          250 AK-GLAFLHEE----AEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAK  291 (490)
Q Consensus       250 ~~-aL~yLH~~----~~~~iiHrDlkp~NILl~-~~~~~kL~DFG~a~  291 (490)
                      .. .+..++..    ....++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  149 EERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            22 23333321    234599999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=4.5e-06  Score=79.99  Aligned_cols=139  Identities=19%  Similarity=0.122  Sum_probs=81.1

Q ss_pred             eccCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEEEE
Q 011234          140 LGEGGF-GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVY  217 (490)
Q Consensus       140 lG~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~  217 (490)
                      |-.|.. ..||+....           +..+.||......   ...+.+|++++..+. +--+.+++++....+..++||
T Consensus         6 ~~~g~~~~~v~~~~~~-----------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   71 (244)
T cd05150           6 VTEGQSGATVYRLDGK-----------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT   71 (244)
T ss_pred             cCCCCCcCeEEEEcCC-----------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence            444555 788988542           2367888875443   234667888888774 333556677766666789999


Q ss_pred             EecCCCCHHHHHh----------------h---cC--CCCCCHH--HHHHHHH--------------------HHHHHHH
Q 011234          218 EFMPRGSLENHLF----------------R---KG--SLPLPWS--IRMKIAL--------------------GAAKGLA  254 (490)
Q Consensus       218 E~~~~g~L~~~l~----------------~---~~--~~~l~~~--~~~~i~~--------------------qi~~aL~  254 (490)
                      |+++|.+|.....                +   ..  ...+...  .......                    .+...+.
T Consensus        72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (244)
T cd05150          72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA  151 (244)
T ss_pred             EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence            9999877764321                0   00  0011100  0000000                    0111122


Q ss_pred             Hhhh----cCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          255 FLHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       255 yLH~----~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .|-.    .....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            2211    1123489999999999999887788999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.36  E-value=2.7e-06  Score=75.58  Aligned_cols=130  Identities=19%  Similarity=0.165  Sum_probs=89.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceec-eeeEEEecCc
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK-LVGYCIEDDQ  212 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~  212 (490)
                      ....+.||+|.+|.||+|.+.           |..+|+|+-+.+..  ...+..|+++|..+.-.++.. +|.|-    .
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~-----------~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~   86 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR-----------GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----E   86 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc-----------CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----h
Confidence            345578999999999999984           55899998776643  367888999999888666543 34332    2


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC-CCceEEcCCCCeEEccccccc
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK-TSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk-p~NILl~~~~~~kL~DFG~a~  291 (490)
                      .++.|||+.|-.|.+.-...     .    .+-...+++.-.-|-..|   |-|+.|. |..++|..++.+.|+||..|+
T Consensus        87 ~~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence            35669999888887765321     1    123334455544455556   8998886 444444455599999999887


Q ss_pred             c
Q 011234          292 D  292 (490)
Q Consensus       292 ~  292 (490)
                      .
T Consensus       155 ~  155 (201)
T COG2112         155 F  155 (201)
T ss_pred             h
Confidence            3

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.35  E-value=3.6e-06  Score=78.96  Aligned_cols=151  Identities=19%  Similarity=0.161  Sum_probs=96.1

Q ss_pred             chhhHHHhhcCCCcCceec---cCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh------------------
Q 011234          123 MFNDLKLATRNFRPESLLG---EGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG------------------  181 (490)
Q Consensus       123 ~~~~~~~~~~~y~~~~~lG---~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~------------------  181 (490)
                      +...+.....+..+..+.|   .|--+.||+|...          .+..||||+.+......                  
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~----------~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~  105 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETG----------DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRS  105 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC----------CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCC
Confidence            3344444455555555544   5666789998652          46789999986432211                  


Q ss_pred             -HH-----HHHHHHHHHhcCC--CCceeceeeEEEecCceEEEEEecCCCCH-HHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 011234          182 -HK-----EWLAEVNFLGNLL--HPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKG  252 (490)
Q Consensus       182 -~~-----~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~E~~~~g~L-~~~l~~~~~~~l~~~~~~~i~~qi~~a  252 (490)
                       .+     ....|+.-|.++.  +-.+.+.+++.    ...|||||+....+ .-.|   ...++.......+..++++.
T Consensus       106 ~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~  178 (268)
T COG1718         106 NRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEY  178 (268)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHH
Confidence             11     1245788887774  44455555543    34799999954311 1111   11223333556667777777


Q ss_pred             HHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          253 LAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       253 L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      +.-|-. .+   +||+||..=|||+. ++.+.|+|||-|....
T Consensus       179 ~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         179 MRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence            777766 55   99999999999998 8899999999887553

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.23  E-value=1.9e-05  Score=72.96  Aligned_cols=128  Identities=17%  Similarity=0.238  Sum_probs=89.2

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----------------hhhHHHHHHHHHHHhcCC----
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------------LQGHKEWLAEVNFLGNLL----  196 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~----------------~~~~~~~~~E~~~l~~l~----  196 (490)
                      ...||.|+.-.||.-  ..+          ....||++....                ....++..+|+.....+.    
T Consensus         6 ~~~i~~G~~R~cy~H--P~d----------p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~   73 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDD----------PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRG   73 (199)
T ss_pred             CcccccCCCceEEEC--CCC----------CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccC
Confidence            467999999999973  222          246789887665                122355666666555554    


Q ss_pred             --CCceeceeeEEEecCceEEEEEecCC------CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 011234          197 --HPNLVKLVGYCIEDDQRLLVYEFMPR------GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  268 (490)
Q Consensus       197 --HpnIv~l~~~~~~~~~~~lv~E~~~~------g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  268 (490)
                        +.+|.+++|+..++...-+|+|.+.+      -+|.+++...   .++. .....   +-+-..||-+.+   |+.+|
T Consensus        74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~---L~~f~~~l~~~~---Iv~~d  143 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQA---LDEFKRYLLDHH---IVIRD  143 (199)
T ss_pred             CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHH---HHHHHHHHHHcC---CeecC
Confidence              88999999999999999999998753      2688888443   3444 33333   334456777766   99999


Q ss_pred             CCCCceEEcCC--C--CeEEcc
Q 011234          269 FKTSNILLDAD--Y--NAKLSD  286 (490)
Q Consensus       269 lkp~NILl~~~--~--~~kL~D  286 (490)
                      |+|.||++...  +  .+.|+|
T Consensus       144 l~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  144 LNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CCcccEEEEecCCCceEEEEEe
Confidence            99999999432  2  577887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=7.5e-06  Score=75.16  Aligned_cols=102  Identities=27%  Similarity=0.239  Sum_probs=80.8

Q ss_pred             HHHHHHhcCCC-CceeceeeEEEecCceEEEEEecCCCCHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011234          187 AEVNFLGNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       187 ~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      .|.-+|..+.+ +++.+++|+|-.    ++|.||...+++...... ..-...+|..+.+||.++++.+.+|+......+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47888888876 699999999843    789999987766432100 001256899999999999999999998554458


Q ss_pred             eecCCCCCceEEcCCCCeEEcccccccc
Q 011234          265 IYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      .-.|++++|+-++++|++|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            8899999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.13  E-value=1.6e-05  Score=83.43  Aligned_cols=140  Identities=18%  Similarity=0.151  Sum_probs=85.8

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-------------------------------HH---
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------------------------------HK---  183 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-------------------------------~~---  183 (490)
                      +.||..+.|.||+|+.+          .|..||||+-+..-...                               .+   
T Consensus       167 ~piaaASlaQVhrA~L~----------~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK----------NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             chhhhcchhheEEEEec----------CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            67999999999999987          37789999865431110                               01   


Q ss_pred             ---HHHHHHHHHh----cCCCCce---eceeeEEE-ecCceEEEEEecCCCCHHHH--HhhcCCCCCCHHHHHHHHHHHH
Q 011234          184 ---EWLAEVNFLG----NLLHPNL---VKLVGYCI-EDDQRLLVYEFMPRGSLENH--LFRKGSLPLPWSIRMKIALGAA  250 (490)
Q Consensus       184 ---~~~~E~~~l~----~l~HpnI---v~l~~~~~-~~~~~~lv~E~~~~g~L~~~--l~~~~~~~l~~~~~~~i~~qi~  250 (490)
                         +|..|.+-..    .+.|-++   |.+=.+|. ......|+||||+|..+.|.  |.+.   .++...+...+.++.
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~  313 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAY  313 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHH
Confidence               1333443322    2334441   11222222 23467899999999877654  3333   344443333333322


Q ss_pred             HHHHHhhhcCCCCeeecCCCCCceEEcC----CCCeEEccccccccCCC
Q 011234          251 KGLAFLHEEAEKPVIYRDFKTSNILLDA----DYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       251 ~aL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~kL~DFG~a~~~~~  295 (490)
                      .-+-+.  .|   ++|+|=+|.||+++.    ++.+.+.|||+......
T Consensus       314 ~~qIf~--~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFK--TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHh--cC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            222222  24   999999999999983    67899999999887654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.12  E-value=2.6e-05  Score=87.83  Aligned_cols=81  Identities=19%  Similarity=0.210  Sum_probs=55.5

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCC-CCce--eceeeEEEec--
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL-HPNL--VKLVGYCIED--  210 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~--  210 (490)
                      .+.|+.|.+..+|+......+       ....+++|+..... ......+.+|+++|+.|. |.+|  .+++.++.+.  
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~-------~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v  115 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGG-------SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV  115 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCC-------cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence            467899999999998664311       11356677654322 223356789999999996 6665  6777777654  


Q ss_pred             -CceEEEEEecCCCC
Q 011234          211 -DQRLLVYEFMPRGS  224 (490)
Q Consensus       211 -~~~~lv~E~~~~g~  224 (490)
                       +..|+||||++|..
T Consensus       116 ~G~~flVME~v~G~~  130 (822)
T PLN02876        116 IGTAFYIMEYLEGRI  130 (822)
T ss_pred             CCCceEEEEecCCcc
Confidence             46789999998754

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=2.8e-05  Score=71.38  Aligned_cols=125  Identities=28%  Similarity=0.410  Sum_probs=88.9

Q ss_pred             cCCCcCceeccCCc-eEEEEEEEccCCCccccCCCCcEEEEEEecCC---C-------hh-----------hHHHHHHHH
Q 011234          132 RNFRPESLLGEGGF-GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---G-------LQ-----------GHKEWLAEV  189 (490)
Q Consensus       132 ~~y~~~~~lG~G~f-g~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~---~-------~~-----------~~~~~~~E~  189 (490)
                      .+++.++.||.|.- |.||++.+           .|..+|+|+...-   .       ..           ...-|..|.
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-----------~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC  105 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-----------DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC  105 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-----------CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence            67899999999999 99999988           4679999993320   0       00           012367788


Q ss_pred             HHHhcCC---CCce--eceeeEEEecC------------------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHH
Q 011234          190 NFLGNLL---HPNL--VKLVGYCIEDD------------------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA  246 (490)
Q Consensus       190 ~~l~~l~---HpnI--v~l~~~~~~~~------------------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~  246 (490)
                      +...+|.   +.++  |+++||..-..                  ...||.||++...           .+.    ..-+
T Consensus       106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~  170 (207)
T PF13095_consen  106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDI  170 (207)
T ss_pred             HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHH
Confidence            8777764   5566  99999874331                  1247888776543           112    2334


Q ss_pred             HHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       247 ~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      .+|.+-|..+|..+   |+-+|+++.|..     .=||+|||.+
T Consensus       171 ~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  171 PQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            56677788899999   999999999987     3489999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.01  E-value=3.7e-05  Score=73.28  Aligned_cols=31  Identities=19%  Similarity=0.219  Sum_probs=25.9

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..++|+|+.+.|||++.++..-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3489999999999998765567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.91  E-value=3.3e-05  Score=85.80  Aligned_cols=195  Identities=22%  Similarity=0.268  Sum_probs=137.0

Q ss_pred             HHHHHHHhcCCCCceeceeeEEEecCce----EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 011234          186 LAEVNFLGNLLHPNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAE  261 (490)
Q Consensus       186 ~~E~~~l~~l~HpnIv~l~~~~~~~~~~----~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~  261 (490)
                      ..|+..+..+.|+|++.++.|-......    .+..++|..-++...+...+  ..+....+.+..++.+||.|+|+.. 
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~-  306 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS-  306 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence            4477778888999999999987654322    34458888888888887665  5778888899999999999999975 


Q ss_pred             CCeeecCCCCC---ceEEcCCCCeEEc--cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCcc--ccchhhHHH
Q 011234          262 KPVIYRDFKTS---NILLDADYNAKLS--DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK--SDVYSFGVV  334 (490)
Q Consensus       262 ~~iiHrDlkp~---NILl~~~~~~kL~--DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~--sDvwSlGvi  334 (490)
                        ..|.-|..+   +...+.++.+.+.  ||+............   ...-+..|.++|......+..+  .|+|.+|..
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence              555555554   4444566677777  998887765433221   1234556888887776655554  799999999


Q ss_pred             HHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       335 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +..+..|..+-.....                   ...+++.        .......++..+|+..++++|+++.+++.+
T Consensus       382 ~~~~~~~~~i~~~~~~-------------------~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV-------------------PVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCcccccccc-------------------hhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999988654321100                   0001110        001256788899999999999999999987


Q ss_pred             h
Q 011234          415 L  415 (490)
Q Consensus       415 L  415 (490)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            5

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.90  E-value=0.00011  Score=69.88  Aligned_cols=75  Identities=21%  Similarity=0.157  Sum_probs=45.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv  216 (490)
                      +.|..|-...+|++.....        .+..|++|+....... .-...+|+.++..+...++ .++++.+.    -.+|
T Consensus         4 ~~l~gG~tN~~~~v~~~~~--------~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l   70 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED--------NQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLI   70 (235)
T ss_pred             EEcCCcccceEEEEEcCCC--------CCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEE
Confidence            5677888899999864310        1346888976543211 1223468888888853333 34443322    2489


Q ss_pred             EEecCCCCH
Q 011234          217 YEFMPRGSL  225 (490)
Q Consensus       217 ~E~~~~g~L  225 (490)
                      |||++|.++
T Consensus        71 ~e~i~G~~l   79 (235)
T cd05157          71 YEFIPGRTL   79 (235)
T ss_pred             EEeeCCCcC
Confidence            999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.86  E-value=0.00024  Score=70.23  Aligned_cols=77  Identities=12%  Similarity=0.045  Sum_probs=53.6

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC---CceeceeeEEEe---
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH---PNLVKLVGYCIE---  209 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~---  209 (490)
                      -.+.||.|..+.||+.....          + .+.+|..+...  ....+..|...|+.|.-   -.+.++++++..   
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~----------~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~   84 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ----------G-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS   84 (297)
T ss_pred             eeeecCCccceeEEEEEcCC----------C-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence            34679999999999975432          2 36667743311  22467789999888753   357777877654   


Q ss_pred             cCceEEEEEecCCCCH
Q 011234          210 DDQRLLVYEFMPRGSL  225 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L  225 (490)
                      .+..+||||++++.++
T Consensus        85 ~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         85 PGPDVLLLERLRGVSV  100 (297)
T ss_pred             CCCeEEEEeccCCEec
Confidence            3668999999988754

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.84  E-value=8.3e-05  Score=73.40  Aligned_cols=142  Identities=17%  Similarity=0.128  Sum_probs=82.0

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc--eeceee------EEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVG------YCI  208 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~------~~~  208 (490)
                      .+.|..|....+|+....           +..+++|+....   ....+..|+.++..|.+-+  +.+++.      +..
T Consensus        19 i~~i~~G~~n~~y~v~~~-----------~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~   84 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-----------SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE   84 (296)
T ss_pred             eecccCccccceEEEEeC-----------CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence            456777888899987542           225888987642   2345666787777775322  344433      123


Q ss_pred             ecCceEEEEEecCCCCHHH----HH----------hhcC-C--------CCCCHHHHH----------HHHHHHHHHHHH
Q 011234          209 EDDQRLLVYEFMPRGSLEN----HL----------FRKG-S--------LPLPWSIRM----------KIALGAAKGLAF  255 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~----~l----------~~~~-~--------~~l~~~~~~----------~i~~qi~~aL~y  255 (490)
                      ..+..++|++|++|..+..    .+          .... .        ....|....          .....+..++.+
T Consensus        85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  164 (296)
T cd05153          85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR  164 (296)
T ss_pred             eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence            3456789999998866421    10          0000 0        001111110          011112334445


Q ss_pred             hhh----cCCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          256 LHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       256 LH~----~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      +..    .....+||+|+.|.|||++.++.+.|+||+.+..
T Consensus       165 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         165 QDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            443    1224599999999999999887778999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.81  E-value=0.00011  Score=70.95  Aligned_cols=137  Identities=15%  Similarity=0.104  Sum_probs=74.9

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceEEEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLVYE  218 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~E  218 (490)
                      +..|-.+.+|+...           .+..+++|........-.-...+|..+++.+..-.+ .+++...  .  -++|||
T Consensus         4 ~~~G~tn~~y~~~~-----------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e   68 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-----------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVE   68 (256)
T ss_pred             CCCcCcCCeEEEEe-----------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEE
Confidence            45688889998752           344688887654322110134668888888864333 2333332  2  378999


Q ss_pred             ecCCCCHHHH--------------Hhh---cC--CCCCCHHH-HHHHHHHH---------HHHHHHhhhc-----CCCCe
Q 011234          219 FMPRGSLENH--------------LFR---KG--SLPLPWSI-RMKIALGA---------AKGLAFLHEE-----AEKPV  264 (490)
Q Consensus       219 ~~~~g~L~~~--------------l~~---~~--~~~l~~~~-~~~i~~qi---------~~aL~yLH~~-----~~~~i  264 (490)
                      |++|..+...              +.+   ..  ...+.... ...+..++         ...+..+-..     ....+
T Consensus        69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  148 (256)
T TIGR02721        69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP  148 (256)
T ss_pred             eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence            9988665321              111   10  11122111 11111111         1112222111     12348


Q ss_pred             eecCCCCCceEEcCCCCeEEcccccccc
Q 011234          265 IYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      +|+|+.|.|||++.++ +.|+||..|..
T Consensus       149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       149 LHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999998876 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.69  E-value=0.00087  Score=68.56  Aligned_cols=76  Identities=20%  Similarity=0.148  Sum_probs=51.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC------C-hhhHHHHHHHHHHHhcCC---CCceeceeeEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGNLL---HPNLVKLVGYC  207 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~------~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~  207 (490)
                      +.||.|.+..||++....         .+..|+||.-...      . .........|.+.|..+.   ..++.+++.+ 
T Consensus        32 ~elggGn~N~VyrV~~~~---------g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-  101 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE---------GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-  101 (401)
T ss_pred             eEcCCCceEEEEEEEeCC---------CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-
Confidence            579999999999998753         2247899974311      1 123345666888887763   3456666665 


Q ss_pred             EecCceEEEEEecCCCC
Q 011234          208 IEDDQRLLVYEFMPRGS  224 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~  224 (490)
                       +.+..++||||+++..
T Consensus       102 -D~~~~~lVME~L~~~~  117 (401)
T PRK09550        102 -DEELAVTVMEDLSDHK  117 (401)
T ss_pred             -CCCCCEEEEecCCCcc
Confidence             4466789999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.62  E-value=0.00038  Score=68.92  Aligned_cols=81  Identities=20%  Similarity=0.200  Sum_probs=47.9

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv  216 (490)
                      +.|..|-...||+........   ....+..+++|+..... .......+|+.++..+....+ .++++++. +   .+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~---~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v   75 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDA---LSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI   75 (302)
T ss_pred             EEecCcccceeEEEEcCCccc---ccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence            456667778999886532110   11235678899876543 222345678888887753333 34444432 2   468


Q ss_pred             EEecCCCCHH
Q 011234          217 YEFMPRGSLE  226 (490)
Q Consensus       217 ~E~~~~g~L~  226 (490)
                      +||++|..+.
T Consensus        76 ~e~i~G~~l~   85 (302)
T cd05156          76 EEFIPSRTLT   85 (302)
T ss_pred             hheeCCCcCC
Confidence            9999887654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.49  E-value=0.003  Score=62.99  Aligned_cols=32  Identities=28%  Similarity=0.382  Sum_probs=26.6

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      +.++||+|+.+.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            34699999999999998665568999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.39  E-value=0.0019  Score=64.23  Aligned_cols=142  Identities=19%  Similarity=0.190  Sum_probs=79.0

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc--eeceeeE------EE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGY------CI  208 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~------~~  208 (490)
                      ...++.|....||+....          .| .+++|+.....  ....+..|++++..|....  +.+++..      ..
T Consensus        27 i~~~~~G~~n~~y~v~t~----------~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~   93 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD----------VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLST   93 (307)
T ss_pred             ccccCCccccceEEEEeC----------CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehh
Confidence            466777877899987542          23 46788765432  1234455677776664211  3333331      12


Q ss_pred             ecCceEEEEEecCCCCHH-----------HHH---hhc-CCCC---------CCHHHHH------------HHHHHHHHH
Q 011234          209 EDDQRLLVYEFMPRGSLE-----------NHL---FRK-GSLP---------LPWSIRM------------KIALGAAKG  252 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~-----------~~l---~~~-~~~~---------l~~~~~~------------~i~~qi~~a  252 (490)
                      ..+..++||+|++|..+.           ..+   ... ....         -.|....            .....+...
T Consensus        94 ~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~  173 (307)
T TIGR00938        94 LAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKE  173 (307)
T ss_pred             cCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHH
Confidence            245678999999885431           111   000 0000         0111100            001123334


Q ss_pred             HHHhhh----cCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          253 LAFLHE----EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       253 L~yLH~----~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      +.++..    .....+||+|+.+.||+++.++.+.|+||+.+.
T Consensus       174 ~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       174 LDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            555532    123569999999999999988777899999775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.37  E-value=3.3e-05  Score=87.58  Aligned_cols=175  Identities=13%  Similarity=-0.004  Sum_probs=120.7

Q ss_pred             EEEEEecCCChhhH-----HHHHHHHHHHhcCCCCceeceeeEEEe--cCceEEEEEecCCCCHHHHHhhcCC--CCCCH
Q 011234          169 VAVKTLNHDGLQGH-----KEWLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS--LPLPW  239 (490)
Q Consensus       169 vAvK~~~~~~~~~~-----~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~  239 (490)
                      +.+|+.+.-..+..     +..+.|...++...|+++...+.-...  ....|.+++|+.+|.+.+.|.+...  ..+..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            45666554433322     234556666777789998877664443  3466899999999999999875422  12222


Q ss_pred             HHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhh
Q 011234          240 SIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV  317 (490)
Q Consensus       240 ~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l  317 (490)
                      .-+.....+.+.+..-+|+..  ..-.+|++||+-|.+|..+.++|+.++|+.+.....  ........+++.|+++++.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHH
Confidence            222222222244555555432  233789999999999999999999999999833221  1222345678899999998


Q ss_pred             hcCCCCccccchhhHHHHHHHHhCCCCC
Q 011234          318 MTGHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       318 ~~~~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                      +.-.++.++|+|..|+.+|++.-|..+|
T Consensus      1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            8889999999999999999999887766

>PLN02236 choline kinase

Probab=97.23  E-value=0.0026  Score=64.25  Aligned_cols=145  Identities=18%  Similarity=0.130  Sum_probs=79.1

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCcee-ceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv  216 (490)
                      ..|-.|-.-.+|++.......     ..+..|++|+........ -...+|+.++..+..-++. ++++.+. .+   .|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~-----~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v  111 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEG-----NLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFP-NG---RV  111 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCC-----CCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEEC-Cc---eE
Confidence            345558888999987543211     134578899876543211 1225688888877643332 4455442 22   58


Q ss_pred             EEecCCCCHHHH--------------Hh---hc---CCC-CCCHHHHHHHHHHH-----------------HHHHHH---
Q 011234          217 YEFMPRGSLENH--------------LF---RK---GSL-PLPWSIRMKIALGA-----------------AKGLAF---  255 (490)
Q Consensus       217 ~E~~~~g~L~~~--------------l~---~~---~~~-~l~~~~~~~i~~qi-----------------~~aL~y---  255 (490)
                      +||+++.+|...              +.   ..   ... ...+..+..+..++                 ...+..   
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            999977665321              00   00   000 11122222222111                 111111   


Q ss_pred             -hhh-cCCCCeeecCCCCCceEEcC-CCCeEEcccccccc
Q 011234          256 -LHE-EAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD  292 (490)
Q Consensus       256 -LH~-~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG~a~~  292 (490)
                       +.. .....++|+||++.|||+++ ++.+.|+||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             221 11234899999999999976 46899999987753

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.06  E-value=0.005  Score=61.24  Aligned_cols=141  Identities=18%  Similarity=0.156  Sum_probs=91.5

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---------h----------------hHHH-HHHH
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------Q----------------GHKE-WLAE  188 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---------~----------------~~~~-~~~E  188 (490)
                      .+...|..|--+-||.|.-.          .|..+|||+++..-+         .                -.+- ...|
T Consensus       147 ~inGCiSTGKEANVYHat~~----------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE  216 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE----------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKE  216 (520)
T ss_pred             ecccccccCccceeEeeecC----------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHH
Confidence            34567888999999998654          477899998753200         0                0111 2458


Q ss_pred             HHHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 011234          189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  267 (490)
Q Consensus       189 ~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  267 (490)
                      ++-|.+|+...|...--+..  ..-+|||+|+.....- -.|   ....++...+..+-.+++.-+.-|-+.+.  +||.
T Consensus       217 ~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHA  289 (520)
T KOG2270|consen  217 MRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHA  289 (520)
T ss_pred             HHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHHHhc--eecc
Confidence            88888886544332222222  1237999999432111 111   23356667777777888887877766543  9999


Q ss_pred             CCCCCceEEcCCCCeEEccccccccC
Q 011234          268 DFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       268 Dlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ||.-=|+|+ .+|.+.|+|-+-+...
T Consensus       290 DLSEfN~Ly-hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  290 DLSEFNLLY-HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             chhhhhheE-ECCEEEEEEccccccC
Confidence            999999999 5679999998876543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.01  E-value=0.00074  Score=65.89  Aligned_cols=135  Identities=16%  Similarity=0.099  Sum_probs=89.7

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--h--------------------hHHHHHHHHHH
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--Q--------------------GHKEWLAEVNF  191 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~--------------------~~~~~~~E~~~  191 (490)
                      +.+++.||-|--+.||.+-+.          .|...++|.-+....  .                    ..-...+|+..
T Consensus        94 ~svGnqIGVGKESDIY~v~d~----------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfaf  163 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE----------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAF  163 (465)
T ss_pred             hhhccccccccccceEEEecC----------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHH
Confidence            677899999999999999775          466788886432110  0                    01123568888


Q ss_pred             HhcCC-CCc-eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011234          192 LGNLL-HPN-LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       192 l~~l~-Hpn-Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      |+.|. |-. |.+.++    -+.-++|||++.+-.|...-.-     .....   +...+..-+.-|-.+|   +||+|+
T Consensus       164 mkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~G---lIHgDF  228 (465)
T KOG2268|consen  164 MKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANHG---LIHGDF  228 (465)
T ss_pred             HHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHcC---ceeccc
Confidence            88875 332 333333    3456899999988777654311     12222   2333334445566667   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccC
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      .-=||++++++.++++||--+...
T Consensus       229 NEFNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  229 NEFNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             chheeEEecCCCEEEeechHhhcc
Confidence            999999999999999999765433

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.94  E-value=0.0084  Score=58.62  Aligned_cols=31  Identities=29%  Similarity=0.394  Sum_probs=25.9

Q ss_pred             CeeecCCCCCceEEcCCCC-eEEccccccccC
Q 011234          263 PVIYRDFKTSNILLDADYN-AKLSDFGLAKDA  293 (490)
Q Consensus       263 ~iiHrDlkp~NILl~~~~~-~kL~DFG~a~~~  293 (490)
                      .++|+|+++.|||++.++. .-|+||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987555 569999988654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.78  E-value=0.017  Score=58.18  Aligned_cols=73  Identities=16%  Similarity=0.119  Sum_probs=45.1

Q ss_pred             eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecC-------CChhhHHHHHHHHHHHhcCC--CC-ceeceeeEEE
Q 011234          139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-------DGLQGHKEWLAEVNFLGNLL--HP-NLVKLVGYCI  208 (490)
Q Consensus       139 ~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~-------~~~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~~  208 (490)
                      .||.|....||++....         .+..|+||.-..       .-.-......-|...|....  -| .+.++|.  .
T Consensus         2 EigdGnlN~VfrV~~~~---------g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQE---------GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--F   70 (370)
T ss_pred             cCCCCceEEEEEEEcCC---------CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--E
Confidence            47999999999998532         234688986421       11222334456777776653  34 3444443  4


Q ss_pred             ecCceEEEEEecCC
Q 011234          209 EDDQRLLVYEFMPR  222 (490)
Q Consensus       209 ~~~~~~lv~E~~~~  222 (490)
                      +.....+|||+++.
T Consensus        71 D~e~~~~vMEdL~~   84 (370)
T TIGR01767        71 DTEMAVTVMEDLSH   84 (370)
T ss_pred             ccccceehHhhCcc
Confidence            55666799999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.72  E-value=0.018  Score=57.03  Aligned_cols=33  Identities=18%  Similarity=0.364  Sum_probs=29.3

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      ..++|+|+.+.||+|+.++-+-|+||+++....
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            459999999999999998889999999987654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.60  E-value=0.012  Score=59.02  Aligned_cols=144  Identities=18%  Similarity=0.221  Sum_probs=76.5

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv  216 (490)
                      +.|..|=...+|+.......      +.+..|++|+....... .-.-.+|..++..+..-++ .++++++ ..+   +|
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~------~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i   88 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEEN------GNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-GNG---MI   88 (330)
T ss_pred             EEeCCcccceEEEEEecCCC------CCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-CCc---Ee
Confidence            34444777889988654311      12336889987654321 1123468888888764444 3445544 222   58


Q ss_pred             EEecCCCCHHH----------HH----hh---cC---CC-CCCHHHHHHHHHHH----------------------HHHH
Q 011234          217 YEFMPRGSLEN----------HL----FR---KG---SL-PLPWSIRMKIALGA----------------------AKGL  253 (490)
Q Consensus       217 ~E~~~~g~L~~----------~l----~~---~~---~~-~l~~~~~~~i~~qi----------------------~~aL  253 (490)
                      .+|+++..|..          .+    .+   ..   .. .-.+..+..+..++                      ..-+
T Consensus        89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  168 (330)
T PLN02421         89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI  168 (330)
T ss_pred             ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence            99987765421          01    11   00   00 11122222222111                      1111


Q ss_pred             HH---hh-hc-CCCCeeecCCCCCceEEcC-CCCeEEcccccccc
Q 011234          254 AF---LH-EE-AEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKD  292 (490)
Q Consensus       254 ~y---LH-~~-~~~~iiHrDlkp~NILl~~-~~~~kL~DFG~a~~  292 (490)
                      ..   +. .. .+.-++|.||.+.|||+++ ++.++++||..|..
T Consensus       169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11   11 11 1223799999999999974 57899999988753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.57  E-value=0.0035  Score=58.59  Aligned_cols=29  Identities=34%  Similarity=0.449  Sum_probs=20.7

Q ss_pred             CeeecCCCCCceEE-cCCCCeEEccccccc
Q 011234          263 PVIYRDFKTSNILL-DADYNAKLSDFGLAK  291 (490)
Q Consensus       263 ~iiHrDlkp~NILl-~~~~~~kL~DFG~a~  291 (490)
                      .++|+||.+.|||+ +.++.++|+||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999998775

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.56  E-value=0.034  Score=55.28  Aligned_cols=31  Identities=16%  Similarity=0.173  Sum_probs=27.9

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..+||+|+.++|||++.++.+.|+||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4599999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.50  E-value=0.002  Score=66.50  Aligned_cols=166  Identities=23%  Similarity=0.312  Sum_probs=92.8

Q ss_pred             HHHHHHHHHHHhcCCCCceeceeeEEEec-CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 011234          182 HKEWLAEVNFLGNLLHPNLVKLVGYCIED-DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA  260 (490)
Q Consensus       182 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~  260 (490)
                      ..+++-...+++.+.|+|+..++++.... ....+|||++ +.+|++.+..+.   +...          +++  -|.  
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~----------s~~--~~~--   87 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN---LKDE----------SLL--AHG--   87 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---cchh----------hhc--ccc--
Confidence            35677788999999999999999876543 3578899999 789999886553   1101          001  121  


Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh
Q 011234          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt  340 (490)
                         +.|-     |       .++++| -++...         ....|                .++||||+|.++.++.-
T Consensus        88 ---~~~~-----~-------~~~~td-~~~t~~---------~~~~~----------------pKsdVwsl~~i~~el~L  126 (725)
T KOG1093|consen   88 ---VLHL-----N-------IIYITD-HFLTKY---------PSPIG----------------PKSDVWSLGFIILELYL  126 (725)
T ss_pred             ---ccee-----h-------hhhccc-cccccC---------CCCCC----------------cchhhhhHHHHHHHHHH
Confidence               3321     1       233333 111100         00111                39999999999999999


Q ss_pred             CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011234          341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       341 G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  412 (490)
                      |...+......   +..+................   .+..+-..++..+.++..+|+-..|..||...++.
T Consensus       127 ~~~l~~~~~~s---~~l~~i~k~~~~d~~~~~~a---~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  127 GISLEAELTES---EYLEILLKYYTDDQELLSTA---MEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             hhHHHHHHHHH---HHHHHHHHhccCchhHHHHH---HHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            97665322111   11111111111110000000   00012234467788999999999999888755443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.43  E-value=0.038  Score=54.71  Aligned_cols=29  Identities=24%  Similarity=0.376  Sum_probs=25.3

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .++||+|+.+.|||++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45999999999999987 678999998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.40  E-value=0.035  Score=54.47  Aligned_cols=73  Identities=21%  Similarity=0.252  Sum_probs=44.7

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCceeceeeEEEecCce
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~  213 (490)
                      .+.|+.|....+|+...           .+..+.||+-...   ....|..|..-|+.|.   --.+.+++++....+..
T Consensus        22 ~~~v~GG~i~~a~~~~~-----------~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~   87 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDT-----------DGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA   87 (288)
T ss_dssp             EEEE--SSSSEEEEEET-----------TS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC
T ss_pred             eEecCCCChhheEEEEC-----------CCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc
Confidence            45689899999998762           4567889987622   2235666777777763   45577888888777778


Q ss_pred             EEEEEecCCC
Q 011234          214 LLVYEFMPRG  223 (490)
Q Consensus       214 ~lv~E~~~~g  223 (490)
                      +|||||++.+
T Consensus        88 fLlle~l~~~   97 (288)
T PF03881_consen   88 FLLLEFLEMG   97 (288)
T ss_dssp             EEEEE-----
T ss_pred             eEEEEeecCC
Confidence            9999999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.35  E-value=0.0092  Score=60.14  Aligned_cols=59  Identities=19%  Similarity=0.158  Sum_probs=40.8

Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      .|+=+|..|-++..++...+   .++.....++.-.+.||.-+--..  +++|.|+.|.||++.
T Consensus       321 vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  321 VLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             eeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            56667888888888886553   455566666666666654333222  299999999999994

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.18  E-value=0.032  Score=56.90  Aligned_cols=75  Identities=20%  Similarity=0.236  Sum_probs=47.4

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-----C-hhhHHHHHHHHHHHhcCC--CC-ceeceeeEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-----G-LQGHKEWLAEVNFLGNLL--HP-NLVKLVGYC  207 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-----~-~~~~~~~~~E~~~l~~l~--Hp-nIv~l~~~~  207 (490)
                      .+.||.|.-.-||++.+..         .+..|+||.-...     . .-...+..-|.+.|+.+.  -| ++.++|.  
T Consensus        34 ~~eigdGnlN~VfrV~~~~---------~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQ---------KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeCC---------CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--
Confidence            4678999999999998732         1346888863211     1 223345566777777653  34 3444543  


Q ss_pred             EecCceEEEEEecCC
Q 011234          208 IEDDQRLLVYEFMPR  222 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~  222 (490)
                      .+.....+|||+++.
T Consensus       103 ~D~e~~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVMNCCVMEDLSD  117 (409)
T ss_pred             ECcHHhhHHHHhCcc
Confidence            455667889998854

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.14  E-value=0.013  Score=58.25  Aligned_cols=72  Identities=19%  Similarity=0.197  Sum_probs=54.6

Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      +.|++|++- |++|.- +.     ...++++..|+++.+..+.-+...  .+.-|||+...||||+ +|+|-|+||-+++
T Consensus       300 y~yl~~kdh-gt~is~-ik-----~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         300 YLYLHFKDH-GTPISI-IK-----ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             EEEEEEecC-Cceeee-ee-----cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeee
Confidence            456777774 555542 21     245678888999887777766653  4589999999999999 9999999999998


Q ss_pred             cC
Q 011234          292 DA  293 (490)
Q Consensus       292 ~~  293 (490)
                      .-
T Consensus       370 l~  371 (488)
T COG5072         370 LS  371 (488)
T ss_pred             cc
Confidence            54

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.01  E-value=0.15  Score=52.28  Aligned_cols=73  Identities=10%  Similarity=0.025  Sum_probs=46.1

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-------hhHHHHHHHHHHHhcCC---CCceeceeeE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLL---HPNLVKLVGY  206 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~---HpnIv~l~~~  206 (490)
                      .+.||.|....||+....           +..|+||.-.....       ........|+..|..+.   ..++.+++.+
T Consensus        37 ~~eiggGn~N~VyrV~~~-----------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~  105 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-----------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHF  105 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-----------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEE
Confidence            467899999999997652           22588887541110       12223344566665553   3467777776


Q ss_pred             EEecCceEEEEEecCC
Q 011234          207 CIEDDQRLLVYEFMPR  222 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~  222 (490)
                      +.  +..+++|||+++
T Consensus       106 de--d~~vlvME~L~~  119 (418)
T PLN02756        106 DR--TMALIGMRYLEP  119 (418)
T ss_pred             CC--CCCEEEEeecCC
Confidence            65  556889999976

>PRK06148 hypothetical protein; Provisional

Probab=95.74  E-value=0.12  Score=59.80  Aligned_cols=32  Identities=44%  Similarity=0.475  Sum_probs=26.3

Q ss_pred             CCCeeecCCCCCceEEcCCC--CeE-Ecccccccc
Q 011234          261 EKPVIYRDFKTSNILLDADY--NAK-LSDFGLAKD  292 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~--~~k-L~DFG~a~~  292 (490)
                      +..+||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            35599999999999998875  554 999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.74  E-value=0.079  Score=52.99  Aligned_cols=138  Identities=22%  Similarity=0.262  Sum_probs=78.3

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc------eeceeeEE--EecC
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKLVGYC--IEDD  211 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~--~~~~  211 (490)
                      |.+ .-..||+....+          |.. ++|+....  ....++..|+..|..|.-..      |..+-|-.  .-.+
T Consensus        34 l~s-~eN~~f~~~~~~----------g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~   99 (331)
T COG2334          34 LNS-EENSNFRVQTED----------GRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSG   99 (331)
T ss_pred             ccc-ccCceEEEEecC----------CCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccC
Confidence            444 556788876643          334 88988765  33455666777777774211      22222211  1223


Q ss_pred             --ceEEEEEecCCCCHHH-H----Hh--------------hcC------CCCCCHHH-------------HHHHHHHHHH
Q 011234          212 --QRLLVYEFMPRGSLEN-H----LF--------------RKG------SLPLPWSI-------------RMKIALGAAK  251 (490)
Q Consensus       212 --~~~lv~E~~~~g~L~~-~----l~--------------~~~------~~~l~~~~-------------~~~i~~qi~~  251 (490)
                        ..+-|++|++|..+.. .    +.              ...      .....|..             -.....++..
T Consensus       100 ~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~  179 (331)
T COG2334         100 GPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLA  179 (331)
T ss_pred             CceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHH
Confidence              6778999999877762 1    10              000      00122220             0112233444


Q ss_pred             HHHHhhhcC----C---CCeeecCCCCCceEEcCCCC-eEEccccccc
Q 011234          252 GLAFLHEEA----E---KPVIYRDFKTSNILLDADYN-AKLSDFGLAK  291 (490)
Q Consensus       252 aL~yLH~~~----~---~~iiHrDlkp~NILl~~~~~-~kL~DFG~a~  291 (490)
                      .+..+.+.-    +   ..+||+|+.|.|||++.+.. +.++|||-+.
T Consensus       180 ~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         180 ALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            444444321    1   22999999999999998874 8999999765

>PTZ00384 choline kinase; Provisional

Probab=95.36  E-value=0.1  Score=53.51  Aligned_cols=81  Identities=12%  Similarity=0.077  Sum_probs=44.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCcee-ceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv  216 (490)
                      +.|..|-...+|++..........   ..+.|.++...... ...-+-.+|++++..|...++- ++++.+.    -++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~---~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l  127 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRY---PIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTI  127 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCcc---ccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEE
Confidence            455558889999987643210000   01124444432211 1111234688899888755444 4455543    2699


Q ss_pred             EEecCCCCHH
Q 011234          217 YEFMPRGSLE  226 (490)
Q Consensus       217 ~E~~~~g~L~  226 (490)
                      .||++|..|.
T Consensus       128 ~efIeGr~l~  137 (383)
T PTZ00384        128 QEWVEGNTMG  137 (383)
T ss_pred             EEEeccccCC
Confidence            9999887653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.33  E-value=0.42  Score=47.83  Aligned_cols=29  Identities=24%  Similarity=0.242  Sum_probs=24.2

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..+||+|+.+.|||++ + .+.|+||+.+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4589999999999995 4 588999997753

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.10  E-value=0.072  Score=49.60  Aligned_cols=102  Identities=14%  Similarity=0.085  Sum_probs=64.6

Q ss_pred             EEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHH
Q 011234          169 VAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL  247 (490)
Q Consensus       169 vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~  247 (490)
                      ..+|.+..-... ...-+..+.+++++++  .|+++..-  ..-.+-+|+|+|-....           ..    ..++.
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFIT  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHH
Confidence            344544433223 3345677888888764  46666621  23355689999832110           00    11222


Q ss_pred             HHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       248 qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      .=+.+|.-.|+.. .+.+|+|..|+||+-|..|.+||.|=+..
T Consensus       149 agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence            2246788889654 45999999999999999999999998753

The function of this family is unknown.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.05  E-value=0.11  Score=48.57  Aligned_cols=70  Identities=24%  Similarity=0.359  Sum_probs=45.6

Q ss_pred             eEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCceeceeeEEEecCceEEEEEecCC
Q 011234          146 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQRLLVYEFMPR  222 (490)
Q Consensus       146 g~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~E~~~~  222 (490)
                      |.|..|+...++        ...+-||+-...   ....|..|+.-|..|.   --.|.+++.+-.+.++.|+||||++-
T Consensus        27 G~inea~~v~dg--------~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          27 GDINEAWRLRDG--------TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             ccccceeEeecC--------CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            455555554432        235778864322   2345666776666654   45577788888888999999999988


Q ss_pred             CCHH
Q 011234          223 GSLE  226 (490)
Q Consensus       223 g~L~  226 (490)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6654

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	490
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-52
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-48
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-44
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-44
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-43
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-41
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-24
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-23
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-21
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-20
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-20
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-20
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		7e-20
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		7e-20
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		7e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-20
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-20
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-19
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-19
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-19
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-19
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-18
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-18
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-18
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-18
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		8e-18
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-18
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-18
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-18
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-17
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-17
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-17
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-17
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-17
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-17
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-17
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-17
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-17
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-17
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		6e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-17
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-16
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-16
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-16
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-16
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-16
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		8e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-16
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-15
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-15
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		6e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		6e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		7e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		7e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		8e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		8e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-14
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-14
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-14
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-14
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-14
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-14
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		8e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-11
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-11
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-11
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		6e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		7e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		7e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		8e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		4e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		6e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		8e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		7e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  204 bits (520), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 116/304 (38%), Positives = 183/304 (60%), Gaps = 17/304 (5%)
Query: 118 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 177
           QL++F   +L++A+ NF  +++LG GGFG V+KG          +   G  VAVK L  +
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKG----------RLADGTLVAVKRLKEE 73
Query: 178 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GS 234
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  +    
Sbjct: 74  RXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 133
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 134 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LM 192
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           +    HV   V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 193 DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 355 N--LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           +  L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 253 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 413 ETLK 416
             L+
Sbjct: 312 RMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  202 bits (515), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 115/304 (37%), Positives = 182/304 (59%), Gaps = 17/304 (5%)
Query: 118 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 177
           QL++F   +L++A+ NF  +++LG GGFG V+KG          +   G  VAVK L  +
Sbjct: 16  QLKRFSLRELQVASDNFXNKNILGRGGFGKVYKG----------RLADGXLVAVKRLKEE 65
Query: 178 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GS 234
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L  +    
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LM 184
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           +    HV   V G  G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 185 DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 355 N--LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           +  L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 413 ETLK 416
             L+
Sbjct: 304 RMLE 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 112/301 (37%), Positives = 175/301 (58%), Gaps = 18/301 (5%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           DL+ AT NF  + L+G G FG V+KG + +          G  VA+K    +  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRM 243
             E+  L    HP+LV L+G+C E ++ +L+Y++M  G+L+ HL+     ++ + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           +I +GAA+GL +LH  A   +I+RD K+ NILLD ++  K++DFG++K   E G+TH+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 362
            V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ ++ P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 422
           H  +  +  +++DP L      +  +K    A +CL+   + RP M +V+  L+    L+
Sbjct: 260 H--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 423 D 423
           +
Sbjct: 318 E 318

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 111/301 (36%), Positives = 174/301 (57%), Gaps = 18/301 (5%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           DL+ AT NF  + L+G G FG V+KG + +          G  VA+K    +  QG +E+
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRD----------GAKVALKRRTPESSQGIEEF 82
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRM 243
             E+  L    HP+LV L+G+C E ++ +L+Y++M  G+L+ HL+     ++ + W  R+
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           +I +GAA+GL +LH  A   +I+RD K+ NILLD ++  K++DFG++K   E  +TH+  
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RP 362
            V GT GY  PEY + G LT KSDVYSFGVVL E+L  R ++ ++ P    NL EWA   
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK 422
           H  +  +  +++DP L      +  +K    A +CL+   + RP M +V+  L+    L+
Sbjct: 260 H--NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 423 D 423
           +
Sbjct: 318 E 318

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 110/309 (35%), Positives = 172/309 (55%), Gaps = 21/309 (6%)
Query: 117 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 229
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 70  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 230 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
              G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +T + +R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 180 ARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 410 EVVETLKPL 418
           +V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  176 bits (445), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 110/309 (35%), Positives = 171/309 (55%), Gaps = 21/309 (6%)
Query: 117 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 10  TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 69
Query: 171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 229
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 70  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 230 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
              G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 179
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +T +  R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 180 ARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 410 EVVETLKPL 418
           +V + L+ +
Sbjct: 296 KVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 109/309 (35%), Positives = 170/309 (55%), Gaps = 21/309 (6%)
Query: 117 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
           ++   F F +LK  T NF  RP S+    +GEGGFG V+KG+V     A  K    + + 
Sbjct: 4   TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 63
Query: 171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 229
            + L        +++  E+  +    H NLV+L+G+  + D   LVY +MP GSL + L 
Sbjct: 64  TEELK-------QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 116
Query: 230 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
              G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 117 CLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 173
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +  +  R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 174 ARASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D ++    S    +    +A+QCL      RP + 
Sbjct: 233 E--PQLLLDIKEEIEDEEKTIEDYIDKKMNDADS-TSVEAMYSVASQCLHEKKNKRPDIK 289
Query: 410 EVVETLKPL 418
           +V + L+ +
Sbjct: 290 KVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  166 bits (419), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 108/307 (35%), Positives = 164/307 (53%), Gaps = 21/307 (6%)
Query: 117 SQLRKFMFNDLKLATRNF--RPESL----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
           ++   F F +LK  T NF  RP S+     GEGGFG V+KG+V     A  K    + + 
Sbjct: 1   TRFHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDIT 60
Query: 171 VKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL- 229
            + L        +++  E+       H NLV+L+G+  + D   LVY + P GSL + L 
Sbjct: 61  TEELK-------QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLS 113
Query: 230 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
              G+ PL W  R KIA GAA G+ FLHE      I+RD K++NILLD  + AK+SDFGL
Sbjct: 114 CLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGL 170
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+ + +  +    +R++GT  Y APE  + G +T KSD+YSFGVVLLE++TG  ++D++R
Sbjct: 171 ARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                 L++       +++     +D +     S    +    +A+QCL      RP + 
Sbjct: 230 E--PQLLLDIKEEIEDEEKTIEDYIDKKXNDADS-TSVEAXYSVASQCLHEKKNKRPDIK 286
Query: 410 EVVETLK 416
           +V + L+
Sbjct: 287 KVQQLLQ 293

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 142/298 (47%), Gaps = 34/298 (11%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  K   P+ WS+++++ L
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLML 129
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVS 302
             A G+ ++  +   P+++RD ++ NI L     +A   AK++DFGL++ +      H  
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSV 183
Query: 303 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           + ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMI 242
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 243 REE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 141/292 (48%), Gaps = 43/292 (14%)
Query: 132 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
           +    E ++G G FG V K  W  ++            VA+K +  +  +  K ++ E+ 
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 54
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW---SIRMKIAL 247
            L  + HPN+VKL G C+  +   LV E+   GSL N L   G+ PLP+   +  M   L
Sbjct: 55  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCL 110
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVM 306
             ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D     +TH+ T   
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNK 165
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           G+  + APE     + + K DV+S+G++L E++T R+  D+    G    + WA  H G 
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGT 222
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           +    + L   +E             L  +C S+DP  RP M E+V+ +  L
Sbjct: 223 RPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 262

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 134/280 (47%), Gaps = 34/280 (12%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 121
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
            +   VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 122 AS---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 177
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 228
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 229 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 90/292 (30%), Positives = 141/292 (48%), Gaps = 43/292 (14%)
Query: 132 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
           +    E ++G G FG V K  W  ++            VA+K +  +  +  K ++ E+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKD------------VAIKQIESESER--KAFIVELR 53
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW---SIRMKIAL 247
            L  + HPN+VKL G C+  +   LV E+   GSL N L   G+ PLP+   +  M   L
Sbjct: 54  QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCL 109
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVM 306
             ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D     +TH+ T   
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHM-TNNK 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           G+  + APE     + + K DV+S+G++L E++T R+  D+    G    + WA  H G 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWAV-HNGT 221
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           +    + L   +E             L  +C S+DP  RP M E+V+ +  L
Sbjct: 222 RPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 141/298 (47%), Gaps = 34/298 (11%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  K   P+ WS+++++ L
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLML 129
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVS 302
             A G+ ++  +   P+++RD ++ NI L     +A   AK++DFG ++ +      H  
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSV 183
Query: 303 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           + ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMI 242
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 243 REE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 15  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 62
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 63  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 121
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 122 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 177
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 178 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 228
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 229 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/298 (28%), Positives = 141/298 (47%), Gaps = 34/298 (11%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           LA      E  +G+GGFG V KG  V++     +K    L +       + ++  +E+  
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQR 72
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV  + NL HPN+VKL G  +  +   +V EF+P G L + L  K   P+ WS+++++ L
Sbjct: 73  EVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLML 129
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKDAPEDGKTHVS 302
             A G+ ++  +   P+++RD ++ NI L     +A   AK++DF L++ +      H  
Sbjct: 130 DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSV 183
Query: 303 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           + ++G + + APE +       T K+D YSF ++L  +LTG    D+    G+   +   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMI 242
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           R   G +        PRL     +            C S DPK RP  S +V+ L  L
Sbjct: 243 REE-GLRPTIPEDCPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 13  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 60
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 119
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 120 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 175
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 226
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 227 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 133/280 (47%), Gaps = 34/280 (12%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 18  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 66  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 124
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 125 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 180
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 181 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 231
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 232 -------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W+ ++            VA+KT+  +G     +++ E   +  L HP
Sbjct: 35  IGSGQFGLVHLGYWLNKD-----------KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHP 82
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C+E     LV+EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 83  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 141
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 142 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 197
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 198 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 248
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 249 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 132/280 (47%), Gaps = 34/280 (12%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W+ ++            VA+KT+  +G    ++++ E   +  L HP
Sbjct: 16  IGSGQFGLVHLGYWLNKD-----------KVAIKTIR-EGAMSEEDFIEEAEVMMKLSHP 63
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L G C+E     LV EFM  G L ++L  +  L    ++ + + L   +G+A+L E
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-LGMCLDVCEGMAYLEE 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                VI+RD    N L+  +   K+SDFG+ +   +D  T  ST       +A+PE   
Sbjct: 123 AC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 178
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
               +SKSDV+SFGV++ E+ +  +   +NR N E  +VE       D    +RL  PRL
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-------DISTGFRLYKPRL 229
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                   S    Q+   C    P+ RP  S ++  L  +
Sbjct: 230 -------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/218 (33%), Positives = 111/218 (50%), Gaps = 32/218 (14%)
Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL----AEVNF 191
           E ++G GGFG V++  W+            G  VAVK   HD  +   + +     E   
Sbjct: 12  EEIIGIGGFGKVYRAFWI------------GDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
              L HPN++ L G C+++    LV EF   G L   L  K    +P  I +  A+  A+
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAVQIAR 116
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL-----DADYN---AKLSDFGLAKDAPEDGKTHVST 303
           G+ +LH+EA  P+I+RD K+SNIL+     + D +    K++DFGLA++     K   + 
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA- 175
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
              G Y + APE +     +  SDV+S+GV+L E+LTG
Sbjct: 176 ---GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/297 (28%), Positives = 139/297 (46%), Gaps = 33/297 (11%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 183
           +D+ +   +   +  +G G FG V +   E +G+          VAVK L        + 
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 184 -EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSI 241
            E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L + G+   L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R+ +A   AKG+ +LH     P+++RD K+ N+L+D  Y  K+ DFGL++   +      
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLX 195
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           S    GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  +   
Sbjct: 196 SKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQ-VV 248
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             +G K +  RL  PR         + +   +   C + +P  RP  + +++ L+PL
Sbjct: 249 AAVGFKCK--RLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 86/298 (28%), Positives = 142/298 (47%), Gaps = 35/298 (11%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK- 183
           +D+ +   +   +  +G G FG V +   E +G+          VAVK L        + 
Sbjct: 30  DDMDIPWCDLNIKEKIGAGSFGTVHRA--EWHGS---------DVAVKILMEQDFHAERV 78
Query: 184 -EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSI 241
            E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L + G+   L    
Sbjct: 79  NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R+ +A   AKG+ +LH     P+++R+ K+ N+L+D  Y  K+ DFGL++       T +
Sbjct: 139 RLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFL 194
Query: 302 STR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
           S++   GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  +  
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQ-V 247
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              +G K +  RL  PR         + +   +   C + +P  RP  + +++ L+PL
Sbjct: 248 VAAVGFKCK--RLEIPR-------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E    +P K    + VAVK L    L   K++  E   L NL H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTK--DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------------RKGSLPLPWSIRMKI 245
           +VK  G C + D  ++V+E+M  G L   L               R+    L  S  + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D        V    
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           M    +  PE +M    T++SDV+SFGV+L E+ T
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E     P +    + VAVKTL        K++  E   L NL H +
Sbjct: 21  LGEGAFGKVFLA--ECYNLCPEQ--DKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------FRKGSLP--LPWSIRMKIALG 248
           +VK  G C+E D  ++V+E+M  G L   L           +G+ P  L  S  + IA  
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            A G+ +L   A +  ++RD  T N L+  +   K+ DFG+++D        V    M  
Sbjct: 137 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 193
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             +  PE +M    T++SDV+S GVVL E+ T
Sbjct: 194 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 45/325 (13%)
Query: 122 FMFNDLKLATRNF---------RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 172
           F F D   A R F         + E ++G G FG V  G ++  G   +       VA+K
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREI------FVAIK 67
Query: 173 TLNHDGLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
           TL     +  + ++L+E + +G   HPN++ L G   +    +++ EFM  GSL++ L R
Sbjct: 68  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-R 126
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
           +          + +  G A G+ +L   A+   ++RD    NIL++++   K+SDFGL++
Sbjct: 127 QNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSR 183
Query: 292 DAPEDGKTHVSTRVMG---TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK 347
              +D      T  +G      + APE +     TS SDV+S+G+V+ E+++ G R    
Sbjct: 184 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 243
Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                  N +E          + YRL  P       +       QL   C  +D   RP+
Sbjct: 244 MTNQDVINAIE----------QDYRLPPP-------MDCPSALHQLMLDCWQKDRNHRPK 286
Query: 408 MSEVVETLKPL----QNLKDMASSS 428
             ++V TL  +     +LK MA  S
Sbjct: 287 FGQIVNTLDKMIRNPNSLKAMAPLS 311

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 35  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 145
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 146 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 202
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 96  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 206
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 207 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 38  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 198 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 148
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWM 205
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 42  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 95
Query: 198 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 96  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 152
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 153 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 209
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 210 ALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 38  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 91
Query: 198 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 92  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 148
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 149 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 205
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 206 ALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 198 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           FL   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 FL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 204
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 36  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 146
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWM 203
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 22  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 199 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           +++K  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 314
           H +     I+R+    N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 134 HSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 189
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +        SDV+SFGV L E+LT
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 22  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHE 76
Query: 199 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           +++K  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 77  HIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYL 133
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 314
           H +     I+R+    N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 134 HAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 189
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +        SDV+SFGV L E+LT
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 12/204 (5%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G FG V     E     P++  TG  VAVK L H   +  +++  E+  L +L H N
Sbjct: 21  LGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 75
Query: 200 LVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           +VK  G C    +R   L+ EF+P GSL  +L +K    +     ++      KG+ +L 
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEY 316
               K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V         + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT 340
           +     +  SDV+SFGVVL E+ T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 36  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 89
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 90  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 146
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 147 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 203
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 29  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 82
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 83  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 139
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 196
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 197 ALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 55  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 108
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 109 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 165
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 166 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 222
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 37  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 90
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 91  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 147
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 148 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 204
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 56  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 109
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 110 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 166
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 167 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 223
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 35  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 88
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 89  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 145
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 202
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 203 ALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 144
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 201
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 32  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 198 PNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AAKGLA 254
           PN++ L+G C+  +   L+V  +M  G L N +  +   P   +++  I  G   AKG+ 
Sbjct: 86  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMK 142
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA--PEDGKTHVSTRVMGTYGYA 312
           +L   A K  ++RD    N +LD  +  K++DFGLA+D    E    H  T       + 
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A E + T   T+KSDV+SFGV+L E++T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQFGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDPSQVYELLEKD 226
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 227 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
           N  +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  ++
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 134
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THV 301
           ++      KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                    + APE +     +  SDV+SFGVVL E+ T
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 12/219 (5%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
           N  +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  ++
Sbjct: 21  NMTQFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 75
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 134
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THV 301
           ++      KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V
Sbjct: 135 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                    + APE +     +  SDV+SFGVVL E+ T
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 119
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 120 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 9   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 122
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 123 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 11  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 65
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 66  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 124
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 125 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 181
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 182 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 5   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 59
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 60  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 118
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 119 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 175
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 176 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 4   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 58
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 59  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 117
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 118 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 174
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 175 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 13  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 67
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 68  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 126
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 127 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 183
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 184 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 10  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 64
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 65  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 123
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 124 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 180
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 181 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 119
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 120 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 176
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 6   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 119
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D K     + 
Sbjct: 120 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD-KEFFKVKE 175
Query: 306 MGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            G     + APE +     +  SDV+SFGVVL E+ T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 12  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 66
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 67  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 125
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 126 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 182
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 183 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 37  QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 91
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 92  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 150
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 151 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 207
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/207 (37%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG      V      P   GTG  VAVK L  D G Q    W  E++ L  L H 
Sbjct: 39  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 199 NLVKLVGYCIEDD---QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           +++K  G C ED       LV E++P GSL ++L R     +  +  +  A    +G+A+
Sbjct: 94  HIIKYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAY 149
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAA 313
           LH +     I+RD    N+LLD D   K+ DFGLAK  PE G      R  G     + A
Sbjct: 150 LHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE-GHEXYRVREDGDSPVFWYA 205
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE +        SDV+SFGV L E+LT
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G FG V +G ++    AP K  +   VA+KTL     +  + E+L+E + +G  
Sbjct: 21  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN+++L G        +++ EFM  G+L++ L    G   +   + M    G A G+ 
Sbjct: 75  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM--LRGIASGMR 132
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 311
           +L   AE   ++RD    NIL++++   K+SDFGL++   E+      T  +G      +
Sbjct: 133 YL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
            APE +     TS SD +S+G+V+ E+++ G R           N +E          + 
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QD 239
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           YRL  P               QL   C  +D  ARPR  +VV  L  +
Sbjct: 240 YRLPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 14/217 (6%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 7   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 61
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +K    +     ++ 
Sbjct: 62  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQY 120
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                KG+ +L     K  I+R+  T NIL++ +   K+ DFGL K  P+D K +   + 
Sbjct: 121 TSQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD-KEYYKVKE 176
Query: 306 MGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            G     + APE +     +  SDV+SFGVVL E+ T
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/288 (28%), Positives = 133/288 (46%), Gaps = 34/288 (11%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G FG V +G ++    AP K  +   VA+KTL     +  + E+L+E + +G  
Sbjct: 19  EEVIGAGEFGEVCRGRLK----APGKKES--CVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN+++L G        +++ EFM  G+L++ L    G   +   + M    G A G+ 
Sbjct: 73  EHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGM--LRGIASGMR 130
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGY 311
           +L   AE   ++RD    NIL++++   K+SDFGL++   E+      T  +G      +
Sbjct: 131 YL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
            APE +     TS SD +S+G+V+ E+++ G R           N +E          + 
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE----------QD 237
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           YRL  P               QL   C  +D  ARPR  +VV  L  +
Sbjct: 238 YRLPPPP-------DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 186
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 187 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 229
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 230 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 198
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 29  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 199 NLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           N+VK  G C ED  +   L+ EF+P GSL+ +L  K    +    ++K A+   KG+ +L
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 142
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAP 314
                +  ++RD    N+L+++++  K+ DFGL K    D +  T    R    + Y AP
Sbjct: 143 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 198
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +M       SDV+SFGV L E+LT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +   R+ +    LG+G FG V     E     P++  TG  VAVK L H   +  +++  
Sbjct: 9   QFEERHLKFLQQLGKGNFGSV-----EMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 63
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L +L H N+VK  G C    +R   L+ E++P GSL ++L +  +  +     ++ 
Sbjct: 64  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKLLQY 122
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTR 304
                KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +   V   
Sbjct: 123 TSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEP 179
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 + APE +     +  SDV+SFGVVL E+ T
Sbjct: 180 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 116/231 (50%), Gaps = 30/231 (12%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLN 175
           +QLR     +LK          +LG G FG V+KG WV E  T  +       VA+K LN
Sbjct: 30  AQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKI------PVAIKILN 76
Query: 176 HD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-- 232
              G + + E++ E   + ++ HP+LV+L+G C+    +L V + MP G L  ++     
Sbjct: 77  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKD 135
Query: 233 ---GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
                L L W +++      AKG+ +L E   + +++RD    N+L+ +  + K++DFGL
Sbjct: 136 NIGSQLLLNWCVQI------AKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGL 186
Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           A+    D K + +        + A E +     T +SDV+S+GV + E++T
Sbjct: 187 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 26  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 76  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 134 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 190
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 191 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 233
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 234 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/206 (35%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 198
           LGEG FG      VE     P    TG  VAVK+L  +    H   L  E+  L NL H 
Sbjct: 17  LGEGHFG-----KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 71
Query: 199 NLVKLVGYCIED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           N+VK  G C ED  +   L+ EF+P GSL+ +L  K    +    ++K A+   KG+ +L
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL 130
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAP 314
                +  ++RD    N+L+++++  K+ DFGL K    D +  T    R    + Y AP
Sbjct: 131 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-AP 186
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +M       SDV+SFGV L E+LT
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 25  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 74
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 132
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 189
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 232
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 267 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 316
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 317 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 374
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+R+    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 375 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 431
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 432 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 474
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL--------QNLKDMASSSY 429
                     +K  +L   C   +P  RP  +E+ +  + +        +  K++   + 
Sbjct: 475 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKENL 534
Query: 430 YFQ 432
           YFQ
Sbjct: 535 YFQ 537

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 230
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 188 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 230
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 19  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 68
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 69  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 127 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKF--PIKWTAPESLA 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T G        P+  + L+E          + YR+  P 
Sbjct: 184 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE----------KDYRMERP- 232
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 233 -EG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 34  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 83
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 84  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 141
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 142 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 198
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 199 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 241
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 242 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 129 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 185
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 228
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 139 LLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL 196
           +LG G FG V+KG WV E  T  +       VA+K LN   G + + E++ E   + ++ 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKI------PVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSIRMKIALGAAK 251
           HP+LV+L+G C+    +L V + MP G L  ++          L L W +++      AK
Sbjct: 76  HPHLVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AK 128
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+ +L E   + +++RD    N+L+ +  + K++DFGLA+    D K + +        +
Sbjct: 129 GMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            A E +     T +SDV+S+GV + E++T
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 128/281 (45%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 228 LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 277
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 335
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+R+    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 392
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKD 435
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 29  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 77
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 78  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 135
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 136 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 192
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 241
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 242 -----NCPEELYQLMRLCWKERPEDRP 263

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 239
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 240 -----NCPEELYQLMRLCWKERPEDRP 261

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 30  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 78
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 79  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 136
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 137 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 193
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 242
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 243 -----NCPEELYQLMRLCWKERPEDRP 264

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG      V      P   GTG  VAVK L    G Q    W  E+  L  L H 
Sbjct: 17  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 71
Query: 199 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           ++VK  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYL 128
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 314
           H +     I+R     N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 129 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 184
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +        SDV+SFGV L E+LT
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 22  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 138 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 239
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 240 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 74/206 (35%), Positives = 99/206 (48%), Gaps = 17/206 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG      V      P   GTG  VAVK L    G Q    W  E+  L  L H 
Sbjct: 16  LGEGHFG-----KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHE 70
Query: 199 NLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           ++VK  G C +  ++   LV E++P GSL ++L R     +  +  +  A    +G+A+L
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYL 127
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT--YGYAAP 314
           H +     I+R     N+LLD D   K+ DFGLAK  PE G  +   R  G     + AP
Sbjct: 128 HAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE-GHEYYRVREDGDSPVFWYAP 183
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT 340
           E +        SDV+SFGV L E+LT
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 31  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 79
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 80  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 137
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 138 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 194
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 243
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 244 -----NCPEELYQLMRLCWKERPEDRP 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 136/298 (45%), Gaps = 36/298 (12%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G FG V  G ++  G   +       VA+KTL     +  + ++L+E + +G  
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREI------FVAIKTLKSGYTEKQRRDFLSEASIMGQF 65
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HPN++ L G   +    +++ EFM  GSL++ L R+          + +  G A G+ +
Sbjct: 66  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKY 124
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG---TYGYA 312
           L   A+   ++R     NIL++++   K+SDFGL++   +D      T  +G      + 
Sbjct: 125 L---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           APE +     TS SDV+S+G+V+ E+++ G R           N +E          + Y
Sbjct: 182 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------QDY 231
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL----QNLKDMA 425
           RL  P       +       QL   C  +D   RP+  ++V TL  +     +LK MA
Sbjct: 232 RLPPP-------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMA 282

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 23  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 71
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 72  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 130 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 186
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 235
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 236 -----NCPEELYQLMRLCWKERPEDRP 257

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 22  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 71
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 72  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T  +        + APE +  
Sbjct: 130 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAY 187
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPRL 378
              + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+   
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 230
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                    +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 231 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 27  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 76  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 133
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 134 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 190
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 239
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 240 -----NCPEELYQLMRLCWKERPEDRP 261

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 32/280 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 23  LGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 72
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 73  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-- 130
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +K  I+RD    N L+  ++  K++DFGL++    D  T  +        + APE +  
Sbjct: 131 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAY 188
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPRL 378
              + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+   
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYELLEKDY 231
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                    +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 232 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 26  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 74
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 75  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 132
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 133 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 189
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 238
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 239 -----NCPEELYQLMRLCWKERPEDRP 260

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 22  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 70
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 71  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 129 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINY 185
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 186 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 234
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 235 -----NCPEELYQLMRLCWKERPEDRP 256

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGLA+   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 32/287 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 46  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 101
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL------PWSIR--MKIALGA 249
            N+V L+G C      L++ E+   G L N L RK    L      P  +R  +  +   
Sbjct: 102 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 161
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V        
Sbjct: 162 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 218
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T +SDV+S+G++L E+     S+  N             P +    +
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGILVNSK 263
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 264 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 310

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 122/287 (42%), Gaps = 32/287 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL------PWSIR--MKIALGA 249
            N+V L+G C      L++ E+   G L N L RK    L      P  +R  +  +   
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQV 169
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V        
Sbjct: 170 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 226
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +     T +SDV+S+G++L E+     S+  N             P +    +
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGILVNSK 271
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 318

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 16  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 64
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 65  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 122
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 123 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 179
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 228
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 229 -----NCPEELYQLMRLCWKERPEDRP 250

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVR 197
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 24  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 140 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 241
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 242 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 124
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 125 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 232
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 233 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 29  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 82
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 83  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 141
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 142 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 249
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 250 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 39  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 92
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 93  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 151
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 152 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 259
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 260 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 137/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +PK RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 137/293 (46%), Gaps = 35/293 (11%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           + ++G G FG V+KG ++ +      P     VA+KTL     +  + ++L E   +G  
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVP-----VAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL--GAAKGL 253
            H N+++L G   +    +++ E+M  G+L+  L  K      +S+   + +  G A G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGM 160
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYG 310
            +L   A    ++RD    NIL++++   K+SDFGL++   D PE   T    ++     
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIR 215
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +     TS SDV+SFG+V+ E++T        RP  E +  E  +  + D    
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTY-----GERPYWELSNHEVMKA-INDG--- 266
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
           +RL  P       +       QL  QC  ++   RP+ +++V  L  L    D
Sbjct: 267 FRLPTP-------MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E+M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL +   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 127/287 (44%), Gaps = 34/287 (11%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN+++L G        ++V E+M  GSL+  L    G   +   + M   +GA  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA--GMR 165
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGY 311
           +L   ++   ++RD    N+L+D++   K+SDFGL++   D P+   T    ++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI--PIRW 220
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +     +S SDV+SFGVV+ E+L        N  N         R  +      Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           RL  P       +       QL   C  +D   RPR S++V  L  L
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 122/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 17  LGAGQFGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 65
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 66  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+R+ + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 124 --RNYIHRNLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINY 180
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 229
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 230 -----NCPEELYQLMRLCWKERPEDRP 251

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/301 (27%), Positives = 134/301 (44%), Gaps = 38/301 (12%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN+++L G        ++V E+M  GSL+  L    G   +   + M   +GA  G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA--GMR 165
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGY 311
           +L   ++   ++RD    N+L+D++   K+SDFGL++   D P+   T    ++     +
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI--PIRW 220
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +     +S SDV+SFGVV+ E+L        N  N         R  +      Y
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---------RDVISSVEEGY 271
Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL----QNLKDMASS 427
           RL  P       +       QL   C  +D   RPR S++V  L  L    ++L+  A+ 
Sbjct: 272 RLPAP-------MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
Query: 428 S 428
           S
Sbjct: 325 S 325

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 8   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 55
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 56  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 110
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 111 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKF 166
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 167 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 217
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 218 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 249

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 10  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 57
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 58  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 112
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 113 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 168
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 219
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 220 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 251

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVCEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 195
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 47  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 101
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 239
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 102 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 262
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 263 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 121/267 (45%), Gaps = 32/267 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G  G V+ G+   NG           VAVK+L   G      +LAE N +  L H  
Sbjct: 21  LGAGQAGEVWMGYY--NGHT--------KVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQR 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L    +  +   ++ E+M  GSL + L     + L  +  + +A   A+G+AF+ E 
Sbjct: 70  LVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             +  I+RD + +NIL+    + K++DFGLA+   ED +            + APE +  
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINY 184
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
           G  T KSDV+SFG++L E++T  R       N E          + +  R YR++ P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRPD-- 233
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARP 406
                   ++  QL   C    P+ RP
Sbjct: 234 -----NCPEELYQLMRLCWKERPEDRP 255

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/236 (30%), Positives = 110/236 (46%), Gaps = 35/236 (14%)
Query: 132 RNFRPESL-----LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 186
           R FRP  L     LG+G FG   K    E         TG  + +K L     +  + +L
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFL 55
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV  +  L HPN++K +G   +D +   + E++  G+L   + +      PWS R+  A
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFA 114
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA------KDAPE----- 295
              A G+A+LH      +I+RD  + N L+  + N  ++DFGLA      K  PE     
Sbjct: 115 KDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 296 ---DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
              D K   +  V+G   + APE +       K DV+SFG+VL E++ GR + D +
Sbjct: 172 KKPDRKKRYT--VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPD 224

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 12  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSKKE--ISVAIKTLKVGYTEKQRRDFL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E M  GSL++ L RK          + + 
Sbjct: 66  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGML 124
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 125 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 232
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 233 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 195
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 49  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 103
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 239
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 104 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 264
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 265 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 34/281 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V+ G         V     LTVAVKTL  D ++  +E+L E   +  + HPN
Sbjct: 40  LGGGQYGEVYVG---------VWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPN 89
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    +V E+MP G+L ++L       +   + + +A   +  + +L   
Sbjct: 90  LVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE-- 147
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM 318
            +K  I+RD    N L+  ++  K++DFGL++    D  T H   +      + APE + 
Sbjct: 148 -KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLA 204
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-DKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S                 P+ G D  + Y LL+  
Sbjct: 205 YNTFSIKSDVWAFGVLLWEIATYGMS-----------------PYPGIDLSQVYDLLEKG 247
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                      K  +L   C    P  RP  +E  +  + +
Sbjct: 248 YRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 195
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 239
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 118/297 (39%), Gaps = 44/297 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 195
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 31  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 239
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 86  -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D   
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 246
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 28/293 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   N   + ++G G FG V  G ++     P K    ++VA+KTL     +  + ++L
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLK----LPSK--KEISVAIKTLKVGYTEKQRRDFL 94
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+++L G   +    ++V E M  GSL++ L RK          + + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGML 153
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
            G A G+ +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR  
Sbjct: 154 RGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 307 GT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + +PE +     TS SDV+S+G+VL E+++        RP  E +     +  + 
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSY-----GERPYWEMS----NQDVIK 261
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                YRL  P       +       QL   C  +D   RP+  ++V  L  L
Sbjct: 262 AVDEGYRLPPP-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 38/284 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VAVK +  +G     E+  E   +  L HP 
Sbjct: 16  LGSGQFGVVKLG----------KWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPK 64
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LVK  G C ++    +V E++  G L N+L   G    P S  +++     +G+AFL   
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYDVCEGMAFLESH 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEY 316
                I+RD    N L+D D   K+SDFG+ +   +D   +VS+  +GT     ++APE 
Sbjct: 124 Q---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSS--VGTKFPVKWSAPEV 176
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
                 +SKSDV++FG+++ E+ +  +       N E  L       +    R YR   P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGHRLYR---P 227
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
            L        S    Q+   C    P+ RP   +++ +++PL+ 
Sbjct: 228 HL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 41/293 (13%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEV 189
           NFR E  +G G F  V++     +G         + VA+K +    L   K   + + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDG---------VPVALKKVQIFDLMDAKARADCIKEI 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL 247
           + L  L HPN++K     IED++  +V E    G L   +  F+K    +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L  +H    + V++RD K +N+ + A    KL D GL +      KT  +  ++G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 198
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE +       KSD++S G +L EM                       P  GDK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM------------------AALQSPFYGDK 240
Query: 368 RRFYRLLDPRLEGHF----SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
              Y L     +  +    S   S++  QL   C++ DP+ RP ++ V +  K
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  + H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKIRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKH----------TKVAVKTMK-PGSMSVEAFLAEANVM 237
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L H  LVKL    +  +   ++ EFM +GSL + L        P    +  +   A+G
Sbjct: 238 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +AF+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + 
Sbjct: 297 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWT 352
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 115/233 (49%), Gaps = 29/233 (12%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           VA+Q  +F  +   L  +  +    +G+G FG V  G    N            VAVK +
Sbjct: 177 VAAQ-DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCI 224
Query: 175 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKG 233
            +D     + +LAE + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G
Sbjct: 225 KNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L     +K +L   + + +L        ++RD    N+L+  D  AK+SDFGL K+A
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 294 P---EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
               + GK  V         + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 340 SSTQDTGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 117/278 (42%), Gaps = 29/278 (10%)
Query: 130 ATRN-FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
            T+N FR   +LG+GGFG V    V   G              K          K+ L +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 189 VNFLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           VN          V  + Y  E  D   LV   M  G L+ H++  G    P +  +  A 
Sbjct: 241 VN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               GL  LH E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV G
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-G 347
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE V     T   D ++ G +L EM+ G+    + +   +   VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
               RL+    E  +S + S +A  L +Q L +DP  R
Sbjct: 399 ----RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD   +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 121/293 (41%), Gaps = 38/293 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N+V L+G C      L++ E+   G L N L RK    L +S                +
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V  
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+S+G++L E+     S+  N             P 
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPG 271
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 324

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 16/211 (7%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 16  SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 64
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L H  LVKL    +  +   ++ EFM +GSL + L        P    +  +   A+G
Sbjct: 65  KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +AF+ +   +  I+RD + +NIL+ A    K++DFGLA+   ED +            + 
Sbjct: 124 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWT 179
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 180 APEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 114/230 (49%), Gaps = 29/230 (12%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           VA+Q  +F  +   L  +  +    +G+G FG V  G    N            VAVK +
Sbjct: 5   VAAQ-DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGN-----------KVAVKCI 52
Query: 175 NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKG 233
            +D     + +LAE + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G
Sbjct: 53  KNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 110
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L     +K +L   + + +L        ++RD    N+L+  D  AK+SDFGL K+A
Sbjct: 111 RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167
Query: 294 P---EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + GK  V         + APE +     ++KSDV+SFG++L E+ +
Sbjct: 168 SSTQDTGKLPVK--------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +G L +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVMEYMSKGCLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 31  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 84
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFL 256
           P++VKL+G  IE++   ++ E  P G L ++L R K SL +     +  +L   K +A+L
Sbjct: 85  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 141
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                   ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE 
Sbjct: 142 E---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPES 197
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           +     T+ SDV+ F V + E+L+ G++            ++E      GD+     L  
Sbjct: 198 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCP 252
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 425
           P L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 253 PVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 291

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 117/278 (42%), Gaps = 29/278 (10%)
Query: 130 ATRN-FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
            T+N FR   +LG+GGFG V    V   G              K          K+ L +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 189 VNFLGNLLHPNLVKLVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           VN          V  + Y  E  D   LV   M  G L+ H++  G    P +  +  A 
Sbjct: 241 VN-------SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               GL  LH E    ++YRD K  NILLD   + ++SD GLA   PE G+T +  RV G
Sbjct: 294 EICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE-GQT-IKGRV-G 347
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T GY APE V     T   D ++ G +L EM+ G+    + +   +   VE         
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--------- 398
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
               RL+    E  +S + S +A  L +Q L +DP  R
Sbjct: 399 ----RLVKEVPE-EYSERFSPQARSLCSQLLCKDPAER 431

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 9   SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 56
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 57  MKKLRHEKLVQLYA-VVSEEPIXIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 111
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 112 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKF 167
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 168 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 218
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 219 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 250

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 15  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 68
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFL 256
           P++VKL+G  IE++   ++ E  P G L ++L R K SL +     +  +L   K +A+L
Sbjct: 69  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 125
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                   ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE 
Sbjct: 126 E---SINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 181
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           +     T+ SDV+ F V + E+L+ G++            ++E      GD+     L  
Sbjct: 182 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCP 236
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 425
           P L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 237 PVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 275

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 138/291 (47%), Gaps = 34/291 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
           +LGEG FG V++G V  N       G  + VAVKT   D    +KE +++E   + NL H
Sbjct: 19  ILGEGFFGEVYEG-VYTN-----HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFL 256
           P++VKL+G  IE++   ++ E  P G L ++L R K SL +     +  +L   K +A+L
Sbjct: 73  PHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYL 129
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
                   ++RD    NIL+ +    KL DFGL++   ED   + ++       + +PE 
Sbjct: 130 E---SINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPES 185
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           +     T+ SDV+ F V + E+L+ G++            ++E      GD+     L  
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-----KGDRLPKPDLCP 240
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL-KDMA 425
           P L              L  +C   DP  RPR +E+V +L  +  + KD+A
Sbjct: 241 PVL------------YTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIA 279

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 19  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +G L +  F KG     L LP  + M  A 
Sbjct: 67  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGCLLD--FLKGEMGKYLRLPQLVDM--AA 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 122 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 177
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 178 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 228
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 229 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 12  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 59
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 60  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 114
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 115 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 170
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 171 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 221
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 222 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 253

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 287
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 288 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 343
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 394
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 395 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 28/208 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G FG V  G    N            VAVK + +D     + +LAE + +  L H N
Sbjct: 20  IGKGEFGDVMLGDYRGN-----------KVAVKCIKNDATA--QAFLAEASVMTQLRHSN 66
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   + + +L  
Sbjct: 67  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 126
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVMGTYGYAAPE 315
                 ++RD    N+L+  D  AK+SDFGL K+A    + GK  V         + APE
Sbjct: 127 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--------WTAPE 175
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
            +     ++KSDV+SFG++L E+ +  R
Sbjct: 176 ALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 287
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 288 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 343
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 394
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 395 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 315
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 316 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 370
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 371 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 426
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 477
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 478 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 509

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 26  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-------------PLPWSIRMKIA 246
           +V+  G C E    L+V+E+M  G L   L   G               PL     + +A
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 142 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 198
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-------------PLPWSIRMKIA 246
           +V+  G C E    L+V+E+M  G L   L   G               PL     + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E +   P +    + VAVK L        +++  E   L  L H +
Sbjct: 20  LGEGAFGKVFLA--ECHNLLPEQ--DKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-------------PLPWSIRMKIA 246
           +V+  G C E    L+V+E+M  G L   L   G               PL     + +A
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D        V  R M
Sbjct: 136 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 192
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               +  PE ++    T++SDV+SFGVVL E+ T
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 30/285 (10%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G FG V  G ++  G         L VA+KTL     +  + ++L E + +G  
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRE------LPVAIKTLKVGYTEKQRRDFLGEASIMGQF 80
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLA 254
            HPN++ L G   +    ++V E+M  GSL+  L +  G   +   + M    G + G+ 
Sbjct: 81  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGM--LRGISAGMK 138
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAA 313
           +L   ++   ++RD    NIL++++   K+SDFGL++   +D +   +TR       + A
Sbjct: 139 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTA 195
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +     TS SDV+S+G+V+ E+++        RP  E       +  +      YRL
Sbjct: 196 PEAIAFRKFTSASDVWSYGIVMWEVVSY-----GERPYWEMT----NQDVIKAVEEGYRL 246
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P       +       QL   C  ++  +RP+  E+V  L  L
Sbjct: 247 PSP-------MDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 113/230 (49%), Gaps = 21/230 (9%)
Query: 122 FMFNDLKLATRNF---------RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 172
           F F D   A R F         + E ++G G FG V  G ++  G   +       VA+K
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIK 63
Query: 173 TLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
           TL      +  +++L+E + +G   HPN++ L G   +    +++ E+M  GSL+  L R
Sbjct: 64  TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-R 122
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
           K          + +  G   G+ +L   ++   ++RD    NIL++++   K+SDFG+++
Sbjct: 123 KNDGRFTVIQLVGMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMSR 179
Query: 292 DAPEDGKTHVSTRVMGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              +D +   +TR       + APE +     TS SDV+S+G+V+ E+++
Sbjct: 180 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 108/219 (49%), Gaps = 28/219 (12%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
           L  +  +    +G+G FG V  G              G  VAVK + +D     + +LAE
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLG-----------DYRGNKVAVKCIKNDATA--QAFLAE 49
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
            + +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTR 304
              + + +L        ++RD    N+L+  D  AK+SDFGL K+A    + GK  V   
Sbjct: 110 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
                 + APE +     ++KSDV+SFG++L E+ +  R
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 25  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++R+    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 141 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 243 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/288 (26%), Positives = 128/288 (44%), Gaps = 36/288 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G    N    +K      VAVKT+N    L+   E+L E + +      
Sbjct: 26  LGQGSFGMVYEG----NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--------RKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L+V E M  G L+++L           G  P      +++A   A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+    K  ++R+    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 142 DGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE +  G  T+ SD++SFGVVL E+ +               L E     L +++  
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 243
Query: 371 YRLLDPRLEGHFSIKGS--QKATQLAAQCLSRDPKARPRMSEVVETLK 416
             ++D    G+     +  ++ T L   C   +P  RP   E+V  LK
Sbjct: 244 KFVMDG---GYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 232
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVGEYMSKGSLLD--FLKGETGKYLRLPQLVDM--AA 287
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 288 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 343
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 344 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 394
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 395 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 426

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M   +
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQI 120
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 121 --ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKF 174
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 225
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 226 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 21  LGAGQFGEVWMGYYN-NST---------KVAVKTLKP-GTMSVQAFLEEANLMKTLQHDK 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH 257
           LV+L      ++   ++ E+M +GSL + L     G + LP  I     +  A+G+A++ 
Sbjct: 70  LVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 127
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 128 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 183
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
             G  T KSDV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 120/291 (41%), Gaps = 36/291 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------------PLPWSIRMKI 245
            N+V L+G C      L++ E+   G L N L RK  +             L     +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+S+G++L E+     S+  N             P + 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGIL 271
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
              +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 44/289 (15%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 75
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL             + IA   A+G+
Sbjct: 76  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGM 133
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 134 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 314 PEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRR 369
           PE +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L     
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 249 KVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 16  SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGTMSPEAFLQEAQV 63
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M   +
Sbjct: 64  MKKLRHEKLVQLYA-VVSEEPIYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQI 120
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGLA+   ED +         
Sbjct: 121 --ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEWTARQGAKF 174
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 175 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 225
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  ++P+ RP
Sbjct: 226 ERGYRMPCPP-------ECPESLHDLMCQCWRKEPEERP 257

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 18  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 133
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 134 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 191 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 232
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 233 -QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 42/279 (15%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + R E  LG+G FG V+ G W   NGT          VA+KTL   G    + +L E   
Sbjct: 186 SLRLEVKLGQGCFGEVWMGTW---NGTT--------RVAIKTLK-PGNMSPEAFLQEAQV 233
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIAL 247
           +  L H  LV+L    + ++   +V E+M +GSL +  F KG     L LP  + M  A 
Sbjct: 234 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDM--AA 288
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+A++        ++RD + +NIL+  +   K++DFGL +   ED +         
Sbjct: 289 QIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKF 344
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
              + APE  + G  T KSDV+SFG++L E+ T  R       N         R  L   
Sbjct: 345 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQV 395
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            R YR+  P        +  +    L  QC  +DP+ RP
Sbjct: 396 ERGYRMPCPP-------ECPESLHDLMCQCWRKDPEERP 427

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V+ G+   N T          VAVKTL   G    + +L E N +  L H  
Sbjct: 20  LGAGQFGEVWMGYYN-NST---------KVAVKTLK-PGTMSVQAFLEEANLMKTLQHDK 68
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLH 257
           LV+L     +++   ++ EFM +GSL + L     G + LP  I     +  A+G+A++ 
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI--AEGMAYIE 126
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  I+RD + +N+L+      K++DFGLA+   ED +            + APE +
Sbjct: 127 R---KNYIHRDLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
             G  T KS+V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 122/300 (40%), Gaps = 45/300 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 39  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 94
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL-------------------P 238
            N+V L+G C      L++ E+   G L N L RK    L                   P
Sbjct: 95  ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRP 154
Query: 239 WSIR--MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
             +R  +  +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D
Sbjct: 155 LELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
               V         + APE +     T +SDV+S+G++L E+     S+  N        
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-------- 259
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                P +    +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 260 ---PYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 316

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 16/217 (7%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L     + E ++G G FG V  G ++  G   V       VA+KTL     +  + ++L
Sbjct: 39  ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDV------AVAIKTLKVGYTEKQRRDFL 92
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E + +G   HPN+V L G        ++V EFM  G+L+  L RK          + + 
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQFTVIQLVGML 151
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK---DAPEDGKTHVST 303
            G A G+ +L   A+   ++RD    NIL++++   K+SDFGL++   D PE   T    
Sbjct: 152 RGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGG 208
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           ++     + APE +     TS SDV+S+G+V+ E+++
Sbjct: 209 KI--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 27  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 143 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 241
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 242 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 10  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 64
Query: 192 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
           L  L    +VK   V Y        LV E++P G L + L R  +  L  S  +  +   
Sbjct: 65  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 308
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G  
Sbjct: 124 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQS 179
Query: 309 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 180 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 117/297 (39%), Gaps = 44/297 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE----VNFLGNL 195
           LG G FG V    VE      +K    +TVAVK L        +E L      +++LGN 
Sbjct: 54  LGAGAFGKV----VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 108
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK----------------GSLPLPW 239
            H N+V L+G C      L++ E+   G L N L RK                  L L  
Sbjct: 109 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+    D   
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            V         + APE +     T +SDV+S+G+ L E+ +   S               
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------- 269
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
             P +    +FY+++              +   +   C   DP  RP   ++V+ ++
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 32  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 75
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY     Q  +V ++    SL +HL             + IA   A+G+
Sbjct: 76  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGM 133
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 134 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 314 PEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRR 369
           PE +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L     
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLS 248
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 249 KVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 22/214 (10%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLAEVNFLGNLL 196
           +LGEG FG V +G +++      + GT L VAVKT+  D     +  E+L+E   + +  
Sbjct: 41  ILGEGEFGSVMEGNLKQ------EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 197 HPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIAL 247
           HPN+++L+G CIE   +     +++  FM  G L  +L       G   +P    +K  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A G+ +L   + +  ++RD    N +L  D    ++DFGL+K     G  +   R+  
Sbjct: 155 DIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAK 210
Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + A E +     TSKSDV++FGV + E+ T
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 11  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 65
Query: 192 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
           L  L    +VK   V Y        LV E++P G L + L R  +  L  S  +  +   
Sbjct: 66  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 124
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 308
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G  
Sbjct: 125 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQS 180
Query: 309 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 181 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 23  RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 192 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
           L  L    +VK   V Y        LV E++P G L + L R  +  L  S  +  +   
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 136
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 308
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D K +   R  G  
Sbjct: 137 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD-KDYYVVREPGQS 192
Query: 309 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 121/291 (41%), Gaps = 36/291 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL-LH 197
           LG G FG V    VE       K    L VAVK L        KE L +E+  + +L  H
Sbjct: 54  LGAGAFGKV----VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-------SLPLPWSIR-----MKI 245
            N+V L+G C      L++ E+   G L N L RK        +  +  S       +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D    V    
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+S+G++L E+     S+  N             P + 
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF----SLGLN-----------PYPGIL 271
Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
              +FY+L+    +        +    +   C + +P  RP   ++   L+
Sbjct: 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/307 (25%), Positives = 138/307 (44%), Gaps = 38/307 (12%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQ 180
           F+ ++ ++A         LG+G FG V++G  +  G    +P T   VA+KT+N    ++
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMR 61
Query: 181 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGS 234
              E+L E + +      ++V+L+G   +    L++ E M RG L+++L           
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 121
Query: 235 LPLPWSIRMKIALGA--AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
           +  P S+   I +    A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D
Sbjct: 122 VLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 178
Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
             E        + +    + +PE +  G  T+ SDV+SFGVVL E+ T            
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------------ 226
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMS 409
              L E  +P+ G      ++L   +EG    K         +L   C   +PK RP   
Sbjct: 227 ---LAE--QPYQGLSNE--QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 279
Query: 410 EVVETLK 416
           E++ ++K
Sbjct: 280 EIISSIK 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 138/311 (44%), Gaps = 38/311 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 26  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 142 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 240
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASS 427
            ++L   +EG    K         +L   C   +PK RP   E++ ++K          S
Sbjct: 241 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 299
Query: 428 SYYFQTMQADN 438
            YY +  + +N
Sbjct: 300 FYYSEENKMEN 310

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R+ +  S LG+G FG V     E     P+   TG  VAVK L H G    +++  E+  
Sbjct: 7   RHLKYISQLGKGNFGSV-----ELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 61
Query: 192 LGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
           L  L    +VK   V Y     +  LV E++P G L + L R  +  L  S  +  +   
Sbjct: 62  LKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQI 120
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT- 308
            KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D    V  R  G  
Sbjct: 121 CKGMEYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV-VREPGQS 176
Query: 309 -YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              + APE +     + +SDV+SFGVVL E+ T
Sbjct: 177 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 20  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 136 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 234
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 235 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 127/289 (43%), Gaps = 44/289 (15%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 20  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 63
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL             + IA   A+G+
Sbjct: 64  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGM 121
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 122 DYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178
Query: 314 PEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-RPHLGDKRR 369
           PE +    +   + +SDVY+FG+VL E++TG+  +  +  N    ++E   R  L     
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQIIEMVGRGSLSPDLS 236
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R   P+           +  +L A+CL +    RP    ++  ++ L
Sbjct: 237 KVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 149 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 247
Query: 371 YRLLDPRLEGHFSIKGS---QKATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 248 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 87
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 88  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 145
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 146 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 261
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 262 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 36  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 79
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 80  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 137
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 138 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 253
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 254 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 290

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 27  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 143 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 200 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 241
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 242 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 117
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H   ++ G+  + A
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 233
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 234 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 55  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 171 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 228 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 269
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 270 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 25  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 249
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 250 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 26  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 142 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 199 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 240
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 241 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           + + E  LG G FG V+     ++            VAVKT+   G    + +LAE N +
Sbjct: 183 SLKLEKKLGAGQFGEVWMATYNKHTK----------VAVKTMK-PGSMSVEAFLAEANVM 231
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L H  LVKL    +  +   ++ EFM +GSL + L        P    +  +   A+G
Sbjct: 232 KTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 290
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--G 310
           +AF+ +   +  I+RD + +NIL+ A    K++DFGLA             RV   +   
Sbjct: 291 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLA-------------RVGAKFPIK 334
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           + APE +  G  T KSDV+SFG++L+E++T  R
Sbjct: 335 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 29  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 253
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 254 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 28  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 252
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 253 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 133/289 (46%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+  A K  ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 149 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 247
Query: 371 YRLLDPRLEGHFSIKGS---QKATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 248 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 131/289 (45%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 23  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        + +    
Sbjct: 139 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 196 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 237
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 238 -QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           +GEG FG VF+      G  P +P T   VAVK L  +       ++  E   +    +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----------------------GSL 235
           N+VKL+G C       L++E+M  G L N   R                        G  
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-- 293
           PL  + ++ IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL+++   
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 294 ----PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 DG   +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 227 ADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +S                +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 301
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 302 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 120
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 121 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 140/295 (47%), Gaps = 40/295 (13%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 185
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR  +    P+ +    E +RP + 
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAK----EDSRPPMA 217
Query: 366 DKRRFYRLLD-------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                + LLD       P+L  G FS+    +      +CL ++P  R  + +++
Sbjct: 218 ----IFELLDYIVNEPPPKLPSGVFSL----EFQDFVNKCLIKNPAERADLKQLM 264

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 192
            + E ++G G FG V  G ++  G   +       VA+KTL      +  +++L+E + +
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
           G   HPN++ L G   +    +++ E+M  GSL+  L RK          + +  G   G
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSG 128
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGY 311
           + +L   ++   ++RD    NIL++++   K+SDFG+++   +D +   +TR       +
Sbjct: 129 MKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            APE +     TS SDV+S+G+V+ E+++
Sbjct: 186 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 115/226 (50%), Gaps = 28/226 (12%)
Query: 127 LKLATRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGL 179
           +K+  R F+   L     LG G FG V KG W+ E  +  +       V +K + +  G 
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGR 56
Query: 180 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLP-- 236
           Q  +     +  +G+L H ++V+L+G C     +L V +++P GSL +H+ + +G+L   
Sbjct: 57  QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQ 115
Query: 237 --LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L W +++      AKG+ +L E     +++R+    N+LL +    +++DFG+A   P
Sbjct: 116 LLLNWGVQI------AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            D K  + +       + A E +  G  T +SDV+S+GV + E++T
Sbjct: 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 38/289 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G  +  G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 20  LGQGSFGMVYEGVAK--GVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIALGA--A 250
           ++V+L+G   +    L++ E M RG L+++L           +  P S+   I +    A
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+L+       ++RD    N  +  D+  K+ DFG+ +D  E        + +    
Sbjct: 136 DGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + +PE +  G  T+ SDV+SFGVVL E+ T               L E  +P+ G     
Sbjct: 193 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAE--QPYQGLSNE- 234
Query: 371 YRLLDPRLEGHFSIKGSQ---KATQLAAQCLSRDPKARPRMSEVVETLK 416
            ++L   +EG    K         +L   C   +PK RP   E++ ++K
Sbjct: 235 -QVLRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 40/271 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V+ G W   NG           VA+KTL   G    + +L E   +  L H 
Sbjct: 17  LGNGQFGEVWMGTW---NGNT--------KVAIKTLK-PGTMSPESFLEEAQIMKKLKHD 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG---SLPLPWSIRMKIALGAAKGLAF 255
            LV+L    + ++   +V E+M +GSL + L + G   +L LP  + M  A   A G+A+
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMNKGSLLDFL-KDGEGRALKLPNLVDM--AAQVAAGMAY 120
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +        I+RD +++NIL+      K++DFGLA+   ED +            + APE
Sbjct: 121 IER---MNYIHRDLRSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPE 176
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
             + G  T KSDV+SFG++L E++T  R       N         R  L    R YR+  
Sbjct: 177 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---------REVLEQVERGYRMPC 227
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           P+ +   S+       +L   C  +DP+ RP
Sbjct: 228 PQ-DCPISLH------ELMIHCWKKDPEERP 251

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 120
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 121 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 43  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 86
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 87  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 144
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 145 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 260
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 261 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 297

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 44  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 87
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 88  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 145
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 146 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 261
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 262 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 298

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 18  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 61
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 62  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 119
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 120 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 235
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 236 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 272

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 21  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +                 +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 245
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 246 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 126
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 127 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 23/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVN 190
             R   +LG G FG V KG W+ E  +  +       V +K + +  G Q  +     + 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKI------PVCIKVIEDKSGRQSFQAVTDHML 85
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLP----LPWSIRMKI 245
            +G+L H ++V+L+G C     +L V +++P GSL +H+ + +G+L     L W +++  
Sbjct: 86  AIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI-- 142
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
               AKG+ +L E     +++R+    N+LL +    +++DFG+A   P D K  + +  
Sbjct: 143 ----AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 195
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                + A E +  G  T +SDV+S+GV + E++T
Sbjct: 196 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 116
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 64
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 65  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 122
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 123 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 238
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 239 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 21  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 64
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              H N++  +GY  +  Q  +V ++    SL +HL    +        + IA   A+G+
Sbjct: 65  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGM 122
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  + A
Sbjct: 123 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 314 PEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           PE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L      
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPDLSK 238
Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 239 VRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 275

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 54/294 (18%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIAL 247
              H N++  +GY  +  Q  +V ++    SL +HL      F    L       + IA 
Sbjct: 60  KTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-------IDIAR 111
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 308 TYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           +  + APE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYL 227
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 228 SPDLSKVRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 116
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V    
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 107/209 (51%), Gaps = 12/209 (5%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFL 192
            + E ++G G FG V  G ++  G   +       VA+KTL      +  +++L+E + +
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREI------CVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
           G   HPN++ L G   +    +++ E+M  GSL+  L RK          + +  G   G
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGMLRGIGSG 122
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGY 311
           + +L   ++   ++RD    NIL++++   K+SDFG+++   +D +   +TR       +
Sbjct: 123 MKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW 179
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            APE +     TS SDV+S+G+V+ E+++
Sbjct: 180 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  +  +  H
Sbjct: 36  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------M 243
            N++ L+G C +D    ++ E+  +G+L  +L  +    L +                 +
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D         +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ T   S     P  E          
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---------- 260
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETL 415
                  ++LL    EGH   K S    +L      C    P  RP   ++VE L
Sbjct: 261 ------LFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 26  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 141
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 142 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 241
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 147 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 197
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 198 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 257
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +  
Sbjct: 258 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 311
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 365
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 366 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 394

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 117/240 (48%), Gaps = 25/240 (10%)
Query: 111 EELKVASQLRK----FMFNDLK---LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 163
           EEL++  Q RK    F+    K   L   +F   S LG G  G VFK           KP
Sbjct: 5   EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFK--------VSHKP 56
Query: 164 GTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
            +GL +A K ++ +     + + + E+  L     P +V   G    D +  +  E M  
Sbjct: 57  -SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           GSL+  L + G +P    I  K+++   KGL +L E+ +  +++RD K SNIL+++    
Sbjct: 116 GSLDQVLKKAGRIP--EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEI 171
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           KL DFG++    +     ++   +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 172 KLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 127/294 (43%), Gaps = 54/294 (18%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLG 193
           +G G FG V+KG W  +             VAVK LN        LQ  K    EV  L 
Sbjct: 16  IGSGSFGTVYKGKWHGD-------------VAVKMLNVTAPTPQQLQAFKN---EVGVLR 59
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLPLPWSIRMKIAL 247
              H N++  +GY     Q  +V ++    SL +HL      F    L       + IA 
Sbjct: 60  KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-------IDIAR 111
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 308 TYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           +  + APE +        + +SDVY+FG+VL E++TG+     N  N +  +    R +L
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYL 227
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  R   P+              +L A+CL +    RP   +++ +++ L
Sbjct: 228 SPDLSKVRSNCPK-----------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 250
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 130 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 183
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQ 138
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A          
Sbjct: 139 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRD 193
Query: 304 RVMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 338
             +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 194 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 130 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 183
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQ 138
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A          
Sbjct: 139 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRXIQRRD 193
Query: 304 RVMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 338
             +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 194 XFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 26/220 (11%)
Query: 130 ATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 183
            TR+  PE        LG+G FG V+K   +E         T +  A K ++    +  +
Sbjct: 29  VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELE 79
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           +++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S   
Sbjct: 80  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQ 138
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +       L +LH   +  +I+RD K  NIL   D + KL+DFG++  A          
Sbjct: 139 VVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRD 193
Query: 304 RVMGTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEM 338
             +GT  + APE VM           K+DV+S G+ L+EM
Sbjct: 194 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 118/281 (41%), Gaps = 36/281 (12%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 144 RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 194
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 254
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T  +  
Sbjct: 255 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-- 308
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 362
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 363 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 391

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/283 (30%), Positives = 118/283 (41%), Gaps = 36/283 (12%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           D ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E 
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEV 54
Query: 186 ---LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
              L E   L N  HP L  L       D+   V E+   G L  HL R+       +  
Sbjct: 55  AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF 114
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
               + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T   
Sbjct: 115 YGAEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 168
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
               GT  Y APE +         D +  GVV+ EM+ GR             L+     
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----- 223
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L +  L +DPK R
Sbjct: 224 -LMEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 253

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 121/293 (41%), Gaps = 41/293 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR------------MK 244
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+               + 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
            +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D        
Sbjct: 153 YSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                 + APE +     T +SDV+SFGV+L E+ +                   A P+ 
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYP 252
Query: 365 GDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMK----------IA 246
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D          
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + APE +     T +SDV+SFGV+L E+ +                   A P+ G 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGV 250
Query: 367 K--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 58
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 116
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++    V    
Sbjct: 117 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 173
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 85/291 (29%), Positives = 121/291 (41%), Gaps = 39/291 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQV----IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMK----------IA 246
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+    K           +
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D          
Sbjct: 151 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + APE +     T +SDV+SFGV+L E+ +                   A P+ G 
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGV 250
Query: 367 K--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 251 KIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 121/294 (41%), Gaps = 42/294 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 36  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSI-------------RM 243
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+                +
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
             +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D       
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV+L E+ +                   A P+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPY 251
Query: 364 LGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
           +  ++ R    LG+G FG V +G       AP   G  ++VAVK L  D L   +   ++
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRG----EWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + EVN + +L H NL++L G  +    ++ V E  P GSL + L RK           + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRY 126
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A+  A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++    V    
Sbjct: 127 AVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 306 MGT-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
               + + APE + T   +  SD + FGV L EM T
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 122/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 72  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+ +               
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 188 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 287
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 288 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 114
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 172
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 173 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 226
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 227 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 117/281 (41%), Gaps = 36/281 (12%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 54
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 55  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 114
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T     
Sbjct: 115 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 168
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 222
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 223 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 251

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 111
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D    G        M    +  
Sbjct: 172 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D    G        M    +  
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 38/307 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
           E +   I+RD K +N+LL      KL+DFG+A     D +   +T V GT  + APE + 
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVIK 177
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL 378
                SK+D++S G+  +E+  G     +  P     L+    P             P L
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PTL 224
Query: 379 EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQADN 438
           EG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +    
Sbjct: 225 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRYK 277
Query: 439 TWSIRNS 445
            W    S
Sbjct: 278 RWKAEQS 284

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/281 (29%), Positives = 117/281 (41%), Gaps = 36/281 (12%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E   
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVI--LVKEKAT-------GRYYAMKILKKEVIVAKDEVAH 55
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
            L E   L N  HP L  L       D+   V E+   G L  HL R+       +    
Sbjct: 56  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 115
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             + +A  L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T     
Sbjct: 116 AEIVSA--LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKX 169
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
             GT  Y APE +         D +  GVV+ EM+ GR             L+      L
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L 223
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            ++ RF R L P            +A  L +  L +DPK R
Sbjct: 224 MEEIRFPRTLGP------------EAKSLLSGLLKKDPKQR 252

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 108/216 (50%), Gaps = 18/216 (8%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 55
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 113
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    ++    ++   +
Sbjct: 114 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFV 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 168 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 185
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ PRG +   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 107 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 161
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 162 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 218 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 412 VE 413
           +E
Sbjct: 260 LE 261

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 185
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 40/310 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 30  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 137
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 317
           E +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVI 191
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                 SK+D++S G+  +E+  G     +  P     L+    P             P 
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PT 238
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 437
           LEG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +   
Sbjct: 239 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRY 291
Query: 438 NTWSIRNSKN 447
             W    S +
Sbjct: 292 KRWKAEQSHD 301

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--EVN 190
           +F    +LG+G FG VF            +P +G   A+K L    L+         E +
Sbjct: 29  HFELLKVLGQGSFGKVFLV------RKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            L ++ HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A   
Sbjct: 83  ILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-EL 139
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A GL  LH      +IYRD K  NILLD + + KL+DFGL+K+A +  K   S    GT 
Sbjct: 140 ALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTV 194
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y APE V     +  +D +S+GV++ EMLTG
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 185
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 18/217 (8%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EW 185
           ++L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQI 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKV 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           ++   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 22/224 (9%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 185
           +KL   NF    +LG+G FG V             + GT    A+K L  D +    +  
Sbjct: 16  VKLTDFNFL--MVLGKGSFGKVMLA---------DRKGTEELYAIKILKKDVVIQDDDVE 64
Query: 186 --LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
             + E   L  L  P  +  +  C +   RL  V E++  G L  H+ + G    P ++ 
Sbjct: 65  CTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 124
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A   + GL FLH+     +IYRD K  N++LD++ + K++DFG+ K+   DG T  +
Sbjct: 125 Y--AAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--T 177
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
               GT  Y APE +         D +++GV+L EML G+   D
Sbjct: 178 REFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +  L H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 94
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 313
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 314 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 421 L 421
           L
Sbjct: 365 L 365

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 30  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 254
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 255 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 421 L 421
           L
Sbjct: 306 L 306

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 20/216 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENG--TAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           K + ++F+    LG G FG V       NG   A       + V +K + H         
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
             E   L  + HP ++++ G   +  Q  ++ +++  G L + L +    P P  +    
Sbjct: 55  -DERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP--VAKFY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A      L +LH    K +IYRD K  NILLD + + K++DFG AK  P+     V+  +
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXL 163
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GT  Y APE V T       D +SFG+++ EML G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           +L   +F   S LG G  G VFK           KP +GL +A K ++ +     + + +
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFK--------VSHKP-SGLVMARKLIHLEIKPAIRNQII 71
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E+  L     P +V   G    D +  +  E M  GSL+  L + G +P    I  K++
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP--EQILGKVS 129
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           +   KGL +L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +
Sbjct: 130 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFV 183
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           GT  Y +PE +   H + +SD++S G+ L+EM  GR
Sbjct: 184 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------------- 235
           HP+++KL G C +D   LL+ E+   GSL   L     +                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 236 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 355 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 414 TLKPL 418
            L+ +
Sbjct: 305 DLEKM 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------------- 235
           HP+++KL G C +D   LL+ E+   GSL   L     +                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 236 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 355 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 414 TLKPL 418
            L+ +
Sbjct: 305 DLEKM 309

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 35  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 259
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 260 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 421 L 421
           L
Sbjct: 311 L 311

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 135/308 (43%), Gaps = 40/308 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            + K  G  ++D +  ++ E++  GS  + L   G  PL  +    I     KGL +LH 
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATILREILKGLDYLHS 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 317
           E +   I+RD K +N+LL      KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVI 176
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                 SK+D++S G+  +E+  G     +  P     L+    P             P 
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-------------PT 223
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 437
           LEG++    S+   +    CL+++P  RP   E+++    L+N K    +SY  + +   
Sbjct: 224 LEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK---KTSYLTELIDRY 276
Query: 438 NTWSIRNS 445
             W    S
Sbjct: 277 KRWKAEQS 284

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 32  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 256
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 257 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 421 L 421
           L
Sbjct: 308 L 308

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 134 FRPES-----LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
            RPE      +LG+GG+G VF+  V +   A       + V  K +     +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
            N L  + HP +V L+ Y  +   +L L+ E++  G L   L R+G      +      +
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG   V+    G
Sbjct: 131 SMA--LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCG 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +M        D +S G ++ +MLTG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 94/207 (45%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +  L H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 108
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 108/239 (45%), Gaps = 26/239 (10%)
Query: 112 ELKVASQLRKFMFND----LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL 167
           E K A+ + KF  N     +KL   NF    +LG+G FG V             + GT  
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTDFNFL--MVLGKGSFGKVM---------LSERKGTDE 367
Query: 168 TVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRG 223
             AVK L  D +    +    + E   L     P  +  +  C +   RL  V E++  G
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 224 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
            L  H+ + G    P ++    A   A GL FL     K +IYRD K  N++LD++ + K
Sbjct: 428 DLMYHIQQVGRFKEPHAVFY--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIK 482
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           ++DFG+ K+   DG T  +    GT  Y APE +         D ++FGV+L EML G+
Sbjct: 483 IADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 16/214 (7%)
Query: 134 FRPES-----LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
            RPE      +LG+GG+G VF+  V +   A       + V  K +     +      AE
Sbjct: 14  IRPECFELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
            N L  + HP +V L+ Y  +   +L L+ E++  G L   L R+G      +      +
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEI 130
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG   V+    G
Sbjct: 131 SMA--LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCG 183
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +M        D +S G ++ +MLTG
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 127/301 (42%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   +++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 121/295 (41%), Gaps = 43/295 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNFLGNL-LH 197
           LG G FG V    +E +     K  T  TVAVK L        H+  ++E+  L ++  H
Sbjct: 37  LGRGAFGQV----IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 198 PNLVKLVGYCIEDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIR-------------- 242
            N+V L+G C +    L+V  EF   G+L  +L  K +  +P+                 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHL 152
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 153 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
                   + APE +     T +SDV+SFGV+L E+ +                   A P
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASP 252
Query: 363 HLGDK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + G K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 253 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWL 186
           L     R   +LG G FG V+KG W+      P      + VA+K L  +   + +KE L
Sbjct: 14  LKETELRKVKVLGSGAFGTVYKGIWI------PDGENVKIPVAIKVLRENTSPKANKEIL 67
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF----RKGSLPLPWSIR 242
            E   +  +  P + +L+G C+    +L V + MP G L +H+     R GS  L     
Sbjct: 68  DEAYVMAGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDL----- 121
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +   +  AKG+++L +     +++RD    N+L+ +  + K++DFGLA+    D   + +
Sbjct: 122 LNWCMQIAKGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 178
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                   + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 DGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 130/305 (42%), Gaps = 52/305 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTG--LTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           LGEG FG V K       TA    G     TVAVK L  +      ++ L+E N L  + 
Sbjct: 31  LGEGEFGKVVKA------TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------------- 235
           HP+++KL G C +D   LL+ E+   GSL   L     +                     
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 236 -PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
             L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  
Sbjct: 145 RALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY 201
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E+      ++      + A E +     T++SDV+SFGV+L E++T    +  N      
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----LGGN------ 251
Query: 355 NLVEWARPHLG-DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  P+ G    R + LL            S++  +L  QC  ++P  RP  +++ +
Sbjct: 252 -------PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304
Query: 414 TLKPL 418
            L+ +
Sbjct: 305 DLEKM 309

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 54
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 55  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 113
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  + 
Sbjct: 114 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 167
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 362
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 168 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 220
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 221 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 250

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 120
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 257 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 181 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 118/293 (40%), Gaps = 49/293 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTA--PVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNL 195
           +LG G FG V       N TA    K G  + VAVK L        +E L +E+  +  L
Sbjct: 52  VLGSGAFGKVM------NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 196 -LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------FRKGSLP------------ 236
             H N+V L+G C       L++E+   G L N+L      F +  +             
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 237 ---LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
              L +   +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGLA+D 
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
             D    V         + APE +  G  T KSDV+S+G++L E+     S+  N     
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF----SLGVN----- 273
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                   P +     FY+L+    +       +++   +   C + D + RP
Sbjct: 274 ------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 129 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 179
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  + 
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 362
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 126 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 8   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 56
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 57  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 115
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 116 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 170
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 110
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 257 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 171 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 57
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +S    
Sbjct: 118 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS---- 168
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 220
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 221 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 109/222 (49%), Gaps = 30/222 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSI 241
           + E++ L  L HPN+VKL+     +++  LV+EF+   S++   F   S    +PLP  +
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLP--L 107
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
                    +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ 
Sbjct: 108 IKSYLFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 164
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
              V  T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 165 HEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 136/301 (45%), Gaps = 41/301 (13%)
Query: 129 LATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           L  ++  PE L      +G+G FG VFKG   +N T  V       VA+K ++ +  +  
Sbjct: 18  LYFQSMDPEELFTKLEKIGKGSFGEVFKGI--DNRTQKV-------VAIKIIDLEEAEDE 68
Query: 183 KEWLA-EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSI 241
            E +  E+  L     P + K  G  ++D +  ++ E++  GS  + L   G  PL  + 
Sbjct: 69  IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQ 125
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
              I     KGL +LH E +   I+RD K +N+LL      KL+DFG+A     D +   
Sbjct: 126 IATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKR 181
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
           +T V GT  + APE +      SK+D++S G+  +E+  G     +  P     L+    
Sbjct: 182 NTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 240
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL 421
           P             P LEG++    S+   +    CL+++P  RP   E+++    L+N 
Sbjct: 241 P-------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 283
Query: 422 K 422
           K
Sbjct: 284 K 284

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 22  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 75
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 76  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 134
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 135 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 185
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 186 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T    
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 163
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 362
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 117/284 (41%), Gaps = 39/284 (13%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           D K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E 
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEV 54
Query: 186 ---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI 241
              + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       + 
Sbjct: 55  AHTVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR 113
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
                + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  
Sbjct: 114 FYGAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 166
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
                GT  Y APE +         D +  GVV+ EM+ GR             L+    
Sbjct: 167 MKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---- 222
Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
             L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 223 --LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 252

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 39/310 (12%)
Query: 107 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 166
           P+ + E ++AS+ +       + A  +F     LG+G FG V+    ++         + 
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SK 59
Query: 167 LTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 223
             +A+K L    L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 224 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           ++   L +        +      L  A  L++ H    K VI+RD K  N+LL +    K
Sbjct: 120 TVYRELQKLSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELK 174
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           ++DFG +  AP   +    T + GT  Y  PE +       K D++S GV+  E L G+ 
Sbjct: 175 IADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
             + N     +  +                   R+E  F    ++ A  L ++ L  +P 
Sbjct: 231 PFEANTYQETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 404 ARPRMSEVVE 413
            RP + EV+E
Sbjct: 273 QRPMLREVLE 282

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 100
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 161 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 30/222 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS----LPLPWSI 241
           + E++ L  L HPN+VKL+     +++  LV+EF+   S++   F   S    +PLP   
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIK 107
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
                L   +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ 
Sbjct: 108 SYLFQL--LQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
              V  T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 163 HEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 120/283 (42%), Gaps = 41/283 (14%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T  + 
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT- 164
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 362
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 165 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 85
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 146 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THE 164
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           + T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T    
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 163
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWARP 362
              GT  Y APE +         D +  GVV+ EM+ GR        N +H  L E    
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF----YNQDHERLFELI-- 217
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
            L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 -LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 94
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 257 HEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 13  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 66
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 126 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 176
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 177 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 18  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 71
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 72  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 130
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 131 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 181
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 182 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ PRG +   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQK 106
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 107 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 161
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +      + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 162 HAPSSRR----XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 218 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 412 VE 413
           +E
Sbjct: 260 LE 261

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 177
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 37  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 90
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 91  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 149
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 150 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 200
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 201 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 109/242 (45%), Gaps = 24/242 (9%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN---HDGLQGHKE 184
           K+    ++    LG GG   V   ++ E+    +K      VA+K +     +  +  K 
Sbjct: 7   KIINERYKIVDKLGGGGMSTV---YLAEDTILNIK------VAIKAIFIPPREKEETLKR 57
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
           +  EV+    L H N+V ++    EDD   LV E++   +L  ++   G L +  +I   
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             +    G+   H+     +++RD K  NIL+D++   K+ DFG+AK   E   T  +  
Sbjct: 118 NQI--LDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNH 171
Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           V+GT  Y +PE          +D+YS G+VL EML G         NGE   V  A  H+
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF-----NGE-TAVSIAIKHI 225
Query: 365 GD 366
            D
Sbjct: 226 QD 227

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L++ +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 11  NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 59
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 60  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 118
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 119 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 173
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 108
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 15  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 68
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 128 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 178
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 179 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++  +  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVI--LVREKAT-------GRYYAMKILRKEVIIAKDEVAH 51
Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+       +   
Sbjct: 52  TVTESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY 110
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
              + +A  L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T    
Sbjct: 111 GAEIVSA--LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MK 163
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
              GT  Y APE +         D +  GVV+ EM+ GR             L+      
Sbjct: 164 XFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------ 217
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L ++ RF R L P            +A  L A  L +DPK R
Sbjct: 218 LMEEIRFPRTLSP------------EAKSLLAGLLKKDPKQR 247

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 5   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 48
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 109 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 164 PSSRR----TTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPXLREVLE 261

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 51
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 110
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 111 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 167
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 53
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 112
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 113 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 169
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 170 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 123/304 (40%), Gaps = 67/304 (22%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +F+   L+G GGFG VFK     +G          T  +K + ++  +  +E    V  L
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIKRVKYNNEKAERE----VKAL 58
Query: 193 GNLLHPNLVKLVG------YCIEDDQR----------LLVYEFMPRGSLENHLFRKGSLP 236
             L H N+V   G      Y  E   +           +  EF  +G+LE  + ++    
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L   + +++     KG+ ++H    K +I RD K SNI L      K+ DFGL      D
Sbjct: 119 LDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           GK     R  GT  Y +PE + +     + D+Y+ G++L E+L                 
Sbjct: 176 GK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL----------------- 215
Query: 357 VEWARPHLGD-----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 H+ D      + F  L D  +   F     +K   L  + LS+ P+ RP  SE+
Sbjct: 216 ------HVCDTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 412 VETL 415
           + TL
Sbjct: 266 LRTL 269

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 10/207 (4%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V      P    + L VAVKTL      Q   ++L E   +    H 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDP----SPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQ 108
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSIRMKIALGAAKGLAF-L 256
           N+V+ +G  ++   R ++ E M  G L++ L      P  P S+ M   L  A+ +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
               E   I+RD    N LL        AK+ DFG+A+D             M    +  
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           PE  M G  TSK+D +SFGV+L E+ +
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 50
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 109
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 110 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 17  SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 60
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 120
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 121 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 175
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 176 PSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 231
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 232 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 273

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 49
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +    
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY 108
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 109 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 165
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 59
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 118
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 119 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 412 VE 413
           +E
Sbjct: 258 LE 259

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL----GAAKGLA 254
           N+V+L+G C +     +V E +  G     L  +G+      +R+K  L     AA G+ 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGME 227
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAA 313
           +L     K  I+RD    N L+      K+SDFG++++   DG    S  +      + A
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVXAASGGLRQVPVKWTA 283
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY-- 371
           PE +  G  +S+SDV+SFG++L E  +   S   N  N +              R F   
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEK 330
Query: 372 --RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
             RL  P L             +L  QC + +P  RP  S + + L+ ++ 
Sbjct: 331 GGRLPCPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 3   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 46
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 47  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 106
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 107 LSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 161
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 162 HAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 218 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 259
Query: 412 VE 413
           +E
Sbjct: 260 LE 261

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 5   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 53
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 54  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 112
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V  T
Sbjct: 113 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--T 167
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 1   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 44
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 105 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 160 PSSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 216 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 5   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 48
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 109 KFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 164 PSSRRTDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 219
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 261

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAE 188
           ++  F+    LG G +  V+KG         +   TG+ VA+K +  D  +G     + E
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG---------LNKTTGVYVALKEVKLDSEEGTPSTAIRE 53
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK--GSLP--LPWSIRMK 244
           ++ +  L H N+V+L      +++  LV+EFM    L+ ++  +  G+ P  L  ++   
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                 +GLAF HE     +++RD K  N+L++     KL DFGLA+       T  S  
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 305 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           V  T  Y AP+ +M     S S D++S G +L EM+TG+
Sbjct: 170 V--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 27  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +VKL+G    D +  ++ EF P G+++  +           I++ +     + L FLH  
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH-- 134
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K +I+RD K  N+L+  + + +L+DFG++  A            +GT  + APE VM 
Sbjct: 135 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 320 GHLTS-----KSDVYSFGVVLLEM 338
             +       K+D++S G+ L+EM
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 4   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 52
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+EF+    L+  +       +P  +       
Sbjct: 53  ISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GL+F H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 112 LLQGLSFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 166
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           +G G FG VF G +  + T          VAVK+         K ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL----GAAKGLA 254
           N+V+L+G C +     +V E +  G     L  +G+      +R+K  L     AA G+ 
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGME 227
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT-YGYAA 313
           +L     K  I+RD    N L+      K+SDFG++++   DG    S  +      + A
Sbjct: 228 YLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTA 283
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY-- 371
           PE +  G  +S+SDV+SFG++L E  +   S   N  N +              R F   
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------------TREFVEK 330
Query: 372 --RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
             RL  P L             +L  QC + +P  RP  S + + L+ ++ 
Sbjct: 331 GGRLPCPEL-------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +    T + 
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/301 (25%), Positives = 126/301 (41%), Gaps = 43/301 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNL-LH 197
           LGEG FG V     E  G    KP   +TVAVK L  D  +    + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-----------FRKGSLP---LPWSIRM 243
            N++ L+G C +D    ++  +  +G+L  +L           +    +P   + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D         +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     T +SDV+SFGV++ E+ T   S     P  E          
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---------- 267
Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA---QCLSRDPKARPRMSEVVETLKPLQN 420
                  ++LL    EGH   K +    +L      C    P  RP   ++VE L  +  
Sbjct: 268 ------LFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 421 L 421
           L
Sbjct: 319 L 319

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G FG V+K   +E         TG   A K +     +  ++++ E+  L    HP 
Sbjct: 19  LGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +VKL+G    D +  ++ EF P G+++  +           I++ +     + L FLH  
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLH-- 126
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K +I+RD K  N+L+  + + +L+DFG++  A            +GT  + APE VM 
Sbjct: 127 -SKRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWMAPEVVMC 183
Query: 320 GHLTS-----KSDVYSFGVVLLEM 338
             +       K+D++S G+ L+EM
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 117 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 412 VE 413
           +E
Sbjct: 258 LE 259

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 131/291 (45%), Gaps = 44/291 (15%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V+KG W   +G   VK      + V     +  Q  +    EV  L    H 
Sbjct: 44  IGSGSFGTVYKGKW---HGDVAVK-----ILKVVDPTPEQFQAFRN---EVAVLRKTRHV 92
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N++  +GY  +D+   +V ++    SL  HL  + +    + + + IA   A+G+ +LH 
Sbjct: 93  NILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTAQGMDYLHA 150
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              K +I+RD K++NI L      K+ DFGLA        +    +  G+  + APE + 
Sbjct: 151 ---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIR 207
Query: 319 TGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL- 374
                  + +SDVYS+G+VL E++TG                E    H+ ++ +   ++ 
Sbjct: 208 MQDNNPFSFQSDVYSYGIVLYELMTG----------------ELPYSHINNRDQIIFMVG 251
Query: 375 ----DPRLEGHFSIKGSQKATQ-LAAQCLSRDPKARPRMSEVVETLKPLQN 420
                P L   +  K   KA + L A C+ +  + RP   +++ +++ LQ+
Sbjct: 252 RGYASPDLSKLY--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 55
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 115
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +    T + 
Sbjct: 116 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 166
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 218
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 219 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 255

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 188
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A 
Sbjct: 83  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 133
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 188
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 60
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 120
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +    T + 
Sbjct: 121 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 171
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 223
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 224 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 260

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 188
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 25  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A 
Sbjct: 83  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 133
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 188
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    E+N        +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLA-REKN--------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 117 L--ANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           NF+    +GEG +G V+K   +  G         L    + +    ++       E++ L
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 56
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L HPN+VKL+     +++  LV+EF+    L+  +       +P  +         +G
Sbjct: 57  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           LAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T  Y 
Sbjct: 116 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 170
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   + ++  D++S G +  EM+T R
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           NF+    +GEG +G V+K   +  G         L    + +    ++       E++ L
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-------EISLL 55
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L HPN+VKL+     +++  LV+EF+    L+  +       +P  +         +G
Sbjct: 56  KELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQG 114
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           LAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T  Y 
Sbjct: 115 LAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYR 169
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
           APE ++   + ++  D++S G +  EM+T R
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 39/310 (12%)
Query: 107 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 166
           P+ + E ++AS+ +       + A  +F     LG+G FG V+    ++         + 
Sbjct: 9   PENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQ---------SK 59
Query: 167 LTVAVKTLNHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 223
             +A+K L    L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G
Sbjct: 60  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 119
Query: 224 SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
           ++   L +        +      L  A  L++ H    K VI+RD K  N+LL +    K
Sbjct: 120 TVYRELQKLSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELK 174
Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           ++DFG +  AP   +  +     GT  Y  PE +       K D++S GV+  E L G+ 
Sbjct: 175 IADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 230
Query: 344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPK 403
             + N     +  +                   R+E  F    ++ A  L ++ L  +P 
Sbjct: 231 PFEANTYQETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 404 ARPRMSEVVE 413
            RP + EV+E
Sbjct: 273 QRPMLREVLE 282

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 21/214 (9%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTV----AVKTLNHDGLQGHKEWLAE 188
            F    +LG+G FG VF   V++   +  +    + V     +K  +    +  ++ L E
Sbjct: 26  QFELLKVLGQGSFGKVF--LVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 83
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           VN      HP +VKL  Y  + + +L L+ +F+  G L   L  K  +     ++  +A 
Sbjct: 84  VN------HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA- 134
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             A  L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K   S    G
Sbjct: 135 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 189
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE V     T  +D +SFGV++ EMLTG
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 22/220 (10%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW- 185
           +KL   NF    +LG+G FG V             + GT    AVK L  D +    +  
Sbjct: 17  MKLTDFNFL--MVLGKGSFGKV---------MLSERKGTDELYAVKILKKDVVIQDDDVE 65
Query: 186 --LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
             + E   L     P  +  +  C +   RL  V E++  G L  H+ + G    P ++ 
Sbjct: 66  CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
              A   A GL FL     K +IYRD K  N++LD++ + K++DFG+ K+   DG T  +
Sbjct: 126 Y--AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--T 178
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
               GT  Y APE +         D ++FGV+L EML G+
Sbjct: 179 KXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 129/295 (43%), Gaps = 60/295 (20%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWLAEVNFLGNL 195
           + ++G+G FG V+ G   +     ++       A+K+L+    +Q  + +L E   +  L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQ------CAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 196 LHPNLVKLVGYCIEDD---QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG--AA 250
            HPN++ L+G  +  +     LL Y  M  G L   +      P   +++  I+ G   A
Sbjct: 80  NHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNP---TVKDLISFGLQVA 134
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE----DGKTHVSTRVM 306
           +G+ +L   AE+  ++RD    N +LD  +  K++DFGLA+D  +      + H   R+ 
Sbjct: 135 RGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL- 190
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
               + A E + T   T+KSDV+SFGV+L E+LT      +  P                
Sbjct: 191 -PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT------RGAPP--------------- 228
Query: 367 KRRFYRLLDPRLEGHFSIKGSQ---------KATQLAAQCLSRDPKARPRMSEVV 412
               YR +DP    HF  +G +            Q+  QC   DP  RP    +V
Sbjct: 229 ----YRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV 279

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 9   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 62
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 63  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 121
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      A+G+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 122 QI------AEGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 172
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 173 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 128/317 (40%), Gaps = 80/317 (25%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +F+   L+G GGFG VFK     +G          T  ++ + ++  +  +E    V  L
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGK---------TYVIRRVKYNNEKAERE----VKAL 59
Query: 193 GNLLHPNLVKLVGYCIE---------DDQR---------------------LLVYEFMPR 222
             L H N+V   G C +         DD                        +  EF  +
Sbjct: 60  AKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           G+LE  + ++    L   + +++     KG+ ++H    K +I+RD K SNI L      
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQV 175
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           K+ DFGL      DGK    TR  GT  Y +PE + +     + D+Y+ G++L E+L   
Sbjct: 176 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL--- 229
Query: 343 RSMDKNRPNGEHNLVEWARPHLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
                               H+ D      +F+   D R +G  S    +K   L  + L
Sbjct: 230 --------------------HVCDTAFETSKFF--TDLR-DGIISDIFDKKEKTLLQKLL 266
Query: 399 SRDPKARPRMSEVVETL 415
           S+ P+ RP  SE++ TL
Sbjct: 267 SKKPEDRPNTSEILRTL 283

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+  L      + +KE L
Sbjct: 46  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIMELREATSPKANKEIL 99
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 159 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 209
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 210 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 141/326 (43%), Gaps = 57/326 (17%)
Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 182
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 24  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 69
Query: 183 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------ 235
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L +   L      
Sbjct: 70  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 129
Query: 236 --------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 287
                    L     +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DF
Sbjct: 130 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 186
Query: 288 GLAKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           GL++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+
Sbjct: 187 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SL 237
Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                 G      + +   G     YRL  P       +    +   L  QC    P  R
Sbjct: 238 GGTPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYER 285
Query: 406 PRMSEVVETL-KPLQNLKDMASSSYY 430
           P  ++++ +L + L+  K   +++ Y
Sbjct: 286 PSFAQILVSLNRMLEERKTYVNTTLY 311

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 16  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 69
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L++ + MP G L +++            L W +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 129 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 179
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 180 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 115/257 (44%), Gaps = 30/257 (11%)
Query: 165 TGLTVAVKTLNHDG-LQGHKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  +AVK +   G  + +K  L +++  L +   P +V+  G  I +    +  E M  
Sbjct: 49  TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-- 106
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA 282
           G+    L ++   P+P  I  K+ +   K L +L E+    VI+RD K SNILLD     
Sbjct: 107 GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQI 164
Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLE 337
           KL DFG++    +D       R  G   Y APE +     T      ++DV+S G+ L+E
Sbjct: 165 KLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 338 MLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQ 396
           + TG+      + + E    V    P             P L GH    G  ++      
Sbjct: 222 LATGQFPYKNCKTDFEVLTKVLQEEP-------------PLLPGHMGFSGDFQS--FVKD 266
Query: 397 CLSRDPKARPRMSEVVE 413
           CL++D + RP+ ++++E
Sbjct: 267 CLTKDHRKRPKYNKLLE 283

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 182
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 141/326 (43%), Gaps = 57/326 (17%)
Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 182
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 14  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 59
Query: 183 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------ 235
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L +   L      
Sbjct: 60  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 119
Query: 236 --------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 287
                    L     +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DF
Sbjct: 120 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 176
Query: 288 GLAKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           GL++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+
Sbjct: 177 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SL 227
Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                 G      + +   G     YRL  P       +    +   L  QC    P  R
Sbjct: 228 GGTPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYER 275
Query: 406 PRMSEVVETL-KPLQNLKDMASSSYY 430
           P  ++++ +L + L+  K   +++ Y
Sbjct: 276 PSFAQILVSLNRMLEERKTYVNTTLY 301

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +L  G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFGLAK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 14  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 67
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 68  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 127 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 177
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 178 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 23  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 77  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 133
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 134 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 189
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 190 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 244
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 245 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 46  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 99
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 100 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 156
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 157 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 212
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 213 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 267
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 268 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 21  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 74
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 75  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 131
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 132 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 187
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 188 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 242
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 243 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 19  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 72
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 73  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 132 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 182
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 183 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 20  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 73
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 74  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 130
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 131 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 186
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 187 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 241
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 242 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 197 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 168
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 169 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPE 223
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 373
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 274
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 275 LEKQIRIPRSL--SVKAASVLKSFLNKDPKER 304

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 2   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 45
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 106 KFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 160
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +  +     GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 161 PSSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 2   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 45
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K+++FG +  A
Sbjct: 106 KFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHA 160
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +    T + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 161 PSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 216
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 258

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 129 LATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNH-DGLQGHKEWL 186
           L    F+   +LG G FG V+KG W+ E     +       VA+K L      + +KE L
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI------PVAIKELREATSPKANKEIL 65
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-----GSLPLPWSI 241
            E   + ++ +P++ +L+G C+    +L+  + MP G L +++            L W +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++      AKG+ +L +   + +++RD    N+L+    + K++DFG AK    + K + 
Sbjct: 125 QI------AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYH 175
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +        + A E ++    T +SDV+S+GV + E++T
Sbjct: 176 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++             +A+K L    L+      +  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRK---------FILALKVLFKAQLEKAGVEHQLR 53
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 113
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     
Sbjct: 114 L--ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---- 164
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 216
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 217 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 253

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 187
           +F+  +LLG+G F  V++              TGL VA+K ++   +  +K  +      
Sbjct: 12  DFKVGNLLGKGSFAGVYRAE---------SIHTGLEVAIKMIDKKAM--YKAGMVQRVQN 60
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV     L HP++++L  Y  + +   LV E    G +  +L  +   P   +       
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMH 119
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               G+ +LH      +++RD   SN+LL  + N K++DFGLA       + H +  + G
Sbjct: 120 QIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCG 174
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE         +SDV+S G +   +L GR   D +      N V  A       
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA------- 227
Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  D  +    SI    +A  L  Q L R+P  R  +S V++
Sbjct: 228 -------DYEMPSFLSI----EAKDLIHQLLRRNPADRLSLSSVLD 262

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/247 (26%), Positives = 113/247 (45%), Gaps = 30/247 (12%)
Query: 112 ELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV 171
           E+ + +Q ++    ++ L+   F  E  LGE  FG V+KG +   G AP +      VA+
Sbjct: 8   EMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAI 61
Query: 172 KTLNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL 229
           KTL  D  +G   +E+  E      L HPN+V L+G   +D    +++ +   G L   L
Sbjct: 62  KTLK-DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
Query: 230 FR----------------KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
                             K +L  P  + +   + A  G+ +L   +   V+++D  T N
Sbjct: 121 VMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRN 175
Query: 274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           +L+    N K+SD GL ++        +    +    + APE +M G  +  SD++S+GV
Sbjct: 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGV 235
Query: 334 VLLEMLT 340
           VL E+ +
Sbjct: 236 VLWEVFS 242

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 186
           +KL   +F    +LG+G FG VF         A  K  T    A+K L  D +    +  
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVF--------LAEFK-KTNQFFAIKALKKDVVLMDDD-- 61
Query: 187 AEVNFLGNLL------HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
            E   +   +      HP L  +       +    V E++  G L  H+  +       S
Sbjct: 62  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLS 119
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKT 299
                A     GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT
Sbjct: 120 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 176
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +      GT  Y APE ++        D +SFGV+L EML G+
Sbjct: 177 N---EFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 197 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 80  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 136
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 137 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPE 191
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 373
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 242
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 243 LEKQIRIPRSM--SVKAASVLKSFLNKDPKER 272

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 15  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 69  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 125
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 181
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 182 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 237 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 197 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 125
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LHE     +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPE 180
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 373
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 231
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 232 LEKQIRIPRSL--SVKAASVLKSFLNKDPKER 261

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 21/236 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N L++     K+SDFGL++   +D +T  S        ++ PE +M 
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMY 195
Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K+++FG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSV 159
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +T +     GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRRTTLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 412 VE 413
           +E
Sbjct: 258 LE 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   L VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--LAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 184
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 197 HPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           HP LV L   C + + RL  V E++  G L  H+ R+  LP   +      +  A  L +
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNY 121
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T  ++   GT  Y APE
Sbjct: 122 LHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPE 176
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRL 373
            +         D ++ GV++ EM+ GR   D   +  N + N  ++          F  +
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------FQVI 227
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           L+ ++    S+  S KA  +    L++DPK R
Sbjct: 228 LEKQIRIPRSL--SVKAASVLKSFLNKDPKER 257

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 123/291 (42%), Gaps = 34/291 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 196
           L+GEG +G V K   ++         TG  VA+K    + D     K  + E+  L  L 
Sbjct: 32  LVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           H NLV L+  C +  +  LV+EF+    L++  LF  G   L + +  K       G+ F
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGF 139
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
            H      +I+RD K  NIL+      KL DFG A+     G+ +     + T  Y APE
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPE 194
Query: 316 YVMTGHLTSKS-DVYSFGVVLLEMLTGRRSM--DKNRPNGEH------NLVEWARPHLGD 366
            ++      K+ DV++ G ++ EM  G      D +     H      NL+   +     
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 367 KRRFYRLLDPRLEGHFSI-----KGSQKATQLAAQCLSRDPKARPRMSEVV 412
              F  +  P ++    +     K S+    LA +CL  DP  RP  +E++
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 508
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ A    KL DFGL++   ED   + +++      + APE +
Sbjct: 509 S---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 564
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 620 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ A    KL DFGL++   ED   + +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 184
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 196
           +G G FG V+      N            VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 62  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN ++  G  + +    LV E+   GS  + L      PL       +  GA +GLA+L
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVSTRVMGTYGYAAPE 315
           H      +I+RD K  NILL      KL DFG A   AP       +   +GT  + APE
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPE 220
Query: 316 YVMT---GHLTSKSDVYSFGVVLLEM 338
            ++    G    K DV+S G+  +E+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/300 (24%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
           S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L  
Sbjct: 1   SKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVLFK 44
Query: 177 DGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG 233
             L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +  
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
                 +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  A
Sbjct: 105 KFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
           P   +      + GT  Y  PE +       K D++S GV+  E L G+   + N     
Sbjct: 160 PSSRR----DTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET 215
Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 216 YKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDG 178
           RKF  +D  +     RP   LG+G FG V+    ++N     K    L V  K+ L  +G
Sbjct: 9   RKFTIDDFDIV----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 56
Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
           ++   +   E+    +L HPN++++  Y  +  +  L+ EF PRG L   L + G     
Sbjct: 57  VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ 114
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            S      L  A     LH   E+ VI+RD K  N+L+      K++DFG +  AP    
Sbjct: 115 RSATFMEELADA-----LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 166
Query: 299 THVSTRVM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
             +  R M GT  Y  PE +       K D++  GV+  E L G    D
Sbjct: 167 --LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAE 188
           NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      + E
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA--IRE 51
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           ++ L  L HPN+VKL+     +++  LV+E +    L+  +       +P  +       
Sbjct: 52  ISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQ 110
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
             +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+  T  + T
Sbjct: 111 LLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVT 165
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDG 178
           RKF  +D  +     RP   LG+G FG V+    ++N     K    L V  K+ L  +G
Sbjct: 10  RKFTIDDFDIG----RP---LGKGKFGNVYLAREKQN-----KFIMALKVLFKSQLEKEG 57
Query: 179 LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
           ++   +   E+    +L HPN++++  Y  +  +  L+ EF PRG L   L + G     
Sbjct: 58  VE--HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQ 115
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            S      L  A     LH   E+ VI+RD K  N+L+      K++DFG +  AP    
Sbjct: 116 RSATFMEELADA-----LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--- 167
Query: 299 THVSTRVM-GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD 346
             +  R M GT  Y  PE +       K D++  GV+  E L G    D
Sbjct: 168 --LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 59
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 120 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---- 170
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 222
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 223 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 38/293 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 122
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 180
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
              +SKSD+++FGV++ E+ +  +   +   N E         H+    R YR   P L 
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR---PHL- 230
Query: 380 GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQ 432
                  S+K   +   C       RP    +      L N+ D+   + Y Q
Sbjct: 231 ------ASEKVYTIMYSCWHEKADERPTFKIL------LSNILDVMDENLYGQ 271

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 127/302 (42%), Gaps = 46/302 (15%)
Query: 115 VASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL 174
           + S+ R++   D ++     RP   LG+G FG V+    ++         +   +A+K L
Sbjct: 1   MESKKRQWALEDFEIG----RP---LGKGKFGNVYLAREKQ---------SKFILALKVL 44
Query: 175 NHDGLQG---HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
               L+      +   EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +
Sbjct: 45  FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 104
Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                   +      L  A  L++ H    K VI+RD K  N+LL +    K++DFG + 
Sbjct: 105 LSKFDEQRTATYITEL--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 159
Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
            AP   +  +     GT  Y  PE +       K D++S GV+  E L G+   + N   
Sbjct: 160 HAPSSRRXXLC----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             +  +                   R+E  F    ++ A  L ++ L  +P  RP + EV
Sbjct: 216 ETYKRIS------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREV 257
Query: 412 VE 413
           +E
Sbjct: 258 LE 259

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 196
           +G G FG V+      N            VA+K +++ G Q +++W   + EV FL  L 
Sbjct: 23  IGHGSFGAVYFARDVRNSE---------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN ++  G  + +    LV E+   GS  + L      PL       +  GA +GLA+L
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKTHVSTRVMGTYGYAAPE 315
           H      +I+RD K  NILL      KL DFG A   AP       +   +GT  + APE
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPE 181
Query: 316 YVMT---GHLTSKSDVYSFGVVLLEM 338
            ++    G    K DV+S G+  +E+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 117 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 16  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 64
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 65  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 121
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 122 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 179
Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 235

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLE 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 184
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 22/218 (10%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEW 185
           +  NF+    +GEG +G V+K     N        TG  VA+K +  D    G+      
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA---RNKL------TGEVVALKKIRLDTETEGVPSTA-- 52
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E++ L  L HPN+VKL+     +++  LV+E + +  L+  +       +P  +    
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSY 111
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+    V
Sbjct: 112 LFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 168
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             T  Y APE ++   + ++  D++S G +  EM+T R
Sbjct: 169 --TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 56
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 116
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 117 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC---- 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 219
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 220 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 256

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 398 IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 451
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 452 HIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 508
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      + APE +
Sbjct: 509 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESI 564
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 620 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/287 (24%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWL 186
           A  +F     LG+G FG V+    ++         +   +A+K L    L+      +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLR 59
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV    +L HPN+++L GY  +  +  L+ E+ P G++   L +        +      
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 119
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           L  A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +  +     
Sbjct: 120 L--ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC---- 170
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT  Y  PE +       K D++S GV+  E L G+   + N     +  +         
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------- 222
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                     R+E  F    ++ A  L ++ L  +P  RP + EV+E
Sbjct: 223 ----------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 259

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 187
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 5   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 53
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 54  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 112
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 113 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 164
Query: 308 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 357
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 165 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 223
Query: 358 EWARP 362
           ++  P
Sbjct: 224 KFLSP 228

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 187
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 15  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 63
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 64  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 122
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 123 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 174
Query: 308 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 357
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 175 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 233
Query: 358 EWARP 362
           ++  P
Sbjct: 234 KFLSP 238

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 12  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 60
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 175
Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 96/219 (43%), Gaps = 22/219 (10%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           +L   NF    +LG+G FG V    V+E         TG   AVK L  D +    +   
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVEC 69
Query: 186 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L     HP L +L       D+   V EF+  G L  H+ +          R 
Sbjct: 70  TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARA 126
Query: 244 KI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
           +  A      L FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +G T  +
Sbjct: 127 RFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--T 181
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
               GT  Y APE +         D ++ GV+L EML G
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG +G V+K   +E         TG  VA+K +  +     +E + E++ +     P+
Sbjct: 37  LGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPH 85
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +VK  G   ++    +V E+   GS+ + + R  +  L       I     KGL +LH  
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
            +   I+RD K  NILL+ + +AKL+DFG+A    +         V+GT  + APE +  
Sbjct: 145 RK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTPFWMAPEVIQE 199
Query: 320 GHLTSKSDVYSFGVVLLEMLTGR 342
                 +D++S G+  +EM  G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 187
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 14  NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 62
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 63  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 122 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 173
Query: 308 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 357
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 174 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 232
Query: 358 EWARP 362
           ++  P
Sbjct: 233 KFLSP 237

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 16/215 (7%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
           +L   +F   S LG G  G V K     +G    +    L +     N        + + 
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRN--------QIIR 63
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E+  L     P +V   G    D +  +  E M  GSL+  L  K +  +P  I  K+++
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEILGKVSI 121
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              +GLA+L E+ +  +++RD K SNIL+++    KL DFG++    +     ++   +G
Sbjct: 122 AVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVG 175
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           T  Y APE +   H + +SD++S G+ L+E+  GR
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 186
           +KL   +F    +LG+G FG VF    ++         T    A+K L  D +    +  
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDD-- 60
Query: 187 AEVNFLGNLL------HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
            E   +   +      HP L  +       +    V E++  G L  H+  +       S
Sbjct: 61  VECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLS 118
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD-APEDGKT 299
                A     GL FLH    K ++YRD K  NILLD D + K++DFG+ K+    D KT
Sbjct: 119 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +      GT  Y APE ++        D +SFGV+L EML G+
Sbjct: 176 NXFC---GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 32  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 80
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 81  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 137
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 138 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 195
Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 251

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/282 (28%), Positives = 123/282 (43%), Gaps = 33/282 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           +GEG FG V +G       +P  P   + VA+KT  +      +E +L E   +    HP
Sbjct: 18  IGEGQFGDVHQGIY----MSPENPA--MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 71
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G  I ++   ++ E    G L + L  RK SL L   I     L  A  LA+L 
Sbjct: 72  HIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLE 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               K  ++RD    N+L+ ++   KL DFGL++   ED     +++      + APE +
Sbjct: 129 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTXXKASKGKLPIKWMAPESI 184
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDP 376
                TS SDV+ FGV + E+L     M   +P  G  N     R   G++        P
Sbjct: 185 NFRRFTSASDVWMFGVCMWEIL-----MHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 239
Query: 377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            L              L  +C + DP  RPR +E+   L  +
Sbjct: 240 TL------------YSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 80/326 (24%), Positives = 141/326 (43%), Gaps = 57/326 (17%)
Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGH 182
           +ND+K        + ++GEG FG V K  ++       K G  +  A+K +  +     H
Sbjct: 21  WNDIKF-------QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDH 66
Query: 183 KEWLAEVNFLGNL-LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL------ 235
           +++  E+  L  L  HPN++ L+G C       L  E+ P G+L + L +   L      
Sbjct: 67  RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 126
Query: 236 --------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF 287
                    L     +  A   A+G+ +L   ++K  I+R+    NIL+  +Y AK++DF
Sbjct: 127 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADF 183
Query: 288 GLAKDAPEDGKTHVSTRVMGT--YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           GL++     G+     + MG     + A E +     T+ SDV+S+GV+L E++    S+
Sbjct: 184 GLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV----SL 234
Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                 G      + +   G     YRL  P       +    +   L  QC    P  R
Sbjct: 235 GGTPYCGMTCAELYEKLPQG-----YRLEKP-------LNCDDEVYDLMRQCWREKPYER 282
Query: 406 PRMSEVVETL-KPLQNLKDMASSSYY 430
           P  ++++ +L + L+  K   +++ Y
Sbjct: 283 PSFAQILVSLNRMLEERKTYVNTTLY 308

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 114/245 (46%), Gaps = 36/245 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLA 187
           N++    LGEG FG V   +            TG  VA+K +N   L     QG  E   
Sbjct: 9   NYQIVKTLGEGSFGKVKLAY---------HTTTGQKVALKIINKKVLAKSDMQGRIE--R 57
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E+++L  L HP+++KL       D+ ++V E+     L +++ ++  +    + R    +
Sbjct: 58  EISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQI 116
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            +A      H+     +++RD K  N+LLD   N K++DFGL+    +      S    G
Sbjct: 117 ISAVEYCHRHK-----IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---G 168
Query: 308 TYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD--------KNRPNGEHNLV 357
           +  YAAPE V++G L +  + DV+S GV+L  ML  R   D        KN  NG + L 
Sbjct: 169 SPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP 227
Query: 358 EWARP 362
           ++  P
Sbjct: 228 KFLSP 232

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 108/236 (45%), Gaps = 21/236 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 23  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 71
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 72  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 128
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
             K  ++RD    N L++     K+SDFGL++   +D  T  S        ++ PE +M 
Sbjct: 129 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLMY 186
Query: 320 GHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
              +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 242

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 191
           ++  + ++G G    V   +      AP K      VA+K +N +  Q    E L E+  
Sbjct: 16  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 66
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKG---SLPLPWSIRMKI 245
           +    HPN+V      +  D+  LV + +  GS+ +   H+  KG   S  L  S    I
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG---KTHVS 302
                +GL +LH+  +   I+RD K  NILL  D + +++DFG++      G   +  V 
Sbjct: 127 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 303 TRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
              +GT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     L    
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-----QLAAQCLSRDPKARPRMSEVV 412
            P             P LE     K   K       ++ + CL +DP+ RP  +E++
Sbjct: 243 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 112/239 (46%), Gaps = 27/239 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V  G          K      VA+K +  +G     E++ E   + NL H  
Sbjct: 17  LGTGQFGVVKYG----------KWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEK 65
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L G C +     ++ E+M  G L N+L R+          +++     + + +L   
Sbjct: 66  LVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLE-- 122
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPEY 316
             K  ++RD    N L++     K+SDFGL++   +D  T  S+R  G+     ++ PE 
Sbjct: 123 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT--SSR--GSKFPVRWSPPEV 177
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK--NRPNGEHNL--VEWARPHLGDKRRF 370
           +M    +SKSD+++FGV++ E+ + G+   ++  N    EH    +   RPHL  ++ +
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 236

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 43/297 (14%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNF 191
           ++  + ++G G    V   +      AP K      VA+K +N +  Q    E L E+  
Sbjct: 11  DYELQEVIGSGATAVVQAAY-----CAPKKE----KVAIKRINLEKCQTSMDELLKEIQA 61
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKG---SLPLPWSIRMKI 245
           +    HPN+V      +  D+  LV + +  GS+ +   H+  KG   S  L  S    I
Sbjct: 62  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 121
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG---KTHVS 302
                +GL +LH+  +   I+RD K  NILL  D + +++DFG++      G   +  V 
Sbjct: 122 LREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 178
Query: 303 TRVMGTYGYAAPEYV--MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
              +GT  + APE +  + G+   K+D++SFG+  +E+ TG     K  P     L    
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237
Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT-----QLAAQCLSRDPKARPRMSEVV 412
            P             P LE     K   K       ++ + CL +DP+ RP  +E++
Sbjct: 238 DP-------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLL 196
           LG G FG V  G  E          TG  VAVK LN   ++      +   E+  L    
Sbjct: 24  LGVGTFGKVKVGKHE---------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HP+++KL           +V E++  G L +++ + G L    S R+   + +  G+ + 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYC 132
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H      V++RD K  N+LLDA  NAK++DFGL+ +   DG+    +   G+  YAAPE 
Sbjct: 133 HRHM---VVHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXS--CGSPNYAAPE- 185
Query: 317 VMTGHLTS--KSDVYSFGVVLLEMLTGRRSMDKN 348
           V++G L +  + D++S GV+L  +L G    D +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 113/228 (49%), Gaps = 46/228 (20%)
Query: 143 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNL 200
           G FGCV+K  +  +            VAVK      LQ  + W +E        + H NL
Sbjct: 26  GRFGCVWKAQLMND-----------FVAVKIFP---LQDKQSWQSEREIFSTPGMKHENL 71
Query: 201 VKLV-----GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
           ++ +     G  +E  +  L+  F  +GSL ++L  KG++ + W+    +A   ++GL++
Sbjct: 72  LQFIAAEKRGSNLEV-ELWLITAFHDKGSLTDYL--KGNI-ITWNELCHVAETMSRGLSY 127
Query: 256 LHE-------EAEKPVI-YRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTR 304
           LHE       E  KP I +RDFK+ N+LL +D  A L+DFGLA   +     G TH    
Sbjct: 128 LHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQ-- 185
Query: 305 VMGTYGYAAPEYVMTGHLTSKS------DVYSFGVVLLEMLTGRRSMD 346
            +GT  Y APE V+ G +  +       D+Y+ G+VL E+++  ++ D
Sbjct: 186 -VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG V+KG   +N T  V       VA+K ++  +     ++   E+  L     P
Sbjct: 27  IGKGSFGEVYKGI--DNHTKEV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            + +  G  ++  +  ++ E++  GS  + L + G  PL  +    I     KGL +LH 
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATILREILKGLDYLHS 134
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS-TRVMGTYGYAAPEYV 317
           E +   I+RD K +N+LL    + KL+DFG+A    +   T +     +GT  + APE +
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD---TQIKRNXFVGTPFWMAPEVI 188
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                  K+D++S G+  +E+  G        P     L+    P             P 
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PT 235
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           LEG    + S+   +    CL++DP+ RP   E+++
Sbjct: 236 LEG----QHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 17/222 (7%)
Query: 121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 180
           K ++ D KL T     +  LG G FG V KG+ +      V     + +     N   L+
Sbjct: 362 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 415
Query: 181 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
              E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +   +     
Sbjct: 416 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 472
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           I  ++    + G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + +
Sbjct: 473 I--ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENY 526
Query: 301 VSTRVMGTY--GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              +  G +   + APE +     +SKSDV+SFGV++ E  +
Sbjct: 527 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 17/222 (7%)
Query: 121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 180
           K ++ D KL T     +  LG G FG V KG+ +      V     + +     N   L+
Sbjct: 361 KEVYLDRKLLTLE---DKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK 414
Query: 181 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
              E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +   +     
Sbjct: 415 --DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI 471
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           I  ++    + G+ +L E      ++RD    N+LL   + AK+SDFGL+K    D + +
Sbjct: 472 I--ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENY 525
Query: 301 VSTRVMGTY--GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
              +  G +   + APE +     +SKSDV+SFGV++ E  +
Sbjct: 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 106/235 (45%), Gaps = 30/235 (12%)
Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-- 181
             ++ L+   F  E  LGE  FG V+KG +   G AP +      VA+KTL  D  +G  
Sbjct: 3   LKEISLSAVRFMEE--LGEDRFGKVYKGHL--FGPAPGEQTQA--VAIKTLK-DKAEGPL 55
Query: 182 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---------- 231
            +E+  E      L HPN+V L+G   +D    +++ +   G L   L            
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 232 ------KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
                 K +L  P  + +   + A  G+ +L   +   V+++D  T N+L+    N K+S
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAA--GMEYL---SSHHVVHKDLATRNVLVYDKLNVKIS 170
Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           D GL ++        +    +    + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 171 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNL 195
           +GEG +G V+K           K   G  VA+K +  D    G+      + E++ L  L
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-GAAKGLA 254
            HPN+V L+     +    LV+EFM +   +     K  L      ++KI L    +G+A
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ---DSQIKIYLYQLLRGVA 133
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
             H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH       T  Y 
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYR 186
Query: 313 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           AP+ +M     S S D++S G +  EM+TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD----GLQGHKEWLAEVNFLGNL 195
           +GEG +G V+K           K   G  VA+K +  D    G+      + E++ L  L
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIRLDAEDEGIPSTA--IREISLLKEL 76
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-GAAKGLA 254
            HPN+V L+     +    LV+EFM +   +     K  L      ++KI L    +G+A
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ---DSQIKIYLYQLLRGVA 133
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
             H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH       T  Y 
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYR 186
Query: 313 APEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           AP+ +M     S S D++S G +  EM+TG+
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 119/284 (41%), Gaps = 52/284 (18%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 159 IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 209
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 210 VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 260
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTY 309
           + LH +    VI+RD K+ +ILL  D   KLSDFG    ++K+ P          ++GT 
Sbjct: 261 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------RKXLVGTP 311
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            + APE +       + D++S G++++EM+ G                 +  P L   + 
Sbjct: 312 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKM 358
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 359 IRDNLPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 400

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 33  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 87
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 88  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEES 144
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 145 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 200
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEES 146
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 202
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 35  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 89
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 90  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEES 146
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 147 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 202
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVGTPYWMAP 185
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E V       K D++S G++ +EM+ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 198
           LG G FG V +G               + VA+K L     +   +E + E   +  L +P
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            +V+L+G C + +  +LV E    G L   L  K    +P S   ++    + G+ +L E
Sbjct: 71  YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEE 128
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 316
              K  ++RD    N+LL   + AK+SDFGL+K    D  ++ + R  G +   + APE 
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPEC 184
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT 340
           +     +S+SDV+S+GV + E L+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALS 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 25  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 79
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 135
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 136 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 192
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 130 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 186
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 182
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 232
Query: 183 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 233 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 289
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 290 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 346
Query: 300 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 347 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 182
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 183 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 290
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 291 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347
Query: 300 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 13  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 67
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 68  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 123
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 124 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 180
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAP 185
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E V       K D++S G++ +EM+ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 28  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 131
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 185
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E V       K D++S G++ +EM+ G 
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           LG GGFG V + W+ ++        TG  VA+K    +    ++E W  E+  +  L HP
Sbjct: 22  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 199 NLVKL------VGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAA 250
           N+V        +     +D  LL  E+   G L  +L  F          IR  ++   +
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DIS 131
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             L +LHE     +I+RD K  NI+L         K+ D G AK   E  +  + T  +G
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVG 185
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           T  Y APE +     T   D +SFG +  E +TG R
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 12/218 (5%)
Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           M  D+K   + +     LGEG F  V+K    +  T  +     + +  ++   DG+  +
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGI--N 56
Query: 183 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  L E+  L  L HPN++ L+          LV++FM    LE  + +  SL L  S  
Sbjct: 57  RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEV-IIKDNSLVLTPSHI 114
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
               L   +GL +LH+     +++RD K +N+LLD +   KL+DFGLAK      + +  
Sbjct: 115 KAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXH 171
Query: 303 TRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEML 339
             V  T  Y APE +    +     D+++ G +L E+L
Sbjct: 172 QVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 132
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 133 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVGTPYWMAP 186
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E V       K D++S G++ +EM+ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 131/303 (43%), Gaps = 40/303 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG VFKG   +N T  V       VA+K ++  +     ++   E+  L      
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQV-------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLH 257
            + K  G  ++  +  ++ E++  GS  + L R G       +  +K  L   KGL +LH
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLH 137
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
            E +   I+RD K +N+LL    + KL+DFG+A     D +   +T V GT  + APE +
Sbjct: 138 SEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFV-GTPFWMAPEVI 192
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPR 377
                 SK+D++S G+  +E+  G        P     L+    P             P 
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP-------------PT 239
Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQTMQAD 437
           L G F    ++   +    CL++DP  RP   E+   LK    +K+   +SY  + +   
Sbjct: 240 LVGDF----TKSFKEFIDACLNKDPSFRPTAKEL---LKHKFIVKNSKKTSYLTELIDRF 292
Query: 438 NTW 440
             W
Sbjct: 293 KRW 295

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLHP 198
           LG GGFG V + W+ ++        TG  VA+K    +    ++E W  E+  +  L HP
Sbjct: 23  LGTGGFGYVLR-WIHQD--------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 73
Query: 199 NLVKL------VGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAA 250
           N+V        +     +D  LL  E+   G L  +L  F          IR  ++   +
Sbjct: 74  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DIS 132
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             L +LHE     +I+RD K  NI+L         K+ D G AK   E  +  + T  +G
Sbjct: 133 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFVG 186
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
           T  Y APE +     T   D +SFG +  E +TG R
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 15  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 69
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 70  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 125
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEYV 317
                ++RD    N+LL   + AK+SDFGL+K    D + +   +  G +   + APE +
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPECI 182
Query: 318 MTGHLTSKSDVYSFGVVLLEMLT 340
                +SKSDV+SFGV++ E  +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V+     ++     K    L V  KT L   G++   +   EV    +L HP
Sbjct: 20  LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHP 72
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+++L GY  +  +  L+ E+ P G++   L +        +      L  A  L++ H 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS 130
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              K VI+RD K  N+LL ++   K++DFG +  AP   +    T + GT  Y  PE + 
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIE 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
                 K D++S GV+  E L G
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 182
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 183 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 290
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 291 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347
Query: 300 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 25/238 (10%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGH 182
           ++ L   +F    ++G GGFG V+            K  TG   A+K L+   +   QG 
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY---------GCRKADTGKMYAMKCLDKKRIKMKQGE 233
Query: 183 KEWLAEVNFLGNLLHPN--LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
              L E   L  +   +   +  + Y      +L  + + M  G L  HL + G      
Sbjct: 234 TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS--- 290
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +   AA+ +  L     + V+YRD K +NILLD   + ++SD GLA D  +  K 
Sbjct: 291 --EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KP 347
Query: 300 HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
           H S   +GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +
Sbjct: 348 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 253
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 82  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 132
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 133 VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 183
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 184 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 238
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 285
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 286 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 323

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 253
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 12/202 (5%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V KG+ +      V     + +     N   L+   E LAE N +  L +P 
Sbjct: 19  LGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALK--DELLAEANVMQQLDNPY 73
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           +V+++G C E +  +LV E    G L  +L +   +     I  ++    + G+ +L E 
Sbjct: 74  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII--ELVHQVSMGMKYLEE- 129
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVM 318
                ++RD    N+LL   + AK+SDFGL+K    D   +   T       + APE + 
Sbjct: 130 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 319 TGHLTSKSDVYSFGVVLLEMLT 340
               +SKSDV+SFGV++ E  +
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 253
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 37/212 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V             +  TG  VAVK ++    Q  +    EV  + +  H N
Sbjct: 53  IGEGSTGIV---------CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDN 103
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V +    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 104 VVDMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLSVLRAL 154
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG----LAKDAPEDGKTHVSTRVMGTY 309
           ++LH +    VI+RD K+ +ILL +D   KLSDFG    ++K+ P+         ++GT 
Sbjct: 155 SYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKXLVGTP 205
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + APE +      ++ D++S G++++EM+ G
Sbjct: 206 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/312 (24%), Positives = 134/312 (42%), Gaps = 40/312 (12%)
Query: 111 EELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVA 170
           + L ++ +L++    D+ +  + F    +LG+G FG V +  +++      + G+ + VA
Sbjct: 3   DSLGISDELKE-KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ------EDGSFVKVA 55
Query: 171 VKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPR 222
           VK L  D +     +E+L E   +    HP++ KLVG  +    +      +++  FM  
Sbjct: 56  VKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKH 115
Query: 223 GSLENHLF--RKGSLP--LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           G L   L   R G  P  LP    ++  +  A G+ +L   + +  I+RD    N +L  
Sbjct: 116 GDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAE 172
Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           D    ++DFGL++                   + A E +     T  SDV++FGV + E+
Sbjct: 173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232
Query: 339 LTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQC 397
           +T  ++      N E +N +      +G      RL  P        +  ++   L  QC
Sbjct: 233 MTRGQTPYAGIENAEIYNYL------IGGN----RLKQPP-------ECMEEVYDLMYQC 275
Query: 398 LSRDPKARPRMS 409
            S DPK RP  +
Sbjct: 276 WSADPKQRPSFT 287

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 13  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 121
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 89/209 (42%), Gaps = 19/209 (9%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG GGFG VF   ++  G              K   + G    K+ LA+V       H 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-------HS 244
Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS----LPLPWSIRMKIALGAAKGL 253
             +  + Y  E    L LV   M  G +  H++           P +I     +    GL
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGL 302
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             LH+   + +IYRD K  N+LLD D N ++SD GLA +  + G+T       GT G+ A
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYA-GTPGFMA 357
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           PE ++        D ++ GV L EM+  R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VA+K ++   L     ++   EV  +  L HPN+VKL      +    L+ E+   
Sbjct: 36  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 95
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     +K       + + H+   K +++RD K  N+LL
Sbjct: 96  GEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLL 144
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +    GK        G+  YAAPE          + DV+S GV+L
Sbjct: 145 DADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 201
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 202 YTLVSGSLPFD 212

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 98/227 (43%), Gaps = 40/227 (17%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPG----TGLTVAVKTLNHDGLQ--GHKEWL 186
           N+R +  +G+G F             A VK      TG  VAVK ++   L     ++  
Sbjct: 16  NYRLQKTIGKGNF-------------AKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF 62
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV  +  L HPN+VKL      +    LV E+   G + ++L   G        RMK  
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG--------RMKEK 114
Query: 247 LGAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
              AK       + + H+   K +++RD K  N+LLD D N K++DFG + +     K  
Sbjct: 115 EARAKFRQIVSAVQYCHQ---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLD 171
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMD 346
                 G+  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 172 T---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 39  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 89
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 90  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 140
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 141 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 195
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 242
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 243 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 280

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG +G V            V   T   VAVK ++    +   +    E+     L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHP 198
           LG G FG V +G               + VA+K L     +   +E + E   +  L +P
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQ-------IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            +V+L+G C + +  +LV E    G L   L  K    +P S   ++    + G+ +L E
Sbjct: 397 YIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLEE 454
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY--GYAAPEY 316
              K  ++R+    N+LL   + AK+SDFGL+K    D  ++ + R  G +   + APE 
Sbjct: 455 ---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPEC 510
Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT 340
           +     +S+SDV+S+GV + E L+
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 37  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 87
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 88  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 138
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 139 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 193
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 240
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 241 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 278

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 118/279 (42%), Gaps = 37/279 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFLGNLLHP 198
           LG G FG V    VEE  +       GL   +KT+N D  Q   E + AE+  L +L HP
Sbjct: 30  LGSGAFGDV--HLVEERSS-------GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--PLPWSIRMKIALGAAKGLAFL 256
           N++K+     +     +V E    G L   +    +    L      ++       LA+ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 257 HEEAEKPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H +    V+++D K  NIL  D   ++  K+ DFGLA+    D     ST   GT  Y A
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMA 194
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE V    +T K D++S GVV+  +LTG                 +  P+   +    R 
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE---CRP 250
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           L P            +A  L  Q L++DP+ RP  ++V+
Sbjct: 251 LTP------------QAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VA+K ++   L     ++   EV  +  L HPN+VKL      +    L+ E+   
Sbjct: 39  TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     +K       + + H+   K +++RD K  N+LL
Sbjct: 99  GEVFDYLVAHG--------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLL 147
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +    GK        G   YAAPE          + DV+S GV+L
Sbjct: 148 DADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 205 YTLVSGSLPFD 215

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 38/232 (16%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 191
           +F P   LG GGFG VF+   + +             A+K +     +  +E  + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDC---------NYAIKRIRLPNRELAREKVMREVKA 56
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL--ENHLFRKGSLPLPW---------- 239
           L  L HP +V+     +E +    +    P+  L  +  L RK +L   W          
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLK-DWMNGRCTIEER 115
Query: 240 --SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL--AKDAPE 295
             S+ + I L  A+ + FLH    K +++RD K SNI    D   K+ DFGL  A D  E
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 296 DGKTHVS--------TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
           + +T ++        T  +GT  Y +PE +     + K D++S G++L E+L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 91/192 (47%), Gaps = 17/192 (8%)
Query: 169 VAVKTLNHDGLQGHKEWLA---EVNFLGNLLHPNLVKLVGYCIEDDQR------LLVYEF 219
           VAVK L  D  +    +L    E      L HP +V +  Y   + +        +V E+
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEY 97
Query: 220 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
           +   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI++ A 
Sbjct: 98  VDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISAT 152
Query: 280 YNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
              K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G VL E+
Sbjct: 153 NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212
Query: 339 LTGRRSMDKNRP 350
           LTG      + P
Sbjct: 213 LTGEPPFTGDSP 224

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 15  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 123
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 73/138 (52%), Gaps = 6/138 (4%)
Query: 215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 334 VLLEMLTGRRSMDKNRPN 351
           VL E+LTG      + P+
Sbjct: 208 VLYEVLTGEPPFTGDSPD 225

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG +G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           L+ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 LISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 334 VLLEMLTGRRSMDKNRP 350
           VL E+LTG      + P
Sbjct: 208 VLYEVLTGEPPFTGDSP 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 28  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 129
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 184
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 231
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 232 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 269

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           +GEG FG        E+G   V         +K +N   +     +E   EV  L N+ H
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYV---------IKEINISRMSSKEREESRREVAVLANMKH 82
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-------ENHLFRKGSLPLPWSIRMKIALGAA 250
           PN+V+      E+    +V ++   G L       +  LF++  + L W +++ +AL   
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQICLALKHV 141
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
                     ++ +++RD K+ NI L  D   +L DFG+A+    +    ++   +GT  
Sbjct: 142 H---------DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPY 190
Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           Y +PE        +KSD+++ G VL E+ T + + +        NLV             
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVLKI---------- 237
Query: 371 YRLLDPRLEGHF---SIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  + G F   S+  S     L +Q   R+P+ RP ++ ++E
Sbjct: 238 -------ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G+G  G V+           +   TG  VA++ +N       +  + E+  +    +PN
Sbjct: 29  IGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL----FRKGSLPLPWSIRMKIALGAAKGLAF 255
           +V  +   +  D+  +V E++  GSL + +      +G +         +     + L F
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-------AVCRECLQALEF 132
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAP 314
           LH      VI+R+ K+ NILL  D + KL+DFG  A+  PE  K    + ++GT  + AP
Sbjct: 133 LHS---NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAP 186
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E V       K D++S G++ +EM+ G 
Sbjct: 187 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 38  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 88
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +C +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 89  DVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 147
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 148 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 116/280 (41%), Gaps = 44/280 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +GEG  G V    V  +G           VAVK ++    Q  +    EV  + +  H N
Sbjct: 32  IGEGSTGIVCIATVRSSGK---------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 82
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAAKGL 253
           +V++    +  D+  +V EF+  G+L +         +    RM       + L   + L
Sbjct: 83  VVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCLAVLQAL 133
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           + LH +    VI+RD K+ +ILL  D   KLSDFG      ++        ++GT  + A
Sbjct: 134 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR--KXLVGTPYWMA 188
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +       + D++S G++++EM+ G                 +  P L   +     
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPY-------------FNEPPLKAMKMIRDN 235
Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           L PRL+    +  S K      + L RDP  R   +E+++
Sbjct: 236 LPPRLKNLHKVSPSLKG--FLDRLLVRDPAQRATAAELLK 273

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/191 (30%), Positives = 86/191 (45%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VAVK ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +     K        G   YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 334 VLLEMLTGRRSMDKNRP 350
           VL E+LTG      + P
Sbjct: 208 VLYEVLTGEPPFTGDSP 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 147
Query: 275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 207
Query: 334 VLLEMLTGRRSMDKNRP 350
           VL E+LTG      + P
Sbjct: 208 VLYEVLTGEPPFTGDSP 224

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VAV+ ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VAV+ ++   L     ++   EV  +  L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 97
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        RMK     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RMKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +     K        G+  YAAPE          + DV+S GV+L
Sbjct: 147 DADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT-LNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V+     ++     K    L V  KT L   G++   +   EV    +L HP
Sbjct: 20  LGKGKFGNVYLARERQS-----KFILALKVLFKTQLEKAGVE--HQLRREVEIQSHLRHP 72
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+++L GY  +  +  L+ E+ P G++   L +        +      L  A  L++ H 
Sbjct: 73  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS 130
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              K VI+RD K  N+LL ++   K++DFG +  AP   +      + GT  Y  PE + 
Sbjct: 131 ---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIE 183
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
                 K D++S GV+  E L G
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 72/137 (52%), Gaps = 6/137 (4%)
Query: 215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V E++   +L + +  +G  P+     +++   A + L F H+     +I+RD K +NI
Sbjct: 110 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANI 164
Query: 275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           ++ A    K+ DFG+A+   + G +   T  V+GT  Y +PE      + ++SDVYS G 
Sbjct: 165 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 224
Query: 334 VLLEMLTGRRSMDKNRP 350
           VL E+LTG      + P
Sbjct: 225 VLYEVLTGEPPFTGDSP 241

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LGEG  G V            V   T   VAVK ++        E + +   +  +L H 
Sbjct: 14  LGEGAAGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+VK  G+  E + + L  E+   G L + +     +P P + R    L A  G+ +LH 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHG 122
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y APE + 
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 319 TGHLTSK-SDVYSFGVVLLEMLTGRRSMDK 347
                ++  DV+S G+VL  ML G    D+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 14/187 (7%)
Query: 165 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 221
           TG  VAVK LN   ++      +   E+  L    HP+++KL           +V E++ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
            G L +++ + G +    + R+   + +A      H      V++RD K  N+LLDA  N
Sbjct: 95  GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMN 149
Query: 282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEML 339
           AK++DFGL+ +   DG+   ++   G+  YAAPE V++G L +  + D++S GV+L  +L
Sbjct: 150 AKIADFGLS-NMMSDGEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALL 205
Query: 340 TGRRSMD 346
            G    D
Sbjct: 206 CGTLPFD 212

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 183
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW--- 239
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N L     +P  W   
Sbjct: 121 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 172
Query: 240 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G 
Sbjct: 173 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 299 THVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
               T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 224 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 183
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW--- 239
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N L     +P  W   
Sbjct: 126 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 177
Query: 240 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G 
Sbjct: 178 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 299 THVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
               T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 229 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 196
           +LG+G FG V K              T    AVK +N    +       L EV  L  L 
Sbjct: 29  MLGKGSFGEVLKCK---------DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN++KL     +     +V E    G L + + ++       + R  I      G+ ++
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYM 137
Query: 257 HEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y A
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIA 191
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE V+ G    K DV+S GV+L  +L+G
Sbjct: 192 PE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 28  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 81
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 82  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 136
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 137 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 191
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 240
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 241 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 270

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 91/181 (50%), Gaps = 16/181 (8%)
Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           +G  VAVK ++    Q  +    EV  + +  H N+V++    +  ++  ++ EF+  G+
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 225 LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           L + +     + L       +     + LA+LH +    VI+RD K+ +ILL  D   KL
Sbjct: 129 LTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKL 182
Query: 285 SDFG----LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           SDFG    ++KD P+         ++GT  + APE +      ++ D++S G++++EM+ 
Sbjct: 183 SDFGFCAQISKDVPK------RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVD 236
Query: 341 G 341
           G
Sbjct: 237 G 237

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 236
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 237 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 266

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 136/309 (44%), Gaps = 48/309 (15%)
Query: 143 GGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLGNLLHPNL 200
           G FGCV+K  +               VAVK      +Q  + W    EV  L  + H N+
Sbjct: 35  GRFGCVWKAQLLNE-----------YVAVKIFP---IQDKQSWQNEYEVYSLPGMKHENI 80
Query: 201 VKLVGY----CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           ++ +G        D    L+  F  +GSL +  F K ++ + W+    IA   A+GLA+L
Sbjct: 81  LQFIGAEKRGTSVDVDLWLITAFHEKGSLSD--FLKANV-VSWNELCHIAETMARGLAYL 137
Query: 257 HEE------AEKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR-VMGT 308
           HE+        KP I +RD K+ N+LL  +  A ++DFGLA    E GK+   T   +GT
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF-EAGKSAGDTHGQVGT 196
Query: 309 YGYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL----VE 358
             Y APE V+ G +        + D+Y+ G+VL E+ +  R    + P  E+ L      
Sbjct: 197 RRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELAS--RCTAADGPVDEYMLPFEEEI 253
Query: 359 WARPHLGDKRR--FYRLLDPRLEGHFSI-KGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
              P L D +    ++   P L  ++    G     +   +C   D +AR     V E +
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERI 313
Query: 416 KPLQNLKDM 424
             +Q L ++
Sbjct: 314 TQMQRLTNI 322

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 24  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 77
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 132
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+   +  + GT  Y APE
Sbjct: 133 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPE 187
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 236
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 237 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 266

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQGHK 183
           DL++   ++    ++G G FG V    V    T  V     L+    +K  +       +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW--- 239
           + +A  N       P +V+L  Y  +DD+ L +V E+MP G L N L     +P  W   
Sbjct: 126 DIMAFAN------SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARF 177
Query: 240 -SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            +  + +AL A   + F+H         RD K  N+LLD   + KL+DFG      ++G 
Sbjct: 178 YTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 299 THVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
               T V GT  Y +PE + +    G+   + D +S GV L EML G
Sbjct: 229 VRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 46  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 99
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 100 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 154
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 155 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 209
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 258
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 259 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 288

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 133 NFRPESLLGEGGFGCVF--KGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLA 187
           +F    ++G+G FG V   +   EE           +  AVK L    +   KE    ++
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEE-----------VFYAVKVLQKKAILKKKEEKHIMS 87
Query: 188 EVN-FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI- 245
           E N  L N+ HP LV L       D+   V +++  G L  HL R+     P   R +  
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFY 144
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   A  L +LH      ++YRD K  NILLD+  +  L+DFGL K+  E   T  ++  
Sbjct: 145 AAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTF 199
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GT  Y APE +         D +  G VL EML G
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 48  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 101
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 156
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 157 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 211
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 260
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 261 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 290

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 14/187 (7%)
Query: 165 TGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP 221
           TG  VAVK LN   ++      +   E+  L    HP+++KL           +V E++ 
Sbjct: 35  TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVS 94
Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
            G L +++ + G +    + R+   + +A      H      V++RD K  N+LLDA  N
Sbjct: 95  GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-----VVHRDLKPENVLLDAHMN 149
Query: 282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS--KSDVYSFGVVLLEML 339
           AK++DFGL+ +   DG+    +   G+  YAAPE V++G L +  + D++S GV+L  +L
Sbjct: 150 AKIADFGLS-NMMSDGEFLRDS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALL 205
Query: 340 TGRRSMD 346
            G    D
Sbjct: 206 CGTLPFD 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNL 195
            +LG+G FG V K              T    AVK +N    +       L EV  L  L
Sbjct: 28  CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HPN++KL     +     +V E    G L + + ++       + R  I      G+ +
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y 
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           APE V+ G    K DV+S GV+L  +L+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 37/277 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
            LG+GGF   F+  + +  T  V  G    +  K+L     Q  K  + E++   +L H 
Sbjct: 22  FLGKGGFAKCFE--ISDADTKEVFAGK---IVPKSLLLKPHQREKMSM-EISIHRSLAHQ 75
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLAF 255
           ++V   G+  ++D   +V E   R SL     R+ +L  P   + +R +I LG      +
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQ----Y 130
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+      + GT  Y APE
Sbjct: 131 LHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPE 185
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
            +     + + DV+S G ++  +L G+       P  E + ++    +L  K+  Y +  
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK-------PPFETSCLKET--YLRIKKNEYSI-- 234
Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
           P+   H +      A  L  + L  DP ARP ++E++
Sbjct: 235 PK---HIN----PVAASLIQKMLQTDPTARPTINELL 264

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 28/221 (12%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPG----TGLTVAVKTLNHDGLQGH--KEWL 186
           N+R    +G+G F             A VK      TG  VAVK ++   L     ++  
Sbjct: 8   NYRLLKTIGKGNF-------------AKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF 54
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            EV  +  L HPN+VKL      +    LV E+   G + ++L   G     W    +  
Sbjct: 55  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEAR 109
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               + ++ +    +K +++RD K  N+LLDAD N K++DFG + +     K        
Sbjct: 110 AKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FC 166
Query: 307 GTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMD 346
           G+  YAAPE          + DV+S GV+L  +++G    D
Sbjct: 167 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVNFLGNLL 196
           LGEG FG V                T   VA+K ++   L+    H     E+++L  L 
Sbjct: 17  LGEGSFGKV---------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HP+++KL          ++V E+   G L +++  K  +      R    +  A      
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
           H+     +++RD K  N+LLD + N K++DFGL+    +      S    G+  YAAPE 
Sbjct: 127 HK-----IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE- 177
Query: 317 VMTGHLTS--KSDVYSFGVVLLEMLTGRRSMD 346
           V+ G L +  + DV+S G+VL  ML GR   D
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNL 195
            +LG+G FG V K              T    AVK +N    +       L EV  L  L
Sbjct: 28  CMLGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HPN++KL     +     +V E    G L + + ++       + R  I      G+ +
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITY 136
Query: 256 LHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +H+     +++RD K  NILL++   D + K+ DFGL+    ++  T +  R+ GT  Y 
Sbjct: 137 MHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYI 190
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           APE V+ G    K DV+S GV+L  +L+G
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 95/220 (43%), Gaps = 27/220 (12%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F    L+G G +G V+KG         VK  TG   A+K ++  G +  +E   E+N L 
Sbjct: 26  FELVELVGNGTYGQVYKG-------RHVK--TGQLAAIKVMDVTGDE-EEEIKQEINMLK 75
Query: 194 NLLHP-NLVKLVGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
              H  N+    G  I+      DDQ  LV EF   GS+ + +       L       I 
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
               +GL+ LH+     VI+RD K  N+LL  +   KL DFG++  A  D         +
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFI 190
Query: 307 GTYGYAAPEYVMTGH-----LTSKSDVYSFGVVLLEMLTG 341
           GT  + APE +            KSD++S G+  +EM  G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 180
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 22  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 72
Query: 181 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 73  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 132
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPE 295
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+     
Sbjct: 133 DAAR--IIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 187
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 188 SKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 29/224 (12%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA- 187
           +AT  + P + +G G +G V+K            P +G  VA+K++      G    L  
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGGGGGGGLPI 56
Query: 188 ----EVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSL 235
               EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +    
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115
Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            LP      +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+    
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY-- 170
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                  T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 171 -SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F+ E + G+G FG V  G          +  TG++VA+K +  D    ++E L  +  L 
Sbjct: 25  FQVERMAGQGTFGTVQLGK---------EKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLA 74
Query: 194 NLLHPNLVKLVGYCI---EDDQRLL----VYEFMP---RGSLENHLFRKGSLPLPWSIRM 243
            L HPN+V+L  Y     E D+R +    V E++P        N+ +R+   P P  I++
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY-YRRQVAPPPILIKV 133
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNAKLSDFGLAK--DAPEDGKTH 300
            +     + +  LH  +   V +RD K  N+L+ +AD   KL DFG AK     E    +
Sbjct: 134 FL-FQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           + +R      Y APE +    H T+  D++S G +  EM+ G
Sbjct: 192 ICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 180
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 39  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 89
Query: 181 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 90  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 149
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPE 295
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+     
Sbjct: 150 DAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 205 SKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 184
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 24/226 (10%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 180
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 40  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 90
Query: 181 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 91  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 150
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPE 295
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+     
Sbjct: 151 DAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             K       +GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 206 SKKMKDK---IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 197
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAP 211
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/154 (34%), Positives = 75/154 (48%), Gaps = 23/154 (14%)
Query: 198 PNLVKLVGYC-IEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW----SIRMKIALGAAK 251
           P +V+L  +C  +DD+ L +V E+MP G L N L     +P  W    +  + +AL A  
Sbjct: 135 PWVVQL--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            +  +H         RD K  N+LLD   + KL+DFG      E G  H  T V GT  Y
Sbjct: 192 SMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDY 241
Query: 312 AAPEYVMT----GHLTSKSDVYSFGVVLLEMLTG 341
            +PE + +    G+   + D +S GV L EML G
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 28/228 (12%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 180
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 66
Query: 181 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
               +  L EV  L  L HPN++KL  +  +     LV E    G L + +  +      
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAK--DA 293
            + R  I      G+ ++H+     +++RD K  N+LL++   D N ++ DFGL+   +A
Sbjct: 127 DAAR--IIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +  K  +     GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 182 SKKMKDKI-----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 186
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 187 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSLPLP 238
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +     LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 197
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+   +  + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT--LCGTPNYIAP 211
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS-----LPLP 238
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +  KG+     L   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEE 111
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           + +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           T  +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 170 TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 10/160 (6%)
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS-----LPLP 238
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +  KG+     L   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEE 111
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           + +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
           T  +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 170 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 197
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 49  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 101
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 156
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 157 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 211
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 184
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 186
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 187 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSLPLP 238
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +     LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 197
            LG+GGF   ++  + +  T  V  G  +  ++    H      KE ++ E+    +L +
Sbjct: 33  FLGKGGFAKCYE--ITDMDTKEVFAGKVVPKSMLLKPH-----QKEKMSTEIAIHKSLDN 85
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKGLA 254
           P++V   G+  +DD   +V E   R SL     R+ ++  P   + +R  I     +G+ 
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQ 140
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           +LH      VI+RD K  N+ L+ D + K+ DFGLA     DG+      + GT  Y AP
Sbjct: 141 YLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAP 195
Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +     + + D++S G +L  +L G+
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK----E 184
           A + +   + +GEG +G VFK    +NG        G  VA+K +    G +G       
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 60
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
            +A +  L    HPN+V+L   C       + +  LV+E + +  L  +L +     +P 
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQ 173
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
              T V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV 142
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +     +  SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 9   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 60  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 118
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 119 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHK-EWL 186
           +AT  + P + +G G +G V+K            P +G  VA+K++   +G +G     +
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKAR---------DPHSGHFVALKSVRVPNGEEGLPISTV 51
Query: 187 AEVNFLGNLL---HPNLVKLVGYCIED--DQRL---LVYEFMPRGSLENHLFRKGSLPLP 238
            EV  L  L    HPN+V+L+  C     D+ +   LV+E + +  L  +L +     LP
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 110
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                 +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+       
Sbjct: 111 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SY 164
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
                 V+ T  Y APE ++     +  D++S G +  EM 
Sbjct: 165 QMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 10  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 60
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 61  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 119
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 120 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/191 (29%), Positives = 84/191 (43%), Gaps = 23/191 (12%)
Query: 165 TGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPR 222
           TG  VAVK ++   L     ++   EV     L HPN+VKL      +    LV E+   
Sbjct: 38  TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASG 97
Query: 223 GSLENHLFRKGSLPLPWSIRMKIALGAAK------GLAFLHEEAEKPVIYRDFKTSNILL 276
           G + ++L   G        R K     AK       + + H+   K +++RD K  N+LL
Sbjct: 98  GEVFDYLVAHG--------RXKEKEARAKFRQIVSAVQYCHQ---KFIVHRDLKAENLLL 146
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVL 335
           DAD N K++DFG + +     K        G   YAAPE          + DV+S GV+L
Sbjct: 147 DADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 336 LEMLTGRRSMD 346
             +++G    D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 11  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 61
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 62  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 120
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 121 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 8   DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 58
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 59  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 117
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 118 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 143
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 144 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 141 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 34  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 84
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 85  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 143
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 144 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 141 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 28/228 (12%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ- 180
           F+ +   + +  ++ + +LG+G FG V                TG   AVK ++   ++ 
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVI---------LCKDKITGQECAVKVISKRQVKQ 66
Query: 181 --GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
               +  L EV  L  L HPN+ KL  +  +     LV E    G L + +  +      
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV 126
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAK--DA 293
            + R  I      G+ + H+     +++RD K  N+LL++   D N ++ DFGL+   +A
Sbjct: 127 DAAR--IIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +  K  +     GT  Y APE V+ G    K DV+S GV+L  +L+G
Sbjct: 182 SKKXKDKI-----GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 31  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 81
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 82  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 141 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 33  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 83
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 84  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 143 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 36  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 86
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 87  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 145
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 146 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 30/189 (15%)
Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
           P+     +  +   A+G+ FL   + +  I+RD    NILL  +   K+ DFGLA+D  +
Sbjct: 195 PITMEDLISYSFQVARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 296 D------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           +      G T +  + M      APE +     ++KSDV+S+GV+L E+ +   S     
Sbjct: 252 NPDYVRKGDTRLPLKWM------APESIFDKIYSTKSDVWSYGVLLWEIFSLGGS---PY 302
Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
           P  + +    +R   G + R      P +             Q+   C  RDPK RPR +
Sbjct: 303 PGVQMDEDFCSRLREGMRMRAPEYSTPEI------------YQIMLDCWHRDPKERPRFA 350
Query: 410 EVVETLKPL 418
           E+VE L  L
Sbjct: 351 ELVEKLGDL 359

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 15  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 65
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      + 
Sbjct: 66  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 124
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 125 SA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     + R   A  
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-E 137
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLA-EV 189
           +F+   +LGEG F  V             +  T    A+K L   H   +    ++  E 
Sbjct: 30  DFKFGKILGEGSFSTV---------VLARELATSREYAIKILEKRHIIKENKVPYVTRER 80
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     + R   A  
Sbjct: 81  DVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-RFYTA-E 137
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +GT
Sbjct: 138 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             Y +PE +        SD+++ G ++ +++ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK------IALGAA 250
           H N++      I D  R    E M    L  HL       L  +  +             
Sbjct: 100 HENIIG-----INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 154
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVSTRVMGTY 309
           +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T   T  + T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            Y APE ++     +KS D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 10/160 (6%)
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGS-----LPLP 238
           ++EVN L  L HPN+V+     I+  +    +V E+   G L + +  KG+     L   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEE 111
Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           + +R+   L  A        +    V++RD K +N+ LD   N KL DFGLA+    D  
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-- 169
Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
              +   +GT  Y +PE +       KSD++S G +L E+
Sbjct: 170 EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 14/164 (8%)
Query: 182 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWS 240
           H+E   E++ L +L HPN++KL     +     LV EF   G L   +  +        +
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA 149
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLSDFGLAKDAPEDG 297
             MK  L    G+ +LH+     +++RD K  NILL+      N K+ DFGL+    +D 
Sbjct: 150 NIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           K       +GT  Y APE V+      K DV+S GV++  +L G
Sbjct: 204 KLRDR---LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 7/155 (4%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLV-YEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           E + +  L HP  VKL  +  +DD++L     +   G L  ++ + GS     +      
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           + +A  L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +   +
Sbjct: 139 IVSA--LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 193
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT  Y +PE +        SD+++ G ++ +++ G
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  Y  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  Y  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 28/225 (12%)
Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 179
           R F  +D ++     RP   LG+G FG V+            +  +   VA+K L    +
Sbjct: 18  RHFTIDDFEIG----RP---LGKGKFGNVYLAR---------EKKSHFIVALKVLFKSQI 61
Query: 180 QGH---KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP 236
           +      +   E+    +L HPN+++L  Y  +  +  L+ E+ PRG L   L  + S  
Sbjct: 62  EKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKEL--QKSCT 119
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
                   I    A  L + H    K VI+RD K  N+LL      K++DFG +  AP  
Sbjct: 120 FDEQRTATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSL 176
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +      + GT  Y  PE +       K D++  GV+  E+L G
Sbjct: 177 RR----KTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  Y  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+MP G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+MP G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 133 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 189 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  K +L    + ++  AL
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 134 --LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCG 185
Query: 308 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +             + D++S GV++  +L G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 117/261 (44%), Gaps = 25/261 (9%)
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMK 244
           L EV  L  L HPN++KL  +  +     LV E    G L + +  +     +  ++ +K
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK 143
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 301
             L    G+ +LH+     +++RD K  N+LL++   D   K+ DFGL+  A  + +  +
Sbjct: 144 QVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLS--AVFENQKKM 195
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG--------RRSMDKNRPNGE 353
             R +GT  Y APE V+      K DV+S GV+L  +L G         + + +    G+
Sbjct: 196 KER-LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK 253
Query: 354 HNLV--EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR-PRMSE 410
           +     EW     G K    ++L    +   S + + +   +   C  ++     P ++ 
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
Query: 411 VVETLKPLQNLKDMASSSYYF 431
            +E ++  QN + +A ++  +
Sbjct: 314 AIENMRKFQNSQKLAQAALLY 334

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 23/220 (10%)
Query: 133 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 60
Query: 189 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  K +L    +   KI  
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET--RKIMR 118
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 119 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCG 172
Query: 308 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +             + D++S GV++  +L G
Sbjct: 173 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 24/227 (10%)
Query: 121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 180
           +FM N     + N+  +  LG+G F  V +          V   TGL  A K +N   L 
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLS 68
Query: 181 GH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPL 237
               ++   E      L HPN+V+L     E+    LV++ +  G L E+ + R+     
Sbjct: 69  ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA 128
Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP 294
             S  ++  L   + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  
Sbjct: 129 DASHCIQQIL---ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +    H      GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 183 DSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  IGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 133 NFRPESLLGEGGFG----CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE 188
           N+ P+ +LG G       C+ K   +E     +    G + + + +     +  +  L E
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ----ELREATLKE 73
Query: 189 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           V+ L  +  HPN+++L      +    LV++ M +G L ++L  K +L    + ++  AL
Sbjct: 74  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
              + +  LH+     +++RD K  NILLD D N KL+DFG +       K      V G
Sbjct: 134 --LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCG 185
Query: 308 TYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTG 341
           T  Y APE +             + D++S GV++  +L G
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 122/299 (40%), Gaps = 46/299 (15%)
Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQGH 182
           +++   +  P   LG G +G V     E+    P    +G  +AVK    T+N    Q  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNS---QEQ 49
Query: 183 KEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG--SLENHLFRKGSLPLPW 239
           K  L +++  +  +  P  V   G    +    +  E M          +  KG   +P 
Sbjct: 50  KRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ-TIPE 108
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
            I  KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++    +D   
Sbjct: 109 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166
Query: 300 HVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
            +     G   Y APE +       G+ + KSD++S G+ ++E+   R   D        
Sbjct: 167 DIDA---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDS------- 215
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               W  P     ++      P+L      K S +     +QCL ++ K RP   E+++
Sbjct: 216 ----WGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 85/322 (26%), Positives = 139/322 (43%), Gaps = 76/322 (23%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 196
           +G+G +G V++G W             G +VAVK  +    +  + W  E      +L  
Sbjct: 16  VGKGRYGEVWRGLW------------HGESVAVKIFSS---RDEQSWFRETEIYNTVLLR 60
Query: 197 HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
           H N++  +   +       Q  L+  +   GSL + L R+   P    + +++A+ AA G
Sbjct: 61  HDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACG 117
Query: 253 LAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 303
           LA LH E      KP I +RDFK+ N+L+ ++    ++D GLA      G  ++      
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAV-MHSQGSDYLDIGNNP 176
Query: 304 RVMGTYGYAAPEY----VMTGHLTSK--SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
           RV GT  Y APE     + T    S   +D+++FG+VL E+   RR++     NG   +V
Sbjct: 177 RV-GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI----VNG---IV 226
Query: 358 EWARPHLGDKRRFYRLL--DPRLEGHFSIKGSQKAT-----------------QLAAQCL 398
           E  RP       FY ++  DP  E    +    + T                 Q+  +C 
Sbjct: 227 EDYRP------PFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECW 280
Query: 399 SRDPKARPRMSEVVETLKPLQN 420
             +P AR     + +TL+ + N
Sbjct: 281 YPNPSARLTALRIKKTLQKISN 302

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 180
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRT---WXLCGTPEYLAPEIIL 232
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 152
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 204
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 42  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 148
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 42  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 92
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 93  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 148
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 200
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVAT 192
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 77/181 (42%), Gaps = 21/181 (11%)
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           +P  I  KI L   K L  L E  +  +I+RD K SNILLD   N KL DFG++    + 
Sbjct: 122 IPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD- 178
Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
             +   TR  G   Y APE +           +SDV+S G+ L E+ TGR       P  
Sbjct: 179 --SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY----PKW 232
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                +  +   GD         P+L      + S         CL++D   RP+  E++
Sbjct: 233 NSVFDQLTQVVKGDP--------PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 413 E 413
           +
Sbjct: 285 K 285

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 41  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 147
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 148 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 131
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 132 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 95
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 152
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 204
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 81
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 128
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 131
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 132 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT 187
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 37  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYREL 84
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 85  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 141
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 142 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 197
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 198 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 27  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 74
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 75  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 131
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 132 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 187
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 3   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 48
Query: 191 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 49  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 105
Query: 245 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 297
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 106 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 165
Query: 298 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 166 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 135
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 136 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 135
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 136 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 183
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 2   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 47
Query: 191 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 48  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 104
Query: 245 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 297
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 298 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 31  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 78
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 79  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 135
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 136 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVAT 191
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 192 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 32  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 79
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 136
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 137 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 192
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 193 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 41  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 91
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 92  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 147
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 148 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 199
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 5   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 50
Query: 191 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 51  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 107
Query: 245 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 297
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 108 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 167
Query: 298 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 168 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYXQRTLREIKILLRFR 83
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
            R    +  +G+G FG V++G              G  VAVK  +    +  + W  E  
Sbjct: 8   ARTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAE 53
Query: 191 FLGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
               ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K
Sbjct: 54  IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIK 110
Query: 245 IALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDG 297
           +AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D 
Sbjct: 111 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 170
Query: 298 KTHVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                   +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 171 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LGEG +  V+KG             T   VA+K +  +  +G     + EV+ L +L H 
Sbjct: 10  LGEGTYATVYKG---------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V L      +    LV+E++ +  L+ +L   G++    ++++       +GLA+ H 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKL-FLFQLLRGLAYCHR 118
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
           +    V++RD K  N+L++     KL+DFGLA+      KT+ +  V  T  Y  P+ ++
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILL 173
Query: 319 -TGHLTSKSDVYSFGVVLLEMLTGR 342
            +   +++ D++  G +  EM TGR
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 42  RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 87
Query: 192 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKL 144
Query: 246 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 298
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 299 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFGLAK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 48  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 152
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 153 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVAT 208
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 29  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 79
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 80  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 135
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 136 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 187
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 48  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 95
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 96  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 152
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 153 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 208
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGF 187
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 49  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 99
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 146
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 147 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 203
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 204 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 32  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 82
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 83  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 138
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 190
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R    +  +G+G FG V++G              G  VAVK  +    +  + W  E   
Sbjct: 29  RTIVLQESIGKGRFGEVWRG-----------KWRGEEVAVKIFSS---REERSWFREAEI 74
Query: 192 LGNLL--HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
              ++  H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+
Sbjct: 75  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKL 131
Query: 246 ALGAAKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGK 298
           AL  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D  
Sbjct: 132 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 191
Query: 299 THVSTRVMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
                  +GT  Y APE     +   H  S  ++D+Y+ G+V  E+
Sbjct: 192 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 189
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-G 248
             L +  H N++ +      D        ++ +  ++  L R  S  +     ++  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--------GKTH 300
             + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E         G+  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             T  + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 178 GMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGF 183
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 45  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 92
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 93  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 149
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+T
Sbjct: 150 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 205
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 206 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 28  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 78
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 79  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 134
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 135 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 186
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 49  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 155
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 131
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 132 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 189 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 35  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 85
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 132
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 133 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 189
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 190 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 26  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 76
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 123
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 124 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 180
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 181 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 35  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 85
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 86  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 141
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 193
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 124
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 125 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 27  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 133
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 37  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 134
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 135 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 191
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 192 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 29  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 126
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 127 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 183
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 184 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 102/223 (45%), Gaps = 23/223 (10%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 189
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-G 248
             L +  H N++ +      D        ++ +  ++  L R  S  +     ++  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--------GKTH 300
             + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E         G+  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
             T  + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 178 GMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 128
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 185
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 27  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 77
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 124
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 125 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 181
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 182 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 27  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 77
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 78  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 133
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 185
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHVSTRVMGTY 309
           +GL ++H      V++RD K SN+L++   + K+ DFGLA+ A PE   T   T  + T 
Sbjct: 155 RGLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            Y APE ++     +KS D++S G +L EML+ R
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 191
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L  + HPN+V L           L+ + +  G L + +  KG      + R+        
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLD 127
Query: 252 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 128 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 88
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 89  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 145
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 146 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT---LCGTPEYLAPEIIL 197
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT---LCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 38/232 (16%)
Query: 133 NFRPESLLGEGGFGCVFKG---------WVEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 180
           +F   ++LG+G FG V K           +++      K  T L+  + + +LNH   ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 181 GHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
            +  WL   NF         VK +    +     +  E+   G+L + L    +L     
Sbjct: 67  YYAAWLERRNF---------VKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRD 116
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED---- 296
              ++     + L+++H +    +I+RD K  NI +D   N K+ DFGLAK+        
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 297 --------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 339
                   G +   T  +GT  Y A E +  TGH   K D+YS G++  EM+
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 6/154 (3%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E    G L  P++V +  +   D Q  +    +    L   L R+G L  P ++ +   +
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQI 143
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G+A               +RD K  NIL+ AD  A L DFG+A    ++  T +   V G
Sbjct: 144 GSAL-----DAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-G 197
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  Y APE     H T ++D+Y+   VL E LTG
Sbjct: 198 TLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI------------- 130
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 31  SYIGEGAYGMVCSAYDNVNK---------VRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 128
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 129 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGF 185
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ DFGL +   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 191
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L  + HPN+V L           L+ + +  G L + +  KG      + R+        
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLD 127
Query: 252 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 128 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 39/267 (14%)
Query: 164 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD--QRLLVYEFMP 221
           G  + V V  +     +  +++  E   L    HPN++ ++G C         L+  +MP
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD-FKTSNILLDADY 280
            GSL N L    +  +  S  +K AL  A+G+AFLH    +P+I R    + ++++D D 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHALNSRSVMIDEDM 150
Query: 281 NAKLS--DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK---SDVYSFGVVL 335
            A++S  D   +  +P  G+       M    + APE +      +    +D++SF V+L
Sbjct: 151 TARISMADVKFSFQSP--GR-------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLL 201
Query: 336 LEMLTGRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
            E++T         N   G    +E  RP           + P +  H S        +L
Sbjct: 202 WELVTREVPFADLSNMEIGMKVALEGLRP----------TIPPGISPHVS--------KL 243
Query: 394 AAQCLSRDPKARPRMSEVVETLKPLQN 420
              C++ DP  RP+   +V  L+ +Q+
Sbjct: 244 MKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 23/213 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 191
           +FR   +LG G F  V     E+  T  +       VA+K +    L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVI--LAEDKRTQKL-------VAIKCIAKKALEGKEGSMENEIAV 69
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L  + HPN+V L           L+ + +  G L + +  KG      + R+   +  A 
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA- 128
Query: 252 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 129 -VKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 121/301 (40%), Gaps = 46/301 (15%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK----TLNHDGLQ 180
            + ++   +  P   LG G +G V     E+    P    +G  +AVK    T+N    Q
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVV-----EKMRHVP----SGQIMAVKRIRATVNS---Q 91
Query: 181 GHKEWLAEVNF-LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG--SLENHLFRKGSLPL 237
             K  L +++  +  +  P  V   G    +    +  E M          +  KG   +
Sbjct: 92  EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQT-I 150
Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
           P  I  KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++    +  
Sbjct: 151 PEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV 208
Query: 298 KTHVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 352
              +     G   Y APE +       G+ + KSD++S G+ ++E+   R   D      
Sbjct: 209 AKTIDA---GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD------ 258
Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                 W  P     ++      P+L      K S +     +QCL ++ K RP   E++
Sbjct: 259 -----SWGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELM 309
Query: 413 E 413
           +
Sbjct: 310 Q 310

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 49/236 (20%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           N +   L+G G +G V+KG ++E      +P     VAVK  +    Q    ++ E N  
Sbjct: 14  NLKLLELIGRGRYGAVYKGSLDE------RP-----VAVKVFSFANRQN---FINEKNIY 59
Query: 193 GNLL--HPNLVKLV--GYCIEDDQR---LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
              L  H N+ + +     +  D R   LLV E+ P GSL  +L    S    W    ++
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRL 116
Query: 246 ALGAAKGLAFLHEEA-----EKPVI-YRDFKTSNILLDADYNAKLSDFGLAKDAP----- 294
           A    +GLA+LH E       KP I +RD  + N+L+  D    +SDFGL+         
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 295 ---EDGKTHVSTRVMGTYGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEML 339
              E+    +S   +GT  Y APE V+ G +          + D+Y+ G++  E+ 
Sbjct: 177 RPGEEDNAAISE--VGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA++ ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIRKISPFEHQTYCQRTLREIKILLRFR 83
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T  + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMK 244
           L EV  L  L HPN++KL  +  +     LV E    G L +  + R+    +  ++ MK
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 111
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 301
             L    G  +LH+     +++RD K  N+LL++   D   K+ DFGL+      GK   
Sbjct: 112 QVLS---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-- 163
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
               +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 164 -KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     +++DFGLAK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 191
           +FR   +LG G F  V     E+  T  +       VA+K +  + L+G +  +  E+  
Sbjct: 21  DFR--DVLGTGAFSEVILA--EDKRTQKL-------VAIKCIAKEALEGKEGSMENEIAV 69
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L  + HPN+V L           L+ + +  G L + +  KG      + R+        
Sbjct: 70  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLD 127
Query: 252 GLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH+     +++RD K  N+L   LD D    +SDFGL+K   ED  + +ST   GT
Sbjct: 128 AVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGT 181
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY APE +     +   D +S GV+   +L G
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLLH 197
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            N+V+L      D +  LV+EF  +  L+ + F   +  L   I         KGL F H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               + V++RD K  N+L++ +   KL+DFGLA+      + + +  V  T  Y  P+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVL 173
Query: 318 MTGHLTSKS-DVYSFGVVLLEMLTGRRSM 345
               L S S D++S G +  E+    R +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
            ++  AT   R    LG G FG V +  +E+  T       G   AVK +  +  +    
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 134
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
              E+     L  P +V L G   E     +  E +  GSL   +  +G LP     R  
Sbjct: 135 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRAL 188
Query: 245 IALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDG---KT 299
             LG A +GL +LH    + +++ D K  N+LL +D  +A L DFG A     DG     
Sbjct: 189 YYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSL 245
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                + GT  + APE V+     +K DV+S   ++L ML G
Sbjct: 246 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ D+GLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 95/222 (42%), Gaps = 29/222 (13%)
Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
            ++  AT   R    LG G FG V +  +E+  T       G   AVK +  +  +    
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHR--MEDKQT-------GFQCAVKKVRLEVFRAE-- 115
Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
              E+     L  P +V L G   E     +  E +  GSL   +  +G LP     R  
Sbjct: 116 ---ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRAL 169
Query: 245 IALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDG---KT 299
             LG A +GL +LH    + +++ D K  N+LL +D  +A L DFG A     DG     
Sbjct: 170 YYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDL 226
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
                + GT  + APE V+     +K DV+S   ++L ML G
Sbjct: 227 LTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 58/242 (23%)
Query: 133 NFRPESLLGEGGFGCVFKG---------WVEENGTAPVKPGTGLT--VAVKTLNHD-GLQ 180
           +F   ++LG+G FG V K           +++      K  T L+  + + +LNH   ++
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 181 GHKEWLAEVNFLGNLL----HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH------LF 230
            +  WL   NF+  +        L   + YC   + R L Y+ +   +L         LF
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYC---ENRTL-YDLIHSENLNQQRDEYWRLF 122
Query: 231 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
           R+                  + L+++H +    +I+RD K  NI +D   N K+ DFGLA
Sbjct: 123 RQ----------------ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLA 163
Query: 291 KDAPED------------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLE 337
           K+                G +   T  +GT  Y A E +  TGH   K D+YS G++  E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 338 ML 339
           M+
Sbjct: 224 MI 225

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMK 244
           L EV  L  L HPN++KL  +  +     LV E    G L +  + R+    +  ++ MK
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHV 301
             L    G  +LH+     +++RD K  N+LL++   D   K+ DFGL+      GK   
Sbjct: 129 QVLS---GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM-- 180
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
               +GT  Y APE V+      K DV+S GV+L  +L G
Sbjct: 181 -KERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 104/223 (46%), Gaps = 23/223 (10%)
Query: 128 KLATRNFRPESLLGEGGFGCVF---KGWVEENGTA-PVKPGTGLTVAVKTLNHDGLQGHK 183
           K+   NF    +LG G +G VF   K    + G    +K     T+  K    +  +  +
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           + L  +        P LV L  Y  + + +L L+ +++  G L  HL ++          
Sbjct: 110 QVLEHIR-----QSPFLVTL-HYAFQTETKLHLILDYINGGELFTHLSQRERFT---EHE 160
Query: 243 MKIALG-AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++I +G     L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D +T  
Sbjct: 161 VQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETER 216
Query: 302 STRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTG 341
           +    GT  Y AP+ V    +GH     D +S GV++ E+LTG
Sbjct: 217 AYDFCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E G             VK    +     K     VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLLH 197
           +GEG +G VFK    +         TG  VA+K    + D     K  L E+  L  L H
Sbjct: 11  IGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           PNLV L+       +  LV+E+     L  H   +    +P  +   I     + + F H
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +      I+RD K  NIL+      KL DFG A+     G +      + T  Y +PE +
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLL--TGPSDYYDDEVATRWYRSPELL 174
Query: 318 M-TGHLTSKSDVYSFGVVLLEMLTG 341
           +         DV++ G V  E+L+G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 23/223 (10%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 189
           + +F+ +SLLGEG +G V         +A  KP TG  VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVV--------CSATHKP-TGEIVAIKKIEPFDKPLFALRTLREI 60
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL-G 248
             L +  H N++ +      D        ++ +  ++  L R  S  +     ++  +  
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--------GKTH 300
             + +  LH      VI+RD K SN+L++++ + K+ DFGLA+   E         G+  
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                + T  Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 51/283 (18%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           F  ES LG G    V++   ++ GT   KP   L V  KT++   ++       E+  L 
Sbjct: 55  FEVESELGRGATSIVYR--CKQKGTQ--KP-YALKVLKKTVDKKIVR------TEIGVLL 103
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK-- 251
            L HPN++KL        +  LV E +  G L + +  KG          + A  A K  
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY------SERDAADAVKQI 157
Query: 252 --GLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              +A+LHE     +++RD K  N+L      D   K++DFGL+K         +   V 
Sbjct: 158 LEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVC 211
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           GT GY APE +       + D++S G++   +L G       R               GD
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER---------------GD 256
Query: 367 KRRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLSRDPKAR 405
           +  F R+L+   E +F      + S  A  L  + +  DPK R
Sbjct: 257 QFMFRRILN--CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKR 297

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 131/295 (44%), Gaps = 55/295 (18%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRV 305
             + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +  L
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VL 239
Query: 365 GDKRR---------FYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
           G   R         +     P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 240 GTPTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 132/293 (45%), Gaps = 51/293 (17%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +  LG 
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIK-VLGT 241
Query: 367 KRR---------FYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
             R         +     P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 131/294 (44%), Gaps = 53/294 (18%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQG      E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQGKAFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRV 305
             + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +   
Sbjct: 188 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLG 240
Query: 365 GDKRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNF 191
           ++  S +G G +G V   +        VK  +GL +AVK L+     +   K    E+  
Sbjct: 53  YQTLSPVGSGAYGSVCSSY-------DVK--SGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 192 LGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++  I
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI 160
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR 
Sbjct: 161 -YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR- 215
Query: 306 MGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
                Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 216 ----WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 164
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 165 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 218
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 276
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDD-HVQFLI-YQILR 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 33  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 83
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 130
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 131 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
               + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 188 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 43/229 (18%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLL 196
           LG+G +G V+K          +   TG  VAVK +  D  Q   +      E+  L  L 
Sbjct: 17  LGKGAYGIVWKS---------IDRRTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELS 66
Query: 197 -HPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            H N+V L+     D+ R   LV+++M     + H   + ++  P   +  +     K +
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVH-KQYVVYQLIKVI 122
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE------------------ 295
            +LH      +++RD K SNILL+A+ + K++DFGL++                      
Sbjct: 123 KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 296 -DGKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
            D    + T  + T  Y APE ++ +   T   D++S G +L E+L G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 42/222 (18%)
Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLL 196
           S +GEG +G V   +   N          + VA+K ++    Q + +  L E+  L    
Sbjct: 34  SYIGEGAYGMVCSAYDNLNK---------VRVAIKKISPFEHQTYCQRTLREIKILLRFR 84
Query: 197 HPNLVKLVG-------------YCIEDDQRLLVYEFMPRGSLEN-HLFRKGSLPLPWSIR 242
           H N++ +               Y ++D     +Y+ +    L N H+             
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI------------- 131
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA-PEDGKTHV 301
                   +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A P+   T  
Sbjct: 132 CYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 188
Query: 302 STRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
               + T  Y APE ++     +KS D++S G +L EML+ R
Sbjct: 189 LXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 61  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 107
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 164
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 165 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 218
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 276
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 65  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 111
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 168
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 169 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 222
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 280
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 281 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 332

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 63  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 109
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 166
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 167 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 220
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 278
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 279 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 330

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 89
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 90  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 146
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 147 ---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 198
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLXGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLAGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 20/206 (9%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG G FG V K   EE  T       GL +A K +   G++  +E   E++ +  L H 
Sbjct: 96  ILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           NL++L       +  +LV E++  G L + +  + S  L     +       +G+  +H 
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH- 204
Query: 259 EAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
             +  +++ D K  NIL    DA    K+ DFGLA+      K  V+    GT  + APE
Sbjct: 205 --QMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVN---FGTPEFLAPE 258
Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTG 341
            V    ++  +D++S GV+   +L+G
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 46  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 92
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 149
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 150 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 203
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 261
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 262 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 313

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 97
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 98  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 154
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 155 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 206
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 40  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 90
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 91  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 146
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 147 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 198
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 50  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 156
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 208
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 94/222 (42%), Gaps = 51/222 (22%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH---KEWLAEVNFLGNLL 196
           +G G +G V          + +   +G  VA+K L+    Q     K    E+  L ++ 
Sbjct: 32  VGSGAYGSV---------CSAIDKRSGEKVAIKKLSR-PFQSEIFAKRAYRELLLLKHMQ 81
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           H N++ L+              F P  SL N  F    L +P+   M+  L    GL F 
Sbjct: 82  HENVIGLLDV------------FTPASSLRN--FYDFYLVMPF---MQTDLQKIMGLKFS 124
Query: 257 HEEAE---------------KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            E+ +                 V++RD K  N+ ++ D   K+ DFGLA+ A  +   +V
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 184
Query: 302 STRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            TR      Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 185 VTR-----WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           L KL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 36  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 86
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 87  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 142
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 194
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 55  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 101
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 158
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 159 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 212
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 270
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 271 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 322

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 35  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 81
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 138
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 139 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 192
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 250
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 251 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 302

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 21/183 (11%)
Query: 169 VAVKTLNH--DGLQGHKEWLAEVNFLGNLLHPNLVKLV-----GYCIED-DQRLLVYEFM 220
           VAVK L+     L   +    E+  L +L H N++ L+        IED  +  LV   M
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 221 PRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
             G+  N++ +  +L       +   L   +GL ++H      +I+RD K SN+ ++ D 
Sbjct: 116 --GADLNNIVKSQALSDEHVQFLVYQL--LRGLKYIHSAG---IIHRDLKPSNVAVNEDS 168
Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEML 339
             ++ DFGLA+ A E+   +V+TR      Y APE ++   H     D++S G ++ E+L
Sbjct: 169 ELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 340 TGR 342
            G+
Sbjct: 224 QGK 226

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 53/294 (18%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 106 VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 152
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRG--SLENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 209
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAP--EDGKTHVSTRV 305
             + LA++H      + +RD K  N+LLD D    KL DFG AK     E   +++ +R 
Sbjct: 210 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 306 MGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
                Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +   
Sbjct: 267 -----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLG 319
Query: 365 GDKRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
              R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 320 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 373

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 142
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 143 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 196
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 254
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 255 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           L KL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           KGL ++H      V++RD K  N+ ++ D   K+ DFGLA+ A  +   +V TR      
Sbjct: 155 KGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 206
Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 49  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 99
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 155
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 207
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 180
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 232
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 103
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           L KL  +  +D+  L +V E+ P G + +HL R G    P +     A        +LH 
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA--RFYAAQIVLTFEYLHS 160
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     K++DFG AK     G+T     + GT  Y APE ++
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 212
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEV-- 189
           + + P+ ++G G    V +          V   TG   AVK +     +   E L EV  
Sbjct: 94  QKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 190 ------NFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
                 + L  +  HP+++ L+          LV++ M +G L ++L  K +L    +  
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET-- 202
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
             I     + ++FLH      +++RD K  NILLD +   +LSDFG +       K    
Sbjct: 203 RSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR-- 257
Query: 303 TRVMGTYGYAAPEYVMTGHLTS------KSDVYSFGVVLLEMLTG 341
             + GT GY APE +      +      + D+++ GV+L  +L G
Sbjct: 258 -ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 23/213 (10%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFL 192
           F  +  LG G F  V             +  TG   AVK +    L+G +  +  E+  L
Sbjct: 24  FEFKETLGTGAFSEV---------VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVL 74
Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAK 251
             + H N+V L       +   LV + +  G L + +  KG       S  ++  L A  
Sbjct: 75  RKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDA-- 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH      +++RD K  N+L    D +    +SDFGL+K    +GK  V +   GT
Sbjct: 133 -VYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSK---MEGKGDVMSTACGT 185
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GY APE +     +   D +S GV+   +L G
Sbjct: 186 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 39  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 85
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 142
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 143 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 196
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 254
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 255 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 306

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WY 184
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 33/226 (14%)
Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--- 182
           +++   R+ +P   +G G +G V          + V   TG  VA+K L +   Q     
Sbjct: 22  EVRAVYRDLQP---VGSGAYGAV---------CSAVDGRTGAKVAIKKL-YRPFQSELFA 68
Query: 183 KEWLAEVNFLGNLLHPNLVKLVGYCIED---DQRLLVYEFMP-RGSLENHLFRKGSLPLP 238
           K    E+  L ++ H N++ L+     D   D     Y  MP  G+    L +   L   
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG-- 126
Query: 239 WSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
              R++ +     KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A  + 
Sbjct: 127 -EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182
Query: 298 KTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
              V TR      Y APE ++     T   D++S G ++ EM+TG+
Sbjct: 183 XGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 40  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 86
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 143
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 144 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 197
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 255
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 256 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 307

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A E+   +V+TR      
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----W 185
Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+  FGLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 28  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 74
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 131
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 132 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 185
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 243
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 244 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 295

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 32  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 78
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 135
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 136 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 189
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 247
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 248 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 299

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +     ++       LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 184
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+++D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIII 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GL ++H      +I+RD K SN+ ++ D   ++ DFGLA+ A E+   +V+TR      
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----W 193
Query: 311 YAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           Y APE ++   H     D++S G ++ E+L G+
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 90/212 (42%), Gaps = 18/212 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 123
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 180
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G T     + GT  Y APE ++
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT---LCGTPEYLAPEIIL 232
Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           +       D ++ GV++ EM  G      ++P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 31  VIGNGSFGVVYQAKLCDSGE---------LVAIKKV----LQDKRFKNRELQIMRKLDHC 77
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 134
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 135 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSX--IC 188
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 246
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 247 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 298

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 132/292 (45%), Gaps = 49/292 (16%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG V++  + ++G           VA+K +    LQ  +    E+  +  L H 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGEL---------VAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 199 NLVKLVGYCI-----EDDQRL-LVYEFMPRGS--LENHLFR-KGSLPLPWSIRMKIALGA 249
           N+V+L  +       +D+  L LV +++P     +  H  R K +LP+   I +K+ +  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV---IYVKLYMYQ 130
Query: 250 A-KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMG 307
             + LA++H      + +RD K  N+LLD D    KL DFG AK     G+ +VS   + 
Sbjct: 131 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVS--YIC 184
Query: 308 TYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           +  Y APE +      TS  DV+S G VL E+L G+     +  +G   LVE  +     
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD--SGVDQLVEIIKVLGTP 242
Query: 367 KRRFYRLLD--------PRLEGH-----FSIKGSQKATQLAAQCLSRDPKAR 405
            R   R ++        P+++ H     F  +   +A  L ++ L   P AR
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 98/239 (41%), Gaps = 41/239 (17%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 190
           N+  + L+G G +G V+  +            T   VA+K +N   + L   K  L E+ 
Sbjct: 27  NYIIKHLIGRGSYGYVYLAY---------DKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77
Query: 191 FLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            L  L    +++L    I DD      L +   +    L+  LF+         I+  I 
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK-LFKTPIFLTEEHIKT-IL 135
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS---- 302
                G  F+HE     +I+RD K +N LL+ D + K+ DFGLA+    +  T++     
Sbjct: 136 YNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 303 ----------------TRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRS 344
                           T  + T  Y APE ++     +KS D++S G +  E+L   +S
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVNFLGNLLH 197
           +GEG +G VFK    E         T   VA+K   L+ D        L E+  L  L H
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            N+V+L      D +  LV+EF  +  L+ + F   +  L   I         KGL F H
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
               + V++RD K  N+L++ +   KL++FGLA+      + + +  V  T  Y  P+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVL 173
Query: 318 MTGHLTSKS-DVYSFGVVLLEMLTGRRSM 345
               L S S D++S G +  E+    R +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TGL VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 190
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 6   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 56
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGA 249
               L HPN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L  
Sbjct: 57  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-- 114
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 306
            + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      
Sbjct: 115 -ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 167
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ +M  G
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 102/250 (40%), Gaps = 46/250 (18%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVN 190
           N+  + L+G G +G V+  + ++N            VA+K +N   + L   K  L E+ 
Sbjct: 29  NYEIKHLIGRGSYGYVYLAY-DKNANK--------NVAIKKVNRMFEDLIDCKRILREIT 79
Query: 191 FLGNLLHPNLVKLVGYCI-ED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
            L  L    +++L    I ED    D+  +V E     S    LF+         ++  I
Sbjct: 80  ILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEQHVKT-I 136
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS--- 302
                 G  F+HE     +I+RD K +N LL+ D + K+ DFGLA+    D   H+    
Sbjct: 137 LYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 303 --------------------TRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
                               T  + T  Y APE ++   + T+  D++S G +  E+L  
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253
Query: 342 RRSMDKNRPN 351
            +S   N  N
Sbjct: 254 MKSHINNPTN 263

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 190
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 7   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGA 249
               L HPN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L  
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-- 115
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 306
            + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      
Sbjct: 116 -ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V      E G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 206 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 263 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 305
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 306 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 50  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 100
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 156
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATR-----WY 208
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V         ++  +  TG  VA+K + +  D +   K  L E+  L +  H
Sbjct: 63  IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 113
Query: 198 PNLVKLVGY---CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
            N++ +       +   +   VY  +     + H     S PL             +GL 
Sbjct: 114 DNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYA 312
           ++H      VI+RD K SN+L++ +   K+ DFG+A+        H    T  + T  Y 
Sbjct: 174 YMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 313 APEYVMTGH-LTSKSDVYSFGVVLLEMLTGRR 343
           APE +++ H  T   D++S G +  EML  R+
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 204 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 261 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 303
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 304 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 70/172 (40%), Gaps = 22/172 (12%)
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D         
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     T +SDV+SFGV+L E+ +                   A P+ G
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPG 298
Query: 366 DK--RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            K    F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 299 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 26/182 (14%)
Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           +P  I  KIA+   K L  LH +    VI+RD K SN+L++A    K  DFG++    +D
Sbjct: 133 IPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
Query: 297 GKTHVSTRVMGTYGYAAPEYV-----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN 351
               +     G   Y APE +       G+ + KSD++S G+  +E+   R   D     
Sbjct: 191 VAKDIDA---GCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYDS---- 242
Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                  W  P     ++      P+L      K S +     +QCL ++ K RP   E+
Sbjct: 243 -------WGTP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPEL 291
Query: 412 VE 413
            +
Sbjct: 292 XQ 293

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVN 190
           N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E  
Sbjct: 7   NYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGA 249
               L HPN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L  
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-- 115
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVM 306
            + +A+ H      +++R+ K  N+LL +       KL+DFGLA +  +    H      
Sbjct: 116 -ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFA 168
Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GT GY +PE +     +   D+++ GV+L  +L G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEV 189
           +N  P   +G G +G V          A     TGL VAVK L+     +   K    E+
Sbjct: 25  QNLSP---VGSGAYGSV---------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 72
Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             L ++ H N++ L+          E +   LV   M  G+  N++ +   L     ++ 
Sbjct: 73  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQF 129
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            I     +GL ++H      +I+RD K SN+ ++ D   K+ D GLA+   ++   +V+T
Sbjct: 130 LI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVAT 185
Query: 304 RVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
           R      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 186 R-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 43/302 (14%)
Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 183
           F  + +  R +     +G GG   VF+   E+     +K      V ++  ++  L  ++
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 184 EWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSI 241
             +A +N L    H + +++L  Y I D     +Y  M  G+++ N   +K     PW  
Sbjct: 75  NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D  + V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV 184
Query: 302 STRVMGTYGYAAPEYV-----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
               +GT  Y  PE +               ++ KSDV+S G +L  M  G+    +   
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-- 242
Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                        +    + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 243 -------------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 411 VV 412
           ++
Sbjct: 290 LL 291

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 82  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 225 LENHLFRKGSLPLPWSIRMKIALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYN-A 282
           L   + + G LP     R    LG A +GL +LH    + +++ D K  N+LL +D + A
Sbjct: 137 LGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 190
Query: 283 KLSDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
            L DFG A     DG          + GT  + APE VM     +K D++S   ++L ML
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250
Query: 340 TG 341
            G
Sbjct: 251 NG 252

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 36/240 (15%)
Query: 197 HPNLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFR---KGSLPLPWSIRMKIALGA 249
           HPN+++LV YC+ +     +  L+  F  RG+L N + R   KG+      I + + LG 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-LWLLLGI 143
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP---EDGKTHVSTRVM 306
            +GL  +H    K   +RD K +NILL  +    L D G    A    E  +  ++ +  
Sbjct: 144 CRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 307 G----TYGYAAPE-YVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
                T  Y APE + +  H  +  ++DV+S G VL  M+ G    D     G+   +  
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA- 259
Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
                         +  +L    S + S    QL    ++ DP  RP +  ++  L+ LQ
Sbjct: 260 --------------VQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 69/169 (40%), Gaps = 22/169 (13%)
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D            
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK- 367
             + APE +     T +SDV+SFGV+L E+ +                   A P+ G K 
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG-----------------ASPYPGVKI 299
Query: 368 -RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
              F R L            + +  Q    C   +P  RP  SE+VE L
Sbjct: 300 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 117/290 (40%), Gaps = 49/290 (16%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
            +R   LLG+GGFG VF G      T  ++    +    + L    L        EV  L
Sbjct: 32  EYRLGPLLGKGGFGTVFAG---HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 193 GNLL----HPNLVKLVGYCIEDDQRLLVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIAL 247
             +     HP +++L+ +    +  +LV E  +P   L +++  KG L    S   +   
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---RCFF 145
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFG---LAKDAPEDGKTHVST 303
           G    +A +     + V++RD K  NIL+D     AKL DFG   L  D P        T
Sbjct: 146 GQV--VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-------YT 196
Query: 304 RVMGTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
              GT  Y+ PE++      +  + V+S G++L +M+ G    ++++   E  L      
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL------ 250
Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                             HF    S     L  +CL+  P +RP + E++
Sbjct: 251 ------------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 26  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 132
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++    V+TR      Y
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WY 184
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 96  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 150
Query: 225 LENHLFRKGSLPLPWSIRMKIALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYN-A 282
           L   + + G LP     R    LG A +GL +LH    + +++ D K  N+LL +D + A
Sbjct: 151 LGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 204
Query: 283 KLSDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
            L DFG A     DG          + GT  + APE VM     +K D++S   ++L ML
Sbjct: 205 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 264
Query: 340 TG 341
            G
Sbjct: 265 NG 266

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V         ++  +  TG  VA+K + +  D +   K  L E+  L +  H
Sbjct: 62  IGNGAYGVV---------SSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH 112
Query: 198 PNLVKLVGYCIEDDQRLLV--------YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            N++      I+D  R  V        Y  +     + H     S PL            
Sbjct: 113 DNII-----AIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL 167
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMG 307
            +GL ++H      VI+RD K SN+L++ +   K+ DFG+A+        H    T  + 
Sbjct: 168 LRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 308 TYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRR 343
           T  Y APE +++ H  T   D++S G +  EML  R+
Sbjct: 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 81/182 (44%), Gaps = 16/182 (8%)
Query: 165 TGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGS 224
           TG   AVK +  +  +     + E+     L  P +V L G   E     +  E +  GS
Sbjct: 98  TGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 152
Query: 225 LENHLFRKGSLPLPWSIRMKIALGAA-KGLAFLHEEAEKPVIYRDFKTSNILLDADYN-A 282
           L   + + G LP     R    LG A +GL +LH    + +++ D K  N+LL +D + A
Sbjct: 153 LGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRA 206
Query: 283 KLSDFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
            L DFG A     DG          + GT  + APE VM     +K D++S   ++L ML
Sbjct: 207 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 266
Query: 340 TG 341
            G
Sbjct: 267 NG 268

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 195
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGLA 254
            H N+VKL        + +LV+E + +   +     +G L    S+  K   L    G+A
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKSFLLQLLNGIA 114
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
           + H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH       T  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           AP+ +M +   ++  D++S G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 30/210 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 195
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGLA 254
            H N+VKL        + +LV+E + +   +     +G L    S+  K   L    G+A
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKSFLLQLLNGIA 114
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
           + H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH       T  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV----TLWYR 167
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           AP+ +M +   ++  D++S G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNL 195
           +GEG +G V+K           +   G T A+K +      +G+      + E++ L  L
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTT--IREISILKEL 57
Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK-IALGAAKGLA 254
            H N+VKL        + +LV+E + +   +     +G L    S+  K   L    G+A
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE---SVTAKSFLLQLLNGIA 114
Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
           + H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH     + T  Y 
Sbjct: 115 YCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYR 167
Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTG 341
           AP+ +M +   ++  D++S G +  EM+ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P +     A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA--RFYAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT  Y AP  ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEYLAPAIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 39/218 (17%)
Query: 140 LGEGGFG--CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGN 194
           +G+G FG  C+    V++N T  +        A+K +N        E      E+  +  
Sbjct: 23  IGKGSFGKVCI----VQKNDTKKM-------YAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL-----FRKGSLPLPWSIRMKIALG 248
           L HP LV L  Y  +D++ + +V + +  G L  HL     F++ ++ L           
Sbjct: 72  LEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICE 123
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               L +L  +    +I+RD K  NILLD   +  ++DF +A   P + +    T + GT
Sbjct: 124 LVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGT 177
Query: 309 YGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRR 343
             Y APE   +      +   D +S GV   E+L GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 43/302 (14%)
Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL   
Sbjct: 15  MADDDVLFEDVYELCEVIGKGAFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST- 70
Query: 183 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS-- 240
           ++   E +    L HP++V+L+     D    +V+EFM    L   + ++      +S  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDG 297
           +         + L + H+     +I+RD K  N+LL +  N+   KL DFG+A    E G
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESG 187
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
              V+   +GT  + APE V         DV+  GV+L  +L+G                
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG---------------- 229
Query: 358 EWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               P  G K R +         ++PR   H     S+ A  L  + L  DP  R  + E
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283
Query: 411 VV 412
            +
Sbjct: 284 AL 285

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSI 241
            E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  
Sbjct: 189 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 246
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGK 298
           +M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+
Sbjct: 247 QMLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 294
Query: 299 THVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           T +   + GT  Y APE ++   T       D +S GV+L   L+G              
Sbjct: 295 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------------- 340
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMS 409
                 P   + R    L D    G ++       + S+KA  L  + L  DPKAR    
Sbjct: 341 -----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 410 EVV 412
           E +
Sbjct: 396 EAL 398

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 50/242 (20%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 242
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 121
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 122 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 169
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 214
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMSE 410
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR    E
Sbjct: 215 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 270
Query: 411 VV 412
            +
Sbjct: 271 AL 272

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 101/242 (41%), Gaps = 50/242 (20%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 242
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 128
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 129 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 176
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 221
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMSE 410
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR    E
Sbjct: 222 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE 277
Query: 411 VV 412
            +
Sbjct: 278 AL 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 242
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 170
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 43/302 (14%)
Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 183
           F  + +  R +     +G GG   VF+   E+     +K      V ++  ++  L  ++
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYR 74
Query: 184 EWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSI 241
             +A +N L    H + +++L  Y I D     +Y  M  G+++ N   +K     PW  
Sbjct: 75  NEIAYLNKLQQ--HSDKIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE- 128
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D    V
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVV 184
Query: 302 STRVMGTYGYAAPEYV-----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
               +GT  Y  PE +               ++ KSDV+S G +L  M  G+    +   
Sbjct: 185 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-- 242
Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                        +    + + ++DP  E  F     +    +   CL RDPK R  + E
Sbjct: 243 -------------INQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPE 289
Query: 411 VV 412
           ++
Sbjct: 290 LL 291

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 242
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 170
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 200 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSIR 242
           E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  +
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQ 122
Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+T
Sbjct: 123 MLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GET 170
Query: 300 HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            +   + GT  Y APE ++   T       D +S GV+L   L+G               
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--------------- 215
Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKAR 405
                P   + R    L D    G ++       + S+KA  L  + L  DPKAR
Sbjct: 216 ----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +      E   EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            +LHPN++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 254 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 89/215 (41%), Gaps = 38/215 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G F  V+KG ++   T  V       +  + L     Q  KE   E   L  L HPN
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEV---AWCELQDRKLTKSERQRFKE---EAEXLKGLQHPN 86
Query: 200 LVKLVGY---------CIEDDQRLLVYEFMPRGSLENHLFR----KGSLPLPWSIRMKIA 246
           +V+             CI     +LV E    G+L+ +L R    K  +   W  ++   
Sbjct: 87  IVRFYDSWESTVKGKKCI-----VLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI--- 138
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRV 305
               KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  V
Sbjct: 139 ---LKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           +GT  + APE     +  S  DVY+FG   LE  T
Sbjct: 191 IGTPEFXAPEXYEEKYDES-VDVYAFGXCXLEXAT 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-----ENHLFRKGSLPLPWSI 241
            E+  L  L HP ++K+  +  + +   +V E M  G L      N   ++ +  L +  
Sbjct: 203 TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL-YFY 260
Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGK 298
           +M +A+       +LHE     +I+RD K  N+LL   + D   K++DFG +K     G+
Sbjct: 261 QMLLAV------QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---GE 308
Query: 299 THVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           T +   + GT  Y APE ++   T       D +S GV+L   L+G              
Sbjct: 309 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-------------- 354
Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSI------KGSQKATQLAAQCLSRDPKARPRMS 409
                 P   + R    L D    G ++       + S+KA  L  + L  DPKAR    
Sbjct: 355 -----YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 409
Query: 410 EVV 412
           E +
Sbjct: 410 EAL 412

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 72
Query: 200 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 73  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 128
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 129 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 185 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---------------IINQ 229
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 230 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 200 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG+G +G V+ G    N          + +A+K +     +  +    E+    +L H 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 79
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK---GLAF 255
           N+V+ +G   E+    +  E +P GSL + L R    PL  +    I     +   GL +
Sbjct: 80  NIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDN-EQTIGFYTKQILEGLKY 137
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           LH+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y A
Sbjct: 138 LHDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMA 191
Query: 314 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           PE +  G       +D++S G  ++EM TG+
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 69
Query: 200 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 70  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 125
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 126 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 226
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAEVNFLGNLLH 197
           +G G +G V          A     TG  VAVK L+     +   K    E+  L ++ H
Sbjct: 30  VGSGAYGSV---------CAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 80
Query: 198 PNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
            N++ L+          E +   LV   M  G+  N++ +   L     ++  I     +
Sbjct: 81  ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDD-HVQFLI-YQILR 136
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           GL ++H      +I+RD K SN+ ++ D   K+ DF LA+   ++   +V+TR      Y
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WY 188
Query: 312 AAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGR 342
            APE ++   H     D++S G ++ E+LTGR
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V     +E+G             VK    +     K  L  VNF      P 
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF------PF 102
Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LVKL  +  +D+  L +V E++  G + +HL R G    P + R   A        +LH 
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RF-YAAQIVLTFEYLHS 159
Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                +IYRD K  N+L+D     +++DFG AK     G+T     + GT    APE ++
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRT---WXLCGTPEALAPEIIL 211
Query: 319 TGHLTSKSDVYSFGVVLLEMLTG 341
           +       D ++ GV++ EM  G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 43/286 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 68
Query: 200 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 69  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 124
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  PE +
Sbjct: 125 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 181 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 225
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 226 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 119/296 (40%), Gaps = 55/296 (18%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LV   G C+  D+ +LV EF+  GSL+ +L + K  + + W + +   L AA     +H 
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA-----MHF 128
Query: 259 EAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDA-PEDGKTHVSTRVMGTY 309
             E  +I+ +    NILL  + +         KLSD G++    P+D    +  R+    
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI---- 181
Query: 310 GYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHL 364
            +  PE +    +L   +D +SFG  L E+ +G      ++D  R               
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--------------- 226
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKA--TQLAAQCLSRDPKARPRMSEVVETLKPL 418
             K +FY       E    +   + A    L   C+  +P  RP    ++  L  L
Sbjct: 227 --KLQFY-------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S GV++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V +          V+  TG     K +N            E++ +  L HP 
Sbjct: 59  LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           L+ L     +  + +L+ EF+  G L + +  +    +  +  +     A +GL  +HE 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 260 AEKPVIYRDFKTSNILLDAD--YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +   +++ D K  NI+ +     + K+ DFGLA     D    V+T    T  +AAPE V
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIV 222
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTG 341
               +   +D+++ GV+   +L+G
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 29/262 (11%)
Query: 164 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD--QRLLVYEFMP 221
           G  + V V  +     +  +++  E   L    HPN++ ++G C         L+  + P
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD-FKTSNILLDADY 280
            GSL N L    +  +  S  +K AL  A+G AFLH    +P+I R    + ++ +D D 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHALNSRSVXIDEDX 150
Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            A++S   +       G+ +    V        PE          +D +SF V+L E++T
Sbjct: 151 TARISXADVKFSFQSPGRXYAPAWVAPEALQKKPEDTN----RRSADXWSFAVLLWELVT 206
Query: 341 GRRSMD--KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
                    N   G    +E  RP           + P +  H S        +L   C 
Sbjct: 207 REVPFADLSNXEIGXKVALEGLRP----------TIPPGISPHVS--------KLXKICX 248
Query: 399 SRDPKARPRMSEVVETLKPLQN 420
           + DP  RP+   +V  L+  Q+
Sbjct: 249 NEDPAKRPKFDXIVPILEKXQD 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG+G +G V+ G    N          + +A+K +     +  +    E+    +L H 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQ---------VRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK---GLAF 255
           N+V+ +G   E+    +  E +P GSL + L R    PL  +    I     +   GL +
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLKDN-EQTIGFYTKQILEGLKY 123
Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           LH+     +++RD K  N+L++  Y+   K+SDFG +K     G    +    GT  Y A
Sbjct: 124 LHDNQ---IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLA--GINPCTETFTGTLQYMA 177
Query: 314 PEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           PE +  G       +D++S G  ++EM TG+
Sbjct: 178 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN+VKL     +     LV E +  G L   + +K       +  +   L +A  ++ +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHM 122
Query: 257 HEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H+     V++RD K  N+L    + +   K+ DFG A+  P D +  + T    T  YAA
Sbjct: 123 HDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPCF-TLHYAA 177
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +         D++S GV+L  ML+G+     +    + +L   +   +  K +    
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH----DRSLTCTSAVEIMKKIK---- 229
Query: 374 LDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 409
                +G FS +G      SQ+A  L    L+ DP  R +MS
Sbjct: 230 -----KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V +  V E  T       G   A K +        +    E+  +  L HP 
Sbjct: 59  LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV L     +D++ +++YEFM  G L   +  + +  +     ++      KGL  +HE 
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 260 AEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                ++ D K  NI+     +   KL DFGL           V+T   GT  +AAPE  
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 222
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTG 341
               +   +D++S GV+   +L+G
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 50/313 (15%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 196
           +G+G +G V+ G W             G  VAVK            W  E      +L  
Sbjct: 45  IGKGRYGEVWMGKW------------RGEKVAVKVF---FTTEEASWFRETEIYQTVLMR 89
Query: 197 HPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
           H N++  +   I+      Q  L+ ++   GSL ++L    S  L     +K+A  +  G
Sbjct: 90  HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSG 146
Query: 253 LAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPEDGKTHV--STR 304
           L  LH E      KP I +RD K+ NIL+  +    ++D GLA K   +  +  +  +TR
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206
Query: 305 VMGTYGYAAPEYVMTG----HLTS--KSDVYSFGVVLLEMLTGRRSMD----KNRPNGEH 354
           V GT  Y  PE +       H  S   +D+YSFG++L E+   RR +     +      H
Sbjct: 207 V-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYH 263
Query: 355 NLVEWARPHLGDKRRFYRL--LDPRLEGHFSIKGS-QKATQLAAQCLSRDPKARPRMSEV 411
           +LV  + P   D R    +  L P     +S     ++  +L  +C + +P +R     V
Sbjct: 264 DLVP-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322
Query: 412 VETLKPLQNLKDM 424
            +TL  +   +D+
Sbjct: 323 KKTLAKMSESQDI 335

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 57/109 (52%), Gaps = 13/109 (11%)
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL--AKDAPEDGK 298
           + + I +  A+ + FLH    K +++RD K SNI    D   K+ DFGL  A D  E+ +
Sbjct: 165 VCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 299 THVSTR--------VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEML 339
           T ++           +GT  Y +PE +   + + K D++S G++L E+L
Sbjct: 222 TVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 29/227 (12%)
Query: 127 LKLATRNFRPESL------LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ 180
           + L T N   +S+      LG+G F  V +          VK   G   A K +N   L 
Sbjct: 11  VDLGTENLYFQSMYQLFEELGKGAFSVVRRC---------VKVLAGQEYAAKIINTKKLS 61
Query: 181 G--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPL 237
              H++   E      L HPN+V+L     E+    L+++ +  G L E+ + R+     
Sbjct: 62  ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA 121
Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP 294
             S  ++  L A      LH   +  V++RD K  N+LL +       KL+DFGLA +  
Sbjct: 122 DASHCIQQILEAV-----LHCH-QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV- 174
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            +G+        GT GY +PE +         D+++ GV+L  +L G
Sbjct: 175 -EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 92/233 (39%), Gaps = 40/233 (17%)
Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +F   ++LG+G FG V K     N             A+K + H   +     L+EV  L
Sbjct: 7   DFEEIAVLGQGAFGQVVKA---RNAL------DSRYYAIKKIRHTE-EKLSTILSEVXLL 56
Query: 193 GNLLHPNLVKLVGYCIE-------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
            +L H  +V+     +E                  +  E+    +L + L    +L    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQR 115
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED--- 296
               ++     + L+++H +    +I+R+ K  NI +D   N K+ DFGLAK+       
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 297 ---------GKTHVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 339
                    G +   T  +GT  Y A E +  TGH   K D YS G++  E +
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V +  V E  T       G   A K +        +    E+  +  L HP 
Sbjct: 165 LGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV L     +D++ +++YEFM  G L   +  + +  +     ++      KGL  +HE 
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 260 AEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
                ++ D K  NI+     +   KL DFGL           V+T   GT  +AAPE  
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVA 328
Query: 318 MTGHLTSKSDVYSFGVVLLEMLTG 341
               +   +D++S GV+   +L+G
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 76/182 (41%), Gaps = 29/182 (15%)
Query: 201 VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP------WSIRMKIALGAAKGL 253
           +  + Y  +DD  L LV ++   G L   L  K    LP      +   M IA+ +   L
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEEMARFYLAEMVIAIDSVHQL 194
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            ++H         RD K  NIL+D + + +L+DFG      EDG    S  V GT  Y +
Sbjct: 195 HYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 244
Query: 314 PEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
           PE +       G    + D +S GV + EML G        P    +LVE     +  K 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE------TPFYAESLVETYGKIMNHKE 298
Query: 369 RF 370
           RF
Sbjct: 299 RF 300

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/286 (22%), Positives = 114/286 (39%), Gaps = 43/286 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G GG   VF+   E+     +K      V ++  ++  L  ++  +A +N L    H +
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIK-----YVNLEEADNQTLDSYRNEIAYLNKLQQ--HSD 116
Query: 200 -LVKLVGYCIEDDQRLLVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            +++L  Y I D     +Y  M  G+++ N   +K     PW  R        + +  +H
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKNMLEAVHTIH 172
Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV 317
           +     +++ D K +N L+  D   KL DFG+A     D  + V    +G   Y  PE +
Sbjct: 173 QHG---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 318 -----------MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
                          ++ KSDV+S G +L  M  G+    +                +  
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI---------------INQ 273
Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
             + + ++DP  E  F     +    +   CL RDPK R  + E++
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 13  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            + HPN++ L          +L+ E +  G L + L  K SL    + +    +    G+
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 121
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT
Sbjct: 122 HYLH---SKRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 174
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE V    L  ++D++S GV+   +L+G                  A P LG+ +
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETK 216
Query: 369 RF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +        ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 19/178 (10%)
Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG 181
           F+   ++L     R   +L EGGF  V++             G+G   A+K L  +  + 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQ---------DVGSGREYALKRLLSNEEEK 68
Query: 182 HKEWLAEVNFLGNLL-HPNLVKLVGYCI----EDDQ---RLLVYEFMPRGSLENHLFRKG 233
           ++  + EV F+  L  HPN+V+          E D      L+   + +G L   L +  
Sbjct: 69  NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128
Query: 234 SL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA 290
           S  PL     +KI     + +  +H + + P+I+RD K  N+LL      KL DFG A
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 20  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 70
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            + HPN++ L          +L+ E +  G L + L  K SL    + +    +    G+
Sbjct: 71  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 128
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT
Sbjct: 129 HYLH---SKRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 181
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE V    L  ++D++S GV+   +L+G                  A P LG+ +
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETK 223
Query: 369 RF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +        ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 224 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 272

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 51/289 (17%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 34  LGSGQFAIVRKCR---------QKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILR 84
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            + HPN++ L          +L+ E +  G L + L  K SL    + +    +    G+
Sbjct: 85  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGV 142
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +LH    K + + D K  NI+L  D N      KL DFG+A    E G       + GT
Sbjct: 143 HYLH---SKRIAHFDLKPENIML-LDKNVPNPRIKLIDFGIAHKI-EAGNEF--KNIFGT 195
Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             + APE V    L  ++D++S GV+   +L+G                  A P LG+ +
Sbjct: 196 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLGETK 237
Query: 369 RF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +        ++   +  +    S+ A     + L +DPK R  +++ +E
Sbjct: 238 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLE 286

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG+G F  +FKG   E G       T   V +K L+       + +    + +  L H +
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKGLAFLHE 258
           LV   G C   D+ +LV EF+  GSL+ +L + K  + + W  ++++A   A  + FL E
Sbjct: 74  LVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEE 131
Query: 259 EAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDA-PEDGKTHVSTRVMGTY 309
                +I+ +    NILL  + +         KLSD G++    P+D    +  R+    
Sbjct: 132 NT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI---- 181
Query: 310 GYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPHL 364
            +  PE +    +L   +D +SFG  L E+ +G      ++D  R               
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--------------- 226
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKA--TQLAAQCLSRDPKARPRMSEVVETLKPL 418
             K +FY       E    +   + A    L   C+  +P  RP    ++  L  L
Sbjct: 227 --KLQFY-------EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 348
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 349 SVDDALQ 355

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 229
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 348
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 349 SVDDALQ 355

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 140 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYY 193
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ EM+ G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 311
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 312 SVDDALQ 318

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 139 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 192
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 252
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 253 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 311
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 312 SVDDALQ 318

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 137 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 190
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 250
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 251 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 309
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 310 SVDDALQ 316

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 13/160 (8%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           E+  L  L HPN+VKLV    +  +D   +V+E + +G +      K   PL        
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQARFY 142
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                KG+ +LH +    +I+RD K SN+L+  D + K++DFG++ +    G   + +  
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDALLSNT 197
Query: 306 MGTYGYAAPEYVMTGH--LTSKS-DVYSFGVVLLEMLTGR 342
           +GT  + APE +       + K+ DV++ GV L   + G+
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 304 SVDDALQ 310

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 303
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 304 SVDDALQ 310

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 304
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 305 SVDDALQ 311

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 245
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 246 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 304
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 305 SVDDALQ 311

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 66/137 (48%), Gaps = 14/137 (10%)
Query: 211 DQRLLVYEFMPRGSL---ENHLF---RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPV 264
           D+  ++YE+M   S+   + + F   +  +  +P  +   I        +++H E  K +
Sbjct: 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNI 173
Query: 265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHL 322
            +RD K SNIL+D +   KLSDFG   +   D K   S    GTY +  PE+    + + 
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFG-ESEYMVDKKIKGSR---GTYEFMPPEFFSNESSYN 229
Query: 323 TSKSDVYSFGVVLLEML 339
            +K D++S G+ L  M 
Sbjct: 230 GAKVDIWSLGICLYVMF 246

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 32/187 (17%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK-NR---------PNGEHN 355
            APE ++        D++S G ++ EM+       GR  +D+ N+         P     
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 251
Query: 356 LVEWARPHLGDKRRFYRLLDPRL---------EGHFSIKGSQKATQLAAQCLSRDPKARP 406
           L    R ++ ++ ++  L  P+L           H  +K SQ A  L ++ L  DP  R 
Sbjct: 252 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ-ARDLLSKMLVIDPAKRI 310
Query: 407 RMSEVVE 413
            + + ++
Sbjct: 311 SVDDALQ 317

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           ++G G FG VF+  + E+            VA+K +    LQ  +    E+  +  + HP
Sbjct: 47  VIGNGSFGVVFQAKLVESD----------EVAIKKV----LQDKRFKNRELQIMRIVKHP 92
Query: 199 NLVKLVGYCIEDDQRL------LVYEFMPRGSLE-NHLFRKGSLPLPWSIRMKIALGAAK 251
           N+V L  +   +  +       LV E++P      +  + K    +P  +         +
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK--DAPEDGKTHVSTRVMGT 308
            LA++H      + +RD K  N+LLD      KL DFG AK   A E   + + +R    
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 309 YGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
             Y APE +    + T+  D++S G V+ E++ G+
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 38/231 (16%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 186
           +   R+      +G+G +G V++G W  EN            VAVK  +    +  K W 
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 48
Query: 187 AEVNFLGNLL--HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
            E      ++  H N++  +   +       Q  L+  +   GSL ++L +  +L     
Sbjct: 49  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSC 107
Query: 241 IRMKIALGAAKGLAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAP 294
           +R  I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   + 
Sbjct: 108 LR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165
Query: 295 EDGKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
              +  V     +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 166 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 254 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           +G+G F  V +          VK  TG   A K +N   L    H++   E      L H
Sbjct: 12  IGKGAFSVVRRC---------VKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
            N+V+L     E+    LV++ +  G L E+ + R+       S  ++  L A      L
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----L 117
Query: 257 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H   +  V++RD K  N+LL +       KL+DFGLA +   D +        GT GY +
Sbjct: 118 HCH-QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D+++ GV+L  +L G
Sbjct: 175 PEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 23/214 (10%)
Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           + F    +LG G F  VF            +  TG   A+K +             E+  
Sbjct: 9   KTFIFMEVLGSGAFSEVF---------LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAV 59
Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP-WSIRMKIALGAA 250
           L  + H N+V L           LV + +  G L + +  +G       S+ ++  L A 
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNIL-LDADYNAKL--SDFGLAKDAPEDGKTHVSTRVMG 307
           K   +LHE     +++RD K  N+L L  + N+K+  +DFGL+K   ++G   + +   G
Sbjct: 120 K---YLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNG---IMSTACG 169
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T GY APE +     +   D +S GV+   +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 254 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +      E   EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 254 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 27/212 (12%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK------EWLAEVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +      E   EV+ L 
Sbjct: 20  LGSGQFAIVKKCR---------EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            +LH N++ L          +L+ E +  G L + L +K SL    +      +    G+
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGV 128
Query: 254 AFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG       + GT 
Sbjct: 129 NYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--KNIFGTP 182
Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + APE V    L  ++D++S GV+   +L+G
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 143 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 196
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+  +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 128 KLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL 186
           +   R       +G+G +G V++G W  EN            VAVK  +    +  K W 
Sbjct: 33  RTVARQITLLECVGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWF 77
Query: 187 AEVNFLGNLL--HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
            E      ++  H N++  +   +       Q  L+  +   GSL ++L +  +L     
Sbjct: 78  RETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSC 136
Query: 241 IRMKIALGAAKGLAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAP 294
           +R  I L  A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   + 
Sbjct: 137 LR--IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 194
Query: 295 EDGKTHVSTR-VMGTYGYAAPEY----VMTGHLTS--KSDVYSFGVVLLEM 338
              +  V     +GT  Y APE     +      S  + D+++FG+VL E+
Sbjct: 195 STNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + + T  + T  Y
Sbjct: 132 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 185
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT------GRRSMDK 347
            APE ++        D++S G ++ EM+       GR  +D+
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 19/215 (8%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNF 191
           +  +  +  G +G V  G   E     +K         +T+N   D     K  L E+  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRL 82
Query: 192 LGNLLHPNLVKLVGYCIEDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           L +  HPN++ L    +  ++       LV E M R  L   +  +  +  P  I+    
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-FM 140
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRV 305
                GL  LHE     V++RD    NILL  + +  + DF LA+ D  +  KTH  T  
Sbjct: 141 YHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH- 196
Query: 306 MGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEML 339
                Y APE VM     T   D++S G V+ EM 
Sbjct: 197 ---RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV+ L  +LH N++ L          +L+ E +  G L + L +K SL    +      +
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNI-LLDADY---NAKLSDFGLAKDAPEDGKTHVST 303
               G+ +LH    K + + D K  NI LLD +    + KL DFGLA +  EDG      
Sbjct: 125 --LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEF--K 176
Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            + GT  + APE V    L  ++D++S GV+   +L+G
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG+G F  V +          +K  TG   A K +N   L    H++   E      L H
Sbjct: 12  LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           PN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L +       
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL- 121
Query: 257 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
                  +++RD K  N+LL +       KL+DFGLA +   D +        GT GY +
Sbjct: 122 -----NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D+++ GV+L  +L G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 42/251 (16%)
Query: 108 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTG 166
           +F E  K  +QL K    +++L   +F    ++G G FG V          A VK   T 
Sbjct: 54  EFLEWAKPFTQLVK----EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTE 99
Query: 167 LTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPR 222
              A+K LN   +    E   +  E + L N      +  + Y  +D+  L LV ++   
Sbjct: 100 RIYAMKILNKWEMLKRAETACFREERDVLVNG-DCQWITALHYAFQDENHLYLVMDYYVG 158
Query: 223 GSLENHLFRKGSLPLPWSI------RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 276
           G L   L  K    LP  +       M +A+ +   L ++H         RD K  N+LL
Sbjct: 159 GDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLL 208
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSF 331
           D + + +L+DFG      +DG    S  V GT  Y +PE +       G    + D +S 
Sbjct: 209 DVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSL 267
Query: 332 GVVLLEMLTGR 342
           GV + EML G 
Sbjct: 268 GVCMYEMLYGE 278

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 42/251 (16%)
Query: 108 KFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTG 166
           +F E  K  +QL K    +++L   +F    ++G G FG V          A VK   T 
Sbjct: 70  EFLEWAKPFTQLVK----EMQLHREDFEIIKVIGRGAFGEV----------AVVKMKNTE 115
Query: 167 LTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPR 222
              A+K LN   +    E   +  E + L N      +  + Y  +D+  L LV ++   
Sbjct: 116 RIYAMKILNKWEMLKRAETACFREERDVLVNG-DCQWITALHYAFQDENHLYLVMDYYVG 174
Query: 223 GSLENHLFRKGSLPLPWSI------RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL 276
           G L   L  K    LP  +       M +A+ +   L ++H         RD K  N+LL
Sbjct: 175 GDLLT-LLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLL 224
Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSF 331
           D + + +L+DFG      +DG    S  V GT  Y +PE +       G    + D +S 
Sbjct: 225 DVNGHIRLADFGSCLKMNDDGTVQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSL 283
Query: 332 GVVLLEMLTGR 342
           GV + EML G 
Sbjct: 284 GVCMYEMLYGE 294

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG GG G VF           V       VA+K +     Q  K  L E+  +  L H N
Sbjct: 19  LGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 200 LVKL--------------VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           +VK+              VG   E +   +V E+M    L N +  +G L L    R+  
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLAN-VLEQGPL-LEEHARL-F 125
Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAK--DAPEDGKTHVS 302
                +GL ++H      V++RD K +N+ ++  D   K+ DFGLA+  D     K H+S
Sbjct: 126 MYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 303 TRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
             ++ T  Y +P  +++  + T   D+++ G +  EMLTG+
Sbjct: 183 EGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 38/219 (17%)
Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-- 196
           +G+G +G V++G W  EN            VAVK  +    +  K W  E      ++  
Sbjct: 16  VGKGRYGEVWRGSWQGEN------------VAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 197 HPNLVKLVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
           H N++  +   +       Q  L+  +   GSL ++L +  +L     +R  I L  A G
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR--IVLSIASG 117
Query: 253 LAFLHEEA----EKPVI-YRDFKTSNILLDADYNAKLSDFGLA-KDAPEDGKTHVSTR-V 305
           LA LH E      KP I +RD K+ NIL+  +    ++D GLA   +    +  V     
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 306 MGTYGYAAPEY------VMTGHLTSKSDVYSFGVVLLEM 338
           +GT  Y APE       V       + D+++FG+VL E+
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 87/215 (40%), Gaps = 19/215 (8%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDGLQGHKEWLAEVNF 191
           +  +  +  G +G V  G   E     +K         +T+N   D     K  L E+  
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-KRVLREIRL 82
Query: 192 LGNLLHPNLVKLVGYCIEDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           L +  HPN++ L    +  ++       LV E M R  L   +  +  +  P  I+    
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-FM 140
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK-DAPEDGKTHVSTRV 305
                GL  LHE     V++RD    NILL  + +  + DF LA+ D  +  KTH  T  
Sbjct: 141 YHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH- 196
Query: 306 MGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEML 339
                Y APE VM     T   D++S G V+ EM 
Sbjct: 197 ---RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRR----FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG+G F  V +          +K  TG   A K +N   L    H++   E      L H
Sbjct: 12  LGKGAFSVVRRC---------MKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           PN+V+L     E+    LV++ +  G L E+ + R+       S  ++  L +       
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL- 121
Query: 257 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
                  +++RD K  N+LL +       KL+DFGLA +   D +        GT GY +
Sbjct: 122 -----NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPGYLS 174
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D+++ GV+L  +L G
Sbjct: 175 PEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 30/218 (13%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 197
           LLGEG +  V            V    G   AVK +             EV  L     +
Sbjct: 20  LLGEGAYAKV---------QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGN 70
Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
            N+++L+ +  EDD R  LV+E +  GS+  H+ ++       + R+   + AA  L FL
Sbjct: 71  KNILELIEF-FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFL 127
Query: 257 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAP-EDGKTHVSTRVM----GT 308
           H    K + +RD K  NIL ++       K+ DF L       +  T ++T  +    G+
Sbjct: 128 H---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGS 184
Query: 309 YGYAAPEY--VMTGHLT---SKSDVYSFGVVLLEMLTG 341
             Y APE   V T   T    + D++S GVVL  ML+G
Sbjct: 185 AEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 35/221 (15%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 197
           +LG+G    VF+G  ++         TG   A+K  N+   L+     + E   L  L H
Sbjct: 16  ILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 198 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKG 252
            N+VKL  + IE++     ++L+ EF P GSL   L     +  LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  ED +  VS  + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVS--LYGT 178
Query: 309 YGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEMLTG 341
             Y  P+      L         +  D++S GV      TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG+G F  V +          VK   G   A   +N   L    H++   E      L H
Sbjct: 19  LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           PN+V+L     E+    L+++ +  G L E+ + R+       S  ++  L A      L
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAV-----L 124
Query: 257 HEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
           H   +  V++R+ K  N+LL +       KL+DFGLA +   +G+        GT GY +
Sbjct: 125 HCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV--EGEQQAWFGFAGTPGYLS 181
Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           PE +         D+++ GV+L  +L G
Sbjct: 182 PEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 87/220 (39%), Gaps = 36/220 (16%)
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN++ L     +     +V E M  G L + + R+       +    +     K + +L
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA--SAVLFTITKTVEYL 132
Query: 257 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 311
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY---TANF 186
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +      +  D++S GV+L  MLTG         NG  +  E     +G      
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF----ANGPDDTPEEILARIG------ 236
Query: 372 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 405
                   G FS+ G      S  A  L ++ L  DP  R
Sbjct: 237 -------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQR 269

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 43/305 (14%)
Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 179
           R  M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL
Sbjct: 14  RGSMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGL 70
Query: 180 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPW 239
              ++   E +    L HP++V+L+     D    +V+EFM    L   + ++      +
Sbjct: 71  ST-EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 129
Query: 240 S--IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAP 294
           S  +         + L + H+     +I+RD K   +LL +  N+   KL  FG+A    
Sbjct: 130 SEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           E G   V+   +GT  + APE V         DV+  GV+L  +L+G             
Sbjct: 187 ESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------------- 231
Query: 355 NLVEWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                  P  G K R +         ++PR   H     S+ A  L  + L  DP  R  
Sbjct: 232 -----CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERIT 282
Query: 408 MSEVV 412
           + E +
Sbjct: 283 VYEAL 287

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN++ L     +     LV E M  G L + + R+       +  +   +G  K + +L
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG--KTVEYL 137
Query: 257 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 311
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 138 HSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---TANF 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +         D++S G++L  ML G         NG  +  E     +G      
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIGS----- 242
Query: 372 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                   G F++ G      S+ A  L ++ L  DP  R    +V++
Sbjct: 243 --------GKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 89/216 (41%), Gaps = 21/216 (9%)
Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 188
           T +++    LG+G F  V +          VK       A K +N   L    H++   E
Sbjct: 30  TDDYQLFEELGKGAFSVVRRC---------VKKTPTQEYAAKIINTKKLSARDHQKLERE 80
Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
                 L HPN+V+L     E+    LV++ +  G L   +  +      +      +  
Sbjct: 81  ARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASHC 135
Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRV 305
             + L  ++   +  +++RD K  N+LL +       KL+DFGLA +    G+       
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV--QGEQQAWFGF 193
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            GT GY +PE +         D+++ GV+L  +L G
Sbjct: 194 AGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A       + T  + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++     +  D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 36/228 (15%)
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN++ L     +     LV E M  G L + + R+       +  +   +G  K + +L
Sbjct: 80  HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG--KTVEYL 137
Query: 257 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 311
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 138 HSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY---TANF 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +         D++S G++L  ML G         NG  +  E     +G      
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF----ANGPSDTPEEILTRIG------ 241
Query: 372 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                   G F++ G      S+ A  L ++ L  DP  R    +V++
Sbjct: 242 -------SGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQ 282

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 116/302 (38%), Gaps = 43/302 (14%)
Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           M +D  L    +    ++G+G F  V +    E G    +    +    K  +  GL   
Sbjct: 15  MADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQ---QFAVKIVDVAKFTSSPGLST- 70
Query: 183 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS-- 240
           ++   E +    L HP++V+L+     D    +V+EFM    L   + ++      +S  
Sbjct: 71  EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDG 297
           +         + L + H+     +I+RD K   +LL +  N+   KL  FG+A    E G
Sbjct: 131 VASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 187
Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
              V+   +GT  + APE V         DV+  GV+L  +L+G                
Sbjct: 188 L--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG---------------- 229
Query: 358 EWARPHLGDKRRFYR-------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
               P  G K R +         ++PR   H     S+ A  L  + L  DP  R  + E
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRMLMLDPAERITVYE 283
Query: 411 VV 412
            +
Sbjct: 284 AL 285

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 48/234 (20%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL--NHDGLQGHKEWLAEVNFLGNLL 196
           L+G G +G V + + +              VA+K +    + L   K  L E+  L  L 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKR---------VVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 197 HPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           H ++VK++   I  D     +  +V E     S    LFR         I+  +      
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPVYLTELHIKT-LLYNLLV 167
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHVS------- 302
           G+ ++H      +++RD K +N L++ D + K+ DFGLA+  D PE+G + +        
Sbjct: 168 GVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 303 ----------------TRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEML 339
                           T  + T  Y APE + +  + T   DV+S G +  E+L
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+  +
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 18  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 125
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 126 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 176
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 218
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 419
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
Query: 420 NLKDMASS 427
             + ++S+
Sbjct: 279 TQQALSSA 286

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 18  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 125
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 126 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 176
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 218
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 419
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 219 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278
Query: 420 NLKDMASS 427
             + ++S+
Sbjct: 279 TQQALSSA 286

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 419
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 420 NLKDMASS 427
             + ++S+
Sbjct: 280 TQQALSSA 287

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 40/237 (16%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV+ L  + HPN++ L          +L+ E +  G L + L  K SL    +      +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTH 300
               G+ +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K  
Sbjct: 124 --LNGVYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 176
Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
               + GT  + APE V    L  ++D++S GV+   +L+G                  A
Sbjct: 177 ----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------A 214
Query: 361 RPHLGDKRR----FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            P LGD ++        ++   E  +    S  A     + L +DPK R  + + ++
Sbjct: 215 SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGKFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 419
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 420 NLKDMASS 427
             + ++S+
Sbjct: 280 TQQALSSA 287

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 6/90 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A       + T  + T  Y
Sbjct: 136 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYY 189
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE ++        D++S G ++ E++ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 197
           +LG+G    VF+G  ++         TG   A+K  N+   L+     + E   L  L H
Sbjct: 16  ILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 198 PNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIALGAAKG 252
            N+VKL  + IE++     ++L+ EF P GSL   L     +  LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +      + GT
Sbjct: 125 MNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VXLYGT 178
Query: 309 YGYAAPEYVMTGHLT--------SKSDVYSFGVVLLEMLTG 341
             Y  P+      L         +  D++S GV      TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 44/254 (17%)
Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIA 246
           EV+ L  + HPN++ L          +L+ E +  G L + L  K SL    +   +K  
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKT 299
           L    G+ +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K 
Sbjct: 124 LN---GVYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
                + GT  + APE V    L  ++D++S GV+   +L+G                  
Sbjct: 177 -----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ 213
Query: 360 ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET- 414
           A P LGD ++        ++   E  +    S  A     + L +DPK R  + + ++  
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273
Query: 415 -LKPLQNLKDMASS 427
            +KP    + ++S+
Sbjct: 274 WIKPKDTQQALSSA 287

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 33/218 (15%)
Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL----NHDGLQGHKEWLAEV 189
           +R  + LGEG +G V+K          +   T  TVA+K +      +G+ G    + EV
Sbjct: 36  YRRITKLGEGTYGEVYKA---------IDTVTNETVAIKRIRLEHEEEGVPGTA--IREV 84
Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
           + L  L H N+++L      + +  L++E+     L+ ++ +   + +   +        
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYMDKNPDVSM--RVIKSFLYQL 141
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--APEDGKTHVS 302
             G+ F H    +  ++RD K  N+LL     +     K+ DFGLA+    P    TH  
Sbjct: 142 INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH-- 196
Query: 303 TRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEML 339
              + T  Y  PE ++ + H ++  D++S   +  EML
Sbjct: 197 --EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 57/284 (20%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
           D ++        ++   E  +    S  A     + L +DPK R
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A   G + +    + T  Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVVTRYY 191
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
            APE ++        D++S G ++ EM+  +
Sbjct: 192 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 195 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 243
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 300
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 134 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 360 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 245 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 299
Query: 416 KPLQNL 421
            P Q +
Sbjct: 300 DPAQRI 305

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 123/308 (39%), Gaps = 59/308 (19%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKCR---------EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKG 252
            + HPN++ L          +L+ E +  G L + L  K SL    +   +K  L    G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN---G 126
Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAK--DAPEDGKTHVSTRV 305
           + +LH      + + D K  NI+L  D N      K+ DFGLA   D   + K      +
Sbjct: 127 VYYLHS---LQIAHFDLKPENIML-LDRNVPKPRIKIIDFGLAHKIDFGNEFKN-----I 177
Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
            GT  + APE V    L  ++D++S GV+   +L+G                  A P LG
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ASPFLG 219
Query: 366 DKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ 419
           D ++        ++   E  +    S  A     + L +DPK R  + + ++   +KP  
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 420 NLKDMASS 427
             + ++S+
Sbjct: 280 TQQALSSA 287

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 119/280 (42%), Gaps = 34/280 (12%)
Query: 146 GCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLV 204
           GC+  G +     A  +   G  V +K L H G  +     +AE  FL  ++HP++V++ 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 205 GYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
            +    D+       +V E++   SL+    R     LP +  +   L     L++LH  
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT 319
               ++Y D K  NI+L  +   KL D G        G  +      GT G+ APE V T
Sbjct: 202 G---LVYNDLKPENIML-TEEQLKLIDLGAVSRINSFGYLY------GTPGFQAPEIVRT 251
Query: 320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGDKRRFYRLL---- 374
           G  T  +D+Y+ G  L  +     ++D    NG + + +    P L     + RLL    
Sbjct: 252 GP-TVATDIYTVGRTLAAL-----TLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAI 305
Query: 375 --DPRLEGHFSIKGSQKATQLAAQCLSRDPKA-RPRMSEV 411
             DPR     + + S + T +  + +++D    RP +S +
Sbjct: 306 DPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 25  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 72
Query: 195 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 243
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 300
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 133 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 185 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243
Query: 360 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 244 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 298
Query: 416 KPLQNL 421
            P Q +
Sbjct: 299 DPAQRI 304

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 195 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 243
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 300
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 134 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 360 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 245 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 299
Query: 416 KPLQNL 421
            P Q +
Sbjct: 300 DPAQRI 305

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 111/287 (38%), Gaps = 59/287 (20%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYEFM-PRGSLENHLFRKGSLPLPWSIRMKIALGA 249
             +      +++L+ +    D  +L+ E M P   L + +  +G+L     +        
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQE--ELARSFFWQV 123
Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPEDGKTHVSTRV 305
            + +   H      V++RD K  NIL+D +    KL DFG   L KD        V T  
Sbjct: 124 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-------VYTDF 173
Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            GT  Y+ PE++       +S  V+S G++L +M+ G    + +         E  R  +
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQV 225
Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             ++R                 S +   L   CL+  P  RP   E+
Sbjct: 226 FFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 76/306 (24%), Positives = 125/306 (40%), Gaps = 50/306 (16%)
Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 26  IGQGTFGEVFKARHRK---------TGQKVALKKV---LMENEKEGFPITALREIKILQL 73
Query: 195 LLHPNLVKLVGYCIEDDQ--------RLLVYEFMPR---GSLENHLFRKGSLPLPWSIRM 243
           L H N+V L+  C               LV++F      G L N L +     +   ++M
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTH 300
            +      GL ++H      +++RD K +N+L+  D   KL+DFGLA+    A       
Sbjct: 134 LL-----NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 185
Query: 301 VSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
              RV+ T  Y  PE ++         D++  G ++ EM T    M  N    +  L+  
Sbjct: 186 YXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 244
Query: 360 ----ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                 P +      Y L + +LE    +KG ++  +   +   RDP A   + +++  L
Sbjct: 245 LCGSITPEVWPNVDNYELYE-KLE---LVKGQKRKVKDRLKAYVRDPYALDLIDKLL-VL 299
Query: 416 KPLQNL 421
            P Q +
Sbjct: 300 DPAQRI 305

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 196
           E+ +G G +G V            V+ GT +  A K +    ++    +  E+  + +L 
Sbjct: 31  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 81
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKGLAF 255
           HPN+++L     ++    LV E    G L   +  K       + R MK  L A   +A+
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAY 138
Query: 256 LHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
            H+     V +RD K  N L      D   KL DFGLA    + GK  + T+V GT  Y 
Sbjct: 139 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKM-MRTKV-GTPYYV 192
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +P+ V+ G    + D +S GV++  +L G
Sbjct: 193 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 196
           E+ +G G +G V            V+ GT +  A K +    ++    +  E+  + +L 
Sbjct: 14  ENTIGRGSWGEV---------KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD 64
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAKGLAF 255
           HPN+++L     ++    LV E    G L   +  K       + R MK  L A   +A+
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAY 121
Query: 256 LHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
            H+     V +RD K  N L      D   KL DFGLA    + GK  + T+V GT  Y 
Sbjct: 122 CHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKM-MRTKV-GTPYYV 175
Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           +P+ V+ G    + D +S GV++  +L G
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 31/163 (19%)
Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           +G+ +LH+     +++ D K  NILL + Y   + K+ DFG+++     G       +MG
Sbjct: 142 EGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMG 195
Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y APE +    +T+ +D+++ G++   +LT                     P +G+ 
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH------------------TSPFVGED 237
Query: 368 RRFYRLLDPRLEGHFSIKG----SQKATQLAAQCLSRDPKARP 406
            +   L   ++   +S +     SQ AT      L ++P+ RP
Sbjct: 238 NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP 280

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 10/131 (7%)
Query: 214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           L++ E M  G L + +  +G          +I       + FLH      + +RD K  N
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 139
Query: 274 ILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 330
           +L    + D   KL+DFG AK+  ++    + T     Y Y APE +         D++S
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPY-YVAPEVLGPEKYDKSCDMWS 195
Query: 331 FGVVLLEMLTG 341
            GV++  +L G
Sbjct: 196 LGVIMYILLCG 206

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 122
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 123 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 170 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 219
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 30  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 141 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 183
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 184 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 233
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 234 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 10/131 (7%)
Query: 214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           L++ E M  G L + +  +G          +I       + FLH      + +RD K  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPEN 158
Query: 274 ILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYS 330
           +L    + D   KL+DFG AK+  ++    + T     Y Y APE +         D++S
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPY-YVAPEVLGPEKYDKSCDMWS 214
Query: 331 FGVVLLEMLTG 341
            GV++  +L G
Sbjct: 215 LGVIMYILLCG 225

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 15  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 126 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 168
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 169 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 218
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 219 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 30  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 141 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 183
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 184 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 233
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 234 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 127 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 170 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 219
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 19/169 (11%)
Query: 188 EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLFRKGS------LPLPW 239
           E+  L  L HPN++ L  V     D +  L++++          F + S      + LP 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----NAKLSDFGLAK--DA 293
            +   +      G+ +LH      V++RD K +NIL+  +       K++D G A+  ++
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
Query: 294 PEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTG 341
           P      +   V+ T+ Y APE ++   H T   D+++ G +  E+LT 
Sbjct: 185 PLKPLADLDP-VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 117
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 118 QVLEAVRHCHNXG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 165 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 215 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 16  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 122
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 123 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 169
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 170 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 219
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 220 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 66/145 (45%), Gaps = 20/145 (13%)
Query: 211 DQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF 269
           D+  LV+E M  GS+ +H+ ++     L  S+   +    A  L FLH    K + +RD 
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKGIAHRDL 137
Query: 270 KTSNILLDADYN---AKLSDFGLAKDAPEDGKTH-VSTRVM----GTYGYAAPEYV---- 317
           K  NIL +        K+ DFGL      +G    +ST  +    G+  Y APE V    
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 318 -MTGHLTSKSDVYSFGVVLLEMLTG 341
                   + D++S GV+L  +L+G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 50  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 161 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 203
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 204 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 253
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 254 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 149
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 150 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 247 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 142 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 184
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 185 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 234
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 58  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 169 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 211
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 212 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 261
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 262 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 299

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 14  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 65  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 124
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 125 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 167
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 168 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 217
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 218 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 142 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 184
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 185 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 234
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 247
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 109/297 (36%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 38  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R       W
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS----FFW 144
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
            +   +      G           V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 145 QVLEAVRHCHNCG-----------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 191
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 192 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 241
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 242 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 279

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 31  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 142 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 184
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 185 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 234
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 235 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 247
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 247
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 248 --------EIIGGQVFFRQ-----------RVSXECQHLIRWCLALRPSDRPTFEEI 285

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 58  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 169 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 211
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 212 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 261
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 262 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 63  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 173
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 174 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 216
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 217 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 266
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 267 ---EIIRGQVFFRQRV----------------SXECQHLIRWCLALRPSDRPTFEEI 304

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 43  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 154 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 196
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 197 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 246
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 247 --------EIIGGQVFFRQ-----------RVSXECQHLIRWCLALRPSDRPTFEEI 284

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 91/227 (40%), Gaps = 55/227 (24%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 44  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 155 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 197
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG 341
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G
Sbjct: 198 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 122 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 165 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              E  R  +  ++R                 S +   L   CL+  P  RP   E+
Sbjct: 215 ---EIIRGQVFFRQRV----------------SSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 79/297 (26%)
Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW------LAEVNFL 192
           LLG GGFG V+ G         ++    L VA+K +  D +    E         EV  L
Sbjct: 11  LLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 193 GNLL--HPNLVKLVGYCIEDDQRLLVYE-----------FMPRGSLENHLFRKGSLPLPW 239
             +      +++L+ +    D  +L+ E              RG+L+  L R     +  
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFG---LAKDAPE 295
           ++R     G               V++RD K  NIL+D +    KL DFG   L KD   
Sbjct: 122 AVRHCHNCG---------------VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
                V T   GT  Y+ PE++       +S  V+S G++L +M+ G    + +      
Sbjct: 165 -----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----- 214
Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    +   + F+R            + S +   L   CL+  P  RP   E+
Sbjct: 215 --------EIIGGQVFFRQ-----------RVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 85/222 (38%), Gaps = 25/222 (11%)
Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
           +L HPN+V+     +      ++ E+   G L   +   G      +      L    G+
Sbjct: 72  SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL--LSGV 129
Query: 254 AFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           ++ H      + +RD K  N LLD       K+ DFG +K +    +   +   +GT  Y
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAY 183
Query: 312 AAPEYVMTGHLTSK-SDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHLGDKRR 369
            APE ++      K +DV+S GV L  ML G     D   P      ++           
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ----------- 232
Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
             R+L  +      I+ S +   L ++    DP  R  + E+
Sbjct: 233 --RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 85/220 (38%), Gaps = 36/220 (16%)
Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           HPN++ L     +     +V E    G L + + R+       +    +     K + +L
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREA--SAVLFTITKTVEYL 132
Query: 257 HEEAEKPVIYRDFKTSNIL-LDADYN---AKLSDFGLAKDA-PEDGKTHVSTRVMGTYGY 311
           H +    V++RD K SNIL +D   N    ++ DFG AK    E+G          T  +
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY---TANF 186
Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +      +  D++S GV+L   LTG         NG  +  E     +G      
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPF----ANGPDDTPEEILARIG------ 236
Query: 372 RLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 405
                   G FS+ G      S  A  L ++ L  DP  R
Sbjct: 237 -------SGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQR 269
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	490
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	0.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-160
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-88
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-67
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-65
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-63
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-63
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-60
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-57
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-46
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-43
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-41
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-41
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	4e-40
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-40
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-40
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-39
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-39
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-38
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-38
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-38
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-35
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-33
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-31
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-31
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-30
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-30
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-30
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-29
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-29
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-29
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-28
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-27
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-04
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-26
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-26
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-26
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	9e-26
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-25
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-25
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	8e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	6e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-23
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-22
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-20
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-20
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-10
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-06

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  535 bits (1382), Expect = 0.0
 Identities = 111/321 (34%), Positives = 175/321 (54%), Gaps = 30/321 (9%)

Query: 111 EELKVAS-QLRKFMFNDLKLATRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKP 163
           + L+V+  +   F F +LK  T NF         + +GEGGFG V+KG+V          
Sbjct: 3   KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT------- 55

Query: 164 GTGLTVAVKTL----NHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 219
               TVAVK L    +    +  +++  E+  +    H NLV+L+G+  + D   LVY +
Sbjct: 56  ----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111

Query: 220 MPRGSLENHLF-RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
           MP GSL + L    G+ PL W +R KIA GAA G+ FLHE      I+RD K++NILLD 
Sbjct: 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168

Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
            + AK+SDFGLA+ + +  +T +++R++GT  Y APE  + G +T KSD+YSFGVVLLE+
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEI 227

Query: 339 LTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCL 398
           +TG  ++D++R      L++       +++     +D ++         +    +A+QCL
Sbjct: 228 ITGLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCL 284

Query: 399 SRDPKARPRMSEVVETLKPLQ 419
                 RP + +V + L+ + 
Sbjct: 285 HEKKNKRPDIKKVQQLLQEMT 305

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  518 bits (1336), Expect = 0.0
 Identities = 114/332 (34%), Positives = 182/332 (54%), Gaps = 16/332 (4%)

Query: 96  TTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEE 155
           +  +  + S     S    V  +  +    DL+ AT NF  + L+G G FG V+KG + +
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 156 NGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL 215
                     G  VA+K    +  QG +E+  E+  L    HP+LV L+G+C E ++ +L
Sbjct: 63  ----------GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112

Query: 216 VYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           +Y++M  G+L+ HL+     ++ + W  R++I +GAA+GL +LH      +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169

Query: 274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGV 333
           ILLD ++  K++DFG++K   E  +TH+ST V GT GY  PEY + G LT KSDVYSFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 334 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
           VL E+L  R ++ ++ P    NL EWA     +  +  +++DP L      +  +K    
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDT 288

Query: 394 AAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 425
           A +CL+   + RP M +V+  L+    L++  
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  457 bits (1177), Expect = e-160
 Identities = 119/304 (39%), Positives = 186/304 (61%), Gaps = 17/304 (5%)

Query: 118 QLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD 177
           QL++F   +L++A+ NF  +++LG GGFG V+KG +  +GT          VAVK L  +
Sbjct: 16  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGT---------LVAVKRLKEE 65

Query: 178 GLQGHK-EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLF--RKGS 234
             QG + ++  EV  +   +H NL++L G+C+   +RLLVY +M  GS+ + L    +  
Sbjct: 66  RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
            PL W  R +IALG+A+GLA+LH+  +  +I+RD K +NILLD ++ A + DFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
               THV+T V GT G+ APEY+ TG  + K+DV+ +GV+LLE++TG+R+ D  R   + 
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244

Query: 355 --NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
              L++W +  L +K +   L+D  L+G++  +  ++  Q+A  C    P  RP+MSEVV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

Query: 413 ETLK 416
             L+
Sbjct: 304 RMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  272 bits (697), Expect = 2e-88
 Identities = 77/322 (23%), Positives = 127/322 (39%), Gaps = 40/322 (12%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           +L   +   +   +   G FGCV+K  +               VAVK      +Q  + W
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFP---IQDKQSW 63

Query: 186 LAE--VNFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPW 239
             E  V  L  + H N+++ +G             L+  F  +GSL + L       + W
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSW 120

Query: 240 SIRMKIALGAAKGLAFLHEE------AEKP-VIYRDFKTSNILLDADYNAKLSDFGLAKD 292
           +    IA   A+GLA+LHE+        KP + +RD K+ N+LL  +  A ++DFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-----KSDVYSFGVVLLEMLTGRRSMDK 347
                    +   +GT  Y APE +            + D+Y+ G+VL E+ +   + D 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 348 NRPNGEHNLVE--WARPHLGDKRRF--YRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDP 402
                     E     P L D +    ++   P L  ++    G     +   +C   D 
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 403 KARPRMSEVVETLKPLQNLKDM 424
           +AR     V E +  +Q L ++
Sbjct: 301 EARLSAGCVGERITQMQRLTNI 322

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (557), Expect = 2e-67
 Identities = 85/344 (24%), Positives = 132/344 (38%), Gaps = 69/344 (20%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           + ++++          +G G FG V K  W                VA+K +  +  +  
Sbjct: 7   YKEIEVEEV-------VGRGAFGVVCKAKW------------RAKDVAIKQIESESER-- 45

Query: 183 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-LPWSI 241
           K ++ E+  L  + HPN+VKL G C+      LV E+   GSL N L     LP    + 
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFGLAKDAPEDGKTH 300
            M   L  ++G+A+LH    K +I+RD K  N+LL A     K+ DFG A D        
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQT 158

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
             T   G+  + APE     + + K DV+S+G++L E++T R      +P  E     + 
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFR 212

Query: 361 ---------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    RP L         L   +E             L  +C S+DP  RP M E+
Sbjct: 213 IMWAVHNGTRPPLIKN------LPKPIE------------SLMTRCWSKDPSQRPSMEEI 254

Query: 412 VETLKPLQN-----LKDMASSSYYFQTMQADNTWSIRNSKNGIR 450
           V+ +  L        + +     +      D             
Sbjct: 255 VKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDFAEFY 298

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  216 bits (552), Expect = 2e-66
 Identities = 65/337 (19%), Positives = 119/337 (35%), Gaps = 53/337 (15%)

Query: 122 FMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQ 180
              ++  L   N +   L+G G +G V+KG   E              VAVK  +     
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER------------PVAVKVFS---FA 47

Query: 181 GHKEWLAEVN--FLGNLLHPNLVKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKG 233
             + ++ E N   +  + H N+ + +            + LLV E+ P GSL  +L    
Sbjct: 48  NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH- 106

Query: 234 SLPLPWSIRMKIALGAAKGLAFLHEEAEK------PVIYRDFKTSNILLDADYNAKLSDF 287
                W    ++A    +GLA+LH E  +       + +RD  + N+L+  D    +SDF
Sbjct: 107 --TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164

Query: 288 GLAK------DAPEDGKTHVSTRVMGTYGYAAPEYVM-------TGHLTSKSDVYSFGVV 334
           GL+             + + +   +GT  Y APE +              + D+Y+ G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224

Query: 335 LLEMLTGRRSMDKNRPNGEHNL----VEWARPHLGDKRRF--YRLLDPRLEGHFSI--KG 386
             E+      +       E+ +         P   D +         P+    +      
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLA 284

Query: 387 SQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
            +   +    C  +D +AR       E +  L  + +
Sbjct: 285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  212 bits (541), Expect = 4e-65
 Identities = 83/309 (26%), Positives = 134/309 (43%), Gaps = 58/309 (18%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           + DL +  +       +G G FG V +  W   +G+          VAVK L        
Sbjct: 36  WCDLNIKEK-------IGAGSFGTVHRAEW---HGS---------DVAVKILMEQDFHAE 76

Query: 183 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPW 239
              E+L EV  +  L HPN+V  +G   +     +V E++ RGSL   L + G+   L  
Sbjct: 77  RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDE 136

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
             R+ +A   AKG+ +LH     P+++R+ K+ N+L+D  Y  K+ DFGL++       +
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS 195

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
             S    GT  + APE +       KSDVYSFGV+L E+ T +      +P G  N  + 
Sbjct: 196 --SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ------QPWGNLNPAQV 247

Query: 360 A--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                    R  +         L+P++              +   C + +P  RP  + +
Sbjct: 248 VAAVGFKCKRLEIPRN------LNPQVA------------AIIEGCWTNEPWKRPSFATI 289

Query: 412 VETLKPLQN 420
           ++ L+PL  
Sbjct: 290 MDLLRPLIK 298

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  209 bits (535), Expect = 2e-64
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 47/307 (15%)

Query: 132 RNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           R FRP  L     LG+G FG   K               TG  + +K L     +  + +
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTH----------RETGEVMVMKELIRFDEETQRTF 54

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           L EV  +  L HPN++K +G   +D +   + E++  G+L   + +      PWS R+  
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSF 113

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT------ 299
           A   A G+A+LH      +I+RD  + N L+  + N  ++DFGLA+   ++         
Sbjct: 114 AKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170

Query: 300 ------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE 353
                      V+G   + APE +       K DV+SFG+VL E++    +     P+  
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYL 226

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              +++      + R F     P                +  +C   DP+ RP   ++  
Sbjct: 227 PRTMDFGL----NVRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEH 275

Query: 414 TLKPLQN 420
            L+ L+ 
Sbjct: 276 WLETLRM 282

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  206 bits (526), Expect = 2e-63
 Identities = 68/314 (21%), Positives = 119/314 (37%), Gaps = 69/314 (21%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           F  L   T+       L E   G ++KG W    G           + VK L        
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRW---QGN---------DIVVKVLKVRDWSTR 49

Query: 183 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFRKGSLPLP 238
             +++  E   L    HPN++ ++G C          +  +MP GSL N L    +  + 
Sbjct: 50  KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVD 109

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            S  +K AL  A+G+AFLH   E  +      + ++++D D  A++S   +         
Sbjct: 110 QSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------F 161

Query: 299 THVSTRVMGTYGYAAPEYVMTG----HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
           +  S   M    + APE  +           +D++SF V+L E++T         P  + 
Sbjct: 162 SFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADL 214

Query: 355 NLVEWA--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           + +E          RP +         + P +            ++L   C++ DP  RP
Sbjct: 215 SNMEIGMKVALEGLRPTIPPG------ISPHV------------SKLMKICMNEDPAKRP 256

Query: 407 RMSEVVETLKPLQN 420
           +   +V  L+ +Q+
Sbjct: 257 KFDMIVPILEKMQD 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (527), Expect = 2e-63
 Identities = 86/318 (27%), Positives = 141/318 (44%), Gaps = 71/318 (22%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 182
            N+++        E  +G+GGFG V KG + ++ +          VA+K+L     +G  
Sbjct: 18  DNEIEY-------EKQIGKGGFGLVHKGRLVKDKS---------VVAIKSLILGDSEGET 61

Query: 183 ------KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP 236
                 +E+  EV  + NL HPN+VKL G         +V EF+P G L + L    + P
Sbjct: 62  EMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRL-LDKAHP 118

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-----ADYNAKLSDFGLAK 291
           + WS+++++ L  A G+ ++  +   P+++RD ++ NI L      A   AK++DFGL++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---HLTSKSDVYSFGVVLLEMLTGRR----- 343
                   H  + ++G + + APE  +       T K+D YSF ++L  +LTG       
Sbjct: 178 Q-----SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

Query: 344 ---SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 400
               +       E  L    RP + +         PRL              +   C S 
Sbjct: 232 SYGKIKFINMIREEGL----RPTIPED------CPPRLR------------NVIELCWSG 269

Query: 401 DPKARPRMSEVVETLKPL 418
           DPK RP  S +V+ L  L
Sbjct: 270 DPKKRPHFSYIVKELSEL 287

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  204 bits (522), Expect = 8e-63
 Identities = 83/316 (26%), Positives = 129/316 (40%), Gaps = 71/316 (22%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           F +L L          +G GGFG V++  W    G           VAVK   HD  +  
Sbjct: 6   FAELTLEEI-------IGIGGFGKVYRAFW---IGD---------EVAVKAARHDPDEDI 46

Query: 183 ----KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP 238
               +    E      L HPN++ L G C+++    LV EF   G L   L  K    +P
Sbjct: 47  SQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIP 103

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--------ADYNAKLSDFGLA 290
             I +  A+  A+G+ +LH+EA  P+I+RD K+SNIL+         ++   K++DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP 350
           ++     K        G Y + APE +     +  SDV+S+GV+L E+LTG        P
Sbjct: 164 REWHRTTKMS----AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VP 213

Query: 351 NGEHNLVEWA--------RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 402
               + +  A           +                           +L   C + DP
Sbjct: 214 FRGIDGLAVAYGVAMNKLALPIPST------CPEPFA------------KLMEDCWNPDP 255

Query: 403 KARPRMSEVVETLKPL 418
            +RP  + +++ L  +
Sbjct: 256 HSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  198 bits (506), Expect = 7e-60
 Identities = 61/345 (17%), Positives = 123/345 (35%), Gaps = 64/345 (18%)

Query: 102 SASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAP 160
           SA S P+ + +  +  Q     F  L++          +G+G FG V+ G W   +G   
Sbjct: 10  SARSFPRKASQTSIFLQEWDIPFEQLEIGEL-------IGKGRFGQVYHGRW---HGE-- 57

Query: 161 VKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 218
                   VA++ ++ +       K +  EV       H N+V  +G C+      ++  
Sbjct: 58  --------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109

Query: 219 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
                +L + + R   + L  +   +IA    KG+ +LH    K ++++D K+ N+  D 
Sbjct: 110 LCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD- 164

Query: 279 DYNAKLSDFGLAK---DAPEDGKTHVSTRVMGTYGYAAPEYVMTG---------HLTSKS 326
           +    ++DFGL           +        G   + APE +              +  S
Sbjct: 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224

Query: 327 DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS 383
           DV++ G +  E+       ++            + W            +    ++     
Sbjct: 225 DVFALGTIWYELHAREWPFKTQPAEA-------IIWQ------MGTGMKPNLSQIGMGKE 271

Query: 384 IKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSS 428
           I        +   C + + + RP  +++++ L+ L   K     S
Sbjct: 272 IS------DILLFCWAFEQEERPTFTKLMDMLEKLP--KRNRRLS 308

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (503), Expect = 8e-60
 Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 43/302 (14%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
              + +  R       +G G FG V+KG W   +G           VAVK LN       
Sbjct: 23  DGQITVGQR-------IGSGSFGTVYKGKW---HGD----------VAVKMLNVTAPTPQ 62

Query: 183 --KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
             + +  EV  L    H N++  +GY     Q  +V ++    SL +HL           
Sbjct: 63  QLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHL-HASETKFEMK 120

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             + IA   A+G+ +LH    K +I+RD K++NI L  D   K+ DFGLA +      +H
Sbjct: 121 KLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177

Query: 301 VSTRVMGTYGYAAPE---YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
              ++ G+  + APE      +   + +SDVY+FG+VL E++TG+       P    N  
Sbjct: 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNR 231

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP 417
           +     +G       L   R      +K      +L A+CL +    RP    ++  ++ 
Sbjct: 232 DQIIEMVGRGSLSPDLSKVRSNCPKRMK------RLMAECLKKKRDERPSFPRILAEIEE 285

Query: 418 LQ 419
           L 
Sbjct: 286 LA 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  194 bits (494), Expect = 2e-58
 Identities = 70/311 (22%), Positives = 116/311 (37%), Gaps = 52/311 (16%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 193
              +G+G +G V++G W  E             VAVK  +    +  K W  E  +    
Sbjct: 13  LECVGKGRYGEVWRGSWQGE------------NVAVKIFSS---RDEKSWFRETELYNTV 57

Query: 194 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            L H N++  +   +       Q  L+  +   GSL ++L       L     ++I L  
Sbjct: 58  MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSI 114

Query: 250 AKGLAFLHEEAEK-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVS 302
           A GLA LH E         + +RD K+ NIL+  +    ++D GLA       +     +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174

Query: 303 TRVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRP----- 350
              +GT  Y APE V+   +         + D+++FG+VL E+     S           
Sbjct: 175 NPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233

Query: 351 ---NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                     E  R  +   ++  R   P     FS        +L  +C  ++P AR  
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQ--RPNIP--NRWFSDPTLTSLAKLMKECWYQNPSARLT 289

Query: 408 MSEVVETLKPL 418
              + +TL  +
Sbjct: 290 ALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  194 bits (496), Expect = 3e-58
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 46/314 (14%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLG 193
              +G+G +G V+ G W  E             VAVK            W    E+    
Sbjct: 42  VKQIGKGRYGEVWMGKWRGE------------KVAVKVFFT---TEEASWFRETEIYQTV 86

Query: 194 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            + H N++  +   I+      Q  L+ ++   GSL ++L       L     +K+A  +
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSS 143

Query: 250 AKGLAFLHEEAEK-----PVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVS 302
             GL  LH E         + +RD K+ NIL+  +    ++D GLA    +  +      
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 303 TRVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-- 353
              +GT  Y  PE V+   L          +D+YSFG++L E+   R          +  
Sbjct: 204 NTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLP 261

Query: 354 HNLVEWARPHLGDKRRF--YRLLDPRLEGHFSIKGSQKA-TQLAAQCLSRDPKARPRMSE 410
           ++ +  + P   D R     + L P     +S     +   +L  +C + +P +R     
Sbjct: 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321

Query: 411 VVETLKPLQNLKDM 424
           V +TL  +   +D+
Sbjct: 322 VKKTLAKMSESQDI 335

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  193 bits (492), Expect = 1e-57
 Identities = 75/317 (23%), Positives = 127/317 (40%), Gaps = 52/317 (16%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAE--VNFLG 193
           +  +G+G FG V++G W  E             VAVK  +    +  + W  E  +    
Sbjct: 47  QESIGKGRFGEVWRGKWRGE------------EVAVKIFS---SREERSWFREAEIYQTV 91

Query: 194 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            L H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+AL  
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALST 148

Query: 250 AKGLAFLHEEAE----KPVI-YRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVS 302
           A GLA LH E      KP I +RD K+ NIL+  +    ++D GLA   D+  D      
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 303 TRVMGTYGYAAPEYVMTGHL-------TSKSDVYSFGVVLLEMLTGRRSMDKNRP----- 350
              +GT  Y APE V+   +         ++D+Y+ G+V  E+         +       
Sbjct: 209 NHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267

Query: 351 ---NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                    VE  R  + +++   R   P      S +  +   ++  +C   +  AR  
Sbjct: 268 YDLVPSDPSVEEMRKVVCEQKL--RPNIP--NRWQSCEALRVMAKIMRECWYANGAARLT 323

Query: 408 MSEVVETLKPLQNLKDM 424
              + +TL  L   + +
Sbjct: 324 ALRIKKTLSQLSQQEGI 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  163 bits (415), Expect = 4e-46
 Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 32/282 (11%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           +G G FG VF G +  + T          VAVK+           ++L E   L    HP
Sbjct: 122 IGRGNFGEVFSGRLRADNT---------LVAVKSCRETLPPDLKAKFLQEARILKQYSHP 172

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V+L+G C +     +V E +  G     L R     L     +++   AA G+ +L  
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE- 230

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
              K  I+RD    N L+      K+SDFG++++  +               + APE + 
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 377
            G  +S+SDV+SFG++L E  +   S   N  N +    VE          +  RL  P 
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE----------KGGRL--PC 336

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
            E            +L  QC + +P  RP  S + + L+ ++
Sbjct: 337 PELC-----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  159 bits (405), Expect = 2e-45
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 45/308 (14%)

Query: 132 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
           R+ +    LG+G FG V    +       P++  TG  VAVK L H   +  +++  E+ 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 247
            L +L H N+VK  G C    +R   L+ E++P GSL ++L + K  +     ++     
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 121

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 303
              KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D +         
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 304 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
                       APE +     +  SDV+SFGVVL E+ T         P  E   +   
Sbjct: 179 SPIFWY------APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGN 230

Query: 361 RPHLGDK--------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                          +   RL  PR +G        +   +  +C + +   RP   ++ 
Sbjct: 231 DKQGQMIVFHLIELLKNNGRL--PRPDG-----CPDEIYMIMTECWNNNVNQRPSFRDLA 283

Query: 413 ETLKPLQN 420
             +  +++
Sbjct: 284 LRVDQIRD 291

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  159 bits (405), Expect = 3e-45
 Identities = 76/311 (24%), Positives = 126/311 (40%), Gaps = 51/311 (16%)

Query: 132 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
           R+ +    LG+G FG V    +       P++  TG  VAVK L H   +  +++  E+ 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYD------PLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 247
            L +L H N+VK  G C    +R   L+ E++P GSL ++L + K  +     ++     
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TS 152

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 303
              KG+ +L     K  I+RD  T NIL++ +   K+ DFGL K  P+D + +       
Sbjct: 153 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 304 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
                       APE +     +  SDV+SFGVVL E+ T         P  E   +   
Sbjct: 210 SPIFWY------APESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGN 261

Query: 361 RPHLGDK--------RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
                          +   RL  P     E +           +  +C + +   RP   
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY----------MIMTECWNNNVNQRPSFR 311

Query: 410 EVVETLKPLQN 420
           ++   +  +++
Sbjct: 312 DLALRVDQIRD 322

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  158 bits (402), Expect = 8e-45
 Identities = 86/303 (28%), Positives = 121/303 (39%), Gaps = 39/303 (12%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 190
           R  +    LGEG FG V     +     P   GTG  VAVK L  D G Q    W  E++
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYD-----PTNDGTGEMVAVKALKADAGPQHRSGWKQEID 85

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
            L  L H +++K  G C +       LV E++P GSL ++L  + S+ L   +    A  
Sbjct: 86  ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF--AQQ 142

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST----- 303
             +G+A+LH    +  I+RD    N+LLD D   K+ DFGLAK  PE  + +        
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199

Query: 304 --RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA 360
                      APE +        SDV+SFGV L E+LT    S        E   +   
Sbjct: 200 PVFWY------APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

Query: 361 RPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +  +           RL  P        K   +   L   C   +   RP    ++  LK
Sbjct: 254 QMTVLRLTELLERGERLPRPD-------KCPAEVYHLMKNCWETEASFRPTFENLIPILK 306

Query: 417 PLQ 419
            + 
Sbjct: 307 TVH 309

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  157 bits (400), Expect = 2e-44
 Identities = 80/303 (26%), Positives = 123/303 (40%), Gaps = 40/303 (13%)

Query: 132 RNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
           R+ +  S LG+G FG V    +       P+   TG  VAVK L H G    +++  E+ 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYD------PLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 247
            L  L    +VK  G      ++   LV E++P G L + L R +  L     +    + 
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY--SS 134

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 303
              KG+ +L     +  ++RD    NIL++++ + K++DFGLAK  P D   +V      
Sbjct: 135 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 304 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW 359
                       APE +     + +SDV+SFGVVL E+ T   +S   +         E 
Sbjct: 192 SPIFWY------APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245

Query: 360 ARPHLGDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
             P L           RL  P            +  +L   C +  P+ RP  S +   L
Sbjct: 246 DVPALSRLLELLEEGQRL--PAPPA-----CPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

Query: 416 KPL 418
             L
Sbjct: 299 DML 301

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (395), Expect = 6e-44
 Identities = 81/306 (26%), Positives = 123/306 (40%), Gaps = 45/306 (14%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVN 190
           R  +    LGEG FG V     +     P    TG  VAVK+L  + G     +   E+ 
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYD-----PEGDNTGEQVAVKSLKPESGGNHIADLKKEIE 75

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--LLVYEFMPRGSLENHLFR-KGSLPLPWSIRMKIAL 247
            L NL H N+VK  G C ED      L+ EF+P GSL+ +L + K  + L   ++   A+
Sbjct: 76  ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY--AV 133

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST---- 303
              KG+ +L     +  ++RD    N+L+++++  K+ DFGL K    D + +       
Sbjct: 134 QICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 304 ---RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV-- 357
                       APE +M       SDV+SFGV L E+LT             +      
Sbjct: 191 SPVFWY------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

Query: 358 -EWARPHLGDK-RRFYRLLDPR---LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            +     L +  +   RL  P     E +          QL  +C    P  R     ++
Sbjct: 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVY----------QLMRKCWEFQPSNRTSFQNLI 294

Query: 413 ETLKPL 418
           E  + L
Sbjct: 295 EGFEAL 300

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (393), Expect = 2e-43
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 54/302 (17%)

Query: 131 TRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 183
            R  +         LG G FG V+KG W+ E     +       VA+K L      + +K
Sbjct: 9   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANK 62

Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIR 242
           E L E   + ++ +P++ +L+G C+      L+ + MP G L +++   K ++   + + 
Sbjct: 63  EILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 121

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
               +  AKG+ +L    ++ +++RD    N+L+    + K++DFGLAK    + K + +
Sbjct: 122 W--CVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLV 357
                   + A E ++    T +SDV+S+GV + E++T G +    +    P  E  +++
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSIL 232

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKAT----QLAAQCLSRDPKARPRMSEVVE 413
           E          +  RL  P              T     +  +C   D  +RP+  E++ 
Sbjct: 233 E----------KGERLPQP-----------PICTIDVYMIMRKCWMIDADSRPKFRELII 271

Query: 414 TL 415
             
Sbjct: 272 EF 273

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  149 bits (379), Expect = 8e-42
 Identities = 64/294 (21%), Positives = 107/294 (36%), Gaps = 47/294 (15%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG+G F  +FKG   E      +       V +K L+       + +    + +  L H 
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHE---TEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           +LV   G C+  D+ +LV EF+  GSL+ +L   K  + + W + +  A   A  + FL 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMHFL- 129

Query: 258 EEAEKPVIYRDFKTSNILLDADYN--------AKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              E  +I+ +    NILL  + +         KLSD G++               +   
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184

Query: 310 GYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDK 367
               PE +    +L   +D +SFG  L E+ +G         +       E         
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--------- 232

Query: 368 RRFYRLLDPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
              ++L  P+  E             L   C+  +P  RP    ++  L  L  
Sbjct: 233 -DRHQLPAPKAAELA----------NLINNCMDYEPDHRPSFRAIIRDLNSLFT 275

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  149 bits (379), Expect = 1e-41
 Identities = 77/356 (21%), Positives = 110/356 (30%), Gaps = 60/356 (16%)

Query: 61  RSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLR 120
                  +   +  +      + RR       S T  S     S    F ++        
Sbjct: 6   HHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ-------- 57

Query: 121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--G 178
                       +F+  S LG G +G VFK               G   AVK       G
Sbjct: 58  ------------SFQRLSRLGHGSYGEVFKV---------RSKEDGRLYAVKRSMSPFRG 96

Query: 179 LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL 237
            +     LAEV     +  HP  V+L     E     L  E     SL+ H    G+  L
Sbjct: 97  PKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SL 154

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
           P +            LA LH    + +++ D K +NI L      KL DFGL  +    G
Sbjct: 155 PEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
              V     G   Y APE +   +  + +DV+S G+ +LE+               H   
Sbjct: 212 AGEV---QEGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMELP--------HGGE 259

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            W    L         L P          S +   +    L  DPK R     ++ 
Sbjct: 260 GW--QQLRQGY-----LPPEFTAGL----SSELRSVLVMMLEPDPKLRATAEALLA 304

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (378), Expect = 3e-41
 Identities = 71/313 (22%), Positives = 137/313 (43%), Gaps = 47/313 (15%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLH 197
           LG G FG V+KG W+ E     +       VA+K L      + +KE L E   + ++ +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIP------VAIKELREATSPKANKEILDEAYVMASVDN 76

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 256
           P++ +L+G C+      L+ + MP G L +++   K ++   + +     +  AKG+ +L
Sbjct: 77  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQIAKGMNYL 133

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
               ++ +++RD    N+L+    + K++DFGLAK    + K + +        + A E 
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKRRFY 371
           ++    T +SDV+S+GV + E++T G +    +    P  E  +++E          +  
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSILE----------KGE 236

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYF 431
           RL  P          +     +  +C   D  +RP+  E++           MA     +
Sbjct: 237 RLPQPP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIE------FSKMARDPQRY 283

Query: 432 QTMQADNTWSIRN 444
             +Q D    + +
Sbjct: 284 LVIQGDERMHLPS 296

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  149 bits (377), Expect = 3e-41
 Identities = 73/315 (23%), Positives = 116/315 (36%), Gaps = 51/315 (16%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
            + +  +++     LGEGGF  V    VE           G   A+K +     Q  +E 
Sbjct: 23  MVIIDNKHYLFIQKLGEGGFSYVDL--VEGLHD-------GHFYALKRILCHEQQDREEA 73

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHL--FRKGSLPLPW 239
             E +      HPN+++LV YC+ +        L+  F  RG+L N +   +     L  
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
              + + LG  +GL  +H    K   +RD K +NILL  +    L D G    A    + 
Sbjct: 134 DQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190

Query: 300 HVSTRVM-------GTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
                 +        T  Y APE         +  ++DV+S G VL  M+ G    D   
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI----KGSQKATQLAAQCLSRDPKAR 405
             G+                    +   ++   SI    + S    QL    ++ DP  R
Sbjct: 251 QKGD-------------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

Query: 406 PRMSEVVETLKPLQN 420
           P +  ++  L+ LQ 
Sbjct: 292 PHIPLLLSQLEALQP 306

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  148 bits (376), Expect = 5e-41
 Identities = 78/311 (25%), Positives = 128/311 (41%), Gaps = 54/311 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V++G     G    +P T   VA+KT+N    ++   E+L E + +      
Sbjct: 33  LGQGSFGMVYEG--VAKGVVKDEPET--RVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------FRKGSLPLPWSIRMKIALGAA 250
           ++V+L+G   +    L++ E M RG L+++L              P   S  +++A   A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTR 304
            G+A+L        ++RD    N ++  D+  K+ DFG+ +D  E       GK  +  R
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVE----W 359
            M      +PE +  G  T+ SDV+SFGVVL E+ T      +   N +    V      
Sbjct: 206 WM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
            +P        + L+                      C   +PK RP   E++ ++K   
Sbjct: 260 DKPD-NCPDMLFELM--------------------RMCWQYNPKMRPSFLEIISSIKEEM 298

Query: 420 NLKDMASSSYY 430
                  S YY
Sbjct: 299 EPGFREVSFYY 309

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (372), Expect = 5e-41
 Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 44/285 (15%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G G FG V  G W        V        A+KT+  +G    ++++ E   +  L HP
Sbjct: 16  IGSGQFGLVHLGYW---LNKDKV--------AIKTI-REGAMSEEDFIEEAEVMMKLSHP 63

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            LV+L G C+E     LV EFM  G L ++L  ++G       + M   L   +G+A+L 
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGM--CLDVCEGMAYL- 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 314
              E  VI+RD    N L+  +   K+SDFG+ +   +D      T   GT     +A+P
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASP 174

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E       +SKSDV+SFGV++ E+ +  +   +NR N E    +             +RL
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------TGFRL 224

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             PRL        S    Q+   C    P+ RP  S ++  L  +
Sbjct: 225 YKPRL-------ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  148 bits (375), Expect = 7e-41
 Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 46/298 (15%)

Query: 131 TRNFRPESL-----LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHK 183
            R F+   L     LG G FG V KG W+ E  +  +       V +K +    G Q  +
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIP------VCIKVIEDKSGRQSFQ 60

Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIR 242
                +  +G+L H ++V+L+G C       LV +++P GSL +H+   +G+L     + 
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
               +  AKG+ +L    E  +++R+    N+LL +    +++DFG+A   P D K  + 
Sbjct: 120 W--GVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLV 357
           +       + A E +  G  T +SDV+S+GV + E++T G      +       E  +L+
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL----RLAEVPDLL 230

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           E          +  RL  P++        +     +  +C   D   RP   E+    
Sbjct: 231 E----------KGERLAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEF 271

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  147 bits (372), Expect = 7e-41
 Identities = 76/309 (24%), Positives = 121/309 (39%), Gaps = 57/309 (18%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
            +F+   L+G GGFG VFK   +           G T  +K + ++  +  +E    V  
Sbjct: 11  MDFKEIELIGSGGFGQVFK--AKHRID-------GKTYVIKRVKYNNEKAERE----VKA 57

Query: 192 LGNLLHPNLVKLVGYCIEDDQRL----------------LVYEFMPRGSLENHLFRKGSL 235
           L  L H N+V   G     D                   +  EF  +G+LE  + ++   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            L   + +++     KG+ ++H    K +I RD K SNI L      K+ DFGL      
Sbjct: 118 KLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           DGK    TR  GT  Y +PE + +     + D+Y+ G++L E+L                
Sbjct: 175 DGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV-------------- 217

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
                       + F  L D  +   F     +K   L  + LS+ P+ RP  SE++ TL
Sbjct: 218 ----CDTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

Query: 416 KPLQNLKDM 424
              +   + 
Sbjct: 270 TVWKKSPEK 278

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (384), Expect = 9e-41
 Identities = 71/281 (25%), Positives = 125/281 (44%), Gaps = 34/281 (12%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G +G V++G W              LTVAVKTL  D ++  +E+L E   +  + HP
Sbjct: 228 LGGGQYGEVYEGVW----------KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHP 276

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           NLV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L  
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-- 334

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
             +K  I+R+    N L+  ++  K++DFGL++                   + APE + 
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLA 392

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 377
               + KSDV++FGV+L E+ T   S        + + L+E          + YR+  P 
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRMERPE 442

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                     +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 443 G-------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  146 bits (370), Expect = 1e-40
 Identities = 77/285 (27%), Positives = 118/285 (41%), Gaps = 44/285 (15%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V  G W    G   V        AVK +  +G     E+  E   +  L HP
Sbjct: 16  LGSGQFGVVKLGKW---KGQYDV--------AVKMIK-EGSMSEDEFFQEAQTMMKLSHP 63

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            LVK  G C ++    +V E++  G L N+L      L     + M       +G+AFL 
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM--CYDVCEGMAFL- 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 314
                  I+RD    N L+D D   K+SDFG+ +   +D         +GT     ++AP
Sbjct: 121 --ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD----QYVSSVGTKFPVKWSAP 174

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E       +SKSDV++FG+++ E+ +  +       N E    V           + +RL
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS----------QGHRL 224

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P L        S    Q+   C    P+ RP   +++ +++PL
Sbjct: 225 YRPHL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  145 bits (367), Expect = 4e-40
 Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 44/285 (15%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V  G W    G   V        A+K +  +G     E++ E   + NL H 
Sbjct: 32  LGTGQFGVVKYGKW---RGQYDV--------AIKMIK-EGSMSEDEFIEEAKVMMNLSHE 79

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
            LV+L G C +     ++ E+M  G L N+L   +        + M       + + +L 
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEM--CKDVCEAMEYL- 136

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAP 314
               K  ++RD    N L++     K+SDFGL++   +D      T  +G+     ++ P
Sbjct: 137 --ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EYTSSVGSKFPVRWSPP 190

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +M    +SKSD+++FGV++ E+ +  +   +   N E    +           +  RL
Sbjct: 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA----------QGLRL 240

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P L        S+K   +   C       RP    ++  +  +
Sbjct: 241 YRPHL-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  146 bits (370), Expect = 4e-40
 Identities = 85/312 (27%), Positives = 136/312 (43%), Gaps = 60/312 (19%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNL 195
           E ++G G  G V  G +   G   V       VA+K L     +  + ++L+E + +G  
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVP------VAIKALKAGYTERQRRDFLSEASIMGQF 107

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN+++L G        ++V E+M  GSL+  L    G   +   + M    G   G+ 
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM--LRGVGAGMR 165

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG---- 310
           +L   ++   ++RD    N+L+D++   K+SDFGL++   +D     +T      G    
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIP 217

Query: 311 --YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPH 363
             + APE +     +S SDV+SFGVV+ E+L  G R   +M     N +  + VE     
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT----NRDVISSVE----- 268

Query: 364 LGDKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL-- 418
                  YRL  P       H          QL   C  +D   RPR S++V  L  L  
Sbjct: 269 -----EGYRLPAPMGCPHALH----------QLMLDCWHKDRAQRPRFSQIVSVLDALIR 313

Query: 419 --QNLKDMASSS 428
             ++L+  A+ S
Sbjct: 314 SPESLRATATVS 325

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (368), Expect = 5e-40
 Identities = 76/303 (25%), Positives = 124/303 (40%), Gaps = 50/303 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           +G G FGCV+ G      T     G  +  AVK+LN    +    ++L E   + +  HP
Sbjct: 33  IGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 86

Query: 199 NLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           N++ L+G C+  +   L+V  +M  G L N + R  +        +   L  AKG+ +L 
Sbjct: 87  NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL- 144

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG------TYGY 311
             A K  ++RD    N +LD  +  K++DFGLA+D  +     V  +             
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM--- 199

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGD 366
            A E + T   T+KSDV+SFGV+L E++T G      ++      +    +         
Sbjct: 200 -ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYLL-------- 246

Query: 367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMAS 426
             +  RLL P               ++  +C     + RP  SE+V  +  +        
Sbjct: 247 --QGRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIG 295

Query: 427 SSY 429
             Y
Sbjct: 296 EHY 298

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (377), Expect = 5e-40
 Identities = 82/284 (28%), Positives = 124/284 (43%), Gaps = 36/284 (12%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL 195
           E  LG+G FG V+ G W   NGT  V        A+KTL   G    + +L E   +  L
Sbjct: 189 EVKLGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKL 236

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            H  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A+
Sbjct: 237 RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPE 315
           +        ++RD + +NIL+  +   K++DFGLA+   ED +            + APE
Sbjct: 296 V---ERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPE 351

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLL 374
             + G  T KSDV+SFG++L E+ T  R       N E  + VE          R YR+ 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMP 401

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            P           +    L  QC  ++P+ RP    +   L+  
Sbjct: 402 CPPE-------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  146 bits (371), Expect = 8e-40
 Identities = 82/380 (21%), Positives = 146/380 (38%), Gaps = 59/380 (15%)

Query: 63  KVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKF 122
           +    + G  +  +  +S  K+     +      T + + ++  P+  + ++        
Sbjct: 29  RGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS 88

Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQG 181
               +           ++G G FGCV+ G      T     G  +  AVK+LN    +  
Sbjct: 89  --LIVHF-------NEVIGRGHFGCVYHG------TLLDNDGKKIHCAVKSLNRITDIGE 133

Query: 182 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWS 240
             ++L E   + +  HPN++ L+G C+  +   L+V  +M  G L N + R  +      
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVK 192

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             +   L  AKG+ FL   A K  ++RD    N +LD  +  K++DFGLA+D  +     
Sbjct: 193 DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249

Query: 301 VSTRVMG------TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRP 350
           V  +              A E + T   T+KSDV+SFGV+L E++T G      ++    
Sbjct: 250 VHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN---- 301

Query: 351 NGE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
             +    +           +  RLL P               ++  +C     + RP  S
Sbjct: 302 TFDITVYLL----------QGRRLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFS 344

Query: 410 EVVETLKPLQNLKDMASSSY 429
           E+V  +  +          Y
Sbjct: 345 ELVSRISAI--FSTFIGEHY 362

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (367), Expect = 8e-40
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 43/261 (16%)

Query: 99  NAESASSTPKFSEELKVASQLRKFMF--NDLKLATRNFRPESLLGEGGFGCVFKGWVEEN 156
           +  S+   P+ SEEL+  ++L   +   N L L         +LGEG FG V +G     
Sbjct: 8   HHHSSGLVPRGSEELQ--NKLEDVVIDRNLLIL-------GKILGEGEFGSVMEG----- 53

Query: 157 GTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR- 213
                + GT L VAVKT+  D    +  +E+L+E   + +  HPN+++L+G CIE   + 
Sbjct: 54  -NLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112

Query: 214 ----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMK----IALGAAKGLAFLHEEAEKPVI 265
               +++  FM  G L  +L        P  I ++      +  A G+ +L   + +  +
Sbjct: 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFL 169

Query: 266 YRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHVSTRVMGTYGYAAPEYVMT 319
           +RD    N +L  D    ++DFGL+K               +  + +      A E +  
Sbjct: 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI------AIESLAD 223

Query: 320 GHLTSKSDVYSFGVVLLEMLT 340
              TSKSDV++FGV + E+ T
Sbjct: 224 RVYTSKSDVWAFGVTMWEIAT 244

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (364), Expect = 1e-39
 Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 40/285 (14%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNL 195
           LG+G FG V +G W   +G         ++VAVK L  D L   +   +++ EVN + +L
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKT-------VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            H NL++L G  +      +V E  P GSL + L   +G   L    R   A+  A+G+ 
Sbjct: 79  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGMG 135

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGY 311
           +L     K  I+RD    N+LL      K+ DFGL +  P++   +V          + +
Sbjct: 136 YL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAW 190

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRF 370
            APE + T   +  SD + FGV L EM T  +         +  + ++         +  
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---------KEG 241

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
            RL  P           Q    +  QC +  P+ RP    + + L
Sbjct: 242 ERLPRPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  143 bits (363), Expect = 2e-39
 Identities = 77/322 (23%), Positives = 128/322 (39%), Gaps = 62/322 (19%)

Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGL--QG 181
             L L  +       LG G FG V KG +  +     V        AVK L ++      
Sbjct: 16  KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTV--------AVKILKNEANDPAL 61

Query: 182 HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSI 241
             E LAE N +  L +P +V+++G C E +  +LV E    G L  +L +   +     I
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
            +      + G+ +L    E   ++RD    N+LL   + AK+SDFGL+K    D   + 
Sbjct: 121 EL--VHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175

Query: 302 STRVMGTYG------YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 351
           +              + APE +     +SKSDV+SFGV++ E  + G++    M      
Sbjct: 176 AQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KG 226

Query: 352 GE-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
            E   ++E          +  R+  P           ++   L   C + D + RP  + 
Sbjct: 227 SEVTAMLE----------KGERMGCPAG-------CPREMYDLMNLCWTYDVENRPGFAA 269

Query: 411 VVETLKPLQNLKDMASSSYYFQ 432
           V   L+      D+ +  ++  
Sbjct: 270 VELRLRNY--YYDVVNEGHHHH 289

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (362), Expect = 2e-39
 Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 42/285 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G +G V++G         V     LTVAVKTL  +     +E+L E   +  + HPN
Sbjct: 21  LGGGQYGEVYEG---------VWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPN 70

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE 259
           LV+L+G C  +    ++ EFM  G+L ++L       +   + + +A   +  + +L   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRV----MGTYGYAAP 314
            +K  I+RD    N L+  ++  K++DFGL++    D    H   +            AP
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------AP 181

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +     + KSDV++FGV+L E+ T   S        + + L+E          + YR+
Sbjct: 182 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----------KDYRM 231

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              R EG       +K  +L   C   +P  RP  +E+ +  + +
Sbjct: 232 --ERPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (365), Expect = 2e-39
 Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 57/296 (19%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLH 197
           +G G FG V+KG     +G   V       VA+KTL      +   ++L E   +G   H
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVP------VAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 256
            N+++L G   +    +++ E+M  G+L+  L  + G   +   + M    G A G+ +L
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM--LRGIAAGMKYL 163

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG------ 310
              A    ++RD    NIL++++   K+SDFGL++   +D +   +T      G      
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIR 215

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLG 365
           + APE +     TS SDV+SFG+V+ E++T G R    +     N E    +        
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----SNHEVMKAIN------- 264

Query: 366 DKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                +RL  P       +          QL  QC  ++   RP+ +++V  L  L
Sbjct: 265 ---DGFRLPTPMDCPSAIY----------QLMMQCWQQERARRPKFADIVSILDKL 307

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (362), Expect = 2e-39
 Identities = 69/310 (22%), Positives = 120/310 (38%), Gaps = 53/310 (17%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGN 194
           +  LG G FG V +G +        V        A+K L         +E + E   +  
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 66

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           L +P +V+L+G C + +  +LV E    G L   L       +P S   ++    + G+ 
Sbjct: 67  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMK 124

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG---- 310
           +L    EK  ++RD    N+LL   + AK+SDFGL+K    D   + +            
Sbjct: 125 YL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWP 176

Query: 311 --YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPH 363
             + APE +     +S+SDV+S+GV + E L+ G++    M       E    +E     
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAFIE----- 227

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL-QNLK 422
                +  R+  P        +   +   L + C     + RP    V + ++    +L 
Sbjct: 228 -----QGKRMECPP-------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

Query: 423 DMASSSYYFQ 432
                 ++  
Sbjct: 276 SKVEGHHHHH 285

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (364), Expect = 3e-39
 Identities = 78/307 (25%), Positives = 122/307 (39%), Gaps = 56/307 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E +   P +      VAVK L        +++  E   L  L H +
Sbjct: 49  LGEGAFGKVFLA--ECHNLLPEQDKM--LVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL---------FRKGSLPLPWSIRMK----IA 246
           +V+  G C E    L+V+E+M  G L   L            G    P  + +     +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTH 300
              A G+ +L   A    ++RD  T N L+      K+ DFG+++D          G+T 
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNL 356
           +  R M       PE ++    T++SDV+SFGVVL E+ T G++    +     N E   
Sbjct: 222 LPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL----SNTE--A 269

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           ++          +   L  PR           +   +   C  R+P+ R  + +V   L+
Sbjct: 270 IDCI-------TQGRELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 417 PLQNLKD 423
            L     
Sbjct: 316 ALAQAPP 322

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  146 bits (370), Expect = 4e-39
 Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 48/285 (16%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG V  G +             G  VAVK + +D     + +LAE + +  L H 
Sbjct: 201 IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 246

Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   + + +L 
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 305

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHVSTRVMGTYGYAAP 314
                  ++RD    N+L+  D  AK+SDFGL K+     + GK  V  +        AP
Sbjct: 306 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------AP 355

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +     ++KSDV+SFG++L E+ +  R      P  +    VE          + Y++
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----------KGYKM 405

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             P                +   C   D   RP   ++ E L+ +
Sbjct: 406 DAPDG-------CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  141 bits (359), Expect = 6e-39
 Identities = 79/305 (25%), Positives = 133/305 (43%), Gaps = 60/305 (19%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           LGEG FG V++G            G  + VAVKT   D    +K ++++E   + NL HP
Sbjct: 20  LGEGFFGEVYEG------VYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G   E+    ++ E  P G L ++L   K SL +   +    +L   K +A+L 
Sbjct: 74  HIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLY--SLQICKAMAYL- 129

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGYA 312
                  ++RD    NIL+ +    KL DFGL++   ++       T +  + M      
Sbjct: 130 --ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------ 181

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           +PE +     T+ SDV+ F V + E+L+ G++    ++    N +   ++E         
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE----NKDVIGVLE--------- 228

Query: 368 RRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDM 424
            +  RL  P L     +           L  +C   DP  RPR +E+V +   L ++  M
Sbjct: 229 -KGDRLPKPDLCPPVLY----------TLMTRCWDYDPSDRPRFTELVCS---LSDVYQM 274

Query: 425 ASSSY 429
                
Sbjct: 275 EKDIA 279

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (360), Expect = 6e-39
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 52/304 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG V+ G          +    +  A+K+L+    +Q  + +L E   +  L HP
Sbjct: 29  IGKGHFGVVYHG------EYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82

Query: 199 NLVKLVGYCIEDD-QRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFL 256
           N++ L+G  +  +    ++  +M  G L   +   + +  +   I     L  A+G+ +L
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF--GLQVARGMEYL 140

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG------TYG 310
              AE+  ++RD    N +LD  +  K++DFGLA+D  +     V            T  
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT-- 195

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLG 365
             A E + T   T+KSDV+SFGV+L E+LT G      +D      +  + +        
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFDLTHFLA------- 242

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMA 425
              +  RL  P               Q+  QC   DP  RP    +V  ++ +  +  + 
Sbjct: 243 ---QGRRLPQPE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI--VSALL 290

Query: 426 SSSY 429
              Y
Sbjct: 291 GDHY 294

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  141 bits (358), Expect = 1e-38
 Identities = 86/305 (28%), Positives = 130/305 (42%), Gaps = 57/305 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LGEG FG VF    E    +P K      VAVK L    L   K++  E   L NL H +
Sbjct: 23  LGEGAFGKVFLA--ECYNLSPTKDKM--LVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRMKI 245
           +VK  G C + D  ++V+E+M  G L   L               R+    L  S  + I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKT 299
           A   A G+ +L   A +  ++RD  T N L+ A+   K+ DFG+++D          G T
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHN 355
            +  R M       PE +M    T++SDV+SFGV+L E+ T G++    +     N E  
Sbjct: 196 MLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL----SNTE-- 243

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           ++E          +   L  PR          ++   +   C  R+P+ R  + E+ + L
Sbjct: 244 VIECI-------TQGRVLERPR-------VCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

Query: 416 KPLQN 420
             L  
Sbjct: 290 HALGK 294

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (359), Expect = 1e-38
 Identities = 77/292 (26%), Positives = 118/292 (40%), Gaps = 49/292 (16%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAEV 189
           NFR E  +G G F  V++               G+ VA+K +    L   K     + E+
Sbjct: 33  NFRIEKKIGRGQFSEVYRA---------ACLLDGVPVALKKVQIFDLMDAKARADCIKEI 83

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL 247
           + L  L HPN++K     IED++  +V E    G L   +  F+K    +P     K  +
Sbjct: 84  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                L  +H    + V++RD K +N+ + A    KL D GL +       T   + V G
Sbjct: 144 QLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-G 198

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y +PE +       KSD++S G +L EM   +                   P  GDK
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDK 240

Query: 368 RRFYRLL--------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
              Y L          P    H+    S++  QL   C++ DP+ RP ++ V
Sbjct: 241 MNLYSLCKKIEQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDVTYV 288

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (356), Expect = 1e-38
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 56/291 (19%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +G+G FG V  G +             G  VAVK + +D     + +LAE + +  L H 
Sbjct: 29  IGKGEFGDVMLGDY------------RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHS 74

Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   + + +L 
Sbjct: 75  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL- 133

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD---APEDGKTHVSTRVMGTYGYAAP 314
                  ++RD    N+L+  D  AK+SDFGL K+     + GK  V  +        AP
Sbjct: 134 --EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV--KWT------AP 183

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDKRR 369
           E +     ++KSDV+SFG++L E+ + GR     +    P  +    VE          +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVE----------K 229

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
            Y++  P               ++   C   D   RP   ++ E L+ ++ 
Sbjct: 230 GYKMDAPDG-------CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  140 bits (356), Expect = 2e-38
 Identities = 65/283 (22%), Positives = 107/283 (37%), Gaps = 41/283 (14%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 189
           R  + +  +G G F  V+KG   E         T + VA   L    L     + +  E 
Sbjct: 26  RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEA 76

Query: 190 NFLGNLLHPNLVKLVGYCI---EDDQRLLVY-EFMPRGSLENHLFRKGSLPLPWSIRMKI 245
             L  L HPN+V+         +  + +++  E M  G+L+ +L R     +   +    
Sbjct: 77  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSW 134

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTR 304
                KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  
Sbjct: 135 CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKA 189

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPH 363
           V+GT  + APE     +     DVY+FG+ +LEM T         P +   N  +     
Sbjct: 190 VIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSE------YPYSECQNAAQI---- 238

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                 + R+        F      +  ++   C+ ++   R 
Sbjct: 239 ------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY 275

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  141 bits (358), Expect = 2e-38
 Identities = 70/329 (21%), Positives = 128/329 (38%), Gaps = 74/329 (22%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLH 197
           LG+G FG V +           + G+ + VAVK L  D +     +E+L E   +    H
Sbjct: 31  LGKGEFGSVREA------QLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84

Query: 198 PNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIRMK----IAL 247
           P++ KLVG  +    +      +++  FM  G L   L        P+++ ++      +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKTHV 301
             A G+ +L   + +  I+RD    N +L  D    ++DFGL++             + +
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201

Query: 302 STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNL 356
             + +      A E +     T  SDV++FGV + E++T G+     ++    N E +N 
Sbjct: 202 PVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE----NAEIYNY 251

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +              RL  P        +  ++   L  QC S DPK RP  + +   L+
Sbjct: 252 LI----------GGNRLKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294

Query: 417 PL---------------QNLKDMASSSYY 430
            +                N++      ++
Sbjct: 295 NILGHLSVLSTSQDPLYINIERAHHHHHH 323

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  140 bits (355), Expect = 2e-38
 Identities = 76/291 (26%), Positives = 117/291 (40%), Gaps = 51/291 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWLAEVNFLGNLLHP 198
           +GEG FG V +G               L VA+KT  +      + ++L E   +    HP
Sbjct: 23  IGEGQFGDVHQG------IYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 76

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLAFLH 257
           ++VKL+G   E+    ++ E    G L + L  RK SL L   I    A   +  LA+L 
Sbjct: 77  HIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILY--AYQLSTALAYL- 132

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTYGYA 312
               K  ++RD    N+L+ ++   KL DFGL++   +       K  +  + M      
Sbjct: 133 --ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------ 184

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           APE +     TS SDV+ FGV + E+L  G +    +     N +    +E         
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE--------- 231

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
               RL  P                L  +C + DP  RPR +E+   L  +
Sbjct: 232 -NGERL--PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (355), Expect = 3e-38
 Identities = 71/307 (23%), Positives = 116/307 (37%), Gaps = 60/307 (19%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGE  FG V+KG     G AP +      VA+KTL         +E+  E      L HP
Sbjct: 17  LGEDRFGKVYKG--HLFGPAPGEQTQ--AVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------FRKGSLPLPWSIRMK---- 244
           N+V L+G   +D    +++ +   G L   L                 +  ++       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GK 298
           +    A G+ +L   +   V+++D  T N+L+    N K+SD GL ++          G 
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE- 353
           + +  R M      APE +M G  +  SD++S+GVVL E+ + G +          N + 
Sbjct: 190 SLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----SNQDV 239

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             ++               L  P                L  +C +  P  RPR  ++  
Sbjct: 240 VEMIR----------NRQVLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDIHS 282

Query: 414 TLKPLQN 420
            L+   N
Sbjct: 283 RLRAWGN 289

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 3e-38
 Identities = 82/292 (28%), Positives = 125/292 (42%), Gaps = 39/292 (13%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG+G FG V+ G W   NGT  V        A+KTL   G    + +L E   +  L H 
Sbjct: 275 LGQGCFGEVWMGTW---NGTTRV--------AIKTL-KPGTMSPEAFLQEAQVMKKLRHE 322

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A++  
Sbjct: 323 KLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-- 379

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM 318
                 ++RD + +NIL+  +   K++DFGLA+   ED +            + APE  +
Sbjct: 380 -ERMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAAL 437

Query: 319 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLLDPR 377
            G  T KSDV+SFG++L E+ T  R       N E  + VE          R YR+  P 
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----------RGYRMPCPP 487

Query: 378 LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
                     +    L  QC  ++P+ RP    +      L++        Y
Sbjct: 488 E-------CPESLHDLMCQCWRKEPEERPTFEYLQAF---LEDYFTSTEPQY 529

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (354), Expect = 4e-38
 Identities = 66/305 (21%), Positives = 112/305 (36%), Gaps = 55/305 (18%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 191
           +F P   LG GGFG VF+                   A+K +     +  +E  + EV  
Sbjct: 6   DFEPIQCLGRGGFGVVFEA---------KNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56

Query: 192 LGNLLHPNLVKLVGYCIEDD---------QRLLVY---EFMPRGSLENHL-FRKGSLPLP 238
           L  L HP +V+     +E +          ++ +Y   +   + +L++ +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------- 291
            S+ + I L  A+ + FLH    K +++RD K SNI    D   K+ DFGL         
Sbjct: 117 RSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 292 ---DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
                         T  +GT  Y +PE +     + K D++S G++L E+L         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
             + +   V               + + +    F+ K       +    LS  P  RP  
Sbjct: 226 PFSTQMERVR----------TLTDVRNLKFPPLFTQK-YPCEYVMVQDMLSPSPMERPEA 274

Query: 409 SEVVE 413
             ++E
Sbjct: 275 INIIE 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (358), Expect = 5e-38
 Identities = 76/293 (25%), Positives = 131/293 (44%), Gaps = 52/293 (17%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL 195
           + ++G G FG V  G ++      +       VA+KTL      +  +++L E + +G  
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEIS------VAIKTLKVGYTEKQRRDFLGEASIMGQF 103

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            HPN+++L G   +    ++V E+M  GSL++ L RK          + +  G A G+ +
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKY 162

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYA 312
           L   ++   ++RD    NIL++++   K+SDFGL +   +D +   +TR  G      + 
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWT 217

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHLGDK 367
           +PE +     TS SDV+S+G+VL E+++ G R    M     N +    V+         
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVIKAVD--------- 264

Query: 368 RRFYRLLDPRLEG-----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
              YRL  P         +          QL   C  +D   RP+  ++V  L
Sbjct: 265 -EGYRL--PPPMDCPAALY----------QLMLDCWQKDRNNRPKFEQIVSIL 304

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  139 bits (352), Expect = 6e-38
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 42/284 (14%)

Query: 140 LGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V+ G +   NG   V        AVK+L   G      +LAE N +  L H 
Sbjct: 21  LGAGQFGEVWMGYY---NGHTKV--------AVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
            LV+L     ++    ++ E+M  GSL + L     + L  +  + +A   A+G+AF+  
Sbjct: 69  RLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-- 125

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGYAAPE 315
             E+  I+RD + +NIL+    + K++DFGLA+   ++      T   G      + APE
Sbjct: 126 -EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPE 180

Query: 316 YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRLL 374
            +  G  T KSDV+SFG++L E++T  R       N E    +E          R YR+ 
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE----------RGYRM- 229

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
             R +        ++  QL   C    P+ RP    +   L+  
Sbjct: 230 -VRPDN-----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (352), Expect = 9e-38
 Identities = 62/312 (19%), Positives = 109/312 (34%), Gaps = 66/312 (21%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
             +F   ++LG+G FG V K                   A+K + H   +     L+EV 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKA---------RNALDSRYYAIKKIRHTEEK-LSTILSEVM 54

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRL-------------LVYEFMPRGSLENHLFRKGSLPL 237
            L +L H  +V+     +E    +             +  E+   G+L + +  +     
Sbjct: 55  LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK------ 291
                 ++     + L+++H    + +I+RD K  NI +D   N K+ DFGLAK      
Sbjct: 115 RDEYW-RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 292 -------DAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGR 342
                          ++++ + GT  Y A E V+  TGH   K D+YS G++  EM+   
Sbjct: 171 DILKLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYP- 227

Query: 343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL---DPRLEGHFSIKGSQKATQLAAQCLS 399
                   +     V              + L          F     +   ++    + 
Sbjct: 228 -------FSTGMERVN-----------ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID 269

Query: 400 RDPKARPRMSEV 411
            DP  RP    +
Sbjct: 270 HDPNKRPGARTL 281

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  142 bits (360), Expect = 1e-37
 Identities = 79/296 (26%), Positives = 125/296 (42%), Gaps = 41/296 (13%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL 195
           E  LG G FG V+   +   N    V        AVKT+   G    + +LAE N +  L
Sbjct: 193 EKKLGAGQFGEVWMATY---NKHTKV--------AVKTM-KPGSMSVEAFLAEANVMKTL 240

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAF 255
            H  LVKL     ++    ++ EFM +GSL + L        P    +  +   A+G+AF
Sbjct: 241 QHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299

Query: 256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRVMGTYGYAAP 314
           +    ++  I+RD + +NIL+ A    K++DFGLA+   ++        +      + AP
Sbjct: 300 I---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP--IKWTAP 354

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRFYRL 373
           E +  G  T KSDV+SFG++L+E++T  R       N E    +E          R YR+
Sbjct: 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE----------RGYRM 404

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
             P           ++   +  +C    P+ RP    +      L +      S Y
Sbjct: 405 PRPEN-------CPEELYNIMMRCWKNRPEERPTFEYIQSV---LDDFYTATESQY 450

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  139 bits (353), Expect = 1e-37
 Identities = 65/358 (18%), Positives = 128/358 (35%), Gaps = 38/358 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 189
            +     +GEG FG                   G    +K +N   +   KE      EV
Sbjct: 25  KYVRLQKIGEGSFGKAILV---------KSTEDGRQYVIKEINISRMS-SKEREESRREV 74

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
             L N+ HPN+V+      E+    +V ++   G L   +  +  +       +   +  
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L  +H+   + +++RD K+ NI L  D   +L DFG+A+    +    ++   +GT 
Sbjct: 135 CLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTP 189

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y +PE        +KSD+++ G VL E+ T + + +          +            
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF------- 242

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNLKDMASS 427
                 P +  H+    S     L +Q   R+P+ RP ++ ++E   +            
Sbjct: 243 ------PPVSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292

Query: 428 SYYFQTMQADNTWSIRNSKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPK 485
                 ++  + +         R   G  + +  P + ++ P   +  P  + +   K
Sbjct: 293 IAEEFCLKTFSKFG-SQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKKYGDK 349

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (365), Expect = 2e-37
 Identities = 75/294 (25%), Positives = 117/294 (39%), Gaps = 51/294 (17%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 195
              +GEG FG V +G               + VA+KT  +       +++L E   +   
Sbjct: 395 GRCIGEGQFGDVHQG------IYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448

Query: 196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKIALGAAKGLA 254
            HP++VKL+G   E+    ++ E    G L + L  RK SL L   I    A   +  LA
Sbjct: 449 DHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILY--AYQLSTALA 505

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED-----GKTHVSTRVMGTY 309
           +L     K  ++RD    N+L+ ++   KL DFGL++   +       K  +  + M   
Sbjct: 506 YL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--- 559

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEWARPHL 364
              APE +     TS SDV+ FGV + E+L  G +    +     N +    +E      
Sbjct: 560 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIGRIE------ 606

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                  RL  P                L  +C + DP  RPR +E+   L  +
Sbjct: 607 ----NGERL--PMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  138 bits (351), Expect = 2e-37
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 33/223 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 43  LGEGAFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L               R     + +   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 301
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D       K   
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 302 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
           + R+    M      APE +     T +SDV+SFGV++ E+ T
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  139 bits (353), Expect = 4e-37
 Identities = 81/314 (25%), Positives = 126/314 (40%), Gaps = 51/314 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LGEG FG V     E  G    KP     VAVK L  D   +   + ++E+  +  +  H
Sbjct: 77  LGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------FRKGSLPLPWSIRMK--- 244
            N++ L+G C +D    ++ E+  +G+L  +L              S      +  K   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 245 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 301
             A   A+G+ +L   A K  I+RD    N+L+  D   K++DFGLA+D       K   
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 302 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNL 356
           + R+    M      APE +     T +SDV+SFGV+L E+ T   S     P  E   L
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           ++            +R+   +         + +   +   C    P  RP   ++VE L 
Sbjct: 306 LK----------EGHRM--DKPSNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348

Query: 417 PLQNLKDMASSSYY 430
            +  L       YY
Sbjct: 349 RIVALTSNQEMGYY 362

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  139 bits (351), Expect = 5e-37
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 51/302 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LGEG FG V     E  G    KP   +TVAVK L  D   +   + ++E+  +  +  H
Sbjct: 89  LGEGCFGQVVMA--EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIRM 243
            N++ L+G C +D    ++ E+  +G+L  +L               R     + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHV 301
                 A+G+ +L   A +  I+RD    N+L+  +   K++DFGLA+D       K   
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 302 STRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNL 356
           + R+    M      APE +     T +SDV+SFGV++ E+ T   S     P  E   L
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           +          +  +R+  P          + +   +   C    P  RP   ++VE L 
Sbjct: 318 L----------KEGHRMDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360

Query: 417 PL 418
            +
Sbjct: 361 RI 362

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  136 bits (344), Expect = 2e-36
 Identities = 79/313 (25%), Positives = 124/313 (39%), Gaps = 54/313 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V  +G           VAVKTL      Q   ++L E   +    H 
Sbjct: 38  LGHGAFGEVYEGQV--SGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL-FRKGSLPLPWSIRMK----IALGAAKGL 253
           N+V+ +G  ++   R ++ E M  G L++ L   +     P S+ M     +A   A G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED------GKTHVSTR 304
            +L    E   I+RD    N LL        AK+ DFG+A+D          G   +  +
Sbjct: 154 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEW 359
            M       PE  M G  TSK+D +SFGV+L E+ + G     S      N E    V  
Sbjct: 211 WM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV-- 258

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
                       R+  P+              ++  QC    P+ RP  + ++E ++   
Sbjct: 259 --------TSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303

Query: 420 NLKDMASSSYYFQ 432
              D+ +++   +
Sbjct: 304 QDPDVINTALPIE 316

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  135 bits (342), Expect = 3e-36
 Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 63/307 (20%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNL 195
           + ++GEG FG V K  ++       K G  +  A+K +        H+++  E+  L  L
Sbjct: 30  QDVIGEGNFGQVLKARIK-------KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82

Query: 196 L-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--------------FRKGSLPLPWS 240
             HPN++ L+G C       L  E+ P G+L + L                  +  L   
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
             +  A   A+G+ +L   ++K  I+RD    NIL+  +Y AK++DFGL++      K  
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 199

Query: 301 VSTRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNG 352
              R+    M      A E +     T+ SDV+S+GV+L E+++ G      M       
Sbjct: 200 -MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCA 248

Query: 353 E-HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
           E +  +           + YRL  P            +   L  QC    P  RP  +++
Sbjct: 249 ELYEKLP----------QGYRLEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQI 291

Query: 412 VETLKPL 418
           + +L  +
Sbjct: 292 LVSLNRM 298

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (354), Expect = 4e-36
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 44/289 (15%)

Query: 137 ESLLGEGGFGCVFKG-WVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGN 194
           +  LG G FG V +G +        V        A+K L         +E + E   +  
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDV--------AIKVLKQGTEKADTEEMMREAQIMHQ 392

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           L +P +V+L+G C + +  +LV E    G L   L       +P S   ++    + G+ 
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMK 450

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT---YGY 311
           +L    EK  ++R+    N+LL   + AK+SDFGL+K    D   + +           +
Sbjct: 451 YL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKW 505

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPHLGDKRRF 370
            APE +     +S+SDV+S+GV + E L+  +   K     E    +E          + 
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE----------QG 555

Query: 371 YRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            R+  P     E +           L + C     + RP    V + ++
Sbjct: 556 KRMECPPECPPELY----------ALMSDCWIYKWEDRPDFLTVEQRMR 594

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  135 bits (342), Expect = 8e-36
 Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 54/299 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LG G FG V++G V  +G           VAVKTL      Q   ++L E   +    H 
Sbjct: 79  LGHGAFGEVYEGQV--SGMPNDPSPL--QVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---KGSLPLPWSIR--MKIALGAAKGL 253
           N+V+ +G  ++   R ++ E M  G L++ L     + S P   ++   + +A   A G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSDFGLAKDAPED------GKTHVSTR 304
            +L    E   I+RD    N LL        AK+ DFG+A+D          G   +  +
Sbjct: 195 QYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGE-HNLVEW 359
            M       PE  M G  TSK+D +SFGV+L E+ + G     S      N E    V  
Sbjct: 252 WM------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK----SNQEVLEFV-- 299

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                       R+  P+              ++  QC    P+ RP  + ++E ++  
Sbjct: 300 --------TSGGRMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (337), Expect = 9e-36
 Identities = 68/321 (21%), Positives = 117/321 (36%), Gaps = 57/321 (17%)

Query: 93  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 152
           S  +T   +  S   ++  E                          +LG+G +G V+ G 
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYD------------------ENGDRVVLGKGTYGIVYAG- 41

Query: 153 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQ 212
                         + +A+K +     +  +    E+    +L H N+V+ +G   E+  
Sbjct: 42  --------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93

Query: 213 RLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT 271
             +  E +P GSL   L  K G L               +GL +LH+     +++RD K 
Sbjct: 94  IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKG 150

Query: 272 SNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV---MTGHLTSKSD 327
            N+L++      K+SDFG +K          +    GT  Y APE +     G+    +D
Sbjct: 151 DNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGY-GKAAD 207

Query: 328 VYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP--HLGDKRRFYRLLDPRLEGHFSIK 385
           ++S G  ++EM TG+       P   + L E       +G  +     + P +       
Sbjct: 208 IWSLGCTIIEMATGK------PPF--YELGEPQAAMFKVGMFK-----VHPEIPESM--- 251

Query: 386 GSQKATQLAAQCLSRDPKARP 406
            S +A     +C   DP  R 
Sbjct: 252 -SAEAKAFILKCFEPDPDKRA 271

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (337), Expect = 2e-35
 Identities = 78/307 (25%), Positives = 116/307 (37%), Gaps = 60/307 (19%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LG G FG V +      G          TVAVK L     L   +  ++E+  L  L  H
Sbjct: 31  LGAGAFGKVVEA--TAYGLIKSDAAM--TVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------------FRKGSLPLPWSI 241
            N+V L+G C      L++ E+   G L N L                     L L    
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED----- 296
            +  +   AKG+AFL   A K  I+RD    NILL      K+ DFGLA+D   D     
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 297 -GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPN 351
            G   +  + M      APE +     T +SDV+S+G+ L E+ + G      M  +   
Sbjct: 204 KGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +     +   +  +R+L P            +   +   C   DP  RP   ++
Sbjct: 256 ---KFYK----MI---KEGFRMLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQI 298

Query: 412 VETLKPL 418
           V+ ++  
Sbjct: 299 VQLIEKQ 305

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  133 bits (337), Expect = 2e-35
 Identities = 69/342 (20%), Positives = 116/342 (33%), Gaps = 54/342 (15%)

Query: 77  GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRP 136
           G  S+ +      +  + ++ S             E  + ++  K +  + +        
Sbjct: 3   GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH 62

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 196
           +  +G G FG V +              TG   AVK +    L+  +    E+     L 
Sbjct: 63  QPRVGRGSFGEVHRM---------KDKQTGFQCAVKKVR---LEVFRV--EELVACAGLS 108

Query: 197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
            P +V L G   E     +  E +  GSL   + + G   LP    +     A +GL +L
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYL 166

Query: 257 HEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR---VMGTYGYA 312
           H      +++ D K  N+LL +D   A L DFG A     DG          + GT  + 
Sbjct: 167 HTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223

Query: 313 APEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-------LVEWARPHL 364
           APE VM      +K D++S   ++L ML G        P  ++        +     P  
Sbjct: 224 APEVVMGKPC-DAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLKIASEPPPI- 275

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                        +        +    Q   + L ++P  R 
Sbjct: 276 -----------REIPPSC----APLTAQAIQEGLRKEPVHRA 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  132 bits (333), Expect = 3e-35
 Identities = 65/290 (22%), Positives = 111/290 (38%), Gaps = 36/290 (12%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 189
            ++     +G G +G   K  +            G  +  K L++  +     +  ++EV
Sbjct: 6   EDYEVLYTIGTGSYGRCQK--IRRKSD-------GKILVWKELDYGSMTEAEKQMLVSEV 56

Query: 190 NFLGNLLHPNLVKLVG-YCIEDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMKI 245
           N L  L HPN+V+         +  L +V E+   G L + +    K    L     +++
Sbjct: 57  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116

Query: 246 ALGAAKGLAFLHE--EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
                  L   H   +    V++RD K +N+ LD   N KL DFGLA+       +   T
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKT 175

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
            V GT  Y +PE +       KSD++S G +L E+           P    +  E A   
Sbjct: 176 FV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKI 228

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              K         R+   +    S +  ++  + L+     RP + E++E
Sbjct: 229 REGKF-------RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 267

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  132 bits (335), Expect = 3e-35
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 20/214 (9%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EV 189
           +R   L+G GG G V++                  VA+K +  + L     +      E 
Sbjct: 36  YRLRRLVGRGGMGDVYEA---------EDTVRERIVALKLM-SETLSSDPVFRTRMQREA 85

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
              G L  P++V +  +   D Q  +    +    L   L R+G L  P ++   I    
Sbjct: 86  RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQI 143

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
              L   H        +RD K  NIL+ AD  A L DFG+A    ++  T +    +GT 
Sbjct: 144 GSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTL 199

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR 343
            Y APE     H T ++D+Y+   VL E LTG  
Sbjct: 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  132 bits (334), Expect = 3e-35
 Identities = 66/305 (21%), Positives = 113/305 (37%), Gaps = 51/305 (16%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH- 182
           F  + +  R +     +G GG   VF+  + E              A+K +N +      
Sbjct: 20  FQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQ---------IYAIKYVNLEEADNQT 69

Query: 183 -KEWLAEVNFLGNLLHPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP 238
              +  E+ +L  L   +   ++L  Y    DQ + +V E      L + L +K S+   
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKKSIDPW 127

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
                       + +  +H+     +++ D K +N L+  D   KL DFG+A     D  
Sbjct: 128 ER--KSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 181

Query: 299 THVSTRVMGTYGYAAPEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDK 347
           + V    +GT  Y  PE +               ++ KSDV+S G +L  M  G+     
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----- 236

Query: 348 NRP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
             P     N +           + + ++DP  E  F     +    +   CL RDPK R 
Sbjct: 237 -TPFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 285

Query: 407 RMSEV 411
            + E+
Sbjct: 286 SIPEL 290

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  132 bits (334), Expect = 4e-35
 Identities = 79/306 (25%), Positives = 118/306 (38%), Gaps = 59/306 (19%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LG G FG V +   +  G          TVAVK L        H+  ++E+  L ++  H
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATCR--TVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 198 PNLVKLVGYCIEDDQ-RLLVYEFMPRGSLENHL--------------FRKGSLPLPWSIR 242
            N+V L+G C +     +++ EF   G+L  +L                     L     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTH 300
           +  +   AKG+ FL   A +  I+RD    NILL      K+ DFGLA+D  +D      
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207

Query: 301 VSTRV----MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNG 352
              R+    M      APE +     T +SDV+SFGV+L E+ + G      +  +    
Sbjct: 208 GDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---- 257

Query: 353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
                      L   +   R+  P          + +  Q    C   +P  RP  SE+V
Sbjct: 258 -EEFCR----RL---KEGTRMRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELV 302

Query: 413 ETLKPL 418
           E L  L
Sbjct: 303 EHLGNL 308

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  132 bits (335), Expect = 4e-35
 Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 42/230 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           +GEG FG VF+      G  P +P T   VAVK L  +       ++  E   +    +P
Sbjct: 55  IGEGAFGRVFQA--RAPGLLPYEPFT--MVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------------------FRKGSLPLPWS 240
           N+VKL+G C       L++E+M  G L   L                    + S P P  
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 241 IRMK----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           +       IA   A G+A+L   +E+  ++RD  T N L+  +   K++DFGL+++    
Sbjct: 171 LSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 297 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                 G   +  R M       PE +     T++SDV+++GVVL E+ +
Sbjct: 228 DYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (335), Expect = 5e-35
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 33/221 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LG G FG V +           K    L VAVK L         +  ++E+  + +L  H
Sbjct: 54  LGAGAFGKVVEATAFG----LGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL------------FRKGSLPLPWSIRMKI 245
            N+V L+G C      L++ E+   G L N L            F   +        +  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED------GKT 299
           +   A+G+AFL   A K  I+RD    N+LL   + AK+ DFGLA+D   D      G  
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
            +  + M      APE +     T +SDV+S+G++L E+ +
Sbjct: 227 RLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (331), Expect = 6e-35
 Identities = 74/292 (25%), Positives = 119/292 (40%), Gaps = 42/292 (14%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWLA---- 187
           ++    LG GG   V+               T L   VA+K +     +  +E L     
Sbjct: 13  YKIVDKLGGGGMSTVYLAE-----------DTILNIKVAIKAI-FIPPREKEETLKRFER 60

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV+    L H N+V ++    EDD   LV E++   +L  ++   G L +  +I      
Sbjct: 61  EVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAIN--FTN 118

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
               G+   H+     +++RD K  NIL+D++   K+ DFG+AK   E   T  +  V+G
Sbjct: 119 QILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLG 174

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGD 366
           T  Y +PE          +D+YS G+VL EML G        P NGE   V  A  H+ D
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------PPFNGE-TAVSIAIKHIQD 227

Query: 367 KR-RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLK 416
                   +   +         Q  + +  +   +D   R + + E+ + L 
Sbjct: 228 SVPNVTTDVRKDI--------PQSLSNVILRATEKDKANRYKTIQEMKDDLS 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  133 bits (336), Expect = 9e-35
 Identities = 73/365 (20%), Positives = 126/365 (34%), Gaps = 67/365 (18%)

Query: 64  VDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFM 123
              S          K +   + +R  +      T + + ASS+                 
Sbjct: 4   HHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSAN--------------- 48

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QG 181
              + +  R +     +G GG   VF+          V        A+K +N +    Q 
Sbjct: 49  -ECISVKGRIYSILKQIGSGGSSKVFQ----------VLNEKKQIYAIKYVNLEEADNQT 97

Query: 182 HKEWLAEVNFLGNLLHPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP 238
              +  E+ +L  L   +   ++L  Y    DQ + +V E      L + L +K S+   
Sbjct: 98  LDSYRNEIAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPW 155

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
              R        + +  +H+     +++ D K +N L+  D   KL DFG+A     D  
Sbjct: 156 E--RKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209

Query: 299 THVSTRVMGTYGYAAPEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDK 347
           + V    +G   Y  PE +               ++ KSDV+S G +L  M  G+     
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK----- 264

Query: 348 NRP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
             P     N +           + + ++DP  E  F     +    +   CL RDPK R 
Sbjct: 265 -TPFQQIINQIS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

Query: 407 RMSEV 411
            + E+
Sbjct: 314 SIPEL 318

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  131 bits (331), Expect = 1e-34
 Identities = 66/230 (28%), Positives = 100/230 (43%), Gaps = 42/230 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHP 198
           LGEG FG V K              T  TVAVK L  +      ++ L+E N L  + HP
Sbjct: 31  LGEGEFGKVVKA--TAFHLKGRAGYT--TVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHL----------------------FRKGSLP 236
           +++KL G C +D   LL+ E+   GSL   L                             
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L     +  A   ++G+ +L   AE  +++RD    NIL+      K+SDFGL++D  E+
Sbjct: 147 LTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203

Query: 297 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
                  +  +  + M      A E +     T++SDV+SFGV+L E++T
Sbjct: 204 DSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  132 bits (332), Expect = 2e-34
 Identities = 50/390 (12%), Positives = 83/390 (21%), Gaps = 63/390 (16%)

Query: 77  GKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRP 136
           G S       R    +        +  ++  +              + + L    R  + 
Sbjct: 7   GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKL 66

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLG 193
              L  G    VF                    A+K           E            
Sbjct: 67  VEPLRVGDRSVVFLV---------RDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 194 NLLHPNLVKLVGYC-----------------------IEDDQRLLVYEFMPR--GSLEN- 227
            LL  +  +                             +D         MP     LE  
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 228 ----HLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
                                +     +  A L     K +++  F   N+ +  D    
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLM 234

Query: 284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTG 341
           L D          G             YA  E++       T   + +  G+ +  +   
Sbjct: 235 LGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289

Query: 342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRD 401
                   P  +     W RP L             L              L  + L+ D
Sbjct: 290 FLPFGLVTPGIKG---SWKRPSLRVPGT------DSLAFGSCTPLPDFVKTLIGRFLNFD 340

Query: 402 PKARPRMSEVVET--LKPLQNLKDMASSSY 429
            + R    E +ET     LQN    + S+ 
Sbjct: 341 RRRRLLPLEAMETPEFLQLQNEISSSLSTG 370

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (329), Expect = 3e-34
 Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 51/290 (17%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH--KEWLAEVNFLGNLL 196
            +G GG   VF+                   A+K +N +         +  E+ +L  L 
Sbjct: 16  QIGSGGSSKVFQV----------LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65

Query: 197 HPNL--VKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
             +   ++L  Y    DQ + +V E      L + L +K S+      R        + +
Sbjct: 66  QHSDKIIRLYDY-EITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAV 121

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
             +H+     +++ D K +N L+  D   KL DFG+A     D  + V    +GT  Y  
Sbjct: 122 HTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 314 PEYVM-----------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWAR 361
           PE +               ++ KSDV+S G +L  M  G+       P     N +    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQIS--- 228

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV 411
                  + + ++DP  E  F     +    +   CL RDPK R  + E+
Sbjct: 229 -------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (329), Expect = 4e-34
 Identities = 73/323 (22%), Positives = 118/323 (36%), Gaps = 67/323 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLL-H 197
           LG G FG V        G +         VAVK L         +  ++E+  +  L  H
Sbjct: 53  LGSGAFGKVMNA--TAYGISKTGVSI--QVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--------------- 242
            N+V L+G C       L++E+   G L N+L  K        I                
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 243 ------MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
                 +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGLA+D   D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 297 ------GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMD 346
                 G   +  + M      APE +  G  T KSDV+S+G++L E+ + G      + 
Sbjct: 226 SNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 347 KNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            +      N  +     +   +  +++  P          +++   +   C + D + RP
Sbjct: 280 VD-----ANFYK----LI---QNGFKMDQPF-------YATEEIYIIMQSCWAFDSRKRP 320

Query: 407 RMSEVVETLKPLQNLKDMASSSY 429
               +   L     L D   + Y
Sbjct: 321 SFPNLTSFLGCQ--LADAEEAMY 341

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (331), Expect = 5e-34
 Identities = 68/340 (20%), Positives = 115/340 (33%), Gaps = 55/340 (16%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
           +LG+G    VF+G             TG   A+K  N+       +  + E   L  L H
Sbjct: 16  ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 198 PNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKG 252
            N+VKL  + IE++      +L+ EF P GSL   L    +   LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +    +   GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 309 YGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEMLTGRR-------------SMDK 347
             Y  P+      L         +  D++S GV      TG                M K
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                    +   +        +   +        S       T + A  L  D +    
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPV--SCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 408 MSEVVETLKPLQNLK-----DMASSSYYFQTMQADNTWSI 442
             +       + +        +   + +   + + NT +I
Sbjct: 297 FDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATI 336

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  129 bits (327), Expect = 5e-34
 Identities = 80/330 (24%), Positives = 130/330 (39%), Gaps = 47/330 (14%)

Query: 91  PVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFK 150
           P  +          + P        A ++ + + +      R +     LG+GGF   F+
Sbjct: 2   PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSR--RRYVRGRFLGKGGFAKCFE 59

Query: 151 GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNLLHPNLVKLVGYC 207
                         T    A K +    L       +   E++   +L H ++V   G+ 
Sbjct: 60  I---------SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF- 109

Query: 208 IEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY 266
            ED+  + +V E   R SL     R+ +L  P + R         G  +LH      VI+
Sbjct: 110 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-R-YYLRQIVLGCQYLHR---NRVIH 164

Query: 267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTS- 324
           RD K  N+ L+ D   K+ DFGLA     DG+     +V+ GT  Y APE V++    S 
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPE-VLSKKGHSF 220

Query: 325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHLGDKRRFYRLLDPRLEGHFS 383
           + DV+S G ++  +L G+       P     L E + R    +    Y +  P+   H  
Sbjct: 221 EVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKKNE----YSI--PK---HI- 264

Query: 384 IKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
              +  A  L  + L  DP ARP ++E++ 
Sbjct: 265 ---NPVAASLIQKMLQTDPTARPTINELLN 291

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  130 bits (329), Expect = 6e-34
 Identities = 55/395 (13%), Positives = 110/395 (27%), Gaps = 98/395 (24%)

Query: 82  EKRRDRPVVPVSSTTTSNAESASSTPKFSEE--LKVASQLRKFMFNDLKLATRNFRPESL 139
            +     V   S    S A+S  ST  ++     +V S+L +          R     ++
Sbjct: 29  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--------PRTLVRGTV 80

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------------- 179
           LG+       +              TG +  V                            
Sbjct: 81  LGQEDPYAYLEA---------TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 180 --------QGHKEWLAEVNFLGNLLHPNLVKLVGYC--IEDDQRLLVYEFM--PRGSLEN 227
                   + H  ++   + + +     ++++      +    R  +Y  M     +   
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 228 HLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
            L    S    L    R+++ L   + LA LH      +++   +  +I+LD      L+
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVV 334
            F        DG   VS     + G+  PE                 +T   D ++ G+V
Sbjct: 249 GFEHLV---RDGARVVS---SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302

Query: 335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLA 394
           +  +           P  +   +  +       +                   Q    L 
Sbjct: 303 IYWIWCAD------LPITKDAALGGSEWIFRSCKNI----------------PQPVRALL 340

Query: 395 AQCLSRDPKARPRMSEVVETLKP-LQNLKDMASSS 428
              L    + R    + +ET  P  + L+   S++
Sbjct: 341 EGFLRYPKEDRLLPLQAMET--PEYEQLRTELSAA 373

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  127 bits (322), Expect = 1e-33
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 45/289 (15%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAE 188
           R +     LG+GGF   F+              T    A K +    L       +   E
Sbjct: 15  RRYVRGRFLGKGGFAKCFEI---------SDADTKEVFAGKIVPKSLLLKPHQREKMSME 65

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           ++   +L H ++V   G+  ED+  + +V E   R SL     R+ +L  P +      +
Sbjct: 66  ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM- 306
               G  +LH      VI+RD K  N+ L+ D   K+ DFGLA     DG+     +V+ 
Sbjct: 125 --VLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLC 176

Query: 307 GTYGYAAPEYVMTGHLTS-KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHL 364
           GT  Y APE V++    S + DV+S G ++  +L G+       P     L E + R   
Sbjct: 177 GTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKK 229

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
            +    Y +  P+   H     +  A  L  + L  DP ARP ++E++ 
Sbjct: 230 NE----YSI--PK---HI----NPVAASLIQKMLQTDPTARPTINELLN 265

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  128 bits (323), Expect = 1e-33
 Identities = 65/314 (20%), Positives = 108/314 (34%), Gaps = 48/314 (15%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFLGNLLH 197
           +LG+G    VF+G             TG   A+K  N+       +  + E   L  L H
Sbjct: 16  ILGQGATANVFRG---------RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 198 PNLVKLVGYCIEDDQR----LLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKG 252
            N+VKL  + IE++      +L+ EF P GSL   L    +   LP S  + +      G
Sbjct: 67  KNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
           +  L E     +++R+ K  NI+     D     KL+DFG A++  +D +    +   GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--SLY-GT 178

Query: 309 YGYAAPEYVMTGHL--------TSKSDVYSFGVVLLEMLTGR------------RSMDKN 348
             Y  P+      L         +  D++S GV      TG             + +   
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
              G+ +          +    +    P      S       T + A  L  D +     
Sbjct: 239 IITGKPSGAISGVQKAENGPIDWSGDMPV-SCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 409 SEVVETLKPLQNLK 422
            +       + +  
Sbjct: 298 DQFFAETSDILHRG 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  133 bits (336), Expect = 1e-33
 Identities = 78/388 (20%), Positives = 126/388 (32%), Gaps = 53/388 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 191
            +  +  LG GGFG V +          +   TG  VA+K    +    ++E W  E+  
Sbjct: 15  PWEMKERLGTGGFGYVLRW---------IHQDTGEQVAIKQCRQELSPKNRERWCLEIQI 65

Query: 192 LGNLLHPNLVKLVGYCIEDDQR--------LLVYEFMPRGSLENHLFRKG-SLPLPWSIR 242
           +  L HPN+V      + D  +        LL  E+   G L  +L +      L     
Sbjct: 66  MKKLNHPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI 123

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA---KLSDFGLAKDAPEDGKT 299
             +    +  L +LHE     +I+RD K  NI+L         K+ D G AK+  +    
Sbjct: 124 RTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR---------SMDKNRP 350
                V GT  Y APE +     T   D +SFG +  E +TG R                
Sbjct: 181 T--EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
              +  +       G  +    L  P    H S   + K  +     L    + R    +
Sbjct: 238 EKSNEHIVVYDDLTGAVKFSSVLPTPN---HLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294

Query: 411 V--------VETLKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGGFMTRN--- 459
                    ++++  L+ L  M   S    T       +++N K+ ++   G        
Sbjct: 295 NPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQEL 354

Query: 460 GQPLRTLSHPNGPHASPYRHPQQSPKPN 487
            Q      +   P               
Sbjct: 355 LQASGLALNSAQPLTQYVIDCTVIDGRQ 382

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  128 bits (324), Expect = 2e-33
 Identities = 54/311 (17%), Positives = 108/311 (34%), Gaps = 64/311 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------------ 187
           L +G F  +     E++             A+K      L+  +++              
Sbjct: 39  LNQGKFNKIIL--CEKDNK---------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 188 -----EVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSI 241
                E+  + ++ +   +   G  I +   + ++YE+M   S+         L   ++ 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146

Query: 242 RMKIALGA------AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            + I +            +++H   EK + +RD K SNIL+D +   KLSDFG ++    
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGRRSMDKNRP-N 351
           D K   S    GTY +  PE   +   +   +K D++S G+ L  M           P +
Sbjct: 204 DKKIKGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV------VPFS 253

Query: 352 GEHNL---------VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 402
            + +L              P   +   +          +  +  S +        L ++P
Sbjct: 254 LKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFL--SNEDIDFLKLFLRKNP 311

Query: 403 KARPRMSEVVE 413
             R    + ++
Sbjct: 312 AERITSEDALK 322

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  127 bits (319), Expect = 9e-33
 Identities = 44/253 (17%), Positives = 80/253 (31%), Gaps = 23/253 (9%)

Query: 104 SSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP 163
           SS P   E       ++     + +L ++      LLGEG F  V++    +      K 
Sbjct: 39  SSYPNTFEWQCKLPAIKPKT--EFQLGSKLVYVHHLLGEGAFAQVYE--ATQGDLNDAK- 93

Query: 164 GTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRG 223
                  +K                +  L   +    +K     +  +  +LV E    G
Sbjct: 94  -NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYG 152

Query: 224 SLENHLFRKGSL---PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---- 276
           +L N +    +     +P  + +  A+     +  +H+     +I+ D K  N +L    
Sbjct: 153 TLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF 209

Query: 277 -------DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 329
                  D      L D G + D     K  + T    T G+   E +       + D +
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269

Query: 330 SFGVVLLEMLTGR 342
                +  ML G 
Sbjct: 270 GVAATVYCMLFGT 282

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (309), Expect = 6e-32
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 23/208 (11%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK--EWLA-EVNFLGNL 195
            LG+G FG V+            +      +A+K L    L+       L  E+    +L
Sbjct: 21  PLGKGKFGNVYLA---------REKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN++++  Y   D +R+ L+ EF PRG L   L + G      S    +    A  L 
Sbjct: 72  RHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS-ATFMEE-LADALH 128

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           + HE   + VI+RD K  N+L+      K++DFG +  AP   +        GT  Y  P
Sbjct: 129 YCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPP 181

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +       K D++  GV+  E L G 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (311), Expect = 6e-32
 Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 45/291 (15%)

Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGL--TVAVKTLNHDGLQGHKEWL 186
           L+ R +    +LG GG   V                      VAVK L    L     + 
Sbjct: 10  LSDR-YELGEILGFGGMSEVHLAR-----------DLRDHRDVAVKVL-RADLARDPSFY 56

Query: 187 A----EVNFLGNLLHPNLVKLVGYCIEDDQRL----LVYEFMPRGSLENHLFRKGSLPLP 238
                E      L HP +V +      +        +V E++   +L + +  +G +   
Sbjct: 57  LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 116

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
            +I   +   A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G 
Sbjct: 117 RAIE--VIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171

Query: 299 THVST-RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNL 356
           +   T  V+GT  Y +PE      + ++SDVYS G VL E+LTG        P  G+ + 
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGD-SP 224

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
           V  A  H+ +           L        S     +  + L+++P+ R +
Sbjct: 225 VSVAYQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQ 267

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  122 bits (309), Expect = 7e-32
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---EWLAEVNFLGNL 195
            LG+G FG V+            +  +   +A+K L    L+      +   EV    +L
Sbjct: 16  PLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66

Query: 196 LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
            HPN+++L GY   D  R+ L+ E+ P G++   L +        +         A  L+
Sbjct: 67  RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT--ATYITELANALS 123

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAP 314
           + H    K VI+RD K  N+LL +    K++DFG +  AP   +        GT  Y  P
Sbjct: 124 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPP 176

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           E +       K D++S GV+  E L G+
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  125 bits (314), Expect = 1e-31
 Identities = 56/393 (14%), Positives = 113/393 (28%), Gaps = 95/393 (24%)

Query: 82  EKRRDRPVVPVSSTTTSNAESASSTPKFSE--ELKVASQLRKFMFNDLKLATRNFRPESL 139
            +     V   S    S A+S  ST  ++     +V S+L +          R     ++
Sbjct: 34  NRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGER--------PRTLVRGTV 85

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---------------------- 177
           LG+       +   +E         TG +  V                            
Sbjct: 86  LGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136

Query: 178 GLQGHKEWLAEVNFLGN---LLHPNLVKLVGYCIEDDQRLLVYEF--MPR-----GSLEN 227
           G++  K+    + F+     +  P   K++   +++    ++  F   PR      +   
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 228 HLFRKGSL--PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS 285
            L    S    L    R+++ L   + LA LH      +++   +  +I+LD      L+
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM----------TGHLTSKSDVYSFGVVL 335
            F           +          G+A PE                +T   D ++ G+ +
Sbjct: 254 GFEHLVRDGASAVS------PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307

Query: 336 LEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
             +           PN +   +  +       +                   Q    L  
Sbjct: 308 YWIWCAD------LPNTDDAALGGSEWIFRSCKNI----------------PQPVRALLE 345

Query: 396 QCLSRDPKARPRMSEVVETLKPLQNLKDMASSS 428
             L    + R    + +ET    + L+   S++
Sbjct: 346 GFLRYPKEDRLLPLQAMET-PEYEQLRTELSAA 377

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  122 bits (308), Expect = 1e-31
 Identities = 62/302 (20%), Positives = 99/302 (32%), Gaps = 65/302 (21%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAE 188
           T  F     +G G FG VFK          VK   G   A+K       G    +  L E
Sbjct: 10  TTEFHELEKIGSGEFGSVFKC---------VKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60

Query: 189 VNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIRMKI 245
           V     L  H ++V+      EDD  L+  E+   GSL + +    +       +    +
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-------------------YNAKLSD 286
            L   +GL ++H  +   +++ D K SNI +                         K+ D
Sbjct: 121 LLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRS 344
            G            V     G   + A E +     HL  K+D+++  + ++        
Sbjct: 178 LGHVT---RISSPQVEE---GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230

Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
                P       +W     G          PR+        SQ+ T+L    +  DP+ 
Sbjct: 231 -----PRNGD---QWHEIRQGRL--------PRIPQVL----SQEFTELLKVMIHPDPER 270

Query: 405 RP 406
           RP
Sbjct: 271 RP 272

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  126 bits (319), Expect = 2e-31
 Identities = 85/364 (23%), Positives = 131/364 (35%), Gaps = 50/364 (13%)

Query: 54  IESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEEL 113
            ++ +                 +     E+   + +    +  T    S +    + + +
Sbjct: 106 TQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSI 165

Query: 114 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 173
                L+        +    FR   +LG+GGFG V     +          TG   A K 
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA--CQ-------VRATGKMYACKK 216

Query: 174 LNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHL 229
           L    ++  K     L E   L  +    +V L  Y  E    L LV   M  G L+ H+
Sbjct: 217 LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHI 275

Query: 230 FRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL 284
           +  G    P + R       I  G    L  LH E    ++YRD K  NILLD   + ++
Sbjct: 276 YHMGQAGFPEA-RAVFYAAEICCG----LEDLHRER---IVYRDLKPENILLDDHGHIRI 327

Query: 285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-- 342
           SD GLA   PE        RV GT GY APE V     T   D ++ G +L EM+ G+  
Sbjct: 328 SDLGLAVHVPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

Query: 343 -RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRD 401
            +   + +      +                + +   E  +S + S +A  L +Q L +D
Sbjct: 385 FQ--QRKKKIKREEV-------------ERLVKEVPEE--YSERFSPQARSLCSQLLCKD 427

Query: 402 PKAR 405
           P  R
Sbjct: 428 PAER 431

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  124 bits (314), Expect = 2e-31
 Identities = 74/340 (21%), Positives = 119/340 (35%), Gaps = 55/340 (16%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +F P+ +LG G  G +        G           VAVK +  +          EV  L
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-----GMF-----DNRDVAVKRILPECFSFADR---EVQLL 71

Query: 193 GNLL-HPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
                HPN+++   +C E D++   +  E     +L+ ++ +K    L       +    
Sbjct: 72  RESDEHPNVIRY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQT 127

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILL-----DADYNAKLSDFGLAKD-APEDGKTHVST 303
             GLA LH      +++RD K  NIL+          A +SDFGL K  A         +
Sbjct: 128 TSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184

Query: 304 RVMGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
            V GT G+ APE +      + T   D++S G V   +++         P G+    +  
Sbjct: 185 GVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ-- 237

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV------VET 414
                       L     E H        A +L  + ++ DP+ RP    V         
Sbjct: 238 ---ANILLGACSLDCLHPEKHE----DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

Query: 415 LKPLQNLKDMASSSYYFQTMQADNTWSIRNSKNGIRTQGG 454
            K LQ  +D+   S   +    D     +  + G      
Sbjct: 291 EKQLQFFQDV---SDRIEKESLDGPIVKQLERGGRAVVKM 327

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  125 bits (315), Expect = 9e-31
 Identities = 81/317 (25%), Positives = 120/317 (37%), Gaps = 38/317 (11%)

Query: 40  EEEEEIGCWVRFRFIESCMPSRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSN 99
           E EEE     R  F    M          S ++  +      +K+    +          
Sbjct: 96  ETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ 155

Query: 100 AESASSTPKFSEELKVASQLR-KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 158
                   KF E  K     + K +  ++ L   +F    ++G GGFG V+         
Sbjct: 156 NLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYG--CR---- 209

Query: 159 APVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFL---GNLLHPNLVKLVGYCIEDDQ 212
              K  TG   A+K L+   ++  +     L E   L        P +V +  Y      
Sbjct: 210 ---KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS-YAFHTPD 265

Query: 213 RL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIY 266
           +L  + + M  G L  HL + G         M+     I LG    L  +H      V+Y
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNRF---VVY 315

Query: 267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS 326
           RD K +NILLD   + ++SD GLA D  +  K H    V GT+GY APE +  G     S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKK-KPH--ASV-GTHGYMAPEVLQKGVAYDSS 371

Query: 327 -DVYSFGVVLLEMLTGR 342
            D +S G +L ++L G 
Sbjct: 372 ADWFSLGCMLFKLLRGH 388

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  124 bits (313), Expect = 1e-30
 Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 60/293 (20%)

Query: 134 FRPESLLGEGGFGCVFKGW---VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEV 189
           +  +  +  GG G ++      V            G  V +K L H G    +   +AE 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVN-----------GRPVVLKGLVHSGDAEAQAMAMAER 130

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRL-----LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
            FL  ++HP++V++  +    D+       +V E++   SL+        LP+  +I   
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIA-- 186

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
             L     L++LH      ++Y D K  NI+L  +   KL D G        G       
Sbjct: 187 YLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------Y 236

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           + GT G+ APE ++    T  +D+Y+ G  L  +                          
Sbjct: 237 LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDL------------------PTRN 277

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLK 416
           G         DP L+ + S        +L  + +  DP+ R     E+   L 
Sbjct: 278 GRYVDGLPEDDPVLKTYDSYG------RLLRRAIDPDPRQRFTTAEEMSAQLT 324

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  122 bits (308), Expect = 4e-30
 Identities = 84/361 (23%), Positives = 126/361 (34%), Gaps = 54/361 (14%)

Query: 62  SKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRK 121
           +      +    ++    +  + R      +         +      F E L     LR 
Sbjct: 112 AAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRF 171

Query: 122 FMFNDL---KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG 178
             +  L    +    F    +LG GGFG VF    +          TG   A K LN   
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFA--CQ-------MKATGKLYACKKLNKKR 222

Query: 179 LQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS 234
           L+  K +   + E   L  +    +V L  Y  E    L LV   M  G +  H++    
Sbjct: 223 LKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281

Query: 235 LPLPWSI-RMK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
               +   R       I  G    L  LH+     +IYRD K  N+LLD D N ++SD G
Sbjct: 282 DNPGFQEPRAIFYTAQIVSG----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLG 334

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR---RS 344
           LA +              GT G+ APE ++ G     S D ++ GV L EM+  R   R+
Sbjct: 335 LAVELKAGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391

Query: 345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA 404
             +   N E                  R+L+  +   +  K S  +       L +DP+ 
Sbjct: 392 RGEKVENKE---------------LKQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEK 434

Query: 405 R 405
           R
Sbjct: 435 R 435

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (298), Expect = 5e-30
 Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 66/331 (19%)

Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKP-GTGLTVAVKTLNHDGLQGHKEW 185
           ++L     R   +L EGGF  V++           +  G+G   A+K L  +  + ++  
Sbjct: 23  VELGELRLRVRRVLAEGGFAFVYE----------AQDVGSGREYALKRLLSNEEEKNRAI 72

Query: 186 LAEVNFLGNLL-HPNLVKLVGYCIEDDQR-------LLVYEFMPRGSLENHLFR---KGS 234
           + EV F+  L  HPN+V+         +         L+   + +G L   L +   +G 
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---K 291
           L    ++  KI     + +  +H   + P+I+RD K  N+LL      KL DFG A    
Sbjct: 133 LSCD-TVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

Query: 292 DAPEDGKTHVSTRVM-------GTYGYAAPEYV-MTGHL--TSKSDVYSFGVVLLEMLTG 341
             P+   +     ++        T  Y  PE + +  +     K D+++ G +L  +   
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249

Query: 342 RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSI----KGSQKATQLAAQC 397
           +       P  +   +                    + G +SI            L    
Sbjct: 250 Q------HPFEDGAKLRI------------------VNGKYSIPPHDTQYTVFHSLIRAM 285

Query: 398 LSRDPKARPRMSEVVETLKPLQNLKDMASSS 428
           L  +P+ R  ++EVV  L+ +   +++   S
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  119 bits (301), Expect = 5e-30
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 39/225 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 189
           +F     +G+G FG V    V++N T           A+K +N        E      E+
Sbjct: 16  HFEILRAIGKGSFGKVCI--VQKNDT-------KKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK---- 244
             +  L HP LV L  Y  +D++ + +V + +  G L  HL +           +K    
Sbjct: 67  QIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFIC 122

Query: 245 -IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            + +     L +L     + +I+RD K  NILLD   +  ++DF +A   P + +    T
Sbjct: 123 ELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---T 172

Query: 304 RVMGTYGYAAPEYVM----TGHLTSKS-DVYSFGVVLLEMLTGRR 343
            + GT  Y APE        G+  S + D +S GV   E+L GRR
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGY--SFAVDWWSLGVTAYELLRGRR 215

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  116 bits (293), Expect = 9e-30
 Identities = 75/297 (25%), Positives = 121/297 (40%), Gaps = 42/297 (14%)

Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           +   +     +F+  +LLG+G F  V++              TGL VA+K ++   +   
Sbjct: 2   LATCIGEKIEDFKVGNLLGKGSFAGVYRA---------ESIHTGLEVAIKMIDKKAMYKA 52

Query: 183 K---EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP 238
                   EV     L HP++++L  Y  ED   + LV E    G +  +L  +      
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSE 111

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
              R  +      G+ +LH      +++RD   SN+LL  + N K++DFGLA       +
Sbjct: 112 NEARHFMH-QIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167

Query: 299 THVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
            H  T + GT  Y +PE    + H   +SDV+S G +   +L GR       P     + 
Sbjct: 168 KH-YT-LCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR------PPFDTDTVK 218

Query: 358 E-WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               +  L D    Y +  P          S +A  L  Q L R+P  R  +S V++
Sbjct: 219 NTLNKVVLAD----YEM--PS---FL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  119 bits (300), Expect = 2e-29
 Identities = 84/345 (24%), Positives = 133/345 (38%), Gaps = 47/345 (13%)

Query: 5   PESVKVKNWEVNNSDNNNNSKSRKVKKKKDGGAEQEEEEEIGCWVRFRFIESCMPSRSKV 64
           P+ V  +   +NN         +  + +                    FI  C+   + +
Sbjct: 42  PQDVDQREAPLNNFSVAQCQLMKTERPRP-----------------NTFIIRCLQWTTVI 84

Query: 65  DSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMF 124
           + +    +     + +   +     +   +    +  S S +     E    S  +    
Sbjct: 85  ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKH- 143

Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
              ++    F    LLG+G FG V    V+E  T       G   A+K L  + +    E
Sbjct: 144 ---RVTMNEFEYLKLLGKGTFGKVIL--VKEKAT-------GRYYAMKILKKEVIVAKDE 191

Query: 185 W---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWS 240
               L E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+        
Sbjct: 192 VAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-- 248

Query: 241 IRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
            R +         L +LH  +EK V+YRD K  N++LD D + K++DFGL K+  +DG T
Sbjct: 249 -RARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 305

Query: 300 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
               +   GT  Y APE V+  +   ++ D +  GVV+ EM+ GR
Sbjct: 306 ---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (296), Expect = 2e-29
 Identities = 80/338 (23%), Positives = 134/338 (39%), Gaps = 55/338 (16%)

Query: 103 ASSTPKFSEELKVASQLRKFMFNDLK---LATRNFRPESLLGEGGFGCVFKGWVEENGTA 159
                +   + +   +L  F+    K   L   +F   S LG G  G VFK   +     
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKP---- 56

Query: 160 PVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYE 218
                +GL +A K ++ +       + + E+  L     P +V   G    D +  +  E
Sbjct: 57  -----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111

Query: 219 FMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA 278
            M  GSL+  L + G +P    I  K+++   KGL +L E+    +++RD K SNIL+++
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQ--ILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNS 167

Query: 279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEM 338
               KL DFG++    +   +  ++ V GT  Y +PE +   H + +SD++S G+ L+EM
Sbjct: 168 RGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

Query: 339 LTGR----------------------RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD- 375
             GR                       +    RP      +             + LLD 
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283

Query: 376 ------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 406
                 P+L  G F    S +      +CL ++P  R 
Sbjct: 284 IVNEPPPKLPSGVF----SLEFQDFVNKCLIKNPAERA 317

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  116 bits (294), Expect = 2e-29
 Identities = 70/225 (31%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K     F    +LG+G FG VF   V++              A+K L    L+       
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFL--VKKISG----SDARQLYAMKVLKKATLKVRDRVRT 73

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
             E + L  + HP +VKL  Y  + + +L L+ +F+  G L   L ++          +K
Sbjct: 74  KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVK 129

Query: 245 -----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
                +AL     L  LH      +IYRD K  NILLD + + KL+DFGL+K++ +  K 
Sbjct: 130 FYLAELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182

Query: 300 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                   GT  Y APE V+     ++S D +SFGV++ EMLTG 
Sbjct: 183 ---AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  115 bits (290), Expect = 4e-29
 Identities = 75/313 (23%), Positives = 121/313 (38%), Gaps = 71/313 (22%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL-AEVNFL 192
           F     +G+G FG VFKG         +   T   VA+K ++ +  +   E +  E+  L
Sbjct: 24  FTKLEKIGKGSFGEVFKG---------IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL---GA 249
                P + K  G  ++D +  ++ E++  GS    L   G L         IA      
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQ-----IATILREI 128

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
            KGL +LH E     I+RD K +N+LL      KL+DFG+A               +GT 
Sbjct: 129 LKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTP 183

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHNLV 357
            + APE +      SK+D++S G+  +E+  G          + +    KN P       
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP------- 236

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE------V 411
                             P LEG++    S+   +    CL+++P  RP   E      +
Sbjct: 237 ------------------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

Query: 412 VETLKPLQNLKDM 424
           +   K    L ++
Sbjct: 275 LRNAKKTSYLTEL 287

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  115 bits (291), Expect = 5e-29
 Identities = 72/226 (31%), Positives = 100/226 (44%), Gaps = 35/226 (15%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V    V E  T       G   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVIL--VREKAT-------GRYYAMKILRKEVIIAKDEVAH 51

Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
            + E   L N  HP L  L  Y  +   RL  V E+   G L  HL R+         R 
Sbjct: 52  TVTESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RA 107

Query: 244 K-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           +     I       L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG 
Sbjct: 108 RFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160

Query: 299 THVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           T    +   GT  Y APE V+  +   ++ D +  GVV+ EM+ GR
Sbjct: 161 T---MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  115 bits (290), Expect = 6e-29
 Identities = 62/255 (24%), Positives = 102/255 (40%), Gaps = 38/255 (14%)

Query: 98  SNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENG 157
             A          +  +   Q RK    D       F+   +LGEG F  V      E  
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVL--ARELA 53

Query: 158 TAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIEDDQRL 214
           T           A+K L    +    +      E + +  L HP  VKL  +  +DD++L
Sbjct: 54  T-------SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQDDEKL 105

Query: 215 -LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRD 268
                +   G L  ++ + GS         +     I       L +LH    K +I+RD
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSA----LEYLHG---KGIIHRD 155

Query: 269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKS-D 327
            K  NILL+ D + +++DFG AK    + K   +   +GT  Y +PE ++T     KS D
Sbjct: 156 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE-LLTEKSACKSSD 214

Query: 328 VYSFGVVLLEMLTGR 342
           +++ G ++ +++ G 
Sbjct: 215 LWALGCIIYQLVAGL 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  114 bits (289), Expect = 9e-29
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 33/227 (14%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK---E 184
           K+    F    +LG+GG+G VF+  V +         TG   A+K L    +  +     
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQ--VRKVTG----ANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 185 W-LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
              AE N L  + HP +V L+ Y  +   +L L+ E++  G L   L R+G         
Sbjct: 67  HTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---T 122

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  I++     L  LH+   K +IYRD K  NI+L+   + KL+DFGL K++  DG
Sbjct: 123 ACFYLAEISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG 175

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                T    GT  Y APE ++     +++ D +S G ++ +MLTG 
Sbjct: 176 TV---THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (286), Expect = 2e-28
 Identities = 74/314 (23%), Positives = 123/314 (39%), Gaps = 48/314 (15%)

Query: 102 SASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPV 161
           S+ S+ K +  L +  Q  +   NDL+           +G G  G V+K    +      
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLEN-------LGEMGSGTCGQVWKMRFRK------ 48

Query: 162 KPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEF 219
              TG  +AVK +   G  + +K  L +++ +      P +V+  G  I +    +  E 
Sbjct: 49  ---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105

Query: 220 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD 279
           M   + +     +G +P    +  K+ +   K L +L E+    VI+RD K SNILLD  
Sbjct: 106 MGTCAEKLKKRMQGPIPERI-LG-KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDER 161

Query: 280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-----TSKSDVYSFGVV 334
              KL DFG++             R  G   Y APE +            ++DV+S G+ 
Sbjct: 162 GQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGIS 218

Query: 335 LLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ 392
           L+E+ TG+      + + E    +++   P L     F                S     
Sbjct: 219 LVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----------------SGDFQS 262

Query: 393 LAAQCLSRDPKARP 406
               CL++D + RP
Sbjct: 263 FVKDCLTKDHRKRP 276

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  113 bits (286), Expect = 4e-28
 Identities = 69/278 (24%), Positives = 111/278 (39%), Gaps = 35/278 (12%)

Query: 80  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 139
           ++           S      +       +    +K   +      +  K+   NF    +
Sbjct: 2   AHHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKV 61

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----LAEVNFLGNL 195
           LG G +G VF   V +         TG   A+K L    +    +       E   L ++
Sbjct: 62  LGTGAYGKVFL--VRKISG----HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 196 LH-PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALG 248
              P LV L  Y  + + +L L+ +++  G L  HL ++          ++     I L 
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLA 171

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
               L  LH+     +IYRD K  NILLD++ +  L+DFGL+K+   D          GT
Sbjct: 172 ----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GT 223

Query: 309 YGYAAPEYVM---TGHLTSKS-DVYSFGVVLLEMLTGR 342
             Y AP+ V    +GH   K+ D +S GV++ E+LTG 
Sbjct: 224 IEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGA 259

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 4e-28
 Identities = 68/297 (22%), Positives = 107/297 (36%), Gaps = 50/297 (16%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKE 184
                  + +    +G G +G V K   +          +G  +AVK +      +  K+
Sbjct: 16  HWDFTAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQ 66

Query: 185 WLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLEN---HLFRKGSLPLPWS 240
            L +++ +      P +V+  G    +    +  E M   S +    +++      +P  
Sbjct: 67  LLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEE 125

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           I  KI L   K L  L E     +I+RD K SNILLD   N KL DFG++    +   + 
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSI 180

Query: 301 VSTRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
             TR  G   Y APE +           +SDV+S G+ L E+ TGR              
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR-------------- 226

Query: 357 VEWARPHLGDKRRFYRLLD-------PRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
                         +  L        P+L      + S         CL++D   RP
Sbjct: 227 -----FPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  112 bits (282), Expect = 4e-28
 Identities = 66/296 (22%), Positives = 106/296 (35%), Gaps = 54/296 (18%)

Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEW 185
           +++   +  P   LG G +G V K              +G  +AVK +      Q  K  
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRL 52

Query: 186 LAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHL--FRKGSLPLPWSIR 242
           L +++     +  P  V   G    +    +  E M   SL+            +P  I 
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL 111

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
            KIA+   K L  LH +    VI+RD K SN+L++A    K+ DFG++            
Sbjct: 112 GKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAK 166

Query: 303 TRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
               G   Y APE +         + KSD++S G+ ++E+   R                
Sbjct: 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR---------------- 210

Query: 359 WARPHLGDKRRFYRLLD-------PRL-EGHFSIKGSQKATQLAAQCLSRDPKARP 406
                       ++ L        P+L    FS     +     +QCL ++ K RP
Sbjct: 211 ---FPYDSWGTPFQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  113 bits (285), Expect = 1e-27
 Identities = 71/316 (22%), Positives = 109/316 (34%), Gaps = 77/316 (24%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
              E +LG G  G V                 G  VAVK +    +      L E+  L 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRML---IDFCDIALMEIKLLT 63

Query: 194 NLL-HPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKI 245
               HPN+++   YC E   R   +  E     +L++ +  K        ++     + +
Sbjct: 64  ESDDHPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-------------ADYNAKLSDFGLAKD 292
               A G+A LH      +I+RD K  NIL+               +    +SDFGL K 
Sbjct: 121 LRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 293 APED---GKTHVSTRVMGTYGYAAPE-------YVMTGHLTSKSDVYSFGVVLLEMLTG- 341
                   +T+++    GT G+ APE             LT   D++S G V   +L+  
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 342 ------RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAA 395
                 + S + N   G  +L E    H                         +AT L +
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSL-------------------IAEATDLIS 277

Query: 396 QCLSRDPKARPRMSEV 411
           Q +  DP  RP   +V
Sbjct: 278 QMIDHDPLKRPTAMKV 293

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  112 bits (283), Expect = 2e-27
 Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 35/256 (13%)

Query: 105 STPKFSEELKVASQLRKF-----MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 159
              + +++  VA  L+          +++L   +F    ++G G F  V    V+   T 
Sbjct: 29  GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAV--VKMKQTG 86

Query: 160 PVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-L 215
            V        A+K +N   +    E   +  E + L N     + +L  +  +D+  L L
Sbjct: 87  QV-------YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138

Query: 216 VYEFMPRGSLENHLFRKGS-LPLPWSIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           V E+   G L   L + G  +P   + R  +A +  A  +  +H       ++RD K  N
Sbjct: 139 VMEYYVGGDLLTLLSKFGERIPAEMA-RFYLAEIVMA--IDSVHR---LGYVHRDIKPDN 192

Query: 274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY---- 329
           ILLD   + +L+DFG       DG       V GT  Y +PE +        +  Y    
Sbjct: 193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPEC 251

Query: 330 ---SFGVVLLEMLTGR 342
              + GV   EM  G+
Sbjct: 252 DWWALGVFAYEMFYGQ 267

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  110 bits (276), Expect = 4e-27
 Identities = 56/308 (18%), Positives = 111/308 (36%), Gaps = 43/308 (13%)

Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
                +   R  +  + L   G    F  W+E       +    + +  ++ +       
Sbjct: 44  RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPS 103

Query: 183 KEWLA--EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP-- 238
                  ++  +      N V  +          +  +   + +L++ + R+ SL     
Sbjct: 104 PMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163

Query: 239 ---WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DA 293
                I ++IA      + FLH    K +++RD K SNI    D   K+ DFGL    D 
Sbjct: 164 GVCLHIFIQIAEA----VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216

Query: 294 PEDGKTHVS--------TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
            E+ +T ++        T  +GT  Y +PE +   + + K D++S G++L E+L      
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---- 272

Query: 346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                + +   V               + + +    F+ K   +   +    LS  P  R
Sbjct: 273 ----FSTQMERVR----------IITDVRNLKFPLLFTQK-YPQEHMMVQDMLSPSPTER 317

Query: 406 PRMSEVVE 413
           P  ++++E
Sbjct: 318 PEATDIIE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 10/82 (12%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVN 190
            +F P   +G GGFG VF+                   A+K +     +  +E  + EV 
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAK---------NKVDDCNYAIKRIRLPNRELAREKVMREVK 56

Query: 191 FLGNLLHPNLVKLVGYCIEDDQ 212
            L  L HP +V+     +E   
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPP 78

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 1e-26
 Identities = 76/305 (24%), Positives = 126/305 (41%), Gaps = 49/305 (16%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
            + +     +G+G  G V+           +   TG  VA++ +N       +  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            +    +PN+V  +   +  D+  +V E++  GSL + +  +  +     I   +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQ-I-AAVCRECL 126

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTY 309
           + L FLH      VI+RD K+ NILL  D + KL+DFG  A+  PE  K    T V GT 
Sbjct: 127 QALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTP 180

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-- 367
            + APE V       K D++S G++ +EM+ G        P           P+L +   
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-------EP-----------PYLNENPL 222

Query: 368 RRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-----VETLKPLQ 419
           R  Y +     P L+     K S        +CL  D + R    E+     ++  KPL 
Sbjct: 223 RALYLIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280

Query: 420 NLKDM 424
           +L  +
Sbjct: 281 SLTPL 285

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  108 bits (273), Expect = 2e-26
 Identities = 69/254 (27%), Positives = 103/254 (40%), Gaps = 42/254 (16%)

Query: 101 ESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAP 160
            + +  P  S+++ +                 +F    ++G+G FG V            
Sbjct: 13  ANPAPPPAPSQQINLGPSSNP------HAKPSDFHFLKVIGKGSFGKVLL--AR------ 58

Query: 161 VKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-L 215
                 +  AVK L    +   KE    ++E N L   + HP LV L  +  +   +L  
Sbjct: 59  -HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYF 116

Query: 216 VYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEAEKPVIYRDFK 270
           V +++  G L  HL R+     P   R +     IA      L +LH      ++YRD K
Sbjct: 117 VLDYINGGELFYHLQRERCFLEP---RARFYAAEIASA----LGYLHS---LNIVYRDLK 166

Query: 271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DV 328
             NILLD+  +  L+DFGL K+  E   T   T    GT  Y APE V+      ++ D 
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE-VLHKQPYDRTVDW 222

Query: 329 YSFGVVLLEMLTGR 342
           +  G VL EML G 
Sbjct: 223 WCLGAVLYEMLYGL 236

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 3e-26
 Identities = 70/290 (24%), Positives = 110/290 (37%), Gaps = 62/290 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL 196
           LG+G FG V                TG   AVK ++   ++   +    L EV  L  L 
Sbjct: 34  LGKGSFGEVILC---------KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 197 HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAA 250
           HPN++KL  +  ED     LV E    G L + +  +       S       ++  L   
Sbjct: 85  HPNIMKLYEFF-EDKGYFYLVGEVYTGGELFDEIISRKRF----SEVDAARIIRQVLSG- 138

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             + ++H   +  +++RD K  N+LL     D N ++ DFGL+               +G
Sbjct: 139 --ITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIG 190

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           T  Y APE V+ G    K DV+S GV+L  +L+G                    P  G  
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC------------------PPFNGAN 231

Query: 368 RRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
                +L    +G ++ +       S+ A  L  + L+  P  R    + 
Sbjct: 232 EY--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  108 bits (271), Expect = 4e-26
 Identities = 70/227 (30%), Positives = 96/227 (42%), Gaps = 36/227 (15%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           KL   +F    +LG+G FG VF    E   T           A+K L  D +    +   
Sbjct: 13  KLKIEDFILHKMLGKGSFGKVFL--AEFKKT-------NQFFAIKALKKDVVLMDDDVEC 63

Query: 186 -LAEVN-FLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
            + E         HP L  +     +  + L  V E++  G L  H+       L    R
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---R 119

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  I LG    L FLH    K ++YRD K  NILLD D + K++DFG+ K+     
Sbjct: 120 ATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                T    GT  Y APE ++ G   + S D +SFGV+L EML G+
Sbjct: 173 AK---TNTFCGTPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  109 bits (274), Expect = 5e-26
 Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 28/229 (12%)

Query: 125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
             ++L   +F    ++G G FG V    V+      V        A+K LN   +    E
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAV--VKLKNADKV-------FAMKILNKWEMLKRAE 117

Query: 185 ---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFR-KGSLPLPW 239
              +  E + L N     +  L  Y  +DD  L LV ++   G L   L + +  LP   
Sbjct: 118 TACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176

Query: 240 SIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           + R  +A +  A  +  +H+      ++RD K  NIL+D + + +L+DFG      EDG 
Sbjct: 177 A-RFYLAEMVIA--IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEMLTGR 342
              S  V GT  Y +PE +              D +S GV + EML G 
Sbjct: 231 VQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  107 bits (268), Expect = 5e-26
 Identities = 77/315 (24%), Positives = 130/315 (41%), Gaps = 55/315 (17%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
                    +GEG  G V             +  +G  VAVK ++    Q  +    EV 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLA---------REKHSGRQVAVKMMDLRKQQRRELLFNEVV 94

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            + +  H N+V++    +  ++  ++ EF+  G+L + +  +  L     I   +     
Sbjct: 95  IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQ-IAT-VCEAVL 151

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTY 309
           + LA+LH +    VI+RD K+ +ILL  D   KLSDFG  A+ + +  K    + V GT 
Sbjct: 152 QALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTP 205

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK-- 367
            + APE +      ++ D++S G++++EM+ G        P           P+  D   
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-------EP-----------PYFSDSPV 247

Query: 368 RRFYRLLD---PRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----------RMSEVVE 413
           +   RL D   P+L+   S K S        + L RDP+ R              + + E
Sbjct: 248 QAMKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305

Query: 414 TLKPLQNLKDMASSS 428
            L PL  L    +S+
Sbjct: 306 CLVPLIQLYRKQTST 320

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  109 bits (275), Expect = 5e-26
 Identities = 68/289 (23%), Positives = 107/289 (37%), Gaps = 61/289 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG G +G V                T +  A+K +    +    + + L EV  L  L H
Sbjct: 45  LGSGAYGEVLLC---------RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 251
           PN++KL  +  ED +   LV E    G L + +  +       +       +K  L    
Sbjct: 96  PNIMKLYDFF-EDKRNYYLVMECYKGGELFDEIIHRMKF----NEVDAAVIIKQVLSG-- 148

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + +LH   +  +++RD K  N+LL   + D   K+ DFGL+               +GT
Sbjct: 149 -VTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGT 201

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y APE V+      K DV+S GV+L  +L G                    P  G   
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY------------------PPFGGQTD 242

Query: 369 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
           +   +L    +G ++         S+ A  L  Q L  D + R    + 
Sbjct: 243 Q--EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  107 bits (269), Expect = 6e-26
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 53/294 (18%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
            L  ++F    ++G G +  V    V           T    A+K +  + +   ++   
Sbjct: 5   PLGLQDFDLLRVIGRGSYAKVLL--VR-------LKKTDRIYAMKVVKKELVNDDEDIDW 55

Query: 186 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
              E +       HP LV L   C + + RL  V E++  G L  H+ R+  LP   + R
Sbjct: 56  VQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-R 113

Query: 243 M---KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT 299
               +I+L     L +LHE   + +IYRD K  N+LLD++ + KL+D+G+ K+    G T
Sbjct: 114 FYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166

Query: 300 HVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR----RSMDKNRPNGE 353
              T    GT  Y APE ++ G     S D ++ GV++ EM+ GR         + P+  
Sbjct: 167 ---TSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKAR 405
                        +   ++++   LE    I    S KA  +    L++DPK R
Sbjct: 223 ------------TEDYLFQVI---LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  107 bits (269), Expect = 7e-26
 Identities = 71/227 (31%), Positives = 104/227 (45%), Gaps = 36/227 (15%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           ++   +F    +LG+G FG V     E       + GT    AVK L  D +    +   
Sbjct: 16  RMKLTDFNFLMVLGKGSFGKVML--SE-------RKGTDELYAVKILKKDVVIQDDDVEC 66

Query: 186 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
            + E   L      P L +L   C +   RL  V E++  G L  H+ + G    P    
Sbjct: 67  TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---H 122

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
                  IA+G    L FL     K +IYRD K  N++LD++ + K++DFG+ K+   DG
Sbjct: 123 AVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T   T+   GT  Y APE ++      KS D ++FGV+L EML G+
Sbjct: 176 VT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  106 bits (266), Expect = 8e-26
 Identities = 65/316 (20%), Positives = 125/316 (39%), Gaps = 70/316 (22%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           +     LG+G FG V+K              TG   A K +     +  ++++ E+  L 
Sbjct: 21  WEIVGELGDGAFGKVYKA---------KNKETGALAAAKVIETKSEEELEDYIVEIEILA 71

Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
              HP +VKL+G    D +  ++ EF P G+++  +  +    L       +     + L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVMGTYG 310
            FLH +    +I+RD K  N+L+  + + +L+DFG++       +   + +     GT  
Sbjct: 131 NFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPY 182

Query: 311 YAAPEYVMTGHLT-----SKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGE 353
           + APE VM   +       K+D++S G+ L+EM             R +    K+ P   
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP--- 239

Query: 354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-- 411
                   P L    ++                S +        L ++P+ RP  +++  
Sbjct: 240 --------PTLLTPSKW----------------SVEFRDFLKIALDKNPETRPSAAQLLE 275

Query: 412 ---VETLKPLQNLKDM 424
              V ++   + L+++
Sbjct: 276 HPFVSSITSNKALREL 291

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  107 bits (270), Expect = 9e-26
 Identities = 83/330 (25%), Positives = 133/330 (40%), Gaps = 51/330 (15%)

Query: 91  PVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFK 150
                TT N     +     EE K A   R+       L  ++F    ++G G +  V  
Sbjct: 11  DYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLL 70

Query: 151 GWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGY 206
             V           T    A++ +  + +   ++      E +       HP LV L   
Sbjct: 71  --VR-------LKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-S 120

Query: 207 CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK-----IALGAAKGLAFLHEEA 260
           C + + RL  V E++  G L  H+ R+  LP       +     I+L     L +LHE  
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLA----LNYLHE-- 171

Query: 261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMT 319
            + +IYRD K  N+LLD++ + KL+D+G+ K+    G T   T    GT  Y APE ++ 
Sbjct: 172 -RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-ILR 226

Query: 320 GHLTSKS-DVYSFGVVLLEMLTGR---RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLD 375
           G     S D ++ GV++ EM+ GR     +  +    ++      +  L  + R  R L 
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL- 285

Query: 376 PRLEGHFSIKGSQKATQLAAQCLSRDPKAR 405
                      S KA  +    L++DPK R
Sbjct: 286 -----------SVKAASVLKSFLNKDPKER 304

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  106 bits (268), Expect = 1e-25
 Identities = 66/259 (25%), Positives = 107/259 (41%), Gaps = 34/259 (13%)

Query: 93  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 152
           ++          S  +F  + K     +    +        F     LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML-- 59

Query: 153 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIE 209
           V+   +       G   A+K L+   +   K+    L E   L  +  P LVKL  +  +
Sbjct: 60  VKHKES-------GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFK 111

Query: 210 DDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGLAFLHEEAEKPVI 265
           D+  L +V E++  G + +HL R G    P + R    +I L       +LH      +I
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAAQIVLT----FEYLHS---LDLI 163

Query: 266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTS 324
           YRD K  N+L+D     +++DFG AK       T     + GT    APE +++ G+  +
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY--N 216

Query: 325 KS-DVYSFGVVLLEMLTGR 342
           K+ D ++ GV++ EM  G 
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  108 bits (272), Expect = 1e-25
 Identities = 71/289 (24%), Positives = 108/289 (37%), Gaps = 61/289 (21%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG+G FG V K              T    AVK +N    +       L EV  L  L H
Sbjct: 30  LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 251
           PN++KL     ED     +V E    G L + + ++       S       +K       
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARIIKQVFSG-- 133

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + ++H   +  +++RD K  NILL   + D + K+ DFGL+    ++         +GT
Sbjct: 134 -ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGT 186

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y APE V+ G    K DV+S GV+L  +L+G                    P  G   
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNE 227

Query: 369 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
               +L     G ++         S  A  L  + L+  P  R   ++ 
Sbjct: 228 Y--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  108 bits (271), Expect = 2e-25
 Identities = 71/341 (20%), Positives = 120/341 (35%), Gaps = 72/341 (21%)

Query: 99  NAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGT 158
           +    SS  +      +A     ++         ++     LG G +G V          
Sbjct: 3   HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLC------- 55

Query: 159 APVKPGTGLTVAVKTLN------------HDGLQGHKEWLA-EVNFLGNLLHPNLVKLVG 205
              +       A+K +             +  ++   E +  E++ L +L HPN++KL  
Sbjct: 56  --KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113

Query: 206 YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKGLAFLHEE 259
              ED +   LV EF   G L   +  +               MK  L     + +LH  
Sbjct: 114 VF-EDKKYFYLVTEFYEGGELFEQIINRHKF----DECDAANIMKQILSG---ICYLH-- 163

Query: 260 AEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEY 316
            +  +++RD K  NILL   ++  N K+ DFGL+    +D   +     +GT  Y APE 
Sbjct: 164 -KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPE- 218

Query: 317 VMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP 376
           V+      K DV+S GV++  +L G                    P  G   +   ++  
Sbjct: 219 VLKKKYNEKCDVWSCGVIMYILLCGY------------------PPFGGQNDQ--DIIKK 258

Query: 377 RLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
             +G +          S +A +L    L+ D   R    E 
Sbjct: 259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (265), Expect = 2e-25
 Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 52/291 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----E 188
           N+R    +G+G F  V                TG  VA+K ++   L      L     E
Sbjct: 16  NYRLLKTIGKGNFAKVKLA---------RHILTGREVAIKIIDKTQLN--PTSLQKLFRE 64

Query: 189 VNFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           V  +  L HPN+VKL  +  IE ++ L L+ E+   G + ++L   G +    +      
Sbjct: 65  VRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
           + +A  + + H+   K +++RD K  N+LLDAD N K++DFG + +    GK        
Sbjct: 123 IVSA--VQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--- 174

Query: 307 GTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           G   YAAPE +  G      + DV+S GV+L  +++G    D        NL E      
Sbjct: 175 GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKE------ 221

Query: 365 GDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                   L +  L G + I    S     L  + L  +P  R  + ++++
Sbjct: 222 --------LRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (264), Expect = 2e-25
 Identities = 70/304 (23%), Positives = 111/304 (36%), Gaps = 53/304 (17%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL 196
           E +LGEG    V            +   T    AVK +             EV  L    
Sbjct: 18  EDVLGEGAHARVQTC---------INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 197 -HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGA 249
            H N+++L+ +  E++ R  LV+E M  GS+ +H+ ++       +       ++    A
Sbjct: 69  GHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRHF----NELEASVVVQDVASA 123

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKD-APEDGKTHVSTRV 305
              L FLH    K + +RD K  NIL    +     K+ DF L          + +ST  
Sbjct: 124 ---LDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 306 M----GTYGYAAPEYVMTGHLTSKS-----DVYSFGVVLLEMLTGRRSMDKNRP-NGEHN 355
           +    G+  Y APE V      +       D++S GV+L  +L+G        P  G   
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY------PPFVGRCG 231

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 409
                            L +   EG +          S  A  L ++ L RD K R   +
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291

Query: 410 EVVE 413
           +V++
Sbjct: 292 QVLQ 295

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  105 bits (264), Expect = 2e-25
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 38/226 (16%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K + ++F+    LG G FG V    +            G   A+K L  + +   K+   
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHL--IRSRHN-------GRYYAMKVLKKEIVVRLKQVEH 52

Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
              E   L  + HP ++++     +D Q++ ++ +++  G L + L +    P P     
Sbjct: 53  TNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VA 108

Query: 244 K-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK 298
           K     + L     L +LH    K +IYRD K  NILLD + + K++DFG AK  P+   
Sbjct: 109 KFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161

Query: 299 THVSTRVMGTYGYAAPEYVMT-GHLTSKS-DVYSFGVVLLEMLTGR 342
           T     + GT  Y APE V T  +  +KS D +SFG+++ EML G 
Sbjct: 162 T-----LCGTPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGY 200

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  108 bits (271), Expect = 3e-25
 Identities = 80/304 (26%), Positives = 118/304 (38%), Gaps = 32/304 (10%)

Query: 51  FRFIESCMPSRSKVDSSMS--GTSTNYDGKSSNEKRRDRPVVPVS--STTTSNAESASST 106
           F    S   S  +           +  +G+  N                    A+    T
Sbjct: 256 FMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGT 315

Query: 107 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTG 166
               E+            N  ++   +F    +LG+G FG V     E       + GT 
Sbjct: 316 KAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVML--SE-------RKGTD 366

Query: 167 LTVAVKTLNHDGLQGHKEW---LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMP 221
              AVK L  D +    +    + E   L      P L +L   C +   RL  V E++ 
Sbjct: 367 ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVN 425

Query: 222 RGSLENHLFRKGSLPLPWSIRMKI-ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
            G L  H+ + G    P        A   A GL FL     K +IYRD K  N++LD++ 
Sbjct: 426 GGDLMYHIQQVGRFKEP---HAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEG 479

Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEM 338
           + K++DFG+ K+   DG T   T+   GT  Y APE ++      KS D ++FGV+L EM
Sbjct: 480 HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEM 535

Query: 339 LTGR 342
           L G+
Sbjct: 536 LAGQ 539

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  105 bits (265), Expect = 3e-25
 Identities = 71/227 (31%), Positives = 98/227 (43%), Gaps = 36/227 (15%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           +L   NF    +LG+G FG V                TG   AVK L  D +    +   
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVML--AR-------VKETGDLYAVKVLKKDVILQDDDVEC 69

Query: 186 -LAEVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
            + E   L     HP L +L   C +   RL  V EF+  G L  H+ +          R
Sbjct: 70  TMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---R 125

Query: 243 MK-----IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG 297
            +     I       L FLH+   K +IYRD K  N+LLD + + KL+DFG+ K+   +G
Sbjct: 126 ARFYAAEIISA----LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 298 KTHVSTRVM-GTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            T   T    GT  Y APE ++   L   + D ++ GV+L EML G 
Sbjct: 179 VT---TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 3e-25
 Identities = 63/297 (21%), Positives = 115/297 (38%), Gaps = 55/297 (18%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 191
           ++  + ++G G    V                    VA+K +N +  Q   + L  E+  
Sbjct: 16  DYELQEVIGSGATAVVQAA---------YCAPKKEKVAIKRINLEKCQTSMDELLKEIQA 66

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK---IAL- 247
           +    HPN+V      +  D+  LV + +  GS+ + +    +     S  +    IA  
Sbjct: 67  MSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 248 --GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVS 302
                +GL +LH+      I+RD K  NILL  D + +++DFG++       +  +  V 
Sbjct: 127 LREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 303 TRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGR---------RSM---DKNR 349
              +GT  + APE +        K+D++SFG+  +E+ TG          + +    +N 
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243

Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           P           P          L     +     K  +   ++ + CL +DP+ RP
Sbjct: 244 P-----------P---------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  106 bits (266), Expect = 3e-25
 Identities = 68/252 (26%), Positives = 109/252 (43%), Gaps = 32/252 (12%)

Query: 105 STPKFSEELKVASQLRKF-----MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTA 159
             P   +   + + L ++        DL++   ++    ++G G FG V    V    T 
Sbjct: 37  DFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL--VRHKSTR 94

Query: 160 PVKPGTGLTVAVKTLNHDGLQGHKE---WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-L 215
            V        A+K L+   +    +   +  E + +     P +V+L  Y  +DD+ L +
Sbjct: 95  KV-------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146

Query: 216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIA-LGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           V E+MP G L N +     +P  W+ R   A +  A  L  +H       I+RD K  N+
Sbjct: 147 VMEYMPGGDLVNLM-SNYDVPEKWA-RFYTAEVVLA--LDAIHS---MGFIHRDVKPDNM 199

Query: 275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----GHLTSKSDVYS 330
           LLD   + KL+DFG      ++G     T V GT  Y +PE + +    G+   + D +S
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWS 258

Query: 331 FGVVLLEMLTGR 342
            GV L EML G 
Sbjct: 259 VGVFLYEMLVGD 270

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (264), Expect = 4e-25
 Identities = 54/304 (17%), Positives = 90/304 (29%), Gaps = 51/304 (16%)

Query: 141 GEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHP 198
           G      V                TG  V V+ +N +            E++      HP
Sbjct: 36  GFEDLMTVNLA---------RYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 199 NLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE 258
           N+V      I D++  +V  FM  GS ++ +       +       I  G  K L ++H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 259 EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-----THVSTRVMGTYGYAA 313
                 ++R  K S+IL+  D    LS           G+            +    + +
Sbjct: 147 MG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 314 PEYVMTGHL---TSKSDVYSFGVVLLEMLTGR---------------------------- 342
           PE V+  +L    +KSD+YS G+   E+  G                             
Sbjct: 204 PE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

Query: 343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDP 402
              ++   +   ++                         +    S        QCL R+P
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322

Query: 403 KARP 406
            ARP
Sbjct: 323 DARP 326

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (260), Expect = 6e-25
 Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 63/312 (20%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
              F     LGEG +G V+K   +E         TG  VA+K +  +     +E + E++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVE--SDLQEIIKEIS 76

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            +     P++VK  G   ++    +V E+   GS+ + + R  +  L       I     
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTL 135

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL-AKDAPEDGKTHVSTRVMGTY 309
           KGL +LH       I+RD K  NILL+ + +AKL+DFG+  +      K +    V+GT 
Sbjct: 136 KGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTP 189

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR---------RSM---DKNRPNGEHNLV 357
            + APE +        +D++S G+  +EM  G+         R++     N P       
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP------- 242

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-----V 412
               P       +                S   T    QCL + P+ R   +++     V
Sbjct: 243 ----PTFRKPELW----------------SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

Query: 413 ETLKPLQNLKDM 424
            + K +  L+D+
Sbjct: 283 RSAKGVSILRDL 294

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (261), Expect = 7e-25
 Identities = 70/295 (23%), Positives = 111/295 (37%), Gaps = 61/295 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           +G+G F  V +          +   TG   AVK ++                 E +    
Sbjct: 32  IGKGPFSVVRRC---------INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALG 248
           L HP++V+L+      D  L +V+EFM    L   + ++      +S       M+  L 
Sbjct: 83  LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           A   L + H   +  +I+RD K   +LL   +     KL  FG+A    E G      RV
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194

Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            GT  + APE V+      K  DV+  GV+L  +L+G                    P  
Sbjct: 195 -GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGC------------------LPFY 234

Query: 365 GDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
           G K R +  +   ++G + +        S+ A  L  + L  DP  R  + E + 
Sbjct: 235 GTKERLFEGI---IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (264), Expect = 8e-25
 Identities = 76/327 (23%), Positives = 119/327 (36%), Gaps = 68/327 (20%)

Query: 117 SQLRKFMFNDLKLATRNFRPESL---------LGEGGFGCVFKGWVEENGTAPVKPGTGL 167
           S+ + F+F DL +  ++  P++L         LG G  G V             +  T  
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA---------FERKTCK 161

Query: 168 TVAVKTLNHDGLQGHKEWLA--------EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEF 219
            VA++ ++           A        E+  L  L HP ++K+  +  + +   +V E 
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220

Query: 220 MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--- 276
           M  G L + +     L           +     + +LH   E  +I+RD K  N+LL   
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQM--LLAVQYLH---ENGIIHRDLKPENVLLSSQ 275

Query: 277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL----TSKSDVYSFG 332
           + D   K++DFG +K   E       T   GT  Y APE V+            D +S G
Sbjct: 276 EEDCLIKITDFGHSKILGETSLM--RTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLG 331

Query: 333 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------ 386
           V+L   L+G                    P   + R    L D    G ++         
Sbjct: 332 VILFICLSG-------------------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372

Query: 387 SQKATQLAAQCLSRDPKARPRMSEVVE 413
           S+KA  L  + L  DPKAR    E + 
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALR 399

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  101 bits (255), Expect = 4e-24
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 56/291 (19%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHP 198
           LGEG F    K          V   +    AVK ++       ++   E+  L     HP
Sbjct: 19  LGEGSFSICRKC---------VHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHP 66

Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 252
           N+VKL      D     LV E +  G L   + +K       S       M+  + A   
Sbjct: 67  NIVKLHEVF-HDQLHTFLVMELLNGGELFERIKKKKHF----SETEASYIMRKLVSA--- 118

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           ++ +H   +  V++RD K  N+L    + +   K+ DFG A+  P D +  + T    T 
Sbjct: 119 VSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTL 173

Query: 310 GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
            YAAPE ++  +   +S D++S GV+L  ML+G+       P         +        
Sbjct: 174 HYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQ------VPF-------QSHDRSLTCT 219

Query: 369 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
               ++    +G FS +G      SQ+A  L    L+ DP  R +MS +  
Sbjct: 220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  100 bits (251), Expect = 6e-24
 Identities = 66/287 (22%), Positives = 105/287 (36%), Gaps = 59/287 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G +G V            V+ GT +  A K +    ++    +  E+  + +L HPN
Sbjct: 17  IGRGSWGEVKIA---------VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKGL 253
           +++L     ED+  + LV E    G L   +  K               MK  L A   +
Sbjct: 68  IIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVF----RESDAARIMKDVLSA---V 119

Query: 254 AFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           A+ H   +  V +RD K  N L      D   KL DFGLA          +    +GT  
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPY 173

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           Y +P+ V+ G    + D +S GV++  +L G                    P        
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY------------------PPFSAPTDS- 213

Query: 371 YRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEV 411
             ++    EG F+         S +A  L  + L++ PK R    + 
Sbjct: 214 -EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 9e-24
 Identities = 73/322 (22%), Positives = 118/322 (36%), Gaps = 81/322 (25%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 187
            + F     +G G FG V+                   VA+K +++ G Q +++W   + 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 103

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV FL  L HPN ++  G  + +    LV E+    + +     K  L         IA 
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAA 158

Query: 248 ---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
              GA +GLA+LH      +I+RD K  NILL      KL DFG A        + ++  
Sbjct: 159 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPA 207

Query: 305 --VMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGR---------RSM---DK 347
              +GT  + APE ++    G    K DV+S G+  +E+   +          ++    +
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267

Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
           N                           P L+       S+        CL + P+ RP 
Sbjct: 268 NES-------------------------PALQSG---HWSEYFRNFVDSCLQKIPQDRPT 299

Query: 408 MSEV-----VETLKPLQNLKDM 424
              +     V   +P   + D+
Sbjct: 300 SEVLLKHRFVLRERPPTVIMDL 321

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  100 bits (251), Expect = 1e-23
 Identities = 67/336 (19%), Positives = 113/336 (33%), Gaps = 69/336 (20%)

Query: 93  SSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGW 152
           S      +  A      + +L    +               ++   LLG GGFG V+ G 
Sbjct: 12  SGLVPRGSHMAPCNDLHATKLAPGKEKEPLE--------SQYQVGPLLGSGGFGSVYSG- 62

Query: 153 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLGNLLH--PNLVKLV 204
                   ++    L VA+K +  D +    E         EV  L  +      +++L+
Sbjct: 63  --------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLL 114

Query: 205 GYCIEDDQRL-LVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEK 262
            +  E      L+ E   P   L + +  +G+L    +          + +   H     
Sbjct: 115 DW-FERPDSFVLILERPEPVQDLFDFITERGALQEELARS--FFWQVLEAVRHCHN---C 168

Query: 263 PVIYRDFKTSNILLDADY-NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH 321
            V++RD K  NIL+D +    KL DFG      +D          GT  Y+ PE++   H
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFD---GTRVYSPPEWIR-YH 223

Query: 322 L--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
                 + V+S G++L +M+ G                    P   D+          + 
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGD------------------IPFEHDEE--------IIR 257

Query: 380 GHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
           G    +   S +   L   CL+  P  RP   E+  
Sbjct: 258 GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 78/325 (24%), Positives = 122/325 (37%), Gaps = 79/325 (24%)

Query: 116 ASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN 175
           A  L +   + L+     F    L+G G +G V+KG   +         TG   A+K ++
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMD 58

Query: 176 HDGLQGHKEWLAEVNFLGNLL-HPNLVK-----LVGYCIEDDQRL-LVYEFMPRGSLEN- 227
             G    +E   E+N L     H N+       +       D +L LV EF   GS+ + 
Sbjct: 59  VTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 228 -HLFRKGSLPLPWSIRMKIAL---GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK 283
               +  +L   W     IA       +GL+ LH+     VI+RD K  N+LL  +   K
Sbjct: 118 IKNTKGNTLKEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169

Query: 284 LSDFGL-AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-----SKSDVYSFGVVLLE 337
           L DFG+ A+     G+ +     +GT  + APE +            KSD++S G+  +E
Sbjct: 170 LVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

Query: 338 MLTGR---------RSM---DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIK 385
           M  G          R++    +N                           PRL+     K
Sbjct: 227 MAEGAPPLCDMHPMRALFLIPRNPA-------------------------PRLKSK---K 258

Query: 386 GSQKATQLAAQCLSRDPKARPRMSE 410
            S+K       CL ++   RP   +
Sbjct: 259 WSKKFQSFIESCLVKNHSQRPATEQ 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 77/287 (26%), Positives = 113/287 (39%), Gaps = 55/287 (19%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLHP 198
           LG G FG V             +  +GL   +KT+N D  Q   E +  E+  L +L HP
Sbjct: 30  LGSGAFGDVHLV---------EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 252
           N++K+     ED   + +V E    G L   +    +     S       MK  + A   
Sbjct: 81  NIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA--- 136

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           LA+ H    + V+++D K  NIL          K+ DFGLA+    D     ST   GT 
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTA 190

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y APE V    +T K D++S GVV+  +LTG                    P  G    
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------------------LPFTGTSLE 231

Query: 370 FYRLLDPRLEGHFSIKG-----SQKATQLAAQCLSRDPKARPRMSEV 411
              +         +        + +A  L  Q L++DP+ RP  ++V
Sbjct: 232 --EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 74/291 (25%), Positives = 112/291 (38%), Gaps = 61/291 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG+G FG V K              T    AVK +N    +       L EV  L  L H
Sbjct: 30  LGKGSFGEVLKC---------KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 251
           PN++KL     ED     +V E    G L + + ++       S       +K       
Sbjct: 81  PNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARIIKQVFSG-- 133

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            + ++H   +  +++RD K  NILL   + D + K+ DFGL+    ++ K     R+ GT
Sbjct: 134 -ITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRI-GT 186

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y APE V+ G    K DV+S GV+L  +L+G                    P  G   
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------------------PPFYGKNE 227

Query: 369 RFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
               +L     G ++         S  A  L  + L+  P  R   ++ +E
Sbjct: 228 Y--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 197
            LGEG +G V            V   T   VAVK ++        E +  E+     L H
Sbjct: 14  TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGL 253
            N+VK  G    +     L  E+   G L + +     +P P + R     +A     G+
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 314 PEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 342
           PE ++          DV+S G+VL  ML G 
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.0 bits (247), Expect = 7e-23
 Identities = 79/377 (20%), Positives = 134/377 (35%), Gaps = 76/377 (20%)

Query: 61  RSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLR 120
           R +    +         +     R  R     S+   + A+  +       E      + 
Sbjct: 19  RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78

Query: 121 KFMFNDLKLATRNFR----PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH 176
                    A + F     P+ ++G G    V +          V   TG   AVK +  
Sbjct: 79  PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---------VHRATGHEFAVKIMEV 129

Query: 177 DGLQGHKEWLA--------EVNFLGNLL-HPNLVKLVGYCIEDDQRL-LVYEFMPRGSLE 226
              +   E L         E + L  +  HP+++ L+    E    + LV++ M +G L 
Sbjct: 130 TAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELF 188

Query: 227 NHLFRKGSLPLPWSIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN 281
           ++L  K +L    S +     M+  L A   ++FLH      +++RD K  NILLD +  
Sbjct: 189 DYLTEKVAL----SEKETRSIMRSLLEA---VSFLHA---NNIVHRDLKPENILLDDNMQ 238

Query: 282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS-------KSDVYSFGVV 334
            +LSDFG +       K        GT GY APE ++   +         + D+++ GV+
Sbjct: 239 IRLSDFGFSCHLEPGEKL--RELC-GTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVI 294

Query: 335 LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQ 388
           L  +L G                    P    ++    +L   +EG +          S 
Sbjct: 295 LFTLLAGS------------------PPFWHRRQ--ILMLRMIMEGQYQFSSPEWDDRSS 334

Query: 389 KATQLAAQCLSRDPKAR 405
               L ++ L  DP+AR
Sbjct: 335 TVKDLISRLLQVDPEAR 351

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 74/290 (25%), Positives = 114/290 (39%), Gaps = 61/290 (21%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EVNFLGNL 195
            LG G FG V  G             TG  VAVK LN   ++          E+  L   
Sbjct: 18  TLGVGTFGKVKIG---------EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68

Query: 196 LHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK-- 251
            HP+++KL  Y  I       +V E++  G L +++ + G        R++         
Sbjct: 69  RHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG--------RVEEMEARRLFQ 118

Query: 252 ----GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
                + + H      V++RD K  N+LLDA  NAK++DFGL+    +      S    G
Sbjct: 119 QILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---G 172

Query: 308 TYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           +  YAAPE V++G L    + D++S GV+L  +L G    D      + ++         
Sbjct: 173 SPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD------DEHVPT------- 218

Query: 366 DKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                  L      G F I    ++    L    L  DP  R  + ++ E
Sbjct: 219 -------LFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 65/330 (19%), Positives = 105/330 (31%), Gaps = 93/330 (28%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-----EVNFLGN 194
           +G+G +G V            ++  T    A+K +N + ++            EV  +  
Sbjct: 34  IGQGSYGVVRVA---------IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 195 LLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG----- 248
           L HPN+ +L     ED+Q + LV E    G L + L               +        
Sbjct: 85  LHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 249 --------------------------AAK-------GLAFLHEEAEKPVIYRDFKTSNIL 275
                                      +         L +LH    + + +RD K  N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200

Query: 276 LDADYNA--KLSDFGLAK--DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS---KSDV 328
              + +   KL DFGL+K      +G+ +  T   GT  + APE V+     S   K D 
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDA 259

Query: 329 YSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG- 386
           +S GV+L  +L G        P  G ++                  +   L      +  
Sbjct: 260 WSAGVLLHLLLMGA------VPFPGVND---------------ADTISQVLNKKLCFENP 298

Query: 387 -----SQKATQLAAQCLSRDPKARPRMSEV 411
                S  A  L +  L+R+   R      
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 75/336 (22%), Positives = 113/336 (33%), Gaps = 69/336 (20%)

Query: 94  STTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWV 153
           S  T   +   + P              F           +R   LLG+GGFG VF G  
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFE--------AEYRLGPLLGKGGFGTVFAG-- 50

Query: 154 EENGTAPVKPGTGLTVAVKTLN------HDGLQGHKEWLAEVNFL----GNLLHPNLVKL 203
                   +    L VA+K +          L        EV  L        HP +++L
Sbjct: 51  -------HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103

Query: 204 VGYCIEDDQRL-LVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAE 261
           + +  E  +   LV E  +P   L +++  KG L    S R          +   H    
Sbjct: 104 LDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS-R-CFFGQVVAAIQHCHS--- 157

Query: 262 KPVIYRDFKTSNILLDADYNA-KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG 320
           + V++RD K  NIL+D      KL DFG       D          GT  Y+ PE++   
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GTRVYSPPEWISRH 213

Query: 321 HLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLE 379
                 + V+S G++L +M+ G                    P   D+          LE
Sbjct: 214 QYHALPATVWSLGILLYDMVCGD------------------IPFERDQE--------ILE 247

Query: 380 GHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                    S     L  +CL+  P +RP + E++ 
Sbjct: 248 AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 72/300 (24%), Positives = 105/300 (35%), Gaps = 69/300 (23%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 191
           LG G  G V             +  T   VA+K ++           A        E+  
Sbjct: 18  LGSGACGEVKLA---------FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIA 246
           L  L HP ++K+  +  + +   +V E M  G L + +     L                
Sbjct: 69  LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRL----KEATCKLYFYQM 123

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVST 303
           L A   + +LH   E  +I+RD K  N+LL   + D   K++DFG +K   E       T
Sbjct: 124 LLA---VQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--RT 175

Query: 304 RVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
              GT  Y APE V+            D +S GV+L   L+G                  
Sbjct: 176 LC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG------------------ 215

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
             P   + R    L D    G ++         S+KA  L  + L  DPKAR    E + 
Sbjct: 216 -YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 31/212 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LAEVNFLGN 194
           +GEG +G VFK    +         TG  VA+K                  L E+  L  
Sbjct: 11  IGEGSYGVVFKCRNRD---------TGQIVAIKKFL---ESEDDPVIKKIALREIRMLKQ 58

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           L HPNLV L+       +  LV+E+    ++ + L R         ++  I     + + 
Sbjct: 59  LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQAVN 116

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH-VSTRVMGTYGY 311
           F H+      I+RD K  NIL+      KL DFG A+    P D     V+TR      Y
Sbjct: 117 FCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WY 168

Query: 312 AAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
            +PE ++         DV++ G V  E+L+G 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 33/212 (15%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP 198
           +LG G F  VF            +  TG   A+K +             E+  L  + H 
Sbjct: 16  VLGSGAFSEVFLV---------KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 252
           N+V L     E      LV + +  G L + +  +G      + +     ++  L A   
Sbjct: 67  NIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGVY----TEKDASLVIQQVLSA--- 118

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH   E  +++RD K  N+L    + +    ++DFGL+K   ++G    ST   GT 
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIM--STAC-GTP 171

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           GY APE +     +   D +S GV+   +L G
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 58/219 (26%), Positives = 87/219 (39%), Gaps = 35/219 (15%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----EVNFLGN 194
           LLGEG +G V +    E         T    AVK L    L+      A    E+  L  
Sbjct: 12  LLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 195 LLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLF---RKGSLPLPWSIRMKIALGA 249
           L H N+++L  V Y  E  +  +V E+   G  E  +     +   P+  +      L  
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQL-- 118

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---KDAPEDGKTHVSTRVM 306
             GL +LH    + ++++D K  N+LL      K+S  G+A        D     S    
Sbjct: 119 IDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ--- 172

Query: 307 GTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGR 342
           G+  +  PE +  G  T    K D++S GV L  + TG 
Sbjct: 173 GSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 26/211 (12%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNFLGNLLH 197
            LGEG +G V            V   T   VAVK ++        E +  E+     L H
Sbjct: 14  TLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM---KIALGAAKGL 253
            N+VK  G    +     L  E+   G L + +     +P P + R     +A     G+
Sbjct: 65  ENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GV 118

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y A
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 314 PEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 342
           PE ++          DV+S G+VL  ML G 
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.9 bits (239), Expect = 5e-22
 Identities = 60/297 (20%), Positives = 103/297 (34%), Gaps = 63/297 (21%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----- 187
            +   S LG G FG V+           V       V VK +  + +             
Sbjct: 25  KYSTMSPLGSGAFGFVWTA---------VDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75

Query: 188 ---EVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGS-LENHLFRKGSLPLPWSIR 242
              E+  L  + H N++K++    E+     LV E    G  L   + R   L  P +  
Sbjct: 76  VTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134

Query: 243 M--KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
           +  ++       + +L     K +I+RD K  NI++  D+  KL DFG A         +
Sbjct: 135 IFRQLVSA----VGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187

Query: 301 VSTRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
                 GT  Y APE V+ G+     + +++S GV L  ++       +           
Sbjct: 188 TFC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------- 232

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                          L+  +E         S++   L +  L   P+ R  + ++V 
Sbjct: 233 ---------------LEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 71/311 (22%), Positives = 117/311 (37%), Gaps = 71/311 (22%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--------HDGLQGH 182
             N+ P+ +LG G    V +          +   T    AVK ++         + +Q  
Sbjct: 16  YENYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66

Query: 183 KEWLA-EVNFLGNL-LHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
           +E    EV+ L  +  HPN+++L     E +    LV++ M +G L ++L  K +L    
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTL---- 121

Query: 240 SIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
           S +     M+  L     +  LH+     +++RD K  NILLD D N KL+DFG +    
Sbjct: 122 SEKETRKIMRALLEV---ICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 295 EDGKTHVSTRVMGTYGYAAPE------YVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
              K        GT  Y APE               + D++S GV++  +L G       
Sbjct: 176 PGEKL--REVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------ 226

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDP 402
                        P    K+    +L   + G++          S     L ++ L   P
Sbjct: 227 ------------PPFWHRKQ--MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272

Query: 403 KARPRMSEVVE 413
           + R    E + 
Sbjct: 273 QKRYTAEEALA 283

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.6 bits (238), Expect = 1e-21
 Identities = 77/406 (18%), Positives = 135/406 (33%), Gaps = 84/406 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G +G V+K   ++              A+K +   G+        E+  L  L HPN
Sbjct: 29  VGRGTYGHVYKAKRKD-------GKDDKDYALKQIEGTGI--SMSACREIALLRELKHPN 79

Query: 200 LVKLVGYCIED-DQRL-LVYEFMP---RGSLENH---LFRKGSLPLPWSIRMKIALGAAK 251
           ++ L    +   D+++ L++++        ++ H      K  + LP  +   +      
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNA----KLSDFGLAK--DAPEDGKTHVSTRV 305
           G+ +LH      V++RD K +NIL+  +       K++D G A+  ++P      +   V
Sbjct: 140 GIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 196

Query: 306 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR-----RSMDKNRPNGEH---- 354
           + T+ Y APE ++ G  H T   D+++ G +  E+LT       R  D    N  H    
Sbjct: 197 V-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254

Query: 355 ----------NLVEW-----------ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQL 393
                        +W                         L   +E H   K   KA  L
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV-KPDSKAFHL 313

Query: 394 AAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYYFQT---------MQADNTWSIRN 444
             + L+ DP  R    +              A    YF                 +  R 
Sbjct: 314 LQKLLTMDPIKRITSEQ--------------AMQDPYFLEDPLPTSDVFAGCQIPYPKRE 359

Query: 445 SKNGIRTQGGFMTRNGQPLRTLSHPNGPHASPYRHPQQSPKPNGKQ 490
                        +N Q  +  +H NG      +    +  P  K+
Sbjct: 360 FLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQGPPLKK 405

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 64/293 (21%), Positives = 108/293 (36%), Gaps = 42/293 (14%)

Query: 66  SSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFN 125
            ++   S    G   +    +      S+   +      S    +  + + +    F   
Sbjct: 17  ENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHR 76

Query: 126 DLKLATRNFR------PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 179
            +                 +LG G FG V K   EE  T       GL +A K +   G+
Sbjct: 77  IVTAKQGAVNSFYTVSKTEILGGGRFGQVHK--CEETAT-------GLKLAAKIIKTRGM 127

Query: 180 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLF-- 230
           +  +E   E++ +  L H NL++L     E    + LV E++  G L      E++    
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186

Query: 231 RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFG 288
               L       MK       G+  +H   +  +++ D K  NIL         K+ DFG
Sbjct: 187 LDTIL------FMKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFG 234

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           LA+      K  V     GT  + APE V    ++  +D++S GV+   +L+G
Sbjct: 235 LARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 33/215 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           LG G +  V+KG  +          TG+ VA+K +  D     +E      + E++ +  
Sbjct: 13  LGNGTYATVYKGLNKT---------TGVYVALKEVKLD----SEEGTPSTAIREISLMKE 59

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMP---RGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           L H N+V+L      +++  LV+EFM    +  +++         L  ++         +
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRVMGTY 309
           GLAF HE     +++RD K  N+L++     KL DFGLA     P +  +     V+ T 
Sbjct: 120 GLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TL 172

Query: 310 GYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            Y AP+ V+ G    ++  D++S G +L EM+TG+
Sbjct: 173 WYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 38/277 (13%)

Query: 80  SNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATRNFRPESL 139
           S   R              +A  +    +  +  KV + +        +    ++    +
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           +G G FG V++  + +         +G  VA+K +    LQ  +    E+  +  L H N
Sbjct: 62  IGNGSFGVVYQAKLCD---------SGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108

Query: 200 LVKLVGYCI------EDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIALGAA 250
           +V+L  Y        +D+  L LV +++P  ++      + +    LP            
Sbjct: 109 IVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKD-APEDGKTH-VSTRVMG 307
           + LA++H      + +RD K  N+LLD D    KL DFG AK     +     + +R   
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--- 220

Query: 308 TYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            Y Y APE ++ G    TS  DV+S G VL E+L G+
Sbjct: 221 -Y-YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 60/317 (18%)

Query: 114 KVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT 173
           +   +  +FM N     + N+  +  LG+G F  V +          V   TGL  A K 
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKI 61

Query: 174 LNHDGLQG--HKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLF 230
           +N   L     ++   E      L HPN+V+L    I+++    LV++ +  G L   + 
Sbjct: 62  INTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIV 120

Query: 231 RKGSLPLPWSIR-----MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNA 282
            +       S       ++  L +   +A+ H      +++R+ K  N+LL         
Sbjct: 121 AREFY----SEADASHCIQQILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170

Query: 283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           KL+DFGLA +  +    H      GT GY +PE +     +   D+++ GV+L  +L G 
Sbjct: 171 KLADFGLAIEVNDSEAWH--GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227

Query: 343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQ 396
                              P   + +  +RL      G +          + +A  L   
Sbjct: 228 ------------------PPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 397 CLSRDPKARPRMSEVVE 413
            L+ +PK R    + ++
Sbjct: 268 MLTVNPKKRITADQALK 284

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 92.2 bits (230), Expect = 4e-21
 Identities = 66/293 (22%), Positives = 113/293 (38%), Gaps = 62/293 (21%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAE 188
           + N+  +  LG+G F  V +          V   TGL  A K +N   L     ++   E
Sbjct: 5   SDNYDVKEELGKGAFSVVRRC---------VHKTTGLEFAAKIINTKKLSARDFQKLERE 55

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR----- 242
                 L HPN+V+L    I+++    LV++ +  G L   +  +       S       
Sbjct: 56  ARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVAREFY----SEADASHC 110

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKT 299
           ++  L +   +A+ H      +++R+ K  N+LL         KL+DFGLA +  +    
Sbjct: 111 IQQILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164

Query: 300 HVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE 358
           H      GT GY +PE V+     +   D+++ GV+L  +L G                 
Sbjct: 165 H--GFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG----------------- 203

Query: 359 WARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKAR 405
              P   + +  +RL      G +          + +A  L    L+ +PK R
Sbjct: 204 -YPPFWDEDQ--HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKR 253

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 60/219 (27%), Positives = 93/219 (42%), Gaps = 31/219 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----LA 187
            +    L+GEG +G V K   ++         TG  VA+K           +      + 
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFL---ESDDDKMVKKIAMR 73

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           E+  L  L H NLV L+  C +  +  LV+EF+   ++ + L       L + +  K   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLF 131

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTH-VSTR 304
               G+ F H      +I+RD K  NIL+      KL DFG A+   AP +     V+TR
Sbjct: 132 QIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR 188

Query: 305 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                 Y APE ++      K+ DV++ G ++ EM  G 
Sbjct: 189 -----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 32/226 (14%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
              F+ E + G+G FG V  G  +          TG++VA+K +  D    ++E L  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPRFRNRE-LQIMQ 71

Query: 191 FLGNLLHPNLVKL------VGYCIEDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSI 241
            L  L HPN+V+L      +G     D  L +V E++P  +L      + +  +  P  +
Sbjct: 72  DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130

Query: 242 RMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDA-PEDGKT 299
                    + +  LH  +   V +RD K  N+L++ AD   KL DFG AK   P +   
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 300 H-VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
             + +R    Y Y APE ++ G  H T+  D++S G +  EM+ G 
Sbjct: 190 AYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 94.1 bits (234), Expect = 1e-20
 Identities = 71/362 (19%), Positives = 112/362 (30%), Gaps = 48/362 (13%)

Query: 60  SRSKVDSSMSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQL 119
                 S     +          KRR    V           + SS              
Sbjct: 85  ENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY 144

Query: 120 RKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL 179
            + +         ++     LG G FG V +  V E  T       G   A K +     
Sbjct: 145 PQPVEIKHDHVLDHYDIHEELGTGAFGVVHR--VTERAT-------GNNFAAKFVMTPHE 195

Query: 180 QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSL-ENHLFRKGSLPLP 238
              +    E+  +  L HP LV L     +D++ +++YEFM  G L E        +   
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED 255

Query: 239 WSIR-MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDAPE 295
            ++  M+      KGL  +H   E   ++ D K  NI+         KL DFGL      
Sbjct: 256 EAVEYMRQVC---KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
                V     GT  +AAPE      +   +D++S GV+   +L+G              
Sbjct: 310 KQSVKV---TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG-------------- 352

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMS 409
                 P  G+       L       +++        S+       + L  DP  R  + 
Sbjct: 353 ----LSPFGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIH 406

Query: 410 EV 411
           + 
Sbjct: 407 QA 408

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 93.7 bits (233), Expect = 1e-20
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 189
           ++     LG G FG V  G             TG  VAVK LN   ++          E+
Sbjct: 17  HYILGDTLGVGTFGKVKVG---------KHELTGHKVAVKILNRQKIRSLDVVGKIRREI 67

Query: 190 NFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
             L    HP+++KL  Y  I     + +V E++  G L +++ + G        R+    
Sbjct: 68  QNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNG--------RLDEKE 117

Query: 248 GAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
                     G+ + H      V++RD K  N+LLDA  NAK++DFGL+    +      
Sbjct: 118 SRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174

Query: 302 STRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGR 342
           S    G+  YAAPE V++G L    + D++S GV+L  +L G 
Sbjct: 175 SC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 68/296 (22%), Positives = 107/296 (36%), Gaps = 70/296 (23%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           +G G +    +          +   T +  AVK ++        E   E+  L     HP
Sbjct: 30  IGVGSYSVCKRC---------IHKATNMEFAVKIIDKSKRDP-TE---EIEILLRYGQHP 76

Query: 199 NLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKG 252
           N++ L     +D + + +V E M  G L + + R+       S R     +         
Sbjct: 77  NIITLKDVY-DDGKYVYVVTELMKGGELLDKILRQKFF----SEREASAVLFTITKT--- 128

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL-DADYNA---KLSDFGLAKDAPEDGKTHVSTRVMGT 308
           + +LH    + V++RD K SNIL  D   N    ++ DFG AK    +    + T    T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YT 183

Query: 309 YGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTG----RRSMDKNRPNGEHNLVEWARPH 363
             + APE V+       + D++S GV+L  MLTG        D                 
Sbjct: 184 ANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE------------- 229

Query: 364 LGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                    +L     G FS+ G      S  A  L ++ L  DP  R   + V+ 
Sbjct: 230 --------EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 62/296 (20%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA---EV 189
            +     LGEG FG V                T   VA+K ++   L+     +    E+
Sbjct: 10  PYIIRETLGEGSFGKVKLA---------THYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 190 NFLGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           ++L  L HP+++KL  Y  I     + +V E+   G L +++  K         RM    
Sbjct: 61  SYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAG-GELFDYIVEKK--------RMTEDE 109

Query: 248 GAAK------GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           G          + + H      +++RD K  N+LLD + N K++DFGL+    +      
Sbjct: 110 GRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166

Query: 302 STRVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
           S    G+  YAAPE V+ G L    + DV+S G+VL  ML GR   D      +  +   
Sbjct: 167 SC---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD------DEFIPN- 215

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKG--SQKATQLAAQCLSRDPKARPRMSEVVE 413
                        L        + +    S  A  L  + +  DP  R  + E+  
Sbjct: 216 -------------LFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           + GTG   A K +    L   +  ++      EVN L 
Sbjct: 13  LGSGQFAIVRKC---------RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 194 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 251
            + HPN++ L     E+   + L+ E +  G L + L  K SL    + + +K  L    
Sbjct: 64  EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD--- 119

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G+ +LH    K + + D K  NI+L      +   KL DFG+A       +      + G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 63/292 (21%), Positives = 109/292 (37%), Gaps = 61/292 (20%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG+G F  V +          VK   G   A   +N   L    H++   E      L H
Sbjct: 19  LGKGAFSVVRRC---------VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 198 PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAK 251
           PN+V+L    I ++    L+++ +  G L   +  +       S       ++  L A  
Sbjct: 70  PNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDIVAREYY----SEADASHCIQQILEA-- 122

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            +   H   +  V++R+ K  N+LL         KL+DFGLA +   + +        GT
Sbjct: 123 -VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFA-GT 176

Query: 309 YGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
            GY +PE V+         D+++ GV+L  +L G                    P   + 
Sbjct: 177 PGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGY------------------PPFWDED 217

Query: 368 RRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
           +  +RL      G +          + +A  L  + L+ +P  R   +E ++
Sbjct: 218 Q--HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 39/223 (17%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           +    ++G G FG VF+  + E+            VA+K +    LQ  +    E+  + 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE----------VAIKKV----LQDKRFKNRELQIMR 87

Query: 194 NLLHPNLVKLVGYCI------EDDQRL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMK 244
            + HPN+V L           +D+  L LV E++P  ++      + K    +P  +   
Sbjct: 88  IVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKL 145

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAKD-APEDGKTH-V 301
                 + LA++H      + +RD K  N+LLD      KL DFG AK     +     +
Sbjct: 146 YMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202

Query: 302 STRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
            +R    Y Y APE ++ G  + T+  D++S G V+ E++ G+
Sbjct: 203 CSR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 194 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 251
            +LH N++ L     E+   + L+ E +  G L + L +K SL    +   +K  L    
Sbjct: 71  QVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--- 126

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G+ +LH    K + + D K  NI+L        + KL DFGLA +  +  +      + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 61/294 (20%), Positives = 102/294 (34%), Gaps = 61/294 (20%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 197
           +LG G  G V +              TG   A+K L         +   EV+        
Sbjct: 36  VLGLGVNGKVLEC---------FHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGG 81

Query: 198 PNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGA 249
           P++V ++    E+        L++ E M  G L + +  +G         +  M+    A
Sbjct: 82  PHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
              + FLH      + +RD K  N+L    + D   KL+DFG AK+  ++    + T   
Sbjct: 141 ---IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQTPC- 190

Query: 307 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEHNLVEWARPHLG 365
            T  Y APE +         D++S GV++  +L G        P                
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF------PPFYSNT----------- 233

Query: 366 DKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
            +     +      G +          S+ A QL    L  DP  R  +++ + 
Sbjct: 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 54/213 (25%), Positives = 84/213 (39%), Gaps = 36/213 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V +          V+  TG     K +N            E++ +  L HP 
Sbjct: 59  LGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSL------ENHLF--RKGSLPLPWSIRMKIALGAA 250
           L+ L     ED   + L+ EF+  G L      E++     +          M+ A    
Sbjct: 110 LINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN------YMRQACE-- 160

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            GL  +H   E  +++ D K  NI+       + K+ DFGLA     D    V      T
Sbjct: 161 -GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTAT 213

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
             +AAPE V    +   +D+++ GV+   +L+G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 90.1 bits (224), Expect = 7e-20
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  +       EV+ L 
Sbjct: 20  LGSGQFAIVKKC---------REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 194 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 251
            +LHPN++ L     E+   + L+ E +  G L + L +K SL    +   +K  L    
Sbjct: 71  QVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD--- 126

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           G+ +LH    K + + D K  NI+L        + KL DFGLA +  +  +      + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.3 bits (220), Expect = 1e-19
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 36/214 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +GEG +G V+K           +   G T A+K +    L+   E      + E++ L  
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIR---LEKEDEGIPSTTIREISILKE 56

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--MKIALGAAKG 252
           L H N+VKL        + +LV+E + +  L+  L          + +  +   L    G
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NG 112

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYG 310
           +A+ H+   + V++RD K  N+L++ +   K++DFGLA+    P    TH    ++ T  
Sbjct: 113 IAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLW 165

Query: 311 YAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           Y AP+ V+ G    ++  D++S G +  EM+ G 
Sbjct: 166 YRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 31/213 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +GEG +G VFK    E         T   VA+K +    L    E      L E+  L  
Sbjct: 10  IGEGTYGTVFKAKNRE---------THEIVALKRVR---LDDDDEGVPSSALREICLLKE 57

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           L H N+V+L      D +  LV+EF  +  L+   F   +  L   I         KGL 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLK-KYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
           F H    + V++RD K  N+L++ +   KL++FGLA+    P    +     V+ T  Y 
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168

Query: 313 APEYVMTG--HLTSKSDVYSFGVVLLEMLTGRR 343
            P+ V+ G    ++  D++S G +  E+    R
Sbjct: 169 PPD-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 32/212 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +GEG +G V+K           K   G  VA+K +    L    E      + E++ L  
Sbjct: 29  VGEGTYGVVYKA----------KDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKE 75

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           L HPN+V L+     +    LV+EFM +  L+  L  +    L  S          +G+A
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL-DENKTGLQDSQIKIYLYQLLRGVA 133

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD--APEDGKTHVSTRVMGTYGYA 312
             H+     +++RD K  N+L+++D   KL+DFGLA+    P    TH    V+ T  Y 
Sbjct: 134 HCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186

Query: 313 APEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           AP+ V+ G    ++  D++S G +  EM+TG+
Sbjct: 187 APD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 57/296 (19%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-EVNF 191
            +     +G G FG                  T   VAVK +         E +  E+  
Sbjct: 21  RYDFVKDIGSGNFGVARLM---------RDKLTKELVAVKYIERGAAI--DENVQREIIN 69

Query: 192 LGNLLHPNLVKLVGY-CIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK----I 245
             +L HPN+V+      I     L ++ E+   G L   +   G      + R      +
Sbjct: 70  HRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-RFFFQQLL 126

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY--NAKLSDFGLAKDAPEDGKTHVST 303
           +     G+++ H      + +RD K  N LLD       K+ DFG +K +    +    +
Sbjct: 127 S-----GVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--S 176

Query: 304 RVMGTYGYAAPEYVMTGHL--TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR 361
            V GT  Y APE V+         +DV+S GV L  ML G    +   P           
Sbjct: 177 TV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE--DPE---------- 222

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKG----SQKATQLAAQCLSRDPKARPRMSEVVE 413
               + R + + +   L   +SI      S +   L ++    DP  R  + E+  
Sbjct: 223 ----EPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 80/356 (22%), Positives = 123/356 (34%), Gaps = 70/356 (19%)

Query: 73  TNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKLATR 132
            ++                 S T ++   +AS  P +  +      L  F          
Sbjct: 5   HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF---------- 54

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
            F  ES LG G    V++           + GT    A+K L        K    E+  L
Sbjct: 55  -FEVESELGRGATSIVYRC---------KQKGTQKPYALKVLKKT--VDKKIVRTEIGVL 102

Query: 193 GNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIA 246
             L HPN++KL     E    + LV E +  G L + +  KG      S R     +K  
Sbjct: 103 LRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYY----SERDAADAVKQI 157

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVST 303
           L A   +A+LHE     +++RD K  N+L      D   K++DFGL+K            
Sbjct: 158 LEA---VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---K 208

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
            V GT GY APE +       + D++S G++   +L G                      
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG-------------------FEP 249

Query: 364 LGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
             D+R    +    L   +          S  A  L  + +  DPK R    + ++
Sbjct: 250 FYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 32/219 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLA 187
            +     LGEG +  V+KG  +          T   VA+K +  +    H+E      + 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLE----HEEGAPCTAIR 49

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV+ L +L H N+V L      +    LV+E++ +  L+ +L       +          
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINMHNVKLFLF 107

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA--KDAPEDGKTHVSTRV 305
              +GLA+ H    + V++RD K  N+L++     KL+DFGLA  K  P     +    V
Sbjct: 108 QLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EV 161

Query: 306 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           + T  Y  P+ ++ G    +++ D++  G +  EM TGR
Sbjct: 162 V-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 31/214 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------EVNFLG 193
           LG G F  V K           +  TGL  A K +     +  +  ++      EV+ L 
Sbjct: 19  LGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 194 NLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-MKIALGAAK 251
            + HPN++ L     E+   + L+ E +  G L + L  K SL    +   +K  L    
Sbjct: 70  EIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG-- 126

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILL----DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
            + +LH      + + D K  NI+L          K+ DFGLA       +      + G
Sbjct: 127 -VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
           T  + APE V    L  ++D++S GV+   +L+G
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 69/230 (30%), Positives = 103/230 (44%), Gaps = 30/230 (13%)

Query: 123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH 182
           M  D+K   + +     LGEG F  V+K   +          T   VA+K +        
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEA 51

Query: 183 KE-----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPL 237
           K+      L E+  L  L HPN++ L+          LV++FM    LE  + +  SL L
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLE-VIIKDNSLVL 109

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPE 295
             S      L   +GL +LH+     +++RD K +N+LLD +   KL+DFGLAK   +P 
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166

Query: 296 DGKTH-VSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
              TH V TR      Y APE ++ G        D+++ G +L E+L   
Sbjct: 167 RAYTHQVVTR-----WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 51/237 (21%), Positives = 89/237 (37%), Gaps = 52/237 (21%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA----------- 187
            +G+G +G V                     A+K L+   L     +             
Sbjct: 20  EIGKGSYGVVKLA---------YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70

Query: 188 ---------------EVNFLGNLLHPNLVKL--VGYCIEDDQRLLVYEFMPRGSLENHLF 230
                          E+  L  L HPN+VKL  V     +D   +V+E + +G +   + 
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VP 129

Query: 231 RKGSLPLPWSIRM--KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG 288
               L    +      +  G    + +LH    + +I+RD K SN+L+  D + K++DFG
Sbjct: 130 TLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT---SKSDVYSFGVVLLEMLTGR 342
           ++ +  +     +S  V GT  + APE +            DV++ GV L   + G+
Sbjct: 183 VSNE-FKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 72/365 (19%), Positives = 115/365 (31%), Gaps = 63/365 (17%)

Query: 68  MSGTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDL 127
           M   S               P  P  +     A+     P+   +  V S L+      +
Sbjct: 1   MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII 60

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA 187
                      +LG G  G V +              T    A+K L         +   
Sbjct: 61  D---DYKVTSQVLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARR 103

Query: 188 EVNFLGNLL-HPNLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLP--- 238
           EV         P++V++V    E+        L+V E +  G L + +  +G        
Sbjct: 104 EVELHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA--KLSDFGLAKDAPE 295
            S  MK    A   + +LH      + +RD K  N+L      NA  KL+DFG AK+   
Sbjct: 163 ASEIMKSIGEA---IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP-NGEH 354
                ++T    T  Y APE +         D++S GV++  +L G        P    H
Sbjct: 217 HNS--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNH 267

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRM 408
                            R+      G +          S++   L    L  +P  R  +
Sbjct: 268 -------GLAISPGMKTRI----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI 316

Query: 409 SEVVE 413
           +E + 
Sbjct: 317 TEFMN 321

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 38/281 (13%), Positives = 74/281 (26%), Gaps = 60/281 (21%)

Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEW 185
              R +R     G       ++                  VA+  ++  G+      +E 
Sbjct: 29  ANGR-YRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQET 78

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           L+    L  +  P + +++         L+V E++  GSL+       S     +IR   
Sbjct: 79  LSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIR--A 134

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
               A      H      V       S + +  D +  L+                    
Sbjct: 135 MQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------- 174

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                              + D+   G  L  +L  R  + +    G  + +  A     
Sbjct: 175 -----TMPDA-------NPQDDIRGIGASLYALLVNRWPLPE---AGVRSGLAPAERDTA 219

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            +      +D  +    S         +AA+ +  D   R 
Sbjct: 220 GQPIEPADIDRDIPFQIS--------AVAARSVQGDGGIRS 252

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.2 bits (209), Expect = 5e-18
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 41/219 (18%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           LGEG +G V+K              T  TVA+K +    L+  +E      + EV+ L  
Sbjct: 42  LGEGTYGEVYKAIDTV---------TNETVAIKRIR---LEHEEEGVPGTAIREVSLLKE 89

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR--MKIALGAAKG 252
           L H N+++L      + +  L++E+     L+ ++ +   +     I+  +   +    G
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-MRVIKSFLYQLI---NG 144

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA-----KLSDFGLAKD--APEDGKTHVSTRV 305
           + F H    +  ++RD K  N+LL     +     K+ DFGLA+    P    TH    +
Sbjct: 145 VNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EI 198

Query: 306 MGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGR 342
           + T  Y  PE ++ G  H ++  D++S   +  EML   
Sbjct: 199 I-TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.2 bits (208), Expect = 6e-18
 Identities = 77/350 (22%), Positives = 109/350 (31%), Gaps = 97/350 (27%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFL------ 192
           LG G FG V +           K  T  TVAVK L        H+  ++E+  L      
Sbjct: 30  LGRGAFGQVIEADAFG----IDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 193 --------------------------GNLLH-------------------PNLVKLVGYC 207
                                     GNL                           VG  
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 208 IEDDQRLLVYEFMPRGSLENHLFRKGSL---------------PLPWSIRMKIALGAAKG 252
             D +R L      + S  +    + SL                L     +  +   AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + FL   A +  I+RD    NILL      K+ DFGLA+D  +D              + 
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 262

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR---SMDKNRPNGEHNLVEWARPHLGDKR 368
           APE +     T +SDV+SFGV+L E+ + G      +  +                   +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRL-------K 310

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
              R+  P          + +  Q    C   +P  RP  SE+VE L  L
Sbjct: 311 EGTRMRAPDY-------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 40/210 (19%), Positives = 79/210 (37%), Gaps = 31/210 (14%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN 199
           LG G FG V +          V+  +  T   K +   G         E++ L    H N
Sbjct: 13  LGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRN 62

Query: 200 LVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR-----MKIALGAAKGL 253
           ++ L     E  + L +++EF+    +   +          + R     +       + L
Sbjct: 63  ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVC---EAL 115

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            FLH      + + D +  NI+     ++  K+ +FG A+         +   +     Y
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEY 169

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            APE      +++ +D++S G ++  +L+G
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +GEG +G VFK    +N         G  VA+K +    +Q  +E      + EV  L +
Sbjct: 19  IGEGAYGKVFKARDLKN--------GGRFVALKRVR---VQTGEEGMPLSTIREVAVLRH 67

Query: 195 L---LHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
           L    HPN+V+L         + + +L LV+E + +  L  +L +     +P      + 
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVSTRV 305
               +GL FLH      V++RD K  NIL+ +    KL+DFGLA+        T     V
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VV 180

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           + T  Y APE ++     +  D++S G +  EM   +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 55/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA--------EVNF 191
           +G G +G V+K              +G  VA+K++    +                EV  
Sbjct: 17  IGVGAYGTVYKARDPH---------SGHFVALKSVR---VPNGGGGGGGLPISTVREVAL 64

Query: 192 LGNL---LHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           L  L    HPN+V+L         + + ++ LV+E + +  L  +L +     LP     
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGK-THVS 302
            +     +GL FLH      +++RD K  NIL+ +    KL+DFGLA+        T   
Sbjct: 124 DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP-- 178

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
             V+ T  Y APE ++     +  D++S G +  EM   +
Sbjct: 179 -VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 47/212 (22%), Positives = 85/212 (40%), Gaps = 29/212 (13%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGNLLH 197
           LG G F  V +          +   TG   A K L           E L E+  L     
Sbjct: 37  LGRGKFAVVRQC---------ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 198 -PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAAKG 252
            P ++ L     E+   + L+ E+   G + +    + +  +        +K  L    G
Sbjct: 88  CPRVINLHEV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---G 143

Query: 253 LAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           + +LH   +  +++ D K  NILL       + K+ DFG+++      +      +MGT 
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG 341
            Y APE +    +T+ +D+++ G++   +LT 
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 55/232 (23%), Positives = 87/232 (37%), Gaps = 41/232 (17%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW----- 185
              +  +  +  G +G V                 G+ VA+K + +    G         
Sbjct: 21  QSPYTVQRFISSGSYGAVCA----------GVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 186 ------LAEVNFLGNLLHPNLVKL----VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGS 234
                 L E+  L +  HPN++ L    V +      +L LV E M    L   +     
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQR 128

Query: 235 LPLPWSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
           + +     ++        GL  LHE A   V++RD    NILL  + +  + DF LA++ 
Sbjct: 129 IVIS-PQHIQYFMYHILLGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 294 PEDGKT--HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
             D     +V+ R      Y APE VM     T   D++S G V+ EM   +
Sbjct: 185 TADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.2 bits (203), Expect = 5e-17
 Identities = 51/222 (22%), Positives = 87/222 (39%), Gaps = 32/222 (14%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
            + ++    +G G  G V                    VA+K L+         K    E
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAA---------YDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111

Query: 189 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  +  + H N++ L+        +E+ Q + LV E M   +    + +        S  
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--DANLCQVIQMELDHERMSYL 169

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT--H 300
           +   L    G+  LH      +I+RD K SNI++ +D   K+ DFGLA+ A        +
Sbjct: 170 LYQML---CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 223

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           V TR      Y APE ++        D++S G ++ EM+  +
Sbjct: 224 VVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 51/219 (23%), Positives = 88/219 (40%), Gaps = 34/219 (15%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +++    LG G +  VF+     N            V VK L        K+   E+  L
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNE---------KVVVKILK---PVKKKKIKREIKIL 84

Query: 193 GNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLP-WSIR--MKIALG 248
            NL   PN++ L     +   R     F     + N  F++    L  + IR  M   L 
Sbjct: 85  ENLRGGPNIITLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEIL- 140

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA-KLSDFGLAK-DAPEDGKTH-VSTRV 305
             K L + H      +++RD K  N+++D ++   +L D+GLA+   P       V++R 
Sbjct: 141 --KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 306 MGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRR 343
                +  PE ++   +   S D++S G +L  M+  + 
Sbjct: 196 -----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 53/232 (22%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
            + +   + +G G +G V            +   +G  VA+K L+         K    E
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSA---------IDKRSGEKVAIKKLSRPFQSEIFAKRAYRE 73

Query: 189 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  L ++ H N++ L+        + +     LV  FM     +  L +         + 
Sbjct: 74  LLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQK--------IMG 120

Query: 243 MKIA-----------LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
           +K +           L   KGL ++H  A   V++RD K  N+ ++ D   K+ DFGLA+
Sbjct: 121 LKFSEEKIQYLVYQML---KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174

Query: 292 DAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
            A  +   +V TR    + Y APE +++  H     D++S G ++ EMLTG+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 34/223 (15%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
            + ++    +G G  G V                    VA+K L+         K    E
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAA---------YDAILERNVAIKKLSRPFQNQTHAKRAYRE 74

Query: 189 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  +  + H N++ L+        +E+ Q + +V E M     + +L +   + L    R
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMEL-DHER 128

Query: 243 MKIAL-GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-- 299
           M   L     G+  LH  A   +I+RD K SNI++ +D   K+ DFGLA+ A        
Sbjct: 129 MSYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185

Query: 300 HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
           +V TR      Y APE ++        D++S G ++ EM+ G 
Sbjct: 186 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 78.0 bits (193), Expect = 6e-16
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 39/222 (17%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLGN 194
           +G+G FG VFK    +         TG  VA+K +    ++  KE      L E+  L  
Sbjct: 25  IGQGTFGEVFKARHRK---------TGQKVALKKVL---MENEKEGFPITALREIKILQL 72

Query: 195 LLHPNLVKLVGYCIEDDQRL--------LVYEFMP---RGSLENHLFRKGSLPLPWSIRM 243
           L H N+V L+  C               LV++F      G L N       +    S   
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-----VLVKFTLSEIK 127

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTHV 301
           ++      GL ++H      +++RD K +N+L+  D   KL+DFGLA+     ++ + + 
Sbjct: 128 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 302 STRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGR 342
            T  + T  Y  PE ++         D++  G ++ EM T  
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 72/259 (27%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK-TLNHDGLQGHKEWLAEV 189
           ++ +     LG G FG V + +  E         +G   A+K  L        +    E+
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDP-----RYKNREL 51

Query: 190 NFLGNLLHPNLVKL-------------------------------------VGYCIEDDQ 212
           + +  L H N++KL                                     V      ++
Sbjct: 52  DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111

Query: 213 RL-LVYEFMPRGSLENHL--FRKGSLPLPWSIRMKIAL-GAAKGLAFLHEEAEKPVIYRD 268
            L ++ E++P  +L   L  F +    +P    + I +    + + F+H      + +RD
Sbjct: 112 YLNVIMEYVP-DTLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSLG---ICHRD 166

Query: 269 FKTSNILLDA-DYNAKLSDFGLAKDA-PEDGKTH-VSTRVMGTYGYAAPEYVMTG--HLT 323
            K  N+L+++ D   KL DFG AK   P +     + +R    + Y APE +M G    T
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYT 220

Query: 324 SKSDVYSFGVVLLEMLTGR 342
              D++S G V  E++ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 32/222 (14%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
              ++  S +G G +G V   +  +         TGL VAVK L+     +   K    E
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRE 78

Query: 189 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  L ++ H N++ L+        +E+   + LV   M  G+  N++ +   L       
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLT---DDH 133

Query: 243 MK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++ +     +GL ++H  A+  +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V
Sbjct: 134 VQFLIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV 190

Query: 302 STRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
           +TR      Y APE ++   H     D++S G ++ E+LTGR
Sbjct: 191 ATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 52/235 (22%), Positives = 94/235 (40%), Gaps = 45/235 (19%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
              +     LG GG G VF           V       VA+K +     Q  K  L E+ 
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSA---------VDNDCDKRVAIKKIVLTDPQSVKHALREIK 60

Query: 191 FLGNLLHPNLVKL-------------VGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLP 236
            +  L H N+VK+                 + +   + +V E+M   +   ++  +G L 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLL 118

Query: 237 LPWSIRMK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAP 294
                  +       +GL ++H  A   V++RD K +N+ ++  D   K+ DFGLA+   
Sbjct: 119 ---EEHARLFMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 295 EDGKT------HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                       + T+      Y +P  +++ +  +K+ D+++ G +  EMLTG+
Sbjct: 173 PHYSHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 42/229 (18%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 189
              +   S +GEG +G V   +   N            VA+K ++  +     +  L E+
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKV---------RVAIKKISPFEHQTYCQRTLREI 76

Query: 190 NFLGNLLHPNLVKLVG----YCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
             L    H N++ +        IE  + + +V + M   +    L +   L    +  + 
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLS---NDHIC 131

Query: 245 I----ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT- 299
                 L   +GL ++H  A   V++RD K SN+LL+   + K+ DFGLA+ A  D    
Sbjct: 132 YFLYQIL---RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 300 -----HVSTRVMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
                +V+TR      Y APE ++     +KS D++S G +L EML+ R
Sbjct: 186 GFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 57/237 (24%), Positives = 100/237 (42%), Gaps = 51/237 (21%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEV 189
           + +F+ +SLLGEG +G V     +  G           VA+K +   D        L E+
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGE---------IVAIKKIEPFDKPLFALRTLREI 60

Query: 190 NFLGNLLHPNLVKLV----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
             L +  H N++ +         E+   + ++ E M     +  L R         I  +
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHR--------VISTQ 107

Query: 245 IALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA---- 290
           + L             + +  LH  +   VI+RD K SN+L++++ + K+ DFGLA    
Sbjct: 108 M-LSDDHIQYFIYQTLRAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163

Query: 291 KDAPEDGKTHVSTRVMGTY----GYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGR 342
           + A ++ +       M  +     Y APE ++T    S++ DV+S G +L E+   R
Sbjct: 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 32/222 (14%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
              +R    +G G +G V            V   TG  VA+K L          K    E
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRE 74

Query: 189 VNFLGNLLHPNLVKLV-----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIR 242
           +  L ++ H N++ L+        ++D     LV  FM  G+    L +   L      R
Sbjct: 75  LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLG---EDR 129

Query: 243 MK-IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV 301
           ++ +     KGL ++H  A   +I+RD K  N+ ++ D   K+ DFGLA+ A  +   +V
Sbjct: 130 IQFLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186

Query: 302 STRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGR 342
            TR      Y APE ++     T   D++S G ++ EM+TG+
Sbjct: 187 VTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 54/329 (16%), Positives = 99/329 (30%), Gaps = 84/329 (25%)

Query: 70  GTSTNYDGKSSNEKRRDRPVVPVSSTTTSNAESASSTPKFSEELKVASQLRKFMFNDLKL 129
           G+S        +       V           +  SS P  S              +D ++
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRP---------HSDWQI 51

Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA-- 187
             R +    L+G G +G V +                  VA+K +               
Sbjct: 52  PDR-YEIRHLIGTGSYGHVCEA---------YDKLEKRVVAIKKILRVF---EDLIDCKR 98

Query: 188 ---EVNFLGNLLHPNLVKLV----GYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPW 239
              E+  L  L H ++VK++       +E    L +V E       ++   +        
Sbjct: 99  ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKK-------- 145

Query: 240 SIRMKIALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
             R  + L              G+ ++H  A   +++RD K +N L++ D + K+ DFGL
Sbjct: 146 LFRTPVYLTELHIKTLLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGL 202

Query: 290 A---------KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH------------LTSKS-- 326
           A                       ++        +  +TGH            L  ++  
Sbjct: 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262

Query: 327 ---DVYSFGVVLLEMLTGRRSMDKNRPNG 352
              DV+S G +  E+L   +       + 
Sbjct: 263 EAIDVWSIGCIFAELLNMIKENVAYHADR 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 54/259 (20%), Positives = 95/259 (36%), Gaps = 63/259 (24%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
             N+  + L+G G +G V+  + +              VA+K +N   + L   K  L E
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEK---------NVAIKKVNRMFEDLIDCKRILRE 75

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRL-----LVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           +  L  L    +++L    I DD        +V E       ++ L +          + 
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKK--------LFKT 122

Query: 244 KIALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA 293
            I L              G  F+HE +   +I+RD K +N LL+ D + K+ DFGLA+  
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 294 PEDGKTHVSTRVMGTYGYAAP---------EYVMT------------GHLTSKSDVYSFG 332
             +  T++   +                   +V+T             + T   D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 333 VVLLEMLTGRRSMDKNRPN 351
            +  E+L   +S   +  N
Sbjct: 240 CIFAELLNMLQSHINDPTN 258

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 54/294 (18%), Positives = 89/294 (30%), Gaps = 83/294 (28%)

Query: 140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP 198
           LG G  G V +              T    A+K L         +   EV         P
Sbjct: 26  LGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQCP 71

Query: 199 NLVKLVGYCIEDDQR-----LLVYEFMPRGSLENHLFRKGSLPLP---WSIRMKIALGAA 250
           ++V++V    E+        L+V E +  G L + +  +G         S  MK    A 
Sbjct: 72  HIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA- 129

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
             + +LH      + +RD K  N+L      +   KL+DFG    A E           G
Sbjct: 130 --IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE---------TTG 172

Query: 308 T-YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS-MDKNRPNGEHNLVEWARPHLG 365
             Y  +              D++S GV++  +L G       +                 
Sbjct: 173 EKYDKSC-------------DMWSLGVIMYILLCGYPPFYSNHGLAISP----------- 208

Query: 366 DKRRFYRLLDPRLEGHFSIKG------SQKATQLAAQCLSRDPKARPRMSEVVE 413
                  +      G +          S++   L    L  +P  R  ++E + 
Sbjct: 209 ------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 46/249 (18%), Positives = 87/249 (34%), Gaps = 56/249 (22%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 197
             LG G F  V+      N T          VA+K +  D     +    E+  L  +  
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDK-VYTEAAEDEIKLLQRVND 74

Query: 198 PNLVKLVG----YCIEDDQRLLVYEFMPRGSLENHL-----------------FRKGSLP 236
            +  K       + +    +LL + F  +G    H+                 +    +P
Sbjct: 75  ADNTKEDSMGANHIL----KLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD------ADYNAKLSDFGLA 290
           L   ++ +I+     GL ++H      +I+ D K  N+L++           K++D G A
Sbjct: 130 LI-YVK-QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

Query: 291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-----RSM 345
               E     + TR      Y +PE ++       +D++S   ++ E++TG         
Sbjct: 186 CWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240

Query: 346 DKNRPNGEH 354
                + +H
Sbjct: 241 HSYTKDDDH 249

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 58/247 (23%), Positives = 95/247 (38%), Gaps = 61/247 (24%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNH--DGLQGHKEWLAE 188
            R +     LG+G +G V+K              TG  VAVK +          +    E
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFRE 58

Query: 189 VNFLGNL-LHPNLVKLVGYCI-EDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           +  L  L  H N+V L+     ++D+ + LV+++M     E  L           IR  I
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHA--------VIRANI 105

Query: 246 ALGAA----------KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            L             K + +LH      +++RD K SNILL+A+ + K++DFGL++    
Sbjct: 106 -LEPVHKQYVVYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 296 DGKTHVSTRVMGTYGYAAP--------EYVMT------------GHLTSKSDVYSFGVVL 335
             +   +  +                 +YV T               T   D++S G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 336 LEMLTGR 342
            E+L G+
Sbjct: 222 GEILCGK 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 53/226 (23%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNLL 196
            ++G+G FG V K +  +             VA+K + N      H++   E+  L +L 
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQ---------HVALKMVRNEKRF--HRQAAEEIRILEHLR 151

Query: 197 H------PNLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRKGSLPLP 238
                   N++ ++         C+  E    LL   +YE      ++ + F+  SLPL 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFE----LLSMNLYEL-----IKKNKFQGFSLPL- 201

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA-KLSDFGLAKDAPED 296
             +R K A    + L  LH+     +I+ D K  NILL     +  K+ DFG +    + 
Sbjct: 202 --VR-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255

Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR 342
             T++ +R      Y APE ++        D++S G +L E+LTG 
Sbjct: 256 VYTYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 61/236 (25%), Positives = 91/236 (38%), Gaps = 54/236 (22%)

Query: 129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLA 187
              R +  +SL+G+G FG V K +                VA+K + N        +   
Sbjct: 52  WMDR-YEIDSLIGKGSFGQVVKAYDRVEQE---------WVAIKIIKNKKAF--LNQAQI 99

Query: 188 EVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHL 229
           EV  L  +          +V L  +       C+  E    +L   +Y+      L N  
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE----MLSYNLYDL-----LRNTN 150

Query: 230 FRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDF 287
           FR  SL L    R K A      L FL    E  +I+ D K  NILL     +  K+ DF
Sbjct: 151 FRGVSLNL---TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205

Query: 288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGR 342
           G +    +    ++ +R      Y +PE V+ G       D++S G +L+EM TG 
Sbjct: 206 GSSCQLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 41/236 (17%), Positives = 80/236 (33%), Gaps = 37/236 (15%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----------LQG 181
           R ++ +S       G +++     +             ++K    DG             
Sbjct: 42  RQWKLKSFQTRDNQGILYEA-APTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAA 100

Query: 182 HKEWLAEVNFLGNLLHPNLVKLVGY-CIEDDQRLLVYEFMPR--GSLENHLFRKGSLPLP 238
               + +   L +     +   +G+   +D  R LV   +P    SL++ L       L 
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSPKHVLS 157

Query: 239 WSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKDAPED 296
               +++A      L FLH   E   ++ +    NI +D +  ++  L+ +G A      
Sbjct: 158 ERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC-P 213

Query: 297 GKTHVSTR------VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
              HV+          G   + +    M  H     + +SD+ S G  +L+ L G 
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 45/236 (19%), Positives = 86/236 (36%), Gaps = 37/236 (15%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 186
             ++    +G+GGFGC++   +  +       G+     VK    D      E       
Sbjct: 35  AAWKVGLPIGQGGFGCIYLADMNSSE----SVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90

Query: 187 AEVNFLGNLLHPNLVKLVG-----YCIEDDQRLLVYEF--MPR--GSLENHLFRKGSLPL 237
           A+   +   +    +K +G          D+    Y F  M R    L+  ++   +   
Sbjct: 91  AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ-KIYEANAKRF 149

Query: 238 PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKD-AP 294
                ++++L     L ++H   E   ++ D K SN+LL+     +  L D+GLA    P
Sbjct: 150 SRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 295 EDGKTHVSTR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
           E      +        GT  + +    +  H     + + D+   G  +++ LTG 
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 51/223 (22%), Positives = 79/223 (35%), Gaps = 33/223 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
            +R    +G G FG ++ G     G           VA+K         H +   E    
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGE---------EVAIKLECVK--TKHPQLHIESKIY 58

Query: 193 GNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
             +     +  +     E D  ++V E +   SLE  LF   S        + +A     
Sbjct: 59  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTVLLLADQMIS 116

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-APEDGKTHVSTR--- 304
            + ++H    K  I+RD K  N L+          + DFGLAK         H+  R   
Sbjct: 117 RIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 305 -VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
            + GT  YA+    +  HL    + + D+ S G VL+    G 
Sbjct: 174 NLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 49/228 (21%), Positives = 80/228 (35%), Gaps = 41/228 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKT--LNHDGLQGHKEWLAEVN 190
           +++    +GEG FG +F+G                 VA+K      D  Q   E+     
Sbjct: 11  HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL 61

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
             G      +  +  +  E    +LV + +   SLE  L                A    
Sbjct: 62  LAGC---TGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTVAMAAKQML 116

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DAPEDGKTHVS 302
             +  +H   EK ++YRD K  N L+    +       + DFG+ K   D     K H+ 
Sbjct: 117 ARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP--VTKQHIP 171

Query: 303 TR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
            R    + GT  Y +    +  HL    + + D+ + G V +  L G 
Sbjct: 172 YREKKNLSGTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 42/278 (15%), Positives = 77/278 (27%), Gaps = 87/278 (31%)

Query: 215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI 274
           +V+E +    L   + +     LP     KI     +GL +LH +    +I+ D K  NI
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178

Query: 275 LLDAD-------------------------------------------------YNAKLS 285
           LL  +                                                    K++
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM 345
           D G A    +     + TR      Y + E ++     + +D++S   +  E+ TG    
Sbjct: 239 DLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

Query: 346 DKNRPNGEHN-------------------LVEWARPHL-----GDKRRFYRLLDPRLEG- 380
           + +                          +V            GD +   +L    L   
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 381 -----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                 +S + +   T      L   P+ R   +E + 
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 41/228 (17%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK--TLNHDGLQGHKEWLAEVN 190
           NFR    +G G FG +  G             T   VA+K   +     Q H E+     
Sbjct: 10  NFRVGKKIGCGNFGELRLG---------KNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ 60

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
                    + ++  +        +V E +   SLE  LF            + IA+   
Sbjct: 61  LGSG---DGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTVLMIAIQLI 115

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK-----LSDFGLAK---DAPEDGKTHVS 302
             + ++H    K +IYRD K  N L+    N       + DF LAK   D   + K H+ 
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP--ETKKHIP 170

Query: 303 TR----VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
            R    + GT  Y +    +  HL    + + D+ + G + +  L G 
Sbjct: 171 YREHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 61/260 (23%), Positives = 89/260 (34%), Gaps = 73/260 (28%)

Query: 121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGL 179
                D  L  R +     LGEG FG V +                  VA+K + N    
Sbjct: 10  VCRIGDW-LQER-YEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVGKY 59

Query: 180 QGHKEWLAEVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMP 221
              +    E+N L  +           V +  +       CI  E    LL    +EF  
Sbjct: 60  --REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFE----LLGKNTFEF-- 111

Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADY 280
              L+ + F+   LP    +R  +A      L FLHE     + + D K  NIL  ++++
Sbjct: 112 ---LKENNFQPYPLPH---VR-HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEF 161

Query: 281 NA------------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL 322
                               +++DFG A    E   T V+TR      Y  PE V+    
Sbjct: 162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPE-VILELG 215

Query: 323 -TSKSDVYSFGVVLLEMLTG 341
                DV+S G +L E   G
Sbjct: 216 WAQPCDVWSIGCILFEYYRG 235

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 54.5 bits (130), Expect = 3e-08
 Identities = 40/226 (17%), Positives = 57/226 (25%), Gaps = 64/226 (28%)

Query: 113 LKVASQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 172
           +   SQ     F+   L T   +    +GEG FG VF+                  VA+K
Sbjct: 2   MGECSQKGPVPFSHC-LPTEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIK 49

Query: 173 TLNHDGLQGH--------KEWLAEVNFLGNLL---------HPNLVKLVGYCI------- 208
            +  +G            +E L E+     L              + L            
Sbjct: 50  IIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPP 109

Query: 209 -----------------------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
                                  +DDQ  +V EF   G     +  K       +    I
Sbjct: 110 LLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSI 166

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                  LA           +RD    N+LL      KL      K
Sbjct: 167 LHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 54.2 bits (131), Expect = 4e-08
 Identities = 69/260 (26%), Positives = 98/260 (37%), Gaps = 73/260 (28%)

Query: 121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGL 179
                D+ L+ R +     LGEG FG V +    + G        G  VAVK + N D  
Sbjct: 5   ICQSGDV-LSAR-YEIVDTLGEGAFGKVVECIDHKAG--------GRHVAVKIVKNVDRY 54

Query: 180 QGHKEWLAEVNFLGNLLHP------NLVKLVGY-------CI--EDDQRLL---VYEFMP 221
              +   +E+  L +L           V+++ +       CI  E    LL    Y+F  
Sbjct: 55  --CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE----LLGLSTYDF-- 106

Query: 222 RGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADY 280
              ++ + F    L     IR K+A    K + FLH      + + D K  NIL   +DY
Sbjct: 107 ---IKENGFLPFRLDH---IR-KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDY 156

Query: 281 NA------------------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL 322
                               K+ DFG A    E   T VSTR      Y APE V+    
Sbjct: 157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH-----YRAPE-VILALG 210

Query: 323 -TSKSDVYSFGVVLLEMLTG 341
            +   DV+S G +L+E   G
Sbjct: 211 WSQPCDVWSIGCILIEYYLG 230

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 57/223 (25%), Positives = 86/223 (38%), Gaps = 33/223 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
            FR    +G G FG ++ G   +             VA+K  N      H + L E    
Sbjct: 8   KFRLGRKIGSGSFGEIYLGTNIQTNE---------EVAIKLENVK--TKHPQLLYESKIY 56

Query: 193 GNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
             L     +  +  + +E D  +LV + +   SLE  LF   S  L     + +A     
Sbjct: 57  RILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMIN 114

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAK---LSDFGLAKD-APEDGKTHVSTR--- 304
            + F+H    K  ++RD K  N L+     A    + DFGLAK         H+  R   
Sbjct: 115 RVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 305 -VMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
            + GT  YA+    +  HL    + + D+ S G VL+  L G 
Sbjct: 172 NLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 9e-08
 Identities = 39/240 (16%), Positives = 77/240 (32%), Gaps = 48/240 (20%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-----L 186
             +     +G GGFG ++  +                  VK    +      E      +
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKP------EKDARHVVKVEYQENGPLFSELKFYQRV 90

Query: 187 AEVNFLGNLLHPNLVKLVG-----YC-----IEDDQRLLVYEFMPR--GSLENHLFRKGS 234
           A+ + +   +    +  +G                 R +V   M R    L+    + G+
Sbjct: 91  AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMV---MERLGIDLQKISGQNGT 147

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK--LSDFGLAKD 292
                ++   + +     L ++H   E   ++ D K +N+LL      +  L+D+GL+  
Sbjct: 148 FKKS-TVLQ-LGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202

Query: 293 APEDGKTHV------STRVMGTYGYAAPEYVMTGHL----TSKSDVYSFGVVLLEMLTGR 342
                  H            GT  + +    +  H     + +SDV   G  +L  L G+
Sbjct: 203 Y-CPNGNHKQYQENPRKGHNGTIEFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 54/248 (21%), Positives = 83/248 (33%), Gaps = 77/248 (31%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTL-NHDGLQGHKEWLAEVNFLGNL- 195
             +G+G FG V      +N             AVK + N       +    E + L  + 
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKK---------YYAVKVVRNIKKY--TRSAKIEADILKKIQ 89

Query: 196 ----LHPNLVKLVGY-------CI--EDDQRLL---VYEFMPRGSLENHLFRKGSLPLPW 239
                + N+VK  G        C+  E     L   +YE      +  + +         
Sbjct: 90  NDDINNNNIVKYHGKFMYYDHMCLIFE----PLGPSLYEI-----ITRNNYN----GFHI 136

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-DADYNA---------------- 282
                  +   K L +L + +   + + D K  NILL D  +                  
Sbjct: 137 EDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 283 --------KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGV 333
                   KL DFG A    +   + ++TR      Y APE V+        SD++SFG 
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGC 247

Query: 334 VLLEMLTG 341
           VL E+ TG
Sbjct: 248 VLAELYTG 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.5 bits (117), Expect = 2e-06
 Identities = 66/419 (15%), Positives = 111/419 (26%), Gaps = 143/419 (34%)

Query: 49  VRFRFIESCMPSRSKVDSSMSGT-STNYDGKSSNEKRRDR-PVVPVSSTTTSNAESASST 106
               F          V   +      NY    S  K   R P +             +  
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 107 PKFSEELKVASQLRKFMFNDLKLATRNFRPESLL---GEGGFGCVFKGWVEENGTAPVKP 163
             F++   V+   R   +  L+ A    RP   +   G  G G   K W           
Sbjct: 124 QVFAK-YNVS---RLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTW----------- 165

Query: 164 GTGLTVAVKTLNHDGLQGHKE----WLAEVNFLGNLLHPNLVKLVGYCIEDDQRL----- 214
                VA+       +Q   +    WL                 +  C   +  L     
Sbjct: 166 -----VALDVCLSYKVQCKMDFKIFWLN----------------LKNCNSPETVLEMLQK 204

Query: 215 LVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN 273
           L+Y+  P   S  +H            I+++I    A+    L          + ++   
Sbjct: 205 LLYQIDPNWTSRSDHSSN---------IKLRIHSIQAELRRLLKS--------KPYENCL 247

Query: 274 ILLDADYNAK-LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFG 332
           ++L    NAK  + F L        K  ++TR                       V  F 
Sbjct: 248 LVLLNVQNAKAWNAFNL------SCKILLTTR--------------------FKQVTDF- 280

Query: 333 VVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQ 392
             L    T   S+D +                         L P            +   
Sbjct: 281 --LSAATTTHISLDHHSMT----------------------LTPD-----------EVKS 305

Query: 393 LAAQCLSRDPKARPRMSEVVETLKPL------QNLKDMASSSYYFQTMQADNTWSIRNS 445
           L  + L   P+  PR  EV+ T  P       ++++D  ++   ++ +  D   +I  S
Sbjct: 306 LLLKYLDCRPQDLPR--EVLTTN-PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	490
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.19
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.1
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.33
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.14
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.96
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.83
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.75
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.48
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.4
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.38
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.25
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.11
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.11
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.81
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.73
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.67
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.18
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.5
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.55

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.5e-60  Score=471.18  Aligned_cols=252  Identities=24%  Similarity=0.381  Sum_probs=207.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++....  ....+.+.+|+.+|++|+|||||++++++.+
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~   94 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTE---------DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE   94 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETT---------TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence            579999999999999999999876         68899999997653  2345678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++.+|||||||+||+|.++|...+...+++..++.|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+
T Consensus        95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccc
Confidence            999999999999999999998776667899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.....  ....+..+||+.|||||++.+..|+.++||||||||||||++|++||.......   +...   .....  
T Consensus       172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~---i~~~~--  241 (350)
T 4b9d_A          172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---LVLK---IISGS--  241 (350)
T ss_dssp             ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH---HHHTC--
T ss_pred             ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHH---HHcCC--
Confidence            9876432  122345789999999999999999999999999999999999999997643221   1111   10000  


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          + +    ..+...+.++.+||.+||+.||++|||+.|++++
T Consensus       242 ----~-~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          242 ----F-P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ----C-C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----C-C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                0 0    1223347889999999999999999999999986

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.2e-59  Score=461.28  Aligned_cols=266  Identities=29%  Similarity=0.446  Sum_probs=218.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|.+.+.||+|+||+||+|++....    ...++..||||+++.......++|.+|+++|++|+|||||+++|+|.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLC----PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC--------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcc----cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            357889999999999999999986421    1236789999999887777778899999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG-----------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +.+|||||||++|+|.++|...+           ...+++..++.|+.||+.||.|||+.+   ||||||||+||||+.+
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence            99999999999999999997642           346999999999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHH
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~  358 (490)
                      +.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.......   +..
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~  241 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE  241 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence            9999999999987654433333344679999999999999999999999999999999998 899997643221   111


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ....   .           .....+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       242 ~i~~---~-----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          242 CITQ---G-----------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHHH---T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHc---C-----------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1110   0           0012334557899999999999999999999999999987643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.7e-59  Score=467.20  Aligned_cols=251  Identities=27%  Similarity=0.392  Sum_probs=212.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ..|++.+.||+|+||+||+|++..         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  144 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  144 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEEeEEeecCcCeEEEEEEECC---------CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            569999999999999999999876         78899999997665455566889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+|||||||+||+|.+++...   .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+
T Consensus       145 ~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          145 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCce
Confidence            999999999999999998753   5899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .+....  ......+||+.|||||++.+..|+.++|||||||+||||++|++||...........+   ...        
T Consensus       219 ~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~--------  285 (346)
T 4fih_A          219 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDN--------  285 (346)
T ss_dssp             ECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS--------
T ss_pred             ecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcC--------
Confidence            765432  2234579999999999999999999999999999999999999999764322211111   110        


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        ..+.+  ......+.++.+||.+||..||++|||+.|+++|
T Consensus       286 --~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          286 --LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             --SCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              01111  1123347899999999999999999999999876

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.3e-59  Score=463.27  Aligned_cols=265  Identities=27%  Similarity=0.434  Sum_probs=211.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||+|+||+||+|++...    ....++..||||+++.......++|.+|+++|++|+|||||+++|+|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~----~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL----LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS----CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc----ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            4678889999999999999998642    112368899999998877777788999999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC
Q 011234          212 QRLLVYEFMPRGSLENHLFRKG-------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      .+|||||||++|+|.++|....             ..++++..++.|+.||+.||.|||+.+   ||||||||+||||+.
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence            9999999999999999997642             235899999999999999999999988   999999999999999


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhH
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~  357 (490)
                      ++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.......   +.
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~  270 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AI  270 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HH
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HH
Confidence            99999999999997755444444456789999999999999999999999999999999998 899997543221   11


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ......              .....+..++.++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       271 ~~i~~g--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          271 DCITQG--------------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHT--------------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHcC--------------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            111100              0112334457899999999999999999999999999987754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-58  Score=455.26  Aligned_cols=263  Identities=26%  Similarity=0.414  Sum_probs=207.6

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +..++|.+.+.||+|+||+||+|++..            .||||+++...  ....+.|.+|+.+|++|+|||||+++|+
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG------------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS------------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC------------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            345678899999999999999998643            59999987543  3445779999999999999999999998


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +. ++.++||||||++|+|.++|.... ..+++..++.|+.||+.||.|||+.+   ||||||||+||||++++.+||+|
T Consensus       101 ~~-~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~D  175 (307)
T 3omv_A          101 MT-KDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGD  175 (307)
T ss_dssp             EC-SSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECC
T ss_pred             EE-CCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEee
Confidence            75 467899999999999999997653 36999999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||+|+..............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||..........  ......
T Consensus       176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~~~  253 (307)
T 3omv_A          176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVGRG  253 (307)
T ss_dssp             CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHTT
T ss_pred             ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHhcC
Confidence            999987654433334456789999999999974   458999999999999999999999997543221111  111000


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               ...+.+ ...+..++..+.+||.+||+.||++|||+.||+++|+.++.
T Consensus       254 ---------~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          254 ---------YASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             ---------CCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             ---------CCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                     011111 12334557899999999999999999999999999987754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.9e-59  Score=460.31  Aligned_cols=251  Identities=23%  Similarity=0.317  Sum_probs=213.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.+...   ...+.+.+|+++|+.|+|||||+++++|.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            469999999999999999999876         788999999975432   23467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcC
Confidence            9999999999999999999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.+............+||+.|||||++.+..|+.++|||||||+||||++|++||.......   +...   ..... 
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~---i~~~~-  250 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAK---IIKLE-  250 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH---HHHTC-
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH---HHcCC-
Confidence            9998765444444556899999999999999999999999999999999999999997543221   1111   10000 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                 ..++...+.++.+||.+||..||++|||+.|++.+
T Consensus       251 -----------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          251 -----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -----------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                       12233447889999999999999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.9e-58  Score=456.53  Aligned_cols=266  Identities=26%  Similarity=0.382  Sum_probs=215.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++++.+.||+|+||+||+|.+....    ...++..||||+++... ....++|.+|+.+|++|+|||||+++|+|.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~  101 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPA----PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD  101 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-----------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCc----cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence            35677899999999999999975311    11257799999997543 23457899999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      +.++||||||++|+|.++|..+.              ...+++..++.|+.||+.||.|||+.+   ||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEE
Confidence            99999999999999999996542              135899999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcch
Q 011234          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHN  355 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~  355 (490)
                      ++++.+||+|||+|+..............+||+.|||||++.++.|+.++|||||||+||||+| |..||......   .
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~  255 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D  255 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---H
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---H
Confidence            9999999999999987654433334455789999999999999999999999999999999998 89999765322   1


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      +......    .          .....+..++..+.+||.+||+.||++||||.||+++|+.+.++
T Consensus       256 ~~~~i~~----~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl  307 (308)
T 4gt4_A          256 VVEMIRN----R----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL  307 (308)
T ss_dssp             HHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred             HHHHHHc----C----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence            2221110    0          01123445678899999999999999999999999999987553

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-58  Score=458.00  Aligned_cols=253  Identities=25%  Similarity=0.285  Sum_probs=210.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||+++.+..     ..+|+.+|+.|+|||||++++++.+++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~---------~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQ---------TGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hheEeCcEeccCCCeEEEEEEECC---------CCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            468888999999999999999876         788999999976533     246999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEcccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDFGLA  290 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DFG~a  290 (490)
                      .+|||||||+||+|.++|...+  .+++..+..++.||+.||.|||+++   ||||||||+||||+.+| .+||+|||+|
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             EEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            9999999999999999998765  6899999999999999999999988   99999999999999987 5999999999


Q ss_pred             ccCCCCCCc---ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKT---HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~---~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +........   .....++||+.|||||++.+..|+.++|||||||+||||++|++||...........+...      .
T Consensus       199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------~  272 (336)
T 4g3f_A          199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE------P  272 (336)
T ss_dssp             EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS------C
T ss_pred             eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC------C
Confidence            877543221   1223468999999999999999999999999999999999999999765544332222110      0


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ..+         ..++..++..+.+||.+||+.||.+|||+.||+++|...
T Consensus       273 ~~~---------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          273 PPI---------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             CGG---------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCc---------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            000         122334578999999999999999999999999998654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5e-58  Score=469.02  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=213.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|++..         +|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+++
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~---------tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~  221 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRS---------SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD  221 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeeEeccCcCcEEEEEEECC---------CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence            569999999999999999999876         78899999998765555567889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+|||||||+||+|.+++...   .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+
T Consensus       222 ~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          222 ELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccce
Confidence            999999999999999998654   5899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .+.....  .....+||+.|||||++.+..|+.++|||||||+||||++|++||...........+   ...        
T Consensus       296 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~~~--------  362 (423)
T 4fie_A          296 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDN--------  362 (423)
T ss_dssp             ECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS--------
T ss_pred             ECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---HcC--------
Confidence            7654322  234579999999999999999999999999999999999999999754322211111   110        


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        ..+.+  ......+.++.+||.+||..||++|||+.|+|+|
T Consensus       363 --~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          363 --LPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             --CCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              11111  1122347889999999999999999999999976

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-57  Score=441.20  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=201.6

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe--
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  209 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--  209 (490)
                      |++.+.||+|+||+||+|.+..         ++..||+|++....  ....+.|.+|+.+|++|+|||||+++++|.+  
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~   98 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   98 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence            4677889999999999999876         67899999986543  3345678999999999999999999999875  


Q ss_pred             --cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEcc
Q 011234          210 --DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSD  286 (490)
Q Consensus       210 --~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~D  286 (490)
                        ++.+|||||||++|+|.++|.+.+  .+++..+..++.||+.||.|||+++ .+||||||||+||||+. ++.+||+|
T Consensus        99 ~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A           99 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             TTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             CCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEe
Confidence              345899999999999999998765  6899999999999999999999876 45999999999999974 78999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+|+.....    .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.......  .+.....   ..
T Consensus       176 FGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i~---~~  245 (290)
T 3fpq_A          176 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVT---SG  245 (290)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHT---TT
T ss_pred             CcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHHH---cC
Confidence            9999864332    2345789999999998864 69999999999999999999999996532211  1111110   00


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                .....++...++++.+||.+||+.||++|||+.|+++|
T Consensus       246 ----------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          246 ----------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      00011122236789999999999999999999999976

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.7e-57  Score=438.36  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=195.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++.+...   .....+.+|+.+|+.|+|||||++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTT---------TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTT---------TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            579999999999999999998865         688999999976532   23456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++.+||||||| +|+|.+++..++  .+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecC
Confidence            999999999999 789999998765  6999999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +|+......   .....+||+.|||||++.+..| +.++|||||||++|||++|+.||......   .+....   ....
T Consensus       158 la~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i---~~~~  228 (275)
T 3hyh_A          158 LSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNI---SNGV  228 (275)
T ss_dssp             CC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTC
T ss_pred             CCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HcCC
Confidence            998764332   2345789999999999988776 57999999999999999999999754221   111111   0000


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                  ..++...+.++.+||.+||+.||++|||+.|++++
T Consensus       229 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 ------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                        01223347889999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.8e-57  Score=447.22  Aligned_cols=252  Identities=29%  Similarity=0.363  Sum_probs=202.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..+.      .+++.||||+++....  .....+.+|+.+|++|+|||||++++++.+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGS------DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSST------TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCC------CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            47999999999999999999875432      2688999999976432  223457889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999999999998765  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+.......  .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+      ....  
T Consensus       173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~--  242 (304)
T 3ubd_A          173 SKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAK--  242 (304)
T ss_dssp             EEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC--
T ss_pred             ceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCC--
Confidence            986543222  234578999999999999999999999999999999999999999764322111111      0000  


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                                ..++...+.++.+||.+||+.||++|||     ++|+++|
T Consensus       243 ----------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          243 ----------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ----------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                      1123344788999999999999999998     4677754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-56  Score=451.33  Aligned_cols=271  Identities=28%  Similarity=0.374  Sum_probs=220.8

Q ss_pred             hHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCC-Cceece
Q 011234          126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLH-PNLVKL  203 (490)
Q Consensus       126 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H-pnIv~l  203 (490)
                      .+++..++|++.+.||+|+||+||+|.+...+.    ..+++.||||.+..... ...++|.+|+.+|.++.| ||||++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~----~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS----TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            344556789999999999999999999865321    12567899999976543 345679999999999965 999999


Q ss_pred             eeEEEec-CceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 011234          204 VGYCIED-DQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRD  268 (490)
Q Consensus       204 ~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrD  268 (490)
                      +|+|.+. +.+|||||||++|+|.++|....              ...+++..++.++.||+.||.|||+.+   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999765 56899999999999999997532              234889999999999999999999988   99999


Q ss_pred             CCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCC
Q 011234          269 FKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDK  347 (490)
Q Consensus       269 lkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~  347 (490)
                      |||+||||++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999997765544444456789999999999999999999999999999999998 9999976


Q ss_pred             CCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ......  +......              ......+..++.++.+||.+||+.||++|||+.||+++|+.+.
T Consensus       291 ~~~~~~--~~~~i~~--------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          291 VKIDEE--FCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             CCCSHH--HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHH--HHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            543221  1111100              0011223345788999999999999999999999999998763

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.9e-55  Score=431.61  Aligned_cols=273  Identities=25%  Similarity=0.311  Sum_probs=201.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|.+.+.||+|+||+||+|++           +|..||||+++..... ...+..|+..+..++|||||++++++.+++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-----------~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~   70 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-----------TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecC
Confidence            4688899999999999999987           4678999999754322 122345666778899999999999998765


Q ss_pred             ----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCceEEcCCCCe
Q 011234          212 ----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       212 ----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~  282 (490)
                          .+|||||||++|+|.++|...   .+++..+..++.|++.||+|||+..     ..+||||||||+||||+.++.+
T Consensus        71 ~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~  147 (303)
T 3hmm_A           71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence                579999999999999999765   5899999999999999999999861     2349999999999999999999


Q ss_pred             EEccccccccCCCCCCc--ceeeccccCCCCCCchhhhcC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          283 KLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      ||+|||+|+........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||.+||.........
T Consensus       148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p  227 (303)
T 3hmm_A          148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence            99999999876443222  122346899999999999764      4678999999999999999999887543221110


Q ss_pred             hhHHhhhcccCCchhh-----hhccCccccCC-CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          355 NLVEWARPHLGDKRRF-----YRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~~-~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      . .... +.......+     ...+++.+... .+..++..+.+||.+||+.||++||||.||++.|+.+...
T Consensus       228 ~-~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          228 Y-YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             T-TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             c-hhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0 0000 000000000     01112222111 1234567899999999999999999999999999887654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.6e-54  Score=423.20  Aligned_cols=249  Identities=25%  Similarity=0.412  Sum_probs=190.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|++++.||+|+||+||+|++..         +|..||||+++.... ...+.+.+|+.+|++|+|||||+++++|.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   75 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEK   75 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETT---------TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence            369999999999999999999876         678999999976543 3446789999999999999999999998765


Q ss_pred             C------------ceEEEEEecCCCCHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          211 D------------QRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       211 ~------------~~~lv~E~~~~g~L~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      +            .+|||||||++|+|.+++...... ..++..++.++.||+.||.|||+++   ||||||||+||||+
T Consensus        76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~  152 (299)
T 4g31_A           76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFT  152 (299)
T ss_dssp             C----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEC
T ss_pred             CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEEC
Confidence            5            368999999999999999765432 3456778899999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCc----------ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCC
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKT----------HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~----------~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~  347 (490)
                      .++.+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||+||||++   ||..
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            9999999999999876543221          11234689999999999999999999999999999999996   6642


Q ss_pred             CCCCCcchhHHhhhcccCCchhhhhccCccccCCCC---hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .     .........          +.    ...++   ...++.+.+||.+||+.||.+|||+.|++++
T Consensus       230 ~-----~~~~~~~~~----------~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          230 Q-----MERVRTLTD----------VR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             H-----HHHHHHHHH----------HH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c-----cHHHHHHHH----------Hh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1     111110000          00    01111   1224567899999999999999999999975

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-53  Score=435.32  Aligned_cols=269  Identities=23%  Similarity=0.326  Sum_probs=207.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++++.||+|+||+||+|++..         +|..||||+++...  ....+.+++|+++|+.|+|||||++++++.
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~  123 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRL---------TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILR  123 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeee
Confidence            3579999999999999999999876         78899999997543  334567889999999999999999999876


Q ss_pred             ec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..      +.+|||||||. |+|.+++...+  .+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+
T Consensus       124 ~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~  197 (398)
T 4b99_A          124 PTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCEL  197 (398)
T ss_dssp             CSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCE
T ss_pred             cccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCE
Confidence            43      57899999995 78999997654  7999999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCC--CcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          283 KLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       283 kL~DFG~a~~~~~~~--~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||+|||+|+.+....  ........+||+.|||||++.+. .|+.++||||||||+|||++|++||.+....+....+..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~  277 (398)
T 4b99_A          198 KIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM  277 (398)
T ss_dssp             EECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred             EEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            999999998764321  12233457999999999998875 579999999999999999999999986543332222211


Q ss_pred             hhcccCC----------chhhhhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 ARPHLGD----------KRRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~----------~~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .......          .......+.+.....   .....+.++.+||.+||..||.+|||+.|+|+|
T Consensus       278 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          278 VLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             HHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1000000          000000111110000   011236789999999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.7e-52  Score=418.57  Aligned_cols=268  Identities=23%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ...++|++.+.||+|+||+||+|+++.+      .+++..||||.+....  ....+.+|+++|..+ +|||||+++++|
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~   89 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF   89 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            3457899999999999999999987632      2267899999987653  235678999999988 699999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CCeEEcc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSD  286 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~kL~D  286 (490)
                      .+.+.+|||||||++|+|.+++.     .+++..+..++.||+.||.|||+++   ||||||||+||||+.+ +.+||+|
T Consensus        90 ~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           90 RKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             EETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             EECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            99999999999999999999883     4889999999999999999999998   9999999999999876 7999999


Q ss_pred             ccccccCCCCCCc--------------------------ceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHH
Q 011234          287 FGLAKDAPEDGKT--------------------------HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEML  339 (490)
Q Consensus       287 FG~a~~~~~~~~~--------------------------~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~ell  339 (490)
                      ||+|+........                          ...+..+||+.|||||++.+. .|+.++||||+|||+|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            9999865432110                          112345899999999999875 5899999999999999999


Q ss_pred             hCCCCCCCCCCCCcchhHHhhhcccC------------------------Cchhhhhc---c---Ccc---------ccC
Q 011234          340 TGRRSMDKNRPNGEHNLVEWARPHLG------------------------DKRRFYRL---L---DPR---------LEG  380 (490)
Q Consensus       340 tG~~pf~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~---~---~~~---------l~~  380 (490)
                      +|+.||.......  .........++                        +...+...   .   .+.         ...
T Consensus       242 ~G~~Pf~~~~~~~--~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  319 (361)
T 4f9c_A          242 SGRYPFYKASDDL--TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL  319 (361)
T ss_dssp             HTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred             HCCCCCCCCCCHH--HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence            9999996433211  10000000000                        00000000   0   000         000


Q ss_pred             CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          381 HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       381 ~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ......+.++.+||.+||..||++|+|++|+|+|
T Consensus       320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            1112346789999999999999999999999976

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-51  Score=439.92  Aligned_cols=252  Identities=27%  Similarity=0.379  Sum_probs=207.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHH---HHHHHHHhcCCCCceecee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEW---LAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~---~~E~~~l~~l~HpnIv~l~  204 (490)
                      .++|+++++||+|+||+||+|++..         +|..||||++.+....   ....+   ..++.+++.++|||||+++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~---------tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~  258 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS  258 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECC---------CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEE
Confidence            4689999999999999999999876         7889999999754221   11222   3456778888999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ++|.+.+.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||
T Consensus       259 ~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL  333 (689)
T 3v5w_A          259 YAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRI  333 (689)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEE
T ss_pred             EEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEe
Confidence            99999999999999999999999998765  6899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      +|||+|+......    ....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||..........+....   
T Consensus       334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---  406 (689)
T 3v5w_A          334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---  406 (689)
T ss_dssp             CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---
T ss_pred             cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---
Confidence            9999998765432    234689999999999974 57999999999999999999999999754433222211111   


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHh
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVETL  415 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~L  415 (490)
                      ...            ...++...+.++.+||.+||..||.+|++     +.||++|-
T Consensus       407 ~~~------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp  451 (689)
T 3v5w_A          407 LTM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESP  451 (689)
T ss_dssp             HHC------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred             cCC------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence            000            11233344789999999999999999998     78988763

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.5e-52  Score=442.41  Aligned_cols=254  Identities=23%  Similarity=0.310  Sum_probs=214.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|+++.         +|..||+|++........+.+.+|+.+|+.|+|||||+++++|.++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~---------tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~  226 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD  226 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3689999999999999999999876         7889999999877766677889999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC--CCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kL~DFG  288 (490)
                      +.+|||||||+||+|.++|.... ..+++..+..++.||+.||.|||+++   |+||||||+||||+.+  +.+||+|||
T Consensus       227 ~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG  302 (573)
T 3uto_A          227 NEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFG  302 (573)
T ss_dssp             SEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred             CEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeecc
Confidence            99999999999999999986543 36899999999999999999999988   9999999999999854  899999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.+....   .....+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.........+...      . 
T Consensus       303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~------~-  372 (573)
T 3uto_A          303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------D-  372 (573)
T ss_dssp             SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------C-
T ss_pred             ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC------C-
Confidence            999875432   234568999999999999999999999999999999999999999764332111111100      0 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ..+........+.++.+||.+||+.||.+|||+.|+|+|
T Consensus       373 -------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          373 -------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   001111112337889999999999999999999999997

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.1e-50  Score=397.79  Aligned_cols=285  Identities=39%  Similarity=0.692  Sum_probs=239.7

Q ss_pred             chhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceec
Q 011234          123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       123 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .+.++...+++|++.+.||+|+||.||+|.+.          +|..||||++........+.+.+|+.+|+.++||||++
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   99 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVS   99 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT----------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEEC----------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEee
Confidence            34455567789999999999999999999864          46789999988776666778999999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +++++.+.+..++||||+++|+|.+++....  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~  176 (321)
T 2qkw_B          100 LIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENF  176 (321)
T ss_dssp             EEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTC
T ss_pred             EEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCC
Confidence            9999999999999999999999999986543  235899999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|.
T Consensus       177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~  256 (321)
T 2qkw_B          177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA  256 (321)
T ss_dssp             CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred             CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence            99999999998654433333334567999999999999999999999999999999999999999877666665555554


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      ..... ...+...+++.+....+...+..+.+|+.+||+.||++|||+.+|+++|+.+...
T Consensus       257 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          257 VESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             HHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            32221 2223345556666667778899999999999999999999999999999877554

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.6e-48  Score=387.47  Aligned_cols=290  Identities=40%  Similarity=0.731  Sum_probs=235.4

Q ss_pred             hhhhhhchhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcC
Q 011234          117 SQLRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNL  195 (490)
Q Consensus       117 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l  195 (490)
                      ..+..+.+.++....++|++.+.||+|+||.||+|.+.          +|..||||++...... ....+.+|+.++..+
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l   84 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----------DGTLVAVKRLKEERTQGGELQFQTEVEMISMA   84 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----------SSCCEEEEECCC-----CCCHHHHHHHGGGTC
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----------CCCEEEEEEeccccCchHHHHHHHHHHHHHhc
Confidence            34566788899999999999999999999999999643          4678999998765322 223688999999999


Q ss_pred             CCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGS--LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       196 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      +||||+++++++...+..++||||+++|+|.+++.....  ..+++..+..++.||+.||.|||+....+|+||||||+|
T Consensus        85 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~N  164 (326)
T 3uim_A           85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAAN  164 (326)
T ss_dssp             CCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGG
T ss_pred             cCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhh
Confidence            999999999999999999999999999999999976532  348999999999999999999999811129999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCC--CC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR--PN  351 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~--~~  351 (490)
                      ||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....  ..
T Consensus       165 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  243 (326)
T 3uim_A          165 ILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND  243 (326)
T ss_dssp             EEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTT
T ss_pred             EEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccc
Confidence            9999999999999999987654322 23344679999999999999999999999999999999999999996221  11


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .......|...... ........+..+...++...+..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus       244 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          244 DDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            22223333333222 2233455566666777888899999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8e-48  Score=379.58  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=211.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG   89 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhceeeeeeeccCCCeEEEEEEECC---------CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC
Confidence            4589999999999999999998765         6779999999766555567789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           90 DELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            9999999999999999999765   5889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  .....+||+.|+|||++.+..++.++|||||||++|||++|..||...........+.  ...       
T Consensus       164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~-------  232 (297)
T 3fxz_A          164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TNG-------  232 (297)
T ss_dssp             EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HHC-------
T ss_pred             eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCC-------
Confidence            87654322  2234679999999999999999999999999999999999999996543221111110  000       


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                          .  .....+...+..+.+||.+||+.||.+|||+.|++++-
T Consensus       233 ----~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          233 ----T--PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             ----S--CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             ----C--CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence                0  00112233478899999999999999999999999763

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-48  Score=382.42  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=215.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.+|..++||||+++++++.++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   79 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRE---------TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD   79 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             hhHeeccceecCCCCEEEEEEEECC---------CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence            3579999999999999999999875         6779999998776666778899999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           80 KRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             CeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccc
Confidence            99999999999999999997753 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcc------------eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          291 KDAPEDGKTH------------VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       291 ~~~~~~~~~~------------~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +.........            .....+||+.|+|||++.+..++.++|||||||++|||++|..||.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            8764432211            0114679999999999999999999999999999999999999986543322111000


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 .....+.    ..+..++..+.+||.+||+.||++|||+.+|++.|+.++.
T Consensus       236 -----------~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          236 -----------VRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             -----------HHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------hhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                       0000000    1122336678999999999999999999999999988754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=5.1e-48  Score=386.54  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=209.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   84 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHIL---------TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE   84 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4579999999999999999999865         67899999987542  334567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG  159 (328)
T 3fe3_A           85 TEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFG  159 (328)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTT
T ss_pred             ECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999999999999997765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........   ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...........+.      .. 
T Consensus       160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~-  229 (328)
T 3fe3_A          160 FSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL------RG-  229 (328)
T ss_dssp             CCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-
T ss_pred             CceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC-
Confidence            9986644322   2456899999999999988775 79999999999999999999997643211111110      00 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                 ...++...+.++.+||.+||..||.+|||+.|++++-
T Consensus       230 -----------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          230 -----------KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence                       0012223478899999999999999999999999763

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-47  Score=390.25  Aligned_cols=269  Identities=24%  Similarity=0.374  Sum_probs=218.2

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+...+.  ....++..||||+++.... ...+.+.+|+.+|..+ +||||+++++++
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCST--TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccC--cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            34679999999999999999998753211  1123677899999976533 3456789999999999 899999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+.+.+|+||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  233 (370)
T 2psq_A          157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  233 (370)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred             ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence            999999999999999999999976532              24789999999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~  352 (490)
                      |||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999999999999999987654333223334567889999999999999999999999999999999 999997643221


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .   ......              ......+..++..+.+||.+||+.||.+||++.||++.|+.+..
T Consensus       314 ~---~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          314 L---FKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             H---HHHHHT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H---HHHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1   111100              01112233457889999999999999999999999999987644

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8e-48  Score=383.91  Aligned_cols=274  Identities=26%  Similarity=0.347  Sum_probs=211.8

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +..++|++.+.||+|+||.||+|++.           +..||||++..... .......|+.+|..++||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL-----------NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET-----------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC-----------CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            34467999999999999999999863           56899999975532 2344567999999999999999999998


Q ss_pred             ecCc----eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCCeeecCCCCCce
Q 011234          209 EDDQ----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE----------AEKPVIYRDFKTSNI  274 (490)
Q Consensus       209 ~~~~----~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~~~~iiHrDlkp~NI  274 (490)
                      ....    +++||||+++|+|.+++...   .+++..++.++.||+.||.|||+.          +   |+||||||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Ni  162 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNV  162 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGE
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhE
Confidence            8553    69999999999999999764   489999999999999999999997          7   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-----CCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----HLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~~~~sDvwSlGvil~elltG~~pf~~~~  349 (490)
                      |++.++.+||+|||+++..............+||+.|+|||++.+.     .++.++|||||||++|||++|+.||....
T Consensus       163 ll~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~  242 (322)
T 3soc_A          163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV  242 (322)
T ss_dssp             EECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCC
T ss_pred             EECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999876544333333446799999999999863     55678899999999999999999997654


Q ss_pred             CCCcchhHHhhhcccCCchhhh-----hccCccccCCC-ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          350 PNGEHNLVEWARPHLGDKRRFY-----RLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      .............. .....+.     ....+.+...+ ...++..+.+||.+||+.||++|||+.+|++.|+.++..
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          243 DEYMLPFEEEIGQH-PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCCCTTHHHHCSS-CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhccchhhhhccC-CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            43322222111000 0000000     01111111111 123467799999999999999999999999999987654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.1e-47  Score=383.35  Aligned_cols=251  Identities=31%  Similarity=0.396  Sum_probs=209.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||+|++....   ......+.+|+.+|..++||||+++++++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~   74 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence            3579999999999999999999875         67899999997542   22345678999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+|.+||+||
T Consensus        75 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           75 QTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeec
Confidence            99999999999999999999997764  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .+....   ... 
T Consensus       150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i---~~~-  220 (337)
T 1o6l_A          150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI---LME-  220 (337)
T ss_dssp             TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHC-
T ss_pred             cchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHH---HcC-
Confidence            99986433222  234578999999999999999999999999999999999999999653221   111110   000 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                                 ...++...+.++.+||.+||..||.+||     ++.+|++|-
T Consensus       221 -----------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          221 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence                       0112334478899999999999999999     899999874

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=380.13  Aligned_cols=263  Identities=26%  Similarity=0.431  Sum_probs=213.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+...+.      .+..||||++.... ....+.+.+|+.+|..++||||+++++++.+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  121 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ------RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR  121 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS------CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC------CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            4579999999999999999999875332      45579999998653 3445678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          122 GRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             GGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             CCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence            999999999999999999996553 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.......   .......     
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~~-----  269 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVEE-----  269 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT-----
T ss_pred             ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHc-----
Confidence            9876543222 12233456788999999999999999999999999999999 999996543221   1111100     


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               ......+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       270 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          270 ---------GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     01112233447889999999999999999999999999988754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-47  Score=377.77  Aligned_cols=263  Identities=29%  Similarity=0.473  Sum_probs=205.8

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      .+..++|++.+.||+|+||.||+|.+           +|..||||++.....  ...+.+.+|+.+|++++||||+++++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~  101 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-----------HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG  101 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-----------CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            34456899999999999999999976           356899999876542  33467889999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      ++.+.+..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             EECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEE
T ss_pred             EEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEE
Confidence            99999999999999999999999976431 13889999999999999999999865 34999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...    
T Consensus       181 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~----  254 (309)
T 3p86_A          181 CDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----  254 (309)
T ss_dssp             CCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS----
T ss_pred             CCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----
Confidence            9999997654321  1223467999999999999999999999999999999999999999754322111111000    


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                  .....++...+..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       255 ------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          255 ------------CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             ------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ------------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                        00112233447889999999999999999999999999987754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-46  Score=381.80  Aligned_cols=254  Identities=25%  Similarity=0.345  Sum_probs=209.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcCCCCceecee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||+|++......      ..+.+.+|+.+|..++||||++++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~---------~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~   81 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH   81 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECC---------CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEE
Confidence            4579999999999999999999875         6789999999765332      346788999999999999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC----
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----  280 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----  280 (490)
                      +++.+.+..++||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    
T Consensus        82 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred             EEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCcc
Confidence            99999999999999999999999997654  6899999999999999999999988   99999999999998777    


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.  
T Consensus       157 ~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~--  231 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--  231 (361)
T ss_dssp             CEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--
T ss_pred             CEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence            799999999987654321   234679999999999999999999999999999999999999997543211111110  


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                          .....+    ++    .+....+..+.+||.+||..||.+|||+.|++++-
T Consensus       232 ----~~~~~~----~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          232 ----AVSYDF----DE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             ----TTCCCC----CH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             ----hcCCCC----Cc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence                000000    00    00112367899999999999999999999999874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=387.02  Aligned_cols=252  Identities=29%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCceecee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLV  204 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~  204 (490)
                      +..++|++.+.||+|+||.||+|++..         +|..||||++....   ......+.+|+.+|..+ +||||++++
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~   90 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKE---------TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF   90 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcC---------CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence            345689999999999999999999875         67899999997542   22345678899999988 699999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +++.+.+.+|||||||++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||
T Consensus        91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL  165 (353)
T 3txo_A           91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKL  165 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999997765  6899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+      .
T Consensus       166 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~  237 (353)
T 3txo_A          166 ADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------L  237 (353)
T ss_dssp             CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------H
T ss_pred             ccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------H
Confidence            9999998643322  2234568999999999999999999999999999999999999999754322111111      0


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~------~evl~~  414 (490)
                      ..            ...++...+..+.+||.+||..||.+||++      .+|++|
T Consensus       238 ~~------------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          238 ND------------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HC------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             cC------------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            00            011233347889999999999999999998      788875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.9e-47  Score=384.82  Aligned_cols=273  Identities=28%  Similarity=0.378  Sum_probs=219.1

Q ss_pred             hhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceec
Q 011234          125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVK  202 (490)
Q Consensus       125 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~  202 (490)
                      ..+....++|++.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.+|..+ +||||++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccccceeeceeecCCCCceEEEEEecccc----ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            344556778999999999999999999875421    123678999999976533 3446789999999999 7999999


Q ss_pred             eeeEEEecCc-eEEEEEecCCCCHHHHHhhcCC-----------------------------------------------
Q 011234          203 LVGYCIEDDQ-RLLVYEFMPRGSLENHLFRKGS-----------------------------------------------  234 (490)
Q Consensus       203 l~~~~~~~~~-~~lv~E~~~~g~L~~~l~~~~~-----------------------------------------------  234 (490)
                      +++++.+.+. .++|||||++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            9999988654 8999999999999999976532                                               


Q ss_pred             -----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCC
Q 011234          235 -----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG  297 (490)
Q Consensus       235 -----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~  297 (490)
                                       ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                             12889999999999999999999988   9999999999999999999999999998765544


Q ss_pred             CcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCc
Q 011234          298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDP  376 (490)
Q Consensus       298 ~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (490)
                      .........||+.|+|||++.+..++.++|||||||++|||++ |..||.........  ......              
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~--------------  311 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKE--------------  311 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHH--------------
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHc--------------
Confidence            4444455678999999999999999999999999999999998 99999765432211  111100              


Q ss_pred             cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          377 RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       377 ~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ......+...+.++.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            00111222346789999999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.3e-46  Score=366.58  Aligned_cols=264  Identities=24%  Similarity=0.364  Sum_probs=210.1

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||+|++....   ....+.+.+|+.++..++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTI---------LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETT---------TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECC---------CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            34689999999999999999998865         67799999985432   3345678899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999997765  6899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........ ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||........  .........  
T Consensus       155 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~~~~--  229 (294)
T 4eqm_A          155 FGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSV--  229 (294)
T ss_dssp             CSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHSSCC--
T ss_pred             CCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhhccC--
Confidence            999987643322 222346799999999999999999999999999999999999999975432111  001000000  


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhccccC
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQNL  421 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-s~~evl~~L~~l~~~  421 (490)
                               +..........+..+.++|.+||..||.+|| ++.++++.|..+...
T Consensus       230 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          230 ---------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ---------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ---------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                     0001112223368899999999999999998 899999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-47  Score=378.12  Aligned_cols=257  Identities=25%  Similarity=0.328  Sum_probs=207.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   76 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE   76 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhceeeeEEecCCCEEEEEEEECC---------CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3579999999999999999998875         677999999875533 223567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++|||||++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           77 GNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             SSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeec
Confidence            999999999999999999986553  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +...............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+....     
T Consensus       152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~-----  225 (323)
T 3tki_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK-----  225 (323)
T ss_dssp             CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTC-----
T ss_pred             cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhccc-----
Confidence            986643333333345789999999999987765 7799999999999999999999975433221 111111100     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                               .........+..+.+||.+||..||.+|||+.|++++-.
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          226 ---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             ---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             ---------ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence                     000011233678899999999999999999999987643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=383.38  Aligned_cols=273  Identities=26%  Similarity=0.376  Sum_probs=220.6

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      +..++|.+.+.||+|+||.||+|.+...+.  .....+..||||++.... ......+.+|+.++..+ +||||++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDK--DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSST--TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccc--cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            344679999999999999999999754221  112356789999997653 33456788999999999 89999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      +...+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~  220 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR  220 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcc
Confidence            9999999999999999999999987542              35899999999999999999999988   999999999


Q ss_pred             ceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCC
Q 011234          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       273 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~  351 (490)
                      ||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~  300 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  300 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654433333344567889999999999999999999999999999999 99999654321


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCcc
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~~  423 (490)
                         ........              ......+..++.++.+||.+||+.||++|||+.+|+++|+.+.....
T Consensus       301 ---~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          301 ---ELFKLLKE--------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             ---HHHHHHHT--------------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             ---HHHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence               11111110              01111223347889999999999999999999999999998765443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.5e-47  Score=388.80  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=212.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +..++|.+.+.||+|+||.||+|.+..         ++..||||++..... .....+.+|+.+|+.++||||+++++++
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRA---------DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEec---------CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            445679999999999999999999875         567899999875532 2335688999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+..++||||+++|+|.+++...+ ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       182 ~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~Df  257 (377)
T 3cbl_A          182 TQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDF  257 (377)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCG
T ss_pred             ecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcC
Confidence            99999999999999999999997653 25889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ..+....    
T Consensus       258 G~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~~~~----  330 (377)
T 3cbl_A          258 GMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREFVEK----  330 (377)
T ss_dssp             GGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHHHHT----
T ss_pred             CCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence            99986543211111112235778999999999999999999999999999998 999997543211   1111100    


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                ......+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       331 ----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          331 ----------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                      00111233347889999999999999999999999999987754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-46  Score=372.21  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=209.1

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCce
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~  213 (490)
                      |...+.||+|+||.||+|++..         +|..||||++........+.+.+|+.+++.++||||+++++++...+..
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKH---------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEEL  117 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             hhccEEeccCCCeEEEEEEECC---------CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence            6777899999999999999865         6779999999876656667889999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          214 LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       214 ~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      ++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       118 ~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  191 (321)
T 2c30_A          118 WVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI  191 (321)
T ss_dssp             EEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence            9999999999999988643   5899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ........          .
T Consensus       192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~~~~~~~----------~  256 (321)
T 2c30_A          192 SKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKRLRD----------S  256 (321)
T ss_dssp             CSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHH----------S
T ss_pred             ccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhc----------C
Confidence            54322  123467999999999999999999999999999999999999999654321   11111110          0


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..+.+  ......+..+.+||.+||+.||++|||+.+++++..
T Consensus       257 ~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          257 PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            01111  111233678999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-45  Score=364.20  Aligned_cols=283  Identities=37%  Similarity=0.622  Sum_probs=225.8

Q ss_pred             hhhhchhhHHHhhcCCCcC------ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC----hhhHHHHHHH
Q 011234          119 LRKFMFNDLKLATRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG----LQGHKEWLAE  188 (490)
Q Consensus       119 ~~~~~~~~~~~~~~~y~~~------~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~----~~~~~~~~~E  188 (490)
                      ...|.+.++..++++|...      +.||+|+||.||+|.+           ++..||||++....    ....+.+.+|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~E   80 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----------NNTTVAVKKLAAMVDITTEELKQQFDQE   80 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-----------SSCEEEEEEECCCTTSCTTTHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-----------CCceEEEEEEecccCcchHHHHHHHHHH
Confidence            3456777777888777766      8999999999999975           35589999986532    2335678899


Q ss_pred             HHHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 011234          189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  267 (490)
Q Consensus       189 ~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  267 (490)
                      +.+++.++||||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||
T Consensus        81 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~  157 (307)
T 2nru_A           81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHR  157 (307)
T ss_dssp             HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred             HHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecC
Confidence            999999999999999999999999999999999999999986432 346899999999999999999999988   9999


Q ss_pred             CCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCC
Q 011234          268 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       268 Dlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~  347 (490)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus       158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence            9999999999999999999999987654433333445679999999998764 588999999999999999999999976


Q ss_pred             CCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      .........+  ..........+...++..+ ...+...+..+.+||.+||+.||.+|||+.+|+++|+.+.
T Consensus       237 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          237 HREPQLLLDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             TBSSSBTTHH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             CcchHHHHHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            5443222111  1111111112223333333 2345667889999999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=386.53  Aligned_cols=267  Identities=27%  Similarity=0.391  Sum_probs=213.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+....    ...++..||||++... .......+.+|+.+|..++||||+++++++.+
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC----CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            457999999999999999999975321    1226789999999754 33445678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC---C
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---N  281 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~  281 (490)
                      ....++|||||++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence            9999999999999999999976532     35889999999999999999999988   99999999999998555   5


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.......   .....
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i  299 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV  299 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence            99999999975432222222334578999999999999999999999999999999998 999997543221   11111


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      ...              .....+..++..+.+||.+||+.||.+|||+.+|+++|+.+...
T Consensus       300 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          300 TSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             HTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcC--------------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            100              01112233467899999999999999999999999999877553

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=374.69  Aligned_cols=254  Identities=17%  Similarity=0.216  Sum_probs=209.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++.... .....+.+|+.+|+.++||||+++++++.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~   73 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             hhceEeeeEEecCCCeEEEEEEECC---------CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence            4579999999999999999999875         67899999987554 3445678999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC--CCCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kL~DFG  288 (490)
                      +..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            99999999999999999986543 36899999999999999999999988   999999999999987  7899999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.  ....... 
T Consensus       150 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~~-  223 (321)
T 1tki_A          150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--NAEYTFD-  223 (321)
T ss_dssp             TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCCCCC-
T ss_pred             CCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH--cCCCCCC-
Confidence            998775432   2234679999999999998889999999999999999999999997543221111110  0000000 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                             .    ......+.++.+||.+||..||.+|||+.|++++-
T Consensus       224 -------~----~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          224 -------E----EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             -------H----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             -------h----hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence                   0    00012367899999999999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-46  Score=384.27  Aligned_cols=258  Identities=24%  Similarity=0.378  Sum_probs=207.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      .++|++.++||+|+||.||+|++..         ++..||+|++++....   ....+..|..+|.++ +|||||+++++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            4579999999999999999999875         6789999999765322   223577899999887 79999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+.+|||||||++|+|..++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEee
Confidence            999999999999999999999998765  6899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch--hHHhhhccc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN--LVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~  364 (490)
                      ||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..........  ......   
T Consensus       197 FGla~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~---  271 (396)
T 4dc2_A          197 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---  271 (396)
T ss_dssp             CTTCBCCCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH---
T ss_pred             cceeeecccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH---
Confidence            999986433222  2345789999999999999999999999999999999999999996432221100  000000   


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH------HHHHHHh
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVETL  415 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~------~evl~~L  415 (490)
                            ..+...  ...++...+.++.+||.+||+.||.+||++      .||+++-
T Consensus       272 ------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp  320 (396)
T 4dc2_A          272 ------QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP  320 (396)
T ss_dssp             ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred             ------HHHhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence                  000000  112333447889999999999999999985      6777763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.6e-47  Score=373.48  Aligned_cols=268  Identities=28%  Similarity=0.405  Sum_probs=218.3

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ....++|.+.+.||+|+||.||+|.+....    ...++..||||++.... ....+.+.+|+.+|+.++||||++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLK----GRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEETGG----GCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccchhheeeeeeecccCCeeEEEEEEeccC----cccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            344568999999999999999999885321    01256789999997653 3445678899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGS----------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      +.+.+..++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||+.+   |
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i  171 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---L  171 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence            9999999999999999999999976542                      23889999999999999999999988   9


Q ss_pred             eecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCC
Q 011234          265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR  343 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~  343 (490)
                      +||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987654433333334567889999999999999999999999999999999 999


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ||...........+..                 ......+...+..+.+||.+||+.||.+||++.+|+++|+.+.
T Consensus       252 p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKT-----------------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             SSTTCCGGGHHHHHHT-----------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHhhc-----------------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            9976543221111110                 0011122344788999999999999999999999999998764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=373.82  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=208.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||+|++.....   ...+.+.+|+.+|..++||||+++++++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            3579999999999999999999875         678999999975422   2345678899999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+.+|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+|.+||+||
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeec
Confidence            99999999999999999999997754  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...   ...   
T Consensus       151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i~---  216 (318)
T 1fot_A          151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KIL---  216 (318)
T ss_dssp             SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHH---
T ss_pred             CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHH---
Confidence            999875432     234689999999999999999999999999999999999999996542211   111   000   


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                             ...  ..++...+.++.+||.+||..||.+||     ++.+|++|-
T Consensus       217 -------~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp  260 (318)
T 1fot_A          217 -------NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP  260 (318)
T ss_dssp             -------HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             -------hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence                   000  012233478899999999999999999     899998763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.3e-47  Score=382.27  Aligned_cols=253  Identities=28%  Similarity=0.421  Sum_probs=207.4

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceece
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKL  203 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l  203 (490)
                      .+..++|.+.+.||+|+||.||+|++..         +|..||||+++....   .....+..|..+|..+ +||||+++
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l   83 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM   83 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence            3456789999999999999999999875         678999999975421   2345677899999876 89999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ++++.+.+..|+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+|.+|
T Consensus        84 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vk  158 (345)
T 1xjd_A           84 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIK  158 (345)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEE
T ss_pred             EEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEE
Confidence            999999999999999999999999997754  6899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....... 
T Consensus       159 L~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~~-  232 (345)
T 1xjd_A          159 IADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIRM-  232 (345)
T ss_dssp             ECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH-
T ss_pred             EeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHh-
Confidence            999999986533221  2345789999999999999999999999999999999999999997543211   1111100 


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~-evl~~  414 (490)
                        .        .    ..++...+.++.+||.+||..||.+||++. +|+++
T Consensus       233 --~--------~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          233 --D--------N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             --C--------C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --C--------C----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence              0        0    112233478899999999999999999997 66654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=375.36  Aligned_cols=253  Identities=24%  Similarity=0.334  Sum_probs=208.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcCCCCceeceee
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      ++|.+.+.||+|+||.||+|.+..         +|..||+|++......      ..+.+.+|+.+|..++||||+++++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   81 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE   81 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECC---------CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            469999999999999999999875         6789999998754322      3567889999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC----C
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  281 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~  281 (490)
                      ++.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCC
T ss_pred             EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCC
Confidence            9999999999999999999999997654  6899999999999999999999988   99999999999998887    7


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... 
T Consensus       157 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~-  232 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-  232 (326)
T ss_dssp             EEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHT-
T ss_pred             EEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhc-
Confidence            99999999987643321   23467999999999999899999999999999999999999999654321111111000 


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       ...            ....+....+..+.+||.+||..||.+|||+.+++++-
T Consensus       233 -~~~------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          233 -NYE------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             -CCC------------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             -CCC------------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence             000            00000112367899999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-46  Score=375.90  Aligned_cols=263  Identities=24%  Similarity=0.392  Sum_probs=207.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|++...+..     ....||+|.+.... ....+.+.+|+.+++.++||||+++++++.+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC---------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCce-----EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            35799999999999999999998653221     23357889886443 2445678999999999999999999999987


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      . ..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~-~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           89 S-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             S-SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             C-CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcc
Confidence            5 4789999999999999997754 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..         
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---------  234 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---------  234 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---------
T ss_pred             eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc---------
Confidence            987654433333344567889999999999999999999999999999999 9999976533222111110         


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              ......+..++..+.+|+.+||+.||.+||++.+|+++|+.+..
T Consensus       235 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 --------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    01111223347789999999999999999999999999987644

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-46  Score=381.78  Aligned_cols=263  Identities=25%  Similarity=0.440  Sum_probs=202.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|.+.+.||+|+||.||+|++....      .++..||||+++... ....+.+.+|+.+|.+++||||+++++++.+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  117 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPS------KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK  117 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTT------SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCC------CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            457999999999999999999876322      256789999997653 3345678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       118 ~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  193 (373)
T 2qol_A          118 SKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGL  193 (373)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             CCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcc
Confidence            999999999999999999997653 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.......   ......      
T Consensus       194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i~------  264 (373)
T 2qol_A          194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAVD------  264 (373)
T ss_dssp             --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHHH------
T ss_pred             ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH------
Confidence            98765432211 1122345788999999999999999999999999999998 999996543211   111110      


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              .......+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       265 --------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          265 --------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             --------TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence                    001111223447889999999999999999999999999987644

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=381.85  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=209.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++....   ......+.+|+.+|..++|||||++++++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKND---------TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4579999999999999999999875         67899999986542   12346788999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEecc
Confidence            99999999999999999999997654  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |++.......   .....+||+.|+|||++.+   ..|+.++|||||||++|||++|..||.................. 
T Consensus       160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-  235 (384)
T 4fr4_A          160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-  235 (384)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-
T ss_pred             ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-
Confidence            9998765432   2245689999999999874   45899999999999999999999999765443322222211110 


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evl~~  414 (490)
                                    ...++...+..+.+||.+||..||.+||+ +.+|+++
T Consensus       236 --------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          236 --------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             --------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                          11223344788999999999999999998 7777764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=377.41  Aligned_cols=269  Identities=25%  Similarity=0.381  Sum_probs=216.5

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ....++|++.+.||+|+||.||+|.+.....    ..++..||||++..... ...+.+.+|+.++..++||||++++++
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLP----YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSST----TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCC----CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3456789999999999999999999864210    12567999999986533 335678899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKG----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      +.+.+..++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||+.+   |
T Consensus       119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---i  195 (343)
T 1luf_A          119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  195 (343)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            999999999999999999999997642                      146899999999999999999999988   9


Q ss_pred             eecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCC
Q 011234          265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRR  343 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~  343 (490)
                      +||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  275 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  275 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999976543322222334578999999999999999999999999999999999 999


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ||......   ........             .. ....+..++..+.+||.+||+.||.+||++.+|+++|+.+..
T Consensus       276 p~~~~~~~---~~~~~~~~-------------~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          276 PYYGMAHE---EVIYYVRD-------------GN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             TTTTSCHH---HHHHHHHT-------------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCCCChH---HHHHHHhC-------------CC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            99654221   11111100             00 011223447789999999999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-46  Score=369.19  Aligned_cols=278  Identities=25%  Similarity=0.377  Sum_probs=212.4

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|++...     ...++..||||++........+.+.+|+.+|..++||||+++++++..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   82 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYS   82 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTT-----CSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecc-----cCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            346799999999999999999986431     223788999999987776667789999999999999999999999865


Q ss_pred             c--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          210 D--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       210 ~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .  ...++||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           83 AGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             HHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred             CCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccC
Confidence            4  458999999999999999976542 5899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++......... .......|+..|+|||++.+..++.++|||||||++|||++|..||.....    ............
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~  234 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQG  234 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH----HHHHHHCTTCCT
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH----HHHhhhcCcccc
Confidence            999876543221 122334577889999999999999999999999999999999998853210    000000000000


Q ss_pred             c---hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 K---RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~---~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .   ......+........+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            0   00001111111122334557899999999999999999999999999987743

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.7e-46  Score=363.72  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=212.8

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+.          ++..||+|++..... ..+++.+|+.++..++||||+++++++.+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   74 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK----------GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK   74 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheeeeeeeccCCCceEEEEEec----------CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            4567999999999999999999775          355799999976543 34678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++...+ ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             CCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCcc
Confidence            999999999999999999997653 25899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+..   .     
T Consensus       151 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~---~-----  221 (268)
T 3sxs_A          151 TRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ---G-----  221 (268)
T ss_dssp             EEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---T-----
T ss_pred             ceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc---C-----
Confidence            987654322 22233456778999999999999999999999999999999 9999965432211111000   0     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                               .....+...+..+.+||.+||+.||.+|||+.+++++|+.+...
T Consensus       222 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          222 ---------HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---------CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                     00011222367899999999999999999999999999988664

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-46  Score=380.02  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=207.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++.....  ...+.+.+|+.+|+.|+||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECC---------CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4579999999999999999998865         678999999976532  34467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC---CCeEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~  285 (490)
                      +.+..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEe
Confidence            9999999999999999999987654  6899999999999999999999988   9999999999999765   459999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........   ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||......   .+.......  
T Consensus       174 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~--  245 (362)
T 2bdw_A          174 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAG--  245 (362)
T ss_dssp             CCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHT--
T ss_pred             ecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhC--
Confidence            9999987654321   23468999999999999989999999999999999999999999654321   111111000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ...        .........+.++.+||.+||..||.+||++.+++++
T Consensus       246 -~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          246 -AYD--------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CCC--------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CCC--------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000        0000112336789999999999999999999999987

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.3e-46  Score=363.14  Aligned_cols=258  Identities=28%  Similarity=0.441  Sum_probs=211.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+.          ++..||+|++..... ..+++.+|+.++++++||||+++++++.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   76 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE   76 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ChhhceeeheecCCCccEEEEEEec----------CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3457999999999999999999875          355799999986543 34678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~  152 (269)
T 4hcu_A           77 QAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGM  152 (269)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTG
T ss_pred             CCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccc
Confidence            999999999999999999996653 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +....... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   ........     
T Consensus       153 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~~-----  223 (269)
T 4hcu_A          153 TRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG-----  223 (269)
T ss_dssp             GGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT-----
T ss_pred             cccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhcC-----
Confidence            98664321 112233456788999999999999999999999999999999 999996543211   11111000     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               .....+...+..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 ---------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence                     0111122336789999999999999999999999999987754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=387.25  Aligned_cols=255  Identities=21%  Similarity=0.286  Sum_probs=208.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++.....  ...+.+.+|+.+|+.++||||+++++++.
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~---------~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVL---------AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETT---------TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            4579999999999999999998875         678999999976543  23456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc---CCCCeEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~  285 (490)
                      +++..|+|||||.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEc
Confidence            9999999999999999999998765  6899999999999999999999988   99999999999998   46789999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........  .....+||+.|+|||++.+..|+.++|||||||++|+|++|.+||...........+......  
T Consensus       156 DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--  231 (444)
T 3soa_A          156 DFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD--  231 (444)
T ss_dssp             CCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--
T ss_pred             cCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC--
Confidence            9999987654322  223468999999999999989999999999999999999999999654321111111100000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                  +........+.++.+||.+||+.||.+|||+.|++++-
T Consensus       232 ------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          232 ------------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             ------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             ------------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence                        00011123378899999999999999999999999873

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.6e-46  Score=375.85  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=205.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-----hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....     ...+.+.+|+.+|+.++||||++++++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   94 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRE---------TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET   94 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            469999999999999999998875         678999999864321     135678899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC---
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---  281 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---  281 (490)
                      +.+++..|+|||||++++|.+++...  ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   
T Consensus        95 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~  171 (351)
T 3c0i_A           95 YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAP  171 (351)
T ss_dssp             EEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCC
T ss_pred             EEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCc
Confidence            99999999999999999999888653  2335899999999999999999999988   999999999999987654   


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-  360 (490)
                      +||+|||++........  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....    ....... 
T Consensus       172 vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~  245 (351)
T 3c0i_A          172 VKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGII  245 (351)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHH
T ss_pred             EEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHH
Confidence            99999999987654322  2234679999999999999999999999999999999999999997531    1111110 


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .....        ..+..    ....+..+.+||.+||..||.+|||+.+++++
T Consensus       246 ~~~~~--------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          246 KGKYK--------MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HTCCC--------CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCCC--------CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00000        00000    01226789999999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-46  Score=369.02  Aligned_cols=267  Identities=24%  Similarity=0.325  Sum_probs=204.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+.          +|..||+|++.....  .....+.+|+.+|+.++||||+++++++.
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   89 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS----------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH   89 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET----------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC----------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc
Confidence            457999999999999999999874          467899999875432  22456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  164 (311)
T 3niz_A           90 SERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG  164 (311)
T ss_dssp             CSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCc
Confidence            9999999999996 58888886653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc--c-
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH--L-  364 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~--~-  364 (490)
                      +++.......  .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......  . 
T Consensus       165 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  242 (311)
T 3niz_A          165 LARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR  242 (311)
T ss_dssp             TCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred             CceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence            9987643221  2234578999999999876 56899999999999999999999999866544332222110000  0 


Q ss_pred             -----CCchhh----hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 -----GDKRRF----YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 -----~~~~~~----~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           .....+    +..+............+.++.+||.+||+.||.+|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          243 EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 000000    00000000000111236789999999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=367.43  Aligned_cols=273  Identities=23%  Similarity=0.284  Sum_probs=213.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++..... ...+.+.+|+.+|+.++||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            3579999999999999999999875         677999999975432 335677899999999999999999999987


Q ss_pred             cC--ceEEEEEecCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE----cCCCCe
Q 011234          210 DD--QRLLVYEFMPRGSLENHLFRKGS-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNA  282 (490)
Q Consensus       210 ~~--~~~lv~E~~~~g~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~  282 (490)
                      .+  ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEE
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceE
Confidence            65  77999999999999999976432 24899999999999999999999988   9999999999999    778889


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhh--------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      ||+|||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|..||.........
T Consensus       156 kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~  232 (319)
T 4euu_A          156 KLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (319)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred             EEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence            9999999987654322   23457999999999987        578899999999999999999999999654332211


Q ss_pred             -hhHHhhhcccCCc--hhhhh------cc--CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          355 -NLVEWARPHLGDK--RRFYR------LL--DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       355 -~~~~~~~~~~~~~--~~~~~------~~--~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                       .............  .....      ..  .......++...+..+.+||.+||+.||++|||+.|++++....
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence             1111110000000  00000      00  00112245567788999999999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-46  Score=367.14  Aligned_cols=263  Identities=26%  Similarity=0.406  Sum_probs=220.6

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +.+..++|++.+.||+|+||.||+|.+..         ++..||+|++.... ...+.+.+|+.+++.++||||++++++
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~   77 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGV   77 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGG---------GTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecC---------CCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34556789999999999999999999876         57789999997654 345678899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+++..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~D  154 (288)
T 3kfa_A           78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD  154 (288)
T ss_dssp             ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEcc
Confidence            999999999999999999999998866667999999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...........+.       
T Consensus       155 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------  226 (288)
T 3kfa_A          155 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------  226 (288)
T ss_dssp             CCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------
T ss_pred             CccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------
Confidence            999987654322 22334567889999999999999999999999999999999 999997643322111111       


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                .......+...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       227 ----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          227 ----------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             ----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence                      011112223447889999999999999999999999999987644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-46  Score=396.78  Aligned_cols=262  Identities=25%  Similarity=0.402  Sum_probs=219.1

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+...+|++.+.||+|+||.||+|.+..         ++..||||+++.... ..+++.+|+.+|++++|||||++++++
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~  285 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC  285 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGG---------GTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcC---------CCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            3445679999999999999999999875         577899999976543 457799999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+..+||||||++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       286 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             ecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence            99999999999999999999998766667999999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++...... ........+++.|+|||++.+..++.++|||||||+||||++ |..||........   .+...     
T Consensus       363 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~~-----  433 (495)
T 1opk_A          363 GLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLE-----  433 (495)
T ss_dssp             TCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHHH-----
T ss_pred             ccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHHH-----
Confidence            9998764432 222233456789999999999999999999999999999999 9999976432221   11111     


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               .......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       434 ---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          434 ---------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             ---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             ---------cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                     111112233457889999999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-46  Score=377.61  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=208.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++.....   ...+.+.+|+.+|..++||||+++++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4679999999999999999999875         678999999865422   2345688999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEccc
Confidence            99999999999999999999998765  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|..||.......   .....   ... 
T Consensus       186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~~-  253 (350)
T 1rdq_E          186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI---VSG-  253 (350)
T ss_dssp             TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HHC-
T ss_pred             ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHHH---HcC-
Confidence            999876432     234689999999999999999999999999999999999999997543211   11100   000 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~L  415 (490)
                               .  ..++...+..+.+||.+||+.||.+||+     +.+|+++-
T Consensus       254 ---------~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          254 ---------K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             ---------C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             ---------C--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence                     0  0122334788999999999999999998     88888764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-46  Score=377.88  Aligned_cols=249  Identities=26%  Similarity=0.328  Sum_probs=206.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+|+.++||||+++++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~   78 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYK---------TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI   78 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            3579999999999999999999865         678999999865422   1234688999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ...+..++||||+ +|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           79 TTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             ECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCS
T ss_pred             EeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEe
Confidence            9999999999999 789999987765  6899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |++.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...........+.        
T Consensus       153 G~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------  221 (336)
T 3h4j_B          153 GLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN--------  221 (336)
T ss_dssp             SCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC--------
T ss_pred             ccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH--------
Confidence            9998765432   1234689999999999988776 689999999999999999999997543221111100        


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                              .  ....++...+..+.+||.+||..||.+|||+.|++++-
T Consensus       222 --------~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          222 --------S--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             --------S--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             --------c--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence                    0  00112233478899999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.3e-46  Score=378.14  Aligned_cols=252  Identities=27%  Similarity=0.382  Sum_probs=208.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceecee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKLV  204 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l~  204 (490)
                      ...++|++.+.||+|+||.||+|++..         +|..||||++.....   .....+..|..+|..+ +||||++++
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~   87 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH   87 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETT---------EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence            445689999999999999999999865         678999999975422   2345678899999988 799999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +++.+.+..||||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.+|.+||
T Consensus        88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL  162 (353)
T 2i0e_A           88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKI  162 (353)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEE
Confidence            99999999999999999999999998765  6899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...   ..
T Consensus       163 ~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~---i~  234 (353)
T 2i0e_A          163 ADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS---IM  234 (353)
T ss_dssp             CCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH---HH
T ss_pred             EeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHH---HH
Confidence            99999986433222  234578999999999999999999999999999999999999999754321   11111   00


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                      .          .  ...++...+.++.+||.+||..||.+||+     +.+|+++
T Consensus       235 ~----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          235 E----------H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             H----------C--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             h----------C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0          0  01123344788999999999999999995     6888876

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-46  Score=375.07  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||+|++....   ......+.+|+.+|..+ +||||++++++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKK---------TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECC---------CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            3579999999999999999999875         67899999997653   23345678899999987 89999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+..|+||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEe
Confidence            999999999999999999999997764  6899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc--hhHHhhhccc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH--NLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~--~~~~~~~~~~  364 (490)
                      ||+++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .......   
T Consensus       154 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---  228 (345)
T 3a8x_A          154 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---  228 (345)
T ss_dssp             GGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHH---
T ss_pred             ccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHH---
Confidence            999986433221  234568999999999999999999999999999999999999999653221110  0000000   


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM------SEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~------~evl~~  414 (490)
                            ..+...  ...++...+..+.+||.+||..||.+||++      .++++|
T Consensus       229 ------~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          229 ------QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             ------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             ------HHHHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                  000000  012233447889999999999999999995      677765

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-46  Score=380.69  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=211.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++..........+.+|+.+|..++||||+++++++.+.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~  120 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK  120 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred             ccceEEEEEEecCCCEEEEEEEECC---------CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC
Confidence            3579999999999999999998875         6779999999877665666789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC--CCCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kL~DFG  288 (490)
                      +..++|||||.+|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||
T Consensus       121 ~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          121 YEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             SEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecc
Confidence            99999999999999999986543 36899999999999999999999988   999999999999974  4779999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++.......   ....+||+.|+|||++.+..++.++|||||||++|||++|..||......   .........     
T Consensus       197 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~i~~~-----  265 (387)
T 1kob_A          197 LATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRC-----  265 (387)
T ss_dssp             TCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHC-----
T ss_pred             cceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHHHHHHhC-----
Confidence            9987654322   23357999999999999999999999999999999999999999754321   111111000     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                            ...+........+.++.+||.+||..||.+|||+.+++++-
T Consensus       266 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          266 ------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             ------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             ------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence                  00011111123478899999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.3e-46  Score=368.65  Aligned_cols=268  Identities=27%  Similarity=0.404  Sum_probs=218.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      ...++|++.+.||+|+||.||+|.+...    ....++..||||++..... ...+.+.+|+.+|..+ +||||++++++
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeec----cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            3456799999999999999999986431    1123678999999976543 3456788999999999 89999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGS----------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      +.+.+..++||||+++|+|.+++.....                ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk  172 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA  172 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence            9999999999999999999999976542                24899999999999999999999988   9999999


Q ss_pred             CCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCC
Q 011234          271 TSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNR  349 (490)
Q Consensus       271 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~  349 (490)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            9999999999999999999987765544333445668899999999999999999999999999999998 999997643


Q ss_pred             CCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ....  .......              ......+...+..+.+||.+||..||.+|||+.+|+++|+.+.
T Consensus       253 ~~~~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          253 VDSK--FYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             SSHH--HHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhH--HHHHhcc--------------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            3211  1111100              0011112234688999999999999999999999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-46  Score=373.12  Aligned_cols=267  Identities=24%  Similarity=0.379  Sum_probs=198.2

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      .+..++|++.+.||+|+||.||+|.+...+.      ....||||++...  .....+.+.+|+.+++.++||||+++++
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   92 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDG------SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG   92 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCC------cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence            3456789999999999999999998765321      2247999999765  2344567899999999999999999999


Q ss_pred             EEEecCce------EEEEEecCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          206 YCIEDDQR------LLVYEFMPRGSLENHLFRKG----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       206 ~~~~~~~~------~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ++......      ++||||+.+|+|.+++....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIl  169 (323)
T 3qup_A           93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCM  169 (323)
T ss_dssp             EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEE
Confidence            99887655      99999999999999986532    225899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~  354 (490)
                      |+.++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus       170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  249 (323)
T 3qup_A          170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY  249 (323)
T ss_dssp             ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence            99999999999999987654433333334567889999999999999999999999999999999 99999764332211


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ..+..      .           .....+...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       250 ~~~~~------~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          250 NYLIG------G-----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHHT------T-----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhc------C-----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11100      0           0011223346889999999999999999999999999987744

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-46  Score=368.22  Aligned_cols=251  Identities=24%  Similarity=0.349  Sum_probs=198.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--------------------------hHHH
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------------------------GHKE  184 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--------------------------~~~~  184 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++......                          ..+.
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   82 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNEN---------DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ   82 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETT---------TTEEEEEEEEECC-------------------------------CH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHH
Confidence            4579999999999999999998865         6789999998755321                          1245


Q ss_pred             HHHHHHHHhcCCCCceeceeeEEEe--cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 011234          185 WLAEVNFLGNLLHPNLVKLVGYCIE--DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEK  262 (490)
Q Consensus       185 ~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~  262 (490)
                      +.+|+.+|+.++||||+++++++.+  .+..++||||+++++|.+++..   ..+++..+..++.||+.||.|||+.+  
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--  157 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--  157 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence            7899999999999999999999987  5678999999999999876532   36899999999999999999999988  


Q ss_pred             CeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCC---CCccccchhhHHHHHHHH
Q 011234          263 PVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEML  339 (490)
Q Consensus       263 ~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGvil~ell  339 (490)
                       |+||||||+|||++.++.+||+|||+++.......  ......||+.|+|||++.+..   ++.++|||||||++|+|+
T Consensus       158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~  234 (298)
T 2zv2_A          158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV  234 (298)
T ss_dssp             -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred             -eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence             99999999999999999999999999987654322  234467999999999997654   477899999999999999


Q ss_pred             hCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          340 TGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       340 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +|+.||......   ........   ..          +........+..+.+||.+||+.||++|||+.|++++
T Consensus       235 ~g~~pf~~~~~~---~~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          235 FGQCPFMDERIM---CLHSKIKS---QA----------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HSSCSSCCSSHH---HHHHHHHH---CC----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HCCCCCCCccHH---HHHHHHhc---cc----------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            999999653211   11111000   00          0000011236789999999999999999999999865

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=9.7e-47  Score=390.92  Aligned_cols=266  Identities=22%  Similarity=0.274  Sum_probs=213.4

Q ss_pred             chhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCc
Q 011234          123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPN  199 (490)
Q Consensus       123 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpn  199 (490)
                      .+.++.+..++|++.++||+|+||+||+|++..         ++..||+|++.+....   ....+.+|+.+|..++|||
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~  135 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN---------ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW  135 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTT
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcC---------CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCC
Confidence            345556677899999999999999999999875         6789999999753221   1223788999999999999


Q ss_pred             eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       200 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      |++++++|.+.+.+|||||||++|+|.+++.... ..+++..+..++.||+.||.|||+.+   ||||||||+||||+.+
T Consensus       136 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~  211 (437)
T 4aw2_A          136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMN  211 (437)
T ss_dssp             BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             EEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCC
Confidence            9999999999999999999999999999997642 36899999999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      +.+||+|||+++....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.........
T Consensus       212 g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~  290 (437)
T 4aw2_A          212 GHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY  290 (437)
T ss_dssp             SCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred             CCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH
Confidence            9999999999987654332 2234468999999999997     467899999999999999999999999754322111


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L  415 (490)
                      ..+      +.....   ..-+.    .....+.++.+||.+||..+|++  |++++|++++-
T Consensus       291 ~~i------~~~~~~---~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          291 GKI------MNHKER---FQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             HHH------HTHHHH---CCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             Hhh------hhcccc---ccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            111      000000   00000    01123788999999999988888  99999999873

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-46  Score=375.83  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=215.6

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      ...++|.+.+.||+|+||.||+|.+....    ..+++..||||++.... ....+.+.+|+.+|..+ .||||++++++
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCS----SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccc----cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            44568999999999999999999974321    12367789999997543 23346788999999999 89999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVI  265 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~ii  265 (490)
                      +...+..++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.+   |+
T Consensus       118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iv  194 (344)
T 1rjb_A          118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CV  194 (344)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence            9999999999999999999999976532                     23789999999999999999999988   99


Q ss_pred             ecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCC
Q 011234          266 YRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRS  344 (490)
Q Consensus       266 HrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~p  344 (490)
                      ||||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999987654433333445678899999999999999999999999999999998 9999


Q ss_pred             CCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      |........  ......              .......+...+..+.+||.+||..||.+|||+.+|+++|+.+..
T Consensus       275 ~~~~~~~~~--~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          275 YPGIPVDAN--FYKLIQ--------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             STTCCCSHH--HHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cccCCcHHH--HHHHHh--------------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            976533211  111111              011112223347889999999999999999999999999987644

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1e-45  Score=363.10  Aligned_cols=265  Identities=23%  Similarity=0.286  Sum_probs=203.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....  .....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   72 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECC---------CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence            479999999999999999999875         677999999975432  334678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++||||+++ +|.+.+.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           73 DKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             TTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            9999999999964 6766665543 36999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc----
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL----  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~----  364 (490)
                      +.......  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......  ..........    
T Consensus       148 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~  223 (292)
T 3o0g_A          148 ARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPT  223 (292)
T ss_dssp             CEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             ceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCC
Confidence            98764322  1223467899999999998765 8999999999999999999888864322111  1111100000    


Q ss_pred             -CCchhhhhcc---------CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 -GDKRRFYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 -~~~~~~~~~~---------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ..........         ............+..+.+||.+||+.||++|||+.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence             0000000000         0000111223447889999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-46  Score=373.99  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=209.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+...+..     ....||+|.+.... ......+.+|+.++..++||||+++++++. 
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGES-----IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCS-----CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCce-----EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            35799999999999999999998763321     23358888875442 222345678999999999999999999886 


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  161 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGV  161 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred             CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCc
Confidence            567899999999999999997652 36888899999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++...............||..|+|||++.+..++.++|||||||++|+|++ |..||...........+....       
T Consensus       162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------  234 (325)
T 3kex_A          162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-------  234 (325)
T ss_dssp             GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC-------
T ss_pred             ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC-------
Confidence            998765544444455678899999999999999999999999999999999 999997654332222221110       


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                ....+..++..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       235 ----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 ----------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ----------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ----------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                      011122235567899999999999999999999999987743

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=8.6e-46  Score=375.28  Aligned_cols=256  Identities=22%  Similarity=0.288  Sum_probs=198.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKL---------TKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETT---------TCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECC---------CCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            3579999999999999999999875         677999999976532 235678999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--eEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--AKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~kL~DFG  288 (490)
                      +..++||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg  163 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFG  163 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecC
Confidence            99999999999999999997665  6899999999999999999999988   999999999999987765  9999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCcc-ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSK-SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~-sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +++......   .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............  .....   
T Consensus       164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~---  235 (361)
T 3uc3_A          164 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRIL---  235 (361)
T ss_dssp             CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHH---
T ss_pred             ccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHh---
Confidence            997543221   1234579999999999988887665 89999999999999999999764433221111  11000   


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                             ............+..+.+||.+||..||.+|||+.|++++-.
T Consensus       236 -------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          236 -------SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             -------TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             -------cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence                   000000111123688999999999999999999999998743

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.1e-46  Score=362.60  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=201.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      +..++|++.+.||+|+||.||+|.+...+.      .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCC------CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            344679999999999999999999865322      46689999987643 33456788999999999999999999997


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                       .++..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           86 -TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             -CSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred             -ccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcc
Confidence             4567899999999999999997653 36899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..   .   
T Consensus       161 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~---~---  233 (281)
T 1mp8_A          161 GLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---G---  233 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---T---
T ss_pred             ccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc---C---
Confidence            999876443221 2233457889999999999999999999999999999996 9999976433221111110   0   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 .....+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       234 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 -----------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                       0011223447889999999999999999999999999987643

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=7e-46  Score=370.79  Aligned_cols=254  Identities=28%  Similarity=0.401  Sum_probs=200.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .++|++.+.||+|+||.||+|+.....      .+|..||+|+++....    .....+.+|+.+|+.++||||++++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   89 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGA------NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYA   89 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSST------TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccC------CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence            357999999999999999999885321      2688999999976532    233457789999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +...+..|+||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           90 FQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             EECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECC
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEe
Confidence            999999999999999999999997765  6889999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....   ...
T Consensus       165 fg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~~  236 (327)
T 3a62_A          165 FGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKI---LKC  236 (327)
T ss_dssp             CSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---HHT
T ss_pred             CCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhC
Confidence            99997643322  12234689999999999999999999999999999999999999997543211   11100   000


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                                  ...++...+..+.+||.+||..||.+||     ++.+++++-
T Consensus       237 ------------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          237 ------------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence                        0112233478899999999999999999     788998864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-46  Score=386.49  Aligned_cols=261  Identities=25%  Similarity=0.316  Sum_probs=210.6

Q ss_pred             hhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCcee
Q 011234          125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPNLV  201 (490)
Q Consensus       125 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~HpnIv  201 (490)
                      .++....++|++.+.||+|+||.||+|++..         ++..||+|++.+....   ....+.+|+.+|..++|||||
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~---------~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv  132 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---------TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV  132 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBC
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECC---------CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence            3445567899999999999999999999875         6789999998653211   123477899999999999999


Q ss_pred             ceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          202 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       202 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ++++++.+.+.+|||||||++|+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.
T Consensus       133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             CEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCC
Confidence            9999999999999999999999999998654   5899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCC----CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH----LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~----~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (490)
                      +||+|||+++....... ......+||+.|+|||++.+..    |+.++|||||||+||||++|+.||...........+
T Consensus       207 ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i  285 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI  285 (410)
T ss_dssp             EEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred             EEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH
Confidence            99999999987654322 2234578999999999998655    889999999999999999999999754322111111


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA--RPRMSEVVETL  415 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~--RPs~~evl~~L  415 (490)
                            +.....   ..   +  ......+.++.+||.+||..+|.+  ||++.||++|-
T Consensus       286 ------~~~~~~---~~---~--p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          286 ------MNHKNS---LT---F--PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             ------HTHHHH---CC---C--CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             ------Hhcccc---cc---C--CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence                  000000   00   0  001123788999999999999988  99999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-45  Score=369.13  Aligned_cols=263  Identities=19%  Similarity=0.185  Sum_probs=211.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+|+.+++.| +||||+++++++..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   76 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLY---------TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC   76 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETT---------TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECC---------CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec
Confidence            4679999999999999999999765         678999999875532  24578899999999 89999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC-----eEE
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-----AKL  284 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~kL  284 (490)
                      .+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           77 GKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             CCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEE
Confidence            99999999999 999999997653 37999999999999999999999988   999999999999998887     999


Q ss_pred             ccccccccCCCCCCcc-----eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          285 SDFGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +|||+++.........     .....+||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~  231 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK  231 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence            9999998764332211     12356899999999999999999999999999999999999999987644433222221


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ....   ...   .....+.    ...+ ++.+||.+||..||.+||++.+|++.|+.+..
T Consensus       232 i~~~---~~~---~~~~~~~----~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          232 IGDT---KRA---TPIEVLC----ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHHH---HHH---SCHHHHT----TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhh---hcc---CCHHHHh----ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence            1000   000   0000000    1124 89999999999999999999999999986644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.9e-46  Score=386.49  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=212.2

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+..++|++.+.||+|+||.||+|.+.           |..||||+++...  ..+.+.+|+.+|++++||||+++++++
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-----------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~  255 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI  255 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET-----------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec-----------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence            345568999999999999999999873           5589999998664  446789999999999999999999998


Q ss_pred             EecC-ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          208 IEDD-QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       208 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      .... ..+||||||++|+|.+++...+...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D  332 (450)
T 1k9a_A          256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSD  332 (450)
T ss_dssp             ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECC
T ss_pred             EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEee
Confidence            7765 7899999999999999998776556899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++.....     .....+++.|+|||++.+..++.++|||||||+||||++ |..||...........+..      
T Consensus       333 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------  401 (450)
T 1k9a_A          333 FGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------  401 (450)
T ss_dssp             CTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT------
T ss_pred             CCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------
Confidence            9999854322     122357889999999999999999999999999999998 9999976543322211110      


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 ......+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       402 -----------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          402 -----------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence                       00112233457899999999999999999999999999987754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-45  Score=367.50  Aligned_cols=265  Identities=25%  Similarity=0.366  Sum_probs=192.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++..... .....+.+|+.+|+.++||||+++++++.+
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   74 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKT---------TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT   74 (317)
T ss_dssp             ---------------CEEEEEECSS---------SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC
T ss_pred             ccceeEeeEECCCCCEEEEEEEECC---------CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE
Confidence            3579999999999999999998765         678999999875532 233568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKG----SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      ++..++||||++ |+|.+++....    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEEC
Confidence            999999999997 69999886532    235889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc-
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH-  363 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~-  363 (490)
                      |||+++.......  .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+...... 
T Consensus       151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  228 (317)
T 2pmi_A          151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP  228 (317)
T ss_dssp             CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999987643221  1234578999999999976 46899999999999999999999999765432211111100000 


Q ss_pred             ----cCCc---------------hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 ----LGDK---------------RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ----~~~~---------------~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          +...               ..+...+.+    ......+.++.+||.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQP----HTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGG----GCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ChhHhhhhhhhhhcccccccccchhHHHhhcc----cccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                0000               000000011    1111236789999999999999999999999875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.2e-46  Score=374.73  Aligned_cols=256  Identities=25%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCC--Cceecee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLH--PNLVKLV  204 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H--pnIv~l~  204 (490)
                      +..++|++.+.||+|+||.||+|.+.          ++..||||++....  ....+.+.+|+.+|..+.|  +||++++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   75 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   75 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT----------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC----------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEe
Confidence            34567999999999999999999764          46789999987543  3345678899999999986  9999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +++..++..+||||+ .+++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||
T Consensus        76 ~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           76 DYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             EEEECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEE
T ss_pred             eeEeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEE
Confidence            999999999999995 5889999998764  6889999999999999999999988   99999999999997 678999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      +|||+++..............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--  226 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--  226 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--
Confidence            99999987755433333445689999999999875           67899999999999999999999999643211  


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                         ..          .+...+++.....++...+..+.+||.+||+.||.+|||+.+++++..
T Consensus       227 ---~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          227 ---IS----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             ---HH----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---HH----------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence               00          111222222223334444678999999999999999999999998753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.4e-46  Score=363.66  Aligned_cols=259  Identities=22%  Similarity=0.376  Sum_probs=208.8

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      +..++|++.+.||+|+||.||+|.+.          ++..||||++..... ..+++.+|+.++..++||||+++++++.
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET----------TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc----------CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            34457999999999999999999875          356799999986543 3467899999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             cCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccc
Confidence            9999999999999999999997643 26899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++....... ........||+.|+|||++.+..++.++|||||||++|+|++ |+.||........   ......     
T Consensus       166 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~-----  236 (283)
T 3gen_A          166 LSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHIAQ-----  236 (283)
T ss_dssp             GGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHT-----
T ss_pred             ccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---HHHHhc-----
Confidence            998664321 111223456788999999999999999999999999999998 9999975432211   111100     


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               ......+...+..+.+||.+||+.||.+|||+.+++++|..+..
T Consensus       237 ---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          237 ---------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence                     00111122336789999999999999999999999999987643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.9e-46  Score=389.35  Aligned_cols=252  Identities=30%  Similarity=0.389  Sum_probs=200.7

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++....   ......+.+|+.+|..++||||++++++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~  216 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKA---------TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS  216 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcC---------CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence            34679999999999999999999875         67899999987542   2233567889999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      +.+.+.++||||||++|+|.+++....  .+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.+||+
T Consensus       217 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~  291 (446)
T 4ejn_A          217 FQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKIT  291 (446)
T ss_dssp             EEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEEC
T ss_pred             EeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEc
Confidence            999999999999999999999997765  68999999999999999999998 77   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.......  .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +....   ..
T Consensus       292 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~  363 (446)
T 4ejn_A          292 DFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---LM  363 (446)
T ss_dssp             CCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH
T ss_pred             cCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH---Hh
Confidence            9999986543222  2345789999999999999999999999999999999999999996543211   11111   00


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L  415 (490)
                      .            ...++...+.++.+||.+||+.||.+||     ++.|+++|-
T Consensus       364 ~------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          364 E------------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             C------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             C------------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            0            0112233478899999999999999999     999999763

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-45  Score=377.70  Aligned_cols=272  Identities=21%  Similarity=0.252  Sum_probs=208.3

Q ss_pred             hcCCCcCceeccC--CceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          131 TRNFRPESLLGEG--GFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G--~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .++|++.+.||+|  +||.||+|++..         +|..||||++....  ....+.+.+|+.+|+.++|||||+++++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   94 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKP---------TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRAT   94 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEE
Confidence            3579999999999  999999999875         67899999997553  2334567889999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+..++|||||++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~d  171 (389)
T 3gni_B           95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSG  171 (389)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcc
Confidence            999999999999999999999998765557999999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCc-----ceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          287 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       287 FG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      ||++.........     ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||..............
T Consensus       172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            9998654322111     11123478999999999987  5799999999999999999999999976543322111000


Q ss_pred             -hhcccCCch-----h-------------hhhcc---------CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011234          360 -ARPHLGDKR-----R-------------FYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       360 -~~~~~~~~~-----~-------------~~~~~---------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev  411 (490)
                       ..+.+.+..     .             +...+         .......++...+..+.+||.+||+.||.+|||+.|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence             000000000     0             00000         0000011233347789999999999999999999999


Q ss_pred             HHH
Q 011234          412 VET  414 (490)
Q Consensus       412 l~~  414 (490)
                      +++
T Consensus       332 l~h  334 (389)
T 3gni_B          332 LNH  334 (389)
T ss_dssp             TTS
T ss_pred             hcC
Confidence            976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.6e-46  Score=374.88  Aligned_cols=276  Identities=23%  Similarity=0.285  Sum_probs=215.8

Q ss_pred             hhhhchhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC--
Q 011234          119 LRKFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--  196 (490)
Q Consensus       119 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--  196 (490)
                      ...+.+.+.....++|++.+.||+|+||.||+|++..         ++..||||++.... .....+..|+.++..+.  
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~   91 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---------NKKYYAVKVVRNIK-KYTRSAKIEADILKKIQND   91 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECC---------CCeEEEEEEeccch-hhhhhhHHHHHHHHHhccc
Confidence            4556667777788899999999999999999999865         67799999997532 34456778999999886  


Q ss_pred             ---CCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          197 ---HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       197 ---HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                         ||||+++++++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N  167 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPEN  167 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCccc
Confidence               999999999999999999999999 999999998776557999999999999999999999988   9999999999


Q ss_pred             eEEcC-------------------------CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccc
Q 011234          274 ILLDA-------------------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDV  328 (490)
Q Consensus       274 ILl~~-------------------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDv  328 (490)
                      |||+.                         ++.+||+|||++......     .....||+.|+|||++.+..++.++||
T Consensus       168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccch
Confidence            99975                         789999999999865432     234679999999999999999999999


Q ss_pred             hhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc--------c-CccccCC------------------
Q 011234          329 YSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL--------L-DPRLEGH------------------  381 (490)
Q Consensus       329 wSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~l~~~------------------  381 (490)
                      |||||++|+|++|+.||...........+........... ....        + ...+...                  
T Consensus       243 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  321 (360)
T 3llt_A          243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNM-LYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL  321 (360)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHH-HHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHH-HhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence            9999999999999999976443222221111110000000 0000        0 0000000                  


Q ss_pred             --CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          382 --FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       382 --~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        +....+..+.+||.+||+.||.+|||+.|+|++
T Consensus       322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence              001113678899999999999999999999865

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.2e-46  Score=380.55  Aligned_cols=254  Identities=22%  Similarity=0.278  Sum_probs=196.1

Q ss_pred             cCCCcC-ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHh-cCCCCceeceeeEEEe
Q 011234          132 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG-NLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~  209 (490)
                      ++|.+. ++||+|+||+||+|.+..         +|..||||++...     ..+.+|+.++. .++||||++++++|..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~---------~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~  126 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN  126 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECC---------CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence            457666 789999999999999875         6789999998643     35667888874 4579999999999876


Q ss_pred             ----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCe
Q 011234          210 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       210 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~  282 (490)
                          ...+|||||||++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+||||+.   ++.+
T Consensus       127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~  203 (400)
T 1nxk_A          127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  203 (400)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCE
T ss_pred             cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccE
Confidence                567899999999999999998766557999999999999999999999988   999999999999987   7899


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch-hHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN-LVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~-~~~~~~  361 (490)
                      ||+|||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.......... ......
T Consensus       204 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          204 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             EEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            999999998664322   2235689999999999999999999999999999999999999997654332111 111000


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ..   .   +.     +........+.++.+||.+||..||.+|||+.+|+++-.
T Consensus       281 ~~---~---~~-----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          281 MG---Q---YE-----FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             HT---C---CC-----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             cC---c---cc-----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            00   0   00     000011234788999999999999999999999999853

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-45  Score=357.49  Aligned_cols=254  Identities=31%  Similarity=0.514  Sum_probs=197.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .++|++.+.||+|+||.||+|.+           +|..||||++.....    ...+.+.+|+.+++.++||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-----------IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV   74 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-----------cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            46799999999999999999987           356899999875432    224678899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC--------
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--------  278 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--------  278 (490)
                      +.+.+..++||||+++++|.+++...   .+++..++.++.||+.||.|||+.+..+|+||||||+|||++.        
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~  151 (271)
T 3dtc_A           75 CLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS  151 (271)
T ss_dssp             ECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCS
T ss_pred             EecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccccccc
Confidence            99999999999999999999988533   6899999999999999999999987445889999999999986        


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      ++.+||+|||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ..
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~  224 (271)
T 3dtc_A          152 NKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---AY  224 (271)
T ss_dssp             SCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HH
T ss_pred             CcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence            6789999999998654322    1235799999999999999999999999999999999999999965321111   00


Q ss_pred             hhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          359 WARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                   ...........+..++..+.+||.+||+.||.+|||+.|++++|+.+
T Consensus       225 -------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          225 -------------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -------------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -------------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                         00111111122334478899999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=368.48  Aligned_cols=263  Identities=24%  Similarity=0.399  Sum_probs=205.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+...+..     ....||+|.+... .....+.+.+|+.+|..++||||+++++++..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-----~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCS-----CCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCce-----EEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence            46799999999999999999998764321     2235688887644 23456788999999999999999999999987


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .. .++||||+.+|+|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        89 ~~-~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~  163 (327)
T 3lzb_A           89 ST-VQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             SS-EEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred             CC-ceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcc
Confidence            54 7899999999999999977543 6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++ |..||...........+..         
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~---------  234 (327)
T 3lzb_A          164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---------  234 (327)
T ss_dssp             ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT---------
T ss_pred             eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---------
Confidence            987654433333344567889999999999999999999999999999999 9999976533222111110         


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              ......+..++.++.+||.+||..||.+||++.|+++.|+.+..
T Consensus       235 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          235 --------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             --------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                    00111223347789999999999999999999999999987754

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.8e-46  Score=364.28  Aligned_cols=261  Identities=23%  Similarity=0.359  Sum_probs=208.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|.+...+..  ....+..||+|++........+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDY--GQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGG--GCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEeccccc--ccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            45799999999999999999998763210  0001357999999876666677899999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--------e
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--------A  282 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~  282 (490)
                      +..++||||+++|+|.+++..... .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.        +
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            999999999999999999976542 4899999999999999999999988   999999999999998887        9


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.......  .......
T Consensus       161 kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~~~~  232 (289)
T 4fvq_A          161 KLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQFYE  232 (289)
T ss_dssp             EECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHH
T ss_pred             eeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHHHhh
Confidence            99999998755321      23568999999999987 779999999999999999999655443221111  1111000


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                          .        ..    .++...+.++.+||.+||+.||.+|||+.+++++|+.+...
T Consensus       233 ----~--------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          233 ----D--------RH----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             ----T--------TC----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             ----c--------cC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence                0        00    11112255688999999999999999999999999988654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=384.55  Aligned_cols=265  Identities=22%  Similarity=0.276  Sum_probs=211.5

Q ss_pred             chhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCCCc
Q 011234          123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLHPN  199 (490)
Q Consensus       123 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpn  199 (490)
                      .+.+..+..++|++.+.||+|+||.||+|++..         +|..||||++.+....   ....+.+|+.+|..++|||
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~---------~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~  122 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---------TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW  122 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTT
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCC
Confidence            345556677899999999999999999999875         6789999999754221   1234778999999999999


Q ss_pred             eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       200 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      |+++++++.+.+.+|||||||++|+|.+++.+.+. .+++..++.++.||+.||.|||+.+   |+||||||+||||+.+
T Consensus       123 Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~  198 (412)
T 2vd5_A          123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRC  198 (412)
T ss_dssp             BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             eeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCC
Confidence            99999999999999999999999999999976532 6899999999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhh-------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~  352 (490)
                      +.+||+|||+++....... ......+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.......
T Consensus       199 g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  277 (412)
T 2vd5_A          199 GHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE  277 (412)
T ss_dssp             SCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             CCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence            9999999999987654322 1223468999999999997       3578999999999999999999999997543221


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCC---CCHHHHHHHh
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR---PRMSEVVETL  415 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R---Ps~~evl~~L  415 (490)
                      ....+......         ..-+.    ++...+.++.+||.+||. +|.+|   |+++||++|-
T Consensus       278 ~~~~i~~~~~~---------~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          278 TYGKIVHYKEH---------LSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             HHHHHHTHHHH---------CCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             HHHHHHhcccC---------cCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence            11111000000         00010    112237889999999999 99998   5999999873

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-45  Score=359.24  Aligned_cols=256  Identities=31%  Similarity=0.551  Sum_probs=206.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-------HHHHHHHHHHHhcCCCCceece
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-------HKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++.......       .+.+.+|+.++..++||||+++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVK---------DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL   88 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETT---------TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hccceehhccccCCceeEEEEEEcC---------CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhh
Confidence            4579999999999999999999875         67799999986543221       1578899999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--  281 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--  281 (490)
                      ++++.+..  ++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.  
T Consensus        89 ~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           89 YGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             EEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTC
T ss_pred             heeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCC
Confidence            99986554  79999999999999887653 37899999999999999999999865 45999999999999988776  


Q ss_pred             ---eEEccccccccCCCCCCcceeeccccCCCCCCchhhh--cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          282 ---AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM--TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       282 ---~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~--~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                         +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|+|++|+.||...........
T Consensus       165 ~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  239 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI  239 (287)
T ss_dssp             SCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH
T ss_pred             ceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH
Confidence               99999999985433     124467999999999984  45678899999999999999999999976543322111


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .....              ......++..++..+.+||.+||+.||.+|||+.+|++.|+.+
T Consensus       240 ~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 NMIRE--------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHHH--------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HHHhc--------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            11100              0111122334478899999999999999999999999999864

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.2e-46  Score=389.91  Aligned_cols=260  Identities=27%  Similarity=0.412  Sum_probs=213.0

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+..++|++.+.||+|+||.||+|.+.          .+..||||+++... ...+.+.+|+.+|+.++|||||++++++
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~  252 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN----------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV  252 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET----------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC----------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence            455668999999999999999999885          35579999998654 3467899999999999999999999998


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      . .+..+||||||++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       253 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DF  328 (454)
T 1qcf_A          253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADF  328 (454)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECST
T ss_pred             e-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeC
Confidence            6 667899999999999999997654446889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++...... ........+++.|+|||++....++.++|||||||+||||++ |+.||.......   ........   
T Consensus       329 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~---  401 (454)
T 1qcf_A          329 GLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALERG---  401 (454)
T ss_dssp             TGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHHT---
T ss_pred             CCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---
Confidence            9998764321 111223456788999999999999999999999999999999 999997543211   11111100   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 .....+..++..+.+||.+||..||++|||+.+|++.|+.+..
T Consensus       402 -----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          402 -----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                       0011223457889999999999999999999999999998754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-45  Score=365.75  Aligned_cols=270  Identities=25%  Similarity=0.329  Sum_probs=203.6

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-----hhHHHHHHHHHHHhcC---CCCce
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----QGHKEWLAEVNFLGNL---LHPNL  200 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l---~HpnI  200 (490)
                      ...++|++.+.||+|+||.||+|++..         +|..||||++.....     .....+.+|+.+++.+   .||||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni   76 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPH---------SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV   76 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTT---------TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe
Confidence            456789999999999999999998765         678999999864321     1123556777777666   49999


Q ss_pred             eceeeEEEecC-----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          201 VKLVGYCIEDD-----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       201 v~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +++++++....     ..++||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||
T Consensus        77 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil  152 (308)
T 3g33_A           77 VRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENIL  152 (308)
T ss_dssp             CCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEE
T ss_pred             EEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEE
Confidence            99999998765     4799999996 69999998776556999999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      ++.++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|++||..........
T Consensus       153 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  229 (308)
T 3g33_A          153 VTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  229 (308)
T ss_dssp             ECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH
T ss_pred             EcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987643322   244689999999999999999999999999999999999999997654322211


Q ss_pred             hHHhhhcccCCchhhh-------hccCc---cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          356 LVEWARPHLGDKRRFY-------RLLDP---RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~-------~~~~~---~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .+....... ....+.       ..+.+   ..........+..+.+||.+||+.||.+|||+.|++++-
T Consensus       230 ~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          230 KIFDLIGLP-PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             HHHHHHCCC-CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             HHHHHhCCC-ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            111000000 000000       00000   000001122367899999999999999999999999763

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-45  Score=361.53  Aligned_cols=266  Identities=23%  Similarity=0.314  Sum_probs=201.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+.          +|..||+|++......  ....+.+|+.+++.++||||+++++++.+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~----------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcC----------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence            47999999999999999999873          5678999998755322  23568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        72 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           72 KKRLVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCeEEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECcc
Confidence            999999999996 59998887643 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-h-cccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R-PHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~-~~~~~  366 (490)
                      +.......  .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...........+... . +....
T Consensus       147 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (288)
T 1ob3_A          147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (288)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence            98654321  11234578999999999976 46899999999999999999999999764322111111000 0 00000


Q ss_pred             chhhh--hccCccc-------cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFY--RLLDPRL-------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~--~~~~~~l-------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .....  ...++.+       ...+....+.++.+||.+||..||++|||+.|++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00000  0000000       011122347889999999999999999999999975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.8e-45  Score=360.24  Aligned_cols=266  Identities=17%  Similarity=0.171  Sum_probs=214.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      +..++|++.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+|+.++..+ +|+||+++++++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~   75 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG   75 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence            345689999999999999999998765         678999999865432  24577899999999 799999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC-----e
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-----A  282 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~  282 (490)
                      .+....++||||+ +++|.+++...+ ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.     +
T Consensus        76 ~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~  150 (298)
T 1csn_A           76 QEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMI  150 (298)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCE
T ss_pred             CCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeE
Confidence            9999999999999 999999997654 36899999999999999999999988   999999999999987776     9


Q ss_pred             EEccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhH
Q 011234          283 KLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV  357 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~  357 (490)
                      ||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus       151 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  230 (298)
T 1csn_A          151 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  230 (298)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHH
Confidence            99999999876543221     1124467999999999999999999999999999999999999999875443332222


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ........      ....+.+    ....+..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       231 ~~~~~~~~------~~~~~~~----~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          231 ERIGEKKQ------STPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHH------HSCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhcc------CccHHHH----HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            21110000      0000000    11236789999999999999999999999999987654

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-45  Score=382.72  Aligned_cols=270  Identities=23%  Similarity=0.312  Sum_probs=190.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||+||+|++..         +|..||||++...  .....+.+.+|+.+|+.++|||||++++++.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  122 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKL---------EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI  122 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC-----------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECC---------CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            3579999999999999999999875         6789999998653  3344567899999999999999999999985


Q ss_pred             ec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          209 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       209 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ..     ..+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||+.+   ||||||||+||||+.++.+|
T Consensus       123 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~k  196 (458)
T 3rp9_A          123 PKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVK  196 (458)
T ss_dssp             CSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEE
T ss_pred             cCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEe
Confidence            44     4689999998 679999886553  6899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCc-------------------------ceeeccccCCCCCCchhh-hcCCCCccccchhhHHHHHH
Q 011234          284 LSDFGLAKDAPEDGKT-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLE  337 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~-------------------------~~~~~~~Gt~~y~aPE~l-~~~~~~~~sDvwSlGvil~e  337 (490)
                      |+|||+++........                         ...+..+||+.|+|||++ .+..|+.++|||||||||||
T Consensus       197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e  276 (458)
T 3rp9_A          197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE  276 (458)
T ss_dssp             ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred             ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence            9999999876432111                         123446899999999986 46679999999999999999


Q ss_pred             HHh-----------CCCCCCCCCCCCc-----------------chhHHhhhcccCCc-------------hhhhhccCc
Q 011234          338 MLT-----------GRRSMDKNRPNGE-----------------HNLVEWARPHLGDK-------------RRFYRLLDP  376 (490)
Q Consensus       338 llt-----------G~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~~~  376 (490)
                      |++           |+++|.+......                 ..........++..             ..+...+..
T Consensus       277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  356 (458)
T 3rp9_A          277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK  356 (458)
T ss_dssp             HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred             HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence            999           6666654331100                 00000000000000             000000100


Q ss_pred             ccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          377 RLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       377 ~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...   .......+.++.+||.+||..||.+|||+.|+|+|-
T Consensus       357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp  398 (458)
T 3rp9_A          357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHP  398 (458)
T ss_dssp             CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence            000   001122378899999999999999999999999873

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.4e-46  Score=369.84  Aligned_cols=270  Identities=25%  Similarity=0.402  Sum_probs=215.8

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      +.+..++|++.+.||+|+||.||+|.+...    ....++..||||++..... .....+.+|+.+++.+.||||+++++
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGV----VKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEE----ETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCc----cCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            345567899999999999999999987631    0112567899999976533 34456889999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKG--------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ++.+.+..++||||+++|+|.+++....        ...+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEc
Confidence            9999999999999999999999986532        135789999999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchh
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   ..
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~  249 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV  249 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH
Confidence            999999999999986543322222234567899999999999999999999999999999999 88998654221   11


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ......   .          . ....+..++..+.+||.+||..||.+|||+.+++++|+.+..
T Consensus       250 ~~~~~~---~----------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRFVME---G----------G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHT---T----------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHc---C----------C-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111100   0          0 011223347889999999999999999999999999987644

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-45  Score=362.60  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=198.3

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +..++|++.+.||+|+||.||+|.+..            .||||+++...  ....+.+.+|+.+|+.++||||++++++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS------------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC------------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            445689999999999999999997643            59999987553  3445678999999999999999999996


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      + .....++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~D  163 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGD  163 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECC
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEcc
Confidence            5 5567899999999999999986553 36899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||++................||+.|+|||++.   +..++.++|||||||++|+|++|+.||.......  .........
T Consensus       164 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~  241 (289)
T 3og7_A          164 FGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRG  241 (289)
T ss_dssp             CC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHHHHHT
T ss_pred             ceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHHhccc
Confidence            99998654332333334567999999999986   5678889999999999999999999997543221  111111100


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                               ...+. .......++..+.+||.+||..||.+|||+.+|++.|+.+.
T Consensus       242 ---------~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          242 ---------SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ---------SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---------ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                     00000 01122344788999999999999999999999999998774

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2e-45  Score=368.16  Aligned_cols=269  Identities=24%  Similarity=0.383  Sum_probs=215.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+.....  ....++..||||++.... ......+.+|+.++..+ +||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDK--DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCST--TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccc--cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            34679999999999999999999864211  112367789999997653 33456788999999999 899999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+.+..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence            999999999999999999999976532              24889999999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            9999999999999999987655433333334567889999999999999999999999999999999 999996543211


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                         ........              .....+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       268 ---~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          268 ---LFKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             ---HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHhcC--------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               11111000              0111223447889999999999999999999999999987754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2e-45  Score=355.78  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=208.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+.           |..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   77 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-----------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ   77 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-----------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-----------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence            457999999999999999999873           5689999997653  334567899999999999999999999998


Q ss_pred             ec--CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          209 ED--DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~--~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.  +..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.++|+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~  156 (271)
T 3kmu_A           78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISM  156 (271)
T ss_dssp             TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred             cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEe
Confidence            87  78899999999999999998776556999999999999999999999865 4499999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCc---cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTS---KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~---~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||++.....       ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||..........  .     
T Consensus       157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~-----  222 (271)
T 3kmu_A          157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM--K-----  222 (271)
T ss_dssp             GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH--H-----
T ss_pred             ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH--H-----
Confidence            988764322       2346899999999998765554   7999999999999999999996542211100  0     


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               .........++...+..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus       223 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          223 ---------VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                     000011112233447889999999999999999999999999988754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.1e-45  Score=366.47  Aligned_cols=260  Identities=24%  Similarity=0.353  Sum_probs=198.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.++..++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   81 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLR---------DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   81 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECC---------CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence            4579999999999999999999865         678999999976532   3345688999999999999999999998


Q ss_pred             EecCce----EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          208 IEDDQR----LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       208 ~~~~~~----~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ......    |+||||+++++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  156 (311)
T 3ork_A           82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK  156 (311)
T ss_dssp             EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEE
T ss_pred             eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEE
Confidence            876543    99999999999999997665  6899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          284 LSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++........ ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........  ......
T Consensus       157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~  234 (311)
T 3ork_A          157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVRE  234 (311)
T ss_dssp             ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHC
T ss_pred             EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcC
Confidence            9999999876443221 2223467999999999999999999999999999999999999999654321110  010000


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH-hhcc
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET-LKPL  418 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~-L~~l  418 (490)
                      ....    ..        ......+.++.+||.+||+.||.+||++.+++.+ |..+
T Consensus       235 ~~~~----~~--------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          235 DPIP----PS--------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCC----HH--------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCC----cc--------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0000    00        0011236789999999999999999977766643 4433

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-45  Score=367.77  Aligned_cols=252  Identities=24%  Similarity=0.417  Sum_probs=198.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++..... ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~   76 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKV---------DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLET   76 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETT---------TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred             hcCceeeEecCCCCeEEEEEEEcC---------CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence            469999999999999999999875         677999999975433 3456789999999999999999999998665


Q ss_pred             C---------------------------------------------------------ceEEEEEecCCCCHHHHHhhcC
Q 011234          211 D---------------------------------------------------------QRLLVYEFMPRGSLENHLFRKG  233 (490)
Q Consensus       211 ~---------------------------------------------------------~~~lv~E~~~~g~L~~~l~~~~  233 (490)
                      .                                                         ..++|||||++++|.+++....
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~  156 (332)
T 3qd2_B           77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC  156 (332)
T ss_dssp             CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred             ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence            4                                                         2799999999999999997654


Q ss_pred             C-CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCc----------cee
Q 011234          234 S-LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT----------HVS  302 (490)
Q Consensus       234 ~-~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~----------~~~  302 (490)
                      . ...++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++........          ...
T Consensus       157 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          157 SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence            3 23566678999999999999999988   999999999999999999999999999876543211          122


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|..|+...     ........             .... ...
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~-------------~~~~-~~~  294 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVR-------------NLKF-PLL  294 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHH-------------TTCC-CHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhh-------------ccCC-Ccc
Confidence            3457999999999999999999999999999999999987654210     00000000             0000 000


Q ss_pred             ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          383 SIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       383 ~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....+..+.+||.+||+.||.+|||+.|++++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            12235677999999999999999999999976

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.7e-46  Score=371.09  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=215.8

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      ...++|.+.+.||+|+||.||+|.+...+.    ...+..||+|.+..... ...+.+.+|+.+|..+ .||||++++++
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGK----EDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSS----SCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCc----ccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345689999999999999999999865321    11345899999976533 3456788999999999 89999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKG------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      +.+.+..++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  195 (333)
T 2i1m_A          119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV  195 (333)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred             EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence            999999999999999999999987532            235789999999999999999999988   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCc
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGE  353 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~  353 (490)
                      |++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            999999999999999986654433333344567889999999999999999999999999999998 9999975432211


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      .  ......              ......+...+..+.+||.+||+.||.+|||+.+|++.|+.+.
T Consensus       276 ~--~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          276 F--YKLVKD--------------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             H--HHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H--HHHHhc--------------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            1  111110              0111112233678999999999999999999999999998654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-45  Score=364.81  Aligned_cols=267  Identities=27%  Similarity=0.419  Sum_probs=203.6

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceecee
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      +.+..++|.+.+.||+|+||.||+|.+..+.      +++..||||++....  ....+.+.+|+.++..++||||++++
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~  102 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQED------GTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL  102 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTT------SCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccC------CceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence            3455678999999999999999999886532      256789999987553  33456788999999999999999999


Q ss_pred             eEEEecC-----ceEEEEEecCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          205 GYCIEDD-----QRLLVYEFMPRGSLENHLFRK----GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       205 ~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      +++.+.+     ..++||||+++|+|.+++...    ....+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIl  179 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCM  179 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEE
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEE
Confidence            9998765     359999999999999998532    2346899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||++................|++.|+|||++.+..++.++|||||||++|+|++ |..||........ 
T Consensus       180 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-  258 (313)
T 3brb_A          180 LRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-  258 (313)
T ss_dssp             ECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred             EcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-
Confidence            99999999999999987654332233334567889999999999999999999999999999999 8889865432211 


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                        .......              .....+...+..+.+||.+||..||.+|||+.+|+++|+.+.
T Consensus       259 --~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          259 --YDYLLHG--------------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             --HHHHHTT--------------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHcC--------------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence              1111000              001122234678999999999999999999999999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.3e-46  Score=377.14  Aligned_cols=246  Identities=28%  Similarity=0.372  Sum_probs=195.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHH-HhcCCCCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNF-LGNLLHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~HpnIv~l~~~  206 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++.+...   .....+..|..+ ++.++||||++++++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~  107 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKA---------EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS  107 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETT---------TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcC---------CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence            3579999999999999999999875         677999999976532   223456677776 577899999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+.+||||||+++|+|.+++.+.+  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.+|.+||+|
T Consensus       108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          108 FQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEee
Confidence            999999999999999999999998764  6889999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++......  ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......   ...   ..+. 
T Consensus       183 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-  253 (373)
T 2r5t_A          183 FGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD---NILN-  253 (373)
T ss_dssp             CCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHH---HHHH-
T ss_pred             CccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHHh-
Confidence            99998643221  12345789999999999999999999999999999999999999996542211   111   0100 


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE  410 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~e  410 (490)
                               ..  ..++...+..+.+||.+||+.||.+||++.+
T Consensus       254 ---------~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          254 ---------KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             ---------SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             ---------cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence                     00  0122234788999999999999999999753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=374.70  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=200.9

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEE
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  215 (490)
                      ..+.||+|+||.||+|.+..         +|..||+|++........+.+.+|+.+|..++||||+++++++.+.+..+|
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETA---------TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             EEEECC-----CEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEecCcCEEEEEEEEcC---------CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            35789999999999998875         677999999988776677789999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE--cCCCCeEEccccccccC
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL--DADYNAKLSDFGLAKDA  293 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl--~~~~~~kL~DFG~a~~~  293 (490)
                      ||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++..
T Consensus       164 v~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~  239 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY  239 (373)
T ss_dssp             EEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence            999999999999887643 36899999999999999999999988   9999999999999  56788999999999876


Q ss_pred             CCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          294 PEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       294 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .....   ....+||+.|+|||++.+..++.++|||||||++|||++|..||..........  ......+.        
T Consensus       240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~i~~~~~~--------  306 (373)
T 2x4f_A          240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN--NILACRWD--------  306 (373)
T ss_dssp             CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHHTCCC--------
T ss_pred             CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCC--------
Confidence            54322   233579999999999999999999999999999999999999997543211111  11110000        


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          +........+.++.+||.+||..||.+|||+.|++++
T Consensus       307 ----~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          307 ----LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ----SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0000011236789999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.9e-45  Score=360.71  Aligned_cols=262  Identities=26%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+           +|..||||++...   ....+..|.+++..  ++||||+++++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~   71 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-----------QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASD   71 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-----------CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence            346799999999999999999987           4668999998654   33455666666665  7899999999987


Q ss_pred             Eec----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCceE
Q 011234          208 IED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH--------EEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       208 ~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiHrDlkp~NIL  275 (490)
                      ...    ...++||||+++|+|.+++...   .+++..++.++.||+.||.|||        +.+   |+||||||+|||
T Consensus        72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nil  145 (301)
T 3q4u_A           72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNIL  145 (301)
T ss_dssp             EEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEE
T ss_pred             ccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEE
Confidence            653    4589999999999999999543   6899999999999999999999        766   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcc--eeeccccCCCCCCchhhhcC------CCCccccchhhHHHHHHHHhC------
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTG------  341 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGvil~elltG------  341 (490)
                      ++.++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|      
T Consensus       146 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~  225 (301)
T 3q4u_A          146 VKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI  225 (301)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             EcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence            9999999999999997654332211  12235799999999999876      455799999999999999999      


Q ss_pred             ----CCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccc-cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          342 ----RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRL-EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       342 ----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                          ..||............. .......      ...+.+ ...++...+..+.+||.+||+.||.+|||+.+|++.|+
T Consensus       226 ~~~~~~pf~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          226 VEDYKPPFYDVVPNDPSFEDM-RKVVCVD------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHH-HHHHTTS------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccccccCCCCcchhhh-hHHHhcc------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence                77876543332211110 0000000      000111 11122345788999999999999999999999999998


Q ss_pred             cc
Q 011234          417 PL  418 (490)
Q Consensus       417 ~l  418 (490)
                      .+
T Consensus       299 ~i  300 (301)
T 3q4u_A          299 KI  300 (301)
T ss_dssp             HH
T ss_pred             cc
Confidence            65

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-45  Score=376.36  Aligned_cols=269  Identities=23%  Similarity=0.330  Sum_probs=196.9

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCC-CCceeceee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLL-HPNLVKLVG  205 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-HpnIv~l~~  205 (490)
                      ...++|++.+.||+|+||.||+|.+..         +|..||||++...  .......+.+|+.+|..+. ||||+++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~   76 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRR---------TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN   76 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETT---------TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECC---------CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeee
Confidence            345689999999999999999998876         6789999998643  3344567889999999997 999999999


Q ss_pred             EEEecC--ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          206 YCIEDD--QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       206 ~~~~~~--~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ++..++  .+|+|||||+ ++|..++...   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus        77 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~k  149 (388)
T 3oz6_A           77 VLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVK  149 (388)
T ss_dssp             EEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             EEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEE
Confidence            998654  6899999996 6999988653   6889999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCC-------------------CcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCC
Q 011234          284 LSDFGLAKDAPEDG-------------------KTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       284 L~DFG~a~~~~~~~-------------------~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~  343 (490)
                      |+|||+++......                   .....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|++
T Consensus       150 l~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  229 (388)
T 3oz6_A          150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP  229 (388)
T ss_dssp             ECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCC
Confidence            99999998653211                   1112344689999999999986 679999999999999999999999


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhcc------------------CccccCC------------CChHhHHHHHHH
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLL------------------DPRLEGH------------FSIKGSQKATQL  393 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~------------~~~~~~~~l~~L  393 (490)
                      ||.+.........+.... .......+....                  .......            ....++.++.+|
T Consensus       230 pf~~~~~~~~~~~i~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  308 (388)
T 3oz6_A          230 IFPGSSTMNQLERIIGVI-DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL  308 (388)
T ss_dssp             SCCCSSHHHHHHHHHHHH-CCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhc-CCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence            997654322211111000 000000000000                  0000000            011336789999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 011234          394 AAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       394 i~~cL~~dP~~RPs~~evl~~  414 (490)
                      |.+||..||.+|||+.|+++|
T Consensus       309 l~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          309 LDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhhccCcccCCCHHHHhCC
Confidence            999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.8e-46  Score=369.23  Aligned_cols=277  Identities=27%  Similarity=0.375  Sum_probs=217.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      .++|++.+.||+|+||.||+|++...     ...++..||||++........+.+.+|+.+|+.++||||+++++++.. 
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPL-----GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTT-----SSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccC-----CCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            35799999999999999999986432     123788999999988776667789999999999999999999999874 


Q ss_pred             -cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          210 -DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 -~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                       ....++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccc
Confidence             4568999999999999999976432 5899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--hcccC
Q 011234          289 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--~~~~~  365 (490)
                      ++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......    .....  .....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~----~~~~~~~~~~~~  248 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE----FLRMMGCERDVP  248 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHCC----CC
T ss_pred             cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch----hhhhcccccccc
Confidence            998765433221 223356888999999999999999999999999999999999998542110    00000  00000


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ........+........+..++..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          249 ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             cHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0011111112222223344557899999999999999999999999999987744

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2e-45  Score=376.44  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCC--CCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL--HPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--HpnIv~l~~~  206 (490)
                      .++|++.+.||+|+||.||+|.+.          ++..||||++....  ......+.+|+.+|..|.  ||||++++++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~----------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~  124 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY  124 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC----------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence            356999999999999999999764          36689999987553  344567899999999996  5999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +..++.+||||| +.+++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+ ++.+||+|
T Consensus       125 ~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~D  197 (390)
T 2zmd_A          125 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLID  197 (390)
T ss_dssp             EECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECC
T ss_pred             EecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEe
Confidence            999999999999 55889999998765  6888899999999999999999988   99999999999995 58999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc-----------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      ||+++..............+||+.|+|||++.+           ..++.++|||||||+||||++|..||......    
T Consensus       198 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----  273 (390)
T 2zmd_A          198 FGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----  273 (390)
T ss_dssp             CSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----
T ss_pred             cCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----
Confidence            999987754433333345689999999999875           46889999999999999999999999643211    


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       ...          +..++++.....++...+..+.+||.+||..||.+|||+.||+++.
T Consensus       274 -~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          274 -ISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             -HHH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             -HHH----------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence             011          1112222222223333367899999999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-45  Score=358.36  Aligned_cols=250  Identities=28%  Similarity=0.431  Sum_probs=205.7

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.+++.++||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY   77 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEcc---------CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence            34679999999999999999998875         677899999865422   224568899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           78 FHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECS
T ss_pred             EecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEe
Confidence            999999999999999999999997764  6889999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++.......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+..       
T Consensus       153 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------  221 (279)
T 3fdn_A          153 FGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-------  221 (279)
T ss_dssp             CCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------
T ss_pred             ccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh-------
Confidence            99986554321    2345799999999999999999999999999999999999999975432111111100       


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                 ....++...+..+.+||.+||..||.+|||+.||+++-
T Consensus       222 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          222 -----------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             -----------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             -----------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                       01112223467899999999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-45  Score=391.32  Aligned_cols=257  Identities=32%  Similarity=0.437  Sum_probs=214.1

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      +..++|++.+.||+|+||.||+|++..         +|..||||++.....   .....+.+|+.+|..++|||||++++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~  251 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRA---------TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY  251 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence            345679999999999999999999875         678999999865422   23456789999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      ++.+.+.+||||||++||+|.+++...+...+++..++.++.||+.||.|||+.+   |+||||||+||||+.+|.+||+
T Consensus       252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEE
Confidence            9999999999999999999999998766556999999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.......   ....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+....  . 
T Consensus       329 DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i--~-  402 (576)
T 2acx_A          329 DLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--K-  402 (576)
T ss_dssp             CCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH--H-
T ss_pred             ecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh--h-
Confidence            9999987654322   234689999999999999999999999999999999999999997654322211111100  0 


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                             .    ....++...+.++.+||.+||..||.+||     ++.||++|
T Consensus       403 -------~----~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          403 -------E----VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             -------H----CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             -------c----ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                   0    01122334478999999999999999999     78999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.7e-45  Score=361.48  Aligned_cols=266  Identities=25%  Similarity=0.310  Sum_probs=201.5

Q ss_pred             cCCCcC-ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          132 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      +.|.+. +.||+|+||.||+|.+..         ++..||||++..........+.+|+.+|.++ .||||+++++++.+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~   82 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLI---------TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE   82 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSS---------SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcC---------CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            468884 789999999999998765         6779999999876555567889999999885 79999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC---eEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~D  286 (490)
                      .+..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~D  157 (316)
T 2ac3_A           83 EDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICD  157 (316)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred             CCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEE
Confidence            999999999999999999997764  6889999999999999999999988   999999999999988776   99999


Q ss_pred             ccccccCCCCCC-----cceeeccccCCCCCCchhhhc-----CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          287 FGLAKDAPEDGK-----THVSTRVMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       287 FG~a~~~~~~~~-----~~~~~~~~Gt~~y~aPE~l~~-----~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                      ||++........     .......+||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+....
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  237 (316)
T 2ac3_A          158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD  237 (316)
T ss_dssp             TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred             ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence            999976542211     111223569999999999875     5688999999999999999999999976543321100


Q ss_pred             HHhhhcccCCchhhh-hccCccccCCCC----hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          357 VEWARPHLGDKRRFY-RLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~-~~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .....+.  ....+. .+....  ..++    ...+..+.+||.+||..||.+|||+.|++++-
T Consensus       238 ~~~~~~~--~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          238 RGEACPA--CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             ---CCHH--HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             ccccchh--HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            0000000  000000 000000  0111    12367899999999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-45  Score=364.60  Aligned_cols=271  Identities=28%  Similarity=0.382  Sum_probs=217.3

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceecee
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLV  204 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~  204 (490)
                      +....++|++.+.||+|+||.||+|.+....    ...++..||||++..... ...+.+.+|+.++..+ +||||++++
T Consensus        22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSS----STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             eecchhheeeeeEEcCCCceeEEEEEEecCC----ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3445678999999999999999999875311    123678999999976543 3446788999999999 699999999


Q ss_pred             eEEEecC-ceEEEEEecCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011234          205 GYCIEDD-QRLLVYEFMPRGSLENHLFRKGS--------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       205 ~~~~~~~-~~~lv~E~~~~g~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      +++...+ ..++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.+   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9988765 58999999999999999976542              12789999999999999999999988   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCC
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKN  348 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~  348 (490)
                      ||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999999999987655433333445678999999999999999999999999999999998 99999764


Q ss_pred             CCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .....  ........              .....+...+..+.+||.+||+.||.+|||+.+|+++|+.+..
T Consensus       255 ~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          255 KIDEE--FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             CCSHH--HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhHH--HHHHhccC--------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            33221  11111000              0011122336789999999999999999999999999987643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-45  Score=371.36  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=204.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++......    ..+|+++|.++ .||||+++++++.+
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~   87 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKA---------TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD   87 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECC---------CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence            4569999999999999999999875         6789999999765432    34688888887 79999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC----CCeEEc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNAKLS  285 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~kL~  285 (490)
                      .+..|+|||||++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||+..+    +.+||+
T Consensus        88 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~  162 (342)
T 2qr7_A           88 GKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRIC  162 (342)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEE
Confidence            999999999999999999997664  6899999999999999999999988   9999999999998443    359999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+......   
T Consensus       163 Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---  237 (342)
T 2qr7_A          163 DFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---  237 (342)
T ss_dssp             CCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---
T ss_pred             ECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---
Confidence            9999987644322  22346899999999999988899999999999999999999999975432222222211110   


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .        ...+...+....+.++.+||.+||..||++||++.+++++-
T Consensus       238 ~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          238 G--------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             C--------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             C--------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            0        00111122234478899999999999999999999999763

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.4e-45  Score=384.35  Aligned_cols=250  Identities=27%  Similarity=0.374  Sum_probs=208.4

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ..++|.+.+.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+|+.++||||++++++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~   84 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHEL---------TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV   84 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETT---------TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            34679999999999999999999875         678999999975432   234568899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +...+..++||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~D  159 (476)
T 2y94_A           85 ISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIAD  159 (476)
T ss_dssp             EECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEe
Confidence            999999999999999999999997654  6899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||++.......   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......   +....     
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i-----  228 (476)
T 2y94_A          160 FGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKI-----  228 (476)
T ss_dssp             CSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHH-----
T ss_pred             ccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHH-----
Confidence            99998765432   2234689999999999988765 689999999999999999999997543211   11111     


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              .+...  ..+...+.++.+||.+||..||.+|||+.+|+++
T Consensus       229 --------~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          229 --------CDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             --------HTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --------hcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                    00000  1122336789999999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-45  Score=363.38  Aligned_cols=246  Identities=27%  Similarity=0.302  Sum_probs=196.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||+||+|.+..         +|..||||++....  ......+..|+..+..+ .||||+++++++.
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~  127 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKE---------DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE  127 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETT---------TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECC---------CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE
Confidence            469999999999999999999875         67799999986543  23334556666666555 8999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+ +++|.+++...+ ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       128 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          128 EGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCT
T ss_pred             eCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccce
Confidence            999999999999 779999887764 36999999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.......   ......||+.|+|||++.+ .++.++|||||||++|||++|..++....     .......       
T Consensus       203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~-------  266 (311)
T 3p1a_A          203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQLRQ-------  266 (311)
T ss_dssp             TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHHTT-------
T ss_pred             eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHhc-------
Confidence            998764432   2234579999999998875 79999999999999999999977664311     1111000       


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ......++...+..+.+||.+||+.||++|||+.|++++
T Consensus       267 -------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 -------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             -------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence                   000001112236889999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=370.53  Aligned_cols=254  Identities=26%  Similarity=0.323  Sum_probs=193.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+..         ++..||||++....  ..+.+.+|+.+|..++||||+++++++.+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~  119 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKG---------TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET  119 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECC---------CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec
Confidence            45679999999999999999999875         67789999997653  34567889999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~D  286 (490)
                      .+..++||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          120 PTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             SSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEcc
Confidence            999999999999999999997654  5899999999999999999999988   999999999999975   88999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++......   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......  ......   ...
T Consensus       195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i---~~~  266 (349)
T 2w4o_A          195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI---LNC  266 (349)
T ss_dssp             CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH---HTT
T ss_pred             CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH---HhC
Confidence            99998664321   2234679999999999999999999999999999999999999996543211  011100   000


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..        .....+....+.++.+||.+||..||++|||+.+++++-
T Consensus       267 ~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          267 EY--------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             CC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             CC--------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            00        000111123477899999999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=360.65  Aligned_cols=267  Identities=25%  Similarity=0.325  Sum_probs=202.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....  ...+.+.+|+.++..++||||+++++++..
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   73 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRD---------TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR   73 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCC---------CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence            579999999999999999999875         677999998865532  234567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           74 KRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            999999999999999988876554  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC---
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG---  365 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~---  365 (490)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+........   
T Consensus       149 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          149 ARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             CEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             chhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccc
Confidence            987653222  2234578999999999976 6789999999999999999999999976543322221111100000   


Q ss_pred             -----Cchhhh--hccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 -----DKRRFY--RLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 -----~~~~~~--~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           ....+.  ...++.....   .....+..+.+||.+||+.||.+|||+.|++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                 000000  0000000000   001236779999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.4e-45  Score=380.81  Aligned_cols=265  Identities=23%  Similarity=0.281  Sum_probs=199.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~  131 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT  131 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECC---------CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEc
Confidence            4689999999999999999998875         6789999999754  3344567889999999999999999999997


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ...      ..||||||+++ +|.+.+..    .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+
T Consensus       132 ~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~  203 (464)
T 3ttj_A          132 PQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  203 (464)
T ss_dssp             SCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCE
T ss_pred             cCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCE
Confidence            653      56999999965 57766632    4889999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-  361 (490)
                      ||+|||+++.....   ...+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+....+....+.... 
T Consensus       204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg  280 (464)
T 3ttj_A          204 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG  280 (464)
T ss_dssp             EECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999999876432   22345689999999999999999999999999999999999999997654322111110000 


Q ss_pred             -------ccc--------C-----CchhhhhccCccccC---CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 -------PHL--------G-----DKRRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 -------~~~--------~-----~~~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                             ..+        .     ....+...+...+..   ......+.++.+||.+||..||++|||+.|+++|-
T Consensus       281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence                   000        0     000000111000000   00111267899999999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.9e-45  Score=355.14  Aligned_cols=252  Identities=22%  Similarity=0.284  Sum_probs=206.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKG---------TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN   78 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCC---------CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3469999999999999999998865         6778999999776555667889999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEEccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DF  287 (490)
                      +..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           79 TDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             CeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            99999999999999999987764  5899999999999999999999988   9999999999999   78899999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+  ........
T Consensus       154 g~~~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~  227 (277)
T 3f3z_A          154 GLAARFKPGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--REGTFTFP  227 (277)
T ss_dssp             TTCEECCTTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCCCCC
T ss_pred             ccceeccCccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhCCCCCC
Confidence            99987654322   234579999999998865 4899999999999999999999999754321111111  00000000


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..            .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       228 ~~------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          228 EK------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HH------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ch------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00            000236789999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.4e-45  Score=376.42  Aligned_cols=200  Identities=29%  Similarity=0.416  Sum_probs=168.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~   95 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKN---------TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII   95 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECC---------CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence            4589999999999999999999875         6789999999754  3344567899999999999999999999998


Q ss_pred             ec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          209 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       209 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ..     ...|+||||+. ++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+|
T Consensus        96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~k  169 (432)
T 3n9x_A           96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVK  169 (432)
T ss_dssp             CSCTTTCCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEE
T ss_pred             cCCCCcCCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEE
Confidence            76     56899999995 69999987543  6899999999999999999999998   99999999999999999999


Q ss_pred             EccccccccCCCCCCc--------------------ceeeccccCCCCCCchhh-hcCCCCccccchhhHHHHHHHHhCC
Q 011234          284 LSDFGLAKDAPEDGKT--------------------HVSTRVMGTYGYAAPEYV-MTGHLTSKSDVYSFGVVLLEMLTGR  342 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~--------------------~~~~~~~Gt~~y~aPE~l-~~~~~~~~sDvwSlGvil~elltG~  342 (490)
                      |+|||+++........                    ...+..+||+.|+|||++ ....|+.++|||||||++|||++|.
T Consensus       170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~  249 (432)
T 3n9x_A          170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML  249 (432)
T ss_dssp             ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred             EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence            9999999876543211                    123457899999999986 4567999999999999999999855


Q ss_pred             CCC
Q 011234          343 RSM  345 (490)
Q Consensus       343 ~pf  345 (490)
                      .||
T Consensus       250 ~p~  252 (432)
T 3n9x_A          250 QSH  252 (432)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            444

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5.1e-45  Score=355.91  Aligned_cols=263  Identities=27%  Similarity=0.393  Sum_probs=210.0

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..++|.+.+.||+|+||.||+|.+....      +++..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHK------GEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTT------CCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCC------CCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            4567999999999999999999876532      246679999998653 344567899999999999999999999976


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      + +..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence            4 56789999999999999997653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++......... ......||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+..   .    
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~----  230 (281)
T 3cc6_A          159 LSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---G----  230 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---T----
T ss_pred             CCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---C----
Confidence            99876543221 1233467889999999999999999999999999999998 9999965432221111110   0    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                                .....+...+..+.+||.+||..||.+|||+.+++++|+.+...
T Consensus       231 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 ----------DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                      00011223367899999999999999999999999999877543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.3e-45  Score=361.72  Aligned_cols=274  Identities=29%  Similarity=0.422  Sum_probs=210.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|++....     ..++..||||++.... ......+.+|+.+|..++||||+++++++.+.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEG-----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTS-----SSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhccCCCCceEEEEEEEcccc-----CccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            45899999999999999999864322     2378899999997543 23346788999999999999999999999877


Q ss_pred             --CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 --~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                        ...++||||+++++|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence              668999999999999999965533 6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC-
Q 011234          289 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD-  366 (490)
Q Consensus       289 ~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-  366 (490)
                      ++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+....    ........+.... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~  247 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----ALFLKMIGPTHGQM  247 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----HHHHHHHCSCCGGG
T ss_pred             ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----hHHhhccCCccccc
Confidence            99876544322 22334578889999999999999999999999999999999998864210    0000000000000 


Q ss_pred             -chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 -KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 -~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                       ...+...+........+...+..+.+||.+||+.||.+|||+.++++.|+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence             0011111111112223344578899999999999999999999999999865

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-45  Score=363.44  Aligned_cols=265  Identities=25%  Similarity=0.419  Sum_probs=206.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ...+|.+.+.||+|+||.||+|.+...+.     ..+..||||++.... ......+.+|+.++..++||||+++++++.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCC-----CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            34578889999999999999998865321     134579999997653 234457889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence            9999999999999999999997653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          289 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +++......... ......||+.|+|||++.+..++.++|||||||++|||++ |..||......   .........   
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~~---  266 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAINDG---  266 (333)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHTT---
T ss_pred             cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHCC---
Confidence            998765432211 1223456789999999999999999999999999999998 99999654221   111111000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 .....+..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       267 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          267 -----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             -----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                       0011123347889999999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.6e-45  Score=367.89  Aligned_cols=251  Identities=26%  Similarity=0.334  Sum_probs=182.1

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l  215 (490)
                      .+.||+|+||.||+|.+..         +|..||||++...   ....+.+|+.+|..+. ||||+++++++.+....|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKK---------SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             SCCSEEETTEEEEEEEETT---------TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCccccCCCeEEEEEEECC---------CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            3789999999999999875         6779999999654   3456778999999997 9999999999999999999


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC---CeEEcccccccc
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY---NAKLSDFGLAKD  292 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~kL~DFG~a~~  292 (490)
                      ||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++.
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             EECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999999999998764  6899999999999999999999988   99999999999997665   799999999986


Q ss_pred             CCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc-hhHHhhhcccCCchhhh
Q 011234          293 APEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH-NLVEWARPHLGDKRRFY  371 (490)
Q Consensus       293 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  371 (490)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...+.........    
T Consensus       159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----  232 (325)
T 3kn6_A          159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----  232 (325)
T ss_dssp             CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC----
T ss_pred             cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC----
Confidence            644322  223467899999999999999999999999999999999999999764332111 1111111000000    


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ..+........+.++.+||.+||..||.+|||+.+++++
T Consensus       233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          233 ----FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             ----CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ----CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                000000112237889999999999999999999999865

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.9e-45  Score=369.36  Aligned_cols=275  Identities=17%  Similarity=0.236  Sum_probs=209.1

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH-----------HHHHHHHHHHhcCCCC
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-----------KEWLAEVNFLGNLLHP  198 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~Hp  198 (490)
                      ..++|++.+.||+|+||.||+|.+.....    ...+..||||++........           ..+..|+..+..+.||
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~  108 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSES----VGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYL  108 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSC----CCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccc----cccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence            34579999999999999999998865321    12467899999876643211           1245577788889999


Q ss_pred             ceeceeeEEEec----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          199 NLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       199 nIv~l~~~~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                      ||+++++++...    ...+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Ni  183 (364)
T 3op5_A          109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNL  183 (364)
T ss_dssp             CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred             CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHE
Confidence            999999998875    4589999999 999999997653 36999999999999999999999988   99999999999


Q ss_pred             EEc--CCCCeEEccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCC
Q 011234          275 LLD--ADYNAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       275 Ll~--~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~  347 (490)
                      ||+  .++.+||+|||+++........     ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            998  8899999999999866432211     111335699999999999999999999999999999999999999975


Q ss_pred             CCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ......  .........  ...+..++++.+.   ...++.++.+||.+||..||.+||++.+|++.|+.+..
T Consensus       264 ~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          264 NLKDPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             GTTCHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cccCHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            332211  111111000  0111112221111   11236789999999999999999999999999987644

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-45  Score=357.75  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=210.9

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +.+..++|++.+.||+|+||.||+|.+.          ++..||||.+.... ...+.+.+|+.+|+.++||||++++++
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV   76 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEc----------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            3445578999999999999999999874          35579999997654 235678999999999999999999998


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +. .+..++||||+++++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        77 ~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~D  152 (279)
T 1qpc_A           77 VT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD  152 (279)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred             Ec-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECC
Confidence            76 456899999999999999986543336899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||++........ .......|+..|+|||++.+..++.++|||||||++|||++ |..||......   .........  
T Consensus       153 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~~--  226 (279)
T 1qpc_A          153 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLERG--  226 (279)
T ss_dssp             CTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHTT--
T ss_pred             CcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHHHHHhcc--
Confidence            999987654321 22233457889999999998999999999999999999999 99999654321   111111000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                                  .....+...+..+.+||.+||..||++|||+.++++.|+.+.
T Consensus       227 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          227 ------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence                        011122234688999999999999999999999999998764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.2e-45  Score=352.57  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=211.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+.          ++..||+|++..... ..+.+.+|+.++..++||||+++++++.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   75 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   75 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeEecCCCceeEEEEEec----------CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            457999999999999999999875          355799999986543 346789999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        76 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           76 APICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             SSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             CCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccc
Confidence            99999999999999999997653 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ....... ........|+..|+|||++.+..++.++||||||+++|+|++ |..||.......   ........      
T Consensus       152 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~------  221 (267)
T 3t9t_A          152 RFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG------  221 (267)
T ss_dssp             GGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT------
T ss_pred             ccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcC------
Confidence            8664321 111223457889999999999999999999999999999999 899996542211   11111000      


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              .....+...+..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       222 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 --------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    0011122336789999999999999999999999999987754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=355.22  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=186.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++.....   ...+.+.+|+.++..++||||+++++++.
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   81 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIH---------TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE   81 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEcc---------CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc
Confidence            579999999999999999998865         677999999864422   12356889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           82 DSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeec
Confidence            9999999999999999999987653 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............      ...  
T Consensus       158 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--  227 (278)
T 3cok_A          158 LATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VLA--  227 (278)
T ss_dssp             TCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CSS--
T ss_pred             ceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hhc--
Confidence            99876432211  22357999999999999889999999999999999999999999754332111100      000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                            +    ...+...+.++.+||.+||..||++|||+.+++++-
T Consensus       228 ------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          228 ------D----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             ------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             ------c----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence                  0    012223467899999999999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-44  Score=356.57  Aligned_cols=263  Identities=26%  Similarity=0.422  Sum_probs=206.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE-
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI-  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-  208 (490)
                      ..+|++.+.||+|+||.||+|.+.....      ++..||+|.+.... ....+.+.+|+.++++++||||+++++++. 
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   97 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCC------ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc
Confidence            3468999999999999999998764321      45579999987643 344567889999999999999999999865 


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        98 ~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  173 (298)
T 3f66_A           98 SEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFG  173 (298)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCG
T ss_pred             CCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccc
Confidence            4567899999999999999997543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc--ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          289 LAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      +++........  .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||................    
T Consensus       174 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~----  249 (298)
T 3f66_A          174 LARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR----  249 (298)
T ss_dssp             GGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC----
T ss_pred             ccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC----
Confidence            99876443211  12234567889999999999999999999999999999999 556665443322211111000    


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                   ....+...+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       250 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          250 -------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                         001122236789999999999999999999999999987644

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-44  Score=360.86  Aligned_cols=254  Identities=24%  Similarity=0.321  Sum_probs=208.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcCCCCceecee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++......      ..+.+.+|+.+|..+.||||++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   81 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKS---------TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH   81 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECC---------CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEE
Confidence            3469999999999999999999875         6779999998754321      356789999999999999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC----
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----  280 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----  280 (490)
                      +++.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           82 DVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSC
T ss_pred             EEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcC
Confidence            99999999999999999999999997654  6899999999999999999999988   99999999999999887    


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......   .....
T Consensus       157 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i  230 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANI  230 (321)
T ss_dssp             CEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH
T ss_pred             CEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH
Confidence            799999999987654321   234579999999999999999999999999999999999999996543211   11110


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .....   .    .++.    +....+..+.+||.+||..||.+|||+.+++++-
T Consensus       231 ~~~~~---~----~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          231 TSVSY---D----FDEE----FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             HTTCC---C----CCHH----HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             Hhccc---c----cChh----hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            00000   0    0000    0112367899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-45  Score=355.35  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=210.5

Q ss_pred             hcCCCcCc-eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|.+.+ .||+|+||.||+|.+...       .++..||||++.... ....+.+.+|+.++..++||||+++++++ 
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HHHhhhhhccccccCceeEEEeEeccC-------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            34566766 999999999999987532       257789999998753 34456789999999999999999999998 


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      ..+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg  155 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG  155 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECccc
Confidence            5567899999999999999986543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          289 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.......   ........   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~---  229 (287)
T 1u59_A          156 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQG---  229 (287)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTT---
T ss_pred             ceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcC---
Confidence            99876543222 11223457889999999998999999999999999999998 999997543321   11111000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 ....++..++..+.+||.+||..||.+||++.+++++|+.+..
T Consensus       230 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          230 -----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       0112233457889999999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-44  Score=353.34  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=207.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKT---------TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   75 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcC---------CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence            4689999999999999999998875         67799999987543  234467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC---eEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN---AKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~kL~  285 (490)
                      +.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+
T Consensus        76 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           76 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEe
Confidence            9999999999999999999887764  6899999999999999999999988   999999999999976655   9999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...  ...
T Consensus       151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~  225 (284)
T 3kk8_A          151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AYD  225 (284)
T ss_dssp             CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCC
T ss_pred             eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--ccc
Confidence            9999987654322   23467999999999999999999999999999999999999999654321111111000  000


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                  .........+..+.+||.+||+.||++|||+.|++++
T Consensus       226 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          226 ------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ------------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                        0000111236789999999999999999999999976

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.9e-45  Score=365.52  Aligned_cols=266  Identities=22%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++......  ....+.+|+.+|+.++||||+++++++.
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTV---------TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH  103 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECC---------CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe
Confidence            3579999999999999999998875         6789999999755432  2346788999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-----CCCCeE
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-----ADYNAK  283 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-----~~~~~k  283 (490)
                      +++..++||||++ |+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+     .++.+|
T Consensus       104 ~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~k  177 (329)
T 3gbz_A          104 HNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLK  177 (329)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEE
T ss_pred             cCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEE
Confidence            9999999999996 59999997765  5899999999999999999999988   99999999999994     455699


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||+++......  ......+||+.|+|||++.+. .++.++|||||||++|||++|..||...........+.....
T Consensus       178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  255 (329)
T 3gbz_A          178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG  255 (329)
T ss_dssp             ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence            99999998654321  122345789999999999874 589999999999999999999999976433221111100000


Q ss_pred             ccCCchh-------------hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRR-------------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~-------------~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ......             +.......+...++...+.++.+||.+||..||.+|||+.|++++
T Consensus       256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          256 -LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             -CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence             000000             000000000000111236789999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.7e-45  Score=357.54  Aligned_cols=261  Identities=27%  Similarity=0.385  Sum_probs=208.7

Q ss_pred             hhcCCCcCc-eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          130 ATRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ..++|.+.+ .||+|+||.||+|.+...       .++..||||++.....  ...+++.+|+.++..++||||++++++
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCC-------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345788888 999999999999976532       2577899999976532  235678999999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      + ..+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEcc
Confidence            8 6678899999999999999997754  5899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhccc
Q 011234          287 FGLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ||++.......... ......|++.|+|||++.+..++.++|||||||++|+|++ |..||.......   .......  
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~--  235 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK--  235 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT--
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc--
Confidence            99998765433221 1223456789999999999899999999999999999999 999997543211   1111100  


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                  .....++..++..+.+||.+||+.||.+||++.+|++.|+.+..
T Consensus       236 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          236 ------------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             ------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                        00111233447889999999999999999999999999987643

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.9e-45  Score=380.70  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+++.+|+.+|+.++||||+++++++
T Consensus       180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          180 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhHceeeeeecCCCCeEEEEEEECC----------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3445679999999999999999998853          3469999998654 3356789999999999999999999998


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+ +..+|||||+++|+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       249 ~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence            76 67899999999999999997543346899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++....... .......+++.|+|||++.+..++.++|||||||+||||++ |..||.......   ........   
T Consensus       325 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~~---  397 (452)
T 1fmk_A          325 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERG---  397 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT---
T ss_pred             ccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---
Confidence            99987643321 12233457889999999999999999999999999999999 999997543211   11111000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 .....+..++..+.+||.+||..||++|||+.+|++.|+.+..
T Consensus       398 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          398 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                       0111233457889999999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-45  Score=370.35  Aligned_cols=261  Identities=27%  Similarity=0.440  Sum_probs=199.7

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe-c
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-D  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~  210 (490)
                      .|.+.+.||+|+||.||+|.+....      +.+..||||.+.... ....+.+.+|+.+|+.++||||+++++++.. +
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  163 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE  163 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT------TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC------CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            4778899999999999999986432      134579999987543 3455778999999999999999999998764 4


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       164 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          164 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             SCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccc
Confidence            67899999999999999997553 36889999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCc--ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +........  .......||+.|+|||++.+..++.++|||||||++|||++ |.+||...........+....      
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~------  313 (373)
T 3c1x_A          240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------  313 (373)
T ss_dssp             ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC------
T ss_pred             ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC------
Confidence            866433211  11233567889999999999999999999999999999999 677876544332211111000      


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 ....+..++..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       314 -----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          314 -----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             -----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                       001122346789999999999999999999999999987643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-45  Score=367.49  Aligned_cols=260  Identities=23%  Similarity=0.268  Sum_probs=201.2

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-----hhhHHHHHHHHHHHhcCCCCceece
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-----LQGHKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      ...++|++.+.||+|+||.||+|.+..         ++..||+|++....     ....+.+.+|+.+|+.++||||+++
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQ---------TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECC---------CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            344579999999999999999998865         67799999986442     2345678899999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcC--------------------------------------CCCCCHHHHHHH
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKG--------------------------------------SLPLPWSIRMKI  245 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------------------------------~~~l~~~~~~~i  245 (490)
                      ++++.+.+..++|||||++|+|.+++....                                      ...+++..+..+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            999999999999999999999999884210                                      112356778889


Q ss_pred             HHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC--CeEEccccccccCCCCC--CcceeeccccCCCCCCchhhhc--
Q 011234          246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY--NAKLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAPEYVMT--  319 (490)
Q Consensus       246 ~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~kL~DFG~a~~~~~~~--~~~~~~~~~Gt~~y~aPE~l~~--  319 (490)
                      +.||+.||.|||+.+   |+||||||+||||+.++  .+||+|||++.......  .........||+.|+|||++.+  
T Consensus       174 ~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          174 MRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            999999999999988   99999999999998776  89999999998653211  1112344679999999999975  


Q ss_pred             CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhh
Q 011234          320 GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS  399 (490)
Q Consensus       320 ~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~  399 (490)
                      ..++.++|||||||++|||++|+.||...........+  .....    .        +........+..+.+||.+||+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~----~--------~~~~~~~~~~~~~~~li~~~l~  316 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKL----C--------FENPNYNVLSPLARDLLSNLLN  316 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCC----C--------TTSGGGGGSCHHHHHHHHHHSC
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHH--Hhccc----c--------cCCcccccCCHHHHHHHHHHcC
Confidence            67899999999999999999999999654322111111  00000    0        0000011236789999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 011234          400 RDPKARPRMSEVVET  414 (490)
Q Consensus       400 ~dP~~RPs~~evl~~  414 (490)
                      .||.+||++.+++++
T Consensus       317 ~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          317 RNVDERFDAMRALQH  331 (345)
T ss_dssp             SCTTTSCCHHHHHHS
T ss_pred             CChhHCCCHHHHhcC
Confidence            999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.9e-45  Score=363.72  Aligned_cols=275  Identities=31%  Similarity=0.420  Sum_probs=212.5

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec-
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED-  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-  210 (490)
                      .|++.+.||+|+||.||+|.+...     ...+|..||||++.... ....+.+.+|+.+|+.++||||+++++++.+. 
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPT-----NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSC-----C--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             HHhhhheecCCCCeEEEEEEEccC-----CCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            359999999999999999977532     22378899999998654 23456789999999999999999999999884 


Q ss_pred             -CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          211 -DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       211 -~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       ...++||||+++|+|.+++...   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             CceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence             5789999999999999999765   4899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +......... .......||..|+|||++.+..++.++|||||||++|+|++|..||....... .....+.... ....
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~-~~~~  258 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQ-MTVL  258 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHH-HHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccc-hhHH
Confidence            9877544322 22334568889999999999999999999999999999999999985421100 0000000000 0000


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .+...+........+..++..+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  310 (318)
T 3lxp_A          259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE  310 (318)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1111111222223344557899999999999999999999999999987754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1e-44  Score=352.25  Aligned_cols=255  Identities=26%  Similarity=0.355  Sum_probs=207.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   77 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEeecCCCcEEEEEEECC---------CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence            569999999999999999998865         67799999986543 23456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           78 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCc
Confidence            99999999999999999886543  6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      ................||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ ....+....     .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----~  226 (276)
T 2yex_A          153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK-----T  226 (276)
T ss_dssp             EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTC-----T
T ss_pred             cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcc-----c
Confidence            86543322223345679999999999987665 7799999999999999999999976433211 111111100     0


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         ..      ......+..+.+||.+||..||.+|||+.+++++-
T Consensus       227 ---~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          227 ---YL------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (276)
T ss_dssp             ---TS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             ---cc------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence               00      00123367899999999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1e-44  Score=384.18  Aligned_cols=256  Identities=26%  Similarity=0.377  Sum_probs=210.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|.+.++||+|+||.||+|++..         +|..||||++.....   .....+.+|+.+|..++||||+++++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~---------tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKA---------TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            4689999999999999999999875         678999999975432   2345678999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      .+.+.+||||||++||+|.+++....  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.+|.+||+
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEe
Confidence            99999999999999999999987653  346899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||...........+  ......
T Consensus       332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~~~i~~  407 (543)
T 3c4z_A          332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQRVLE  407 (543)
T ss_dssp             CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--HHHHHH
T ss_pred             ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--HHHHhh
Confidence            9999987654322  123468999999999999999999999999999999999999999765332211111  111100


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~-----~evl~~  414 (490)
                                .  ...++...+..+.+||.+||..||.+||++     .+|+++
T Consensus       408 ----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          408 ----------Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ----------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ----------c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                      0  012233447889999999999999999965     677754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-45  Score=369.07  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=207.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||+|++.... ....+.+.+|+.+|..++||||+++++++.
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  101 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY  101 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECC---------CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence            35689999999999999999999875         67799999997653 334567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      +++..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+. +   |+||||||+||||+.++.+||+||
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Df  176 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  176 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEEC
Confidence            9999999999999999999997765  588999999999999999999985 7   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh------
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR------  361 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~------  361 (490)
                      |++......    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................      
T Consensus       177 g~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3eqc_A          177 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  252 (360)
T ss_dssp             CCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred             CCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence            998754221    1234579999999999999999999999999999999999999997543211100000000      


Q ss_pred             ----------------cccCCchhhhh----ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 ----------------PHLGDKRRFYR----LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ----------------~~~~~~~~~~~----~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                      ...........    +.............+.++.+||.+||+.||.+|||+.+++++-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                            00000000000    0000001111122367899999999999999999999999764

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-44  Score=357.16  Aligned_cols=264  Identities=26%  Similarity=0.366  Sum_probs=202.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .+|++.+.||+|+||.||+|.+..         +|..||||++...   .......+.+|+.+++.++||||+++++++.
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  102 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLL---------DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI  102 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETT---------TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcC---------CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            469999999999999999998865         5779999998753   2334567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      ..+..++||||+++++|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~D  179 (310)
T 2wqm_A          103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGD  179 (310)
T ss_dssp             ETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             cCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEe
Confidence            999999999999999999998642  2346899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||++........  ......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..........   
T Consensus       180 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---  253 (310)
T 2wqm_A          180 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQC---  253 (310)
T ss_dssp             C--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHHHHTT---
T ss_pred             ccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHHhhcc---
Confidence            999986643221  1234578999999999999999999999999999999999999996543211 1111111000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCcc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~~  423 (490)
                            ...+    ......+.++.+||.+||..||.+|||+.+|++.|+.+.....
T Consensus       254 ------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          254 ------DYPP----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             ------CSCC----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ------cCCC----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence                  0000    0112336789999999999999999999999999998876544

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.5e-45  Score=364.43  Aligned_cols=267  Identities=27%  Similarity=0.386  Sum_probs=207.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+....    ...++..||||++.... ......+.+|+.++..+.||||+++++++.+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP----NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC----CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            457999999999999999999864311    11267899999997543 3445678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCC
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGS-----LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYN  281 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~  281 (490)
                      .+..++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence            9999999999999999999986542     34889999999999999999999988   999999999999984   446


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......   ......
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~  258 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV  258 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH
Confidence            99999999975533322222334578999999999999999999999999999999998 99999654221   111111


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      ...              .....+..++..+.+||.+||..||.+||++.+|+++|+.+...
T Consensus       259 ~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          259 TSG--------------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcC--------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            100              00112233467899999999999999999999999999877554

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-44  Score=357.66  Aligned_cols=267  Identities=24%  Similarity=0.362  Sum_probs=201.7

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC--CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL--LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~~~  206 (490)
                      ...++|++.+.||+|+||.||+|.+           +|..||||++....   ...+..|.+++..+  +||||++++++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~   99 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKW-----------RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAA   99 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEE-----------CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEE
Confidence            3446799999999999999999987           35689999986442   23445566666554  89999999999


Q ss_pred             EEec----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc--------CCCCeeecCCCCCce
Q 011234          207 CIED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE--------AEKPVIYRDFKTSNI  274 (490)
Q Consensus       207 ~~~~----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~~~~iiHrDlkp~NI  274 (490)
                      +...    ...++||||+++|+|.+++...   .+++..++.++.||+.||.|||+.        +   |+||||||+||
T Consensus       100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Ni  173 (337)
T 3mdy_A          100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNI  173 (337)
T ss_dssp             EEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGE
T ss_pred             EccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHE
Confidence            9887    6789999999999999999654   589999999999999999999987        6   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcc--eeeccccCCCCCCchhhhcCCCCcc------ccchhhHHHHHHHHhC-----
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTGHLTSK------SDVYSFGVVLLEMLTG-----  341 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~~~~~~------sDvwSlGvil~elltG-----  341 (490)
                      ||+.++.+||+|||++..........  .....+||+.|+|||++.+..++..      +|||||||++|||++|     
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            99999999999999997664432211  1124579999999999987776665      9999999999999999     


Q ss_pred             -----CCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCC-CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          342 -----RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       342 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                           ..||............ ... ...     .....+.+... .+..++..+.+||.+||+.||.+|||+.+|+++|
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~-~~~-~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  326 (337)
T 3mdy_A          254 IVEEYQLPYHDLVPSDPSYED-MRE-IVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL  326 (337)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHH-HHH-HHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ccccccccHhhhcCCCCchhh-hHH-HHh-----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHH
Confidence                 5555433222211100 000 000     00011111111 1125688899999999999999999999999999


Q ss_pred             hccccCc
Q 011234          416 KPLQNLK  422 (490)
Q Consensus       416 ~~l~~~~  422 (490)
                      +.+....
T Consensus       327 ~~l~~~~  333 (337)
T 3mdy_A          327 AKMSESQ  333 (337)
T ss_dssp             HHHHHTT
T ss_pred             HHHHhhc
Confidence            9876543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-44  Score=360.28  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=206.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcE--EEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..  ||+|.+.... ....+.+.+|+.+|..+ +||||+++++++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKK---------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEE---------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEcc---------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            579999999999999999999876         4444  5999887532 23345688999999999 899999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                      .+.+..++||||+++++|.+++....              ...+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~N  172 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARN  172 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccce
Confidence            99999999999999999999997643              236899999999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCC
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNG  352 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~  352 (490)
                      ||++.++.+||+|||+++.....   .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~  249 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE  249 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence            99999999999999999754321   11223457889999999999999999999999999999998 999996543211


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                         ......              .......+...+..+.+||.+||..||.+|||+.+++++|..+...
T Consensus       250 ---~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          250 ---LYEKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             ---HHHHGG--------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---HHHHhh--------------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence               111110              0011122334478899999999999999999999999999876543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.3e-45  Score=355.25  Aligned_cols=252  Identities=28%  Similarity=0.362  Sum_probs=199.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|.+.+.||+|+||.||+|.+..         +|..||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   92 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERS---------SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY   92 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hheeecceeccCCCeEEEEEEEcc---------CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence            368999999999999999998865         67799999987653 23456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEEc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLS  285 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~  285 (490)
                      +..++||||+++|+|.+++...  ....+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~  169 (285)
T 3is5_A           93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKII  169 (285)
T ss_dssp             SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEE
Confidence            9999999999999999988543  2246899999999999999999999988   9999999999999   456789999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++.......   ......||+.|+|||++. ..++.++|||||||++|+|++|..||.................   
T Consensus       170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~---  242 (285)
T 3is5_A          170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP---  242 (285)
T ss_dssp             CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---
T ss_pred             eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc---
Confidence            999998664432   123467999999999875 5789999999999999999999999975432211111111000   


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                 .... .....+..+.+||.+||+.||.+|||+.||+++
T Consensus       243 -----------~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          243 -----------NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -----------CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             -----------cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0000 001126788999999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=6.9e-45  Score=366.17  Aligned_cols=269  Identities=17%  Similarity=0.211  Sum_probs=202.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-----------HHHHHHHHHHHhcCCCCc
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------HKEWLAEVNFLGNLLHPN  199 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~Hpn  199 (490)
                      .++|.+.+.||+|+||.||+|.+...+.      ++..||||++.......           ...+.+|+.++..+.|||
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n  109 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE------KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG  109 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCG------GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCC------ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence            4579999999999999999999875322      46689999987653221           123667899999999999


Q ss_pred             eeceeeEEEe----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          200 LVKLVGYCIE----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       200 Iv~l~~~~~~----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      |+++++++..    ....++||||+ +++|.+++...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  183 (345)
T 2v62_A          110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLL  183 (345)
T ss_dssp             CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEE
Confidence            9999999988    67889999999 999999987665  7899999999999999999999988   999999999999


Q ss_pred             EcCCC--CeEEccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 011234          276 LDADY--NAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       276 l~~~~--~~kL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~  348 (490)
                      |+.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  263 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN  263 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98877  9999999999866432111     1113457999999999999999999999999999999999999999643


Q ss_pred             CCCCcchhHHhhhcccCCc-hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          349 RPNGEHNLVEWARPHLGDK-RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       349 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ....... ........... ..+.....       ....+.++.+||.+||..||++||++.+|++.|+.+.
T Consensus       264 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          264 LKDPVAV-QTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             TTCHHHH-HHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccccHHH-HHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            2211111 00000000000 00000000       0123678999999999999999999999999998763

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=366.33  Aligned_cols=264  Identities=23%  Similarity=0.331  Sum_probs=193.8

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYC  207 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~  207 (490)
                      +...+|++.+.||+|+||.||+|.+..         +|..||||++..........+.+|+.++..+. ||||+++++++
T Consensus        25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~   95 (337)
T 3ll6_A           25 LGELRLRVRRVLAEGGFAFVYEAQDVG---------SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA   95 (337)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             ccCceEEEEEEEccCCceEEEEEEECC---------CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence            344579999999999999999999865         67799999987776666778899999999996 99999999998


Q ss_pred             Ee--------cCceEEEEEecCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC
Q 011234          208 IE--------DDQRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       208 ~~--------~~~~~lv~E~~~~g~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      ..        ....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+.+ .+|+||||||+||||+.
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECT
T ss_pred             cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECC
Confidence            53        335799999995 7999988652 2336999999999999999999999865 34999999999999999


Q ss_pred             CCCeEEccccccccCCCCCCcc----------eeeccccCCCCCCchhh---hcCCCCccccchhhHHHHHHHHhCCCCC
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTH----------VSTRVMGTYGYAAPEYV---MTGHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~----------~~~~~~Gt~~y~aPE~l---~~~~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                      ++.+||+|||++..........          ......||+.|+|||++   .+..++.++|||||||++|+|++|..||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            9999999999998765432211          11135689999999998   5667899999999999999999999999


Q ss_pred             CCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCcc
Q 011234          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD  423 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~~  423 (490)
                      ........   ..                 ...........+..+.+||.+||+.||.+|||+.|++++|+.+.....
T Consensus       254 ~~~~~~~~---~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          254 EDGAKLRI---VN-----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             cchhHHHh---hc-----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            64322110   00                 000000111124568899999999999999999999999988765433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-44  Score=353.97  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=207.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .|.+.+.||+|+||.||+|.+.....      ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   95 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ------NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE   95 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS------CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred             EEccCceeccCCCceEEEEEEecCCC------ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence            46677999999999999999865322      455799999876433 44567889999999999999999999998766


Q ss_pred             ce-EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          212 QR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       212 ~~-~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      .. ++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             CCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCc
Confidence            55 99999999999999997643 36899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCc--ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCC-CCCCCCCcchhHHhhhcccCCc
Q 011234          291 KDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSM-DKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       291 ~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf-~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +........  .......||+.|+|||.+.+..++.++|||||||++|+|++|..|+ .......   ........    
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~----  244 (298)
T 3pls_A          172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFLAQG----  244 (298)
T ss_dssp             CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHHHTT----
T ss_pred             ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHhhcC----
Confidence            865432211  1123356789999999999999999999999999999999965554 3322211   11111100    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                .....+...+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       245 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          245 ----------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      0011122346789999999999999999999999999987643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.9e-45  Score=363.52  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=208.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++....   ....+.+.+|+.+++.+.||||+++++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  110 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF  110 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4579999999999999999999875         67799999987542   23456788999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          111 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred             ecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeec
Confidence            99999999999999999999987654  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++.........  .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.  .    . 
T Consensus       186 g~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~----~-  256 (335)
T 2owb_A          186 GLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK--K----N-  256 (335)
T ss_dssp             TTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--H----T-
T ss_pred             cCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh--c----C-
Confidence            999876433221  234679999999999999999999999999999999999999996532111100000  0    0 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             .    ..++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       257 -------~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          257 -------E----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -------C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -------C----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0    01122336788999999999999999999999865

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.5e-45  Score=366.14  Aligned_cols=249  Identities=28%  Similarity=0.405  Sum_probs=203.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..|.+.+.||+|+||.||+|++..         +|..||||++.....   ...+.+.+|+.+|..++||||+++++++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEcc---------CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            358999999999999999998865         678999999975432   23456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      .++..++||||+. |+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeecc
Confidence            9999999999996 68888876543 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ++......      ...+||+.|+|||++.   ...++.++|||||||++|||++|..||........  +......   
T Consensus       200 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~---  268 (348)
T 1u5q_A          200 SASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN---  268 (348)
T ss_dssp             TCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHS---
T ss_pred             CceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhc---
Confidence            99865432      2357999999999985   56789999999999999999999999965422111  0000000   


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                              ..+.   ..+...+..+.+||.+||+.||++|||+.+++++..
T Consensus       269 --------~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          269 --------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             --------CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             --------CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence                    0000   111233678999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=366.19  Aligned_cols=245  Identities=23%  Similarity=0.296  Sum_probs=205.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--------hHHHHHHHHHHHhcCCCCceec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++......        ....+.+|+.+|..++||||++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~   93 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKE---------KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK   93 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETT---------TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCC
T ss_pred             ccceEEEeEEEecCCEEEEEEEECC---------CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEee
Confidence            4579999999999999999998875         6789999999765321        2235678999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          203 LVGYCIEDDQRLLVYEFMPRG-SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      +++++.+.+..++||||+.+| +|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~  168 (335)
T 3dls_A           94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFT  168 (335)
T ss_dssp             EEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCc
Confidence            999999999999999999776 9999987654  6899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||++........   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....        ..
T Consensus       169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~  237 (335)
T 3dls_A          169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TV  237 (335)
T ss_dssp             EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GT
T ss_pred             EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HH
Confidence            99999999987654322   234679999999999988776 7899999999999999999999954210        00


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .    .      ..      ..+...+.++.+||.+||+.||.+|||+.+++++-.
T Consensus       238 ~----~------~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          238 E----A------AI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             T----T------CC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             h----h------cc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            0    0      00      111123678999999999999999999999998743

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.5e-45  Score=375.48  Aligned_cols=243  Identities=18%  Similarity=0.203  Sum_probs=192.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC---ChhhHHHHHHHH---HHHhcCCCCceecee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD---GLQGHKEWLAEV---NFLGNLLHPNLVKLV  204 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~HpnIv~l~  204 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++...   .....+.+.+|+   ++|+.++|||||+++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-C---------CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEECC---------CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            4679999999999999999998765         6779999998743   334456788999   555666899999998


Q ss_pred             -------eEEEecCc-----------------eEEEEEecCCCCHHHHHhhcCCC-----CCCHHHHHHHHHHHHHHHHH
Q 011234          205 -------GYCIEDDQ-----------------RLLVYEFMPRGSLENHLFRKGSL-----PLPWSIRMKIALGAAKGLAF  255 (490)
Q Consensus       205 -------~~~~~~~~-----------------~~lv~E~~~~g~L~~~l~~~~~~-----~l~~~~~~~i~~qi~~aL~y  255 (490)
                             +++.+.+.                 .||||||+ +|+|.+++...+..     .+++..++.++.||+.||.|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   66665532                 78999999 68999999764321     23357888899999999999


Q ss_pred             hhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-----------CCCc
Q 011234          256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-----------HLTS  324 (490)
Q Consensus       256 LH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----------~~~~  324 (490)
                      ||+.+   |+||||||+||||+.++.+||+|||+++....     .....+| +.|+|||++.+.           .++.
T Consensus       222 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~  292 (377)
T 3byv_A          222 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTF  292 (377)
T ss_dssp             HHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCH
T ss_pred             HHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCCh
Confidence            99988   99999999999999999999999999986432     2344678 999999999887           8999


Q ss_pred             cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC
Q 011234          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  404 (490)
Q Consensus       325 ~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~  404 (490)
                      ++|||||||+||||++|+.||...........+                ...      ....+..+.+||.+||..||.+
T Consensus       293 ~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~~------~~~~~~~~~~li~~~L~~dp~~  350 (377)
T 3byv_A          293 SFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FRS------CKNIPQPVRALLEGFLRYPKED  350 (377)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GSS------CCCCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hhh------ccCCCHHHHHHHHHHcCCCchh
Confidence            999999999999999999999654332211111                000      0122678999999999999999


Q ss_pred             CCCHHHHHHH
Q 011234          405 RPRMSEVVET  414 (490)
Q Consensus       405 RPs~~evl~~  414 (490)
                      |||+.+++++
T Consensus       351 Rpt~~e~l~h  360 (377)
T 3byv_A          351 RLLPLQAMET  360 (377)
T ss_dssp             CCCHHHHHTS
T ss_pred             CCCHHHHhhC
Confidence            9999999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.9e-45  Score=354.30  Aligned_cols=251  Identities=29%  Similarity=0.435  Sum_probs=207.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ...+|++.+.||+|+||.||+|.+..         +|..||+|++....    ..+.+|+.++..++||||+++++++..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRI---------DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDG   75 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETT---------TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEcC---------CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence            34569999999999999999999875         57799999997654    346689999999999999999998864


Q ss_pred             ----------------cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCc
Q 011234          210 ----------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSN  273 (490)
Q Consensus       210 ----------------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~N  273 (490)
                                      ....++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~N  152 (284)
T 2a19_B           76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSN  152 (284)
T ss_dssp             EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred             cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHH
Confidence                            345799999999999999997665557999999999999999999999988   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      ||++.++.+||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...     
T Consensus       153 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  224 (284)
T 2a19_B          153 IFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----  224 (284)
T ss_dssp             EEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----
T ss_pred             EEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----
Confidence            9999999999999999987654322   23457999999999999999999999999999999999999886311     


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      .....             .+....    ++...+..+.+||.+||..||.+|||+.+++++|+.+...
T Consensus       225 ~~~~~-------------~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          225 SKFFT-------------DLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHH-------------HHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHHH-------------Hhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            00000             011111    1122367789999999999999999999999999877553

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=353.88  Aligned_cols=254  Identities=23%  Similarity=0.289  Sum_probs=203.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||+|++.....    .....+.+|+.+++.++||||++++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSE---------TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTT---------TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECC---------CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            4689999999999999999998765         677999999975432    334678899999999999999999999


Q ss_pred             EE--ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          207 CI--EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       207 ~~--~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      +.  +.+..++||||+.++ |.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEe
Confidence            85  445789999999765 888887665567999999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      +|||++................||+.|+|||++.+..  ++.++|||||||++|+|++|..||......   ........
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~  227 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY---KLFENIGK  227 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH---HHHHHHhc
Confidence            9999998765433333334567999999999987644  377999999999999999999999753211   11111000


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         .        .    ..++..++..+.+||.+||..||.+|||+.+++++-
T Consensus       228 ---~--------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          228 ---G--------S----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             ---C--------C----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             ---C--------C----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence               0        0    012223467899999999999999999999999763

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-44  Score=356.54  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=205.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||+|++..........+.+|+.++..++||||+++++++.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRL---------TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST   78 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hccceeeeeccCCCCceEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence            3469999999999999999999865         6779999999866544456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEEccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~DF  287 (490)
                      +..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           79 THYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             CEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccC
Confidence            99999999999999999987665  6889999999999999999999988   9999999999999   78899999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ..........   
T Consensus       154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~---  223 (304)
T 2jam_A          154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGY---  223 (304)
T ss_dssp             STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCC---
T ss_pred             CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCC---
Confidence            999765332    123357999999999999999999999999999999999999999654321   1111110000   


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .        .....+....+..+.+||.+||..||.+|||+.+++++-
T Consensus       224 ~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          224 Y--------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             C--------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             C--------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            0        001111223468899999999999999999999999863

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=8.8e-45  Score=360.28  Aligned_cols=264  Identities=27%  Similarity=0.346  Sum_probs=207.6

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++........+.+.+|+.+++.++||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLH---------DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecC---------CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            34679999999999999999999865         677999999877666667788999999999999999999999873


Q ss_pred             ----cCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          210 ----DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ----~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                          ....++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~k  174 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPV  174 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEE
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEE
Confidence                34789999999999999998752  2346899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcc-------eeeccccCCCCCCchhhhcCC---CCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          284 LSDFGLAKDAPEDGKTH-------VSTRVMGTYGYAAPEYVMTGH---LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~-------~~~~~~Gt~~y~aPE~l~~~~---~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      |+|||++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........
T Consensus       175 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  254 (317)
T 2buj_A          175 LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD  254 (317)
T ss_dssp             ECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred             EEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc
Confidence            99999987653211100       012246799999999987543   68899999999999999999999953111100


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      . .......              ......+...+..+.+||.+||..||.+|||+.+|+++|+.++.
T Consensus       255 ~-~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          255 S-VALAVQN--------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             C-HHHHHHC--------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             h-hhHHhhc--------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            0 0000000              00011112336789999999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.5e-44  Score=354.83  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||+|++....   ....+.+.+|+.+++.+.||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDAD---------TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF   84 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECC---------CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence            3579999999999999999999875         67799999986542   23456788999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           85 EDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             ccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence            99999999999999999999887654  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++.........  .....||+.|+|||++.+..++.++||||||+++|+|++|..||........   ...   ..   
T Consensus       160 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~---~~---  228 (294)
T 2rku_A          160 GLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET---YLR---IK---  228 (294)
T ss_dssp             TTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHH---HH---
T ss_pred             cCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH---Hh---
Confidence            999876433221  2346799999999999988899999999999999999999999965432111   000   00   


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                             ..  ...++...+..+.+||.+||+.||++|||+.+++++-
T Consensus       229 -------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          229 -------KN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             -------TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             -------hc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                   00  0012223367899999999999999999999998653

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.8e-45  Score=354.07  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=201.8

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+           +|..||||++....  ..+.+.+|+.++..++||||+++++++.+
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (278)
T 1byg_A           19 NMKELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE   85 (278)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE-----------TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             ChhhceEEeEEecCCCceEEEEEE-----------cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence            346799999999999999999976           35689999997653  44678899999999999999999999765


Q ss_pred             c-CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          210 D-DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       210 ~-~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      . +..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             C--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecc
Confidence            5 47899999999999999997654334789999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++.......     ....+++.|+|||++.+..++.++|||||||++|+|++ |..||........   .....      
T Consensus       163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~------  228 (278)
T 1byg_A          163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE------  228 (278)
T ss_dssp             C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHT------
T ss_pred             ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh------
Confidence            987654321     22467899999999999999999999999999999998 9999975432211   11110      


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              .......+...+..+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       229 --------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          229 --------KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             --------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence                    001112233447889999999999999999999999999988754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=371.43  Aligned_cols=277  Identities=22%  Similarity=0.270  Sum_probs=214.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|++..         +|..||||++..... ...+.+.+|+.+|+.++||||+++++++..
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKK---------TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECC---------CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            3579999999999999999999875         677999999975432 335667899999999999999999999987


Q ss_pred             cC--ceEEEEEecCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE----cCCCCe
Q 011234          210 DD--QRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DADYNA  282 (490)
Q Consensus       210 ~~--~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~  282 (490)
                      .+  ..++|||||++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  155 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVY  155 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEE
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeE
Confidence            65  6799999999999999987643 223899999999999999999999988   9999999999999    777889


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc--------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCC-c
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG-E  353 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~-~  353 (490)
                      ||+|||+++......   .....+||+.|+|||++.+        ..++.++|||||||++|||++|+.||....... .
T Consensus       156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~  232 (396)
T 4eut_A          156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN  232 (396)
T ss_dssp             EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred             EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence            999999998764432   1234679999999999875        567889999999999999999999996543222 1


Q ss_pred             chhHHhhhcccCC-c-hhhhh--------ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCc
Q 011234          354 HNLVEWARPHLGD-K-RRFYR--------LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       354 ~~~~~~~~~~~~~-~-~~~~~--------~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~  422 (490)
                      ............. . .....        ..+......++...+..+.+||.+||..||++||++.++++.+..+.+.+
T Consensus       233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence            1111111000000 0 00000        00001122345667889999999999999999999999999998765543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.3e-44  Score=353.55  Aligned_cols=248  Identities=26%  Similarity=0.396  Sum_probs=207.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.....   .....+.+|+.++..++||||+++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQ---------NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcC---------CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            3579999999999999999998865         677899999865422   2245688999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+.+..++||||+++++|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCC
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecc
Confidence            99999999999999999999997765  6889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++.......    .....|++.|+|||++.+..++.++|||||||++|+|++|..||........   ..   ....  
T Consensus       159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~---~~~~--  226 (284)
T 2vgo_A          159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HR---RIVN--  226 (284)
T ss_dssp             TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HH---HHHT--
T ss_pred             cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HH---HHhc--
Confidence            9987654321    2345799999999999999999999999999999999999999965422111   00   0000  


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                            .+    ..++...+..+.+||.+||..||.+||++.+++++
T Consensus       227 ------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          227 ------VD----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ------TC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ------cc----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                  00    11223346789999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=366.51  Aligned_cols=260  Identities=17%  Similarity=0.179  Sum_probs=206.5

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCceecee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLV  204 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~  204 (490)
                      .+..++|.+.+.||+|+||.||+|.+....    ...++..||||++.....   .++..|+.++..+.   |+||+.++
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLN----DAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-----------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCc----ccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            345678999999999999999999643211    112678999999976543   45667777777776   99999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRK---GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---  278 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---  278 (490)
                      +++...+..+||||||++|+|.+++...   ....+++..++.++.||+.||.|||+.+   ||||||||+||||+.   
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence            9999999999999999999999999752   2346999999999999999999999988   999999999999998   


Q ss_pred             --------CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 011234          279 --------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       279 --------~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~  350 (490)
                              ++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999765432333344567899999999999999999999999999999999999999853321


Q ss_pred             CCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCC-CCHHHHHHHhhccc
Q 011234          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKAR-PRMSEVVETLKPLQ  419 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~R-Ps~~evl~~L~~l~  419 (490)
                      ...      .             ....+.. +  ..+..+.+++..||+.+|.+| |++.++.+.|+.+.
T Consensus       291 ~~~------~-------------~~~~~~~-~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          291 GEC------K-------------PEGLFRR-L--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             TEE------E-------------ECSCCTT-C--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             Cce------e-------------echhccc-c--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            100      0             0000000 0  126778899999999999999 67888888887653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.7e-45  Score=395.54  Aligned_cols=253  Identities=26%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcC-CCCceece
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNL-LHPNLVKL  203 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~HpnIv~l  203 (490)
                      ....++|++++.||+|+||.||+|++..         ++..||||+++....   ...+.+..|..+|..+ +||||+.+
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~---------~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l  407 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKG---------TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL  407 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESS---------SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECC---------CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            3456789999999999999999999875         677999999975421   2335678899999988 69999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ++++.+.+.+||||||+++|+|.+++...+  .+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+|
T Consensus       408 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          408 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             EEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEE
T ss_pred             EEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEE
Confidence            999999999999999999999999998765  6899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+++.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||......   .+..   ..
T Consensus       483 L~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~---~i  554 (674)
T 3pfq_A          483 IADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ---SI  554 (674)
T ss_dssp             ECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HH
T ss_pred             EeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHH---HH
Confidence            999999986443322  234578999999999999999999999999999999999999999764321   1111   11


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM-----SEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~-----~evl~~  414 (490)
                      +          ...  ..++...+.++.+||.+||..||.+||++     .||+++
T Consensus       555 ~----------~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          555 M----------EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             H----------SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             H----------hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            1          111  12333457899999999999999999997     777765

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-44  Score=355.81  Aligned_cols=260  Identities=23%  Similarity=0.284  Sum_probs=202.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++.....   ...+.+.+|+.++..++||||+++++++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~  103 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTV---------RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG  103 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcC---------CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence            4679999999999999999998865         677999999875532   2346788999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      ..++..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       104 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Df  178 (309)
T 2h34_A          104 EIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDF  178 (309)
T ss_dssp             EETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSC
T ss_pred             eeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecC
Confidence            99999999999999999999997764  6899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ............ 
T Consensus       179 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~-  253 (309)
T 2h34_A          179 GIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIPR-  253 (309)
T ss_dssp             CC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCCC-
T ss_pred             ccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCCC-
Confidence            999866443221 223457999999999999999999999999999999999999999753211   111111000000 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-s~~evl~~L~~l~~  420 (490)
                                 ....+...+..+.+||.+||..||.+|| ++.++++.|+.+..
T Consensus       254 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 -----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             -----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             -----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                       0112223467899999999999999999 99999999986644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.4e-44  Score=371.95  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=196.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCce
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNL  200 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnI  200 (490)
                      ...++|.+.+.||+|+||.||+|.+..         ++..||||++.....        .....+.+|+.+|++++||||
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni  202 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI  202 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECC---------CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE
Confidence            445789999999999999999999876         678999999875421        112247889999999999999


Q ss_pred             eceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          201 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       201 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +++++++. .+..++||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       203 v~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~  276 (419)
T 3i6u_A          203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQE  276 (419)
T ss_dssp             CCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSS
T ss_pred             eeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCC
Confidence            99999975 456899999999999999886654  6899999999999999999999988   99999999999996544


Q ss_pred             ---CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          281 ---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       281 ---~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                         .+||+|||+++.....   ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........ 
T Consensus       277 ~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-  352 (419)
T 3i6u_A          277 EDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-  352 (419)
T ss_dssp             SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-
T ss_pred             CcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-
Confidence               5999999999876432   22345689999999999853   6788899999999999999999999975433221 


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       +.........   .+    .+..    ....+..+.+||.+||+.||.+|||+.|++++-
T Consensus       353 -~~~~i~~~~~---~~----~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          353 -LKDQITSGKY---NF----IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             -HHHHHHTTCC---CC----CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             -HHHHHhcCCC---CC----Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence             1111110000   00    0000    012367899999999999999999999999874

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-44  Score=365.70  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~   94 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   94 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence            3579999999999999999998865         6789999998654  2233567889999999999999999999998


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..+      .+|+||||+ +++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~  167 (367)
T 1cm8_A           95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL  167 (367)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             cCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCE
Confidence            763      459999999 88999998763   5899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.....     .+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....
T Consensus       168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  242 (367)
T 1cm8_A          168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  242 (367)
T ss_dssp             EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999999875432     234678999999999987 689999999999999999999999997654322111110000


Q ss_pred             cc--------cCC--chhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PH--------LGD--KRRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~--------~~~--~~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..        +..  ...+...+.....   .......+..+.+||.+||..||.+|||+.+++++
T Consensus       243 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          243 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            00        000  0000000000000   01122347889999999999999999999999987

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.5e-45  Score=389.52  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=212.0

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .+..++|++.+.||+|+||.||+|.+..          +..||||+++... ...+++.+|+.+|+.|+||||+++++++
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~----------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETT----------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECC----------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3455679999999999999999998863          3469999998654 3356799999999999999999999998


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+ +..+||||||.+|+|.++|.......+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       332 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  407 (535)
T 2h8h_A          332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  407 (535)
T ss_dssp             CS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCT
T ss_pred             ee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccc
Confidence            66 67899999999999999997543346899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+++...... ........++..|+|||++.+..++.++|||||||+||||++ |..||.......   ........   
T Consensus       408 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~~~---  480 (535)
T 2h8h_A          408 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVERG---  480 (535)
T ss_dssp             TSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHHTT---
T ss_pred             ccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC---
Confidence            9998764321 111223456789999999999999999999999999999999 999996543211   11111000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                                 .....+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       481 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          481 -----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                       0111223457889999999999999999999999999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=365.14  Aligned_cols=268  Identities=22%  Similarity=0.323  Sum_probs=198.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhH-HHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~-~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||.||+|.+..         ++..||||++........ ..+.+|+.+|+.++||||+++++++.+.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   72 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKL---------TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE   72 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS
T ss_pred             CceEEEEEEcCCCCEEEEEEEECC---------CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC
Confidence            479999999999999999999875         677999999875532211 2355799999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||++ |+|.+++...+. .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        73 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           73 KSLTLVFEYLD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             SCEEEEEECCS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             CEEEEEecccc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccc
Confidence            99999999996 699998876643 6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc------
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH------  363 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~------  363 (490)
                      .......  ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......      
T Consensus       148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  225 (324)
T 3mtl_A          148 RAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETW  225 (324)
T ss_dssp             ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhc
Confidence            8654322  12234578999999999876 57899999999999999999999999765432221111110000      


Q ss_pred             --cCCchhhhhccCccccC----CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          364 --LGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       364 --~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                        ......+.....+....    ......+.++.+||.+||+.||.+|||+.|++++-
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          226 PGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             TTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             hhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence              00000000000000000    00112367889999999999999999999999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=355.17  Aligned_cols=255  Identities=31%  Similarity=0.500  Sum_probs=198.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+.           +..||||.+...  ...+.+.+|+.+|++++||||+++++++.  
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--   71 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-----------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--   71 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-----------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-----------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence            357899999999999999999873           558999998754  34567899999999999999999999876  


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC-eEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSL-PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-AKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-~kL~DFG  288 (490)
                      +..++||||+++|+|.+++...... .+++..++.++.||+.||.|||+.+.++|+||||||+|||++.++. +||+|||
T Consensus        72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg  151 (307)
T 2eva_A           72 NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG  151 (307)
T ss_dssp             TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCC
T ss_pred             CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccc
Confidence            4589999999999999999765422 4788899999999999999999943234999999999999988886 7999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+...      
T Consensus       152 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~-~~~~~~------  218 (307)
T 2eva_A          152 TACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-R-IMWAVH------  218 (307)
T ss_dssp             C-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-H-HHHHHH------
T ss_pred             cccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-H-HHHHHh------
Confidence            99765332     1234699999999999999999999999999999999999999975432211 0 101000      


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                         ....+    ......+..+.+||.+||..||.+|||+.++++.|+.+..
T Consensus       219 ---~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          219 ---NGTRP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ---TTCCC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ---cCCCC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence               00001    1122336789999999999999999999999999987754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-44  Score=371.03  Aligned_cols=200  Identities=22%  Similarity=0.325  Sum_probs=175.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC------CCCceecee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL------LHPNLVKLV  204 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~  204 (490)
                      ..+|++.+.||+|+||.||+|.+..         ++..||||++.... .....+.+|+.++..+      .|+||++++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~---------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~  165 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHK---------VHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHML  165 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECC---------CCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence            4579999999999999999998875         67899999997643 3345677788887776      578999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--e
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--A  282 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~  282 (490)
                      +++...+..++||||+. ++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.  +
T Consensus       166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             EEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCE
T ss_pred             eecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcce
Confidence            99999999999999995 79999998776667999999999999999999999998   999999999999999887  9


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~  349 (490)
                      ||+|||++......     ....+||+.|+|||++.+..++.++|||||||+||||++|.+||....
T Consensus       242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            99999999765432     223579999999999999999999999999999999999999997654

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5e-44  Score=350.74  Aligned_cols=264  Identities=19%  Similarity=0.225  Sum_probs=206.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE-Ee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC-IE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++......  ..+.+|+.++..+.|++++..+.++ ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcC---------CCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence            4689999999999999999999865         6789999987654322  3577899999999988877766655 56


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~D  286 (490)
                      .+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~D  151 (296)
T 4hgt_A           77 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECC
T ss_pred             CCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEec
Confidence            67789999999 999999987543 36899999999999999999999988   9999999999999   7889999999


Q ss_pred             ccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          287 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       287 FG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus       152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 4hgt_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence            9999876543221     12234679999999999999999999999999999999999999998655443333222111


Q ss_pred             -cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          362 -PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       362 -~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                       ......       .+.+    ....+..+.+||.+||+.||++|||+.+|++.|+.+...
T Consensus       232 ~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          232 EKKMSTP-------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHHHSC-------HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccccch-------hhhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence             000000       0000    012267899999999999999999999999999877553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-44  Score=361.97  Aligned_cols=263  Identities=20%  Similarity=0.275  Sum_probs=208.9

Q ss_pred             hhhHHHhhcCCCcC-ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCC-CCc
Q 011234          124 FNDLKLATRNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL-HPN  199 (490)
Q Consensus       124 ~~~~~~~~~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-Hpn  199 (490)
                      +.......++|.+. +.||+|+||.||+|.+..         +|..||||++....  ......+.+|+.++..+. |||
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   90 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKS---------TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR   90 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCC
Confidence            34444555678887 899999999999999875         67799999987543  233567889999999995 699


Q ss_pred             eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-
Q 011234          200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-  278 (490)
Q Consensus       200 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-  278 (490)
                      |+++++++.+.+..++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++. 
T Consensus        91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSI  167 (327)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCB
T ss_pred             EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecC
Confidence            9999999999999999999999999999987655557999999999999999999999988   999999999999987 


Q ss_pred             --CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          279 --DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       279 --~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                        ++.+||+|||+++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  244 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN  244 (327)
T ss_dssp             TTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence              78999999999987643321   2346799999999999999999999999999999999999999965432211111


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      +...              ............+..+.+||.+||+.||.+|||+.+++++-
T Consensus       245 i~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          245 ISQV--------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             HHHT--------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             HHhc--------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence            1100              00011111223477899999999999999999999999763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.6e-44  Score=379.48  Aligned_cols=252  Identities=26%  Similarity=0.343  Sum_probs=201.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++....  ......+.+|+.+|+.++||||+++++++.
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  106 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKV---------THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE  106 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETT---------TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECC---------CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3469999999999999999999875         67799999987653  223467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCeEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNAKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~kL~  285 (490)
                      +.+..|+|||||.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.   ++.+||+
T Consensus       107 ~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          107 DKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEE
Confidence            9999999999999999999987764  6899999999999999999999988   999999999999976   4459999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++.......   .....+||+.|+|||++. ..|+.++|||||||++|+|++|.+||...........+....... 
T Consensus       182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~-  256 (494)
T 3lij_A          182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTF-  256 (494)
T ss_dssp             CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-
T ss_pred             ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-
Confidence            999998765432   223467999999999876 569999999999999999999999997643322111111100000 


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              ..+     .....+..+.+||.+||+.||.+|||+.+++++
T Consensus       257 --------~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 --------DSP-----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             --------CSG-----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             --------Cch-----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                    000     011236789999999999999999999999976

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.1e-44  Score=378.87  Aligned_cols=254  Identities=25%  Similarity=0.322  Sum_probs=204.6

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-------------hhHHHHHHHHHHHhcCC
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------------QGHKEWLAEVNFLGNLL  196 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~  196 (490)
                      ..++|.+.+.||+|+||.||+|.+..         ++..||||++.....             ...+.+.+|+.+|+.++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  104 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKN---------GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD  104 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETT---------TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC
T ss_pred             cccceEEEeEecccCCeEEEEEEECC---------CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC
Confidence            35689999999999999999999875         677999999875432             22457889999999999


Q ss_pred             CCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       197 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      ||||+++++++.+....++|||||++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus       105 hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          105 HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILL  179 (504)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEE
Confidence            9999999999999999999999999999999997764  6899999999999999999999988   9999999999999


Q ss_pred             cCCC---CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          277 DADY---NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       277 ~~~~---~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      +.++   .+||+|||++.......   .....+||+.|+|||++. +.++.++|||||||++|+|++|..||........
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            8776   69999999998765432   223467999999999886 5699999999999999999999999976433221


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...+.......  ...            .....+.++.+||.+||..||.+|||+.|++++-
T Consensus       256 ~~~i~~~~~~~--~~~------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          256 IKKVEKGKYYF--DFN------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             HHHHHHCCCCC--CHH------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHcCCCCC--Ccc------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            11111100000  000            0012367899999999999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=9.3e-44  Score=349.05  Aligned_cols=265  Identities=19%  Similarity=0.227  Sum_probs=209.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE-Ee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC-IE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~  209 (490)
                      .++|++.+.||+|+||.||+|++..         +|..||||++......  ..+.+|+.++..+.|++++..+.++ ..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~   76 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAE   76 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcC---------CCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence            4689999999999999999999865         6789999998765432  4578999999999988877666655 55


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~D  286 (490)
                      .+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|
T Consensus        77 ~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           77 GDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEee
Confidence            67789999999 999999997543 36999999999999999999999988   9999999999999   4888999999


Q ss_pred             ccccccCCCCCCcc-----eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          287 FGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       287 FG~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||++..........     ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            99998765432211     1234679999999999999999999999999999999999999998654433322221111


Q ss_pred             c-ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCc
Q 011234          362 P-HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       362 ~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~  422 (490)
                      . .....       .+.+    ....+..+.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus       232 ~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          232 EKKMSTP-------IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHSC-------HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ccccCCc-------hHHH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            0 00000       0000    1123678999999999999999999999999998775543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-44  Score=352.54  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=203.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcCCCCceeceee
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||+|++......      ..+.+.+|+.++..++||||+++++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   75 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKG---------TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD   75 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcC---------CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhh
Confidence            469999999999999999999875         6779999998754321      3567899999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC----C
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----N  281 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----~  281 (490)
                      ++.+.+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           76 IFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCC
T ss_pred             eecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCc
Confidence            9999999999999999999999997654  6899999999999999999999988   99999999999998877    8


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+... 
T Consensus       151 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-  226 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-  226 (283)
T ss_dssp             EEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-
T ss_pred             eEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc-
Confidence            99999999987644321   23457999999999999999999999999999999999999999754321111100000 


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ...            .........+..+.+||.+||..||.+|||+.+++++
T Consensus       227 -~~~------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          227 -NYD------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -CCC------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -ccC------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence             000            0000011226789999999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-44  Score=362.93  Aligned_cols=272  Identities=24%  Similarity=0.300  Sum_probs=200.6

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-----HHHHHHHHHHHhcCCCCceece
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGNLLHPNLVKL  203 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l  203 (490)
                      ...++|++.+.||+|+||.||+|.+..         +|..||||++.......     .+.+.+|+.++..++||||+++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   77 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL   77 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECC---------CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence            345689999999999999999998865         67799999987543221     2357899999999999999999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ++++.+.+..++||||+++ +|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           78 LDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             EEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             EEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEE
Confidence            9999999999999999965 8988886543 36888899999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--  360 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--  360 (490)
                      |+|||+++.......  .....+||+.|+|||++.+. .++.++|||||||++|||++|.+||...........+...  
T Consensus       153 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~  230 (346)
T 1ua2_A          153 LADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG  230 (346)
T ss_dssp             ECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcC
Confidence            999999987643322  22346799999999999764 5899999999999999999999999765322111111000  


Q ss_pred             hcccCCchhhhhccCccccCC--------CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          361 RPHLGDKRRFYRLLDPRLEGH--------FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~--------~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      .+............+......        .....+.++.+||.+||..||.+|||+.|++++-.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             CCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence            000000000000000000000        01233688999999999999999999999998743

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=358.19  Aligned_cols=277  Identities=25%  Similarity=0.373  Sum_probs=214.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+...     ...+|..||||++........+.+.+|+.+|+.++||||+++++++...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  114 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPL-----QDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA  114 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTT-----SSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccc-----cCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence            35689999999999999999986431     1237889999999877666677899999999999999999999998765


Q ss_pred             C--ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          211 D--QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       211 ~--~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +  ..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCc
Confidence            4  7899999999999999997764 36899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          289 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       289 ~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++.......... ......|+..|+|||++.+..++.++|||||||++|+|++|..||.....    .............
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~~~~~  266 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGNDKQGQ  266 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTTCCTH
T ss_pred             chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccccchh
Confidence            998765433221 12234578889999999999999999999999999999999998753200    0000000000000


Q ss_pred             ---hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 ---RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ---~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                         ..+...+........+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence               00011111111112233457889999999999999999999999999987643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=365.92  Aligned_cols=259  Identities=28%  Similarity=0.365  Sum_probs=206.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      ++|++.+.||+|+||.||+|++....      .+|..||||+++....    ...+.+.+|+.+|..+ +||||++++++
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccC------CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            57999999999999999999885321      2688999999875421    2234567799999999 69999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +...+..+|||||+++|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEee
Confidence            999999999999999999999997764  6899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ||+++...... .......+||+.|+|||++.+  ..++.++|||||||+||||++|+.||...........+  .....
T Consensus       203 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~  279 (355)
T 1vzo_A          203 FGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRIL  279 (355)
T ss_dssp             SSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHH
T ss_pred             CCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHh
Confidence            99998664322 222334689999999999985  35788999999999999999999999754332221111  11000


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHhh
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVETLK  416 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~L~  416 (490)
                      .        .    ...++...+..+.+||.+||..||.+||     ++.+++++..
T Consensus       280 ~--------~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          280 K--------S----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             H--------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             c--------c----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence            0        0    0122334477899999999999999999     9999998764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-44  Score=351.23  Aligned_cols=247  Identities=21%  Similarity=0.253  Sum_probs=201.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++....  .....++.+|+.++..+ .||||+++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~   80 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRL---------DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW   80 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcC---------CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            4579999999999999999999875         67799999987642  33456788999999999 899999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC------
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------  279 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------  279 (490)
                      .+.+..++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+      
T Consensus        81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~  157 (289)
T 1x8b_A           81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAA  157 (289)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------
T ss_pred             ecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccc
Confidence            99999999999999999999997642  136899999999999999999999988   9999999999999844      


Q ss_pred             -------------CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCC
Q 011234          280 -------------YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       280 -------------~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                                   ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|.+++
T Consensus       158 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~  231 (289)
T 1x8b_A          158 SEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP  231 (289)
T ss_dssp             ------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCC
Confidence                         479999999998764421      23589999999999865 6678999999999999999998876


Q ss_pred             CCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ....     ........           ..    ..++...+..+.+||.+||..||.+|||+.+++++-
T Consensus       232 ~~~~-----~~~~~~~~-----------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          232 RNGD-----QWHEIRQG-----------RL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             SSSH-----HHHHHHTT-----------CC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             cchh-----HHHHHHcC-----------CC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            4221     11111000           00    112223478899999999999999999999999764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.2e-45  Score=363.33  Aligned_cols=267  Identities=27%  Similarity=0.405  Sum_probs=201.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++.....  ...+.+.+|+.++..++||||+++++++.+
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKD---------TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETT---------TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECC---------CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            479999999999999999999875         677999999865432  334567899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~  170 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGF  170 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCC
Confidence            999999999999988888765543  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh-ccc---
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR-PHL---  364 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~---  364 (490)
                      +........  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.... ...   
T Consensus       171 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (331)
T 4aaa_A          171 ARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH  248 (331)
T ss_dssp             C--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence            986543322  22345799999999999875 78999999999999999999999997653322111110000 000   


Q ss_pred             ----CCchhhhhccCccccCC-----CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 ----GDKRRFYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ----~~~~~~~~~~~~~l~~~-----~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          .....+.....+.+...     .....+..+.+||.+||+.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00000000000111110     011337889999999999999999999999876

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-44  Score=380.71  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++....   ......+.+|+.+|+.++||||+++++++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~   95 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKI---------TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF   95 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECC---------CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3469999999999999999999875         67899999986543   23456789999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEE
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKL  284 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL  284 (490)
                      .+.+..++|||||.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl  170 (484)
T 3nyv_A           96 EDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRI  170 (484)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEE
T ss_pred             EeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEE
Confidence            99999999999999999999997654  6899999999999999999999988   9999999999999   56789999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||+++.......   ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...........+...... 
T Consensus       171 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~-  245 (484)
T 3nyv_A          171 IDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT-  245 (484)
T ss_dssp             CCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-
T ss_pred             EeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            99999987654322   234579999999998865 7999999999999999999999999764322211111110000 


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                   .........+..+.+||.+||+.||.+|||+.+++++-
T Consensus       246 -------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          246 -------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             -------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             -------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence                         00001123378899999999999999999999999863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.5e-44  Score=374.10  Aligned_cols=266  Identities=21%  Similarity=0.241  Sum_probs=210.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC-CceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++......  .++..|++++..|.| ++|..+..++..
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~   74 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQ---------TNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVE   74 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETT---------TCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECC---------CCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            4689999999999999999999865         6779999988755322  357889999999986 566666667777


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE---cCCCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL---DADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~kL~D  286 (490)
                      .+..+|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+   ||||||||+||||   +.++.+||+|
T Consensus        75 ~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~D  149 (483)
T 3sv0_A           75 GDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIID  149 (483)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECC
T ss_pred             CCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEe
Confidence            88889999999 999999997543 36999999999999999999999988   9999999999999   6889999999


Q ss_pred             ccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          287 FGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       287 FG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+++........     ......+||+.|+|||++.+..++.++||||||||||||++|+.||................
T Consensus       150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~  229 (483)
T 3sv0_A          150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS  229 (483)
T ss_dssp             CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred             CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence            9999876543221     11235689999999999999999999999999999999999999998755443333222111


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCc
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~  422 (490)
                      ...     +...+ ..+.    ..++.++.+||.+||..||++||++.+|++.|+.+....
T Consensus       230 ~~~-----~~~~~-~~l~----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          230 EKK-----VATSI-EALC----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHH-----HHSCH-HHHH----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcc-----ccccH-HHHh----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            000     00000 0000    122678999999999999999999999999998775533

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.6e-44  Score=378.69  Aligned_cols=252  Identities=26%  Similarity=0.350  Sum_probs=204.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|.+..         +|..||||++....  ......+.+|+.+|+.++||||+++++++.+
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETT---------TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECC---------CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            469999999999999999999875         67799999986432  2235678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc---CCCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~D  286 (490)
                      .+..|+|||||.+|+|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+||||+   .++.+||+|
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEE
Confidence            999999999999999999987765  6899999999999999999999988   99999999999995   456799999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+++......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||...........+......   
T Consensus       168 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~---  240 (486)
T 3mwu_A          168 FGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA---  240 (486)
T ss_dssp             CSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---
T ss_pred             CCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---
Confidence            99998764432   1234679999999998875 5999999999999999999999999764322111111100000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                 .........+.++.+||.+||..||.+|||+.+++++-
T Consensus       241 -----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          241 -----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             -----------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             -----------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence                       00001123378899999999999999999999999873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.5e-44  Score=386.61  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=205.1

Q ss_pred             cCCCcCc-eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|.+.+ .||+|+||.||+|.+...       +++..||||+++... ....+++.+|+++|+.++|||||++++++..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMR-------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECS-------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecC-------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            3445555 799999999999988642       146689999998653 2356789999999999999999999999876


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                       +..+||||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       408 -~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGl  482 (613)
T 2ozo_A          408 -EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGL  482 (613)
T ss_dssp             -SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCST
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccC
Confidence             56899999999999999997553 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      ++........ .......+++.|+|||++.+..++.++|||||||+||||++ |+.||...........+.   .     
T Consensus       483 a~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~-----  554 (613)
T 2ozo_A          483 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---Q-----  554 (613)
T ss_dssp             TTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH---T-----
T ss_pred             cccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c-----
Confidence            9876543221 11122346789999999999999999999999999999998 999997654322111111   0     


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                               ......+..++..+.+||.+||..||++||++.+|++.|+.+
T Consensus       555 ---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          555 ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     001122334578999999999999999999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.7e-44  Score=349.15  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=201.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +.|++.+.||+|+||.||+|.+..         ++..||+|++....  ....+.+.+|+.+|+.++||||+++++++..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecC---------CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            458889999999999999998865         67789999987543  3345678899999999999999999999876


Q ss_pred             ----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-CCCCeEE
Q 011234          210 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKL  284 (490)
Q Consensus       210 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL  284 (490)
                          ....++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl  173 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKI  173 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEE
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEE
Confidence                345899999999999999997754  6889999999999999999999865 3499999999999997 7899999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      +|||++......    ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.......  ......... 
T Consensus       174 ~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~-  245 (290)
T 1t4h_A          174 GDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSG-  245 (290)
T ss_dssp             CCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTT-
T ss_pred             eeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHhcc-
Confidence            999999765432    123457999999999876 569999999999999999999999996532211  111111000 


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                  .....++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       246 ------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          246 ------------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ------------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------------CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                        00011112225789999999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-44  Score=356.28  Aligned_cols=266  Identities=25%  Similarity=0.387  Sum_probs=189.6

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+..++|++.+.||+|+||.||+|.+..         ++..||||++..... ....++.+|+.++..++||||++++++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   81 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAP---------KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS   81 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC-------------CEEEEECCC----------------CCCCCCCTTBCCEEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECC---------CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEE
Confidence            3456789999999999999999998765         577899999875432 334568899999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRK------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +...+..++||||+++++|.+++...      ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~  158 (303)
T 2vwi_A           82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDG  158 (303)
T ss_dssp             EESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred             EeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCC
Confidence            99999999999999999999998641      2336899999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCC---cceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          281 NAKLSDFGLAKDAPEDGK---THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~---~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                      .+||+|||++........   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus       159 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  238 (303)
T 2vwi_A          159 SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML  238 (303)
T ss_dssp             CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred             CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence            999999999976543221   111234579999999999876 5789999999999999999999999976543221111


Q ss_pred             HHhhhcccCCchhhh-hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          357 VEWARPHLGDKRRFY-RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .  ...   ...... ...++    ......+..+.+||.+||+.||.+|||+.+++++
T Consensus       239 ~--~~~---~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          239 T--LQN---DPPSLETGVQDK----EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             H--HTS---SCCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             H--hcc---CCCccccccccc----hhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0  000   000000 00011    1112236789999999999999999999999976

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=348.82  Aligned_cols=254  Identities=23%  Similarity=0.335  Sum_probs=202.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|....+||+|+||.||+|.+..         ++..||||.+........+.+.+|+.+++.++||||+++++++...+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   92 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLS---------NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG   92 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETT---------TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cCCCCcEEEeecCcEEEEEEEECC---------CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence            345566699999999999999865         67799999998766556677899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCCeEEccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGL  289 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~kL~DFG~  289 (490)
                      ..++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++. ++.+||+|||+
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~  169 (295)
T 2clq_A           93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGT  169 (295)
T ss_dssp             EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred             cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeeccc
Confidence            9999999999999999997653 335678889999999999999999988   999999999999987 89999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCC--CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      +........  ......||+.|+|||++.+..  ++.++|||||||++|+|++|+.||........ .....  ..    
T Consensus       170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~--~~----  240 (295)
T 2clq_A          170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKV--GM----  240 (295)
T ss_dssp             CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-HHHHH--HH----
T ss_pred             ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-HHHhh--cc----
Confidence            987643221  123457999999999997653  88999999999999999999999954221110 00000  00    


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          ....    ..++...+..+.+||.+||..||++||++.+++++
T Consensus       241 ----~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          241 ----FKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ----HCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ----cccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                0011    12233447889999999999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.1e-44  Score=361.72  Aligned_cols=255  Identities=25%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHhcC-CCCc
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNL-LHPN  199 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l-~Hpn  199 (490)
                      ...++|.+.+.||+|+||.||+|.+..         +|..||||++.....        ...+.+.+|+.++..+ .|||
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~---------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~  161 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRA---------TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH  161 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECC---------CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            345679999999999999999999865         677999999875431        1134577899999999 7999


Q ss_pred             eeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          200 LVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       200 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      |+++++++...+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus       162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN  236 (365)
T ss_dssp             BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred             EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence            9999999999999999999999999999997654  6899999999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC------CCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      +.+||+|||++........   ....+||+.|+|||++.+.      .++.++|||||||++|+|++|..||......  
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--  311 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--  311 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--
Confidence            9999999999987654322   2346899999999998743      5888999999999999999999999653211  


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       .........   ...+   ..+..     ...+..+.+||.+||..||.+|||+.+++++
T Consensus       312 -~~~~~i~~~---~~~~---~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          312 -LMLRMIMEG---QYQF---SSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -HHHHHHHHT---CCCC---CHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHHHHHhC---CCCC---CCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             111111000   0000   00000     1125779999999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.8e-44  Score=360.52  Aligned_cols=270  Identities=24%  Similarity=0.311  Sum_probs=203.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++.....  .....+.+|+.+|..++||||+++++++..
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   87 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   87 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETT---------TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cceeEEEEEecCCCcEEEEEEECC---------CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeec
Confidence            579999999999999999999865         677999999865432  223567899999999999999999999887


Q ss_pred             c--------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          210 D--------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 ~--------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      .        +..++||||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           88 KASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             C--------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             cccccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCC
Confidence            3        46899999996 58887776543 36899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCC--cceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          282 AKLSDFGLAKDAPEDGK--THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +||+|||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........+.
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  242 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  242 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999986643221  122244678999999999876 568999999999999999999999997654332222221


Q ss_pred             hhhcccCC-----ch--hhhhccCccccCCCCh-------HhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          359 WARPHLGD-----KR--RFYRLLDPRLEGHFSI-------KGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       359 ~~~~~~~~-----~~--~~~~~~~~~l~~~~~~-------~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ........     ..  ..+..+..........       ..+..+.+||.+||+.||.+|||+.|++++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            11100000     00  0000000000000000       0146689999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-44  Score=350.83  Aligned_cols=260  Identities=23%  Similarity=0.328  Sum_probs=206.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII   75 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECC---------CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            3579999999999999999998875         67799999997653  234567889999999999999999999886


Q ss_pred             e--cCceEEEEEecCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCceEEcCCCCe
Q 011234          209 E--DDQRLLVYEFMPRGSLENHLFRKG--SLPLPWSIRMKIALGAAKGLAFLHEEA--EKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~--~~~~~lv~E~~~~g~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      +  ....++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.+  ..+|+||||||+|||++.++.+
T Consensus        76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~  155 (279)
T 2w5a_A           76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNV  155 (279)
T ss_dssp             EGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCE
T ss_pred             cCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCE
Confidence            4  567899999999999999987532  335899999999999999999999866  2349999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||++........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   ........
T Consensus       156 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i~~  230 (279)
T 2w5a_A          156 KLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE  230 (279)
T ss_dssp             EECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred             EEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHHhh
Confidence            9999999987643321  123457999999999999999999999999999999999999999754321   11111100


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .          .    ...++...+.++.+||.+||..||.+||++.+|++++..-
T Consensus       231 ~----------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          231 G----------K----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             T----------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             c----------c----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            0          0    0012223478899999999999999999999999887654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.6e-44  Score=358.03  Aligned_cols=271  Identities=23%  Similarity=0.358  Sum_probs=197.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHH--HHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN--FLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~--~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+           ++..||||++....   ...+..|.+  .+..+.||||+++++++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~   76 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-----------DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGD   76 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-----------TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-----------CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecc
Confidence            346799999999999999999976           46789999997543   233444444  45568999999999865


Q ss_pred             Eec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCCeeecCCCCCc
Q 011234          208 IED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE---------AEKPVIYRDFKTSN  273 (490)
Q Consensus       208 ~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~~~~iiHrDlkp~N  273 (490)
                      ...     ..+++||||+++|+|.+++...   ..++..+..++.||+.||.|||+.         +   |+||||||+|
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~N  150 (336)
T 3g2f_A           77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRN  150 (336)
T ss_dssp             EEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGG
T ss_pred             cccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccce
Confidence            432     2568999999999999999765   358899999999999999999998         6   9999999999


Q ss_pred             eEEcCCCCeEEccccccccCCCCCC------cceeeccccCCCCCCchhhhc-------CCCCccccchhhHHHHHHHHh
Q 011234          274 ILLDADYNAKLSDFGLAKDAPEDGK------THVSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT  340 (490)
Q Consensus       274 ILl~~~~~~kL~DFG~a~~~~~~~~------~~~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGvil~ellt  340 (490)
                      |||+.++.+||+|||+++.......      .......+||+.|+|||++.+       ..++.++|||||||++|||++
T Consensus       151 ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  230 (336)
T 3g2f_A          151 VLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM  230 (336)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHh
Confidence            9999999999999999986643211      112234579999999999976       456678999999999999999


Q ss_pred             CCCCCCCCCCCCcch-hHHhhhcccCCchhhh-----hccCccccCCC--ChHhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011234          341 GRRSMDKNRPNGEHN-LVEWARPHLGDKRRFY-----RLLDPRLEGHF--SIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       341 G~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~l~~~~--~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  412 (490)
                      |..||.......... ................     ....+.+...+  ....+..+.+||.+||..||++|||+.||+
T Consensus       231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l  310 (336)
T 3g2f_A          231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE  310 (336)
T ss_dssp             TBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHH
Confidence            977764332221111 1000000000000000     00111111111  123577899999999999999999999999


Q ss_pred             HHhhcccc
Q 011234          413 ETLKPLQN  420 (490)
Q Consensus       413 ~~L~~l~~  420 (490)
                      +.|+.+..
T Consensus       311 ~~L~~ll~  318 (336)
T 3g2f_A          311 ERMAELMM  318 (336)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987644

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.2e-44  Score=366.89  Aligned_cols=265  Identities=20%  Similarity=0.256  Sum_probs=207.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC--------CCceec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL--------HPNLVK  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~  202 (490)
                      .++|++.+.||+|+||.||+|++..         ++..||||++... ....+.+.+|+.+|+.+.        |+||++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQ---------GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecC---------CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            4679999999999999999998865         6789999999754 234567889999999885        788999


Q ss_pred             eeeEEE----ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEc
Q 011234          203 LVGYCI----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       203 l~~~~~----~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~  277 (490)
                      +++++.    .....+|||||+ +++|.+.+.......+++..++.++.||+.||.|||+. +   |+||||||+||||+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~  181 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLS  181 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEEC
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEe
Confidence            999988    456789999999 67888877766555799999999999999999999997 7   99999999999998


Q ss_pred             CCC-------------------------------------------------CeEEccccccccCCCCCCcceeeccccC
Q 011234          278 ADY-------------------------------------------------NAKLSDFGLAKDAPEDGKTHVSTRVMGT  308 (490)
Q Consensus       278 ~~~-------------------------------------------------~~kL~DFG~a~~~~~~~~~~~~~~~~Gt  308 (490)
                      .++                                                 .+||+|||++......     ....+||
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt  256 (397)
T 1wak_A          182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQT  256 (397)
T ss_dssp             CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSC
T ss_pred             ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCC
Confidence            775                                                 7999999999876432     2345799


Q ss_pred             CCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH---hhhcccCCc------------------
Q 011234          309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE---WARPHLGDK------------------  367 (490)
Q Consensus       309 ~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~---~~~~~~~~~------------------  367 (490)
                      +.|+|||++.+..++.++|||||||+||||++|+.||.............   .....++..                  
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            99999999999999999999999999999999999997654433211111   000000000                  


Q ss_pred             hhhhhccCcc---------ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          368 RRFYRLLDPR---------LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~---------l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..+..+.+..         -...++...+..+.+||.+||+.||.+|||+.||+++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0000000000         0112355668889999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=359.93  Aligned_cols=259  Identities=29%  Similarity=0.406  Sum_probs=201.9

Q ss_pred             hhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceece
Q 011234          125 NDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKL  203 (490)
Q Consensus       125 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l  203 (490)
                      ..+....++|++.+.||+|+||.||+|.+..         +|..||||++..... ....+.+|+.++..+ .||||+++
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~   86 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVK---------TGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATY   86 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECC---------CCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeee
Confidence            3344456789999999999999999999865         677999999875532 346788999999999 79999999


Q ss_pred             eeEEEe------cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          204 VGYCIE------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       204 ~~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ++++..      .+..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLT  163 (326)
T ss_dssp             EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEC
T ss_pred             eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEc
Confidence            999987      467899999999999999998765457899999999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~  352 (490)
                      .++.+||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||.......
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             TTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            99999999999998654321  1123457999999999987     5678999999999999999999999996543211


Q ss_pred             cchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          353 EHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       353 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....  ...           ...+.   ..+...+..+.+||.+||..||.+||++.+++++
T Consensus       242 ~~~~--~~~-----------~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          242 ALFL--IPR-----------NPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHH--HHH-----------SCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHH--hhc-----------Ccccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1000  000           00000   1112236789999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6e-44  Score=352.18  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=208.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      +.|++.+.||+|+||.||+|.+..         ++..||||++.... ....+.+.+|+.++..+.||||+++++++.+.
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   92 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNR---------TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   92 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HHHHHhhhhcccCCeEEEEEEECC---------CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            468999999999999999998865         67799999987553 23456788999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~  166 (303)
T 3a7i_A           93 TKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA  166 (303)
T ss_dssp             TEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccc
Confidence            9999999999999999998643   6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   .....         
T Consensus       167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~---------  232 (303)
T 3a7i_A          167 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLIP---------  232 (303)
T ss_dssp             EECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHH---------
T ss_pred             eecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHhh---------
Confidence            87643321  12345799999999999999999999999999999999999999965432111   11000         


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                       ....+.    ++...+..+.+||.+||..||.+|||+.+++++..-
T Consensus       233 -~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  274 (303)
T 3a7i_A          233 -KNNPPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFI  274 (303)
T ss_dssp             -HSCCCC----CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred             -cCCCCC----CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence             001111    122336789999999999999999999999987543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-44  Score=353.73  Aligned_cols=263  Identities=26%  Similarity=0.399  Sum_probs=201.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|.+....      +.+..||||++....   ....+.+.+|+.++..++||||+++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCC------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            357999999999999999999875421      134479999987542   23456788999999999999999999998


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .... .++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccc
Confidence            8754 899999999999999997653 25889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          288 GLAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       288 G~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |++.......... ......||..|+|||++.+..++.++|||||||++|+|++ |..||.......   ......   .
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~---~  239 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID---K  239 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH---T
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHH---c
Confidence            9998765433221 2233567889999999999999999999999999999999 999996543211   111110   0


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .          ......+...+..+.+||.+||..||.+|||+.++++.|+.++.
T Consensus       240 ~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          240 E----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             S----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             c----------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            0          00011122347889999999999999999999999999987754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.1e-44  Score=347.53  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=199.4

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      +..++|.+.+.||+|+||.||+|.+..         +|..||||++.....   .....+.+|+.+++.++||||+++++
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   78 (276)
T 2h6d_A            8 VKIGHYVLGDTLGVGTFGKVKIGEHQL---------TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ   78 (276)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ceeccEEEEeeecCCCCeEEEEEEECC---------CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            345689999999999999999999875         677999999865422   23457889999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      ++...+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~  153 (276)
T 2h6d_A           79 VISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIA  153 (276)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEEC
T ss_pred             EEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEe
Confidence            9999999999999999999999997764  5889999999999999999999998   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||++........   .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||......   ......... 
T Consensus       154 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~-  226 (276)
T 2h6d_A          154 DFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKIRGG-  226 (276)
T ss_dssp             CCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHC-
T ss_pred             ecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHhhcC-
Confidence            9999987654321   234578999999999987765 68999999999999999999999653211   111111000 


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        .            ..++...+..+.+||.+||+.||.+|||+.+++++
T Consensus       227 --~------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 --V------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --c------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0            01122336789999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-44  Score=366.74  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=199.5

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ....++|++.+.||+|+||.||+|.+..         +|..||||++..+..    ...+|+.+|+.++||||+++++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~   69 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIE---------SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYF   69 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECC---------CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhhee
Confidence            3456789999999999999999999875         678999999875532    224699999999999999999998


Q ss_pred             Eec--------------------------------------CceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHH
Q 011234          208 IED--------------------------------------DQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIAL  247 (490)
Q Consensus       208 ~~~--------------------------------------~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~  247 (490)
                      ...                                      ...++||||++ |+|.+.+..  .....+++..+..++.
T Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~  148 (383)
T 3eb0_A           70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIY  148 (383)
T ss_dssp             EEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHH
T ss_pred             eecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHH
Confidence            543                                      34789999997 588777753  2234799999999999


Q ss_pred             HHHHHHHHhhhcCCCCeeecCCCCCceEEc-CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCcc
Q 011234          248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSK  325 (490)
Q Consensus       248 qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~  325 (490)
                      ||+.||.|||+.+   |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.+
T Consensus       149 qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          149 QLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             HHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             HHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcc
Confidence            9999999999988   99999999999997 688999999999987644322   2345789999999998865 58999


Q ss_pred             ccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh-------------hhhccCccccCCCChHhHHHHHH
Q 011234          326 SDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR-------------FYRLLDPRLEGHFSIKGSQKATQ  392 (490)
Q Consensus       326 sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~l~~~~~~~~~~~l~~  392 (490)
                      +|||||||++|||++|+.||......+....+  ....-.....             +...........++...+.++.+
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRI--IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            99999999999999999999764332211111  1000000000             00000001111123334788999


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 011234          393 LAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       393 Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ||.+||..||.+|||+.|++++
T Consensus       301 li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHccCChhhCCCHHHHhcC
Confidence            9999999999999999999976

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.3e-44  Score=354.92  Aligned_cols=259  Identities=22%  Similarity=0.280  Sum_probs=202.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEe-
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE-  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~-  209 (490)
                      ++|++.+.||+|+||.||+|++..         ++..||||++....   .+.+.+|+.+|..+. ||||+++++++.+ 
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~  103 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP  103 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             CceEEEEEecccCCeEEEEEEECC---------CCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC
Confidence            579999999999999999998865         67799999997543   357889999999997 9999999999988 


Q ss_pred             -cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEccc
Q 011234          210 -DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       210 -~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF  287 (490)
                       ....++||||+.+++|.+++.     .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       104 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Df  175 (330)
T 3nsz_A          104 VSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW  175 (330)
T ss_dssp             TTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeC
Confidence             567899999999999998874     3788999999999999999999988   99999999999999776 8999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC-
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG-  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-  365 (490)
                      |+++.......   .....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+.... ..+. 
T Consensus       176 g~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~-~~~~~  250 (330)
T 3nsz_A          176 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIA-KVLGT  250 (330)
T ss_dssp             TTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHH-HHHCH
T ss_pred             CCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHH-HhcCC
Confidence            99987654322   233578999999999987 6799999999999999999999999954322111 000000 0000 


Q ss_pred             -------------Cchhhhhcc--------CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          366 -------------DKRRFYRLL--------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       366 -------------~~~~~~~~~--------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                                   ....+....        ............+.++.+||.+||+.||.+|||+.|++++-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp  321 (330)
T 3nsz_A          251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP  321 (330)
T ss_dssp             HHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSG
T ss_pred             chhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCc
Confidence                         000000000        00011111222478899999999999999999999999763

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.8e-44  Score=387.53  Aligned_cols=251  Identities=28%  Similarity=0.403  Sum_probs=201.3

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  215 (490)
                      +.||+|+||.||+|.+...       .++..||||+++....  ...+++.+|+.+|..|+|||||++++++. .+..+|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~l  446 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWML  446 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS-------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred             CEeccCCCEEEEEEEEcCC-------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEE
Confidence            4799999999999977542       2567899999976432  33578999999999999999999999986 456899


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      |||||++|+|.+++....  .+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++....
T Consensus       447 v~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          447 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             EEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            999999999999997654  6899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCC-cceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          296 DGK-THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       296 ~~~-~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      ... ........||+.|+|||++.+..++.++|||||||+||||++ |+.||...........+.               
T Consensus       522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---------------  586 (635)
T 4fl3_A          522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---------------  586 (635)
T ss_dssp             -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---------------
T ss_pred             CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------
Confidence            322 122233457889999999999999999999999999999998 999997643221111111               


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                        .......+..++.++.+||.+||..||++||++.+|++.|+.+
T Consensus       587 --~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          587 --KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              0011122334578999999999999999999999999999865

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-43  Score=359.61  Aligned_cols=269  Identities=23%  Similarity=0.307  Sum_probs=205.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++..... .....+.+|+.+|..++||||+++++++..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   96 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNL---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   96 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECC---------CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence            3579999999999999999998865         677999999975432 334678899999999999999999999976


Q ss_pred             c-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          210 D-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      .     ...++||||+. |+|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||
T Consensus        97 ~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A           97 PTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             SSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred             CCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEE
Confidence            5     36899999996 6999988654   5899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCc-ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      +|||++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  249 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG  249 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence            999999876432211 11234689999999998764 5589999999999999999999999976544332222111000


Q ss_pred             ccC--------Cc--hhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLG--------DK--RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~--------~~--~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...        ..  ..+...+.....   ..+....+.++.+||.+||..||.+|||+.|++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            000        00  000000000000   001122367899999999999999999999999763

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=351.78  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++....  ....+.+|+.++..+.||||+++++++..
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   95 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKE---------TGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK   95 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETT---------TCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECC---------CCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            34679999999999999999998865         67799999997653  33678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           96 NTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             TTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeeccc
Confidence            999999999999999999986442 36899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........   ......       
T Consensus       172 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~-------  239 (314)
T 3com_A          172 AGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA---IFMIPT-------  239 (314)
T ss_dssp             CEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH-------
T ss_pred             chhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHhc-------
Confidence            976643211  12345789999999999998999999999999999999999999965322111   000000       


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                         ...+.  ...+...+..+.+||.+||..||.+|||+.+++++-
T Consensus       240 ---~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          240 ---NPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             ---SCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ---CCCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence               00000  011223367899999999999999999999999753

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.4e-44  Score=367.94  Aligned_cols=262  Identities=26%  Similarity=0.350  Sum_probs=197.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|++..         +|..||||++.....    .+.+|+++|+.|+|||||+++++|....
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~  120 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSG  120 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECC---------CCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence            368999999999999999999875         677999999865432    2346999999999999999999986532


Q ss_pred             ------ceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC-CCe
Q 011234          212 ------QRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNA  282 (490)
Q Consensus       212 ------~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~  282 (490)
                            .+++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+.+   |+||||||+||||+.+ +.+
T Consensus       121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~  196 (420)
T 1j1b_A          121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVL  196 (420)
T ss_dssp             TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEE
T ss_pred             CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeE
Confidence                  36799999965 67666543  22347999999999999999999999988   9999999999999965 568


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.......   ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||......+.  +.+...
T Consensus       197 kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~  271 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIK  271 (420)
T ss_dssp             EECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH
T ss_pred             EeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence            9999999987644322   2345789999999999765 799999999999999999999999976432211  111111


Q ss_pred             cccCCchhhhhccCcc--------c-----cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 PHLGDKRRFYRLLDPR--------L-----EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~--------l-----~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..-.........+++.        +     ...++...+.++.+||.+||..||.+|||+.|+++|-
T Consensus       272 ~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          272 VLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             HHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            0000000000000000        0     0012233478899999999999999999999999863

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-44  Score=354.29  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||+|++........+.+.+|+.++..++||||+++++++...
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   88 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKE---------TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD   88 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETT---------TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred             ccceeecceeccCCCeEEEEEEEcC---------CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence            4579999999999999999999875         6779999999876656677899999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  164 (302)
T 2j7t_A           89 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS  164 (302)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred             CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCC
Confidence            99999999999999999887643 36899999999999999999999988   999999999999999999999999987


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ......  ........||+.|+|||++.     +..++.++|||||||++|+|++|..||........  ........  
T Consensus       165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--  238 (302)
T 2j7t_A          165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSD--  238 (302)
T ss_dssp             HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC--
T ss_pred             cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccC--
Confidence            532111  11122357899999999984     56789999999999999999999999975432111  00100000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                               .+  ....+...+..+.+||.+||..||.+|||+.+++++
T Consensus       239 ---------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 ---------PP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             ---------CC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             ---------Cc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                     00  001122346789999999999999999999999876

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.4e-43  Score=352.88  Aligned_cols=253  Identities=26%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHhcCCCCceec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLLHPNLVK  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~HpnIv~  202 (490)
                      .++|.+.+.||+|+||.||+|.+..         ++..||||++.....        .....+.+|+.+|..++||||++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERK---------TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcC---------CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            4579999999999999999998875         678999999875432        11234788999999999999999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC-
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN-  281 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~-  281 (490)
                      +++++..++ .++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++. 
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSS
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCC
Confidence            999987654 899999999999999886544  6899999999999999999999988   999999999999987654 


Q ss_pred             --eEEccccccccCCCCCCcceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          282 --AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       282 --~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                        +||+|||++......   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||.........  
T Consensus       154 ~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--  228 (322)
T 2ycf_A          154 CLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--  228 (322)
T ss_dssp             CCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--
T ss_pred             CeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--
Confidence              999999999876432   1123457999999999975   467899999999999999999999999764433221  


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ........   ..    ..+..    ....+..+.+||.+||..||.+||++.+++++
T Consensus       229 ~~~~~~~~---~~----~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          229 KDQITSGK---YN----FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHHHHTC---CC----CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhCc---cc----cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            11110000   00    00000    01226789999999999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=364.13  Aligned_cols=274  Identities=19%  Similarity=0.243  Sum_probs=207.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceec--------
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVK--------  202 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~--------  202 (490)
                      .++|++.+.||+|+||.||+|.+...... .....+..||||++...     ..+.+|+.++..+.||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~-~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC-DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccc-cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            35799999999999999999998752110 00113678999998754     35778999999999999988        


Q ss_pred             -------eeeEEEe-cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCce
Q 011234          203 -------LVGYCIE-DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       203 -------l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NI  274 (490)
                             +++++.. ++..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                   6777776 67889999999 999999998763447999999999999999999999988   99999999999


Q ss_pred             EEcCCC--CeEEccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCC
Q 011234          275 LLDADY--NAKLSDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDK  347 (490)
Q Consensus       275 Ll~~~~--~~kL~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~  347 (490)
                      |++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  8999999999866432211     112335799999999999999999999999999999999999999975


Q ss_pred             CCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccC
Q 011234          348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNL  421 (490)
Q Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~  421 (490)
                      ...... ..............   ......   ......+..+.+||.+||..||.+|||+.+|++.|+.+...
T Consensus       271 ~~~~~~-~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          271 CLPNTE-DIMKQKQKFVDKPG---PFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             GTTCHH-HHHHHHHHHHHSCC---CEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCcCHH-HHHHHHHhccCChh---hhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            432211 11111110000000   000000   00012268899999999999999999999999999876543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-43  Score=361.24  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=195.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...  .....+.+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   94 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAI---------LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT   94 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECC---------CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence            4689999999999999999998865         6789999998754  2334567889999999999999999999998


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..+      ..++||||++ ++|.+++..    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A           95 PQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             SCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCE
T ss_pred             cccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCE
Confidence            765      6799999996 578888742    4889999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||+++.....   ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+  . .
T Consensus       167 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~-~  240 (371)
T 2xrw_A          167 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV--I-E  240 (371)
T ss_dssp             EECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--H-C
T ss_pred             EEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H-H
Confidence            99999999865432   1223467999999999999999999999999999999999999999764322111100  0 0


Q ss_pred             ccCCc------------------------hhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDK------------------------RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~------------------------~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .+...                        ..+...+.....   .......+..+.+||.+||..||.+|||+.|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          241 QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             -CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            00000                        000000000000   001122367899999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.5e-44  Score=364.60  Aligned_cols=254  Identities=15%  Similarity=0.062  Sum_probs=184.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHH---HHHhcCCCCceecee-
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV---NFLGNLLHPNLVKLV-  204 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~---~~l~~l~HpnIv~l~-  204 (490)
                      .+|.+.+.||+|+||.||+|.+..         +|..||||++.....   ...+.+.+|+   .+|+. +||||++++ 
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~  131 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVE---------RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRR  131 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------
T ss_pred             eeeeeeeeccCCCCEEEEEEEECC---------CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhce
Confidence            458899999999999999999875         678999999987643   2334566774   55555 799988755 


Q ss_pred             ------eEEEecC-----------------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHH
Q 011234          205 ------GYCIEDD-----------------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIR------MKIALGAAKGLAF  255 (490)
Q Consensus       205 ------~~~~~~~-----------------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~y  255 (490)
                            +++...+                 ..|||||||+ |+|.+++...+. .+++..+      ..++.||+.||.|
T Consensus       132 ~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHH
Confidence                  5554432                 3799999998 899999976432 3455555      6788999999999


Q ss_pred             hhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc--CCCCccccchhhHH
Q 011234          256 LHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGV  333 (490)
Q Consensus       256 LH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGv  333 (490)
                      ||+.+   |+||||||+||||+.++.+||+|||+++.....     .....||+.|+|||++.+  ..++.++|||||||
T Consensus       210 LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          210 LQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            99988   999999999999999999999999999866421     124567799999999987  68999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 011234          334 VLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE  413 (490)
Q Consensus       334 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~  413 (490)
                      +||||++|+.||............   ....      .......+........+..+.+||.+||+.||++|||+.++++
T Consensus       282 il~elltg~~Pf~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGSWK---RPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTCCC---BCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             HHHHHHhCCCCCCCcCcccccchh---hhhh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999999999999765433211100   0000      0000001111111234788999999999999999999999986


Q ss_pred             H
Q 011234          414 T  414 (490)
Q Consensus       414 ~  414 (490)
                      +
T Consensus       353 h  353 (371)
T 3q60_A          353 T  353 (371)
T ss_dssp             S
T ss_pred             C
Confidence            5

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=4.7e-44  Score=350.10  Aligned_cols=254  Identities=26%  Similarity=0.322  Sum_probs=189.1

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHH-HHHHHHHHHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHK-EWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~-~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++..... .... .+.++...++.+.||||+++++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~   75 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVP---------SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL   75 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecC---------CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee
Confidence            45679999999999999999999865         678999999976532 2223 344555568889999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEE
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      .+++..++||||++ |+|.+++..  .....+++..++.++.||+.||.|||+. +   |+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl  151 (290)
T 3fme_A           76 FREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKM  151 (290)
T ss_dssp             ECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEB
T ss_pred             eccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999996 588877754  2234799999999999999999999997 8   999999999999999999999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhh----hcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +|||++........   .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||........ ......
T Consensus       152 ~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~  227 (290)
T 3fme_A          152 CDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQVV  227 (290)
T ss_dssp             CCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHHH
T ss_pred             eecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHHh
Confidence            99999987644321   2234799999999996    456789999999999999999999999964321110 111110


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..              ..........+.++.+||.+||+.||.+|||+.|++++
T Consensus       228 ~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          228 EE--------------PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HS--------------CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cc--------------CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            00              00001112336789999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-43  Score=352.86  Aligned_cols=266  Identities=26%  Similarity=0.380  Sum_probs=206.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhc--CCCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN--LLHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~  206 (490)
                      ...++|.+.+.||+|+||.||+|.+           +|..||||++...   ....+.+|++++..  ++||||++++++
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----------~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~  104 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAA  104 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE-----------TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEE
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE-----------cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEee
Confidence            3456799999999999999999987           3668999999644   34567788888877  789999999999


Q ss_pred             EEecC----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCCeeecCCCCCce
Q 011234          207 CIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH--------EEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       207 ~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~~~~iiHrDlkp~NI  274 (490)
                      +....    ..++||||+++|+|.+++...   .+++..++.++.||+.||.|||        +.+   |+||||||+||
T Consensus       105 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI  178 (342)
T 1b6c_B          105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI  178 (342)
T ss_dssp             EECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred             ecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence            98876    789999999999999999764   5899999999999999999999        666   99999999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcc--eeeccccCCCCCCchhhhcC------CCCccccchhhHHHHHHHHhC-----
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMTG------HLTSKSDVYSFGVVLLEMLTG-----  341 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~~------~~~~~sDvwSlGvil~elltG-----  341 (490)
                      ||+.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            99999999999999997664432211  12345799999999999765      234689999999999999999     


Q ss_pred             -----CCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCC-CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          342 -----RRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       342 -----~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                           ..||.......... ..+......      ....+.+... .+..++..+.+||.+||+.||++|||+.+|+++|
T Consensus       259 ~~~~~~~p~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L  331 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSDPSV-EEMRKVVCE------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  331 (342)
T ss_dssp             BCCCCCCTTTTTSCSSCCH-HHHHHHHTT------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred             cccccccCccccCcCcccH-HHHHHHHHH------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence                 66775543322111 111100000      0111111111 1235578899999999999999999999999999


Q ss_pred             hccccC
Q 011234          416 KPLQNL  421 (490)
Q Consensus       416 ~~l~~~  421 (490)
                      +.+...
T Consensus       332 ~~i~~~  337 (342)
T 1b6c_B          332 SQLSQQ  337 (342)
T ss_dssp             HHHHHT
T ss_pred             HHHHHH
Confidence            987553

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1e-43  Score=360.75  Aligned_cols=264  Identities=25%  Similarity=0.371  Sum_probs=187.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...  .....+.+.+|+.+|+.++||||+++++++.
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   98 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   98 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETT---------TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECC---------CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            3689999999999999999998865         6889999998754  2334567889999999999999999999987


Q ss_pred             ec------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 ED------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..      ...|+||||+ +++|.+++..   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~  171 (367)
T 2fst_X           99 PARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL  171 (367)
T ss_dssp             SCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             cCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCE
Confidence            54      5679999999 7899988864   26899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+....
T Consensus       172 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~  246 (367)
T 2fst_X          172 KILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  246 (367)
T ss_dssp             EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999865432     234679999999999887 689999999999999999999999997654322211111000


Q ss_pred             c--------ccCCc--hhhhhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          362 P--------HLGDK--RRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       362 ~--------~~~~~--~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .        .+...  ..+...+.......   .....+..+.+||.+||..||.+|||+.+++++-
T Consensus       247 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          247 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             CSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence            0        00000  00000000000000   0012367899999999999999999999999873

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-43  Score=346.54  Aligned_cols=253  Identities=26%  Similarity=0.341  Sum_probs=205.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---------hhHHHHHHHHHHHhcCC-CCce
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHKEWLAEVNFLGNLL-HPNL  200 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~-HpnI  200 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++.....         ...+.+.+|+.+|.++. ||||
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i   86 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI   86 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred             hhccceeeeecCCCceEEEEEEEcC---------cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence            4579999999999999999999865         678999999875431         22356788999999996 9999


Q ss_pred             eceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          201 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       201 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +++++++...+..++||||+++++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~  161 (298)
T 1phk_A           87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDM  161 (298)
T ss_dssp             CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTC
T ss_pred             eeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCC
Confidence            999999999999999999999999999997654  6899999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhh------cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM------TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~------~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      .+||+|||++........   .....||+.|+|||++.      ...++.++|||||||++|+|++|..||.......  
T Consensus       162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--  236 (298)
T 1phk_A          162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--  236 (298)
T ss_dssp             CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--
Confidence            999999999987654322   23457999999999985      4568889999999999999999999996542211  


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       .......   ...        ..........+..+.+||.+||..||.+|||+.+++++
T Consensus       237 -~~~~~~~---~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          237 -MLRMIMS---GNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             -HHHHHHH---TCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             -HHHHHhc---CCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence             1110000   000        00000112346789999999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.2e-43  Score=351.30  Aligned_cols=268  Identities=23%  Similarity=0.310  Sum_probs=208.2

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCC------ceec
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP------NLVK  202 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~  202 (490)
                      ...++|++.+.||+|+||.||+|.+...        +|..||||++.... ...+.+.+|+.++..+.|+      +|++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~   81 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKA--------GGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQ   81 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCC--------CCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence            3456899999999999999999987431        57799999997542 3446678899999888655      5999


Q ss_pred             eeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC----
Q 011234          203 LVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA----  278 (490)
Q Consensus       203 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~----  278 (490)
                      +++++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.    
T Consensus        82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~  157 (339)
T 1z57_A           82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT  157 (339)
T ss_dssp             EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEE
T ss_pred             eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccc
Confidence            999999999999999999 899999998876667899999999999999999999988   999999999999987    


Q ss_pred             ---------------CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCC
Q 011234          279 ---------------DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR  343 (490)
Q Consensus       279 ---------------~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~  343 (490)
                                     ++.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             EEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                           668999999999865432     234579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCc-------hh------------------hhhccCccc-cCCCChHhHHHHHHHHHHh
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDK-------RR------------------FYRLLDPRL-EGHFSIKGSQKATQLAAQC  397 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~-------~~------------------~~~~~~~~l-~~~~~~~~~~~l~~Li~~c  397 (490)
                      ||...........+..........       ..                  ......+.. ........+..+.+||.+|
T Consensus       233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  312 (339)
T 1z57_A          233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM  312 (339)
T ss_dssp             SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence            997654322211111110000000       00                  000000000 0112234578899999999


Q ss_pred             hhcCCCCCCCHHHHHHH
Q 011234          398 LSRDPKARPRMSEVVET  414 (490)
Q Consensus       398 L~~dP~~RPs~~evl~~  414 (490)
                      |..||.+|||+.|++++
T Consensus       313 L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          313 LEYDPAKRITLREALKH  329 (339)
T ss_dssp             TCSSTTTSCCHHHHTTS
T ss_pred             hCcCcccccCHHHHhcC
Confidence            99999999999999976

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=361.52  Aligned_cols=271  Identities=22%  Similarity=0.343  Sum_probs=186.7

Q ss_pred             CCCc-CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe--
Q 011234          133 NFRP-ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  209 (490)
Q Consensus       133 ~y~~-~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--  209 (490)
                      .|.+ .++||+|+||.||+|.+...       .++..||||++......  ..+.+|+.+|+.|+||||+++++++..  
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~-------~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDG-------KDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSS-------SCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccC-------CCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            4666 45899999999999997642       25678999999765432  467899999999999999999999965  


Q ss_pred             cCceEEEEEecCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE----cC
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRK-------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL----DA  278 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl----~~  278 (490)
                      ....+|||||+. ++|.+++...       ....+++..++.++.||+.||.|||+.+   |+||||||+||||    +.
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~  167 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPE  167 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCC
Confidence            568899999995 6888877532       1224899999999999999999999988   9999999999999    67


Q ss_pred             CCCeEEccccccccCCCCCCc-ceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc---
Q 011234          279 DYNAKLSDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE---  353 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~---  353 (490)
                      ++.+||+|||+++........ ......+||+.|+|||++.+ ..++.++|||||||+||||++|.+||........   
T Consensus       168 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  247 (405)
T 3rgf_A          168 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  247 (405)
T ss_dssp             TTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------C
T ss_pred             CCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccc
Confidence            789999999999876432111 22244689999999999987 4599999999999999999999999975443210   


Q ss_pred             ---chhHHhhhcccC--------------CchhhhhccCccccC---------CCChHhHHHHHHHHHHhhhcCCCCCCC
Q 011234          354 ---HNLVEWARPHLG--------------DKRRFYRLLDPRLEG---------HFSIKGSQKATQLAAQCLSRDPKARPR  407 (490)
Q Consensus       354 ---~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~---------~~~~~~~~~l~~Li~~cL~~dP~~RPs  407 (490)
                         ..........++              ....+...+......         ......+..+.+||.+||..||.+|||
T Consensus       248 ~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t  327 (405)
T 3rgf_A          248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  327 (405)
T ss_dssp             CCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred             cchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence               000000000000              000000000000000         000112567899999999999999999


Q ss_pred             HHHHHHHhh
Q 011234          408 MSEVVETLK  416 (490)
Q Consensus       408 ~~evl~~L~  416 (490)
                      +.|+|++-.
T Consensus       328 a~e~L~hp~  336 (405)
T 3rgf_A          328 SEQAMQDPY  336 (405)
T ss_dssp             HHHHHTSGG
T ss_pred             HHHHhcChh
Confidence            999998754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.9e-44  Score=353.12  Aligned_cols=263  Identities=25%  Similarity=0.371  Sum_probs=202.4

Q ss_pred             hhchhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCC--
Q 011234          121 KFMFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLL--  196 (490)
Q Consensus       121 ~~~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~--  196 (490)
                      .+.+..+.+..++|++.+.||+|+||.||+|.+.          ++..||||++....  ......+.+|+.++..+.  
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~   86 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE----------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH   86 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT----------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGG
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC----------CCcEEEEEEeccccccccchHHHHHHHHHHHhcccc
Confidence            3444555666778999999999999999999864          46689999987543  344567889999999997  


Q ss_pred             CCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          197 HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       197 HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                      |+||+++++++...+..++||| +.+++|.+++....  .+++..+..++.||+.||.|||+.+   |+||||||+|||+
T Consensus        87 ~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~  160 (313)
T 3cek_A           87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLI  160 (313)
T ss_dssp             CTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             CCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEE
Confidence            5999999999999999999999 45889999998764  6889999999999999999999988   9999999999999


Q ss_pred             cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-----------CCCCccccchhhHHHHHHHHhCCCCC
Q 011234          277 DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-----------GHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       277 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----------~~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                      + ++.+||+|||++................||+.|+|||++.+           ..++.++|||||||++|+|++|..||
T Consensus       161 ~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (313)
T 3cek_A          161 V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF  239 (313)
T ss_dssp             E-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             E-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCch
Confidence            6 48999999999987654433323344679999999999875           47888999999999999999999999


Q ss_pred             CCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ......     ...          +....++.....++...+..+.+||.+||..||.+||++.+++++.
T Consensus       240 ~~~~~~-----~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          240 QQIINQ-----ISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             TTCCSH-----HHH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hhHHHH-----HHH----------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            643211     000          1111122222223333367899999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.8e-43  Score=351.92  Aligned_cols=268  Identities=24%  Similarity=0.313  Sum_probs=202.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   80 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKP---------TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRP   80 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECC---------CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecc
Confidence            4689999999999999999999865         67899999997543 3344568899999999999999999998876


Q ss_pred             c-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEE
Q 011234          210 D-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKL  284 (490)
Q Consensus       210 ~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL  284 (490)
                      .     ...++||||+. ++|.+++...   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl  153 (353)
T 2b9h_A           81 DSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKV  153 (353)
T ss_dssp             SCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEE
T ss_pred             cccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEE
Confidence            4     67899999996 6999988763   5899999999999999999999988   999999999999999999999


Q ss_pred             ccccccccCCCCCCcc--------eeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          285 SDFGLAKDAPEDGKTH--------VSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~--------~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      +|||++..........        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus       154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  233 (353)
T 2b9h_A          154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL  233 (353)
T ss_dssp             CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999998764322111        1223578999999998865 678999999999999999999999997653221111


Q ss_pred             hHHhhhcccC--C------c---hhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          356 LVEWARPHLG--D------K---RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~--~------~---~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+........  .      .   ..+...+.....   .......+.++.+||.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1100000000  0      0   000000000000   00012346789999999999999999999999976

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=349.19  Aligned_cols=268  Identities=24%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEE--
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCI--  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++........+.+.+|+.+++.++||||+++++++.  
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   80 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDND---------CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPS   80 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETT---------TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred             CCceeEEEEeccCCCeEEEEEEECC---------CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence            4579999999999999999999875         67899999998777666778999999999999999999999874  


Q ss_pred             ------------ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE
Q 011234          209 ------------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       209 ------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl  276 (490)
                                  +....++||||+. |+|.+++...   .+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  153 (320)
T 2i6l_A           81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFI  153 (320)
T ss_dssp             SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEE
T ss_pred             ccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEE
Confidence                        3467899999996 6999988542   6889999999999999999999988   9999999999999


Q ss_pred             c-CCCCeEEccccccccCCCCCC-cceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          277 D-ADYNAKLSDFGLAKDAPEDGK-THVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       277 ~-~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      + .++.+||+|||+++....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus       154 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  233 (320)
T 2i6l_A          154 NTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ  233 (320)
T ss_dssp             ETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             cCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            7 567999999999987643211 111234568999999998876 6789999999999999999999999976542211


Q ss_pred             chhHHhhhcccCC--chhhhhcc---------Ccc-ccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          354 HNLVEWARPHLGD--KRRFYRLL---------DPR-LEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       354 ~~~~~~~~~~~~~--~~~~~~~~---------~~~-l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...+....+....  ...+...+         .+. ....+....+.++.+||.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1111000000000  00000000         000 0000112237889999999999999999999999975

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.6e-43  Score=349.83  Aligned_cols=270  Identities=25%  Similarity=0.354  Sum_probs=204.1

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcC---CCCceecee
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLV  204 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~  204 (490)
                      ..++|++.+.||+|+||.||+|.+...        +|..||||++......  ....+.+|+.+++.+   .||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~   80 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   80 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCC--------CCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence            456899999999999999999998531        5778999998643211  123455677776665   899999999


Q ss_pred             eEEE-----ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC
Q 011234          205 GYCI-----EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD  279 (490)
Q Consensus       205 ~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~  279 (490)
                      +++.     .....++||||+. |+|.+++.......+++..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~  156 (326)
T 1blx_A           81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSS  156 (326)
T ss_dssp             EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTT
T ss_pred             eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCC
Confidence            9987     4567899999996 69999998776556999999999999999999999988   9999999999999999


Q ss_pred             CCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          280 YNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       280 ~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +.+||+|||++......   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..
T Consensus       157 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~  233 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  233 (326)
T ss_dssp             CCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            99999999999865432   122346789999999999999999999999999999999999999976532211111100


Q ss_pred             h-h-c---ccCC----chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 A-R-P---HLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~-~-~---~~~~----~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      . . +   .+..    ....+..........+....+..+.+||.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0 0 0   0000    000000000000111223347889999999999999999999999965

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-43  Score=359.33  Aligned_cols=274  Identities=23%  Similarity=0.295  Sum_probs=200.3

Q ss_pred             chhhHHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-----------hhHHHHHHHHHH
Q 011234          123 MFNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-----------QGHKEWLAEVNF  191 (490)
Q Consensus       123 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-----------~~~~~~~~E~~~  191 (490)
                      .+.++....++|++.+.||+|+||.||+|.+.          .|..||||++.....           ...+.+.+|+.+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   82 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS----------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL   82 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT----------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECC----------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHH
Confidence            35567788899999999999999999999864          467899999864321           123678999999


Q ss_pred             HhcCCCCceeceeeEEEec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 011234          192 LGNLLHPNLVKLVGYCIED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  266 (490)
Q Consensus       192 l~~l~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  266 (490)
                      |..++||||+++++++...     ...|+||||+. |+|.+++... ...+++..+..++.||+.||.|||+.+   |+|
T Consensus        83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH  157 (362)
T 3pg1_A           83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVH  157 (362)
T ss_dssp             HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEe
Confidence            9999999999999998653     35799999996 6888888754 336899999999999999999999988   999


Q ss_pred             cCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCC
Q 011234          267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       267 rDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                      |||||+|||++.++.+||+|||++.......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus       158 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  234 (362)
T 3pg1_A          158 RDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF  234 (362)
T ss_dssp             CCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC
Confidence            9999999999999999999999997543322   2234678999999999887 67999999999999999999999999


Q ss_pred             CCCCCCCcchhHHhhhcccC-------CchhhhhccCccc-------cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHH
Q 011234          346 DKNRPNGEHNLVEWARPHLG-------DKRRFYRLLDPRL-------EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV  411 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l-------~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~ev  411 (490)
                      ...........+........       ........+...+       ........+..+.+||.+||+.||.+|||+.|+
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            76432221111100000000       0000000000000       001112236779999999999999999999999


Q ss_pred             HHH
Q 011234          412 VET  414 (490)
Q Consensus       412 l~~  414 (490)
                      +++
T Consensus       315 l~h  317 (362)
T 3pg1_A          315 LRH  317 (362)
T ss_dssp             HTS
T ss_pred             HcC
Confidence            986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9e-44  Score=357.65  Aligned_cols=265  Identities=19%  Similarity=0.275  Sum_probs=206.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-----------------HHHHHHHHHHHh
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----------------HKEWLAEVNFLG  193 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-----------------~~~~~~E~~~l~  193 (490)
                      .++|++.+.||+|+||.||+|.+           +|..||||++.......                 ...+.+|+.++.
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-----------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   98 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-----------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT   98 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-----------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-----------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH
Confidence            46899999999999999999987           36689999986442211                 167899999999


Q ss_pred             cCCCCceeceeeEEEecCceEEEEEecCCCCHHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeee
Q 011234          194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENH------LFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIY  266 (490)
Q Consensus       194 ~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiH  266 (490)
                      .++||||+++++++.+.+..++||||+++++|.++      +.......+++..++.++.||+.||.|||+ .+   |+|
T Consensus        99 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H  175 (348)
T 2pml_X           99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICH  175 (348)
T ss_dssp             TCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             hCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---Eee
Confidence            99999999999999999999999999999999998      655434579999999999999999999999 88   999


Q ss_pred             cCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCc-cccchhhHHHHHHHHhCCCC
Q 011234          267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTS-KSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       267 rDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~-~sDvwSlGvil~elltG~~p  344 (490)
                      |||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  251 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP  251 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876432    23446799999999999877 6666 99999999999999999999


Q ss_pred             CCCCCCCCcchhHHhhhcc---cCC-chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          345 MDKNRPNGEHNLVEWARPH---LGD-KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      |......  ..........   +.. ...+................+..+.+||.+||..||.+|||+.+++++-
T Consensus       252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp  324 (348)
T 2pml_X          252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE  324 (348)
T ss_dssp             SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            9765432  1111111100   000 0000000000000011133478899999999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-42  Score=353.79  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=199.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  111 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT  111 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECC---------CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhhee
Confidence            3579999999999999999999875         67899999997643  233567889999999999999999999998


Q ss_pred             ecCce------EEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~~~------~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..+..      ++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+
T Consensus       112 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~  183 (371)
T 4exu_A          112 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL  183 (371)
T ss_dssp             SCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             ccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCE
Confidence            87655      99999996 68887763    24899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.....     ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....
T Consensus       184 kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~  258 (371)
T 4exu_A          184 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  258 (371)
T ss_dssp             EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence            99999999865432     234678999999999987 689999999999999999999999997643221111110000


Q ss_pred             c--------ccCCc--hhhhhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 P--------HLGDK--RRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~--------~~~~~--~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .        .+...  ..+...+.......   +....+..+.+||.+||+.||.+|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0        00000  00000000000000   112236889999999999999999999999976

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.4e-43  Score=352.21  Aligned_cols=268  Identities=26%  Similarity=0.373  Sum_probs=191.3

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ....++|++.+.||+|+||.||+|.+..         +|..||||++..... ....+.+|++.+..++||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~   88 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKS---------TGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYF   88 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETT---------TCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhh
Confidence            3445789999999999999999999875         677999998865432 223566788889999999999999999


Q ss_pred             EecCc-------eEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCCeeecCCCCCceEE
Q 011234          208 IEDDQ-------RLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLH--EEAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       208 ~~~~~-------~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH--~~~~~~iiHrDlkp~NILl  276 (490)
                      ...+.       .++||||+++ +|...+..  .....+++..+..++.||+.||.|||  +.+   |+||||||+||||
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll  164 (360)
T 3e3p_A           89 YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLV  164 (360)
T ss_dssp             EEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEE
T ss_pred             hccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEE
Confidence            76543       7899999975 66554432  23346889999999999999999999  777   9999999999999


Q ss_pred             cC-CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcc
Q 011234          277 DA-DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH  354 (490)
Q Consensus       277 ~~-~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~  354 (490)
                      +. ++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.........
T Consensus       165 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  241 (360)
T 3e3p_A          165 NEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL  241 (360)
T ss_dssp             ETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             eCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH
Confidence            96 89999999999987654322   2345789999999998765 4899999999999999999999999764332211


Q ss_pred             hhHHhhhcccCCchhhhhccCc----------------cccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          355 NLVEWARPHLGDKRRFYRLLDP----------------RLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~----------------~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..+  ..............+++                ..........+.++.+||.+||+.||.+|||+.|++++
T Consensus       242 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          242 HEI--VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHH--HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHH--HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111  11000000000000000                00011222347899999999999999999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8e-43  Score=342.83  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=195.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++... ......+.+|+.+++.++||||+++++++.+ 
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   74 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNAL---------DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLER   74 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             cccchhhheeccCCcEEEEEEEEcC---------CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence            3469999999999999999999865         6779999998653 2345678899999999999999999998865 


Q ss_pred             ------------cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          210 ------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       210 ------------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                                  .+..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~  150 (303)
T 1zy4_A           75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFID  150 (303)
T ss_dssp             CCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred             cchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEc
Confidence                        356799999999999999997653 36788899999999999999999988   99999999999999


Q ss_pred             CCCCeEEccccccccCCCCCC------------cceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCC
Q 011234          278 ADYNAKLSDFGLAKDAPEDGK------------THVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~------------~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~p  344 (490)
                      .++.+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   |
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p  227 (303)
T 1zy4_A          151 ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---P  227 (303)
T ss_dssp             TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---C
T ss_pred             CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---c
Confidence            999999999999986643210            1112345799999999999864 78999999999999999998   4


Q ss_pred             CCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          345 MDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      |....  ..........           .....+...++...+..+.+||.+||..||.+|||+.+++++-
T Consensus       228 ~~~~~--~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          228 FSTGM--ERVNILKKLR-----------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             CSSHH--HHHHHHHHHH-----------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             cCCch--hHHHHHHhcc-----------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            43110  0001111100           0111122233444567899999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.6e-43  Score=381.24  Aligned_cols=263  Identities=24%  Similarity=0.372  Sum_probs=209.7

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+..++|++.+.||+|+||.||+|.+...+.      .+..||||.+.... ....+.+.+|+.+|+.++||||++++++
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN------PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSS------CCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCC------ccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3445679999999999999999999865322      46689999987643 3344678999999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +. ++..++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~D  534 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGD  534 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEe
Confidence            84 567899999999999999997653 36899999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.......   ........  
T Consensus       535 FG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~~--  608 (656)
T 2j0j_A          535 FGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENG--  608 (656)
T ss_dssp             CCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHHT--
T ss_pred             cCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHcC--
Confidence            999987654322 22233567889999999999999999999999999999997 999997543221   11111000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                                  .....+..++..+.+||.+||..||.+|||+.+|++.|+.+.
T Consensus       609 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 ------------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             ------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                        001123344788999999999999999999999999998764

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-42  Score=354.81  Aligned_cols=206  Identities=24%  Similarity=0.284  Sum_probs=175.0

Q ss_pred             HHHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CC-----ce
Q 011234          127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HP-----NL  200 (490)
Q Consensus       127 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nI  200 (490)
                      .....++|++.+.||+|+||.||+|.+..         ++..||||++.... ....++..|+.++..+. |+     +|
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i  118 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRV---------EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYI  118 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcC---------CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeE
Confidence            34456789999999999999999998865         67899999997542 33456777888888775 44     49


Q ss_pred             eceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc--C
Q 011234          201 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--A  278 (490)
Q Consensus       201 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~  278 (490)
                      +++++++...+..+|||||+. ++|.+++.......+++..+..++.||+.||.|||.+. .+|+||||||+||||+  .
T Consensus       119 v~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~  196 (382)
T 2vx3_A          119 VHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPK  196 (382)
T ss_dssp             CCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTT
T ss_pred             EEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCC
Confidence            999999999999999999995 69999998765557999999999999999999999531 2399999999999994  4


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCC
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR  349 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~  349 (490)
                      ++.+||+|||+++.....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       197 ~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          197 RSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             SCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            778999999999876432     234679999999999999999999999999999999999999997654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-43  Score=362.18  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      .+|++.+.||+|+||.||+|.+..         ++ .||+|.+......    ..+|+.+|+.++||||+++++++...+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~---------~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE---------SD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNG  105 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT---------TE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC---------CC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence            469999999999999999998864         33 4888877544321    236999999999999999999997654


Q ss_pred             c------eEEEEEecCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-CCCCe
Q 011234          212 Q------RLLVYEFMPRGSLENHLFR--KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNA  282 (490)
Q Consensus       212 ~------~~lv~E~~~~g~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~  282 (490)
                      .      .++||||+++ +|...+..  .....+++..+..++.||+.||.|||+.+   |+||||||+||||+ .++.+
T Consensus       106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~  181 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVL  181 (394)
T ss_dssp             SSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEE
T ss_pred             CCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcE
Confidence            3      7899999976 44444332  22347899999999999999999999988   99999999999998 79999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+...  ....
T Consensus       182 kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~  256 (394)
T 4e7w_A          182 KLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIK  256 (394)
T ss_dssp             EECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHH
T ss_pred             EEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHH
Confidence            9999999987643322   2345789999999998765 59999999999999999999999997653222111  1111


Q ss_pred             cccCCchh-------------hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRR-------------FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~-------------~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ..-.....             +.......+...++...+.++.+||.+||..||.+|||+.|+++|
T Consensus       257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00000000             000000001111222347889999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=354.42  Aligned_cols=262  Identities=19%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceee
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~  205 (490)
                      .+..++|++.+.||+|+||.||+|.+..            .||+|++.....  ...+.+.+|+.+++.++||||+++++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~------------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG------------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG   96 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS------------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC------------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            4456789999999999999999998753            499999875422  22345678999999999999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      ++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+
T Consensus        97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B           97 ACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             EEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEEC
T ss_pred             EEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEe
Confidence            9999999999999999999999986643 36889999999999999999999988   99999999999998 6799999


Q ss_pred             cccccccCCCCC---CcceeeccccCCCCCCchhhhc---------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCc
Q 011234          286 DFGLAKDAPEDG---KTHVSTRVMGTYGYAAPEYVMT---------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE  353 (490)
Q Consensus       286 DFG~a~~~~~~~---~~~~~~~~~Gt~~y~aPE~l~~---------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~  353 (490)
                      |||++.......   .........||+.|+|||++.+         ..++.++|||||||++|||++|..||....... 
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-  250 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-  250 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            999987553211   1111233568999999999874         357889999999999999999999996543211 


Q ss_pred             chhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccccCc
Q 011234          354 HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLK  422 (490)
Q Consensus       354 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~~~  422 (490)
                        .......          ...+..   .....+..+.+||.+||..||.+|||+.+|++.|+.+....
T Consensus       251 --~~~~~~~----------~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          251 --IIWQMGT----------GMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             --HHHHHHT----------TCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             --HHHHhcc----------CCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence              1110000          000100   11123567899999999999999999999999999887654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.9e-43  Score=356.21  Aligned_cols=264  Identities=19%  Similarity=0.264  Sum_probs=203.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-----------CCc
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----------HPN  199 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpn  199 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++.... .....+.+|+.++..+.           |+|
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~   87 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANH   87 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecC---------CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccch
Confidence            4579999999999999999998865         67899999997543 33456788999998886           899


Q ss_pred             eeceeeEEEecC----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCce
Q 011234          200 LVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNI  274 (490)
Q Consensus       200 Iv~l~~~~~~~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NI  274 (490)
                      |+++++++...+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+. +   |+||||||+||
T Consensus        88 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NI  163 (373)
T 1q8y_A           88 ILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENV  163 (373)
T ss_dssp             BCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGE
T ss_pred             HHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHe
Confidence            999999988754    789999999 89999999876655799999999999999999999997 8   99999999999


Q ss_pred             EEc------CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCC
Q 011234          275 LLD------ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN  348 (490)
Q Consensus       275 Ll~------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~  348 (490)
                      ||+      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus       164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            994      3447999999999876432     23357899999999999999999999999999999999999999754


Q ss_pred             CCCCcc---hhHHhhhcccCCchh-----------------------------hhhccCccccCCCChHhHHHHHHHHHH
Q 011234          349 RPNGEH---NLVEWARPHLGDKRR-----------------------------FYRLLDPRLEGHFSIKGSQKATQLAAQ  396 (490)
Q Consensus       349 ~~~~~~---~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~~~~~~~~~~l~~Li~~  396 (490)
                      ......   .........++....                             ....+.  ....++...+.++.+||.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  316 (373)
T 1q8y_A          239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSP  316 (373)
T ss_dssp             ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGG
T ss_pred             cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHH
Confidence            322111   000000000000000                             000000  0113456678899999999


Q ss_pred             hhhcCCCCCCCHHHHHHHh
Q 011234          397 CLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       397 cL~~dP~~RPs~~evl~~L  415 (490)
                      ||+.||.+|||+.||+++-
T Consensus       317 ~L~~dP~~Rpt~~ell~hp  335 (373)
T 1q8y_A          317 MLQLDPRKRADAGGLVNHP  335 (373)
T ss_dssp             GGCSSTTTCBCHHHHHTCG
T ss_pred             HhccCccccCCHHHHhhCh
Confidence            9999999999999999763

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.2e-42  Score=347.73  Aligned_cols=267  Identities=21%  Similarity=0.253  Sum_probs=205.3

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc------eece
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN------LVKL  203 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l  203 (490)
                      ..++|++.+.||+|+||.||+|.+...        .+..||||++.... .....+.+|+.++..+.|++      |+.+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHAR--------GKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCC--------CceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            356899999999999999999988652        23689999997542 34456788999999887655      9999


Q ss_pred             eeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEE-------
Q 011234          204 VGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILL-------  276 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl-------  276 (490)
                      ++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||       
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~  163 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFET  163 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEE
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccc
Confidence            99999999999999999 778888887765557999999999999999999999988   9999999999999       


Q ss_pred             ------------cCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCC
Q 011234          277 ------------DADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       277 ------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~p  344 (490)
                                  +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  238 (355)
T 2eu9_A          164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL  238 (355)
T ss_dssp             EECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence                        56789999999999865432     1345799999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchhHHhhhcccCCc-------h------------------hhhhccCcc-ccCCCChHhHHHHHHHHHHhh
Q 011234          345 MDKNRPNGEHNLVEWARPHLGDK-------R------------------RFYRLLDPR-LEGHFSIKGSQKATQLAAQCL  398 (490)
Q Consensus       345 f~~~~~~~~~~~~~~~~~~~~~~-------~------------------~~~~~~~~~-l~~~~~~~~~~~l~~Li~~cL  398 (490)
                      |...........+..........       .                  .......+. .........+..+.+||.+||
T Consensus       239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            97643322111111110000000       0                  000000000 000112234678999999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 011234          399 SRDPKARPRMSEVVET  414 (490)
Q Consensus       399 ~~dP~~RPs~~evl~~  414 (490)
                      ..||.+|||+.|++++
T Consensus       319 ~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          319 EFDPAQRITLAEALLH  334 (355)
T ss_dssp             CSSTTTSCCHHHHTTS
T ss_pred             cCChhhCcCHHHHhcC
Confidence            9999999999999865

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.2e-42  Score=346.61  Aligned_cols=258  Identities=27%  Similarity=0.362  Sum_probs=183.2

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHH-HHhcCCCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVN-FLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~-~l~~l~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+..         +|..||||++..... ....++..|+. +++.+.||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKP---------SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETT---------TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcC---------CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            34689999999999999999999865         678999999976532 33445666666 77888999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeE
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFR---KGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ...+..++||||+. ++|.+++..   .....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+|
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~k  166 (327)
T 3aln_A           91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIK  166 (327)
T ss_dssp             ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEE
T ss_pred             EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEE
Confidence            99999999999996 588777753   2234789999999999999999999998 8   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhh----hcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l----~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      |+|||+++......   ......||+.|+|||++    .+..++.++|||||||++|+|++|..||........     .
T Consensus       167 l~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~  238 (327)
T 3aln_A          167 LCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----Q  238 (327)
T ss_dssp             ECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----H
Confidence            99999998764332   12334799999999998    456789999999999999999999999975322110     0


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .......       ..+.+........+..+.+||.+||..||.+|||+.+|+++-
T Consensus       239 ~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          239 LTQVVKG-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             -CCCCCS-------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             HHHHhcC-------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence            0000000       001111111223477899999999999999999999998753

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-42  Score=339.65  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=203.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         ++..||||++....  ......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~---------~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   91 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRI---------TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE   91 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcC---------CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe
Confidence            4579999999999999999998865         57799999986542  234567889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC---CCeEEc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD---YNAKLS  285 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~kL~  285 (490)
                      +.+..++||||+++++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           92 DSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEe
Confidence            9999999999999999999887654  6899999999999999999999988   9999999999999654   469999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccC
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......   ........  
T Consensus       167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~--  237 (287)
T 2wei_A          167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETG--  237 (287)
T ss_dssp             STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHC--
T ss_pred             ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcC--
Confidence            9999987644321   123468999999998865 58999999999999999999999997543221   11111000  


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ...    .+.    ......+.++.+||.+||..||.+|||+.+++++
T Consensus       238 -~~~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          238 -KYA----FDL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             -CCC----CCS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -CCC----CCc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence             000    000    0001236789999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-42  Score=349.20  Aligned_cols=255  Identities=23%  Similarity=0.276  Sum_probs=177.1

Q ss_pred             hcCCCcCc-eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|.+.+ +||+|+||.||+|.+..         +|..||||++....    .........+..+.||||+++++++..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~---------~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRR---------TGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECC---------CCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence            45788854 69999999999999875         67799999986542    111222334566789999999999876


Q ss_pred             ----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCe
Q 011234          210 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       210 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~  282 (490)
                          ....++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||+.   ++.+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~  170 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL  170 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCE
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceE
Confidence                445899999999999999998776667999999999999999999999988   999999999999976   4559


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||++.......    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.............  ..
T Consensus       171 kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~  244 (336)
T 3fhr_A          171 KLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RR  244 (336)
T ss_dssp             EECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred             EEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hh
Confidence            999999998654321    234578999999999988899999999999999999999999996543322110000  00


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ....        ...+........+..+.+||.+||..||.+|||+.+++++-
T Consensus       245 ~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          245 IRLG--------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhcc--------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0000        00000011123478899999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=347.45  Aligned_cols=262  Identities=24%  Similarity=0.349  Sum_probs=199.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|.+.+.||+|+||.||+|.+..         +|..||||++....  ....+.+.+|+.+|+.++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   93 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKR---------SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFT   93 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECC---------CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEe
Confidence            3579999999999999999998865         67899999997643  233467889999999999999999999998


Q ss_pred             ecCc------eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDDQ------RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~~------~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..+.      .++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        94 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~  165 (353)
T 3coi_A           94 PASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCEL  165 (353)
T ss_dssp             SCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCE
T ss_pred             cccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcE
Confidence            7654      499999996 68887763    25899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+....
T Consensus       166 kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~  240 (353)
T 3coi_A          166 KILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT  240 (353)
T ss_dssp             EECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHH
T ss_pred             EEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999865332     234578999999999887 678999999999999999999999997643221111110000


Q ss_pred             c--------ccCCc--hhhhhccCcccc---CCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 P--------HLGDK--RRFYRLLDPRLE---GHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~--------~~~~~--~~~~~~~~~~l~---~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .        .+...  ..+...+.....   .......+..+.+||.+||..||.+|||+.+++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0        00000  000000000000   11122447889999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=342.42  Aligned_cols=245  Identities=28%  Similarity=0.452  Sum_probs=195.0

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcC----CCC
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNL----LHP  198 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l----~Hp  198 (490)
                      ...++|++.+.||+|+||.||+|.+..         +|..||||++......      ....+.+|+.++..+    .||
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~   98 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---------DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP   98 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECTT---------TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEcc---------CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence            445689999999999999999998765         6779999999765332      122356789999888    899


Q ss_pred             ceeceeeEEEecCceEEEEEe-cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc
Q 011234          199 NLVKLVGYCIEDDQRLLVYEF-MPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD  277 (490)
Q Consensus       199 nIv~l~~~~~~~~~~~lv~E~-~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~  277 (490)
                      ||+++++++...+..++|||| +.+++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~  173 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILID  173 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEE
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEe
Confidence            999999999999999999999 78999999998764  6899999999999999999999998   99999999999998


Q ss_pred             -CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCC-ccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          278 -ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLT-SKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       278 -~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~-~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                       .++.+||+|||++.......    .....||..|+|||++.+..+. .++|||||||++|+|++|+.||....     .
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~  244 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E  244 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H
T ss_pred             CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H
Confidence             88999999999998765432    2345799999999999876664 58999999999999999999996321     0


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ...   .                ...++...+..+.+||.+||..||++|||+.+++++-
T Consensus       245 ~~~---~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          245 ILE---A----------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             HHH---T----------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             Hhh---h----------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            000   0                0012223467899999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.1e-42  Score=344.45  Aligned_cols=246  Identities=25%  Similarity=0.393  Sum_probs=202.3

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcCC--CCc
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLL--HPN  199 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--Hpn  199 (490)
                      ....++|++.+.||+|+||.||+|.+..         +|..||||++......      ....+.+|+.++..+.  |+|
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~  109 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG  109 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETT---------TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCS
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCC
Confidence            3445689999999999999999998865         6789999998754321      1234667999999996  599


Q ss_pred             eeceeeEEEecCceEEEEEecCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-
Q 011234          200 LVKLVGYCIEDDQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-  277 (490)
Q Consensus       200 Iv~l~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-  277 (490)
                      |+++++++...+..++||||+.+ ++|.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++ 
T Consensus       110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL  184 (320)
T ss_dssp             BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred             ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence            99999999999999999999976 89999997754  6889999999999999999999988   99999999999998 


Q ss_pred             CCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchh
Q 011234          278 ADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL  356 (490)
Q Consensus       278 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~  356 (490)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....       
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------  253 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------  253 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------
Confidence            78899999999998765422    234579999999999987665 678999999999999999999995421       


Q ss_pred             HHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                       ......                ..++...+.++.+||.+||..||.+|||+.+|+++-
T Consensus       254 -~~~~~~----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          254 -EIIRGQ----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             -HHHHCC----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             -hhhccc----------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence             000000                001122367899999999999999999999999753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.9e-42  Score=339.17  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=182.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHH-HHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKE-WLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~-~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++.+.||+|+||.||+|.+..         +|..||||++...... ...+ +..+..++..+.||||+++++++.
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   94 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRK---------TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI   94 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETT---------TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEec---------CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence            4579999999999999999999875         6779999999765432 2233 444556788889999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE-AEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      +.+..++||||+ ++.+..++... ...+++..+..++.||+.||.|||+. +   |+||||||+|||++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           95 TNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             CSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCC
T ss_pred             cCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEEC
Confidence            999999999999 55665555433 33689999999999999999999995 8   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |++.......   ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||......  .......  
T Consensus       170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~--  242 (318)
T 2dyl_A          170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKV--  242 (318)
T ss_dssp             TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH--
T ss_pred             CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHH--
Confidence            9997654322   123457999999999984     567889999999999999999999999753211  1111110  


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                       ....       .+.+..  ....+..+.+||.+||..||.+||++.+|+++
T Consensus       243 -~~~~-------~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          243 -LQEE-------PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -HHSC-------CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -hccC-------CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             0000       000100  11236789999999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-41  Score=351.32  Aligned_cols=254  Identities=26%  Similarity=0.310  Sum_probs=187.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~  210 (490)
                      +.|.+.+.||+|+||+||.+...          +|..||||++..+.   ...+.+|+.+|..+ +|||||++++++.+.
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~----------~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF----------QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES----------SSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             heeeccCeEeeCCCeEEEEEEEE----------CCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            34666789999999999865332          57799999986542   34578899999876 899999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCC-----CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC------
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPL-----PWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD------  279 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l-----~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~------  279 (490)
                      +..+||||||. |+|.+++........     .+..++.++.||+.||.|||+.+   |+||||||+||||+.+      
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~  157 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTAD  157 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSC
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccc
Confidence            99999999995 699999976542211     22345679999999999999988   9999999999999654      


Q ss_pred             -------CCeEEccccccccCCCCCCcc--eeeccccCCCCCCchhhhc-------CCCCccccchhhHHHHHHHHh-CC
Q 011234          280 -------YNAKLSDFGLAKDAPEDGKTH--VSTRVMGTYGYAAPEYVMT-------GHLTSKSDVYSFGVVLLEMLT-GR  342 (490)
Q Consensus       280 -------~~~kL~DFG~a~~~~~~~~~~--~~~~~~Gt~~y~aPE~l~~-------~~~~~~sDvwSlGvil~ellt-G~  342 (490)
                             +.+||+|||+++.........  .....+||+.|+|||++.+       ..++.++|||||||++|||++ |.
T Consensus       158 ~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~  237 (434)
T 2rio_A          158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK  237 (434)
T ss_dssp             CTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCC
Confidence                   489999999998765432211  1234679999999999975       678999999999999999999 99


Q ss_pred             CCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          343 RSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       343 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .||....... ....   .....         .+..........+.++.+||.+||+.||.+|||+.+|+++-
T Consensus       238 ~Pf~~~~~~~-~~i~---~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp  297 (434)
T 2rio_A          238 HPFGDKYSRE-SNII---RGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP  297 (434)
T ss_dssp             CTTCSTTTHH-HHHH---HTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             CCCCCchhhH-HHHh---cCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence            9996532211 1111   00000         00011112345578999999999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=350.82  Aligned_cols=251  Identities=24%  Similarity=0.330  Sum_probs=186.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      ..+|.+.++||+|+||+||.....          +|..||||++......   .+.+|+.+|+.+ +|||||++++++.+
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~----------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~   89 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMF----------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD   89 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEES----------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEe----------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec
Confidence            346899999999999996543222          5678999999765432   346799999999 79999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-----CCCeEE
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----DYNAKL  284 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kL  284 (490)
                      ....|||||||. |+|.+++..... .+.+..+..++.||+.||.|||+.+   |+||||||+||||+.     ...+||
T Consensus        90 ~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL  164 (432)
T 3p23_A           90 RQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMI  164 (432)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred             CCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEE
Confidence            999999999995 699999976543 3444556789999999999999988   999999999999953     235789


Q ss_pred             ccccccccCCCCCCc-ceeeccccCCCCCCchhhh---cCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHh
Q 011234          285 SDFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM---TGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~---~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~  359 (490)
                      +|||+++........ ......+||+.|+|||++.   ...++.++|||||||++|||++ |..||.......    ...
T Consensus       165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~  240 (432)
T 3p23_A          165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANI  240 (432)
T ss_dssp             CCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHH
T ss_pred             ecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHH
Confidence            999999876543211 2234467999999999997   4567889999999999999999 999985432111    000


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .   .... .. ..      .......+..+.+||.+||+.||.+|||+.+|+++
T Consensus       241 ~---~~~~-~~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          241 L---LGAC-SL-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             H---TTCC-CC-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             H---hccC-Cc-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0   0000 00 00      01112346778999999999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-40  Score=324.88  Aligned_cols=234  Identities=14%  Similarity=0.100  Sum_probs=186.6

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ..++|++.+.||+|+||.||+|++..         +|..||||++.....   ...+.+.+|+.++..++||||++++++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTA---------LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETT---------TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecC---------CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            34679999999999999999999865         678999999976533   334678999999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+.+..|+||||+++++|.+++...    .....+..++.||+.||.|||+.+   |+||||||+||||+.++.+||++
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECS
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEe
Confidence            99999999999999999999998432    345567889999999999999988   99999999999999999999985


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +|                      |++       .++.++|||||||++|||++|+.||............   ......
T Consensus       173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~  220 (286)
T 3uqc_A          173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAG  220 (286)
T ss_dssp             CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTS
T ss_pred             cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhcc
Confidence            54                      333       3688999999999999999999999865433211000   000000


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ......        .+....+..+.+||.+||+.||.+| |+.|+++.|+.+..
T Consensus       221 ~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          221 QPIEPA--------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             CBCCHH--------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             CCCChh--------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence            000000        1112236789999999999999999 99999999987644

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.2e-41  Score=362.43  Aligned_cols=259  Identities=27%  Similarity=0.365  Sum_probs=200.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      ++|++.+.||+|+||.||+|.+..         +|..||||++... .....+.+.+|+.+|..++||||+++++++.. 
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~---------tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~   84 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQD---------TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL   84 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTT---------TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECC---------CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence            579999999999999999998765         6778999998765 33445678999999999999999999998765 


Q ss_pred             -----cCceEEEEEecCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC--
Q 011234          210 -----DDQRLLVYEFMPRGSLENHLFRKG-SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN--  281 (490)
Q Consensus       210 -----~~~~~lv~E~~~~g~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~--  281 (490)
                           .+..++|||||++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  
T Consensus        85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSC
T ss_pred             ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCce
Confidence                 667899999999999999997643 235888899999999999999999988   999999999999987765  


Q ss_pred             -eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 -AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 -~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                       +||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....     ...|.
T Consensus       162 ~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~  233 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWH  233 (676)
T ss_dssp             EEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSS
T ss_pred             eEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhh
Confidence             99999999987654322   2346799999999999999999999999999999999999999965311     11111


Q ss_pred             hcc-------------cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 011234          361 RPH-------------LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV  412 (490)
Q Consensus       361 ~~~-------------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl  412 (490)
                      ...             ......+...  ......+....+..+.+||.+||..||.+|||+.+++
T Consensus       234 ~~i~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          234 GKVREKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             TTCC------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhhcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            000             0000000000  0111234455689999999999999999999998744

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.3e-40  Score=323.70  Aligned_cols=229  Identities=21%  Similarity=0.304  Sum_probs=182.2

Q ss_pred             cCCCcC-ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHH-hcCCCCceeceeeEEEe
Q 011234          132 RNFRPE-SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL-GNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~-~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~  209 (490)
                      ++|.+. ++||+|+||.||+|.+..         ++..||||++...     ..+.+|+.++ +.+.||||+++++++..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~---------~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcC---------CCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            457776 789999999999999875         6779999998643     4567788888 56689999999999887


Q ss_pred             ----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCCe
Q 011234          210 ----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYNA  282 (490)
Q Consensus       210 ----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~  282 (490)
                          ....++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence                677899999999999999998876667999999999999999999999988   999999999999988   7889


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      ||+|||++....                        +..++.++|||||||++|||++|..||............   ..
T Consensus       160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~  212 (299)
T 3m2w_A          160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KT  212 (299)
T ss_dssp             EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---CC
T ss_pred             EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---HH
Confidence            999999986432                        245678999999999999999999999654322110000   00


Q ss_pred             ccCCchhhhhccCccccCCCC----hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          363 HLGDKRRFYRLLDPRLEGHFS----IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~----~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      ..         ...  ...++    ...+.++.+||.+||+.||.+|||+.|++++-
T Consensus       213 ~~---------~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          213 RI---------RMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             SS---------CTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HH---------hhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00         000  00011    12377899999999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-41  Score=345.22  Aligned_cols=244  Identities=18%  Similarity=0.165  Sum_probs=184.4

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHHHHHHHHHhcCCC-Ccee----
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEWLAEVNFLGNLLH-PNLV----  201 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~H-pnIv----  201 (490)
                      ..+.|.+.++||+|+||.||+|.+..         +|..||||++......   ..+.+.+|+.++..+.| .|+.    
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~---------~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~  146 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQE---------TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV  146 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHH
T ss_pred             CceeEEEecccccCCCEEEEEEEecC---------CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHH
Confidence            34458888999999999999999875         6779999998844322   24678899999999987 2211    


Q ss_pred             -----cee------------eEEEe-----cCceEEEEEecCCCCHHHHHhh-----cCCCCCCHHHHHHHHHHHHHHHH
Q 011234          202 -----KLV------------GYCIE-----DDQRLLVYEFMPRGSLENHLFR-----KGSLPLPWSIRMKIALGAAKGLA  254 (490)
Q Consensus       202 -----~l~------------~~~~~-----~~~~~lv~E~~~~g~L~~~l~~-----~~~~~l~~~~~~~i~~qi~~aL~  254 (490)
                           ..+            .++..     ...++++|+++ +++|.+++..     .....+++..++.++.||+.||.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  225 (413)
T 3dzo_A          147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLA  225 (413)
T ss_dssp             HTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHH
Confidence                 111            11111     12457778776 7899998842     22335778889999999999999


Q ss_pred             HhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhh----------hcCCCCc
Q 011234          255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYV----------MTGHLTS  324 (490)
Q Consensus       255 yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l----------~~~~~~~  324 (490)
                      |||+.+   |+||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.
T Consensus       226 ~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          226 SLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             HHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             HHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            999988   999999999999999999999999998865332     344678 999999999          4456888


Q ss_pred             cccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCC
Q 011234          325 KSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKA  404 (490)
Q Consensus       325 ~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~  404 (490)
                      ++|||||||++|||++|+.||...........                ++...      ...+..+.+||.+||+.||++
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~----------------~~~~~------~~~~~~~~~li~~~l~~dP~~  354 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDDAALGGSEW----------------IFRSC------KNIPQPVRALLEGFLRYPKED  354 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG----------------GGSSC------CCCCHHHHHHHHHHTCSSGGG
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCcchhhhHHH----------------HHhhc------ccCCHHHHHHHHHHccCChhh
Confidence            99999999999999999999965432211110                01100      122678999999999999999


Q ss_pred             CCCHHHHHHH
Q 011234          405 RPRMSEVVET  414 (490)
Q Consensus       405 RPs~~evl~~  414 (490)
                      ||++.+++++
T Consensus       355 Rpt~~~~l~~  364 (413)
T 3dzo_A          355 RLLPLQAMET  364 (413)
T ss_dssp             SCCHHHHTTS
T ss_pred             CcCHHHHHhC
Confidence            9999999875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-40  Score=361.36  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=194.4

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..++|++.+.||+|+||.||+|.+...        +|..||||++.... ......+.+|+.+|..++||||+++++++.
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  149 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNV--------NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVE  149 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGG--------TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCC--------CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence            346899999999999999999998642        46789999987543 344557889999999999999999999998


Q ss_pred             ecCc-----eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          209 EDDQ-----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       209 ~~~~-----~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ..+.     .||||||+++++|.+++..    .+++..++.++.||+.||.|||+.+   ||||||||+||||+.+ .+|
T Consensus       150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~k  221 (681)
T 2pzi_A          150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLK  221 (681)
T ss_dssp             EECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEE
T ss_pred             ecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEE
Confidence            8766     7999999999999887643    6899999999999999999999988   9999999999999875 999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+++.....      ...+||+.|+|||++.+. ++.++|||||||+||+|++|.+||........          
T Consensus       222 l~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------  284 (681)
T 2pzi_A          222 LIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------  284 (681)
T ss_dssp             ECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------
T ss_pred             EEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------
Confidence            9999999876432      345799999999998765 48899999999999999999988754211100          


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-HHHHHHHhhcc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLKPL  418 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-~~evl~~L~~l  418 (490)
                       ..             .......+..+.+||.+||+.||.+||+ ++++.+.|..+
T Consensus       285 -~~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 -PE-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -CT-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -cc-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence             00             0001123567899999999999999995 55565555543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-40  Score=333.67  Aligned_cols=244  Identities=17%  Similarity=0.149  Sum_probs=183.9

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--------hhHHHHHHHHHHHhcCC------
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------QGHKEWLAEVNFLGNLL------  196 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~------  196 (490)
                      .++|++.+.||+|+||.||+|++           +|..||||++.....        ...+.+.+|+.+|+.++      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-----------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~   87 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-----------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV   87 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-----------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCS
T ss_pred             cccchheeeecccCceEEEEEEe-----------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccc
Confidence            35689999999999999999987           357899999976532        22367888998888875      


Q ss_pred             ---CCceeceeeEEE-----------------e-------------cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHH
Q 011234          197 ---HPNLVKLVGYCI-----------------E-------------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM  243 (490)
Q Consensus       197 ---HpnIv~l~~~~~-----------------~-------------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~  243 (490)
                         |||||++++++.                 +             .+..|||||||++|++.+.+.+   ..+++..++
T Consensus        88 ~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~  164 (336)
T 2vuw_A           88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAK  164 (336)
T ss_dssp             SSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHH
T ss_pred             cccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHH
Confidence               777777766543                 2             6789999999999987777644   258999999


Q ss_pred             HHHHHHHHHHHHhh-hcCCCCeeecCCCCCceEEcCCC--------------------CeEEccccccccCCCCCCccee
Q 011234          244 KIALGAAKGLAFLH-EEAEKPVIYRDFKTSNILLDADY--------------------NAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       244 ~i~~qi~~aL~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~kL~DFG~a~~~~~~~~~~~~  302 (490)
                      .++.||+.||.||| +.+   |+||||||+||||+.++                    .+||+|||+|+.....      
T Consensus       165 ~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------  235 (336)
T 2vuw_A          165 SILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------
T ss_pred             HHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------
Confidence            99999999999999 888   99999999999999887                    8999999999865431      


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHH-HHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVV-LLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH  381 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvi-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  381 (490)
                       ..+||+.|+|||++.+.. +.++||||||++ .+++++|..||....  ......+......        .........
T Consensus       236 -~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~  303 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--WLHYLTDKMLKQM--------TFKTKCNTP  303 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--HHHHHHHHHHHTC--------CCSSCCCSH
T ss_pred             -cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--hhhHHHHhhhhhh--------ccCcccchh
Confidence             347999999999998666 889999998777 777889998883210  0000000000000        000111111


Q ss_pred             CChHhHHHHHHHHHHhhhcCCCCCCCHHHHH-HH
Q 011234          382 FSIKGSQKATQLAAQCLSRDPKARPRMSEVV-ET  414 (490)
Q Consensus       382 ~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl-~~  414 (490)
                      .....+.++.+||.+||+.|     |+.|++ +|
T Consensus       304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            22346889999999999977     999998 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=9.9e-34  Score=302.63  Aligned_cols=185  Identities=18%  Similarity=0.111  Sum_probs=131.0

Q ss_pred             eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----------hhHHHHHHHHHHHhcC-CCCceeceeeEEE
Q 011234          140 LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----------QGHKEWLAEVNFLGNL-LHPNLVKLVGYCI  208 (490)
Q Consensus       140 lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~  208 (490)
                      ++.|++|.+..++...         .|..||+|++..+..          ...++|.+|+++|+++ .|+||+++++++.
T Consensus       242 ~~~~~~~~h~~~rr~~---------fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e  312 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYF---------FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE  312 (569)
T ss_dssp             -C--------CCEEEE---------ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE
T ss_pred             cccCCccccccccccc---------ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE
Confidence            4455555555544333         577899999976521          2235689999999999 6999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..|||||||+|++|.++|...+  +++..   .|+.||+.||+|||++|   ||||||||+||||+.+|.+||+|||
T Consensus       313 d~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFG  384 (569)
T 4azs_A          313 NAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFG  384 (569)
T ss_dssp             CSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecc
Confidence            9999999999999999999998765  56554   58899999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCC
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRS  344 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~p  344 (490)
                      +|+.......  .....+||+.|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       385 lAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          385 SIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            9987654322  2345789999999998865 567789999999999988766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=1.8e-29  Score=268.21  Aligned_cols=185  Identities=19%  Similarity=0.224  Sum_probs=145.8

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--------hHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--------GHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      ...++||+|+||.||+|..           .+..+|+|........        ..+.+.+|+++|++++||||+++..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-----------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~  407 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-----------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIF  407 (540)
T ss_dssp             ---------CCEEEEEEEC-----------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-----------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEE
Confidence            4457899999999999944           4567899986443211        13457899999999999999977777


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +...+..|||||||++++|.+++..          +..++.||+.||.|||+.+   |+||||||+|||++.  .+||+|
T Consensus       408 ~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          408 DVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             EEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECC
T ss_pred             EEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEE
Confidence            7788888999999999999999865          4579999999999999988   999999999999998  999999


Q ss_pred             ccccccCCCCCCcc-----eeeccccCCCCCCchhhhc--CCCCccccchhhHHHHHHHHhCCCCC
Q 011234          287 FGLAKDAPEDGKTH-----VSTRVMGTYGYAAPEYVMT--GHLTSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       287 FG~a~~~~~~~~~~-----~~~~~~Gt~~y~aPE~l~~--~~~~~~sDvwSlGvil~elltG~~pf  345 (490)
                      ||+++.........     .....+||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999875432111     1235789999999999986  67888999999999999988877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.2e-25  Score=219.41  Aligned_cols=161  Identities=14%  Similarity=0.076  Sum_probs=126.6

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh------------------hhHHHHHHHH
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------------------QGHKEWLAEV  189 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~------------------~~~~~~~~E~  189 (490)
                      ......|.+.+.||+|+||.||+|.+ .         +|..||||+++....                  .....+.+|+
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~---------~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~  155 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYS-E---------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF  155 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEE-T---------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHH
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEe-C---------CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHH
Confidence            34455677889999999999999998 4         577999999964321                  1345688999


Q ss_pred             HHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 011234          190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF  269 (490)
Q Consensus       190 ~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDl  269 (490)
                      .+|..++  | +++++++.. +..|+||||+++++|.+ +..        .....++.||+.||.|||+.+   |+||||
T Consensus       156 ~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDl  219 (282)
T 1zar_A          156 RALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDL  219 (282)
T ss_dssp             HHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred             HHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCC
Confidence            9999998  5 777775543 56799999999999988 421        123469999999999999988   999999


Q ss_pred             CCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhc----------CCCCccccchh
Q 011234          270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT----------GHLTSKSDVYS  330 (490)
Q Consensus       270 kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~----------~~~~~~sDvwS  330 (490)
                      ||+|||++ ++.+||+|||+|+.               +..|+|||++..          ..|+..+|+|.
T Consensus       220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99999999 99999999999863               345899998854          34555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.8e-21  Score=187.27  Aligned_cols=137  Identities=18%  Similarity=0.067  Sum_probs=105.7

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcE--EEEEEecCCChh------------------------hHHHHHH
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLT--VAVKTLNHDGLQ------------------------GHKEWLA  187 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~--vAvK~~~~~~~~------------------------~~~~~~~  187 (490)
                      |.+.+.||+|+||.||+|.+..         +|..  ||||+++.....                        ....+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~---------~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  119 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVF---------DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEK  119 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEE---------TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcC---------CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHH
Confidence            6788999999999999998854         5678  999987543211                        1135778


Q ss_pred             HHHHHhcCCCCce--eceeeEEEecCceEEEEEecCC-C----CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-hc
Q 011234          188 EVNFLGNLLHPNL--VKLVGYCIEDDQRLLVYEFMPR-G----SLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH-EE  259 (490)
Q Consensus       188 E~~~l~~l~HpnI--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~  259 (490)
                      |+.+|..|.|++|  ..++++    +..+|||||+.+ |    +|.+++..     .++..+..++.||+.||.||| +.
T Consensus       120 E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~  190 (258)
T 1zth_A          120 EFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA  190 (258)
T ss_dssp             HHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence            9999999988764  333332    367899999942 3    67766432     123456789999999999999 88


Q ss_pred             CCCCeeecCCCCCceEEcCCCCeEEccccccccC
Q 011234          260 AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDA  293 (490)
Q Consensus       260 ~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~  293 (490)
                      +   |+||||||+|||++.  .++|+|||+|...
T Consensus       191 g---ivHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 E---LVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             C---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             C---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            8   999999999999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=9.3e-19  Score=176.07  Aligned_cols=138  Identities=14%  Similarity=0.115  Sum_probs=98.4

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--------------hhHHH--------HHHHHH
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--------------QGHKE--------WLAEVN  190 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--------------~~~~~--------~~~E~~  190 (490)
                      -|.+.+.||.|+||.||+|...          +|..||||+++....              .....        ..+|..
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~----------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~  165 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE----------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA  165 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT----------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred             EEEecCEeeeCCceEEEEEECC----------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence            3899999999999999999864          577999998753210              00111        134666


Q ss_pred             HHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 011234          191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFK  270 (490)
Q Consensus       191 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlk  270 (490)
                      .|.+|.+.++....-+..  ...+|||||++|++|..+..      .+  ....++.||+.+|.|||+.+   |||||||
T Consensus       166 nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH~~g---IVHrDLK  232 (397)
T 4gyi_A          166 FMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLAKHG---LIHGDFN  232 (397)
T ss_dssp             HHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred             HHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHHHCC---CcCCCCC
Confidence            666665444322222212  23479999999888865431      11  23567899999999999988   9999999


Q ss_pred             CCceEEcCCC----------CeEEccccccccC
Q 011234          271 TSNILLDADY----------NAKLSDFGLAKDA  293 (490)
Q Consensus       271 p~NILl~~~~----------~~kL~DFG~a~~~  293 (490)
                      |.||||++++          .+.|+||+-+...
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            9999998776          3899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=3.9e-13  Score=128.79  Aligned_cols=143  Identities=14%  Similarity=-0.013  Sum_probs=110.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~  209 (490)
                      ...|++...++.|+++.||++..           .+..+++|+...........+.+|+.+|+.|. +..+.++++++.+
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~-----------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~   81 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH   81 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEEC-----------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec
Confidence            34688889999999999999863           24579999986532122235778999999885 6778889999988


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-----------------------------  260 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----------------------------  260 (490)
                      .+..|+||||++|.+|.+.+..       ......++.+++.+|..||+..                             
T Consensus        82 ~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           82 DGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             CCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence            8899999999999999876321       1123467889999999999811                             


Q ss_pred             ---------------------------CCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          261 ---------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       261 ---------------------------~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                                                 ...++|+|+++.|||++.+..+.|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                       1338999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=6.9e-12  Score=119.38  Aligned_cols=136  Identities=17%  Similarity=0.054  Sum_probs=97.8

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc--eeceeeEEEec
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN--LVKLVGYCIED  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~  210 (490)
                      .|.+..+.+.|..+.||++...          +|..+++|+.....   ...+.+|+.+|+.+.+.+  +.+++++....
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~----------~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~   87 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEA   87 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECT----------TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred             CCceEecccCCCCceEEEEecC----------CCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence            4555444456677999998542          35579999976542   234677899988886444  45688888877


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------  260 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------  260 (490)
                      +..++||||++|.+|.  ..     ...   ...++.+++..|..||+..                              
T Consensus        88 ~~~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (264)
T 1nd4_A           88 GRDWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD  157 (264)
T ss_dssp             SCEEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred             CCCEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence            8899999999998874  21     111   1256777788888888643                              


Q ss_pred             -------------------------CCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          261 -------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       261 -------------------------~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                                               ...++|+|++|.|||++.++.+.|+|||.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                     1229999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.19  E-value=5.9e-11  Score=119.12  Aligned_cols=143  Identities=15%  Similarity=0.185  Sum_probs=104.9

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEec--CCC-hhhHHHHHHHHHHHhcCC--CCceeceeeEEEec
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN--HDG-LQGHKEWLAEVNFLGNLL--HPNLVKLVGYCIED  210 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~  210 (490)
                      ..+.|+.|.++.||++...           +..+++|+..  ... ......+.+|+.+|+.|.  +..+.+++.++.+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-----------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~  110 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-----------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE  110 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-----------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT
T ss_pred             eEEEcCCcccceEEEEEEC-----------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC
Confidence            4567999999999998653           2368888775  332 122346778999999887  45578888887766


Q ss_pred             ---CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------
Q 011234          211 ---DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA---------------------------  260 (490)
Q Consensus       211 ---~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---------------------------  260 (490)
                         +..|+||||++|..+.+..    ...++......++.+++..|..||...                           
T Consensus       111 ~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3dxp_A          111 SVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQY  186 (359)
T ss_dssp             TTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHH
T ss_pred             CccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHH
Confidence               4589999999988775422    124677888889999999999999831                           


Q ss_pred             ----------------------------CCCeeecCCCCCceEEcCCCC--eEEccccccccC
Q 011234          261 ----------------------------EKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDA  293 (490)
Q Consensus       261 ----------------------------~~~iiHrDlkp~NILl~~~~~--~kL~DFG~a~~~  293 (490)
                                                  ...+||+|+++.|||++.++.  +.|+||+.+...
T Consensus       187 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          187 KLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                        245999999999999987753  689999988643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.10  E-value=2.3e-10  Score=112.00  Aligned_cols=183  Identities=21%  Similarity=0.214  Sum_probs=120.5

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCc--eeceeeEEEecC--
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPN--LVKLVGYCIEDD--  211 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~--  211 (490)
                      .+.++.|.+..||++.              ..+++|+....  .....+.+|+.+|+.+. +..  +.+++......+  
T Consensus        25 i~~~~~G~~n~v~~v~--------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~   88 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN--------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETY   88 (304)
T ss_dssp             CCEEEECSSEEEEEST--------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSC
T ss_pred             eEecCCCCcceEEEEC--------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCC
Confidence            4569999999999852              24888986533  33456888999998874 333  334444333332  


Q ss_pred             -ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------
Q 011234          212 -QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------  260 (490)
Q Consensus       212 -~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------  260 (490)
                       ..|+||++++|.+|......    .++......++.+++..|..||+..                              
T Consensus        89 ~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (304)
T 3sg8_A           89 QMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRE  164 (304)
T ss_dssp             SCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhccc
Confidence             34889999999888754332    4667777788888888888888611                              


Q ss_pred             -------------------------CCCeeecCCCCCceEEcC--CCCeEEccccccccCCCCCCcceeeccccCCCC--
Q 011234          261 -------------------------EKPVIYRDFKTSNILLDA--DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY--  311 (490)
Q Consensus       261 -------------------------~~~iiHrDlkp~NILl~~--~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y--  311 (490)
                                               ...++|+|+++.|||++.  +..+.|+||+.+.......      .+.....+  
T Consensus       165 ~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~  238 (304)
T 3sg8_A          165 LKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDE  238 (304)
T ss_dssp             SCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTT
T ss_pred             CCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhcc
Confidence                                     134899999999999988  4568899999886542210      01111111  


Q ss_pred             -CCchhhhc-----CCC---------CccccchhhHHHHHHHHhCCCCC
Q 011234          312 -AAPEYVMT-----GHL---------TSKSDVYSFGVVLLEMLTGRRSM  345 (490)
Q Consensus       312 -~aPE~l~~-----~~~---------~~~sDvwSlGvil~elltG~~pf  345 (490)
                       ..|+....     +..         ....+.|+++.++|.+.+|..+|
T Consensus       239 ~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          239 EYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             SCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             23332211     010         12258999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=6.2e-07  Score=87.68  Aligned_cols=136  Identities=21%  Similarity=0.142  Sum_probs=91.4

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCC---ceeceeeEEE-ecCc
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYCI-EDDQ  212 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~  212 (490)
                      .+.++.|....||+.              |..+++|+...  ......+.+|+.+|..|.+.   .|.+++.+.. ..+.
T Consensus        24 v~~l~~G~~n~v~~v--------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~   87 (306)
T 3tdw_A           24 VESLGEGFRNYAILV--------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGN   87 (306)
T ss_dssp             EEEEEECSSEEEEEE--------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSC
T ss_pred             eeecCCCcceeEEEE--------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCc
Confidence            456888999999987              12478887532  23345688999999998742   2455666654 3456


Q ss_pred             eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------
Q 011234          213 RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEE---------------------------------  259 (490)
Q Consensus       213 ~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------------------------------  259 (490)
                      .++||||++|..|......    .++......++.+++..|..||+.                                 
T Consensus        88 ~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           88 PFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             EEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             eEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            7899999999888663211    233444444555555555555542                                 


Q ss_pred             ------------------------CCCCeeecCCCCCceEEcC---CCC-eEEcccccccc
Q 011234          260 ------------------------AEKPVIYRDFKTSNILLDA---DYN-AKLSDFGLAKD  292 (490)
Q Consensus       260 ------------------------~~~~iiHrDlkp~NILl~~---~~~-~kL~DFG~a~~  292 (490)
                                              ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                    2234799999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.55  E-value=3.1e-07  Score=87.73  Aligned_cols=136  Identities=17%  Similarity=0.082  Sum_probs=93.5

Q ss_pred             eeccCCce-EEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEEE
Q 011234          139 LLGEGGFG-CVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       139 ~lG~G~fg-~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv  216 (490)
                      .+..|..| .||+.....         .+..+++|+-...   ....+.+|..+|+.|. +--|.++++++.+.+..++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~---------~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKP---------NAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             EEECSSSSCEEEEEECCT---------TCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             EccCCCcCCeEEEEEecC---------CCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            34455555 689876543         3456888976432   3456778999998875 33366788888888999999


Q ss_pred             EEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 011234          217 YEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA------------------------------------  260 (490)
Q Consensus       217 ~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~------------------------------------  260 (490)
                      ||+++|.++.+......      .....++.+++..|.-||...                                    
T Consensus        99 me~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             EECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99999988876653221      122345555666666666421                                    


Q ss_pred             -------------------CCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          261 -------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       261 -------------------~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                                         ...++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               11279999999999999877778999997753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.36  E-value=6.6e-07  Score=89.20  Aligned_cols=85  Identities=5%  Similarity=-0.078  Sum_probs=53.3

Q ss_pred             Ccee-ccCCceEEEEEEEcc--CCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCC-C--CceeceeeEE
Q 011234          137 ESLL-GEGGFGCVFKGWVEE--NGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLL-H--PNLVKLVGYC  207 (490)
Q Consensus       137 ~~~l-G~G~fg~Vy~~~~~~--~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~  207 (490)
                      .+.| +.|....+|+.....  ++.     ..+..+++|+.....   ......+.+|+.+|+.|. +  -.+.+++.++
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~-----~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~   99 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGR-----SIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIE   99 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTE-----EEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred             EEECCCCCccceEEEEEEecccCCC-----CCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence            3567 889999999886531  000     014568888765432   101234667888887774 2  2466777776


Q ss_pred             Eec---CceEEEEEecCCCCHH
Q 011234          208 IED---DQRLLVYEFMPRGSLE  226 (490)
Q Consensus       208 ~~~---~~~~lv~E~~~~g~L~  226 (490)
                      .+.   +..++||||++|..+.
T Consensus       100 ~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          100 TTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             CSSTTTSSCEEEEECCCCBCCC
T ss_pred             cCCCccCCceEEEEecCCCChh
Confidence            554   3568999999886654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.33  E-value=1.8e-06  Score=87.47  Aligned_cols=76  Identities=14%  Similarity=0.104  Sum_probs=48.2

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-------hhHHHHHHHHHHHhcCCC--Cc-eeceeeE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-------QGHKEWLAEVNFLGNLLH--PN-LVKLVGY  206 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--pn-Iv~l~~~  206 (490)
                      .+.||.|.++.||++....         .+..|+||.......       .....+..|.++|..+..  +. +.+++.+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~---------~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~  105 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS  105 (397)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE
T ss_pred             EEECCCCceEEEEEEEECC---------CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE
Confidence            4679999999999997543         345799997643211       112345678888887642  33 3345543


Q ss_pred             EEecCceEEEEEecCCC
Q 011234          207 CIEDDQRLLVYEFMPRG  223 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g  223 (490)
                        +.+..++||||+++.
T Consensus       106 --d~~~~~lvmE~l~g~  120 (397)
T 2olc_A          106 --DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --ETTTTEEEECCCTTS
T ss_pred             --cCCccEEEEEeCCCc
Confidence              455678999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.14  E-value=1.9e-05  Score=77.61  Aligned_cols=31  Identities=19%  Similarity=0.201  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..+||+|+++.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            4599999999999998888999999997653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.96  E-value=4.3e-05  Score=77.94  Aligned_cols=77  Identities=14%  Similarity=0.155  Sum_probs=45.5

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeecccc--CCCCCCchhhhcC---CCCccccchhhHHHHH
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG--TYGYAAPEYVMTG---HLTSKSDVYSFGVVLL  336 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~G--t~~y~aPE~l~~~---~~~~~sDvwSlGvil~  336 (490)
                      ..++|+|+++.|||++.++ ++|+||+.+......-.  .. ...+  ...|++|+.....   .-....++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4499999999999998776 99999998875431100  00 0000  1235555544211   1111244557777778


Q ss_pred             HHHhCC
Q 011234          337 EMLTGR  342 (490)
Q Consensus       337 elltG~  342 (490)
                      +++.+.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            777653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.83  E-value=0.00013  Score=71.19  Aligned_cols=75  Identities=19%  Similarity=0.099  Sum_probs=57.3

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC---CCceeceeeEEEecCce
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL---HPNLVKLVGYCIEDDQR  213 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~  213 (490)
                      .+.|+.|.+..+|+...           .+..+++|+....   ....+..|+..|+.|.   ...+.+++.+....+..
T Consensus        41 ~~~l~gG~~n~~y~v~~-----------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~  106 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-----------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS  106 (312)
T ss_dssp             EEEECCSSSSEEEEEES-----------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred             eEEeCCccceeeeEEEE-----------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence            45799999999999864           2346888986543   2456778988888874   35677888888777889


Q ss_pred             EEEEEecCCCCH
Q 011234          214 LLVYEFMPRGSL  225 (490)
Q Consensus       214 ~lv~E~~~~g~L  225 (490)
                      ++||||+++..+
T Consensus       107 ~lvme~l~G~~~  118 (312)
T 3jr1_A          107 FLLLEALNKSKN  118 (312)
T ss_dssp             EEEEECCCCCCC
T ss_pred             EEEEEeccCCCC
Confidence            999999998754

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.75  E-value=0.00013  Score=70.22  Aligned_cols=81  Identities=20%  Similarity=0.176  Sum_probs=55.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCC---ceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP---NLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~  207 (490)
                      .....-.+.+|.|..+.||+....          +|..|.+|+...........+..|+..|+.|.-.   -+.+++++ 
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~----------DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-   82 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELA----------DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-   82 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEET----------TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-
T ss_pred             CCCeEEEEecCCCCCeEEEEEEEC----------CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-
Confidence            345556678999999999999875          4778999986544333334567899988877421   23344443 


Q ss_pred             EecCceEEEEEecCCCCH
Q 011234          208 IEDDQRLLVYEFMPRGSL  225 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L  225 (490)
                         +..++||||++++..
T Consensus        83 ---~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           83 ---DDRTLAMEWVDERPP   97 (288)
T ss_dssp             ---ETTEEEEECCCCCCC
T ss_pred             ---cCceEEEEeecccCC
Confidence               234889999987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00014  Score=71.06  Aligned_cols=141  Identities=14%  Similarity=0.135  Sum_probs=75.4

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-----CCceecee-e--EEEe
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----HPNLVKLV-G--YCIE  209 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~-~--~~~~  209 (490)
                      +.|+.|....+|+.....          | .+++|+.....  ....+..|+.++..|.     -|.++... |  +...
T Consensus        28 ~~i~~G~~n~~~~v~~~~----------g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTK----------D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             EEECC---EEEEEEEESS----------C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             eccCCCcccceEEEEeCC----------c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            457778889999986532          2 57899886531  1123455777766653     23333211 1  1223


Q ss_pred             cCceEEEEEecCCCCHHH-----------H---Hhhc-CCCC------C---CHHHHHH------------HHHHHHHHH
Q 011234          210 DDQRLLVYEFMPRGSLEN-----------H---LFRK-GSLP------L---PWSIRMK------------IALGAAKGL  253 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~-----------~---l~~~-~~~~------l---~~~~~~~------------i~~qi~~aL  253 (490)
                      .+..++||+|++|..+..           .   +... ....      .   .|.....            +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            456789999998764311           0   1110 0000      1   1211100            001133445


Q ss_pred             HHhhhc----CCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          254 AFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       254 ~yLH~~----~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+|+..    ....+||+|+.+.|||++.++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            555532    13459999999999999877656899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.48  E-value=0.00017  Score=69.91  Aligned_cols=72  Identities=7%  Similarity=0.042  Sum_probs=43.0

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceE
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRL  214 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~  214 (490)
                      -.+.|+.|....+|++  .             .+++|+....... .....+|+.+++.+..-.+ .+++++  +.+.-+
T Consensus        22 ~i~~l~gG~tN~~~~~--~-------------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~   83 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA--G-------------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGV   83 (301)
T ss_dssp             SCEEEESCSSEEEEEE--T-------------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCC
T ss_pred             ceeEcCCcccccccee--e-------------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCE
Confidence            3678999999999998  2             3788887643211 1112457777766642222 344433  444568


Q ss_pred             EEEEec-CCCCH
Q 011234          215 LVYEFM-PRGSL  225 (490)
Q Consensus       215 lv~E~~-~~g~L  225 (490)
                      +|+||+ ++.+|
T Consensus        84 ~v~e~i~~g~~l   95 (301)
T 3dxq_A           84 MVTRYIAGAQTM   95 (301)
T ss_dssp             EEEECCTTCEEC
T ss_pred             EEEeecCCCccC
Confidence            999999 65444

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.40  E-value=0.00029  Score=71.97  Aligned_cols=80  Identities=18%  Similarity=0.104  Sum_probs=49.1

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~l  215 (490)
                      .+.|+.|....||++........  ....+..+++|+.....  ....+..|+.++..|...+| .++++.+.  +  .+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~--~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPP--IRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCC--SSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEeCCCcccceEEEEeCCCccc--cCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            45688888999999976421100  00124578899884421  12455678888888753333 55666543  2  38


Q ss_pred             EEEecCCCC
Q 011234          216 VYEFMPRGS  224 (490)
Q Consensus       216 v~E~~~~g~  224 (490)
                      ||||++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            999998643

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.38  E-value=0.00051  Score=68.89  Aligned_cols=148  Identities=15%  Similarity=0.106  Sum_probs=80.3

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l  215 (490)
                      .+.|..|-...+|++.......  ...+.+..+++|+.... ......+.+|.++++.|. +.-..++++++.+    .+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~--~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLP--SVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSC--CCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEEcCCcccccEEEEEeCCCcc--ccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            3567778889999987642100  00113457889986332 223455668999888775 3223455655432    39


Q ss_pred             EEEecCCCCHHH--------------HHh---hcC---CCCC--CHHHHHHHHHHHHH-------------------HHH
Q 011234          216 VYEFMPRGSLEN--------------HLF---RKG---SLPL--PWSIRMKIALGAAK-------------------GLA  254 (490)
Q Consensus       216 v~E~~~~g~L~~--------------~l~---~~~---~~~l--~~~~~~~i~~qi~~-------------------aL~  254 (490)
                      ||||++|..|..              .|.   ...   ....  -+..+..+..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            999998755421              111   000   0111  13444444433321                   122


Q ss_pred             Hh----hhc-CCCCeeecCCCCCceEEcCC----CCeEEccccccc
Q 011234          255 FL----HEE-AEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAK  291 (490)
Q Consensus       255 yL----H~~-~~~~iiHrDlkp~NILl~~~----~~~kL~DFG~a~  291 (490)
                      .|    ... ....++|+|+.+.|||++.+    +.+.|+||..+.
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            32    221 12359999999999999876    789999998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0015  Score=63.81  Aligned_cols=141  Identities=16%  Similarity=0.099  Sum_probs=77.3

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCC--ceeceeeE-----EEec
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHP--NLVKLVGY-----CIED  210 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~-----~~~~  210 (490)
                      ..|+ |....||++...          .|..+++|+..... .....+..|+.++..|...  .+.+++..     ...+
T Consensus        32 ~~l~-g~~n~~y~v~~~----------~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~   99 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQ   99 (328)
T ss_dssp             EEEC-CSSSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEET
T ss_pred             Eeec-CcccceEEEEcC----------CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEEC
Confidence            4576 888899987542          34568999986432 1234566677777766421  23334432     2234


Q ss_pred             CceEEEEEecCCCCHH-----H------HH---hh----cC---CCCCCHHHH----HHH---------------HHHHH
Q 011234          211 DQRLLVYEFMPRGSLE-----N------HL---FR----KG---SLPLPWSIR----MKI---------------ALGAA  250 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~-----~------~l---~~----~~---~~~l~~~~~----~~i---------------~~qi~  250 (490)
                      +..++||+|++|..+.     .      .|   ..    ..   ...+.+...    ..+               ...+.
T Consensus       100 g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  179 (328)
T 1zyl_A          100 GFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATD  179 (328)
T ss_dssp             TEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHH
T ss_pred             CEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHH
Confidence            5668899999874331     1      11   00    00   001121111    000               00111


Q ss_pred             HHHHHhhhc----CCCCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          251 KGLAFLHEE----AEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       251 ~aL~yLH~~----~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..+..+...    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       180 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          180 ELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            122222221    234589999999999998 4 899999987754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.25  E-value=0.0017  Score=63.56  Aligned_cols=32  Identities=28%  Similarity=0.318  Sum_probs=27.5

Q ss_pred             CCeeecCCCCCceEEcCC----CCeEEccccccccC
Q 011234          262 KPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDA  293 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~----~~~kL~DFG~a~~~  293 (490)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            459999999999999874    67999999988654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.11  E-value=0.0024  Score=58.20  Aligned_cols=140  Identities=14%  Similarity=0.034  Sum_probs=90.1

Q ss_pred             CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCCCCCccee
Q 011234          223 GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS  302 (490)
Q Consensus       223 g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~  302 (490)
                      -+|.+.|...+. ++++++++.++.|.+.+|.-+-... . -..+=+-|..|+|..+|.|-+.+ ..+.           
T Consensus        33 vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~-~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRR-Q-PRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTT-C-CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhcc-c-CCceecCCcceEEecCCceeccc-cccc-----------
Confidence            378999887754 8999999999999999887662111 0 12333457999999999988864 2110           


Q ss_pred             eccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCC
Q 011234          303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHF  382 (490)
Q Consensus       303 ~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  382 (490)
                         .....+.+||... ...+.+.=|||||+++|..+--..|-.                                   -
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-----------------------------------e  138 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-----------------------------------E  138 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------------------E
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-----------------------------------c
Confidence               1122466888653 344567789999999999885332210                                   0


Q ss_pred             ChHhHHHHHHHHHHhhhc-------------------------CCCCCCCHHHHHHHhh
Q 011234          383 SIKGSQKATQLAAQCLSR-------------------------DPKARPRMSEVVETLK  416 (490)
Q Consensus       383 ~~~~~~~l~~Li~~cL~~-------------------------dP~~RPs~~evl~~L~  416 (490)
                      ....++.+.+||..|...                         .+..|+++.+|++.-.
T Consensus       139 E~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~  197 (229)
T 2yle_A          139 ERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCA  197 (229)
T ss_dssp             EECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHH
T ss_pred             chhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHH
Confidence            011277888899888765                         2468899999987764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.11  E-value=0.00072  Score=67.40  Aligned_cols=82  Identities=9%  Similarity=-0.013  Sum_probs=43.0

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc-eeceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-LVKLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~l  215 (490)
                      ...|+.|....+|++........ ..+..+..+++|+...... .......|..++..|...+ +.++++..  .  -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~-~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETAN-NYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHT-TCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcc-cccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcE
Confidence            35677888899999876421000 0001235788888754321 1112346777777765223 33555543  2  378


Q ss_pred             EEEecCCCC
Q 011234          216 VYEFMPRGS  224 (490)
Q Consensus       216 v~E~~~~g~  224 (490)
                      ||||++|..
T Consensus       112 v~e~i~G~~  120 (369)
T 3c5i_A          112 IEEWLYGDP  120 (369)
T ss_dssp             EEECCCSEE
T ss_pred             EEEEecCCc
Confidence            999998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.11  E-value=0.0013  Score=67.76  Aligned_cols=75  Identities=13%  Similarity=0.026  Sum_probs=45.5

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCce-eceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNL-VKLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~l  215 (490)
                      .+.|+.|-...+|++....         .+..+++|+....... .-...+|+.+|..|...++ .++++++.  +  .+
T Consensus       113 i~~lsgG~tN~~y~v~~~~---------~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~  178 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS---------KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GR  178 (458)
T ss_dssp             EEEECC--CEEEEEEEETT---------TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EE
T ss_pred             EEEcCCCeEeEEEEEEECC---------CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eE
Confidence            3568888889999987642         2357889987533211 1112468888888864444 46666652  2  35


Q ss_pred             EEEecCCCCH
Q 011234          216 VYEFMPRGSL  225 (490)
Q Consensus       216 v~E~~~~g~L  225 (490)
                      ||||++|..|
T Consensus       179 v~e~I~G~~l  188 (458)
T 2qg7_A          179 IEEFMDGYAL  188 (458)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEeeCCccC
Confidence            9999987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.81  E-value=0.011  Score=58.23  Aligned_cols=31  Identities=13%  Similarity=0.149  Sum_probs=27.4

Q ss_pred             CCeeecCCCCCceEEcCCCCeEEcccccccc
Q 011234          262 KPVIYRDFKTSNILLDADYNAKLSDFGLAKD  292 (490)
Q Consensus       262 ~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~  292 (490)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.67  E-value=0.029  Score=56.88  Aligned_cols=82  Identities=9%  Similarity=-0.019  Sum_probs=46.5

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l  215 (490)
                      .+.|..|-...+|++........  .+..+..+++++..... ...-...+|..+++.|. +.-..++++.+  .  -++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~--~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMS--LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEEcCCCcccceEEEEeCCCccc--ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            35677788899999987531100  00125678898864432 11112346777777774 22234455432  2  378


Q ss_pred             EEEecCCCCH
Q 011234          216 VYEFMPRGSL  225 (490)
Q Consensus       216 v~E~~~~g~L  225 (490)
                      ||||++|..|
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999988653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.18  E-value=0.11  Score=52.26  Aligned_cols=29  Identities=28%  Similarity=0.319  Sum_probs=24.5

Q ss_pred             eeecCCCCCceEE------cCCCCeEEcccccccc
Q 011234          264 VIYRDFKTSNILL------DADYNAKLSDFGLAKD  292 (490)
Q Consensus       264 iiHrDlkp~NILl------~~~~~~kL~DFG~a~~  292 (490)
                      ++|+|+.+.|||+      +++..+.|+||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6799999999999      4567799999987753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.52  E-value=0.96  Score=41.08  Aligned_cols=115  Identities=11%  Similarity=0.118  Sum_probs=75.9

Q ss_pred             CCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeecCCCCCce
Q 011234          196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA-FLHEEAEKPVIYRDFKTSNI  274 (490)
Q Consensus       196 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~-yLH~~~~~~iiHrDlkp~NI  274 (490)
                      .||++  -..+-.+++.+.+.++.-+++.=...+.     .++...+++++.+|+.... +++.     -+|--|.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            57877  3444466777777777653432233332     4677888999998887666 5544     67778999999


Q ss_pred             EEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCC
Q 011234          275 LLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       275 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~  346 (490)
                      +++.++.++|.-.|+-..+.+.              =+.+|-+          +-.+=|++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~lpP~--------------e~~ee~f----------l~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESLPPD--------------EWDDERL----------LREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTTBSSC--------------SCCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcccCCCC--------------CCCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            9999999999988864433211              1222322          2356678888888877663

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.50  E-value=0.87  Score=41.20  Aligned_cols=123  Identities=9%  Similarity=0.035  Sum_probs=80.0

Q ss_pred             HHHHHhcCCCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 011234          188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYR  267 (490)
Q Consensus       188 E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHr  267 (490)
                      |+.+|. ..||+++.. .+-.+++.+.+.++.-+  +...+-.-+   .++....++++.+|+....+++.     =+|-
T Consensus        36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~~-----r~tf  103 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNRT-----RYTF  103 (215)
T ss_dssp             GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGGS-----SEEC
T ss_pred             HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhcC-----ceEE
Confidence            444443 358888876 46666676666666543  222222111   46778889999999887765554     4677


Q ss_pred             CCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCC
Q 011234          268 DFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMD  346 (490)
Q Consensus       268 Dlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~  346 (490)
                      -|.|+||+++.++.+++.-.|+-..+....              +..|-+          +-.+=|++..+++++..|+
T Consensus       104 ~L~P~NL~f~~~~~p~i~~RGik~~l~P~~--------------~~ee~f----------L~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          104 VLAPDELFFTRDGLPIAKTRGLQNVVDPLP--------------VSEAEF----------LTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CCSGGGEEECTTSCEEESCCEETTTBSCCC--------------CCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred             EEecceEEEcCCCCEEEEEccCccCCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence            899999999999999999888644332210              112222          3356688888999887774

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.55  E-value=0.097  Score=53.71  Aligned_cols=63  Identities=11%  Similarity=0.156  Sum_probs=18.6

Q ss_pred             CcCceeccCCceEEEEEEEccCCCccccCCCCcEEEE------EEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          135 RPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAV------KTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       135 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAv------K~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+.+.||   ||.||+|.+..         +...||+      |.......  .....+.+|..++..+.|||+++.+++
T Consensus       145 ~l~~~lG---fG~v~~g~~~~---------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f  212 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYK---------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF  212 (463)
T ss_dssp             CSTTTSS---BCCC------------------CCBGGGC-----------------------------------CBCCCE
T ss_pred             cccccCC---chhhhcccccc---------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence            4556776   99999998864         2236777      66554322  223467889999999999999999987


Q ss_pred             EEe
Q 011234          207 CIE  209 (490)
Q Consensus       207 ~~~  209 (490)
                      ...
T Consensus       213 ~~~  215 (463)
T 3cxl_A          213 KVH  215 (463)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	490
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-69
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-69
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-68
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-68
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-68
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-68
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-66
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-65
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-65
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-64
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-64
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-63
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-63
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-62
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-61
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-59
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-58
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-58
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-58
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-56
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-55
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-53
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-52
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-51
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-49
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-48
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-47
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-47
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-46
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-46
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-43
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-41
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-32
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 2e-76
 Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 34/292 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 190
                  +G G FG V+KG                 VAVK LN      Q  + +  EV 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVG 56

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            L    H N++  +GY     Q  +V ++    SL +HL    +        + IA   A
Sbjct: 57  VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTA 114

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +G+ +LH    K +I+RD K++NI L  D   K+ DFGLA        +H   ++ G+  
Sbjct: 115 QGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 311 YAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
           + APE +        + +SDVY+FG+VL E++TG+       P    N  +     +G  
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMVGRG 225

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
                L   R          +   +L A+CL +    RP   +++ +++ L 
Sbjct: 226 YLSPDLSKVRSN------CPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 2e-69
 Identities = 70/314 (22%), Positives = 127/314 (40%), Gaps = 44/314 (14%)

Query: 127 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEW 185
           ++L   +F   S LG G  G VFK              +GL +A K ++ +       + 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKV---------SHKPSGLVMARKLIHLEIKPAIRNQI 51

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           + E+  L     P +V   G    D +  +  E M  GSL+  L + G   +P  I  K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKV 109

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
           ++   KGL +L E+    +++RD K SNIL+++    KL DFG++    +     ++   
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSF 163

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR---------------------- 343
           +GT  Y +PE +   H + +SD++S G+ L+EM  GR                       
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223

Query: 344 ----SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLS 399
                  +       +    +RP +        +++       S   S +      +CL 
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 283

Query: 400 RDPKARPRMSEVVE 413
           ++P  R  + +++ 
Sbjct: 284 KNPAERADLKQLMV 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 4e-69
 Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 32/286 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
             +    LG G FG V+ G+                VAVK+L          +LAE N +
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLM 62

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L H  LV+L       +   ++ E+M  GSL + L     + L  +  + +A   A+G
Sbjct: 63  KQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +AF+ E   +  I+RD + +NIL+    + K++DFGLA+   ++ +            + 
Sbjct: 122 MAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWT 177

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +  G  T KSDV+SFG++L E++T  R       N E          + +  R YR
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYR 228

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           ++ P           ++  QL   C    P+ RP    +   L+  
Sbjct: 229 MVRPD-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  219 bits (560), Expect = 8e-69
 Identities = 71/302 (23%), Positives = 129/302 (42%), Gaps = 30/302 (9%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK 183
           ++  ++   +   +  LG G +G V++G         V     LTVAVKTL  D ++  +
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEG---------VWKKYSLTVAVKTLKEDTMEV-E 58

Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           E+L E   +  + HPNLV+L+G C  +    ++ EFM  G+L ++L       +   + +
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 118

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +A   +  + +L    +K  I+RD    N L+  ++  K++DFGL++    D       
Sbjct: 119 YMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHA 174

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
                  + APE +     + KSDV++FGV+L E+ T   S        +          
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 224

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
                  Y LL+            +K  +L   C   +P  RP  +E+ +  + +     
Sbjct: 225 ------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278

Query: 424 MA 425
           ++
Sbjct: 279 IS 280

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (556), Expect = 1e-68
 Identities = 79/287 (27%), Positives = 124/287 (43%), Gaps = 32/287 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
                  +G G FG V  G+                VA+KT+        ++++ E   +
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVM 54

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L HP LV+L G C+E     LV+EFM  G L ++L  +  L       + + L   +G
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEG 113

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +A+L E     VI+RD    N L+  +   K+SDFG+ +   +D +   ST       +A
Sbjct: 114 MAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWA 169

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           +PE       +SKSDV+SFGV++ E+ +  +   +NR N E          + D    +R
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFR 220

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
           L  PRL        S    Q+   C    P+ RP  S ++  L  + 
Sbjct: 221 LYKPRLA-------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (555), Expect = 2e-68
 Identities = 72/292 (24%), Positives = 123/292 (42%), Gaps = 42/292 (14%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           +  +    +G+G FG V  G              G  VAVK + +D     + +LAE + 
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-----------RGNKVAVKCIKNDATA--QAFLAEASV 53

Query: 192 LGNLLHPNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
           +  L H NLV+L+G  +E+   L +V E+M +GSL ++L  +G   L     +K +L   
Sbjct: 54  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVC 113

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           + + +L        ++RD    N+L+  D  AK+SDFGL K+A     T           
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVK 165

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWARPHLGDKR 368
           + APE +     ++KSDV+SFG++L E+ +  R      P  +    + +  +    D  
Sbjct: 166 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 225

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN 420
                                  ++   C   D   RP   ++ E L+ ++ 
Sbjct: 226 ------------------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 3e-68
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 32/285 (11%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           ++      LG G FG V  G                 VA+K +         E++ E   
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGS-MSEDEFIEEAKV 52

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           + NL H  LV+L G C +     ++ E+M  G L N+L             +++     +
Sbjct: 53  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCE 111

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            + +L     K  ++RD    N L++     K+SDFGL++   +D +   S        +
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRW 167

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
           + PE +M    +SKSD+++FGV++ E+ +  +      P       E A        +  
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----MPYERFTNSETAE----HIAQGL 218

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           RL  P L        S+K   +   C       RP    ++  + 
Sbjct: 219 RLYRPHLA-------SEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (557), Expect = 5e-68
 Identities = 73/307 (23%), Positives = 115/307 (37%), Gaps = 45/307 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 191
           N     +LG G FG V             K G  + VAVK L        +E  ++E+  
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGIS----KTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 192 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------- 235
           +  L  H N+V L+G C       L++E+   G L N+L  K                  
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 236 ------PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL 289
                  L +   +  A   AKG+ FL     K  ++RD    N+L+      K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 349
           A+D   D    V         + APE +  G  T KSDV+S+G++L E+ +   +     
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 350 PNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS 409
           P   +               FY+L+    +       +++   +   C + D + RP   
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 410 EVVETLK 416
            +   L 
Sbjct: 316 NLTSFLG 322

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 6e-68
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 32/295 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNFLGNLLH 197
           ++G G FGCV+ G + +N       G  +  AVK+LN     G   ++L E   + +  H
Sbjct: 34  VIGRGHFGCVYHGTLLDND------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 198 PNLVKLVGYCIEDDQR-LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFL 256
           PN++ L+G C+  +   L+V  +M  G L N +  +   P      +   L  AKG+ FL
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGFGLQVAKGMKFL 146

Query: 257 HEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG--KTHVSTRVMGTYGYAAP 314
                K  ++RD    N +LD  +  K++DFGLA+D  +      H  T       + A 
Sbjct: 147 AS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 315 EYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLL 374
           E + T   T+KSDV+SFGV+L E++T         P  + N  +     L    +  RLL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLL----QGRRLL 254

Query: 375 DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSY 429
            P               ++  +C     + RP  SE+V  +  +          Y
Sbjct: 255 QPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAI--FSTFIGEHY 300

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  217 bits (554), Expect = 8e-68
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 39/310 (12%)

Query: 122 FMFNDLKLATRNFRPE---------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVK 172
           F F D   A R F  E          ++G G FG V  G ++  G         + VA+K
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPG------KREIFVAIK 60

Query: 173 TLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR 231
           TL      +  +++L+E + +G   HPN++ L G   +    +++ EFM  GSL++ L +
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120

Query: 232 KGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK 291
                      + +  G A G+ +L +      ++RD    NIL++++   K+SDFGL++
Sbjct: 121 NDG-QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 292 DAPEDGKTHVSTRV---MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN 348
              +D      T          + APE +     TS SDV+S+G+V+ E+++        
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----- 231

Query: 349 RPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
           RP  +    +       D R               +       QL   C  +D   RP+ 
Sbjct: 232 RPYWDMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKF 280

Query: 409 SEVVETLKPL 418
            ++V TL  +
Sbjct: 281 GQIVNTLDKM 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (547), Expect = 1e-66
 Identities = 79/314 (25%), Positives = 118/314 (37%), Gaps = 45/314 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 191
                  LG G FG V +          +K    +TVAVK L        +E  ++E+  
Sbjct: 24  RLSFGKTLGAGAFGKVVEATA----YGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 192 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG----------------S 234
           L  L  H N+V L+G C      L++ E+   G L N L RK                  
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 235 LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP 294
           L L     +  +   AKG+AFL     K  I+RD    NILL      K+ DFGLA+D  
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 295 EDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEH 354
            D    V         + APE +     T +SDV+S+G+ L E+ +   S     P    
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET 414
                          FY+++              +   +   C   DP  RP   ++V+ 
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 415 LKPLQNLKDMASSS 428
           ++     K ++ S+
Sbjct: 302 IE-----KQISEST 310

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 3e-66
 Identities = 69/314 (21%), Positives = 121/314 (38%), Gaps = 36/314 (11%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNF 191
           R    +  +G+G FG V++G              G  VAVK  +    +      AE+  
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREER-SWFREAEIYQ 50

Query: 192 LGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
              L H N++  +    +D+    Q  LV ++   GSL ++L R     +     +K+AL
Sbjct: 51  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLAL 107

Query: 248 GAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH 300
             A GLA LH E      +  + +RD K+ NIL+  +    ++D GLA   D+  D    
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167

Query: 301 VSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRR----SMDKNRP 350
                +GT  Y APE +             ++D+Y+ G+V  E+           D   P
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227

Query: 351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
             +    + +   +       +L         S +  +   ++  +C   +  AR     
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287

Query: 411 VVETLKPLQNLKDM 424
           + +TL  L   + +
Sbjct: 288 IKKTLSQLSQQEGI 301

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 2e-65
 Identities = 69/311 (22%), Positives = 120/311 (38%), Gaps = 32/311 (10%)

Query: 126 DLKLATRNFRPESL-LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-K 183
            L L   N     + LG G FG V +G               + VA+K L     +   +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKK-------QIDVAIKVLKQGTEKADTE 54

Query: 184 EWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
           E + E   +  L +P +V+L+G C + +  +LV E    G L   L  K    +P S   
Sbjct: 55  EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVA 112

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKT-HVS 302
           ++    + G+ +L E   K  ++RD    N+LL   + AK+SDFGL+K    D       
Sbjct: 113 ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
           +       + APE +     +S+SDV+S+GV + E L+  +     +P  +    E    
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE---- 220

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK-PLQNL 421
                      ++         +   +   L + C     + RP    V + ++    +L
Sbjct: 221 -------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273

Query: 422 KDMASSSYYFQ 432
                  ++  
Sbjct: 274 ASKVEGHHHHH 284

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  209 bits (533), Expect = 9e-65
 Identities = 68/318 (21%), Positives = 114/318 (35%), Gaps = 46/318 (14%)

Query: 124 FNDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-H 182
              L+    N      +GEG FG VF+          +       VAVK L  +      
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARA----PGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 183 KEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKG--------- 233
            ++  E   +    +PN+VKL+G C       L++E+M  G L   L             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 234 -------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY 280
                          PL  + ++ IA   A G+A+L E   +  ++RD  T N L+  + 
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177

Query: 281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT 340
             K++DFGL+++                  +  PE +     T++SDV+++GVVL E+ +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 341 GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSR 400
                     + E                 Y + D  +          +   L   C S+
Sbjct: 238 YGLQPYYGMAHEE---------------VIYYVRDGNIL-ACPENCPLELYNLMRLCWSK 281

Query: 401 DPKARPRMSEVVETLKPL 418
            P  RP    +   L+ +
Sbjct: 282 LPADRPSFCSIHRILQRM 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 2e-64
 Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 27/298 (9%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHK-EWL 186
           ++       + ++G G FG V+KG ++ +          + VA+KTL     +  + ++L
Sbjct: 3   EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK-----KEVPVAIKTLKAGYTEKQRVDFL 57

Query: 187 AEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
            E   +G   H N+++L G   +    +++ E+M  G+  +   R+          + + 
Sbjct: 58  GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGML 116

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDG-KTHVSTRV 305
            G A G+ +L        ++RD    NIL++++   K+SDFGL++   +D   T+ ++  
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
                + APE +     TS SDV+SFG+V+ E++T          N E            
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKD 423
                 + ++        +       QL  QC  ++   RP+ +++V  L  L    D
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-64
 Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 30/292 (10%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAE 188
           ++ R    LG+G FG V +G  +         G  ++VAVK L  D L   +   +++ E
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIRE 61

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
           VN + +L H NL++L G  +    ++ V E  P GSL + L +            + A+ 
Sbjct: 62  VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQ 119

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHV-STRVMG 307
            A+G+ +L     K  I+RD    N+LL      K+ DFGL +  P++   +V       
Sbjct: 120 VAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176

Query: 308 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK 367
            + + APE + T   +  SD + FGV L EM T  +      P    N  +       + 
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEG 231

Query: 368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
            R      PR E        Q    +  QC +  P+ RP    + + L   Q
Sbjct: 232 ERL-----PRPEDC-----PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 4e-64
 Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 34/297 (11%)

Query: 137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVNFLGN 194
           +  LG G FG V KG+ +             TVAVK L ++        E LAE N +  
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKV-------VKTVAVKILKNEANDPALKDELLAEANVMQQ 64

Query: 195 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLA 254
           L +P +V+++G C E +  +LV E    G L  +L +     +     +++    + G+ 
Sbjct: 65  LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMK 121

Query: 255 FLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMGTYGYAA 313
           +L E      ++RD    N+LL   + AK+SDFGL+K    D   +   T       + A
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 314 PEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL 373
           PE +     +SKSDV+SFGV++ E  +  +     +P       E              +
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAM 222

Query: 374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQNLKDMASSSYY 430
           L+            ++   L   C + D + RP  + V   L+      D+ +  ++
Sbjct: 223 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY--YYDVVNEGHH 277

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (524), Expect = 2e-63
 Identities = 75/309 (24%), Positives = 127/309 (41%), Gaps = 48/309 (15%)

Query: 131 TRNFRPE------SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE 184
           TR+  PE        LG+G FG V+K              T +  A K ++    +  ++
Sbjct: 5   TRDLNPEDFWEIIGELGDGAFGKVYKA---------QNKETSVLAAAKVIDTKSEEELED 55

Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
           ++ E++ L +  HPN+VKL+     ++   ++ EF   G+++  +      PL  S    
Sbjct: 56  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQV 114

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +       L +LH   +  +I+RD K  NIL   D + KL+DFG++       +      
Sbjct: 115 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DS 169

Query: 305 VMGTYGYAAPEYVMT-----GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW 359
            +GT  + APE VM           K+DV+S G+ L+EM           P+ E N +  
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRV 223

Query: 360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEV-------V 412
                  K     L  P        + S        +CL ++  AR   S++       V
Sbjct: 224 LLKIA--KSEPPTLAQPS-------RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274

Query: 413 ETLKPLQNL 421
           ++ KP++ L
Sbjct: 275 DSNKPIREL 283

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-63
 Identities = 65/283 (22%), Positives = 109/283 (38%), Gaps = 31/283 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLN-HDGLQGHKEWLAEVNF 191
           ++     LGEG +G V            V   T   VAVK ++    +   +    E+  
Sbjct: 6   DWDLVQTLGEGAYGEVQLA---------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
              L H N+VK  G+  E + + L  E+   G L + +       +P     +       
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA 114

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
           G+ +LH      + +RD K  N+LLD   N K+SDFGLA     + +  +  ++ GT  Y
Sbjct: 115 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 312 AAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
            APE +          DV+S G+VL  ML G    D+   + +                +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------Y 216

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               + +   +   K       L  + L  +P AR  + ++ +
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 7e-63
 Identities = 66/289 (22%), Positives = 113/289 (39%), Gaps = 36/289 (12%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 190
           ++     +G G +G   K           +   G  +  K L++  +     +  ++EVN
Sbjct: 5   DYEVLYTIGTGSYGRCQKI---------RRKSDGKILVWKELDYGSMTEAEKQMLVSEVN 55

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLL--VYEFMPRGSLENHLFR--KGSLPLPWSIRMKIA 246
            L  L HPN+V+     I+     L  V E+   G L + + +  K    L     +++ 
Sbjct: 56  LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115

Query: 247 LGAAKGLAFLHE--EAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                 L   H   +    V++RD K +N+ LD   N KL DFGLA+    D  T  +  
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKA 173

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            +GT  Y +PE +       KSD++S G +L E+           P    +  E A    
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
             K         R+   +    S +  ++  + L+     RP + E++E
Sbjct: 228 EGKF-------RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (521), Expect = 7e-63
 Identities = 73/325 (22%), Positives = 131/325 (40%), Gaps = 49/325 (15%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNF 191
           + + + ++GEG FG V K  ++++G         +  A+K +        H+++  E+  
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLR-------MDAAIKRMKEYASKDDHRDFAGELEV 63

Query: 192 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------------P 236
           L  L  HPN++ L+G C       L  E+ P G+L + L +   L               
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L     +  A   A+G+ +L +   K  I+RD    NIL+  +Y AK++DFGL++     
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
            K    T       + A E +     T+ SDV+S+GV+L E+++   +     P      
Sbjct: 181 VKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTC 232

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
            E            Y  L         +    +   L  QC    P  RP  ++++ +L 
Sbjct: 233 AEL-----------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

Query: 417 PLQNLKDMASSSYYFQTMQADNTWS 441
            +   +     +Y   T+    T++
Sbjct: 282 RMLEER----KTYVNTTLYEKFTYA 302

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-62
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 32/286 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           + R E  LG+G FG V+ G                 VA+KTL        + +L E   +
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR----------VAIKTLKPG-TMSPEAFLQEAQVM 66

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L H  LV+L      ++   +V E+M +GSL + L  +    L     + +A   A G
Sbjct: 67  KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 125

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           +A++        ++RD + +NIL+  +   K++DFGLA+   ED +            + 
Sbjct: 126 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWT 181

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE  + G  T KSDV+SFG++L E+ T  R       N E                   
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLD 225

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
            ++         +  +    L  QC  ++P+ RP    +   L+  
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 4e-62
 Identities = 62/286 (21%), Positives = 121/286 (42%), Gaps = 27/286 (9%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFL 192
           F+   +LG G FG V+KG     G         + VA+K L      + +KE L E   +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
            ++ +P++ +L+G C+    +L + + MP G L +++       +     +   +  AKG
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 123

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + +L +   + +++RD    N+L+    + K++DFGLAK    + K + +        + 
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           A E ++    T +SDV+S+GV + E++T         P  E                   
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISS 224

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
           +L+           +     +  +C   D  +RP+  E++     +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 5e-62
 Identities = 68/284 (23%), Positives = 112/284 (39%), Gaps = 39/284 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 189
           +F     LG+G FG V+            +  +   +A+K L    L       +   EV
Sbjct: 7   DFEIGRPLGKGKFGNVYLA---------REKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
               +L HPN+++L GY  +  +  L+ E+ P G++   L +                  
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITEL 115

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTY 309
           A  L++ H    K VI+RD K  N+LL +    K++DFG +  AP   +T +     GT 
Sbjct: 116 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTL 168

Query: 310 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR 369
            Y  PE +       K D++S GV+  E L G+   + N     +  +        D   
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV- 227

Query: 370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                            ++ A  L ++ L  +P  RP + EV+E
Sbjct: 228 -----------------TEGARDLISRLLKHNPSQRPMLREVLE 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 2e-61
 Identities = 64/289 (22%), Positives = 108/289 (37%), Gaps = 39/289 (13%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 189
           R  + +  +G G F  V+KG         +   T + VA   L    L     + +  E 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKG---------LDTETTVEVAWCELQDRKLTKSERQRFKEEA 59

Query: 190 NFLGNLLHPNLVKLVGYCIE----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
             L  L HPN+V+               +LV E M  G+L+ +L R     +   +    
Sbjct: 60  EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSW 117

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGKTHVSTR 304
                KGL FLH     P+I+RD K  NI +     + K+ D GLA       +   +  
Sbjct: 118 CRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKA 172

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           V+GT  + APE +         DVY+FG+ +LEM T      + +   +           
Sbjct: 173 VIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------- 221

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                + R+        F      +  ++   C+ ++   R  + +++ 
Sbjct: 222 -----YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (509), Expect = 5e-61
 Identities = 71/309 (22%), Positives = 117/309 (37%), Gaps = 47/309 (15%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LA 187
            + F     +G G FG V+                   VA+K +++ G Q +++W   + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFA---------RDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV FL  L HPN ++  G  + +    LV E+    + +     K   PL       +  
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTH 122

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMG 307
           GA +GLA+LH      +I+RD K  NILL      KL DFG A           +   +G
Sbjct: 123 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173

Query: 308 TYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
           T  + APE ++    G    K DV+S G+  +E+   +       P    N +       
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIA 227

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE-----TLKPLQ 419
            ++     L             S+        CL + P+ RP    +++       +P  
Sbjct: 228 QNESPA--LQSGHW--------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

Query: 420 NLKDMASSS 428
            + D+   +
Sbjct: 278 VIMDLIQRT 286

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-59
 Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 37/303 (12%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVN 190
            + +     +G+G  G V+           +   TG  VA++ +N       +  + E+ 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTA---------MDVATGQEVAIRQMNLQQQPKKELIINEIL 69

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            +    +PN+V  +   +  D+  +V E++  GSL + +               +     
Sbjct: 70  VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECL 126

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           + L FLH      VI+RD K+ NILL  D + KL+DFG       +      + ++GT  
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPY 181

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           + APE V       K D++S G++ +EM+ G        P    N +             
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIA--TNGT 233

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE-----TLKPLQNLKDMA 425
             L +P        K S        +CL  D + R    E+++       KPL +L  + 
Sbjct: 234 PELQNPE-------KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLI 286

Query: 426 SSS 428
           +++
Sbjct: 287 AAA 289

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 3e-58
 Identities = 67/287 (23%), Positives = 114/287 (39%), Gaps = 29/287 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNF 191
                  +GEG FG V +G               L VA+KT  +      +E +L E   
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPE------NPALAVAIKTCKNCTSDSVREKFLQEALT 61

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAK 251
           +    HP++VKL+G    ++   ++ E    G L + L  +    L  +  +  A   + 
Sbjct: 62  MRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLST 119

Query: 252 GLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGY 311
            LA+L     K  ++RD    N+L+ ++   KL DFGL++   ED   + +++      +
Sbjct: 120 ALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKW 175

Query: 312 AAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY 371
            APE +     TS SDV+ FGV + E+L         +P       +        +R   
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER--- 227

Query: 372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                 +  +           L  +C + DP  RPR +E+   L  +
Sbjct: 228 ----LPMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 3e-58
 Identities = 80/303 (26%), Positives = 117/303 (38%), Gaps = 39/303 (12%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-HKEWLAEVNF 191
             +    LG G FG V +           K  T  TVAVK L        H+  ++E+  
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGID----KTATCRTVAVKMLKEGATHSEHRALMSELKI 69

Query: 192 LGNLLH-PNLVKLVGYCIEDDQRL-LVYEFMPRGSLENHLFRKGSL-------------- 235
           L ++ H  N+V L+G C +    L ++ EF   G+L  +L  K +               
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 236 PLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE 295
            L     +  +   AKG+ FL     +  I+RD    NILL      K+ DFGLA+D  +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 296 DGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 355
           D              + APE +     T +SDV+SFGV+L E+ +   S     P     
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVK 241

Query: 356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETL 415
           + E     L +  R                 + +  Q    C   +P  RP  SE+VE L
Sbjct: 242 IDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 416 KPL 418
             L
Sbjct: 292 GNL 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 5e-58
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 36/295 (12%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNF 191
                  LG+G FG V++G         VK      VA+KT+N    ++   E+L E + 
Sbjct: 21  KITMSRELGQGSFGMVYEGVA----KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 76

Query: 192 LGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSL--------PLPWSIRM 243
           +      ++V+L+G   +    L++ E M RG L+++L              P   S  +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
           ++A   A G+A+L+       ++RD    N ++  D+  K+ DFG+ +D  E        
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE--HNLVEWAR 361
           + +    + +PE +  G  T+ SDV+SFGVVL E+ T      +   N +    ++E   
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253

Query: 362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
               D                         +L   C   +PK RP   E++ ++K
Sbjct: 254 LDKPDNC------------------PDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-57
 Identities = 75/305 (24%), Positives = 118/305 (38%), Gaps = 37/305 (12%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEVNF 191
                  LGEG FG V     E  G    KP     VAVK L  D  +    + ++E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLA--EAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 192 LGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLP-------------- 236
           +  +  H N++ L+G C +D    ++ E+  +G+L  +L  +                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 237 LPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPED 296
           L     +  A   A+G+ +L     K  I+RD    N+L+  D   K++DFGLA+D    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 297 GKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
                +T       + APE +     T +SDV+SFGV+L E+ T   S     P  E   
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
                         ++LL            + +   +   C    P  RP   ++VE L 
Sbjct: 246 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 417 PLQNL 421
            +  L
Sbjct: 293 RIVAL 297

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 1e-56
 Identities = 61/297 (20%), Positives = 104/297 (35%), Gaps = 39/297 (13%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKE 184
           K    +F+   +LGEG F  V             +  T    A+K L    +        
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLA---------RELATSREYAIKILEKRHIIKENKVPY 54

Query: 185 WLAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
              E + +  L HP  VKL     +D++      +   G L  ++ + G      +    
Sbjct: 55  VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRF 112

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                   L +LH    K +I+RD K  NILL+ D + +++DFG AK    + K   +  
Sbjct: 113 YTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
            +GT  Y +PE +        SD+++ G ++ +++ G                    P  
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFR 211

Query: 365 GDKRRFYRLLDPRLEGHFSI--KGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ 419
                 Y +    ++  +    K   KA  L  + L  D   R    E+        
Sbjct: 212 AGNE--YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  185 bits (471), Expect = 5e-55
 Identities = 63/283 (22%), Positives = 102/283 (36%), Gaps = 32/283 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           ++     LG G FG V +           +  TG   A K +        +    E+  +
Sbjct: 27  HYDIHEELGTGAFGVVHRV---------TERATGNNFAAKFVMTPHESDKETVRKEIQTM 77

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L HP LV L     +D++ +++YEFM  G L   +  + +  +     ++      KG
Sbjct: 78  SVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKG 136

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYN--AKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           L  +H   E   ++ D K  NI+     +   KL DFGL           V     GT  
Sbjct: 137 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAE 190

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           +AAPE      +   +D++S GV+   +L+G        P G  N  E  R         
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWNM 244

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  +        S+       + L  DP  R  + + +E
Sbjct: 245 DDSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 37/296 (12%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG---HKEWLAEVN 190
           +    +LG GG   V                    VAVK L  D  +    +  +  E  
Sbjct: 9   YELGEILGFGGMSEVHLA---------RDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 59

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRL----LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
               L HP +V +      +        +V E++   +L + +  +G  P+     +++ 
Sbjct: 60  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVI 117

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST-RV 305
             A + L F H+     +I+RD K +NI++ A    K+ DFG+A+   + G +   T  V
Sbjct: 118 ADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           +GT  Y +PE      + ++SDVYS G VL E+LTG        P    + V  A  H+ 
Sbjct: 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHVR 228

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-MSEVVETLKPLQN 420
           +           L        S     +  + L+++P+ R +  +E+   L  + N
Sbjct: 229 EDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  181 bits (460), Expect = 2e-53
 Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 32/283 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
            +     LG G FG V +          V+  TG     K +N            E++ +
Sbjct: 30  YYDILEELGSGAFGVVHRC---------VEKATGRVFVAKFINTPYPLDKYTVKNEISIM 80

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L HP L+ L     +  + +L+ EF+  G L + +  +    +  +  +     A +G
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEG 139

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           L  +H   E  +++ D K  NI+ +    +  K+ DFGLA     D           T  
Sbjct: 140 LKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAE 193

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           +AAPE V    +   +D+++ GV+   +L+G        P    + +E  +        F
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL------SPFAGEDDLETLQNVKRCDWEF 247

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  +        S +A       L ++P+ R  + + +E
Sbjct: 248 DEDAFSSV--------SPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  176 bits (446), Expect = 3e-52
 Identities = 69/297 (23%), Positives = 111/297 (37%), Gaps = 47/297 (15%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---------QGHK 183
           N+ P+ +LG G    V +          +   T    AVK ++  G          +  +
Sbjct: 4   NYEPKEILGRGVSSVVRRC---------IHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 54

Query: 184 EWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
             L EV+ L  +  HPN+++L      +    LV++ M +G L ++L  K    L     
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKET 112

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
            KI     + +  LH   +  +++RD K  NILLD D N KL+DFG +       K    
Sbjct: 113 RKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--- 166

Query: 303 TRVMGTYGYAAPEYVMTGHL------TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL 356
             V GT  Y APE +             + D++S GV++  +L G        P      
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQ 220

Query: 357 VEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
           +   R  +    +F                S     L ++ L   P+ R    E + 
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (441), Expect = 4e-51
 Identities = 56/281 (19%), Positives = 94/281 (33%), Gaps = 29/281 (10%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-WLAEVNFL 192
           +    +LG G F  V                T   VA+K +    L+G +     E+  L
Sbjct: 11  YDFRDVLGTGAFSEVILA---------EDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             + HPN+V L           L+ + +  G L + +  KG          ++       
Sbjct: 62  HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDA 119

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYA 312
           + +LH+        +        LD D    +SDFGL+K           +   GT GY 
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL---STACGTPGYV 176

Query: 313 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR 372
           APE +     +   D +S GV+   +L G        P  + N  +     L  +  F  
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDS 230

Query: 373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                +        S  A       + +DP+ R    + ++
Sbjct: 231 PYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-50
 Identities = 54/337 (16%), Positives = 117/337 (34%), Gaps = 45/337 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
            +     LG G FG V +          V+  +  T   K +   G         E++ L
Sbjct: 6   KYMIAEDLGRGEFGIVHRC---------VETSSKKTYMAKFVKVKGTD-QVLVKKEISIL 55

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
               H N++ L       ++ ++++EF+    +   +       L     +       + 
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEA 114

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYNA--KLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           L FLH      + + D +  NI+     ++  K+ +FG A+         +   +     
Sbjct: 115 LQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPE 168

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           Y APE      +++ +D++S G ++  +L+G        P       +     +  +  F
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTF 222

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV------ETLKPLQN--LK 422
                  +        S +A     + L ++ K+R   SE +      + ++ +    ++
Sbjct: 223 DEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274

Query: 423 DMASSSYYFQTMQADNTWSI----RNSKNGIRTQGGF 455
            +    YY   ++ D    +     +    IR+Q G 
Sbjct: 275 TLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  173 bits (439), Expect = 3e-50
 Identities = 70/285 (24%), Positives = 107/285 (37%), Gaps = 40/285 (14%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEV 189
           +F    ++G GGFG V+            K  TG   A+K L+   +   QG    L E 
Sbjct: 5   DFSVHRIIGRGGFGEVYGC---------RKADTGKMYAMKCLDKKRIKMKQGETLALNER 55

Query: 190 N---FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIA 246
                +     P +V +       D+   + + M  G L  HL + G      +     A
Sbjct: 56  IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYA 113

Query: 247 LGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVM 306
                GL  +H    + V+YRD K +NILLD   + ++SD GLA D  +          +
Sbjct: 114 AEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166

Query: 307 GTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLG 365
           GT+GY APE +  G    S +D +S G +L ++L G     +++   +H +         
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 224

Query: 366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                       L   F    S +   L    L RD   R     
Sbjct: 225 ---------AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLG 256

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-49
 Identities = 72/278 (25%), Positives = 103/278 (37%), Gaps = 38/278 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEV 189
           +F    +LG+G FG VF               T    A+K L  D +    +    + E 
Sbjct: 3   DFILHKMLGKGSFGKVFLA---------EFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 53

Query: 190 NFLGNLL-HPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
             L     HP L  +       +    V E++  G L  H+          S     A  
Sbjct: 54  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAE 111

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
              GL FLH    K ++YRD K  NILLD D + K++DFG+ K+              GT
Sbjct: 112 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y APE ++        D +SFGV+L EML G+       P    +  E       D  
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNP 220

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
            + R L             ++A  L  +   R+P+ R 
Sbjct: 221 FYPRWL------------EKEAKDLLVKLFVREPEKRL 246

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (419), Expect = 4e-48
 Identities = 49/299 (16%), Positives = 92/299 (30%), Gaps = 34/299 (11%)

Query: 126 DLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW 185
           +L++  R +R    +G G FG ++ G              G  VA+K         H + 
Sbjct: 2   ELRVGNR-YRLGRKIGSGSFGDIYLG---------TDIAAGEEVAIKLECVK--TKHPQL 49

Query: 186 LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
             E      +     +  + +C  +    ++   +   SLE+               + +
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLL 108

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNIL---LDADYNAKLSDFGLAKDAPEDG----- 297
           A      + ++H    K  I+RD K  N L           + DFGLAK   +       
Sbjct: 109 ADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

Query: 298 KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV 357
               +  + GT  YA+    +    + + D+ S G VL+    G       +   +    
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

Query: 358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK 416
           E          +        L   +      +       C S     +P  S + +  +
Sbjct: 226 ER------ISEKKMSTPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-47
 Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 32/291 (10%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE-----WLAEVNFLG 193
            LGEG F  V+K              T   VA+K +        K+      L E+  L 
Sbjct: 5   FLGEGQFATVYKA---------RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 55

Query: 194 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
            L HPN++ L+          LV++FM        + +  SL L  S      L   +GL
Sbjct: 56  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGL 113

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAA 313
            +LH   +  +++RD K +N+LLD +   KL+DFGLAK      + +  T  + T  Y A
Sbjct: 114 EYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRA 168

Query: 314 PEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRP----------NGEHNLVEWARP 362
           PE +    +     D+++ G +L E+L     +  +             G     +W   
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                   ++        H           L       +P AR   ++ ++
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-47
 Identities = 70/309 (22%), Positives = 126/309 (40%), Gaps = 33/309 (10%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 190
           NF+    +GEG +G V+K              TG  VA+K +  D          + E++
Sbjct: 3   NFQKVEKIGEGTYGVVYKA---------RNKLTGEVVALKKIRLDTETEGVPSTAIREIS 53

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            L  L HPN+VKL+     +++  LV+EF+ +  L+  +       +P  +         
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           +GLAF H      V++RD K  N+L++ +   KL+DFGLA+      +T+ +  V+  + 
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWY 168

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWA 360
            A    +   + ++  D++S G +  EM+T R     +             G  + V W 
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228

Query: 361 RP-HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVV------E 413
               + D +  +     +          +    L +Q L  DP  R      +      +
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288

Query: 414 TLKPLQNLK 422
             KP+ +L+
Sbjct: 289 VTKPVPHLR 297

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (413), Expect = 6e-47
 Identities = 68/278 (24%), Positives = 110/278 (39%), Gaps = 40/278 (14%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE---WLAE 188
           ++F+    LG G FG V                 G   A+K L  + +   K+      E
Sbjct: 4   QDFQILRTLGTGSFGRVHLI---------RSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 54

Query: 189 VNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALG 248
              L  + HP ++++ G   +  Q  ++ +++  G L + L +    P P +      + 
Sbjct: 55  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV- 113

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
                  L     K +IYRD K  NILLD + + K++DFG AK  P+   T       GT
Sbjct: 114 ----CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GT 164

Query: 309 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR 368
             Y APE V T       D +SFG+++ EML G        P  + N ++     L  + 
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY------TPFYDSNTMKTYEKILNAEL 218

Query: 369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP 406
           RF                ++    L ++ ++RD   R 
Sbjct: 219 RFPPFF------------NEDVKDLLSRLITRDLSQRL 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 8e-47
 Identities = 66/308 (21%), Positives = 110/308 (35%), Gaps = 44/308 (14%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLA------ 187
           +     LG G F  V K           +  TGL  A K +     +  +  ++      
Sbjct: 12  YDTGEELGSGQFAVVKKC---------REKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 188 EVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIAL 247
           EV+ L  + HPN++ L          +L+ E +  G L + L  K    L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLK 120

Query: 248 GAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD----YNAKLSDFGLAKDAPEDGKTHVST 303
               G+ +LH      + + D K  NI+L          K+ DFGLA       +     
Sbjct: 121 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---K 174

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
            + GT  + APE V    L  ++D++S GV+   +L+G        P       E     
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANV 228

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQNL 421
                 F                S  A     + L +DPK R  + + ++   +KP ++ 
Sbjct: 229 SAVNYEFEDEYFSNT--------SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP-KDT 279

Query: 422 KDMASSSY 429
           +   SS++
Sbjct: 280 QQALSSAW 287

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-46
 Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 36/315 (11%)

Query: 130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---- 185
           A + +   + +GEG +G VFK    +NG        G  VA+K +     +         
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNG--------GRFVALKRVRVQTGEEGMPLSTIR 56

Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMP----RGSLENHLFRKGSLPLPWS 240
            +A +  L    HPN+V+L   C            +        L  +L +     +P  
Sbjct: 57  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE 116

Query: 241 IRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH 300
               +     +GL FLH      V++RD K  NIL+ +    KL+DFGLA+         
Sbjct: 117 TIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---M 170

Query: 301 VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV--- 357
             T V+ T  Y APE ++     +  D++S G +  EM   +     +    +   +   
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230

Query: 358 -------EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
                  +W R     ++ F+      +E   +    +    L  +CL+ +P  R     
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYS 289

Query: 411 VVET--LKPLQNLKD 423
            +     + L+  K+
Sbjct: 290 ALSHPYFQDLERCKE 304

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-46
 Identities = 60/300 (20%), Positives = 110/300 (36%), Gaps = 29/300 (9%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGH-KEWLAEV 189
              +   S +GEG +G V   +              + VA+K ++    Q + +  L E+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAY---------DNVNKVRVAIKKISPFEHQTYCQRTLREI 57

Query: 190 NFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRK-GSLPLPWSIRMKIALG 248
             L    H N++ +           +   ++    +   L++   +  L           
Sbjct: 58  KILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQ 117

Query: 249 AAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTH-VSTRVMG 307
             +GL ++H      V++RD K SN+LL+   + K+ DFGLA+ A  D       T  + 
Sbjct: 118 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 308 TYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD 366
           T  Y APE ++     +KS D++S G +L EML+ R          + N +         
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 367 KRRFYRLLDPRLEGHFSIKG-------------SQKATQLAAQCLSRDPKARPRMSEVVE 413
           +     +         S+                 KA  L  + L+ +P  R  + + + 
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  158 bits (399), Expect = 2e-45
 Identities = 58/294 (19%), Positives = 111/294 (37%), Gaps = 29/294 (9%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 190
            +     +GEG +G V+K           +   G T A+K +  +          + E++
Sbjct: 3   KYHGLEKIGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            L  L H N+VKL        + +LV+E + +   +     +G   L         L   
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLL 110

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            G+A+ H+   + V++RD K  N+L++ +   K++DFGLA+      + +    ++  + 
Sbjct: 111 NGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWY 166

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN----------GEHNLVEWA 360
            A    + +   ++  D++S G +  EM+ G                    G  N   W 
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 361 R-PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
               L      + + +P     F     +    L ++ L  DP  R    + +E
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  156 bits (396), Expect = 8e-45
 Identities = 46/296 (15%), Positives = 86/296 (29%), Gaps = 35/296 (11%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +++    +GEG FG +F+G                 VA+K           +   E    
Sbjct: 6   HYKVGRRIGEGSFGVIFEG---------TNLLNNQQVAIKFEPRR--SDAPQLRDEYRTY 54

Query: 193 GNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKG 252
             L     +  V Y  ++    ++   +   SLE+ L   G            A      
Sbjct: 55  KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-KFSVKTVAMAAKQMLAR 113

Query: 253 LAFLHEEAEKPVIYRDFKTSNILLDADYN-----AKLSDFGLAKDAPEDG-----KTHVS 302
           +  +HE   K ++YRD K  N L+    +       + DFG+ K   +            
Sbjct: 114 VQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 303 TRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP 362
             + GT  Y +    +    + + D+ + G V +  L G       +        E    
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-- 228

Query: 363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL 418
                 +        L   F     ++  +      +    A P    +      +
Sbjct: 229 ----GEKKQSTPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 9e-45
 Identities = 55/283 (19%), Positives = 93/283 (32%), Gaps = 38/283 (13%)

Query: 139 LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-H 197
           +LG G  G V +              T    A+K L         +   EV         
Sbjct: 19  VLGLGINGKVLQI---------FNKRTQEKFALKMLQD-----CPKARREVELHWRASQC 64

Query: 198 PNLVKLVGYC----IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGL 253
           P++V++V             L+V E +  G L + +  +G          +I     + +
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 254 AFLHEEAEKPVIYRDFKTSNILLDADYN---AKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
            +LH      + +RD K  N+L  +       KL+DFG AK+               T  
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPY 178

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF 370
           Y APE +         D++S GV++  +L G      N  +G              +  F
Sbjct: 179 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIRMGQYEF 236

Query: 371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                  +        S++   L    L  +P  R  ++E + 
Sbjct: 237 PNPEWSEV--------SEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-44
 Identities = 80/284 (28%), Positives = 109/284 (38%), Gaps = 37/284 (13%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW-- 185
           K+   +F    LLG+G FG V             +  TG   A+K L  + +    E   
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILV---------REKATGRYYAMKILRKEVIIAKDEVAH 51

Query: 186 -LAEVNFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
            + E   L N  HP L  L       D+   V E+   G L  HL R+            
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARF 109

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
                   L +LH    + V+YRD K  N++LD D + K++DFGL K+   DG T     
Sbjct: 110 YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KT 164

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL 364
             GT  Y APE +         D +  GVV+ EM+ GR       P    +        L
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELIL 218

Query: 365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRM 408
            ++ RF R L P            +A  L A  L +DPK R   
Sbjct: 219 MEEIRFPRTLSP------------EAKSLLAGLLKKDPKQRLGG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 9e-44
 Identities = 60/290 (20%), Positives = 102/290 (35%), Gaps = 51/290 (17%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKE------WLA 187
           ++   LLG GGFG V+ G         ++    L VA+K +  D +    E         
Sbjct: 6   YQVGPLLGSGGFGSVYSG---------IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56

Query: 188 EVNFLGNL--LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           EV  L  +      +++L+ +    D  +L+ E             +    L   +    
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSF 115

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR 304
                + +   H      V++RD K  NIL+D +    KL DFG      +   T     
Sbjct: 116 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---- 168

Query: 305 VMGTYGYAAPEYVMTGHLTSKS-DVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH 363
             GT  Y+ PE++       +S  V+S G++L +M+ G    +      +  ++      
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEII------ 217

Query: 364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                R       R+        S +   L   CL+  P  RP   E+  
Sbjct: 218 -----RGQVFFRQRV--------SSECQHLIRWCLALRPSDRPTFEEIQN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 6e-43
 Identities = 62/300 (20%), Positives = 106/300 (35%), Gaps = 37/300 (12%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           ++    ++G G FG V++              +G  VA+K +  D     +    E+  +
Sbjct: 21  SYTDTKVIGNGSFGVVYQA---------KLCDSGELVAIKKVLQD----KRFKNRELQIM 67

Query: 193 GNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHL-FRKGSLPLPWSIRMKI 245
             L H N+V+L  +     ++       LV +++P         + +    LP       
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY 127

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTR 304
                + LA++H      + +RD K  N+LLD D    KL DFG AK           + 
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SY 182

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA---- 360
           +   Y  A          TS  DV+S G VL E+L G+     +    +   +       
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242

Query: 361 --RPHLGDKRRFYRLLDPRLEGH-----FSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                      +     P+++ H     F  +   +A  L ++ L   P AR    E   
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-42
 Identities = 62/308 (20%), Positives = 109/308 (35%), Gaps = 41/308 (13%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG--HKEWLAEVN 190
            +   + +G+G FG VFK              TG  VA+K +  +  +       L E+ 
Sbjct: 11  KYEKLAKIGQGTFGEVFKA---------RHRKTGQKVALKKVLMENEKEGFPITALREIK 61

Query: 191 FLGNLLHPNLVKLVGYCIEDDQR--------LLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
            L  L H N+V L+  C               LV++F                 L    R
Sbjct: 62  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR 121

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK--DAPEDGKTH 300
           +   L     L  L+      +++RD K +N+L+  D   KL+DFGLA+     ++ + +
Sbjct: 122 VMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 176

Query: 301 VSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRP--------N 351
             T  + T  Y  PE ++         D++  G ++ EM T    M  N           
Sbjct: 177 RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236

Query: 352 GEHNLVEWARPHLGDKRRFYRLLDPR------LEGHFSIKGSQKATQLAAQCLSRDPKAR 405
              ++     P++ +   + +L   +       +   +      A  L  + L  DP  R
Sbjct: 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 296

Query: 406 PRMSEVVE 413
               + + 
Sbjct: 297 IDSDDALN 304

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 62/295 (21%), Positives = 103/295 (34%), Gaps = 29/295 (9%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVN 190
            +     +GEG +G VFK              T   VA+K +  D          L E+ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKA---------KNRETHEIVALKRVRLDDDDEGVPSSALREIC 53

Query: 191 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAA 250
            L  L H N+V+L      D +  LV+EF  +   +      G   L   I         
Sbjct: 54  LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLL 111

Query: 251 KGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYG 310
           KGL F H    + V++RD K  N+L++ +   KL++FGLA+      + + S  V+  + 
Sbjct: 112 KGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWY 167

Query: 311 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-----------GEHNLVEW 359
                       ++  D++S G +  E+    R +                 G     +W
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 360 AR-PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVE 413
                L D + +          +   K +     L    L  +P  R    E ++
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 8e-40
 Identities = 69/324 (21%), Positives = 117/324 (36%), Gaps = 43/324 (13%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNF 191
           +R    +G G +G V            V   TG  VA+K L          K    E+  
Sbjct: 20  YRDLQPVGSGAYGAVCSA---------VDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70

Query: 192 LGNLLHPNLVKLVGYCIEDDQR------LLVYEFMPRGSLENHLFRKGSLPLPWSIRMKI 245
           L ++ H N++ L+     D+         LV  FM  G+    L +     L       +
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFL 126

Query: 246 ALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRV 305
                KGL ++H      +I+RD K  N+ ++ D   K+ DFGLA+ A       ++  V
Sbjct: 127 VYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYV 179

Query: 306 MGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLV-------- 357
           +  +  A    +     T   D++S G ++ EM+TG+     +    +   +        
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239

Query: 358 -EWARPHLGDKRRFYRLLDPRLEG----HFSIKGSQKATQLAAQCLSRDPKARPRMSEVV 412
            E+ +    D+ + Y    P LE           S  A  L  + L  D + R    E +
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299

Query: 413 ET--LKPLQNLKDMASSSYYFQTM 434
                + L + +D      Y  + 
Sbjct: 300 AHPYFESLHDTEDEPQVQKYDDSF 323

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 1e-38
 Identities = 71/317 (22%), Positives = 111/317 (35%), Gaps = 49/317 (15%)

Query: 102 SASSTPKFSEELKVASQL---RKFMFNDLKLATRN------FRPESLLGEGGFGCVFKGW 152
           +A++  K SE+  V   L   ++      +  ++N      F     LG G FG V    
Sbjct: 2   NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV- 60

Query: 153 VEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEW---LAEVNFLGNLLHPNLVKLVGYCIE 209
                       +G   A+K L+   +   K+    L E   L  +  P LVKL     +
Sbjct: 61  --------KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112

Query: 210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDF 269
           +    +V E++  G + +HL R G            A        +LH      +IYRD 
Sbjct: 113 NSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDL 167

Query: 270 KTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVY 329
           K  N+L+D     +++DFG AK       T     + GT    APE +++       D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWW 222

Query: 330 SFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQK 389
           + GV++ EM  G        P      ++     +  K RF                S  
Sbjct: 223 ALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHF------------SSD 264

Query: 390 ATQLAAQCLSRDPKARP 406
              L    L  D   R 
Sbjct: 265 LKDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-37
 Identities = 70/290 (24%), Positives = 114/290 (39%), Gaps = 33/290 (11%)

Query: 128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHK 183
           K+   NF    +LG G +G VF               TG   A+K L    +    +  +
Sbjct: 20  KVGIENFELLKVLGTGAYGKVFLVRKISG------HDTGKLYAMKVLKKATIVQKAKTTE 73

Query: 184 EWLAEVNFLGNLLH-PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIR 242
               E   L ++   P LV L      + +  L+ +++  G L  HL ++          
Sbjct: 74  HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133

Query: 243 MKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVS 302
                   + +  L    +  +IYRD K  NILLD++ +  L+DFGL+K+   D +T  +
Sbjct: 134 Y-----VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-ETERA 187

Query: 303 TRVMGTYGYAAPEYVMTGH--LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 360
               GT  Y AP+ V  G        D +S GV++ E+LTG           +++  E +
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAEIS 245

Query: 361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSE 410
           R  L  +  + + +            S  A  L  + L +DPK R     
Sbjct: 246 RRILKSEPPYPQEM------------SALAKDLIQRLLMKDPKKRLGCGP 283

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 53/306 (17%), Positives = 101/306 (33%), Gaps = 48/306 (15%)

Query: 133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFL 192
           +++    LG G +  VF+          +       V VK L        K+   E+  L
Sbjct: 36  DYQLVRKLGRGKYSEVFEA---------INITNNEKVVVKILKPVK---KKKIKREIKIL 83

Query: 193 GNL-LHPNLVKLVGYCIEDDQRL--LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGA 249
            NL   PN++ L     +   R   LV+E +     +          L            
Sbjct: 84  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEI 138

Query: 250 AKGLAFLHEEAEKPVIYRDFKTSNILLDAD-YNAKLSDFGLAKDAPEDGKTHVSTRVMGT 308
            K L + H      +++RD K  N+++D +    +L D+GLA+      +       + +
Sbjct: 139 LKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVAS 192

Query: 309 YGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-------------- 353
             +  PE ++         D++S G +L  M+  +        N +              
Sbjct: 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 252

Query: 354 ------HNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR 407
                 +N+    R +    R   +  +  +        S +A     + L  D ++R  
Sbjct: 253 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312

Query: 408 MSEVVE 413
             E +E
Sbjct: 313 AREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-32
 Identities = 59/314 (18%), Positives = 111/314 (35%), Gaps = 52/314 (16%)

Query: 132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEV 189
           + ++    +G G  G V   +                VA+K L+         K    E+
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAY---------DAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 190 NFLGNLLHPNLVKLVGYCI------EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRM 243
             +  + H N++ L+          E     LV E M     +                 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122

Query: 244 KIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVST 303
            +      G+  LH      +I+RD K SNI++ +D   K+ DFGLA+     G + + T
Sbjct: 123 YLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMT 176

Query: 304 RVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR----------------RSMDK 347
             + T  Y APE ++        D++S G ++ EM+  +                  +  
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236

Query: 348 NRPNGEHNLVEWARPHLGDKRRFYRLLDPRL--------EGHFSIKGSQKATQLAAQCLS 399
             P     L    R ++ ++ ++  L  P+L        +   +   + +A  L ++ L 
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296

Query: 400 RDPKARPRMSEVVE 413
            DP  R  + + ++
Sbjct: 297 IDPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-32
 Identities = 62/300 (20%), Positives = 112/300 (37%), Gaps = 37/300 (12%)

Query: 131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAE 188
              ++  S +G G +G V   +            TGL VAVK L+         K    E
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAF---------DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 67

Query: 189 VNFLGNLLHPNLVKLVGYCIED----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMK 244
           +  L ++ H N++ L+          +   +       G+  N++ +     L       
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQF 125

Query: 245 IALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTR 304
           +     +GL ++H      +I+RD K SN+ ++ D   K+ DFGLA+   ++   +V+TR
Sbjct: 126 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182

Query: 305 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKN----------RPNGEH 354
               +  A    +   H     D++S G ++ E+LTGR                R  G  
Sbjct: 183 ----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 355 NLVEWARPHLGDKRRFYRLLDPRLEGHFS---IKGSQKATQLAAQCLSRDPKARPRMSEV 411
                 +      R + + L    + +F+   I  +  A  L  + L  D   R   ++ 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (271), Expect = 8e-27
 Identities = 52/325 (16%), Positives = 100/325 (30%), Gaps = 57/325 (17%)

Query: 134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLG 193
           +     LG G F  V+      N T          VA+K +  D +   +    E+  L 
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNT---------HVAMKIVRGDKVY-TEAAEDEIKLLQ 64

Query: 194 NLLHPNLVKLVGYCIEDDQRLL-VYEFMPRGSLENHLF-------------RKGSLPLPW 239
            +   +  K          +LL  +       +   +              +     +P 
Sbjct: 65  RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124

Query: 240 SIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYNAKLSDFGLAKDAPEDGK 298
               +I+     GL ++H      +I+ D K  N+L++  D    L    +A        
Sbjct: 125 IYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

Query: 299 THVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR--------------- 343
               T  + T  Y +PE ++       +D++S   ++ E++TG                 
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242

Query: 344 --------------SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGH-FSIKGSQ 388
                          + +N                  K +F+ L D   E + FS   ++
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302

Query: 389 KATQLAAQCLSRDPKARPRMSEVVE 413
           + +   +  L  DP+ R     +V 
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 75.2 bits (184), Expect = 2e-16
 Identities = 25/155 (16%), Positives = 50/155 (32%), Gaps = 9/155 (5%)

Query: 138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH 197
            L+GEG    VF  + E+ G   VK       + K +      G   +            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 198 PNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLH 257
             L KL G  +        Y +     L   +  K    +      ++     + +A  +
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120

Query: 258 EEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKD 292
               + +++ D    N+L+  +    + DF  + +
Sbjct: 121 ---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	490
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.64
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.0
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.25
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.99
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.32

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=438.60  Aligned_cols=254  Identities=26%  Similarity=0.338  Sum_probs=208.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||||++..... ...+.+.+|+.+|+.++|||||++++++.++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~   75 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRV---------TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG   75 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC
Confidence            579999999999999999999876         678999999976543 2345688999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..|||||||++|+|.++|....  .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|
T Consensus        76 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          76 NIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             TEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhh
Confidence            99999999999999999986544  6899999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +..............+||+.|||||++.+..+ +.++|||||||+||||++|+.||........... ....        
T Consensus       151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~~--------  221 (271)
T d1nvra_         151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKE--------  221 (271)
T ss_dssp             EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHHT--------
T ss_pred             eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHhc--------
Confidence            87754443444456789999999999988776 5789999999999999999999975443221111 1100        


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                            ...........+.++.+||.+||+.||++|||++|++++
T Consensus       222 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         222 ------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             ------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  000001112337889999999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=437.39  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=212.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||||++........+.+.+|+.+|+.++|||||++++++.+++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   90 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVA---------TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTT---------TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC
Confidence            479999999999999999998865         67899999998665555678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      .+|||||||++|+|.+++...   .+++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+|+
T Consensus        91 ~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          91 ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhhe
Confidence            999999999999999987654   5899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFY  371 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (490)
                      .......  .....+||+.|||||++.+..|+.++|||||||++|+|++|+.||...........+  ....        
T Consensus       165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--~~~~--------  232 (293)
T d1yhwa1         165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI--ATNG--------  232 (293)
T ss_dssp             ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHHC--------
T ss_pred             eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH--HhCC--------
Confidence            7654322  234568999999999999999999999999999999999999999654322111110  0000        


Q ss_pred             hccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          372 RLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       372 ~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           ......+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       233 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         233 -----TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             -----SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             -----CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00111223447889999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=435.90  Aligned_cols=263  Identities=27%  Similarity=0.440  Sum_probs=207.2

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC--ChhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD--GLQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +..++|++.+.||+|+||.||+|++..            .||||+++..  .....+.|.+|+.+|++++|||||+++++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~------------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS------------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC------------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            445689999999999999999997542            5999998754  33456788999999999999999999998


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +. ++.++||||||++|+|.+++..... .+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|
T Consensus        73 ~~-~~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~D  147 (276)
T d1uwha_          73 ST-APQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGD  147 (276)
T ss_dssp             EC-SSSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECC
T ss_pred             Ee-ccEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEcc
Confidence            65 4678999999999999999976543 6999999999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      ||+|+...............||+.|||||++.+   ..|+.++|||||||+||||+||+.||............  ....
T Consensus       148 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~  225 (276)
T d1uwha_         148 FGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRG  225 (276)
T ss_dssp             CCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHT
T ss_pred             ccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcC
Confidence            999987654434344456789999999999864   35899999999999999999999999764332211111  1000


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                               ...+. ....+..++.++.+||.+||..||++|||+.+|+++|+.+.+
T Consensus       226 ---------~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         226 ---------YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ---------SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     00111 112233457889999999999999999999999999987754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=432.16  Aligned_cols=247  Identities=28%  Similarity=0.435  Sum_probs=209.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||+|++.....   ...+.+.+|+.+|+.++|||||++++++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQ---------SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECC---------CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            469999999999999999999875         678999999865422   23467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++..|||||||++|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccc
Confidence            9999999999999999999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+......    ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+.          
T Consensus       152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~----------  217 (263)
T d2j4za1         152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----------  217 (263)
T ss_dssp             SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----------
T ss_pred             eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH----------
Confidence            998765432    234689999999999999999999999999999999999999997543221111110          


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                            ..  ...++...+.++.+||.+||+.||++|||+.|+++|
T Consensus       218 ------~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         218 ------RV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ------TT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ------cC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                  00  011233347889999999999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-56  Score=437.22  Aligned_cols=263  Identities=26%  Similarity=0.396  Sum_probs=219.5

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ++..++|++.+.||+|+||+||+|++..         +|..||||+++.+. ...+++.+|+.+|++++|||||+++++|
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKK---------YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGG---------GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             EecHHHeEEeeEEeeCCCeEEEEEEECC---------CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            3445679999999999999999999876         67799999997654 3456799999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+++..+||||||++|+|.+++.......+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccc
Confidence            99999999999999999999998776678999999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+....... .......||+.|||||++.+..|+.++|||||||++|||++|..||......  ....+.        
T Consensus       160 G~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~--------  228 (287)
T d1opja_         160 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYEL--------  228 (287)
T ss_dssp             CCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHH--------
T ss_pred             cceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHH--------
Confidence            99987654322 2334456899999999999999999999999999999999977766432211  111111        


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                            +.......++..++.++.+||.+||+.||++|||+.||++.|+.+..
T Consensus       229 ------i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         229 ------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ------HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  11111222334457889999999999999999999999999987644

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-56  Score=432.91  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=210.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      +.|++++.||+|+||.||+|++..         +|..||||++........+.+.+|+++|++|+|||||++++++.+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   82 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKE---------TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   82 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECC---------CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            368999999999999999999876         67899999998776666678899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..+||||||++|+|.+++.... ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+
T Consensus        83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhh
Confidence            9999999999999999887653 36999999999999999999999988   9999999999999999999999999997


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhh-----cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVM-----TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      .....  .......+||+.|||||++.     +..|+.++|||||||+||||++|+.||...........+  ....   
T Consensus       159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~~~~---  231 (288)
T d2jfla1         159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--AKSE---  231 (288)
T ss_dssp             ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HHSC---
T ss_pred             ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--HcCC---
Confidence            65321  11223468999999999984     456899999999999999999999999765433221111  1000   


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                              .+  ....+...+.++.+||.+||+.||++|||+.|++++
T Consensus       232 --------~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 --------PP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             --------CC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             --------CC--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    00  011223447899999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-56  Score=442.12  Aligned_cols=267  Identities=25%  Similarity=0.381  Sum_probs=209.2

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ..++|++++.||+|+||+||+|++..         +|..||+|+++.... .....+.+|+.+|+.++|||||+++++|.
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~   74 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKP---------SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY   74 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETT---------TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            45689999999999999999999865         788999999976532 33467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      +++.+|||||||++|+|.+++.+.+  .+++..+..++.||+.||.|||+ ++   |+||||||+||||+.++.+||+||
T Consensus        75 ~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          75 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             CSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeC
Confidence            9999999999999999999998765  68999999999999999999997 47   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH-hhhcccC-
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-WARPHLG-  365 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~-~~~~~~~-  365 (490)
                      |+|+.....    .....+||+.|||||++.+..|+.++|||||||++|||++|+.||............. ....... 
T Consensus       150 Gla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  225 (322)
T d1s9ja_         150 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE  225 (322)
T ss_dssp             CCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------
T ss_pred             CCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCccc
Confidence            999865321    2234689999999999999999999999999999999999999997643321100000 0000000 


Q ss_pred             --------------------Cchhhhh----ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 --------------------DKRRFYR----LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 --------------------~~~~~~~----~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                          .......    ..............+.++.+||.+||+.||.+|||++|+++|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                0000000    000000000111236789999999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-56  Score=428.68  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=197.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||||++.....  ...+.+.+|+++|++++|||||++++++.+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   74 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKS---------DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID   74 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred             hhCEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence            579999999999999999999876         678999999976543  334568899999999999999999999875


Q ss_pred             --cCceEEEEEecCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhhcCC--CCeeecCCCCCceEEcCCCCeE
Q 011234          210 --DDQRLLVYEFMPRGSLENHLFRK--GSLPLPWSIRMKIALGAAKGLAFLHEEAE--KPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 --~~~~~lv~E~~~~g~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~~--~~iiHrDlkp~NILl~~~~~~k  283 (490)
                        ++.+|||||||++|+|.+++.+.  ....+++..++.++.||+.||.|||+.+.  .+||||||||+||||+.++.+|
T Consensus        75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk  154 (269)
T d2java1          75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK  154 (269)
T ss_dssp             ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred             CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence              45689999999999999998642  23469999999999999999999998651  3499999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |+|||+|+......  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||......   .+...... 
T Consensus       155 l~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~-  228 (269)
T d2java1         155 LGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE-  228 (269)
T ss_dssp             ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH-
T ss_pred             EeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHc-
Confidence            99999998765432  2234578999999999999999999999999999999999999999754322   11111100 


Q ss_pred             cCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                  ... ..++...+.++.+||.+||+.||.+|||+.||+++
T Consensus       229 ------------~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         229 ------------GKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             ------------TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                        000 01223447889999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=435.28  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=207.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++++.||+|+||+||+|++..         +|..||||++.....   ...+.+.+|+.+|++++|||||++++++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   78 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELA---------TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ   78 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE
Confidence            579999999999999999999875         678999999875422   23456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++.+|||||||++|+|.+++...+  .+++..++.++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||
T Consensus        79 ~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          79 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccc
Confidence            9999999999999999999988765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+..............+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+      ...  
T Consensus       154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~--  225 (288)
T d1uu3a_         154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKL--  225 (288)
T ss_dssp             TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTT--
T ss_pred             cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------HcC--
Confidence            999776544444445578999999999999999999999999999999999999999754321111111      000  


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                ...++...+.++.+||.+||+.||.+|||++|++++
T Consensus       226 ----------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         226 ----------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ----------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ----------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                      012233447889999999999999999999997654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=424.91  Aligned_cols=255  Identities=28%  Similarity=0.435  Sum_probs=200.9

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|.+.          ++..||||+++... ...+++.+|++++++++|||||+++|++.+++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~   73 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL----------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   73 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET----------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC----------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence            57899999999999999999875          35579999998654 34568999999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        74 ~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~  149 (263)
T d1sm2a_          74 PICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTR  149 (263)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred             ceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchhe
Confidence            9999999999999999987653 36899999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhC-CCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTG-RRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ........ ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....   ..........       
T Consensus       150 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~~-------  218 (263)
T d1sm2a_         150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTG-------  218 (263)
T ss_dssp             ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHHT-------
T ss_pred             eccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHHHHHHhc-------
Confidence            76543222 22346799999999999999999999999999999999995 555543211   1111111110       


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                             .....+..++.++.+||.+||+.||++|||++||+++|+.+.
T Consensus       219 -------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         219 -------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence                   111123344788999999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-55  Score=429.51  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=203.1

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ..+|++.++||+|+||+||+|++..++.      ....||||.+.... ....++|.+|+.+|++|+|||||+++|++.+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGK------REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            3568889999999999999999875322      33479999987653 3445679999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++|||||++|+|.+++..... .+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             CCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCccc
Confidence            9999999999999999998876533 6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcce---eeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccC
Q 011234          290 AKDAPEDGKTHV---STRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLG  365 (490)
Q Consensus       290 a~~~~~~~~~~~---~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~  365 (490)
                      |+..........   .....||+.|||||++.++.|+.++|||||||+||||+| |+.||.......   +......   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~---  248 (299)
T d1jpaa_         175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ---  248 (299)
T ss_dssp             ---------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT---
T ss_pred             ceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc---
Confidence            987654322211   123467999999999999999999999999999999998 899997543221   1111110   


Q ss_pred             CchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          366 DKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       366 ~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                 ......+..++..+.+||.+||+.||++|||+.||++.|+.+
T Consensus       249 -----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         249 -----------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             -----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                       011122344578899999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-55  Score=425.26  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      ++..++|++.+.||+|+||.||+|.++          ++..||||+++... ...+.+.+|+.+|++++|||||++++++
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~   77 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYN----------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV   77 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET----------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEEC----------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeee
Confidence            344567999999999999999999875          35689999997654 3456799999999999999999999987


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      . ++..+||||||++|+|.+++.......+++..++.++.||+.||.|||+.+   |+||||||+||||++++.+||+||
T Consensus        78 ~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DF  153 (272)
T d1qpca_          78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADF  153 (272)
T ss_dssp             C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             c-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccc
Confidence            5 456799999999999999886655456899999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+...... ........||+.|||||++.++.++.++|||||||+||||+||..|+......  .........     
T Consensus       154 Gla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~~-----  225 (272)
T d1qpca_         154 GLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLER-----  225 (272)
T ss_dssp             TTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT-----
T ss_pred             cceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh-----
Confidence            9998775432 22334567999999999999999999999999999999999965554322111  111111110     


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                               ......+..++.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       226 ---------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         226 ---------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence                     011112234478899999999999999999999999998864

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=418.95  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=200.8

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe--
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE--  209 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--  209 (490)
                      |++.+.||+|+||+||+|++..         ++..||+|.+....  ....+.+.+|+++|++++|||||++++++.+  
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~---------~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   81 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTE---------TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV   81 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred             EEeeeEEecCcCcEEEEEEECC---------CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence            4677889999999999999875         67799999987543  3345678899999999999999999999875  


Q ss_pred             --cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc-CCCCeEEcc
Q 011234          210 --DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD-ADYNAKLSD  286 (490)
Q Consensus       210 --~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~kL~D  286 (490)
                        ...+|||||||++|+|.+++.+..  .+++..++.++.||+.||+|||+++ .+|+||||||+||||+ .++.+||+|
T Consensus        82 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          82 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             ccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEee
Confidence              345799999999999999997765  6899999999999999999999866 4599999999999996 578999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+|+.....    .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.......  .+......   .
T Consensus       159 FGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~---~  228 (270)
T d1t4ha_         159 LGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTS---G  228 (270)
T ss_dssp             TTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTT---T
T ss_pred             cCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHc---C
Confidence            9999865332    2245689999999998865 69999999999999999999999996532211  11111100   0


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                                .....++...++++.+||.+||+.||++|||+.|+++|
T Consensus       229 ----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         229 ----------VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ----------CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----------CCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                      00011122236789999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-54  Score=433.91  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=212.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||+|+||.||+|++..         +|..||||++........+.+.+|+.+|++|+|||||++++++.+++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~---------~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   96 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERA---------TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN   96 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            579999999999999999999875         78899999998777666778899999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC--CCCeEEccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA--DYNAKLSDFGL  289 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~kL~DFG~  289 (490)
                      .+|||||||++|+|.+++.... ..+++..+..++.||+.||.|||+++   ||||||||+||||+.  ++.+||+|||+
T Consensus        97 ~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          97 EMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecch
Confidence            9999999999999999986543 26999999999999999999999988   999999999999954  67899999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+......   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+...  .      
T Consensus       173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~------  241 (350)
T d1koaa2         173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--D------  241 (350)
T ss_dssp             CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--C------
T ss_pred             heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C------
Confidence            98775432   224468999999999999999999999999999999999999999754322111111100  0      


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                            ..+........+.++.+||.+||..||++|||+.|+++|
T Consensus       242 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 ------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  001111112347889999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-55  Score=432.16  Aligned_cols=264  Identities=25%  Similarity=0.400  Sum_probs=213.8

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||+||+|++...+.    ...+..||+|.+.... ......+.+|+.+|.++ +|||||++++++
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISK----TGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSS----SSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCc----ccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            34579999999999999999999865321    1234579999986543 23345788999999998 899999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGS---------------------LPLPWSIRMKIALGAAKGLAFLHEEAEKPVIY  266 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiH  266 (490)
                      .+.+..+||||||++|+|.++|.....                     ..+++..++.++.||+.||.|||+++   |||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH  187 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH  187 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            999999999999999999999976432                     24889999999999999999999988   999


Q ss_pred             cCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCC
Q 011234          267 RDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSM  345 (490)
Q Consensus       267 rDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf  345 (490)
                      |||||+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||++ |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            99999999999999999999999987655444444455778999999999999999999999999999999997 89999


Q ss_pred             CCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 011234          346 DKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLK  416 (490)
Q Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~  416 (490)
                      ........  +.....              .......+..++.++.+||.+||+.||++|||++||+++|.
T Consensus       268 ~~~~~~~~--~~~~~~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         268 PGIPVDAN--FYKLIQ--------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TTCCCSHH--HHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCHHHH--HHHHHh--------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            76443221  111111              11111233445789999999999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.5e-55  Score=428.27  Aligned_cols=253  Identities=23%  Similarity=0.345  Sum_probs=194.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .+.|++.+.||+|+||+||+|++..         +|..||||++...... ....+.+|+.+|+.++|||||++++++.+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~   78 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKR---------TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES   78 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETT---------TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECC---------CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3569999999999999999999875         6789999999765433 23457789999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc---CCCCeEEcc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSD  286 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~D  286 (490)
                      ++.+|||||||+||+|.++|...+  .+++..+..++.||+.||.|||+.+   |+||||||+|||+.   .++.+||+|
T Consensus        79 ~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          79 GGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             CCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEec
Confidence            999999999999999999997654  6999999999999999999999988   99999999999994   578999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      ||+|+......   .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   .....   ...
T Consensus       154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i---~~~  224 (307)
T d1a06a_         154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI---LKA  224 (307)
T ss_dssp             C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH---HTT
T ss_pred             cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH---hcc
Confidence            99998664332   2234689999999999999999999999999999999999999997543211   11111   000


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .        ..+........+.++.+||.+||+.||++|||+.|++++
T Consensus       225 ~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 E--------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             C--------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             C--------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            0        011111223447889999999999999999999999987

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=412.61  Aligned_cols=254  Identities=23%  Similarity=0.378  Sum_probs=213.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++.+.||+|+||+||+|+++          ++..||||+++.... ..+++.+|+.++++++|||||+++|++.+++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~   72 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR----------GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR   72 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET----------TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC----------CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence            58999999999999999999985          466899999987654 4468999999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      ..++||||+++|+|..++..... .+++..++.++.||++||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        73 ~~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~  148 (258)
T d1k2pa_          73 PIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSR  148 (258)
T ss_dssp             SEEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred             ceEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhhe
Confidence            99999999999999998765533 6889999999999999999999988   9999999999999999999999999998


Q ss_pred             cCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          292 DAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       292 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      ....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......   .......    .   
T Consensus       149 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~----~---  217 (258)
T d1k2pa_         149 YVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQ----G---  217 (258)
T ss_dssp             BCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT----T---
T ss_pred             eccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHh----C---
Confidence            7654322 22334679999999999999999999999999999999998 899997654221   1111110    0   


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                             .....+..++.++.+||.+||+.||++|||+.+|+++|..+
T Consensus       218 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         218 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                   01122334468899999999999999999999999998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.3e-54  Score=433.17  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=213.1

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEecC
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDD  211 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~  211 (490)
                      ++|++++.||+|+||.||+|++..         +|..||||+++.......+.+.+|+.+|++|+|||||+++++|.+++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   99 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKA---------TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY   99 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred             cceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            469999999999999999999875         67899999998877666677889999999999999999999999999


Q ss_pred             ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc--CCCCeEEccccc
Q 011234          212 QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD--ADYNAKLSDFGL  289 (490)
Q Consensus       212 ~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~kL~DFG~  289 (490)
                      .+|||||||++|+|.+++...+ ..+++..++.++.||+.||.|||+.+   ||||||||+||||+  .++.+||+|||+
T Consensus       100 ~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         100 EMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccc
Confidence            9999999999999998876553 36999999999999999999999988   99999999999997  678999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      |+......   ......||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+..          
T Consensus       176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----------  242 (352)
T d1koba_         176 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR----------  242 (352)
T ss_dssp             CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH----------
T ss_pred             ceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence            98875432   23446799999999999999999999999999999999999999975432211111100          


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          .+..+........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       243 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         243 ----CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00111112223347889999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=420.32  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=210.2

Q ss_pred             hcCCCcCce-eccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESL-LGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~-lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|.+.+. ||+|+||.||+|.+...+       ++..||||+++... ....++|.+|+++|++++|||||+++|++.
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~   79 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRK-------KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ   79 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC----------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCC-------CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence            346777775 999999999999876422       46689999997654 344577999999999999999999999986


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      . +.+|||||||++|+|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        80 ~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFG  154 (285)
T d1u59a_          80 A-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFG  154 (285)
T ss_dssp             S-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCT
T ss_pred             c-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccch
Confidence            5 56899999999999999886543 36999999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          289 LAKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +|+........ .......||+.|||||++.++.++.++|||||||++|||+| |+.||.......   +......    
T Consensus       155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~~----  227 (285)
T d1u59a_         155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQ----  227 (285)
T ss_dssp             TCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHT----
T ss_pred             hhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence            99877543322 22234578999999999999999999999999999999998 999997653321   1111110    


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                                ......+..++.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       228 ----------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         228 ----------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             ----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                      001123344578999999999999999999999999988754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-54  Score=425.29  Aligned_cols=246  Identities=27%  Similarity=0.404  Sum_probs=204.1

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .|++++.||+|+||+||+|++..         +|..||||++.....   ...+.+.+|+.+|++|+|||||++++++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVR---------NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECC---------CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            48999999999999999999875         688999999976543   234568899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..|||||||.+|+|..++....  .+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccc
Confidence            999999999999999987665554  6899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc---CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT---GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~---~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      |+.....      ...+||+.|||||++.+   +.|+.++|||||||++|||++|..||...........+  ..    .
T Consensus       162 a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i--~~----~  229 (309)
T d1u5ra_         162 ASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ----N  229 (309)
T ss_dssp             CBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HH----S
T ss_pred             ccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--Hh----C
Confidence            9865432      34679999999999864   46899999999999999999999999654321111000  00    0


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                             ..+.   ..+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       230 -------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         230 -------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                   0000   1112337889999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-54  Score=428.08  Aligned_cols=250  Identities=31%  Similarity=0.394  Sum_probs=211.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++++.||+|+||.||+|++..         +|..||||++++...   ...+.+.+|+.+|+.++|||||++++++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~---------~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~   74 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKA---------TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence            3579999999999999999999876         788999999975422   2346788999999999999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+++.+|+|||||++|+|.+++...+  .+++..++.++.||+.||.|||+++   ||||||||+||||+.+|.+||+||
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeec
Confidence            99999999999999999999998765  6899999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||++|++||...........+.      .. 
T Consensus       150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------~~-  220 (337)
T d1o6la_         150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------ME-  220 (337)
T ss_dssp             TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-
T ss_pred             ccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh------cC-
Confidence            99987654322  2345789999999999999999999999999999999999999997653221111110      00 


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                                 ...++...+.++.+||.+||+.||.+|++     +.|+++|
T Consensus       221 -----------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                       01223344788999999999999999995     8899876

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=415.08  Aligned_cols=250  Identities=28%  Similarity=0.398  Sum_probs=201.8

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEecCceEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIEDDQRLL  215 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l  215 (490)
                      +.||+|+||.||+|.+...       +++..||||+++....  ...+++.+|+.+|++++|||||++++++.. +..+|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK-------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS-------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEE
T ss_pred             CCcccCCCeEEEEEEEccC-------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEE
Confidence            4799999999999987642       2567899999975432  334679999999999999999999999864 56789


Q ss_pred             EEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCCC
Q 011234          216 VYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPE  295 (490)
Q Consensus       216 v~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~~  295 (490)
                      |||||++|+|.+++....  .+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+++....
T Consensus        85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccc
Confidence            999999999999987654  6899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchhhhhc
Q 011234          296 DGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRRFYRL  373 (490)
Q Consensus       296 ~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  373 (490)
                      .... .......||+.|||||++.+..++.++|||||||++|||++ |+.||.......   +......           
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~-----------  225 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK-----------  225 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-----------
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHc-----------
Confidence            3322 22234678999999999999999999999999999999998 899997543221   1111110           


Q ss_pred             cCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 011234          374 LDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKP  417 (490)
Q Consensus       374 ~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~  417 (490)
                         ......+..++.++.+||.+||+.||++|||+++|++.|+.
T Consensus       226 ---~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         226 ---GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence               00112334457889999999999999999999999988864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-54  Score=417.31  Aligned_cols=265  Identities=25%  Similarity=0.411  Sum_probs=205.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ...|++.++||+|+||.||+|.+...+.     .....||||++..... ....+|.+|+.+|++++|||||+++|++.+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSG-----KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC--------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCC-----EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            3468889999999999999999875321     1235799999976533 334578999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+..++|||||.+++|.+++.... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGl  156 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGL  156 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             CCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccch
Confidence            999999999999999998886653 36999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCc-ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKT-HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++........ .......||+.|||||++.++.++.++|||||||+||||++|..|+......  .......        
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i--------  226 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI--------  226 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH--------
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHH--------
Confidence            9876543222 2233457899999999999999999999999999999999976665432211  1111111        


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                            ........+..++..+.+||.+||+.||++|||+.||++.|+.+..
T Consensus       227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         227 ------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ------HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ------hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                  1111122334457889999999999999999999999999987644

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-54  Score=420.03  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=209.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh------hhHHHHHHHHHHHhcCCCCceecee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL------QGHKEWLAEVNFLGNLLHPNLVKLV  204 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~l~  204 (490)
                      .++|++++.||+|+||+||+|++..         +|..||||++.+...      ...+.+.+|+.+|++|+|||||+++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~   79 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKS---------TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH   79 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETT---------TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECC---------CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            3579999999999999999999875         688999999875432      2356789999999999999999999


Q ss_pred             eEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC----
Q 011234          205 GYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY----  280 (490)
Q Consensus       205 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~----  280 (490)
                      +++.+++.+|||||||++|+|.++|...+  .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    
T Consensus        80 ~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          80 EVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             EEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSC
T ss_pred             EEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCccc
Confidence            99999999999999999999999997765  6899999999999999999999988   99999999999998776    


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||+|........   .....||+.|+|||++.+..++.++|||||||+||||++|+.||...........+.. 
T Consensus       155 ~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-  230 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-  230 (293)
T ss_dssp             CEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-
T ss_pred             ceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh-
Confidence            499999999987654322   2346799999999999999999999999999999999999999976432211111100 


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                           ...        ......+...+..+.+||.+||+.||.+|||++|++++
T Consensus       231 -----~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         231 -----VNY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             -----TCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -----cCC--------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000        00001112236789999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-53  Score=419.20  Aligned_cols=246  Identities=27%  Similarity=0.404  Sum_probs=208.5

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++++.||+|+||+||+|++..         +|..||||+++....   ...+.+.+|+.+|+.++|||||++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~---------~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRH---------NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            469999999999999999999875         678999999975422   23467889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +++.+|+|||||.||+|..++....  .+++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCc
Confidence            9999999999999999999887765  6788899999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+      .    
T Consensus       150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~----  214 (316)
T d1fota_         150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------L----  214 (316)
T ss_dssp             SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H----
T ss_pred             cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------H----
Confidence            99876432     23468999999999999999999999999999999999999999754322111111      0    


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                            ..  ...++...+.++.+||.+||..||.+|+     |++++++|
T Consensus       215 ------~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         215 ------NA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------HC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------cC--CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                  00  0122333478899999999999999996     89999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=413.29  Aligned_cols=260  Identities=24%  Similarity=0.368  Sum_probs=202.3

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      .++|++.+.||+|+||.||+|++...+.      .+..||||.++.... ...+.+.+|+.+|++++|||||++++++. 
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~------~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPEN------PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCc------eeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4579999999999999999999865322      456899999875433 33567899999999999999999999985 


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..++|||||++|+|.+++.... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             cCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence            567899999999999999876553 37899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      |+...... ........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...........+   ...     
T Consensus       155 a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i---~~~-----  225 (273)
T d1mp8a_         155 SRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---ENG-----  225 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTT-----
T ss_pred             heeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH---HcC-----
Confidence            98764332 222345678999999999999999999999999999999998 89999765433221111   100     


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                               .....+..++..+.+||.+||..||++|||+.||+++|+.+.
T Consensus       226 ---------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         226 ---------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                     001233445789999999999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=417.78  Aligned_cols=261  Identities=24%  Similarity=0.397  Sum_probs=207.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+|+++++||+|+||+||+|.+..++..     .+..||+|.++.. .....+++.+|+.+|++++|||||+++|++.++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK-----VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC---------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE-----EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            4699999999999999999998753321     2346999988654 334567899999999999999999999999764


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                       ..+++|||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|
T Consensus        84 -~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          84 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             -SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             -CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccc
Confidence             5678899999999999887653 47999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCchh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKRR  369 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~  369 (490)
                      +...............||+.|||||++.++.|+.++|||||||+||||+| |.+||...........+..          
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~----------  228 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------  228 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH----------
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence            98765444444445679999999999999999999999999999999998 7888875433222111110          


Q ss_pred             hhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          370 FYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       370 ~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                             ......+..++..+.+||.+||+.||.+|||+.||+++|+.+.
T Consensus       229 -------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 -------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence                   0011223345788999999999999999999999999987653

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.6e-52  Score=406.91  Aligned_cols=262  Identities=25%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYC  207 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~  207 (490)
                      .++|++.+.||+|+||.||+|++..         +|+.||||+++....   .....+.+|+.+|+.++|||||++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLR---------LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            3579999999999999999999875         688999999976533   3345688999999999999999999999


Q ss_pred             EecCc----eEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          208 IEDDQ----RLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       208 ~~~~~----~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ...+.    .|||||||+|++|.+++...+  .+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.++
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccce
Confidence            87653    789999999999999987765  6899999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCC-CcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          284 LSDFGLAKDAPEDG-KTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~-~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||.+....... ........+||+.|||||++.+..|+.++|||||||++|||++|++||........      ...
T Consensus       152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~  225 (277)
T d1o6ya_         152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQ  225 (277)
T ss_dssp             ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH
T ss_pred             eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHH
Confidence            99999987654322 22233456899999999999999999999999999999999999999975432211      111


Q ss_pred             ccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcccc
Q 011234          363 HLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-RMSEVVETLKPLQN  420 (490)
Q Consensus       363 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-s~~evl~~L~~l~~  420 (490)
                      .+.....        .........+.++.+||.+||+.||.+|| |++++++.|..+++
T Consensus       226 ~~~~~~~--------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         226 HVREDPI--------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHCCCC--------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHhcCCC--------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1101000        00111123378899999999999999998 89999988877643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=412.23  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=204.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++.+.||+|+||.||+|++..          +..||||+++... ...+.|.+|+.+|++++|||||++++++. +
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~----------~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~   83 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG----------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E   83 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT----------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC----------CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c
Confidence            4579999999999999999998863          3479999997654 34577999999999999999999999985 4


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..++|||||++|+|..++.......+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchh
Confidence            66899999999999999887654446999999999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhh
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRF  370 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  370 (490)
                      +....... .......||+.|+|||++..+.++.++|||||||+||||++|..||......  .........        
T Consensus       161 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~--------  229 (285)
T d1fmka3         161 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVER--------  229 (285)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT--------
T ss_pred             hhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHh--------
Confidence            87644322 2234467999999999999999999999999999999999976665433211  111111110        


Q ss_pred             hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          371 YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       371 ~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                            ......+..++.++.+||.+||+.||++||++.+|++.|+.+.
T Consensus       230 ------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         230 ------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                  0111233445788999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.7e-53  Score=421.21  Aligned_cols=246  Identities=26%  Similarity=0.335  Sum_probs=208.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++++.||+|+||.||+|++..         +|..||||++.....   ...+.+.+|+++|+.++|||||++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~---------~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKE---------SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECC---------CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            579999999999999999999875         688999999865422   23456889999999999999999999999


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      +....++||||+.+|+|..++...+  .+++..++.++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeece
Confidence            9999999999999999999998765  6899999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +|+.....     ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.......   ......   ... 
T Consensus       187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~---~~~-  254 (350)
T d1rdqe_         187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIV---SGK-  254 (350)
T ss_dssp             TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---HCC-
T ss_pred             eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHh---cCC-
Confidence            99876432     234689999999999999999999999999999999999999997543211   111100   000 


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                                 ..++...+.++.+||.+||..||.+|+     |+++|++|
T Consensus       255 -----------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         255 -----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                       012233478899999999999999994     89999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=412.84  Aligned_cols=268  Identities=24%  Similarity=0.365  Sum_probs=215.7

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh-hHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ-GHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      +...++|++.+.||+|+||+||+|++....    ...++..||||+++..... ..+++.+|+.+|++++||||++++++
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLL----PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSS----TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCc----cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            334568999999999999999999986421    1225678999999765433 35679999999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKG----------------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPV  264 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~i  264 (490)
                      +...+..++||||+++|+|.+++....                      ...+++..++.|+.||+.||+|||+.+   |
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence            999999999999999999999986432                      224789999999999999999999988   9


Q ss_pred             eecCCCCCceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCC-C
Q 011234          265 IYRDFKTSNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-R  343 (490)
Q Consensus       265 iHrDlkp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~-~  343 (490)
                      |||||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..|+.++|||||||+||||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998665444444445578999999999999999999999999999999999996 5


Q ss_pred             CCCCCCCCCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          344 SMDKNRPNGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       344 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ||.......   .......             .. ....+..++.++.+||.+||+.||++||||.||++.|+++.
T Consensus       242 p~~~~~~~e---~~~~v~~-------------~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         242 PYYGMAHEE---VIYYVRD-------------GN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTTTSCHHH---HHHHHHT-------------TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCHHH---HHHHHHc-------------CC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            675543221   1111110             00 01123344778999999999999999999999999998763

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-53  Score=413.58  Aligned_cols=267  Identities=28%  Similarity=0.369  Sum_probs=204.8

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      +..++|++.+.||+|+||.||+|.+.....    ..+++.||||+++... ....+.+.+|+.++.++ +|+|||.++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDK----TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTS----SSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCc----ccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            344679999999999999999999865321    2367799999997653 33456678888888777 58999999998


Q ss_pred             EEec-CceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          207 CIED-DQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       207 ~~~~-~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      +... ..+++|||||++|+|.++|....              ...+++..+..++.||+.||.|||+++   ||||||||
T Consensus        86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp  162 (299)
T d1ywna1          86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  162 (299)
T ss_dssp             ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred             eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence            8765 46899999999999999997542              224889999999999999999999988   99999999


Q ss_pred             CceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCC-CCCCCCCC
Q 011234          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~~  350 (490)
                      +||||+.++.+||+|||+|+..............+||+.|||||++.+..++.++|||||||++|||++|. +||.....
T Consensus       163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~  242 (299)
T d1ywna1         163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  242 (299)
T ss_dssp             GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred             cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998765544444445578999999999999999999999999999999999874 57754432


Q ss_pred             CCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      ...  +......              ......+..++.++.+||.+||+.||++|||+.||+++|+.+
T Consensus       243 ~~~--~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         243 DEE--FCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             SHH--HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH--HHHHHhc--------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            211  1111110              001122233478899999999999999999999999999876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-53  Score=405.97  Aligned_cols=252  Identities=28%  Similarity=0.440  Sum_probs=202.2

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEe-
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  209 (490)
                      .++|++.+.||+|+||.||+|.++           |..||||+++.+.  ..+.+.+|+++|++++|||||+++|++.+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~   72 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-----------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE   72 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-----------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence            457889999999999999999873           5589999997653  34678999999999999999999999865 


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      .+.+++||||+++|+|.++|.......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~  149 (262)
T d1byga_          73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL  149 (262)
T ss_dssp             --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred             CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeeccccc
Confidence            456899999999999999997665446899999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      ++.....     .....+|..|+|||++.+..++.++|||||||++|||++ |++||.......   .......      
T Consensus       150 s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~------  215 (262)
T d1byga_         150 TKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK------  215 (262)
T ss_dssp             -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT------
T ss_pred             ceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHc------
Confidence            9865432     223468999999999999999999999999999999998 687776543222   1211110      


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                              .....++...+.++.+||.+||+.||.+|||+.+|+++|+.++.
T Consensus       216 --------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 --------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                    01112333447889999999999999999999999999987754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.3e-52  Score=418.66  Aligned_cols=250  Identities=27%  Similarity=0.384  Sum_probs=205.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---hHHHH---HHHHHHHhcCCCCceeceee
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---GHKEW---LAEVNFLGNLLHPNLVKLVG  205 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---~~~~~---~~E~~~l~~l~HpnIv~l~~  205 (490)
                      ++|++.++||+|+||.||+|++..         +|..||||++......   ....+   ..|+.+++.++|||||++++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~---------t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~   74 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKAD---------TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSY   74 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECC---------CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEE
Confidence            579999999999999999999876         6889999998643221   12223   34577888889999999999


Q ss_pred             EEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          206 YCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       206 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      ++.+++.+|||||||++|+|.++|....  .+++..++.++.||+.||.|||+.+   ||||||||+||||+.+|.+||+
T Consensus        75 ~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          75 AFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEEC
T ss_pred             EEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEe
Confidence            9999999999999999999999998765  6889999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          286 DFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       286 DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      |||+|+......    ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+...   ..
T Consensus       150 DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~  222 (364)
T d1omwa3         150 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL  222 (364)
T ss_dssp             CCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SS
T ss_pred             eeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cc
Confidence            999998765432    234689999999999975 5689999999999999999999999976544332222111   11


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPR-----MSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs-----~~evl~~  414 (490)
                      ..            ...++...+.++.+||.+||+.||.+|||     ++||++|
T Consensus       223 ~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         223 TM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SC------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             cC------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            00            11122334788999999999999999999     7899876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-52  Score=411.78  Aligned_cols=253  Identities=18%  Similarity=0.236  Sum_probs=208.8

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .++|++++.||+|+||+||+|.+..         +|..||||+++.... ....+.+|+.+|+.++|||||++++++.++
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~---------~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~   73 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETS---------SKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESM   73 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred             ccceEEEEEEecCCCeEEEEEEECC---------CCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            3679999999999999999999876         788999999987653 335678999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCC--CCeEEcccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDAD--YNAKLSDFG  288 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~kL~DFG  288 (490)
                      +.+|||||||+||+|.++|...+ ..+++..++.++.||+.||.|||+.+   |+||||||+||||+.+  +.+||+|||
T Consensus        74 ~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG  149 (321)
T d1tkia_          74 EELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             TEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccc
Confidence            99999999999999999997653 36899999999999999999999988   9999999999999754  489999999


Q ss_pred             ccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCch
Q 011234          289 LAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKR  368 (490)
Q Consensus       289 ~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~  368 (490)
                      +++......   .....+||+.|+|||.+.+..|+.++|||||||++|+|++|..||...........+.  ....    
T Consensus       150 ~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~--~~~~----  220 (321)
T d1tkia_         150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM--NAEY----  220 (321)
T ss_dssp             TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCC----
T ss_pred             hhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hCCC----
Confidence            998764432   2234679999999999999999999999999999999999999997643221111110  0000    


Q ss_pred             hhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          369 RFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       369 ~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+        ........+.++.+||.+||..||.+|||+.|+++|
T Consensus       221 ~~--------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         221 TF--------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CC--------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CC--------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00        000001236789999999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.2e-52  Score=402.74  Aligned_cols=252  Identities=26%  Similarity=0.333  Sum_probs=208.2

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh---------hHHHHHHHHHHHhcCC-CCcee
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ---------GHKEWLAEVNFLGNLL-HPNLV  201 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~-HpnIv  201 (490)
                      ++|++.+.||+|+||+||+|++..         +|+.||||++......         ..+.+.+|+.+|++|. |||||
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~---------~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv   73 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKP---------TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   73 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             ccCEEceEEecCcCeEEEEEEECC---------CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeE
Confidence            579999999999999999999875         6789999998764321         1235788999999997 99999


Q ss_pred             ceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          202 KLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       202 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                      ++++++.+++..|||||||++|+|.++|...+  .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.
T Consensus        74 ~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCC
Confidence            99999999999999999999999999998765  6899999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhc------CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcch
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT------GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN  355 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~  355 (490)
                      +||+|||+++.......   ....+||+.|+|||++.+      ..++.++||||+||+||||++|+.||..........
T Consensus       149 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~  225 (277)
T d1phka_         149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR  225 (277)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence            99999999987754322   244689999999999864      356889999999999999999999997653222111


Q ss_pred             hHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          356 LVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .+..      ..        ..+........+.++.+||.+||+.||.+|||+.||+++
T Consensus       226 ~i~~------~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         226 MIMS------GN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHH------TC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHh------CC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            1110      00        001111122447899999999999999999999999876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=406.11  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=201.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC---hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG---LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      ++|++.+.||+|+||.||+|++....      +....||||+++...   ....++|.+|+.+|++++|||||+++|++.
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPS------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCC------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            57999999999999999999886432      234579999987653   234567899999999999999999999996


Q ss_pred             ecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccc
Q 011234          209 EDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFG  288 (490)
Q Consensus       209 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG  288 (490)
                      + +..++|||||++|+|.+++..... .+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus        82 ~-~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          82 T-PPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             e-cchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence            5 567899999999999998876533 6999999999999999999999988   9999999999999999999999999


Q ss_pred             ccccCCCCCCcc-eeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCCCcchhHHhhhcccCC
Q 011234          289 LAKDAPEDGKTH-VSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPNGEHNLVEWARPHLGD  366 (490)
Q Consensus       289 ~a~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~  366 (490)
                      +++......... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.......   ......     
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~-----  228 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKID-----  228 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH-----
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHH-----
Confidence            999875543332 2234568889999999999999999999999999999998 899996543221   111110     


Q ss_pred             chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          367 KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       367 ~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                              ........+..++..+.+||.+||+.||++|||+.+|++.|++.
T Consensus       229 --------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 --------KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --------TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                    00111122234468899999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=414.25  Aligned_cols=249  Identities=27%  Similarity=0.424  Sum_probs=206.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh---hhHHHHHHHHHHHh-cCCCCceeceeeEE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL---QGHKEWLAEVNFLG-NLLHPNLVKLVGYC  207 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~---~~~~~~~~E~~~l~-~l~HpnIv~l~~~~  207 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++++...   ...+.+..|+.++. .++|||||++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~---------t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKK---------TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECC---------CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            579999999999999999999875         788999999975421   23345677777765 68999999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccc
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDF  287 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DF  287 (490)
                      .+++..|||||||++|+|.+++....  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceecccc
Confidence            99999999999999999999997765  6889999999999999999999988   999999999999999999999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCc
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDK  367 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~  367 (490)
                      |+++......  ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+...       
T Consensus       148 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~-------  218 (320)
T d1xjda_         148 GMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD-------  218 (320)
T ss_dssp             TTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------
T ss_pred             chhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------
Confidence            9998664432  2234468999999999999999999999999999999999999999764322111111100       


Q ss_pred             hhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 011234          368 RRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMS-EVVET  414 (490)
Q Consensus       368 ~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~-evl~~  414 (490)
                             .+    .++...+.++.+||.+||..||.+||++. +|++|
T Consensus       219 -------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         219 -------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -------CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                   01    12333478899999999999999999995 77764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=413.92  Aligned_cols=254  Identities=22%  Similarity=0.258  Sum_probs=202.7

Q ss_pred             hcCCCcCc-eeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhc-CCCCceeceeeEEE
Q 011234          131 TRNFRPES-LLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGN-LLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~-~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~  208 (490)
                      .++|.+.. +||+|+||+||+|++..         +|..||||+++..     ..+.+|+.++.+ ++|||||+++++|.
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~   75 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKR---------TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYE   75 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETT---------TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECC---------CCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence            35788875 69999999999999875         6789999998643     456789998765 47999999999987


Q ss_pred             e----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC---CCC
Q 011234          209 E----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA---DYN  281 (490)
Q Consensus       209 ~----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~---~~~  281 (490)
                      +    +..+|||||||+||+|.++|..++...+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++.
T Consensus        76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~  152 (335)
T d2ozaa1          76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAI  152 (335)
T ss_dssp             EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCC
T ss_pred             ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccc
Confidence            6    457899999999999999998776667999999999999999999999988   999999999999975   567


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      +||+|||+|+.......   ....+||+.|||||++.+..|+.++|||||||+||+|++|+.||...........+..  
T Consensus       153 ~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~--  227 (335)
T d2ozaa1         153 LKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT--  227 (335)
T ss_dssp             EEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred             ccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH--
Confidence            99999999987654322   2346899999999999999999999999999999999999999975443222111100  


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ......        ..+........+.++.+||.+||+.||++|||+.|++++
T Consensus       228 ~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         228 RIRMGQ--------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             CCCSCS--------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhcCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            000000        000001112347889999999999999999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-52  Score=407.11  Aligned_cols=269  Identities=26%  Similarity=0.379  Sum_probs=213.5

Q ss_pred             HhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeE
Q 011234          129 LATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGY  206 (490)
Q Consensus       129 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~  206 (490)
                      +..++|++.+.||+|+||.||+|++...+..  ...++..||||+++.+.. ....++.+|+..+.++ +|||||+++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKD--KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcc--cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            3346799999999999999999987653221  123456899999987643 3456788999999888 79999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKG--------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTS  272 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~  272 (490)
                      |.+++..++|||||++|+|.++|....              ...+++..++.++.||+.||+|||+.+   ||||||||+
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~  164 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR  164 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence            999999999999999999999997553              235899999999999999999999988   999999999


Q ss_pred             ceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCCC
Q 011234          273 NILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRPN  351 (490)
Q Consensus       273 NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~~  351 (490)
                      |||++.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||......
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            99999999999999999987765544444455789999999999999999999999999999999998 68888654322


Q ss_pred             CcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          352 GEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       352 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      .   ......              ......++...+.++.+||.+||+.||++|||+.||++.|+.+.
T Consensus       245 ~---~~~~i~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 E---LFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             H---HHHHHH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H---HHHHHH--------------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            1   111111              01111223344788999999999999999999999999998763

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=402.85  Aligned_cols=268  Identities=25%  Similarity=0.352  Sum_probs=203.7

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|.+..         +|..||||+++....  ...+.+.+|+++|++++|||||++++++.+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~   72 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKL---------TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   72 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence            579999999999999999999876         678999999975532  224678899999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++.+|+||||+. +++.+++.......+++..++.++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          73 ENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             ccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCc
Confidence            999999999995 56666665555557999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh--hcccCC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA--RPHLGD  366 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~--~~~~~~  366 (490)
                      |+.......  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||......+....+...  .+....
T Consensus       149 a~~~~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         149 ARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             HHHHCCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceeccCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhh
Confidence            987644322  223457999999999887655 578999999999999999999999754322111111000  000000


Q ss_pred             chhhhhc------cCccccC---CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          367 KRRFYRL------LDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       367 ~~~~~~~------~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .......      .......   ......+.++.+||.+||..||.+|||+.|+++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000000      0000000   0011236789999999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-52  Score=408.14  Aligned_cols=263  Identities=24%  Similarity=0.282  Sum_probs=196.8

Q ss_pred             cCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhh-----HHHHHHHHHHHhcCCCCceeceeeEEEec
Q 011234          136 PESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQG-----HKEWLAEVNFLGNLLHPNLVKLVGYCIED  210 (490)
Q Consensus       136 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~-----~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  210 (490)
                      .+++||+|+||+||+|++..         +|+.||||+++......     .+.+.+|+.+|++++|||||++++++.++
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~   72 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKN---------TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   72 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSS---------CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             cceEeccCcCeEEEEEEECC---------CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC
Confidence            35789999999999998865         68899999987553322     23578999999999999999999999999


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcccccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLA  290 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a  290 (490)
                      +..|||||||.++++..++...  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        73 ~~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a  147 (299)
T d1ua2a_          73 SNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  147 (299)
T ss_dssp             TCCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             CceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccc
Confidence            9999999999887766554333  36888899999999999999999988   999999999999999999999999999


Q ss_pred             ccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--c---cc
Q 011234          291 KDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--P---HL  364 (490)
Q Consensus       291 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~---~~  364 (490)
                      +........  ....+||+.|+|||++.. ..|+.++|||||||++|||++|.+||......+....+....  +   .+
T Consensus       148 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~  225 (299)
T d1ua2a_         148 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW  225 (299)
T ss_dssp             STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            876543222  234689999999999875 468999999999999999999999997654322211111000  0   00


Q ss_pred             CCchhhhh-----ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          365 GDKRRFYR-----LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~-----~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ........     ..............+.++.+||.+||+.||++|||+.|+|+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00000000     000000000011236789999999999999999999999865

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=405.12  Aligned_cols=266  Identities=27%  Similarity=0.401  Sum_probs=216.5

Q ss_pred             hhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh-hhHHHHHHHHHHHhcC-CCCceeceeeEE
Q 011234          130 ATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL-QGHKEWLAEVNFLGNL-LHPNLVKLVGYC  207 (490)
Q Consensus       130 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~HpnIv~l~~~~  207 (490)
                      ..++|++.+.||+|+||.||+|.+...    ....++..||||+++.... ....++.+|+.++..+ +|||||++++++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~----~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGL----IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESS----SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEecc----ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            346789999999999999999987532    1123678999999986543 3455788999999999 699999999999


Q ss_pred             EecCceEEEEEecCCCCHHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 011234          208 IEDDQRLLVYEFMPRGSLENHLFRKG----------------SLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKT  271 (490)
Q Consensus       208 ~~~~~~~lv~E~~~~g~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp  271 (490)
                      .+.+..+||||||++|+|.+++....                ...+++..+..++.||+.||+|||+++   ||||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence            99999999999999999999997643                225889999999999999999999988   99999999


Q ss_pred             CceEEcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHh-CCCCCCCCCC
Q 011234          272 SNILLDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLT-GRRSMDKNRP  350 (490)
Q Consensus       272 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~ellt-G~~pf~~~~~  350 (490)
                      +|||++.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998766555555566789999999999999999999999999999999999 5555544332


Q ss_pred             CCcchhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          351 NGEHNLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       351 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .....  ...              ........+...+..+.+||.+||+.||.+|||+.+|++.|++.
T Consensus       254 ~~~~~--~~i--------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         254 DSKFY--KMI--------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SHHHH--HHH--------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHH--HHH--------------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            21111  111              01111122233478899999999999999999999999999753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=403.52  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=206.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcC-CCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNL-LHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~  209 (490)
                      ++|++.+.||+|+||.||+|.+..++       ....||||.+.... ....+.+.+|+++|.++ +|||||++++++.+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETT-------EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCC-------eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            57899999999999999999987632       12357888876442 23456789999999999 69999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRK--------------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      ++.+++||||+++|+|.++|...              ....+++..+..++.||+.||.|||+.+   |+||||||+|||
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL  159 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNIL  159 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEE
Confidence            99999999999999999999654              2346899999999999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCC-CCCCCCCCCcc
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRR-SMDKNRPNGEH  354 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~-pf~~~~~~~~~  354 (490)
                      ++.++.+||+|||+++.......   .....||..|+|||.+.+..|+.++|||||||++|||++|.. ||......   
T Consensus       160 ~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---  233 (309)
T d1fvra_         160 VGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---  233 (309)
T ss_dssp             ECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred             EcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---
Confidence            99999999999999986543221   223568999999999999999999999999999999999764 56543211   


Q ss_pred             hhHHhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          355 NLVEWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .+.....              .......+..++.++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       234 ~~~~~i~--------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         234 ELYEKLP--------------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHHGG--------------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHH--------------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111111              001112334457899999999999999999999999999987643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=399.81  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=205.5

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC-ChhhHHHHHHHHHHHhcCCCCceeceeeEEEe-cCceE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD-GLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE-DDQRL  214 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~  214 (490)
                      .++||+|+||+||+|++..++.      +...||||.++.. .....++|.+|+++|++++|||||+++|++.. ++..+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~------~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~  105 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  105 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC------EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceE
Confidence            5789999999999999865321      3457999999754 44456789999999999999999999999876 46889


Q ss_pred             EEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccccccCC
Q 011234          215 LVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAP  294 (490)
Q Consensus       215 lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~~~~  294 (490)
                      +|||||++|+|.+++.... ..+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++...
T Consensus       106 lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         106 VVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999999999999886553 36788889999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCCc--ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcccCCchhhhh
Q 011234          295 EDGKT--HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLGDKRRFYR  372 (490)
Q Consensus       295 ~~~~~--~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  372 (490)
                      .....  .......||+.|+|||++.+..++.++|||||||+||||++|..||.......  .......   ...     
T Consensus       182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~---~g~-----  251 (311)
T d1r0pa_         182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL---QGR-----  251 (311)
T ss_dssp             TTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TTC-----
T ss_pred             ccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH---cCC-----
Confidence            43222  22234578999999999999999999999999999999999888875432111  1111111   000     


Q ss_pred             ccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          373 LLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       373 ~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                            ....+..++.++.+||.+||+.||++||++.||+++|+.+.+
T Consensus       252 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         252 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                  001223346789999999999999999999999999988754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=399.96  Aligned_cols=269  Identities=25%  Similarity=0.397  Sum_probs=215.7

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~  206 (490)
                      .+..++|++.+.||+|+||.||+|.+....    ...++..||||+++... ......+.+|+.++++++|||||+++++
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~----~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVV----KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEE----TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcc----cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            344567899999999999999999885311    11145689999997653 3344568999999999999999999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRK--------GSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA  278 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~--------~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~  278 (490)
                      +..++..++|||||++|+|.+++...        ....+++..+..++.||+.||.|||+.+   |+||||||+||||+.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecC
Confidence            99999999999999999999988643        1235789999999999999999999988   999999999999999


Q ss_pred             CCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCC-CCCCCCCCCCcchhH
Q 011234          279 DYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGR-RSMDKNRPNGEHNLV  357 (490)
Q Consensus       279 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~-~pf~~~~~~~~~~~~  357 (490)
                      ++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||+||||++|. +||.......   ..
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~~  245 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VL  245 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HH
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence            9999999999998765544444445567999999999999999999999999999999999985 6665432211   11


Q ss_pred             HhhhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          358 EWARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       358 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      ...             .+.. ....+..++..+.+||.+||+.||++|||+.+|+++|+....
T Consensus       246 ~~i-------------~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFV-------------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHH-------------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-------------HhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111             0100 011223446889999999999999999999999999986533

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=396.40  Aligned_cols=274  Identities=24%  Similarity=0.328  Sum_probs=203.5

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcC---CCCceeceee
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNL---LHPNLVKLVG  205 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~HpnIv~l~~  205 (490)
                      .++|++++.||+|+||+||+|++...        +++.||||+++.....  ....+.+|+.+|+.|   +||||+++++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~   77 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN--------GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   77 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT--------TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC--------CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence            46899999999999999999998542        3668999998654221  123456677776655   7999999999


Q ss_pred             EEEe-----cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC
Q 011234          206 YCIE-----DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       206 ~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~  280 (490)
                      +|..     ....+++||||.++.+.... ......+++..++.++.||+.||+|||+++   ||||||||+|||++.++
T Consensus        78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          78 VCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             EEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTC
T ss_pred             eecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCC
Confidence            9864     34679999999876665443 344457899999999999999999999988   99999999999999999


Q ss_pred             CeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          281 NAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      .+||+|||+++.....   ......+||+.|||||++.+..|+.++|||||||++|||++|++||......+....+...
T Consensus       154 ~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~  230 (305)
T d1blxa_         154 QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV  230 (305)
T ss_dssp             CEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             Ceeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence            9999999998865432   2234578999999999999999999999999999999999999999765432221111110


Q ss_pred             hc-----ccCC----chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhccc
Q 011234          361 RP-----HLGD----KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ  419 (490)
Q Consensus       361 ~~-----~~~~----~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~l~  419 (490)
                      ..     .+..    ....+..........+....+..+.+||.+||+.||++|||+.|+++|  |+.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            00     0000    000000000111112233347889999999999999999999999986  44443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-51  Score=395.30  Aligned_cols=241  Identities=25%  Similarity=0.411  Sum_probs=199.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------hHHHHHHHHHHHhcCC--CCceece
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------GHKEWLAEVNFLGNLL--HPNLVKL  203 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--HpnIv~l  203 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||||++......      ....+.+|+.+|++++  |||||++
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~   74 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVS---------DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL   74 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECC---------CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEE
Confidence            579999999999999999999875         6789999998754221      1234668999999987  8999999


Q ss_pred             eeEEEecCceEEEEEecCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-CCC
Q 011234          204 VGYCIEDDQRLLVYEFMPR-GSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-DYN  281 (490)
Q Consensus       204 ~~~~~~~~~~~lv~E~~~~-g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-~~~  281 (490)
                      ++++.+.+..++||||+.+ +++.+++....  .+++..++.++.||+.||.|||+.+   |+||||||+|||++. ++.
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          75 LDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             EEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTE
T ss_pred             EEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCe
Confidence            9999999999999999976 67888877654  6899999999999999999999988   999999999999985 479


Q ss_pred             eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCC-CccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh
Q 011234          282 AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHL-TSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA  360 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~  360 (490)
                      +||+|||+|+.....    ..+..+||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     . +...
T Consensus       150 vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-i~~~  219 (273)
T d1xwsa_         150 LKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-IIRG  219 (273)
T ss_dssp             EEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-HHHC
T ss_pred             EEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-Hhhc
Confidence            999999999865432    2345689999999999987665 677999999999999999999996421     0 1000


Q ss_pred             hcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 RPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                        .                ..++...+.++.+||.+||..||++|||++|++++
T Consensus       220 --~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 --Q----------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             --C----------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --c----------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence              0                01122337889999999999999999999999976

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=396.99  Aligned_cols=271  Identities=25%  Similarity=0.358  Sum_probs=201.0

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHH--HHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWL--AEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~--~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|.+.+.||+|+||.||+|++           +|..||||+++....   +.+.  .|+..+..++|||||++++++.+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-----------~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~   68 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-----------RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-----------TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-----------CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEe
Confidence            5688899999999999999986           467899999975432   3333  45556678899999999999987


Q ss_pred             cC----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCceEEcCCC
Q 011234          210 DD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA-----EKPVIYRDFKTSNILLDADY  280 (490)
Q Consensus       210 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----~~~iiHrDlkp~NILl~~~~  280 (490)
                      ++    .+|||||||++|+|.++|.+.   .+++..++.++.|++.||.|||+..     .++||||||||+||||+.++
T Consensus        69 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~  145 (303)
T d1vjya_          69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred             CCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence            65    578999999999999999765   5899999999999999999999741     24599999999999999999


Q ss_pred             CeEEccccccccCCCCCCc--ceeeccccCCCCCCchhhhcCC------CCccccchhhHHHHHHHHhCCCCCCCCCCCC
Q 011234          281 NAKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTGH------LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG  352 (490)
Q Consensus       281 ~~kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~~------~~~~sDvwSlGvil~elltG~~pf~~~~~~~  352 (490)
                      .+||+|||+++........  ......+||+.|||||++.+..      ++.++|||||||+||||+||..||.......
T Consensus       146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~  225 (303)
T d1vjya_         146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence            9999999999876443222  1223568999999999987543      5778999999999999999998875433221


Q ss_pred             cchhHHhhh--cccCCc--hhhhhccCccccCCC-ChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcccc
Q 011234          353 EHNLVEWAR--PHLGDK--RRFYRLLDPRLEGHF-SIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQN  420 (490)
Q Consensus       353 ~~~~~~~~~--~~~~~~--~~~~~~~~~~l~~~~-~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~~  420 (490)
                      .... ....  ......  ......+++.+...+ +......+.+|+.+||+.||++|||+.||++.|+++..
T Consensus       226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         226 LPYY-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CTTT-TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchh-hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            1100 0000  000000  000111122221111 22346779999999999999999999999999988754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.5e-50  Score=390.77  Aligned_cols=266  Identities=22%  Similarity=0.315  Sum_probs=201.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh--hHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ--GHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++.          +|..||||+++.....  ..+.+.+|+.+|++++|||||++++++..
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~----------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~   71 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN----------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT   71 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET----------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeC----------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence            57999999999999999999874          4678999999765432  24678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ++..+++|||+.++.+..+....  ..+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||+
T Consensus        72 ~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          72 KKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             SSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             CCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccc
Confidence            99999999999776665554433  37999999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh--cc---
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR--PH---  363 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~--~~---  363 (490)
                      +........  ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....  +.   
T Consensus       147 a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~  224 (286)
T d1ob3a_         147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN  224 (286)
T ss_dssp             HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence            987644322  1233578999999999875 457899999999999999999999997643222111111000  00   


Q ss_pred             cCCchhh------hhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDKRRF------YRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~~~~------~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      +......      .....+.....+....+..+.+||.+||+.||++|||++|+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000000      00001111111223346789999999999999999999999865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=390.82  Aligned_cols=268  Identities=24%  Similarity=0.324  Sum_probs=200.6

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++++.||+|+||+||+|.+..         +|+.||||+++...  ....+.+.+|+.+|+.++|||||+++++|.
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~   87 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGR---------TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT   87 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETT---------TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence            4689999999999999999999875         68899999997543  233567889999999999999999999998


Q ss_pred             ecC------ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCe
Q 011234          209 EDD------QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNA  282 (490)
Q Consensus       209 ~~~------~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~  282 (490)
                      ..+      .+||||||| +.+|..++...   .+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~  160 (346)
T d1cm8a_          88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCEL  160 (346)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             cCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccc
Confidence            765      569999999 66787766543   6899999999999999999999988   9999999999999999999


Q ss_pred             EEccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhh
Q 011234          283 KLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWAR  361 (490)
Q Consensus       283 kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~  361 (490)
                      ||+|||+|+.....     .+..+||+.|+|||++.+ ..++.++|||||||++|+|++|++||................
T Consensus       161 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~  235 (346)
T d1cm8a_         161 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT  235 (346)
T ss_dssp             EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             ccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhcc
Confidence            99999999876432     234679999999999886 457899999999999999999999997653322211111000


Q ss_pred             ccc--------C-C-chhhhhccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhccc
Q 011234          362 PHL--------G-D-KRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET--LKPLQ  419 (490)
Q Consensus       362 ~~~--------~-~-~~~~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~--L~~l~  419 (490)
                      ...        . . .......+....   ........+..+.+||.+||..||.+|||+.|+|+|  |+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            000        0 0 000000000000   001112346789999999999999999999999987  55543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-48  Score=387.07  Aligned_cols=269  Identities=22%  Similarity=0.301  Sum_probs=200.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC-hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG-LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      +.+|++++.||+|+||+||+|++..         +|..||||++.... ....+.+.+|+.+|+.|+||||+++++++..
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~   77 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNV---------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA   77 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETT---------TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECC---------CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEee
Confidence            3579999999999999999998865         68899999997653 3345678899999999999999999999876


Q ss_pred             cC----ceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEc
Q 011234          210 DD----QRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLS  285 (490)
Q Consensus       210 ~~----~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~  285 (490)
                      ..    ..+++++|+.+|+|.+++...   .+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+
T Consensus        78 ~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~  151 (345)
T d1pmea_          78 PTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC  151 (345)
T ss_dssp             SSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEc
Confidence            53    234555666799999999754   5899999999999999999999988   9999999999999999999999


Q ss_pred             cccccccCCCCCCc-ceeeccccCCCCCCchhhh-cCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhcc
Q 011234          286 DFGLAKDAPEDGKT-HVSTRVMGTYGYAAPEYVM-TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPH  363 (490)
Q Consensus       286 DFG~a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~-~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~  363 (490)
                      |||+++........ ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||......+...........
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~  231 (345)
T d1pmea_         152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS  231 (345)
T ss_dssp             CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred             ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence            99999866433221 1224467999999999985 457789999999999999999999999765432221111111000


Q ss_pred             cCCc----------hhhhhccCccccC---CCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          364 LGDK----------RRFYRLLDPRLEG---HFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       364 ~~~~----------~~~~~~~~~~l~~---~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ....          .............   ......+.++.+||.+||..||.+|||+.|+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000          0000000000000   0011235689999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=384.98  Aligned_cols=270  Identities=23%  Similarity=0.292  Sum_probs=197.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh--hhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL--QGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+.+|+.+|+.++||||+++++++..
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~   80 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRK---------TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT   80 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCEEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeec
Confidence            579999999999999999999875         678999999865422  234678899999999999999999998865


Q ss_pred             --------cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCC
Q 011234          210 --------DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYN  281 (490)
Q Consensus       210 --------~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~  281 (490)
                              ++..|+|||||.++.+......  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.
T Consensus        81 ~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          81 KASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             ----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSC
T ss_pred             ccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCc
Confidence                    3467999999977665544332  336889999999999999999999988   999999999999999999


Q ss_pred             eEEccccccccCCCCCCc--ceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH
Q 011234          282 AKLSDFGLAKDAPEDGKT--HVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE  358 (490)
Q Consensus       282 ~kL~DFG~a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~  358 (490)
                      +||+|||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||...........+.
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~  235 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS  235 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHH
Confidence            999999999866543221  122335799999999998765 68999999999999999999999997643322222211


Q ss_pred             hhhcccCCc-------hhhhhccCccccCCCC-------hHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 011234          359 WARPHLGDK-------RRFYRLLDPRLEGHFS-------IKGSQKATQLAAQCLSRDPKARPRMSEVVETL  415 (490)
Q Consensus       359 ~~~~~~~~~-------~~~~~~~~~~l~~~~~-------~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L  415 (490)
                      .........       ................       ...+..+.+||.+||+.||++|||+.|+++|=
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence            111000000       0000000000000000       11256778999999999999999999999763

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=390.44  Aligned_cols=263  Identities=24%  Similarity=0.312  Sum_probs=196.3

Q ss_pred             CCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCceeceeeEEEec--
Q 011234          133 NFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLVKLVGYCIED--  210 (490)
Q Consensus       133 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--  210 (490)
                      +|+..++||+|+||+||+|++..         +|+.||||++..+..    ...+|+.+|++|+|||||+++++|...  
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~   87 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCD---------SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGE   87 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETT---------TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             CcEeeeEEeeCcCeEEEEEEECC---------CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCc
Confidence            58888999999999999999876         688999999976542    234699999999999999999998653  


Q ss_pred             ----CceEEEEEecCCCCHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEE
Q 011234          211 ----DQRLLVYEFMPRGSLENHLF-RKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKL  284 (490)
Q Consensus       211 ----~~~~lv~E~~~~g~L~~~l~-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL  284 (490)
                          .++|||||||+++.+..+.. ......+++..++.++.||+.||+|||+++   |+||||||+||||+.++ .+||
T Consensus        88 ~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl  164 (350)
T d1q5ka_          88 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKL  164 (350)
T ss_dssp             CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEE
T ss_pred             cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeE
Confidence                24789999997654333322 123447999999999999999999999988   99999999999999775 8999


Q ss_pred             ccccccccCCCCCCcceeeccccCCCCCCchhhhc-CCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh---
Q 011234          285 SDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMT-GHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA---  360 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~---  360 (490)
                      +|||+++.......   ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|++||......+....+...   
T Consensus       165 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         165 CDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT  241 (350)
T ss_dssp             CCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999987654322   234689999999998875 57899999999999999999999999765432211111000   


Q ss_pred             ------hcccCC--chhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          361 ------RPHLGD--KRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       361 ------~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                            ......  ...+................+.++.+||.+||..||++|||+.|+|+|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000000  000000000001111222347889999999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-47  Score=374.67  Aligned_cols=260  Identities=19%  Similarity=0.212  Sum_probs=200.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCcee-ceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPNLV-KLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~  210 (490)
                      ++|++.+.||+|+||+||+|++..         +|..||||++.....  ..++..|+++++.+.|+|++ .+.+++.+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~   75 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIA---------AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   75 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETT---------TTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECC---------CCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence            479999999999999999999865         678999999876532  24578899999999876654 555566777


Q ss_pred             CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEc---CCCCeEEccc
Q 011234          211 DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLD---ADYNAKLSDF  287 (490)
Q Consensus       211 ~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~kL~DF  287 (490)
                      +..++||||+ +++|.+.+.... ..+++..+..++.|++.||+|||+++   ||||||||+|||++   .+..+||+||
T Consensus        76 ~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          76 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             CEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeecc
Confidence            8889999999 667777665543 36899999999999999999999988   99999999999985   3557999999


Q ss_pred             cccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhh-h
Q 011234          288 GLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA-R  361 (490)
Q Consensus       288 G~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~-~  361 (490)
                      |+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||............... .
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~  230 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  230 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence            999876543221     1224568999999999999999999999999999999999999999765444332222111 0


Q ss_pred             cccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcc
Q 011234          362 PHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPL  418 (490)
Q Consensus       362 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l  418 (490)
                      .....       ..+.+    ...++.++.+||.+||..||++||++.++.+.|+.+
T Consensus       231 ~~~~~-------~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         231 KKMST-------PIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHS-------CHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCC-------ChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            00000       00001    112367899999999999999999999998888765

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=374.13  Aligned_cols=267  Identities=23%  Similarity=0.274  Sum_probs=206.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|..||||+++...  ......+.+|+.+|+.++|||||++++++.+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~---------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   72 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRE---------THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS   72 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETT---------TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCCEeeeEEecCcCeEEEEEEECC---------CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence            479999999999999999999875         67899999986543  2345678999999999999999999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEccccc
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSDFGL  289 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~DFG~  289 (490)
                      ....++|||++.+++|..++...+  .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.
T Consensus        73 ~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          73 DKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             SSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecch
Confidence            999999999999988888776554  6889999999999999999999988   99999999999999999999999999


Q ss_pred             cccCCCCCCcceeeccccCCCCCCchhhhcCC-CCccccchhhHHHHHHHHhCCCCCCCCCCCCc-chhHHhhhcc--cC
Q 011234          290 AKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGH-LTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGE-HNLVEWARPH--LG  365 (490)
Q Consensus       290 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~~~~sDvwSlGvil~elltG~~pf~~~~~~~~-~~~~~~~~~~--~~  365 (490)
                      ++........  .....+++.|+|||++.+.. ++.++|||||||++|||++|+.||........ ...+......  ..
T Consensus       148 a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  225 (292)
T d1unla_         148 ARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE  225 (292)
T ss_dssp             CEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             hhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence            9876543322  23346788999999987654 68999999999999999999999754322111 1111000000  00


Q ss_pred             Cchhhhhcc---------CccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          366 DKRRFYRLL---------DPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       366 ~~~~~~~~~---------~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      .........         ............+..+.+||.+||+.||.+|||++|||+|
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000000         0001111223446789999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-48  Score=383.99  Aligned_cols=257  Identities=28%  Similarity=0.364  Sum_probs=207.4

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCCh----hhHHHHHHHHHHHhcCCC-CceeceeeE
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGL----QGHKEWLAEVNFLGNLLH-PNLVKLVGY  206 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~H-pnIv~l~~~  206 (490)
                      ++|++++.||+|+||+||+|++..+.      .+|..||||+++....    ...+.+.+|+++|++++| |||++++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~------~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~   97 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGH------DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   97 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSST------TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccC------CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeee
Confidence            46999999999999999999885432      3788999999865421    223567789999999976 899999999


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeEEcc
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAKLSD  286 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~kL~D  286 (490)
                      +.+....++||||+.+|+|.+++...+  .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|
T Consensus        98 ~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_          98 FQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             eccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEee
Confidence            999999999999999999999998776  5778899999999999999999988   99999999999999999999999


Q ss_pred             ccccccCCCCCCcceeeccccCCCCCCchhhhcC--CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhccc
Q 011234          287 FGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG--HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHL  364 (490)
Q Consensus       287 FG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~  364 (490)
                      ||+++....... .......|++.|+|||.+.+.  .++.++|||||||+||||++|..||...........+....  .
T Consensus       173 FG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~  249 (322)
T d1vzoa_         173 FGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--L  249 (322)
T ss_dssp             SSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--H
T ss_pred             ccchhhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--c
Confidence            999987644322 223446899999999999754  46789999999999999999999997765443322221110  0


Q ss_pred             CCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 011234          365 GDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARP-----RMSEVVET  414 (490)
Q Consensus       365 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RP-----s~~evl~~  414 (490)
                      .            ....++...+.++.+||.+||..||.+||     |++|+++|
T Consensus       250 ~------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         250 K------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             H------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             c------------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            0            00112334588999999999999999999     48899865

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4e-47  Score=371.66  Aligned_cols=263  Identities=17%  Similarity=0.185  Sum_probs=209.4

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC-CceeceeeEEEe
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH-PNLVKLVGYCIE  209 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~  209 (490)
                      .++|++++.||+|+||+||+|++..         +|+.||||++.....  ...+.+|++++..|.| +||+.+++++..
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~---------~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~   72 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLL---------NNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE   72 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETT---------TTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence            4689999999999999999999875         678999999865432  2356778999999875 899999999999


Q ss_pred             cCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcC-----CCCeEE
Q 011234          210 DDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDA-----DYNAKL  284 (490)
Q Consensus       210 ~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~kL  284 (490)
                      ....++||||+ +++|.+++...+. .+++..+..++.|++.||.|||+.+   ||||||||+||||+.     ++.+||
T Consensus        73 ~~~~~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          73 GLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             CCccEEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEE
Confidence            99999999999 7899998876543 6899999999999999999999988   999999999999964     578999


Q ss_pred             ccccccccCCCCCCc-----ceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHh
Q 011234          285 SDFGLAKDAPEDGKT-----HVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEW  359 (490)
Q Consensus       285 ~DFG~a~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~  359 (490)
                      +|||+|+........     ......+||+.|||||++.+..++.++|||||||++|||++|..||..............
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            999999876433211     122346899999999999999999999999999999999999999976554433322211


Q ss_pred             hhcccCCchhhhhccCccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhccc
Q 011234          360 ARPHLGDKRRFYRLLDPRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVETLKPLQ  419 (490)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~L~~l~  419 (490)
                      ..... ......     .+    ...++.++.+|+..|+..+|++||++..+.+.|+.+.
T Consensus       228 i~~~~-~~~~~~-----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         228 IGEKK-QSTPLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHH-HHSCHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhcc-CCCChH-----Hh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11000 000000     01    1123678999999999999999999999988887653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.5e-47  Score=380.78  Aligned_cols=260  Identities=20%  Similarity=0.262  Sum_probs=199.8

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEec
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIED  210 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~  210 (490)
                      ++|++++.||+|+||+||+|++..         +|..||||+++...   .+.+.+|+.+|..+. ||||+++++++...
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~---------~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~  102 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINIT---------NNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP  102 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred             cCeEEEEEEecCcCeEEEEEEECC---------CCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence            579999999999999999999865         78899999997653   356889999999996 99999999999754


Q ss_pred             --CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCC-CeEEccc
Q 011234          211 --DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADY-NAKLSDF  287 (490)
Q Consensus       211 --~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~kL~DF  287 (490)
                        ...++|||||.+++|..+.     ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++ .+||+||
T Consensus       103 ~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DF  174 (328)
T d3bqca1         103 VSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDW  174 (328)
T ss_dssp             TTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCG
T ss_pred             CCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeeccc
Confidence              5689999999999987653     25899999999999999999999998   99999999999998655 6999999


Q ss_pred             cccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchh-H-H------
Q 011234          288 GLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNL-V-E------  358 (490)
Q Consensus       288 G~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~-~-~------  358 (490)
                      |+|+.......   ....+||+.|+|||.+.+. .++.++|||||||++|||++|+.||........... + .      
T Consensus       175 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~  251 (328)
T d3bqca1         175 GLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED  251 (328)
T ss_dssp             GGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHH
T ss_pred             ccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCch
Confidence            99987654322   2346799999999998765 579999999999999999999999975433211100 0 0      


Q ss_pred             ---hhh-cccCCchhhhhccC--------ccccCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          359 ---WAR-PHLGDKRRFYRLLD--------PRLEGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ---~~~-~~~~~~~~~~~~~~--------~~l~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                         +.. ........+.....        ...........+.++.+||.+||..||.+|||++|+|+|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000 00000000000000        001111112346789999999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-47  Score=379.95  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=192.6

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEEe
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCIE  209 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  209 (490)
                      ++|++++.||+|+||+||+|++..         +|..||||++....  ......+.+|+.+|++++|||||+++++|..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~---------t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~   87 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAV---------LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETT---------TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             CCeEEEEEeecCcCeEEEEEEECC---------CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEec
Confidence            579999999999999999999875         78899999997553  2334568899999999999999999999964


Q ss_pred             c------CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          210 D------DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       210 ~------~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      .      ..+|+|||||.+ ++.+.+.    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~k  159 (355)
T d2b1pa1          88 QKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_dssp             CCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             ccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCcccccccccccee
Confidence            3      578999999965 5555542    25889999999999999999999998   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHH-----
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVE-----  358 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~-----  358 (490)
                      |+|||+++......   ..+..+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.     
T Consensus       160 l~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~  236 (355)
T d2b1pa1         160 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT  236 (355)
T ss_dssp             ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             eechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccC
Confidence            99999988664432   2345679999999999999999999999999999999999999997543221111100     


Q ss_pred             ----hhhccc------------CCchhhhhccCccc---cCCCChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          359 ----WARPHL------------GDKRRFYRLLDPRL---EGHFSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       359 ----~~~~~~------------~~~~~~~~~~~~~l---~~~~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                          +.....            ..............   ........+.++.+||.+||..||++|||++|||+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                000000            00000000110000   001123347889999999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=379.43  Aligned_cols=264  Identities=24%  Similarity=0.347  Sum_probs=198.7

Q ss_pred             hcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCC--hhhHHHHHHHHHHHhcCCCCceeceeeEEE
Q 011234          131 TRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDG--LQGHKEWLAEVNFLGNLLHPNLVKLVGYCI  208 (490)
Q Consensus       131 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  208 (490)
                      .++|++++.||+|+||+||+|++..         +|+.||||++....  ....+.+.+|+.+|+.|+|||||++++++.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~---------~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~   87 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTK---------TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   87 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETT---------TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECC---------CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4679999999999999999999875         78899999997653  334567889999999999999999999986


Q ss_pred             ec-----CceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceEEcCCCCeE
Q 011234          209 ED-----DQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDADYNAK  283 (490)
Q Consensus       209 ~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NILl~~~~~~k  283 (490)
                      ..     ...++||+|+.+|+|.+++...   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        88 ~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~k  161 (348)
T d2gfsa1          88 PARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  161 (348)
T ss_dssp             SCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             eccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCcccccccccccc
Confidence            43     3446677788899999988543   5999999999999999999999988   99999999999999999999


Q ss_pred             EccccccccCCCCCCcceeeccccCCCCCCchhhhcC-CCCccccchhhHHHHHHHHhCCCCCCCCCCCCcchhHHhhhc
Q 011234          284 LSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTG-HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARP  362 (490)
Q Consensus       284 L~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~~~~sDvwSlGvil~elltG~~pf~~~~~~~~~~~~~~~~~  362 (490)
                      |+|||++......     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+.....
T Consensus       162 l~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~  236 (348)
T d2gfsa1         162 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  236 (348)
T ss_dssp             ECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999765322     2346789999999987765 568899999999999999999999976543222211111000


Q ss_pred             ccC--------C--chhhhhccCccccCC---CChHhHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 011234          363 HLG--------D--KRRFYRLLDPRLEGH---FSIKGSQKATQLAAQCLSRDPKARPRMSEVVET  414 (490)
Q Consensus       363 ~~~--------~--~~~~~~~~~~~l~~~---~~~~~~~~l~~Li~~cL~~dP~~RPs~~evl~~  414 (490)
                      ...        .  ...+...+.......   .....+.++.+||.+||..||.+|||+.|+|+|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            000        0  000000000000000   011236789999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.7e-42  Score=343.28  Aligned_cols=265  Identities=20%  Similarity=0.267  Sum_probs=193.3

Q ss_pred             cCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-----------CCce
Q 011234          132 RNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-----------HPNL  200 (490)
Q Consensus       132 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnI  200 (490)
                      .+|++++.||+|+||+||+|++..         +|..||||+++.+.. ..+.+.+|+.+|+.++           |+||
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~---------~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~i   82 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMV---------NNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHI   82 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETT---------TTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECC---------CCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCce
Confidence            359999999999999999999876         688999999986643 2356778888888775           5789


Q ss_pred             eceeeEEEec--CceEEEEEecCCCC-HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeecCCCCCceEE
Q 011234          201 VKLVGYCIED--DQRLLVYEFMPRGS-LENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHE-EAEKPVIYRDFKTSNILL  276 (490)
Q Consensus       201 v~l~~~~~~~--~~~~lv~E~~~~g~-L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~~~~iiHrDlkp~NILl  276 (490)
                      +++++++...  ...+++|+++..+. ............+++..+..++.||+.||.|||+ .+   |+||||||+||||
T Consensus        83 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll  159 (362)
T d1q8ya_          83 LKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLM  159 (362)
T ss_dssp             CCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEE
T ss_pred             EEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeee
Confidence            9999987654  45667777765543 3344444445578999999999999999999998 66   9999999999999


Q ss_pred             cCCCC------eEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHHHHHHhCCCCCCCCCC
Q 011234          277 DADYN------AKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRP  350 (490)
Q Consensus       277 ~~~~~------~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil~elltG~~pf~~~~~  350 (490)
                      +.++.      ++|+|||.+......     ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.....
T Consensus       160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            86654      999999999865432     2346799999999999999999999999999999999999999975433


Q ss_pred             CCcchhHHhh---hcccCCc-----------hhhh------hccCc----------cccCCCChHhHHHHHHHHHHhhhc
Q 011234          351 NGEHNLVEWA---RPHLGDK-----------RRFY------RLLDP----------RLEGHFSIKGSQKATQLAAQCLSR  400 (490)
Q Consensus       351 ~~~~~~~~~~---~~~~~~~-----------~~~~------~~~~~----------~l~~~~~~~~~~~l~~Li~~cL~~  400 (490)
                      ..........   ...++..           ..++      .....          .....+....+.++.+||.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            2211110000   0000000           0000      00000          001123455688999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 011234          401 DPKARPRMSEVVET  414 (490)
Q Consensus       401 dP~~RPs~~evl~~  414 (490)
                      ||.+|||++|+|+|
T Consensus       315 dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         315 DPRKRADAGGLVNH  328 (362)
T ss_dssp             STTTCBCHHHHHTC
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999976

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.3e-25  Score=204.08  Aligned_cols=170  Identities=15%  Similarity=0.121  Sum_probs=119.2

Q ss_pred             CCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChh------------------hHHHHHHHHHHHhcC
Q 011234          134 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQ------------------GHKEWLAEVNFLGNL  195 (490)
Q Consensus       134 y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~------------------~~~~~~~E~~~l~~l  195 (490)
                      +.+.+.||+|+||+||+|.+.          +|..||||+++.....                  .......|+..|.++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~----------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   71 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE----------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL   71 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET----------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             chhCCEeeeCcceEEEEEECC----------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc
Confidence            346789999999999999874          5778999987532110                  112345688999999


Q ss_pred             CCCceeceeeEEEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCceE
Q 011234          196 LHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNIL  275 (490)
Q Consensus       196 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~~~~iiHrDlkp~NIL  275 (490)
                      .|.+++..+++.    ..+++|||+++..+..         ++......++.|++.+|.|||+.+   |+||||||+|||
T Consensus        72 ~~~~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NIL  135 (191)
T d1zara2          72 QGLAVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  135 (191)
T ss_dssp             TTSSSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             cCCCcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhhee
Confidence            999999887653    2379999998765432         223345678999999999999988   999999999999


Q ss_pred             EcCCCCeEEccccccccCCCCCCcceeeccccCCCCCCchhhhcCCCCccccchhhHHHH
Q 011234          276 LDADYNAKLSDFGLAKDAPEDGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVL  335 (490)
Q Consensus       276 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~~~~sDvwSlGvil  335 (490)
                      ++++ .++|+|||+|.............+.+..    -.+ +....|+.++|+||+.--+
T Consensus       136 v~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         136 VSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             eeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence            9865 5999999999766432211100000000    001 1236788999999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.64  E-value=6.9e-08  Score=89.57  Aligned_cols=146  Identities=14%  Similarity=0.001  Sum_probs=96.4

Q ss_pred             HHhhcCCCcCceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeE
Q 011234          128 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGY  206 (490)
Q Consensus       128 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~  206 (490)
                      ......|++.+..+.++.+.||+...           .+..+.||............+.+|...|..|. +--+.+++.+
T Consensus        10 ~~~~~~~~~~~~~~G~s~~~v~rv~~-----------~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~   78 (263)
T d1j7la_          10 KKLIEKYRCVKDTEGMSPAKVYKLVG-----------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHF   78 (263)
T ss_dssp             HHHHTTSEEEECSCCCSSSEEEEEEC-----------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEE
T ss_pred             HHhhhceEEEEcCCCCCCCcEEEEEe-----------CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEE
Confidence            34445677777666566678998753           34467888876543333345677888877664 3335667777


Q ss_pred             EEecCceEEEEEecCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------------------
Q 011234          207 CIEDDQRLLVYEFMPRGSLENHLFRKGSLPLPWSIRMKIALGAAKGLAFLHEEA--------------------------  260 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--------------------------  260 (490)
                      ..+++..++||++++|.++.+.....    ..   ...++.+++..|..||+..                          
T Consensus        79 ~~~~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (263)
T d1j7la_          79 ERHDGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA  151 (263)
T ss_dssp             EEETTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred             EecCCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhh
Confidence            78888899999999988876544211    11   1223444555555555321                          


Q ss_pred             ------------------------------CCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          261 ------------------------------EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       261 ------------------------------~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                                                    ...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                          1227999999999999877666799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.00  E-value=1.3e-05  Score=73.23  Aligned_cols=73  Identities=21%  Similarity=0.111  Sum_probs=49.0

Q ss_pred             eccCC-ceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCC--CceeceeeEEEecCceEEE
Q 011234          140 LGEGG-FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLH--PNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       140 lG~G~-fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv  216 (490)
                      +..|. -+.||+....          .|..+++|........   .+..|+..|+.|..  --+.+++.+..+++..++|
T Consensus        18 ~~~G~s~~~v~r~~~~----------~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQ----------GRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             CSCTTSSCEEEEEECT----------TSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             cCCcccCCeEEEEEeC----------CCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            44444 3678987643          4556888986554322   35567777776642  2356677777888889999


Q ss_pred             EEecCCCCH
Q 011234          217 YEFMPRGSL  225 (490)
Q Consensus       217 ~E~~~~g~L  225 (490)
                      |++++|.++
T Consensus        85 ~~~i~G~~~   93 (255)
T d1nd4a_          85 LGEVPGQDL   93 (255)
T ss_dssp             EECCSSEET
T ss_pred             EEeeecccc
Confidence            999987655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=1.3e-05  Score=78.65  Aligned_cols=77  Identities=14%  Similarity=0.071  Sum_probs=46.9

Q ss_pred             CceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCC------C-hhhHHHHHHHHHHHhcCC-C--CceeceeeE
Q 011234          137 ESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHD------G-LQGHKEWLAEVNFLGNLL-H--PNLVKLVGY  206 (490)
Q Consensus       137 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~------~-~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~  206 (490)
                      .+.||.|....||++....         ++..|+||.-...      . .........|...|..+. +  ..+.+++. 
T Consensus        31 ~~eig~G~~N~vfrV~~~~---------~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~-  100 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQE---------HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY-  100 (392)
T ss_dssp             EEECCSSSSEEEEEEEC-------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE-
T ss_pred             EEEeCCCceEeEEEEEeCC---------CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE-
Confidence            3468999999999987654         4567889964321      1 111223456777776653 2  33455554 


Q ss_pred             EEecCceEEEEEecCCCC
Q 011234          207 CIEDDQRLLVYEFMPRGS  224 (490)
Q Consensus       207 ~~~~~~~~lv~E~~~~g~  224 (490)
                       .+++..++|||++.+..
T Consensus       101 -~d~~~~~lvmE~L~~~~  117 (392)
T d2pula1         101 -SDTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             -EETTTTEEEECCCTTSE
T ss_pred             -EcCCCCEEEEeccCCcc
Confidence             35567789999997654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.25  E-value=0.00033  Score=68.28  Aligned_cols=80  Identities=18%  Similarity=0.067  Sum_probs=51.0

Q ss_pred             ceeccCCceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCC-CCceeceeeEEEecCceEEE
Q 011234          138 SLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLL-HPNLVKLVGYCIEDDQRLLV  216 (490)
Q Consensus       138 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv  216 (490)
                      +.|+.|-.-.+|++.......  +.......|.+++.....  ......+|..+++.+. +.-..++++++.+    .+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~--~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYP--PIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSC--CSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEcCCccccceEEEEeCCCCc--cccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            568888899999998764321  112234567788765332  2234567888888876 4333466666532    689


Q ss_pred             EEecCCCCH
Q 011234          217 YEFMPRGSL  225 (490)
Q Consensus       217 ~E~~~~g~L  225 (490)
                      |||++|..|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.99  E-value=0.0013  Score=62.01  Aligned_cols=68  Identities=15%  Similarity=0.035  Sum_probs=43.3

Q ss_pred             ceEEEEEEEccCCCccccCCCCcEEEEEEecCCChhhHHHHHHHHHHHhcCCCCc-----eecee--eEEEecCceEEEE
Q 011234          145 FGCVFKGWVEENGTAPVKPGTGLTVAVKTLNHDGLQGHKEWLAEVNFLGNLLHPN-----LVKLV--GYCIEDDQRLLVY  217 (490)
Q Consensus       145 fg~Vy~~~~~~~~~~~~~~~~g~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-----Iv~l~--~~~~~~~~~~lv~  217 (490)
                      --.||++...          +|..|++|+.+... ....++..|...|..|....     .+..-  ..+...+..+.++
T Consensus        35 EN~vy~v~~~----------dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~  103 (325)
T d1zyla1          35 ENRVYQFQDE----------DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF  103 (325)
T ss_dssp             SSEEEEECCT----------TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred             cceeEEEEcC----------CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEE
Confidence            3589998764          46679999986542 34466778888887764222     12211  1234456778899


Q ss_pred             EecCCC
Q 011234          218 EFMPRG  223 (490)
Q Consensus       218 E~~~~g  223 (490)
                      ++++|.
T Consensus       104 ~~~~G~  109 (325)
T d1zyla1         104 PSVGGR  109 (325)
T ss_dssp             ECCCCE
T ss_pred             eecCCc
Confidence            999764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.32  E-value=0.013  Score=54.41  Aligned_cols=31  Identities=29%  Similarity=0.259  Sum_probs=27.1

Q ss_pred             CCCeeecCCCCCceEEcCCCCeEEccccccc
Q 011234          261 EKPVIYRDFKTSNILLDADYNAKLSDFGLAK  291 (490)
Q Consensus       261 ~~~iiHrDlkp~NILl~~~~~~kL~DFG~a~  291 (490)
                      +.++||+|+.++|||++.+...-|+||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3569999999999999988777899999774